PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hoashi, T; Sato, S; Yamaguchi, Y; Passeron, T; Tamaki, K; Hearing, VJ				Hoashi, Toshihiko; Sato, Shinichi; Yamaguchi, Yuji; Passeron, Thierry; Tamaki, Kunihiko; Hearing, Vincent J.			Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein	FASEB JOURNAL			English	Article						ectodomain shedding; glycosylation; phorbol ester	MALIGNANT-MELANOMA; DESMOPLASTIC MELANOMA; PRECURSOR PROTEIN; REPEAT DOMAIN; EXPRESSION; PMEL17; CLEAVAGE; OSTEOACTIVIN; ECTODOMAIN; MEMBRANE	Melanosomes are organelles specialized for the production of melanin pigment and are specifically produced by melanocytic cells. More than 150 pigmentation-related genes have been identified, including glycoprotein nonmetastatic melanoma protein b (GPNMB). A recent proteomics analysis revealed that GPNMB is localized in melanosomes, and GPNMB is a membrane-bound glycoprotein that shows high homology with a well-known melanosomal structural protein, Pmel17/gp100. In this study, we show that GPNMB is expressed in melanocytes of normal human skin, as well as in human melanoma cells. GPNMB is heavily glycosylated and is enriched in mature (stage III and IV) melanosomes in contrast to MART-1 and Pmel17, which are abundant in early (stage I and II) melanosomes. MART-1 and Pmel17 play critical roles in the maturation of early melanosomes; thus, we speculate that GPNMB might be important in the functions of late melanosomes, possibly their transport and/or transfer to keratinocytes. We also demonstrate that a secreted form of GPNMB is released by ectodomain shedding from the largely Golgi-modified form of GPNMB and that the PKC and Ca2+ intracellular signaling pathways regulate that shedding. We conclude that GPNMB is a melanosomal protein that is released by proteolytic ectodomain shedding and might be a useful and specific histological marker of melanocytic cells.-Hoashi, T., Sato, S., Yamaguchi, Y., Passeron, T., Tamaki, K., Hearing, V. J. Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein. FASEB J. 24, 1616-1629 (2010). www.fasebj.org	[Hoashi, Toshihiko; Yamaguchi, Yuji; Passeron, Thierry; Hearing, Vincent J.] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Hoashi, Toshihiko; Sato, Shinichi; Tamaki, Kunihiko] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 113, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Tokyo	Hearing, VJ (corresponding author), NCI, Cell Biol Lab, NIH, Bldg 37,Rm 2132, Bethesda, MD 20892 USA.	thoashi-tky@umin.ac.jp; hearingv@nih.gov	Yamaguchi, Yuji/X-6681-2019; Yamaguchi, Yuji/B-9312-2008	Passeron, Thierry/0000-0002-0797-6570; Yamaguchi, Yuji/0000-0003-4338-2662	Shiseido grant for science research; U.S. National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010785] Funding Source: NIH RePORTER	Shiseido grant for science research; U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully thank Dr. Michael S. Marks (University of Pennsylvania, Philadelphia, PA, USA) for kindly providing the Pmel17-i vector. This work was largely supported by a Shiseido grant for science research (T.H.) and in part by the Intramural Research Program of the U.S. National Institutes of Health, National Cancer Institute.	Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; Aisner DL, 2005, HUM PATHOL, V36, P1016, DOI 10.1016/j.humpath.2005.07.010; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Angles-Cano E, 2002, BIOL CHEM, V383, P93, DOI 10.1515/BC.2002.009; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; BAKKER ABH, 1994, J EXP MED, V179, P1005, DOI 10.1084/jem.179.3.1005; Basrur V, 2003, J PROTEOME RES, V2, P69, DOI 10.1021/pr025562r; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Bosserhoff AK, 1997, CANCER RES, V57, P3149; Boyle JL, 2002, ARCH PATHOL LAB MED, V126, P816; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Carlson JA, 2005, J AM ACAD DERMATOL, V52, P743, DOI 10.1016/j.jaad.2004.08.034; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; Diaz-Rodriguez E, 2000, BIOCHEM J, V346, P359, DOI 10.1042/0264-6021:3460359; Dlugosz A, 2002, J INVEST DERM SYMP P, V7, P17, DOI 10.1046/j.1523-1747.2002.19631.x; Dowdy JC, 1995, PHOTODERMATOL PHOTO, V11, P143, DOI 10.1111/j.1600-0781.1995.tb00156.x; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Harper DC, 2008, J BIOL CHEM, V283, P2307, DOI 10.1074/jbc.M708007200; Hoashi T, 2005, J BIOL CHEM, V280, P14006, DOI 10.1074/jbc.M413692200; Hoashi T, 2008, J DERMATOL, V35, P122, DOI 10.1111/j.1346-8138.2008.00427.x; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; Hoashi T, 2010, FASEB J, V24, P916, DOI 10.1096/fj.09-140921; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; ITO S, 1984, J CHROMATOGR, V311, P154, DOI 10.1016/S0378-4347(00)84702-7; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; King R, 1999, AM J PATHOL, V155, P731, DOI 10.1016/S0002-9440(10)65172-3; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KOBAYASHI T, 1994, J BIOL CHEM, V269, P29198; Kummer MP, 2009, J BIOL CHEM, V284, P2296, DOI 10.1074/jbc.M808904200; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; KWON BS, 1987, MOL BIOL MED, V4, P339; KWON BS, 1995, NUCLEIC ACIDS RES, V23, P154, DOI 10.1093/nar/23.1.154; Lambert DW, 2008, FEBS LETT, V582, P385, DOI 10.1016/j.febslet.2007.11.085; Le Borgne R, 2001, J CELL SCI, V114, P2831; Loftus SK, 2009, PIGM CELL MELANOMA R, V22, P99, DOI 10.1111/j.1755-148X.2008.00518.x; MARESH GA, 1994, ARCH BIOCHEM BIOPHYS, V311, P95, DOI 10.1006/abbi.1994.1213; McGlinchey RP, 2009, P NATL ACAD SCI USA, V106, P13731, DOI 10.1073/pnas.0906509106; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Ogawa T, 2005, AM J PHYSIOL-CELL PH, V289, pC697, DOI 10.1152/ajpcell.00565.2004; Ohsie SJ, 2008, J CUTAN PATHOL, V35, P433, DOI 10.1111/j.1600-0560.2007.00891.x; ORLOW SJ, 1995, J INVEST DERMATOL, V105, P3, DOI 10.1111/1523-1747.ep12312291; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Qian XZ, 2008, MOL ONCOL, V2, P81, DOI 10.1016/j.molonc.2008.02.002; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sadhukhan R, 1998, P NATL ACAD SCI USA, V95, P138, DOI 10.1073/pnas.95.1.138; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; SCANU AM, 1995, BBA-LIPID LIPID MET, V1256, P1, DOI 10.1016/0005-2760(95)00012-2; SEIJI M, 1963, NATURE, V197, P1082, DOI 10.1038/1971082a0; Sheffield MV, 2002, AM J CLIN PATHOL, V118, P930, DOI 10.1092/AU8L65UJFQ75DVGC; Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Slominski A, 2002, ARCH PATHOL LAB MED, V126, P775; Slominski A, 2001, ARCH PATHOL LAB MED, V125, P1295; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomihari M, 2009, EXP DERMATOL, V18, P586, DOI 10.1111/j.1600-0625.2008.00830.x; Truschel ST, 2009, TRAFFIC, V10, P1318, DOI 10.1111/j.1600-0854.2009.00955.x; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; Valencia JC, 2006, J CELL SCI, V119, P1080, DOI 10.1242/jcs.02804; Valencia JC, 2007, J BIOL CHEM, V282, P11266, DOI 10.1074/jbc.M608449200; VOGEL AM, 1988, CANCER RES, V48, P1286; Watabe H, 2004, J BIOL CHEM, V279, P7971, DOI 10.1074/jbc.M309714200; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yasumoto K, 2004, J BIOL CHEM, V279, P28330, DOI 10.1074/jbc.M401269200	74	76	86	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1616	1629		10.1096/fj.09-151019	http://dx.doi.org/10.1096/fj.09-151019			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20056711	Green Published			2022-12-25	WOS:000277158900033
J	Iturrioz, X; Alvear-Perez, R; De Mota, N; Franchet, C; Guillier, F; Leroux, V; Dabire, H; Le Jouan, M; Chabane, H; Gerbier, R; Bonnet, D; Berdeaux, A; Maigret, B; Galzi, JL; Hibert, M; Llorens-Cortes, C				Iturrioz, Xavier; Alvear-Perez, Rodrigo; De Mota, Nadia; Franchet, Christel; Guillier, Fabrice; Leroux, Vincent; Dabire, Hubert; Le Jouan, Melissande; Chabane, Hadjila; Gerbier, Romain; Bonnet, Dominique; Berdeaux, Alain; Maigret, Bernard; Galzi, Jean-Luc; Hibert, Marcel; Llorens-Cortes, Catherine			Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist	FASEB JOURNAL			English	Article							NITRIC-OXIDE; ENDOGENOUS LIGAND; BIASED AGONISM; BLOOD-PRESSURE; APJ RECEPTOR; CORECEPTOR; PEPTIDE; VASOPRESSIN; INHIBITION; IMMUNOREACTIVITY	Apelin plays a prominent role in body fluid and cardiovascular homeostasis. To explore further upstream the role played by this peptide, nonpeptidic agonists and antagonists of the apelin receptor are required. To identify such compounds that do not exist to date, we used an original fluorescence resonance energy transfer-based assay to screen a G-protein-coupled receptor-focused library of fluorescent compounds on the human EGFP-tagged apelin receptor. This led to isolated E339-3D6 that displayed a 90 nM affinity and behaved as a partial agonist with regard to cAMP production and as a full agonist with regard to apelin receptor internalization. Finally, E339-3D6 induced vasorelaxation of rat aorta precontracted with noradrenaline and potently inhibited systemic vasopressin release in water-deprived mice when intracerebroventricularly injected. This compound represents the first nonpeptidic agonist of the apelin receptor, the optimization of which will allow development of a new generation of vasodilator and aquaretic agents.-Iturrioz, X., Alvear-Perez, R., De Mota, N., Franchet, C., Guillier, F., Leroux, V., Dabire, H., Le Jouan, M., Chabane, H., Gerbier, R., Bonnet, D., Berdeaux, A., Maigret, B., Galzi J.-L., Hibert, M., Llorens-Cortes, C. Identification and pharmacological properties of E339-3D6, FASEB J. 24, 1506-1517 (2010). www.fasebj.org	[Iturrioz, Xavier; Alvear-Perez, Rodrigo; De Mota, Nadia; Le Jouan, Melissande; Gerbier, Romain; Llorens-Cortes, Catherine] Univ Paris 06, INSERM, U691, Coll France, F-75005 Paris, France; [Franchet, Christel; Guillier, Fabrice; Chabane, Hadjila; Bonnet, Dominique; Galzi, Jean-Luc; Hibert, Marcel] Univ Strasbourg 1, CNRS, Fac Pharm, UMR 7175,LC1, Illkirch Graffenstaden, France; [Franchet, Christel; Guillier, Fabrice; Chabane, Hadjila; Bonnet, Dominique; Galzi, Jean-Luc; Hibert, Marcel] Ecole Biotechnol, Illkirch Graffenstaden, France; [Leroux, Vincent; Maigret, Bernard] H Poincare Univ, Fac 7503, CNRS, Unite Mixte Rech,Orpailleur Grp,Lab Lorrain Rech, Nancy, France; [Dabire, Hubert; Berdeaux, Alain] Univ Paris, Fac Med, INSERM, U955, Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Llorens-Cortes, C (corresponding author), Univ Paris 06, INSERM, U691, Coll France, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	c.llorens-cortes@college-de-france.fr	Llorens-Cortès, catherine/AAL-3893-2021; Bonnet, Dominique/N-7275-2014; Llorens-Cortes, Catherine/E-5839-2016; GERBIER, Romain/ABF-2481-2020; Iturrioz, Xavier/AAS-3555-2020; DABIRE, Hubert/G-5488-2018; ITURRIOZ, Xavier/Q-4406-2017	Llorens-Cortès, catherine/0000-0002-7667-0401; Bonnet, Dominique/0000-0002-8252-9199; Llorens-Cortes, Catherine/0000-0002-7667-0401; Iturrioz, Xavier/0000-0001-7143-8323; DABIRE, Hubert/0000-0002-5829-2718; ITURRIOZ, Xavier/0000-0001-7143-8323; DE MOTA, Nadia/0000-0003-3754-3722; Leroux, Vincent/0000-0002-4142-0883; Gerbier, Romain/0000-0003-4617-4850	Agence Nationale pour la Recherche Cardiovasculaire Obesite et Diabete [2005]; Societe Francaise d'Hypertension Arterielle; Ile de France Domaine d'Interet Majeur-Maladies Cardiovasculaires, Diabete et Obesite	Agence Nationale pour la Recherche Cardiovasculaire Obesite et Diabete(French National Research Agency (ANR)); Societe Francaise d'Hypertension Arterielle; Ile de France Domaine d'Interet Majeur-Maladies Cardiovasculaires, Diabete et Obesite	This work was supported by the Agence Nationale pour la Recherche Cardiovasculaire Obesite et Diabete 2005. X. I. was supported by a grant from the Societe Francaise d'Hypertension Arterielle. R. G. was supported by a grant from the Ile de France Domaine d'Interet Majeur-Maladies Cardiovasculaires, Diabete et Obesite. The authors declare no competing financial interests.	Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Azizi M, 2008, J AM SOC NEPHROL, V19, P1015, DOI 10.1681/ASN.2007070816; BASCANDS JL, 1993, MOL PHARMACOL, V44, P818; Berry MF, 2004, CIRCULATION, V110, pII187, DOI 10.1161/01.CIR.0000138382.57325.5c; Bonnet D, 2006, BIOCONJUGATE CHEM, V17, P1618, DOI 10.1021/bc060140j; Brailoiu GC, 2002, NEUROSCI LETT, V327, P193, DOI 10.1016/S0304-3940(02)00411-1; Choe H, 1998, J VIROL, V72, P6113, DOI 10.1128/JVI.72.7.6113-6118.1998; CORTES CL, 2008, Patent No. 1903052; De Mota N, 2000, NEUROENDOCRINOLOGY, V72, P400, DOI 10.1159/000054609; De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Edinger AL, 1998, J VIROL, V72, P7934, DOI 10.1128/JVI.72.10.7934-7940.1998; Evans NA, 2001, J NEUROCHEM, V77, P476, DOI 10.1046/j.1471-4159.2001.00269.x; Fan XJ, 2003, BIOCHEMISTRY-US, V42, P10163, DOI 10.1021/bi030049s; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; GALZI JL, 2003, Patent No. 2003107004; GALZI JL, 1998, Patent No. 199855873; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Hibert M., 2006, Patent, Patent No. [WO 2006003329 A1, 2006003329]; HIBERT M, 2006, Patent No. 2006003330; Hus-Citharel A, 2008, KIDNEY INT, V74, P486, DOI 10.1038/ki.2008.199; Ilien B, 2003, J NEUROCHEM, V85, P768, DOI 10.1046/j.1471-4159.2003.01717.x; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Iturrioz X, 2000, BIOCHEMISTRY-US, V39, P3061, DOI 10.1021/bi9925726; Japp AG, 2008, BIOCHEM PHARMACOL, V75, P1882, DOI 10.1016/j.bcp.2007.12.015; Katugampola SD, 2002, CAN J PHYSIOL PHARM, V80, P369, DOI 10.1139/Y02-029; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Lenkei Z, 2000, J HISTOCHEM CYTOCHEM, V48, P1553, DOI 10.1177/002215540004801112; MASRI B, 2004, FASEB J, V22, P22; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; Moon MJ, 2007, MOL CELL ENDOCRINOL, V277, P51, DOI 10.1016/j.mce.2007.07.008; O'Carroll AM, 2000, BBA-GENE STRUCT EXPR, V1492, P72, DOI 10.1016/S0167-4781(00)00072-5; O'Carroll AM, 2003, J NEUROENDOCRINOL, V15, P661, DOI 10.1046/j.1365-2826.2003.01044.x; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Puybasset L, 1996, CIRC RES, V79, P343, DOI 10.1161/01.RES.79.2.343; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reaux A, 2002, NEUROSCIENCE, V113, P653, DOI 10.1016/S0306-4522(02)00192-6; Reaux-Le Goazigo A, 2004, ENDOCRINOLOGY, V145, P4392, DOI 10.1210/en.2004-0384; Salcedo A, 2007, REGUL PEPTIDES, V144, P50, DOI 10.1016/j.regpep.2007.06.005; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Trochu JN, 1999, BRIT J PHARMACOL, V128, P69, DOI 10.1038/sj.bjp.0702797; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Vollmer JY, 1999, J BIOL CHEM, V274, P37915, DOI 10.1074/jbc.274.53.37915; Zeng XXI, 2007, DEV CELL, V12, P391, DOI 10.1016/j.devcel.2007.01.011; Zhong JC, 2007, CARDIOVASC RES, V74, P388, DOI 10.1016/j.cardiores.2007.02.002; Zhou NM, 2003, VIROLOGY, V317, P84, DOI 10.1016/j.virol.2003.08.026; Zhou NM, 2003, VIROLOGY, V312, P196, DOI 10.1016/S0042-6822(03)00185-5	54	86	100	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1506	1517		10.1096/fj.09-140715	http://dx.doi.org/10.1096/fj.09-140715			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20040517	Green Submitted			2022-12-25	WOS:000277158900023
J	Lai, IL; Lin, TP; Yao, YL; Lin, CY; Hsieh, MJ; Yang, WM				Lai, I-Lu; Lin, Tung-Ping; Yao, Ya-Li; Lin, Ching-Yi; Hsieh, Mei-Ju; Yang, Wen-Ming			Histone Deacetylase 10 Relieves Repression on the Melanogenic Program by Maintaining the Deacetylation Status of Repressors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WAARDENBURG-SYNDROME; TRANSCRIPTION FACTOR; IN-VIVO; PAX3; GENES; ACETYLATION; EXPRESSION; PROTEIN; HDAC10; MICROPHTHALMIA	HDAC10 belongs to the class II histone deacetylase family; however, its functions remain enigmatic. We report here that the HDAC10 protein complex contained deacetylated chaperone protein hsc70, and HDAC10 relieved repression of melanogenesis by decreasing the repressional activity of two transcriptional regulators, paired box protein 3 (Pax3) and KRAB-associated protein 1 (KAP1). HDAC10 physically interacted with Pax3 and KAP1 in a ternary complex and maintained Pax3 and KAP1 in a deacetylated state. Deacetylated Pax3 and KAP1 derepressed promoters of microphthalmia-associated transcription factor (MITF) and melanocyte-specific tyrosinase-related protein 1 and 2 (TRP-1 and TRP-2), three genes of the melanogenesis cascade, in a trichostatin A-sensitive manner. Co-occupancy of melanogenic promoters by HDAC10, Pax3, and KAP1 only happened in cells of the melanocyte lineage, and KAP1 facilitated nuclear enrichment of HDAC10. Finally, cellular melanin content correlated directly with the expression level and activity of HDAC10. Our results not only show that HDAC10 regulates melanogenesis but also demonstrate that the transcriptional activities of Pax3 and KAP1 are intimately linked to their acetylation status.	[Lai, I-Lu; Lin, Tung-Ping; Hsieh, Mei-Ju; Yang, Wen-Ming] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Yao, Ya-Li; Lin, Ching-Yi] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan; [Yao, Ya-Li; Lin, Ching-Yi] Asia Univ, Dept Bioinformat, Taichung 41354, Taiwan	National Chung Hsing University; Asia University Taiwan; Asia University Taiwan	Yang, WM (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, 250 Kuo Kuang Rd, Taichung 40227, Taiwan.	yangwm@mail.nchu.edu.tw		Yang, Wen-Ming/0000-0002-5871-5979	National Health Research Institutes [NHRI-9212SI]; National Science Council [NSC96-2311-B-005-006-MY3, NSC95-2311-B-468-001-MY3]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institutes Grant NHRI-9212SI (to W.- M. Y.) and by National Science Council Grants NSC96-2311-B-005-006-MY3 (to W.- M. Y.) and NSC95-2311-B-468-001-MY3 (to Y.- L. Y.).	Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; Fischer DD, 2002, J BIOL CHEM, V277, P6656, DOI 10.1074/jbc.M108055200; Galibert MD, 1999, J BIOL CHEM, V274, P26894, DOI 10.1074/jbc.274.38.26894; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Hsieh MJ, 2006, BIOCHEM BIOPH RES CO, V349, P573, DOI 10.1016/j.bbrc.2006.08.064; Jepsen K, 2002, J CELL SCI, V115, P689; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; KOBAYASHI T, 1995, J CELL SCI, V108, P2301; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Mayanil CSK, 2006, J BIOL CHEM, V281, P24544, DOI 10.1074/jbc.M512449200; Medugno L, 2005, GENE, V359, P35, DOI 10.1016/j.gene.2005.06.021; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Oka M, 1996, J INVEST DERMATOL, V106, P377, DOI 10.1111/1523-1747.ep12343168; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Osada H, 2004, INT J CANCER, V112, P26, DOI 10.1002/ijc.20395; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Tachibana M, 1999, J INVEST DERM SYMP P, V4, P126, DOI 10.1038/sj.jidsp.5640195; Tong JJ, 2002, NUCLEIC ACIDS RES, V30, P1114, DOI 10.1093/nar/30.5.1114; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Verastegui C, 2000, J BIOL CHEM, V275, P30757, DOI 10.1074/jbc.C000445200; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Watanabe A, 1998, NAT GENET, V18, P283, DOI 10.1038/ng0398-283; Yang WM, 2001, EMBO J, V20, P4814, DOI 10.1093/emboj/20.17.4814; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	37	32	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7187	7196		10.1074/jbc.M109.061861	http://dx.doi.org/10.1074/jbc.M109.061861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20032463	hybrid, Green Published			2022-12-25	WOS:000275415600032
J	Yang, YJ; Cimen, HY; Han, MJ; Shi, T; Deng, JH; Koc, H; Palacios, OM; Montier, L; Bai, YD; Tong, Q; Koc, EC				Yang, Yongjie; Cimen, Huseyin; Han, Min-Joon; Shi, Tong; Deng, Jian-Hong; Koc, Hasan; Palacios, Orsolya M.; Montier, Laura; Bai, Yidong; Tong, Qiang; Koc, Emine C.			NAD(+)-dependent Deacetylase SIRT3 Regulates Mitochondrial Protein Synthesis by Deacetylation of the Ribosomal Protein MRPL10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SMALL-SUBUNIT; IDENTIFICATION; HOMOLOG; ACETYLATION; GENE; BINDING; SITES; STALK; RNA	A member of the sirtuin family of NAD(+)-dependent deacetylases, SIRT3, is located in mammalian mitochondria and is important for regulation of mitochondrial metabolism, cell survival, and longevity. In this study, MRPL10 (mitochondrial ribosomal protein L10) was identified as the major acetylated protein in the mitochondrial ribosome. Ribosome-associated SIRT3 was found to be responsible for deacetylation of MRPL10 in an NAD(+)-dependent manner. We mapped the acetylated Lys residues by tandem mass spectrometry and determined the role of these residues in acetylation of MRPL10 by site-directed mutagenesis. Furthermore, we observed that the increased acetylation of MRPL10 led to an increase in translational activity of mitochondrial ribosomes in Sirt3(-/-) mice. In a similar manner, ectopic expression and knockdown of SIRT3 in C2C12 cells resulted in the suppression and enhancement of mitochondrial protein synthesis, respectively. Our findings constitute the first evidence for the regulation of mitochondrial protein synthesis by the reversible acetylation of the mitochondrial ribosome and characterize MRPL10 as a novel substrate of the NAD(+)-dependent deacetylase, SIRT3.	[Yang, Yongjie; Shi, Tong; Palacios, Orsolya M.; Tong, Qiang] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Cimen, Huseyin; Han, Min-Joon; Koc, Hasan; Koc, Emine C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Deng, Jian-Hong; Montier, Laura; Bai, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas Health San Antonio	Tong, Q (corresponding author), Baylor Coll Med, Childrens Nutr Res Ctr, 1100 Bates St,Rm 5076, Houston, TX 77030 USA.	qtong@bcm.edu; eck12@psu.edu	Bai, Yidong/A-4959-2012; Montier, Laura/AAA-2031-2021; Cimen, Huseyin/H-7272-2012	Cimen, Huseyin/0000-0003-0801-3554	National Institutes of Health [R01AG025223, R01DK075978, R01GM071034]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG025223 ( to Y. B.), R01DK075978 ( to Q. T.), and R01GM071034 ( to E. C. K.).	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Chintharlapalli SR, 2005, J CELL BIOCHEM, V94, P611, DOI 10.1002/jcb.20292; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Haque ME, 2008, MITOCHONDRION, V8, P254, DOI 10.1016/j.mito.2008.04.004; Hunter SE, 2004, BIOCHEMISTRY-US, V43, P6917, DOI 10.1021/bi036068j; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JACKSON PJ, 1986, BIOCHEM J, V235, P577, DOI 10.1042/bj2350577; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kissil JL, 1999, EMBO J, V18, P353, DOI 10.1093/emboj/18.2.353; Koc EC, 2000, J BIOL CHEM, V275, P32585, DOI 10.1074/jbc.M003596200; Koc EC, 1999, BIOCHEM BIOPH RES CO, V266, P141, DOI 10.1006/bbrc.1999.1785; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Koc EC, 2001, PROTEIN SCI, V10, P471, DOI 10.1110/ps.35301; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Landry J, 2003, METHODS, V31, P33, DOI 10.1016/S1046-2023(03)00085-9; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Miller JL, 2008, PROTEIN SCI, V17, P251, DOI 10.1110/ps.073185608; Miller JL, 2009, J PROTEOME RES, V8, P4789, DOI 10.1021/pr9004844; O'Brien TW, 2005, GENE, V354, P147, DOI 10.1016/j.gene.2005.03.026; O'Brien TW, 1999, J BIOL CHEM, V274, P36043, DOI 10.1074/jbc.274.51.36043; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shao ZH, 2003, PHARMACOL RES, V47, P463, DOI 10.1016/S1043-6618(03)00041-0; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Soung GY, 2009, J PROTEOME RES, V8, P3390, DOI 10.1021/pr900042e; Spremulli Linda L, 2007, Methods Mol Biol, V372, P265, DOI 10.1007/978-1-59745-365-3_19; Suzuki T, 2001, J BIOL CHEM, V276, P21724, DOI 10.1074/jbc.M100432200; Wahl MC, 2002, CURR PROTEIN PEPT SC, V3, P93, DOI 10.2174/1389203023380756; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; Woriax VL, 1997, BBA-GENE STRUCT EXPR, V1352, P91, DOI 10.1016/S0167-4781(97)00002-X; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yoo YA, 2005, MOL CELL BIOL, V25, P6603, DOI 10.1128/MCB.25.15.6603-6616.2005; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zanotto E, 2008, BBA-MOL CELL RES, V1783, P2352, DOI 10.1016/j.bbamcr.2008.08.001; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200	50	121	134	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7417	7429		10.1074/jbc.M109.053421	http://dx.doi.org/10.1074/jbc.M109.053421			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042612	Green Published, hybrid			2022-12-25	WOS:000275415600054
J	Malnou, CE; Brockly, F; Favard, C; Moquet-Torcy, G; Piechaczyk, M; Jariel-Encontre, I				Malnou, Cecile E.; Brockly, Frederique; Favard, Cyril; Moquet-Torcy, Gabriel; Piechaczyk, Marc; Jariel-Encontre, Isabelle			Heterodimerization with Different Jun Proteins Controls c-Fos Intranuclear Dynamics and Distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY GENE-PRODUCTS; LIVING CELLS; ANDROGEN RECEPTOR; DNA-BINDING; TRANSCRIPTIONAL ACTIVITY; PROTEASOMAL DEGRADATION; NUCLEAR TRANSLOCATION; G0-TO-G1 TRANSITION; MOUSE FIBROBLASTS; LAMIN A/C	The c-Fos proto-oncogenic transcription factor defines a multigene family controlling many processes both at the cell and the whole organism level. To bind to its target AP-1/12-O-tetradecanoylphorbol-13-acetate-responsive element or cAMP-responsive element DNA sequences in gene promoters and exert its transcriptional part, c-Fos must heterodimerize with other bZip proteins, its best studied partners being the Jun proteins (c-Jun, JunB, and JunD). c-Fos expression is regulated at many transcriptional and post-transcriptional levels, yet little is known on how its localization is dynamically regulated in the cell. Here we have investigated its intranuclear mobility using fluorescence recovery after photobleaching, genetic, and biochemical approaches. Whereas monomeric c-Fos is highly mobile and distributed evenly with nucleolar exclusion in the nucleus, heterodimerization with c-Jun entails intranuclear redistribution and dramatic reduction in mobility of c-Fos caused by predominant association with the nuclear matrix independently of any binding to AP-1/12-O-tetradecanoylphorbol-13-acetate-responsive element or cAMP-responsive element sequences. In contrast to c-Jun, dimerization with JunB does not detectably affect c-Fos mobility. However, dimerization with JunB affects intranuclear distribution with significant differences in the localization of c-Fos.c-Jun and c-Fos.JunB dimers. Moreover, c-Jun and JunB exert comparable effects on another Fos family member, Fra-1. Thus, we report a novel regulation, i.e. differentially regulated intranuclear mobility and distribution of Fos proteins by their Jun partners, and suggest the existence of intranuclear storage sites for latent c-Fos.c-Jun AP-1 complexes. This may affect the numerous physiopathological functions these transcription factors control.	[Malnou, Cecile E.; Brockly, Frederique; Moquet-Torcy, Gabriel; Piechaczyk, Marc; Jariel-Encontre, Isabelle] CNRS, IGMM, UMR5535, F-34293 Montpellier 5, France; [Malnou, Cecile E.; Brockly, Frederique; Moquet-Torcy, Gabriel; Piechaczyk, Marc; Jariel-Encontre, Isabelle] Univ Montpellier 2, F-34095 Montpellier 5, France; [Malnou, Cecile E.; Brockly, Frederique; Moquet-Torcy, Gabriel; Piechaczyk, Marc; Jariel-Encontre, Isabelle] Univ Montpellier 1, F-34967 Montpellier 2, France; [Favard, Cyril] Aix Marseille Univ, Ecole Cent Marseille, CNRS, UMR6133,Inst Fresnel, F-13013 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Jariel-Encontre, I (corresponding author), CNRS, IGMM, UMR5535, 1919 Route Mende, F-34293 Montpellier 5, France.	marc.piechaczyk@igmm.cnrs.fr; isabelle.jariel@igmm.cnrs.fr	PIECHACZYK, Marc/E-7896-2013; Favard, Cyril/P-6392-2016; MALNOU, Cécile/O-9970-2019; MALNOU, Cécile E/K-1569-2014	PIECHACZYK, Marc/0000-0003-1367-2597; Favard, Cyril/0000-0002-8304-2980; MALNOU, Cécile/0000-0002-1223-0247; MALNOU, Cécile E/0000-0002-1223-0247	ARC, Association pour la Recherche sur le Cancer; Agence Nationale de Recherches [ANR-08-BLAN-007-01]; French Ligue Nationale Contre le Cancer; CNRS	ARC, Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de Recherches(French National Research Agency (ANR)); French Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the ARC, Association pour la Recherche sur le Cancer, the Agence Nationale de Recherches (ANR-08-BLAN-007-01), the French Ligue Nationale Contre le Cancer, and by the CNRS.	Albrethsen J, 2009, J PROTEOMICS, V72, P71, DOI 10.1016/j.jprot.2008.09.005; Arnold M, 2006, J BIOL CHEM, V281, P5492, DOI 10.1074/jbc.M513281200; Basbous J, 2008, BIOCHIMIE, V90, P296, DOI 10.1016/j.biochi.2007.07.016; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bossis G, 2003, MOL CELL BIOL, V23, P7425, DOI 10.1128/MCB.23.20.7425-7436.2003; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Bussolino DF, 2001, FASEB J, V15, P556; Chalmers CJ, 2007, CELL SIGNAL, V19, P695, DOI 10.1016/j.cellsig.2006.09.001; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Christensen MO, 2004, J BIOL CHEM, V279, P21873, DOI 10.1074/jbc.M400498200; Damdimopoulos AE, 2008, ENDOCRINOLOGY, V149, P339, DOI 10.1210/en.2007-0198; DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Farla P, 2005, J CELL SCI, V118, P4187, DOI 10.1242/jcs.02546; Farla P, 2004, J STRUCT BIOL, V147, P50, DOI 10.1016/j.jsb.2004.01.002; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Ferrara P, 2003, ONCOGENE, V22, P1461, DOI 10.1038/sj.onc.1206266; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Gilley R, 2009, CELL SIGNAL, V21, P969, DOI 10.1016/j.cellsig.2009.02.006; Gomard T, 2008, BIOCHEM SOC T, V36, P858, DOI 10.1042/BST0360858; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Higashi N, 2004, GENES CELLS, V9, P233, DOI 10.1111/j.1356-9597.2004.00715.x; Houtsmuller AB, 2001, HISTOCHEM CELL BIOL, V115, P13, DOI 10.1007/s004180000234; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; JARIELENCONTRE I, 2008, TARGETED PROTEIN DAT, DOI DOI 10.2970/TPDB.2009.0218; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Karpova TS, 2004, EMBO REP, V5, P1064, DOI 10.1038/sj.embor.7400281; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; KOVARY K, 1992, MOL CELL BIOL, V12, P5015, DOI 10.1128/MCB.12.11.5015; KOVARY K, 1991, MOL CELL BIOL, V11, P2451, DOI 10.1128/MCB.11.5.2451; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Laricchia-Robbio L, 2005, P NATL ACAD SCI USA, V102, P14368, DOI 10.1073/pnas.0504014102; Lever E, 2010, J PATHOL, V220, P114, DOI 10.1002/path.2651; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Malnou CE, 2007, J BIOL CHEM, V282, P31046, DOI 10.1074/jbc.M702833200; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Mayr BM, 2005, J BIOL CHEM, V280, P15103, DOI 10.1074/jbc.M414144200; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; PIECHACZYK M, 1994, CRIT REV ONCOL HEMAT, V17, P93, DOI 10.1016/1040-8428(94)90021-3; Prufer K, 2008, EXP CELL RES, V314, P2652, DOI 10.1016/j.yexcr.2008.05.005; RANSONE LJ, 1990, P NATL ACAD SCI USA, V87, P3806, DOI 10.1073/pnas.87.10.3806; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D; ROUX P, 1994, C FOS C JUN FAMILIES, P87; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Schaaf MJM, 2006, J BIOL CHEM, V281, P22409, DOI 10.1074/jbc.M511086200; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SPECTOR DL, 1998, CELLS LAB MANUAL, V1; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; TRATNER I, 1991, ONCOGENE, V6, P2049; van Drogen Frank, 2004, Methods Mol Biol, V284, P287; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; VRIZ S, 1992, MOL CELL BIOL, V12, P3548, DOI 10.1128/MCB.12.8.3548; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338	72	26	27	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6552	6562		10.1074/jbc.M109.032680	http://dx.doi.org/10.1074/jbc.M109.032680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20053986	Green Published, hybrid			2022-12-25	WOS:000275367500060
J	Owens, L; Simanski, S; Squire, C; Smith, A; Cartzendafner, J; Cavett, V; Busby, JC; Sato, T; Ayad, NG				Owens, Laura; Simanski, Scott; Squire, Christopher; Smith, Anthony; Cartzendafner, Jeff; Cavett, Valerie; Busby, Jennifer Caldwell; Sato, Trey; Ayad, Nagi G.			Activation Domain-dependent Degradation of Somatic Wee1 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE OSCILLATOR; MITOTIC ENTRY; S PHASE; DNA; PHOSPHORYLATION; INHIBITION; G1; IDENTIFICATION; CHECKPOINT; P27(KIP1)	Cell cycle progression is dependent upon coordinate regulation of kinase and proteolytic pathways. Inhibitors of cell cycle transitions are degraded to allow progression into the subsequent cell cycle phase. For example, the tyrosine kinase and Cdk1 inhibitor Wee1 is degraded during G(2) and mitosis to allow mitotic progression. Previous studies suggested that the N terminus of Wee1 directs Wee1 destruction. Using a chemical mutagenesis strategy, we report that multiple regions of Wee1 control its destruction. Most notably, we find that the activation domain of the Wee1 kinase is also required for its degradation. Mutations in this domain inhibit Wee1 degradation in somatic cell extracts and in cells without affecting the overall Wee1 structure or kinase activity. More broadly, these findings suggest that kinase activation domains may be previously unappreciated sites of recognition by the ubiquitin proteasome pathway.	[Ayad, Nagi G.] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Cartzendafner, Jeff; Cavett, Valerie; Busby, Jennifer Caldwell] Scripps Florida, Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Squire, Christopher] Univ Auckland, Sch Biol Sci, Auckland 1001, New Zealand; [Squire, Christopher] Univ Auckland, Ctr Mol Biodiscovery, Auckland 1001, New Zealand; [Sato, Trey] Scripps Florida, Scripps Res Inst, Dept Biochem, Jupiter, FL 33458 USA	Scripps Research Institute; State University System of Florida; University of Florida; Scripps Research Institute; State University System of Florida; University of Florida; University of Auckland; University of Auckland; Scripps Research Institute; State University System of Florida; University of Florida	Ayad, NG (corresponding author), Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	nayad@scripps.edu		Squire, Christopher/0000-0001-9212-0461; Simanski, Scott/0000-0002-7594-5952	National Institutes of Health [1 R21 NS056991-01]; Landenberger Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Landenberger Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R21 NS056991-01. This work was also supported by a Landenberger Foundation grant (to N.G.A.).	Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Ayad NG, 2005, METHOD ENZYMOL, V399, P404, DOI 10.1016/S0076-6879(05)99028-9; COREY RB, 1953, REV SCI INSTRUM, V24, P621, DOI 10.1063/1.1770803; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; LI C, 2009, MOL CELL BIOL, V1, P116; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; McMillan JN, 2002, MOL BIOL CELL, V13, P3560, DOI 10.1091/mbc.E02-05-0283; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; Murakami MS, 2004, DEVELOPMENT, V131, P571, DOI 10.1242/dev.00971; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Smith A, 2007, CELL CYCLE, V6, P2795, DOI 10.4161/cc.6.22.4919; Squire CJ, 2005, STRUCTURE, V13, P541, DOI 10.1016/j.str.2004.12.017; TESSMAN I, 1964, J MOL BIOL, V9, P352, DOI 10.1016/S0022-2836(64)80212-6; Tominaga Y, 2006, INT J BIOL SCI, V2, P161; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Zhang GJ, 2004, NAT MED, V10, P643, DOI 10.1038/nm1047	29	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6761	6769		10.1074/jbc.M109.093237	http://dx.doi.org/10.1074/jbc.M109.093237			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20038582	Green Published, hybrid			2022-12-25	WOS:000275367500079
J	Allam, H; Ali, N				Allam, Heba; Ali, Naushad			Initiation Factor eIF2-independent Mode of c-Src mRNA Translation Occurs via an Internal Ribosome Entry Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C; MEDIATED TRANSLATION; VIRUS-RNA; EUKARYOTIC TRANSLATION; PROTEIN-SYNTHESIS; TYROSINE KINASES; PROSTATE-CANCER; CARCINOMA CELLS; CULTURED-CELLS; BREAST-CANCER	Overexpression and activation of the c-Src protein have been linked to the development of a wide variety of cancers. The molecular mechanism(s) of c-Src overexpression in cancer cells is not clear. We report here an internal ribosome entry site (IRES) in the c-Src mRNA that is constituted by both 5'-noncoding and -coding regions. The inhibition of cap-dependent translation by m(7)GDP in the cell-free translation system or induction of endoplasmic reticulum stress in hepatoma-derived cells resulted in stimulation of the c-Src IRES activities. Sucrose density gradient analyses revealed formation of a stable binary complex between the c-Src IRES and purified HeLa 40 S ribosomal subunit in the absence of initiation factors. We further demonstrate eIF2-independent assembly of 80 S initiation complex on the c-Src IRES. These features of the c-Src IRES appear to be reminiscent of that of hepatitis C virus-like IRESs and translation initiation in prokaryotes. Transfection studies and genetic analysis revealed that the c-Src IRES permitted initiation at the authentic AUG351, which is also used for conventional translation initiation of the c-Src mRNA. Our studies unveiled a novel regulatory mechanism of c-Src synthesis mediated by an IRES element, which exhibits enhanced activity during cellular stress and is likely to cause c-Src overexpression during oncogenesis and metastasis.	[Allam, Heba; Ali, Naushad] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA	University of Denver	Ali, N (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Digest Dis & Nutr, 975 NE 10th St,BRC W 1268A, Oklahoma City, OK 73104 USA.	naushad-ali@ouhsc.edu	Allam, Heba/AAC-9226-2019	Allam, Heba/0000-0003-3053-8066; Ali, Naushad/0000-0002-0058-7396	National Institutes of Health [R03AI063046]; Egyptian Student Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI063046] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Egyptian Student Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R03AI063046 (to N. A.).r Recipient of an Egyptian Student Fellowship.	Abbott CM, 2004, TRENDS BIOCHEM SCI, V29, P25, DOI 10.1016/j.tibs.2003.11.006; ALI N, 1995, J VIROL, V69, P6367, DOI 10.1128/JVI.69.10.6367-6375.1995; Ali N, 1997, P NATL ACAD SCI USA, V94, P2249, DOI 10.1073/pnas.94.6.2249; Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Barton DJ, 1996, METHOD ENZYMOL, V275, P35; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Bonham K, 2000, J BIOL CHEM, V275, P37604, DOI 10.1074/jbc.M004882200; BONHAM K, 1993, ONCOGENE, V8, P1973; Chang YM, 2007, NEOPLASIA, V9, P90, DOI 10.1593/neo.06694; Chao TSO, 1997, CANCER RES, V57, P3168; Chappell SA, 2000, ONCOGENE, V19, P4437, DOI 10.1038/sj.onc.1203791; Collier AJ, 1998, J GEN VIROL, V79, P2359, DOI 10.1099/0022-1317-79-10-2359; DAVIDPFEUTY T, 1993, J CELL SCI, V105, P613; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Filbin ME, 2009, CURR OPIN STRUC BIOL, V19, P267, DOI 10.1016/j.sbi.2009.03.005; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Fizazi K, 2007, ANN ONCOL, V18, P1765, DOI 10.1093/annonc/mdm086; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Giaccone G, 2008, ANN ONCOL, V19, P1219, DOI 10.1093/annonc/mdn048; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Horn S, 2003, ONCOGENE, V22, P7170, DOI 10.1038/sj.onc.1206856; Ito Y, 2001, J HEPATOL, V35, P68, DOI 10.1016/S0168-8278(01)00077-0; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Karni R, 2005, MOL CELL BIOL, V25, P5031, DOI 10.1128/MCB.25.12.5031-5039.2005; Kentsis A, 2005, RNA, V11, P1762, DOI 10.1261/rna.2238705; Kozak M, 2007, GENE, V403, P194, DOI 10.1016/j.gene.2007.08.017; Lancaster AM, 2006, RNA, V12, P894, DOI 10.1261/rna.2342306; Le SY, 1997, NUCLEIC ACIDS RES, V25, P362, DOI 10.1093/nar/25.2.362; Lewis SM, 2008, NUCLEIC ACIDS RES, V36, P168, DOI 10.1093/nar/gkm1007; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Michel YM, 2000, J BIOL CHEM, V275, P32268, DOI 10.1074/jbc.M004304200; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Murray KE, 2001, RNA, V7, P1126, DOI 10.1017/S1355838201010044; Naarmann IS, 2008, J BIOL CHEM, V283, P18461, DOI 10.1074/jbc.M710328200; Nanbru C, 1997, J BIOL CHEM, V272, P32061, DOI 10.1074/jbc.272.51.32061; Oneyama C, 2008, GENES CELLS, V13, P1, DOI 10.1111/j.1365-2443.2007.01145.x; Pestova TV, 2008, EMBO J, V27, P1060, DOI 10.1038/emboj.2008.49; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; REYNOLDS JE, 1995, EMBO J, V14, P6010, DOI 10.1002/j.1460-2075.1995.tb00289.x; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Seal R, 2005, NUCLEIC ACIDS RES, V33, P376, DOI 10.1093/nar/gki169; Semler BL, 2008, TRENDS MICROBIOL, V16, P1, DOI 10.1016/j.tim.2007.11.001; Serrels B, 2009, CARCINOGENESIS, V30, P249, DOI 10.1093/carcin/bgn278; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Soto Rifo R, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm682; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Vojtechova M, 2008, NEOPLASIA, V10, P99, DOI 10.1593/neo.07905; WANG CY, 1993, J VIROL, V67, P3338, DOI 10.1128/JVI.67.6.3338-3344.1993; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WONG WL, 1993, BIOCHEM J, V289, P71, DOI 10.1042/bj2890071; Yamamoto N, 2006, J CELL SCI, V119, P4623, DOI 10.1242/jcs.03236; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zoll WL, 2002, J BIOL CHEM, V277, P37079, DOI 10.1074/jbc.M207109200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	64	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5713	5725		10.1074/jbc.M109.029462	http://dx.doi.org/10.1074/jbc.M109.029462			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028973	hybrid, Green Published			2022-12-25	WOS:000275327200064
J	Fan, YH; Yu, Y; Shi, Y; Sun, WJ; Xie, M; Ge, NL; Mao, RF; Chang, A; Xu, GF; Schneider, MD; Zhang, H; Fu, SB; Qin, J; Yang, JH				Fan, Yihui; Yu, Yang; Shi, Yi; Sun, Wenjing; Xie, Min; Ge, Ningling; Mao, Renfang; Chang, Alex; Xu, Gufeng; Schneider, Michael D.; Zhang, Hong; Fu, Songbin; Qin, Jun; Yang, Jianhua			Lysine 63-linked Polyubiquitination of TAK1 at Lysine 158 Is Required for Tumor Necrosis Factor alpha- and Interleukin-1 beta-induced IKK/NF-kappa B and JNK/AP-1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-DEPENDENT KINASE; BETA SIGNAL-TRANSDUCTION; LYS63-LINKED POLYUBIQUITINATION; LIVER DEGENERATION; DEFICIENT MICE; IL-1; PROTEIN; PHOSPHORYLATION; PATHWAY; BINDING	Transforming growth factor-beta-activated kinase 1 (TAK1) plays an essential role in the tumor necrosis factor alpha (TNF alpha)- and interleukin-1 beta (IL-1 beta)-induced I kappa B kinase (IKK)/nuclear factor-kappa B (NF-kappa B) and c-Jun N-terminal kinase (JNK)/activator protein 1 (AP-1) activation. Here we report that TNF alpha and IL-1 beta induce Lys(63)-linked TAK1 polyubiquitination at the Lys(158) residue within the kinase domain. Tumor necrosis factor receptor-associated factors 2 and 6 (TRAF2 and -6) act as the ubiquitin E3 ligases to mediate Lys(63)-linked TAK1 polyubiquitination at the Lys(158) residue in vivo and in vitro. Lys(63)-linked TAK1 polyubiquitination at the Lys(158) residue is required for TAK1-mediated IKK complex recruitment. Reconstitution of TAK1-deficient mouse embryo fibroblast cells with TAK1 wild type or a TAK1 mutant containing a K158R mutation revealed the importance of this site in TNF alpha and IL-1 beta-mediated IKK/NF-kappa B and JNK/AP-1 activation as well as IL-6 gene expression. Our findings demonstrate that Lys(63)-linked polyubiquitination of TAK1 at Lys(158) is essential for its own kinase activation and its ability to mediate its downstream signal transduction pathways in response to TNF alpha and IL-1 beta stimulation.	[Yang, Jianhua] Baylor Coll Med, Dept Pediat, Dan L Duncan Canc Ctr, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Fan, Yihui; Yu, Yang; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin 150081, Peoples R China; [Mao, Renfang; Zhang, Hong] Baylor Coll Med, Dept Pathol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Shi, Yi; Qin, Jun] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Xie, Min; Schneider, Michael D.] Baylor Coll Med, Ctr Cardiovasc Dev, Dept Med, Houston, TX 77030 USA; [Schneider, Michael D.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England	Baylor College of Medicine; Texas Children's Cancer Center; Harbin Medical University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Imperial College London	Yang, JH (corresponding author), Baylor Coll Med, Dept Pediat, Dan L Duncan Canc Ctr, Texas Childrens Canc Ctr, 1 Baylor Plaza,BCM320,6621 Fannin St,MC3-3320, Houston, TX 77030 USA.	jianhuay@bcm.edu	Shi, Yi/P-7972-2018	Shi, Yi/0000-0002-2761-8324; Schneider, Michael/0000-0001-9645-1938; Xie, Min/0000-0002-2967-3490	National Institutes of Health; NCI [1R21CA106513-01A2]; American Cancer Society [RSG-06-070-01-TBE]; Virginia and L. E. Simmons Family Foundation; NATIONAL CANCER INSTITUTE [R21CA106513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Virginia and L. E. Simmons Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant 1R21CA106513-01A2 (to J.Y.). This work was also supported by American Cancer Society Grant RSG-06-070-01-TBE (to J.Y.) and a grant from the Virginia and L. E. Simmons Family Foundation Collaborative Research Fund (to J.Y.).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Carter RS, 2005, J BIOL CHEM, V280, P43272, DOI 10.1074/jbc.M508656200; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Davis RJ, 1999, BIOCHEM SOC SYMP, P1; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaur S, 2005, J BIOL CHEM, V280, P38599, DOI 10.1074/jbc.M505671200; Koga T, 2008, J BIOL CHEM, V283, P12546, DOI 10.1074/jbc.M710518200; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Prickett TD, 2008, J BIOL CHEM, V283, P19245, DOI 10.1074/jbc.M800943200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Rudolph D, 2000, GENE DEV, V14, P854; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sun WJ, 2009, CELL SIGNAL, V21, P1488, DOI 10.1016/j.cellsig.2009.05.007; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Thiefes A, 2006, EMBO REP, V7, P838, DOI 10.1038/sj.embor.7400754; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	51	123	128	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5347	5360		10.1074/jbc.M109.076976	http://dx.doi.org/10.1074/jbc.M109.076976			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20038579	Green Published, hybrid			2022-12-25	WOS:000275327200028
J	Ng, Y; Ramm, G; James, DE				Ng, Yvonne; Ramm, Georg; James, David E.			Dissecting the Mechanism of Insulin Resistance Using a Novel Heterodimerization Strategy to Activate Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT/PROTEIN-KINASE-B; 3T3-L1 ADIPOCYTES; RECEPTOR SUBSTRATE-1; GLUT4 TRANSLOCATION; 3-KINASE PATHWAY; SKELETAL-MUSCLE; PHOSPHORYLATION; GROWTH; CELLS; MICE	Insulin resistance can occur in response to many different external insults, including chronic exposure to insulin itself as well as other agonists such as dexamethasone. It is generally thought that such defects arise due to a defect(s) at an early stage in the insulin signaling cascade. One model suggests that this involves activation of the mammalian target of rapamycin/S6 kinase pathway, which inactivates insulin receptor substrate via Ser/Thr phosphorylation. However, we have recently shown that insulin receptor substrate is not a major node for insulin resistance defects. To explore the mechanism of insulin resistance, we have developed a novel system to activate Akt independently of its upstream effectors as well as other insulin-responsive pathways such as mitogen-activated protein kinase. 3T3-L1 adipocytes were rendered insulin-resistant either with chronic insulin or dexamethasone treatment, but conditional activation of Akt2 stimulated hemagglutinin-tagged glucose transporter 4 translocation to the same extent in these insulin-resistant and control cells. However, addition of insulin to cells in which Akt was conditionally activated resulted in a reversion to the insulin-resistant state, indicating a feedforward inhibitory mechanism activated by insulin itself. This effect was overcome with wortmannin, implicating a role for phosphatidylinositol 3-kinase in this inhibitory process. We conclude that in chronic insulin- and dexamethasone-treated cells, acute activation with insulin itself is required to activate a feedforward inhibitory pathway likely emanating from phosphatidylinositol 3-kinase that converges on a target downstream of Akt to cause insulin resistance.	[Ng, Yvonne; Ramm, Georg] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW 2010, Australia; [Ng, Yvonne; James, David E.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Ramm, Georg] Monash Univ, Sch Biomed Sci, Melbourne, Vic 3800, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; Monash University		d.james@garvan.org.au		Ramm, Georg/0000-0003-3596-2288; James, David/0000-0001-5946-5257	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia.	Adam RM, 2007, CANCER RES, V67, P6238, DOI 10.1158/0008-5472.CAN-07-0288; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Chen GL, 2004, J BIOL CHEM, V279, P39705, DOI 10.1074/jbc.C400171200; Cheng KKY, 2009, CELL METAB, V9, P417, DOI 10.1016/j.cmet.2009.03.013; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Ho PC, 2009, CELL METAB, V10, P516, DOI 10.1016/j.cmet.2009.09.012; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li JP, 1999, J BIOL CHEM, V274, P9351, DOI 10.1074/jbc.274.14.9351; Li MJ, 2005, METH MOL B, V309, P261; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Pirola L, 2003, J BIOL CHEM, V278, P15641, DOI 10.1074/jbc.M208984200; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Storz P, 2002, FRONT BIOSCI-LANDMRK, V7, pD886, DOI 10.2741/storz; Thomson MJ, 1997, J BIOL CHEM, V272, P7759, DOI 10.1074/jbc.272.12.7759; Tremblay F, 2001, J BIOL CHEM, V276, P38052; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Whiteman EL, 2003, ENDOCRINOLOGY, V144, P3811, DOI 10.1210/en.2003-0480; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8	36	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5232	5239		10.1074/jbc.M109.060632	http://dx.doi.org/10.1074/jbc.M109.060632			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022950	hybrid, Green Published			2022-12-25	WOS:000275327200016
J	Hallstrand, TS; Wurfel, MM; Lai, Y; Ni, ZL; Gelb, MH; Altemeier, WA; Beyer, RP; Aitken, ML; Henderson, WR				Hallstrand, Teal S.; Wurfel, Mark M.; Lai, Ying; Ni, Zhanglin; Gelb, Michael H.; Altemeier, William A.; Beyer, Richard P.; Aitken, Moira L.; Henderson, William R., Jr.			Transglutaminase 2, a Novel Regulator of Eicosanoid Production in Asthma Revealed by Genome-Wide Expression Profiling of Distinct Asthma Phenotypes	PLOS ONE			English	Article							AIRWAY INFLAMMATION; EXERCISE; GENES; IDENTIFICATION; METHACHOLINE; CHALLENGE; CHILDREN; A(2)	Background: A frequent manifestation of asthma, exercise-induced bronchoconstriction (EIB), occurs in 30-50% of asthmatics and is characterized by increased release of inflammatory eicosanoids. The objective of this study was to identify genes differentially expressed in EIB and to understand the function of these genes in the biology of asthma. Methodology/Principal Findings: Genome-wide expression profiling of airway leukocytes and epithelial cells obtained by induced sputum was conducted in two groups of subjects with asthma with and without EIB (n = 7 per group), at baseline and following exercise challenge. Based on the results of the gene expression study, additional comparisons were made with a normal control group (n = 10). Localization studies were conducted on epithelial brushings and biopsies from an additional group of asthmatics with EIB (n = 3). Genes related to epithelial repair and mast cell infiltration including beta-tryptase and carboxypeptidase A3 were upregulated by exercise challenge in the asthma group with EIB. A gene novel to asthma pathogenesis, transglutaminase 2 (TGM2), was the most differentially expressed at baseline between the groups. In vivo studies confirmed the increased expression of TGM2 in airway cells and airway lining fluid, and demonstrate that TGM2 is avidly expressed in the asthmatic airway epithelium. In vitro studies using recombinant human enzymes reveal that TGM2 augments the enzymatic activity of secreted phospholipase A2 (PLA(2)) group X (sPLA(2)-X), an enzyme recently implicated in asthma pathogenesis. Conclusions/Significance: This study found that TGM2, a mediator that is novel to asthma pathogenesis, is overexpressed in asthmatic airways and functions to increase sPLA(2)-X enzymatic activity. Since PLA(2) serves as the first rate-limiting step leading to eicosanoid formation, these results suggest that TGM2 may be a key initiator of the airway inflammatory cascade in asthma.	[Hallstrand, Teal S.; Wurfel, Mark M.; Lai, Ying; Altemeier, William A.; Aitken, Moira L.] Univ Washington, Div Pulm & Crit Care, Dept Med, Seattle, WA 98195 USA; [Henderson, William R., Jr.] Univ Washington, Div Allergy & Infect Dis, Dept Med, Seattle, WA 98195 USA; [Beyer, Richard P.] Univ Washington, Dept Environm Hlth, Seattle, WA 98195 USA; [Ni, Zhanglin; Gelb, Michael H.] Univ Washington, Dept Chem & Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hallstrand, TS (corresponding author), Univ Washington, Div Pulm & Crit Care, Dept Med, Seattle, WA 98195 USA.	tealh@u.washington.edu	Ni, Zhanglin/E-5175-2010	gelb, michael/0000-0001-7000-5219; Altemeier, William/0000-0001-8860-405X; Hallstrand, Teal/0000-0002-5059-6872	National Institutes of Health [R01HL089215, R01HL072370, R01HL036253, M01RR000037, P30ES07033]; American Lung Association Career Investigator Award [CI-22138-N]; Royalty Research Fund; National Center for Research Resources [1S10RR019423-01, 1S10RR021108-01]; M.J. Murdoch Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019423, M01RR000037, S10RR021108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089215, R01HL072370, R01HL086883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association Career Investigator Award; Royalty Research Fund; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); M.J. Murdoch Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by National Institutes of Health grants R01HL089215, R01HL072370, R01HL036253, M01RR000037, and P30ES07033, an American Lung Association Career Investigator Award CI-22138-N, and a Royalty Research Fund grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Microarray assays were performed at the Center for Array Technologies (CAT) at the University of Washington. The CAT resources were partially funded under the following grants from the National Institutes of Health, National Center for Research Resources 1S10RR019423-01 and 1S10RR021108-01 and an initial grant from the M.J. Murdoch Charitable Trust.	Anderson SD, 2000, J ALLERGY CLIN IMMUN, V106, P453, DOI 10.1067/mai.2000.109822; Anderson SD, 2002, J ALLERGY CLIN IMMUN, V109, P771, DOI 10.1067/mai.2002.123644; Antonyak MA, 2006, P NATL ACAD SCI USA, V103, P18609, DOI 10.1073/pnas.0604844103; Cabral ALB, 1999, AM J RESP CRIT CARE, V159, P1819, DOI 10.1164/ajrccm.159.6.9805093; Carraro S, 2005, J ALLERGY CLIN IMMUN, V115, P764, DOI 10.1016/j.jaci.2004.10.043; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; EFTHIMIADIS A, 2002, EUR RESPIR J, V37, P19; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hallstrand TS, 2007, AM J RESP CRIT CARE, V176, P1072, DOI 10.1164/rccm.200707-1088OC; Hallstrand TS, 2007, J ALLERGY CLIN IMMUN, V119, P1092, DOI 10.1016/j.jaci.2007.01.005; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P586, DOI 10.1016/j.jaci.2005.04.035; Hallstrand TS, 2005, AM J RESP CRIT CARE, V172, P679, DOI 10.1164/rccm.200412-1667OC; Hallstrand TS, 2002, J PEDIATR-US, V141, P343, DOI 10.1067/mpd.2002.125729; HALLSTRAND TS, 2009, ANN ALLERGY IN PRESS; HALLSTRAND TS, 2009, P AM THORAC SOC, V6, P325; HALLSTRAND TS, 2004, AM J RESP CRIT CARE, V167, pA16; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Henriksen AH, 2002, PEDIATR ALLERGY IMMU, V13, P203, DOI 10.1034/j.1399-3038.2002.01034.x; Hess A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-96; Holzer K, 2002, J ALLERGY CLIN IMMUN, V110, P374, DOI 10.1067/mai.2002.127784; Joos GF, 2003, EUR RESPIR J, V21, P1050, DOI 10.1183/09031936.03.00008403; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Kuperman DA, 2005, J ALLERGY CLIN IMMUN, V116, P305, DOI 10.1016/j.jaci.2005.03.024; Laprise C, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-21; Lee JM, 2004, J BIOL CHEM, V279, P53725, DOI 10.1074/jbc.M407627200; Lilly CM, 2005, AM J RESP CRIT CARE, V171, P579, DOI 10.1164/rccm.200404-532OC; Ma Y, 2003, ONCOGENE, V22, P4924, DOI 10.1038/sj.onc.1206728; Mickleborough TD, 2005, MED SCI SPORT EXER, V37, P904, DOI 10.1249/01.mss.0000166949.11296.2b; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sohn J, 2003, J CLIN INVEST, V111, P121, DOI 10.1172/JCI200315937; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Touaibia M, 2007, J MED CHEM, V50, P1618, DOI 10.1021/jm060082n; Triggiani M, 2005, J ALLERGY CLIN IMMUN, V116, P1000, DOI 10.1016/j.jaci.2005.08.011; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vianna EO, 2002, J ALLERGY CLIN IMMUN, V110, P236, DOI 10.1067/mai.2002.125981; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Wurfel MM, 2005, J IMMUNOL, V175, P2570, DOI 10.4049/jimmunol.175.4.2570; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	41	54	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8583	10.1371/journal.pone.0008583	http://dx.doi.org/10.1371/journal.pone.0008583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052409	Green Published, gold			2022-12-25	WOS:000273338500025
J	Kern, A; Ackermann, B; Clement, AM; Duerk, H; Behl, C				Kern, Andreas; Ackermann, Bianca; Clement, Albrecht M.; Duerk, Heike; Behl, Christian			HSF1-Controlled and Age-Associated Chaperone Capacity in Neurons and Muscle Cells of C. elegans	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CAENORHABDITIS-ELEGANS; STRESS-RESPONSE; AGGREGATION; TOXICITY; DISEASE; HSP70; INDUCTION; FACTOR-1; GENES	Protein stability under changing conditions is of vital importance for the cell and under the control of a fine-tuned network of molecular chaperones. Aging and age-related neurodegenerative diseases are directly associated with enhanced protein instability. Employing C. elegans expressing GFP-tagged luciferase as a reporter for evaluation of protein stability we show that the chaperoning strategy of body wall muscle cells and neurons is significantly different and that both are differently affected by aging. Muscle cells of young worms are largely resistant to heat stress, which is directly mediated by the stress response controlled through Heat Shock Transcription Factor 1. During recovery following heat stress the ability to refold misfolded proteins is missing. Young neurons are highly susceptible to chronic heat stress, but show a high potency to refold or disaggregate proteins during subsequent recovery. The particular proteome instability in neurons results from a delayed induction of the heat shock response. In aged neurons protein stability is increased during heat stress, whereas muscle cells show enhanced protein instability due to a deteriorated heat shock response. An efficient refolding activity is absent in both aged tissues. These results provide molecular insights into the differential protein stabilization capacity in different tissues and during aging.	[Kern, Andreas; Ackermann, Bianca; Clement, Albrecht M.; Duerk, Heike; Behl, Christian] Johannes Gutenberg Univ Mainz, Inst Pathobiochem, Univ Med Ctr, Mainz, Germany	Johannes Gutenberg University of Mainz	Kern, A (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pathobiochem, Univ Med Ctr, Mainz, Germany.	cbehl@uni-mainz.de		Behl, Christian/0000-0001-8453-2378	Fritz and Hildegard Berg-Foundation; Interdisciplinary Neuroscience Program of the Johannes Gutenberg-University	Fritz and Hildegard Berg-Foundation; Interdisciplinary Neuroscience Program of the Johannes Gutenberg-University	This work was supported by grants from the Fritz and Hildegard Berg-Foundation (to C.B.) and from the Interdisciplinary Neuroscience Program of the Johannes Gutenberg-University (to A.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Batulan Z, 2003, J NEUROSCI, V23, P5789; BENZVI A, 2009, P NATL ACAD SCI US; BRENNER S, 1974, GENETICS, V77, P71; Chang Hung-Chun, 2007, Cell, V128, P212; Chow AM, 2007, CELL STRESS CHAPERON, V12, P237, DOI 10.1379/CSC-269.1; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Dwyer DS, 1996, NEUROCHEM RES, V21, P659, DOI 10.1007/BF02527722; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Jolly C, 2002, J CELL BIOL, V156, P775, DOI 10.1083/jcb.200109018; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; MANZERRA P, 1993, J NEUROSCI RES, V36, P480, DOI 10.1002/jnr.490360414; Soti C, 2007, J BIOSCIENCES, V32, P511, DOI 10.1007/s12038-007-0050-z; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Tartaglia GG, 2007, TRENDS BIOCHEM SCI, V32, P204, DOI 10.1016/j.tibs.2007.03.005; Witan H, 2008, HUM MOL GENET, V17, P1373, DOI 10.1093/hmg/ddn025; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	25	35	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8568	10.1371/journal.pone.0008568	http://dx.doi.org/10.1371/journal.pone.0008568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052290	Green Submitted, gold, Green Published			2022-12-25	WOS:000273338500012
J	Igarashi, M; Ito, K; Yoshida, R; Tomabechi, D; Kida, H; Takada, A				Igarashi, Manabu; Ito, Kimihito; Yoshida, Reiko; Tomabechi, Daisuke; Kida, Hiroshi; Takada, Ayato			Predicting the Antigenic Structure of the Pandemic (H1N1) 2009 Influenza Virus Hemagglutinin	PLOS ONE			English	Article							SWINE; ORIGIN; VACCINE; SOLVATION; MUTATIONS; EVOLUTION; HUMANS; SITES; TOOLS	The pandemic influenza virus (2009 H1N1) was recently introduced into the human population. The hemagglutinin (HA) gene of 2009 H1N1 is derived from "classical swine H1N1'' virus, which likely shares a common ancestor with the human H1N1 virus that caused the pandemic in 1918, whose descendant viruses are still circulating in the human population with highly altered antigenicity of HA. However, information on the structural basis to compare the HA antigenicity among 2009 H1N1, the 1918 pandemic, and seasonal human H1N1 viruses has been lacking. By homology modeling of the HA structure, here we show that HAs of 2009 H1N1 and the 1918 pandemic virus share a significant number of amino acid residues in known antigenic sites, suggesting the existence of common epitopes for neutralizing antibodies cross-reactive to both HAs. It was noted that the early human H1N1 viruses isolated in the 1930s-1940s still harbored some of the original epitopes that are also found in 2009 H1N1. Interestingly, while 2009 H1N1 HA lacks the multiple N-glycosylations that have been found to be associated with an antigenic change of the human H1N1 virus during the early epidemic of this virus, 2009 H1N1 HA still retains unique three-codon motifs, some of which became N-glycosylation sites via a single nucleotide mutation in the human H1N1 virus. We thus hypothesize that the 2009 H1N1 HA antigenic sites involving the conserved amino acids will soon be targeted by antibody-mediated selection pressure in humans. Indeed, amino acid substitutions predicted here are occurring in the recent 2009 H1N1 variants. The present study suggests that antibodies elicited by natural infection with the 1918 pandemic or its early descendant viruses play a role in specific immunity against 2009 H1N1, and provides an insight into future likely antigenic changes in the evolutionary process of 2009 H1N1 in the human population.	[Igarashi, Manabu; Ito, Kimihito; Yoshida, Reiko; Tomabechi, Daisuke; Kida, Hiroshi; Takada, Ayato] Hokkaido Univ, Dept Global Epidemiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] Hokkaido Univ, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] OIE Reference Lab Highly Pathogen Avian Influenza, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Igarashi, M (corresponding author), Hokkaido Univ, Dept Global Epidemiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.	atakada@czc.hokudai.ac.jp	Kida, Hiroshi/F-7244-2012; Igarashi, Manabu/F-6871-2012; YOSHIDA, Reiko/F-6883-2012; Ito, Kimihito/E-9975-2012; Takada, Ayato/A-6679-2012	Ito, Kimihito/0000-0003-4986-1795; 	Japan Society for the Promotion of Science (JSPS) [19300041]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21780272, 05021011]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (B) (19300041) from the Japan Society for the Promotion of Science (JSPS), and for Young Scientists (B) (21780272) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (http://www. mext. go. jp/english/index. htm), and in part, by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases (05021011) from MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownlee GG, 2001, PHILOS T ROY SOC B, V356, P1871, DOI 10.1098/rstb.2001.1001; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; GALLAGHER P, 1988, J CELL BIOL, V107, P2059, DOI 10.1083/jcb.107.6.2059; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Hooft RWW, 1996, COMPUT APPL BIOSCI, V12, P525; IGARASHI M, GLYCOMICROBIOLOGY; Igarashi M, 2008, VIROLOGY, V376, P323, DOI 10.1016/j.virol.2008.03.036; ITOH Y, 2009, NATURE IN PRESS; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee MS, 2003, J INFECT DIS, V188, P1362, DOI 10.1086/379045; LUOH SM, 1992, J VIROL, V66, P1066, DOI 10.1128/JVI.66.2.1066-1073.1992; Maurer-Stroh S, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-18; Reid AH, 2003, J GEN VIROL, V84, P2285, DOI 10.1099/vir.0.19302-0; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; SHEERAR MG, 1989, J GEN VIROL, V70, P3297, DOI 10.1099/0022-1317-70-12-3297; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; SUGITA S, 1991, J MOL EVOL, V32, P16, DOI 10.1007/BF02099924; Taubenberger JK, 1997, SCIENCE, V275, P1793, DOI 10.1126/science.275.5307.1793; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Vincent AL, 2006, VET MICROBIOL, V118, P212, DOI 10.1016/j.vetmic.2006.07.017	29	125	153	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8553	10.1371/journal.pone.0008553	http://dx.doi.org/10.1371/journal.pone.0008553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049332	Green Published, Green Submitted, gold			2022-12-25	WOS:000273225000016
J	Tsumiyama, K; Miyazaki, Y; Shiozawa, S				Tsumiyama, Ken; Miyazaki, Yumi; Shiozawa, Shunichi			Self-Organized Criticality Theory of Autoimmunity	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; T-CELL-RECEPTOR; RHEUMATOID-ARTHRITIS; V(D)J RECOMBINATION; MICE; DISEASE; SUPERANTIGEN; LYMPHOCYTES; INDUCTION; NEPHRITIS	Background: The cause of autoimmunity, which is unknown, is investigated from a different angle, i.e., the defect in immune 'system', to explain the cause of autoimmunity. Methodology/Principal Findings: Repeated immunization with antigen causes systemic autoimmunity in mice otherwise not prone to spontaneous autoimmune diseases. Overstimulation of CD4(+) T cells led to the development of autoantibody-inducing CD4(+) T (aiCD4(+) T) cell which had undergone T cell receptor (TCR) revision and was capable of inducing autoantibodies. The aiCD4+ T cell was induced by de novo TCR revision but not by cross-reaction, and subsequently overstimulated CD8(+) T cells, driving them to become antigen-specific cytotoxic T lymphocytes (CTL). These CTLs could be further matured by antigen cross-presentation, after which they caused autoimmune tissue injury akin to systemic lupus erythematosus (SLE). Conclusions/Significance: Systemic autoimmunity appears to be the inevitable consequence of over-stimulating the host's immune 'system' by repeated immunization with antigen, to the levels that surpass system's self-organized criticality.	[Tsumiyama, Ken; Miyazaki, Yumi; Shiozawa, Shunichi] Kobe Univ, Grad Sch Hlth Sci, Dept Biophys, Kobe, Hyogo 657, Japan; [Shiozawa, Shunichi] Kobe Univ, Grad Sch Med, Dept Med, Kobe, Hyogo 657, Japan; [Shiozawa, Shunichi] Kobe Univ Hosp, Ctr Rheumat Dis, Kobe, Hyogo, Japan; [Shiozawa, Shunichi] GCOE, Tokyo, Japan	Kobe University; Kobe University; Kobe University	Tsumiyama, K (corresponding author), Kobe Univ, Grad Sch Hlth Sci, Dept Biophys, Kobe, Hyogo 657, Japan.	shioz@med.kobe-u.ac.jp	Shiozawa, Shunichi/W-2992-2019		Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Organization	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Organization	This work is supported by the Global Center of Excellence (GCOE) Program grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Science and Technology Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2008, NAT BIOTECHNOL, V26, P817, DOI 10.1038/nbt1412; Blanco P, 2005, ARTHRITIS RHEUM, V52, P201, DOI 10.1002/art.20745; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Couzi L, 2007, ARTHRITIS RHEUM, V56, P2362, DOI 10.1002/art.22654; de Lema GP, 2005, J AM SOC NEPHROL, V16, P3592, DOI 10.1681/ASN.2005040426; Duty JA, 2009, J EXP MED, V206, P139, DOI 10.1084/jem.20080611; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Haas C, 1997, J IMMUNOL, V158, P5484; Han JH, 2007, IMMUNITY, V27, P64, DOI 10.1016/j.immuni.2007.05.018; Heinlen LD, 2007, ARTHRITIS RHEUM, V56, P2344, DOI 10.1002/art.22665; Huang CY, 2002, J IMMUNOL, V168, P3259, DOI 10.4049/jimmunol.168.7.3259; KALLENBACH S, 1992, P NATL ACAD SCI USA, V89, P2799, DOI 10.1073/pnas.89.7.2799; KAWABE Y, 1990, J EXP MED, V172, P1065, DOI 10.1084/jem.172.4.1065; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Kuwata N, 1999, J IMMUNOL, V163, P6355; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; PALIARD X, 1991, SCIENCE, V253, P325, DOI 10.1126/science.1857971; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Richards HB, 2001, KIDNEY INT, V60, P2173, DOI 10.1046/j.1523-1755.2001.00045.x; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105	25	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8382	10.1371/journal.pone.0008382	http://dx.doi.org/10.1371/journal.pone.0008382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046868	Green Published, gold			2022-12-25	WOS:000273180200001
J	Xu, ZX; Ding, T; Haridas, V; Connolly, F; Gutterman, JU				Xu, Zhi-Xiang; Ding, Tian; Haridas, Valsala; Connolly, Fiona; Gutterman, Jordan U.			Avicin D, a Plant Triterpenoid, Induces Cell Apoptosis by Recruitment of Fas and Downstream Signaling Molecules into Lipid Rafts	PLOS ONE			English	Article							ACACIA-VICTORIAE BENTHAM; DEATH RECEPTOR; ACTIVATION; SAPONINS; CHOLESTEROL; LOCALIZATION; AUTOPHAGY; MEMBRANES; FAS/CD95; ANTIBODY	Avicins, a family of triterpene electrophiles originally identified as potent inhibitors of tumor cell growth, have been shown to be pleiotropic compounds that also possess antioxidant, anti-mutagenic, and anti-inflammatory activities. We previously showed that Jurkat cells, which express a high level of Fas, are very sensitive to treatment with avicins. Thus, we hypothesized that avicins may induce cell apoptosis by activation of the Fas pathway. By using a series of cell lines deficient in cell death receptors, we demonstrated that upon avicin D treatment, Fas translocates to the cholesterol- and sphingolipid-enriched membrane microdomains known as lipid rafts. In the lipid rafts, Fas interacts with Fas-associated death domain (FADD) and Caspase-8 to form death-inducing signaling complex (DISC) and thus mediates cell apoptosis. Interfering with lipid raft organization by using a cholesterol- depleting compound, methyl-beta-cyclodextrin, not only prevents the clustering of Fas and its DISC complex but also reduces the sensitivity of the cells to avicin D. Avicin D activates Fas pathways independent of the association between extracellular Fas ligands and Fas receptors. A deficiency in Fas and its downstream signaling molecules leads to the resistance of the cells to avicin D treatment. Taken together, our results demonstrate that avicin D triggers the redistribution of Fas in the membrane lipid rafts, where Fas activates receptor-mediated cell death.	[Xu, Zhi-Xiang; Haridas, Valsala; Connolly, Fiona; Gutterman, Jordan U.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Xu, Zhi-Xiang] Univ Alabama, Div Hematol & Oncol, Birmingham, AL USA; [Ding, Tian] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Ding, Tian] Genscript Inc, Piscataway, NJ USA	University of Texas System; UTMD Anderson Cancer Center; University of Alabama System; University of Alabama Birmingham; University of Texas System; UTMD Anderson Cancer Center	Xu, ZX (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	zhi-xiang.xu@ccc.uab.edu			Clayton Foundation for Research; Wendy Will Case Cancer Fund, Inc.; National Cancer Institutes [R01CA133053]; NATIONAL CANCER INSTITUTE [R01CA133053] Funding Source: NIH RePORTER	Clayton Foundation for Research; Wendy Will Case Cancer Fund, Inc.; National Cancer Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Clayton Foundation for Research (to J.U.G.), Wendy Will Case Cancer Fund, Inc., and National Cancer Institutes research grant R01CA133053 (to Z.X.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beneteau M, 2008, MOL CANCER RES, V6, P604, DOI 10.1158/1541-7786.MCR-07-0331; Blackstone NW, 2005, P ROY SOC B-BIOL SCI, V272, P527, DOI 10.1098/rspb.2004.2981; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Gaikwad A, 2005, CLIN CANCER RES, V11, P1953, DOI 10.1158/1078-0432.CCR-04-1704; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Gutterman JU, 2005, P NATL ACAD SCI USA, V102, P12771, DOI 10.1073/pnas.0505758102; Hanausek M, 2001, P NATL ACAD SCI USA, V98, P11551, DOI 10.1073/pnas.191363198; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Haridas V, 2005, P NATL ACAD SCI USA, V102, P10088, DOI 10.1073/pnas.0504430102; Haridas V, 2004, J CLIN INVEST, V113, P65, DOI 10.1172/JCI200418699; Haridas V, 2001, P NATL ACAD SCI USA, V98, P5821, DOI 10.1073/pnas.101619098; Haridas V, 2001, P NATL ACAD SCI USA, V98, P11557, DOI 10.1073/pnas.191363498; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Kabouridis PS, 2008, FEBS LETT, V582, P3711, DOI 10.1016/j.febslet.2008.10.006; Li XX, 2005, BIOPHYS J, V88, P2577, DOI 10.1529/biophysj.104.049403; Lincoln JE, 2006, INVEST OPHTH VIS SCI, V47, P2172, DOI 10.1167/iovs.05-1167; Mollinedo F, 2006, DRUG RESIST UPDATE, V9, P51, DOI 10.1016/j.drup.2006.04.002; Mujoo K, 2001, CANCER RES, V61, P5486; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Pimentel-Muinos FX, 1999, IMMUNITY, V11, P783, DOI 10.1016/S1074-7613(00)80152-1; Schattenberg JM, 2006, LIVER INT, V26, P904, DOI 10.1111/j.1478-3231.2006.01324.x; Scheel-Toellner D, 2004, BIOCHEM SOC T, V32, P679, DOI 10.1042/BST0320679; Scheel-Toellner D, 2003, CANCER BIOL THER, V2, P396, DOI 10.4161/cbt.2.4.455; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; WATANABE SI, 1995, INT IMMUNOL, V7, P1037, DOI 10.1093/intimm/7.7.1037; Xu ZX, 2007, CELL DEATH DIFFER, V14, P1948, DOI 10.1038/sj.cdd.4402207; Xu ZX, 2004, J BIOL CHEM, V279, P1838, DOI 10.1074/jbc.M310987200; Xu ZX, 2003, MOL CELL BIOL, V23, P4247, DOI 10.1128/MCB.23.12.4247-4256.2003	35	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8532	10.1371/journal.pone.0008532	http://dx.doi.org/10.1371/journal.pone.0008532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046832	Green Published, gold, Green Submitted			2022-12-25	WOS:000273180200013
J	Leszczynska, A; Burzynska, B; Plochocka, D; Kaminska, J; Zimnicka, M; Kania, M; Kiliszek, M; Wysocka-Kapcinska, M; Danikiewicz, W; Szkopinska, A				Leszczynska, Agata; Burzynska, Beata; Plochocka, Danuta; Kaminska, Joanna; Zimnicka, Magdalena; Kania, Magdalena; Kiliszek, Marek; Wysocka-Kapcinska, Monika; Danikiewicz, Witold; Szkopinska, Anna			Investigating the Effects of Statins on Cellular Lipid Metabolism Using a Yeast Expression System	PLOS ONE			English	Article							HMG-COA REDUCTASE; SACCHAROMYCES-CEREVISIAE; PARTICLES; ENZYME; CELLS; PCR	In humans, defects in lipid metabolism are associated with a number of severe diseases such as atherosclerosis, obesity and type II diabetes. Hypercholesterolemia is a primary risk factor for coronary artery disease, the major cause of premature deaths in developed countries. Statins are inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), the key enzyme of the sterol synthesis pathway. Since yeast Saccharomyces cerevisiae harbours many counterparts of mammalian enzymes involved in lipid-synthesizing pathways, conclusions drawn from research with this single cell eukaryotic organism can be readily applied to higher eukaryotes. Using a yeast strain with deletions of both HMG; and HMG2 genes (i.e. completely devoid of HMGR activity) with introduced wild-type or mutant form of human HMGR (hHMGR) gene we investigated the effects of statins on the lipid metabolism of the cell. The relative quantification of mRNA demonstrated a different effect of simvastatin on the expression of the wild-type and mutated hHMGR gene. GC/MS analyses showed a significant decrease of sterols and enhanced conversion of squalene and sterol precursors into ergosterol. This was accompanied by the mobilization of ergosterol precursors localized in lipid particles in the form of steryl esters visualized by confocal microscopy. Changes in the level of ergosterol and its precursors in cells treated with simvastatin depend on the mutation in the hHMGR gene. HPLC/MS analyses indicated a reduced level of phospholipids not connected with the mevalonic acid pathway. We detected two significant phenomena. First, cells treated with simvastatin develop an adaptive response compensating the lower activity of HMGR. This includes enhanced conversion of sterol precursors into ergosterol, mobilization of steryl esters and increased expression of the hHMGR gene. Second, statins cause a substantial drop in the level of glycerophospholipids.	[Leszczynska, Agata; Burzynska, Beata; Plochocka, Danuta; Kaminska, Joanna; Wysocka-Kapcinska, Monika; Szkopinska, Anna] Polish Acad Sci, Inst Biochem & Biophys PAS, Warsaw, Poland; [Zimnicka, Magdalena; Kania, Magdalena; Danikiewicz, Witold] Polish Acad Sci, Inst Organ Chem PAS, Warsaw, Poland; [Kiliszek, Marek] Med Univ Warsaw, Dept Cardiol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Polish Academy of Sciences; Institute of Organic Chemistry of the Polish Academy of Sciences; Medical University of Warsaw	Leszczynska, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys PAS, Warsaw, Poland.	babel@ibb.waw.pl	Burzynska, Beata/A-4691-2013; Kamińska, Joanna/D-1063-2011; Danikiewicz, Witold/H-2257-2016; Zimnicka, Magdalena/AAT-1794-2021	Kamińska, Joanna/0000-0002-0168-7882; Danikiewicz, Witold/0000-0003-0484-2689; Zimnicka, Magdalena/0000-0001-5078-4374; Burzynska, Beata/0000-0003-1595-0036	National Centre for Research and Development (NCBiR) [R13 0001 06]	National Centre for Research and Development (NCBiR)	This work was supported by a grant R13 0001 06 from The National Centre for Research and Development (NCBiR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartz F, 2009, CELL METAB, V10, P63, DOI 10.1016/j.cmet.2009.05.009; BASSON ME, 1988, MOL CELL BIOL, V8, P3797, DOI 10.1128/MCB.8.9.3797; Beltowski J, 2009, CURR DRUG SAF, V4, P209, DOI 10.2174/157488609789006949; Chopra V, 2007, CARDIOVASC DRUG THER, V21, P161, DOI 10.1007/s10557-007-6025-3; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Dietzen DJ, 2007, ARTERIOSCL THROM VAS, V27, P690, DOI 10.1161/01.ATV.0000255949.51053.ce; Duncan RE, 2005, CANCER EPIDEM BIOMAR, V14, P1897, DOI 10.1158/1055-9965.EPI-05-0027; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRANK RE, 2009, J INSUR MED, V4, P132; Gerber R, 2004, ANAL BIOCHEM, V329, P28, DOI 10.1016/j.ab.2004.03.023; GREENSPAN P, 1985, J LIPID RES, V26, P781; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; LIJNEN P, 1995, J HUM HYPERTENS, V9, P557; Mangravite LM, 2006, PHARMACOGENOMICS J, V6, P360, DOI 10.1038/sj.tpj.6500384; Morikawa S, 2005, J ATHEROSCLER THROMB, V12, P121, DOI 10.5551/jat.12.121; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROSE MD, 1990, METHODS YEAST GENET; Vecka M, 2004, TOHOKU J EXP MED, V204, P299, DOI 10.1620/tjem.204.299; Wagner A, 2009, BBA-MOL CELL BIOL L, V1791, P118, DOI 10.1016/j.bbalip.2008.11.004; Wysocka-Kapcinska M, 2009, J APPL MICROBIOL, V106, P895, DOI 10.1111/j.1365-2672.2008.04060.x; YANAGITA T, 1994, CLIN THER, V16, P200; Zhou Q, 2009, CURR PHARM DESIGN, V15, P467, DOI 10.2174/138161209787315684	24	12	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8499	10.1371/journal.pone.0008499	http://dx.doi.org/10.1371/journal.pone.0008499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041128	Green Published, Green Submitted, gold			2022-12-25	WOS:000278068700014
J	Zaman, RU; Alamgir, ASM; Rahman, M; Azziz-Baumgartner, E; Gurley, ES; Sharker, MAY; Brooks, WA; Azim, T; Fry, AM; Lindstrom, S; Gubareva, LV; Xu, XY; Garten, RJ; Hossain, MJ; Khan, SU; Faruque, LI; Ameer, SS; Klimov, AI; Rahman, M; Luby, SP				Zaman, Rashid Uz; Alamgir, A. S. M.; Rahman, Mustafizur; Azziz-Baumgartner, Eduardo; Gurley, Emily S.; Sharker, M. Abu Yushuf; Brooks, W. Abdullah; Azim, Tasnim; Fry, Alicia M.; Lindstrom, Stephen; Gubareva, Larisa V.; Xu, Xiyan; Garten, Rebecca J.; Hossain, M. Jahangir; Khan, Salah Uddin; Faruque, Labib Imran; Ameer, Syeda Shegufta; Klimov, Alexander I.; Rahman, Mahmudur; Luby, Stephen P.			Influenza in Outpatient ILI Case-Patients in National Hospital-Based Surveillance, Bangladesh, 2007-2008	PLOS ONE			English	Article							SEASONAL INFLUENZA; VIRUS; CHILDREN; ILLNESS; BURDEN; IMPACT; EPIDEMIOLOGY; INFECTION; SEVERITY; TRENDS	Background: Recent population-based estimates in a Dhaka low-income community suggest that influenza was prevalent among children. To explore the epidemiology and seasonality of influenza throughout the country and among all age groups, we established nationally representative hospital-based surveillance necessary to guide influenza prevention and control efforts. Methodolgy/Principal Findings: We conducted influenza-like illness and severe acute respiratory illness sentinel surveillance in 12 hospitals across Bangladesh during May 2007-December 2008. We collected specimens from 3,699 patients, 385 (10%) which were influenza positive by real time RT-PCR. Among the sample-positive patients, 192 (51%) were type A and 188 (49%) were type B. Hemagglutinin subtyping of type A viruses detected 137 (71%) A/H1 and 55 (29%) A/H3, but no A/H5 or other novel influenza strains. The frequency of influenza cases was highest among children aged under 5 years (44%), while the proportions of laboratory confirmed cases was highest among participants aged 11-15 (18%). We applied kriging, a geo-statistical technique, to explore the spatial and temporal spread of influenza and found that, during 2008, influenza was first identified in large port cities and then gradually spread to other parts of the country. We identified a distinct influenza peak during the rainy season (May-September). Conclusions/Significance: Our surveillance data confirms that influenza is prevalent throughout Bangladesh, affecting a wide range of ages and causing considerable morbidity and hospital care. A unimodal influenza seasonality may allow Bangladesh to time annual influenza prevention messages and vaccination campaigns to reduce the national influenza burden. To scale-up such national interventions, we need to quantify the national rates of influenza and the economic burden associated with this disease through further studies.	[Zaman, Rashid Uz; Rahman, Mustafizur; Azziz-Baumgartner, Eduardo; Gurley, Emily S.; Sharker, M. Abu Yushuf; Brooks, W. Abdullah; Azim, Tasnim; Hossain, M. Jahangir; Khan, Salah Uddin; Faruque, Labib Imran; Ameer, Syeda Shegufta; Luby, Stephen P.] ICDDR B, Dhaka, Bangladesh; [Alamgir, A. S. M.; Rahman, Mahmudur] IEDCR, Dhaka, Bangladesh; [Azziz-Baumgartner, Eduardo; Fry, Alicia M.; Lindstrom, Stephen; Gubareva, Larisa V.; Xu, Xiyan; Garten, Rebecca J.; Klimov, Alexander I.; Luby, Stephen P.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Gurley, Emily S.; Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zaman, RU (corresponding author), ICDDR B, Dhaka, Bangladesh.	zaman.rashid@gmail.com	Zaman, Rashid/AAM-5209-2020; Brooks, W. Abdullah/AAD-3876-2021; Gurley, Emily S/B-7903-2010; rahman, mustafizur/E-6918-2010	Brooks, W. Abdullah/0000-0001-9871-5546; Gurley, Emily S/0000-0002-8648-9403; Khan, M. Salah Uddin/0000-0001-5928-9257; Zaman, Rashid/0000-0002-8556-4993	Centers for Disease Control and Prevention (CDC) (www.cdc.gov), United States of America [U01 CI000298]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000298] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC) (www.cdc.gov), United States of America(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This surveillance was funded by the Centers for Disease Control and Prevention (CDC) (www.cdc.gov), United States of America, under cooperative agreement U01 CI000298. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahmed NU, 2006, J HEALTH POPUL NUTR, V24, P456; Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; ALSABIR A, 2005, BANGLADESH DEMOGRAPH; [Anonymous], 2002, Wkly Epidemiol Rec, V77, P381; [Anonymous], 2006, HSB (Health Science Bulletin), V4, P1; BBS, 2013, TIM US PIL SURV; Biswas PK, 2008, EMERG INFECT DIS, V14, P1909, DOI 10.3201/eid1412.071567; Brooks WA, 2007, EMERG INFECT DIS, V13, P1507, DOI 10.3201/eid1310.070368; Brooks WA, 2009, EMERG INFECT DIS, V15, P1311, DOI 10.3201/eid1508.090283; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; Cannell JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-29; *CDC, 2008, INFL DIS FLU BAS; CHEVEZ AE, 2006, PAN AM HLTH ORG IMMU, V28, P1; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Couch RB, 2000, ANN INTERN MED, V133, P992, DOI 10.7326/0003-4819-133-12-200012190-00015; Couch RB, 2008, VACCINE, V26, pD5, DOI 10.1016/j.vaccine.2008.05.076; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; FRANK AL, 1985, J INFECT DIS, V151, P73, DOI 10.1093/infdis/151.1.73; Gachara G, 2006, J CLIN VIROL, V35, P117, DOI 10.1016/j.jcv.2005.10.004; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Jennings JC, 1999, VACCINE, V17, pS115, DOI 10.1016/S0264-410X(99)00260-1; Langley JM, 2004, CAN MED ASSOC J, V171, P1213, DOI 10.1503/cmaj.1031737; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; Mereckiene J, 2008, EUROSURVEILLANCE, V13, P1; *MILL PROJ, 2005, INV DEV PRACT PLAN A, P158; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mugglin AS, 2002, STAT MED, V21, P2703, DOI 10.1002/sim.1217; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; NICOLL A, 2008, EUROSURVEILLANCE, V13, P1; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Ramamurty N, 2005, INDIAN J MED RES, V121, P776; Rao B. L., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P906; RAO BL, 1993, B WORLD HEALTH ORGAN, V71, P177; Rizzo C, 2007, EMERG INFECT DIS, V13, P694, DOI 10.3201/eid1305.061309; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Sakai T, 2004, EMERG INFECT DIS, V10, P1822, DOI 10.3201/eid1010.040147; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simmerman JM, 2006, VACCINE, V24, P4417, DOI 10.1016/j.vaccine.2005.12.060; Simmerman JM, 2004, VACCINE, V23, P182, DOI 10.1016/j.vaccine.2004.05.025; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; Szucs T, 1999, J ANTIMICROB CHEMOTH, V44, P11, DOI 10.1093/jac/44.suppl_2.11; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; *WHO, 2003, 211 WHO; WHO, 2007, REC LAB PROC DET AV; WRIGHT PF, 1980, AM J EPIDEMIOL, V112, P814, DOI 10.1093/oxfordjournals.aje.a113053; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	49	84	87	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8452	10.1371/journal.pone.0008452	http://dx.doi.org/10.1371/journal.pone.0008452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041114	gold, Green Published, Green Submitted			2022-12-25	WOS:000273105200003
J	Kawaguchi-Ito, Y; Li, SF; Tagawa, M; Araki, H; Goshono, M; Yamamoto, S; Tanaka, M; Narita, M; Tanaka, K; Liu, SX; Shikata, E; Sano, T				Kawaguchi-Ito, Yoko; Li, Shi-Fang; Tagawa, Masaya; Araki, Hiroyuki; Goshono, Masafumi; Yamamoto, Shingen; Tanaka, Mayumi; Narita, Masako; Tanaka, Kazuaki; Liu, Sheng-Xue; Shikata, Eishiro; Sano, Teruo			Cultivated Grapevines Represent a Symptomless Reservoir for the Transmission of Hop Stunt Viroid to Hop Crops: 15 Years of Evolutionary Analysis	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; PATHOGENICITY DETERMINANT; PHYLOGENETIC ANALYSIS; GENETIC DIVERSITY; HOST INTERACTIONS; RNA; VARIANTS; CITRUS; IDENTIFICATION; DISEASE	Hop stunt was a mysterious disorder that first emerged in the 1940s in commercial hops in Japan. To investigate the origin of this disorder, we infected hops with natural Hop stunt viroid (HpSVd) isolates derived from four host species ( hop, grapevine, plum and citrus), which except for hop represent possible sources of the ancestral viroid. These plants were maintained for 15 years, then analyzed the HpSVd variants present. Here we show that the variant originally found in cultivated grapevines gave rise to various combinations of mutations at positions 25, 26, 54, 193, and 281. However, upon prolonged infection, these variants underwent convergent evolution resulting in a limited number of adapted mutants. Some of them showed nucleotide sequences identical to those currently responsible for hop stunt epidemics in commercial hops in Japan, China, and the United States. Therefore, these results indicate that we have successfully reproduced the original process by which a natural HpSVd variant naturally introduced into cultivated hops was able to mutate into the HpSVd variants that are currently present in commercial hops. Furthermore, and importantly, we have identified cultivated grapevines as a symptomless reservoir in which HSVd can evolve and be transmitted to hop crops to cause epidemics.	[Kawaguchi-Ito, Yoko] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 020, Japan; [Li, Shi-Fang] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Tagawa, Masaya; Araki, Hiroyuki; Goshono, Masafumi; Yamamoto, Shingen; Tanaka, Mayumi; Narita, Masako; Tanaka, Kazuaki; Sano, Teruo] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Liu, Sheng-Xue] Xinjiang Prod & Construct Grp, Key Oasis Ecoagr Lab, Shihezi, Peoples R China; [Shikata, Eishiro] Hokkaido Univ, Grad Sch Agr, Japan Acad, Sapporo, Hokkaido, Japan	Iwate University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Hirosaki University; Hokkaido University	Kawaguchi-Ito, Y (corresponding author), Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 020, Japan.	sfli@ippcaas.cn; sano@cc.hirosaki-u.ac.jp		li, shifang/0000-0003-4614-1768	Japan Society for the Promotion of Science [B18380028, 21380029, 18658016, FY2008]; Grant-in-Aid for Scientific Research of Priority Area, Hirosaki University; Bilateral Joint Projects between Japan and China-NSFC [30811140157]; National Basic Research and Development Program of China [2009CB119200]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grant-in-Aid for Scientific Research of Priority Area, Hirosaki University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Bilateral Joint Projects between Japan and China-NSFC; National Basic Research and Development Program of China(National Basic Research Program of China)	This work was supported in part by Grant-in-Aid for Scientific Research B18380028, 21380029 and 18658016 from Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research of Priority Area, Hirosaki University 2004-2006, 2008, Japan Society for the Promotion of Science FY2008 Bilateral Joint Projects between Japan and China-NSFC (30811140157), and the National Basic Research and Development Program of China (No. 2009CB119200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari K, 2001, J GEN VIROL, V82, P953, DOI 10.1099/0022-1317-82-4-953; Astruc N, 1996, EUR J PLANT PATHOL, V102, P837, DOI 10.1007/BF01877053; Codoner FM, 2006, PLOS PATHOG, V2, P1187, DOI 10.1371/journal.ppat.0020136; De la Pena M, 2002, J MOL BIOL, V321, P411, DOI 10.1016/S0022-2836(02)00629-0; DIENER TO, 1987, VIROIDS, P9; Ding B, 1997, PLANT J, V12, P931, DOI 10.1046/j.1365-313X.1997.12040931.x; Ding B, 2009, ANNU REV PHYTOPATHOL, V47, P105, DOI 10.1146/annurev-phyto-080508-081927; Duran-Vila N, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P43, DOI 10.1016/B978-0-12-374153-0.00002-3; EASTWELL KC, 2007, ONLINE PLANT HLTH PR, DOI DOI 10.1094/PHP-2007-1127-01-RS; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Gago S, 2009, SCIENCE, V323, P1308, DOI 10.1126/science.1169202; Gas ME, 2007, PLOS PATHOG, V3, P1813, DOI 10.1371/journal.ppat.0030182; Ge LM, 2007, J VIROL, V81, P5902, DOI 10.1128/JVI.02431-06; Gomez G, 2005, PLANT J, V41, P107, DOI 10.1111/j.1365-313X.2004.02278.x; Gomez G, 2009, TRENDS PLANT SCI, V14, P264, DOI 10.1016/j.tplants.2009.03.002; Guo L, 2008, PLANT PATHOL, V57, P764, DOI 10.1111/j.1365-3059.2008.01875.x; Harkins GW, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-104; Hassen IF, 2007, VIROLOGY, V360, P50, DOI 10.1016/j.virol.2006.10.021; James T, 2008, PLANT PATHOL, V57, P400, DOI 10.1111/j.1365-3059.2007.01727.x; Jiang DM, 2009, VIRUS GENES, V38, P178, DOI 10.1007/s11262-008-0306-1; KEESE P, 1985, P NATL ACAD SCI USA, V82, P4582, DOI 10.1073/pnas.82.14.4582; Kofalvi SA, 1997, J GEN VIROL, V78, P3177, DOI 10.1099/0022-1317-78-12-3177; LEE JY, 1988, NUCLEIC ACIDS RES, V16, P8708, DOI 10.1093/nar/16.17.8708; Matousek J, 2007, J VIROL, V81, P11891, DOI 10.1128/JVI.01165-07; Mori Y., 1995, HOP; OHNO T, 1983, NUCLEIC ACIDS RES, V11, P6185, DOI 10.1093/nar/11.18.6185; Owens RA, 1999, ANN APPL BIOL, V134, P73, DOI 10.1111/j.1744-7348.1999.tb05237.x; Owens Robert A., 2008, P83, DOI 10.1007/978-3-540-75763-4_5; Pelchat M, 2003, NUCLEIC ACIDS RES, V31, P444, DOI 10.1093/nar/gkg026; Pita Justin S., 2008, P109, DOI 10.1007/978-3-540-75763-4_6; PUCHTA H, 1988, NUCLEIC ACIDS RES, V16, P2730, DOI 10.1093/nar/16.6.2730; Qi YJ, 2004, PLANT CELL, V16, P1741, DOI 10.1105/tpc.021980; Reanwarakorn K, 1999, PHYTOPATHOLOGY, V89, P568, DOI 10.1094/PHYTO.1999.89.7.568; Rodio ME, 2006, J GEN VIROL, V87, P231, DOI 10.1099/vir.0.81356-0; SANO T, 1992, P NATL ACAD SCI USA, V89, P10104, DOI 10.1073/pnas.89.21.10104; SANO T, 1988, NUCLEIC ACIDS RES, V16, P347, DOI 10.1093/nar/16.1.347; SANO T, 1985, P JPN ACAD B-PHYS, V61, P265, DOI 10.2183/pjab.61.265; Sano T., 2003, Viroids, P165; Sano T., 2003, Viroids, P207; SANO T, 1989, J GEN VIROL, V70, P1311, DOI 10.1099/0022-1317-70-6-1311; Sano T, 1998, VIROLOGY, V240, P238, DOI 10.1006/viro.1997.8899; SANO T, 1986, J GEN VIROL, V67, P1673, DOI 10.1099/0022-1317-67-8-1673; Sano T, 2001, VIRUS GENES, V22, P53, DOI 10.1023/A:1008182302704; SANO T, 1985, SHOKUBUTU BOUEKI, V39, P361; Sano T, 2008, VIRUS GENES, V37, P298, DOI 10.1007/s11262-008-0270-9; Sano Teruo, 2004, Journal of General Plant Pathology, V70, P181, DOI 10.1007/s10327-004-0105-z; SASAKI M, 1977, P JPN ACAD B-PHYS, V53, P109, DOI 10.2183/pjab.53.109; Schneider WL, 2001, J VIROL, V75, P6566, DOI 10.1128/JVI.75.14.6566-6571.2001; SERIO FD, 2007, J PLANT PATHOL, V89, P297; Serra P, 2008, VIRUS RES, V138, P130, DOI 10.1016/j.virusres.2008.08.003; SHIKATA E, 1990, SEMIN VIROL, V1, P107; Szychowski JA, 2005, J GEN VIROL, V86, P473, DOI 10.1099/vir.0.80699-0; Tsagris EM, 2008, CELL MICROBIOL, V10, P2168, DOI 10.1111/j.1462-5822.2008.01231.x; Ukawa S., 1973, REPT RES LAB KIRIN B, V16, P49; VERHOEVEN JTJ, 2008, PLANT PATHOL, V57, P399; Zhang BL, 2009, EUR J PLANT PATHOL, V125, P665, DOI 10.1007/s10658-009-9504-5; Zhong XH, 2008, PLANT CELL, V20, P35, DOI 10.1105/tpc.107.056606; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	58	41	45	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8386	10.1371/journal.pone.0008386	http://dx.doi.org/10.1371/journal.pone.0008386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041179	Green Submitted, Green Published, gold			2022-12-25	WOS:000273104000002
J	Nohr, EA; Timpson, NJ; Andersen, CS; Smith, GD; Olsen, J; Sorensen, TIA				Nohr, Ellen A.; Timpson, Nicholas J.; Andersen, Camilla S.; Smith, George Davey; Olsen, Jorn; Sorensen, Thorkild I. A.			Severe Obesity in Young Women and Reproductive Health: The Danish National Birth Cohort	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL OBESITY; WEIGHT-GAIN; METABOLIC RISK; PREGNANCY; COMPLICATIONS; OUTCOMES; GROWTH; ASSOCIATION; CONCEPTION	Background: Little is known about reproductive health in severely obese women. In this study, we present associations between different levels of severe obesity and a wide range of health outcomes in the mother and child. Methods: From the Danish National Birth Cohort, we obtained self-reported information about prepregnant body mass index (BMI) for 2451 severely obese women and 2450 randomly selected women from the remaining cohort who served as a comparison group. Information about maternal and infant outcomes was also self-reported or came from registers. Logistic regression was used to estimate the association between different levels of severe obesity and reproductive outcomes. Principal Findings: Subfecundity was more frequent in severely obese women, and during pregnancy, they had an excess risk of urinary tract infections, gestational diabetes, preeclampsia and other hypertensive disorders which increased with severity of obesity. They tended to have a higher risk of both pre- and post-term birth, and risk of cesarean and instrumental deliveries increased across obesity categories. After birth, severely obese women more often failed to initiate or sustain breastfeeding. Risk of weight retention 1.5 years after birth was similar to that of other women, but after adjustment for gestational weight gain, the risk was increased, especially in women in the lowest obesity category. In infants, increasing maternal obesity was associated with decreased risk of a low birth weight and increased risk of a high birth weight. Estimates for ponderal index showed the same pattern indicating an increasing risk of neonatal fatness with severity of obesity. Infant obesity measured one year after birth was also increased in children of severely obese mothers. Conclusion: Severe obesity is correlated with a substantial disease burden in reproductive health. Although the causal mechanisms remain elusive, these findings are useful for making predictions and planning health care at the individual level.	[Nohr, Ellen A.] Univ Aarhus, Dept Epidemiol, Aarhus, Denmark; [Timpson, Nicholas J.; Smith, George Davey] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Andersen, Camilla S.; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	Aarhus University; University of Bristol; University of Copenhagen; University of California System; University of California Los Angeles	Nohr, EA (corresponding author), Univ Aarhus, Dept Epidemiol, Aarhus, Denmark.	ean@soci.au.dk	Fox, Laura J/C-6249-2016; Timpson, Nicholas John/O-7548-2015; Attrill, Lauren/V-1688-2018; Olsen, Jørn/F-8801-2015; Davey Smith, George/A-7407-2013	Timpson, Nicholas John/0000-0002-7141-9189; Olsen, Jørn/0000-0001-7462-5140; Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Wellcome Trust [084762/Z/08/Z]; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The present study is based on an initial sample for the genome-wide association study GOYA ( Genomics of Obesity in Young Adults), supported by the Wellcome Trust ( grant no. 084762/Z/08/Z). The Danish National Research Foundation established the Danish Epidemiology Science Centre, which initiated and created the Danish National Birth Cohort. The cohort is furthermore a result of a major grant from this foundation. Additional support for the Danish National Birth Cohort was obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation and the Augustinus Foundation. The present study is included in the Danish Obesity Research Centre (DanORC, see www. danorc. dk). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAGAARD NE, 2005, THESIS U AARHUS; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Baker JL, 2007, AM J CLIN NUTR, V86, P404, DOI 10.1093/ajcn/86.2.404; Basso O, 2004, JAMA-J AM MED ASSOC, V291, P1564, DOI 10.1001/jama.291.13.1564-c; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Bianco AT, 1998, OBSTET GYNECOL, V91, P97, DOI 10.1016/S0029-7844(97)00578-4; Bolumar F, 2000, AM J EPIDEMIOL, V151, P1072, DOI 10.1093/oxfordjournals.aje.a010150; Bonde JP, 2006, EPIDEMIOLOGY, V17, P347, DOI 10.1097/01.ede.0000210239.80406.46; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chomtho S, 2008, AM J CLIN NUTR, V87, P1776, DOI 10.1093/ajcn/87.6.1776; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; *DAN I PUBL HLTH, 2004, DAN HLTH MORB SURV 2; Donath SM, 2008, MATERN CHILD NUTR, V4, P163, DOI 10.1111/j.1740-8709.2008.00134.x; EDWARDS LE, 1978, AM J OBSTET GYNECOL, V131, P479, DOI 10.1016/0002-9378(78)90106-0; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Frisancho AR, 2000, AM J CLIN NUTR, V72, P1186; Gale CR, 2007, J CLIN ENDOCR METAB, V92, P3904, DOI 10.1210/jc.2007-0088; GALTIERDEREURE F, 1995, INT J OBESITY, V19, P443; Griffiths LJ, 2007, INT J EPIDEMIOL, V36, P104, DOI 10.1093/ije/dyl210; Gunderson EP, 2001, INT J OBESITY, V25, P853, DOI 10.1038/sj.ijo.0801631; Jensen TK, 1999, EPIDEMIOLOGY, V10, P422, DOI 10.1097/00001648-199907000-00014; Jiang JX, 2009, PUBLIC HEALTH NUTR, V12, P973, DOI 10.1017/S1368980008003509; Lamas O, 2002, EUR J CLIN NUTR, V56, pS42, DOI 10.1038/sj.ejcn.1601484; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Li RW, 2003, AM J CLIN NUTR, V77, P931, DOI 10.1093/ajcn/77.4.931; Linne Y, 2004, OBES RES, V12, P1166, DOI 10.1038/oby.2004.146; Manios Y, 2009, PUBLIC HEALTH NUTR, V12, P517, DOI 10.1017/S1368980008002838; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Rasmussen KM, 2007, ANNU REV NUTR, V27, P103, DOI 10.1146/annurev.nutr.27.061406.093738; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Robinson HE, 2005, OBSTET GYNECOL, V106, P1357, DOI 10.1097/01.AOG.0000188387.88032.41; Rooney BL, 2005, OBSTET GYNECOL, V106, P1349, DOI 10.1097/01.AOG.0000185480.09068.4a; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Singhal A, 2007, CIRCULATION, V115, P213, DOI 10.1161/CIRCULATIONAHA.106.617811; van der Steeg JW, 2008, HUM REPROD, V23, P324, DOI 10.1093/humrep/dem371; Vohr BR, 1999, DIABETES CARE, V22, P1284, DOI 10.2337/diacare.22.8.1284; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; WHO, 2000, OB PREV MAN GLOB EP	42	76	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8444	10.1371/journal.pone.0008444	http://dx.doi.org/10.1371/journal.pone.0008444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041193	Green Published, gold, Green Submitted			2022-12-25	WOS:000273104000009
J	Glasgow, JN; Mikheeva, G; Krasnykh, V; Curiel, DT				Glasgow, Joel N.; Mikheeva, Galina; Krasnykh, Victor; Curiel, David T.			A Strategy for Adenovirus Vector Targeting with a Secreted Single Chain Antibody	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; INTRACELLULAR ANTIBODIES; CAPTURE TECHNOLOGY; GENE DELIVERY; FIBER PROTEIN; REPLICATING ADENOVIRUS; LEUCINE ZIPPERS; CELLS; COXSACKIEVIRUS; GENERATION	Background: Successful gene therapy will require targeted delivery vectors capable of self-directed localization. In this regard, the use of antibodies or single chain antibody fragments (scFv) in conjunction with adenovirus (Ad) vectors remains an attractive means to achieve cell-specific targeting. However, a longstanding barrier to the development of Ad vectors with genetically incorporated scFvs has been the biosynthetic incompatibility between Ad capsid proteins and antibody-derived species. Specifically, scFv require posttranslational modifications not available to Ad capsid proteins due to their cytoplasmic routing during protein synthesis and virion assembly. Methodology/Principal Findings: We have therefore sought to develop scFv-targeted Ad vectors using a secreted scFv that undergoes the requisite posttranslational modifications and is trafficked for secretion. Formation of the scFv-targeted Ad vector is achieved via highly specific association of the Ad virion and a targeting scFv employing synthetic leucine zipper-like dimerization domains (zippers) that have been optimized for structural compatibility with the Ad capsid and for association with the secreted scFv. Our results show that zipper-containing Ad fiber molecules trimerize and incorporate into mature virions and that zippers can be genetically fused to scFv without ablating target recognition. Most importantly, we show that zipper-tagged virions and scFv provide target-specific gene transfer. Conclusions/Significance: This work describes a new approach to produce targeted Ad vectors using a secreted scFv molecule, thereby avoiding the problem of structural and biosynthetic incompatibility between Ad and a complex targeting ligand. This approach may facilitate Ad targeting using a wide variety of targeting ligands directed towards a variety of cellular receptors.	[Glasgow, Joel N.] Univ Alabama, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Glasgow, Joel N.; Curiel, David T.] Univ Alabama, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; [Glasgow, Joel N.; Curiel, David T.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Glasgow, Joel N.; Curiel, David T.] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA; [Glasgow, Joel N.; Curiel, David T.] Univ Alabama, Gene Therapy Ctr, Birmingham, AL 35294 USA; [Glasgow, Joel N.; Curiel, David T.] Univ Alabama, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Mikheeva, Galina; Krasnykh, Victor] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Texas System; UTMD Anderson Cancer Center	Glasgow, JN (corresponding author), Univ Alabama, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA.	jng@uab.edu		Glasgow, Joel/0000-0002-2842-7917	NIH [7P01 CA104177, R01 CA116621]; U.S. Army Medical Research and Materiel Command [DAMD17-02-C-0006]; NATIONAL CANCER INSTITUTE [R01CA116621, P01CA104177] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors wish to acknowledge NIH grant award 7P01 CA104177 (D. T. C.), grant award DAMD17-02-C-0006 from the U.S. Army Medical Research and Materiel Command, and NIH award R01 CA116621 (V. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUFDERMAUR A, 2002, J BIOL CHEM, V277, P45075; Belousova N, 2003, J VIROL, V77, P11367, DOI 10.1128/JVI.77.21.11367-11377.2003; Belousova N, 2002, J VIROL, V76, P8621, DOI 10.1128/JVI.76.17.8621-8631.2002; Carette JE, 2007, VIROLOGY, V361, P56, DOI 10.1016/j.virol.2006.11.011; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Davison E, 1999, J VIROL, V73, P4513, DOI 10.1128/JVI.73.5.4513-4517.1999; der Maur Adrian Auf, 2004, Methods (Amsterdam), V34, P215; Dmitriev I, 2000, J VIROL, V74, P6875, DOI 10.1128/JVI.74.15.6875-6884.2000; Everts M, 2005, GENE THER, V12, P1042, DOI 10.1038/sj.gt.3302491; GRAHAM FL, 1995, MOL BIOTECHNOL, V3, P207, DOI 10.1007/BF02789331; Haisma HJ, 2000, CANCER GENE THER, V7, P901, DOI 10.1038/sj.cgt.7700198; Haisma HJ, 1999, GENE THER, V6, P1469, DOI 10.1038/sj.gt.3300969; Hedley SJ, 2006, GENE THER, V13, P88, DOI 10.1038/sj.gt.3302603; Hemminki A, 2001, CANCER RES, V61, P6377; Hemminki A, 2003, CANCER GENE THER, V10, P583, DOI 10.1038/sj.cgt.7700606; IYER SV, 1991, MOL CELL BIOL, V11, P4863, DOI 10.1128/MCB.11.10.4863; Jakubczak JL, 2001, J VIROL, V75, P2972, DOI 10.1128/JVI.75.6.2972-2981.2001; Kashentseva EA, 2002, CANCER RES, V62, P609; Katz BZ, 1998, BIOTECHNIQUES, V25, P298, DOI 10.2144/98252rr01; Kirby I, 2000, J VIROL, V74, P2804, DOI 10.1128/JVI.74.6.2804-2813.2000; Kirby I, 2001, J VIROL, V75, P7210, DOI 10.1128/JVI.75.15.7210-7214.2001; Korokhov N, 2003, J VIROL, V77, P12931, DOI 10.1128/JVI.77.24.12931-12940.2003; Krasnykh V, 1998, J VIROL, V72, P1844, DOI 10.1128/JVI.72.3.1844-1852.1998; Krasnykh V, 2001, J VIROL, V75, P4176, DOI 10.1128/JVI.75.9.4176-4183.2001; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; KRYLOV D, 1994, EMBO J, V13, P2849, DOI 10.1002/j.1460-2075.1994.tb06579.x; Li HJ, 2007, CANCER RES, V67, P5354, DOI 10.1158/0008-5472.CAN-06-4679; Li HJ, 2009, CANCER RES, V69, P554, DOI 10.1158/0008-5472.CAN-08-3209; Magnusson MK, 2002, J GENE MED, V4, P356, DOI 10.1002/jgm.285; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Moll JR, 2001, PROTEIN SCI, V10, P649, DOI 10.1110/ps.39401; Noureddini SC, 2006, VIRUS RES, V116, P185, DOI 10.1016/j.virusres.2005.10.002; Pereboev AV, 2002, GENE THER, V9, P1189, DOI 10.1038/sj.gt.3301767; Reynolds PN, 2001, NAT BIOTECHNOL, V19, P838, DOI 10.1038/nbt0901-838; Reynolds PN, 2000, MOL THER, V2, P562, DOI 10.1006/mthe.2000.0205; Stocks M, 2005, CURR OPIN CHEM BIOL, V9, P359, DOI 10.1016/j.cbpa.2005.06.003; Tse E, 2002, J MOL BIOL, V317, P85, DOI 10.1006/jmbi.2002.5403; van Beusechem VW, 2003, GENE THER, V10, P1982, DOI 10.1038/sj.gt.3302103; Visintin M, 2004, METHODS, V34, P200, DOI 10.1016/j.ymeth.2004.04.008; Visintin M, 2002, J MOL BIOL, V317, P73, DOI 10.1006/jmbi.2002.5392; Watkins SJ, 1997, GENE THER, V4, P1004, DOI 10.1038/sj.gt.3300511; Wirtz P, 1999, PROTEIN SCI, V8, P2245; Wu HJ, 2002, HUM GENE THER, V13, P1647, DOI 10.1089/10430340260201734; 2008, J GENE MED CLIN TRIA	44	22	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8355	10.1371/journal.pone.0008355	http://dx.doi.org/10.1371/journal.pone.0008355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027223	Green Submitted, Green Published, gold			2022-12-25	WOS:000272940100003
J	Choi, E; Abbott, GW				Choi, Eun; Abbott, Geoffrey W.			A shared mechanism for lipid- and beta-subunit-coordinated stabilization of the activated K+ channel voltage sensor	FASEB JOURNAL			English	Article						KCNQ1; KCNE3; MinK-related peptide; colonic epithelium; activation gating	KCNQ1 POTASSIUM CHANNEL; GASTRIC-ACID-SECRETION; MEMBRANE; PROTEINS; K(V)LQT1; PORE; CONDUCTANCE; FAMILY; KCNE1; FORM	The low-dielectric plasma membrane provides an energy barrier hindering transmembrane movement of charged particles. The positively charged, voltage-sensing fourth transmembrane domain (S4) of voltage-gated ion channels must surmount this energy barrier to initiate channel activation, typically necessitating both membrane depolarization and interaction with membrane lipid phospho-head groups (MLPHGs). In contrast, and despite containing S4, the KCNQ1 K+ channel alpha subunit exhibits predominantly constitutive activation when in complexes with transmembrane beta subunits, MinK-related peptide (MiRP) 1 (KCNE2) or MiRP2 (KCNE3). Here, using a 2-electrode voltage clamp and scanning mutagenesis of channels heterologously expressed in Xenopus laevis oocytes, we discovered that 2 of the 8 MiRP2 extracellular domain acidic residues (D54 and D55) are important for KCNQ1-MiRP2 constitutive activation. Double-mutant thermodynamic cycle analysis revealed energetic coupling of D54 and D55 to R237 in KCNQ1 S4 but not to 10 other native or introduced polar residues in KCNQ1 S4 and surrounding linkers. MiRP2-D54 and KCNQ1-R237 also similarly dictated susceptibility to the inhibitory effects of MLPHG hydrolysis, whereas other closely situated polar residues did not. Thus, by providing negative charge near the plasma membrane extracellular face, MiRP2 uses a lipomimetic mechanism to constitutively stabilize the activated KCNQ1 voltage sensor.-Choi, E., Abbott, G. W. A shared mechanism for lipid-and beta-subunit-coordinated stabilization of the activated K+ channel voltage sensor. FASEB J. 24, 1518-1524 (2010). www.fasebj.org	[Abbott, Geoffrey W.] Cornell Univ, Weill Med Coll, Greenberg Div Cardiol, Dept Med, New York, NY 10021 USA; [Choi, Eun; Abbott, Geoffrey W.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Cornell University; Cornell University	Abbott, GW (corresponding author), Cornell Univ, Weill Med Coll, Greenberg Div Cardiol, Dept Med, Starr 463,1300 York Ave, New York, NY 10021 USA.	gwa2001@med.cornell.edu		Abbott, Geoffrey/0000-0003-4552-496X	National Institutes of Health [R01 HL079275]; American Heart Association [0855756D]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful to Dr. Gianina Panaghie (Weill Medical College, Cornell University) for construction of mutant KCNQ1 cDNAs, and Kerry Purtell for expert technical assistance. G.W.A. is supported by the National Institutes of Health (R01 HL079275) and the American Heart Association (0855756D).	Angelo K, 2002, BIOPHYS J, V83, P1997, DOI 10.1016/S0006-3495(02)73961-1; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bleich M, 2000, PFLUG ARCH EUR J PHY, V440, P202, DOI 10.1007/s004240000257; Chang HR, 2008, J NEUROSCI, V28, P1546, DOI 10.1523/JNEUROSCI.3485-07.2008; Coll O, 2007, J LIPID RES, V48, P1924, DOI 10.1194/jlr.M700069-JLR200; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Kang CB, 2008, BIOCHEMISTRY-US, V47, P7999, DOI 10.1021/bi800875q; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Lambrecht NWG, 2005, PHYSIOL GENOMICS, V21, P81, DOI 10.1152/physiolgenomics.00212.2004; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Melman YF, 2002, J BIOL CHEM, V277, P25187, DOI 10.1074/jbc.M200564200; Melman YF, 2004, NEURON, V42, P927, DOI 10.1016/j.neuron.2004.06.001; Melman YF, 2001, J BIOL CHEM, V276, P6439, DOI 10.1074/jbc.M010713200; Panaghie G, 2006, J PHYSIOL-LONDON, V570, P455, DOI 10.1113/jphysiol.2005.100644; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Ries L MD, 2008, SEER CANC STAT REV 1; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Rost B, 1996, METHOD ENZYMOL, V266, P525; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Saslowsky DE, 2009, FASEB J, V23, P259, DOI 10.1096/fj.08-116467; Schroer TA, 2000, TRAFFIC, V1, P3, DOI 10.1034/j.1600-0854.2000.010102.x; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618	32	13	13	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2010	24	5					1518	1524		10.1096/fj.09-145219	http://dx.doi.org/10.1096/fj.09-145219			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20040519	Green Published			2022-12-25	WOS:000277158900024
J	Fulcher, AJ; Roth, DM; Fatima, S; Alvisi, G; Jans, DA				Fulcher, Alex J.; Roth, Daniela M.; Fatima, Shadma; Alvisi, Gualtiero; Jans, David A.			The BRCA-1 binding protein BRAP2 is a novel, negative regulator of nuclear import of viral proteins, dependent on phosphorylation flanking the nuclear localization signal	FASEB JOURNAL			English	Article						SV40 large-tumor antigen; T-ag; cytomegalovirus processivity factor ppUL44; cytoplasmic retention factor; nuclear transport regulation; p53 tumor suppressor	NF-KAPPA-B; DYSPLASIA/AUTOSOMAL SEX REVERSAL; TRANSCRIPTION FACTOR PHO4; VIRUS MATRIX PROTEIN; SV40 T-ANTIGEN; TARGETING SIGNAL; CYTOPLASMIC RETENTION; SITE FLANKING; DNA-BINDING; TRANSPORT	This study describes for the first time the ability of the novel BRCA1-binding protein 2 (BRAP2) to inhibit the nuclear import of specific viral proteins dependent on phosphorylation. Ectopic expression of BRAP2 in transfected African green monkey kidney COS-7 cells was found to significantly reduce nuclear localization signal (NLS)-dependent nuclear accumulation of either simian virus SV40 large-tumor antigen (T-ag) or human cytomegalovirus DNA polymerase processivity factor ppUL44; this was also observed in HL-60 human promyelocytic leukemia cells on induction of BRAP2 expression by vitamin D3 treatment. BRAP2 inhibition of nuclear accumulation was dependent on phosphorylation sites flanking the respective NLSs, where substitution of the cyclin-dependent kinase site T124 of T-ag with Ala or Asp prevented or enhanced BRAP2 inhibition of nuclear import, respectively. Substitution of T427 within the NLS of ppUL44 gave similar results, whereas no effect of BRAP2 was observed on nuclear targeting of other viral proteins, such as herpes simplex virus-1 pUL30, which lacks a phosphorylation site near its NLS, and the human immunodeficiency virus-1 Tat protein. Pulldowns/AlphaScreen assays indicated direct, high-affinity binding of BRAP2(442-592) to T-ag(111-135), strictly dependent on negative charge at T124 and the NLS. All results are consistent with BRAP2 being a novel, phosphorylation-regulated negative regulator of nuclear import, with potential as an antiviral agent.-Fulcher, A. J., Roth, D. M., Fatima, S., Alvisi, G., and Jans, D. A. The BRCA-1 binding protein BRAP2 is a novel, negative regulator of nuclear import of viral proteins, dependent on phosphorylation flanking the nuclear localization signal. FASEB J. 24, 1454-1466 (2010). www.fasebj.org	[Fulcher, Alex J.; Roth, Daniela M.; Fatima, Shadma; Alvisi, Gualtiero; Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Nucl Signaling Lab, Clayton, Vic 3800, Australia; [Fatima, Shadma; Jans, David A.] Monash Univ, Australian Res Council, Ctr Excellence Biotechnol & Dev, Clayton, Vic 3800, Australia	Monash University; Monash University	Jans, DA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Nucl Signaling Lab, Wellington Rd, Clayton, Vic 3800, Australia.	david.jans@med.monash.edu.au	Fatima, Shadma/HCG-9539-2022; Alvisi, Gualtiero/F-9915-2012	Alvisi, Gualtiero/0000-0002-8177-3616; Fatima, Shadma/0000-0002-3583-1301; Jans, David/0000-0001-5115-4745	Australian National Health and Medical Research Council [334013, 491055]; Australian Research Council (ARC Centre of Excellence) [CE0348239]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC Centre of Excellence)(Australian Research Council)	The authors acknowledge the support of the Australian National Health and Medical Research Council (fellowship 334013 and project grant 491055) and the Australian Research Council (ARC Centre of Excellence grant CE0348239), and thank Manisha Dias and Tracy Waterhouse for skilled technical assistance, and Stefan Huebner and Teodora Paicu for assistance with preliminary experiments.	Alvisi G, 2005, TRAFFIC, V6, P1002, DOI 10.1111/j.1600-0854.2005.00331.x; Alvisi G, 2008, BBA-PROTEINS PROTEOM, V1784, P213, DOI 10.1016/j.bbapap.2007.08.021; Alvisi G, 2007, BIOCHEMISTRY-US, V46, P9155, DOI 10.1021/bi7002394; Alvisi G, 2006, BIOCHEMISTRY-US, V45, P6866, DOI 10.1021/bi060086u; Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; Asada M, 2004, MOL CELL BIOL, V24, P8236, DOI 10.1128/MCB.24.18.8236-8243.2004; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; Briggs LJ, 1998, J BIOL CHEM, V273, P22745, DOI 10.1074/jbc.273.35.22745; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Fridell RA, 1997, J CELL SCI, V110, P1325; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Ghildyal R, 2009, J VIROL, V83, P5353, DOI 10.1128/JVI.02374-08; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; Hubner S, 2006, J CELL BIOCHEM, V98, P810, DOI 10.1002/jcb.20791; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; JANS DA, 1995, J BIOL CHEM, V270, P17064, DOI 10.1074/jbc.270.29.17064; Jans DA, 1996, J BIOL CHEM, V271, P30781, DOI 10.1074/jbc.271.48.30781; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kim IS, 2000, J BIOL CHEM, V275, P23139, DOI 10.1074/jbc.M909256199; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Liang SH, 2001, EUR J BIOCHEM, V268, P2779, DOI 10.1046/j.1432-1327.2001.02227.x; Mikenberg I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000589; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Nakajima A, 2003, CANCER LETT, V201, P195, DOI 10.1016/S0304-3835(03)00443-9; Nakielny S, 1996, EXP CELL RES, V229, P261, DOI 10.1006/excr.1996.0369; Nguyen NL, 2008, J VIROL, V82, P5381, DOI 10.1128/JVI.02697-07; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Pei Y, 2008, VIRUS RES, V135, P107, DOI 10.1016/j.virusres.2008.02.012; Piller SC, 1999, J VIROL, V73, P4230, DOI 10.1128/JVI.73.5.4230-4238.1999; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Poon IH, 2005, CANCER RES, V65, P7059, DOI 10.1158/0008-5472.CAN-05-1370; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Poon IKH, 2005, J VIROL, V79, P1339, DOI 10.1128/JVI.79.2.1339-1341.2005; Preiss S, 2001, J BIOL CHEM, V276, P27864, DOI 10.1074/jbc.M101278200; Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x; RIHS HP, 1991, FEBS LETT, V291, P6, DOI 10.1016/0014-5793(91)81090-U; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; Rodriguez-Vilarrupla A, 2002, FEBS LETT, V531, P319, DOI 10.1016/S0014-5793(02)03549-4; SCHEIDTMANN KH, 1984, J VIROL, V50, P1; Sim H, 2005, MOL ENDOCRINOL, V19, P1884, DOI 10.1210/me.2004-0334; Sunn KL, 2005, BIOCHEM J, V388, P509, DOI 10.1042/BJ20042040; Tago K, 2004, MOL CELL ENDOCRINOL, V213, P131, DOI 10.1016/j.mce.2003.10.057; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Trapani JA, 1998, CELL DEATH DIFFER, V5, P488, DOI 10.1038/sj.cdd.4400373; Truant R, 1999, MOL CELL BIOL, V19, P1210; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Xiao CY, 1997, J BIOL CHEM, V272, P22191, DOI 10.1074/jbc.272.35.22191	56	33	35	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1454	1466		10.1096/fj.09-136564	http://dx.doi.org/10.1096/fj.09-136564			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20040518	Green Submitted			2022-12-25	WOS:000277158900018
J	van den Broek, NMA; Ciapaite, J; De Feyter, HMML; Houten, SM; Wanders, RJA; Jeneson, JAL; Nicolay, K; Prompers, JJ				van den Broek, N. M. A.; Ciapaite, J.; De Feyter, H. M. M. L.; Houten, S. M.; Wanders, R. J. A.; Jeneson, J. A. L.; Nicolay, K.; Prompers, J. J.			Increased mitochondrial content rescues in vivo muscle oxidative capacity in long-term high-fat-diet-fed rats	FASEB JOURNAL			English	Article						diabetes; insulin resistance; magnetic resonance spectroscopy; intramyocellular lipid; mitochondrial function	SATURATION-TRANSFER MEASUREMENTS; INTRAMYOCELLULAR LIPID-CONTENT; SKELETAL-MUSCLE; INSULIN-RESISTANCE; LIVER-MITOCHONDRIA; GENE-EXPRESSION; ACID OXIDATION; PHOSPHORYLATION; DEHYDROGENASE; DYSFUNCTION	Mitochondria are thought to play a crucial role in the etiology of muscle insulin resistance (IR). The aim of this study was to gain more insight into the timing and nature of mitochondrial adaptations during the development of high-fat-diet (HFD)-induced IR. Adult Wistar rats were fed HFD or normal chow for 2.5 and 25 wk. Intramyocellular lipids (IMCLs) were quantified in vivo using H-1 magnetic resonance spectroscopy (MRS). Muscle oxidative capacity was assessed in vivo using P-31 MRS and in vitro by measuring mitochondrial DNA copy number and oxygen consumption in isolated mitochondria. MRS in tibialis anterior muscle revealed 3.3-fold higher IMCL content and 1.2-fold increased oxidative capacity after 2.5 wk of HFD feeding. The latter result could be fully accounted for by increased mitochondrial content. After 25 wk of HFD, maximal ADP-stimulated oxygen consumption in isolated mitochondria oxidizing pyruvate plus malate remained unaffected, while IMCL and mitochondrial content had further increased compared to controls (5.1-fold and 1.4-fold, respectively). Interestingly, in vivo oxidative capacity at this time point was identical to controls. These results show that skeletal muscle in HFD-induced IR accompanied by IMCL accumulation requires a progressively larger mitochondrial pool size to maintain normal oxidative capacity in vivo.-Van den Broek, N. M. A., Ciapaite, J., De Feyter, H. M. M. L., Houten, S. M., Wanders, R. J. A., Jeneson, J. A. L., Nicolay, K., Prompers, J. J. Increased mitochondrial content rescues in vivo muscle oxidative capacity in long-term high-fat-diet-fed rats. FASEB J. 24, 1354-1364 (2010). www.fasebj.org	[van den Broek, N. M. A.; Ciapaite, J.; Jeneson, J. A. L.; Nicolay, K.; Prompers, J. J.] Eindhoven Univ Technol, Biomed NMR, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Ciapaite, J.; Jeneson, J. A. L.] Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [De Feyter, H. M. M. L.] Yale Univ, Sch Med, Dept Diagnost Radiol, Magnet Resonance Res Ctr, New Haven, CT 06510 USA; [Houten, S. M.; Wanders, R. J. A.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Houten, S. M.; Wanders, R. J. A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	Eindhoven University of Technology; Yale University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Prompers, JJ (corresponding author), Eindhoven Univ Technol, Biomed NMR, Dept Biomed Engn, NL B1-08,POB 513, NL-5600 MB Eindhoven, Netherlands.	j.j.prompers@tue.nl	De Feyter, Henk/B-8107-2008; Houten, Sander/Y-3599-2019; Nicolay, Klaas/F-4192-2010	De Feyter, Henk/0000-0001-6111-0316; Houten, Sander/0000-0002-6167-9147; Ciapaite, Jolita/0000-0001-8761-9233; Nicolay, Klaas/0000-0002-4179-616X; Prompers, Jeanine/0000-0002-4756-4474	Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research; Netherlands Organisation for Scientific Research (VIDI) [700.58.421, 016.086.336]	Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (VIDI)(Netherlands Organization for Scientific Research (NWO))	The authors thank J. W. Habets, L. B. P. Niesen, and R. A. M. Jonkers for technical assistance. The work of J. C. and J. A. L. J. is financed by the Netherlands Consortium for Systems Biology (NCSB), which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research. J. J. P. and S. M. H. are supported by VIDI grants from the Netherlands Organisation for Scientific Research (VIDI grants 700.58.421 and 016.086.336, respectively).	Andrade FH, 2005, INVEST OPHTH VIS SCI, V46, P4541, DOI 10.1167/iovs.05-0809; Boden G, 2001, DIABETES, V50, P1612, DOI 10.2337/diabetes.50.7.1612; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; BRASS EP, 1980, BIOCHEM J, V190, P495, DOI 10.1042/bj1900495; BRINDLE KM, 1989, BIOCHEMISTRY-US, V28, P4887, DOI 10.1021/bi00437a054; BRINDLE KM, 1987, BIOCHIM BIOPHYS ACTA, V928, P45, DOI 10.1016/0167-4889(87)90084-X; Chanseaume E, 2007, OBESITY, V15, P50, DOI 10.1038/oby.2007.511; Ciapaite J, 2007, BBA-MOL BASIS DIS, V1772, P307, DOI 10.1016/j.bbadis.2006.10.018; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; Costford SR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1018, DOI 10.1152/ajpendo.00779.2007; De Feyter HM, 2008, EUR J ENDOCRINOL, V158, P643, DOI 10.1530/EJE-07-0756; De Feyter HM, 2008, FASEB J, V22, P3947, DOI 10.1096/fj.08-112318; De Feyter HMML, 2006, MAGN RESON MED, V56, P19, DOI 10.1002/mrm.20924; de Graaf RA, 1998, MAGNET RESON MED, V40, P690, DOI 10.1002/mrm.1910400508; Didier L, 2007, AM J PHYSIOL-ENDOC M, V293, pE1169, DOI 10.1152/ajpendo.00263.2007; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Hoeks J, 2008, FEBS LETT, V582, P510, DOI 10.1016/j.febslet.2008.01.013; Iossa S, 2003, BRIT J NUTR, V90, P953, DOI 10.1079/BJN2003000968; KEMP GJ, 1994, MAGN RESON QUART, V10, P43; Kemp GJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE640, DOI 10.1152/ajpendo.00797.2007; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; LAAKSO M, 1992, DIABETES, V41, P1076, DOI 10.2337/diabetes.41.9.1076; LERNER E, 1972, J BIOL CHEM, V247, P1513; LIN BJ, 2002, J MICROLITH MICROFAB, V1, P1; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; McAinch AJ, 2003, OBES RES, V11, P1471, DOI 10.1038/oby.2003.197; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; NEMETH PM, 1992, AM J PHYSIOL, V262, pC282, DOI 10.1152/ajpcell.1992.262.2.C282; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; QUISTORFF B, 1993, BIOCHEM J, V291, P681, DOI 10.1042/bj2910681; REICHERT M, 1978, ACTA BIOL MED GER, V37, P1167; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Sahlin K, 1978, Acta Physiol Scand Suppl, V455, P1; Short KR, 2004, NEW ENGL J MED, V350, P2419; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; SRERE PA, 1963, ACTA CHEM SCAND, V17, P129, DOI 10.3891/acta.chem.scand.17s-0129; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Szuhai K, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e13; Taylor D J, 1983, Mol Biol Med, V1, P77; Toledo FGS, 2007, DIABETES, V56, P2142, DOI 10.2337/db07-0141; Tran TT, 2003, CANCER EPIDEM BIOMAR, V12, P47; Turner N, 2008, TRENDS ENDOCRIN MET, V19, P324, DOI 10.1016/j.tem.2008.08.001; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; van Hall G, 1999, P NUTR SOC, V58, P899, DOI 10.1017/S0029665199001202; van Loon LJC, 2004, AM J PHYSIOL-ENDOC M, V287, pE558, DOI 10.1152/ajpendo.00464.2003; Van Vlies N, 2005, BIOCHEM J, V387, P185, DOI 10.1042/BJ20041489; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Vicini P, 2000, AM J PHYSIOL-CELL PH, V279, pC213, DOI 10.1152/ajpcell.2000.279.1.C213; Wagenmakers AJM, 2005, PLOS MED, V2, P839, DOI 10.1371/journal.pmed.0020289; Wanders RJA, 1999, J INHERIT METAB DIS, V22, P442, DOI 10.1023/A:1005504223140; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	63	41	42	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1354	1364		10.1096/fj.09-143842	http://dx.doi.org/10.1096/fj.09-143842			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20040520				2022-12-25	WOS:000277158900009
J	Sarilla, S; Habib, SY; Kravtsov, DV; Matafonov, A; Gailani, D; Verhamme, IM				Sarilla, Suryakala; Habib, Sally Y.; Kravtsov, Dmitri V.; Matafonov, Anton; Gailani, David; Verhamme, Ingrid M.			Sucrose Octasulfate Selectively Accelerates Thrombin Inactivation by Heparin Cofactor II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; CATALYZED PROTEASE INACTIVATION; BLOOD-COAGULATION PROTEINASES; DISSEMINATED INTRAVASCULAR COAGULATION; PEPTIDE CHLOROMETHYL KETONES; LACTOBIONIC ACID-AMIDES; REGULATORY EXOSITE I; HUMAN-FACTOR V; ANTITHROMBIN-III; FACTOR-XA	Inactivation of thrombin (T) by the serpins heparin cofactor II (HCII) and antithrombin (AT) is accelerated by a heparin template between the serpin and thrombin exosite II. Unlike AT, HCII also uses an allosteric interaction of its NH2-terminal segment with exosite I. Sucrose octasulfate (SOS) accelerated thrombin inactivation by HCII but not AT by 2000-fold. SOS bound to two sites on thrombin, with dissociation constants (K-D) of 10 +/- 4 mu M and 400 +/- 300 mu M that were not kinetically resolvable, as evidenced by single hyperbolic SOS concentration dependences of the inactivation rate (k(obs)). SOS bound HCII with K-D 1.45 +/- 0.30 mM, and this binding was tightened in the T.SOS.HCII complex, characterized by K-complex of similar to 0.20 mu M. Inactivation data were incompatible with a model solely depending on HCII.SOS but fit an equilibrium linkage model employing T.SOS binding in the pathway to higher order complex formation. Hirudin-(54-65)(SO3-) caused a hyperbolic decrease of the inactivation rates, suggesting partial competitive binding of hirudin-(54-65)(SO3-) and HCII to exosite I. Meizothrombin(des-fragment 1), binding SOS with K-D = 1600 +/- 300 mu M, and thrombin were inactivated at comparable rates, and an exosite II aptamer had no effect on the inactivation, suggesting limited exosite II involvement. SOS accelerated inactivation of meizothrombin 1000-fold, reflecting the contribution of direct exosite I interaction with HCII. Thrombin generation in plasma was suppressed by SOS, both in HCII-dependent and -independent processes. The ex vivo HCII-dependent process may utilize the proposed model and suggests a potential for oversulfated disaccharides in controlling HCII-regulated thrombin generation.	[Sarilla, Suryakala; Habib, Sally Y.; Kravtsov, Dmitri V.; Matafonov, Anton; Gailani, David; Verhamme, Ingrid M.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University	Verhamme, IM (corresponding author), C3321A Med Ctr N, Nashville, TN 37232 USA.	ingrid.verhamme@vanderbilt.edu			National Institutes of Health, NHLBI [RO1 HL 080018, RO1 HL058837]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080018, R01HL058837] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grants RO1 HL 080018 (to I. M. V.) and RO1 HL058837 (to D. G.).	Baglin T, 2005, BRIT J HAEMATOL, V130, P653, DOI 10.1111/j.1365-2141.2005.05612.x; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Bauman SJ, 1999, J BIOL CHEM, V274, P34556, DOI 10.1074/jbc.274.49.34556; BEGUIN SS, 1991, SEMIN THROMB HEMOST, V17, P126; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BODE W, 1992, PROTEIN SCI, V1, P426; Bohme C, 2002, EUR J BIOCHEM, V269, P977, DOI 10.1046/j.0014-2956.2001.02732.x; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; CHURCH FC, 1989, J BIOL CHEM, V264, P3618; CHURCH FC, 1987, ARCH BIOCHEM BIOPHYS, V259, P331, DOI 10.1016/0003-9861(87)90499-1; Colwell NS, 1999, BBA-PROTEIN STRUCT M, V1431, P148, DOI 10.1016/S0167-4838(99)00051-5; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; DANIELSSON A, 1986, J BIOL CHEM, V261, P5467; DESAI UR, 1995, CARBOHYD RES, V275, P391, DOI 10.1016/0008-6215(95)00159-Q; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; Dharmawardana KR, 1999, J BIOL CHEM, V274, P18635, DOI 10.1074/jbc.274.26.18635; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; DUGGLEBY RG, 1977, BIOCHIM BIOPHYS ACTA, V481, P297, DOI 10.1016/0005-2744(77)90264-9; Fannon M, 2008, J CELL PHYSIOL, V215, P434, DOI 10.1002/jcp.21327; FENTON JW, 1977, J BIOL CHEM, V252, P3587; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Hayakawa Y, 2000, BBA-PROTEIN STRUCT M, V1543, P86, DOI 10.1016/S0167-4838(00)00193-X; He L, 2002, J CLIN INVEST, V109, P213, DOI 10.1172/JCI200213432; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Hiebert LM, 2002, PHARM RES-DORDR, V19, P838, DOI 10.1023/A:1016161001013; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; HORTIN GL, 1989, J BIOL CHEM, V264, P13979; Hung KW, 2005, BIOCHEMISTRY-US, V44, P15787, DOI 10.1021/bi051030n; Innis CA, 2003, J BIOL CHEM, V278, P39969, DOI 10.1074/jbc.M211284200; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KARIO K, 1992, THROMB RES, V66, P435, DOI 10.1016/0049-3848(92)90292-I; KLAUSER RJ, 1991, J PHARMACOL EXP THER, V259, P8; KLAUSER RJ, 1991, SEMIN THROMB HEMOST, V17, P118; KLAUSER RJ, 1991, THROMB RES, V62, P557, DOI 10.1016/0049-3848(91)90028-U; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Kulahin N, 2008, ACTA CRYSTALLOGR F, V64, P448, DOI 10.1107/S174430910801066X; LOTTENBERG R, 1981, METHOD ENZYMOL, V80, P341; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; Mammen EF, 2008, SEMIN THROMB HEMOST, V34, pA22, DOI 10.1055/s-2007-995819; MANN KG, 1981, METHOD ENZYMOL, V80, P286; Martin DJ, 1999, J PHARMACOL EXP THER, V288, P516; Meagher JL, 2000, J BIOL CHEM, V275, P2698, DOI 10.1074/jbc.275.4.2698; Mitchell JW, 2002, J BIOL CHEM, V277, P19823, DOI 10.1074/jbc.M200630200; Myles T, 1998, J BIOL CHEM, V273, P31203, DOI 10.1074/jbc.273.47.31203; NAGASHIMA R, 1981, J CLIN GASTROENTEROL, V3, P117; Noda A, 2002, CLIN APPL THROMB-HEM, V8, P265, DOI 10.1177/107602960200800311; O'Keeffe D, 2004, J BIOL CHEM, V279, P50267, DOI 10.1074/jbc.M408774200; OFOSU FA, 1992, EUR J BIOCHEM, V203, P121, DOI 10.1111/j.1432-1033.1992.tb19836.x; OLSON ST, 1986, J BIOL CHEM, V261, P3151; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; OLSON ST, 1988, J BIOL CHEM, V263, P1698; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Papaconstantinou ME, 2008, CELL MOL LIFE SCI, V65, P3688, DOI 10.1007/s00018-008-8502-7; RAAKE W, 1991, SEMIN THROMB HEMOST, V17, P129; RAGG H, 1990, J BIOL CHEM, V265, P22386; Rand MD, 1996, BLOOD, V88, P3432, DOI 10.1182/blood.V88.9.3432.bloodjournal8893432; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; ROGERS SJ, 1992, J BIOL CHEM, V267, P3613; STREUSAND VJ, 1995, J BIOL CHEM, V270, P9043, DOI 10.1074/jbc.270.16.9043; STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Tchaikovski SN, 2007, J THROMB HAEMOST, V5, P2079, DOI 10.1111/j.1538-7836.2007.02719.x; TIAN WX, 1982, BIOCHEMISTRY-US, V21, P1028, DOI 10.1021/bi00534a031; TOLLEFSEN DM, 1995, THROMB HAEMOSTASIS, V74, P1209; TOLLEFSEN DM, 1983, J BIOL CHEM, V258, P6713; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; VANDEERLIN VMD, 1991, J BIOL CHEM, V266, P20223; Verhamme IM, 2004, J BIOL CHEM, V279, P9785, DOI 10.1074/jbc.M313962200; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; VOLKIN DB, 1993, BIOCHIM BIOPHYS ACTA, V1203, P18, DOI 10.1016/0167-4838(93)90031-L; Wall D, 2001, THROMB RES, V103, P325, DOI 10.1016/S0049-3848(01)00314-0; Yeh BK, 2002, MOL CELL BIOL, V22, P7184, DOI 10.1128/MCB.22.20.7184-7192.2002; ZHU XT, 1993, STRUCTURE, V1, P27, DOI 10.1016/0969-2126(93)90006-3	80	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8278	8289		10.1074/jbc.M109.005967	http://dx.doi.org/10.1074/jbc.M109.005967			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20053992	Green Published, hybrid			2022-12-25	WOS:000275413800046
J	Bellei, B; Maresca, V; Flori, E; Pitisci, A; Larue, L; Picardo, M				Bellei, Barbara; Maresca, Vittoria; Flori, Enrica; Pitisci, Angela; Larue, Lionel; Picardo, Mauro			p38 Regulates Pigmentation via Proteasomal Degradation of Tyrosinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MELANOMA-CELL DIFFERENTIATION; NORMAL HUMAN MELANOCYTES; ULTRAVIOLET-B RADIATION; TRANSCRIPTION FACTOR; MAP KINASE; MOUSE MELANOMA; ERK ACTIVATION; NITRIC-OXIDE; INDUCED MELANOGENESIS	The synthesis of melanin pigments, or melanogenesis, is regulated by the balance of a variety of signal transduction pathways. Among these pathways, p38 MAPK signaling was found to be involved in stress-induced melanogenesis and to be activated by alpha-melanocyte-stimulating hormone (alpha-MSH) and ultraviolet irradiation. Previous studies have shown that alpha-MSH-stimulated melanogenesis can be inhibited by blocking p38 MAPK activity with SB203580, a pyridinyl imidazole compound. Consistent with this, we observed that pyridinyl imidazoles (SB203580 and SB202190) inhibited both basal and alpha-MSH-induced melanogenesis in B16 melanoma cells. However, SB202474, which has no ability to inhibit p38 MAPK activity and is usually used as a negative control compound in p38 MAPK studies, also suppressed melanin synthesis induction. Furthermore, the independence of the p38 kinase pathway from the repression of melanogenesis by pyridinyl imidazole compounds was also confirmed by small interfering RNA experiments. Interfering with p38 MAPK expression surprisingly stimulated melanogenesis and tyrosinase family protein expression. Although the molecular mechanism(s) by which p38 promotes the degradation of melanogenic enzymes remain to be determined, the involvement of the ubiquitin-proteasome pathway was demonstrated by co-treatment with the proteasome-specific inhibitor MG132 and the relative decrease in the ubiquitination of tyrosinase in cells transfected with p38-specific small interfering RNA.	[Bellei, Barbara] IRCCS, Lab Cutaneous Physiopathol, Ist Dermatol San Gallicano, I-00144 Rome, Italy; [Larue, Lionel] CNRS, Inst Curie, UMR 146, F-91405 Orsay, France	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Bellei, B (corresponding author), IRCCS, Lab Cutaneous Physiopathol, Ist Dermatol San Gallicano, Via Elio Chianesi 53, I-00144 Rome, Italy.	citolab@ifo.it	Pitisci, Angela/AAH-9415-2019; maresca, vittoria/J-3272-2016; Larue, Lionel/I-6532-2016; Picardo, Mauro/A-6978-2011; Larue, Lionel/F-7355-2013; Flori, Enrica/H-4417-2014; Bellei, Barbara/K-5288-2016	maresca, vittoria/0000-0001-9239-6978; Picardo, Mauro/0000-0003-4899-6639; Flori, Enrica/0000-0002-9275-1041; Bellei, Barbara/0000-0002-3883-5500	Ministero della Salute (Italy) [onc-ord/32/07]	Ministero della Salute (Italy)(Ministry of Health, Italy)	This work was supported in part by Grant onc-ord/32/07 from the Ministero della Salute (Italy).	ABDELMALEK Z, 1994, PIGM CELL RES, V7, P326, DOI 10.1111/j.1600-0749.1994.tb00635.x; ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789; Ahn JH, 2008, ARCH DERMATOL RES, V300, P325, DOI 10.1007/s00403-008-0863-0; Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Al-Shanti N, 2008, J ENDOCRINOL, V198, P243, DOI 10.1677/JOE-08-0151; Ando H, 2004, J BIOL CHEM, V279, P15427, DOI 10.1074/jbc.M313701200; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; Benedito E, 1997, BBA-GEN SUBJECTS, V1336, P59, DOI 10.1016/S0304-4165(97)00011-1; Bertolotto C, 1998, ONCOGENE, V16, P1665, DOI 10.1038/sj.onc.1201685; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Borovansky J, 2008, PIGM CELL MELANOMA R, V21, P298; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Casanovas O, 2004, ONCOGENE, V23, P7537, DOI 10.1038/sj.onc.1208040; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chung SY, 2009, BIOSCI BIOTECH BIOCH, V73, P1704, DOI 10.1271/bbb.80766; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Englaro W, 1998, J BIOL CHEM, V273, P9966, DOI 10.1074/jbc.273.16.9966; Fang D, 2001, PIGM CELL RES, V14, P132, DOI 10.1034/j.1600-0749.2001.140209.x; FULLER BB, 1987, J BIOL CHEM, V262, P4024; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Godbole D, 2006, CELL BIOL INT, V30, P895, DOI 10.1016/j.cellbi.2006.06.009; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; HALABAN R, 1983, J CELL BIOL, V97, P480, DOI 10.1083/jcb.97.2.480; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; HALABAN R, 1977, EXP CELL RES, V108, P111, DOI 10.1016/S0014-4827(77)80016-5; Hasegawa T, 2008, J NEUROCHEM, V105, P1700, DOI 10.1111/j.1471-4159.2008.05277.x; Hata K, 2003, J BIOCHEM, V134, P441, DOI 10.1093/jb/mvg162; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hornyak TJ, 2000, J INVEST DERMATOL, V115, P106, DOI 10.1046/j.1523-1747.2000.00030.x; Huang M, 2002, J BIOL CHEM, V277, P28364, DOI 10.1074/jbc.C200321200; Im SB, 1998, CANCER RES, V58, P47; Jimenez-Cervantes C, 2001, J CELL SCI, V114, P2335; Khaled M, 2003, J INVEST DERMATOL, V121, P831, DOI 10.1046/j.1523-1747.2003.12420.x; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; Kim DS, 2007, ARCH PHARM RES, V30, P581, DOI 10.1007/BF02977652; Kim DS, 2006, PIGM CELL RES, V19, P146, DOI 10.1111/j.1600-0749.2005.00287.x; Kim DS, 2004, ARCH PHARM RES, V27, P334, DOI 10.1007/BF02980069; Kim DS, 2003, J CELL SCI, V116, P1699, DOI 10.1242/jcs.00366; Kim DS, 2002, CELL SIGNAL, V14, P779, DOI 10.1016/S0898-6568(02)00024-4; KOBAYASHI T, 1994, EMBO J, V13, P5818, DOI 10.1002/j.1460-2075.1994.tb06925.x; Kono M, 2006, MOL CANCER RES, V4, P779, DOI 10.1158/1541-7786.MCR-06-0077; LASKIN JD, 1982, J CELL PHYSIOL, V113, P481, DOI 10.1002/jcp.1041130318; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee J, 2007, BIOCHEM PHARMACOL, V74, P960, DOI 10.1016/j.bcp.2007.06.007; Newton RA, 2007, J INVEST DERMATOL, V127, P2216, DOI 10.1038/sj.jid.5700840; PARK HY, 1993, J BIOL CHEM, V268, P11742; Park HY, 1996, EXP CELL RES, V227, P70, DOI 10.1006/excr.1996.0251; Park HY, 1999, J BIOL CHEM, V274, P16470, DOI 10.1074/jbc.274.23.16470; PAVAN WJ, 1994, P NATL ACAD SCI USA, V91, P7159, DOI 10.1073/pnas.91.15.7159; RomeroGraillet C, 1997, J CLIN INVEST, V99, P635, DOI 10.1172/JCI119206; RomeroGraillet C, 1996, J BIOL CHEM, V271, P28052, DOI 10.1074/jbc.271.45.28052; Rouzaud F, 2003, FASEB J, V17, P2154, DOI 10.1096/fj.03-0206fje; Sasaki M, 2000, PIGM CELL RES, V13, P248, DOI 10.1034/j.1600-0749.2000.130406.x; Shibazaki M, 2004, J BIOL CHEM, V279, P3869, DOI 10.1074/jbc.M305880200; Shimo T, 2007, J CELL COMMUN SIGNAL, V1, P103, DOI 10.1007/s12079-007-0010-2; SIEGRIST W, 1986, ANAL BIOCHEM, V159, P191, DOI 10.1016/0003-2697(86)90327-1; Singh SK, 2005, PIGM CELL RES, V18, P113, DOI 10.1111/j.1600-0749.2005.00219.x; Smalley K, 2000, FEBS LETT, V476, P198, DOI 10.1016/S0014-5793(00)01726-9; Smalley KSM, 2002, MELANOMA RES, V12, P187, DOI 10.1097/00008390-200206000-00001; Tachibana M, 1996, NAT GENET, V14, P50, DOI 10.1038/ng0996-50; Watabe H, 2004, J BIOL CHEM, V279, P7971, DOI 10.1074/jbc.M309714200; WINDER A, 1994, CELL MOL BIOL RES, V40, P613; WONG G, 1975, NATURE, V255, P644, DOI 10.1038/255644a0; Wu M, 2000, GENE DEV, V14, P301; YOKOYAMA K, 1994, BBA-GENE STRUCT EXPR, V1217, P317, DOI 10.1016/0167-4781(94)90292-5; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116	68	89	90	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7288	7299		10.1074/jbc.M109.070573	http://dx.doi.org/10.1074/jbc.M109.070573			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20053998	Green Published, hybrid			2022-12-25	WOS:000275415600041
J	Christgen, M; Geffers, R; Ballmaier, M; Christgen, H; Poczkaj, J; Krech, T; Kreipe, H; Lehmann, U				Christgen, Matthias; Geffers, Robert; Ballmaier, Matthias; Christgen, Henriette; Poczkaj, Janette; Krech, Till; Kreipe, Hans; Lehmann, Ulrich			Down-regulation of the Fetal Stem Cell Factor SOX17 by H33342 A MECHANISM RESPONSIBLE FOR DIFFERENTIAL GENE EXPRESSION IN BREAST CANCER SIDE POPULATION CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POPULATION CELLS; STEM/PROGENITOR CELLS; CARCINOMA; IDENTIFICATION; JAG1; PHENOTYPE; SURVIVAL; PATHWAY; EFFLUX; LINES	Human solid tumors contain rare cancer side population (SP) cells, which expel the fluorescent dye Hoechst 33342 (H33342) and display cancer stem cell characteristics. Transcriptional profiling of cancer SP cells isolated by H33342 fluorescence analysis is a newly emerging approach to discover cancer stem cell markers and aberrant differentiation pathways. Using Affymetrix expression microarrays and quantitative reverse transcription-PCR, we investigated differential gene expression between SP and non-SP (NSP) cells isolated from human mammary carcinoma cell lines. A total of 136 genes were up-regulated in breast cancer SP relative to NSP cells, one of which was the fetal stem cell factor and Wnt/beta-catenin signaling pathway target SOX17. Strikingly, we discovered that SOX17 was down-regulated by H33342 in a dose-dependent manner. In SP cells, which expel H33342, down-regulation of SOX17 was less pronounced than in NSP cells, which retain H33342. As a result of this, SOX17 displayed a 10-20-fold overexpression in cancer SP relative to NSP cells. Similar results were obtained for further stemness-related genes, namely EPC1 and SPRY1. These findings establish a previously unidentified gene-regulatory impact of H33342 as a novel mechanism responsible for differential gene expression in cancer SP cells. This has significant implications for the future interpretation of cancer SP cells.	[Christgen, Matthias; Christgen, Henriette; Poczkaj, Janette; Krech, Till; Kreipe, Hans; Lehmann, Ulrich] Hannover Med Sch, Inst Pathol, D-30625 Hannover, Germany; [Ballmaier, Matthias] Hannover Med Sch, Cell Sorting Core Facil, D-30625 Hannover, Germany; [Geffers, Robert] Helmholtz Ctr, Dept Cell Biol, D-38124 Braunschweig, Germany	Hannover Medical School; Hannover Medical School	Christgen, M (corresponding author), Hannover Med Sch, Inst Pathol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	christgen.matthias@MH-Hannover.de	Ballmaier, Matthias/J-4175-2014	Ballmaier, Matthias/0000-0002-1352-5995				Behbod F, 2006, STEM CELLS, V24, P1065, DOI 10.1634/stemcells.2005-0375; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; CAMARGO FD, 2004, HDB STEM CELLS, P329; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Christgen M, 2007, MOL CELL BIOCHEM, V306, P201, DOI 10.1007/s11010-007-9570-y; Christgen M, 2009, J PATHOL, V217, P620, DOI 10.1002/path.2495; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Decraene C, 2005, PHYSIOL GENOMICS, V23, P132, DOI 10.1152/physiolgenomics.00141.2004; Dickson BC, 2007, MODERN PATHOL, V20, P685, DOI 10.1038/modpathol.3800785; Du YC, 2009, GASTROENTEROLOGY, V137, P1346, DOI 10.1053/j.gastro.2009.06.041; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; FRIED J, 1982, CYTOMETRY, V3, P42, DOI 10.1002/cyto.990030110; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Harris MA, 2008, CANCER RES, V68, P10051, DOI 10.1158/0008-5472.CAN-08-0786; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DZ, 2009, STEM CELLS DEV, V18, P465, DOI 10.1089/scd.2008.0033; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Liang SX, 2005, PHYSIOL GENOMICS, V23, P172, DOI 10.1152/physiolgenomics.00059.2005; Nishii T, 2009, CANCER SCI, V100, P1397, DOI 10.1111/j.1349-7006.2009.01211.x; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Phillips TM, 2007, NEOPLASIA, V9, P1122, DOI 10.1593/neo.07694; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Reedijk M, 2008, BREAST CANCER RES TR, V111, P439, DOI 10.1007/s10549-007-9805-3; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Simon R, 2004, DESIGN ANAL DNA MICR; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Zheng XS, 2007, CANCER RES, V67, P3691, DOI 10.1158/0008-5472.CAN-06-3912; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	41	15	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6412	6418		10.1074/jbc.M109.082941	http://dx.doi.org/10.1074/jbc.M109.082941			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040597	Green Published, hybrid			2022-12-25	WOS:000275367500045
J	Gout, E; Garlatti, V; Smith, DF; Lacroix, M; Dumestre-Perard, C; Lunardi, T; Martin, L; Cesbron, JY; Arlaud, GJ; Gaboriaud, C; Thielens, NM				Gout, Evelyne; Garlatti, Virginie; Smith, David F.; Lacroix, Monique; Dumestre-Perard, Chantal; Lunardi, Thomas; Martin, Lydie; Cesbron, Jean-Yves; Arlaud, Gerard J.; Gaboriaud, Christine; Thielens, Nicole M.			Carbohydrate Recognition Properties of Human Ficolins GLYCAN ARRAY SCREENING REVEALS THE SIALIC ACID BINDING SPECIFICITY OF M-FICOLIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE COMPLEXES; N-ACETYLNEURAMINIC ACID; CRYSTAL-STRUCTURE; INNATE IMMUNITY; HAKATA ANTIGEN; LECTIN PATHWAY; CELL-SURFACE; H-FICOLIN; PATTERN; IDENTIFICATION	Ficolins are oligomeric innate immune recognition proteins consisting of a collagen-like region and a fibrinogen-like recognition domain that bind to pathogen- and apoptotic cell-associated molecular patterns. To investigate their carbohydrate binding specificities, serum-derived L-ficolin and recombinant H- and M-ficolins were fluorescently labeled, and their carbohydrate binding ability was analyzed by glycan array screening. L-ficolin preferentially recognized disulfated N-acetyllactosamine and tri- and tetrasaccharides containing terminal galactose or N-acetylglucosamine. Binding was sensitive to the position and orientation of the bond between N-acetyllactosamine and the adjacent carbohydrate. No significant binding of H- ficolin to any of the 377 glycans probed could be detected, providing further evidence for its poor lectin activity. M-ficolin bound preferentially to 9-O-acetylated 2-6-linked sialic acid derivatives and to various glycans containing sialic acid engaged in a 2-3 linkage. To further investigate the structural basis of sialic acid recognition by M-ficolin, point mutants were produced in which three residues of the fibrinogen domain were replaced by their counterparts in L-ficolin. Mutations G221F and A256V inhibited binding to the 9-O-acetylated sialic acid derivatives, whereas Y271F abolished interaction with all sialic acid-containing glycans. The crystal structure of the Y271F mutant fibrinogen domain was solved, showing that the mutation does not alter the structure of the ligand binding pocket. These analyses reveal novel ficolin ligands such as sulfated N-acetyllactosamine (L-ficolin) and gangliosides (M-ficolin) and provide precise insights into the sialic acid binding specificity of M-ficolin, emphasizing the essential role of Tyr(271) in this respect.	[Gout, Evelyne; Lacroix, Monique; Lunardi, Thomas; Arlaud, Gerard J.; Thielens, Nicole M.] Univ Grenoble 1, CNRS, UMR 5075, Inst Biol Struct Jean Pierre Ebel,CEA,Lab Enzymol, F-38027 Grenoble 1, France; [Garlatti, Virginie; Martin, Lydie; Gaboriaud, Christine] Univ Grenoble 1, CNRS, UMR 5075, Inst Biol Struct Jean Pierre Ebel,CEA,Lab Cristal, F-38027 Grenoble 1, France; [Smith, David F.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Dumestre-Perard, Chantal; Cesbron, Jean-Yves] Univ Grenoble 1, CNRS, UMR 5163, Lab Adaptat & Pathogenie Microorganismes, F-38042 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Emory University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Thielens, NM (corresponding author), Univ Grenoble 1, CNRS, UMR 5075, Inst Biol Struct Jean Pierre Ebel,CEA,Lab Enzymol, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	nicole.thielens@ibs.fr	Thielens, Nicole M/F-2512-2013	Thielens, Nicole M/0000-0002-7354-0302; gaboriaud, christine/0000-0001-5308-0516	Commissariat a l'Energie Atomique; CNRS; Universite Joseph Fourier; Grenoble; Agence Nationale de la Recherche [ANR-05-MIME-023-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Commissariat a l'Energie Atomique(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier; Grenoble(Region Auvergne-Rhone-Alpes); Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Commissariat a l'Energie Atomique, the CNRS, the Universite Joseph Fourier, Grenoble, and Agence Nationale de la Recherche Grant ANR-05-MIME-023-01.	Aoyagi Y, 2005, J IMMUNOL, V174, P418, DOI 10.4049/jimmunol.174.1.418; Aoyagi Y, 2008, INFECT IMMUN, V76, P179, DOI 10.1128/IAI.00837-07; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; DeAngelis PL, 2002, ANAT RECORD, V268, P317, DOI 10.1002/ar.10163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faro J, 2008, CLIN EXP IMMUNOL, V151, P275, DOI 10.1111/j.1365-2249.2007.03538.x; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Fraser DA, 2008, CURR DRUG TARGETS, V9, P113, DOI 10.2174/138945008783502476; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Garlatti V, 2007, J BIOL CHEM, V282, P35814, DOI 10.1074/jbc.M705741200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Garlatti V, 2010, J INNATE IMMUN, V2, P17, DOI 10.1159/000233475; Ghoshal A, 2009, PARASITOLOGY, V136, P159, DOI 10.1017/S0031182008005180; Harumiya S, 1996, J BIOCHEM-TOKYO, V120, P745; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; Honore C, 2008, MOL IMMUNOL, V45, P4134, DOI 10.1016/j.molimm.2008.08.117; Jensen ML, 2007, MOL IMMUNOL, V44, P856, DOI 10.1016/j.molimm.2006.04.002; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kairies N, 2001, P NATL ACAD SCI USA, V98, P13519, DOI 10.1073/pnas.201523798; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Kilpatrick DC, 1999, IMMUNOL LETT, V67, P109, DOI 10.1016/S0165-2478(98)00147-3; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Krarup A, 2008, IMMUNOL LETT, V118, P152, DOI 10.1016/j.imlet.2008.03.014; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; Le Y, 1998, FEBS LETT, V425, P367, DOI 10.1016/S0014-5793(98)00267-1; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lu JH, 1996, BIOCHEM J, V313, P473, DOI 10.1042/bj3130473; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Mandal C, 2000, BRIT J HAEMATOL, V110, P801, DOI 10.1046/j.1365-2141.2000.02105.x; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2002, IMMUNOBIOLOGY, V205, P490, DOI 10.1078/0171-2985-00149; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Monteiro VG, 2005, PARASITOL RES, V97, P380, DOI 10.1007/s00436-005-1460-1; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohashi T, 2004, J BIOL CHEM, V279, P6534, DOI 10.1074/jbc.M310555200; Ohashi T, 1998, ARCH BIOCHEM BIOPHYS, V360, P223, DOI 10.1006/abbi.1998.0957; Rodrigues ML, 1997, INFECT IMMUN, V65, P4937, DOI 10.1128/IAI.65.12.4937-4942.1997; SAHU A, 1993, MOL IMMUNOL, V30, P679, DOI 10.1016/0161-5890(93)90079-Q; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Sinha D, 2000, TRENDS GLYCOSCI GLYC, V12, P17, DOI 10.4052/tigg.12.17; Soares RMA, 2000, BBA-GEN SUBJECTS, V1474, P262, DOI 10.1016/S0304-4165(00)00003-9; Sugimoto R, 1998, J BIOL CHEM, V273, P20721, DOI 10.1074/jbc.273.33.20721; Tanio M, 2007, J BIOL CHEM, V282, P3889, DOI 10.1074/jbc.M608627200; Tanio M, 2009, BIOCHEM J, V417, P485, DOI 10.1042/BJ20081640; Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Tsujimura M, 2001, CLIN DIAGN LAB IMMUN, V8, P454, DOI 10.1128/CDLI.8.2.454-459.2001; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; WITTENBORN T, 2010, J INNATE IM IN PRESS; Yu RK, 2006, INFECT IMMUN, V74, P6517, DOI 10.1128/IAI.00967-06; Zacho RM, 2008, MOL IMMUNOL, V45, P4135, DOI 10.1016/j.molimm.2008.08.118	58	89	91	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6612	6622		10.1074/jbc.M109.065854	http://dx.doi.org/10.1074/jbc.M109.065854			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032467	hybrid, Green Published			2022-12-25	WOS:000275367500066
J	Li, M; Aliotta, JM; Asara, JM; Wu, Q; Dooner, MS; Tucker, LD; Wells, A; Quesenberry, PJ; Ramratnam, B				Li, Ming; Aliotta, Jason M.; Asara, John M.; Wu, Qian; Dooner, Mark S.; Tucker, Lynne D.; Wells, Alan; Quesenberry, Peter J.; Ramratnam, Bharat			Intercellular Transfer of Proteins as Identified by Stable Isotope Labeling of Amino Acids in Cell Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN EXPRESSION; EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; EMBRYONIC STEM-CELLS; REPRESSES E-CADHERIN; GENE-EXPRESSION; TUMOR-CELLS; DEACETYLASE COMPLEX; PROTEOMIC APPROACH; BREAST-CANCER	We tracked the extracellular fate of proteins of pulmonary origin using the technique of stable isotope labeling of amino acids in cell culture (SILAC) in cell-impermeable Transwell culture systems. We find that irradiation to murine lung and lung-derived cells induces their release of proteins that are capable of entering neighboring cells, including primary murine bone marrow cells as well as prostate cancer and hematopoietic cell lines. The functional classification of transferred proteins was broad and included transcription factors, mediators of basic cellular processes and components of the nucleosome remodeling and deacetylase complex, including metastasis associated protein 3 and retinoblastoma-binding protein 7. In further analysis we find that retinoblastoma-binding protein 7 is a transcriptional activator of E-cadherin and that its intercellular transfer leads to decreased gene expression of downstream targets such as N-cadherin and vimentin. SILAC-generated data sets offer a valuable tool to identify and validate potential paracrine networks that may impact relevant biologic processes associated with phenotypic and genotypic signatures of health and disease.	[Ramratnam, Bharat] Brown Univ, Dept Med, Div Infect Dis, Lab Retrovirol,Warren Alpert Med Sch, Providence, RI 02903 USA; [Aliotta, Jason M.; Dooner, Mark S.; Quesenberry, Peter J.] Brown Univ, Rhode Isl Hosp, Dept Med, Div Hematol & Oncol, Providence, RI 02903 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Asara, John M.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Wu, Qian; Wells, Alan] Pittsburgh Vet Adm Med Ctr, Dept Pathol, Pittsburgh, PA 15219 USA; [Wu, Qian; Wells, Alan] Univ Pittsburgh, Pittsburgh, PA 15219 USA	Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ramratnam, B (corresponding author), Brown Univ, Dept Med, Div Infect Dis, Lab Retrovirol,Warren Alpert Med Sch, 55 Claverick St, Providence, RI 02903 USA.	BRamratnam@lifespan.org		Wells, Alan/0000-0002-1637-8150; Dooner, Mark/0000-0003-0653-6562	National Institutes of Health [P20RR025179]; Lifespan/Brown/Tufts Center for AIDS Research [P30AI042853]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR025179] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103726, K08HL086868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lifespan/Brown/Tufts Center for AIDS Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR025179 and by Lifespan/Brown/Tufts Center for AIDS Research Grant P30AI042853 for assay support.	Aliotta JM, 2007, STEM CELLS, V25, P2245, DOI 10.1634/stemcells.2007-0128; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BEHRENS J, 1991, P NATL ACAD SCI USA, V88, P11495, DOI 10.1073/pnas.88.24.11495; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Doucet A, 2008, MOL CELL PROTEOMICS, V7, P1925, DOI 10.1074/mcp.R800012-MCP200; Everley PA, 2004, MOL CELL PROTEOMICS, V3, P729, DOI 10.1074/mcp.M400021-MCP200; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Gioia Magda, 2009, V539, P131, DOI 10.1007/978-1-60327-003-8_8; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hajra KM, 2002, CANCER RES, V62, P1613; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hennig G, 1996, J BIOL CHEM, V271, P595, DOI 10.1074/jbc.271.1.595; Ibarrola N, 2003, ANAL CHEM, V75, P6043, DOI 10.1021/ac034931f; JACOB L, 1987, P NATL ACAD SCI USA, V84, P1361, DOI 10.1073/pnas.84.5.1361; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; KOOYMAN DL, 1995, SCIENCE, V269, P89, DOI 10.1126/science.7541557; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Levchenko A, 2005, P NATL ACAD SCI USA, V102, P1933, DOI 10.1073/pnas.0401851102; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Niu XL, 2009, J CELL SCI, V122, P600, DOI 10.1242/jcs.031427; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; QIAN YW, 1995, J BIOL CHEM, V270, P25507, DOI 10.1074/jbc.270.43.25507; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Selbach M, 2006, NAT METHODS, V3, P981, DOI 10.1038/nmeth972; Thakur A, 2007, MOL CANCER RES, V5, P171, DOI 10.1158/1541-7786.MCR-06-0071; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	49	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6285	6297		10.1074/jbc.M109.057943	http://dx.doi.org/10.1074/jbc.M109.057943			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20026604	Green Published, hybrid			2022-12-25	WOS:000275367500033
J	Palacios, G; Hornig, M; Cisterna, D; Savji, N; Bussetti, AV; Kapoor, V; Hui, J; Tokarz, R; Briese, T; Baumeister, E; Lipkin, WI				Palacios, Gustavo; Hornig, Mady; Cisterna, Daniel; Savji, Nazir; Bussetti, Ana Valeria; Kapoor, Vishal; Hui, Jeffrey; Tokarz, Rafal; Briese, Thomas; Baumeister, Elsa; Lipkin, W. Ian			Streptococcus pneumoniae Coinfection Is Correlated with the Severity of H1N1 Pandemic Influenza	PLOS ONE			English	Article							A H1N1; BACTERIAL PNEUMONIA; UNITED-STATES; NEURAMINIDASE; PATHOGENS	Background: Initial reports in May 2009 of the novel influenza strain H1N1pdm estimated a case fatality rate (CFR) of 0.6%, similar to that of seasonal influenza. In July 2009, however, Argentina reported 3056 cases with 137 deaths, representing a CFR of 4.5%. Potential explanations for increased CFR included virus reassortment or genetic drift, or infection of a more vulnerable population. Virus genomic sequencing of 26 Argentinian samples representing both severe and mild disease indicated no evidence of reassortment, mutations associated with resistance to antiviral drugs, or genetic drift that might contribute to virulence. Furthermore, no evidence was found for increased frequency of risk factors for H1N1pdm disease. Methods/Principal Findings: We examined nasopharyngeal swab samples (NPS) from 199 cases of H1N1pdm infection from Argentina with MassTag PCR, testing for 33 additional microbial agents. The study population consisted of 199 H1N1pdm-infected subjects sampled between 23 June and 4 July 2009. Thirty-nine had severe disease defined as death (n = 20) or hospitalization (n = 19); 160 had mild disease. At least one additional agent of potential pathogenic importance was identified in 152 samples (76%), including Streptococcus pneumoniae (n = 62); Haemophilus influenzae (n = 104); human respiratory syncytial virus A (n = 11) and B (n = 1); human rhinovirus A (n = 1) and B (n = 4); human coronaviruses 229E (n = 1) and OC43 (n = 2); Klebsiella pneumoniae (n = 2); Acinetobacter baumannii (n = 2); Serratia marcescens (n = 1); and Staphylococcus aureus (n = 35) and methicillin-resistant S. aureus (MRSA, n = 6). The presence of S. pneumoniae was strongly correlated with severe disease. S. pneumoniae was present in 56.4% of severe cases versus 25% of mild cases; more than one-third of H1N1pdm NPS with S. pneumoniae were from subjects with severe disease (22 of 62 S. pneumoniae-positive NPS, p = 0.0004). In subjects 6 to 55 years of age, the adjusted odds ratio (OR) of severe disease in the presence of S. pneumoniae was 125.5 (95% confidence interval [CI], 16.95, 928.72; p < 0.0001). Conclusions/Significance: The association of S. pneumoniae with morbidity and mortality is established in the current and previous influenza pandemics. However, this study is the first to demonstrate the prognostic significance of non-invasive antemortem diagnosis of S. pneumoniae infection and may provide insights into clinical management.	[Palacios, Gustavo; Hornig, Mady; Savji, Nazir; Bussetti, Ana Valeria; Kapoor, Vishal; Hui, Jeffrey; Tokarz, Rafal; Briese, Thomas; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA; [Cisterna, Daniel; Baumeister, Elsa] Inst Nacl Enfermedades Infecciosas, Adm Nacl Labs, Buenos Aires, DF, Argentina; [Cisterna, Daniel; Baumeister, Elsa] Inst Salud Dr Carlos G Malbran, Buenos Aires, DF, Argentina	Columbia University	Palacios, G (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.	gp2050@columbia.edu; wil2001@columbia.edu	Lipkin, W. Ian/ABE-6216-2020; Hornig, Mady/AAE-8431-2020; CIsterna, Daniel/ABC-4873-2021; Palacios, Gustavo/I-7773-2015	Lipkin, W. Ian/0000-0002-8768-9386; Hornig, Mady/0000-0001-7572-3092; Palacios, Gustavo/0000-0001-5062-1938	National Institutes of Health [AI051292, U54 AI5715, R01 AI300278]; Department of Defense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051292, U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health awards AI051292, U54 AI57158 (Northeast Biodefense Center - Lipkin), and R01 AI30027, and the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briese T, 2005, EMERG INFECT DIS, V11, P310, DOI 10.3201/eid1102.040492; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hackett S, 2009, LANCET, V374, P605, DOI 10.1016/S0140-6736(09)61511-7; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; *MSAL, 2009, INFL PAND H1N1 2009; Peltola VT, 2005, J INFECT DIS, V192, P249, DOI 10.1086/430954; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; VAILLANT L, 2009, EURO SURVEILL, V14; World Health Organization, 2009, CDC PROT REAL TIM RT	14	204	216	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8540	10.1371/journal.pone.0008540	http://dx.doi.org/10.1371/journal.pone.0008540			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046873	Green Published, Green Submitted, gold			2022-12-25	WOS:000273180200019
J	Lin, S; Shi, YC; Yulyaningsih, E; Aljanova, A; Zhang, L; Macia, L; Nguyen, AD; Lin, EJD; During, MJ; Herzog, H; Sainsbury, A				Lin, Shu; Shi, Yan-Chuan; Yulyaningsih, Ernie; Aljanova, Aygul; Zhang, Lei; Macia, Laurence; Nguyen, Amy D.; Lin, En-Ju Deborah; During, Matthew J.; Herzog, Herbert; Sainsbury, Amanda			Critical Role of Arcuate Y4 Receptors and the Melanocortin System in Pancreatic Polypeptide-Induced Reduction in Food Intake in Mice	PLOS ONE			English	Article							SUBTYPE MESSENGER-RNAS; NEUROPEPTIDE-Y; STIMULATING HORMONE; PEPTIDE YY3-36; BODY-WEIGHT; PYY3-36; BRAIN; INHIBITION; EXPRESSION; ADIPOSITY	Background: Pancreatic polypeptide (PP) is a potent anti-obesity agent known to inhibit food intake in the absence of nausea, but the mechanism behind this process is unknown. Methodology/Principal Findings: Here we demonstrate that in response to i.p. injection of PP in wild type but not in Y4 receptor knockout mice, immunostaining for the neuronal activation marker c-Fos is induced specifically in neurons of the nucleus tractus solitarius and the area postrema in the brainstem, notably in cells also showing immunostaining for tyrosine hydroxylase. Importantly, strong c-Fos activation is also detected in the arcuate nucleus of the hypothalamus (ARC), particularly in neurons that co-express alpha melanocyte stimulating hormone (alpha-MSH), the anorexigenic product of the proopiomelanocortin (POMC) gene. Interestingly, other hypothalamic regions such as the paraventricular nucleus, the ventromedial nucleus and the lateral hypothalamic area also show c-Fos induction after PP injection. In addition to c-Fos activation, PP injection up-regulates POMC mRNA expression in the ARC as detected by in situ hybridization. These effects are a direct consequence of local Y4 signaling, since hypothalamus-specific conditional Y4 receptor knockout abolishes PP-induced ARC c-Fos activation and blocks the PP-induced increase in POMC mRNA expression. Additionally, the hypophagic effect of i.p. PP seen in wild type mice is completely absent in melanocortin 4 receptor knockout mice. Conclusions/Significance: Taken together, these findings show that PP reduces food intake predominantly via stimulation of the anorexigenic alpha-MSH signaling pathway, and that this effect is mediated by direct action on local Y4 receptors within the ARC, highlighting a potential novel avenue for the treatment of obesity.	[Lin, Shu; Shi, Yan-Chuan; Yulyaningsih, Ernie; Aljanova, Aygul; Zhang, Lei; Macia, Laurence; Nguyen, Amy D.; Herzog, Herbert; Sainsbury, Amanda] St Vincents Hosp, Garvan Inst Med Res, Neurosci Program, Sydney, NSW 2010, Australia; [Sainsbury, Amanda] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Herzog, Herbert] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Lin, En-Ju Deborah; During, Matthew J.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Lin, En-Ju Deborah; During, Matthew J.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Canc Genet & Neurosci Program, Columbus, OH 43210 USA	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lin, S (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Neurosci Program, Sydney, NSW 2010, Australia.	h.herzog@garvan.org.au	Macia, laurence/D-5983-2016; /A-4361-2010; Nguyen, Amy D/K-2588-2019; During, Matthew/AAC-1388-2020; Herzog, Herbert/B-8294-2008; /E-2900-2010; /A-6021-2011; Salis, Amanda/A-3187-2011; /B-6258-2012	Macia, laurence/0000-0003-0835-851X; Nguyen, Amy D/0000-0003-4603-564X; /0000-0003-2110-2017; Salis, Amanda/0000-0001-9176-1574; , Herbert/0000-0002-1713-1029; lin, shu/0000-0002-4239-2028	National Health and Medical Research Council (NHMRC) of Australia [427661, 427606]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported the National Health and Medical Research Council (NHMRC) of Australia grants #427661 & #427606, and AS and HH are supported by NHMRC Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2005, J NEUROSCI, V25, P7406, DOI 10.1523/JNEUROSCI.1008-05.2005; Asakawa A, 2003, GASTROENTEROLOGY, V124, P1325, DOI 10.1016/S0016-5085(03)00216-6; Balasubramaniam A, 2006, J MED CHEM, V49, P2661, DOI 10.1021/jm050907d; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Batterham RL, 2003, J CLIN ENDOCR METAB, V88, P3989, DOI 10.1210/jc.2003-030630; BERNTSON GG, 1993, PEPTIDES, V14, P497, DOI 10.1016/0196-9781(93)90138-7; Blomqvist AG, 1997, TRENDS NEUROSCI, V20, P294, DOI 10.1016/S0166-2236(96)01057-0; Challis BG, 2003, BIOCHEM BIOPH RES CO, V311, P915, DOI 10.1016/j.bbrc.2003.10.089; Chelikani PK, 2006, AM J PHYSIOL-REG I, V290, pR298, DOI 10.1152/ajpregu.00674.2005; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Date Y, 2006, CELL METAB, V4, P323, DOI 10.1016/j.cmet.2006.09.004; Ellacott KLJ, 2004, RECENT PROG HORM RES, V59, P395, DOI 10.1210/rp.59.1.395; Erondu N, 2007, OBESITY, V15, P895, DOI 10.1038/oby.2007.620; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gantz I, 2007, J CLIN ENDOCR METAB, V92, P1754, DOI 10.1210/jc.2006-1806; GETTYS TW, 1991, PANCREAS, V6, P46, DOI 10.1097/00006676-199101000-00007; GLASER B, 1988, HORM METAB RES, V20, P288, DOI 10.1055/s-2007-1010817; Halatchev IG, 2004, ENDOCRINOLOGY, V145, P2585, DOI 10.1210/en.2003-1754; Halatchev IG, 2005, CELL METAB, V1, P159, DOI 10.1016/j.cmet.2005.02.003; HORVATH TL, 1992, NEUROSCIENCE, V51, P391, DOI 10.1016/0306-4522(92)90323-T; INOUE S, 1991, BRAIN RES BULL, V27, P511, DOI 10.1016/0361-9230(91)90151-9; Iyengar S, 1999, J PHARMACOL EXP THER, V289, P1031; JEGOU S, 1993, ANN NY ACAD SCI, V680, P260, DOI 10.1111/j.1749-6632.1993.tb19689.x; Jesudason DR, 2007, BRIT J NUTR, V97, P426, DOI 10.1017/S0007114507336799; JIA BQ, 1984, GASTROENTEROLOGY, V87, P338; Jobst EE, 2004, TRENDS ENDOCRIN MET, V15, P488, DOI 10.1016/j.tem.2004.10.007; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kushi A, 1998, P NATL ACAD SCI USA, V95, P15659, DOI 10.1073/pnas.95.26.15659; Levi R, 2007, BIOCHEM PHARMACOL, V73, P1146, DOI 10.1016/j.bcp.2007.01.001; Mahon MJ, 2006, MOL ENDOCRINOL, V20, P136, DOI 10.1210/me.2005-0169; Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718; McMinn JE, 2000, AM J PHYSIOL-REG I, V279, pR695, DOI 10.1152/ajpregu.2000.279.2.R695; McTigue DM, 1997, J PHYSIOL-LONDON, V499, P475, DOI 10.1113/jphysiol.1997.sp021942; Parker R, 2000, METH MOL B, V153, P165; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Parkinson JRC, 2009, NEUROIMAGE, V44, P1022, DOI 10.1016/j.neuroimage.2008.09.047; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pittner R, 2004, INT J OBESITY, P1; Reinehr T, 2006, INT J OBESITY, V30, P1476, DOI 10.1038/sj.ijo.0803393; Sainsbury A, 2002, GENE DEV, V16, P1077, DOI 10.1101/gad.979102; Sainsbury A, 2002, P NATL ACAD SCI USA, V99, P8938, DOI 10.1073/pnas.132043299; SMITH MS, 1993, ENDOCRINOLOGY, V133, P1258, DOI 10.1210/en.133.3.1258; TOMITA T, 1989, PANCREAS, V4, P395, DOI 10.1097/00006676-198908000-00001; Ueno N, 1999, GASTROENTEROLOGY, V117, P1427, DOI 10.1016/S0016-5085(99)70293-3; Vergoni AV, 2000, EUR J PHARMACOL, V405, P25, DOI 10.1016/S0014-2999(00)00538-0; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR1037, DOI 10.1152/ajpregu.00125.2007; Wang HC, 2001, CRIT REV IMMUNOL, V21, P323	49	50	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8488	10.1371/journal.pone.0008488	http://dx.doi.org/10.1371/journal.pone.0008488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041129	Green Published, Green Submitted, gold			2022-12-25	WOS:000278068700006
J	Yang, JH; Pospisil, R; Ray, S; Milton, J; Mage, RG				Yang, Jiahui; Pospisil, Richard; Ray, Satyajit; Milton, Jacqueline; Mage, Rose G.			Investigations of a Rabbit (Oryctolagus cuniculus) Model of Systemic Lupus Erythematosus (SLE), BAFF and Its Receptors	PLOS ONE			English	Article							LYMPHOCYTE STIMULATOR BLYS; ANTI-DNA ANTIBODIES; B-CELL; EXPRESSION; TACI; AUTOIMMUNITY; SURVIVAL; DISEASE; TISSUES; CD5	B-cell activation factor belonging to the tumor necrosis factor family (BAFF) is a major contributor to survival of B lymphocytes during development and maturation. A relationship between circulating BAFF levels and disease activity has been reported in patients with the autoimmune disease Systemic Lupus Erythematosus (SLE). Clinical trials targeting BAFF or its receptors are currently in progress. In order to further characterize a rabbit (Oryctolagus cuniculus) model of SLE, we investigated the expression of BAFF and its receptors in non-inbred, pedigreed rabbits derived from breeding and selection based on autoantibody responses. We immunized rabbits related to previous groups that developed autoantibodies and inflammatory responses after immunizations with peptides synthesized on multiple antigen-branched polylysine backbones. Blood and sera collected before immunization and after boosts were used for health monitoring, analyses of serum autoantibody responses by ELISA and immunofluorescence. Peripheral blood mononuclear cells (PBMC) were studied by flow cytometry and were the source of mRNA for quantitative PCR analyses. We hypothesized that BAFF mRNA expression and serum BAFF levels measured indirectly through BAFF receptor binding might increase in autoantibody-producing rabbits. Immunized rabbits developed elevated levels of leucocyte populations, anti-nuclear, anti-dsDNA and other autoantibodies. BR3 mRNA levels in total PBMC decreased and BAFF levels remained low and unchanged in most immunized rabbits. By flow cytometry, percentages of BAFF positive cells decreased. Percentages of transmembrane activator and CAML interactor (TACI) decreased in most rabbits from all the immunized groups. The rabbit is an important model for human autoimmune and infectious diseases, and a high quality draft rabbit genome assembly was recently completed. Human disease models developed in non-inbred pedigreed animals are better able to reflect the complexities of diseases such as SLE with familial patterns of inheritance. Although no consistent pattern of elevated expression of BAFF mRNA or protein was found in the rabbits studied, the data collected and reported here build upon previous data to refine understanding of a rabbit model of SLE.	[Yang, Jiahui; Pospisil, Richard; Ray, Satyajit; Milton, Jacqueline; Mage, Rose G.] NIAID, Immunol Lab, NIH, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA)	Yang, JH (corresponding author), NIAID, Immunol Lab, NIH, Baltimore, MD USA.	rmage@niaid.nih.gov	Pospisil, Richard/B-7467-2012		NIH; NIAID; Oak Ridge Associated Universities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000036] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Oak Ridge Associated Universities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the intramural research program of the NIH, NIAID (http://www3.niaid.nih.gov/) and the Oak Ridge Associated Universities (http://www.orau.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardoin SP, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2488; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Cancro MP, 2009, J CLIN INVEST, V119, P1066, DOI 10.1172/JCI38010; Carter RH, 2005, ARTHRITIS RHEUM-US, V52, P3943, DOI 10.1002/art.21489; Darce JR, 2007, J IMMUNOL, V179, P7276, DOI 10.4049/jimmunol.179.11.7276; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Diamond B, 2006, ADV IMMUNOL, V89, P289, DOI 10.1016/S0065-2776(05)89007-8; Ding C, 2008, BIODRUGS, V22, P239, DOI 10.2165/00063030-200822040-00003; Furie R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2506; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; JAMES JA, 1995, J EXP MED, V181, P453, DOI 10.1084/jem.181.2.453; Ju SQ, 2006, CLIN BIOCHEM, V39, P1131, DOI 10.1016/j.clinbiochem.2006.09.010; Mackay F, 2008, CYTOKINE GROWTH F R, V19, P263, DOI 10.1016/j.cytogfr.2008.04.006; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; Ng LG, 2006, EUR J IMMUNOL, V36, P1837, DOI 10.1002/eji.200635956; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Pego-Reigosa JM, 2008, EXPERT OPIN INV DRUG, V17, P31, DOI 10.1517/13543784.17.1.31; Petri M, 2008, ARTHRITIS RHEUM, V58, P2453, DOI 10.1002/art.23678; Pospisil R, 2005, VET IMMUNOL IMMUNOP, V103, P257, DOI 10.1016/j.vetimm.2004.09.030; Pospisil R, 2006, DEV COMP IMMUNOL, V30, P711, DOI 10.1016/j.dci.2005.10.001; Pospisil R, 2009, MOL IMMUNOL, V46, P2456, DOI 10.1016/j.molimm.2009.05.026; Puliyath N, 2008, VET IMMUNOL IMMUNOP, V125, P251, DOI 10.1016/j.vetimm.2008.05.020; Rai G, 2006, J IMMUNOL, V176, P660, DOI 10.4049/jimmunol.176.1.660; RAMAN C, 1992, J IMMUNOL, V149, P3858; Sakurai D, 2007, EUR J IMMUNOL, V37, P110, DOI 10.1002/eji.200636623; Salzer U, 2005, CURR OPIN ALLERGY CL, V5, P496, DOI 10.1097/01.all.0000191887.89773.cc; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Servais G, 2009, CLIN CHEM LAB MED, V47, P543, DOI 10.1515/CCLM.2009.122; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Treml JF, 2009, CELL BIOCHEM BIOPHYS, V53, P1, DOI 10.1007/s12013-008-9036-1; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; Yang JH, 2009, DEV COMP IMMUNOL, V33, P697, DOI 10.1016/j.dci.2008.12.001	36	4	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8494	10.1371/journal.pone.0008494	http://dx.doi.org/10.1371/journal.pone.0008494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041151	Green Submitted, gold, Green Published			2022-12-25	WOS:000278068700009
J	Christiansen, HE; Lang, MR; Pace, JM; Parichy, DM				Christiansen, Helena E.; Lang, Michael R.; Pace, James M.; Parichy, David M.			Critical Early Roles for col27a1a and col27a1b in Zebrafish Notochord Morphogenesis, Vertebral Mineralization and Post-embryonic Axial Growth	PLOS ONE			English	Article							LOW-BACK-PAIN; COLLAGEN GENE; LYSYL OXIDASE; SCOLIOSIS; EXPRESSION; MUTATIONS; GASTRULATION; KNOCKDOWN; MOVEMENTS; DEFECTS	Background: Fibrillar collagens are well known for their links to human diseases, with which all have been associated except for the two most recently identified fibrillar collagens, type XXIV collagen and type XXVII collagen. To assess functions and potential disease phenotypes of type XXVII collagen, we examined its roles in zebrafish embryonic and post-embryonic development. Methodology/Principal Findings: We identified two type XXVII collagen genes in zebrafish, col27a1a and col27a1b. Both col27a1a and col27a1b were expressed in notochord and cartilage in the embryo and early larva. To determine sites of type XXVII collagen function, col27a1a and col27a1b were knocked down using morpholino antisense oligonucleotides. Knockdown of col27a1a singly or in conjunction with col27a1b resulted in curvature of the notochord at early stages and formation of scoliotic curves as well as dysmorphic vertebrae at later stages. These defects were accompanied by abnormal distributions of cells and protein localization in the notochord, as visualized by transmission electron microscopy, as well as delayed vertebral mineralization as detected histologically. Conclusions/Significance: Together, our findings indicate a key role for type XXVII collagen in notochord morphogenesis and axial skeletogenesis and suggest a possible human disease phenotype.	[Christiansen, Helena E.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Lang, Michael R.; Parichy, David M.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Pace, James M.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Christiansen, HE (corresponding author), Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA.	jpace@u.washington.edu; dparichy@u.washington.edu			National Institutes of Health [NIH P01 GM078195, NIH R01 GM62182, NIH R03 AR052476]; National Science Foundation Graduate Research Fellowship; National Institutes of Health NRSA Predoctoral Fellowship [1F31 AG032825-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR052476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062182, P01GM078195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG032825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health NRSA Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funding from the National Institutes of Health (NIH P01 GM078195 and NIH R01 GM62182 to DMP; NIH R03 AR052476 to JMP). HEC was supported by the National Science Foundation Graduate Research Fellowship and National Institutes of Health NRSA Predoctoral Fellowship (1F31 AG032825-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DS, 1990, DEVELOPMENT, V110, P115; Anderson C, 2007, MOL BIOSYST, V3, P51, DOI 10.1039/b613673g; Biot B, 1982, ANN MED PHYS, V25, P251; Boot-Handford RP, 2003, J BIOL CHEM, V278, P31067, DOI 10.1074/jbc.M212889200; Budi EH, 2008, DEVELOPMENT, V135, P2603, DOI 10.1242/dev.019299; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Daffner Scott D, 2003, Am J Orthop (Belle Mead NJ), V32, P77; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Erol B, 2004, J PEDIATR ORTHOPED, V24, P674, DOI 10.1097/01241398-200411000-00015; FENQ H, 2006, J BONE JOINT SURG S2, V88, P25; Gansner JM, 2007, DEV BIOL, V307, P202, DOI 10.1016/j.ydbio.2007.04.029; Gansner JM, 2008, DEV DYNAM, V237, P3715, DOI 10.1002/dvdy.21779; Gorman KF, 2007, SPINE, V32, P735, DOI 10.1097/01.brs.0000259081.40354.e2; Gorman KF, 2009, MED HYPOTHESES, V72, P348, DOI 10.1016/j.mehy.2008.09.052; Guiot BH, 2000, NEUROSURGERY, V47, P1034, DOI 10.1097/00006123-200011000-00003; Hjorten R, 2007, BONE, V41, P535, DOI 10.1016/j.bone.2007.06.024; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimmel CB, 2007, J EXP ZOOL PART B, V308B, P609, DOI 10.1002/jez.b.21155; KOSTUIK JP, 1981, SPINE, V6, P268, DOI 10.1097/00007632-198105000-00009; Madsen EC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000261; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pace JM, 2003, MATRIX BIOL, V22, P3, DOI 10.1016/S0945-053X(03)00007-6; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Parichy DM, 2000, DEVELOPMENT, V127, P3031; PERENNOU D, 1994, SPINE, V19, P123, DOI 10.1097/00007632-199401001-00001; POTTHOFF T, 1984, AM SOC ICHTHYOLOGIST, V1, P35; Reynaud C, 2008, MATRIX BIOL, V27, P547, DOI 10.1016/j.matbio.2008.03.002; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stemple DL, 1996, DEVELOPMENT, V123, P117; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308	37	39	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8481	10.1371/journal.pone.0008481	http://dx.doi.org/10.1371/journal.pone.0008481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041163	Green Published, gold, Green Submitted			2022-12-25	WOS:000273105200014
J	Hasan, Z; Cliff, JM; Dockrell, HM; Jamil, B; Irfan, M; Ashraf, M; Hussain, R				Hasan, Zahra; Cliff, Jacqueline M.; Dockrell, Hazel M.; Jamil, Bushra; Irfan, Muhammad; Ashraf, Mussarat; Hussain, Rabia			CCL2 Responses to Mycobacterium tuberculosis Are Associated with Disease Severity in Tuberculosis	PLOS ONE			English	Article							EXTRA-PULMONARY TUBERCULOSIS; TNF-ALPHA PRODUCTION; EXTRAPULMONARY TUBERCULOSIS; IFN-GAMMA; GENE-EXPRESSION; CHEMOKINE LIGAND-2; HUMAN MONOCYTES; BOVIS BCG; INFECTION; MACROPHAGES	Background: Leucocyte activating chemokines such as CCL2, CCL3, and CXCL8 together with proinflammatory IFN gamma, TNF alpha and downmodulatory IL10 play a central role in the restriction of M. tuberculosis infections, but is unclear whether these markers are indicative of tuberculosis disease severity. Methodology: We investigated live M. tuberculosis- and M. bovis BCG- induced peripheral blood mononuclear cell responses in patients with tuberculosis (TB) and healthy endemic controls (ECs, n = 36). TB patients comprised pulmonary (PTB, n = 34) and extrapulmonary groups, subdivided into those with less severe localized extrapulmonary TB (L-ETB, n = 16) or severe disseminated ETB (D-ETB, n = 16). Secretion of CCL2, IFN gamma, IL10 and CCL3, and mRNA expression of CCL2, TNF alpha, CCL3 and CXCL8 were determined. Results: M. tuberculosis- and BCG- induced CCL2 secretion was significantly increased in both PTB and D-ETB (p<0.05, p<0.01) as compared with L-ETB patients. CCL2 secretion in response to M. tuberculosis was significantly greater than to BCG in the PTB and D-ETB groups. M. tuberculosis- induced CCL2 mRNA transcription was greater in PTB than L-ETB (p = 0.023), while CCL2 was reduced in L-ETB as compared with D-ETB (p = 0.005) patients. M. tuberculosis -induced IFN gamma was greater in L-ETB than PTB (p = 0.04), while BCG- induced IFN gamma was greater in L-ETB as compared with D-ETB patients (p = 0.036). TNF alpha mRNA expression was raised in PTB as compared with L-ETB group in response to M. tuberculosis (p = 0.02) and BCG (p = 0.03). Mycobacterium-induced CCL3 and CXCL8 was comparable between TB groups. Conclusions: The increased CCL2 and TNF alpha in PTB patients may support effective leucocyte recruitment and M. tuberculosis localization. CCL2 alone is associated with severity of TB, possibly due to increased systemic inflammation found in severe disseminated TB or due to increased monocyte infiltration to lung parenchyma in pulmonary disease.	[Hasan, Zahra; Jamil, Bushra; Irfan, Muhammad; Ashraf, Mussarat; Hussain, Rabia] Aga Khan Univ, Karachi, Pakistan; [Cliff, Jacqueline M.; Dockrell, Hazel M.] London Sch Hyg & Trop Med, London WC1, England	Aga Khan University; University of London; London School of Hygiene & Tropical Medicine	Hasan, Z (corresponding author), Aga Khan Univ, Karachi, Pakistan.	zahra.hasan@aku.edu	Hasan, Zahra/AAF-2191-2020; Hussain, Rabia/E-9982-2015; Hasan, Zahra/F-5111-2015; Irfan, Muhammad/G-2058-2015	Hasan, Zahra/0000-0001-7580-372X; Cliff, Jackie/0000-0002-5653-1818; Irfan, Muhammad/0000-0002-5796-2548; Dockrell, Hazel/0000-0003-1869-9107	United Nations Children's Fund (UNICEF); United Nations Development Programme (UNDP); World Bank; World Health Organization (WHO)	United Nations Children's Fund (UNICEF); United Nations Development Programme (UNDP); World Bank(The World Bank India); World Health Organization (WHO)(World Health Organization)	This investigation received financial support from the United Nations Children's Fund (UNICEF)/United Nations Development Programme (UNDP)/World Bank/World Health Organization (WHO) and was funded by the Special Programme for Training in Tropical Diseases Research, TDR, WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2000, INT J LEPROSY, V68, P156; Algood HMS, 2004, J IMMUNOL, V172, P6846, DOI 10.4049/jimmunol.172.11.6846; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; [Anonymous], 2009, GLOB TUB CONTR; Bean AGD, 1999, J IMMUNOL, V162, P3504; Cagatay AA, 2004, SCAND J INFECT DIS, V36, P799, DOI 10.1080/00365540410025339; Chaly YV, 2000, CYTOKINE, V12, P636, DOI 10.1006/cyto.1999.0664; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; *CONS CONS SOC, 2000, 3 PART EV EXP PROGR; CROFTON J, 1990, CROFTON DOUGLAS RESP, P395; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Ebdrup L, 2003, SCAND J INFECT DIS, V35, P244, DOI 10.1080/00365540310000274; Fine PEM, 2001, SCAND J INFECT DIS, V33, P243, DOI 10.1080/003655401300077144; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2000, CURR OPIN IMMUNOL, V12, P432, DOI 10.1016/S0952-7915(00)00116-3; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; FRIEDLAND JS, 1995, CLIN EXP IMMUNOL, V100, P233; HARRIES AD, 1990, LANCET, V335, P387, DOI 10.1016/0140-6736(90)90216-R; Hasan Z, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-14; Hasan Z, 2003, TUBERCULOSIS, V83, P299, DOI 10.1016/S1472-9792(03)00003-9; Hasan Z, 2009, SCAND J IMMUNOL, V69, P259, DOI 10.1111/j.1365-3083.2008.02217.x; Hasan Z, 2009, CLIN VACCINE IMMUNOL, V16, P991, DOI 10.1128/CVI.00091-09; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005158; Hussain R, 2007, CLIN VACCINE IMMUNOL, V14, P1578, DOI 10.1128/CVI.00289-07; Hussain Rabia, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P257; Hussain R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007444; Jamil B, 2007, TUBERCULOSIS, V87, P279, DOI 10.1016/j.tube.2007.03.004; Jo EK, 2003, CURR OPIN INFECT DIS, V16, P205, DOI 10.1097/00001432-200306000-00004; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Keane J, 2002, TUBERCULOSIS, V82, P55, DOI 10.1054/tube.2002.0322; Kim DK, 2006, RESPIROLOGY, V11, P557, DOI 10.1111/j.1440-1843.2006.00896.x; Kipnis A, 2003, IMMUNOLOGY, V109, P547, DOI 10.1046/j.1365-2567.2003.01680.x; Kurashima K, 1997, AM J RESP CRIT CARE, V155, P1474, DOI 10.1164/ajrccm.155.4.9105097; Mastroianni CM, 1998, CLIN EXP IMMUNOL, V114, P210; Mollenkopf HJ, 2006, MICROBES INFECT, V8, P136, DOI 10.1016/j.micinf.2005.06.015; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; ORME IM, 1993, CURR OPIN IMMUNOL, V5, P497, DOI 10.1016/0952-7915(93)90029-R; Park JS, 2003, SCAND J IMMUNOL, V57, P463, DOI 10.1046/j.1365-3083.2003.01201.x; Penido C, 2003, J IMMUNOL, V171, P6788, DOI 10.4049/jimmunol.171.12.6788; Qiu LY, 2008, J INFECT DIS, V198, P1514, DOI 10.1086/592448; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Saukkonen JJ, 2002, INFECT IMMUN, V70, P1684, DOI 10.1128/IAI.70.4.1684-1693.2002; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Sharma SK, 2002, J CLIN IMMUNOL, V22, P345, DOI 10.1023/A:1020604331886; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Sterling TR, 2007, PEDIATRICS, V120, pE912, DOI 10.1542/peds.2006-3150; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; Thwaites GE, 2003, J INFECT DIS, V188, P1105, DOI 10.1086/378642; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Volpe E, 2006, IMMUNOLOGY, V118, P449, DOI 10.1111/j.1365-2567.2006.02378.x; WALZ A, 1987, BIOCHEM BIOPH RES CO, V149, P755, DOI 10.1016/0006-291X(87)90432-3; *WHO, 2008, COUNTR PROF PAK, P133; WHO, 2008, IMPL WHO STOP TB STR; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005	58	50	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8459	10.1371/journal.pone.0008459	http://dx.doi.org/10.1371/journal.pone.0008459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041183	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000273105200005
J	Arazi, A; Sharabi, A; Zinger, H; Mozes, E; Neumann, AU				Arazi, Arnon; Sharabi, Amir; Zinger, Heidy; Mozes, Edna; Neumann, Avidan U.			In Vivo Dynamical Interactions between CD4 Tregs, CD8 Tregs and CD4(+)CD25(-) Cells in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; COMPLEMENTARITY-DETERMINING REGION-1; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTI-DNA; MURINE LUPUS; TGF-BETA; PEPTIDE; AUTOANTIBODY; RESPONSES; MANIFESTATIONS	Background: Regulatory T cells (Tregs) were shown to be central in maintaining immunological homeostasis and preventing the development of autoimmune diseases. Several subsets of Tregs have been identified to date; however, the dynamics of the interactions between these subsets, and their implications on their regulatory functions are yet to be elucidated. Methodology/Principal Findings: We employed a combination of mathematical modeling and frequent in vivo measurements of several T cell subsets. Healthy BALB/c mice received a single injection of either hCDR1 - a tolerogenic peptide previously shown to induce Tregs, a control peptide or vehicle alone, and were monitored for 16 days. During this period, splenocytes from the treated mice were analyzed for the levels of CD4, CD25, CD8, CD28 and Foxp3. The collected data were then fitted to mathematical models, in order to test competing hypotheses regarding the interactions between the followed T cell subsets. In all 3 treatment groups, a significant, lasting, non-random perturbation of the immune system could be observed. Our analysis predicted the emergence of functional CD4 Tregs based on inverse oscillations of the latter and CD4(+)CD25(-) cells. Furthermore, CD4 Tregs seemed to require a sufficiently high level of CD8 Tregs in order to become functional, while conversion was unlikely to be their major source. Our results indicated in addition that Foxp3 is not a sufficient marker for regulatory activity. Conclusions/Significance: In this work, we unraveled the dynamics of the interplay between CD4, CD8 Tregs and effector T cells, using, for the first time, a mathematical-mechanistic perspective in the analysis of Treg kinetics. Furthermore, the results obtained from this interdisciplinary approach supported the notion that CD4 Tregs need to interact with CD8 Tregs in order to become functional. Finally, we generated predictions regarding the time-dependent function of Tregs, which can be further tested empirically in future work.	[Arazi, Arnon; Neumann, Avidan U.] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Sharabi, Amir; Zinger, Heidy; Mozes, Edna] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Bar Ilan University; Weizmann Institute of Science	Arazi, A (corresponding author), Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel.	neumann@mail.biu.ac.il	Sharabi, Amir/I-1742-2019	Sharabi, Amir/0000-0002-6242-6774	Israeli Council for Higher Education; Bar-Ilan University	Israeli Council for Higher Education; Bar-Ilan University	AA is funded by the Converging Technologies PhD scholarship, given by the Israeli Council for Higher Education, and by the Bar-Ilan University President's PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banham AH, 2006, EUR J IMMUNOL, V36, P2832, DOI 10.1002/eji.200636459; Borghans JAM, 2007, IMMUNOL REV, V216, P35; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Jiang Qi, 2006, BMC Immunol, V7, P6, DOI 10.1186/1471-2172-7-6; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lan RY, 2005, AUTOIMMUN REV, V4, P351, DOI 10.1016/j.autrev.2005.01.007; Luger D, 2004, J CLIN IMMUNOL, V24, P579, DOI 10.1007/s10875-004-6245-2; Mahnke K, 2007, INT J CANCER, V120, P2723, DOI 10.1002/ijc.22617; Masteller EL, 2003, J IMMUNOL, V171, P5587, DOI 10.4049/jimmunol.171.10.5587; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nolte-'t Hoen ENM, 2008, J LEUKOCYTE BIOL, V83, P112, DOI 10.1189/jlb.0607436; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Regoes RR, 2007, IMMUNOL CELL BIOL, V85, P274, DOI 10.1038/sj.icb.7100053; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sela U, 2005, J IMMUNOL, V175, P7255, DOI 10.4049/jimmunol.175.11.7255; Selvaraj RK, 2007, J IMMUNOL, V178, P7667, DOI 10.4049/jimmunol.178.12.7667; Sharabi A, 2006, CLIN IMMUNOL, V119, P146, DOI 10.1016/j.clim.2006.01.007; Sharabi A, 2008, J IMMUNOL, V181, P3243, DOI 10.4049/jimmunol.181.5.3243; Sharabi A, 2007, J IMMUNOL, V179, P4979, DOI 10.4049/jimmunol.179.8.4979; Sharabi A, 2006, P NATL ACAD SCI USA, V103, P8810, DOI 10.1073/pnas.0603201103; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Singh RP, 2008, J IMMUNOL, V180, P2069, DOI 10.4049/jimmunol.180.4.2069; Sthoeger ZM, 2003, CLIN EXP IMMUNOL, V131, P385, DOI 10.1046/j.1365-2249.2003.02058.x; Ueha S, 2007, J LEUKOCYTE BIOL, V82, P1230, DOI 10.1189/jlb.0906574; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; WAISMAN A, 1995, INT IMMUNOL, V7, P689, DOI 10.1093/intimm/7.4.689; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282; Zelinskyy G, 2006, EUR J IMMUNOL, V36, P2658, DOI 10.1002/eji.200636059	30	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8447	10.1371/journal.pone.0008447	http://dx.doi.org/10.1371/journal.pone.0008447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041142	Green Published, gold, Green Submitted			2022-12-25	WOS:000273104000012
J	an der Heiden, M; Buchholz, U; Krause, G; Kirchner, G; Claus, H; Haas, WH				an der Heiden, Matthias; Buchholz, Udo; Krause, Gerard; Kirchner, Goeran; Claus, Hermann; Haas, Walter H.			Breaking the Waves: Modelling the Potential Impact of Public Health Measures to Defer the Epidemic Peak of Novel Influenza A/H1N1	PLOS ONE			English	Article							MITIGATION STRATEGIES	Background: On June 11, 2009, the World Health Organization declared phase 6 of the novel influenza A/H1N1 pandemic. Although by the end of September 2009, the novel virus had been reported from all continents, the impact in most countries of the northern hemisphere has been limited. The return of the virus in a second wave would encounter populations that are still nonimmune and not vaccinated yet. We modelled the effect of control strategies to reduce the spread with the goal to defer the epidemic wave in a country where it is detected in a very early stage. Methodology/Principal Findings: We constructed a deterministic SEIR model using the age distribution and size of the population of Germany based on the observed number of imported cases and the early findings for the epidemiologic characteristics described by Fraser (Science, 2009). We propose a two-step control strategy with an initial effort to trace, quarantine, and selectively give prophylactic treatment to contacts of the first 100 to 500 cases. In the second step, the same measures are focused on the households of the next 5,000 to 10,000 cases. As a result, the peak of the epidemic could be delayed up to 7.6 weeks if up to 30% of cases are detected. However, the cumulative attack rates would not change. Necessary doses of antivirals would be less than the number of treatment courses for 0.1% of the population. In a sensitivity analysis, both case detection rate and the variation of R0 have major effects on the resulting delay. Conclusions/Significance: Control strategies that reduce the spread of the disease during the early phase of a pandemic wave may lead to a substantial delay of the epidemic. Since prophylactic treatment is only offered to the contacts of the first 10,000 cases, the amount of antivirals needed is still very limited.	[an der Heiden, Matthias; Buchholz, Udo; Krause, Gerard; Kirchner, Goeran; Claus, Hermann; Haas, Walter H.] Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany	Robert Koch Institute	an der Heiden, M (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany.	anderHeidenM@rki.de		Claus, Hermann/0000-0002-0120-1846; an der Heiden, Matthias/0000-0001-5863-4549; Krause, Gerard/0000-0003-3328-8808				*AHO, 2009, FLU PAND AL RAIS PHA; ANDERSON R M, 1991; Bacaer N, 2009, B MATH BIOL, V71, P1954, DOI 10.1007/s11538-009-9433-7; Bitar D, 2009, EUROSURVEILLANCE, V14; Carrat F, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-26; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cohen J, 2009, SCIENCE, V324, P996, DOI 10.1126/science.324_996; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Davey VJ, 2008, EMERG INFECT DIS, V14, P365, DOI 10.3201/eid1403.070673; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; *ECDC, 2009, ECDC SIT REP INFL A; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; FRASER C, 2009, PANDEMIC POTENTIAL S, P1557; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Pitman RJ, 2005, BRIT MED J, V331, P1242, DOI 10.1136/bmj.38573.696100.3A; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; WHO, 2009, WKLY EPIDEMIOL REC, V84, P213; World Health Organization, 2009, PAND INFL PREP RESP; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	21	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8356	10.1371/journal.pone.0008356	http://dx.doi.org/10.1371/journal.pone.0008356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027293	gold, Green Submitted, Green Published			2022-12-25	WOS:000272940100004
J	Coe, H; Jung, J; Groenendyk, J; Prins, D; Michalak, M				Coe, Helen; Jung, Joanna; Groenendyk, Jody; Prins, Daniel; Michalak, Marek			ERp57 Modulates STAT3 Signaling from the Lumen of the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; GLUCOSE-REGULATED PROTEIN-58; CALCIUM-BINDING; SARCOPLASMIC-RETICULUM; GENE-EXPRESSION; QUALITY-CONTROL; CALRETICULIN; CHAPERONE; CELL; CALNEXIN	ERp57 is an endoplasmic reticulum (ER) resident thiol disulfide oxidoreductase. Using the gene trap technique, we created a ERp57-deficient mouse model. Targeted deletion of the Pdia3 gene, which encodes ERp57, in mice is embryonic lethal at embryonic day (E) 13.5. beta-Galactosidase reporter gene analysis revealed that ERp57 is expressed early on during blastocyst formation with the highest expression in the inner cell mass. In early stages of mouse embryonic development (E11.5) there is a relatively low level of expression of ERp57. As the embryos developed, ERp57 became highly expressed in both the brain and the lungs (E15.5 and E18.5). The absence of ERp57 has no impact on ER morphology; expression of ER-associated chaperones and folding enzymes, ER stress, or apoptosis. ERp57 has been reported to interact with STAT3 (signal transducer and activator of transcription)-DNA complexes. We show here that STAT3 dependent signaling is increased in the absence of ERp57 and this can be rescued by expression of ER-targeted ER p57 but not by cytoplasmic- targeted protein, indicating that ERp57 affects STAT3 signaling from the lumen of the ER. ERp57 effects on STAT3 signaling are enhanced by ER luminal complex formation between ERp57 and calreticulin. In conclusion, we show that ERp57 deficiency in mouse is embryonic lethal at E13.5 and ERp57-dependent modulation of STAT3 signaling may contribute to this phenotype.	[Coe, Helen; Michalak, Marek] Univ Alberta, Dept Pediat, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Michalak, M (corresponding author), Univ Alberta, Dept Pediat, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada.	marek.michalak@ualberta.ca			Canadian Institutes of Health Research [MOP-15291]; Heart and Stroke Foundation of Alberta; Alberta Heritage Foundation for Medical Research; Heart and Stroke Foundation of Canada Membrane Protein; Cardiovascular Disease Training Program; Alberta Heritage Foundation for Medical Research Summer Studentship; Canadian Institutes of Health Research Frederick Banting; Charles Best Canada Graduate Scholarship Master's Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Heart and Stroke Foundation of Canada Membrane Protein(Heart & Stroke Foundation of Canada); Cardiovascular Disease Training Program; Alberta Heritage Foundation for Medical Research Summer Studentship; Canadian Institutes of Health Research Frederick Banting(Canadian Institutes of Health Research (CIHR)); Charles Best Canada Graduate Scholarship Master's Award	This work was supported in part by Canadian Institutes of Health Research Grant MOP-15291, the Heart and Stroke Foundation of Alberta, and the Alberta Heritage Foundation for Medical Research.; <SUP>1</SUP>Recipients of studentship awards from the Alberta Heritage Foundation for Medical Research.; <SUP>2</SUP>Supported by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada Membrane Protein and the Cardiovascular Disease Training Program.; <SUP>3</SUP>Supported by an Alberta Heritage Foundation for Medical Research Summer Studentship and the Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship Master's Award.	ALTIERI F, 1993, BIOCHEM BIOPH RES CO, V194, P992, DOI 10.1006/bbrc.1993.1919; Alvarez C, 1999, EUR J CELL BIOL, V78, P1; Argon Y, 1999, SEMIN CELL DEV BIOL, V10, P495, DOI 10.1006/scdb.1999.0320; Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200; Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Chung YH, 2004, J VIROL, V78, P6489, DOI 10.1128/JVI.78.12.6489-6497.2004; Coe H, 2008, CELL STRESS CHAPERON, V13, P497, DOI 10.1007/s12192-008-0049-x; Coppari S, 2002, J CELL BIOCHEM, V85, P325, DOI 10.1002/jcb.10137; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Eufemi M, 2004, BIOCHEM BIOPH RES CO, V323, P1306, DOI 10.1016/j.bbrc.2004.09.009; Ferraro A, 1999, J CELL BIOCHEM, V72, P528, DOI 10.1002/(SICI)1097-4644(19990315)72:4<528::AID-JCB8>3.0.CO;2-V; Fischer P, 2007, BASIC RES CARDIOL, V102, P393, DOI 10.1007/s00395-007-0674-z; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Garbi N, 2007, CURR OPIN IMMUNOL, V19, P99, DOI 10.1016/j.coi.2006.11.013; Ghassemifar MR, 2003, MOL HUM REPROD, V9, P245, DOI 10.1093/molehr/gag033; Grillo C, 2002, BIOCHEM BIOPH RES CO, V295, P67, DOI 10.1016/S0006-291X(02)00634-4; Guo GG, 2002, J INTERF CYTOK RES, V22, P555, DOI 10.1089/10799900252982034; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; HIRANO N, 1995, EUR J BIOCHEM, V234, P336, DOI 10.1111/j.1432-1033.1995.336_c.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Khanal RC, 2007, CURR MED CHEM, V14, P1087, DOI 10.2174/092986707780362871; Kita K, 2006, FEBS LETT, V580, P199, DOI 10.1016/j.febslet.2005.11.074; Knoblach B, 2003, MOL CELL PROTEOMICS, V2, P1104, DOI 10.1074/mcp.M300053-MCP200; LEBECHE D, 1994, BIOCHEM BIOPH RES CO, V202, P556, DOI 10.1006/bbrc.1994.1964; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Lozyk MD, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-54; Lucero HA, 1999, J BIOL CHEM, V274, P3243, DOI 10.1074/jbc.274.5.3243; Lucero HA, 1998, J BIOL CHEM, V273, P9857, DOI 10.1074/jbc.273.16.9857; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; MAZZARELLA RA, 1994, ARCH BIOCHEM BIOPHYS, V308, P454, DOI 10.1006/abbi.1994.1064; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; MILNER RE, 1991, J BIOL CHEM, V266, P7155; MILNER RE, 1991, BIOCHIM BIOPHYS ACTA, V1063, P120, DOI 10.1016/0005-2736(91)90361-B; Muhlenkamp CR, 1998, TOXICOL APPL PHARM, V148, P101, DOI 10.1006/taap.1997.8323; Nakamura K, 2000, J CELL BIOL, V150, P731, DOI 10.1083/jcb.150.4.731; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Ndubuisi MI, 1999, J BIOL CHEM, V274, P25499, DOI 10.1074/jbc.274.36.25499; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Okiyoneda T, 2004, MOL BIOL CELL, V15, P563, DOI 10.1091/mbc.E03-06-0379; Panaretakis T, 2008, CELL DEATH DIFFER, V15, P1499, DOI 10.1038/cdd.2008.67; Putney JW, 2007, CELL CALCIUM, V42, P103, DOI 10.1016/j.ceca.2007.01.011; Reddy RK, 2002, CANCER RES, V62, P7207; Reddy RK, 1999, J BIOL CHEM, V274, P28476, DOI 10.1074/jbc.274.40.28476; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200; Suter DM, 2006, STEM CELLS, V24, P615, DOI 10.1634/stemcells.2005-0226; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Wyse B, 2002, AM J PHYSIOL-RENAL, V282, pF424, DOI 10.1152/ajprenal.0028.2001; Xu D, 2009, AM J PHYSIOL-LUNG C, V297, pL44, DOI 10.1152/ajplung.90626.2008; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200	60	85	88	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6725	6738		10.1074/jbc.M109.054015	http://dx.doi.org/10.1074/jbc.M109.054015			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20022947	Green Published, hybrid			2022-12-25	WOS:000275367500076
J	Gruszka, A; de Marco, A				Gruszka, Alicja; de Marco, Ario			A (musical) note on protein purification	FASEB JOURNAL			English	Editorial Material									[de Marco, Ario] IFOM IEO Campus Oncogenom, Prot Chem Unit, Cogentech, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO)	de Marco, A (corresponding author), IFOM IEO Campus Oncogenom, Prot Chem Unit, Cogentech, Via Adamello 16, I-20139 Milan, Italy.	ario.demarco@ifom-ieo-campus.it	Gruszka, Alicja M/O-5398-2019; de Marco, Ario/A-2760-2014	Gruszka, Alicja M/0000-0002-5359-0281; de Marco, Ario/0000-0001-7729-819X					0	0	0	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					6	6		10.1096/fj.10-0103ufm	http://dx.doi.org/10.1096/fj.10-0103ufm			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	20047895				2022-12-25	WOS:000273233600002
J	Li, ZJ; Wilson, KD; Smith, B; Kraft, DL; Jia, FJ; Huang, M; Xie, XY; Robbins, RC; Gambhir, SS; Weissman, IL; Wu, JC				Li, Zongjin; Wilson, Kitchener D.; Smith, Bryan; Kraft, Daniel L.; Jia, Fangjun; Huang, Mei; Xie, Xiaoyan; Robbins, Robert C.; Gambhir, Sanjiv S.; Weissman, Irving L.; Wu, Joseph C.			Functional and Transcriptional Characterization of Human Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Myocardial Infarction	PLOS ONE			English	Article							PROGENITOR CELLS; EXTRACELLULAR-MATRIX; PERIPHERAL-BLOOD; CORD BLOOD; CARDIOMYOCYTES; MORPHOGENESIS; NEOVASCULARIZATION; TRANSPLANTATION; ISCHEMIA; SURVIVAL	Background: Differentiation of human embryonic stem cells into endothelial cells (hESC-ECs) has the potential to provide an unlimited source of cells for novel transplantation therapies of ischemic diseases by supporting angiogenesis and vasculogenesis. However, the endothelial differentiation efficiency of the conventional embryoid body (EB) method is low while the 2-dimensional method of co-culturing with mouse embryonic fibroblasts (MEFs) require animal product, both of which can limit the future clinical application of hESC-ECs. Moreover, to fully understand the beneficial effects of stem cell therapy, investigators must be able to track the functional biology and physiology of transplanted cells in living subjects over time. Methodology: In this study, we developed an extracellular matrix (ECM) culture system for increasing endothelial differentiation and free from contaminating animal cells. We investigated the transcriptional changes that occur during endothelial differentiation of hESCs using whole genome microarray, and compared to human umbilical vein endothelial cells (HUVECs). We also showed functional vascular formation by hESC-ECs in a mouse dorsal window model. Moreover, our study is the first so far to transplant hESC-ECs in a myocardial infarction model and monitor cell fate using molecular imaging methods. Conclusion: Taken together, we report a more efficient method for derivation of hESC-ECs that express appropriate patterns of endothelial genes, form functional vessels in vivo, and improve cardiac function. These studies suggest that hESC-ECs may provide a novel therapy for ischemic heart disease in the future.	[Li, Zongjin; Wilson, Kitchener D.; Smith, Bryan; Jia, Fangjun; Huang, Mei; Xie, Xiaoyan; Gambhir, Sanjiv S.; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Li, Zongjin; Wilson, Kitchener D.; Smith, Bryan; Jia, Fangjun; Huang, Mei; Xie, Xiaoyan; Gambhir, Sanjiv S.; Wu, Joseph C.] Stanford Univ, Sch Med, MIPS, Stanford, CA 94305 USA; [Wilson, Kitchener D.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Kraft, Daniel L.; Weissman, Irving L.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Robbins, Robert C.] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Weissman, Irving L.; Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Sch Med, Div Cardiol, Dept Med, Stanford, CA 94305 USA; [Li, Zongjin] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Nankai University	Li, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA.	joewu@stanford.edu	Li, Zongjin/A-1115-2014; Smith, Bryan/AAS-1108-2021; Li, Zongjin/G-3118-2010; Wilson, Kitchener/A-7146-2016; Wu, Joseph/H-1067-2013	Li, Zongjin/0000-0002-4603-3743; Smith, Bryan/0000-0002-5990-2901; Li, Zongjin/0000-0002-4603-3743; Wu, Joseph/0000-0002-6068-8041	BWF CAMS; CIRM [RS1-00322, R21HL091453, R21HL091453-01A1S109]; CA BCRP [14IB-0039]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091453] Funding Source: NIH RePORTER	BWF CAMS; CIRM(California Institute for Regenerative Medicine); CA BCRP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding supports are from BWF CAMS, CIRM RS1-00322, R21HL091453, R21HL091453-01A1S109, CA BCRP 14IB-0039 (JCW), and Mitzi and William Blahd, MD Pilot Research Grant (ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318; Cao F, 2007, J TISSUE ENG REGEN M, V1, P465, DOI 10.1002/term.55; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Chen SS, 2003, STEM CELLS, V21, P281, DOI 10.1634/stemcells.21-3-281; Chen T, 2007, STEM CELLS, V25, P392, DOI 10.1634/stemcells.2006-0145; Davis GE, 2008, CURR OPIN HEMATOL, V15, P197, DOI 10.1097/MOH.0b013e3282fcc321; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Gong J, 2008, EXP EYE RES, V86, P957, DOI 10.1016/j.exer.2008.03.014; Heeschen C, 2006, J AM COLL CARDIOL, V48, P2553, DOI 10.1016/j.jacc.2006.07.066; Hsiai TK, 2008, CURR CARDIOL REV, V4, P269, DOI 10.2174/157340308786349471; Huang PP, 2007, THROMB HAEMOSTASIS, V98, P1335, DOI 10.1160/TH07-02-0137; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kudo T, 2002, CIRCULATION, V106, P118, DOI 10.1161/01.CIR.0000020221.28996.78; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; LEHR HA, 1993, AM J PATHOL, V143, P1055; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Li ZJ, 2005, J CELL BIOCHEM, V95, P559, DOI 10.1002/jcb.20436; Li ZJ, 2008, STEM CELLS, V26, P864, DOI 10.1634/stemcells.2007-0843; Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Li ZJ, 2009, J CELL BIOCHEM, V106, P194, DOI 10.1002/jcb.22003; Liu YQ, 2004, FASEB J, V18, P457, DOI 10.1096/fj.03-0948com; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Malinda KM, 2003, METH MOLEC MED, V78, P329; Nguyen M, 2001, INT J BIOCHEM CELL B, V33, P960, DOI 10.1016/S1357-2725(01)00007-3; Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172; Smith BR, 2008, NANO LETT, V8, P2599, DOI 10.1021/nl080141f; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Toyama H, 2004, NUCL MED BIOL, V31, P251, DOI 10.1016/S0969-8051(03)00124-0; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Whelan MC, 2003, J BIOL CHEM, V278, P327, DOI 10.1074/jbc.M207554200; Wollert KC, 2005, CIRC RES, V96, P151, DOI 10.1161/01.RES.0000155333.69009.63; Xu CH, 2006, STEM CELLS DEV, V15, P931, DOI 10.1089/scd.2006.15.931; Xu MF, 2007, J MOL CELL CARDIOL, V42, P441, DOI 10.1016/j.yjmcc.2006.10.009; Yamahara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001666; Yang C, 2004, THROMB HAEMOSTASIS, V91, P1202, DOI 10.1160/TH03-06-0378	42	106	113	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8443	10.1371/journal.pone.0008443	http://dx.doi.org/10.1371/journal.pone.0008443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046878	Green Published, gold, Green Submitted			2022-12-25	WOS:000273180200002
J	Andersson, T; Simonyte, K; Andrew, R; Strand, M; Buren, J; Walker, BR; Mattsson, C; Olsson, T				Andersson, Therese; Simonyte, Kotryna; Andrew, Ruth; Strand, Magnus; Buren, Jonas; Walker, Brian R.; Mattsson, Cecilia; Olsson, Tommy			Tissue-Specific Increases in 11 beta-Hydroxysteroid Dehydrogenase Type 1 in Normal Weight Postmenopausal Women	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; BODY-FAT DISTRIBUTION; CORTISOL METABOLISM; SEXUAL-DIMORPHISM; GLUCOCORTICOID METABOLISM; VISCERAL OBESITY; GENE-EXPRESSION; GROWTH-HORMONE; AROMATASE GENE; IN-VIVO	With age and menopause there is a shift in adipose distribution from gluteo-femoral to abdominal depots in women. Associated with this redistribution of fat are increased risks of type 2 diabetes and cardiovascular disease. Glucocorticoids influence body composition, and 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta HSD1) which converts inert cortisone to active cortisol is a putative key mediator of metabolic complications in obesity. Increased 11 beta HSD1 in adipose tissue may contribute to postmenopausal central obesity. We hypothesized that tissue-specific 11 beta HSD1 gene expression and activity are up-regulated in the older, postmenopausal women compared to young, premenopausal women. Twenty-three pre- and 23 postmenopausal, healthy, normal weight women were recruited. The participants underwent a urine collection, a subcutaneous adipose tissue biopsy and the hepatic 11 beta HSD1 activity was estimated by the serum cortisol response after an oral dose of cortisone. Urinary (5 alpha-tetrahydrocortisol+5 beta-tetrahydrocortisol)/tetrahydrocortisone ratios were higher in postmenopausal women versus premenopausal women in luteal phase (P<0.05), indicating an increased whole-body 11 beta HSD1 activity. Postmenopausal women had higher 11 beta HSD1 gene expression in subcutaneous fat (P<0.05). Hepatic first pass conversion of oral cortisone to cortisol was also increased in postmenopausal women versus premenopausal women in follicular phase of the menstrual cycle (P<0.01, at 30 min post cortisone ingestion), suggesting higher hepatic 11 beta HSD1 activity. In conclusion, our results indicate that postmenopausal normal weight women have increased 11 beta HSD1 activity in adipose tissue and liver. This may contribute to metabolic dysfunctions with menopause and ageing in women.	[Andersson, Therese; Simonyte, Kotryna; Strand, Magnus; Buren, Jonas; Mattsson, Cecilia; Olsson, Tommy] Umea Univ Hosp, Div Med, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden; [Andrew, Ruth; Walker, Brian R.] Univ Edinburgh, Endocrinol Unit, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	Umea University; University of Edinburgh	Andersson, T (corresponding author), Umea Univ Hosp, Div Med, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden.	tommy.olsson@medicin.umu.se	Simonyté Sjödin, Kotryna/CAI-1642-2022; Simonyté Sjödin, Kotryna/CAF-5168-2022; Andrew, Ruth/C-2727-2008	Simonyté Sjödin, Kotryna/0000-0002-1323-9913; Simonyté Sjödin, Kotryna/0000-0002-1323-9913; Andrew, Ruth/0000-0002-6916-2994; Buren, Jonas/0000-0001-5846-9002; Olsson, Tommy/0000-0001-7768-1076	Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Diabetes Foundation; Umea University; Vasterbotten County Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Diabetes Foundation; Umea University; Vasterbotten County Council	This study was supported by the Swedish Research Council (http://www.vr.se), the Swedish Heart-Lung Foundation (http://www.hjart-lungfonden.se), the Swedish Diabetes Foundation (http://www.diabetes.se), Umea University (http://www.umu.se), and Vasterbotten County Council (http://www.vll.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON T, 2009, OBESITY SIL IN PRESS; Andrew R, 2002, J CLIN ENDOCR METAB, V87, P277, DOI 10.1210/jc.87.1.277; Best R, 1997, J ENDOCRINOL, V153, P41, DOI 10.1677/joe.0.1530041; Bjorkelund C, 1996, INT J OBESITY, V20, P213; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Dieudonne MN, 2006, J STEROID BIOCHEM, V99, P189, DOI 10.1016/j.jsbmb.2006.01.007; DUBUC PU, 1974, ENDOCRINOLOGY, V95, P1733, DOI 10.1210/endo-95-6-1733; Engeli S, 2004, OBES RES, V12, P9, DOI 10.1038/oby.2004.3; Finken MJJ, 1999, J CLIN ENDOCR METAB, V84, P3316, DOI 10.1210/jc.84.9.3316; Gabrielsson BG, 2005, OBES RES, V13, P649, DOI 10.1038/oby.2005.72; Genazzani AR, 2006, GYNECOL ENDOCRINOL, V22, P145, DOI 10.1080/09513590600629092; Jamieson PM, 1999, J ENDOCRINOL, V160, P103, DOI 10.1677/joe.0.1600103; Johansson A, 2001, J CLIN ENDOCR METAB, V86, P4276, DOI 10.1210/jc.86.9.4276; Kalleinen N, 2008, J CLIN ENDOCR METAB, V93, P1655, DOI 10.1210/jc.2007-2677; Lee MJ, 2008, OBESITY, V16, P1178, DOI 10.1038/oby.2008.207; Li X, 2007, INT J OBESITY, V31, P820, DOI 10.1038/sj.ijo.0803470; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; LOW SC, 1994, J ENDOCRINOL, V143, P541, DOI 10.1677/joe.0.1430541; Masuzaki H, 2003, J CLIN INVEST, V112, P83, DOI 10.1172/JCI17845; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mattsson C, 2009, J CLIN ENDOCR METAB, V94, P1347, DOI 10.1210/jc.2008-2054; McKenzie J, 2006, CLIN ENDOCRINOL, V65, P40, DOI 10.1111/j.1365-2265.2006.02543.x; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Misso ML, 2005, MENOPAUSE, V12, P210, DOI 10.1097/00042192-200512020-00016; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Nwe KHH, 2000, STEROIDS, V65, P40, DOI 10.1016/S0039-128X(99)00078-1; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Paulsen SK, 2008, OBESITY, V16, P731, DOI 10.1038/oby.2008.2; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rask E, 2002, J CLIN ENDOCR METAB, V87, P3330, DOI 10.1210/jc.87.7.3330; Seckl JR, 2004, RECENT PROG HORM RES, V59, P359, DOI 10.1210/rp.59.1.359; Shen W, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-17; Simonyte K, 2009, OBESITY, V17, P1982, DOI 10.1038/oby.2009.99; Tomlinson JW, 2001, ENDOCRINOLOGY, V142, P1982, DOI 10.1210/en.142.5.1982; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Veilleux A, 2009, J CLIN ENDOCR METAB, V94, P3550, DOI 10.1210/jc.2008-2011; Walker BR, 2006, ANN NY ACAD SCI, V1083, P165, DOI 10.1196/annals.1367.012; Walker GE, 2007, OBESITY, V15, P1933, DOI 10.1038/oby.2007.231; WALTON C, 1993, EUR J CLIN INVEST, V23, P466, DOI 10.1111/j.1365-2362.1993.tb00792.x; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; ZHAO Y, 1995, MOL ENDOCRINOL, V9, P340, DOI 10.1210/me.9.3.340	42	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8475	10.1371/journal.pone.0008475	http://dx.doi.org/10.1371/journal.pone.0008475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041117	gold, Green Published, Green Submitted			2022-12-25	WOS:000273105200011
J	Grimplet, J; Cramer, GR; Dickerson, JA; Mathiason, K; Van Hemert, J; Fennell, AY				Grimplet, Jerome; Cramer, Grant R.; Dickerson, Julie A.; Mathiason, Kathy; Van Hemert, John; Fennell, Anne Y.			VitisNet: "Omics" Integration through Grapevine Molecular Networks	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; CV CABERNET-SAUVIGNON; PROTEOMIC ANALYSIS; METABOLIC NETWORK; SEQUENCE TAGS; TRANSCRIPT; PROTEIN; REVEALS; RESPONSES; BIOSYNTHESIS	Background: Genomic data release for the grapevine has increased exponentially in the last five years. The Vitis vinifera genome has been sequenced and Vitis EST, transcriptomic, proteomic, and metabolomic tools and data sets continue to be developed. The next critical challenge is to provide biological meaning to this tremendous amount of data by annotating genes and integrating them within their biological context. We have developed and validated a system of Grapevine Molecular Networks (VitisNet). Methodology/Principal Findings: The sequences from the Vitis vinifera (cv. Pinot Noir PN40024) genome sequencing project and ESTs from the Vitis genus have been paired and the 39,424 resulting unique sequences have been manually annotated. Among these, 13,145 genes have been assigned to 219 networks. The pathway sets include 88 "Metabolic", 15 "Genetic Information Processing", 12 "Environmental Information Processing", 3 "Cellular Processes", 21 "Transport", and 80 "Transcription Factors". The quantitative data is loaded onto molecular networks, allowing the simultaneous visualization of changes in the transcriptome, proteome, and metabolome for a given experiment. Conclusions/Significance: VitisNet uses manually annotated networks in SBML or XML format, enabling the integration of large datasets, streamlining biological functional processing, and improving the understanding of dynamic processes in systems biology experiments. VitisNet is grounded in the Vitis vinifera genome (currently at 8x coverage) and can be readily updated with subsequent updates of the genome or biochemical discoveries. The molecular network files can be dynamically searched by pathway name or individual genes, proteins, or metabolites through the MetNet Pathway database and web-portal at http://metnet3.vrac.iastate.edu/. All VitisNet files including the manual annotation of the grape genome encompassing pathway names, individual genes, their genome identifier, and chromosome location can be accessed and downloaded from the VitisNet tab at http://vitis-dormancy.sdstate.org.	[Grimplet, Jerome; Mathiason, Kathy; Fennell, Anne Y.] S Dakota State Univ, Hort Forestry Landscape & Pk Dept, Brookings, SD 57007 USA; [Cramer, Grant R.] Univ Nevada, Dept Biochem, Reno, NV 89557 USA; [Dickerson, Julie A.; Van Hemert, John] Iowa State Univ, Dept Elect & Comp Engn, Ames, IA USA; [Dickerson, Julie A.; Van Hemert, John] Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA USA	South Dakota State University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Iowa State University; Iowa State University	Grimplet, J (corresponding author), S Dakota State Univ, Hort Forestry Landscape & Pk Dept, Brookings, SD 57007 USA.	anne.fennell@sdstate.edu	Grimplet, Jérôme/M-4589-2019; Grimplet, Jerome/A-3422-2011; Cramer, Grant R/E-1815-2011	Grimplet, Jérôme/0000-0002-3265-4012; Grimplet, Jerome/0000-0002-3265-4012; Dickerson, Julie A/0000-0003-4973-5641	National Science Foundation Plant Genome Program [DBI-0604755]	National Science Foundation Plant Genome Program(National Science Foundation (NSF))	This work was support by a grant from the National Science Foundation Plant Genome Program (DBI-0604755) to Anne Y. Fennell, Grant R. Cramer, Julie A. Dickerson and Karen Schlauch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Albert R, 2007, PLANT CELL, V19, P3327, DOI 10.1105/tpc.107.054700; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Bylesjo M, 2007, PLANT J, V52, P1181, DOI 10.1111/j.1365-313X.2007.03293.x; Bylesjo M, 2009, J PROTEOME RES, V8, P199, DOI 10.1021/pr800298s; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Castro AJ, 2005, J EXP BOT, V56, P2783, DOI 10.1093/jxb/eri271; Cramer GR, 2007, FUNCT INTEGR GENOMIC, V7, P111, DOI 10.1007/s10142-006-0039-y; da Silva FG, 2005, PLANT PHYSIOL, V139, P574, DOI 10.1104/pp.105.065748; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Doerks T, 2002, TRENDS BIOCHEM SCI, V27, P168, DOI 10.1016/S0968-0004(01)02042-4; Espinoza C, 2007, FUNCT INTEGR GENOMIC, V7, P95, DOI 10.1007/s10142-006-0031-6; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Figueiredo A, 2008, J EXP BOT, V59, P3371, DOI 10.1093/jxb/ern187; Funahashi A., 2004, 8 ANN INT C RES COMP; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Fung RWM, 2008, PLANT PHYSIOL, V146, P236, DOI 10.1104/pp.107.108712; Giribaldi M, 2007, PROTEOMICS, V7, P3154, DOI 10.1002/pmic.200600974; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; Grimplet J, 2009, PROTEOMICS, V9, P2503, DOI 10.1002/pmic.200800158; Guo AY, 2008, NUCLEIC ACIDS RES, V36, pD966, DOI 10.1093/nar/gkm841; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hirai MY, 2005, J BIOL CHEM, V280, P25590, DOI 10.1074/jbc.M502332200; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jellouli N, 2008, J PLANT PHYSIOL, V165, P471, DOI 10.1016/j.jplph.2007.02.009; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lucker J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-50; Lund ST, 2008, PLANT MOL BIOL, V68, P301, DOI 10.1007/s11103-008-9371-z; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mathiason K, 2009, FUNCT INTEGR GENOMIC, V9, P81, DOI 10.1007/s10142-008-0090-y; Mesarovic MD, 1968, SYSTEMS THEORY BIOL, P59, DOI [DOI 10.1007/978-3-642-88343-9_3, 10.1007/978-3-642-88343-9_3]; Miller JG, 1978, LIVING SYSTEMS; Moser C., 2005, Functional & Integrative Genomics, V5, P208, DOI 10.1007/s10142-005-0143-4; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Oresic Matej, 2004, Appl Bioinformatics, V3, P205; Peng FY, 2007, GENE, V402, P40, DOI 10.1016/j.gene.2007.07.016; Pilati S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-428; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Rischer H, 2006, P NATL ACAD SCI USA, V103, P5614, DOI 10.1073/pnas.0601027103; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sarry JE, 2004, PROTEOMICS, V4, P201, DOI 10.1002/pmic.200300499; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tattersall EAR, 2007, FUNCT INTEGR GENOMIC, V7, P317, DOI 10.1007/s10142-007-0051-x; Terrier N, 2005, PLANTA, V222, P832, DOI 10.1007/s00425-005-0017-y; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vezzulli S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-128; Vincent D, 2007, J EXP BOT, V58, P1873, DOI 10.1093/jxb/erm012; Von Bertalanffy L, 1968, GEN SYSTEM THEORY FD; Waters Daniel L. E., 2005, Functional & Integrative Genomics, V5, P40, DOI 10.1007/s10142-004-0124-z; Wise Roger P., 2007, V406, P347; Wurtele ES, 2007, CONCEPTS IN PLANT METABOLOMICS, P145, DOI 10.1007/978-1-4020-5608-6_10; Zhang PF, 2005, PLANT PHYSIOL, V138, P27, DOI 10.1104/pp.105.060376	60	99	100	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8365	10.1371/journal.pone.0008365	http://dx.doi.org/10.1371/journal.pone.0008365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027228	Green Published, Green Submitted, gold			2022-12-25	WOS:000272940100011
J	Murai-Takeda, A; Shibata, H; Kurihara, I; Kobayashi, S; Yokota, K; Suda, N; Mitsuishi, Y; Jo, R; Kitagawa, H; Kato, S; Saruta, T; Itoh, H				Murai-Takeda, Ayano; Shibata, Hirotaka; Kurihara, Isao; Kobayashi, Sakiko; Yokota, Kenichi; Suda, Noriko; Mitsuishi, Yuko; Jo, Rie; Kitagawa, Hirochika; Kato, Shigeaki; Saruta, Takao; Itoh, Hiroshi			NF-YC Functions as a Corepressor of Agonist-bound Mineralocorticoid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-I; SELECTIVE COREGULATOR; DEPENDENT INTERACTION; NUCLEAR RECEPTORS; COACTIVATOR; BINDING; ACTIVATION; TRANSACTIVATION; SPECIFICITY; EXPRESSION	The role of aldosterone has been implicated in the metabolic syndrome and cardiovascular diseases. The biological actions of aldosterone are mediated through mineralocorticoid receptor (MR). Nuclear receptor-mediated gene expression is regulated by dynamic and coordinated recruitment of coactivators and corepressors. To identify new coregulators of the MR, full-length MR was used as bait in yeast two-hybrid screening. We isolated NF-YC, one of the subunits of heterotrimeric transcription factor NF-Y. Specific interaction between MR and NF-YC was confirmed by yeast two-hybrid, mammalian two-hybrid, coimmunoprecipitation assays, and fluorescence subcellular imaging. Transient transfection experiments in COS-7 cells demonstrated that NF-YC repressed MR transactivation in a hormone-sensitive manner. Moreover, reduction of NF-YC protein levels by small interfering RNA potentiated hormonal activation of endogenous target genes in stably MR-expressing cells, indicating that NF-YC functions as an agonist-dependent MR corepressor. The corepressor function of NF-YC is selective for MR, because overexpression of NF-YC did not affect transcriptional activity mediated by androgen, progesterone, or glucocorticoid receptors. Chromatin immunoprecipitation experiments showed that endogenous MR and steroid receptor coactivator-1 were recruited to an endogenous ENaC gene promoter in a largely aldosterone-dependent manner, and endogenous NF-YC was sequentially recruited to the same element. Immunohistochemistry showed that endogenous MR and NF-YC were colocalized within the mouse kidney. Although aldosterone induces interaction of the N and C termini of MR, NF-YC inhibited the N/C interaction. These findings indicate that NF-YC functions as a new corepressor of agonist-bound MR via alteration of aldosterone-induced MR conformation.	[Shibata, Hirotaka] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan; [Kitagawa, Hirochika; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Keio University; University of Tokyo	Shibata, H (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hiro-405@cb3.so-net.ne.jp			Pfizer Pharmaceuticals Inc.; Ministry of Health, Labor, and Welfare, Japan; Advancement of Education and Research; Keio Gijuku Academic Development Funds; Smoking Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045999] Funding Source: NIH RePORTER	Pfizer Pharmaceuticals Inc.(Pfizer); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Advancement of Education and Research; Keio Gijuku Academic Development Funds; Smoking Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an investigator-initiated research grant from Pfizer Pharmaceuticals Inc. (to H. S.), a Health Labor Science Research Grant for Disorders of Adrenocortical Hormone Production from the Ministry of Health, Labor, and Welfare, Japan (to H. S.), Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research (to H. S.), Keio Gijuku Academic Development Funds (to H. S.), and a grant from Smoking Research Foundation (to H. I. and H. S.).	Bellorini M, 1997, GENE, V193, P119, DOI 10.1016/S0378-1119(97)00109-1; Bellorini M, 1997, NUCLEIC ACIDS RES, V25, P2174, DOI 10.1093/nar/25.11.2174; di Silvio A, 1999, NUCLEIC ACIDS RES, V27, P2578; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Frontini M, 2004, CELL CYCLE, V3, P217; Fuse H, 2000, MOL ENDOCRINOL, V14, P889, DOI 10.1210/me.14.6.889; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Hultman ML, 2005, MOL ENDOCRINOL, V19, P1460, DOI 10.1210/me.2004-0537; Kahle J, 2005, MOL CELL BIOL, V25, P5339, DOI 10.1128/MCB.25.13.5339-5354.2005; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kitagawa H, 2002, MOL CELL BIOL, V22, P3698, DOI 10.1128/MCB.22.11.3698-3706.2002; Kobayashi S, 2004, J MOL ENDOCRINOL, V32, P69, DOI 10.1677/jme.0.0320069; Kurihara I, 2005, J BIOL CHEM, V280, P6721, DOI 10.1074/jbc.M411820200; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Matuoka K, 1999, EXP CELL RES, V253, P365, DOI 10.1006/excr.1999.4605; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Metivier R, 2001, MOL ENDOCRINOL, V15, P1953, DOI 10.1210/me.15.11.1953; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; ONATE SA, 1995, SCIENCE, V270, P1354; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P1158, DOI 10.1210/me.2004-0331; Pippal JB, 2009, MOL ENDOCRINOL, V23, P1360, DOI 10.1210/me.2009-0032; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rogerson FM, 2004, MOL CELL ENDOCRINOL, V217, P203, DOI 10.1016/j.mce.2003.10.021; Rogerson FM, 2003, J STEROID BIOCHEM, V85, P389, DOI 10.1016/S0960-0760(03)00200-0; Rogerson FM, 2003, MOL CELL ENDOCRINOL, V200, P45, DOI 10.1016/S0303-7207(02)00413-6; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Sanchez-Martinez R, 2008, MOL CELL BIOL, V28, P3817, DOI 10.1128/MCB.01909-07; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Tetel MJ, 1999, MOL ENDOCRINOL, V13, P910, DOI 10.1210/me.13.6.910; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Yang J, 2009, J MOL ENDOCRINOL, V43, P53, DOI 10.1677/JME-09-0031; Yokota K, 2007, J BIOL CHEM, V282, P1998, DOI 10.1074/jbc.M607741200; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	40	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8084	8093		10.1074/jbc.M109.053371	http://dx.doi.org/10.1074/jbc.M109.053371			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20054001	hybrid, Green Published			2022-12-25	WOS:000275413800026
J	Marom, M; Hagalili, Y; Sebag, A; Tzvier, L; Atlas, D				Marom, Merav; Hagalili, Yamit; Sebag, Ariel; Tzvier, Lior; Atlas, Daphne			Conformational Changes Induced in Voltage-gated Calcium Channel Cav1.2 by BayK 8644 or FPL64176 Modify the Kinetics of Secretion Independently of Ca2+ Influx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY DIHYDROPYRIDINE-BINDING; DEPOLARIZATION-INDUCED EXOCYTOSIS; ADRENAL CHROMAFFIN CELLS; FUSION-PORE KINETICS; SYNTAXIN 1A; HIPPOCAMPAL-NEURONS; LC-TYPE; NEUROTRANSMITTER RELEASE; ALLOSTERIC INTERACTIONS; MEMBRANE CAPACITANCE	The role of the L-type calcium channel (Cav1.2) as a molecular switch that triggers secretion prior to Ca2+ transport has previously been demonstrated in bovine chromaffin cells and rat pancreatic beta cells. Here, we examined the effect of specific Cav1.2 allosteric modulators, BayK 8644 (BayK) and FPL64176 (FPL), on the kinetics of catecholamine release, as monitored by amperometry in single bovine chromaffin cells. We show that 2 mu M BayK or 0.5 mu M FPL accelerates the rate of catecholamine secretion to a similar extent in the presence either of the permeable Ca2+ and Ba2+ or the impermeable charge carrier La3+. These results suggest that structural rearrangements generated through the binding of BayK or FPL, by altering the channel activity, could affect depolarization-evoked secretion prior to cation transport. FPL also accelerated the rate of secretion mediated by a Ca2+-impermeable channel made by replacing the wild type alpha(1)1.2 subunit was replaced with the mutant alpha(1)1.2/L775P. Furthermore, BayK and FPL modified the kinetic parameters of the fusion pore formation, which represent the initial contact between the vesicle lumen and the extracellular medium. A direct link between the channel activity and evoked secretion lends additional support to the view that the voltage-gated Ca2+ channels act as a signaling molecular switch, triggering secretion upstream to ion transport into the cell.	[Marom, Merav; Hagalili, Yamit; Sebag, Ariel; Tzvier, Lior; Atlas, Daphne] Hebrew Univ Jerusalem, Dept Biol Chem, Inst Life Sci, IL-919104 Jerusalem, Israel	Hebrew University of Jerusalem	Atlas, D (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Inst Life Sci, IL-919104 Jerusalem, Israel.	datlas@vms.huji.ac.il			Betty Feffer Fund; H. L. Lauterbach; The Zentner Fund	Betty Feffer Fund; H. L. Lauterbach; The Zentner Fund	This work was supported by an operating grant (to D. A.) from The Betty Feffer Fund, H. L. Lauterbach, and The Zentner Fund.	Arien H, 2003, J BIOL CHEM, V278, P29231, DOI 10.1074/jbc.M301401200; ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; Atlas D, 2001, CELL MOL NEUROBIOL, V21, P717, DOI 10.1023/A:1015104105262; Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; BAXTER AJG, 1993, J MED CHEM, V36, P2739, DOI 10.1021/jm00071a004; Borges R, 2002, ANN NY ACAD SCI, V971, P184, DOI 10.1111/j.1749-6632.2002.tb04462.x; BOSSU JL, 1991, J PHYSIOL-LONDON, V437, P603, DOI 10.1113/jphysiol.1991.sp018614; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; Cano-Abad MF, 2001, J BIOL CHEM, V276, P39695, DOI 10.1074/jbc.M102334200; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; CENA V, 1983, NEUROSCIENCE, V10, P1455, DOI 10.1016/0306-4522(83)90126-4; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Cloues RK, 1997, J NEUROSCI, V17, P6493; Cohen R, 2005, BIOPHYS J, V89, P4364, DOI 10.1529/biophysj.105.064642; Cohen R, 2003, J BIOL CHEM, V278, P9258, DOI 10.1074/jbc.M210270200; Cohen Roy, 2008, V440, P269, DOI 10.1007/978-1-59745-178-9_21; Cohen R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001273; Colliver TL, 2000, J NEUROCHEM, V74, P1086; Fan JS, 2001, AM J PHYSIOL-CELL PH, V280, pC565, DOI 10.1152/ajpcell.2001.280.3.C565; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; GARCIA AG, 1984, NATURE, V309, P69, DOI 10.1038/309069a0; Garcia-Palomero E, 2001, NEUROENDOCRINOLOGY, V74, P251, DOI 10.1159/000054692; Hagalili Y, 2008, BIOCHEMISTRY-US, V47, P13822, DOI 10.1021/bi801619f; He M, 1997, J BIOL CHEM, V272, P2629, DOI 10.1074/jbc.272.5.2629; Herzig S, 1996, EUR J PHARMACOL, V295, P113, DOI 10.1016/0014-2999(95)00673-7; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; Hohaus A, 2005, J BIOL CHEM, V280, P38471, DOI 10.1074/jbc.M507013200; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; Hui K, 2005, BIOCHEM BIOPH RES CO, V338, P783, DOI 10.1016/j.bbrc.2005.10.014; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Kavalali ET, 1996, J NEUROSCI, V16, P1072; KOKUBUN S, 1984, P NATL ACAD SCI-BIOL, V81, P4824, DOI 10.1073/pnas.81.15.4824; KUNZE DL, 1992, MOL PHARMACOL, V42, P666; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; Lauven M, 1999, N-S ARCH PHARMACOL, V360, P122, DOI 10.1007/s002109900059; Lerner I, 2006, J NEUROCHEM, V97, P116, DOI 10.1111/j.1471-4159.2006.03709.x; LESZCZYSZYN DJ, 1991, J NEUROCHEM, V56, P1855, DOI 10.1111/j.1471-4159.1991.tb03441.x; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Liu LW, 2003, NEUROPHARMACOLOGY, V45, P281, DOI 10.1016/S0028-3908(03)00153-9; Marom M, 2007, CHANNELS, V1, P377, DOI 10.4161/chan.5398; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; McDonough SI, 2005, BIOPHYS J, V88, P211, DOI 10.1529/biophysj.104.051714; MONTIEL C, 1994, EUR J PHARM-MOLEC PH, V268, P293, DOI 10.1016/0922-4106(94)90053-1; Peterson BZ, 2006, MOL PHARMACOL, V70, P667, DOI 10.1124/mol.105.020644; PETERSON BZ, 1995, J BIOL CHEM, V270, P18201, DOI 10.1074/jbc.270.31.18201; Peterson BZ, 1996, J BIOL CHEM, V271, P5293, DOI 10.1074/jbc.271.10.5293; RAMPE D, 1991, J PHARMACOL EXP THER, V259, P982; Rodriguez-Contreras A, 2003, BIOPHYS J, V84, P3457, DOI 10.1016/S0006-3495(03)70066-6; Rosa JM, 2009, PFLUG ARCH EUR J PHY, V458, P795, DOI 10.1007/s00424-009-0662-2; Striessnig J, 1998, TRENDS PHARMACOL SCI, V19, P108, DOI 10.1016/S0165-6147(98)01171-7; Tavalin SJ, 2004, J NEUROPHYSIOL, V92, P824, DOI 10.1152/jn.00700.2003; Tobi D, 1998, RECEPTOR CHANNEL, V6, P89; Trus M, 2001, NEUROSCIENCE, V104, P599, DOI 10.1016/S0306-4522(01)00083-5; Trus M, 2007, BIOCHEMISTRY-US, V46, P14461, DOI 10.1021/bi7016816; USOWICZ MM, 1995, J PHARMACOL EXP THER, V275, P638; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Wiser O, 1997, FEBS LETT, V404, P203, DOI 10.1016/S0014-5793(97)00130-0; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wiser O, 2002, P NATL ACAD SCI USA, V99, P3968, DOI 10.1073/pnas.052017299; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Yamaguchi S, 2000, J BIOL CHEM, V275, P41504, DOI 10.1074/jbc.M007165200; ZHENG W, 1991, MOL PHARMACOL, V40, P734	64	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6996	7005		10.1074/jbc.M109.059865	http://dx.doi.org/10.1074/jbc.M109.059865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20054004	Green Published, hybrid			2022-12-25	WOS:000275415600013
J	Artavanis-Tsakonas, K; Weihofen, WA; Antos, JM; Coleman, BI; Comeaux, CA; Duraisingh, MT; Gaudet, R; Ploegh, HL				Artavanis-Tsakonas, Katerina; Weihofen, Wilhelm A.; Antos, John M.; Coleman, Bradley I.; Comeaux, Christy A.; Duraisingh, Manoj T.; Gaudet, Rachelle; Ploegh, Hidde L.			Characterization and Structural Studies of the Plasmodium falciparum Ubiquitin and Nedd8 Hydrolase UCHL3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL HYDROLASES; DEUBIQUITINATING ENZYMES; MALARIA PARASITES; FUNCTIONAL PROTEOMICS; DECONJUGATING ENZYMES; MOLECULAR-DYNAMICS; SPECIFICITY; SUBSTRATE; UCH-L3; INHIBITORS	Like their human hosts, Plasmodium falciparum parasites rely on the ubiquitin-proteasome system for survival. We previously identified PfUCHL3, a deubiquitinating enzyme, and here we characterize its activity and changes in active site architecture upon binding to ubiquitin. We find strong evidence that PfUCHL3 is essential to parasite survival. The crystal structures of both PfUCHL3 alone and in complex with the ubiquitin-based suicide substrate UbVME suggest a rather rigid active site crossover loop that likely plays a role in restricting the size of ubiquitin adduct substrates. Molecular dynamics simulations of the structures and a model of the PfUCHL3-PfNedd8 complex allowed the identification of shared key interactions of ubiquitin and PfNedd8 with PfUCHL3, explaining the dual specificity of this enzyme. Distinct differences observed in ubiquitin binding between PfUCHL3 and its human counterpart make it likely that the parasitic DUB can be selectively targeted while leaving the human enzyme unaffected.	[Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Weihofen, Wilhelm A.; Gaudet, Rachelle] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Coleman, Bradley I.; Comeaux, Christy A.; Duraisingh, Manoj T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr,Rm 361, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	Gaudet, Rachelle/I-4133-2014; Gaudet, Rachelle/Y-3985-2019	Gaudet, Rachelle/0000-0002-9177-054X; Gaudet, Rachelle/0000-0002-9177-054X; Coleman, Bradley/0000-0003-4217-508X	National Institutes of Health [RR-15301]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Stephen Harrison, David Fidock, Rich Eastman, Max Popp, and Marcos Sotomayor for helpful discussions. Simulations were performed using National Science Foundation TeraGrid resources provided by the National Center for Supercomputing Applications and Texas Advanced Computing Center (TRAC MCB080015), and x-ray data collection was done using the Northeastern Collaborative Access Team beamlines (supported by National Institutes of Health Award RR-15301) at the Advanced Photon Source (supported by United States Department of Energy Contract DE-AC02-06CH11357).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Artavanis-Tsakonas K, 2006, MOL MICROBIOL, V61, P1187, DOI 10.1111/j.1365-2958.2006.05307.x; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Featherstone C, 1997, MOL MED TODAY, V3, P367; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Frickel EM, 2007, CELL MICROBIOL, V9, P1601, DOI 10.1111/j.1462-5822.2007.00896.x; Ganesan K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000214; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Hooft RWW, 1996, J MOL GRAPHICS, V14, P168, DOI 10.1016/S0263-7855(96)00055-0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunt P, 2007, MOL MICROBIOL, V65, P27, DOI 10.1111/j.1365-2958.2007.05753.x; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; MACKERELL J, 1998, ENCY COMPUTATIONAL C, V1, P271; Mermerian AH, 2007, BIOORG MED CHEM LETT, V17, P3729, DOI 10.1016/j.bmcl.2007.04.027; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Misaghi S, 2006, MOL MICROBIOL, V61, P142, DOI 10.1111/j.1365-2958.2006.05199.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ponder EL, 2007, EUKARYOT CELL, V6, P1943, DOI 10.1128/EC.00282-07; Popp MW, 2009, J BIOL CHEM, V284, P3593, DOI 10.1074/jbc.M807172200; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun Y, 2003, CANCER BIOL THER, V2, P623; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Triglia T, 1998, EMBO J, V17, P3807, DOI 10.1093/emboj/17.14.3807; Wada H, 1998, BIOCHEM BIOPH RES CO, V251, P688, DOI 10.1006/bbrc.1998.9532; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227	39	35	36	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6857	6866		10.1074/jbc.M109.072405	http://dx.doi.org/10.1074/jbc.M109.072405			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20042598	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000275367500088
J	Jerneren, F; Sesma, A; Francheschetti, M; Hamberg, M; Oliw, EH				Jerneren, Fredrik; Sesma, Ane; Francheschetti, Marina; Hamberg, Mats; Oliw, Ernst H.			Gene Deletion of 7,8-Linoleate Diol Synthase of the Rice Blast Fungus STUDIES ON PATHOGENICITY, STEREOCHEMISTRY, AND OXYGENATION MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNAPORTHE-GRISEA; LINOLEIC-ACID; APPRESSORIUM FORMATION; GAEUMANNOMYCES-GRAMINIS; HYDROPEROXIDE ISOMERASE; ASPERGILLUS-NIDULANS; PLANT INFECTION; MASS-SPECTROMETRY; MAP KINASE; REVEALS	Linoleate diol synthases (LDS) are heme enzymes, which oxygenate 18:2n-6 sequentially to (8R)-hydroperoxylinoleic acid ((8R)-HPODE) and to(5S,8R)-dihydroxy-, (7S,8S)-dihydroxy-, or (8R,11S)-dihydroxylinoleic acids (DiHODE). The genome of the rice blast fungus, Magnaporthe oryzae, contains two genes with homology to LDS. M. oryzae oxidized 18:2n-6 to (8R)-HPODE and to (7S,8S)-DiHODE, (6S,8R)-DiHODE, and (8R,11S)-HODE. Small amounts of 10-hydroxy-(8E,12Z)-octadecadienoic acid and traces of 5,8-DiHODE were also detected by liquid chromatography-mass spectrometry. The contribution of the 7,8-LDS gene to M. oryzae pathogenicity was evaluated by replacement of the catalytic domain with hygromycin and green fluorescent protein variant (SGFP) cassettes. This genetically modified strain Delta 7,8-LDS infected rice leaves and roots and formed appressoria and conidia as the native fungus. The Delta 7,8-LDS mutant had lost the capacity to biosynthesize all the metabolites except small amounts of 8-hydroxylinoleic acid. Studies with stereospecifically deuterated linoleic acids showed that (8R)-HPODE was formed by abstraction of the pro-S hydrogen at C-8 and antarafacial oxygenation, whereas (7S,8S)-DiHODE and (8R,11S)-DiHODE were formed from (8R)-HPODE by suprafacial hydrogen abstraction and oxygenation at C-7 and C-11, respectively. A mac1 suppressor mutant (Delta mac1 sum1-99) of M. oryzae, which shows cAMP-independent protein kinase A activity, oxygenated 18:2n-6 to increased amounts of (10R)-HPODE and (5S,8R)-DiHODE. Expression of the 7,8-LDS gene but not of the second homologue was detected in the suppressor mutant. This suggests that PKA-mediated signaling pathway regulates the dioxygenase and hydroperoxide isomerase activities of M. oryzae.	[Jerneren, Fredrik; Oliw, Ernst H.] Uppsala Univ, Dept Pharmaceut Biosci, Sect Biochem Pharmacol, Biomed Ctr, SE-75124 Uppsala, Sweden; [Sesma, Ane; Francheschetti, Marina] John Innes Ctr, Dept Dis & Stress Biol, Norwich NR4 7UH, Norfolk, England; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Uppsala University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Karolinska Institutet	Oliw, EH (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Sect Biochem Pharmacol, Biomed Ctr, POB 591, SE-75124 Uppsala, Sweden.	Ernst.Oliw@farmbio.uu.se	Sesma, Ane/AAF-4796-2021; Sesma, Ane/A-8883-2010	Sesma, Ane/0000-0003-3982-8932; Hamberg, Mats/0000-0002-8910-7810; Oliw, Ernst/0000-0002-7986-8130; Jerneren, Fredrik/0000-0003-0897-7177	Vetenskapsradet Medicin [03X-06523]; The Knut and Alice Wallenberg Foundation [KAW 2004.0123]; The Swedish Research Council for Environmental, Agricultural Sciences [222-2005-1733]; Spatial Planning Project [229-2004833]; The Biotechnology and Biological Sciences Research Council [BB/C520720/1]; Biotechnology and Biological Sciences Research Council [BB/C520720/1] Funding Source: researchfish	Vetenskapsradet Medicin; The Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); The Swedish Research Council for Environmental, Agricultural Sciences; Spatial Planning Project; The Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Vetenskapsradet Medicin/Grant 03X-06523 (to E.O.), The Knut and Alice Wallenberg Foundation/Grant KAW 2004.0123 and Formas/Grant 222-2005-1733, The Swedish Research Council for Environmental, Agricultural Sciences, and Spatial Planning Project 229-2004833 (to M.H.), and The Biotechnology and Biological Sciences Research Council Grant BB/C520720/1, United Kingdom (to A.S.).	Adachi K, 1998, PLANT CELL, V10, P1361, DOI 10.1105/tpc.10.8.1361; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; BRODOWSKY ID, 1992, J BIOL CHEM, V267, P14738; Cannon P. F., 1994, Systema Ascomycetum, V13, P25; Capdevila JH, 1996, J BIOL CHEM, V271, P22663, DOI 10.1074/jbc.271.37.22663; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Cook RJ, 2003, PHYSIOL MOL PLANT P, V62, P73, DOI 10.1016/S0885-5765(03)00042-0; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; Cristea M, 2003, LIPIDS, V38, P1275, DOI 10.1007/s11745-003-1189-3; Dagenais TRT, 2008, INFECT IMMUN, V76, P3214, DOI 10.1128/IAI.00009-08; DAVIS LV, 1994, BUILDING WOMENS STRE, P1; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Deng JX, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-30; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; Garscha U, 2008, FEBS LETT, V582, P3547, DOI 10.1016/j.febslet.2008.09.031; Garscha U, 2007, J BIOL CHEM, V282, P34707, DOI 10.1074/jbc.M705366200; Garscha U, 2007, ANAL BIOCHEM, V367, P238, DOI 10.1016/j.ab.2007.04.045; Garscha U, 2009, J BIOL CHEM, V284, P13755, DOI 10.1074/jbc.M808665200; HAMBERG M, 1994, ARCH BIOCHEM BIOPHYS, V309, P77, DOI 10.1006/abbi.1994.1087; HASLBECK F, 1983, BIOCHIM BIOPHYS ACTA, V750, P185, DOI 10.1016/0005-2760(83)90219-9; Hornsten L, 1999, J BIOL CHEM, V274, P28219, DOI 10.1074/jbc.274.40.28219; Huber SMFE, 2002, MOL GENET GENOMICS, V267, P757, DOI 10.1007/s00438-002-0717-y; JERNEREN F, 2010, BIOCH BIOPH IN PRESS; Kitazume T, 2000, J BIOL CHEM, V275, P39734, DOI 10.1074/jbc.M005617200; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; Oesch-Bartlomowicz B, 2003, ARCH BIOCHEM BIOPHYS, V409, P228, DOI 10.1016/S0003-9861(02)00558-1; Oh Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r85; Oliw EH, 1998, LIPIDS, V33, P843, DOI 10.1007/s11745-998-0280-0; Oliw EH, 2001, BIOCHEM PHARMACOL, V62, P407, DOI 10.1016/S0006-2952(01)00683-9; Ou SH, 1985, RICE DIS; Park G, 2002, MOL PLANT MICROBE IN, V15, P183, DOI 10.1094/MPMI.2002.15.3.183; Rho HS, 2001, MOL CELLS, V12, P407; Ribot C, 2008, J PLANT PHYSIOL, V165, P114, DOI 10.1016/j.jplph.2007.06.013; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Su C, 1998, J BIOL CHEM, V273, P20744, DOI 10.1074/jbc.273.33.20744; Su C, 1996, J BIOL CHEM, V271, P14112, DOI 10.1074/jbc.271.24.14112; Talbot NJ, 2001, ADV BOT RES, V34, P263, DOI 10.1016/S0065-2296(01)34011-9; TALBOT NJ, 2001, MOL CELLULAR BIOL FI, P25; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Tsitsigiannis DI, 2006, MOL MICROBIOL, V59, P882, DOI 10.1111/j.1365-2958.2005.05000.x; Tsitsigiannis DI, 2005, MICROBIOL-SGM, V151, P1809, DOI 10.1099/mic.0.27880-0; Wadman MW, 2005, LIPIDS, V40, P1163, DOI 10.1007/s11745-005-1481-2; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xu JR, 1997, MOL PLANT MICROBE IN, V10, P187, DOI 10.1094/MPMI.1997.10.2.187; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696	50	27	28	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5308	5316		10.1074/jbc.M109.062810	http://dx.doi.org/10.1074/jbc.M109.062810			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20023302	Green Published, hybrid			2022-12-25	WOS:000275327200024
J	Chen, WY; Bergsman, JB; Wang, XH; Gilkey, G; Pierpoint, CR; Daniel, EA; Awumey, EM; Dauban, P; Dodd, RH; Ruat, M; Smith, SM				Chen, Wenyan; Bergsman, Jeremy B.; Wang, Xiaohua; Gilkey, Gawain; Pierpoint, Carol-Renee; Daniel, Erin A.; Awumey, Emmanuel M.; Dauban, Philippe; Dodd, Robert H.; Ruat, Martial; Smith, Stephen M.			Presynaptic External Calcium Signaling Involves the Calcium-Sensing Receptor in Neocortical Nerve Terminals	PLOS ONE			English	Article							EXTRACELLULAR CA2+-SENSING RECEPTOR; CELL-SURFACE EXPRESSION; SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; GLUTAMATE RELEASE; CATION CHANNEL; PROTEIN-KINASE; ACID RECEPTOR; CA2+; RAT	Background: Nerve terminal invasion by an axonal spike activates voltage-gated channels, triggering calcium entry, vesicle fusion, and release of neurotransmitter. Ion channels activated at the terminal shape the presynaptic spike and so regulate the magnitude and duration of calcium entry. Consequently characterization of the functional properties of ion channels at nerve terminals is crucial to understand the regulation of transmitter release. Direct recordings from small neocortical nerve terminals have revealed that external [Ca2+] ([Ca2+](o)) indirectly regulates a non- selective cation channel (NSCC) in neocortical nerve terminals via an unknown [Ca2+](o) sensor. Here, we identify the first component in a presynaptic calcium signaling pathway. Methodology/Principal Findings: By combining genetic and pharmacological approaches with direct patch-clamp recordings from small acutely isolated neocortical nerve terminals we identify the extracellular calcium sensor. Our results show that the calcium-sensing receptor (CaSR), a previously identified G-protein coupled receptor that is the mainstay in serum calcium homeostasis, is the extracellular calcium sensor in these acutely dissociated nerve terminals. The NSCC currents from reduced function mutant CaSR mice were less sensitive to changes in [Ca2+](o) than wild-type. Calindol, an allosteric CaSR agonist, reduced NSCC currents in direct terminal recordings in a dose-dependent and reversible manner. In contrast, glutamate and GABA did not affect the NSCC currents. Conclusions/Significance: Our experiments identify CaSR as the first component in the [Ca2+](o) sensor-NSCC signaling pathway in neocortical terminals. Decreases in [Ca2+](o) will depress synaptic transmission because of the exquisite sensitivity of transmitter release to [Ca2+](o) following its entry via voltage-activated Ca2+ channels. CaSR may detects such falls in [Ca2+](o) and increase action potential duration by increasing NSCC activity, thereby attenuating the impact of decreases in [Ca2+](o) on release probability. CaSR is positioned to detect the dynamic changes of [Ca2+](o) and provide presynaptic feedback that will alter brain excitability.	[Chen, Wenyan; Bergsman, Jeremy B.; Wang, Xiaohua; Gilkey, Gawain; Pierpoint, Carol-Renee; Daniel, Erin A.; Smith, Stephen M.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Awumey, Emmanuel M.] N Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC USA; [Dauban, Philippe; Dodd, Robert H.] CNRS, Inst Chim Subst Nat, Gif Sur Yvette, France; [Ruat, Martial] CNRS, Inst Neurobiol Alfred Fessard, Gif Sur Yvette, France	Oregon Health & Science University; University of North Carolina; North Carolina Central University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Chen, WY (corresponding author), Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA.	smisteph@ohsu.edu	Ruat, Martial/E-5544-2016; Chen, Wenyan/V-7000-2019	Smith, Stephen/0000-0002-0331-7615	OHSU-HHMI Biomedical Support Program; NINDS [R01-NS 43444]; OHSU President's Fund; French Agence Nationale de la Recherche [07-physio-027-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL099139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043444] Funding Source: NIH RePORTER	OHSU-HHMI Biomedical Support Program; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OHSU President's Fund; French Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the OHSU-HHMI Biomedical Support Program, NINDS (R01-NS 43444), and OHSU President's Fund. M. R. is supported by a grant from the French Agence Nationale de la Recherche (07-physio-027-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG CM, 1991, P NATL ACAD SCI USA, V88, P6528, DOI 10.1073/pnas.88.15.6528; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; Awumey EM, 2007, AM J PHYSIOL-CELL PH, V292, pC1895, DOI 10.1152/ajpcell.00404.2006; Azkue JJ, 2001, J COMP NEUROL, V430, P448, DOI 10.1002/1096-9861(20010219)430:4<448::AID-CNE1042>3.0.CO;2-O; Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Bailey TW, 2006, J NEUROSCI, V26, P6131, DOI 10.1523/JNEUROSCI.5176-05.2006; Billinton A, 1999, BRIT J PHARMACOL, V126, P1387, DOI 10.1038/sj.bjp.0702460; Bischofberger J, 2002, J NEUROSCI, V22, P10593; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Bouschet T, 2008, TRENDS PHARMACOL SCI, V29, P633, DOI 10.1016/j.tips.2008.09.002; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 1998, RECENT PROG HORM RES, V53, P257; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; Brown EM, 1998, ANNU REV MED, V49, P15, DOI 10.1146/annurev.med.49.1.15; Chang WH, 2007, J BIOL CHEM, V282, P25030, DOI 10.1074/jbc.M700924200; Chattopadhyay N, 1998, GLIA, V24, P449, DOI 10.1002/(SICI)1098-1136(199812)24:4<449::AID-GLIA10>3.3.CO;2-0; Chen WY, 2007, CHANNELS, V1, P281, DOI 10.4161/chan.4988; Cheng ZQ, 2007, ENDOCRINOLOGY, V148, P4984, DOI 10.1210/en.2007-0653; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; CONLEY YP, 2008, AM J MED GENET B; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; FATT P, 1951, J PHYSIOL-LONDON, V115, P320, DOI 10.1113/jphysiol.1951.sp004675; Ferry S, 2000, EUR J NEUROSCI, V12, P872, DOI 10.1046/j.1460-9568.2000.00980.x; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Gama L, 2001, J BIOL CHEM, V276, P39053, DOI 10.1074/jbc.M105662200; GARRETT JE, 1995, ENDOCRINOLOGY, V136, P5202, DOI 10.1210/en.136.11.5202; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; HARNETT MT, 2009, NEUROPHARMACOLOGY; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; Hofer AM, 2000, NAT CELL BIOL, V2, P392, DOI 10.1038/35017020; Hofer AM, 2005, J CELL SCI, V118, P855, DOI 10.1242/jcs.01705; Ikeda K, 2008, J NEUROSCI, V28, P13563, DOI 10.1523/JNEUROSCI.3350-08.2008; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Kapoor A, 2008, ANN NEUROL, V64, P158, DOI 10.1002/ana.21428; Kessler A, 2004, BIOORG MED CHEM LETT, V14, P3345, DOI 10.1016/j.bmcl.2004.03.056; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Li LY, 2007, J NEUROSCI, V27, P13420, DOI 10.1523/JNEUROSCI.1709-07.2007; LI PA, 1995, EXP BRAIN RES, V105, P363; LLINAS R, 1976, P NATL ACAD SCI USA, V73, P2918, DOI 10.1073/pnas.73.8.2918; Lorenz S, 2007, ENDOCRINOLOGY, V148, P2398, DOI 10.1210/en.2006-1035; McNeil SE, 1998, J BIOL CHEM, V273, P1114, DOI 10.1074/jbc.273.2.1114; Miedlich SU, 2004, J BIOL CHEM, V279, P7254, DOI 10.1074/jbc.M307191200; Mun HC, 2004, J BIOL CHEM, V279, P51739, DOI 10.1074/jbc.M406164/200; Nearing J, 2002, P NATL ACAD SCI USA, V99, P9231, DOI 10.1073/pnas.152294399; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; Oda Y, 2000, J BIOL CHEM, V275, P1183, DOI 10.1074/jbc.275.2.1183; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; Peters JH, 2008, J NEUROSCI, V28, P11731, DOI 10.1523/JNEUROSCI.3419-08.2008; Petrel C, 2004, J BIOL CHEM, V279, P18990, DOI 10.1074/jbc.M400724200; Phillips CG, 2008, J NEUROSCI, V28, P12062, DOI 10.1523/JNEUROSCI.4134-08.2008; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Ray K, 2005, J BIOL CHEM, V280, P37013, DOI 10.1074/jbc.M506681200; Ruat M, 1996, J BIOL CHEM, V271, P5972, DOI 10.1074/jbc.271.11.5972; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Saunders R, 1998, NEUROPHARMACOLOGY, V37, P273, DOI 10.1016/S0028-3908(98)00027-6; Silve C, 2005, J BIOL CHEM, V280, P37917, DOI 10.1074/jbc.M506263200; Smith SM, 2004, NEURON, V41, P243, DOI 10.1016/S0896-6273(03)00837-7; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Vyleta NP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003155; Ward DT, 2004, CELL CALCIUM, V35, P217, DOI 10.1016/j.ceca.2003.10.017; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wise A, 1999, NEUROPHARMACOLOGY, V38, P1647, DOI 10.1016/S0028-3908(99)00119-7; Wittmann M, 2001, J NEUROPHYSIOL, V85, P1960, DOI 10.1152/jn.2001.85.5.1960; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Yamada K, 1999, J NEUROPHYSIOL, V81, P2875, DOI 10.1152/jn.1999.81.6.2875	77	32	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8563	10.1371/journal.pone.0008563	http://dx.doi.org/10.1371/journal.pone.0008563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052292	Green Published, Green Submitted, gold			2022-12-25	WOS:000273338500008
J	Musazzi, L; Milanese, M; Farisello, P; Zappettini, S; Tardito, D; Barbiero, VS; Bonifacino, T; Mallei, A; Baldelli, P; Racagni, G; Raiteri, M; Benfenati, F; Bonanno, G; Popoli, M				Musazzi, Laura; Milanese, Marco; Farisello, Pasqualina; Zappettini, Simona; Tardito, Daniela; Barbiero, Valentina S.; Bonifacino, Tiziana; Mallei, Alessandra; Baldelli, Pietro; Racagni, Giorgio; Raiteri, Maurizio; Benfenati, Fabio; Bonanno, Giambattista; Popoli, Maurizio			Acute Stress Increases Depolarization-Evoked Glutamate Release in the Rat Prefrontal/Frontal Cortex: The Dampening Action of Antidepressants	PLOS ONE			English	Article							MINERALOCORTICOID RECEPTORS; MAJOR DEPRESSION; MEMBRANE-FUSION; FRONTAL-CORTEX; MESSENGER-RNA; SNARE COMPLEX; HIPPOCAMPUS; SYNAPTOSOMES; BRAIN; CORTICOSTERONE	Background: Behavioral stress is recognized as a main risk factor for neuropsychiatric diseases. Converging evidence suggested that acute stress is associated with increase of excitatory transmission in certain forebrain areas. Aim of this work was to investigate the mechanism whereby acute stress increases glutamate release, and if therapeutic drugs prevent the effect of stress on glutamate release. Methodology/Findings: Rats were chronically treated with vehicle or drugs employed for therapy of mood/anxiety disorders (fluoxetine, desipramine, venlafaxine, agomelatine) and then subjected to unpredictable footshock stress. Acute stress induced marked increase in depolarization-evoked release of glutamate from synaptosomes of prefrontal/frontal cortex in superfusion, and the chronic drug treatments prevented the increase of glutamate release. Stress induced rapid increase in the circulating levels of corticosterone in all rats (both vehicle- and drug-treated), and glutamate release increase was blocked by previous administration of selective antagonist of glucocorticoid receptor (RU 486). On the molecular level, stress induced accumulation of presynaptic SNARE complexes in synaptic membranes (both in vehicle- and drug-treated rats). Patch-clamp recordings of pyramidal neurons in the prefrontal cortex revealed that stress increased glutamatergic transmission through both pre- and postsynaptic mechanisms, and that antidepressants may normalize it by reducing release probability. Conclusions/Significance: Acute footshock stress up-regulated depolarization-evoked release of glutamate from synaptosomes of prefrontal/frontal cortex. Stress-induced increase of glutamate release was dependent on stimulation of glucocorticoid receptor by corticosterone. Because all drugs employed did not block either elevation of corticosterone or accumulation of SNARE complexes, the dampening action of the drugs on glutamate release must be downstream of these processes. This novel effect of antidepressants on the response to stress, shown here for the first time, could be related to the therapeutic action of these drugs.	[Musazzi, Laura; Tardito, Daniela; Barbiero, Valentina S.; Mallei, Alessandra; Racagni, Giorgio; Popoli, Maurizio] Univ Milan, Dept Pharmacol Sci, Ctr Neuropharmacol, Milan, Italy; [Musazzi, Laura; Tardito, Daniela; Barbiero, Valentina S.; Mallei, Alessandra; Racagni, Giorgio; Popoli, Maurizio] Univ Milan, Ctr Excellence Neurodegenerat Dis, Milan, Italy; [Milanese, Marco; Zappettini, Simona; Bonifacino, Tiziana; Racagni, Giorgio; Raiteri, Maurizio; Bonanno, Giambattista] Univ Genoa, Dept Expt Med, Sect Pharmacol & Toxicol, Genoa, Italy; [Farisello, Pasqualina; Baldelli, Pietro; Racagni, Giorgio; Benfenati, Fabio] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy; [Racagni, Giorgio] Ist Ricovero & Cura Carattere Sci San Giovanni di, Brescia, Italy; [Milanese, Marco; Zappettini, Simona; Bonifacino, Tiziana; Racagni, Giorgio; Raiteri, Maurizio; Bonanno, Giambattista] Ctr Excellence Biomed Res, Genoa, Italy; [Milanese, Marco; Farisello, Pasqualina; Zappettini, Simona; Bonifacino, Tiziana; Baldelli, Pietro; Racagni, Giorgio; Raiteri, Maurizio; Benfenati, Fabio; Bonanno, Giambattista] Natl Inst Neurosci, Genoa, Italy; [Farisello, Pasqualina; Baldelli, Pietro; Racagni, Giorgio; Benfenati, Fabio] Univ Genoa, Dept Expt Med, Physiol Sect, Genoa, Italy	University of Milan; University of Milan; University of Genoa; Istituto Italiano di Tecnologia - IIT; University of Genoa	Musazzi, L (corresponding author), Univ Milan, Dept Pharmacol Sci, Ctr Neuropharmacol, Milan, Italy.	maurizio.popoli@unimi.it	Bonanno, Giambattista/C-5856-2008; Milanese, Marco/C-4444-2013; Racagni, Giorgio A./B-5826-2011; Baldelli, Pietro/AAH-2493-2021; Tardito, Daniela/J-8076-2015; Baldelli, Pietro/AAA-6298-2020; Milanese, Marco/AAB-2238-2021; Bonifacino, Tiziana/AAA-5471-2019	Milanese, Marco/0000-0003-3384-0666; Tardito, Daniela/0000-0001-5585-1054; Milanese, Marco/0000-0003-3384-0666; Bonifacino, Tiziana/0000-0002-3966-9874; Mallei, Alessandra/0000-0001-6955-4755; Bonanno, Giambattista/0000-0003-3744-5786; Baldelli, Pietro/0000-0001-9599-3436	Italian Ministry of University and Research; PRIN [2003053993, 2005054953, 2008T4ZCNL, 2008JRRXCN]; Italian Ministry of Health Progetto Giovani; Compagnia di San Paolo, Telethon - Italy; Servier	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Health Progetto Giovani(Ministry of Health, Italy); Compagnia di San Paolo, Telethon - Italy(Compagnia di San PaoloFondazione Telethon); Servier(Servier)	This study was supported by grants from the Italian Ministry of University and Research, PRIN no. 2003053993 and 2005054953, 2008T4ZCNL and 2008JRRXCN; Italian Ministry of Health Progetto Giovani, Compagnia di San Paolo, Telethon - Italy and a research grant from Servier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agid O, 2008, EXPERT OPIN EMERG DR, V13, P479, DOI [10.1517/14728214.13.3.479, 10.1517/14728214.13.3.479 ]; Agid Y, 2007, NAT REV DRUG DISCOV, V6, P189, DOI 10.1038/nrd2217; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Audinot V, 2003, N-S ARCH PHARMACOL, V367, P553, DOI 10.1007/s00210-003-0751-2; Azpiroz A, 1999, PSYCHONEUROENDOCRINO, V24, P345, DOI 10.1016/S0306-4530(98)00084-5; Bagley J, 1997, NEUROSCIENCE, V77, P65, DOI 10.1016/S0306-4522(96)00435-6; Barbiero VS, 2007, NEUROPSYCHOPHARMACOL, V32, P2511, DOI 10.1038/sj.npp.1301378; Bianchi R, 2009, J NEUROSCI, V29, P3497, DOI 10.1523/JNEUROSCI.5447-08.2009; Bonanno G, 2005, J NEUROSCI, V25, P3270, DOI 10.1523/JNEUROSCI.5033-04.2005; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Conti AC, 2004, J NEUROSCI, V24, P1967, DOI 10.1523/JNEUROSCI.4804-03.2004; de Kloet ER, 2008, FRONT NEUROENDOCRIN, V29, P268, DOI 10.1016/j.yfrne.2007.10.002; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dow AL, 2005, J NEUROSCI, V25, P4908, DOI 10.1523/JNEUROSCI.5155-04.2005; Du Jing, 2006, Drug Discov Today Ther Strateg, V3, P519, DOI 10.1016/j.ddstr.2006.11.012; Duncan GE, 1998, J PHARMACOL EXP THER, V285, P579; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; Holden C, 2003, SCIENCE, V300, P1866, DOI 10.1126/science.300.5627.1866; Honer WG, 2002, CEREB CORTEX, V12, P349, DOI 10.1093/cercor/12.4.349; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lonart G, 2000, J BIOL CHEM, V275, P27703; LOWY MT, 1995, J NEUROCHEM, V65, P268; Matar MA, 2009, EUR NEUROPSYCHOPHARM, V19, P283, DOI 10.1016/j.euroneuro.2008.12.004; Matveeva EA, 2003, J NEUROCHEM, V84, P621, DOI 10.1046/j.1471-4159.2003.01589.x; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Michael-Titus AT, 2000, NEUROSCIENCE, V100, P681, DOI 10.1016/S0306-4522(00)00390-0; Millan MJ, 2003, J PHARMACOL EXP THER, V306, P954, DOI 10.1124/jpet.103.051797; MOGHADDAM B, 1994, BRAIN RES, V655, P251, DOI 10.1016/0006-8993(94)91622-5; Moulder KL, 2006, MOL NEUROBIOL, V33, P133, DOI 10.1385/MN:33:2:133; Olijslagers JE, 2008, EUR J NEUROSCI, V27, P2542, DOI 10.1111/j.1460-9568.2008.06220.x; Pittaluga A, 2007, NEUROPHARMACOLOGY, V53, P27, DOI 10.1016/j.neuropharm.2007.04.006; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Raiteri L, 2000, NEUROCHEM RES, V25, P1265, DOI 10.1023/A:1007648229795; RAITERI M, 1983, EUR J PHARMACOL, V91, P141, DOI 10.1016/0014-2999(83)90377-1; RAITERI M, 1974, EUR J PHARMACOL, V25, P411, DOI 10.1016/0014-2999(74)90272-6; Raiteri M, 2000, J NEUROCHEM, V74, P423, DOI 10.1046/j.1471-4159.2000.0740423.x; Reagan LP, 2004, P NATL ACAD SCI USA, V101, P2179, DOI 10.1073/pnas.0307294101; Reznikov LR, 2007, EUR J NEUROSCI, V25, P3109, DOI 10.1111/j.1460-9568.2007.05560.x; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Sapolsky RM, 2000, BIOL PSYCHIAT, V48, P755, DOI 10.1016/S0006-3223(00)00971-9; STEINBEHRENS BA, 1994, J NEUROCHEM, V63, P596; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; TARDITO D, 2009, INT J NEUROPSYCHOPHA; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; Timmerman W, 1997, SYNAPSE, V27, P242, DOI 10.1002/(SICI)1098-2396(199711)27:3<242::AID-SYN9>3.0.CO;2-D; Tokarski K, 2008, NEUROSCIENCE, V153, P789, DOI 10.1016/j.neuroscience.2008.03.007; Venero C, 1999, EUR J NEUROSCI, V11, P2465, DOI 10.1046/j.1460-9568.1999.00668.x; Vollmayr B, 2001, BRAIN RES PROTOC, V8, P1, DOI 10.1016/S1385-299X(01)00067-8; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106	54	206	213	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8566	10.1371/journal.pone.0008566	http://dx.doi.org/10.1371/journal.pone.0008566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052403	gold, Green Published, Green Submitted			2022-12-25	WOS:000273338500010
J	Chalopin, M; Tesse, A; Martinez, MC; Rognan, D; Arnal, JF; Andriantsitohaina, R				Chalopin, Matthieu; Tesse, Angela; Martinez, Maria Carmen; Rognan, Didier; Arnal, Jean-Francois; Andriantsitohaina, Ramaroson			Estrogen Receptor Alpha as a Key Target of Red Wine Polyphenols Action on the Endothelium	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; CARDIOVASCULAR ALTERATIONS; DEPENDENT VASORELAXATION; VASCULAR FUNCTION; CELLS; HYPERTENSION; RESVERATROL; SYNTHASE; RATS; MICROPARTICLES	Background: A greater reduction in cardiovascular risk and vascular protection associated with diet rich in polyphenols are generally accepted; however, the molecular targets for polyphenols effects remain unknown. Meanwhile evidences in the literature have enlightened, not only structural similarities between estrogens and polyphenols known as phytoestrogens, but also in their vascular effects. We hypothesized that alpha isoform of estrogen receptor (ER alpha) could be involved in the transduction of the vascular benefits of polyphenols. Methodology/Principal Findings: Here, we used ER alpha deficient mice to show that endothelium-dependent vasorelaxation induced either by red wine polyphenol extract, Provinols (TM), or delphinidin, an anthocyanin that possesses similar pharmacological profile, is mediated by ER alpha. Indeed, Provinols (TM), delphinidin and ER alpha agonists, 17-beta-estradiol and PPT, are able to induce endothelial vasodilatation in aorta from ER alpha Wild-Type but not from Knock-Out mice, by activation of nitric oxide (NO) pathway in endothelial cells. Besides, silencing the effects of ER alpha completely prevented the effects of Provinols (TM) and delphinidin to activate NO pathway (Src, ERK 1/2, eNOS, caveolin-1) leading to NO production. Furthermore, direct interaction between delphinidin and ER alpha activator site is demonstrated using both binding assay and docking. Most interestingly, the ability of short term oral administration of Provinols (TM) to decrease response to serotonin and to enhance sensitivity of the endothelium-dependent relaxation to acetylcholine, associated with concomitant increased NO production and decreased superoxide anions, was completely blunted in ER alpha deficient mice. Conclusions/Significance: This study provides evidence that red wine polyphenols, especially delphinidin, exert their endothelial benefits via ER alpha activation. It is a major breakthrough bringing new insights of the potential therapeutic of polyphenols against cardiovascular pathologies.	[Chalopin, Matthieu; Tesse, Angela; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson] Univ Angers, INSERM, U771, CNRS UMR 6214, Angers, France; [Rognan, Didier] Univ Louis Pasteur Strasbourg 1, UMR 7175, CNRS, Illkirch Graffenstaden, France; [Arnal, Jean-Francois] Univ Toulouse 3, INSERM, U858, CHU, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Chalopin, M (corresponding author), Univ Angers, INSERM, U771, CNRS UMR 6214, Angers, France.	ramaroson.andriantsitohaina@univ-angers.fr	Tesse, Angela/D-4803-2015; ARNAL, Jean Francois/K-7004-2014; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; Rognan, Didier/B-9939-2014	Tesse, Angela/0000-0002-2153-4357; Martinez, M Carmen/0000-0003-3897-7397; ARNAL, Jean Francois/0000-0003-2229-6300; chalopin, matthieu/0000-0002-9285-8869; andriantsitohaina, ramaroson/0000-0002-4770-3585	Fonds Europeen pour le Developpement Regional [8891]; INSERM; Universite d'Angers	Fonds Europeen pour le Developpement Regional; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite d'Angers	Supported by institutional grants from the Fonds Europeen pour le Developpement Regional (no. 8891), INSERM, and Universite d'Angers. R. A. was supported by a Contrat d'Interface INSERM. M. C. is recipient of a doctoral fellowship from French Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2007, FASEB J, V21, P2735, DOI 10.1096/fj.07-8079com; Agouni A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005557; Andriambeloson E, 1997, BRIT J PHARMACOL, V120, P1053, DOI 10.1038/sj.bjp.0701011; Andriambeloson E, 1998, J NUTR, V128, P2324, DOI 10.1093/jn/128.12.2324; Arnal JF, 2007, CURR OPIN LIPIDOL, V18, P554, DOI 10.1097/MOL.0b013e3282ef3bca; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bernatova I, 2002, AM J PHYSIOL-HEART C, V282, pH942, DOI 10.1152/ajpheart.00724.2001; Kim KH, 2008, STEROIDS, V73, P864, DOI 10.1016/j.steroids.2008.01.008; Klinge CM, 2008, FASEB J, V22, P2185, DOI 10.1096/fj.07-103366; Klinge CM, 2005, J BIOL CHEM, V280, P7460, DOI 10.1074/jbc.M411565200; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Li L, 2007, P NATL ACAD SCI USA, V104, P16468, DOI 10.1073/pnas.0704315104; Martin S, 2003, BRIT J PHARMACOL, V139, P1095, DOI 10.1038/sj.bjp.0705347; Martin S, 2002, BRIT J PHARMACOL, V135, P1579, DOI 10.1038/sj.bjp.0704603; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Miller VM, 2007, TRENDS PHARMACOL SCI, V28, P263, DOI 10.1016/j.tips.2007.04.004; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; Pechanova O, 2006, PHYSIOL RES, V55, pS17, DOI 10.33549/physiolres.930000.55.S1.17; Pechanova O, 2004, J HYPERTENS, V22, P1551, DOI 10.1097/01.hjh.0000133734.32125.c7; Rathel TR, 2005, BRIT J PHARMACOL, V144, P394, DOI 10.1038/sj.bjp.0706075; Renaud SC, 2004, AM J CLIN NUTR, V80, P621; Ritz MF, 2008, J NUTR, V138, P519, DOI 10.1093/jn/138.3.519; Sakamoto K, 2008, CELL METAB, V7, P3, DOI 10.1016/j.cmet.2007.12.005; Vera R, 2007, CLIN SCI, V112, P183, DOI 10.1042/CS20060185; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; Walker HA, 2001, CIRCULATION, V103, P258, DOI 10.1161/01.CIR.103.2.258; Wyckoff MH, 2001, J BIOL CHEM, V276, P27071, DOI 10.1074/jbc.M100312200	28	92	98	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8554	10.1371/journal.pone.0008554	http://dx.doi.org/10.1371/journal.pone.0008554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049322	Green Published, gold			2022-12-25	WOS:000273225000017
J	Camats, M; Kokolo, M; Heesom, KJ; Ladomery, M; Bach-Elias, M				Camats, Maria; Kokolo, Mariette; Heesom, Kate J.; Ladomery, Michael; Bach-Elias, Montse			P19 H-Ras Induces G1/S Phase Delay Maintaining Cells in a Reversible Quiescence State	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXO3A; C-JUN; PROTEIN; EXPRESSION; PATHWAY; PROLIFERATION; PROTOONCOGENE; PROGRESSION; ACTIVATION; GROWTH	Background:Three functional c-ras genes, known as c-H-ras, c-K-ras, and c-N-ras, have been largely studied in mammalian cells with important insights into normal and tumorigenic cellular signal transduction events. Two K-Ras mRNAs are obtained from the same pre-mRNA by alternative splicing. H-Ras pre-mRNA can also be alternatively spliced in the IDX and 4A terminal exons, yielding the p19 and p21 proteins, respectively. However, despite the Ras gene family's established role in tumorigenic cellular signal transduction events, little is known about p19 function. Previous results showed that p19 did not interact with two known p21 effectors, Raf1 and Rini, but was shown to interact with RACK1, a scaffolding protein that promotes multi-protein complexes in different signaling pathways (Cancer Res 2003, 63 p5178). This observation suggests that p19 and p21 play differential and complementary roles in the cell. Principal Findings: We found that p19 regulates telomerase activity through its interaction with p73a./I3 proteins. We also found that p19 overexpression induces G1/S phase delay; an observation that correlates with hypophosphorylation of both Akt and p7OSK6. Similarly, we also observed that FOX01 is upregulated when p19 is overexpressed. The three observations of (1) hypophosphorylation of Akt, (2) G1/S phase delay and (3) upregulation of FOX01 lead us to conclude that p19 induces G1/S phase delay, thereby maintaining cells in a reversible quiescence state and preventing entry into apoptosis. We then assessed the effect of p19 RNAi on HeLa cell growth and found that p19 RNAi increases cell growth, thereby having the opposite effect of arrest of the G1/S phase or producing a cellular quiescence state. Significance:Interestingly, p19 induces FOX01 that in combination with the G1/S phase delay and hypophosphorylation of both Akt and p7OSK6 leads to maintenance of a reversible cellular quiescence state, thereby preventing entry into apoptosis.	[Camats, Maria; Kokolo, Mariette; Bach-Elias, Montse] CSIC, Inst Invest Biomed Barcelona, Unidad Splicing, Barcelona, Spain; [Heesom, Kate J.] Univ Bristol, Prote Facil, Bristol, Avon, England; [Ladomery, Michael] Univ W England, Fac Hlth & Life Sci, Ctr Res Biomed, Bristol BS16 1QY, Avon, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; University of Bristol; University of West England	Camats, M (corresponding author), CSIC, Inst Invest Biomed Barcelona, Unidad Splicing, Barcelona, Spain.	mbebmc@cid.csic.es			Fundacion de Investigacion Medica Mutua Madrilena Automovilista (Fundacion MMA); Plan Nacional (MEC) [51U200500701]; Fundacion Eugenio Rodriguez Pascual	Fundacion de Investigacion Medica Mutua Madrilena Automovilista (Fundacion MMA); Plan Nacional (MEC)(Spanish Government); Fundacion Eugenio Rodriguez Pascual	This work was supported by Fundacion de Investigacion Medica Mutua Madrilena Automovilista (Fundacion MMA), the Plan Nacional (MEC) 51U200500701 and the Fundacion Eugenio Rodriguez Pascual. M.C. was a recipient of a Fmed MMA fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Cai DC, 2004, BRAIN RES, V1014, P14, DOI 10.1016/j.brainres.2004.04.008; COHEN JB, 1989, CELL, V58, P461, DOI 10.1016/0092-8674(89)90427-3; Dereure O, 2006, ANN DERMATOL VENER, V133, P731, DOI 10.1016/S0151-9638(06)71003-1; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Gripp KW, 2006, AM J MED GENET A, V140A, P2163, DOI 10.1002/ajmg.a.31456; Guil S, 2003, CANCER RES, V63, P5178; Guil S, 2003, MOL CELL BIOL, V23, P2927, DOI 10.1128/MCB.23.8.2927-2941.2003; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Jeong MH, 2006, J BIOL CHEM, V281, P8707, DOI 10.1074/jbc.M513853200; Kim JW, 2008, BIOCHEM BIOPH RES CO, V373, P146, DOI 10.1016/j.bbrc.2008.06.010; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Malumbres M, 1998, FRONT BIOSCI-LANDMRK, V3, P887; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Marabese M, 2007, EUR J CANCER, V43, P1361, DOI 10.1016/j.ejca.2007.01.042; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; MCGRATH JP, 1983, NATURE, V304, P501, DOI 10.1038/304501a0; Pells S, 1997, ONCOGENE, V15, P1781, DOI 10.1038/sj.onc.1201354; Rahman-Roblick R, 2007, P NATL ACAD SCI USA, V104, P5401, DOI 10.1073/pnas.0700794104; Rangatia J, 2003, ONCOGENE, V22, P4760, DOI 10.1038/sj.onc.1206664; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Tanno T, 2007, FEBS LETT, V581, P1022, DOI 10.1016/j.febslet.2007.02.001; Taub J, 2003, NATURE, V421, P764, DOI 10.1038/nature01425; Toh WH, 2005, J BIOL CHEM, V280, P17329, DOI 10.1074/jbc.M500044200; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Villanueva J, 2007, MOL BIOL CELL, V18, P1457, DOI 10.1091/mbc.E06-10-0908	35	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8513	10.1371/journal.pone.0008513	http://dx.doi.org/10.1371/journal.pone.0008513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20046837	Green Published, gold, Green Submitted			2022-12-25	WOS:000278068700024
J	Mithani, SK; Shao, C; Tan, M; Smith, IM; Califano, JA; El-Naggar, AK; Ha, PK				Mithani, Suhail K.; Shao, Chunbo; Tan, Marietta; Smith, Ian M.; Califano, Joseph A.; El-Naggar, Adel K.; Ha, Patrick K.			Mitochondrial Mutations in Adenoid Cystic Carcinoma of the Salivary Glands	PLOS ONE			English	Article							DNA G10398A POLYMORPHISM; AFRICAN-AMERICAN WOMEN; INVASIVE BREAST-CANCER; ESOPHAGEAL CANCER; MTDNA MUTATIONS; GENOME INSTABILITY; DISTANT METASTASIS; KIT PROTEIN; TUMORS; EXPRESSION	Background: The Mito Chip v2.0 resequencing array is an array-based technique allowing for accurate and complete sequencing of the mitochondrial genome. No studies have investigated mitochondrial mutation in salivary gland adenoid cystic carcinomas. Methodology:The entire mitochondrial genome of 22 salivary gland adenoid cystic carcinomas (ACC) of salivary glands and matched leukocyte DNA was sequenced to determine the frequency and distribution of mitochondrial mutations in ACC tumors. Principal Findings: Seventeen of 22 ACCs (77%) carried mitochondrial mutations, ranging in number from 1 to 37 mutations. A disproportionate number of mutations occurred in the D-loop. Twelve of 17 tumors (70.6%) carried mutations resulting in amino acid changes of translated proteins. Nine of 17 tumors (52.9%) with a mutation carried an amino acid changing mutation in the nicotinamide adenine dinucleotide dehydrogenase (NADH) complex. Conclusions/Significance: Mitochondrial mutation is frequent in salivary ACCs. The high incidence of amino acid changing mutations implicates alterations in aerobic respiration in ACC carcinogenesis. D-loop mutations are of unclear significance, but may be associated with alterations in transcription or replication.	[Mithani, Suhail K.] Johns Hopkins Med Inst, Dept Surg, Div Plast & Reconstruct Surg, Baltimore, MD 21205 USA; [Shao, Chunbo; Tan, Marietta; Smith, Ian M.; Califano, Joseph A.; Ha, Patrick K.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Califano, Joseph A.; Ha, Patrick K.] Milton J Dance Head & Neck Ctr, Greater Baltimore Med Ctr, Baltimore, MD USA; [El-Naggar, Adel K.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center; University of Texas System; UTMD Anderson Cancer Center	Mithani, SK (corresponding author), Johns Hopkins Med Inst, Dept Surg, Div Plast & Reconstruct Surg, Baltimore, MD 21205 USA.	pha1@jhmi.edu	Shao, Chunbo/C-5412-2011	Mithani, Suhail/0000-0002-3762-0831	Flight Attendant Medical Research Institute; NIDCR [1R01DE015939, 9P50DE019032]; NCI [5P20CA118782]; Johns Hopkins Clinician Scientist Award; NIDCR Head and Neck SPORE [9P50DE019032]; NATIONAL CANCER INSTITUTE [P20CA118782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K08DE018463, R01DE015939] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Johns Hopkins Clinician Scientist Award; NIDCR Head and Neck SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Clinical Innovator Award from the Flight Attendant Medical Research Institute, and the NIDCR 1R01DE015939, and NIDCR Head and Neck SPORE 9P50DE019032, and NCI 5P20CA118782 to JC and also by the NIDCR K08DE018463, the Johns Hopkins Clinician Scientist Award, and the NIDCR Head and Neck SPORE 9P50DE019032 to PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrendt SA, 1999, P NATL ACAD SCI USA, V96, P7382, DOI 10.1073/pnas.96.13.7382; Allalunis-Turner J, 2006, CANCER LETT, V243, P193, DOI 10.1016/j.canlet.2005.11.035; BROWN MD, 1992, GENETICS, V130, P163; Canter JA, 2005, CANCER RES, V65, P8028, DOI 10.1158/0008-5472.CAN-05-1428; Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Daa T, 2004, MODERN PATHOL, V17, P1475, DOI 10.1038/modpathol.3800209; Darvishi K, 2007, CANCER LETT, V249, P249, DOI 10.1016/j.canlet.2006.09.005; DeHaan C, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-19; Dodd RL, 2006, ORAL ONCOL, V42, P759, DOI 10.1016/j.oraloncology.2006.01.001; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Franchi A, 1999, AM J CLIN PATHOL, V111, P43; Hibi K, 2001, INT J CANCER, V94, P429, DOI 10.1002/ijc.1480; Hibi K, 2001, INT J CANCER, V92, P319, DOI 10.1002/ijc.1204; Holst VA, 1999, MODERN PATHOL, V12, P956; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Ishikawa Y, 1997, J ORAL MAXIL SURG, V55, P1460, DOI 10.1016/S0278-2391(97)90651-0; Jeng YM, 2000, CANCER LETT, V154, P107, DOI 10.1016/S0304-3835(00)00387-6; Johns MM, 1996, CANCER RES, V56, P1151; Khan AJ, 2001, INT J CANCER, V96, P149, DOI 10.1002/ijc.1013; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Liu VWS, 2003, BRIT J CANCER, V89, P697, DOI 10.1038/sj.bjc.6601110; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mims MP, 2006, CANCER RES, V66, P1880, DOI 10.1158/0008-5472.CAN-05-3774; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Setiawan VW, 2008, CANCER GENET CYTOGEN, V181, P16, DOI 10.1016/j.cancergencyto.2007.10.019; Shahsavari Fatemeh, 2005, Asian Pac J Cancer Prev, V6, P527; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Shintani S, 2000, ANTICANCER RES, V20, P2169; Spiro RH, 1997, AM J SURG, V174, P495; Sui GP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-73; Takata T, 1999, CANCER, V86, P928, DOI 10.1002/(SICI)1097-0142(19990915)86:6<928::AID-CNCR6>3.3.CO;2-O; Tamura G, 1999, EUR J CANCER, V35, P316, DOI 10.1016/S0959-8049(98)00360-8; Tan DJ, 2003, GENE CHROMOSOME CANC, V37, P186, DOI 10.1002/gcc.10217; Tan DJ, 2002, CANCER RES, V62, P972; Tan DJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-93; Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269; Teymoortash A, 2006, J CANCER RES CLIN, V132, P51, DOI 10.1007/s00432-005-0040-1; Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Vered M, 2002, HEAD NECK-J SCI SPEC, V24, P632, DOI 10.1002/hed.10104; Voo KS, 2006, CANCER RES, V66, P5919, DOI 10.1158/0008-5472.CAN-05-4574; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Yeh JJ, 2000, ONCOGENE, V19, P2060, DOI 10.1038/sj.onc.1203537; Zhao YB, 2005, WORLD J GASTROENTERO, V11, P3304, DOI 10.3748/wjg.v11.i21.3304; Zhidkov I, 2009, GENOME RES, V19, P576, DOI 10.1101/gr.086462.108; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104; Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008	51	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8493	10.1371/journal.pone.0008493	http://dx.doi.org/10.1371/journal.pone.0008493			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041111	Green Published, gold, Green Submitted			2022-12-25	WOS:000278068700008
J	Woodard, GE; Lopez, JJ; Jardin, I; Salido, GM; Rosado, JA				Woodard, Geoffrey E.; Lopez, Jose J.; Jardin, Isaac; Salido, Gines M.; Rosado, Juan A.			TRPC3 Regulates Agonist-stimulated Ca2+ Mobilization by Mediating the Interaction between Type I Inositol 1,4,5-Trisphosphate Receptor, RACK1, and Orai1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; STORE DEPLETION; CALCIUM-ENTRY; CHANNELS; STIM1; ACTIVATION; COMPLEX; CRAC; PROTEINS; RELEASE	There is a body of evidence suggesting that Ca2+ handling proteins assemble into signaling complexes required for a fine regulation of Ca2+ signals, events that regulate a variety of critical cellular processes. Canonical transient receptor potential (TRPC) and Orai proteins have both been proposed to form Ca2+-permeable channels mediating Ca2+ entry upon agonist stimulation. A number of studies have demonstrated that inositol 1,4,5-trisphosphate receptors (IP(3)Rs) interact with plasma membrane TRPC channels; however, at present there is no evidence supporting the interaction between Orai proteins and IP(3)Rs. Here we report that treatment with thapsigargin or cellular agonists results in association of Orai1 with types I and II IP(3)Rs. In addition, we have found that TRPC3, RACK1 (receptor for activated protein kinase C-1), and STIM1 (stromal interaction molecule 1) interact with Orai1 upon stimulation with agonists. TRPC3 expression silencing prevented both the interaction of Orai1 with TRPC3 and, more interestingly, the association of Orai1 with the type I IP3R, but not with the type II IP3R, thus suggesting that TRPC3 selectively mediates interaction between Orai1 and type I IP3R. In addition, TRPC3 expression silencing attenuated ATP- and CCh-stimulated interaction between RACK1 and the type I IP3R, as well as Ca2+ release and entry. In conclusion, our results indicate that agonist stimulation results in the formation of an Orai1-STIM1-TRPC3-RACK1-type I IP3R complex, where TRPC3 plays a central role. This Ca2+ signaling complex might be important for both agonist-induced Ca2+ release and entry.	[Lopez, Jose J.; Jardin, Isaac; Salido, Gines M.; Rosado, Juan A.] Univ Extremadura, Cell Physiol Res Grp, Dept Physiol, Caceres 10071, Spain; [Woodard, Geoffrey E.] NIDDK, NIH, Bethesda, MD 20892 USA	Universidad de Extremadura; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rosado, JA (corresponding author), Univ Extremadura, Cell Physiol Res Grp, Dept Physiol, Caceres 10071, Spain.	jarosado@unex.es	Rosado, Juan A/H-3488-2015; Salido, Gines M/A-4292-2009; Lopez, Jose J/F-4602-2016; Woodard, Geoffrey/A-8608-2009; Jardin, Isaac/E-8310-2016	Rosado, Juan A/0000-0002-9749-2325; Salido, Gines M/0000-0002-8687-2445; Lopez, Jose J/0000-0002-5234-1478; Jardin, Isaac/0000-0003-4575-8264	Spanish Ministry of Science and Innovation [BFI2007-60104]; National Institutes of Health; Direccion General de Investigation (DGI) [BES-2005-6899, BFU2007-60104]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direccion General de Investigation (DGI)	This work was supported by Spanish Ministry of Science and Innovation Grant BFI2007-60104. This work was authored, in whole or in part, by National Institutes of Health staff.; <SUP>1</SUP>Supported by Direccion General de Investigation (DGI) fellowship BES-2005-6899.; <SUP>2</SUP>Supported by DGI fellowship BFU2007-60104.	Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Bandyopadhyay BC, 2008, J BIOL CHEM, V283, P32821, DOI 10.1074/jbc.M805382200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Groschner K, 2005, N-S ARCH PHARMACOL, V371, P251, DOI 10.1007/s00210-005-1054-6; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jardin I, 2008, J BIOL CHEM, V283, P25296, DOI 10.1074/jbc.M802904200; Jardin I, 2008, CELL SIGNAL, V20, P737, DOI 10.1016/j.cellsig.2007.12.010; Jardin I, 2009, BIOCHEM J, V420, P267, DOI 10.1042/BJ20082179; Kim JY, 2006, J BIOL CHEM, V281, P32540, DOI 10.1074/jbc.M602496200; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Lee EH, 2006, J BIOL CHEM, V281, P10042, DOI 10.1074/jbc.M600981200; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XB, 2003, J BIOL CHEM, V278, P11337, DOI 10.1074/jbc.M213271200; Lopez JJ, 2006, CELL SIGNAL, V18, P373, DOI 10.1016/j.cellsig.2005.05.006; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; MANDERS EMM, 1992, J CELL SCI, V103, P857; Maruyama Y, 2009, J BIOL CHEM, V284, P13676, DOI 10.1074/jbc.M900812200; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Miller LD, 2004, ONCOGENE, V23, P5682, DOI 10.1038/sj.onc.1207735; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Putney James W Jr, 2004, Novartis Found Symp, V258, P123; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Redondo PC, 2008, BBA-MOL CELL RES, V1783, P1163, DOI 10.1016/j.bbamcr.2007.12.008; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosado JA, 2000, BIOCHEM J, V350, P631, DOI 10.1042/0264-6021:3500631; Rosado JA, 2001, BIOCHEM J, V356, P191, DOI 10.1042/0264-6021:3560191; Rosado JA, 2006, J CELL PHYSIOL, V209, P142, DOI 10.1002/jcp.20715; Salido GM, 2009, BBA-MOL CELL RES, V1793, P223, DOI 10.1016/j.bbamcr.2008.11.001; Shuttleworth TJ, 2007, CELL CALCIUM, V42, P183, DOI 10.1016/j.ceca.2007.01.012; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Soboloff J., 2007, V179, P575; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Tai K, 2008, EUR J PHARMACOL, V583, P135, DOI 10.1016/j.ejphar.2008.01.007; THASTRUP O, 1987, BIOCHEM BIOPH RES CO, V142, P654, DOI 10.1016/0006-291X(87)91464-1; Thebault S, 2005, J CELL PHYSIOL, V204, P320, DOI 10.1002/jcp.20301; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wedel BJ, 2003, J BIOL CHEM, V278, P25758, DOI 10.1074/jbc.M303890200; Woo JS, 2008, BIOCHEM J, V411, P399, DOI [10.1042/BJ20071504, 10.1042/bj20071504]; Woodard GE, 2008, AM J PHYSIOL-CELL PH, V294, pC1323, DOI 10.1152/ajpcell.00071.2008; Xi Q, 2008, CIRC RES, V102, P1118, DOI 10.1161/CIRCRESAHA.108.173948; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zubov AI, 1999, J BIOL CHEM, V274, P25983, DOI 10.1074/jbc.274.37.25983	60	62	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8045	8053		10.1074/jbc.M109.033605	http://dx.doi.org/10.1074/jbc.M109.033605			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20022948	hybrid, Green Published			2022-12-25	WOS:000275413800022
J	Li, N; Henry, E; Guiot, E; Rigolet, P; Brochon, JC; Xi, XG; Deprez, E				Li, Na; Henry, Etienne; Guiot, Elvire; Rigolet, Pascal; Brochon, Jean-Claude; Xi, Xu-Guang; Deprez, Eric			Multiple Escherichia coli RecQ Helicase Monomers Cooperate to Unwind Long DNA Substrates A FLUORESCENCE CROSS-CORRELATION SPECTROSCOPY STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOMS-SYNDROME HELICASE; SINGLE-STRANDED-DNA; C VIRUS HELICASE; HIV-1 INTEGRASE; IN-VITRO; UNZIPPING MECHANISM; HEXAMERIC HELICASE; SYNDROME PROTEIN; RING HELICASE; BINDING	The RecQ family helicases catalyze the DNA unwinding reaction in an ATP hydrolysis-dependent manner. We investigated the mechanism of DNA unwinding by the Escherichia coli RecQ helicase using a new sensitive helicase assay based on fluorescence cross-correlation spectroscopy (FCCS) with two-photon excitation. The FCCS-based assay can be used to measure the unwinding activity under both single and multiple turnover conditions with no limitation related to the size of the DNA strands constituting the DNA substrate. We found that the monomeric helicase was sufficient to perform the unwinding of short DNA substrates. However, a significant increase in the activity was observed using longer DNA substrates, under single turnover conditions, originating from the simultaneous binding of multiple helicase monomers to the same DNA molecule. This functional cooperativity was strongly dependent on several factors, including DNA substrate length, the number and size of single-stranded 3'-tails, and the temperature. Regarding the latter parameter, a strong cooperativity was observed at 37 degrees C, whereas only modest or no cooperativity was observed at 25 degrees C regardless of the nature of the DNA substrate. Consistently, the functional cooperativity was found to be tightly associated with a cooperative DNA binding mode. We also showed that the cooperative binding of helicase to the DNA substrate indirectly accounts for the sigmoidal dependence of unwinding activity on ATP concentration, which also occurs only at 37 degrees C but not at 25 degrees C. Finally, we further examined the influences of spontaneous DNA rehybridization (after helicase translocation) and the single-stranded DNA binding property of helicase on the unwinding activity as detected in the FCCS assay.	[Li, Na; Henry, Etienne; Guiot, Elvire; Brochon, Jean-Claude; Deprez, Eric] Ecole Normale Super, Lab Biol & Pharmacol Appl, CNRS, Inst Alembert,UMR8113, F-94235 Cachan, France; [Rigolet, Pascal; Xi, Xu-Guang] Ctr Univ Orsay, Lab Genotoxicol & Cycle Cellulaire, CNRS, Inst Curie Sect Rech,UMR2027, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay	Deprez, E (corresponding author), Ecole Normale Super, Lab Biol & Pharmacol Appl, CNRS, Inst Alembert,UMR8113, 61 Ave President Wilson, F-94235 Cachan, France.	deprez@lbpa.ens-cachan.fr	Rigolet, Pascal/S-8602-2018; Xi, Xu Guang/AAK-4511-2020; HENRY, Etienne/J-8118-2014	Rigolet, Pascal/0000-0001-6868-4953; HENRY, Etienne/0000-0002-2547-3467	CNRS; Ecole Normale Superieure de Cachan; East China Normal University (ECNU)-Shanghai; Institut d'Alembert	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure de Cachan; East China Normal University (ECNU)-Shanghai; Institut d'Alembert	This work was supported by grants from the CNRS, Ecole Normale Superieure de Cachan, East China Normal University (ECNU)-Shanghai, and the Institut d'Alembert.	Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Cheng W, 2001, J MOL BIOL, V310, P327, DOI 10.1006/jmbi.2001.4758; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Clamme JP, 2003, BIOPHYS J, V84, P1960, DOI 10.1016/S0006-3495(03)75004-8; Collini M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni166; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Delelis O, 2008, J BIOL CHEM, V283, P27838, DOI 10.1074/jbc.M803257200; Deprez E, 2004, MOL PHARMACOL, V65, P85, DOI 10.1124/mol.65.1.85; Dou SX, 2004, J BIOL CHEM, V279, P6354, DOI 10.1074/jbc.M311272200; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Jahnz M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni060; Janscak P, 2003, J MOL BIOL, V330, P29, DOI 10.1016/S0022-2836(03)00534-5; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Kettling U, 1998, P NATL ACAD SCI USA, V95, P1416, DOI 10.1073/pnas.95.4.1416; Killoran MP, 2006, NUCLEIC ACIDS RES, V34, P4098, DOI 10.1093/nar/gkl538; Kohl T, 2005, BIOPHYS J, V89, P2770, DOI 10.1529/biophysj.105.061127; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; NAKAYAMA H, 1984, MOL GEN GENET, V195, P474, DOI 10.1007/BF00341449; Norcum MT, 2005, P NATL ACAD SCI USA, V102, P3623, DOI 10.1073/pnas.0500713102; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Pinskaya M, 2004, BIOCHEMISTRY-US, V43, P8735, DOI 10.1021/bi049706m; Rarbach M, 2001, METHODS, V24, P104, DOI 10.1006/meth.2001.1172; ROMAN LJ, 1991, P NATL ACAD SCI USA, V88, P3367, DOI 10.1073/pnas.88.8.3367; Sharma S, 2008, CELL CYCLE, V7, P989, DOI 10.4161/cc.7.8.5707; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Soultanas P, 2000, CURR OPIN STRUC BIOL, V10, P124, DOI 10.1016/S0959-440X(99)00059-7; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Xu HQ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng070; Xu HQ, 2003, J BIOL CHEM, V278, P34925, DOI 10.1074/jbc.M303581200; Yang Y, 2008, NUCLEIC ACIDS RES, V36, P1976, DOI 10.1093/nar/gkm1174; Yu X, 2000, J MOL BIOL, V299, P1279, DOI 10.1006/jmbi.2000.3810; Yu X, 1996, J MOL BIOL, V259, P7, DOI 10.1006/jmbi.1996.0297; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200; Zhang XD, 2005, ACTA BIOCH BIOPH SIN, V37, P593, DOI 10.1111/j.1745-7270.2005.00084.x; Zhang X, 2008, J GENE MED, V10, P527, DOI 10.1002/jgm.1167	56	17	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6922	6936		10.1074/jbc.M109.069286	http://dx.doi.org/10.1074/jbc.M109.069286			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048388	Green Published, hybrid			2022-12-25	WOS:000275415600006
J	Wang, B; Hsu, SH; Majumder, S; Kutay, H; Huang, W; Jacob, ST; Ghoshal, K				Wang, B.; Hsu, S-H; Majumder, S.; Kutay, H.; Huang, W.; Jacob, S. T.; Ghoshal, K.			TGF beta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3	ONCOGENE			English	Article						miR-181b; TIMP3; hepatocarcinogenesis; CDAA diet; doxorubicin; hepatocullular carcinoma	CHOLINE-DEFICIENT; TISSUE INHIBITOR; BREAST-CANCER; IN-VIVO; MICRORNA; GENE; EXPRESSION; HSA-MIR-181B; INFLAMMATION; BIOGENESIS	To identify microRNAs (miRNAs) that may have a causal role in hepatocarcinogenesis, we used an animal model in which C57BL/6 mice fed choline-deficient and amino acid defined (CDAA) diet develop preneoplastic lesions at 65 weeks and hepatocellular carcinomas after 84 weeks. miRNA expression profiling showed significant upregulation of miR-181b and miR-181d in the livers of mice as early as 32 weeks that persisted at preneoplastic stage. The expression of tissue inhibitor of metalloprotease 3 (TIMP3), a tumor suppressor and a validated miR-181 target, was markedly suppressed in the livers of mice fed CDAA diet. Upregulation of hepatic transforming growth factor (TGF)beta and its downstream mediators Smad 2, 3 and 4 and increase in phospho-Smad2 in the liver nuclear extract correlated with elevated miR-181b/d in mice fed CDAA diet. The levels of the precursor and mature miR-181b were augmented on exposure of hepatic cells to TGF beta and were significantly reduced by small interference RNA-mediated depletion of Smad4, showing the involvement of TGFb signaling pathway in miR-181b expression. Ectopic expression and depletion of miR-181b showed that miR-181b enhanced matrix metallopeptidases (MMP)2 and MMP9 activity and promoted growth, clonogenic survival, migration and invasion of hepatocellular carcinoma (HCC) cells that could be reversed by modulating TIMP3 level. Further, depletion of miR-181b inhibited tumor growth of HCC cells in nude mice. miR-181b also enhanced resistance of HCC cells to the anticancer drug doxorubicin. On the basis of these results, we conclude that upregulation of miR-181b at early stages of feeding CDAA diet promotes hepatocarcinogenesis. Oncogene (2010) 29, 1787-1797; doi:10.1038/onc.2009.468; published online 21 December 2009	[Wang, B.; Hsu, S-H; Majumder, S.; Kutay, H.; Huang, W.; Jacob, S. T.; Ghoshal, K.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Jacob, S. T.; Ghoshal, K.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Jacob, ST (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, 420 W 12th Ave,646 TMRF, Columbus, OH 43210 USA.	Samson.Jacob@osumc.edu; kalpana.ghoshal@osumc.edu	Jacob, Samson/H-3135-2011; Huang, Wei/E-3270-2011; Wang, Bo/F-6519-2011	HSU, SHU-HAO/0000-0002-9444-4192; Wang, Bo/0000-0001-9234-035X	National Institutes of Health [CA086978, CA101956]; NATIONAL CANCER INSTITUTE [R01CA086978, P01CA101956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs David P Bartel and John Taylor for pIS0 vectors and Huh-7 cells, respectively. This work was supported by the grants CA086978 and CA101956 from National Institutes of Health. Grant support: CA086978 and CA101956 from National Institutes of Health.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2007, BEST PRACT RES CL HA, V20, P425, DOI 10.1016/j.beha.2007.02.003; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Day CP, 2006, LIVER INT, V26, P1021, DOI 10.1111/j.1478-3231.2006.01323.x; Denda A, 2002, JPN J CANCER RES, V93, P125, DOI 10.1111/j.1349-7006.2002.tb01250.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Ghoshal K, 2006, J NUTR, V136, P1522, DOI 10.1093/jn/136.6.1522; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Menghini R, 2009, GASTROENTEROLOGY, V136, P663, DOI 10.1053/j.gastro.2008.10.079; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Nakajima Go, 2006, Cancer Genomics & Proteomics, V3, P317; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Thomas M, 2009, J GASTROENTEROL, V44, P136, DOI 10.1007/s00535-008-2252-z; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808	38	309	334	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	12					1787	1797		10.1038/onc.2009.468	http://dx.doi.org/10.1038/onc.2009.468			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	574VR	20023698	Green Accepted			2022-12-25	WOS:000276022800008
J	Bi, WZ; Xiao, L; Jia, YF; Wu, JB; Xie, Q; Ren, J; Ji, GJ; Yuan, ZQ				Bi, Wenzhi; Xiao, Lei; Jia, Yunfeng; Wu, Junbing; Xie, Qi; Ren, Jian; Ji, Guangju; Yuan, Zengqiang			c-Jun N-terminal Kinase Enhances MST1-mediated Pro-apoptotic Signaling through Phosphorylation at Serine 82	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STE20-LIKE PROTEIN-KINASE; CELL-DEATH MACHINERY; PROMOTES APOPTOSIS; JNK PHOSPHORYLATION; STERILE-20 KINASE; HISTONE H2B; MST1 KINASE; ACTIVATION; CASPASE; PATHWAY	Protein kinases play an important role in the maintenance of homeostasis between cell survival and apoptosis. Deregulation of these kinases leads to various pathological manifestations, such as cancer and neurodegenerative diseases. The MST1 encodes a serine/threonine kinase that is activated upon apoptotic stimulation, which in turn phosphorylates its downstream targets, Histone H2B and FOXO. However, the upstream regulators of MST1 kinase have been poorly studied. In this study, we report that JNK (c-Jun N-terminal kinase) phosphorylates MST1 at serine 82, which leads to the enhancement of MST1 activation. Accordingly, the activation of MST1 phosphorylates FOXO3 at serine 207 and promotes cell death. The inhibition of JNK kinase per se attenuates MST1 activity and nuclear translocation as well as MST1-induced apoptosis. We also find the S82A (serine mutated to alanine) diminishes MST1 activation and its effect on the FOXO transcription activity. Collectively, these findings define the novel feedback regulation of MST1 kinase activation by its putative substrate, JNK, with implication for our understanding of the signaling mechanism during cell death.	[Xiao, Lei; Wu, Junbing; Xie, Qi; Ren, Jian; Ji, Guangju; Yuan, Zengqiang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Bi, Wenzhi] Chinese Peoples Liberat Army Gen Hosp, Clin Div Surg, Dept Orthoped, Beijing 100853, Peoples R China; [Jia, Yunfeng] Chinese PLA 306 Hosp, Dept Neurosurg, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese People's Liberation Army General Hospital	Ji, GJ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	gj28@ibp.ac.cn; zqyuan@ibp.ac.cn	Xiao, Lei/I-3655-2017; xiao, Lei/J-4217-2017; Yuan, Zengqiang/G-5245-2017	Ji, Guangju/0000-0001-8626-3490; Xie, Qi/0000-0002-2370-2078	National Science Foundation of China [30870792]; Ministry of Science and Technology of China [973-2009CB918704]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Science Foundation of China (30870792) and the Ministry of Science and Technology of China (973-2009CB918704).	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Anand R, 2008, BIOCHEMISTRY-US, V47, P6719, DOI 10.1021/bi800309m; Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lehtinen MK, 2008, CURR MOL MED, V8, P313, DOI 10.2174/156652408784533805; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Ura S, 2001, GENES CELLS, V6, P519, DOI 10.1046/j.1365-2443.2001.00439.x; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; Wang P, 2007, NEUROSCI LETT, V415, P248, DOI 10.1016/j.neulet.2007.01.050; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200	30	54	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6259	6264		10.1074/jbc.M109.038570	http://dx.doi.org/10.1074/jbc.M109.038570			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20028971	hybrid, Green Published			2022-12-25	WOS:000275367500030
J	Bushman, JD; Gay, JW; Tewson, P; Stanley, CA; Shyng, SL				Bushman, Jeremy D.; Gay, Joel W.; Tewson, Paul; Stanley, Charles A.; Shyng, Show-Ling			Characterization and Functional Restoration of a Potassium Channel Kir6.2 Pore Mutation Identified in Congenital Hyperinsulinism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; INSULIN-SECRETION; INWARD RECTIFICATION; MOLECULAR-BASIS; SUBUNITS; GLYCINE; DISEASE; STABILIZATION; STOICHIOMETRY; MECHANISM	The inwardly rectifying potassium channel Kir6.2 assembles with sulfonylurea receptor 1 to form the ATP-sensitive potassium (K-ATP) channels that regulate insulin secretion in pancreatic beta-cells. Mutations in K-ATP channels underlie insulin secretion disease. Here, we report the characterization of a heterozygous missense Kir6.2 mutation, G156R, identified in congenital hyperinsulinism. Homomeric mutant channels reconstituted in COS cells show similar surface expression as wild-type channels but fail to conduct potassium currents. The mutated glycine is in the pore-lining transmembrane helix of Kir6.2; an equivalent glycine in other potassium channels has been proposed to serve as a hinge to allow helix bending during gating. We found that mutation of an adjacent asparagine, Asn-160, to aspartate, which converts the channel from a weak to a strong inward rectifier, on the G156R background restored ion conduction in the mutant channel. Unlike N160D channels, however, G156R/N160D channels are not blocked by intracellular polyamines at positive membrane potential and exhibit wildtype- like nucleotide sensitivities, suggesting the aspartate introduced at position 160 interacts with arginine at 156 to restore ion conduction and gating. Using tandem Kir6.2 tetramers containing G156R and/or N160D in designated positions, we show that one mutant subunit in the tetramer is insufficient to abolish conductance and that G156R and N160D can interact in the same or adjacent subunits to restore conduction. We conclude that the glycine at 156 is not essential for K-ATP channel gating and that the Kir6.2 gating defect caused by the G156R mutation could be rescued by manipulating chemical interactions between pore residues.	[Bushman, Jeremy D.; Gay, Joel W.; Tewson, Paul; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA; [Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol Diabet, Philadelphia, PA 19104 USA	Oregon Health & Science University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu		STANLEY, CHARLES/0000-0003-4881-9392	National Institutes of Health [R01DK066485, F31NS065688, R01DK56268]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056268, R01DK066485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS065688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK066485 (to S.-L.S.), F31NS065688 (to J.D.B.), and R01DK56268 (to C.A.S.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 2001, RECENT PROG HORM RES, V56, P47, DOI 10.1210/rp.56.1.47; Aguilar-Bryan L, 1998, PHYSIOL REV, V78, P227, DOI 10.1152/physrev.1998.78.1.227; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; Glaser B, 2000, SEMIN PERINATOL, V24, P150, DOI 10.1053/sp.2000.6365; Haider S, 2007, BIOCHEMISTRY-US, V46, P3643, DOI 10.1021/bi062210f; HILLE B, 2001, ION CHANNELS EXCITAB, P150; Huopio H, 2002, AM J PHYSIOL-ENDOC M, V283, pE207, DOI 10.1152/ajpendo.00047.2002; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2004, J GEN PHYSIOL, V124, P541, DOI 10.1085/jgp.200409159; Lin CW, 2006, DIABETES, V55, P1738, DOI 10.2337/db05-1571; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; Lin YW, 2006, J BIOL CHEM, V281, P3006, DOI 10.1074/jbc.M511875200; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU Z, 1995, BIOCHEMISTRY-US, V34, P13133, DOI 10.1021/bi00040a026; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pinney SE, 2008, J CLIN INVEST, V118, P2877, DOI 10.1172/JCI35414; Robertson JL, 2008, J GEN PHYSIOL, V132, P613, DOI 10.1085/jgp.200810068; Rosenhouse-Dantsker A, 2007, CHANNELS, V1, P189, DOI 10.4161/chan.4475; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Shang L, 2008, EUR BIOPHYS J BIOPHY, V37, P165, DOI 10.1007/s00249-007-0206-7; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Stanley CA, 2002, J CLIN ENDOCR METAB, V87, P4857, DOI 10.1210/jc.2002-021403; Taschenberger G, 2002, J BIOL CHEM, V277, P17139, DOI 10.1074/jbc.M200363200; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yi BA, 2001, P NATL ACAD SCI USA, V98, P11016, DOI 10.1073/pnas.191351798	45	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6012	6023		10.1074/jbc.M109.085860	http://dx.doi.org/10.1074/jbc.M109.085860			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032456	hybrid, Green Published			2022-12-25	WOS:000275367500004
J	Pafundo, DE; Alvarez, CL; Krumschnabel, G; Schwarzbaum, PJ				Pafundo, Diego E.; Alvarez, Cora L.; Krumschnabel, Gerhard; Schwarzbaum, Pablo J.			A Volume Regulatory Response Can Be Triggered by Nucleosides in Human Erythrocytes, a Perfect Osmometer No Longer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; ECTO-ATPASE ACTIVITY; ANION-EXCHANGER; GOLDFISH HEPATOCYTES; ADENOSINE RECEPTORS; ADENINE-NUCLEOTIDES; TRANSPORT-SYSTEMS; EPITHELIAL-CELLS; ION-TRANSPORT; RELEASE	Human erythrocytes have been regarded as perfect osmometers, which swell or shrink as dictated by their osmotic environment. In contrast, in most other cells, swelling elicits a regulatory volume decrease (RVD) modulated by the activation of purinic and pyrimidinic receptors (P receptors). For human erythrocytes this modulation has not been tested, and we thus investigated whether P receptor activation can induce RVD in these cells. Further, because ectonucleotidases may scavenge ATP or ADP or act as a source for extracellular adenosine and therefore modulate P receptor activation and RVD, we also determined their activity in intact erythrocytes. We found relatively low ectoATPase but significant ectoADPase and ectoAMPase activities. When erythrocytes were exposed to hypotonic medium alone, they swelled as expected for an osmometric response and showed no RVD. Activation of P2 receptors by exogenous ATP or ADP did not trigger RVD, whereas P1 agonists adenosine and adenosine-5'-N-ethylcarboxamide induced significant RVD. The effect of adenosine-5'-N-ethylcarboxamide was dose-dependent (maximal RVD of 27%; apparent K-1/2 of 1.6 +/- 1.7 mu M). The RVD induced by adenosine was blocked 80% with the non-selective P1 antagonist 8-(p-sulfophenyl theophylline) or the P1-A(2B) inhibitor MRS1754, but not by inhibitors of P1 subtypes A(1), A(2A), and A(3). In addition, forskolin (an inducer of intracellular cAMP formation) could mimic the effect of adenosine, supporting the idea of P1-A(2B) receptor activation. In conclusion, we report a novel P1-A(2B) receptor-mediated RVD activation in mature human erthrocytes and thus indicate that these long held perfect osmometers are not so perfect after all.	[Pafundo, Diego E.; Alvarez, Cora L.; Schwarzbaum, Pablo J.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol, RA-1113 Buenos Aires, DF, Argentina; [Krumschnabel, Gerhard] Innsbruck Med Univ, Div Dev Immunol, Bioctr, A-6020 Innsbruck, Austria	University of Buenos Aires; Medical University of Innsbruck	Schwarzbaum, PJ (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol, Junin 956 C1113AAD, RA-1113 Buenos Aires, DF, Argentina.	pablos@qb.ffyb.uba.ar	Krumschnabel, Gerhard/E-3694-2010	Krumschnabel, Gerhard/0000-0003-0804-1248; Pafundo, Diego/0000-0002-2535-9111; schwarzbaum, pablo/0000-0002-5176-089X	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Buenos Aires and Agencia Nacional de Promocion Cientifica y Tecnologica [1432]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires and Agencia Nacional de Promocion Cientifica y Tecnologica	This work was supported in part by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Universidad de Buenos Aires and Agencia Nacional de Promocion Cientifica y Tecnologica (Grant 1432) of Argentina.	Bencic DC, 1997, PHYSIOL ZOOL, V70, P621, DOI 10.1086/515873; BIENZLE U, 1977, CLIN CHIM ACTA, V76, P183, DOI 10.1016/0009-8981(77)90094-8; Braunstein GM, 2001, J BIOL CHEM, V276, P6621, DOI 10.1074/jbc.M005893200; Brugnara C, 1997, Curr Opin Hematol, V4, P122; CALA PM, 1977, J GEN PHYSIOL, V69, P537, DOI 10.1085/jgp.69.5.537; CANESSA M, 1990, J MEMBRANE BIOL, V116, P107, DOI 10.1007/BF01868669; CANESSA M, 1991, HEMATOL ONCOL CLIN N, V5, P495, DOI 10.1016/S0889-8588(18)30427-1; COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531; COLMAN RW, 1990, FASEB J, V4, P1425, DOI 10.1096/fasebj.4.5.2407587; FUGELLI K, 1986, J PHYSIOL-LONDON, V374, P245, DOI 10.1113/jphysiol.1986.sp016077; GARCIAROMEU F, 1991, J PHYSIOL-LONDON, V440, P547, DOI 10.1113/jphysiol.1991.sp018724; GarciaRomeu F, 1996, CELL MOL BIOL, V42, P985; Griffiths M, 1997, NAT MED, V3, P89, DOI 10.1038/nm0197-89; Guest GM, 1942, J CLIN INVEST, V21, P257, DOI 10.1172/JCI101297; GUEST MM, 1947, AM J PHYSIOL, V150, P471, DOI 10.1152/ajplegacy.1947.150.3.471; Guizouarn H, 2001, J PHYSIOL-LONDON, V535, P497, DOI 10.1111/j.1469-7793.2001.t01-1-00497.x; Gusev G P, 1997, Membr Cell Biol, V11, P305; HAAS M, 1989, AM J PHYSIOL, V256, pC265, DOI 10.1152/ajpcell.1989.256.2.C265; Hamann S, 2005, J PHYSIOL-LONDON, V568, P123, DOI 10.1113/jphysiol.2005.093526; Hategan A, 2003, BIOPHYS J, V85, P2746, DOI 10.1016/S0006-3495(03)74697-9; Heptinstall S, 2005, J THROMB HAEMOST, V3, P2331, DOI 10.1111/j.1538-7836.2005.01489.x; Hoffman JF, 2003, P NATL ACAD SCI USA, V100, P7366, DOI 10.1073/pnas.1232342100; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jindal HK, 1996, BLOOD, V88, P1479, DOI 10.1182/blood.V88.4.1479.bloodjournal8841479; JOINER CH, 2005, ASH ANN M, V106, P2321; KADLUBOWSKI M, 1977, BRIT J HAEMATOL, V37, P111; Kim HD, 1996, AM J PHYSIOL-CELL PH, V270, pC86, DOI 10.1152/ajpcell.1996.270.1.C86; Koziak K, 1999, THROMB HAEMOSTASIS, V82, P1538; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LAUF PK, 1983, AM J PHYSIOL, V245, pC445, DOI 10.1152/ajpcell.1983.245.5.C445; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Light DB, 2001, J MEMBRANE BIOL, V182, P193, DOI 10.1007/s0023201-0043-z; Light DB, 1999, AM J PHYSIOL-CELL PH, V277, pC480, DOI 10.1152/ajpcell.1999.277.3.C480; LINDERKAMP O, 1982, BLOOD, V59, P1121; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; LUTHJE J, 1989, KLIN WOCHENSCHR, V67, P317, DOI 10.1007/BF01741386; MACEY RI, 1988, AM J PHYSIOL, V254, pC669, DOI 10.1152/ajpcell.1988.254.5.C669; Mairbaurl H, 2000, AM J PHYSIOL-CELL PH, V279, pC1621, DOI 10.1152/ajpcell.2000.279.5.C1621; MEL HC, 1977, BLOOD, V49, P1001; Musante L, 1999, J BIOL CHEM, V274, P11701, DOI 10.1074/jbc.274.17.11701; Musch MW, 2008, AM J PHYSIOL-REG I, V294, pR1657, DOI 10.1152/ajpregu.00837.2007; ONEILL WC, 1989, AM J PHYSIOL, V256, pC858, DOI 10.1152/ajpcell.1989.256.4.C858; Pafundo DE, 2004, AM J PHYSIOL-REG I, V287, pR833, DOI 10.1152/ajpregu.00199.2004; Pafundo DE, 2008, AM J PHYSIOL-REG I, V294, pR220, DOI 10.1152/ajpregu.00522.2007; PONDER E, 1951, J GEN PHYSIOL, V34, P567, DOI 10.1085/jgp.34.5.567; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Schwarzbaum PJ, 1998, AM J PHYSIOL-REG I, V274, pR1031, DOI 10.1152/ajpregu.1998.274.4.R1031; SCHWARZBAUM PJ, 1995, BBA-BIOMEMBRANES, V1233, P33, DOI 10.1016/0005-2736(94)00229-I; Sevigny J, 1997, BBA-GEN SUBJECTS, V1334, P73, DOI 10.1016/S0304-4165(96)00079-7; Sluyter R, 2004, J BIOL CHEM, V279, P44749, DOI 10.1074/jbc.M405631200; SOHN DH, 1991, J CELL PHYSIOL, V146, P318, DOI 10.1002/jcp.1041460217; Sprague RS, 2009, PHARMACOL REP, V61, P183, DOI 10.1016/S1734-1140(09)70020-9; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Venerando B, 2002, BLOOD, V99, P1064, DOI 10.1182/blood.V99.3.1064; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; Wang Y, 1996, P NATL ACAD SCI USA, V93, P12020, DOI 10.1073/pnas.93.21.12020; WILEY JS, 1979, BRIT J HAEMATOL, V41, P133, DOI 10.1111/j.1365-2141.1979.tb03689.x; Wurm A, 2009, MOL VIS, V15, P1858	60	20	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6134	6144		10.1074/jbc.M109.078246	http://dx.doi.org/10.1074/jbc.M109.078246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040601	hybrid, Green Published			2022-12-25	WOS:000275367500017
J	Spanova, M; Czabany, T; Zellnig, G; Leitner, E; Hapala, I; Daum, G				Spanova, Miroslava; Czabany, Tibor; Zellnig, Guenther; Leitner, Erich; Hapala, Ivan; Daum, Guenther			Effect of Lipid Particle Biogenesis on the Subcellular Distribution of Squalene in the Yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROLS; BIOSYNTHESIS; LOCALIZATION; ACCUMULATION; EPOXIDASE; REDUCTASE; MUTANTS; PROTON; OXYGEN	Squalene belongs to the group of isoprenoids and is a precursor for the synthesis of sterols, steroids, and ubiquinons. In the yeast Saccharomyces cerevisiae, the amount of squalene can be increased by variation of growth conditions or by genetic manipulation. In this report, we show that a hem1 Delta mutant accumulated a large amount of squalene, which was stored almost exclusively in cytoplasmic lipid particles/droplets. Interestingly, a strain bearing a hem1 Delta deletion in a dga1 Delta lro1 Delta are1 Delta are2 Delta quadruple mutant background (QMhem1 Delta), which is devoid of the classical storage lipids, triacylglycerols and steryl esters, and lacks lipid particles, accumulated squalene at similar amounts as the hem1 Delta mutant in a wild type background. In QMhem1 Delta, however, increased amounts of squalene were found in cellular membranes, especially in microsomes. The fact that QMhem1 Delta did not form lipid particles indicated that accumulation of squalene solely was not sufficient to initiate proliferation of lipid particles. Most importantly, these results also demonstrated that (i) squalene was not lipotoxic under the conditions tested, and (ii) organelle membranes in yeast can accommodate relatively large quantities of this non-polar lipid without compromising cellular functions. In summary, localization of squalene as described here can be regarded as an unconventional example of non-polar lipid storage in cellular membranes.	[Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Leitner, Erich] Graz Univ Technol, Inst Analyt Chem & Food Technol, A-8010 Graz, Austria; [Zellnig, Guenther] Graz Univ, Inst Plant Sci, A-8010 Graz, Austria; [Hapala, Ivan] Slovak Acad Sci, Inst Anim Biochem & Genet, Ivanka Pri Dunaji 90028, Slovakia	Graz University of Technology; Graz University of Technology; University of Graz; Slovak Academy of Sciences	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at	Leitner, Erich/AAG-8826-2021; Hapala, Ivan/ABB-5807-2021	Czabany, Tibor/0000-0003-1754-6723; Leitner, Erich/0000-0003-2520-2111	Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich [18857, W901-B05]; Slovak Agency for Science and Technology Project [APVV-0681-07, VEGA2/7135/27]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich(Austrian Science Fund (FWF)); Slovak Agency for Science and Technology Project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich Projects 18857 and W901-B05 (to G. D.) and by Slovak Agency for Science and Technology Project APVV-0681-07 and Grant VEGA2/7135/27 (to I. H.).	ANDREASEN AA, 1954, J CELL COMPAR PHYSL, V43, P271, DOI 10.1002/jcp.1030430303; ANDREASEN AA, 1953, J CELL COMPAR PHYSL, V41, P23, DOI 10.1002/jcp.1030410103; Athenstaedt K, 2006, PROTEOMICS, V6, P1450, DOI 10.1002/pmic.200500339; BARD M, 1974, BIOCHEM BIOPH RES CO, V56, P324, DOI 10.1016/0006-291X(74)90845-6; BARD M, 1993, LIPIDS, V28, P963, DOI 10.1007/BF02537115; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Desai KN, 1996, CANCER LETT, V101, P93, DOI 10.1016/0304-3835(96)04122-5; Donald KAG, 1997, APPL ENVIRON MICROB, V63, P3341, DOI 10.1128/AEM.63.9.3341-3344.1997; Ferreira T, 2004, BIOCHEM J, V378, P899, DOI 10.1042/BJ20031064; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; GOLLUB EG, 1977, J BIOL CHEM, V252, P2846; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; HAID A, 1983, METHOD ENZYMOL, V96, P192; Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1; Hauss T, 2002, BBA-BIOENERGETICS, V1556, P149, DOI 10.1016/S0005-2728(02)00346-8; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; IKEKAWA T, 1986, YAKUGAKU ZASSHI, V106, P578, DOI 10.1248/yakushi1947.106.7_578; IVASHKEVICH S P, 1981, Biokhimiya, V46, P1420; JAHNKE L, 1983, J BACTERIOL, V155, P488, DOI 10.1128/JB.155.2.488-492.1983; KALB VF, 1986, GENE, V45, P237, DOI 10.1016/0378-1119(86)90021-1; Ko TF, 2002, J AGR FOOD CHEM, V50, P5343, DOI 10.1021/jf0203500; KOHNO Y, 1995, BBA-LIPID LIPID MET, V1256, P52, DOI 10.1016/0005-2760(95)00005-W; LAEMMLI UK, 1970, NATURE, V227, P685; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; LOHNER K, 1993, BIOCHIM BIOPHYS ACTA, V1152, P69, DOI 10.1016/0005-2736(93)90232-O; LORENZ RT, 1989, J BACTERIOL, V171, P6169, DOI 10.1128/jb.171.11.6169-6173.1989; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Milla P, 2002, J BIOL CHEM, V277, P2406, DOI 10.1074/jbc.M104195200; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Polakowski T, 1998, APPL MICROBIOL BIOT, V49, P66, DOI 10.1007/s002530051138; Quail M A, 1996, Methods Mol Biol, V53, P123; Qureshi AA, 1996, J NUTR, V126, P1972; Reiner S, 2006, MOL BIOL CELL, V17, P90, DOI 10.1091/mbc.e05-06-0515; Rissmann R, 2008, BBA-BIOMEMBRANES, V1778, P2350, DOI 10.1016/j.bbamem.2008.06.017; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; STAMELLOS KD, 1993, J BIOL CHEM, V268, P12825; Valachovic M, 2002, FEMS MICROBIOL LETT, V206, P121, DOI 10.1016/S0378-1097(01)00529-8; Voelker DR, 2005, TRENDS BIOCHEM SCI, V30, P396, DOI 10.1016/j.tibs.2005.05.008; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	44	56	58	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6127	6133		10.1074/jbc.M109.074229	http://dx.doi.org/10.1074/jbc.M109.074229			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032462	Green Published, hybrid			2022-12-25	WOS:000275367500016
J	Yamamoto, S; Inoue, K; Murata, T; Kamigaso, S; Yasujima, T; Maeda, JY; Yoshida, Y; Ohta, KY; Yuasa, H				Yamamoto, Syunsuke; Inoue, Katsuhisa; Murata, Tomoaki; Kamigaso, Syunsuke; Yasujima, Tomoya; Maeda, Jun-ya; Yoshida, Yukihiro; Ohta, Kin-ya; Yuasa, Hiroaki			Identification and Functional Characterization of the First Nucleobase Transporter in Mammals IMPLICATION IN THE SPECIES DIFFERENCE IN THE INTESTINAL ABSORPTION MECHANISM OF NUCLEOBASES AND THEIR ANALOGS BETWEEN HIGHER PRIMATES AND OTHER MAMMALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDER MEMBRANE-VESICLES; ACID-XANTHINE PERMEASE; RAT SMALL-INTESTINE; PURINE-RICH FOODS; ASPERGILLUS-NIDULANS; URIC-ACID; MOLECULAR CHARACTERIZATION; EVOLUTIONARY IMPLICATIONS; URATE OXIDASE; NUCLEOSIDE	Nucleobases are important compounds that constitute nucleosides and nucleic acids. Although it has long been suggested that specific transporters are involved in their intestinal absorption and uptake in other tissues, none of their molecular entities have been identified in mammals to date. Here we describe identification of rat Slc23a4 as the first sodium-dependent nucleobase transporter (rSNBT1). The mRNA of rSNBT1 was expressed highly and only in the small intestine. When transiently expressed in HEK293 cells, rSNBT1 could transport uracil most efficiently. The transport of uracil mediated by rSNBT1 was sodium-dependent and saturable with a Michaelis constant of 21.2 mu M. Thymine, guanine, hypoxanthine, and xanthine were also transported, but adenine was not. It was also suggested by studies of the inhibitory effect on rSNBT1-mediated uracil transport that several nucleobase analogs such as 5-fluorouracil are recognized by rSNBT1, but cytosine and nucleosides are not or only poorly recognized. Furthermore, rSNBT1 fused with green fluorescent protein was mainly localized at the apical membrane, when stably expressed in polarized Madin-Darby canine kidney II cells. These characteristics of rSNBT1 were almost fully in agreement with those of the carrier-mediated transport system involved in intestinal uracil uptake. Therefore, it is likely that rSNBT1 is its molecular entity or at least in part responsible for that. It was also found that the gene orthologous to the rSNBT1 gene is genetically defective in humans. This may have a biological and evolutional meaning in the transport and metabolism of nucleobases. The present study provides novel insights into the specific transport and metabolism of nucleobases and their analogs for therapeutic use.	[Yamamoto, Syunsuke; Inoue, Katsuhisa; Murata, Tomoaki; Kamigaso, Syunsuke; Yasujima, Tomoya; Maeda, Jun-ya; Yoshida, Yukihiro; Ohta, Kin-ya; Yuasa, Hiroaki] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Nagoya, Aichi 4678603, Japan	Nagoya City University	Inoue, K (corresponding author), 3-1 Tanabe Dori,Mizuho Ku, Nagoya, Aichi 4678603, Japan.	kinoue@phar.nagoya-cu.ac.jp	Yuasa, Hiroaki/AGW-4587-2022	Yuasa, Hiroaki/0000-0001-8349-6694; Yamamoto, Syunsuke/0000-0002-0257-1216	Ministry of Education, Culture, Sports, Science and Technology, Japan; Nagoya City University	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagoya City University	This work was supported in part by a grant-in-aid for young scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a grant-in-aid for research in Nagoya City University.	ANDERSEN PS, 1995, J BACTERIOL, V177, P2008, DOI 10.1128/jb.177.8.2008-2013.1995; Anzai N, 2007, CURR OPIN RHEUMATOL, V19, P151, DOI 10.1097/BOR.0b013e328032781a; Argyrou E, 2001, PLANT CELL, V13, P953, DOI 10.1105/tpc.13.4.953; Baker SD, 1996, J CLIN ONCOL, V14, P3085, DOI 10.1200/JCO.1996.14.12.3085; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; BRONK JR, 1987, J PHYSIOL-LONDON, V382, P475, DOI 10.1113/jphysiol.1987.sp016379; Burchmore RJS, 2003, J BIOL CHEM, V278, P23502, DOI 10.1074/jbc.M301252200; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cecchetto G, 2004, J BIOL CHEM, V279, P3132, DOI 10.1074/jbc.M308826200; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; CLIFFORD AJ, 1976, J NUTR, V106, P428, DOI 10.1093/jn/106.3.428; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cropp CD, 2008, MOL PHARMACOL, V73, P1151, DOI 10.1124/mol.107.043117; de Koning H, 2000, MOL MEMBR BIOL, V17, P75; Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; DIALLINAS G, 1989, GENETICS, V122, P341; DIASIO RB, 1989, CLIN PHARMACOKINET, V16, P215, DOI 10.2165/00003088-198916040-00002; Faaland CA, 1998, BBA-GENE STRUCT EXPR, V1442, P353, DOI 10.1016/S0167-4781(98)00151-1; Gillissen B, 2000, PLANT CELL, V12, P291, DOI 10.1105/tpc.12.2.291; GORFINKIEL L, 1993, J BIOL CHEM, V268, P23376; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Govindarajan R, 2007, AM J PHYSIOL-REG I, V293, pR1809, DOI 10.1152/ajpregu.00293.2007; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; GRIFFITH DA, 1994, BIOCHEM J, V303, P901, DOI 10.1042/bj3030901; GRIFFITH DA, 1993, J BIOL CHEM, V268, P20085; GUIMARAES MJ, 1995, DEVELOPMENT, V121, P3335; HUANG QQ, 1994, J BIOL CHEM, V269, P17757; Inoue K, 2008, AM J PHYSIOL-GASTR L, V294, pG660, DOI 10.1152/ajpgi.00309.2007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOHAMEDALI KA, 1993, J BIOL CHEM, V268, P23728; Molina-Arcas M, 2008, NUCLEOS NUCLEOT NUCL, V27, P769, DOI 10.1080/15257770802145819; Moriwaki Y, 1999, HISTOL HISTOPATHOL, V14, P1321, DOI 10.14670/HH-14.1321; Nakai Y, 2007, J PHARMACOL EXP THER, V322, P469, DOI 10.1124/jpet.107.122606; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Ohta KY, 2006, DRUG METAB DISPOS, V34, P1868, DOI 10.1124/dmd.106.010876; Ortiz D, 2007, MOL MICROBIOL, V64, P1228, DOI 10.1111/j.1365-2958.2007.05730.x; PLAGEMANN PGW, 1988, BIOCHIM BIOPHYS ACTA, V947, P405, DOI 10.1016/0304-4157(88)90002-0; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Takanaga H, 2004, PFLUG ARCH EUR J PHY, V447, P677, DOI 10.1007/s00424-003-1104-1; Theisinger A, 2003, J COMP PHYSIOL B, V173, P165, DOI 10.1007/s00360-002-0324-6; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Valdes R, 2000, GASTROENTEROLOGY, V119, P1623, DOI 10.1053/gast.2000.20183; WASHINGTON CB, 1995, J BIOL CHEM, V270, P22816, DOI 10.1074/jbc.270.39.22816; WEBER E, 1990, MOL MICROBIOL, V4, P585, DOI 10.1111/j.1365-2958.1990.tb00627.x; WITTE DP, 1991, J CELL BIOL, V115, P179, DOI 10.1083/jcb.115.1.179; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; Yamamoto S, 2009, J BIOCHEM, V145, P437, DOI 10.1093/jb/mvn181; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yuasa H, 1996, BIOL PHARM BULL, V19, P94; ZOLLNER N, 1982, P NUTR SOC, V41, P329, DOI 10.1079/PNS19820048	52	61	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6522	6531		10.1074/jbc.M109.032961	http://dx.doi.org/10.1074/jbc.M109.032961			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20042597	hybrid, Green Published			2022-12-25	WOS:000275367500057
J	Kim, JH; Kim, K; Jin, HM; Song, I; Youn, BU; Lee, SH; Choi, Y; Kim, N				Kim, Jung Ha; Kim, Kabsun; Jin, Hye Mi; Song, Insun; Youn, Bang Ung; Lee, Seoung-Hoon; Choi, Yongwon; Kim, Nacksung			Negative Feedback Control of Osteoclast Formation through Ubiquitin-mediated Down-regulation of NFATc1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS C1; NUCLEAR-FACTOR; CBL-B; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; RECEPTOR; DIFFERENTIATION; BONE; ACTIVATION; PROTEINS	The regulation of NFATc1 expression is important for osteoclast differentiation and function. Herein, we demonstrate that macrophage-colony-stimulating factor induces NFATc1 degradation via Cbl proteins in a Src kinase-dependent manner. NFATc1 proteins are ubiquitinated and rapidly degraded during late stage osteoclastogenesis, and this degradation is mediated by Cbl-b and c-Cbl ubiquitin ligases in a Src-dependent manner. In addition, NFATc1 interacts endogenously with c-Src, c-Cbl, and Cbl-b in osteoclasts. Overexpression of c-Src induces down-regulation of NFATc1, and depletion of Cbl proteins blocks NFATc1 degradation during late stage osteoclastogenesis. Taken together, our data provide a negative regulatory mechanism by which macrophage-colony-stimulating factor activates Src family kinases and Cbl proteins, and subsequently, induces NFATc1 degradation during osteoclast differentiation.	[Kim, Nacksung] Chonnam Natl Univ, Sch Med, Natl Res Lab Regulat Bone Metab & Dis, Med Res Ctr Gene Regulat,Res Inst Med Sci,Dept Ph, Kwangju 501746, South Korea; [Lee, Seoung-Hoon] Wonkwang Univ, Sch Dent, Dept Oral Microbiol & Immunol, Iksan 570749, South Korea; [Lee, Seoung-Hoon; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Chonnam National University; Wonkwang University; University of Pennsylvania	Kim, N (corresponding author), Chonnam Natl Univ, Sch Med, Natl Res Lab Regulat Bone Metab & Dis, Med Res Ctr Gene Regulat,Res Inst Med Sci,Dept Ph, Hak Dong 5, Kwangju 501746, South Korea.	nacksung@chonnam.ac.kr			National Institutes of Health [AR053843, DE19381]; Medical Research Center for Gene Regulation at Chonnam National University, Korean government [R0A-2007-000-20025-0, R13-2002-013-03001-0]; Brain Korea 21 Project; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Center for Gene Regulation at Chonnam National University, Korean government(Korean Government); Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants AR053843 and DE19381 ( to Y.C.). This work was also supported in part by the Korea Science and Engineering Foundation National Research Laboratory Program grant funded by the Korean government Grant R0A-2007-000-20025-0 and Grant R13-2002-013-03001-0 from the Korea Science and Engineering Foundation through the Medical Research Center for Gene Regulation at Chonnam National University and by a grant from the Brain Korea 21 Project ( to J.H.K. and K. K.).	Arron JR, 2001, J BIOL CHEM, V276, P30011, DOI 10.1074/jbc.M100414200; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Elly C, 1999, ONCOGENE, V18, P1147, DOI 10.1038/sj.onc.1202411; Hakak Y, 1999, CURR BIOL, V9, P1039, DOI 10.1016/S0960-9822(99)80453-9; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Insogna KL, 1997, J CLIN INVEST, V100, P2476, DOI 10.1172/JCI119790; Kassenbrock CK, 2002, J BIOL CHEM, V277, P24967, DOI 10.1074/jbc.M201026200; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kim YJ, 2005, J BIOL CHEM, V280, P21515, DOI 10.1074/jbc.M502230200; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Rangachari M, 2004, CURR OPIN PHARMACOL, V4, P415, DOI 10.1016/j.coph.2004.03.007; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thien CBF, 2005, GROWTH FACTORS, V23, P161, DOI 10.1080/08977190500153763; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200	38	37	38	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5224	5231		10.1074/jbc.M109.042812	http://dx.doi.org/10.1074/jbc.M109.042812			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20037154	Green Published, hybrid			2022-12-25	WOS:000275327200015
J	Liu, YY; Fang, YA; Shao, HB; Lindsey-Boltz, L; Sancar, A; Modrich, P				Liu, Yiyong; Fang, Yanan; Shao, Hongbing; Lindsey-Boltz, Laura; Sancar, Aziz; Modrich, Paul			Interactions of Human Mismatch Repair Proteins MutS alpha and MutL alpha with Proteins of the ATR-Chk1 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRO-N-NITROSOGUANIDINE; CELL-CYCLE ARREST; DNA-DAMAGE; IN-VITRO; CHECKPOINT KINASE; NUCLEAR EXTRACTS; ATR KINASE; TOPBP1; O-6-METHYLGUANINE; RECONSTITUTION	At clinically relevant doses, chemotherapeutic SN1 DNA methylating agents induce an ATR-mediated checkpoint response in human cells that is dependent on functional MutS alpha and MutL alpha. Deficiency of either mismatch repair activity renders cells highly resistant to this class of drug, but the mechanisms linking mismatch repair to checkpoint activation have remained elusive. In this study we have systematically examined the interactions of human MutS alpha and MutL alpha with proteins of the ATR-Chk1 pathway using both nuclear extracts and purified proteins. Using nuclear co-immunoprecipitation, we have detected interaction of MutS alpha with ATR, TopBP1, Claspin, and Chk1 and interaction of MutL alpha with TopBP1 and Claspin. We were unable to detect interaction of MutS alpha or MutL alpha with Rad17, Rad9, or replication protein A in the extract system. Use of purified proteins confirmed direct interaction of MutS alpha with ATR, TopBP1, and Chk1 and of MutL alpha with TopBP1. MutS alpha Claspin and MutL alpha-Claspin interactions were not demonstrable with purified proteins, suggesting that extract interactions are indirect or depend on post-translational modification. Use of a modified chromatin immunoprecipitation assay showed that proliferating cell nuclear antigen, ATR, TopBP1, and Chk1 are recruited to chromatin in a MutL alpha- and MutS alpha-dependent fashion after N-methyl-N'-nitro-N-nitrosoguanidine treatment. However, chromatin enrichment of replication protein A, Claspin, Rad17-RFC, and Rad9-Rad1-Hus1 was not detected in these experiments. Although our failure to observe enrichment of the latter activities could be due to sensitivity limitations, these observations may indicate a novel mechanism for ATR activation.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Liu, Yiyong; Fang, Yanan; Shao, Hongbing; Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Lindsey-Boltz, Laura; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Duke University; Duke University; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine		modrich@biochem.duke.edu	Lindsey-Boltz, Laura/A-3121-2010	Lindsey-Boltz, Laura/0000-0001-6493-8194; Fang, Yanan/0000-0002-1112-9569; Modrich, Paul/0000-0001-8708-9885	National Institutes of Health [GM45190, GM32833]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190, R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM45190 (to P. M.) and GM32833 (to A. S.).	Adamson AW, 2005, MOL BIOL CELL, V16, P1513, DOI 10.1091/mbc.E04-02-0089; Beardsley DI, 2005, MOL PHARMACOL, V68, P1049, DOI 10.1124/mol.105.013888; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Ceccotti S, 1996, CURR BIOL, V6, P1528, DOI 10.1016/S0960-9822(96)00758-0; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Coin F, 2008, MOL CELL, V31, P9, DOI 10.1016/j.molcel.2008.04.024; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Duckett DR, 1999, P NATL ACAD SCI USA, V96, P12384, DOI 10.1073/pnas.96.22.12384; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Edelmann W, 2000, CANCER RES, V60, P803; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; GOLDMACHER VS, 1986, J BIOL CHEM, V261, P2462; Haracska L, 2000, MOL CELL BIOL, V20, P8001, DOI 10.1128/MCB.20.21.8001-8007.2000; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Iams K, 2002, J BIOL CHEM, V277, P30805, DOI 10.1074/jbc.M200846200; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; KARRAN P, 1992, NUCLEIC ACIDS RES, V20, P2933, DOI 10.1093/nar/20.12.2933; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Klapacz J, 2009, P NATL ACAD SCI USA, V106, P576, DOI 10.1073/pnas.0811991106; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; LAEMMLI UK, 1970, NATURE, V227, P685; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; Longley MJ, 1997, J BIOL CHEM, V272, P10917; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Navadgi-Patil VM, 2009, DNA REPAIR, V8, P996, DOI 10.1016/j.dnarep.2009.03.011; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; O'Brien V, 2006, CARCINOGENESIS, V27, P682, DOI 10.1093/carcin/bgi298; Quaresima B, 2006, HUM MUTAT, V27, P715, DOI 10.1002/humu.9427; Ramilo C, 2002, MOL CELL BIOL, V22, P2037, DOI 10.1128/MCB.22.7.2037-2046.2002; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Szadkowski M, 2005, CANCER RES, V65, P4525, DOI 10.1158/0008-5472.CAN-05-0080; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Tominaga Y, 1997, CARCINOGENESIS, V18, P889, DOI 10.1093/carcin/18.5.889; Wang Q, 2001, ONCOGENE, V20, P4640, DOI 10.1038/sj.onc.1204625; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wang Y, 2000, GENE DEV, V14, P927; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; York SJ, 2006, J BIOL CHEM, V281, P22674, DOI 10.1074/jbc.M603667200; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	61	56	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5974	5982		10.1074/jbc.M109.076109	http://dx.doi.org/10.1074/jbc.M109.076109			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20029092	Green Published, hybrid			2022-12-25	WOS:000275327200087
J	Musset, B; Capasso, M; Cherny, VV; Morgan, D; Bhamrah, M; Dyer, MJS; DeCoursey, TE				Musset, Boris; Capasso, Melania; Cherny, Vladimir V.; Morgan, Deri; Bhamrah, Mandeep; Dyer, Martin J. S.; DeCoursey, Thomas E.			Identification of Thr(29) as a Critical Phosphorylation Site That Activates the Human Proton Channel Hvcn1 in Leukocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDASE-RELATED PROTON; NADPH OXIDASE; HUMAN-NEUTROPHILS; ELECTRON CURRENTS; VOLTAGE-DEPENDENCE; H+ CHANNEL; EOSINOPHILS; PH; CONDUCTANCE; PHAGOCYTES	Voltage-gated proton channels and NADPH oxidase function cooperatively in phagocytes during the respiratory burst, when reactive oxygen species are produced to kill microbial invaders. Agents that activate NADPH oxidase also enhance proton channel gating profoundly, facilitating its roles in charge compensation and pH(i) regulation. The "enhanced gating mode" appears to reflect protein kinase C (PKC) phosphorylation. Here we examine two candidates for PKC-delta phosphorylation sites in the human voltage-gated proton channel, H(V)1 (Hvcn1), Thr(29) and Ser(97), both in the intracellular N terminus. Channel phosphorylation was reduced in single mutants S97A or T29A, and further in the double mutant T29A/S97A, by an in vitro kinase assay with PKC-delta. Enhanced gating was evaluated by expressing wild-type (WT) or mutant H(V)1 channels in LK35.2 cells, a B cell hybridoma. Stimulation by phorbol myristate acetate enhanced WT channel gating, and this effect was reversed by treatment with the PKC inhibitor GF109203X. The single mutant T29A or double mutant T29A/S97A failed to respond to phorbol myristate acetate or GF109203X. In contrast, the S97A mutant responded like cells transfected with WT H(V)1. We conclude that under these conditions, direct phosphorylation of the proton channel molecule at Thr(29) is primarily responsible for the enhancement of proton channel gating. This phosphorylation is crucial to activation of the proton conductance during the respiratory burst in phagocytes.	[Musset, Boris; Cherny, Vladimir V.; Morgan, Deri] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA; [Capasso, Melania; Bhamrah, Mandeep; Dyer, Martin J. S.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	Rush University; University of Leicester	DeCoursey, TE (corresponding author), Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, 1750 W Harrison, Chicago, IL 60612 USA.	tdecours@rush.edu	DeCoursey, Thomas/A-6820-2009; Musset, Boris/J-2520-2013; Musset, Boris/AAD-4158-2022; Dyer, Martin/F-2691-2014	DeCoursey, Thomas/0000-0002-4263-180X; Musset, Boris/0000-0001-8242-8817; Musset, Boris/0000-0001-8242-8817; Capasso, Melania/0000-0001-8659-9867; Dyer, Martin/0000-0002-5033-2236	National Institutes of Health Research through the NHLBI [HL61437]; Philip Morris USA Inc.; Philip Morris International; MRC, United Kingdom; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087507] Funding Source: NIH RePORTER; Medical Research Council [MC_U132670597] Funding Source: researchfish; MRC [MC_U132670597] Funding Source: UKRI	National Institutes of Health Research through the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Philip Morris USA Inc.; Philip Morris International; MRC, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Research Grant HL61437 through the NHLBI. This work was also supported by grants from Prof. Dr. Adolf Schmidtmann-Stiftung, Philip Morris USA Inc. and Philip Morris International, and the MRC, United Kingdom.	Banfi B, 1999, J EXP MED, V190, P183, DOI 10.1084/jem.190.2.183; Bankers-Fulbright JL, 2001, J CELL PHYSIOL, V189, P306, DOI 10.1002/jcp.10022; CAPASSO M, 2010, NAT IMMUNOL IN PRESS; Cheng N, 2007, J IMMUNOL, V179, P7720, DOI 10.4049/jimmunol.179.11.7720; CHVAPIL M, 1977, INFECT IMMUN, V16, P367, DOI 10.1128/IAI.16.1.367-373.1977; DeCoursey TE, 2000, P NATL ACAD SCI USA, V97, P6885, DOI 10.1073/pnas.100047297; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; DECOURSEY TE, 1993, BIOPHYS J, V65, P1590, DOI 10.1016/S0006-3495(93)81198-6; DeCoursey TE, 2001, J PHYSIOL-LONDON, V535, P767, DOI 10.1111/j.1469-7793.2001.00767.x; DeCoursey TE, 2001, J BIOL CHEM, V276, P36063, DOI 10.1074/jbc.C100352200; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Femling JK, 2006, J GEN PHYSIOL, V127, P659, DOI 10.1085/jgp.200609504; Fujii K, 2004, P NATL ACAD SCI USA, V101, P13744, DOI 10.1073/pnas.0401881101; He R, 2004, J IMMUNOL, V173, P7462, DOI 10.4049/jimmunol.173.12.7462; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; HENDERSON LM, 1988, BIOCHEM J, V255, P285; HENDERSON LM, 1995, J BIOL CHEM, V270, P5909, DOI 10.1074/jbc.270.11.5909; KAPUS A, 1992, BIOCHEM J, V281, P697, DOI 10.1042/bj2810697; Lowenthal A, 1999, J BIOL CHEM, V274, P21603, DOI 10.1074/jbc.274.31.21603; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Morgan D, 2003, J PHYSIOL-LONDON, V550, P447, DOI 10.1113/jphysiol.2003.041525; Morgan D, 2007, J PHYSIOL-LONDON, V579, P327, DOI 10.1113/jphysiol.2006.124248; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Murphy R, 2006, BBA-BIOENERGETICS, V1757, P996, DOI 10.1016/j.bbabio.2006.01.005; Musset B, 2008, J PHYSIOL-LONDON, V586, P2477, DOI 10.1113/jphysiol.2007.149427; Musset B, 2008, P NATL ACAD SCI USA, V105, P11020, DOI 10.1073/pnas.0800886105; Musset B, 2009, BIOPHYS J, V96, p667A, DOI 10.1016/j.bpj.2008.12.3528; Musset B, 2009, FEBS LETT, V583, P7, DOI 10.1016/j.febslet.2008.12.005; NANDA A, 1991, P NATL ACAD SCI USA, V88, P10816, DOI 10.1073/pnas.88.23.10816; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Petheo GL, 2005, BIOCHEM J, V388, P485, DOI 10.1042/BJ20041889; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; SIMCHOWITZ L, 1990, J BIOL CHEM, V265, P13449; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Zhao XX, 2005, J LEUKOCYTE BIOL, V77, P414, DOI 10.1189/jlb.0504284	37	51	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5117	5121		10.1074/jbc.C109.082727	http://dx.doi.org/10.1074/jbc.C109.082727			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20037153	Green Published, hybrid			2022-12-25	WOS:000275327200001
J	Essabbani, A; Margottin-Goguet, F; Chiocchia, G				Essabbani, Abdellatif; Margottin-Goguet, Florence; Chiocchia, Gilles			Identification of Clusterin Domain Involved in NF-kappa B Pathway Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE ATTACK COMPLEX; CELL-DEATH; BETA-TRCP; RHEUMATOID-ARTHRITIS; PROTEIN; APOPTOSIS; CANCER; DEGRADATION; EXPRESSION	Clusterin (CLU) is a ubiquitous protein that has been implicated in tumorigenesis, apoptosis, inflammation, and cell proliferation. We and others have previously shown that CLU is an inhibitor of the NF-kappa B pathway. However, the exact form of CLU and the region(s) of CLU involved in this effect were unknown. Using newly generated molecular constructs encoding for CLU and various regions of the molecule, we demonstrated that the presecretory form of CLU (psCLU) form bears the NF-kappa B regulatory activity. Sequence comparison analysis showed sequence motif identity between CLU and beta-transducin repeat-containing protein (beta-TrCP), a main E3 ubiquitin ligase involvedinI kappa B-alpha degradation. These homologies were localized in the disulfide constraint region of CLU. We generated a specific molecular construct of this region, named Delta CLU, and showed that it has the same NF-kappa B regulatory activity as CLU. Neither the alpha-chain nor the beta-chain of CLU had any NF-kappa B regulatory activity. Furthermore, we showed that following tumor necrosis factor-alpha stimulation of transfected cells, we could co-immunoprecipitate phospho-I kappa B-alpha with Delta CLU. Moreover, we showed that Delta CLU could localize both in the cytoplasm and in the nucleus. These results demonstrate the identification of a new CLU activity site involved in NF-kappa B pathway regulation.	[Chiocchia, Gilles] INSERM, Inst Cochin, U567, Dept Immunol & Hematol, F-75014 Paris, France; [Essabbani, Abdellatif; Margottin-Goguet, Florence; Chiocchia, Gilles] Univ Paris 05, CNRS, UMR 8104, F-75014 Paris, France; [Chiocchia, Gilles] Hop Ambroise Pare, Serv Rhumatol, F-92100 Boulogne, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Chiocchia, G (corresponding author), INSERM, Inst Cochin, U567, Dept Immunol & Hematol, Pavillon Hardy A 1Er Etage,27 Rue Faubourg St Jac, F-75014 Paris, France.	gilles.chiocchia@inserm.fr	Margottin-Goguet, Florence/F-9272-2013; CHIOCCHIA, Gilles R/F-6287-2013	Margottin-Goguet, Florence/0000-0002-3124-6690; CHIOCCHIA, Gilles R/0000-0001-9973-0940	Societe Francaise de Rhumatologie (SFR); Fondation Arthritis Courtin; Association pour la Recherche contre le Cancer	Societe Francaise de Rhumatologie (SFR); Fondation Arthritis Courtin; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by a grant from the Societe Francaise de Rhumatologie (SFR) and Fondation Arthritis Courtin.; Supported by SFR and Association pour la Recherche contre le Cancer.	Chen XD, 2003, P NATL ACAD SCI USA, V100, P9530, DOI 10.1073/pnas.1233633100; CHOI NH, 1990, INT IMMUNOL, V2, P413, DOI 10.1093/intimm/2.5.413; CHOI NH, 1989, MOL IMMUNOL, V26, P835; Devauchelle V, 2004, GENES IMMUN, V5, P597, DOI 10.1038/sj.gene.6364132; Devauchelle V, 2006, J IMMUNOL, V177, P6471, DOI 10.4049/jimmunol.177.9.6471; DUVERGER E, 1995, J CELL SCI, V108, P1325; Evrard-Todeschi N, 2008, J CHEM INF MODEL, V48, P2350, DOI 10.1021/ci800248u; FRENCH LE, 1994, J CLIN INVEST, V93, P877, DOI 10.1172/JCI117043; Gilmore TD, 1996, ONCOGENE, V13, P1367; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Kaisman-Elbaz T, 2009, J CELL PHYSIOL, V220, P222, DOI 10.1002/jcp.21754; Kapron JT, 1997, PROTEIN SCI, V6, P2120; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Markopoulou S, 2009, FEBS J, V276, P4208, DOI 10.1111/j.1742-4658.2009.07093.x; Murphy B F, 1989, Int Immunol, V1, P551, DOI 10.1093/intimm/1.5.551; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Savkovic V, 2007, BIOCHEM BIOPH RES CO, V356, P431, DOI 10.1016/j.bbrc.2007.02.148; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Trougakos IP, 2009, CANCER RES, V69, P403, DOI 10.1158/0008-5472.CAN-08-2912; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291	24	30	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4273	4277		10.1074/jbc.C109.057133	http://dx.doi.org/10.1074/jbc.C109.057133			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20028970	hybrid, Green Published			2022-12-25	WOS:000275274800003
J	Little, MP; Heidenreich, WF; Li, GQ				Little, Mark P.; Heidenreich, Wolfgang F.; Li, Guangquan			Parameter Identifiability and Redundancy in a General Class of Stochastic Carcinogenesis Models	PLOS ONE			English	Article							CLONAL EXPANSION MODEL; COLON-CANCER DATA; GENOMIC INSTABILITY; REPARAMETERISATIONS; IDENTIFICATION; SYSTEMS	Background: Heidenreich et al. ( Risk Anal 1997 17 391-399) considered parameter identifiability in the context of the two-mutation cancer model and demonstrated that combinations of all but two of the model parameters are identifiable. We consider the problem of identifiability in the recently developed carcinogenesis models of Little and Wright ( Math Biosci 2003 183 111-134) and Little et al. (J Theoret Biol 2008 254 229-238). These models, which incorporate genomic instability, generalize a large number of other quasi-biological cancer models, in particular those of Armitage and Doll (Br J Cancer 1954 8 1-12), the two-mutation model (Moolgavkar et al. Math Biosci 1979 47 55-77), the generalized multistage model of Little ( Biometrics 1995 51 1278-1291), and a recently developed cancer model of Nowak et al. (PNAS 2002 99 16226-16231). Methodology/Principal Findings: We show that in the simpler model proposed by Little and Wright ( Math Biosci 2003 183 111-134) the number of identifiable combinations of parameters is at most two less than the number of biological parameters, thereby generalizing previous results of Heidenreich et al. ( Risk Anal 1997 17 391-399) for the two-mutation model. For the more general model of Little et al. ( J Theoret Biol 2008 254 229-238) the number of identifiable combinations of parameters is at most r + 1 less than the number of biological parameters, where r is the number of destabilization types, thereby also generalizing all these results. Numerical evaluations suggest that these bounds are sharp. We also identify particular combinations of identifiable parameters. Conclusions/Significance: We have shown that the previous results on parameter identifiability can be generalized to much larger classes of quasi-biological carcinogenesis model, and also identify particular combinations of identifiable parameters. These results are of theoretical interest, but also of practical significance to anyone attempting to estimate parameters for this large class of cancer models.	[Little, Mark P.; Li, Guangquan] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Heidenreich, Wolfgang F.] Helmholtz Zentrum Munchen, Inst Strahlenschutz, Neuherberg, Germany	Imperial College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Little, MP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England.	mark.little@imperial.ac.uk	Li, Guangquan/AAW-6920-2021	Li, Guangquan/0000-0002-8736-5349; Little, Mark/0000-0003-0980-7567	European Commission [FI6R-CT-2003-508842, FP6-036465]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded partially by the European Commission under contract FI6R-CT-2003-508842 (RISC-RAD) and FP6-036465 ( NOTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Catchpole EA, 1997, BIOMETRIKA, V84, P187, DOI 10.1093/biomet/84.1.187; Chappell MJ, 1998, MATH BIOSCI, V148, P21, DOI 10.1016/S0025-5564(97)10004-9; COLE D, 2009, DETERMINING PARAMETR; Evans ND, 2000, MATH BIOSCI, V168, P137, DOI 10.1016/S0025-5564(00)00047-X; Golub GH., 2013, MATRIX COMPUTATIONS; Hanin LG, 1996, RISK ANAL, V16, P711, DOI 10.1111/j.1539-6924.1996.tb00819.x; Hanin LG, 2002, DISCRETE DYN NAT SOC, V7, P177, DOI 10.1080/1026022021000001454; Heidenreich WF, 1996, RADIAT ENVIRON BIOPH, V35, P127, DOI 10.1007/s004110050020; Heidenreich WF, 1997, RISK ANAL, V17, P391, DOI 10.1111/j.1539-6924.1997.tb00878.x; JACQUEZ JA, 1990, AM J PHYSIOL, V258, pE727, DOI 10.1152/ajpendo.1990.258.4.E727; Little MP, 2008, J THEOR BIOL, V254, P229, DOI 10.1016/j.jtbi.2008.05.027; Little MP, 2007, CARCINOGENESIS, V28, P479, DOI 10.1093/carcin/bgl173; Little MP, 2003, MATH BIOSCI, V183, P111, DOI 10.1016/S0025-5564(03)00040-3; Little MP, 1995, BIOMETRICS, V51, P1278, DOI 10.2307/2533259; LITTLE MP, 2009, PLOS ONE UNPUB; McCullagh P, 1989, GEN LINEAR MODELS; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; *NUM ALG GROUP, 2006, NAG LIB MARK 21; Press W., 1992, NUMERICAL RECIPES FO; ROTHENBERG TJ, 1971, ECONOMETRICA, V39, P577, DOI 10.2307/1913267; Silvey S.D., 1975, REPRINTING MONOGRAPH	23	15	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8520	10.1371/journal.pone.0008520	http://dx.doi.org/10.1371/journal.pone.0008520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	538JK	20046831	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000273180200008
J	Nagao, K; Zhu, JJ; Heneghan, MB; Hanson, JC; Morasso, MI; Tessarollo, L; Mackem, S; Udey, MC				Nagao, Keisuke; Zhu, Jianjian; Heneghan, Mallorie B.; Hanson, Jeffrey C.; Morasso, Maria I.; Tessarollo, Lino; Mackem, Susan; Udey, Mark C.			Abnormal Placental Development and Early Embryonic Lethality in EpCAM-Null Mice	PLOS ONE			English	Article							CELL ADHESION MOLECULE; CD44 VARIANT ISOFORMS; EP-CAM; E-CADHERIN; EPITHELIAL GLYCOPROTEIN; INSERTIONAL MUTATIONS; MURINE HOMOLOG; EXPRESSION; GENE; ANTIGEN	Background: EpCAM (CD326) is encoded by the tacstd1 gene and expressed by a variety of normal and malignant epithelial cells and some leukocytes. Results of previous in vitro experiments suggested that EpCAM is an intercellular adhesion molecule. EpCAM has been extensively studied as a potential tumor marker and immunotherapy target, and more recent studies suggest that EpCAM expression may be characteristic of cancer stem cells. Methodology/Principal Findings: To gain insights into EpCAM function in vivo, we generated EpCAM -/- mice utilizing an embryonic stem cell line with a tacstd1 allele that had been disrupted. Gene trapping resulted in a protein comprised of the N-terminus of EpCAM encoded by 2 exons of the tacstd1 gene fused in frame to beta geo. EpCAM +/- mice were viable and fertile and exhibited no obvious abnormalities. Examination of EpCAM +/- embryos revealed that bgeo was expressed in several epithelial structures including developing ears (otocysts), eyes, branchial arches, gut, apical ectodermal ridges, lungs, pancreas, hair follicles and others. All EpCAM -/- mice died in utero by E12.5, and were small, developmentally delayed, and displayed prominent placental abnormalities. In developing placentas, EpCAM was expressed throughout the labyrinthine layer and by spongiotrophoblasts as well. Placentas of EpCAM -/- embryos were compact, with thin labyrinthine layers lacking prominent vascularity. Parietal trophoblast giant cells were also dramatically reduced in EpCAM -/- placentas. Conclusion: EpCAM was required for differentiation or survival of parietal trophoblast giant cells, normal development of the placental labyrinth and establishment of a competent maternal-fetal circulation. The findings in EpCAM-reporter mice suggest involvement of this molecule in development of vital organs including the gut, kidneys, pancreas, lungs, eyes, and limbs.	[Nagao, Keisuke; Heneghan, Mallorie B.; Udey, Mark C.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Nagao, Keisuke; Heneghan, Mallorie B.; Udey, Mark C.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Zhu, Jianjian; Hanson, Jeffrey C.; Mackem, Susan] NCI, Pathol Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Zhu, Jianjian; Hanson, Jeffrey C.; Mackem, Susan] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Morasso, Maria I.] NIAMSD, Dev Skin Biol Unit, NIH, Bethesda, MD 20892 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Zhu, Jianjian; Mackem, Susan] NCI, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Zhu, Jianjian; Mackem, Susan] NCI, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nagao, K (corresponding author), Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan.	udeym@mail.nih.gov	Nagao, Keisuke/J-5116-2013; Nagao, Keisuke/P-3837-2018	Nagao, Keisuke/0000-0002-7005-3138; Nagao, Keisuke/0000-0002-7005-3138	NIH; Center for Cancer Research of the NCI; NIAMS; NATIONAL CANCER INSTITUTE [ZIABC010956] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported the Intramural Program of the NIH, specifically the Center for Cancer Research of the NCI and the Intramural Program of NIAMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 1999, J REPROD FERTIL, V116, P379, DOI 10.1530/jrf.0.1160379; Bany BM, 2006, DEV BIOL, V294, P445, DOI 10.1016/j.ydbio.2006.03.006; BERGSAGEL PL, 1992, J IMMUNOL, V148, P590; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Bonin A, 2000, METH MOL B, V158, P121; Borkowski TA, 1996, EUR J IMMUNOL, V26, P110, DOI 10.1002/eji.1830260117; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; EDWARDS DP, 1986, CANCER RES, V46, P1306; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; HERLYN M, 1979, P NATL ACAD SCI USA, V76, P1438, DOI 10.1073/pnas.76.3.1438; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Kraut N, 1998, EMBO J, V17, P6276, DOI 10.1093/emboj/17.21.6276; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Nelson AJ, 1996, EUR J IMMUNOL, V26, P401, DOI 10.1002/eji.1830260220; Pizard Anne, 2004, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1409s66; Radice GL, 1997, J CELL BIOL, V139, P1025, DOI 10.1083/jcb.139.4.1025; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; ROSS AH, 1986, BIOCHEM BIOPH RES CO, V135, P297, DOI 10.1016/0006-291X(86)90976-9; Schmidt DS, 2004, EXP CELL RES, V297, P329, DOI 10.1016/j.yexcr.2004.02.023; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Sivagnanam M, 2008, GASTROENTEROLOGY, V135, P429, DOI 10.1053/j.gastro.2008.05.036; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Soler AP, 1997, HUM PATHOL, V28, P734, DOI 10.1016/S0046-8177(97)90184-2; Stephan JP, 1999, ENDOCRINOLOGY, V140, P5841, DOI 10.1210/en.140.12.5841; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Townley DJ, 1997, GENOME RES, V7, P293, DOI 10.1101/gr.7.3.293; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Winter MJ, 2003, EXP CELL RES, V285, P50, DOI 10.1016/S0014-4827(02)00045-9; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908	42	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8543	10.1371/journal.pone.0008543	http://dx.doi.org/10.1371/journal.pone.0008543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046825	gold, Green Submitted, Green Published			2022-12-25	WOS:000273180200020
J	Ji, Z; Tian, B				Ji, Zhe; Tian, Bin			Reprogramming of 3 ' Untranslated Regions of mRNAs by Alternative Polyadenylation in Generation of Pluripotent Stem Cells from Different Cell Types	PLOS ONE			English	Article							MICRORNA TARGETS; SITE SELECTION; MOUSE TESTIS; GENES; ELEMENTS; 3'-END; REPRESSION; MECHANISM; EVOLUTION; REVEALS	Background: The 3' untranslated regions (3'UTRs) of mRNAs contain cis elements involved in post-transcriptional regulation of gene expression. Over half of all mammalian genes contain multiple polyadenylation sites that lead to different 3'UTRs for a gene. Studies have shown that the alternative polyadenylation (APA) pattern varies across tissues, and is dynamically regulated in proliferating or differentiating cells. Generation of induced pluripotent stem (iPS) cells, in which differentiated cells are reprogrammed to an embryonic stem (ES) cell-like state, has been intensively studied in recent years. However, it is not known how 3'UTRs are regulated during cell reprogramming. Methods/Main Findings: Using a computational method that robustly examines APA across DNA microarray data sets, we analyzed 3'UTR dynamics in generation of iPS cells from different cell types. We found that 3'UTRs shorten during reprogramming of somatic cells, the extent of which depends on the type of source cell. By contrast, reprogramming of spermatogonial cells involves 3'UTR lengthening. The alternative polyadenylation sites that are highly responsive to change of cell state in generation of iPS cells are also highly regulated during embryonic development in opposite directions. Compared with other sites, they are more conserved, can lead to longer alternative 3'UTRs, and are associated with more cis elements for polyadenylation. Consistently, reprogramming of somatic cells and germ cells involves significant upregulation and downregulation, respectively, of mRNAs encoding polyadenylation factors, and RNA processing is one of the most significantly regulated biological processes during cell reprogramming. Furthermore, genes containing target sites of ES cell-specific microRNAs (miRNAs) in different portions of 3'UTR are distinctively regulated during cell reprogramming, suggesting impact of APA on miRNA targeting. Conclusions/Significance: Taken together, these findings indicate that reprogramming of 3'UTRs by APA, which result from regulation of both general polyadenylation activity and cell type-specific factors and can reset post-transcriptional gene regulatory programs in the cell, is an integral part of iPS cell generation, and the APA pattern can be a good biomarker for cell type and state, useful for sample classification. The results also suggest that perturbation of the mRNA polyadenylation machinery or RNA processing activity may facilitate generation of iPS cells.	[Ji, Zhe] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ji, Z (corresponding author), Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Newark, NJ 07103 USA.	btian@umdnj.edu	Ji, Zhe/P-7094-2018; Ji, Zhe/U-8320-2018	Ji, Zhe/0000-0002-1809-8099; Tian, Bin/0000-0001-8903-8256	NIH [R01 GM084089]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084089] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from NIH (R01 GM084089) to BT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Canadillas JMP, 2003, EMBO J, V22, P2821, DOI 10.1093/emboj/cdg259; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Legendre M, 2006, PLOS COMPUT BIOL, V2, P333, DOI 10.1371/journal.pcbi.0020043; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Liu DL, 2007, NUCLEIC ACIDS RES, V35, P234, DOI 10.1093/nar/gkl919; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lowry WE, 2008, NAT BIOTECHNOL, V26, P1246, DOI 10.1038/nbt1108-1246; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; Yan J, 2005, GENOME RES, V15, P369, DOI 10.1101/gr.3109605; Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	56	192	202	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8419	10.1371/journal.pone.0008419	http://dx.doi.org/10.1371/journal.pone.0008419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037631	Green Submitted, Green Published, gold			2022-12-25	WOS:000272998100010
J	Nasrin, N; Kaushik, VK; Fortier, E; Wall, D; Pearson, KJ; de Cabo, R; Bordone, L				Nasrin, Nargis; Kaushik, Virendar K.; Fortier, Eric; Wall, Daniel; Pearson, Kevin J.; de Cabo, Rafael; Bordone, Laura			JNK1 Phosphorylates SIRT1 and Promotes Its Enzymatic Activity	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; OXIDATIVE STRESS; CALORIE RESTRICTION; CAENORHABDITIS-ELEGANS; HISTONE DEACETYLASE; CELL APOPTOSIS; LONGEVITY; TRANSCRIPTION; PATHWAYS; SURVIVAL	SIRT1 is a NAD-dependent deacetylase that regulates a variety of pathways including the stress protection pathway. SIRT1 deacetylates a number of protein substrates, including histones, FOXOs, PGC-1 alpha, and p53, leading to cellular protection. We identified a functional interaction between cJUN N-terminal kinase (JNK1) and SIRT1 by coimmunoprecipitation of endogenous proteins. The interaction between JNK1 and SIRT1 was identified under conditions of oxidative stress and required activation of JNK1 via phosphorylation. Modulation of SIRT1 activity or protein levels using nicotinamide or RNAi did not modify JNK1 activity as measured by its ability to phosphorylate cJUN. In contrast, human SIRT1 was phosphorylated by JNK1 on three sites: Ser27, Ser47, and Thr530 and this phosphorylation of SIRT1 increased its nuclear localization and enzymatic activity. Surprisingly, JNK1 phosphorylation of SIRT1 showed substrate specificity resulting in deacetylation of histone H3, but not p53. These findings identify a mechanism for regulation of SIRT1 enzymatic activity in response to oxidative stress and shed new light on its role in the stress protection pathway.	[Nasrin, Nargis; Kaushik, Virendar K.; Fortier, Eric; Bordone, Laura] Novartis Inst BioMed Res Inc, Cardiovasc & Metab Dis Area, Cambridge, MA USA; [Kaushik, Virendar K.] Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer USDA, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Pearson, Kevin J.; de Cabo, Rafael] NIA, NIH, Bethesda, MD 20892 USA	Novartis; Tufts University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Nasrin, N (corresponding author), Novartis Inst BioMed Res Inc, Cardiovasc & Metab Dis Area, Cambridge, MA USA.	laura.bordone@novartis.com	de Cabo, Rafael/E-7996-2010; de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442	National Institutes of Health (NIH); National Institute on Aging (NIA); Novartis Institutes for Biomedical Research; NATIONAL INSTITUTE ON AGING [ZIAAG000363] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Novartis Institutes for Biomedical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Institute on Aging (NIA), and by internal funding from Novartis Institutes for Biomedical Research. Employees of the entities sponsoring the work were involved in conception, experimental design, analysis, and preparation of the paper.	Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Berthiaume M, 2006, DNA CELL BIOL, V25, P124, DOI 10.1089/dna.2006.25.124; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hasegawa K, 2008, BIOCHEM BIOPH RES CO, V372, P51, DOI 10.1016/j.bbrc.2008.04.176; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Kume S, 2006, FREE RADICAL BIO MED, V40, P2175, DOI 10.1016/j.freeradbiomed.2006.02.014; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088	24	191	205	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8414	10.1371/journal.pone.0008414	http://dx.doi.org/10.1371/journal.pone.0008414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027304	Green Submitted, gold, Green Published			2022-12-25	WOS:000272998000018
J	Strunnikova, NV; Barb, J; Sergeev, YV; Thiagarajasubramanian, A; Silvin, C; Munson, PJ; MacDonald, IM				Strunnikova, Natalia V.; Barb, Jennifer; Sergeev, Yuri V.; Thiagarajasubramanian, Ashwin; Silvin, Christopher; Munson, Peter J.; MacDonald, Ian M.			Loss-of-Function Mutations in Rab Escort Protein 1 (REP-1) Affect Intracellular Transport in Fibroblasts and Monocytes of Choroideremia Patients	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; DRUSEN FORMATION; GENE-EXPRESSION; MOLECULAR-BASIS; CELLS; RPE; DYSFUNCTION; EXOCYTOSIS; EFFECTORS; DEGENERATION	Background: Choroideremia (CHM) is a progressive X-linked retinopathy caused by mutations in the CHM gene, which encodes Rab escort protein-1 (REP-1), an escort protein involved in the prenylation of Rabs. Under-prenylation of certain Rabs, as a result of loss of function mutations in REP-1, could affect vesicular trafficking, exocytosis and secretion in peripheral cells of CHM patients. Methodology/Principal Findings: To evaluate this hypothesis, intracellular vesicle transport, lysosomal acidification and rates of proteolytic degradation were studied in monocytes (CD14+ fraction) and primary skin fibroblasts from the nine age-matched controls and thirteen CHM patients carrying 10 different loss-of-function mutations. With the use of pHrodo (TM) BioParticles (R) conjugated with E. coli, collagen I coated FluoSpheres beads and fluorescent DQ (TM) ovalbumin with BODYPY FL dye, we demonstrated for the first time that lysosomal pH was increased in monocytes of CHM patients and, as a consequence, the rates of proteolytic degradation were slowed. Microarray analysis of gene expression revealed that some genes involved in the immune response, small GTPase regulation, transcription, cell adhesion and the regulation of exocytosis were significantly up and down regulated in cells from CHM patients compared to controls. Finally, CHM fibroblasts secreted significantly lower levels of cytokine/growth factors such as macrophage chemoattractant protein-1 (MCP-1), pigment epithelial derived factor (PEDF), tumor necrosis factor (TNF) alpha, fibroblast growth factor (FGF) beta and interleukin (IL)-8. Conclusions/Significance: We demonstrated for the first time that peripheral cells of CHM patients had increased pH levels in lysosomes, reduced rates of proteolytic degradation and altered secretion of cytokines. Peripheral cells from CHM patients expose characteristics that were not previously recognized and could used as an alternative models to study the effects of different mutations in the REP-1 gene on mechanism of CHM development in human population.	[Strunnikova, Natalia V.; Sergeev, Yuri V.; Thiagarajasubramanian, Ashwin] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Barb, Jennifer; Munson, Peter J.] NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bethesda, MD 20892 USA; [Silvin, Christopher] NIH, Genet & Mol Biol Branch, NHGRI, Bethesda, MD 20892 USA; [MacDonald, Ian M.] Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Alberta	Strunnikova, NV (corresponding author), NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA.	Strunnikovan@nei.nih.gov		Barb, Jennifer/0000-0003-3022-0154; MacDonald, Ian/0000-0001-7472-8385	National Institutes of Health (NIH); CENTER FOR INFORMATION TECHNOLOGY [ZIACT000266] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000476] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the Intramural NIH research program. The sponsor had no role in the design, data analysis, interpretation, or writing of the report. The manuscript was reviewed and cleared for publication by the Division of Intramural Research, National Institutes of Health prior to submission.	ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; Alory C, 2000, J CELL BIOL, V150, P89, DOI 10.1083/jcb.150.1.89; An Y, 2003, STRUCTURE, V11, P347, DOI 10.1016/S0969-2126(03)00034-0; Andersson LIM, 2007, SCAND J IMMUNOL, V66, P52, DOI 10.1111/j.1365-3083.2007.01948.x; Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; BOK D, 1993, J CELL SCI, P189; Bonilha VL, 2008, OPHTHALMIC GENET, V29, P99, DOI 10.1080/13816810802206499; Brignull HR, 2007, ADV EXP MED BIOL, V594, P167; Chen H, 2009, INVEST OPHTH VIS SCI, V50, P1895, DOI 10.1167/iovs.08-2850; Corbeel L, 2008, EUR J PEDIATR, V167, P723, DOI 10.1007/s00431-008-0740-z; CREMERS FPM, 1990, HUM GENET, V86, P61, DOI 10.1007/BF00205174; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; Fukuda M, 2006, BIOCHEM SOC T, V34, P691, DOI 10.1042/BST0340691; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; GORDIYENKO NV, 2009, INVEST OPHTHALMOL VI; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Izumi T, 2003, CELL STRUCT FUNCT, V28, P465, DOI 10.1247/csf.28.465; Izumi T, 2007, ENDOCR J, V54, P649, DOI 10.1507/endocrj.KR-78; Kaemmerer E, 2007, INVEST OPHTH VIS SCI, V48, P1342, DOI 10.1167/iovs.06-0549; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Krock BL, 2007, P NATL ACAD SCI USA, V104, P4600, DOI 10.1073/pnas.0605818104; Larijani B, 2003, J BIOL CHEM, V278, P46798, DOI 10.1074/jbc.M307799200; LEE C, 1991, J MOL BIOL, V217, P373, DOI 10.1016/0022-2836(91)90550-P; Liu J, 2008, INVEST OPHTH VIS SCI, V49, P772, DOI 10.1167/iovs.07-0675; MacDonald IM, 2009, SURV OPHTHALMOL, V54, P401, DOI 10.1016/j.survophthal.2009.02.008; MacDonald IM, 2004, EXPERT REV MOL DIAGN, V4, P478, DOI 10.1586/14737159.4.4.478; MacDonald IM, 1998, OPHTHALMOLOGY, V105, P1637, DOI 10.1016/S0161-6420(98)99031-5; Mahon GJ, 2004, CURR EYE RES, V28, P277, DOI 10.1076/ceyr.28.4.277.27835; MARMOR M F, 1975, International Ophthalmology Clinics, V15, P115, DOI 10.1097/00004397-197501510-00010; McTaggart KE, 2002, HUM MUTAT, V20, P189, DOI 10.1002/humu.10114; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; Nabavi N, 2008, J BIOL CHEM, V283, P19678, DOI 10.1074/jbc.M802517200; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pawliczak R, 2005, PHYSIOL GENOMICS, V23, P28, DOI 10.1152/physiolgenomics.00011.2005; Pereira-Leal JB, 2001, FEBS LETT, V498, P197, DOI 10.1016/S0014-5793(01)02483-8; Peters S, 2006, OPHTHAL RES, V38, P83, DOI 10.1159/000090268; Preising Markus, 2004, Ophthalmic Genet, V25, P101, DOI 10.1080/13816810490514333; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; RODRIGUES MM, 1984, OPHTHALMOLOGY, V91, P873; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Sergeev YV, 2009, MUTAT RES-FUND MOL M, V665, P44, DOI 10.1016/j.mrfmmm.2009.02.015; Shi W, 2004, DEV BIOL, V272, P53, DOI 10.1016/j.ydbio.2004.04.016; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sundelin SP, 2002, APMIS, V110, P481, DOI 10.1034/j.1600-0463.2002.100606.x; Talwar S, 2006, PHYSIOL GENOMICS, V25, P203, DOI 10.1152/physiolgenomics.00192.2005; Tanaka D, 2008, GENES CELLS, V13, P1141, DOI 10.1111/j.1365-2443.2008.01232.x; Tolmachova T, 2006, J CLIN INVEST, V116, P386, DOI 10.1172/JCI26617; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; vandenHurk JAJM, 1997, HUM MUTAT, V9, P110, DOI 10.1002/(SICI)1098-1004(1997)9:2<110::AID-HUMU2>3.3.CO;2-9; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; Wang AL, 2009, AUTOPHAGY, V5, P563, DOI 10.4161/auto.5.4.8163; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Zarbin MA, 2008, AM J OPHTHALMOL, V146, P151, DOI 10.1016/j.ajo.2008.05.027	61	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8402	10.1371/journal.pone.0008402	http://dx.doi.org/10.1371/journal.pone.0008402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027300	Green Published, gold, Green Submitted			2022-12-25	WOS:000272998000009
J	Rawlinson, SCF; Mckay, IJ; Ghuman, M; Wellmann, C; Ryan, P; Prajaneh, S; Zaman, G; Hughes, FJ; Kingsmill, VJ				Rawlinson, Simon C. F.; Mckay, Ian J.; Ghuman, Mandeep; Wellmann, Claudia; Ryan, Paul; Prajaneh, Saengsome; Zaman, Gul; Hughes, Francis J.; Kingsmill, Virginia J.			Adult Rat Bones Maintain Distinct Regionalized Expression of Markers Associated with Their Development	PLOS ONE			English	Article							SPINAL-CORD-INJURY; GENE-EXPRESSION; MINERAL DENSITY; OSTEOCYTE DENSITY; ENDOCHONDRAL BONE; MECHANICAL STRAIN; EMBRYONIC ORIGIN; EARLY RESPONSES; CALVARIAL BONE; LONG-BONE	The incidence of limb bone fracture and subsequent morbidity and mortality due to excessive bone loss is increasing in the progressively ageing populations of both men and women. In contrast to bone loss in the weight-bearing limb, bone mass in the protective skull vault is maintained. One explanation for this could be anatomically diverse bone matrix characteristics generated by heterogeneous osteoblast populations. We have tested the hypothesis that adult bones demonstrate site-specific characteristics, and report differences at the organ, cell and transcriptome levels. Limb bones contain greater amounts of polysulphated glycosaminoglycan stained with Alcian Blue and have significantly higher osteocyte densities than skull bone. Site-specific patterns persist in cultured adult bone-derived cells both phenotypically (proliferation rate, response to estrogen and cell volumes), and at the level of specific gene expression (collagen triple helix repeat containing 1, reelin and ras-like and estrogen-regulated growth inhibitor). Based on genome-wide mRNA expression and cluster analysis, we demonstrate that bones and cultured adult bone-derived cells segregate according to site of derivation. We also find the differential expression of genes associated with embryological development (Skull: Zic, Dlx, Irx, Twist1 and Cart1; Limb: Hox, Shox2, and Tbx genes) in both adult bones and isolated adult bone-derived cells. Together, these site-specific differences support the view that, analogous to different muscle types (cardiac, smooth and skeletal), skull and limb bones represent separate classes of bone. We assign these differences, not to mode of primary ossification, but to the embryological cell lineage; the basis and implications of this division are discussed.	[Rawlinson, Simon C. F.; Mckay, Ian J.; Wellmann, Claudia; Ryan, Paul; Kingsmill, Virginia J.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England; [Ghuman, Mandeep; Prajaneh, Saengsome; Hughes, Francis J.] Kings Coll London, Guys Hosp, Inst Dent, London WC2R 2LS, England; [Zaman, Gul] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England	University of London; Queen Mary University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University of London Royal Veterinary College	Rawlinson, SCF (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England.	s.c.f.rawlinson@qmul.ac.uk		Rawlinson, Simon/0000-0003-2367-7391; Ghuman, Mandeep/0000-0001-8927-0741; Hughes, Francis/0000-0001-9073-8962; Ryan, Paul/0000-0002-7091-9974	NIHR Clinician Scientist Fellowship; MRC Clinical Research Training Fellow; MRC [G0601408] Funding Source: UKRI; Medical Research Council [G0601408] Funding Source: researchfish	NIHR Clinician Scientist Fellowship; MRC Clinical Research Training Fellow(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a NIHR Clinician Scientist Fellowship awarded to VJK. MG is a MRC Clinical Research Training Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2004, AM J MED GENET B, V127B, P51, DOI 10.1002/ajmg.b.20142; Abzhanov A, 2007, DEVELOPMENT, V134, P3133, DOI 10.1242/dev.002709; Acampora D, 1999, DEVELOPMENT, V126, P3795; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bais M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005393; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Boonen S, 2007, BONE, V40, pS26, DOI 10.1016/j.bone.2007.03.003; CHAYEN J, 1973, PRACTICAL HISTOCHEMI; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; CITARDI MJ, 1994, OTOLARYNG CLIN N AM, V27, P891; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Everts V, 1999, FASEB J, V13, P1219, DOI 10.1096/fasebj.13.10.1219; Everts V, 2009, BBA-MOL BASIS DIS, V1792, P757, DOI 10.1016/j.bbadis.2009.05.004; FINKELMAN RD, 1994, PLAST RECONSTR SURG, V93, P732; Finlin BS, 2001, J BIOL CHEM, V276, P42259, DOI 10.1074/jbc.M105888200; GARLAND DE, 1992, J ORTHOPAED RES, V10, P371, DOI 10.1002/jor.1100100309; Gersch RP, 2005, J ORTHOP RES, V23, P882, DOI 10.1016/j.orthres.2005.02.005; GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K; HARDESTY RA, 1990, PLAST RECONSTR SURG, V85, P5, DOI 10.1097/00006534-199001000-00002; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Hatton DC, 2002, J APPL PHYSIOL, V92, P3, DOI 10.1152/jappl.2002.92.1.3; Hillam R, 1996, BONE, V19, P686, DOI DOI 10.1016/S8756-3282(97)84305-0; Huang LF, 1997, DEV DYNAM, V210, P33, DOI 10.1002/(SICI)1097-0177(199709)210:1<33::AID-AJA4>3.0.CO;2-2; Jansen I.D., 2009, FASEB J; Kimura H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003174; Kingsmill VJ, 1999, OSTEOPOROSIS INT, V9, P260, DOI 10.1007/s001980050146; LANYON LE, 1984, CALCIFIED TISSUE INT, V36, pS56, DOI 10.1007/BF02406134; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; LANYON LE, 1993, CALCIF TISSUE INT S1, V53, pS106; LeClair R, 2007, TRENDS CARDIOVAS MED, V17, P202, DOI 10.1016/j.tcm.2007.05.004; Lee JY, 2006, MOL CELLS, V22, P182; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; Li QY, 1997, NAT GENET, V15, P21; Ma YL, 2008, J BIOMECH, V41, P1324, DOI 10.1016/j.jbiomech.2008.01.017; Maimoun L, 2002, METABOLISM, V51, P958, DOI [10.1053/meta.2002.34013, 10.1053/meta2002.34013]; MANI P, 2009, DEV DYNAM, DOI DOI 10.1002/DVDY.22072; Mason D. J., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P406; Mason DJ, 1997, BONE, V20, P199, DOI 10.1016/S8756-3282(96)00386-9; McGonnell IM, 2001, DEV BIOL, V236, P354, DOI 10.1006/dbio.2001.0330; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Osborn MJ, 1998, BON PHYSL STRAT RES, P80; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Pitsillides AA, 1995, FASEB J, V9, P1614, DOI 10.1096/fasebj.9.15.8529841; Power J, 2002, BONE, V30, P859, DOI 10.1016/S8756-3282(02)00731-7; RAGO R, 1990, ANAL BIOCHEM, V191, P31; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; RAWLINSON SCF, 1995, J BONE MINER RES, V10, P1225; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; RUBIN CT, 1982, J EXP BIOL, V101, P187; Schrauwen I, 2009, AM J HUM GENET, V84, P328, DOI 10.1016/j.ajhg.2009.01.023; SCOTT CK, 1991, CALCIFIED TISSUE INT, V49, P349, DOI 10.1007/BF02556258; Skerry TM, 1999, J BONE MINER METAB, V17, P66, DOI 10.1007/s007740050067; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Turner AS, 1997, CALCIFIED TISSUE INT, V61, P110, DOI 10.1007/s002239900305; TURNER CH, 1991, BONE, V12, P203, DOI 10.1016/8756-3282(91)90043-I; Turner CH, 2002, CALCIFIED TISSUE INT, V70, P435, DOI 10.1007/s00223-001-1024-z; van den Bos T, 2008, BONE, V43, P459, DOI 10.1016/j.bone.2008.05.009; Vatsa A, 2008, BONE, V43, P452, DOI 10.1016/j.bone.2008.01.030; VICO L, 1995, J APPL PHYSIOL, V79, P1426, DOI 10.1152/jappl.1995.79.5.1426; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zhao CY, 2009, ENDOCRINE, V36, P224, DOI 10.1007/s12020-009-9233-8; ZHAO GQ, 1993, P NATL ACAD SCI USA, V90, P8633, DOI 10.1073/pnas.90.18.8633; Zhao Q, 1996, NAT GENET, V13, P275, DOI 10.1038/ng0796-275; ZINS JE, 1983, PLAST RECONSTR SURG, V72, P778, DOI 10.1097/00006534-198312000-00005	71	50	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8358	10.1371/journal.pone.0008358	http://dx.doi.org/10.1371/journal.pone.0008358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027296	Green Published, Green Submitted, gold			2022-12-25	WOS:000272940100006
J	Thomas, BE; Dewan, PK; Vijay, S; Thomas, A; Chauhan, LS; Vedachalam, C; Vaidyanathan, P; Swaminathan, S				Thomas, Beena E.; Dewan, Puneet K.; Vijay, Sophia; Thomas, Aleyamma; Chauhan, Lakhdir Singh; Vedachalam, Chandrasekaran; Vaidyanathan, Preetish; Swaminathan, Soumya			Perceptions of Tuberculosis Patients on Provider-Initiated HIV Testing and Counseling - A Study from South India	PLOS ONE			English	Article							ROUTINE; MORTALITY; ADULTS; RISK	Background: The acceptability and feasibility of provider-initiated HIV testing and counseling (PITC) in many settings across Asia with concentrated HIV epidemics is not known. A pilot study of the PITC policy undertaken within the public health care systems in two districts in India offered the opportunity to understand patient's perspectives on the process of referral for HIV testing and linking to HIV treatment and care. Methods: We conducted a cross-sectional study of randomly selected TB patients registered by the TB control program between July and November 2007 in two districts in south India. Trained interviewers met patients shortly after TB diagnosis and administered a structured questionnaire. Patients were assessed regarding their experience with HIV status assessment, referral for counseling and testing, and for HIV-infected patients the counseling itself and subsequent referral for HIV treatment and care. Results: Of the 568 interviewed TB patients, 455 (80%) reported being referred for HIV testing after they presented to the health facility for investigations or treatment for TB. Over half the respondents reported having to travel long distances and incurred financial difficulties in reaching the Integrated Counselling and Testing Centre (ICTC) and two-thirds had to make more than two visits. Only 48% reported having been counseled before the test. Of the 110 HIV-infected patients interviewed, (including 43 with previously-known positive HIV status and 67 detected by PITC), 89 (81%) reported being referred for anti-retroviral treatment (ART); 82 patients reached the ART centre but only 44 had been initiated on ART. Conclusions: This study provides the first evidence from India that routine, provider-initiated voluntary HIV testing of TB patients is acceptable, feasible and can be achieved with very high efficiency under programmatic conditions. While PITC is useful in identifying new HIV-infected patients so that they can be successfully linked to ART, the convenience and proximity of testing centres, quality of HIV counseling, and efficiency of ART services need attention.	[Thomas, Beena E.; Thomas, Aleyamma; Vedachalam, Chandrasekaran; Swaminathan, Soumya] TB Res Ctr, Madras, Tamil Nadu, India; [Dewan, Puneet K.] Reg Off SE Asia, WHO, New Delhi, India; [Vijay, Sophia; Vaidyanathan, Preetish] Natl TB Inst, Bangalore, Karnataka, India; [Chauhan, Lakhdir Singh] Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization	Thomas, BE (corresponding author), TB Res Ctr, Madras, Tamil Nadu, India.	beenaelli@hotmail.com			Central Tuberculosis Division, Ministry of Health, Government of India	Central Tuberculosis Division, Ministry of Health, Government of India	This study was funded by the Central Tuberculosis Division, Ministry of Health, Government of India. http://www.tbcindia.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckwith CG, 2005, CLIN INFECT DIS, V40, P1037, DOI 10.1086/428620; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Corbett EL, 2002, LANCET, V359, P2177, DOI 10.1016/S0140-6736(02)09095-5; DEGU J, 2007, BMC INT HEALTH HUM R, V7, P4; Frieden TR, 2005, NEW ENGL J MED, V353, P2397, DOI 10.1056/NEJMsb053133; Gasana M, 2008, INT J TUBERC LUNG D, V12, pS39; Girardi E, 2000, AIDS, V14, pS47; Harries AD, 2004, INT J TUBERC LUNG D, V8, P384; *JOINT UN PROGR HI, 2002, UNAIDS CAS STUD; *KAIS FAM FDN, 2006, KAIS FAM FND SURV AM; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lopez-Quintero C, 2005, AIDS PATIENT CARE ST, V19, P672, DOI 10.1089/apc.2005.19.672; Mimiaga MJ, 2007, SEX TRANSM DIS, V34, P113, DOI 10.1097/01.olq.0000225327.13214.bf; Mugisha B, 2006, INT J TUBERC LUNG D, V10, P761; *NACO, 2007, EST HIV INF IND; Nateniyom S, 2008, INT J TUBERC LUNG D, V12, P955; SOPHIA V, 2009, PROVIDER INITI UNPUB; Thomas BE, 2007, INT J TUBERC LUNG D, V11, P1296; Wandwalo Eliud, 2004, Afr Health Sci, V4, P109; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; *WHO, 2004, WHOHTMTB2004342; *WHO UNAIDS, 2004, UNAIDS WHO POL STAT; World Health Organization (WHO), 2003, RIGHT KNOW NEW APPR; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015; Zachariah R, 2004, INT J TUBERC LUNG D, V8, P1058	25	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8389	10.1371/journal.pone.0008389	http://dx.doi.org/10.1371/journal.pone.0008389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20041167	Green Published, Green Accepted, gold			2022-12-25	WOS:000272940100022
J	Wang, Y; Zhang, GP; Zhou, HW; Barakat, A; Querfurth, H				Wang, Yun; Zhang, Guangping; Zhou, Hongwei; Barakat, Amey; Querfurth, Henry			Opposite Effects of Low and High Doses of A beta 42 on Electrical Network and Neuronal Excitability in the Rat Prefrontal Cortex	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; CA1 PYRAMIDAL NEURONS; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; PRECURSOR PROTEIN; FREQUENCY OSCILLATIONS; INTERSTITIAL FLUID; MEMORY; PEPTIDE; SYNCHRONIZATION	Changes in neuronal synchronization have been found in patients and animal models of Alzheimer's disease (AD). Synchronized behaviors within neuronal networks are important to such complex cognitive processes as working memory. The mechanisms behind these changes are not understood but may involve the action of soluble beta-amyloid (A beta) on electrical networks. In order to determine if A beta can induce changes in neuronal synchronization, the activities of pyramidal neurons were recorded in rat prefrontal cortical (PFC) slices under calcium-free conditions using multi-neuron patch clamp technique. Electrical network activities and synchronization among neurons were significantly inhibited by low dose A beta 42 (1 nM) and initially by high dose A beta 42 (500 nM). However, prolonged application of high dose A beta 42 resulted in network activation and tonic firing. Underlying these observations, we discovered that prolonged application of low and high doses of A beta 42 induced opposite changes in action potential (AP)-threshold and after-hyperpolarization (AHP) of neurons. Accordingly, low dose A beta 42 significantly increased the AP-threshold and deepened the AHP, making neurons less excitable. In contrast, high dose A beta 42 significantly reduced the AP-threshold and shallowed the AHP, making neurons more excitable. These results support a model that low dose A beta 42 released into the interstitium has a physiologic feedback role to dampen electrical network activity by reducing neuronal excitability. Higher concentrations of A beta 42 over time promote supra-synchronization between individual neurons by increasing their excitability. The latter may disrupt frontal-based cognitive processing and in some cases lead to epileptiform discharges.	[Wang, Yun; Zhang, Guangping; Zhou, Hongwei; Barakat, Amey; Querfurth, Henry] Tufts Med Sch, Caritas St Elizabeths Med Ctr, Boston, MA USA	St. Elizabeth's Medical Center; Tufts Medical Center; Tufts University	Wang, Y (corresponding author), Tufts Med Sch, Caritas St Elizabeths Med Ctr, Boston, MA USA.	yun.wang@tufts.edu	Zhang, Guang-Ping/T-2664-2019; Zhang, Guang-Ping/C-8300-2011	Zhang, Guang-Ping/0000-0002-1620-0221; Zhang, Guang-Ping/0000-0002-1620-0221	Caritas St. Elizabeth's Medical Center	Caritas St. Elizabeth's Medical Center	This study was supported by the starting grant from Caritas St. Elizabeth's Medical Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZLEEFMANS FJ, 1979, J PHYSIOL-LONDON, V294, P387, DOI 10.1113/jphysiol.1979.sp012936; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Good TA, 1996, P NATL ACAD SCI USA, V93, P15130, DOI 10.1073/pnas.93.26.15130; HAAS HL, 1984, J PHYSIOL-LONDON, V354, P185, DOI 10.1113/jphysiol.1984.sp015371; Hestrin S, 2005, TRENDS NEUROSCI, V28, P304, DOI 10.1016/j.tins.2005.04.001; Hormuzdi SG, 2004, BBA-BIOMEMBRANES, V1662, P113, DOI 10.1016/j.bbamem.2003.10.023; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Yun SH, 2006, NEUROSCI LETT, V403, P162, DOI 10.1016/j.neulet.2006.04.065; Jedlicka P, 2006, PHYSIOL RES, V55, P139, DOI 10.33549/physiolres.930764; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; Jin Hong-wei, 2002, Yaoxue Xuebao, V37, P598; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Klyubin I, 2004, EUR J NEUROSCI, V19, P2839, DOI 10.1111/j.1460-9568.2004.03389.x; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lima PA, 2007, BRAIN RES, V1150, P74, DOI 10.1016/j.brainres.2007.02.067; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mercer A, 2006, BRAIN CELL BIOL, V35, P13, DOI 10.1007/s11068-006-9005-9; MILLER C, 2000, GENOME BIOL, V1, P4; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Missonnier P, 2006, DEMENT GERIATR COGN, V22, P250, DOI 10.1159/000094974; MORRIS RG, 1988, J CLIN EXP NEUROPSYC, V10, P279, DOI 10.1080/01688638808408242; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Pijnenburg YAL, 2004, CLIN NEUROPHYSIOL, V115, P1332, DOI 10.1016/j.clinph.2003.12.029; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Reid W, 1996, ARCH NEUROL-CHICAGO, V53, P1056, DOI 10.1001/archneur.1996.00550100142023; ROMANELLI MF, 1990, ARCH NEUROL-CHICAGO, V47, P847, DOI 10.1001/archneur.1990.00530080029006; Rowan MJ, 2004, EXP GERONTOL, V39, P1661, DOI 10.1016/j.exger.2004.06.020; Rowan MJ, 2003, PHILOS T R SOC B, V358, P821, DOI 10.1098/rstb.2002.1240; Sakurai Y, 2006, J NEUROSCI, V26, P10141, DOI 10.1523/JNEUROSCI.2423-06.2006; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; TRAUB RD, 1985, NEUROSCIENCE, V14, P1033, DOI 10.1016/0306-4522(85)90274-X; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Wang Y, 2004, P NATL ACAD SCI USA, V101, P5093, DOI 10.1073/pnas.0400954101; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; WANG Y, 2009, FRONTIERS N IN PRESS; Yu SP, 1998, NEUROBIOL DIS, V5, P81, DOI 10.1006/nbdi.1998.0186; Zhuo JM, 2008, CURR ALZHEIMER RES, V5, P385, DOI 10.2174/156720508785132280; Zoghbi HY, 2000, CURR OPIN NEUROBIOL, V10, P655, DOI 10.1016/S0959-4388(00)00135-5	63	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8366	10.1371/journal.pone.0008366	http://dx.doi.org/10.1371/journal.pone.0008366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027222	Green Published, Green Submitted, gold			2022-12-25	WOS:000272940100012
J	Zhang, ZY; Liew, CW; Handy, DE; Zhang, YY; Leopold, JA; Hu, J; Guo, LL; Kulkarni, RN; Loscalzo, J; Stanton, RC				Zhang, Zhaoyun; Liew, Chong Wee; Handy, Diane E.; Zhang, Yingyi; Leopold, Jane A.; Hu, Ji; Guo, Lili; Kulkarni, Rohit N.; Loscalzo, Joseph; Stanton, Robert C.			High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis	FASEB JOURNAL			English	Article						diabetes mellitus; islets; antioxidants; pentose phosphate pathway	ENZYME GENE-EXPRESSION; GLUTATHIONE-PEROXIDASE; PANCREATIC-ISLETS; INSULIN-RELEASE; OXIDANT STRESS; IN-VITRO; TOXICITY; 6-AMINONICOTINAMIDE; PROTECTION; MECHANISM	Patients with type 2 diabetes lose beta cells, but the underlying mechanisms are incompletely understood. Glucose-6-phosphate dehydrogenase (G6PD) is the principal source of the major intracellular reductant, NADPH, which is required by many enzymes, including enzymes of the antioxidant pathway. Previous work from our laboratory has shown that high glucose impairs G6PD activity in endothelial and kidney cells, which leads to decreased cell survival. Pancreatic beta cells are highly sensitive to increased ROS. This study aimed to determine whether G6PD and NADPH play central roles in beta-cell survival. Human and mouse islets, MIN6 cell line, and G6PD deficient mice were studied. High glucose inhibited G6PD expression and activity. Inhibition of G6PD with siRNA led to increased ROS and apoptosis, decreased proliferation, and impaired insulin secretion. High glucose decreased insulin secretion, which was improved by overexpressing G6PD. G6PD-deficient mice had smaller islets and impaired glucose tolerance compared with control mice, which suggests that G6PD deficiency per se leads to beta-cell dysfunction and death. G6PD plays an important role in beta-cell function and survival. High-glucose-mediated decrease in G6PD activity may provide a mechanistic explanation for the gradual loss of beta cells in patients with diabetes.-Zhang, Z., Liew, C. W., Handy, D. E., Zhang, Y., Leopold, J. A., Hu, J., Guo, L., Kulkarni, R. N., Loscalzo, J., Stanton, R. C. High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis. FASEB J. 24, 1497-1505 (2010). www.fasebj.org	[Zhang, Zhaoyun; Liew, Chong Wee; Hu, Ji; Guo, Lili; Kulkarni, Rohit N.; Stanton, Robert C.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA; [Handy, Diane E.; Zhang, Yingyi; Leopold, Jane A.; Loscalzo, Joseph] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02115 USA; [Zhang, Zhaoyun] Huashan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Fudan University	Stanton, RC (corresponding author), Joslin Diabet Ctr, Div Renal, 1 Joslin Pl, Boston, MA 02215 USA.	robert.stanton@joslin.harvard.edu	Loscalzo, Joseph/ABD-8980-2021; Stanton, Robert C/AAG-7584-2020	Stanton, Robert C/0000-0002-3056-1277; Handy, Diane/0000-0002-4310-8527; Liew, Chong Wee/0000-0001-9904-0958	U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01-DK54380]; NIH/National Heart, Lung, and Blood Institute (NHLBI) [HL 61795, N01 HV 28178, P01 HL 81857, U54 HL 070819, HL 089734]; NIH [RO1 DK 68721, RO1 DK 67536, T32DK007260]; Diabetes Endocrinology Research Center (DERC) [P30DK036836]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061795, R01HL081857, P01HL081587, R21HL089734, U54HL070819, R37HL061795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK068721, R01DK054380, R01DK067536, T32DK007260] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center (DERC); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dan Kawamori, Xiaodan Wang, Wan-Chun Li, Jiang Hu, and Hui Li for technical assistance. This work was supported by U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01-DK54380 to R.C.S.; NIH/National Heart, Lung, and Blood Institute (NHLBI) grants HL 61795, N01 HV 28178, P01 HL 81857, and U54 HL 070819 to J.A.L.; and NIH/NHLBI grant HL 089734 to D.E.H. with Jacob Joseph (Brigham and Women's Hospital, Boston, MA, USA). R.N.K. was supported by NIH grants RO1 DK 68721 and RO1 DK 67536; and C.L.W. is supported by NIH training grant T32DK007260. The Joslin Core Facilities were used for islet isolation and other measurements, which are funded by Diabetes Endocrinology Research Center (DERC) grant P30DK036836. The authors declare no conflicts of interests.	AMMON HPT, 1972, DIABETES, V21, P143, DOI 10.2337/diab.21.3.143; AMMON HPT, 1972, ENDOCRINOLOGY, V91, P33, DOI 10.1210/endo-91-1-33; AMMON HPT, 1973, BIOCHIM BIOPHYS ACTA, V297, P352, DOI 10.1016/0304-4165(73)90083-4; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Benhamou PY, 1998, DIABETOLOGIA, V41, P1093, DOI 10.1007/s001250051035; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Diaz-Flores M, 2006, LIFE SCI, V78, P2601, DOI 10.1016/j.lfs.2005.10.022; Eisenbarth GS, 2007, J CLIN ENDOCR METAB, V92, P2403, DOI 10.1210/jc.2007-0339; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Gupte RS, 2007, J CARD FAIL, V13, P497, DOI 10.1016/j.cardfail.2007.04.003; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; Iatropoulos MJ, 1996, EXP TOXICOL PATHOL, V48, P175, DOI 10.1016/S0940-2993(96)80039-X; Jain M, 2003, CIRC RES, V93, pE9, DOI 10.1161/01.RES.0000083489.83704.76; Kirkman HN, 1999, J BIOL CHEM, V274, P13908, DOI 10.1074/jbc.274.20.13908; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Leopold JA, 2003, J BIOL CHEM, V278, P32100, DOI 10.1074/jbc.M301293200; Leopold JA, 2003, ARTERIOSCL THROM VAS, V23, P411, DOI 10.1161/01.ATV.0000056744.26901.BA; Lupi R, 2008, DIABETES METAB, V34, pS56, DOI 10.1016/S1262-3636(08)73396-2; Marchetti P, 2004, J CLIN ENDOCR METAB, V89, P5535, DOI 10.1210/jc.2004-0150; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Martini G, 1996, BIOESSAYS, V18, P631, DOI 10.1002/bies.950180806; Matsui R, 2006, ARTERIOSCL THROM VAS, V26, P910, DOI 10.1161/01.ATV.0000205850.49390.3b; Mazumder Suparna, 2008, V414, P13; Moriscot C, 2003, DIABETES METAB, V29, P145, DOI 10.1016/S1262-3636(07)70021-6; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Park J, 2006, DIABETES, V55, P2939, DOI 10.2337/db05-1570; PRETSCH W, 1988, BIOCHEM GENET, V26, P89, DOI 10.1007/BF00555491; Qiu LH, 2005, MOL CELL PROTEOMICS, V4, P1311, DOI 10.1074/mcp.M500016-MCP200; Robertson RP, 2007, CELL BIOCHEM BIOPHYS, V48, P139, DOI 10.1007/s12013-007-0026-5; Robertson RP, 2007, FEBS LETT, V581, P3743, DOI 10.1016/j.febslet.2007.03.087; Robertson RP, 2005, ANN NY ACAD SCI, V1043, P513, DOI 10.1196/annals.1333.058; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Salvemini F, 1999, J BIOL CHEM, V274, P2750, DOI 10.1074/jbc.274.5.2750; Sanders S, 1997, MUTAT RES-FUND MOL M, V374, P79, DOI 10.1016/S0027-5107(96)00222-9; Starborg M, 1996, J CELL SCI, V109, P143; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Tian WN, 1999, AM J PHYSIOL-CELL PH, V276, pC1121, DOI 10.1152/ajpcell.1999.276.5.C1121; TIAN WN, 1994, J BIOL CHEM, V269, P14798; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tiedge M, 1998, DIABETES, V47, P1578, DOI 10.2337/diabetes.47.10.1578; Ursini MV, 1997, BIOCHEM J, V323, P801, DOI 10.1042/bj3230801; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Xu YZ, 2005, AM J PHYSIOL-RENAL, V289, pF1040, DOI 10.1152/ajprenal.00076.2005; Zhang ZQ, 2000, J BIOL CHEM, V275, P40042, DOI 10.1074/jbc.M007505200	50	150	162	1	31	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1497	1505		10.1096/fj.09-136572	http://dx.doi.org/10.1096/fj.09-136572			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20032314	Green Published			2022-12-25	WOS:000277158900022
J	Won, EY; Cha, K; Byun, JS; Kim, DU; Shin, S; Ahn, B; Kim, YH; Rice, AJ; Walz, T; Kwon, BS; Cho, HS				Won, Eun-Young; Cha, Kiweon; Byun, Jung-Sue; Kim, Dong-Uk; Shin, Sumi; Ahn, Byungchan; Kim, Young Ho; Rice, Amanda J.; Walz, Thomas; Kwon, Byoung S.; Cho, Hyun-Soo			The Structure of the Trimer of Human 4-1BB Ligand Is Unique among Members of the Tumor Necrosis Factor Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CELL-ACTIVATION; TNF; STIMULATION; RECOGNITION; RESOLUTION; SOFTWARE; COMPLEX; FAMILY; DOMAIN	Binding of the 4-1BB ligand (4-1BBL) to its receptor, 4-1BB, provides the T lymphocyte with co-stimulatory signals for survival, proliferation, and differentiation. Importantly, the 4-1BB4-1BBL pathway is a well known target for anti-cancer immunotherapy. Here we present the 2.3-A crystal structure of the extracellular domain of human 4-1BBL. The ectodomain forms a homotrimer with an extended, three-bladed propeller structure that differs from trimers formed by other members of the tumor necrosis factor (TNF) superfamily. Based on the 4-1BBL structure, we modeled its complex with 4-1BB, which was consistent with images obtained by electron microscopy, and verified the binding site by site-directed mutagenesis. This structural information will facilitate the development of immunotherapeutics targeting 4-1BB.	[Shin, Sumi; Kim, Young Ho; Kwon, Byoung S.] Natl Canc Ctr, Div Cell & Immunobiol, Goyang 410769, Gyonggi Do, South Korea; [Shin, Sumi; Kim, Young Ho; Kwon, Byoung S.] Natl Canc Ctr, R&D Ctr Canc Therapeut, Goyang 410769, Gyonggi Do, South Korea; [Won, Eun-Young; Byun, Jung-Sue; Kim, Dong-Uk; Cho, Hyun-Soo] Yonsei Univ, Dept Biol, Seoul 120749, South Korea; [Cha, Kiweon; Cho, Hyun-Soo] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu 70042, South Korea; [Ahn, Byungchan] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Rice, Amanda J.; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Yonsei University; Kyungpook National University; University of Ulsan; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Kwon, BS (corresponding author), Natl Canc Ctr, Div Cell & Immunobiol, Goyang 410769, Gyonggi Do, South Korea.	bskwon@ncc.re.kr; hscho8@yonsei.ac.kr		Walz, Thomas/0000-0003-2606-2835	National Institutes of Health [GM62580]; Korea Research Foundation [KRF-2006-005-J04502, KRF-2008-313-C00745, KRF-C00040, KRF-2005-201-E00008, KRF-2005-084E00001]; Korea Science and Engineering Foundation; Arthritis Foundation Innovative Research Award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F31ES027301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Arthritis Foundation Innovative Research Award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62580. This work was also supported by Korea Research Foundation Grants KRF-2006-005-J04502 and KRF-2008-313-C00745 (to H.-S. C.), KRF-C00040 (to K. C.), and KRF-2005-201-E00008 and KRF-2005-084E00001 (to B. S. K.); by the SRC Fund from the Korea Science and Engineering Foundation; and by the Arthritis Foundation Innovative Research Award (to B. S. K.).	Arens R, 2004, J IMMUNOL, V173, P3901, DOI 10.4049/jimmunol.173.6.3901; ARMITAGE RJ, 1994, CURR OPIN IMMUNOL, V6, P407, DOI 10.1016/0952-7915(94)90119-8; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Byun JS, 2006, ACTA CRYSTALLOGR F, V62, P23, DOI 10.1107/S1744309105039242; Cha SS, 2000, J BIOL CHEM, V275, P31171, DOI 10.1074/jbc.M004414200; Chattopadhyay K, 2007, P NATL ACAD SCI USA, V104, P19452, DOI 10.1073/pnas.0709264104; Compaan DM, 2006, STRUCTURE, V14, P1321, DOI 10.1016/j.str.2006.06.015; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Eissner G, 2004, CYTOKINE GROWTH F R, V15, P353, DOI 10.1016/j.cytogfr.2004.03.011; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GOH CR, 1991, PROTEIN ENG, V4, P785; GRUSS HJ, 1995, BLOOD, V85, P3378, DOI 10.1182/blood.V85.12.3378.bloodjournal85123378; Halstead ES, 2002, NAT IMMUNOL, V3, P536, DOI 10.1038/ni798; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; Liu YF, 2002, CELL, V108, P383, DOI 10.1016/S0092-8674(02)00631-1; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POLLOK KE, 1994, EUR J IMMUNOL, V24, P367, DOI 10.1002/eji.1830240215; POLLOK KE, 1993, J IMMUNOL, V150, P771; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Rabu C, 2005, J BIOL CHEM, V280, P41472, DOI 10.1074/jbc.M506881200; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SMITH CS, 1994, J IMMUNOL, V153, P3997; Soellner L, 2007, CELL SIGNAL, V19, P1899, DOI 10.1016/j.cellsig.2007.04.014; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; Vinay DS, 2006, J MOL MED, V84, P726, DOI 10.1007/s00109-006-0072-2; Vinay DS, 1998, SEMIN IMMUNOL, V10, P481, DOI 10.1006/smim.1998.0157; Watts AD, 1999, EMBO J, V18, P2119, DOI 10.1093/emboj/18.8.2119; YAMAGISHI J, 1990, PROTEIN ENG, V3, P713, DOI 10.1093/protein/3.8.713; Ye ZM, 2002, NAT MED, V8, P343, DOI 10.1038/nm0402-343	40	42	57	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9202	9210		10.1074/jbc.M109.084442	http://dx.doi.org/10.1074/jbc.M109.084442			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20032458	Green Published, hybrid			2022-12-25	WOS:000275553700069
J	Jiao, XM; Katiyar, S; Willmarth, NE; Liu, MR; Ma, XJ; Flomenberg, N; Lisanti, MP; Pestell, RG				Jiao, Xuanmao; Katiyar, Sanjay; Willmarth, Nicole E.; Liu, Manran; Ma, Xiaojing; Flomenberg, Neal; Lisanti, Michael P.; Pestell, Richard G.			c-Jun Induces Mammary Epithelial Cellular Invasion and Breast Cancer Stem Cell Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDEHYDE DEHYDROGENASE-ACTIVITY; CHEMOKINE RANTES; TYROSINE KINASE; TRANSGENIC MICE; EXPRESSION; METASTASIS; CARCINOMA; MIGRATION; PROGRESSION; MOTILITY	The molecular mechanisms governing breast tumor cellular self-renewal contribute to breast cancer progression and therapeutic resistance. The ErbB2 oncogene is overexpressed in similar to 30% of human breast cancers. c-Jun, the first cellular protooncogene, is overexpressed in human breast cancer. However, the role of endogenous c-Jun in mammary tumor progression is unknown. Herein, transgenic mice expressing the mammary gland-targeted ErbB2 oncogene were crossed with c-jun(f/f) transgenic mice to determine the role of endogenous c-Jun in mammary tumor invasion and stem cell function. The excision of c-jun by Cre recombinase reduced cellular migration, invasion, and mammosphere formation of ErbB2-induced mammary tumors. Proteomic analysis identified a subset of secreted proteins (stem cell factor (SCF) and CCL5) induced by ErbB2 expression that were dependent upon endogenous c-Jun expression. SCF and CCL5 were identified as transcriptionally induced by c-Jun. CCL5 rescued the c-Jun-deficient breast tumor cellular invasion phenotype. SCF rescued the c-Jun-deficient mammosphere production. Endogenous c-Jun thus contributes to ErbB2-induced mammary tumor cell invasion and self-renewal.	[Lisanti, Michael P.; Pestell, Richard G.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; [Flomenberg, Neal; Lisanti, Michael P.; Pestell, Richard G.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Oncol, Philadelphia, PA 19107 USA; [Ma, Xiaojing] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	Jefferson University; Jefferson University; Cornell University	Pestell, RG (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	richard.pestell@jefferson.edu	Lisanti, Michael/B-6131-2018; Lisanti, Michael P/C-6866-2013	Lisanti, Michael/0000-0003-2034-1382; Katiyar, Sanjay/0000-0003-1622-5661	National Institutes of Health [R01CA70896, R01CA75503, R01CA107382, R01CA120876]; Dr. Ralph and Marian C. Falk Medical Research Trust; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA120876, R01CA070896, R01CA107382, R01CA075503, R01CA100223, P30CA056036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Ralph and Marian C. Falk Medical Research Trust; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA70896, R01CA75503, and R01CA107382 (to R. G. P.) and R01CA120876 (to M. P. L.). This project was also funded in part by grants from the Dr. Ralph and Marian C. Falk Medical Research Trust and the Pennsylvania Department of Health (to R. G. P.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ali S, 2000, AM J PATHOL, V157, P313, DOI 10.1016/S0002-9440(10)64542-7; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Azenshtein E, 2002, CANCER RES, V62, P1093; Bottcher MF, 2000, PEDIATR RES, V47, P592, DOI 10.1203/00006450-200005000-00006; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; D'Amico M, 2003, CANCER RES, V63, P3395; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grange C, 2008, NEOPLASIA, V10, P1433, DOI 10.1593/neo.08902; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Hulit J, 2006, CANCER RES, V66, P8529, DOI 10.1158/0008-5472.CAN-06-0149; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jiao XM, 2008, MOL BIOL CELL, V19, P1378, DOI 10.1091/mbc.E07-08-0753; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Katiyar S, 2007, MOL CELL BIOL, V27, P1356, DOI 10.1128/MCB.01061-06; Leek RD, 1996, CANCER RES, V56, P4625; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Li ZP, 2006, CANCER RES, V66, P9986, DOI 10.1158/0008-5472.CAN-06-1596; Li ZP, 2006, MOL CELL BIOL, V26, P4240, DOI 10.1128/MCB.02124-05; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lindsay J, 2008, CTS-CLIN TRANSL SCI, V1, P107, DOI 10.1111/j.1752-8062.2008.00041.x; Liu YM, 2004, ONCOGENE, V23, P8238, DOI 10.1038/sj.onc.1207889; Luboshits G, 1999, CANCER RES, V59, P4681; Maeda S, 2003, CANCER CELL, V3, P102, DOI 10.1016/S1535-6108(03)00025-4; Matsui J, 2004, J BIOL CHEM, V279, P18600, DOI 10.1074/jbc.M311643200; Michie CA, 1998, EUR CYTOKINE NETW, V9, P123; Mrowietz U, 1999, BRIT J CANCER, V79, P1025, DOI 10.1038/sj.bjc.6690164; Negus RPM, 1997, AM J PATHOL, V150, P1723; Neumeister P, 2003, MOL BIOL CELL, V14, P2005, DOI 10.1091/mbc.02-07-0102; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; Sugimoto Y, 1999, J CELL PHYSIOL, V181, P285, DOI 10.1002/(SICI)1097-4652(199911)181:2<285::AID-JCP10>3.0.CO;2-O; Tanaka T, 2005, CANCER SCI, V96, P317, DOI 10.1111/j.1349-7006.2005.00059.x; VANNETTEN JP, 1993, LANCET, V342, P872, DOI 10.1016/0140-6736(93)92734-B; Velasco-Velazquez MA, 2009, EXPERT REV ANTICANC, V9, P275, DOI 10.1586/14737140.9.3.275; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; vonLuettichau I, 1996, CYTOKINE, V8, P89, DOI 10.1006/cyto.1996.0012; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	56	100	107	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8218	8226		10.1074/jbc.M110.100792	http://dx.doi.org/10.1074/jbc.M110.100792			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20053993	Green Published, hybrid			2022-12-25	WOS:000275413800040
J	Sato, Y; Probst, HC; Tatsumi, R; Ikeuchi, Y; Neuberger, MS; Rada, C				Sato, Yusuke; Probst, Hans Christian; Tatsumi, Ryuichi; Ikeuchi, Yoshihide; Neuberger, Michael S.; Rada, Cristina			Deficiency in APOBEC2 Leads to a Shift in Muscle Fiber Type, Diminished Body Mass, and Myopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA DEAMINASE DOMAIN; CYTIDINE DEAMINASE; SKELETAL-MUSCLE; AID/APOBEC FAMILY; CRYSTAL-STRUCTURE; PURIFICATION; RAT; AID	The apoB RNA-editing enzyme, catalytic polypeptide-like (APOBEC) family of proteins includes APOBEC1, APOBEC3, and activation-induced deaminase, all of which are zinc-dependent cytidine deaminases active on polynucleotides and involved in RNA editing or DNA mutation. In contrast, the biochemical and physiological functions of APOBEC2, a muscle-specific member of the family, are unknown, although it has been speculated, like APOBEC1, to be an RNA-editing enzyme. Here, we show that, although expressed widely in striated muscle (with levels peaking late during myoblast differentiation), APOBEC2 is preferentially associated with slow-twitch muscle, with its abundance being considerably greater in soleus compared with gastrocnemius muscle and, within soleus muscle, in slow as opposed to fast muscle fibers. Its abundance also decreases following muscle denervation. We further show that APOBEC2-deficient mice harbor a markedly increased ratio of slow to fast fibers in soleus muscle and exhibit an similar to 15-20% reduction in body mass from birth onwards, with elderly mutant animals revealing clear histological evidence of a mild myopathy. Thus, APOBEC2 is essential for normal muscle development and maintenance of fiber-type ratios; although its molecular function remains to be identified, biochemical analyses do not especially argue for any role in RNA editing.	Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Agr, Higashi Ku, Fukuoka 8128581, Japan; [Probst, Hans Christian; Neuberger, Michael S.; Rada, Cristina] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Kyushu University; MRC Laboratory Molecular Biology		ikeuchiy@agr.kyushu-u.ac.jp; msn@mrc-lmb.cam.ac.uk		PROBST, Hans Christian/0000-0002-7926-0651	Human Frontier Science Program; MRC [MC_U105178806] Funding Source: UKRI; Medical Research Council [MC_U105178806] Funding Source: researchfish	Human Frontier Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a fellowship from the Human Frontier Science Program. Present address: Inst. of Immunology, Johannes Gutenberg-Universitat Mainz, 55131 Mainz, Germany.	Agbulut O, 2009, AM J PHYSIOL-CELL PH, V296, pC205, DOI 10.1152/ajpcell.00408.2008; Anant S, 2001, AM J PHYSIOL-CELL PH, V281, pC1904, DOI 10.1152/ajpcell.2001.281.6.C1904; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Liao W, 1999, BIOCHEM BIOPH RES CO, V260, P398, DOI 10.1006/bbrc.1999.0925; MIDRIO M, 1992, PFLUG ARCH EUR J PHY, V420, P446, DOI 10.1007/BF00374618; Mikl MC, 2005, MOL CELL BIOL, V25, P7270, DOI 10.1128/MCB.25.16.7270-7277.2005; Mizunoya W, 2008, ANAL BIOCHEM, V377, P111, DOI 10.1016/j.ab.2008.02.021; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Navaratnam N, 2006, INT J HEMATOL, V83, P195, DOI 10.1532/IJH97.06032; NAVARATNAM N, 1993, P NATL ACAD SCI USA, V90, P222, DOI 10.1073/pnas.90.1.222; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; NWOYE L, 1982, AM J PHYSIOL, V242, pR401, DOI 10.1152/ajpregu.1982.242.3.R401; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Piec I, 2005, FASEB J, V19, P1143, DOI 10.1096/fj.04-3084fje; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Sato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1748, DOI 10.1271/bbb.90085; Spencer MJ, 2002, HUM MOL GENET, V11, P2645, DOI 10.1093/hmg/11.21.2645; TAKEKURA H, 1987, J MUSCLE RES CELL M, V8, P342, DOI 10.1007/BF01568890; YAFFE D, 1977, DIFFERENTIATION, V7, P159, DOI 10.1111/j.1432-0436.1977.tb01507.x	31	83	86	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7111	7118		10.1074/jbc.M109.052977	http://dx.doi.org/10.1074/jbc.M109.052977			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20022958	Green Published, hybrid			2022-12-25	WOS:000275415600024
J	Xi, G; Shen, XC; Clemmons, DR				Xi, Gang; Shen, Xinchun; Clemmons, David R.			p66(shc) Inhibits Insulin-like Growth Factor-I Signaling via Direct Binding to Src through Its Polyproline and Src Homology 2 Domains, Resulting in Impairment of Src Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; FAMILY TYROSINE KINASES; OXIDATIVE STRESS; PROTEIN-KINASE; C-SRC; ADAPTER PROTEIN; INDUCED APOPTOSIS; FACTOR RECEPTOR; BREAST-CANCER; 3T3-L1 CELLS	p66(shc) is increased in response to cell stress, and these increases regulate growth factor actions. These studies were conducted to determine how p66(shc) alters IGF-I-stimulated Src activation, leading to decreased IGF-I actions. Our results show that p66(shc) binds to Src through a polyproline sequence motif contained in the CH2 domain, a unique domain in p66(shc), and IGF-I stimulates this interaction. Disruption of this interaction using a synthetic peptide containing the p66(shc) polyproline domain or expression of a p66(shc) mutant containing substitutions for the proline residues (P47A/P48A/P50A) resulted in enhanced Src kinase activity, p52(shc) phosphorylation, MAPK activation, and cell proliferation in response to IGF-I. To determine the mechanism of inhibition, the full-length CH2 domain and intact p66(shc) were tested for their ability to directly inhibit Src kinase activation in vitro. The CH2 domain peptide was clearly inhibitory, but full-length p66(shc) had a greater effect. Deletion of the C-terminal Src homology 2 domain in p66(shc) reduced its ability to inhibit Src kinase activation. These findings demonstrate that p66(shc) utilizes a novel mechanism for modulating Src kinase activation and that this interaction is mediated through both its collagen homologous region 2 and Src homology 2 domains.	[Clemmons, David R.] Univ N Carolina, Div Endocrinol, Dept Med, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, Dept Med, Sch Med, CB 7170,5030 Burnett Womack, Chapel Hill, NC 27599 USA.	david_clemmons@med.unc.edu	Xi, Gang/C-1498-2011		National Institutes of Health [HL56850, AG02331]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG002331, R37AG002331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56850 and AG02331.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Alper O, 2005, CURR PHARM DESIGN, V11, P1119, DOI 10.2174/1381612053507576; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Boney CM, 2001, CELL GROWTH DIFFER, V12, P379; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104; Campbell M, 2005, CIRC RES, V96, P197, DOI 10.1161/01.RES.0000152966.88353.9d; Campbell M, 2003, DIABETES, V52, P519, DOI 10.2337/diabetes.52.2.519; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chen Y, 1998, GROWTH HORM IGF RES, V8, P299, DOI 10.1016/S1096-6374(98)80125-1; Chintapalli J, 2007, AM J PHYSIOL-RENAL, V292, pF523, DOI 10.1152/ajprenal.00215.2006; Chong YP, 2004, J BIOL CHEM, V279, P20752, DOI 10.1074/jbc.M309865200; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Cui QL, 2005, J BIOL CHEM, V280, P8918, DOI 10.1074/jbc.M414267200; Favetta LA, 2004, EXP CELL RES, V299, P36, DOI 10.1016/j.yexcr.2004.05.009; Favetta LA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-132; GOCKERMAN A, 1995, CIRC RES, V76, P514, DOI 10.1161/01.RES.76.4.514; Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482; Kang BPS, 2003, AM J PHYSIOL-RENAL, V284, pF455, DOI 10.1152/ajprenal.00137.2002; Knowlden JM, 2005, ENDOCRINOLOGY, V146, P4609, DOI 10.1210/en.2005-0247; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lieskovska J, 2006, J BIOL CHEM, V281, P25041, DOI 10.1074/jbc.M602866200; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Maile LA, 2007, ENDOCRINOLOGY, V148, P2435, DOI 10.1210/en.2006-1440; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miller EC, 2007, INVEST OPHTH VIS SCI, V48, P3878, DOI 10.1167/iovs.07-0014; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MURPHY SM, 1993, MOL CELL BIOL, V13, P5290, DOI 10.1128/MCB.13.9.5290; Nam TJ, 2000, ENDOCRINOLOGY, V141, P1100, DOI 10.1210/en.141.3.1100; Okada S, 1997, J BIOL CHEM, V272, P28042, DOI 10.1074/jbc.272.44.28042; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pellegrini M, 2005, APOPTOSIS, V10, P13, DOI 10.1007/s10495-005-6057-8; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Ruiz E, 2006, DIABETES, V55, P1243, DOI 10.2337/db05-0949; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Sasaoka T, 2001, ENDOCRINOLOGY, V142, P5226, DOI 10.1210/en.142.12.5226; Sato K, 1997, BIOCHEM BIOPH RES CO, V240, P399, DOI 10.1006/bbrc.1997.7667; Schulte RJ, 2003, BIOCHEMISTRY-US, V42, P9424, DOI 10.1021/bi034519u; Sekimoto H, 2005, MOL ENDOCRINOL, V19, P1859, DOI 10.1210/me.2004-0481; Shigematsu S, 1999, ENDOCR J, V46, pS59; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yang S, 2005, AM J PHYSIOL-RENAL, V289, pF1144, DOI 10.1152/ajprenal.00094.2005; Yang S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000047	54	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6937	6951		10.1074/jbc.M109.069872	http://dx.doi.org/10.1074/jbc.M109.069872			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048152	Green Published, hybrid			2022-12-25	WOS:000275415600007
J	Yu, Q; Kuzmiak, H; Olsen, L; Kulkarni, A; Fink, E; Zou, YF; Bi, X				Yu, Qun; Kuzmiak, Holly; Olsen, Lars; Kulkarni, Ajit; Fink, Emma; Zou, Yanfei; Bi, Xin			Saccharomyces cerevisiae Esc2p Interacts with Sir2p through a Small Ubiquitin-like Modifier (SUMO)-binding Motif and Regulates Transcriptionally Silent Chromatin in a Locus-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TELOMERE LENGTH REGULATION; CELL-CYCLE PROGRESSION; PROTEIN SUMOYLATION; RENT COMPLEX; YEAST; DNA; DOMAIN; RDNA; HMR; HETEROCHROMATIN	Saccharomyces cerevisiae Esc2p is a member of a conserved family of proteins that contain small ubiquitin-like modifier (SUMO)-like domains. It has been implicated in transcriptional silencing and shown to interact with the silencing protein Sir2p in a two-hybrid analysis. However, little is known about how Esc2p regulates the structure of silent chromatin. We demonstrate here that ESC2 differentially regulates silent chromatin at telomeric, rDNA, and HM loci. Specifically, ESC2 is required for efficient telomeric silencing and Sir2p association with telomeric silent chromatin and for silencing and maintenance of silent chromatin structure at rDNA. On the other hand, ESC2 negatively regulates silencing at HML and HMR and destabilizes HML silent chromatin without affecting Sir2p association with chromatin. We present evidence that Esc2p is associated with both transcriptionally silent and active loci in the genome, and the abundance of Esc2p is not correlated with the chromatin state at a particular locus. Using affinity pull-down analyses, we show that Esc2p and Sir2p interact in vivo, and recombinant Esc2p and Sir2p interact directly. Moreover, we dissect Esc2p and identify a putative SUMO-binding motif that is necessary and sufficient for interacting with Sir2p and SUMO and is required for the function of Esc2p in transcriptional silencing.	[Yu, Qun; Kuzmiak, Holly; Olsen, Lars; Kulkarni, Ajit; Fink, Emma; Zou, Yanfei; Bi, Xin] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Bi, X (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	xinbi@mail.rochester.edu			National Institutes of Health [GM62484]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62484 ( to X. B.).	Andrulis ED, 2004, GENETICS, V166, P631, DOI 10.1534/genetics.166.1.631; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Bi X, 2004, J MOL BIOL, V344, P893, DOI 10.1016/j.jmb.2004.10.002; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bi X, 1997, MOL CELL BIOL, V17, P7077, DOI 10.1128/MCB.17.12.7077; Bi X, 1999, GENE DEV, V13, P1089, DOI 10.1101/gad.13.9.1089; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; BUCK SW, 1995, GENE DEV, V9, P370, DOI 10.1101/gad.9.3.370; Cheng TH, 1998, P NATL ACAD SCI USA, V95, P5521, DOI 10.1073/pnas.95.10.5521; CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6; Chiu YH, 2003, GENETICS, V165, P115; Cuperus G, 2002, GENETICS, V162, P633; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; GINIGER E, 1987, NATURE, V330, P670, DOI 10.1038/330670a0; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hickman M, 2007, J MOL BIOL, V367, P1246, DOI 10.1016/j.jmb.2007.01.044; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; James P, 1996, GENETICS, V144, P1425; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; LAMAN H, 1995, MOL CELL BIOL, V15, P3608; Liachko I, 2005, GENETICS, V171, P503, DOI 10.1534/genetics.105.042333; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Lustig AJ, 1996, MOL CELL BIOL, V16, P2483; MAHONEY DJ, 1989, MOL CELL BIOL, V9, P4621, DOI 10.1128/MCB.9.11.4621; Mankouri HW, 2009, MOL BIOL CELL, V20, P1683, DOI 10.1091/mbc.E08-08-0877; Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Novatchkova M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-22; Ohya T, 2008, GENETICS, V180, P41, DOI 10.1534/genetics.107.086249; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Raffa GD, 2006, J BIOL CHEM, V281, P27973, DOI 10.1074/jbc.M601943200; Roy N, 2000, CURR BIOL, V10, P111, DOI 10.1016/S0960-9822(00)00298-0; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Shore D, 1997, BIOL CHEM, V378, P591; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Singer MS, 1998, GENETICS, V150, P613; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smolikov S, 2004, P NATL ACAD SCI USA, V101, P1656, DOI 10.1073/pnas.0307796100; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Xu EY, 2005, MOL CELL BIOL, V25, P1846, DOI 10.1128/MCB.25.5.1846-1859.2005; Yu Q, 2009, J BIOL CHEM, V284, P740, DOI 10.1074/jbc.M806274200; Zou YF, 2006, GENETICS, V174, P203, DOI 10.1534/genetics.106.055525	55	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7525	7536		10.1074/jbc.M109.016360	http://dx.doi.org/10.1074/jbc.M109.016360			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048165	Green Published, hybrid			2022-12-25	WOS:000275415600064
J	Arcemisbehere, L; Sen, T; Boudier, L; Balestre, MN; Gaibelet, G; Detouillon, E; Orcel, H; Mendre, C; Rahmeh, R; Granier, S; Vives, C; Fieschi, F; Damian, M; Durroux, T; Baneres, JL; Mouillac, B				Arcemisbehere, Laure; Sen, Tuhinadri; Boudier, Laure; Balestre, Marie-Noelle; Gaibelet, Gerald; Detouillon, Emilie; Orcel, Helene; Mendre, Christiane; Rahmeh, Rita; Granier, Sebastien; Vives, Corinne; Fieschi, Franck; Damian, Marjorie; Durroux, Thierry; Baneres, Jean-Louis; Mouillac, Bernard			Leukotriene BLT2 Receptor Monomers Activate the G(i2) GTP-binding Protein More Efficiently than Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; AMINO-ACID-SEQUENCE; COUPLED RECEPTORS; B-4 RECEPTOR; ESCHERICHIA-COLI; CONFORMATIONAL-CHANGES; GPCR FUNCTION; RHODOPSIN; PURIFICATION; TRANSDUCIN	Accumulating evidence indicates that G protein-coupled receptors can assemble as dimers/oligomers but the role of this phenomenon in G protein coupling and signaling is not yet clear. We have used the purified leukotriene B-4 receptor BLT2 as a model to investigate the capacity of receptor monomers and dimers to activate the adenylyl cyclase inhibitory G(i2) protein. For this, we overexpressed the recombinant receptor as inclusion bodies in the Escherichia coli prokaryotic system, using a human alpha(5) integrin as a fusion partner. This strategy allowed the BLT2 as well as several other G protein-coupled receptors from different families to be produced and purified in large amounts. The BLT2 receptor was then successfully refolded to its native state, as measured by high-affinity LTB4 binding in the presence of the purified G protein G alpha(i2). The receptor dimer, in which the two protomers displayed a well defined parallel orientation as assessed by fluorescence resonance energy transfer, was then separated from the monomer. Using two methods of receptor-catalyzed guanosine 5'-3-O-(thio) triphosphate binding assay, we clearly demonstrated that monomeric BLT2 stimulates the purified G alpha(i2)beta(1)gamma(2) protein more efficiently than the dimer. These data suggest that assembly of two BLT2 protomers into a dimer results in the reduced ability to signal.	[Mouillac, Bernard] IGF, Dept Mol Pharmacol, CNRS, UMR 5203, F-34094 Montpellier, France; [Arcemisbehere, Laure; Sen, Tuhinadri; Boudier, Laure; Balestre, Marie-Noelle; Gaibelet, Gerald; Detouillon, Emilie; Orcel, Helene; Mendre, Christiane; Rahmeh, Rita; Granier, Sebastien; Durroux, Thierry; Mouillac, Bernard] INSERM, U661, Montpellier, France; [Arcemisbehere, Laure; Sen, Tuhinadri; Boudier, Laure; Balestre, Marie-Noelle; Gaibelet, Gerald; Detouillon, Emilie; Orcel, Helene; Mendre, Christiane; Rahmeh, Rita; Granier, Sebastien; Durroux, Thierry; Mouillac, Bernard] Univ Montpellier I, F-34094 Montpellier, France; [Arcemisbehere, Laure; Sen, Tuhinadri; Boudier, Laure; Balestre, Marie-Noelle; Gaibelet, Gerald; Detouillon, Emilie; Orcel, Helene; Mendre, Christiane; Rahmeh, Rita; Granier, Sebastien; Durroux, Thierry; Mouillac, Bernard] Univ Montpellier 2, F-34094 Montpellier, France; [Vives, Corinne; Fieschi, Franck] CEA, CNRS, UMR 5075, Inst Biol Struct JP Ebel,Lab Prot Membranaires, Grenoble, France; [Vives, Corinne; Fieschi, Franck] Univ Grenoble 1, F-38027 Grenoble 1, France; Fac Pharm Montpellier, Inst Biomol Max Mousseron, CNRS, UMR 5247, Montpellier, France; [Damian, Marjorie; Baneres, Jean-Louis] Univ Montpellier I, F-34093 Montpellier 05, France; [Damian, Marjorie; Baneres, Jean-Louis] Univ Montpellier 2, F-34093 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	Mouillac, B (corresponding author), IGF, Dept Mol Pharmacol, CNRS, UMR 5203, 141 Rue Cardonille, F-34094 Montpellier, France.	Bernard.Mouillac@igf.cnrs.fr	MOUILLAC, Bernard/M-3896-2014; Granier, Sebastien/J-1089-2016; Fieschi, Franck/W-2748-2019	MOUILLAC, Bernard/0000-0002-3906-8673; Baneres, jean-louis/0000-0001-7078-1285; FIESCHI, Franck/0000-0003-1194-8107; Rahmeh, Rita/0000-0001-5118-3650; Durroux, Thierry/0000-0003-1091-6066	INSERM; CNRS; European community [LSHB-CT-2003-503337]; ANRS Foundation [AC14]; French Ministry of Research [ACI BCMS 328]; National Agency of Research [ANR 06-BLAN-0087]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); European community(European Commission); ANRS Foundation(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); National Agency of Research(French National Research Agency (ANR))	This work was supported in part by INSERM, CNRS, European community Grant LSHB-CT-2003-503337, ANRS Foundation Grant AC14, French Ministry of Research Grant ACI BCMS 328, and National Agency of Research Grant ANR 06-BLAN-0087.	Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Baneres JL, 1998, J BIOL CHEM, V273, P24744, DOI 10.1074/jbc.273.38.24744; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hickerson R, 2005, J MOL BIOL, V354, P459, DOI 10.1016/j.jmb.2005.09.010; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Jager M, 2006, PROTEIN SCI, V15, P640, DOI 10.1110/ps.051851506; Kamohara M, 2000, J BIOL CHEM, V275, P27000; Kiefer H, 1996, BIOCHEMISTRY-US, V35, P16077, DOI 10.1021/bi9612069; Kiefer H, 2003, BBA-BIOMEMBRANES, V1610, P57, DOI 10.1016/S0005-2736(02)00717-4; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Mesnier D, 2004, J BIOL CHEM, V279, P49664, DOI 10.1074/jbc.M404941200; Mouillac B, 2002, PROG BRAIN RES, V139, P163; Nomine Y, 2001, PROTEIN ENG, V14, P297, DOI 10.1093/protein/14.4.297; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; Poudrel JM, 1999, J MED CHEM, V42, P5289, DOI 10.1021/jm9910573; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sabirsh A, 2005, J LIPID RES, V46, P1339, DOI 10.1194/jlr.D500005-JLR200; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Tan CA, 1997, PROTEIN EXPRES PURIF, V10, P365, DOI 10.1006/prep.1997.0756; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; TSO JY, 1982, J BIOL CHEM, V257, P3525; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WILKINSON DL, 1991, BIO-TECHNOL, V9, P443, DOI 10.1038/nbt0591-443; WYMAN J, 1990, BINDING LINKAGE FUNC, P33; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 2001, ARCH BIOCHEM BIOPHYS, V385, P231, DOI 10.1006/abbi.2000.2168	49	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6337	6347		10.1074/jbc.M109.083477	http://dx.doi.org/10.1074/jbc.M109.083477			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20026606	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-25	WOS:000275367500038
J	Kitazume, S; Imamaki, R; Ogawa, K; Komi, Y; Futakawa, S; Kojima, S; Hashimoto, Y; Marth, JD; Paulson, JC; Taniguchi, N				Kitazume, Shinobu; Imamaki, Rie; Ogawa, Kazuko; Komi, Yusuke; Futakawa, Satoshi; Kojima, Soichi; Hashimoto, Yasuhiro; Marth, Jamey D.; Paulson, James C.; Taniguchi, Naoyuki			alpha 2,6-Sialic Acid on Platelet Endothelial Cell Adhesion Molecule (PECAM) Regulates Its Homophilic Interactions and Downstream Antiapoptotic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIC ACIDS; CD22 LIGANDS; APOPTOSIS; GLYCANS; SIALYLTRANSFERASE; ANGIOGENESIS; TRANSDUCTION; SIALYLATION; ENDOCYTOSIS; ACTIVATION	Antiangiogenesis therapies are now part of the standard repertoire of cancer therapies, but the mechanisms for the proliferation and survival of endothelial cells are not fully understood. Although endothelial cells are covered with a glycocalyx, little is known about how endothelial glycosylation regulates endothelial functions. Here, we show that alpha 2,6-sialic acid is necessary for the cell-surface residency of platelet endothelial cell adhesion molecule ( PECAM), a member of the immunoglobulin superfamily that plays multiple roles in cell adhesion, mechanical stress sensing, antiapoptosis, and angiogenesis. As a possible underlying mechanism, we found that the homophilic interactions of PECAM in endothelial cells were dependent on alpha 2,6-sialic acid. We also found that the absence of alpha 2,6-sialic acid down-regulated the tyrosine phosphorylation of PECAM and recruitment of Src homology 2 domain-containing protein-tyrosine phosphatase 2 and rendered the cells more prone to mitochondrion-dependent apoptosis, as evaluated using PECAM-deficient endothelial cells. The present findings open up a new possibility that modulation of glycosylation could be one of the promising strategies for regulating angiogenesis.	[Kitazume, Shinobu; Imamaki, Rie; Ogawa, Kazuko; Taniguchi, Naoyuki] RIKEN Adv Sci Inst, Dis Glyc Team, Wako, Saitama 3510198, Japan; [Komi, Yusuke; Kojima, Soichi] RIKEN Adv Sci Inst, Mol Ligand Biol Res Team, Wako, Saitama 3510198, Japan; [Futakawa, Satoshi; Hashimoto, Yasuhiro] Fukushima Med Univ, Sch Med, Dept Biochem, Fukushima 9601295, Japan; [Marth, Jamey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Marth, Jamey D.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Paulson, James C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Taniguchi, Naoyuki] Osaka Univ, Microbial Dis Res Inst, Dept Dis Glyc Lab, Osaka 565871, Japan	RIKEN; RIKEN; Fukushima Medical University; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Osaka University	Taniguchi, N (corresponding author), RIKEN Adv Sci Inst, Dis Glyc Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tani@sanken.osaka-u.ac.jp	Kojima, Soichi/N-7104-2015; Paulson, James/AAG-3565-2019; Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Kojima, Soichi/0000-0002-5252-1612; Taniguchi, Naoyuki/0000-0001-5889-5968	National Institutes of Health [HL57345]; Systems Glycobiology Research Project; RIKEN; Japan Foundation for Applied Enzymology; Yamada Science Foundation; Ministry of Education, Science, Sports and Culture of Japan [18570141]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Systems Glycobiology Research Project; RIKEN; Japan Foundation for Applied Enzymology; Yamada Science Foundation; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL57345 (to J. M.). This work was also supported by grants from the Systems Glycobiology Research Project (to N. T.), the Chemical Genomics Research Project from RIKEN (to S. Kojima), Japan Foundation for Applied Enzymology (to S. Kitazume), Yamada Science Foundation (to S. Kitazume), and Grant 18570141 from the Ministry of Education, Science, Sports and Culture of Japan (to S. Kitazume).	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Bird IN, 1999, J CELL SCI, V112, P1989; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrero E, 2003, BLOOD, V101, P186, DOI 10.1182/blood-2002-03-0768; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gao CJ, 2003, BLOOD, V102, P169, DOI 10.1182/blood-2003-01-0003; Geyer H, 1999, GLYCOBIOLOGY, V9, P915, DOI 10.1093/glycob/9.9.915; Grewal PK, 2006, MOL CELL BIOL, V26, P4970, DOI 10.1128/MCB.00308-06; HANASAKI K, 1994, J BIOL CHEM, V269, P10637; HANASAKI K, 1995, J BIOL CHEM, V270, P7533, DOI 10.1074/jbc.270.13.7533; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Limaye V, 2005, BLOOD, V105, P3169, DOI 10.1182/blood-2004-02-0452; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Nitschke L, 1999, J EXP MED, V189, P1513, DOI 10.1084/jem.189.9.1513; Noble KE, 1999, J IMMUNOL, V162, P1376; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Poe JC, 2004, NAT IMMUNOL, V5, P1078, DOI 10.1038/ni1121; POWELL LD, 1993, J BIOL CHEM, V268, P7019; Sugimoto I, 2007, J BIOL CHEM, V282, P34896, DOI 10.1074/jbc.M704766200; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Zhou Z, 1999, Angiogenesis, V3, P181, DOI 10.1023/A:1009092107382; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	34	85	86	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6515	6521		10.1074/jbc.M109.073106	http://dx.doi.org/10.1074/jbc.M109.073106			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20048157	Green Published, hybrid			2022-12-25	WOS:000275367500056
J	Paik, JC; Wang, B; Liu, K; Lue, JK; Lin, WC				Paik, Jason C.; Wang, Bing; Liu, Kang; Lue, Jerry K.; Lin, Weei-Chin			Regulation of E2F1-induced Apoptosis by the Nucleolar Protein RRP1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; DNA-DAMAGE; RIBOSOMAL-PROTEINS; CELL-CYCLE; C-MYC; DIFFERENTIAL REGULATION; RETINOBLASTOMA PROTEIN; GENE-TRANSCRIPTION; HISTONE CHAPERONE; E2F1	Regulation of the E2F family of transcription factors is important in control of cellular proliferation; dysregulation of the E2Fs is a hallmark of many cancers. One member of the E2F family, E2F1, also has the paradoxical ability to induce apoptosis; however, the mechanisms underlying this selectivity are not fully understood. We now identify a nucleolar protein, RRP1B, as an E2F1-specific transcriptional target. We characterize the RRP1B promoter and demonstrate its selective response to E2F1. Consistent with the activation of E2F1 activity upon DNA damage, RRP1B is induced by several DNA-damaging agents. Importantly, RRP1B is required for the expression of certain E2F1 proapoptotic target genes and the induction of apoptosis by DNA-damaging agents. This activity is mediated in part by complex formation between RRP1B and E2F1 on selective E2F1 target gene promoters. Interaction between RRP1B and E2F1 can be found inside the nucleolus and diffuse nucleoplasmic punctates. Thus, E2F1 makes use of its transcriptional target RRP1B to activate other genes directly involved in apoptosis. Our data also suggest an underappreciated role for nucleolar proteins in transcriptional regulation.	Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA; [Paik, Jason C.; Lin, Weei-Chin] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Lin, WC (corresponding author), 1 Baylor Plaza,MS BCM187, Houston, TX 77030 USA.	weeichil@bcm.tmc.edu		Paik, Jason/0000-0002-9075-4679	National Institutes of Health [T32 GM008361, CA100857]; Department of Defense Breast Cancer Research Program [W81XWH-09-1-0338, W81XWH-06-1-0708]; NATIONAL CANCER INSTITUTE [R01CA100857, R01CA138641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM008361 (to J.C.P.) and CA100857 (to W.-C. L.). This work was also supported by Department of Defense Breast Cancer Research Program Grants W81XWH-09-1-0338 (to W.-C. L.) and W81XWH-06-1-0708 (to J.C.P.). This work is submitted in partial fulfillment of the requirements for the UAB Cell Biology Graduate Program (J. C. P.).	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; ANDERSON DF, 2002, INT J COMMUTATIVE RI, V1, P11; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Ayrault O, 2006, ONCOGENE, V25, P7577, DOI 10.1038/sj.onc.1209743; Ayrault O, 2006, EXP CELL RES, V312, P1185, DOI 10.1016/j.yexcr.2006.01.027; Ayrault O, 2004, ONCOGENE, V23, P8097, DOI 10.1038/sj.onc.1207968; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Burke Emily, 2003, Methods Mol Biol, V226, P525; Chiu CM, 2002, J BIOL CHEM, V277, P39102, DOI 10.1074/jbc.M205915200; Crawford NPS, 2007, PLOS GENET, V3, P2296, DOI 10.1371/journal.pgen.0030214; Crawford NPS, 2009, J BIOL CHEM, V284, P28660, DOI 10.1074/jbc.M109.023457; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Datta A, 2005, MOL CELL BIOL, V25, P8024, DOI 10.1128/MCB.25.18.8024-8036.2005; Datta A, 2002, MOL CELL BIOL, V22, P8398, DOI 10.1128/MCB.22.24.8398-8408.2002; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; E SY, 2009, J BIOL CHEM, V284, P14558, DOI 10.1074/jbc.M900185200; FABIAN GR, 1987, J BACTERIOL, V169, P1571, DOI 10.1128/jb.169.4.1571-1578.1987; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Grinstein E, 2006, J BIOL CHEM, V281, P22223, DOI 10.1074/jbc.M513335200; Hallstrom TC, 2006, GENE DEV, V20, P613, DOI 10.1101/gad.1345006; Hauck L, 2002, MOL CELL BIOL, V22, P2147, DOI 10.1128/MCB.22.7.2147-2158.2002; Horsey EW, 2004, RNA, V10, P813, DOI 10.1261/rna.5255804; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Huddleson JP, 2006, J BIOL CHEM, V281, P15121, DOI 10.1074/jbc.M513406200; Hunt KK, 1997, CANCER RES, V57, P4722; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Kel-Margoulis OV, 2000, NUCLEIC ACIDS RES, V28, P311, DOI 10.1093/nar/28.1.311; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kim H, 2006, NEURON, V49, P707, DOI 10.1016/j.neuron.2006.01.035; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Leotoing L, 2008, ONCOGENE, V27, P2858, DOI 10.1038/sj.onc.1210942; LI Y, 1994, MOL CELL BIOL, V14, P1861, DOI 10.1128/MCB.14.3.1861; Li ZL, 2008, P NATL ACAD SCI USA, V105, P18794, DOI 10.1073/pnas.0806879105; Lin WC, 2001, GENE DEV, V15, P1833; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Liu H, 2007, EMBO REP, V8, P394, DOI 10.1038/sj.embor.7400909; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Maggi LB, 2005, CANCER INVEST, V23, P599, DOI 10.1080/07357900500283085; Masumi A, 2006, ONCOGENE, V25, P5113, DOI 10.1038/sj.onc.1209522; Meng RD, 1999, INT J ONCOL, V14, P5; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Ni JQ, 2006, GENE DEV, V20, P1959, DOI 10.1101/gad.390106; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Phillips AC, 1997, GENE DEV, V11, P1853, DOI 10.1101/gad.11.14.1853; Pruschy M, 1999, CELL GROWTH DIFFER, V10, P141; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Samuel S, 2008, MOL CARCINOGEN, V47, P34, DOI 10.1002/mc.20358; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Savino TM, 1999, J CELL SCI, V112, P1889; Savino TM, 2001, J CELL BIOL, V153, P1097, DOI 10.1083/jcb.153.5.1097; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Shandilya J, 2009, MOL CELL BIOL, V29, P5115, DOI 10.1128/MCB.01969-08; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Swaminathan V, 2005, MOL CELL BIOL, V25, P7534, DOI 10.1128/MCB.25.17.7534-7545.2005; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128; Zou YL, 2008, J BIOL CHEM, V283, P5728, DOI 10.1074/jbc.M709932200	74	21	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6348	6363		10.1074/jbc.M109.072074	http://dx.doi.org/10.1074/jbc.M109.072074			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040599	Green Published, hybrid			2022-12-25	WOS:000275367500039
J	Marfil, V; Moya, M; Pierreux, CE; Castell, JV; Lemaigre, FP; Real, FX; Bort, R				Marfil, Vanessa; Moya, Marta; Pierreux, Christophe E.; Castell, Jose V.; Lemaigre, Frederic P.; Real, Francisco X.; Bort, Roque			Interaction between Hhex and SOX13 Modulates Wnt/TCF Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEOBOX GENE HEX; TRANSCRIPTION FACTOR; BETA-CATENIN; HOMEODOMAIN PROTEIN; DNA-BINDING; HEMATOPOIETIC-CELLS; ENDOTHELIAL-CELLS; LIVER BUD; EXPRESSION; DIFFERENTIATION	Fine-tuning of the Wnt/TCF pathway is crucial for multiple embryological processes, including liver development. Here we describe how the interaction between Hhex (hematopoietically expressed homeobox) and SOX13 (SRY-related high mobility group box transcription factor 13), modulates Wnt/TCF pathway activity. Hhex is a homeodomain factor expressed in multiple endoderm-derived tissues, like the liver, where it is essential for proper development. The pleiotropic expression of Hhex during embryonic development and its dual role as a transcriptional repressor and activator suggest the presence of different tissue-specific partners capable of modulating its activity and function. While searching for developmentally regulated Hhex partners, we set up a yeast two-hybrid screening using an E9.5-10.5 mouse embryo library and the N-terminal domain of Hhex as bait. Among the putative protein interactors, we selected SOX13 for further characterization. We found that SOX13 interacts directly with full-length Hhex, and we delineated the interaction domains within the two proteins. SOX13 is known to repress Wnt/TCF signaling by interacting with TCF1. We show that Hhex is able to block the SOX13-dependent repression of Wnt/TCF activity by displacing SOX13 from the SOX13.TCF1 complex. Moreover, Hhex de-repressed the Wnt/TCF pathway in the ventral foregut endoderm of cultured mouse embryos electroporated with a SOX13-expressing plasmid. We conclude that the interaction between Hhex and SOX13 may contribute to control Wnt/TCF signaling in the early embryo.	[Marfil, Vanessa] Univ Pompeu Fabra, Inst Municipal Invest Med, Unitat Biol Cellular & Mol, Barcelona 08003, Spain; [Moya, Marta; Castell, Jose V.; Bort, Roque] Hosp Univ Fe, Ctr Invest, Unidad Hepatol Expt, Valencia 46009, Spain; [Pierreux, Christophe E.; Lemaigre, Frederic P.] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Real, Francisco X.] Ctr Nacl Invest Oncol, Mol Pathol Programme, Epithelial Carcinogenesis Grp, E-28029 Madrid, Spain	Pompeu Fabra University; Universite Catholique Louvain	Bort, R (corresponding author), Ctr Invest Fe, Avda Campanar 21, Valencia 46009, Spain.	bort_ber@gva.es	Arribas, Francisco X Real/H-5275-2015; Castell, Jose V/I-9529-2016; Bort, Roque/Y-5466-2019	Arribas, Francisco X Real/0000-0001-9501-498X; Castell, Jose V/0000-0003-1179-6430; Bort, Roque/0000-0002-7285-0536; Lemaigre, Frederic/0000-0002-3609-434X	Spanish Ministry of Science [SAF-64414]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Supported by Spanish Ministry of Science Grant SAF-64414.	Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bess KL, 2003, BIOCHEM J, V374, P667, DOI 10.1042/BJ20030769; Bischof J, 2004, DEV BIOL, V276, P552, DOI 10.1016/j.ydbio.2004.09.035; Bogue CW, 2000, DEV DYNAM, V219, P84, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1028>3.0.CO;2-5; Bogue CW, 2003, P NATL ACAD SCI USA, V100, P556, DOI 10.1073/pnas.0236979100; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Brickman JM, 2000, DEVELOPMENT, V127, P2303; Cong R, 2006, BIOCHEM BIOPH RES CO, V346, P535, DOI 10.1016/j.bbrc.2006.05.153; CROMPTON MR, 1992, NUCLEIC ACIDS RES, V20, P5661, DOI 10.1093/nar/20.21.5661; Denson LA, 2000, AM J PHYSIOL-GASTR L, V279, pG347, DOI 10.1152/ajpgi.2000.279.2.G347; Fagotto F, 1997, DEVELOPMENT, V124, P453; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GOMEZFOIX AM, 1992, J BIOL CHEM, V267, P25129; Guo Y, 2003, BLOOD, V102, P2428, DOI 10.1182/blood-2003-02-0634; Hallaq H, 2004, DEVELOPMENT, V131, P5197, DOI 10.1242/dev.01393; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Hunter MP, 2007, DEV BIOL, V308, P355, DOI 10.1016/j.ydbio.2007.05.028; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kasamatsu S, 2004, J BIOCHEM, V135, P217, DOI 10.1093/jb/mvh025; Kasimiotis H, 2000, DIABETES, V49, P555, DOI 10.2337/diabetes.49.4.555; Keng VW, 2000, BIOCHEM BIOPH RES CO, V276, P1155, DOI 10.1006/bbrc.2000.3548; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kubo A, 2005, BLOOD, V105, P4590, DOI 10.1182/blood-2004-10-4137; Lioubinski O, 2003, DEV DYNAM, V227, P402, DOI 10.1002/dvdy.10311; Martinez-Jimenez CP, 2006, J BIOL CHEM, V281, P29840, DOI 10.1074/jbc.M604046200; Martinez-Jimenez CP, 2006, MOL PHARMACOL, V70, P1681, DOI 10.1124/mol.106.025403; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Minami T, 2004, J BIOL CHEM, V279, P20626, DOI 10.1074/jbc.M308730200; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Obinata A, 2002, DEV GROWTH DIFFER, V44, P281; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pierreux CE, 2004, J BIOL CHEM, V279, P51298, DOI 10.1074/jbc.M409038200; Pierreux CE, 2005, J PANCREAS, V6, P128; Puppin C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-192; Roose J, 1999, GENOMICS, V57, P301, DOI 10.1006/geno.1999.5779; Roose J, 1998, NUCLEIC ACIDS RES, V26, P469, DOI 10.1093/nar/26.2.469; Schaefer LK, 2001, J BIOL CHEM, V276, P43074, DOI 10.1074/jbc.M102552200; Schreiber J, 1997, P NATL ACAD SCI USA, V94, P4739, DOI 10.1073/pnas.94.9.4739; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soufi A, 2009, NUCLEIC ACIDS RES, V37, P3288, DOI 10.1093/nar/gkp197; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Tanaka T, 1999, BIOCHEM J, V339, P111, DOI 10.1042/0264-6021:3390111; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Topcu Z, 1999, ONCOGENE, V18, P7091, DOI 10.1038/sj.onc.1203201; Topisirovic I, 2003, MOL CELL BIOL, V23, P8992, DOI 10.1128/MCB.23.24.8992-9002.2003; Tremblay KD, 2005, DEV BIOL, V280, P87, DOI 10.1016/j.ydbio.2005.01.003; Valenta T, 2006, EMBO J, V25, P2326, DOI 10.1038/sj.emboj.7601147; Wang Y, 2006, J HISTOCHEM CYTOCHEM, V54, P1327, DOI 10.1369/jhc.6A6923.2006; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105; Zamparini AL, 2006, DEVELOPMENT, V133, P3709, DOI 10.1242/dev.02516	63	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5726	5737		10.1074/jbc.M109.046649	http://dx.doi.org/10.1074/jbc.M109.046649			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028982	Green Published, hybrid			2022-12-25	WOS:000275327200065
J	Ahmed, RPH; Haider, KH; Shujia, J; Afzal, MR; Ashraf, M				Ahmed, Rafeeq P. H.; Haider, Khawaja Husnain; Shujia, Jiang; Afzal, Muhammad Rizwan; Ashraf, Muhammad			Sonic Hedgehog Gene Delivery to the Rodent Heart Promotes Angiogenesis via iNOS/Netrin-1/PKC Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; CELLS; TRANSPLANTATION; ACTIVATION; NETRIN-1; MOTILITY	Background: We hypothesized that genetic modification of mesenchymal stem cells (MSCs) with Sonic Hedgehog (Shh) transgene, a morphogen during embryonic development and embryonic and adult stem cell growth, improved their survival and angiogenic potential in the ischemic heart via iNOS/netrin/PKC pathway. Methods/Principal Findings: MSCs from young Fisher-344 rat bone marrow were purified and transfected with pCMV Shh plasmid ((MSCs)-M-Shh). Immunofluorescence, RT-PCR and Western blotting showed higher expression of Shh in (MSCs)-M-Shh which also led to increased expression of angiogenic and pro-survival growth factors in (MSCs)-M-Shh. Significantly improved migration and tube formation was seen in Shh MSCs as compared to empty vector transfected MSCs ((MSCs)-M-Emp). Significant upregulation of netrin-1 and iNOS was observed in (MSCs)-M-Shh in P13K independent but PKC dependent manner. For in vivo studies, acute myocardial infarction model was developed in Fisher-344 rats. The animals were grouped to receive 70 mu l basal DMEM without cells (group-1) or containing 1x10(6) (MSCs)-M-Emp (group-2) and (MSCs)-M-Shh (group-3). Group-4 received recombinant netrin-1 protein injection into the infarcted heart. FISH and sry-quantification revealed improved survival of (MSCs)-M-Shh post engraftment. Histological studies combined with fluorescent microspheres showed increased density of functionally competent blood vessels in group-3 and group-4. Echocardiography showed significantly preserved heart function indices post engraftment with (MSCs)-M-Shh in group-3 animals. Conclusions/Significance: Reprogramming of stem cells with Shh maximizes their survival and angiogenic potential in the heart via iNOS/netrin-1/PKC signaling.	[Ahmed, Rafeeq P. H.; Haider, Khawaja Husnain; Shujia, Jiang; Afzal, Muhammad Rizwan; Ashraf, Muhammad] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Ahmed, RPH (corresponding author), Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45221 USA.	muhammad.ashraf@uc.edu	Ashraf, Muhammad/ABB-3463-2021		National Institutes of Health [R37-HL074272, HL-080686, HL087246, HL087288, HL089535]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL074272, R01HL087288, R01HL089535, R01HL080686, R01HL087246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants #R37-HL074272; HL-080686; HL087246 to M.A. and HL087288; HL089535 to Kh.H.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; ANDREA JE, 1992, HYPERTENSION, V20, P585, DOI 10.1161/01.HYP.20.5.585; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Cooney R, 2006, J VASC RES, V43, P462, DOI 10.1159/000095163; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Heo JS, 2007, STEM CELLS, V25, P3069, DOI 10.1634/stemcells.2007-0550; Jiang SJ, 2006, CIRC RES, V99, P776, DOI 10.1161/01.RES.0000244687.97719.4f; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Massard C, 2006, ANN ONCOL, V17, P1620, DOI 10.1093/annonc/mdl074; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Pola R, 2003, CIRCULATION, V108, P479, DOI 10.1161/01.CIR.0000080338.60981.FA; Purdie KJ, 2002, CARDIOVASC RES, V54, P659, DOI 10.1016/S0008-6363(02)00255-9; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; STRAFACE G, 2008, J CELL MOL MED; Sun MH, 2005, WORLD J GASTROENTERO, V11, P5931, DOI 10.3748/wjg.v11.i38.5931; White D, 2007, J EXP BIOL, V210, P4053, DOI 10.1242/jeb.007013; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Zardoya R, 1996, TRENDS GENET, V12, P496, DOI 10.1016/S0168-9525(96)20014-9	27	59	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8576	10.1371/journal.pone.0008576	http://dx.doi.org/10.1371/journal.pone.0008576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052412	Green Submitted, gold, Green Published			2022-12-25	WOS:000273338500019
J	Kelker, HC; Itri, VR; Valentine, FT				Kelker, Hanna C.; Itri, Vincenza R.; Valentine, Fred T.			A Strategy for Eliciting Antibodies against Cryptic, Conserved, Conformationally Dependent Epitopes of HIV Envelope Glycoprotein	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; CLADE NEUTRALIZING ACTIVITY; HIV-1/SIV CHIMERIC VIRUS; CD4 BINDING-SITE; TYPE-1 GP120; GLYCOSYLATION SITES; PASSIVE TRANSFER; DISULFIDE BONDS; PEPTIDE	Background: Novel strategies are needed for the elicitation of broadly neutralizing antibodies to the HIV envelope glycoprotein, gp120. Experimental evidence suggests that combinations of antibodies that are broadly neutralizing in vitro may protect against challenge with HIV in nonhuman primates, and a small number of these antibodies have been selected by repertoire sampling of B cells and by the fractionation of antiserum from some patients with prolonged disease. Yet no additional strategies for identifying conserved epitopes, eliciting antibodies to these epitopes, and determining whether these epitopes are accessible to antibodies have been successful to date. The defining of additional conserved, accessible epitopes against which one can elicit antibodies will increase the probability that some may be the targets of broadly neutralizing antibodies. Methodology/Principal Findings: We postulate that additional cryptic epitopes of gp120 are present, against which neutralizing antibodies might be elicited even though these antibodies are not elicited by gp120, and that many of these epitopes may be accessible to antibodies should they be formed. We demonstrate a strategy for eliciting antibodies in mice against selected cryptic, conformationally dependent conserved epitopes of gp120 by immunizing with multiple identical copies of covalently linked peptides (MCPs). This has been achieved with MCPs representing 3 different domains of gp120. We show that some cryptic epitopes on gp120 are accessible to the elicited antibodies, and some epitopes in the CD4 binding region are not accessible. The antibodies bind to gp120 with relatively high affinity, and bind to oligomeric gp120 on the surface of infected cells. Conclusions/Significance: Immunization with MCPs comprised of selected peptides of HIV gp120 is able to elicit antibodies against conserved, conformationally dependent epitopes of gp120 that are not immunogenic when presented as gp120. Some of these cryptic epitopes are accessible to the elicited antibodies.	[Kelker, Hanna C.; Itri, Vincenza R.; Valentine, Fred T.] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Valentine, Fred T.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University	Kelker, HC (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.	Fred.Valentine@nyumc.org		Valentine, Fred/0000-0002-6046-5913	National Institutes of Health [RO1 AI43898]; New York University Center for AIDS Research [P30AI27742]; Robert Farber Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Center for AIDS Research; Robert Farber Foundation	National Institutes of Health grants: RO1 AI43898, the New York University Center for AIDS Research grant P30AI27742 and a grant from the Robert Farber Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303; Baba T, 2000, MOL CELL BIOCHEM, V206, P1, DOI 10.1023/A:1007007626813; Boots LJ, 1997, AIDS RES HUM RETROV, V13, P1549, DOI 10.1089/aid.1997.13.1549; Bradney AP, 1999, J INFECT DIS, V179, P1264, DOI 10.1086/314711; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Cole KS, 2004, J VIROL, V78, P1525, DOI 10.1128/JVI.78.3.1525-1539.2004; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; Graham BS, 2005, J INFECT DIS, V191, P647, DOI 10.1086/428406; Grundner C, 2005, VIROLOGY, V331, P33, DOI 10.1016/j.virol.2004.09.022; Haynes BF, 2006, EXPERT REV VACCINES, V5, P347, DOI 10.1586/14760584.5.3.347; Humbert M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003937; Karle S, 2003, VACCINE, V21, P1213, DOI 10.1016/S0264-410X(02)00504-2; KELKER HC, 1994, J IMMUNOL, V152, P4139; KNIGHT DM, 1993, MOL IMMUNOL, V30, P1443, DOI 10.1016/0161-5890(93)90106-L; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; Kumar A, 2000, VIROLOGY, V274, P149, DOI 10.1006/viro.2000.0444; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Montefiori David C., 1999, AIDS Research and Human Retroviruses, V15, P689, DOI 10.1089/088922299310773; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; MOORE JP, 1994, J VIROL, V68, P469, DOI 10.1128/JVI.68.1.469-484.1994; MOORE JP, 1993, J VIROL, V67, P863, DOI 10.1128/JVI.67.2.863-875.1993; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; Nishimura Y, 2002, J VIROL, V76, P2123, DOI 10.1128/jvi.76.5.2123-2130.2002; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pitisuttithum P, 2004, JAIDS-J ACQ IMM DEF, V37, P1160, DOI 10.1097/01.qai.0000136091.72955.4b; POSNER MR, 1991, J IMMUNOL, V146, P4325; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Ren XP, 2005, J VIROL, V79, P5616, DOI 10.1128/JVI.79.9.5616-5624.2005; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sanders RW, 2008, MOL BIOL CELL, V19, P4707, DOI 10.1091/mbc.E08-07-0670; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; SUN NC, 1989, J VIROL, V63, P3579, DOI 10.1128/JVI.63.9.3579-3585.1989; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; THALI M, 1992, J VIROL, V66, P5635, DOI 10.1128/JVI.66.9.5635-5641.1992; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wallace A, 2009, J VIROL, V83, P7883, DOI 10.1128/JVI.00582-09; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Yuan W, 2005, VIROLOGY, V332, P369, DOI 10.1016/j.virol.2004.11.013; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, AIDS RES HUM RETROV, V20, P1254, DOI 10.1089/aid.2004.20.1254; Zwick MB, 2001, J VIROL, V75, P6692, DOI 10.1128/JVI.75.14.6692-6699.2001; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	68	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8555	10.1371/journal.pone.0008555	http://dx.doi.org/10.1371/journal.pone.0008555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052405	Green Submitted, Green Published, gold			2022-12-25	WOS:000273338500005
J	Holman, RC; Belay, ED; Christensen, KY; Maddox, RA; Minino, AM; Folkema, AM; Haberling, DL; Hammett, TA; Kochanek, KD; Sejvar, JJ; Schonberger, LB				Holman, Robert C.; Belay, Ermias D.; Christensen, Krista Y.; Maddox, Ryan A.; Minino, Arialdi M.; Folkema, Arianne M.; Haberling, Dana L.; Hammett, Teresa A.; Kochanek, Kenneth D.; Sejvar, James J.; Schonberger, Lawrence B.			Human Prion Diseases in the United States	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; NATIONAL MORTALITY DATA; DEATH CERTIFICATES; PROTEIN; CLASSIFICATION; EPIDEMIOLOGY; CANADA	Background: Prion diseases are a family of rare, progressive, neurodegenerative disorders that affect humans and animals. The most common form of human prion disease, Creutzfeldt-Jakob disease (CJD), occurs worldwide. Variant CJD (vCJD), a recently emerged human prion disease, is a zoonotic foodborne disorder that occurs almost exclusively in countries with outbreaks of bovine spongiform encephalopathy. This study describes the occurrence and epidemiology of CJD and vCJD in the United States. Methodology/Principal Findings: Analysis of CJD and vCJD deaths using death certificates of US residents for 1979-2006, and those identified through other surveillance mechanisms during 1996-2008. Since CJD is invariably fatal and illness duration is usually less than one year, the CJD incidence is estimated as the death rate. During 1979 through 2006, an estimated 6,917 deaths with CJD as a cause of death were reported in the United States, an annual average of approximately 247 deaths (range 172-304 deaths). The average annual age-adjusted incidence for CJD was 0.97 per 1,000,000 persons. Most (61.8%) of the CJD deaths occurred among persons >= 65 years of age for an average annual incidence of 4.8 per 1,000,000 persons in this population. Most deaths were among whites (94.6%); the age-adjusted incidence for whites was 2.7 times higher than that for blacks (1.04 and 0.40, respectively). Three patients who died since 2004 were reported with vCJD; epidemiologic evidence indicated that their infection was acquired outside of the United States. Conclusion/Significance: Surveillance continues to show an annual CJD incidence rate of about 1 case per 1,000,000 persons and marked differences in CJD rates by age and race in the United States. Ongoing surveillance remains important for monitoring the stability of the CJD incidence rates, and detecting occurrences of vCJD and possibly other novel prion diseases in the United States.	[Holman, Robert C.; Belay, Ermias D.; Christensen, Krista Y.; Maddox, Ryan A.; Folkema, Arianne M.; Haberling, Dana L.; Hammett, Teresa A.; Sejvar, James J.; Schonberger, Lawrence B.] Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, US Dept HHS, Atlanta, GA 30333 USA; [Minino, Arialdi M.; Kochanek, Kenneth D.] Ctr Dis Control & Prevent, Div Vital Stat, Natl Ctr Hlth Stat, US Dept HHS, Hyattsville, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Holman, RC (corresponding author), Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, US Dept HHS, Atlanta, GA 30333 USA.	rholman@cdc.gov	Belay, Ermias/A-8829-2013	Haberling, Dana/0000-0002-3871-8216; Christensen, Krista/0000-0003-4431-336X; Belay, Ermias/0000-0002-9837-0960				[Anonymous], 1992, INT STAT CLASS DIS R, V1-3; Belay ED, 2005, ANNU REV PUBL HEALTH, V26, P191, DOI 10.1146/annurev.publhealth.26.021304.144536; Belay ED, 2005, EMERG INFECT DIS, V11, P1351, DOI 10.3201/eid1109.050371; Belay ED, 2005, CLIN INFECT DIS, V41, P834, DOI 10.1086/432726; Belay ED, 2003, NEUROLOGY, V60, P176, DOI 10.1212/01.WNL.0000036913.87823.D6; Belay ED, 2002, CLIN LAB MED, V22, P849, DOI 10.1016/S0272-2712(02)00024-0; Belay ED, 1999, ANNU REV MICROBIOL, V53, P283, DOI 10.1146/annurev.micro.53.1.283; Brown P, 2001, EMERG INFECT DIS, V7, P6, DOI 10.3201/eid0701.010102; *BUR CENS, 2008, INT EST POP AG SEX R; *CDC, VAR C JAK DIS; *CDC, 1996, MMWR-MORBID MORTAL W, V45, P665; Comoy EE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003017; DAVANIPOUR Z, 1995, NEUROEPIDEMIOLOGY, V14, P1, DOI 10.1159/000109771; deSilva R, 1997, POSTGRAD MED J, V73, P557, DOI 10.1136/pgmj.73.863.557; *DHHS CDC NCHS, MORT DAT NAT VIT STA; ElSaadany S, 2005, NEUROEPIDEMIOLOGY, V24, P15, DOI 10.1159/000081044; GAJDUSEK DC, 1996, FIELDS VIROLOGY, V2, P2851; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Ghosh S, 2004, ADV DRUG DELIVER REV, V56, P915, DOI 10.1016/j.addr.2003.10.035; Gibbons RV, 2000, JAMA-J AM MED ASSOC, V284, P2322, DOI 10.1001/jama.284.18.2322; HARRIESJONES R, 1988, J NEUROL NEUROSUR PS, V51, P1113, DOI 10.1136/jnnp.51.9.1113; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Holman RC, 1996, EMERG INFECT DIS, V2, P333, DOI 10.3201/eid0204.960409; HOLMAN RC, 1995, NEUROEPIDEMIOLOGY, V14, P174, DOI 10.1159/000109793; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; Klein RJSC., 2001, HLTH PEOPLE STAT NOT, V20; Kleinbaum DG, 1998, APPL REGRESSION ANAL; Klug GM, 2006, COMMUN DIS INTELL, V30, P144; KOVANEN J, 1988, ACTA NEUROL SCAND, V77, P474, DOI 10.1111/j.1600-0404.1988.tb05943.x; Ladogana A, 2005, NEUROLOGY, V64, P1586, DOI 10.1212/01.WNL.0000160117.56690.B2; MAYTENYI K, 1991, EUR J EPIDEMIOL, V7, P457, DOI 10.1007/BF00143121; Melonie Heron Ph.D, 2009, NATL VITAL STAT REPO, V57; MOORE RA, 2009, CURR OPIN STRUC 0119; *NAT CTR HLTH STAT, 1984, PUBL US DAT TAP DOC; National Center for Health Statistics, 1985, PUBL US DAT TAP DOC; *NCJDSU, C JAK DIS SURV; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; *US BUR CENS, CENS REG DIV US; *US DEP HHS, 2008, VIT STAT MORT DAT MU; Valleron AJ, 2001, SCIENCE, V294, P1726, DOI 10.1126/science.1066838; WHO, 1977, MAN INT STAT CLASS D, V1; Will RG, 2003, BRIT MED BULL, V66, P255, DOI 10.1093/bmb/66.1.255; Will Robert G., 2004, VVolume 41, P629; Zou S, 2008, TRANSFUS MED REV, V22, P58, DOI 10.1016/j.tmrv.2007.09.003; WORLD ANIMAL HLTH SI; BSE BOVINE SPONGIFOR	47	64	65	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8521	10.1371/journal.pone.0008521	http://dx.doi.org/10.1371/journal.pone.0008521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049325	Green Published, gold			2022-12-25	WOS:000273225000004
J	D'Orsogna, MR; Chou, T				D'Orsogna, Maria R.; Chou, Tom			Optimal Cytoplasmic Transport in Viral Infections	PLOS ONE			English	Article							TRIM5-ALPHA RESTRICTION FACTOR; PROCESSIVE RUN-LENGTH; VIRUS TYPE-1 CORE; REVERSE-TRANSCRIPTASE; NONDIVIDING CELLS; INTRACELLULAR TRAFFICKING; ENVELOPED VIRUSES; REPLICATION; MUTATIONS; HIV	For many viruses, the ability to infect eukaryotic cells depends on their transport through the cytoplasm and across the nuclear membrane of the host cell. During this journey, viral contents are biochemically processed into complexes capable of both nuclear penetration and genomic integration. We develop a stochastic model of viral entry that incorporates all relevant aspects of transport, including convection along microtubules, biochemical conversion, degradation, and nuclear entry. Analysis of the nuclear infection probabilities in terms of the transport velocity, degradation, and biochemical conversion rates shows how certain values of key parameters can maximize the nuclear entry probability of the viral material. The existence of such "optimal" infection scenarios depends on the details of the biochemical conversion process and implies potentially counterintuitive effects in viral infection, suggesting new avenues for antiviral treatment. Such optimal parameter values provide a plausible transport-based explanation of the action of restriction factors and of experimentally observed optimal capsid stability. Finally, we propose a new interpretation of how genetic mutations unrelated to the mechanism of drug action may nonetheless confer novel types of overall drug resistance.	[D'Orsogna, Maria R.] Calif State Univ Northridge, Dept Math, Los Angeles, CA USA; [Chou, Tom] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA; [Chou, Tom] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90024 USA	California State University System; California State University Northridge; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	D'Orsogna, MR (corresponding author), Calif State Univ Northridge, Dept Math, Los Angeles, CA USA.	tomchou@ucla.edu			Division of Mathematical Sciences of the National Science Foundation [DMS-0719462, DMS-0349195]; National Institutes of Health [K25AI058672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI058672] Funding Source: NIH RePORTER	Division of Mathematical Sciences of the National Science Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Mathematical Sciences of the National Science Foundation through grants DMS-0719462 (MRD) and DMS-0349195 (TC), and by the National Institutes of Health through grant K25AI058672 (TC). Part of this work was performed during the "Optimal Transport" program at the Institute for Pure and Applied Mathematics (IPAM) at University of California, Los Angeles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2005, GENE THER, V12, P1667, DOI 10.1038/sj.gt.3302591; Arfi V, 2009, J VIROL, V83, P7524, DOI 10.1128/JVI.00429-09; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Baldanti F, 2003, AIDS, V17, P1568, DOI 10.1097/00002030-200307040-00021; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bukrinsky M, 2004, MOL MED, V10, P1; Cherwa JE, 2009, J VIROL, V83, P11746, DOI 10.1128/JVI.01297-09; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Chou T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2764053; Dee KU, 1997, BIOTECHNOL BIOENG, V54, P468, DOI 10.1002/(SICI)1097-0290(19970605)54:5<468::AID-BIT7>3.0.CO;2-C; Dinh AT, 2005, BIOPHYS J, V89, P1574, DOI 10.1529/biophysj.105.059477; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; Fields B. N., 2007, FIELDS VIROLOGY; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gao YQ, 2006, BIOPHYS J, V90, P811, DOI 10.1529/biophysj.105.073189; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; HOLEMAN D, 2008, SIAM J APPL MATH, V68, P1146; Iordanskiy S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-4; Krogstad P, 1996, AIDS RES HUM RETROV, V12, P977, DOI 10.1089/aid.1996.12.977; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; LUBYPHELPS K, 1988, CELL MOTIL CYTOSKEL, V10, P28, DOI 10.1002/cm.970100107; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Naeger LK, 2001, ANTIVIR THER, V6, P115; Nowak SA, 2009, BIOPHYS J, V96, P2624, DOI 10.1016/j.bpj.2009.01.018; Paolucci S, 2004, ANTIMICROB AGENTS CH, V48, P4611, DOI 10.1128/AAC.48.12.4611-4617.2004; PARKIN N, 2003, ANTIVIR THER, V8, pS31; Perron MJ, 2007, J VIROL, V81, P2138, DOI 10.1128/JVI.02318-06; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Sharma PL, 1999, J VIROL, V73, P8448, DOI 10.1128/JVI.73.10.8448-8456.1999; Singh MP, 2005, P NATL ACAD SCI USA, V102, P12059, DOI 10.1073/pnas.0501570102; Smith DA, 2001, BIOPHYS J, V80, P45, DOI 10.1016/S0006-3495(01)75994-2; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Thomas JA, 2008, J VIROL, V82, P9318, DOI 10.1128/JVI.00583-08; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Vivet-Boudou V, 2006, CELL MOL LIFE SCI, V63, P163, DOI 10.1007/s00018-005-5367-x; Vodicka Marie A., 2001, Somatic Cell and Molecular Genetics, V26, P35, DOI 10.1023/A:1021022629126; Yamashita M, 2006, VIROLOGY, V344, P88, DOI 10.1016/j.virol.2005.09.012; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004	45	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8165	10.1371/journal.pone.0008165	http://dx.doi.org/10.1371/journal.pone.0008165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20046829	Green Published, gold, Green Submitted			2022-12-25	WOS:000278068700001
J	Domingues, MM; Castanho, MARB; Santos, NC				Domingues, Marco M.; Castanho, Miguel A. R. B.; Santos, Nuno C.			rBPI(21) Promotes Lipopolysaccharide Aggregation and Exerts Its Antimicrobial Effects by (Hemi)fusion of PG-Containing Membranes	PLOS ONE			English	Article							BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; LPS-BINDING-PROTEIN; INTEGRAL-EQUATIONS; TERMINAL FRAGMENT; ESCHERICHIA-COLI; LIGHT-SCATTERING; HOST-DEFENSE; PEPTIDES; BACTERIAL; BPI	Antimicrobial peptides (AMPs) are important potential alternatives to conventional therapies against bacterial infections. rBPI(21) is a 21 kDa peptide based on the N-terminal region of the neutrophil bactericidal/permeability-increasing protein (BPI). This AMP possesses highly selective bactericidal effects on Gram-negative bacteria and have affinity for lipopolysaccharide (LPS) which is believed to be at the origin of its neutralizing effect of the LPS segregated into the bloodstream. We aim at understanding the molecular bases of rBPI(21) bactericidal and LPS neutralization actions, using biomembrane model systems. Using dynamic light scattering spectroscopy we demonstrate that rBPI(21) promotes aggregation of negatively charged large unilamellar vesicles (LUV), even in the absence of LPS, and LPS aggregates, while for zwitterionic phosphatidylcholine (POPC) LUV the size remains unchanged. The peptide also promotes the fusion (or hemifusion) of membranes containing phosphatidylglycerol (POPG). The aggregation and fusion of negatively charged LUV are peptide concentration-dependent until massive aggregation is reached, followed by sample flocculation/precipitation. Concomitantly, there is a progressive change in the zeta-potential of the LUV systems and LPS aggregates. LUV systems composed of phosphatidylglycerol (POPG) and lipid mixtures with POPG have higher zeta-potential variations than in the absence of POPG. The interaction of rBPI(21) with lipid vesicles is followed by leakage, with higher effect in POPG-containing membranes. LPS aggregation can be related with a decreased toxicity, possibly by facilitating its clearance by macrophage phagocytosis and/or blocking of LPS specific receptor recognition. Our data indicate that rBPI(21) mechanism of action at the molecular level involves the interaction with the LPS of the outer membrane of Gram-negative bacteria, followed by internalization and leakage induction through the (hemi) fusion of the bacterial outer and inner membranes, both enriched in phosphatidylglycerol.	[Domingues, Marco M.; Castanho, Miguel A. R. B.; Santos, Nuno C.] Univ Lisbon, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal	Universidade de Lisboa	Domingues, MM (corresponding author), Univ Lisbon, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal.	nsantos@fm.ul.pt	Santos, Nuno/N-7248-2013; Domingues, Marco/AAA-9690-2021	Santos, Nuno/0000-0002-0580-0475; FCCN, Bogus/0000-0003-1034-3552; Domingues, Marco/0000-0003-1502-1421; FCCN, Bogus/0000-0001-6282-8004; Castanho, Miguel/0000-0001-7891-7562	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/41750/2007]; Ministerio da Ciencia, Tecnologia e Ensino Superior (Portugal)	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Ministerio da Ciencia, Tecnologia e Ensino Superior (Portugal)	This work was partially supported by Fundacao para a Ciencia e a Tecnologia (FCT), from the Ministerio da Ciencia, Tecnologia e Ensino Superior (Portugal). M. M. D. acknowledges FCT PhD fellowship SFRH/BD/41750/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELMELK BJ, 1994, INFECT IMMUN, V62, P3564, DOI 10.1128/IAI.62.8.3564-3567.1994; Aurell CA, 1998, BIOCHEM BIOPH RES CO, V253, P119, DOI 10.1006/bbrc.1998.9773; BARTLETT GR, 1959, J BIOL CHEM, V234, P468; BAYER ME, 1968, J GEN MICROBIOL, V53, P395, DOI 10.1099/00221287-53-3-395; Beamer LJ, 1998, PROTEIN SCI, V7, P906; Beamer LJ, 1999, BIOCHEM PHARMACOL, V57, P225, DOI 10.1016/S0006-2952(98)00279-2; Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; CAPODICI C, 1994, INFECT IMMUN, V62, P259, DOI 10.1128/IAI.62.1.259-265.1994; Dawson RM, 2008, CRIT REV MICROBIOL, V34, P89, DOI [10.1080/10408410802143808, 10.1080/10408410802143808 ]; DeMeulenaer B, 1997, J COLLOID INTERF SCI, V189, P254, DOI 10.1006/jcis.1997.4789; Domingues MM, 2008, J PEPT SCI, V14, P394, DOI 10.1002/psc.1007; Domingues MM, 2009, BIOPHYS J, V96, P987, DOI 10.1016/j.bpj.2008.10.044; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; Garcia-Verdugo I, 2005, BIOCHEM J, V391, P115, DOI 10.1042/BJ20050529; Garcia-Verdugo I, 2007, BIOPHYS J, V93, P3529, DOI 10.1529/biophysj.107.109793; GAZZANOSANTORO H, 1992, INFECT IMMUN, V60, P4754, DOI 10.1128/IAI.60.11.4754-4761.1992; Gura T, 2001, SCIENCE, V291, P2068, DOI 10.1126/science.291.5511.2068; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Herbig ME, 2005, BBA-BIOMEMBRANES, V1712, P197, DOI 10.1016/j.bbamem.2005.04.006; Horwitz AH, 2000, PROTEIN EXPRES PURIF, V18, P77, DOI 10.1006/prep.1999.1163; KAMIO Y, 1976, BIOCHEMISTRY-US, V15, P2561, DOI 10.1021/bi00657a012; LEEUWENBERG JFM, 1994, J IMMUNOL, V152, P5070; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; Levy O, 2004, J LEUKOCYTE BIOL, V76, P909, DOI 10.1189/jlb.0604320; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Muller M, 2003, J MEMBRANE BIOL, V192, P33, DOI 10.1007/s00232-002-1062-0; Nomura K, 2008, BIOPHYS J, V95, P1226, DOI 10.1529/biophysj.108.131706; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; SCHUMANN RR, 1992, RES IMMUNOL, V143, P11, DOI 10.1016/0923-2494(92)80074-U; Tobias PS, 1997, J BIOL CHEM, V272, P18682, DOI 10.1074/jbc.272.30.18682; van Balen GP, 2004, MED RES REV, V24, P299, DOI 10.1002/med.10063; WEISS J, 1978, J BIOL CHEM, V253, P2664; Wiese A, 1997, BIOCHEMISTRY-US, V36, P10311, DOI 10.1021/bi970177e; Wiese A, 1997, BIOCHEMISTRY-US, V36, P10301, DOI 10.1021/bi970176m	41	65	66	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8385	10.1371/journal.pone.0008385	http://dx.doi.org/10.1371/journal.pone.0008385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027298	gold, Green Published, Green Submitted			2022-12-25	WOS:000272998000002
J	Leitao, B; Jones, MC; Fusi, L; Higham, J; Lee, Y; Takano, M; Goto, T; Christian, M; Lam, EWF; Brosens, JJ				Leitao, Beatriz; Jones, Marius C.; Fusi, Luca; Higham, Jenny; Lee, Yun; Takano, Masashi; Goto, Tomoko; Christian, Mark; Lam, Eric W. -F.; Brosens, Jan J.			Silencing of the JNK pathway maintains progesterone receptor activity in decidualizing human endometrial stromal cells exposed to oxidative stress signals	FASEB JOURNAL			English	Article						sumoylation; MKP1; reactive oxygen species; pregnancy	ACTIVATED PROTEIN-KINASE; IMMEDIATE-EARLY GENE; N-TERMINAL KINASE; SUMO MODIFICATIONS; INDUCED APOPTOSIS; CROSS-TALK; EXPRESSION; SUMOYLATION; DEATH; DIFFERENTIATION	Survival of the conceptus is dependent on continuous progesterone signaling in the maternal decidua but how this is achieved under conditions of oxidative stress that characterize early pregnancy is unknown. Using primary cultures, we show that modest levels of reactive oxygen species (ROS) increase sumoylation in human endometrial stromal cells (HESCs), leading to enhanced modification and transcriptional inhibition of the progesterone receptor (PR). The ability of ROS to induce a sustained hypersumoylation response, or interfere with PR activity, was lost upon differentiation of HESCs into decidual cells. Hypersumoylation in response to modest levels of ROS requires activation of the JNK pathway. Although ROS-dependent JNK signaling is disabled on decidualization, the cells continue to mount a transcriptional response, albeit distinct from that observed in undifferentiated HESCs. We further show that attenuated JNK signaling in decidual cells is a direct consequence of altered expression of key pathway modulators, including induction of MAP kinase phosphatase 1 (MKP1). Overexpression of MKP1 dampens JNK signaling, prevents hypersumoylation, and maintains PR activity in undifferentiated HESCs exposed to ROS. Thus, JNK silencing uncouples ROS signaling from the SUMO conjugation pathway and maintains progesterone responses and cellular homeostasis in decidual cells under oxidative stress conditions imposed by pregnancy.-Leitao, B., Jones, M. C., Fusi, L., Higham, J., Lee, Y. Takano, M., Goto, T., Christian, M., Lam, E. W.-F., Brosens, J. J. Silencing of the Jnk pathway maintains progesterone receptor activity in decidualizing human endometrial stromal cells exposed to oxidative stress signals. FASEB J. 24, 1541-1551 (2010). www.fasebj.org	[Leitao, Beatriz; Jones, Marius C.; Fusi, Luca; Higham, Jenny; Lee, Yun; Takano, Masashi; Goto, Tomoko; Christian, Mark; Brosens, Jan J.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Hammersmith Hosp, London W12 0NN, England; [Lam, Eric W. -F.] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, London W12 0NN, England	Imperial College London; Imperial College London	Brosens, JJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Hammersmith Campus,Du Canc Rd, London W12 0NN, England.	j.brosens@imperial.ac.uk	Lam, Eric W-F/AAW-8566-2020	Lam, Eric W-F/0000-0003-1274-3576; Brosens, Jan/0000-0003-0116-9329; Christian, Mark/0000-0002-1616-4179	Wellcome Trust [084336]; Institute of Obstetrics and Gynaecology (IOG) Trust; National Institute for Health Research (NIHR) Biomedical Research Centre; Cancer Research UK [12011] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Institute of Obstetrics and Gynaecology (IOG) Trust; National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK)	The authors are grateful to all the women who participated in this study. This work was supported by the Wellcome Trust (084336), the Institute of Obstetrics and Gynaecology (IOG) Trust, and the National Institute for Health Research (NIHR) Biomedical Research Centre funding scheme. The authors declare no conflicts of interest.	Abdel-Hafiz H, 2002, J BIOL CHEM, V277, P33950, DOI 10.1074/jbc.M204573200; Barthel A, 2005, BIOL CHEM, V386, P207, DOI 10.1515/BC.2005.026; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bogoyevitch MA, 2006, BIOESSAYS, V28, P923, DOI 10.1002/bies.20458; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Brar AK, 2001, PHYSIOL GENOMICS, V7, P135, DOI 10.1152/physiolgenomics.00061.2001; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; CHARLES CH, 1992, ONCOGENE, V7, P187; Christian M, 2002, MOL ENDOCRINOL, V16, P141, DOI 10.1210/me.16.1.141; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Critchley HOD, 2001, CLIN ENDOCRINOL, V55, P701, DOI 10.1046/j.1365-2265.2001.01432.x; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; EMSLIE EA, 1994, HUM GENET, V93, P513; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Holgado-Madruga M, 2003, MOL CELL BIOL, V23, P4471, DOI 10.1128/MCB.23.13.4471-4484.2003; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kuwano Y, 2008, CELL CYCLE, V7, P2640, DOI 10.4161/cc.7.17.6534; Labied S, 2006, MOL ENDOCRINOL, V20, P35, DOI 10.1210/me.2005-0275; Lievre M, 2009, CONTRACEPTION, V80, P95, DOI 10.1016/j.contraception.2009.01.011; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Meinecke I, 2007, P NATL ACAD SCI USA, V104, P5073, DOI 10.1073/pnas.0608773104; Molton SA, 2003, ONCOGENE, V22, P4690, DOI 10.1038/sj.onc.1206692; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Sanchez-Perez I, 2002, MOL BIOL CELL, V13, P2933, DOI 10.1091/mbc.E02-01-0022; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Tung RM, 1997, ONCOGENE, V14, P653, DOI 10.1038/sj.onc.1200877; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Venugopal SK, 2007, J BIOL CHEM, V282, P31900, DOI 10.1074/jbc.M703729200; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; Xie P, 2009, J BIOL CHEM, V284, P5488, DOI 10.1074/jbc.M806487200; Xu QH, 2004, FREE RADICAL BIO MED, V36, P985, DOI 10.1016/j.freeradbiomed.2004.01.009; Xu Z, 2008, FASEB J, V22, P127, DOI 10.1096/fj.06-7871com; YAN MH, 1994, NATURE, V372, P798; Yang JJ, 2002, BIOCHEM BIOPH RES CO, V297, P105, DOI 10.1016/S0006-291X(02)02123-X; Yao ZB, 1997, J BIOL CHEM, V272, P32378, DOI 10.1074/jbc.272.51.32378; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	53	67	68	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1541	1551		10.1096/fj.09-149153	http://dx.doi.org/10.1096/fj.09-149153			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20026682	hybrid, Green Published			2022-12-25	WOS:000277158900027
J	Wang, GR; Guo, XX; DiAngelo, S; Thomas, NJ; Floros, J				Wang, Guirong; Guo, Xiaoxuan; DiAngelo, Susan; Thomas, Neal J.; Floros, Joanna			Humanized SFTPA1 and SFTPA2 Transgenic Mice Reveal Functional Divergence of SP-A1 and SP-A2 FORMATION OF TUBULAR MYELIN IN VIVO REQUIRES BOTH GENE PRODUCTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACTANT-PROTEIN-A; HUMAN FETAL LUNG; DEFICIENT MICE; OZONE EXPOSURE; SP-C; PSEUDOMONAS-AERUGINOSA; BIOCHEMICAL-PROPERTIES; INSITU HYBRIDIZATION; BIOLOGICAL FUNCTION; CYTOKINE PRODUCTION	Surfactant protein A (SP-A) plays a role in lung innate immunity and surfactant-related functions. Two functional genes, SP-A1 (SFTPA1) and SP-A2 (SFTPA2), are present in humans and primates (rodents have one gene). Single gene SP-A1 or SP-A2 proteins expressed in vitro are functional. To study their role in vivo, we generated humanized transgenic (hTG) C57BL/6 mice, SP-A1(6A(4)) and SP-A2(1A(3)). The SP-A cDNA in experimental constructs was driven by the 3.7-kb SP-C promoter. Positive hTG mice were bred with SP-A knock-out mice to generate F8 offspring for study. Epithelial alveolar type II cells were SPA-positive, and Clara cells were negative by immunohistochemistry in hTG mice. The levels of SP-A in lungs of two hTG lines used were comparable with those in human lungs. Southern blot analysis indicated that two cDNA copies of either SP-A1(6A4) or SP-A2(1A(3)) were integrated as a concatemer into the genome of each of the two hTG lines. Electron microscopy analysis revealed that hTG mice with a single SP-A1(6A(4)) or SP-A2(1A(3)) gene product lacked tubular myelin (TM), but hTG mice carrying both had TM. Furthermore, TM was observed in human bronchoalveolar lavage fluid only if both SP-A1 and SP-A2 gene products were present and not in those containing primarily (>99.7%) either SP-A1 or SP-A2 gene products. In vivo rescue study confirmed that TM can only be restored after administering exogenous SP-A containing both SP-A1 and SP-A2 into the lungs of SP-A knock-out mice. These observations indicate that SP-A1 and SP-A2 diverged functionally at least in terms of TM formation.	[Wang, Guirong; DiAngelo, Susan; Thomas, Neal J.; Floros, Joanna] Penn State Univ, Penn State Hershey Coll Med, Penn State Ctr Host Def Inflammat & Lung Dis Res, Dept Pediat, Hershey, PA 17033 USA; [Guo, Xiaoxuan] Penn State Univ, Penn State Hershey Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Thomas, Neal J.] Penn State Univ, Penn State Hershey Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [Floros, Joanna] Penn State Univ, Penn State Hershey Coll Med, Dept Obstet & Gynecol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Floros, J (corresponding author), Penn State Univ, Coll Med, Penn State CHILD Res, Dept Pediat, H085,500 Univ Dr, Hershey, PA 17033 USA.	jfloros@psu.edu		Thomas, Neal/0000-0002-7991-7510	National Institutes of Health [ES09882]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES09882.	Akiyama J, 2002, J HISTOCHEM CYTOCHEM, V50, P993, DOI 10.1177/002215540205000713; Albertelli MA, 2006, MOL ENDOCRINOL, V20, P1248, DOI 10.1210/me.2006-0021; AUTEN RL, 1990, AM J RESP CELL MOL, V3, P491, DOI 10.1165/ajrcmb/3.5.491; Bates SR, 2008, AM J PHYSIOL-LUNG C, V294, pL325, DOI 10.1152/ajplung.00341.2007; Berg T, 2000, BBA-PROTEIN STRUCT M, V1543, P159, DOI 10.1016/S0167-4838(00)00184-9; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Elhalwagi BM, 1999, AM J RESP CELL MOL, V21, P380, DOI 10.1165/ajrcmb.21.3.3676; Fehrenbach H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-60; FLOROS J, 1986, J BIOL CHEM, V261, P9029; FLOROS J, 2002, SURFACTANT UPDATE IN, V6, P87; Floros J, 2009, CRIT REV EUKAR GENE, V19, P125, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.30; FROH D, 1990, BIOCHIM BIOPHYS ACTA, V1052, P78, DOI 10.1016/0167-4889(90)90060-Q; FungLeung WP, 1996, J EXP MED, V183, P49, DOI 10.1084/jem.183.1.49; Garcia-Verdugo I, 2002, BIOCHEMISTRY-US, V41, P14041, DOI 10.1021/bi026540l; Giannoni E, 2006, AM J RESP CELL MOL, V34, P704, DOI 10.1165/rcmb.2005-0461OC; Glasser SW, 2005, AM J PHYSIOL-LUNG C, V288, pL625, DOI 10.1152/ajplung.00250.2004; Glasser SW, 2000, AM J PHYSIOL-LUNG C, V278, pL933, DOI 10.1152/ajplung.2000.278.5.L933; GLASSER SW, 1991, AM J PHYSIOL, V261, pL349, DOI 10.1152/ajplung.1991.261.4.L349; Gonzalez FJ, 2006, ANNU REV PHARMACOL, V46, P41, DOI 10.1146/annurev.pharmtox.45.120403.100007; Goss KL, 1998, AM J RESP CELL MOL, V19, P613, DOI 10.1165/ajrcmb.19.4.3155; Haque R, 2007, TOXICOL APPL PHARM, V220, P72, DOI 10.1016/j.taap.2006.12.017; Hattori A, 1996, BIOCHEM J, V317, P939, DOI 10.1042/bj3170939; Hattori A, 1996, AM J RESP CELL MOL, V14, P608, DOI 10.1165/ajrcmb.14.6.8652189; Hoover RR, 1999, AM J PHYSIOL-LUNG C, V276, pL917, DOI 10.1152/ajplung.1999.276.6.L917; Huang WX, 2004, AM J PHYSIOL-LUNG C, V286, pL546, DOI 10.1152/ajplung.00267.2003; Ikegami M, 1998, AM J PHYSIOL-LUNG C, V275, pL247, DOI 10.1152/ajplung.1998.275.2.L247; Ikegami M, 2001, J BIOL CHEM, V276, P38542, DOI 10.1074/jbc.M102054200; Jain D, 2003, AM J PHYSIOL-LUNG C, V284, pL759, DOI 10.1152/ajplung.00200.2002; Karinch AM, 1997, BIOCHEM J, V321, P39, DOI 10.1042/bj3210039; Kingma PS, 2006, J BIOL CHEM, V281, P24496, DOI 10.1074/jbc.M600651200; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; LeVine AM, 1997, J IMMUNOL, V158, P4336; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; Li G, 2002, AM J RESP CELL MOL, V26, P277, DOI 10.1165/ajrcmb.26.3.4584; Lin ZW, 2001, PEDIATR PATHOL MOL M, V20, P367, DOI 10.1080/15513810109168621; MacNeill C, 2004, IMMUNOLOGY, V111, P91, DOI 10.1111/j.1365-2567.2004.01782.x; Mikerov AN, 2005, AM J PHYSIOL-LUNG C, V288, pL150, DOI 10.1152/ajplung.00135.2004; Mikerov AN, 2008, AM J PHYSIOL-LUNG C, V294, pL121, DOI 10.1152/ajplung.00288.2007; Mikerov AN, 2007, INFECT IMMUN, V75, P1403, DOI 10.1128/IAI.01341-06; Mikerov AN, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-77; Oberley RE, 2003, AM J PHYSIOL-LUNG C, V284, pL871, DOI 10.1152/ajplung.00241.2002; Ochs M, 2002, AM J RESP CELL MOL, V26, P91, DOI 10.1165/ajrcmb.26.1.4570; Palaniyar N, 2002, J BIOL CHEM, V277, P26971, DOI 10.1074/jbc.M110080200; PHELPS DS, 1988, AM REV RESPIR DIS, V137, P939, DOI 10.1164/ajrccm/137.4.939; PHELPS DS, 1991, EXP LUNG RES, V17, P985, DOI 10.3109/01902149109064330; POULAIN FR, 1992, AM J PHYSIOL, V262, pL730, DOI 10.1152/ajplung.1992.262.6.L730; Poulain FR, 1999, AM J RESP CELL MOL, V20, P1049, DOI 10.1165/ajrcmb.20.5.3497; Raquel R, 2009, PNEUMON, V22, P143; Reaume AG, 1996, J BIOL CHEM, V271, P23380, DOI 10.1074/jbc.271.38.23380; Saitoh H, 1998, AM J RESP CELL MOL, V19, P202, DOI 10.1165/ajrcmb.19.2.3239; Scheer N, 2008, J CLIN INVEST, V118, P3228, DOI 10.1172/JCI35483; Schmiedl A, 2007, PEDIATR PULM, V42, P548, DOI 10.1002/ppul.20623; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Tagaram HRS, 2007, AM J PHYSIOL-LUNG C, V292, pL1052, DOI 10.1152/ajplung.00249.2006; Taneja V, 1998, J CLIN INVEST, V101, P921, DOI 10.1172/JCI2860; VOORHOUT WF, 1991, J HISTOCHEM CYTOCHEM, V39, P1331, DOI 10.1177/39.10.1940306; VOSS T, 1991, AM J RESP CELL MOL, V4, P88, DOI 10.1165/ajrcmb/4.1.88; Wang GR, 2005, AM J PHYSIOL-LUNG C, V289, pL497, DOI 10.1152/ajplung.00100.2005; Wang GR, 2004, BIOCHEMISTRY-US, V43, P4227, DOI 10.1021/bi036023i; Wang GR, 2002, ENVIRON HEALTH PERSP, V110, P79, DOI 10.1289/ehp.0211079; Wang GR, 2000, AM J PHYSIOL-LUNG C, V278, pL946, DOI 10.1152/ajplung.2000.278.5.L946; Wang GR, 2007, BBA-BIOMEMBRANES, V1768, P2060, DOI 10.1016/j.bbamem.2007.06.025; Wang GR, 2007, BIOCHEMISTRY-US, V46, P8425, DOI 10.1021/bi7004569; WILLIAMS MC, 1991, AM J RESP CELL MOL, V5, P41, DOI 10.1165/ajrcmb/5.1.41; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528	65	57	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11998	12010		10.1074/jbc.M109.046243	http://dx.doi.org/10.1074/jbc.M109.046243			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20048345	Green Published, hybrid			2022-12-25	WOS:000276787100029
J	Periyasamy, S; Hinds, T; Shemshedini, L; Shou, W; Sanchez, ER				Periyasamy, S.; Hinds, T., Jr.; Shemshedini, L.; Shou, W.; Sanchez, E. R.			FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A	ONCOGENE			English	Article						transcription; prostate cancer; androgen receptor; Cyp40; FKBP51; FKBP52	NF-KAPPA-B; PEPTIDYL-PROLYL ISOMERASE; IMMUNOPHILIN FKBP51; IDIOPATHIC MYELOFIBROSIS; GLUCOCORTICOID-RECEPTOR; INSENSITIVITY SYNDROME; MOLECULAR-MECHANISMS; MEDIATED REGULATION; FACTOR INDEPENDENCE; SQUIRREL-MONKEY	Prostate cancer (PCa) growth is dependent on androgens and on the androgen receptor (AR), which acts by modulating gene transcription. Tetratricopeptide repeat (TPR) proteins (FKBP52, FKBP51 and Cyp40) interact with AR in PCa cells, suggesting roles in AR-mediated gene transcription and cell growth. We report here that FKBP51 and Cyp40, but not FKBP52, are significantly elevated in PCa tissues and in androgen-dependent (AD) and androgen-independent (AI) cell lines. Overexpression of FKBP51 in AD LNCaP cells increased AR transcriptional activity in the presence and absence of androgen, whereas siRNA knockdown of FKBP51 dramatically decreased AD gene transcription and proliferation. Knockdown of Cyp40 also inhibited androgen-mediated transcription and growth in LNCaP cells. However, disruption of FKBP51 and Cyp40 in AI C4-2 cells caused only a small reduction in proliferation, indicating that Cyp40 and FKBP51 predominantly regulate AD cell proliferation. Under knockdown conditions, the inhibitory effects of TPR ligands, cyclosporine A (CsA) and FK506, on AR activity were not observed, indicating that Cyp40 and FKBP51 are the targets of CsA and FK506, respectively. Our findings show that FKBP51 and Cyp40 are positive regulators of AR that can be selectively targeted by CsA and FK506 to achieve inhibition of androgen-induced cell proliferation. These proteins and their cognate ligands thus provide new strategies in the treatment of PCa. Oncogene (2010) 29, 1691-1701; doi:10.1038/onc.2009.458; published online 21 December 2009	[Shemshedini, L.] Univ Toledo Main Campus, Dept Biol Sci, Toledo, OH USA; [Shou, W.] Indiana Univ, Sch Med, Dept Pediat, Pediat Cardiol Sect,Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Periyasamy, S.; Hinds, T., Jr.; Sanchez, E. R.] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, CeDER, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University of Toledo Health Science Campus; Indiana University System; Indiana University-Purdue University Indianapolis; University System of Ohio; University of Toledo	Periyasamy, S (corresponding author), Univ Toledo Hlth Sci Campus, Dept Physiol & Pharmacol, 3000 Arlington Ave,Mail Stop 1008, Toledo, OH 43614 USA.	sumudra.periyasamy@utoledo.edu	Hinds, Terry/B-8495-2015	Hinds, Terry/0000-0002-7599-1529	National Institutes of Health [DK73402, DK70127]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK084958, R01DK073402, R01DK070127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs Theo Rein (Max Planck Institute of Psychiatry) and Marianne Sadar (British Columbia Cancer Agency) for the generous gift of Flag-tagged FKBP51 and PSA-luciferase reporter plasmid, respectively. This study was supported in part by National Institutes of Health grants DK73402 to WS and DK70127 to ERS.	Ahonen TJ, 2003, J BIOL CHEM, V278, P27287, DOI 10.1074/jbc.M304307200; Amler LC, 2000, CANCER RES, V60, P6134; Avellino R, 2005, BLOOD, V106, P1400, DOI 10.1182/blood-2005-03-0929; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Banerjee A, 2008, BIOCHEMISTRY-US, V47, P10471, DOI 10.1021/bi8011862; BATCH JA, 1992, HUM MOL GENET, V1, P497, DOI 10.1093/hmg/1.7.497; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Chen CD, 2002, MOL CELL BIOL, V22, P2862, DOI 10.1128/MCB.22.8.2862-2870.2002; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Cheung-Flynn J, 2003, J BIOL CHEM, V278, P17388, DOI 10.1074/jbc.M300955200; Cinar B, 2004, BIOCHEM J, V379, P421, DOI 10.1042/BJ20031661; Craft N, 1998, CANCER METAST REV, V17, P421, DOI 10.1023/A:1006141806801; Dehm SM, 2007, CANCER RES, V67, P10067, DOI 10.1158/0008-5472.CAN-07-1267; Dehm SM, 2006, J BIOL CHEM, V281, P27882, DOI 10.1074/jbc.M605002200; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Febbo PG, 2005, J UROLOGY, V173, P1772, DOI 10.1097/01.ju.0000155845.44729.ba; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Giraudier S, 2002, BLOOD, V100, P2932, DOI 10.1182/blood-2002-02-0485; Gregory CW, 2001, CANCER RES, V61, P4315; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Han GZ, 2005, P NATL ACAD SCI USA, V102, P1151, DOI 10.1073/pnas.0408925102; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hubler TR, 2003, ENDOCRINOLOGY, V144, P2380, DOI 10.1210/en.2003-0092; Igawa T, 2002, PROSTATE, V50, P222, DOI 10.1002/pros.10054; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jiang W, 2008, NEOPLASIA, V10, P235, DOI 10.1593/neo.07929; Komura E, 2003, EXP HEMATOL, V31, P622, DOI 10.1016/S0301-472X(03)00085-7; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; Lee SO, 2005, PROSTATE, V64, P160, DOI 10.1002/pros.20218; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Liao XB, 2005, MOL CANCER THER, V4, P505, DOI 10.1158/1535-7163.MCT-04-0313; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Makkonen H, 2009, NUCLEIC ACIDS RES, V37, P4135, DOI 10.1093/nar/gkp352; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McEwan IJ, 2004, ENDOCR-RELAT CANCER, V11, P281, DOI 10.1677/erc.0.0110281; Mousses S, 2001, ONCOGENE, V20, P6718, DOI 10.1038/sj.onc.1204889; NAKAO R, 1992, J CLIN ENDOCR METAB, V74, P1152, DOI 10.1210/jc.74.5.1152; Periyasamy S, 2007, ENDOCRINOLOGY, V148, P4716, DOI 10.1210/en.2007-0145; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Ratajczak T, 2003, CURR TOP MED CHEM, V3, P1348, DOI 10.2174/1568026033451934; Reid J, 2002, J BIOL CHEM, V277, P41247, DOI 10.1074/jbc.M205220200; Reynolds PD, 1999, J CLIN ENDOCR METAB, V84, P663, DOI 10.1210/jc.84.2.663; Riggs DL, 2007, MOL CELL BIOL, V27, P8658, DOI 10.1128/MCB.00985-07; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Romano MF, 2004, EUR J CANCER, V40, P2829, DOI 10.1016/j.ejca.2004.08.017; Scherr D, 2003, UROLOGY, V61, P14, DOI 10.1016/S0090-4295(02)02395-6; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Thalmann GN, 2000, PROSTATE, V44, P91; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Vanaja DK, 2002, CELL STRESS CHAPERON, V7, P55, DOI 10.1379/1466-1268(2002)007<0055:EOGOAR>2.0.CO;2; Velasco AM, 2004, ENDOCRINOLOGY, V145, P3913, DOI 10.1210/en.2004-0311; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P742, DOI 10.1021/bi00147a029; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Yong WD, 2007, J BIOL CHEM, V282, P5026, DOI 10.1074/jbc.M609360200; Zhu W, 2001, CARCINOGENESIS, V22, P1399, DOI 10.1093/carcin/22.9.1399	64	90	91	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2010	29	11					1691	1701		10.1038/onc.2009.458	http://dx.doi.org/10.1038/onc.2009.458			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	570RC	20023700	Green Accepted			2022-12-25	WOS:000275694700014
J	Bargagna-Mohan, P; Paranthan, RR; Hamza, A; Dimova, N; Trucchi, B; Srinivasan, C; Elliott, GI; Zhan, CG; Lau, DL; Zhu, HY; Kasahara, K; Inagaki, M; Cambi, F; Mohan, R				Bargagna-Mohan, Paola; Paranthan, Riya R.; Hamza, Adel; Dimova, Neviana; Trucchi, Beatrice; Srinivasan, Cidambi; Elliott, Gregory I.; Zhan, Chang-Guo; Lau, Daniel L.; Zhu, Haiyan; Kasahara, Kousuke; Inagaki, Masaki; Cambi, Franca; Mohan, Royce			Withaferin A Targets Intermediate Filaments Glial Fibrillary Acidic Protein and Vimentin in a Model of Retinal Gliosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE DEFICIENT; MULLER CELLS; GFAP; PHOSPHORYLATION; ASTROCYTES; DYNAMICS; INJURY; PROLIFERATION; CYTOSKELETAL; INHIBITION	Gliosis is a biological process that occurs during injury repair in the central nervous system and is characterized by the overexpression of the intermediate filaments (IFs) glial fibrillary acidic protein (GFAP) and vimentin. A common thread in many retinal diseases is reactive Muller cell gliosis, an untreatable condition that leads to tissue scarring and even blindness. Here, we demonstrate that the vimentin-targeting small molecule withaferin A (WFA) is a novel chemical probe of GFAP. Using molecular modeling studies that build on the x-ray crystal structure of tetrameric vimentin rod 2B domain we reveal that the WFA binding site is conserved in the corresponding domain of tetrameric GFAP. Consequently, we demonstrate that WFA covalently binds soluble recombinant tetrameric human GFAP at cysteine 294. In cultured primary astrocytes, WFA binds to and down-regulates soluble vimentin and GFAP expression to cause cell cycle G(0)/G(1) arrest. Exploiting a chemical injury model that overexpresses vimentin and GFAP in retinal Muller glia, we demonstrate that systemic delivery of WFA down-regulates soluble vimentin and GFAP expression in mouse retinas. This pharmacological knockdown of soluble IFs results in the impairment of GFAP filament assembly and inhibition of cell proliferative response in Muller glia. We further show that a more severe GFAP filament assembly deficit manifests in vimentin-deficient mice, which is partly rescued by WFA. These findings illustrate WFA as a chemical probe of type III IFs and illuminate this class of with anolide as a potential treatment for diverse gliosis-dependent central nervous system traumatic injury conditions and diseases, and for orphan IF-dependent pathologies.	[Hamza, Adel; Elliott, Gregory I.; Zhan, Chang-Guo; Mohan, Royce] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Dimova, Neviana; Zhu, Haiyan; Cambi, Franca] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Srinivasan, Cidambi] Univ Kentucky, Dept Stat, Lexington, KY 40536 USA; [Elliott, Gregory I.] Univ Kentucky, Dept Chem, Lexington, KY 40536 USA; [Lau, Daniel L.] Univ Kentucky, Dept Elect & Comp Engn, Lexington, KY 40536 USA; Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40536 USA; [Kasahara, Kousuke; Inagaki, Masaki] Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 4648681, Japan	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Aichi Cancer Center	Mohan, R (corresponding author), Lab Chem Biol & Drug Discovery, 166 HSRB,1095 VA Dr, Lexington, KY 40536 USA.	Royce.Mohan@uky.edu	zhu, xueqiong/U-1320-2019; Inagaki, Masaki/B-9920-2016; Lau, Daniel L/O-5169-2014	Lau, Daniel L/0000-0003-1377-4622	National Institutes of Health [R21 NS053593, R01 EY0167821, R01 DA013930, R01 DA025100, R01 DA021416, R01NS053905]; Kentucky Science and Technology Corporation [KSTC-144-401-07-020]; Kentucky Science and Engineering Foundation [KSEF-578-RDE-005]; Research to Prevent Blindness, Inc.; European Leukodystrophy Association Foundation; NATIONAL EYE INSTITUTE [R01EY016782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053905, R21NS053593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021416, R01DA025100, R01DA013930] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [19057010] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Science and Technology Corporation; Kentucky Science and Engineering Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); European Leukodystrophy Association Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 NS053593, R01 EY0167821, R01 DA013930, R01 DA025100, and R01 DA021416 (C.-G.Z.), and R01NS053905, the Fight for Sight, Inc., Grant KSTC-144-401-07-020 from the Kentucky Science and Technology Corporation and KSEF-578-RDE-005 from the Kentucky Science and Engineering Foundation (to R.M.), and additionally by a Challenge Grant from Research to Prevent Blindness, Inc. and a grant from the European Leukodystrophy Association Foundation (to F.C.).	Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2006, INVEST OPHTH VIS SCI, V47, P4138, DOI 10.1167/iovs.05-1452; Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; Bornheim R, 2008, J CELL SCI, V121, P3737, DOI 10.1242/jcs.030312; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Colakoglu G, 2009, J CELL BIOL, V185, P769, DOI 10.1083/jcb.200809166; DAHL D, 1982, J HISTOCHEM CYTOCHEM, V30, P207, DOI 10.1177/30.3.7037941; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Eckes B, 2000, J CELL SCI, V113, P2455; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Fisher SK, 2003, VISION RES, V43, P887, DOI 10.1016/S0042-6989(02)00680-6; FRANKE WW, 1979, J CELL BIOL, V81, P570, DOI 10.1083/jcb.81.3.570; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Galou M, 1996, J CELL BIOL, V133, P853, DOI 10.1083/jcb.133.4.853; Gillard BK, 1998, EXP CELL RES, V242, P561, DOI 10.1006/excr.1998.4126; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003; Guidry C, 2005, PROG RETIN EYE RES, V24, P75, DOI 10.1016/j.preteyeres.2004.07.001; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Huang Z, 2002, MOL CELL NEUROSCI, V19, P250, DOI 10.1006/mcne.2001.1077; INAGAKI M, 1990, J BIOL CHEM, V265, P4722; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200; KOUKLIS PD, 1992, J CELL SCI, V102, P31; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Li HH, 2006, J CELL SCI, V119, P4452, DOI 10.1242/jcs.03219; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; MALLOCH GDA, 1987, J NEUROCHEM, V48, P299, DOI 10.1111/j.1471-4159.1987.tb13162.x; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Mignot C, 2007, EXP CELL RES, V313, P2766, DOI 10.1016/j.yexcr.2007.04.035; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Moromizato Y, 2000, AM J PATHOL, V157, P1277, DOI 10.1016/S0002-9440(10)64643-3; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Nielsen AL, 2004, J BIOL CHEM, V279, P41537, DOI 10.1074/jbc.M406601200; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2001, Prog Brain Res, V132, P23; Petrukhin K, 2007, EXPERT OPIN THER TAR, V11, P625, DOI 10.1517/14728222.11.5.625; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Rogers KR, 1996, J STRUCT BIOL, V117, P55, DOI 10.1006/jsbi.1996.0069; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Spurny R, 2008, EXP CELL RES, V314, P3570, DOI 10.1016/j.yexcr.2008.09.012; Tackenberg MA, 2009, MOL VIS, V15, P1886; Takemura M, 2002, J NEUROSCI, V22, P6972; Tian RJ, 2006, AM J PATHOL, V168, P888, DOI 10.2353/ajpath.2006.051028; TRAUB P, 1994, BIOESSAYS, V16, P349, DOI 10.1002/bies.950160510; Tura A, 2009, INVEST OPHTH VIS SCI, V50, P452, DOI 10.1167/iovs.08-1973; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Wang N, 2000, AM J PHYSIOL-CELL PH, V279, pC188, DOI 10.1152/ajpcell.2000.279.1.C188; Yokota Y, 2006, BIOORG MED CHEM LETT, V16, P2603, DOI 10.1016/j.bmcl.2006.02.039	67	51	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7657	7669		10.1074/jbc.M109.093765	http://dx.doi.org/10.1074/jbc.M109.093765			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048155	hybrid, Green Published			2022-12-25	WOS:000275415600076
J	Matsunaga-Udagawa, R; Fujita, Y; Yoshiki, S; Terai, K; Kamioka, Y; Kiyokawa, E; Yugi, K; Aoki, K; Matsuda, M				Matsunaga-Udagawa, Rie; Fujita, Yoshihisa; Yoshiki, Sayaka; Terai, Kenta; Kamioka, Yuji; Kiyokawa, Etsuko; Yugi, Katsuyuki; Aoki, Kazuhiro; Matsuda, Michiyuki			The Scaffold Protein Shoc2/SUR-8 Accelerates the Interaction of Ras and Raf	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; KINASE; ACTIVATION; PHOSPHORYLATION; MECHANISM; CASCADES; DYNAMICS; COMPLEX; DOMAIN; SUR-8	Shoc2/SUR-8 positively regulates Ras/ERK MAP kinase signaling by serving as a scaffold for Ras and Raf. Here, we examined the role of Shoc2 in the spatio-temporal regulation of Ras by using a fluorescence resonance energy transfer (FRET)-based biosensor, together with computational modeling. In epidermal growth factor-stimulated HeLa cells, RNA-mediated Shoc2 knockdown reduced the phosphorylation of MEK and ERK with half-maximal inhibition, but not the activation of Ras. For the live monitoring of Ras binding to Raf, we utilized a FRET biosensor wherein Ras and the Ras-binding domain of Raf were connected tandemly and sandwiched with acceptor and donor fluorescent proteins for the FRET measurement. With this biosensor, we found that Shoc2 was required for the rapid interaction of Ras with Raf upon epidermal growth factor stimulation. To decipher the molecular mechanisms underlying the kinetics, we developed two computational models that might account for the action of Shoc2 in the Ras-ERK signaling. One of these models, the Shoc2 accelerator model, provided a reasonable explanation of the experimental observations. In this Shoc2 accelerator model, Shoc2 accelerated both the association and dissociation of Ras-Raf interaction. We propose that Shoc2 regulates the spatio-temporal patterns of the Ras-ERK signaling pathway primarily by accelerating the Ras-Raf interaction.	[Aoki, Kazuhiro; Matsuda, Michiyuki] Kyoto Univ, Lab Bioimaging & Cell Signaling, Grad Sch Biostudies, Kyoto 6068501, Japan; [Kamioka, Yuji; Kiyokawa, Etsuko; Matsuda, Michiyuki] Kyoto Univ, Dept Pathol & Biol Dis, Grad Sch Med, Kyoto 6068501, Japan; [Yugi, Katsuyuki] Keio Univ, Dept Biosci & Informat, Kanagawa 2238522, Japan; [Aoki, Kazuhiro] Japan Sci & Technol Agcy JST, PREST, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Kyoto University; Keio University; Japan Science & Technology Agency (JST)	Aoki, K (corresponding author), Kyoto Univ, Lab Bioimaging & Cell Signaling, Grad Sch Biostudies, Kyoto 6068501, Japan.	k-aoki@lif.kyoto-u.ac.jp	寺井, 健太/AFQ-7663-2022; Aoki, Kazuhiro/I-5483-2019; Aoki, Kazuhiro/B-5777-2013	寺井, 健太/0000-0001-7638-3720; Aoki, Kazuhiro/0000-0001-7263-1555; Aoki, Kazuhiro/0000-0001-7263-1555; Matsuda, Michiyuki/0000-0002-5876-9969; Fujita, Yoshihisa/0000-0002-5086-8188	Ministry of Education, Culture, Sports, and Science of Japan; Sagawa Cancer Research; Japan Science and Technology PRESTO; Kyoto University Global COE	Ministry of Education, Culture, Sports, and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sagawa Cancer Research; Japan Science and Technology PRESTO; Kyoto University Global COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, and Science of Japan, a Sagawa Cancer Research Grant, the Japan Science and Technology PRESTO program, and funds from the Kyoto University Global COE program, "Center for Frontier Medicine."	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Anselmo AN, 2002, J BIOL CHEM, V277, P5940, DOI 10.1074/jbc.M110498200; Aoki K, 2008, PHILOS T R SOC B, V363, P2143, DOI 10.1098/rstb.2008.2267; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; BOS JL, 1989, CANCER RES, V49, P4682; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen D, 1996, J BIOL CHEM, V271, P6328, DOI 10.1074/jbc.271.11.6328; Dai PG, 2006, J BIOL CHEM, V281, P927, DOI 10.1074/jbc.M507360200; Day RN, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2939094; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Hara S, 2008, MOL BIOL CELL, V19, P3823, DOI 10.1091/mbc.E08-03-0314; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kiyokawa E, 2006, CANCER SCI, V97, P8, DOI 10.1111/j.1349-7006.2006.00141.x; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li WQ, 2000, GENE DEV, V14, P895; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; McCormick F, 1996, CURR OPIN BIOTECH, V7, P449, DOI 10.1016/S0958-1669(96)80123-6; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Ohba Y, 2003, EMBO J, V22, P859, DOI 10.1093/emboj/cdg087; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P5, DOI 10.1023/B:MCBI.0000009855.14648.2c; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pollok BA, 1999, TRENDS CELL BIOL, V9, P57, DOI 10.1016/S0962-8924(98)01434-2; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sauro Herbert M., 2003, OMICS A Journal of Integrative Biology, V7, P355, DOI 10.1089/153623103322637670; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Wu N, 2001, J AM CHEM SOC, V123, P6465, DOI 10.1021/ja010219t	41	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7818	7826		10.1074/jbc.M109.053975	http://dx.doi.org/10.1074/jbc.M109.053975			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20051520	hybrid, Green Published			2022-12-25	WOS:000275415600089
J	Bernot, D; Barruet, E; Poggi, M; Bonardo, B; Alessi, MC; Peiretti, F				Bernot, Denis; Barruet, Emilie; Poggi, Marjorie; Bonardo, Bernadette; Alessi, Marie-Christine; Peiretti, Franck			Down-regulation of Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) Expression Is Necessary for Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUTRITIONALLY INDUCED OBESITY; SP1 TRANSCRIPTION FACTOR; WHITE ADIPOSE-TISSUE; MATRIX METALLOPROTEINASES; GENE-TRANSCRIPTION; FUNCTIONAL-ROLE; MICE; ADIPOGENESIS; APOPTOSIS; PROMOTER	Matrix metalloproteinase activity is essential for proper extracellular matrix remodeling that takes place during adipose tissue formation. Four tissue inhibitors of matrix metalloproteinases (TIMPs) regulate their activity. However, the role of TIMPs in adipocyte differentiation is poorly understood. We found that the expression of all TIMPs was modified during adipocyte differentiation, but that of TIMP-3 was distinguished by its extreme down-regulation. TIMP-3 expression was closely linked to the differentiation process. Indeed, it remained low during the adipocyte differentiation but increased when cell differentiation was prevented. We identified the transcription factor Sp1 as being responsible for the regulation of TIMP-3 expression during adipocyte differentiation. Overexpression of TIMP-3 reduced adipocyte differentiation, underlining its active role in this process. TIMP-3 overexpression decreased the expression of the early and obligate key inductors of adipogenesis Kruppel-like factor 4 (Klf4), early growth response 2 (Egr2/Krox20), and CAAT/enhancer-binding protein beta (C/EBP beta). Our results indicate that during preadipocyte differentiation, the Sp1-dependent decrease in TIMP-3 expression is required for the successful implementation of the adipocyte differentiation program.	[Bernot, Denis; Barruet, Emilie; Poggi, Marjorie; Bonardo, Bernadette; Alessi, Marie-Christine; Peiretti, Franck] Univ Aix Marseille 2, Fac Med, INSERM, U626, F-13385 Marseille 5, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Peiretti, F (corresponding author), Univ Aix Marseille 2, Fac Med, INSERM, U626, 27 Blvd Jean Moulin, F-13385 Marseille 5, France.	Franck.Peiretti@univmed.fr	poggi, marjorie/ABG-6438-2021; peiretti, franck/L-2718-2017; ALESSI, Marie-christine/AAK-3582-2020; Peiretti, Franck/GLV-3378-2022	poggi, marjorie/0000-0001-6331-9682; peiretti, franck/0000-0001-7198-0534; ALESSI, Marie-christine/0000-0003-3927-5792; Peiretti, Franck/0000-0001-7198-0534	INSERM (Paris, France)	INSERM (Paris, France)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by INSERM (Paris, France).	Alexander CM, 2001, J CELL BIOL, V152, P693, DOI 10.1083/jcb.152.4.693; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Boyle KB, 2009, CELL DEATH DIFFER, V16, P782, DOI 10.1038/cdd.2009.11; Butler GS, 1999, J BIOL CHEM, V274, P10846, DOI 10.1074/jbc.274.16.10846; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Christiaens V, 2008, THROMB HAEMOSTASIS, V99, P290, DOI 10.1160/TH07-10-0589; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Croissandeau G, 2002, BIOCHEM J, V364, P739, DOI 10.1042/BJ20011158; Deng XY, 2006, EUR J CANCER, V42, P3267, DOI 10.1016/j.ejca.2006.07.003; Drynda A, 2005, J IMMUNOL, V174, P6524, DOI 10.4049/jimmunol.174.10.6524; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Finan KM, 2006, LUNG CANCER-J IASLC, V53, P273, DOI 10.1016/j.lungcan.2006.06.006; Lijnen HR, 2003, THROMB HAEMOSTASIS, V89, P249; Lijnen HR, 2002, ARTERIOSCL THROM VAS, V22, P374, DOI 10.1161/hq0302.104522; Lijnen HR, 2001, THROMB HAEMOSTASIS, V85, P1111; Lijnen HR, 2002, THROMB HAEMOSTASIS, V87, P530; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Mansilla S, 2004, BIOCHEMISTRY-US, V43, P7584, DOI 10.1021/bi036185e; Mansilla S, 2008, BIOCHIMIE, V90, P976, DOI 10.1016/j.biochi.2007.12.008; Maquoi E, 2003, THROMB HAEMOSTASIS, V89, P696, DOI 10.1055/s-0037-1613586; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pendas AM, 2004, MOL CELL BIOL, V24, P5304, DOI 10.1128/MCB.24.12.5304-5313.2004; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Poggi M, 2009, DIABETOLOGIA, V52, P1152, DOI 10.1007/s00125-009-1267-1; Qureshi HY, 2005, J CELL PHYSIOL, V203, P345, DOI 10.1002/jcp.20228; Rosen ED, 2000, GENE DEV, V14, P1293; Scroyen I, 2007, J THROMB HAEMOST, V5, P139, DOI 10.1111/j.1538-7836.2006.02284.x; Stohr H, 1995, GENOME RES, V5, P483, DOI 10.1101/gr.5.5.483; SUN Y, 1995, J BIOL CHEM, V270, P19312, DOI 10.1074/jbc.270.33.19312; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; Van Hul M, 2008, J THROMB HAEMOST, V6, P1198, DOI 10.1111/j.1538-7836.2008.02988.x; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wang YH, 2006, MOL CELL BIOL, V26, P5421, DOI 10.1128/MCB.02437-05; WICK M, 1995, BIOCHEM J, V311, P549, DOI 10.1042/bj3110549; Zhang Y, 2008, GYNECOL ONCOL, V108, P234, DOI 10.1016/j.ygyno.2007.09.033	38	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6508	6514		10.1074/jbc.M109.078444	http://dx.doi.org/10.1074/jbc.M109.078444			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20056610	hybrid, Green Published			2022-12-25	WOS:000275367500055
J	Knoblach, B; Rachubinski, RA				Knoblach, Barbara; Rachubinski, Richard A.			Phosphorylation-dependent Activation of Peroxisome Proliferator Protein PEX11 Controls Peroxisome Abundance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; YARROWIA-LIPOLYTICA; DIVISION; YEAST; BIOGENESIS; TRANSCRIPTION; INHERITANCE; EXPRESSION	Peroxisomes are dynamic organelles that divide continuously in growing cell cultures and expand extensively in lipid-rich medium. Peroxisome population control is achieved in part by Pex11p-dependent regulation of peroxisome size and number. Although the production of Pex11p in yeast is tightly linked to peroxisome biogenesis by transcriptional regulation of the PEX11 gene, it remains unclear if and how Pex11p activity could be modulated by rapid signaling. We report the reversible phosphorylation of Saccharomyces cerevisiae Pex11p in response to nutritional cues and delineate a mechanism for phosphorylation-dependent activation of Pex11p through the analysis of phosphomimicking mutants. Peroxisomal phenotypes in the PEX11-A and PEX11-D strains expressing constitutively dephosphorylated and phosphorylated forms of Pex11p resemble those of PEX11 gene knock-out and overexpression mutants, although PEX11 transcript and Pex11 protein levels remain unchanged. We demonstrate functional inequality and differences in subcellular localization of the Pex11p forms. Pex11Dp promotes peroxisome fragmentation when reexpressed in cells containing induced peroxisomes. Pex11p translocates between endoplasmic reticulum and peroxisomes in a phosphorylation-dependent manner, whereas Pex11Ap and Pex11Dp are impaired in trafficking and constitutively associated with mature and proliferating peroxisomes, respectively. Overexpression of cyclin-dependent kinase Pho85p results in hyperphosphorylation of Pex11p and peroxisome proliferation. This study provides the first evidence for control of peroxisome dynamics by phosphorylation-dependent regulation of a peroxin.	[Knoblach, Barbara; Rachubinski, Richard A.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Rachubinski, RA (corresponding author), Univ Alberta, Dept Cell Biol, MSB 5-14, Edmonton, AB T6G 2H7, Canada.	rick.rachubinski@ualberta.ca	Knoblach, Barbara/B-9454-2009		Canadian Institutes of Health Research [15131]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant 15131.	Barnett P, 2000, TRENDS BIOCHEM SCI, V25, P227, DOI 10.1016/S0968-0004(00)01579-6; EINERHAND AWC, 1991, EUR J BIOCHEM, V200, P113, DOI 10.1111/j.1432-1033.1991.tb21056.x; Eitzen GA, 1997, J CELL BIOL, V137, P1265, DOI 10.1083/jcb.137.6.1265; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Fagarasanu A, 2006, DEV CELL, V10, P587, DOI 10.1016/j.devcel.2006.04.012; Fagarasanu A, 2009, J CELL BIOL, V186, P541, DOI 10.1083/jcb.200904050; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Marshall PA, 1996, J CELL BIOL, V135, P123, DOI 10.1083/jcb.135.1.123; MARSHALL PA, 1995, J CELL BIOL, V129, P345, DOI 10.1083/jcb.129.2.345; Measday V, 1997, MOL CELL BIOL, V17, P1212, DOI 10.1128/MCB.17.3.1212; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Platta HW, 2007, FEBS LETT, V581, P2811, DOI 10.1016/j.febslet.2007.04.001; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rout MP, 2008, J CELL BIOL, V181, P185, DOI 10.1083/jcb.200803126; Saleem RA, 2008, J CELL BIOL, V181, P281, DOI 10.1083/jcb.200710009; Schekman R, 2005, CELL, V122, P1, DOI 10.1016/j.cell.2005.06.033; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Schrader M, 2006, INT REV CYTOL, V255, P237, DOI 10.1016/S0074-7696(06)55005-3; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Tabak HF, 2008, CURR OPIN CELL BIOL, V20, P393, DOI 10.1016/j.ceb.2008.05.008; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Tedrick K, 2004, MOL BIOL CELL, V15, P4609, DOI 10.1091/mbc.E04-03-0194; Thoms S, 2005, FEBS J, V272, P5169, DOI 10.1111/j.1742-4658.2005.04939.x; Titorenko VI, 2000, J CELL BIOL, V148, P29, DOI 10.1083/jcb.148.1.29; Titorenko VI, 2001, NAT REV MOL CELL BIO, V2, P357, DOI 10.1038/35073063; Titorenko VI, 2006, J CELL BIOL, V174, P11, DOI 10.1083/jcb.200604036; Yan MD, 2005, CURR OPIN CELL BIOL, V17, P376, DOI 10.1016/j.ceb.2005.06.003; Yan M, 2008, MOL BIOL CELL, V19, P885, DOI 10.1091/mbc.E07-10-1042	43	54	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6670	6680		10.1074/jbc.M109.094805	http://dx.doi.org/10.1074/jbc.M109.094805			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20028986	Green Published, hybrid			2022-12-25	WOS:000275367500071
J	Kruse, T; Gehl, C; Geisler, M; Lehrke, M; Ringel, P; Hallier, S; Hansch, R; Mendel, RR				Kruse, Tobias; Gehl, Christian; Geisler, Mirco; Lehrke, Markus; Ringel, Phillip; Hallier, Stephan; Haensch, Robert; Mendel, Ralf R.			Identification and Biochemical Characterization of Molybdenum Cofactor-binding Proteins from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS-REINHARDTII; NITRATE REDUCTASE; ESCHERICHIA-COLI; CARRIER PROTEIN; MOLYBDOPTERIN; INSERTION; BIOSYNTHESIS; ENZYMES; INVOLVEMENT; ALIGNMENT	The molybdenum cofactor (Moco) forms part of the catalytic center in all eukaryotic molybdenum enzymes and is synthesized in a highly conserved pathway. Among eukaryotes, very little is known about the processes taking place subsequent to Moco biosynthesis, i.e. Moco transfer, allocation, and insertion into molybdenum enzymes. In the model plant Arabidopsis thaliana, we identified a novel protein family consisting of nine members that after recombinant expression are able to bind Moco with K-D values in the low micromolar range and are therefore named Moco-binding proteins (MoBP). For two of the nine proteins atomic structures are available in the Protein Data Bank. Surprisingly, both crystal structures lack electron density for the C terminus, which may indicate a high flexibility of this part of the protein. C-terminal truncated MoBPs showed significantly decreased Moco binding stoichiometries. Experiments where the MoBP C termini were exchanged among MoBPs converted a weak Moco-binding MoBP into a strong binding MoBP, thus indicating that the MoBP C terminus, which is encoded by a separate exon, is involved in Moco binding. MoBPs were able to enhance Moco transfer to apo-nitrate reductase in the Mocofree Neurospora crassa mutant nit-1. Furthermore, we show that the MoBPs are localized in the cytosol and undergo protein-protein contact with both the Moco donor protein Cnx1 and the Moco acceptor protein nitrate reductase under in vivo conditions, thus indicating for the MoBPs a function in Arabidopsis cellular Moco distribution.	[Kruse, Tobias; Gehl, Christian; Geisler, Mirco; Lehrke, Markus; Ringel, Phillip; Hallier, Stephan; Haensch, Robert; Mendel, Ralf R.] Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, D-38106 Braunschweig, Germany	Braunschweig University of Technology	Mendel, RR (corresponding author), Humboldt St 1, D-38106 Braunschweig, Germany.	r.mendel@tu-bs.de		Hansch, Robert/0000-0003-1310-8419	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ataya FS, 2003, J BIOL CHEM, V278, P10885, DOI 10.1074/jbc.M211320200; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bhat RA, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-12; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fischer K, 2006, J BIOL CHEM, V281, P30186, DOI 10.1074/jbc.M603919200; Gehl C, 2009, MOL PLANT, V2, P1051, DOI 10.1093/mp/ssp040; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Hille R, 2005, ARCH BIOCHEM BIOPHYS, V433, P107, DOI 10.1016/j.abb.2004.08.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeon WB, 2006, PROTEINS, V65, P1051, DOI 10.1002/prot.21166; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Llamas A, 2004, J BIOL CHEM, V279, P55241, DOI 10.1074/jbc.M409862200; Llamas A, 2006, J BIOL CHEM, V281, P18343, DOI 10.1074/jbc.M601415200; Mendel RR, 2002, J EXP BOT, V53, P1689, DOI 10.1093/jxb/erf038; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; PHAN APH, 1982, ANAL BIOCHEM, V120, P193, DOI 10.1016/0003-2697(82)90336-0; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwarz G, 1997, J BIOL CHEM, V272, P26811, DOI 10.1074/jbc.272.43.26811; Schwarz G, 2000, PLANT CELL, V12, P2455, DOI 10.1105/tpc.12.12.2455; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; STEWART V, 1982, J BACTERIOL, V151, P788, DOI 10.1128/JB.151.2.788-799.1982; Vergnes A, 2006, J BIOL CHEM, V281, P2170, DOI 10.1074/jbc.M505902200; Witte CP, 1998, FEBS LETT, V431, P205, DOI 10.1016/S0014-5793(98)00756-X	30	40	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6623	6635		10.1074/jbc.M109.060640	http://dx.doi.org/10.1074/jbc.M109.060640			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040598	hybrid, Green Published			2022-12-25	WOS:000275367500067
J	Kyriazis, GA; Belal, C; Madan, M; Taylor, DG; Wang, J; Wei, ZL; Pattisapu, JV; Chan, SL				Kyriazis, George A.; Belal, Cherine; Madan, Meenu; Taylor, David G.; Wang, Jang; Wei, Zelan; Pattisapu, Jogi V.; Chan, Sic L.			Stress-induced Switch in Numb Isoforms Enhances Notch-dependent Expression of Subtype-specific Transient Receptor Potential Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; AMYLOID PRECURSOR PROTEIN; STORE-OPERATED CHANNELS; MAMMALIAN NUMB; PTB DOMAIN; CELL FATE; FACTOR WITHDRAWAL; CORTICAL-NEURONS; BETA-PEPTIDE; CA2+ ENTRY	The Notch signaling pathway plays an essential role in the regulation of cell specification by controlling differentiation, proliferation, and apoptosis. Numb is an intrinsic regulator of the Notch pathway and exists in four alternative splice variants that differ in the length of their phosphotyrosine-binding domain (PTB) and proline-rich region domains. The physiological relevance of the existence of the Numb splice variants and their exact regulation are still poorly understood. We previously reported that Numb switches from isoforms containing the insertion in PTB to isoforms lacking this insertion in neuronal cells subjected to trophic factor withdrawal (TFW). The functional relevance of the TFW-induced switch in Numb isoforms is not known. Here we provide evidence that the TFW-induced switch in Numb isoforms regulates Notch signaling strength and Notch target gene expression. PC12 cells stably overexpressing Numbisoforms lacking the PTB insertion exhibited higher basal Notch activity and Notch-dependent transcription of the transient receptor potential channel 6 (TRPC6) when compared with those overexpressing Numb isoforms with the PTB insertion. The differential regulation of TRPC6 expression is correlated with perturbed calcium signaling and increased neuronal vulnerability to TFW-induced death. Pharmacological inhibition of the Notch pathway or knockdown of TRPC6 function ameliorates the adverse effects caused by the TFW-induced switch in Numb isoforms. Taken together, our results indicate that Notch and Numb interaction may influence the sensitivity of neuronal cells to injurious stimuli by modulating calcium-dependent apoptotic signaling cascades.	[Kyriazis, George A.; Belal, Cherine; Madan, Meenu; Taylor, David G.; Wei, Zelan; Pattisapu, Jogi V.; Chan, Sic L.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA; [Wang, Jang] Johns Hopkins Asthma & Allergy Ctr, Div Pulm & Crit Care Med, Baltimore, MD 21224 USA	State University System of Florida; University of Central Florida; Johns Hopkins University; Johns Hopkins Medicine	Chan, SL (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.	schan@mail.ucf.edu		Kyriazis, George/0000-0001-9514-3482	University of Central Florida	University of Central Florida	This work was supported by start-up funds from the University of Central Florida.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Baba A, 2003, J NEUROSCI, V23, P7737; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Bouron A, 2005, DEV BRAIN RES, V159, P64, DOI 10.1016/j.devbrainres.2005.07.001; Brechard S, 2008, CELL CALCIUM, V44, P492, DOI 10.1016/j.ceca.2008.03.002; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chan SL, 2006, J BIOL CHEM, V281, P37391, DOI 10.1074/jbc.M605552200; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Chan SL, 2002, NEUROMOL MED, V1, P55; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Dineley KT, 2007, NEUROBIOL LEARN MEM, V88, P217, DOI 10.1016/j.nlm.2007.03.010; FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Guo Q, 1997, J NEUROSCI, V17, P4212; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jafar-Nejad H, 2002, DEV CELL, V3, P155, DOI 10.1016/S1534-5807(02)00228-9; Jehn BM, 2002, J BIOL CHEM, V277, P8033, DOI 10.1074/jbc.M108552200; Kim HS, 2000, FASEB J, V14, P1508, DOI 10.1096/fj.14.11.1508; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Kyriazis GA, 2008, J BIOL CHEM, V283, P25492, DOI 10.1074/jbc.M802072200; Lai EC, 2002, EMBO REP, V3, P840, DOI 10.1093/embo-reports/kvf170; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; Mattson MP, 2001, J MOL NEUROSCI, V17, P205, DOI 10.1385/JMN:17:2:205; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Munaron L, 2004, J CELL MOL MED, V8, P161, DOI 10.1111/j.1582-4934.2004.tb00271.x; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Pedersen WA, 2002, J NEUROCHEM, V82, P976, DOI 10.1046/j.1471-4159.2002.01036.x; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Snyder SH, 1998, TRENDS PHARMACOL SCI, V19, P21, DOI 10.1016/S0165-6147(97)01146-2; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Tesfai Y, 2001, BIOCHEM J, V358, P717, DOI 10.1042/0264-6021:3580717; Tu P, 2009, J NEUROCHEM, V108, P126, DOI 10.1111/j.1471-4159.2008.05752.x; Uehara A, 2002, CELL CALCIUM, V31, P89, DOI 10.1054/ceca.2001.0257; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang J, 2004, AM J PHYSIOL-LUNG C, V286, pL848, DOI 10.1152/ajplung.00319.2003; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wang ZZ, 2009, EMBO J, V28, P2360, DOI 10.1038/emboj.2009.190; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Xifro X, 2008, J NEUROCHEM, V105, P1596, DOI 10.1111/j.1471-4159.2008.05252.x; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zwahlen C, 2000, EMBO J, V19, P1505, DOI 10.1093/emboj/19.7.1505	86	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6811	6825		10.1074/jbc.M109.074690	http://dx.doi.org/10.1074/jbc.M109.074690			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20038578	Green Published, hybrid			2022-12-25	WOS:000275367500084
J	Zhong, SM; Magnolo, AL; Sundaram, M; Zhou, H; Yao, EF; Di Leo, E; Loria, P; Wang, SA; Bamji-Mirza, M; Wang, LS; McKnight, CJ; Figeys, D; Wang, YW; Tarugi, P; Yao, ZM				Zhong, Shumei; Magnolo, Antonia Lucia; Sundaram, Meenakshi; Zhou, Hu; Yao, Erik F.; Di Leo, Enza; Loria, Paola; Wang, Shuai; Bamji-Mirza, Michelle; Wang, Lisheng; McKnight, C. Jamie; Figeys, Daniel; Wang, Yuwei; Tarugi, Patrizia; Yao, Zemin			Nonsynonymous Mutations within APOB in Human Familial Hypobetalipoproteinemia EVIDENCE FOR FEEDBACK INHIBITION OF LIPOGENESIS AND POSTENDOPLASMIC RETICULUM DEGRADATION OF APOLIPOPROTEIN B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LOW-DENSITY LIPOPROTEINS; HUMAN APOLIPOPROTEIN-B; MCA-RH7777 CELLS; ATHEROGENIC LIPOPROTEINS; LIPID RECRUITMENT; QUALITY-CONTROL; AMINO-TERMINUS; BINDING-SITE; SECRETION	Five nontruncating missense APOB mutations, namely A31P, G275S, L324M, G912D, and G945S, were identified in heterozygous carriers of familial hypobetalipoproteinemia (FHBL) in the Italian population. To test that the FHBL phenotype was a result of impaired hepatic secretion of mutant apoB proteins, we performed transfection studies using McA-RH7777 cells stably expressing wild type or mutant forms of human apolipoprotein B-48 (apoB-48). All mutant proteins displayed varied impairment in secretion, with G912D the least affected and A31P barely secreted. Although some A31P was degraded by proteasomes, a significant proportion of it (although inappropriately glycosylated) escaped endoplasmic reticulum (ER) quality control and presented in the Golgi compartment. Degradation of the post-ER A31P was achieved by autophagy. Expression of A31P also decreased secretion of endogenous apoB and triglycerides, yet the impaired lipoprotein secretion did not lead to lipid accumulation in the cells or ER stress. Rather, expression of genes involved in lipogenesis was down-regulated, including liver X receptor alpha, sterol regulator element-binding protein 1c, fatty acid synthase, acetyl-CoA carboxylase 1, stearoyl-CoA desaturase 1, and lipin-1. These results suggest that feedback inhibition of hepatic lipogenesis in conjunction with post-ER degradation of misfolded apoB proteins can contribute to reduce fat accumulation in the FHBL liver.	[Magnolo, Antonia Lucia; Di Leo, Enza; Tarugi, Patrizia] Univ Modena & Reggio Emilia, Dipartimento Sci Biomed, I-41100 Modena, Italy; [Zhong, Shumei; Sundaram, Meenakshi; Zhou, Hu; Yao, Erik F.; Wang, Shuai; Bamji-Mirza, Michelle; Wang, Lisheng; Figeys, Daniel; Wang, Yuwei; Yao, Zemin] Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [McKnight, C. Jamie] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Loria, Paola] Univ Modena & Reggio Emilia, Dipartimento Med, I-41100 Modena, Italy	Universita di Modena e Reggio Emilia; University of Ottawa; Boston University; Universita di Modena e Reggio Emilia	Tarugi, P (corresponding author), Univ Modena & Reggio Emilia, Dipartimento Sci Biomed, Via Campi 287, I-41100 Modena, Italy.	tarugi@unimore.it; zyao@uottawa.ca	Tarugi, Patrizia/D-2179-2015	Tarugi, Patrizia/0000-0001-6864-7853; McKnight, Christopher/0000-0002-3237-0896; Figeys, Daniel/0000-0002-5373-7546	National Institutes of Health [HL-26335]; Heart and Stroke Foundation of Ontario [T-4643]; Genome Canada [2008-OGI-TD-01]; Canadian Institutes of Health Research (CIHR) [MOP-158235]; Telethon Foundation Onlus, Italy [GGP05042]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL026335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Genome Canada(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Telethon Foundation Onlus, Italy(Fondazione Telethon); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL-26335 (to C.J.M.), Heart and Stroke Foundation of Ontario Grant T-4643 (to Z.Y.), Genome Canada Grant 2008-OGI-TD-01 (to D. F.), Canadian Institutes of Health Research (CIHR) Grant MOP-158235 (to L. W.), and Telethon Foundation Onlus, Italy Grant GGP05042 (to P. T.).	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; BLACKHART BD, 1990, J BIOL CHEM, V265, P8358; BOREN J, 1992, J BIOL CHEM, V267, P9858; Bradbury P, 1999, J BIOL CHEM, V274, P3159, DOI 10.1074/jbc.274.5.3159; Burnett JR, 2007, J BIOL CHEM, V282, P24270, DOI 10.1074/jbc.M702442200; Burnett JR, 2003, J BIOL CHEM, V278, P13442, DOI 10.1074/jbc.M300235200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; CHAN L, 1992, J BIOL CHEM, V267, P25621; Chen ZJ, 2002, J BIOL CHEM, V277, P14135, DOI 10.1074/jbc.M200617200; Dashti N, 2007, J BIOL CHEM, V282, P28597, DOI 10.1074/jbc.M700229200; Dejgaard S, 2004, CURR ISSUES MOL BIOL, V6, P29; den Dunnen JT, 2003, HUM MUTAT, V22, P181, DOI 10.1002/humu.10262; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Di Leo E, 2007, J MED GENET, V44, P219, DOI 10.1136/jmg.2006.046359; Fasano T, 2007, ARTERIOSCL THROM VAS, V27, P677, DOI 10.1161/01.ATV.0000255311.26383.2f; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Flood C, 2002, J BIOL CHEM, V277, P32228, DOI 10.1074/jbc.M204053200; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Gretch DG, 1996, J BIOL CHEM, V271, P8682, DOI 10.1074/jbc.271.15.8682; Huang XF, 1997, J BIOL CHEM, V272, P31872, DOI 10.1074/jbc.272.50.31872; Hussain MM, 1998, J BIOL CHEM, V273, P25612, DOI 10.1074/jbc.273.40.25612; Ishimoto K, 2009, J BIOL CHEM, V284, P22195, DOI 10.1074/jbc.M109.028753; Jiang ZHG, 2006, BIOCHEMISTRY-US, V45, P11799, DOI 10.1021/bi060600w; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lancellotti S, 2005, J HEPATOL, V43, P188, DOI 10.1016/j.jhep.2005.03.012; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin X, 2002, ARTERIOSCL THROM VAS, V22, P476, DOI 10.1161/hq0302.105271; Lin XB, 2006, AM J PHYSIOL-GASTR L, V290, pG1170, DOI 10.1152/ajpgi.00402.2005; Mann CJ, 1999, J MOL BIOL, V285, P391, DOI 10.1006/jmbi.1998.2298; McLeod RS, 1996, J BIOL CHEM, V271, P18445, DOI 10.1074/jbc.271.31.18445; MCLEOD RS, 1994, J BIOL CHEM, V269, P2852; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Pan MH, 2008, P NATL ACAD SCI USA, V105, P5862, DOI 10.1073/pnas.0707460104; Richardson PE, 2005, BIOPHYS J, V88, P2789, DOI 10.1529/biophysj.104.046235; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schonfeld G, 2003, J LIPID RES, V44, P878, DOI 10.1194/jlr.R300002-JLR200; Segrest JP, 1999, J LIPID RES, V40, P1401; Su QZ, 2009, HEPATOLOGY, V50, P77, DOI 10.1002/hep.22960; Tarugi P, 2001, J LIPID RES, V42, P1552; Tarugi P, 2007, ATHEROSCLEROSIS, V195, pE19, DOI 10.1016/j.atherosclerosis.2007.05.003; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thompson JR, 2002, BIOCHEMISTRY-US, V41, P9398, DOI 10.1021/bi025674w; Tran K, 1998, J BIOL CHEM, V273, P7244, DOI 10.1074/jbc.273.13.7244; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Wang YW, 1997, J BIOL CHEM, V272, P12272, DOI 10.1074/jbc.272.19.12272; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; Yamazaki T, 2005, J BIOL CHEM, V280, P21506, DOI 10.1074/jbc.M412989200; YAO ZM, 1994, BBA-LIPID LIPID MET, V1212, P152, DOI 10.1016/0005-2760(94)90249-6; YAO ZM, 1991, J BIOL CHEM, V266, P3300; Zhou H, 2009, J PROTEOME RES, V8, P556, DOI 10.1021/pr800734r	55	50	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6453	6464		10.1074/jbc.M109.060467	http://dx.doi.org/10.1074/jbc.M109.060467			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032471	hybrid, Green Published			2022-12-25	WOS:000275367500050
J	Sun, T; Adra, S; Smallwood, R; Holcombe, M; MacNeil, S				Sun, Tao; Adra, Salem; Smallwood, Rod; Holcombe, Mike; MacNeil, Sheila			Exploring Hypotheses of the Actions of TGF-beta 1 in Epidermal Wound Healing Using a 3D Computational Multiscale Model of the Human Epidermis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BASEMENT-MEMBRANE FORMATION; TRANSFORMING GROWTH-FACTOR-BETA-1; HUMAN KERATINOCYTES; IN-VITRO; EXTRACELLULAR-MATRIX; BINDING-PROTEIN; GENE-EXPRESSION; ACTIVATION; REEPITHILIALIZATION	In vivo and in vitro studies give a paradoxical picture of the actions of the key regulatory factor TGF-beta 1 in epidermal wound healing with it stimulating migration of keratinocytes but also inhibiting their proliferation. To try to reconcile these into an easily visualized 3D model of wound healing amenable for experimentation by cell biologists, a multiscale model of the formation of a 3D skin epithelium was established with TGF-beta 1 literature-derived rule sets and equations embedded within it. At the cellular level, an agent-based bottom-up model that focuses on individual interacting units ( keratinocytes) was used. This was based on literature-derived rules governing keratinocyte behavior and keratinocyte/ECM interactions. The selection of these rule sets is described in detail in this paper. The agent-based model was then linked with a subcellular model of TGF-beta 1 production and its action on keratinocytes simulated with a complex pathway simulator. This multiscale model can be run at a cellular level only or at a combined cellular/subcellular level. It was then initially challenged ( by wounding) to investigate the behavior of keratinocytes in wound healing at the cellular level. To investigate the possible actions of TGF-beta 1, several hypotheses were then explored by deliberately manipulating some of these rule sets at subcellular levels. This exercise readily eliminated some hypotheses and identified a sequence of spatial-temporal actions of TGF-beta 1 for normal successful wound healing in an easy-to-follow 3D model. We suggest this multiscale model offers a valuable, easy-to-visualize aid to our understanding of the actions of this key regulator in wound healing, and provides a model that can now be used to explore pathologies of wound healing.	[Sun, Tao] Univ Glasgow, Ctr Cell Engn, Glasgow, Lanark, Scotland; [Adra, Salem; Smallwood, Rod; Holcombe, Mike] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [MacNeil, Sheila] Univ Sheffield, Dept Mat Engn, Sheffield S10 2TN, S Yorkshire, England	University of Glasgow; University of Sheffield; University of Sheffield	Sun, T (corresponding author), Univ Glasgow, Ctr Cell Engn, Glasgow, Lanark, Scotland.	t.sun@bio.gla.ac.uk; s.macneil@sheffield.ac.uk	Smallwood, Rod/C-5583-2011	Smallwood, Rod/0000-0003-0134-0632	Engineering and Physical Sciences Research Council (EPSRC) [GR/S62321/01]; University of York [GR/S62338/01]; Engineering and Physical Sciences Research Council [GR/S62321/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of York(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is part of the Epitheliome Project, which is funded by the Engineering and Physical Sciences Research Council (EPSRC) through two grants: one to the University of Sheffield (GR/S62321/01), and the other to the University of York (GR/S62338/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendt C, 2002, J CELL SCI, V115, P2189; Anders RA, 1998, J BIOL CHEM, V273, P23118, DOI 10.1074/jbc.273.36.23118; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arany PR, 2006, P NATL ACAD SCI USA, V103, P9250, DOI 10.1073/pnas.0602473103; Aukhil I, 2000, PERIODONTOL 2000, V22, P44, DOI 10.1034/j.1600-0757.2000.2220104.x; Baker CTH, 1998, J MATH BIOL, V37, P341, DOI 10.1007/s002850050133; Barcellos-Hoff MH, 1996, J MAMMARY GLAND BIOL, V1, P353, DOI 10.1007/BF02017391; BHORA FY, 1995, J SURG RES, V59, P236, DOI 10.1006/jsre.1995.1160; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Breitkreutz D, 2004, J CELL SCI, V117, P2611, DOI 10.1242/jcs.01127; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Clark R. A. F, 1996, MOL CELLULAR BIOL WO; Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715; COFFEY RJ, 1988, MOL CELL BIOL, V8, P3088, DOI 10.1128/MCB.8.8.3088; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Fleischmajer R, 2000, MATRIX BIOL, V19, P637, DOI 10.1016/S0945-053X(00)00092-5; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; Frank S, 1996, J BIOL CHEM, V271, P10188, DOI 10.1074/jbc.271.17.10188; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; GAILIT J, 1994, J INVEST DERMATOL, V103, P221, DOI 10.1111/1523-1747.ep12393176; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; GARLICK JA, 1994, LAB INVEST, V70, P916; GARLICK JA, 1994, J INVEST DERMATOL, V103, P554, DOI 10.1111/1523-1747.ep12396847; GRINNELL F, 1992, J CELL SCI, V101, P1; Hakkinen L, 2004, AM J PATHOL, V164, P229, DOI 10.1016/S0002-9440(10)63113-6; HEBDA PA, 1988, J INVEST DERMATOL, V91, P440, DOI 10.1111/1523-1747.ep12476480; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Krampert M, 2004, MOL BIOL CELL, V15, P5242, DOI 10.1091/mbc.E04-02-0109; Kutz SM, 2001, J CELL SCI, V114, P3905; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MATOLTSY AG, 1970, J INVEST DERMATOL, V55, P20, DOI 10.1111/1523-1747.ep12290488; Mazzieri R, 2005, J CELL SCI, V118, P2177, DOI 10.1242/jcs.02352; Morel D, 2001, ACTA BIOTHEOR, V49, P219, DOI 10.1023/A:1014201805222; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nodder S, 1997, ANAT EMBRYOL, V195, P215, DOI 10.1007/s004290050041; Olofsson A, 1995, J BIOL CHEM, V270, P31294, DOI 10.1074/jbc.270.52.31294; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Rashbass J, 1996, TRENDS CELL BIOL, V6, P280, DOI 10.1016/0962-8924(96)60028-2; SELLHEYER K, 1993, P NATL ACAD SCI USA, V90, P5237, DOI 10.1073/pnas.90.11.5237; Shiou SR, 2006, J BIOL CHEM, V281, P33971, DOI 10.1074/jbc.M607010200; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smola H, 1998, EXP CELL RES, V239, P399, DOI 10.1006/excr.1997.3910; STREULI CH, 1993, J CELL BIOL, V120, P253, DOI 10.1083/jcb.120.1.253; Sun T, 2007, J R SOC INTERFACE, V4, P1077, DOI 10.1098/rsif.2007.0227; Vespa A, 2005, MOL BIOL CELL, V16, P4084, DOI 10.1091/mbc.e05-02-0087; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025; Wang XJ, 1997, P NATL ACAD SCI USA, V94, P2386, DOI 10.1073/pnas.94.6.2386; Wawersik MJ, 2001, MOL BIOL CELL, V12, P3439, DOI 10.1091/mbc.12.11.3439; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Woolley K, 2000, BIOESSAYS, V22, P911; Yamasaki M, 2008, AM J RESP CELL MOL, V38, P346, DOI 10.1165/rcmb.2007-0276OC; Yang LJ, 1999, AM J PATHOL, V154, P105, DOI 10.1016/S0002-9440(10)65256-X; Yang LJ, 2001, AM J PATHOL, V159, P2147, DOI 10.1016/S0002-9440(10)63066-0; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853	66	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8515	10.1371/journal.pone.0008515	http://dx.doi.org/10.1371/journal.pone.0008515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046881	Green Published, Green Accepted, gold			2022-12-25	WOS:000273180200006
J	Cordeiro, JV; Guerra, S; Arakawa, Y; Dodding, MP; Esteban, M; Way, M				Cordeiro, Joao V.; Guerra, Susana; Arakawa, Yoshiki; Dodding, Mark P.; Esteban, Mariano; Way, Michael			F11-Mediated Inhibition of RhoA Signalling Enhances the Spread of Vaccinia Virus In Vitro and In Vivo in an Intranasal Mouse Model of Infection	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; EXTRACELLULAR ENVELOPED VIRUS; N-WASP; F11L-MEDIATED INHIBITION; INTRACELLULAR MOVEMENT; PROTEIN; MICROTUBULES; VIRIONS; KINASES; COMPLEX	The cortical actin cytoskeleton beneath the plasma membrane represents a physical barrier that vaccinia virus has to overcome during its exit from an infected cell. Previous observations using overexpression and pharmacological approaches suggest that vaccinia enhances its release by modulating the cortical actin cytoskeleton by inhibiting RhoA signalling using the viral protein F11. We have now examined the role of El 1 and its ability to interact with RhoA to inhibit its downstream signalling in the spread of vaccinia infection both in vitro and in vivo. Live cell imaging over 48 hours reveals that loss of Eli or its ability to bind RhoA dramatically reduces the rate of cell-to-cell spread of the virus in a cell monolayer. Cells infected with the AF11L virus also maintained their cell-to-cell contacts, and did not undergo virus-induced motility as observed during wild-type infections. The AF11L virus is also attenuated in intranasal mouse models of infection, as it is impaired in its ability to spread from the initial sites of infection to the lungs and spleen. Loss of the ability of F11 to bind RhoA also reduces viral spread in vivo. Our results clearly establish that viral-mediated inibition of RhoA signalling can enhance the spread of infection not only in cell monolayers, but also in vivo.	[Cordeiro, Joao V.; Arakawa, Yoshiki; Dodding, Mark P.; Way, Michael] London Res Inst, Cell Motil Lab, London, England; [Guerra, Susana; Esteban, Mariano] Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Guerra, Susana] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Arakawa, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid; Kyoto University	Cordeiro, JV (corresponding author), London Res Inst, Cell Motil Lab, London, England.	Michael.Way@cancer.org.uk	guerra, susana/K-5972-2014; Cordeiro, Joao V/M-6122-2013; Arakawa, Yoshiki/H-6067-2017; Esteban, Mariano/ABG-5375-2020	guerra, susana/0000-0001-9067-2991; Cordeiro, Joao V/0000-0003-4605-1615; Arakawa, Yoshiki/0000-0003-4626-4645; Esteban, Mariano/0000-0003-0846-2827; Way, Michael/0000-0001-7207-2722; Dodding, Mark/0000-0001-8091-6534	Cancer Research UK; European Union [CT-2006-03954]; Foundation Botin; Ramon y Cajal of Spain	Cancer Research UK(Cancer Research UK); European Union(European Commission); Foundation Botin; Ramon y Cajal of Spain	This investigation was supported by Cancer Research UK (to MW, JVC, VA, and MPD), and in part by the European Union (CT-2006-03954) and Foundation Botin (to ME). SG holds a research contract from the program Ramon y Cajal of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa Y, 2007, CELL HOST MICROBE, V1, P227, DOI 10.1016/j.chom.2007.04.006; Arakawa Y, 2007, CELL HOST MICROBE, V1, P213, DOI 10.1016/j.chom.2007.04.007; Backert S, 2008, TRENDS BIOCHEM SCI, V33, P80, DOI 10.1016/j.tibs.2007.10.006; Boeda B, 2007, MOL CELL, V28, P1071, DOI 10.1016/j.molcel.2007.10.033; Boulter E A, 1973, Prog Med Virol, V16, P86; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; Cudmore S, 1996, J CELL SCI, V109, P1739; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; Dodding MP, 2009, CELL MICROBIOL, V11, P808, DOI 10.1111/j.1462-5822.2009.01296.x; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Favoreel HW, 2007, TRENDS MICROBIOL, V15, P426, DOI 10.1016/j.tim.2007.08.003; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Geada MM, 2001, J GEN VIROL, V82, P2747, DOI 10.1099/0022-1317-82-11-2747; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Guerra S, 2005, J VIROL, V79, P2133, DOI 10.1128/JVI.79.4.2133-2140.2005; HILLER G, 1985, J VIROL, V55, P651, DOI 10.1128/JVI.55.3.651-659.1985; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kato SEM, 2004, J VIROL METHODS, V115, P31, DOI 10.1016/j.jviromet.2003.09.011; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; Morales I, 2008, TRAFFIC, V9, P1283, DOI 10.1111/j.1600-0854.2008.00762.x; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Moss B, 2007, FIELDS VIROLOGY; Newsome TP, 2006, CELL MICROBIOL, V8, P233, DOI 10.1111/j.1462-5822.2005.00613.x; Newsome TP, 2004, SCIENCE, V306, P124, DOI 10.1126/science.1101509; PAYNE LG, 1980, J GEN VIROL, V50, P89, DOI 10.1099/0022-1317-50-1-89; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; RODRIGUEZ JF, 1985, J VIROL, V56, P482, DOI 10.1128/JVI.56.2.482-488.1985; Rottger S, 1999, J VIROL, V73, P2863; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Scaplehorn N, 2002, CURR BIOL, V12, P740, DOI 10.1016/S0960-9822(02)00812-6; Schepis A, 2006, TRAFFIC, V7, P308, DOI 10.1111/j.1600-0854.2005.00381.x; Schramm B, 2005, TRAFFIC, V6, P839, DOI 10.1111/j.1600-0854.2005.00324.x; Schramm B, 2006, TRAFFIC, V7, P1352, DOI 10.1111/j.1600-0854.2006.00470.x; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Smith GL, 1998, ADV EXP MED BIOL, V440, P395; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Thorne SH, 2005, CURR OPIN MOL THER, V7, P359; Valderrama F, 2006, SCIENCE, V311, P377, DOI 10.1126/science.1122411; van Eijl H, 2000, VIROLOGY, V271, P26, DOI 10.1006/viro.2000.0260; Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001; Ward BM, 2001, J VIROL, V75, P4802, DOI 10.1128/JVI.75.10.4802-4813.2001; Weisswange I, 2009, NATURE, V458, P87, DOI 10.1038/nature07773; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Zhang WH, 2000, J VIROL, V74, P11654, DOI 10.1128/JVI.74.24.11654-11662.2000	54	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8506	10.1371/journal.pone.0008506	http://dx.doi.org/10.1371/journal.pone.0008506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041165	Green Published, gold, Green Submitted			2022-12-25	WOS:000278068700020
J	Feng, JN; Zhang, ZF; Li, WY; Shen, XM; Song, WJ; Yang, CM; Chang, F; Longmate, J; Marek, C; St Amand, RP; Krontiris, TG; Shively, JE; Sommer, SS				Feng, Jinong; Zhang, Zhifang; Li, Wenyan; Shen, Xiaoming; Song, Wenjia; Yang, Chunmei; Chang, Frances; Longmate, Jeffrey; Marek, Claudia; St Amand, R. Paul; Krontiris, Theodore G.; Shively, John E.; Sommer, Steve S.			Missense Mutations in the MEFV Gene Are Associated with Fibromyalgia Syndrome and Correlate with Elevated IL-1 beta Plasma Levels	PLOS ONE			English	Article							FAMILIAL MEDITERRANEAN FEVER; IRRITABLE-BOWEL-SYNDROME; NOD-LIKE RECEPTORS; CIAS1 MUTATIONS; T102C POLYMORPHISM; MOLECULAR-BASIS; DISEASE; CRYOPYRIN; DOMAIN; PYRIN	Background: Fibromyalgia syndrome (FMS), a common, chronic, widespread musculoskeletal pain disorder found in 2% of the general population and with a preponderance of 85% in females, has both genetic and environmental contributions. Patients and their parents have high plasma levels of the chemokines MCP-1 and eotaxin, providing evidence for both a genetic and an immunological/inflammatory origin for the syndrome (Zhang et al., 2008, Exp. Biol. Med. 233: 1171-1180). Methods and Findings: In a search for a candidate gene affecting inflammatory pathways, among five screened in our patient samples (100 probands with FMS and their parents), we found 10 rare and one common alleles for MEFV, a gene in which various compound heterozygous mutations lead to Familial Mediterranean Fever (FMF). A total of 2.63 megabases of genomic sequence of the MEFV gene were scanned by direct sequencing. The collection of rare missense mutations (all heterozygotes and tested in the aggregate) had a significant elevated frequency of transmission to affecteds (p = 0.0085, one-sided, exact binomial test). Our data provide evidence that rare missense variants of the MEFV gene are, collectively, associated with risk of FMS and are present in a subset of 15% of FMS patients. This subset had, on average, high levels of plasma IL-1 beta (p = 0.019) compared to FMS patients without rare variants, unaffected family members with or without rare variants, and unrelated controls of unknown genotype. IL-1 beta is a cytokine associated with the function of the MEFV gene and thought to be responsible for its symptoms of fever and muscle aches. Conclusions: Since misregulation of IL-1 beta expression has been predicted for patients with mutations in the MEFV gene, we conclude that patients heterozygous for rare missense variants of this gene may be predisposed to FMS, possibly triggered by environmental factors.	[Feng, Jinong; Li, Wenyan; Shen, Xiaoming; Song, Wenjia; Yang, Chunmei; Sommer, Steve S.] City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Genet, Duarte, CA 91010 USA; [Feng, Jinong; Zhang, Zhifang; Chang, Frances; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA; [Longmate, Jeffrey] City Hope Natl Med Ctr, Beckman Res Inst, Dept Biostat, Duarte, CA USA; [Marek, Claudia; St Amand, R. Paul] Fibromyalgia Treatment Ctr, Los Angeles, CA USA; [Krontiris, Theodore G.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Genet, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Feng, JN (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Genet, Duarte, CA 91010 USA.	jshively@coh.org; ssommer@medomics.com		Longmate, Jeffrey/0000-0002-0869-7928	Los Angeles Fibromyalgia Foundation; National Institutes of Health General Clinical Research Center [M01 RR00043]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000043] Funding Source: NIH RePORTER	Los Angeles Fibromyalgia Foundation; National Institutes of Health General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by a grant from the Los Angeles Fibromyalgia Foundation and in part by an National Institutes of Health General Clinical Research Center Grant, M01 RR00043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablin J, 2008, JOINT BONE SPINE, V75, P273, DOI 10.1016/j.jbspin.2007.09.010; Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; Arnold LM, 2007, PAIN MED, V8, pS63, DOI 10.1111/j.1526-4637.2006.00178.x; Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Baio P, 2008, CLIN EXP RHEUMATOL, V26, pS74; Berkun Y, 2007, CLIN EXP RHEUMATOL, V25, pS6; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bondy B, 1999, NEUROBIOL DIS, V6, P433, DOI 10.1006/nbdi.1999.0262; Buskila D, 1997, J RHEUMATOL, V24, P941; Buskila D, 1996, SEMIN ARTHRITIS RHEU, V26, P605, DOI 10.1016/S0049-0172(96)80011-4; Buskila D, 2008, AUTOIMMUN REV, V8, P41, DOI 10.1016/j.autrev.2008.07.023; Buskila D, 2007, PHARMACOGENOMICS, V8, P67, DOI 10.2217/14622416.8.1.67; Cazeneuve C, 1999, AM J HUM GENET, V65, P88, DOI 10.1086/302459; Chen G., 2008, ANN REV PATHOL; Cohen H, 2002, ARTHRITIS RHEUM, V46, P845, DOI 10.1002/art.10103; Crofford LJ, 2008, CURR OPIN RHEUMATOL, V20, P246, DOI 10.1097/BOR.0b013e3282fb0268; Dan B, 2004, MOL PSYCHIATR, V9, P730, DOI 10.1038/sj.mp.4001506; Dinarello CA, 2007, ARTHRITIS RHEUM-US, V56, P2817, DOI 10.1002/art.22841; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Gavrilin MA, 2000, BIOCHEM BIOPH RES CO, V277, P37, DOI 10.1006/bbrc.2000.3619; Giaglis S, 2007, CLIN GENET, V71, P458, DOI 10.1111/j.1399-0004.2007.00789.x; Gursoy S, 2001, RHEUMATOL INT, V21, P58, DOI 10.1007/s002960100130; Gursoy S, 2003, RHEUMATOL INT, V23, P104, DOI 10.1007/s00296-002-0260-5; Kato K, 2006, ARTHRITIS RHEUM-US, V54, P1682, DOI 10.1002/art.21798; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Locati M, 1999, ANNU REV MED, V50, P425, DOI 10.1146/annurev.med.50.1.425; Mathews RJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2525; MCCARTHY MI, 2009, EXPLORING UNKNOWN A; Neven B, 2004, BLOOD, V103, P2809, DOI 10.1182/blood-2003-07-2531; Offenbaecher M, 1999, ARTHRITIS RHEUM-US, V42, P2482, DOI 10.1002/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B; Ogilvie P, 2001, BLOOD, V97, P1920, DOI 10.1182/blood.V97.7.1920; Onen F, 2006, RHEUMATOL INT, V26, P489, DOI 10.1007/s00296-005-0074-3; Pace F, 2006, WORLD J GASTROENTERO, V12, P3874, DOI 10.3748/wjg.v12.i24.3874; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Ritis K, 2004, ANN RHEUM DIS, V63, P438, DOI 10.1136/ard.2003.009258; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Saito M, 2008, BLOOD, V111, P2132, DOI 10.1182/blood-2007-06-094201; Samuels J, 2006, CURR OPIN RHEUMATOL, V18, P108, DOI 10.1097/01.bor.0000198006.65697.5b; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Schwarz MJ, 2003, ADV EXP MED BIOL, V527, P265; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Shinkai K, 2005, ARCH DERMATOL, V141, P242, DOI 10.1001/archderm.141.2.242; Slager SL, 2000, GENET EPIDEMIOL, V18, P143, DOI 10.1002/(SICI)1098-2272(200002)18:2<143::AID-GEPI4>3.0.CO;2-5; Sperber AD, 1999, AM J GASTROENTEROL, V94, P3541, DOI 10.1111/j.1572-0241.1999.01643.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sprott H, 2004, ANN RHEUM DIS, V63, P245, DOI 10.1136/ard.2002.004762; Stehlik C, 2007, CURR PROTEIN PEPT SC, V8, P293, DOI 10.2174/138920307780831857; Strober W, 2008, MUCOSAL IMMUNOL, V1, pS5, DOI 10.1038/mi.2008.42; Sun JH, 2006, J NEUROPHYSIOL, V96, P2189, DOI 10.1152/jn.00222.2006; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Watanabe T, 2005, GUT, V54, P1515, DOI 10.1136/gut.2005.071795; WOLFE F, 1990, ARCH INTERN MED, V150, P460, DOI 10.1001/archinte.150.2.460; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003; Zhang ZF, 2008, EXP BIOL MED, V233, P1171, DOI 10.3181/0712-RM-328	58	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8480	10.1371/journal.pone.0008480	http://dx.doi.org/10.1371/journal.pone.0008480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041150	Green Published, Green Submitted, gold			2022-12-25	WOS:000278068700005
J	Love, HD; Booton, SE; Boone, BE; Breyer, JP; Koyama, T; Revelo, MP; Shappell, SB; Smith, JR; Hayward, SW				Love, Harold D.; Booton, S. Erin; Boone, Braden E.; Breyer, Joan P.; Koyama, Tatsuki; Revelo, Monica P.; Shappell, Scott B.; Smith, Jeffrey R.; Hayward, Simon W.			Androgen Regulated Genes in Human Prostate Xenografts in Mice: Relation to BPH and Prostate Cancer	PLOS ONE			English	Article							UROGENITAL SINUS MESENCHYME; PROTEASE-ACTIVATED RECEPTOR-1; MESSENGER-RNA EXPRESSION; FIBROBLAST GROWTH-FACTOR; BINDING PROTEIN; CARCINOMA-CELLS; TISSUE FACTOR; IN-VIVO; INHIBITS PROLIFERATION; ENDOTHELIAL LIPASE	Benign prostatic hyperplasia (BPH) and prostate carcinoma (CaP) are linked to aging and the presence of androgens, suggesting that androgen regulated genes play a major role in these common diseases. Androgen regulation of prostate growth and development depends on the presence of intact epithelial-stromal interactions. Further, the prostatic stroma is implicated in BPH. This suggests that epithelial cell lines are inadequate to identify androgen regulated genes that could contribute to BPH and CaP and which could serve as potential clinical biomarkers. In this study, we used a human prostate xenograft model to define a profile of genes regulated in vivo by androgens, with an emphasis on identifying candidate biomarkers. Benign transition zone (TZ) human prostate tissue from radical prostatectomies was grafted to the sub-renal capsule site of intact or castrated male immunodeficient mice, followed by the removal or addition of androgens, respectively. Microarray analysis of RNA from these tissues was used to identify genes that were; 1) highly expressed in prostate, 2) had significant expression changes in response to androgens, and, 3) encode extracellular proteins. A total of 95 genes meeting these criteria were selected for analysis and validation of expression in patient prostate tissues using quantitative real-time PCR. Expression levels of these genes were measured in pooled RNAs from human prostate tissues with varying severity of BPH pathologic changes and CaP of varying Gleason score. A number of androgen regulated genes were identified. Additionally, a subset of these genes were over-expressed in RNA from clinical BPH tissues, and the levels of many were found to correlate with disease status. Our results demonstrate the feasibility, and some of the problems, of using a mouse xenograft model to characterize the androgen regulated expression profiles of intact human prostate tissues.	[Love, Harold D.; Shappell, Scott B.; Hayward, Simon W.] Vanderbilt Univ, Sch Med, Dept Urol Surg, Nashville, TN 37212 USA; [Booton, S. Erin] Vanderbilt Univ, Sch Med, Div Dermatol, Nashville, TN 37212 USA; [Breyer, Joan P.; Smith, Jeffrey R.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Koyama, Tatsuki; Smith, Jeffrey R.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Shappell, Scott B.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Koyama, Tatsuki; Hayward, Simon W.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Smith, Jeffrey R.; Hayward, Simon W.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Smith, Jeffrey R.] VA Tennessee Valley Healthcare Syst, Med Res Serv, Nashville, TN USA; [Revelo, Monica P.] Univ Utah, Dept Pathol & Lab Med, Lake City, UT USA; [Shappell, Scott B.] Avero Diagnost, Dallas, TX USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Utah System of Higher Education; University of Utah	Love, HD (corresponding author), Vanderbilt Univ, Sch Med, Dept Urol Surg, Nashville, TN 37212 USA.	Simon.Hayward@vanderbilt.edu	Smith, Jeff/C-3484-2012	Smith, Jeffrey/0000-0001-8424-910X; Hayward, Simon/0000-0002-6059-6550	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) MPSA Consortium [UO1-DK63587]; National Institutes of Health (NIH) [DK067049]; Vanderbilt Microarray Shared Resource; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Center [P30 DK58404]; Vanderbilt Vision Center [P30 EY08126]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK067049, U01DK063587, P30DK058404, R01DK067049] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) MPSA Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Microarray Shared Resource; Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Center; Vanderbilt Vision Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work supported by The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) MPSA Consortium grant UO1-DK63587, National Institutes of Health (NIH) grant DK067049 and The Vanderbilt Microarray Shared Resource, supported by the Vanderbilt Ingram Cancer Center, grant P30 CA68485, and the Vanderbilt Digestive Disease Center, grant P30 DK58404, and the Vanderbilt Vision Center, grant P30 EY08126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2004, J BIOL CHEM, V279, P23038, DOI 10.1074/jbc.M401376200; Aigner A, 2002, ONCOGENE, V21, P5733, DOI 10.1038/sj.onc.1205560; Badellino KO, 2008, CIRCULATION, V117, P678, DOI 10.1161/CIRCULATIONAHA.107.707349; Begley LA, 2008, NEOPLASIA, V10, P244, DOI 10.1593/neo.07976; Bhattacharjee G, 2008, CIRC RES, V102, P457, DOI 10.1161/CIRCRESAHA.107.167759; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Camerer E, 2004, BLOOD, V104, P397, DOI 10.1182/blood-2004-02-0434; Cardillo M, 1997, J UROLOGY, V158, P212, DOI 10.1097/00005392-199707000-00073; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Chokkalingam AP, 2002, PROSTATE, V52, P98, DOI 10.1002/pros.10096; CUNHA GR, 1983, J CELL BIOL, V96, P1662, DOI 10.1083/jcb.96.6.1662; CUNHA GR, 1981, J STEROID BIOCHEM, V14, P1317, DOI 10.1016/0022-4731(81)90338-1; Cunha GR, 1996, PROSTATE, P22; DEHARO MSL, 1988, BIOCHEM J, V250, P647, DOI 10.1042/bj2500647; Delgado-Olguin P, 2008, BBA-GENE REGUL MECH, V1779, P74, DOI 10.1016/j.bbagrm.2007.09.002; Djonov V, 1997, PROSTATE, V31, P103; DONJACOUR AA, 1993, ENDOCRINOLOGY, V132, P2342, DOI 10.1210/en.132.6.2342; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Gale AJ, 2001, ACTA HAEMATOL-BASEL, V106, P25, DOI 10.1159/000046586; GRIGNON D, 1985, PROSTATE, V7, P195, DOI 10.1002/pros.2990070209; Grossklaus DJ, 2001, J UROLOGY, V165, P455, DOI 10.1097/00005392-200102000-00024; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Hayward SW, 1996, ANN NY ACAD SCI, V784, P50, DOI 10.1111/j.1749-6632.1996.tb16227.x; Imasato Y, 2000, J UROLOGY, V164, P1819, DOI 10.1016/S0022-5347(05)67113-3; ISAACS JT, 1989, PROSTATE, P33; Jack GS, 2000, HUM PATHOL, V31, P1146, DOI 10.1053/hupa.2000.16670; Jack GS, 2002, J UROLOGY, V168, P519, DOI 10.1016/S0022-5347(05)64671-X; Kim J, 2005, CANCER RES, V65, P6189, DOI 10.1158/0008-5472.CAN-04-4439; Kramer G, 2006, CURR OPIN UROL, V16, P25; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; LEE C, 1995, UROL CLIN N AM, V22, P237; Lein M, 1998, UROLOGE A, V37, P377, DOI 10.1007/s001200050194; Luo J, 2001, CANCER RES, V61, P4683; Luo J, 2002, PROSTATE, V51, P189, DOI 10.1002/pros.10087; Macoska JA, 2008, PROSTATE, V68, P442, DOI 10.1002/pros.20717; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; McNeal J E, 1984, Prog Clin Biol Res, V145, P27; McNeal J. E., 1983, BENIGN PROSTATIC HYP, P152; McNeal JE., 1985, REGULATION ANDROGEN, P191; Mishra VC, 2007, BJU INT, V100, P327, DOI 10.1111/j.1464-410X.2007.06910.x; MORI H, 1990, PROSTATE, V16, P71, DOI 10.1002/pros.2990160108; MYDLO JH, 1988, PROSTATE, V13, P241, DOI 10.1002/pros.2990130306; Nakamura T, 2003, CANCER RES, V63, P6543; Nakamura T, 2003, UROLOGY, V61, P1042, DOI 10.1016/S0090-4295(02)02443-3; Paradis ME, 2006, J LIPID RES, V47, P2808, DOI 10.1194/jlr.P600002-JLR200; PARTIN AW, 1991, J UROLOGY, V145, P405, DOI 10.1016/S0022-5347(17)38353-2; Qi H, 2002, CANCER RES, V62, P721; Rafii MS, 2006, J CELL PHYSIOL, V209, P439, DOI 10.1002/jcp.20740; Riewald M, 2001, BLOOD, V97, P3109, DOI 10.1182/blood.V97.10.3109; Roehrborn Claus G, 2005, Rev Urol, V7 Suppl 9, pS3; Ropiquet F, 1999, J UROLOGY, V162, P595, DOI 10.1016/S0022-5347(05)68632-6; Rosini P, 2002, PROSTATE, V53, P310, DOI 10.1002/pros.10164; Ruf W, 2003, CRIT CARE MED, V31, pS231, DOI 10.1097/01.CCM.0000057848.27456.04; SCHULZ P, 1985, BIOL CHEM H-S, V366, P1033, DOI 10.1515/bchm3.1985.366.2.1033; SCIARRA A, 2007, J STEROID BIOCH MOL; Scorilas A, 2006, BIOL CHEM, V387, P789, DOI 10.1515/BC.2006.099; Segawa T, 2002, ONCOGENE, V21, P8749, DOI 10.1038/sj.onc.1205992; Shappell SB, 2001, NEOPLASIA, V3, P287, DOI 10.1038/sj.neo.7900166; Shappell SB, 2001, CANCER RES, V61, P497; Shaw A, 2007, J UROLOGY, V177, P832, DOI 10.1016/j.juro.2006.10.061; Sinowatz F, 2000, HISTOL HISTOPATHOL, V15, P475, DOI 10.14670/HH-15.475; Smitherman AB, 2004, J UROLOGY, V171, P916, DOI 10.1097/01.ju.0000104674.70170.cd; Soulitzis N, 2006, INT J ONCOL, V29, P305; Staack A, 2003, PROSTATE, V54, P212, DOI 10.1002/pros.10179; Trojan L, 2006, EUR UROL, V49, P286, DOI 10.1016/j.eururo.2005.08.022; Vaarala MH, 2000, LAB INVEST, V80, P1259, DOI 10.1038/labinvest.3780134; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; Veltri RW, 1999, UROLOGY, V53, P139, DOI 10.1016/S0090-4295(98)00455-5; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Wei JT, 2005, J UROLOGY, V173, P1256, DOI 10.1097/01.ju.0000155709.37840.fe; Williams K, 2005, PROSTATE, V63, P369, DOI 10.1002/pros.20200; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146; Zhao HJ, 2007, J CELL PHYSIOL, V210, P111, DOI 10.1002/jcp.20828	76	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8384	10.1371/journal.pone.0008384	http://dx.doi.org/10.1371/journal.pone.0008384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027305	Green Published, gold, Green Submitted			2022-12-25	WOS:000272940100019
J	Dames, SA				Dames, Sonja A.			Structural Basis for the Association of the Redox-sensitive Target of Rapamycin FATC Domain with Membrane-mimetic Micelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; SUBCELLULAR-LOCALIZATION; 3-DIMENSIONAL STRUCTURE; NMR-SPECTROSCOPY; MTOR PATHWAY; COMPLEX; KINASE; TOR; ACTIVATION	The target of rapamycin (TOR) is a conserved eukaryotic Ser/Thr kinase that regulates cellular growth in response to the nutrient and energy state. TOR signaling plays an important role in the development of diseases such as cancer, obesity, and diabetes and in different redox-sensitive processes (hypoxia, apoptosis, and aging). Because TOR has been detected at different cellular membranes and in the nucleus, its localization may influence the specific signaling readout. To better understand how TOR can associate with different membranes, the lipid-binding properties of the redox-sensitive yeast TOR1 FATC domain (y1fatc) have been characterized by solution NMR spectroscopy. Binding studies with different lipids indicate that y1fatc interacts specifically with a membrane-mimetic environment but appears not to recognize a specific lipid headgroup. In both, the structures of oxidized and reduced micelle-bound y1fatc, residues Ile-2456 to Trp-2470 of the lipid-binding motif form a hydrophobic bulb that has a rim of charged residues. The diffusion constants for both micelle-bound states are consistent with the rotational correlation times from the analysis of the N-15 relaxation data. Based on the K-d values, the oxidized form (K-d similar to 0.31 mM) binds dodecyl phosphocholine micelles slightly tighter than the reduced form (K-d similar to 1.86 mM). Binding studies with y1fatc in which one or both tryptophans (Trp-2466 and Trp-2470) were replaced by alanine suggest that these residues are important for the exact positioning in the membrane and that the other aromatic (His-2462, Tyr-2463, and Phe-2469) and aliphatic residues (Ile-2456, Leu-2459, Ile-2464, and Pro-2468) in the lipid-binding motif contribute significantly to the affinity.	[Dames, Sonja A.] Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Dames, SA (corresponding author), Tech Univ Munich, Dept Chem, Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany.	sonja.dames@tum.de		Dames, Sonja/0000-0001-7495-6943	Swiss National Science Foundation [31-109712]; German Research Foundation (Deutsche Forschungsgemeinschaft) [1195/3-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported in part by the Swiss National Science Foundation through a grant (SNF Grant 31-109712) to Stephan Grzesiek and by the German Research Foundation (Deutsche Forschungsgemeinschaft Grant DA 1195/3-1 to S.A.D.).	Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040; Ahn HC, 2006, J AM CHEM SOC, V128, P4398, DOI 10.1021/ja057773d; Almeida M, 2009, J BIOL CHEM, V284, P27438, DOI 10.1074/jbc.M109.023572; Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; Begotka BA, 2006, MAGN RESON CHEM, V44, P586, DOI 10.1002/mrc.1793; Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Ha SH, 2006, CELL SIGNAL, V18, P2283, DOI 10.1016/j.cellsig.2006.05.021; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200; Kutateladze TG, 2004, J BIOL CHEM, V279, P3050, DOI 10.1074/jbc.M309007200; Lane HA, 2009, CURR OPIN CELL BIOL, V21, P219, DOI 10.1016/j.ceb.2009.01.016; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4; Lazaridis T, 2005, J PHYS CHEM B, V109, P15098, DOI 10.1021/jp0516801; Liu W, 2006, BIOCHEMISTRY-US, V45, P11713, DOI 10.1021/bi0608414; Lucas LH, 2004, CONCEPT MAGN RESON A, V20A, P24, DOI 10.1002/cmr.a.10094; Nanga RPR, 2009, J AM CHEM SOC, V131, P8252, DOI 10.1021/ja9010095; Orfi L, 1998, ANAL CHEM, V70, P1339, DOI 10.1021/ac971011m; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seewald MJ, 2000, PROTEIN SCI, V9, P1177, DOI 10.1110/ps.9.6.1177; Shao C, 2008, J BIOL CHEM, V283, P7230, DOI 10.1074/jbc.M705195200; Sun H, 2008, J BIOL CHEM, V283, P22233, DOI 10.1074/jbc.M802074200; Takahashi T, 2000, GENES CELLS, V5, P765, DOI 10.1046/j.1365-2443.2000.00365.x; Thevenot C, 2005, COLLOID SURFACE A, V252, P105, DOI 10.1016/j.colsurfa.2004.10.062; Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Withers DJ, 1997, BIOCHEM BIOPH RES CO, V241, P704, DOI 10.1006/bbrc.1997.7878; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200	58	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7766	7775		10.1074/jbc.M109.058404	http://dx.doi.org/10.1074/jbc.M109.058404			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042596	Green Published, hybrid			2022-12-25	WOS:000275415600084
J	Rauert, H; Wicovsky, A; Muller, N; Siegmund, D; Spindler, V; Waschke, J; Kneitz, C; Wajant, H				Rauert, Hilka; Wicovsky, Andreas; Mueller, Nicole; Siegmund, Daniela; Spindler, Volker; Waschke, Jens; Kneitz, Christian; Wajant, Harald			Membrane Tumor Necrosis Factor (TNF) Induces p100 Processing via TNF Receptor-2 (TNFR2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; OSTEOCLAST DIFFERENTIATION; DENDRITIC CELLS; DOWN-REGULATION; CUTTING EDGE; ALPHA; LIGAND; INDUCTION; APOPTOSIS; TRAF2	Tumor necrosis factor (TNF) elicits its biological activities by stimulation of two receptors, TNFR1 and TNFR2, both belonging to the TNF receptor superfamily. Whereas TNFR1-mediated signal transduction has been intensively studied and is understood in detail, especially with respect to activation of the classical NF kappa B pathway, cell death induction, and MAP kinase signaling, TNFR2-associated signal transduction is poorly defined. Here, we demonstrate in various tumor cell lines and primary T-cells that TNFR2, but not TNFR1, induces activation of the alternative NF kappa B pathway. In accord with earlier findings demonstrating that only membrane TNF, but not soluble TNF, properly activates TNFR2, we further show by use of TNFR1- and TNFR2-specific mutants of soluble TNF and membrane TNF that soluble ligand trimers fail to activate the alternative NF kappa B pathway. In accord with the known inhibitory role of TRAF2 in the alternative NF kappa B pathway, TNFR2-, but not TNFR1-specific TNF induced depletion of cytosolic TRAF2. Thus, we identified activation of the alternative NF kappa B pathway as a TNF signaling effect that can be specifically assigned to TNFR2 and membrane TNF.	[Wajant, Harald] Univ Hosp Wurzburg, Dept Internal Med 2, Div Mol Internal Med, D-97070 Wurzburg, Germany; [Kneitz, Christian] Hosp Sudstadt Rostock, Dept Rheumatol & Immunol, Clin Internal Med 2, D-18059 Rostock, Germany; [Spindler, Volker; Waschke, Jens] Univ Wurzburg, Dept Anat & Cell Biol, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Wajant, H (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 2, Div Mol Internal Med, Rontgenring 11, D-97070 Wurzburg, Germany.	harald.wajant@mail.uni-wuerzburg.de	Spindler, Volker/G-1704-2019; Wajant, Harald/A-3020-2017	Spindler, Volker/0000-0002-1302-5421; Wajant, Harald/0000-0002-2005-3949; Muller-Sienerth, Nicole/0000-0002-7527-5127	Wyeth BioPharma; Deutsche Forschungsgemeinschaft [B7, Wa 1025/18-1]; IZKF Wurzburg [A-49]	Wyeth BioPharma; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Wurzburg	This work was supported by Wyeth BioPharma (Forschungspreis Rheumatologie 2007), Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 487, Project B7, Clinical Research Unit 216, Project 8, and Grant Wa 1025/18-1), and IZKF Wurzburg ( Project A-49).	Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Berg D, 2007, CELL DEATH DIFFER, V14, P2021, DOI 10.1038/sj.cdd.4402213; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567; Chaisson ML, 2004, J BIOL CHEM, V279, P54841, DOI 10.1074/jbc.M406392200; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Chandrasekharan UM, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000264129.47500.56; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; Declercq W, 1998, J IMMUNOL, V161, P390; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Funk JO, 2000, J IMMUNOL, V165, P4792, DOI 10.4049/jimmunol.165.9.4792; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602; Kim EY, 2006, J IMMUNOL, V176, P1026, DOI 10.4049/jimmunol.176.2.1026; Kim EY, 2004, J IMMUNOL, V173, P4500, DOI 10.4049/jimmunol.173.7.4500; Kim EY, 2001, J IMMUNOL, V167, P6812, DOI 10.4049/jimmunol.167.12.6812; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; LOETSCHER H, 1993, J BIOL CHEM, V268, P26350; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Muller N, 2008, FEBS J, V275, P2296, DOI 10.1111/j.1742-4658.2008.06382.x; Pan S, 2002, MOL CELL BIOL, V22, P7512, DOI 10.1128/MCB.22.21.7512-7523.2002; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Pimentel-Muinos FX, 1999, IMMUNITY, V11, P783, DOI 10.1016/S1074-7613(00)80152-1; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Speirs K, 2004, J IMMUNOL, V172, P752, DOI 10.4049/jimmunol.172.2.752; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Takayama K, 1999, J INVEST DERMATOL, V113, P541, DOI 10.1046/j.1523-1747.1999.00629.x; Teh HS, 2000, J IMMUNOL, V165, P4814, DOI 10.4049/jimmunol.165.9.4814; Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; VANDENABEELE P, 1995, J IMMUNOL, V154, P2904; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; VERCAMMEN D, 1995, CYTOKINE, V7, P463, DOI 10.1006/cyto.1995.0063; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2001, ONCOGENE, V20, P4101, DOI 10.1038/sj.onc.1204558; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Weiss T, 1998, J IMMUNOL, V161, P3136; Weiss T, 1997, J IMMUNOL, V158, P2398; Wicovsky A, 2009, ONCOGENE, V28, P1769, DOI 10.1038/onc.2009.29; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Zanetti M, 2003, ANN NY ACAD SCI, V987, P249, DOI 10.1111/j.1749-6632.2003.tb06056.x; Zhang R, 2003, J BIOL CHEM, V278, P51267, DOI 10.1074/jbc.M310678200	56	122	128	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7394	7404		10.1074/jbc.M109.037341	http://dx.doi.org/10.1074/jbc.M109.037341			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20038584	Green Published, hybrid			2022-12-25	WOS:000275415600052
J	Tsukamoto, H; Terakita, A; Shichida, Y				Tsukamoto, Hisao; Terakita, Akihisa; Shichida, Yoshinori			A Pivot between Helices V and VI near the Retinal-binding Site Is Necessary for Activation in Rhodopsins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; MOVEMENT; IDENTIFICATION; ABILITY; PIGMENT; FAMILY; OPSIN	Rhodopsins are photoreceptor proteins that have diverged from ligand-binding G protein-coupled receptors (GPCRs). Unlike other GPCRs, rhodopsins contain an intrinsic antagonist, 11-cis-retinal, which is converted to the agonist all-transretinal upon absorption of a photon. Through evolution, vertebrate rhodopsins have lost the ability of direct binding to the agonist, but some invertebrate and vertebrate non-visual rhodopsins have retained this ability. Here, we investigated the difference in the agonist-binding state between these rhodopsins to further our understanding of the structural and functional diversity of rhodopsins. Mutational analyses of agonist-binding rhodopsin showed that replacement of Ala-269, one of the residues constituting the antagonist-binding site, with bulky amino acids resulted in a large spectral shift in its active state and a great reduction in G protein activity, whereas these were rescued by subsequent replacement of Phe-208 with smaller amino acids. Although similar replacements in vertebrate rhodopsin did not cause a spectral shift in the active state, a similar reduction in and recovery of G protein activity was observed. Therefore, the agonist is located close to Ala-269 in the agonist-binding rhodopsin, but not in vertebrate rhodopsins, and Ala-269 with Phe-208 acts as a pivot for the formation of the G protein-activating state in both rhodopsins. The positions corresponding to Ala-269 and Phe-208 in other GPCRs have been reported to form part of an agonist-binding site. Therefore, an agonist-binding rhodopsin has the molecular architecture of the agonist-binding site similar to that of a general GPCR, whereas vertebrate rhodopsins changed the architecture, resulting in loss of agonist binding during molecular evolution.	[Tsukamoto, Hisao; Terakita, Akihisa; Shichida, Yoshinori] Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto 6068502, Japan	Kyoto University	Shichida, Y (corresponding author), Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto 6068502, Japan.	shichida@rh.biophys.kyoto-u.ac.jp		Terakita, Akihisa/0000-0002-8379-8913	Japanese Ministry of Education, Science, Sports, and Culture; Yamada Science Foundation; Japan Society for the Promotion of Science for Young Scientists	Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science Foundation; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research from the Japanese Ministry of Education, Science, Sports, and Culture (to Y. S. and A. T.) and by the Yamada Science Foundation (to A. T.).; Supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists.	Ahuja S, 2009, J BIOL CHEM, V284, P10190, DOI 10.1074/jbc.M805725200; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Blackshaw S, 1997, J NEUROSCI, V17, P8083; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; CHOTHIA C, 1984, ANNU REV BIOCHEM, V53, P537; DIXON RAF, 1988, COLD SPRING HARB SYM, V53, P487, DOI 10.1101/SQB.1988.053.01.056; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Johnson MP, 1997, MOL BRAIN RES, V49, P1, DOI 10.1016/S0169-328X(97)00115-0; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Patel AB, 2004, P NATL ACAD SCI USA, V101, P10048, DOI 10.1073/pnas.0402848101; Roth BL, 1997, MOL PHARMACOL, V52, P259, DOI 10.1124/mol.52.2.259; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; STRADER CD, 1989, J BIOL CHEM, V264, P13572; Struthers M, 1999, BIOCHEMISTRY-US, V38, P6597, DOI 10.1021/bi9902384; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Tsukamoto H, 2005, P NATL ACAD SCI USA, V102, P6303, DOI 10.1073/pnas.0500378102; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212	26	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7351	7357		10.1074/jbc.M109.078709	http://dx.doi.org/10.1074/jbc.M109.078709			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20053991	Green Published, hybrid			2022-12-25	WOS:000275415600047
J	Vina-Vilaseca, A; Sorkin, A				Vina-Vilaseca, Arnau; Sorkin, Alexander			Lysine 63-linked Polyubiquitination of the Dopamine Transporter Requires WW3 and WW4 Domains of Nedd4-2 and UBE2D Ubiquitin-conjugating Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; EGF RECEPTOR; NA+ CHANNEL; LIGASE; DEGRADATION; ENDOCYTOSIS; INTERNALIZATION; UBIQUITYLATION; TRAFFICKING; ISOFORMS	RNA interference screen previously revealed that a HECT-domain E3 ubiquitin ligase, neuronal precursor cell expressed, developmentally down-regulated 4-2 (Nedd4-2), is necessary for ubiquitination and endocytosis of the dopamine transporter (DAT) induced by the activation of protein kinase C (PKC). To further confirm the role of Nedd4-2 in DAT ubiquitination and endocytosis, we demonstrated that the depletion of Nedd4-2 by two different small interfering RNA ( siRNA) duplexes suppressed PKC-dependent ubiquitination and endocytosis of DAT in human and porcine cells, whereas knock-down of a highly homologous E3 ligase, Nedd4-1, had no effect on DAT. The abolished DAT ubiquitination in Nedd4-2-depleted cells was rescued by expression of recombinant Nedd4-2. Moreover, overexpression of Nedd4-2 resulted in increased PKC-dependent ubiquitination of DAT. Mutational inactivation of the HECT domain of Nedd4-2 inhibited DAT ubiquitination and endocytosis. Structure-function analysis of Nedd4-2-mediated DAT ubiquitination revealed that the intact WW4 domain and to a lesser extent WW3 domain are necessary for PKC-dependent DAT ubiquitination. Moreover, a fragment of the Nedd4-2 molecule containing WW3, WW4, and HECT domains was sufficient for fully potentiating PKC-dependent ubiquitination of DAT. Analysis of DAT ubiquitination using polyubiquitin chain-specific antibodies showed that DAT is mainly conjugated with Lys(63)-linked ubiquitin chains. siRNA analysis demonstrated that this polyubiquitination is mediated by Nedd4-2 cooperation with UBE2D and UBE2L3 E2 ubiquitin-conjugating enzymes. The model is proposed whereby each ubiquitinated DAT molecule is modified by a single four-ubiquitin Lys(63)-linked chain that can be conjugated to various lysine residues of DAT.	[Vina-Vilaseca, Arnau; Sorkin, Alexander] Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO 80010 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Sorkin, A (corresponding author), Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO 80010 USA.	alexander.sorkin@ucdenver.edu	Vina-Vilaseca, Arnau/O-1779-2015	Vina-Vilaseca, Arnau/0000-0003-0447-5268; Sorkin, Alexander/0000-0002-4446-1920	NIDA, National Institutes of Health [DA014204]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014204] Funding Source: NIH RePORTER	NIDA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA014204 from the NIDA.	Almaca J, 2009, PFLUG ARCH EUR J PHY, V458, P713, DOI 10.1007/s00424-009-0660-4; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Asher C, 2003, BBA-BIOMEMBRANES, V1612, P59, DOI 10.1016/S0005-2736(03)00083-X; Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Boehmer C, 2006, J NEUROCHEM, V97, P911, DOI 10.1111/j.1471-4159.2006.03629.x; Chan W, 2009, J BIOL CHEM, V284, P8185, DOI 10.1074/jbc.M806877200; Conkright JJ, 2010, AM J RESP CELL MOL, V42, P181, DOI 10.1165/rcmb.2009-0058OC; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Debonneville C, 2004, MOL CELL BIOL, V24, P2397, DOI 10.1128/MCB.24.6.2397-2409.2004; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Edinger RS, 2009, J BIOL CHEM, V284, P150, DOI 10.1074/jbc.M807358200; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Erpapazoglou Z, 2008, TRAFFIC, V9, P1372, DOI 10.1111/j.1600-0854.2008.00766.x; Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x; Fotia AB, 2006, INT J BIOCHEM CELL B, V38, P472, DOI 10.1016/j.biocel.2005.11.006; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Itani OA, 2005, AM J PHYSIOL-RENAL, V289, pF334, DOI 10.1152/ajprenal.00394.2004; Itani OA, 2003, AM J PHYSIOL-RENAL, V285, pF916, DOI 10.1152/ajprenal.00203.2003; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kaliszewski P, 2008, ACTA BIOCHIM POL, V55, P649; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lee JRE, 2009, J BIOL CHEM, V284, P32126, DOI 10.1074/jbc.M109.048629; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Mosesson Y, 2006, ISR MED ASSOC J, V8, P233; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Paiva S, 2009, J BIOL CHEM, V284, P19228, DOI 10.1074/jbc.M109.008318; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Raikwar NS, 2008, AM J PHYSIOL-RENAL, V294, pF1157, DOI 10.1152/ajprenal.00339.2007; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	58	53	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7645	7656		10.1074/jbc.M109.058990	http://dx.doi.org/10.1074/jbc.M109.058990			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20051513	Green Published, hybrid			2022-12-25	WOS:000275415600075
J	Yokota, A; Tsumoto, K; Shiroishi, M; Nakanishi, T; Kondo, H; Kumagai, I				Yokota, Akiko; Tsumoto, Kouhei; Shiroishi, Mitsunori; Nakanishi, Takeshi; Kondo, Hidemasa; Kumagai, Izumi			Contribution of Asparagine Residues to the Stabilization of a Proteinaceous Antigen-Antibody Complex, HyHEL-10-Hen Egg White Lysozyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTILYSOZYME MONOCLONAL-ANTIBODY; SALT BRIDGE FORMATION; ENTROPIC CONTRIBUTION; STRUCTURAL FEATURES; CRYSTAL-STRUCTURES; WATER-MOLECULES; BINDING-ENERGY; HYDROGEN-BONDS; TYR RESIDUES; SPECIFICITY	Many germ line antibodies have asparagine residues at specific sites to achieve specific antigen recognition. To study the role of asparagine residues in the stabilization of antigen-antibody complexes, we examined the interaction between hen egg white lysozyme (HEL) and the corresponding HyHEL-10 variable domain fragment (Fv). We introduced Ala and Asp substitutions into the Fv side chains of L-Asn-31, L-Asn-32, and L-Asn-92, which interact directly with residues in HEL via hydrogen bonding in the wild-type Fv-HEL complex, and we investigated the interactions between these mutant antibodies and HEL. Isothermal titration calorimetric analysis showed that all the mutations decreased the negative enthalpy change and decreased the association constants of the interaction. Structural analyses showed that the effects of the mutations on the structure of the complex could be compensated for by conformational changes and/or by gains in other interactions. Consequently, the contribution of two hydrogen bonds was minor, and their abolition by mutation resulted in only a slight decrease in the affinity of the antibody for its antigen. By comparison, the other two hydrogen bonds buried at the interfacial area had large enthalpic advantage, despite entropic loss that was perhaps due to stiffening of the interface by the bonds, and were crucial to the strength of the interaction. Deletion of these strong hydrogen bonds could not be compensated for by other structural changes. Our results suggest that asparagine can provide the two functional groups for strong hydrogen bond formation, and their contribution to the antigen-antibody interaction can be attributed to their limited flexibility and accessibility at the complex interface.	[Yokota, Akiko; Tsumoto, Kouhei; Shiroishi, Mitsunori; Nakanishi, Takeshi; Kumagai, Izumi] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Yokota, Akiko] Natl Inst Adv Ind Sci & Technol, Prot Design Res Grp, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058566, Japan; [Tsumoto, Kouhei] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Kashiwa, Chiba 2778562, Japan; [Kondo, Hidemasa] Natl Inst Adv Ind Sci & Technol, Funct Prot Res Grp, Res Inst Genome Based Biofactory, Sapporo, Hokkaido 0628517, Japan	Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Tsumoto, K (corresponding author), Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Aoba Yama 6-6-11, Sendai, Miyagi 9808579, Japan.	tsumoto@k.u-tokyo.ac.jp; kmiz@kuma.che.tohoku.ac.jp	Yokota, Akiko/M-1807-2018; Kondo, Hidemasa/M-7465-2018	Yokota, Akiko/0000-0002-5896-9899; Kondo, Hidemasa/0000-0003-2799-1775; Shiroishi, Mitsunori/0000-0002-3133-157X	grants-in-aid for general research	grants-in-aid for general research	This work was supported by grants-in-aid for general research (to K.T. and I.K.).	Aitio O, 2008, J MOL BIOL, V382, P167, DOI 10.1016/j.jmb.2008.07.008; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTLETT PA, 1987, SCIENCE, V235, P569, DOI 10.1126/science.3810155; BHAT TN, 1994, P NATL ACAD SCI USA, V91, P1089, DOI 10.1073/pnas.91.3.1089; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BOHM HJ, 2003, PROTEIN LIGAND INTER, V19, P21; BRADEN BC, 1995, FASEB J, V9, P9, DOI 10.1096/fasebj.9.1.7821765; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; BRUMMELL DA, 1993, BIOCHEMISTRY-US, V32, P1180, DOI 10.1021/bi00055a024; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clements CS, 2006, CURR OPIN STRUC BIOL, V16, P787, DOI 10.1016/j.sbi.2006.09.004; COLMAN PM, 1988, ADV IMMUNOL, V43, P99; CONNELLY PR, 1994, P NATL ACAD SCI USA, V91, P1964, DOI 10.1073/pnas.91.5.1964; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Desiraju G. R., 2001, WEAK HYDROGEN BOND S, P343; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Fields BA, 1996, BIOCHEMISTRY-US, V35, P15494, DOI 10.1021/bi961709e; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2984; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Goldman ER, 1997, BIOCHEMISTRY-US, V36, P49, DOI 10.1021/bi961769k; Imoto T., 1972, ENZYMES, V7, P665; Jackson RM, 1999, PROTEIN SCI, V8, P603; James LC, 2003, PROTEIN SCI, V12, P2183, DOI 10.1110/ps.03172703; JANIN J, 1990, J BIOL CHEM, V265, P16027; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABAT EA, 1977, J BIOL CHEM, V252, P6609; KABAT EA, 1976, P NATL ACAD SCI USA, V73, P4471, DOI 10.1073/pnas.73.12.4471; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kondo H, 1999, J BIOL CHEM, V274, P27623, DOI 10.1074/jbc.274.39.27623; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LADBURY JE, 1994, J MOL BIOL, V238, P669, DOI 10.1006/jmbi.1994.1328; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE KH, 1994, PROTEINS, V20, P68, DOI 10.1002/prot.340200108; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; LO CL, 1999, J MOL BIOL, V285, P2177; MANDELGUTFREUND Y, 1995, J MOL BIOL, V253, P370, DOI 10.1006/jmbi.1995.0559; MARIUZZA RA, 1993, CURR OPIN IMMUNOL, V5, P50, DOI 10.1016/0952-7915(93)90080-C; Merk H, 1999, J BIOCHEM, V125, P328, DOI 10.1093/oxfordjournals.jbchem.a022290; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; MURPHY KP, 1995, PROTEINS, V21, P83, DOI 10.1002/prot.340210202; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Nishimiya Y, 2000, J BIOL CHEM, V275, P12813, DOI 10.1074/jbc.275.17.12813; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; Padlan EA, 1996, ADV PROTEIN CHEM, V49, P57, DOI 10.1016/S0065-3233(08)60488-X; PADLAN EA, 1990, PROTEINS, V7, P112, DOI 10.1002/prot.340070203; POMES R, 1995, PROTEIN ENG, V8, P663, DOI 10.1093/protein/8.7.663; Pons J, 1999, PROTEIN SCI, V8, P958, DOI 10.1110/ps.8.5.958; Rajpal A, 1998, PROTEIN SCI, V7, P1868, DOI 10.1002/pro.5560070903; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; Shiroishi M, 2001, J BIOL CHEM, V276, P23042, DOI 10.1074/jbc.M100480200; Shiroishi M, 2007, J BIOL CHEM, V282, P6783, DOI 10.1074/jbc.M605197200; SMITHGILL SJ, 1991, CURR OPIN BIOTECH, V2, P568, DOI 10.1016/0958-1669(91)90082-G; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Sundberg EJ, 2000, BIOCHEMISTRY-US, V39, P15375, DOI 10.1021/bi000704l; TORIGOE H, 1995, J BIOL CHEM, V270, P22218, DOI 10.1074/jbc.270.38.22218; TRONRUD DE, 1987, SCIENCE, V235, P571, DOI 10.1126/science.3810156; TSUMOTO K, 1995, J BIOL CHEM, V270, P18551, DOI 10.1074/jbc.270.31.18551; TSUMOTO K, 1994, J BIOL CHEM, V269, P28777; TSUMOTO K, 1994, BIOCHEM BIOPH RES CO, V201, P546, DOI 10.1006/bbrc.1994.1736; Tsumoto K, 1996, J BIOL CHEM, V271, P32612, DOI 10.1074/jbc.271.51.32612; Ueda H, 1996, NAT BIOTECHNOL, V14, P1714, DOI 10.1038/nbt1296-1714; UEDA Y, 1993, GENE, V129, P129; Wang YH, 1997, P NATL ACAD SCI USA, V94, P1657, DOI 10.1073/pnas.94.5.1657; WEBSTER DM, 1994, CURR OPIN STRUC BIOL, V4, P123, DOI 10.1016/S0959-440X(94)90070-1; Wibbenmeyer JA, 1999, J BIOL CHEM, V274, P26838, DOI 10.1074/jbc.274.38.26838; Wilkinson RA, 2005, J VIROL, V79, P13060, DOI 10.1128/JVI.79.20.13060-13069.2005; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Yokota A, 2003, J BIOL CHEM, V278, P5410, DOI 10.1074/jbc.M210182200	80	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7686	7696		10.1074/jbc.M109.089623	http://dx.doi.org/10.1074/jbc.M109.089623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20038580	hybrid, Green Published			2022-12-25	WOS:000275415600078
J	Buddai, SK; Layzer, JM; Lu, GM; Rusconi, CP; Sullenger, BA; Monroe, DM; Krishnaswamy, S				Buddai, Sai K.; Layzer, Juliana M.; Lu, Genmin; Rusconi, Christopher P.; Sullenger, Bruce A.; Monroe, Dougald M.; Krishnaswamy, Sriram			An Anticoagulant RNA Aptamer That Inhibits Proteinase-Cofactor Interactions within Prothrombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION FACTOR; HUMAN-FACTOR-X; MACROMOLECULAR SUBSTRATE RECOGNITION; PROPOSED STRUCTURAL MODELS; FACTOR PATHWAY INHIBITOR; EXTRINSIC XASE COMPLEX; FACTOR-VA; BINDING-SITE; EXTINCTION COEFFICIENTS; CRYSTAL-STRUCTURE	The interaction of factor Xa with factor Va on membranes to form prothrombinase profoundly increases the rate of the proteolytic conversion of prothrombin to thrombin. We present the characterization of an RNA aptamer (RNA(11F7t)) selected from a combinatorial library based on its ability to bind factor Xa. We show that RNA(11F7t) inhibits thrombin formation catalyzed by prothrombinase without obscuring the active site of Xa within the enzyme complex. Selective inhibition of protein substrate cleavage arises from the ability of the aptamer to bind to factor Xa and exclude interactions between the proteinase and cofactor within prothrombinase. Competition for enzyme complex assembly results from the binding of RNA(11F7t) to factor Xa with nanomolar affinity in a Ca2+-dependent interaction. RNA(11F7t) binds equivalently to the zymogen factor X as well as derivatives lacking gamma-carboxyglutamic acid residues. We suggest that the ability of RNA(11F7t) to compete for the Xa-Va interaction with surprisingly high affinity likely reflects a significant contribution from its ability to indirectly impact regions of Xa that participate in the proteinase-cofactor interaction. Thus, despite the complexity of the macromolecular interactions that underlie the assembly of prothrombinase, efficient inhibition of enzyme complex assembly and thrombin formation can be achieved by tight binding ligands that target factor Xa in a discrete manner.	[Buddai, Sai K.; Lu, Genmin; Krishnaswamy, Sriram] Childrens Hosp Philadelphia, Joseph Stokes Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Layzer, Juliana M.; Rusconi, Christopher P.; Sullenger, Bruce A.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27705 USA; [Monroe, Dougald M.] Univ N Carolina, Div Hematol & Oncol, Chapel Hill, NC 27599 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, Joseph Stokes Res Inst, 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019	Monroe, Dougald/0000-0002-0493-2943	National Institutes of Health [HL-74124, HL-47465, HL-65222, NHLBI0]; Medical Research Foundation of the University of North Carolina, Chapel Hill; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047465, R01HL065222, P01HL074124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Foundation of the University of North Carolina, Chapel Hill; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-74124, HL-47465 ( to S. K.), and HL-65222 ( to B. A. S.) (NHLBI0). This work was also supported by the Coagulation Research Trust Fund from the Medical Research Foundation of the University of North Carolina, Chapel Hill ( to D. M. M.).	Adler M, 2000, BIOCHEMISTRY-US, V39, P12534, DOI 10.1021/bi001477q; Autin L, 2006, PROTEINS, V63, P440, DOI 10.1002/prot.20848; BAJAJ SP, 1981, J BIOL CHEM, V256, P253; Bauer KA, 2008, CURR OPIN HEMATOL, V15, P509, DOI 10.1097/MOH.0b013e328309ecbc; Baugh RJ, 2000, J BIOL CHEM, V275, P28826, DOI 10.1074/jbc.M005266200; Baugh RJ, 1998, J BIOL CHEM, V273, P4378, DOI 10.1074/jbc.273.8.4378; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bevington P. R., 1992, DATA REDUCTION ERROR, P141; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; Bonifacio GF, 1997, BIOPHYS J, V73, P1532, DOI 10.1016/S0006-3495(97)78185-2; Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Cao WJ, 2008, P NATL ACAD SCI USA, V105, P7416, DOI 10.1073/pnas.0801735105; CHASE T, 1970, METHOD ENZYMOL, V19, P20; CHATTOPADHYAY A, 1992, J BIOL CHEM, V267, P12323; DISCIPIO RG, 1978, J CLIN INVEST, V61, P1528, DOI 10.1172/JCI109073; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; DUFFY EJ, 1992, J BIOL CHEM, V267, P7821; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; FURIE B, 1992, NEW ENGL J MED, V326, P800; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Greenspan NS, 1999, NAT BIOTECHNOL, V17, P936, DOI 10.1038/13590; Gross PL, 2008, ARTERIOSCL THROM VAS, V28, P380, DOI 10.1161/ATVBAHA.108.162677; Hacisalihoglu A, 2007, J BIOL CHEM, V282, P32974, DOI 10.1074/jbc.M706529200; Jeter ML, 2004, FEBS LETT, V568, P10, DOI 10.1016/j.febslet.2004.04.087; Kalafatis M, 2005, CURR OPIN HEMATOL, V12, P141, DOI 10.1097/01.moh.0000155016.30296.90; Kalafatis M, 2002, BIOCHEMISTRY-US, V41, P12715, DOI 10.1021/bi026208+; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; KIM DJ, 1994, BIOTECHNOL LETT, V16, P549, DOI 10.1007/BF00128598; Kojima Y, 1998, J BIOL CHEM, V273, P14900, DOI 10.1074/jbc.273.24.14900; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P3319, DOI 10.1021/bi9623993; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lee AYY, 2003, J INTERN MED, V254, P313, DOI 10.1046/j.1365-2796.2003.01224.x; Lee CJ, 2008, J THROMB HAEMOST, V6, P83; Long SB, 2008, RNA, V14, P2504, DOI 10.1261/rna.1239308; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lu G, 2004, J BIOL CHEM, V279, P17241, DOI 10.1074/jbc.M312827200; LUCKOW EA, 1989, BIOCHEMISTRY-US, V28, P2348, DOI 10.1021/bi00431a055; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1990, BLOOD, V76, P1; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; OLSON ST, 1991, ARCH BIOCHEM BIOPHYS, V286, P533, DOI 10.1016/0003-9861(91)90076-U; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; PABORSKY LR, 1993, J BIOL CHEM, V268, P20808; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; PERSSON E, 1989, J BIOL CHEM, V264, P16897; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Rusconi CP, 2000, THROMB HAEMOSTASIS, V84, P841; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; TAYLOR FB, 1991, BLOOD, V78, P364; Toso R, 2008, J BIOL CHEM, V283, P18627, DOI 10.1074/jbc.M802205200; TUCKER MM, 1983, J BIOL CHEM, V258, P1210; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; WALKER RK, 1994, J BIOL CHEM, V269, P27441; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495	64	30	30	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5212	5223		10.1074/jbc.M109.049833	http://dx.doi.org/10.1074/jbc.M109.049833			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022942	Green Published, hybrid			2022-12-25	WOS:000275327200014
J	Betapudi, V				Betapudi, Venkaiah			Myosin II Motor Proteins with Different Functions Determine the Fate of Lamellipodia Extension during Cell Spreading	PLOS ONE			English	Article							RAT SYMPATHETIC NEURONS; INTERFERING RNAS; MESSENGER-RNA; LEADING-EDGE; ACTIN; ISOFORMS; LOCALIZATION; CYTOKINESIS; EXPRESSION; MOTILITY	Non-muscle cells express multiple myosin-II motor proteins myosin IIA, myosin IIB and myosin IIC transcribed from different loci in the human genome. Due to a significant homology in their sequences, these ubiquitously expressed myosin II motor proteins are believed to have overlapping cellular functions, but the mechanistic details are not elucidated. The present study uncovered a mechanism that coordinates the distinctly localized myosin IIA and myosin IIB with unexpected opposite mechanical roles in maneuvering lamellipodia extension, a critical step in the initiation of cell invasion, spreading, and migration. Myosin IIB motor protein by localizing at the front drives lamellipodia extension during cell spreading. On the other hand, myosin IIA localizes next to myosin IIB and attenuates or retracts lamellipodia extension. Myosin IIA and IIB increase cell adhesion by regulating focal contacts formation in the spreading margins and central part of the spreading cell, respectively. Spreading cells expressing both myosin IIA and myosin IIB motor proteins display an organized actin network consisting of retrograde filaments, arcs and central filaments attached to focal contacts. This organized actin network especially arcs and focal contacts formation in the spreading margins were lost in myosin II (A) over bar cells. Surprisingly, myosin II (B) over bar cells displayed long parallel actin filaments connected to focal contacts in the spreading margins. Thus, with different roles in the regulation of the actin network and focal contacts formation, both myosin IIA and IIB determine the fate of lamellipodia extension during cell spreading.	[Betapudi, Venkaiah] Case Western Reserve Univ, Dept Cell Biol, Lerner Coll Med, Cleveland, OH 44106 USA; [Betapudi, Venkaiah] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Betapudi, V (corresponding author), Case Western Reserve Univ, Dept Cell Biol, Lerner Coll Med, Cleveland, OH 44106 USA.	betapuv@ccf.org			U.S. National Institutes of Health [GM077224]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077224] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the U.S. National Institutes of Health to TTE (grant GM077224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Brown ME, 2003, J CELL SCI, V116, P1087, DOI 10.1242/jcs.00335; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Cramer Louise P., 1997, Frontiers in Bioscience (online), V2, pD260; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; HODGE TP, 1992, J CELL BIOL, V118, P1085, DOI 10.1083/jcb.118.5.1085; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Kolega J, 1998, J CELL SCI, V111, P2085; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leal A, 2003, GENE, V312, P165, DOI 10.1016/S0378-1119(03)00613-9; Liang WC, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-19; Lord M, 2005, MOL BIOL CELL, V16, P5346, DOI 10.1091/mbc.E05-07-0601; Malashkevich VN, 2008, BIOCHEMISTRY-US, V47, P5111, DOI 10.1021/bi702537s; MANSTEIN DJ, 1989, SCIENCE, V246, P656, DOI 10.1126/science.2530629; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Rey M, 2007, J CELL SCI, V120, P1126, DOI 10.1242/jcs.03415; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Rosenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001496; SAEZ CG, 1990, P NATL ACAD SCI USA, V87, P1164, DOI 10.1073/pnas.87.3.1164; Saitoh T, 2001, FEBS LETT, V509, P365, DOI 10.1016/S0014-5793(01)03186-6; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Semizarov D, 2004, NUCLEIC ACIDS RES, V32, P3836, DOI 10.1093/nar/gkh714; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; Takagishi Y, 2005, J PHYSIOL-LONDON, V569, P195, DOI 10.1113/jphysiol.2005.095943; Togo T, 2004, MOL BIOL CELL, V15, P688, DOI 10.1091/mbc.E03-06-0430; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; WANG YL, 2007, SCI STKE, pE10; Wei Q, 2002, MOL BIOL CELL, V13, P683, DOI 10.1091/mbc.01-07-0358; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Wylie SR, 2003, MOL BIOL CELL, V14, P4654, DOI 10.1091/mbc.E03-03-0187; Wylie SR, 1998, P NATL ACAD SCI USA, V95, P12967, DOI 10.1073/pnas.95.22.12967; Wylie SR, 2001, NAT CELL BIOL, V3, P88, DOI 10.1038/35050613; Wylie SR, 2008, MOL BIOL CELL, V19, P3956, DOI 10.1091/mbc.E07-08-0744; Zhou M, 2008, MOL BIOL CELL, V19, P318, DOI 10.1091/mbc.E07-08-0783; Zimerman B, 2004, IEE Proc Nanobiotechnol, V151, P62, DOI 10.1049/ip-nbt:20040474	65	58	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8560	10.1371/journal.pone.0008560	http://dx.doi.org/10.1371/journal.pone.0008560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052411	Green Published, gold, Green Submitted			2022-12-25	WOS:000273338500007
J	Caschera, F; Gazzola, G; Bedau, MA; Moreno, CB; Buchanan, A; Cawse, J; Packard, N; Hanczyc, MM				Caschera, Filippo; Gazzola, Gianluca; Bedau, Mark A.; Moreno, Carolina Bosch; Buchanan, Andrew; Cawse, James; Packard, Norman; Hanczyc, Martin M.			Automated Discovery of Novel Drug Formulations Using Predictive Iterated High Throughput Experimentation	PLOS ONE			English	Article							AMPHOTERICIN-B; PROTEIN CRYSTALLIZATION; OPTIMIZATION; GLUCOSIDE; AMBISOME; BILAYERS	Background: We consider the problem of optimizing a liposomal drug formulation: a complex chemical system with many components (e. g., elements of a lipid library) that interact nonlinearly and synergistically in ways that cannot be predicted from first principles. Methodology/Principal Findings: The optimization criterion in our experiments was the percent encapsulation of a target drug, Amphotericin B, detected experimentally via spectrophotometric assay. Optimization of such a complex system requires strategies that efficiently discover solutions in extremely large volumes of potential experimental space. We have designed and implemented a new strategy of evolutionary design of experiments (Evo-DoE), that efficiently explores high-dimensional spaces by coupling the power of computer and statistical modeling with experimentally measured responses in an iterative loop. Conclusions: We demonstrate how iterative looping of modeling and experimentation can quickly produce new discoveries with significantly better experimental response, and how such looping can discover the chemical landscape underlying complex chemical systems.	[Caschera, Filippo; Gazzola, Gianluca; Bedau, Mark A.; Moreno, Carolina Bosch; Buchanan, Andrew; Cawse, James; Packard, Norman; Hanczyc, Martin M.] ProtoLife Inc, San Francisco, CA USA; [Caschera, Filippo; Hanczyc, Martin M.] Univ So Denmark, Inst Chem & Phys, Odense, Denmark; [Packard, Norman] Santa Fe Inst, Santa Fe, NM 87501 USA; [Bedau, Mark A.; Packard, Norman] European Ctr Living Technol, Venice, Italy; [Bedau, Mark A.] Reed Coll, Portland, OR 97202 USA; [Bedau, Mark A.] Univ So Denmark, Initiat Sci Soc & Policy, Odense, Denmark; [Cawse, James] Cawse & Effect, Pittsfield, MA USA	University of Southern Denmark; The Santa Fe Institute; Reed College - Oregon; University of Southern Denmark	Caschera, F (corresponding author), ProtoLife Inc, San Francisco, CA USA.	martin@ifk.sdu.dk	CASCHERA, FILIPPO/ABF-7941-2021; Gazzola, Gianluca/AAD-3204-2020	CASCHERA, FILIPPO/0000-0001-9884-775X; Gazzola, Gianluca/0000-0002-8306-1225; Hanczyc, Martin/0000-0002-5453-2139	ProtoLife Srl	ProtoLife Srl	This work was funded internally by ProtoLife Srl. All research was conducted at ProtoLife's laboratories in Venice, Italy. At that time, all of the authors were employed by ProtoLife Srl. The authors and therefore ProtoLife Srl designed and executed the study. The role of the funders was to supply the funds.	Adler-Moore J, 2002, J ANTIMICROB CHEMOTH, V49, P21, DOI 10.1093/jac/49.suppl_1.21; [Anonymous], 1998, NEURAL NETWORKS COMP; Boswell GW, 1998, J CLIN PHARMACOL, V38, P583, DOI 10.1002/j.1552-4604.1998.tb04464.x; CARTER CW, 1979, J BIOL CHEM, V254, P2219; Cawse J. N., 2002, 2002GRC253, P25; CAWSE JN, 2007, COMBINATORIAL MAT SC, P21; Davison AC, 1997, BOOTSTRAP METHODS TH; DeLucas LJ, 2003, J STRUCT BIOL, V142, P188, DOI 10.1016/S1047-8477(03)00050-9; DEVARIAS DP, 2005, ADV NEURAL INFORM PR, P1; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Fujii G, 1997, BIOCHEMISTRY-US, V36, P4959, DOI 10.1021/bi962894z; Gagos M, 2001, BBA-BIOMEMBRANES, V1511, P90, DOI 10.1016/S0005-2736(00)00386-2; He LZ, 2000, J MOL LIQ, V89, P239, DOI 10.1016/S0167-7322(00)90017-5; Keller M, 1997, BBA-BIOMEMBRANES, V1326, P178, DOI 10.1016/S0005-2736(97)00022-9; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; NIST/SEMATECH, NIST SEMATECH E HDB; PROFFITT RT, 2004, Patent No. 6770290; Selassie C.D., 2003, BURGERS MED CHEM DRU, P1, DOI DOI 10.1002/0471266949.BMC001; Singh J, 1996, J AM CHEM SOC, V118, P1669, DOI 10.1021/ja953172i; THEIS M, 2006, ECCS06 ONL P OXF; WEBER L, 1995, ANGEW CHEM INT EDIT, V34, P2280, DOI 10.1002/anie.199522801; WOLF D, 2002, EXPT DESIGN COMBINAT, P147	22	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8546	10.1371/journal.pone.0008546	http://dx.doi.org/10.1371/journal.pone.0008546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049327	Green Submitted, Green Published, gold			2022-12-25	WOS:000273225000011
J	Sahar, S; Zocchi, L; Kinoshita, C; Borrelli, E; Sassone-Corsi, P				Sahar, Saurabh; Zocchi, Loredana; Kinoshita, Chisato; Borrelli, Emiliana; Sassone-Corsi, Paolo			Regulation of BMAL1 Protein Stability and Circadian Function by GSK3 beta-Mediated Phosphorylation	PLOS ONE			English	Article							CLOCK; COMPONENT; TRANSCRIPTION; INHIBITION; ACTIVATION; REVEALS; GSK-3; AGE	Background: Circadian rhythms govern a large array of physiological and metabolic functions. To achieve plasticity in circadian regulation, proteins constituting the molecular clock machinery undergo various post-translational modifications (PTMs), which influence their activity and intracellular localization. The core clock protein BMAL1 undergoes several PTMs. Here we report that the Akt-GSK3 beta signaling pathway regulates BMAL1 protein stability and activity. Principal Findings: GSK3 beta phosphorylates BMAL1 specifically on Ser 17 and Thr 21 and primes it for ubiquitylation. In the absence of GSK3 beta-mediated phosphorylation, BMAL1 becomes stabilized and BMAL1 dependent circadian gene expression is dampened. Dopamine D2 receptor mediated signaling, known to control the Akt-GSK3 beta pathway, influences BMAL1 stability and in vivo circadian gene expression in striatal neurons. Conclusions: These findings uncover a previously unknown mechanism of circadian clock control. The GSK3 beta kinase phosphorylates BMAL1, an event that controls the stability of the protein and the amplitude of circadian oscillation. BMAL1 phosphorylation appears to be an important regulatory step in maintaining the robustness of the circadian clock.	[Sahar, Saurabh; Zocchi, Loredana; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Kinoshita, Chisato; Borrelli, Emiliana] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Sahar, Saurabh; Borrelli, Emiliana; Sassone-Corsi, Paolo] Univ Calif Irvine, Unite 904, INSERM Epigenet & Neuronal Plast, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Sahar, S (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	psc@uci.edu	Borrelli, Emiliana/M-8994-2018; Kinoshita, Chisato/AAW-5116-2020; Sassone-Corsi, Paolo/H-6182-2011	Kinoshita, Chisato/0000-0001-5877-0196; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024689] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA024689, R01-DA024689] Funding Source: Medline; NIGMS NIH HHS [R01 GM081634, R01-GM081634-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; MacAulay K, 2008, EXPERT OPIN THER TAR, V12, P1265, DOI 10.1517/14728222.12.10.1265 ; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Tamaru T, 2009, NAT STRUCT MOL BIOL, V16, P446, DOI 10.1038/nsmb.1578; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Virshup DM, 2007, CELL, V129, P857, DOI 10.1016/j.cell.2007.05.015; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; WOODGETT JR, 2001, SCI STKE, pRE12; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yujnovsky I, 2006, P NATL ACAD SCI USA, V103, P6386, DOI 10.1073/pnas.0510691103	45	200	211	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8561	10.1371/journal.pone.0008561	http://dx.doi.org/10.1371/journal.pone.0008561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049328	Green Published, gold			2022-12-25	WOS:000273225000020
J	Raffegerst, SH; Hoelzlwimmer, G; Kunder, S; Mysliwietz, J; Quintanilla-Martinez, L; Schendel, DJ				Raffegerst, Silke H.; Hoelzlwimmer, Gabriele; Kunder, Sandra; Mysliwietz, Josef; Quintanilla-Martinez, Leticia; Schendel, Dolores J.			Diverse Hematological Malignancies Including Hodgkin-Like Lymphomas Develop in Chimeric MHC Class II Transgenic Mice	PLOS ONE			English	Article							COMBINED IMMUNODEFICIENT MICE; REED-STERNBERG CELLS; RECEPTOR BETA-CHAINS; CENTER B-CELLS; HEMATOPOIETIC NEOPLASMS; REARRANGEMENT ANALYSIS; BETHESDA PROPOSALS; DEFICIENT MICE; DISEASE; MODELS	A chimeric HLA-DR4-H2-E (DR4) homozygous transgenic mouse line spontaneously develops diverse hematological malignancies with high frequency (70%). The majority of malignancies were distributed equally between T and B cell neoplasms and included lymphoblastic T cell lymphoma (LTCL), lymphoblastic B cell lymphoma (LBCL), diffuse large B cell lymphoma (DLBCL), the histiocyte/T cell rich variant of DLBCL (DLBCL-HA/T cell rich DLBCL), splenic marginal zone lymphoma (SMZL), follicular B cell lymphoma (FBL) and plasmacytoma (PCT). Most of these neoplasms were highly similar to human diseases. Also, some non-lymphoid malignancies such as acute myeloid leukemia (AML) and histiocytic sarcoma were found. Interestingly, composite lymphomas, including Hodgkin-like lymphomas, were also detected that had CD30(+) Hodgkin/Reed-Sternberg (H/RS)-like cells, representing a tumor type not previously described in mice. Analysis of microdissected H/RS-like cells revealed their origin as germinal center B cells bearing somatic hypermutations and, in some instances, crippled mutations, as described for human Hodgkin lymphoma (HL). Transgene integration in an oncogene was excluded as an exclusive driving force of tumorigenesis and age-related lymphoma development suggests a multi-step process. Thus, this DR4 line is a useful model to investigate common molecular mechanisms that may contribute to important neoplastic diseases in man.	[Raffegerst, Silke H.; Mysliwietz, Josef; Schendel, Dolores J.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany; [Raffegerst, Silke H.; Schendel, Dolores J.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Immune Monitoring, Munich, Germany; [Hoelzlwimmer, Gabriele; Kunder, Sandra; Quintanilla-Martinez, Leticia] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Raffegerst, SH (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany.	silke.raffegerst@helmholtz-muenchen.de	Mysliwietz, Josef/B-8941-2015	Mysliwietz, Josef/0000-0003-4418-5345	Federal Ministry of Education and Research [NGFN2]; Helmholtz Society [HA-202]; German Research Foundation [SFB-TR36]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Society(Helmholtz Association); German Research Foundation(German Research Foundation (DFG))	This work was partially supported by the Federal Ministry of Education and Research (NGFN2), the Helmholtz Society (Alliance for Immunotherapy of Cancer, HA-202) and the German Research Foundation (SFB-TR36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARD DA, 1989, METHOD CELL BIOL, V30, P353; AKESON EC, 2001, CURR PROTOC HUM GENE, pCH4; BARGOU RC, 1993, J EXP MED, V177, P1257, DOI 10.1084/jem.177.5.1257; Bellan C, 2002, DIAGN MOL PATHOL, V11, P2, DOI 10.1097/00019606-200203000-00002; Brauninger A, 1999, NEW ENGL J MED, V340, P1239, DOI 10.1056/NEJM199904223401604; Brunning RD., 2001, PATHOLOGY GENETICS T; Caleo A, 2003, AM J SURG PATHOL, V27, P1577, DOI 10.1097/00000478-200312000-00012; Deshpande AJ, 2007, CELL CYCLE, V6, P543, DOI 10.4161/cc.6.5.3968; Eriksson B, 1999, EXP HEMATOL, V27, P682, DOI 10.1016/S0301-472X(99)00003-X; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; GRUSBY MJ, 1995, ANNU REV IMMUNOL, V13, P417, DOI 10.1146/annurev.iy.13.040195.002221; Henegariu O, 2001, CYTOMETRY, V43, P101, DOI 10.1002/1097-0320(20010201)43:2<101::AID-CYTO1024>3.0.CO;2-8; Hoogervorst EM, 2005, MUTAT RES-FUND MOL M, V574, P3, DOI 10.1016/j.mrfmmm.2005.01.018; Ito K, 1996, J EXP MED, V183, P2635, DOI 10.1084/jem.183.6.2635; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; Jardin F, 2007, PATHOL BIOL, V55, P73, DOI 10.1016/j.patbio.2006.04.001; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; KAPP U, 1993, BLOOD, V82, P1247; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kunder S, 2007, TOXICOL PATHOL, V35, P366, DOI 10.1080/01926230701230296; Kuppers R, 1996, ANN ONCOL, V7, P27; Largaespada DA, 2000, LEUKEMIA, V14, P1174, DOI 10.1038/sj.leu.2401852; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; Lim MS, 2002, AM J SURG PATHOL, V26, P1458, DOI 10.1097/00000478-200211000-00008; Lin YW, 2006, BLOOD, V107, P2540, DOI 10.1182/blood-2005-07-3013; Mikkers H, 2002, ONCOGENE, V21, P6559, DOI 10.1038/sj.onc.1205930; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; PADOVAN E, 1995, J EXP MED, V181, P1587, DOI 10.1084/jem.181.4.1587; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Park SS, 2005, CANCER RES, V65, P1306, DOI 10.1158/0008-5472.CAN-04-0268; Schwering I, 2003, BLOOD, V101, P1505, DOI 10.1182/blood-2002-03-0839; SIMPSON E, 1995, EUR J IMMUNOL, V25, P2813, DOI 10.1002/eji.1830251015; Sonderstrup G, 1999, IMMUNOL REV, V172, P335, DOI 10.1111/j.1600-065X.1999.tb01377.x; VONKALLE C, 1992, INT J CANCER, V52, P887, DOI 10.1002/ijc.2910520610; Ward JM, 2006, EXP TOXICOL PATHOL, V57, P377, DOI 10.1016/j.etp.2006.01.007; Zettl A, 2005, HISTOPATHOLOGY, V46, P217, DOI 10.1111/j.1365-2559.2005.02046.x	36	6	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8539	10.1371/journal.pone.0008539	http://dx.doi.org/10.1371/journal.pone.0008539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046882	Green Submitted, Green Published, gold			2022-12-25	WOS:000273180200018
J	Abiola, M; Favier, M; Christodoulou-Vafeiadou, E; Pichard, AL; Martelly, I; Guillet-Deniau, I				Abiola, Mounira; Favier, Maryline; Christodoulou-Vafeiadou, Eleni; Pichard, Anne-Lise; Martelly, Isabelle; Guillet-Deniau, Isabelle			Activation of Wnt/beta-Catenin Signaling Increases Insulin Sensitivity through a Reciprocal Regulation of Wnt10b and SREBP-1c in Skeletal Muscle Cells	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1C; GLUCOSE-TRANSPORT; GENE-EXPRESSION; MYOGENIC CELLS; FATTY-ACIDS; RAT MUSCLES; KINASE; DIFFERENTIATION; PHOSPHORYLATION; ADIPOGENESIS	Background: Intramyocellular lipid accumulation is strongly related to insulin resistance in humans, and we have shown that high glucose concentration induced de novo lipogenesis and insulin resistance in murin muscle cells. Alterations in Wnt signaling impact the balance between myogenic and adipogenic programs in myoblasts, partly due to the decrease of Wnt10b protein. As recent studies point towards a role for Wnt signaling in the pathogenesis of type 2 diabetes, we hypothesized that activation of Wnt signaling could play a crucial role in muscle insulin sensitivity. Methodology/Principal Findings: Here we demonstrate that SREBP-1c and Wnt10b display inverse expression patterns during muscle ontogenesis and regeneration, as well as during satellite cells differentiation. The Wnt/beta-catenin pathway was reactivated in contracting myotubes using siRNA mediated SREBP-1 knockdown, Wnt10b over-expression or inhibition of GSK-3 beta, whereas Wnt signaling was inhibited in myoblasts through silencing of Wnt10b. SREBP-1 knockdown was sufficient to induce Wnt10b protein expression in contracting myotubes and to activate the Wnt/beta-catenin pathway. Conversely, silencing Wnt10b in myoblasts induced SREBP-1c protein expression, suggesting a reciprocal regulation. Stimulation of the Wnt/beta-catenin pathway i) drastically decreased SREBP-1 c protein and intramyocellular lipid deposition in myotubes; ii) increased basal glucose transport in both insulin-sensitive and insulin-resistant myotubes through a differential activation of Akt and AMPK pathways; iii) restored insulin sensitivity in insulin-resistant myotubes. Conclusions/Significance:We conclude that activation of Wnt/beta-catenin signaling in skeletal muscle cells improved insulin sensitivity by i) decreasing intramyocellular lipid deposition through downregulation of SREBP-1c; ii) increasing insulin effects through a differential activation of the Akt/PKB and AMPK pathways; iii) inhibiting the MAPK pathway. A crosstalk between these pathways and Wnt/beta-catenin signaling in skeletal muscle opens the exciting possibility that organ-selective modulation of Wnt signaling might become an attractive therapeutic target in regenerative medicine and to treat obese and diabetic populations.	[Abiola, Mounira; Favier, Maryline; Christodoulou-Vafeiadou, Eleni; Pichard, Anne-Lise; Guillet-Deniau, Isabelle] Univ Paris 05, CNRS, UMR 8104, Genet & Dev Dept,Inst Cochin, Paris, France; [Abiola, Mounira; Favier, Maryline; Christodoulou-Vafeiadou, Eleni; Pichard, Anne-Lise; Guillet-Deniau, Isabelle] INSERM, U567, Paris, France; [Martelly, Isabelle] Univ Paris 12, CNRS, UMR 7149, CRRET, Creteil, France; [Guillet-Deniau, Isabelle] UPMC Paris 6, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Sorbonne Universite	Abiola, M (corresponding author), Univ Paris 05, CNRS, UMR 8104, Genet & Dev Dept,Inst Cochin, Paris, France.	isabelle.guillet-deniau@inserm.fr						Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anagnostou SH, 2008, BIOCHEM J, V416, P211, DOI 10.1042/BJ20081426; BASSAGLIA Y, 1995, J MUSCLE RES CELL M, V16, P420, DOI 10.1007/BF00114507; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Bizeau ME, 2003, J NUTR, V133, P1787, DOI 10.1093/jn/133.6.1787; Bouzakri K, 2006, CELL METAB, V4, P89, DOI 10.1016/j.cmet.2006.04.008; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Etgen GJ, 1997, DIABETES, V46, P1915, DOI 10.2337/diabetes.46.11.1915; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Grimaldi PA, 1997, PROSTAG LEUKOTR ESS, V57, P71, DOI 10.1016/S0952-3278(97)90495-6; Guillet-Deniau I, 2004, J CELL SCI, V117, P1937, DOI 10.1242/jcs.01069; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; GUILLETDENIAU I, 1994, J CELL SCI, V107, P487; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Jensen TE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002102; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kanazawa A, 2004, AM J HUM GENET, V75, P832, DOI 10.1086/425340; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Machann J, 2004, DIABETES OBES METAB, V6, P239, DOI 10.1111/j.1462-8902.2004.00339.x; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Millar JBA, 2002, GENOME BIOL, V3; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Nadeau KJ, 2004, J BIOL CHEM, V279, P34380, DOI 10.1074/jbc.M403596200; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SIMONEAU JA, 1995, FASEB J, V9, P273, DOI 10.1096/fasebj.9.2.7781930; Takata H, 2007, DEV DYNAM, V236, P2800, DOI 10.1002/dvdy.21327; Taylor-Jones JM, 2002, MECH AGEING DEV, V123, P649, DOI 10.1016/S0047-6374(01)00411-0; TEBOUL L, 1995, J BIOL CHEM, V270, P28183, DOI 10.1074/jbc.270.47.28183; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; Vertino AM, 2005, MOL BIOL CELL, V16, P2039, DOI 10.1091/mbc.E04-08-0720; Virkamaki A, 2001, DIABETES, V50, P2337, DOI 10.2337/diabetes.50.10.2337; Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004; Zahler S, 2007, CHEM BIOL, V14, P1207, DOI 10.1016/j.chembiol.2007.10.010	46	90	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8509	10.1371/journal.pone.0008509	http://dx.doi.org/10.1371/journal.pone.0008509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041157	Green Published, gold, Green Submitted			2022-12-25	WOS:000278068700022
J	Guittot, SM; Bouchard, MF; Robert-Grenon, JP; Robert, C; Goodyer, CG; Silversides, DW; Viger, RS				Guittot, Severine Mazaud; Bouchard, Marie France; Robert-Grenon, Jean-Philippe; Robert, Claude; Goodyer, Cynthia G.; Silversides, David W.; Viger, Robert S.			Conserved Usage of Alternative 5 ' Untranslated Exons of the GATA4 Gene	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-4; MOUSE GONADAL DEVELOPMENT; HEART TUBE FORMATION; VENTRAL MORPHOGENESIS; REGULATORY ELEMENTS; EXPRESSION; PROMOTERS; FAMILY; TISSUE; FETAL	Background: GATA4 is an essential transcription factor required for the development and function of multiple organs. Despite this important role, our knowledge of how the GATA4 gene is regulated remains limited. To better understand this regulation, we characterized the 59 region of the mouse, rat, and human GATA4 genes. Methodology/Principal Findings: Using 59 RACE, we identified novel transcription start sites in all three species. GATA4 is expressed as multiple transcripts with varying 59 ends encoded by alternative untranslated first exons. Two of these non-coding first exons are conserved between species: exon 1a located 3.5 kb upstream of the GATA4 ATG site in exon 2, and a second first exon (exon 1b) located 28 kb further upstream. Expression of both mRNA variants was found in all GATA4-expressing organs but with a preference for the exon 1a-containing transcript. The exception was the testis where exon 1a- and 1b-containing transcripts were similarly expressed. In some tissues such as the intestine, alternative transcript expression appears to be regionally regulated. Polysome analysis suggests that both mRNA variants contribute to GATA4 protein synthesis. Conclusions/Significance: Taken together, our results indicate that the GATA4 gene closely resembles the other GATA family members in terms of gene structure where alternative first exon usage appears to be an important mechanism for regulating its tissue- and cell-specific expression.	[Guittot, Severine Mazaud; Bouchard, Marie France; Viger, Robert S.] CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Guittot, Severine Mazaud; Bouchard, Marie France; Robert-Grenon, Jean-Philippe; Robert, Claude; Viger, Robert S.] Univ Laval, CRBR, Quebec City, PQ, Canada; [Robert-Grenon, Jean-Philippe; Robert, Claude] Univ Laval, Dept Anim Sci, Quebec City, PQ, Canada; [Goodyer, Cynthia G.] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Res Inst, Montreal, PQ H3H 1P3, Canada; [Silversides, David W.] Univ Montreal, Fac Vet Med, St Hyacinthe, PQ J2S 7C6, Canada; [Viger, Robert S.] Univ Laval, Dept Obstet & Gynecol, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; McGill University; Universite de Montreal; Laval University	Guittot, SM (corresponding author), Univ Rennes 1, INSERM, GERHM, Rennes, France.	robert.viger@crchul.ulaval.ca	Mazaud-Guittot, Severine/I-4694-2015	Mazaud-Guittot, Severine/0000-0003-0566-4124; Robert, Claude/0000-0001-9690-8088	Canadian Institutes of Health Research (CIHR) [MOP-14796]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	To SMG, a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR) Institute of Gender and Health: www.cihr.ca/e/8673. html. To RSV, a Canada Research Chair in Reproduction and Sex Development: www.chairs-chaires.gc.ca, and CIHR operating grant MOP-14796: www.cihr.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Bouchard MF, 2009, J MOL ENDOCRINOL, V42, P149, DOI 10.1677/JME-08-0089; Bouma GJ, 2007, P NATL ACAD SCI USA, V104, P14994, DOI 10.1073/pnas.0701677104; Brewer A, 1999, J BIOL CHEM, V274, P38004, DOI 10.1074/jbc.274.53.38004; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Dusing MR, 2005, J MOL HISTOL, V36, P15, DOI 10.1007/s10735-004-2908-9; Fang RX, 2006, GENE EXPR PATTERNS, V6, P426, DOI 10.1016/j.modgep.2005.09.003; Guigon CJ, 2005, ENDOCRINOLOGY, V146, P2992, DOI 10.1210/en.2005-0045; Guittot SM, 2007, BIOL REPROD, V76, P85, DOI 10.1095/biolreprod.106.055137; Harigae H, 2006, TOHOKU J EXP MED, V210, P1, DOI 10.1620/tjem.210.1; Heicklen-Klein A, 2004, DEV BIOL, V267, P490, DOI 10.1016/j.ydbio.2003.09.042; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; Jacobsen CM, 2005, DEV DYNAM, V234, P355, DOI 10.1002/dvdy.20552; Jacobsen CM, 2002, DEV BIOL, V241, P34, DOI 10.1006/dbio.2001.0424; Ketola I, 1999, ENDOCRINOLOGY, V140, P1470, DOI 10.1210/en.140.3.1470; Ketola I, 2004, MOL CELL ENDOCRINOL, V226, P51, DOI 10.1016/j.mce.2004.06.007; Kiiveri S, 2002, ENDOCRINOLOGY, V143, P3136, DOI 10.1210/endo.143.8.8939; Kimura R, 2000, BIOCHEM BIOPH RES CO, V278, P63, DOI 10.1006/bbrc.2000.3774; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; LaVoie HA, 2003, EXP BIOL MED, V228, P1282, DOI 10.1177/153537020322801107; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; MacNeill C, 1997, J BIOL CHEM, V272, P8396, DOI 10.1074/jbc.272.13.8396; Manuylov NL, 2007, DEV BIOL, V307, P356, DOI 10.1016/j.ydbio.2007.04.040; Matzura O, 1996, COMPUT APPL BIOSCI, V12, P247; Mazaud S, 2002, ENDOCRINOLOGY, V143, P4775, DOI 10.1210/en.2002-220464; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; MUNSICK RA, 1984, AM J OBSTET GYNECOL, V149, P883, DOI 10.1016/0002-9378(84)90609-4; Nemer G, 2003, DEV BIOL, V254, P131, DOI 10.1016/S0012-1606(02)00026-X; Nony P, 1998, J BIOL CHEM, V273, P32910, DOI 10.1074/jbc.273.49.32910; Ohara Y, 2006, BIOL PHARM BULL, V29, P410, DOI 10.1248/bpb.29.410; Onodera K, 1997, J BIOCHEM, V121, P251; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Rojas A, 2005, DEVELOPMENT, V132, P3405, DOI 10.1242/dev.01913; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Shil Pratip, 2006, In Silico Biology, V6, P373; TAMURA S, 1993, P NATL ACAD SCI USA, V90, P10876, DOI 10.1073/pnas.90.22.10876; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; Tremblay JJ, 2001, ENDOCRINOLOGY, V142, P977, DOI 10.1210/en.142.3.977; Tremblay JJ, 2003, J STEROID BIOCHEM, V85, P291, DOI 10.1016/S0960-0760(03)00211-5; Viger RS, 2008, MOL ENDOCRINOL, V22, P781, DOI 10.1210/me.2007-0513; Viger RS, 2004, J ANDROL, V25, P441; Viger RS, 1998, DEVELOPMENT, V125, P2665; Wang HZ, 2009, ENDOCRINOLOGY, V150, P3301, DOI 10.1210/en.2008-1812; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Watt AJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-37; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013	52	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8454	10.1371/journal.pone.0008454	http://dx.doi.org/10.1371/journal.pone.0008454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041118	Green Submitted, Green Published, gold			2022-12-25	WOS:000273104000016
J	Wang, YG; Mukhopadhyay, D; Mathew, S; Hasebe, T; Heimeier, RA; Azuma, Y; Kolli, N; Shi, YB; Wilkinson, KD; Dasso, M				Wang, Yonggang; Mukhopadhyay, Debaditya; Mathew, Smita; Hasebe, Takashi; Heimeier, Rachel A.; Azuma, Yoshiaki; Kolli, Nagamalleswari; Shi, Yun-Bo; Wilkinson, Keith D.; Dasso, Mary			Identification and Developmental Expression of Xenopus laevis SUMO Proteases	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEINS; SMAD TRANSCRIPTIONAL ACTIVITY; CAENORHABDITIS-ELEGANS; STRUCTURAL BASIS; DOWN-REGULATION; GENE-REGULATION; SUMOYLATION; PATHWAY; YEAST; VERTEBRATE	SUMO proteins are small ubiquitin-related modifiers. All SUMOs are synthesized as propeptides that are post-translationally cleaved prior to conjugation. After processing, SUMOs become covalently conjugated to cellular targets through a pathway that is similar to ubiquitination. Ubiquitin like protein proteases/Sentrin specific proteases (Ulp/SENPs) mediate both processing and deconjugation of SUMOs. The action of Ulp/SENPs makes SUMOylation a highly dynamic post-translational modification. To investigate how Ulp/SENPs are regulated in a developmental context, we isolated and characterized all Ulp/SENPs in Xenopus laevis. Xenopus possess homologues of mammalian SENP3, 5, 6 and 7. All of these enzymes reacted with HA-tagged vinyl sulfone derivatives of SUMO-2 (HA-SU2-VS) but not SUMO-1 ( HA-SU1-VS), suggesting that they act primarily on SUMO-2 and -3. In contrast, Xenopus possess a single member of the SENP1/SENP2 subfamily of Ulp/SENPs, most closely related to mammalian SENP1. Xenopus SENP1 reacted with HA-SU1-VS and HA-SU2-VS, suggesting that it acts on all SUMO paralogues. We analyzed the mRNA and protein levels for each of the Ulp/SENPs through development; we found that they show distinct patterns of expression that may involve both transcriptional and post-transcriptional regulation. Finally, we have characterized the developmental function of the most abundant Ulp/SENP found within Xenopus eggs, SENP3. Depletion of SENP3 using morpholino antisense oligonucleotides (morpholinos) caused accumulation of high molecular weight SUMO-2/3 conjugated species, defects in developing embryos and changes in the expression of some genes regulated by the transforming growth factor beta (TGF-beta) pathway. These findings collectively indicate that SUMO proteases are both highly regulated and essential for normal development.	[Wang, Yonggang; Mukhopadhyay, Debaditya; Mathew, Smita; Hasebe, Takashi; Heimeier, Rachel A.; Azuma, Yoshiaki; Shi, Yun-Bo; Dasso, Mary] NICHHD, Lab Gene Regulat & Dev, Bethesda, MD 20892 USA; [Kolli, Nagamalleswari; Wilkinson, Keith D.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Emory University	Wang, YG (corresponding author), NICHHD, Lab Gene Regulat & Dev, Bethesda, MD 20892 USA.	mdasso@helix.nih.gov		Dasso, Mary/0000-0002-5410-1371; Hasebe, Takashi/0000-0001-7200-8173; Shi, Yun-Bo/0000-0002-6330-0639	National Institute of Child Health and Human Development; National Institutes of Health [5R01GM066355]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901, ZIAHD001902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066355] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Child Health and Human Development intramural funds ( to Y. Wang, D. Mukhopadhyay, S. Mathew, T. Hasebe, R. Heimeier, Y. Azuma, Y.- B. Shi and M. Dasso) and by National Institutes of Health grant # 5R01GM066355 ( to N. Kolli and K. D. Wilkinson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Boyarchuk Y, 2007, J CELL BIOL, V176, P919, DOI 10.1083/jcb.200609044; Broday L, 2004, GENE DEV, V18, P2380, DOI 10.1101/gad.1227104; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Daniels M, 2004, DEVELOPMENT, V131, P5613, DOI 10.1242/dev.01449; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; DUVAL C, 1990, MOL CELL BIOL, V10, P4123, DOI 10.1128/MCB.10.8.4123; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Hasebe T, 2007, MECH DEVELOP, V124, P11, DOI 10.1016/j.mod.2006.09.001; Hay RT, 2006, E SCHERING RES FDN W, V57, P173; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Heimeier RA, 2009, ENDOCRINOLOGY, V150, P2964, DOI 10.1210/en.2008-1503; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Hocking JC, 2007, INT J DEV BIOL, V51, P161, DOI 10.1387/ijdb.062185jh; Imoto S, 2004, BIOCHEM BIOPH RES CO, V319, P275, DOI 10.1016/j.bbrc.2004.04.161; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kadoya T, 2002, MOL CELL BIOL, V22, P3803, DOI 10.1128/MCB.22.11.3803-3819.2002; Kang JS, 2008, NAT CELL BIOL, V10, P654, DOI 10.1038/ncb1728; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KORNBLUTH S, 2001, CURRENT PROTOCOLS CE; Lee PSW, 2003, J BIOL CHEM, V278, P27853, DOI 10.1074/jbc.M301755200; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; LIMA CD, 2008, J BIOL CHEM; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nowak M, 2006, MOL BIOL CELL, V17, P5324, DOI 10.1091/mbc.E06-05-0413; Panse VG, 2006, TRAFFIC, V7, P1311, DOI 10.1111/j.1600-0854.2006.00471.x; Pollet N, 2006, GENOME DYN, V2, P138, DOI 10.1159/000095101; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Schwienhorst I, 2000, MOL GEN GENET, V263, P771, DOI 10.1007/s004380000254; Seeler JS, 2007, CURR TOP MICROBIOL, V313, P49; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Stade K, 2002, J BIOL CHEM, V277, P49554, DOI 10.1074/jbc.M207991200; Talamillo A, 2008, BIOCHEM SOC T, V36, P868, DOI 10.1042/BST0360868; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Xu Z, 2005, BIOCHEM J, V386, P325, DOI 10.1042/BJ20041210; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Yukita A, 2004, GENES CELLS, V9, P723, DOI 10.1111/j.1356-9597.2004.00757.x; Yukita A, 2007, DEV DYNAM, V236, P2757, DOI 10.1002/dvdy.21297; YUN C, 2008, J CELL BIOL IN PRESS; Yun CW, 2008, J CELL BIOL, V183, P589, DOI 10.1083/jcb.200807185; Zhang H, 2004, NAT GENET, V36, P507, DOI 10.1038/ng1336	54	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8462	10.1371/journal.pone.0008462	http://dx.doi.org/10.1371/journal.pone.0008462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041154	Green Submitted, Green Published, gold			2022-12-25	WOS:000273104000022
J	Wong, ACN; Palmeri, TJ; Rogers, BP; Gore, JC; Gauthier, I				Wong, Alan C. -N.; Palmeri, Thomas J.; Rogers, Baxter P.; Gore, John C.; Gauthier, Isabel			Beyond Shape: How You Learn about Objects Affects How They Are Represented in Visual Cortex	PLOS ONE			English	Article							FUSIFORM FACE AREA; HUMAN EXTRASTRIATE CORTEX; INFERIOR TEMPORAL CORTEX; PERCEPTUAL EXPERTISE; SINGLE LETTERS; FMRI DATA; RECOGNITION; CATEGORIZATION; ORGANIZATION; SELECTIVITY	Background: Experience can alter how objects are represented in the visual cortex. But experience can take different forms. It is unknown whether the kind of visual experience systematically alters the nature of visual cortical object representations. Methodology/Principal Findings: We take advantage of different training regimens found to produce qualitatively different types of perceptual expertise behaviorally in order to contrast the neural changes that follow different kinds of visual experience with the same objects. Two groups of participants went through training regimens that required either subordinate-level individuation or basic-level categorization of a set of novel, artificial objects, called "Ziggerins''. fMRI activity of a region in the right fusiform gyrus increased after individuation training and was correlated with the magnitude of configural processing of the Ziggerins observed behaviorally. In contrast, categorization training caused distributed changes, with increased activity in the medial portion of the ventral occipito-temporal cortex relative to more lateral areas. Conclusions/Significance: Our results demonstrate that the kind of experience with a category of objects can systematically influence how those objects are represented in visual cortex. The demands of prior learning experience therefore appear to be one factor determining the organization of activity patterns in visual cortex.	[Wong, Alan C. -N.] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China; [Palmeri, Thomas J.; Gauthier, Isabel] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Rogers, Baxter P.; Gore, John C.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37240 USA	Chinese University of Hong Kong; Vanderbilt University; Vanderbilt University	Wong, ACN (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China.	alanwong@psy.cuhk.edu.hk	Wong, Alan C.-N./H-3414-2019	Wong, Alan C.-N./0000-0002-2129-3485; Rogers, Baxter/0000-0002-5666-2797; Gauthier, Isabel/0000-0002-6249-4769; Palmeri, Thomas/0000-0001-7617-9797; Lauwereyns, Jan/0000-0003-0551-2550	James S. McDonnell Foundation; Temporal Dynamics of Learning Center [SBE-0542013]; NSF Science of Learning Center; National Institutes of Health; National Eye Institute [EY13441]; NATIONAL EYE INSTITUTE [R01EY013441] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Temporal Dynamics of Learning Center; NSF Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by a grant from the James S. McDonnell Foundation and the Temporal Dynamics of Learning Center (SBE-0542013), and the NSF Science of Learning Center, to I. G. and T.J.P, and the National Institutes of Health and the National Eye Institute (EY13441) to I. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bukach CM, 2006, TRENDS COGN SCI, V10, P159, DOI 10.1016/j.tics.2006.02.004; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; ENGEL SA, 2009, P SPIE, V7263; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Freedman DJ, 2006, CEREB CORTEX, V16, P1631, DOI 10.1093/cercor/bhj100; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; Gauthier I, 2000, TRENDS COGN SCI, V4, P1, DOI 10.1016/S1364-6613(99)01416-3; Gillebert CR, 2009, J COGNITIVE NEUROSCI, V21, P1054, DOI 10.1162/jocn.2009.21089; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; James KH, 2009, COGN NEUROPSYCHOL, V26, P91, DOI 10.1080/02643290802425914; James KH, 2005, COGN AFFECT BEHAV NE, V5, P452, DOI 10.3758/CABN.5.4.452; Jiang X, 2007, NEURON, V53, P891, DOI 10.1016/j.neuron.2007.02.015; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Longcamp M, 2003, NEUROIMAGE, V19, P1492, DOI 10.1016/S1053-8119(03)00088-0; Mahon BZ, 2007, NEURON, V55, P507, DOI 10.1016/j.neuron.2007.07.011; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Moore CD, 2006, J NEUROSCI, V26, P11187, DOI 10.1523/JNEUROSCI.1873-06.2006; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Op de Beeck H, 2000, NEUROIMAGE, V12, P28, DOI 10.1006/nimg.2000.0598; Op de Beeck HP, 2008, CEREB CORTEX, V18, P1676, DOI 10.1093/cercor/bhm196; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006; Op de Beeck HP, 2008, J NEUROSCI, V28, P10111, DOI 10.1523/JNEUROSCI.2511-08.2008; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Polk TA, 1998, P NATL ACAD SCI USA, V95, P847, DOI 10.1073/pnas.95.3.847; Riesenhuber M, 2004, P ROY SOC B-BIOL SCI, V271, pS448, DOI 10.1098/rsbl.2004.0216; Scott LS, 2008, BRAIN RES, V1210, P204, DOI 10.1016/j.brainres.2008.02.054; Scott LS, 2006, J COGNITIVE NEUROSCI, V18, P1453, DOI 10.1162/jocn.2006.18.9.1453; Tanaka JW, 2005, PSYCHOL SCI, V16, P145, DOI 10.1111/j.0956-7976.2005.00795.x; Tanaka JW, 2001, J EXP PSYCHOL GEN, V130, P534, DOI 10.1037/0096-3445.130.3.534; Tyler LK, 2004, J COGNITIVE NEUROSCI, V16, P351, DOI 10.1162/089892904322926692; Wong ACN, 2007, VIS COGN, V15, P854, DOI 10.1080/13506280600948350; Wong ACN, 2009, PSYCHOL SCI, V20, P1108, DOI 10.1111/j.1467-9280.2009.02430.x; Wong ACN, 2009, COGN NEUROPSYCHOL, V26, P111, DOI 10.1080/02643290802340972; WONG YK, J COGNITIVE IN PRESS; Xu YD, 2005, CEREB CORTEX, V15, P1234, DOI 10.1093/cercor/bhi006; Xue G, 2007, J COGNITIVE NEUROSCI, V19, P1643, DOI 10.1162/jocn.2007.19.10.1643; Yamane Y, 2008, NAT NEUROSCI, V11, P1352, DOI 10.1038/nn.2202; Yue XM, 2006, VISION RES, V46, P3802, DOI 10.1016/j.visres.2006.06.017	45	73	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8405	10.1371/journal.pone.0008405	http://dx.doi.org/10.1371/journal.pone.0008405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	535US	20027229	gold, Green Published, Green Submitted			2022-12-25	WOS:000272998000010
J	Wang, FE; Zhang, CN; Maminishkis, A; Dong, LJ; Zhi, CN; Li, R; Zhao, J; Majerciak, V; Gaur, AB; Chen, S; Miller, SS				Wang, Fei E.; Zhang, Connie; Maminishkis, Arvydas; Dong, Lijin; Zhi, Connie; Li, Rong; Zhao, Jing; Majerciak, Vladimir; Gaur, Arti B.; Chen, Shan; Miller, Sheldon S.			MicroRNA-204/211 alters epithelial physiology	FASEB JOURNAL			English	Article						tumorigenesis; transepithelial resistance; membrane potential; tight junctions; claudins; retinal pigment epithelium	RETINAL-PIGMENT EPITHELIUM; CENTRAL-NERVOUS-SYSTEM; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; FLUID TRANSPORT; MESENCHYMAL TRANSITION; GENE-EXPRESSION; MIR-200 FAMILY; CANCER-CELLS; MICRORNAS	MicroRNA (miRNA) expression in fetal human retinal pigment epithelium (hfRPE), retina, and choroid were pairwise compared to determine those miRNAs that are enriched by 10-fold or more in each tissue compared with both of its neighbors. miRs-184, 187, 200a/200b, 204/211, and 221/222 are enriched in hfRPE by 10- to 754-fold compared with neuroretina or choroid (P<0.05). Five of these miRNAs are enriched in RPE compared with 20 tissues throughout the body and are 10- to 20,000-fold more highly expressed (P<0.005). miR-204 and 211 are the most highly expressed in the RPE. In addition, expression of miR-204/211 is significantly lower in the NCI60 tumor cell line panel compared with that in 13 normal tissues, suggesting the progressive disruption of epithelial barriers and increased proliferation. We demonstrated that TGF-beta receptor 2 (TGF-beta R2) and SNAIL2 are direct targets of miR-204 and that a reduction in miR-204 expression leads to reduced expression of claudins 10, 16, and 19 (message/protein) consistent with our observation that anti-miR-204/211 decreased transepithelial resistance by 80% and reduced cell membrane voltage and conductance. The anti-miR-204-induced decrease in Kir7.1 protein levels suggests a signaling pathway that connects TGF-beta R2 and maintenance of potassium homeostasis. Overall, these data indicate a critical role for miR-204/211 in maintaining epithelial barrier function and cell physiology.-Wang, F. E., Zhang, C., Maminishkis, A., Dong, L., Zhi, C., Li, R., Zhao, J., Majerciak, V., Gaur, A. B., Chen, S., Miller, S. S. MicroRNA-204/211 alters epithelial physiology. FASEB J. 24, 1552-1571 (2010). www.fasebj.org	[Miller, Sheldon S.] NEI, NIH, Bethesda, MD 20892 USA; [Majerciak, Vladimir] NCI, HIV & AIDS Malignancy Branch, NIH, Bethesda, MD 20892 USA; [Gaur, Arti B.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Dartmouth College; Norris Cotton Cancer Center	Miller, SS (corresponding author), NEI, NIH, 31 Ctr Dr,MSC 2510, Bethesda, MD 20892 USA.	millers@nei.nih.gov		Maminishkis, Arvydas/0000-0003-3345-3375; Majerciak, Vladimir/0000-0003-2907-4583	Intramural NIH HHS [Z01 EY000421-04] Funding Source: Medline; NATIONAL EYE INSTITUTE [ZIAEY000421, ZIAEY000419, ZICEY000458] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adijanto J, 2009, J GEN PHYSIOL, V133, P603, DOI 10.1085/jgp.200810169; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Bharti K, 2008, DEVELOPMENT, V135, P1169, DOI 10.1242/dev.014142; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Carrozzino F, 2005, AM J PHYSIOL-CELL PH, V289, pC1002, DOI 10.1152/ajpcell.00175.2005; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Economopoulou M, 2009, INVEST OPHTH VIS SCI, V50, P1454, DOI 10.1167/iovs.08-2129; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FISHER SK, 1982, J COMP NEUROL, V206, P131, DOI 10.1002/cne.902060204; GALLEMORE R, 1998, RETINAL PIGMENT EPIT; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Harteneck C, 2007, BIOCHEM SOC T, V35, P91, DOI 10.1042/BST0350091; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hejtmancik JF, 2008, AM J HUM GENET, V82, P174, DOI 10.1016/j.ajhg.2007.08.002; Hou JH, 2008, J CLIN INVEST, V118, P619, DOI 10.1172/JCI33970; Hou JH, 2009, P NATL ACAD SCI USA, V106, P15350, DOI 10.1073/pnas.0907724106; HUGHES B, 1998, RETINAL PIGMENT EPIT; JOSEPH DP, 1991, J PHYSIOL-LONDON, V435, P439, DOI 10.1113/jphysiol.1991.sp018518; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Klaassen I, 2009, EXP EYE RES, V89, P4, DOI 10.1016/j.exer.2009.01.006; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Levin MH, 2006, J MEMBRANE BIOL, V210, P105, DOI 10.1007/s00232-005-0849-1; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li R, 2007, INVEST OPHTH VIS SCI, V48, P5722, DOI 10.1167/iovs.07-0327; Li R, 2009, INVEST OPHTH VIS SCI, V50, P5988, DOI 10.1167/iovs.09-3591; Li R, 2009, AM J PHYSIOL-CELL PH, V297, pC1452, DOI 10.1152/ajpcell.00255.2009; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Marchi N, 2003, J NEUROSCI, V23, P1949; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mueller DW, 2009, BRIT J CANCER, V101, P551, DOI 10.1038/sj.bjc.6605204; Murisier F, 2006, HISTOL HISTOPATHOL, V21, P567, DOI 10.14670/HH-21.567; Nandrot EF, 2008, ADV EXP MED BIOL, V613, P369, DOI 10.1007/978-0-387-74904-4_43; Nussenblatt RB, 2007, AM J OPHTHALMOL, V144, P618, DOI 10.1016/j.ajo.2007.06.025; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Parry DA, 2009, AM J HUM GENET, V84, P683, DOI 10.1016/j.ajhg.2009.04.005; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rizzolo LJ, 2007, INT REV CYTOL, V258, P195, DOI 10.1016/S0074-7696(07)58004-6; Ryan D, 2006, MOL VIS, V12, P1175; Saika S, 2004, LAB INVEST, V84, P1245, DOI 10.1038/labinvest.3700156; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu SP, 2009, CHINESE J STRUC CHEM, V28, P87; Yakmovych I, 2001, FASEB J, V15, P553; Yang DL, 2003, INVEST OPHTH VIS SCI, V44, P3178, DOI 10.1167/iovs.02-1189; Yang DL, 2008, EXP EYE RES, V87, P176, DOI 10.1016/j.exer.2008.05.010; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhang W, 2008, BIOCHEM BIOPH RES CO, V377, P981, DOI 10.1016/j.bbrc.2008.10.110; Zhiqi S, 2004, MELANOMA RES, V14, P509, DOI 10.1097/00008390-200412000-00011	73	183	200	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1552	1571		10.1096/fj.08-125856	http://dx.doi.org/10.1096/fj.08-125856			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20056717	Green Published			2022-12-25	WOS:000277158900028
J	Tsuchimochi, K; Otero, M; Dragomir, CL; Plumb, DA; Zerbini, LF; Libermann, TA; Marcu, KB; Komiya, S; Ijiri, K; Goldring, MB				Tsuchimochi, Kaneyuki; Otero, Miguel; Dragomir, Cecilia L.; Plumb, Darren A.; Zerbini, Luiz F.; Libermann, Towia A.; Marcu, Kenneth B.; Komiya, Setsuro; Ijiri, Kosei; Goldring, Mary B.			GADD45 beta Enhances Col10a1 Transcription via the MTK1/MKK3/6/p38 Axis and Activation of C/EBP beta-TAD4 in Terminally Differentiating Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCHONDRAL BONE-FORMATION; BINDING PROTEIN-ALPHA; P38 MAP KINASE; SIGNAL-TRANSDUCTION PATHWAY; STRESS-INDUCED ACTIVATION; X COLLAGEN GENE; C/EBP-BETA; IN-VIVO; HYPERTROPHIC CHONDROCYTES; DNA-BINDING	GADD45 beta (growth arrest- and DNA damage-inducible) interacts with upstream regulators of the JNK and p38 stress response kinases. Previously, we reported that the hypertrophic zone of the Gadd45 beta(-/-) mouse embryonic growth plate is compressed, and expression of type X collagen (Col10a1) and matrix metalloproteinase 13 (Mmp13) genes is decreased. Herein, we report that GADD45 beta enhances activity of the proximal Col10a1 promoter, which contains evolutionarily conserved AP-1, cAMP-response element, and C/EBP half-sites, in synergism with C/EBP family members, whereas the MMP13 promoter responds to GADD45 beta together with AP-1, ATF, or C/EBP family members. C/EBP beta expression also predominantly co-localizes with GADD45 beta in the embryonic growth plate. Moreover, GADD45 beta enhances C/EBP beta activation via MTK1, MKK3, and MKK6, and dominant-negative p38 alpha apf, but not JNKapf, disrupts the combined trans-activating effect of GADD45 beta and C/EBP beta on the Col10a1 promoter. Importantly, GADD45 beta knockdown prevents p38 phosphorylation while decreasing Col10a1 mRNA levels but does not affect C/EBP beta binding to the Col10a1 promoter in vivo, indicating that GADD45 beta influences the transactivation function of DNA-bound C/EBP beta. In support of this conclusion, we show that the evolutionarily conserved TAD4 domain of C/EBP beta is the target of the GADD45 beta-dependent signaling. Collectively, we have uncovered a novel molecular mechanism linking GADD45 beta via the MTK1/MKK3/6/p38 axis to C/EBP beta-TAD4 activation of Col10a1 transcription in terminally differentiating chondrocytes.	[Tsuchimochi, Kaneyuki; Otero, Miguel; Dragomir, Cecilia L.; Plumb, Darren A.; Goldring, Mary B.] Hosp Special Surg, Weill Cornell Med Coll, Div Res, Lab Cartilage Biol, New York, NY 10021 USA; [Tsuchimochi, Kaneyuki; Komiya, Setsuro; Ijiri, Kosei] Kagoshima Univ, Dept Orthoped Surg, Grad Sch Med & Dent, Kagoshima 8908520, Japan; [Zerbini, Luiz F.; Libermann, Towia A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Genom Ctr, Boston, MA 02115 USA; [Marcu, Kenneth B.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Marcu, Kenneth B.] Rizzoli Orthoped Inst, Dept Immunol & Genet, I-40136 Bologna, Italy	Cornell University; Kagoshima University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; IRCCS Istituto Ortopedico Rizzoli	Goldring, MB (corresponding author), Hosp Special Surg, Weill Cornell Med Coll, Div Res, Lab Cartilage Biol, Caspary Res Bldg,5th Floor,535 E 70th St, New York, NY 10021 USA.	goldringm@hss.edu	Libermann, Towia/F-9866-2010; Zerbini, Luiz/B-7720-2015	Zerbini, Luiz/0000-0003-0736-9508; Libermann, Towia/0000-0002-4006-8179	National Institutes of Health [AG022021, CA85467, GM066882]; Department of Defense [PC051217]; Arthritis Foundation; NATIONAL CANCER INSTITUTE [R01CA085467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC4AR060546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG022021, R01AG022021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Arthritis Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG022021 (to M. B. G.), CA85467 (to T. A. L.), and GM066882 (to K. B. M.). This work was also supported by Department of Defense Grant PC051217 (to L. F. Z.) and an Arthritis Foundation postdoctoral fellowship (to M. O.).	Abell AN, 2005, MOL CELL BIOL, V25, P8948, DOI 10.1128/MCB.25.20.8948-8959.2005; Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262; Ambrosino C, 2006, BIOCHEM J, V396, P163, DOI 10.1042/BJ20051502; Aouadi M, 2007, FEBS LETT, V581, P5591, DOI 10.1016/j.febslet.2007.10.064; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; Bobick Brent E., 2008, Birth Defects Research, V84, P131, DOI 10.1002/bdrc.20126; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Chang WZ, 2004, J BIOL CHEM, V279, P42438, DOI 10.1074/jbc.M405549200; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chumakov AM, 2007, BLOOD, V109, P4209, DOI 10.1182/blood-2005-09-031963; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; D'Angelo M, 2000, J CELL BIOCHEM, V77, P678, DOI 10.1002/(SICI)1097-4644(20000615)77:4<678::AID-JCB15>3.3.CO;2-G; DERJARD B, 1994, CELL, V76, P1025; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Gebhard S, 2004, MATRIX BIOL, V23, P309, DOI 10.1016/j.matbio.2004.05.010; Gebhard S, 2007, HISTOCHEM CELL BIOL, V127, P183, DOI 10.1007/s00418-006-0236-8; Gerits N, 2007, TRANSGENIC RES, V16, P281, DOI 10.1007/s11248-006-9052-0; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gupta M, 2006, J BIOL CHEM, V281, P17552, DOI 10.1074/jbc.M600950200; Hayashida M, 2009, ARTHRITIS RHEUM-US, V60, P708, DOI 10.1002/art.24332; Higashikawa A, 2009, ARTHRITIS RHEUM-US, V60, P166, DOI 10.1002/art.24243; Hirata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004543; Hoffman B, 2009, J CELL PHYSIOL, V218, P26, DOI 10.1002/jcp.21582; Ijiri K, 2005, J BIOL CHEM, V280, P38544, DOI 10.1074/jbc.M504202200; Ijiri K, 2008, ARTHRITIS RHEUM-US, V58, P2075, DOI 10.1002/art.23504; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Karreth F, 2004, DEVELOPMENT, V131, P5717, DOI 10.1242/dev.01414; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; Massa PE, 2005, J BIOL CHEM, V280, P14057, DOI 10.1074/jbc.M414401200; Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200; Minina E, 2001, DEVELOPMENT, V128, P4523; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Papa S, 2007, J BIOL CHEM, V282, P19029, DOI 10.1074/jbc.M703112200; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Provot S, 2008, MOL CELL BIOL, V28, P344, DOI 10.1128/MCB.00617-07; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Selvamurugan N, 2006, J CELL BIOCHEM, V99, P545, DOI 10.1002/jcb.20878; Seto H, 2004, J CLIN INVEST, V113, P718, DOI 10.1172/JCI200419899; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Stanton LA, 2007, EXP CELL RES, V313, P146, DOI 10.1016/j.yexcr.2006.09.027; SUTHERLAND JA, 1992, GENE DEV, V6, P1810, DOI 10.1101/gad.6.9.1810; Svensson CI, 2009, ARTHRITIS RHEUM-US, V60, P3229, DOI 10.1002/art.24887; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Vairapandi M, 2000, J BIOL CHEM, V275, P16810, DOI 10.1074/jbc.275.22.16810; Vale-Cruz DS, 2008, MECH DEVELOP, V125, P843, DOI 10.1016/j.mod.2008.06.010; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Wu JJ, 2005, MOL CELL BIOL, V25, P4792, DOI 10.1128/MCB.25.11.4792-4803.2005; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yamaguchi Y, 1998, NUCLEIC ACIDS RES, V26, P3854, DOI 10.1093/nar/26.16.3854; Yang G, 2005, GENESIS, V42, P33, DOI 10.1002/gene.20120; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680; Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103; Zheng QP, 2009, J BONE MINER RES, V24, P1022, DOI [10.1359/JBMR.081249, 10.1359/jbmr.081249]; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	81	37	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8395	8407		10.1074/jbc.M109.038638	http://dx.doi.org/10.1074/jbc.M109.038638			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20048163	Green Published, hybrid			2022-12-25	WOS:000275413800055
J	Gao, XL; Chaturvedi, D; Patel, TB				Gao, Xianlong; Chaturvedi, Deepti; Patel, Tarun B.			p90 Ribosomal S6 Kinase 1 (RSK1) and the Catalytic Subunit of Protein Kinase A (PKA) Compete for Binding the Pseudosubstrate Region of PKAR1 alpha ROLE IN THE REGULATION OF PKA AND RSK1 ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELL-PROLIFERATION; REGULATORY SUBUNIT; CRYSTAL-STRUCTURE; CARNEY COMPLEX; SOLUTION NMR; I-ALPHA; PHOSPHORYLATION; ACTIVATION; BAD; ERK	Previously we showed that the inactive form of p90 ribosomal S6 kinase 1 (RSK1) interacts with the regulatory subunit, PKARI alpha, of protein kinase A (PKA), whereas the active RSK1 interacts with the catalytic subunit (PKAc) of PKA. Herein, we demonstrate that the N-terminal kinase domain (NTK) of RSK1 is necessary for interactions with PKARI alpha. Substitution of the activation loop phosphorylation site (Ser-221) in the NTK with the negatively charged Asp residue abrogated the association between RSK1 and PKARI alpha. This explains the lack of an interaction between active RSK1 and PKARI alpha. Full-length RSK1 bound to PKARI alpha with an affinity of 0.8 nM. The NTK domain of RSK1 competed with PKAc for binding to the pseudosubstrate region (amino acids 93-99) of PKARI alpha. Overexpressed RSK1 dissociated PKAc from PKARI alpha, increasing PKAc activity, whereas silencing of RSK1 increased PKAc/PKARI alpha interactions and decreased PKAc activity. Unlike PKAc, which requires Arg-95 and -96 in the pseudosubstrate region of PKARI alpha for their interactions, RSK1/PKARI alpha association requires all four Arg residues (Arg-93-96) in the pseudosubstrate site of PKARI alpha. A peptide (Wt-PS) corresponding to residues 91-99 of PKARI alpha competed for binding of RSK1 with PKARI alpha both in vitro and in intact cells. Furthermore, peptide Wt-PS (but not control peptide Mut-PS), by dissociating RSK1 from PKARI alpha, activated RSK1 in the absence of any growth factors and protected cells from apoptosis. Thus, by competing for binding to the pseudosubstrate region of PKARI alpha, RSK1 regulates PKAc activity in a cAMP-independent manner, and PKARI alpha by associating with RSK1 regulates its activation and its biological functions.	[Gao, Xianlong; Chaturvedi, Deepti; Patel, Tarun B.] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, Maywood, IL 60153 USA	Loyola University Chicago	Patel, TB (corresponding author), Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, 2160 S 1st Ave, Maywood, IL 60153 USA.	tpatel7@lumc.edu			National Institutes of Health [GM079226]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM079226.	Banky P, 2000, J BIOL CHEM, V275, P35146, DOI 10.1074/jbc.M003961200; Bertolotto C, 2000, J BIOL CHEM, V275, P37246, DOI 10.1074/jbc.M007732200; Boucher MJ, 2001, BIOCHEM BIOPH RES CO, V285, P207, DOI 10.1006/bbrc.2001.5147; BUECHLER YJ, 1991, J BIOL CHEM, V266, P3491; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Cavet ME, 2003, J BIOL CHEM, V278, P18376, DOI 10.1074/jbc.M208475200; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; Chaturvedi D, 2009, J BIOL CHEM, V284, P23670, DOI 10.1074/jbc.M109.032813; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Clark DE, 2005, CANCER RES, V65, P3108; DOSKELAND SO, 1993, BIOCHIM BIOPHYS ACTA, V1178, P249, DOI 10.1016/0167-4889(93)90201-Y; Dummler BA, 2005, J BIOL CHEM, V280, P13304, DOI 10.1074/jbc.M408194200; Gao XL, 2009, J BIOL CHEM, V284, P33070, DOI 10.1074/jbc.M109.058453; HERBERG FW, 1994, BIOCHEMISTRY-US, V33, P7485, DOI 10.1021/bi00189a057; Ikuta M, 2007, PROTEIN SCI, V16, P2626, DOI 10.1110/ps.073123707; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; SARASWAT LD, 1988, METHOD ENZYMOL, V159, P325; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Skalhegg Bjorn S., 1997, Frontiers in Bioscience (online), V2, pD331; Smith JA, 2005, CANCER RES, V65, P1027; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8	36	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6970	6979		10.1074/jbc.M109.083642	http://dx.doi.org/10.1074/jbc.M109.083642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048145	Green Published, hybrid			2022-12-25	WOS:000275415600010
J	Gomes, AM; Kozlowski, EO; Pomin, VH; de Barros, CM; Zaganeli, JL; Pavao, MSG				Gomes, Angelica M.; Kozlowski, Eliene O.; Pomin, Vitor H.; de Barros, Cintia Monteiro; Zaganeli, Jose L.; Pavao, Mauro S. G.			Unique Extracellular Matrix Heparan Sulfate from the Bivalve Nodipecten nodosus (Linnaeus, 1758) Safely Inhibits Arterial Thrombosis after Photochemically Induced Endothelial Lesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHRIMP PENAEUS-BRASILIENSIS; HIGH ANTICOAGULANT ACTIVITY; MOLECULAR-WEIGHT HEPARIN; ANOMALOCARDIA-BRASILIANA; BINDING SEQUENCE; GLYCOSAMINOGLYCANS; PURIFICATION; TUNICATA; MOLLUSKS; C-13	Heparin-like glycans with diverse disaccharide composition and high anticoagulant activity have been described in several families of marine mollusks. The present work focused on the structural characterization of a new heparan sulfate (HS)-like polymer isolated from the mollusk Nodipecten nodosus (Linnaeus, 1758) and on its anticoagulant and antithrombotic properties. Total glycans were extracted from the mollusk and fractionated by ethanol precipitation. The main component (> 90%) was identified as HS-like glycosaminoglycan, representing similar to 4.6 mg g(-1) of dry tissue. The mollusk HS resists degradation with heparinase I but is cleaved by nitrous acid. Analysis of the mollusk glycan by one-dimensional H-1, two-dimensional correlated spectroscopy, and heteronuclear single quantum coherence nuclear magnetic resonance revealed characteristic signals of glucuronic acid and glucosamine residues. Signals corresponding to anomeric protons of nonsulfated, 3- or 2-sulfated glucuronic acid as well as N-sulfated and/or 6-sulfated glucosamine were also observed. The mollusk HS has an anticoagulant activity of 36 IU mg(-1), 5-fold lower than porcine heparin (180 IU mg(-1)), as measured by the activated partial thromboplastin time assay. It also inhibits factor Xa (IC50 = 0.835 mu g ml(-1)) and thrombin (IC50 = 9.3 mu g ml(-1)) in the presence of antithrombin. In vivo assays demonstrated that at the dose of 1 mg kg(-1), the mollusk HS inhibited thrombus growth in photochemically injured arteries. No bleeding effect, factor XIIa-mediated kallikrein activity, or toxic effect on fibroblast cells was induced by the invertebrate HS at the antithrombotic dose.	[Gomes, Angelica M.; Kozlowski, Eliene O.; de Barros, Cintia Monteiro; Pavao, Mauro S. G.] Univ Fed Rio de Janeiro, Lab Tecido Conjunt, Inst Bioquim Med, Programa Glicobiol, BR-21941590 Rio De Janeiro, Brazil; [Gomes, Angelica M.; Kozlowski, Eliene O.; de Barros, Cintia Monteiro; Pavao, Mauro S. G.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, BR-21941590 Rio De Janeiro, Brazil; [Pomin, Vitor H.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Zaganeli, Jose L.] Inst Ecodesenvolvimento Baia Ilha Grande, BR-23905000 Angra Dos Reis, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; University System of Georgia; University of Georgia	Pavao, MSG (corresponding author), Hosp Univ Clementino Fraga Filho, Lab Tecido Conjunt, Rua Rodolpho Paulo Rocco 255,4 Andar,Sala 4A-8,Ci, BR-21941913 Rio De Janeiro, Brazil.	mpavao@hucff.ufrj.br	Wang, Lingchong/G-8417-2011; de Barros, Cintia Monteiro/AAP-8834-2021; Pavao, Mauro Sergio Goncalves/B-1979-2010	Pavao, Mauro Sergio Goncalves/0000-0002-1336-4271	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [PDE 201019/2008-6]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Mizutani Foundation for Glycoscience	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Mizutani Foundation for Glycoscience	The work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and the Mizutani Foundation for Glycoscience (to M. S. G.; Supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Postdoctoral Fellowship PDE 201019/2008-6.	Arumugam M., 2004, Indian Journal of Experimental Biology, V42, P529; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Bourne NF, 2000, AQUACULT INT, V8, P113, DOI 10.1023/A:1009212226803; BURSON SL, 1956, J AM CHEM SOC, V78, P5874, DOI 10.1021/ja01603a045; CARDOSO LEM, 1994, ARTERIOSCLER THROMB, V14, P115, DOI 10.1161/01.ATV.14.1.115; CASU B, 1981, BIOCHEM J, V197, P599, DOI 10.1042/bj1970599; Cavalcante MCM, 2000, J BIOL CHEM, V275, P36189, DOI 10.1074/jbc.M005830200; Cesaretti M, 2004, GLYCOBIOLOGY, V14, P1275, DOI 10.1093/glycob/cwh128; CHANTAL C, 2004, ADV SEA CUCUMBER AQU, P439; Chavante SF, 2000, INT J BIOL MACROMOL, V27, P49, DOI 10.1016/S0141-8130(99)00114-2; Choay J, 1981, Ann N Y Acad Sci, V370, P644, DOI 10.1111/j.1749-6632.1981.tb29770.x; Demir M, 2001, CLIN APPL THROMB-HEM, V7, P44, DOI 10.1177/107602960100700110; DIETRICH CP, 1985, BIOCHIM BIOPHYS ACTA, V843, P1, DOI 10.1016/0304-4165(85)90041-8; DIETRICH CP, 1989, INT J BIOL MACROMOL, V11, P361, DOI 10.1016/0141-8130(89)90008-1; Dietrich CP, 1999, BBA-GEN SUBJECTS, V1428, P273, DOI 10.1016/S0304-4165(99)00087-2; Guerrini M, 2005, ANAL BIOCHEM, V337, P35, DOI 10.1016/j.ab.2004.10.012; HELM MM, 2004, HATCHERY CULTURE BIV, P201; Herbert JM, 1996, CIRC RES, V79, P590, DOI 10.1161/01.RES.79.3.590; Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994; HOVINGH P, 1982, J BIOL CHEM, V257, P9840; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; JORDAN RE, 1986, ARCH BIOCHEM BIOPHYS, V248, P690, DOI 10.1016/0003-9861(86)90524-2; JORDAN RE, 1980, J BIOL CHEM, V255, P73; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551; LINHARDT RJ, 1992, BIOCHEMISTRY-US, V31, P12441, DOI 10.1021/bi00164a020; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Luppi E, 2005, BIOMACROMOLECULES, V6, P1672, DOI 10.1021/bm049196b; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; MAEDAMARTINEZ AN, 2001, MOLUSCOS PECTINIDOS, P469; Melo EI, 2008, REV BRAS CIR CARDIOV, V23, P169, DOI 10.1590/S0102-76382008000200004; Mulloy B, 2000, THROMB HAEMOSTASIS, V84, P1052; NADER HB, 1984, J BIOL CHEM, V259, P1431; Pavao MSG, 1998, J BIOL CHEM, V273, P27848, DOI 10.1074/jbc.273.43.27848; PEJLER G, 1987, J BIOL CHEM, V262, P11413; Pomin VH, 2005, GLYCOBIOLOGY, V15, P1376, DOI 10.1093/glycob/cwj030; Santos JC, 2007, THROMB RES, V121, P213, DOI 10.1016/j.thromres.2007.03.025; Saravanan R, 2010, APPL BIOCHEM BIOTECH, V160, P791, DOI 10.1007/s12010-008-8498-3; Vicente CP, 2004, BLOOD, V104, P3965, DOI 10.1182/blood-2004-02-0598; Vijayabaskar P, 2008, METHOD FIND EXP CLIN, V30, P175, DOI 10.1358/mf.2008.30.3.1159654	40	52	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7312	7323		10.1074/jbc.M109.091546	http://dx.doi.org/10.1074/jbc.M109.091546			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20053999	Green Published, hybrid			2022-12-25	WOS:000275415600043
J	Stapleton, M; Haq, I; Hunt, DM; Arnvig, KB; Artymiuk, PJ; Buxton, RS; Green, J				Stapleton, Melanie; Haq, Ihtshamul; Hunt, Debbie M.; Arnvig, Kristine B.; Artymiuk, Peter J.; Buxton, Roger S.; Green, Jeffrey			Mycobacterium tuberculosis cAMP Receptor Protein (Rv3676) Differs from the Escherichia coli Paradigm in Its cAMP Binding and DNA Binding Properties and Transcription Activation Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; BOVIS BCG; GENE-EXPRESSION; MACROPHAGES; MUTATIONS; COMPLEX; FAMILY; WHIB; STREPTOMYCES; REGULATOR	The pathogen Mycobacterium tuberculosis produces a burst of cAMP upon infection of macrophages. Bacterial cyclic AMP receptor proteins (CRP) are transcription factors that respond to cAMP by binding at target promoters when cAMP concentrations increase. Rv3676 (CRPMt) is a CRP family protein that regulates expression of genes (rpfA and whiB1) that are potentially involved in M. tuberculosis persistence and/or emergence from the dormant state. Here, the CRPMt homodimer is shown to bind two molecules of cAMP(one per protomer) at non-interacting sites. Furthermore, cAMP binding by CRPMt was relatively weak, entropy driven, and resulted in a relatively small enhancement in DNA binding. Tandem CRPMt-binding sites (CRP1 at -58.5 and CRP2 at -37.5) were identified at the whiB1 promoter (PwhiB1). In vitro transcription reactions showed that CRP1 is an activating site and that CRP2, which was only occupied in the presence of cAMP or at high CRPMt concentrations in the absence of cAMP, is a repressing site. Binding of CRPMt to CRP1 was not essential for open complex formation but was required for transcription activation. Thus, these data suggest that binding of CRPMt to the PwhiB1 CRP1 site activates transcription at a step after open complex formation. In contrast, high cAMP concentrations allowed occupation of both CRP1 and CRP2 sites, resulting in inhibition of open complex formation. Thus, M. tuberculosis CRP has evolved several distinct characteristics, compared with the Escherichia coli CRP paradigm, to allow it to regulate gene expression against a background of high concentrations of cAMP.	[Stapleton, Melanie; Artymiuk, Peter J.; Green, Jeffrey] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Haq, Ihtshamul] Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England; [Hunt, Debbie M.; Arnvig, Kristine B.; Buxton, Roger S.] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England	University of Sheffield; University of Sheffield; MRC National Institute for Medical Research	Green, J (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	jeff.green@sheffield.ac.uk		Arnvig, Kristine/0000-0002-6850-2547	Wellcome Trust [078731/Z/05/Z]; Medical Research Council; Medical Research Council [MC_U117585867] Funding Source: researchfish; MRC [MC_U117585867] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Wellcome Trust Grant 078731/Z/05/Z and the Medical Research Council.	Agarwal N, 2006, MICROBIOL-SGM, V152, P2749, DOI 10.1099/mic.0.28924-0; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Akhter Y, 2007, INT J MED MICROBIOL, V297, P451, DOI 10.1016/j.ijmm.2007.04.009; Alam MS, 2009, FEBS J, V276, P76, DOI 10.1111/j.1742-4658.2008.06755.x; ANGULO J, 1986, J BIOL CHEM, V261, P1315; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Bai GC, 2007, INFECT IMMUN, V75, P5509, DOI 10.1128/IAI.00658-07; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; Beaucher J, 2002, MOL MICROBIOL, V45, P1527, DOI 10.1046/j.1365-2958.2002.03135.x; BELL A, 1990, NUCLEIC ACIDS RES, V18, P7243, DOI 10.1093/nar/18.24.7243; BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; BUSBY S, 1983, J MOL BIOL, V167, P259, DOI 10.1016/S0022-2836(83)80335-0; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Busby Stephen, 1996, P255; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; den Hengst CD, 2008, BBA-GEN SUBJECTS, V1780, P1201, DOI 10.1016/j.bbagen.2008.01.008; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Gazdik MA, 2005, J BACTERIOL, V187, P2681, DOI 10.1128/JB.187.8.2681-2692.2005; GORSHKOVA I, 1995, J BIOL CHEM, V270, P21679, DOI 10.1074/jbc.270.37.21679; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; Hunt DM, 2008, INFECT IMMUN, V76, P2227, DOI 10.1128/IAI.01410-07; Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200; KIRIN E, 2002, MICROBIOLOGY, V148, P1553; KUBICA G P, 1972, International Journal of Systematic Bacteriology, V22, P99; LODGE J, 1990, FEMS MICROBIOL LETT, V67, P221, DOI 10.1016/0378-1097(90)90199-Z; LOWRIE DB, 1975, NATURE, V254, P600, DOI 10.1038/254600a0; MARSH P, 1986, NUCLEIC ACIDS RES, V14, P3603, DOI 10.1093/nar/14.8.3603; MAXAM AM, 1980, METHOD ENZYMOL, V65, P560; Miller JH., 1972, EXPT MOL GENETICS; Moore JL, 1996, J BIOL CHEM, V271, P21273, DOI 10.1074/jbc.271.35.21273; Mukamolova GV, 2002, MOL MICROBIOL, V46, P623, DOI 10.1046/j.1365-2958.2002.03184.x; PADH H, 1976, MICROBIOS, V16, P183; Papavinasasundaram KG, 2001, MICROBIOL-SGM, V147, P3271, DOI 10.1099/00221287-147-12-3271; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Reddy MCM, 2009, J BIOL CHEM, V284, P36581, DOI 10.1074/jbc.M109.041343; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sambrook J, 2001, MOL CLONING LAB MANU; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; SINGH A, 2009, PLOS PATHOG, V8; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Soliveri JA, 2000, MICROBIOL-SGM, V146, P333, DOI 10.1099/00221287-146-2-333; Spreadbury CL, 2005, MICROBIOL-SGM, V151, P547, DOI 10.1099/mic.0.27444-0; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; TAKAHASHI M, 1989, J MOL BIOL, V207, P783, DOI 10.1016/0022-2836(89)90244-1; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	51	60	65	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7016	7027		10.1074/jbc.M109.047720	http://dx.doi.org/10.1074/jbc.M109.047720			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20028978	hybrid, Green Published			2022-12-25	WOS:000275415600015
J	Zhu, S; Sachdeva, M; Wu, F; Lu, Z; Mo, YY				Zhu, S.; Sachdeva, M.; Wu, F.; Lu, Z.; Mo, Y-Y			Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner	ONCOGENE			English	Article						cell invasion; metastasis; miRNA; miR-224; CXCR4; Ubc9	CANCER-CELLS; REPRESSORS ZEB1; RT-PCR; SUMO; MICRORNAS; PROTEIN; ALPHA; EXPRESSION; INDUCTION; RECEPTOR	Ubc9 is an E2-conjugating enzyme that transfers the activated small ubiquitin-like modifier (SUMO) to protein substrates, and thus it has an important function in sumoylation-mediated cellular pathways. We have earlier reported that Ubc9 promotes tumor growth in the xenograft mouse model using breast cancer cell line MCF-7 in part through regulation of Bcl-2 expression. In this study, we show that ectopic expression of wild-type Ubc9 (Ubc9-WT) promotes cell invasion and metastasis. Surprisingly, the dominant negative mutant Ubc9 (Ubc9-DN) also causes the same phenotype, indicating that the ability of Ubc9 to promote invasion and metastasis is distinct from its ability to conjugate SUMO to protein substrates. Of considerable interest, several microRNAs such as miR-224 are regulated by Ubc9. Although ectopic expression of Ubc9 causes downregulation of miR-224, suppression of Ubc9 by Ubc9-siRNAs leads to its upregulation. We further show that miR-224 can inhibit cell invasion and directly targets CDC42 and CXCR4, and that suppression of CDC42 and CXCR4 by RNAi causes inhibition of Ubc9-mediated invasion. Together, these results show a molecular link between Ubc9 and the metastasis genes such as CDC42 and CXCR4, and thus provide new insight into the mechanism by which Ubc9 promotes tumor invasion and metastasis. Oncogene (2010) 29, 1763-1772; doi:10.1038/onc.2009.459; published online 21 December 2009	[Zhu, S.; Sachdeva, M.; Wu, F.; Lu, Z.; Mo, Y-Y] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University	Mo, YY (corresponding author), So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, 825 N Rutledge,POB 19626, Springfield, IL 62794 USA.	ymo@siumed.edu	Mo, Yin-Yuan/B-6141-2011; zhu, shoumin/F-4564-2011; Mo, Yin-Yuan/R-8255-2019		NCI [CA102630]; Illinois Department of Public Health; NATIONAL CANCER INSTITUTE [R01CA102630] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Illinois Department of Public Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr Joan Massague for providing LM2-4142 cells. This study is supported by grants CA102630 from NCI and postdoctoral fellowship award from Illinois Department of Public Health.	Baek SH, 2006, CELL CYCLE, V5, P1492, DOI 10.4161/cc.5.14.3008; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Guo YG, 2008, BIOCHEM BIOPH RES CO, V374, P570, DOI 10.1016/j.bbrc.2008.07.064; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kaul S, 2002, J BIOL CHEM, V277, P12541, DOI 10.1074/jbc.M112330200; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Kobayashi S, 2004, ENDOCR RES, V30, P617, DOI 10.1081/ERC-200043789; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kurihara I, 2005, J BIOL CHEM, V280, P6721, DOI 10.1074/jbc.M411820200; Kurtzman AL, 2001, P NATL ACAD SCI USA, V98, P5602, DOI 10.1073/pnas.101129698; Lao KQ, 2006, BIOCHEM BIOPH RES CO, V343, P85, DOI 10.1016/j.bbrc.2006.02.106; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Lu ZH, 2006, EXP CELL RES, V312, P1865, DOI 10.1016/j.yexcr.2006.02.017; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mo YY, 1999, EXP CELL RES, V252, P50, DOI 10.1006/excr.1999.4616; Mo YY, 2005, EXPERT OPIN THER TAR, V9, P1203, DOI 10.1517/14728222.9.6.1203; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Moschos SJ, 2007, ONCOGENE, V26, P4216, DOI 10.1038/sj.onc.1210216; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Tomoiu A, 2006, J VIROL, V80, P10218, DOI 10.1128/JVI.00375-06; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wilke K, 1997, GENOMICS, V45, P1, DOI 10.1006/geno.1997.4885; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	41	94	99	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	12					1763	1772		10.1038/onc.2009.459	http://dx.doi.org/10.1038/onc.2009.459			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	574VR	20023705	Green Accepted			2022-12-25	WOS:000276022800006
J	Zhou, XY; Yin, ZA; Guo, XZ; Hajjar, DP; Han, JH				Zhou, Xiaoye; Yin, Zhinan; Guo, Xianzhi; Hajjar, David P.; Han, Jihong			Inhibition of ERK1/2 and Activation of Liver X Receptor Synergistically Induce Macrophage ABCA1 Expression and Cholesterol Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER A1; HIGH-DENSITY-LIPOPROTEIN; CORONARY-ARTERY DISEASE; APOLIPOPROTEIN-E; TANGIER-DISEASE; TARGETED DISRUPTION; SCAVENGER RECEPTORS; HDL CHOLESTEROL; GENE-EXPRESSION; TRANSGENIC MICE	ATP-binding cassette transporter A1 (ABCA1), a molecule mediating free cholesterol efflux from peripheral tissues to apoAI and high density lipoprotein (HDL), inhibits the formation of lipid-laden macrophage/foam cells and the development of atherosclerosis. ERK1/2 are important signaling molecules regulating cellular growth and differentiation. The ERK1/2 signaling pathway is implicated in cardiac development and hypertrophy. However, the role of ERK1/2 in the development of atherosclerosis, particularly in macrophage cholesterol homeostasis, is unknown. In this study, we investigated the effects of ERK1/2 activity on macrophage ABCA1 expression and cholesterol efflux. Compared with a minor effect by inhibition of other kinases, inhibition of ERK1/2 significantly increased macrophage cholesterol efflux to apoAI and HDL. In contrast, activation of ERK1/2 reduced macrophage cholesterol efflux and ABCA1 expression. The increased cholesterol efflux by ERK1/2 inhibitors was associated with the increased ABCA1 levels and the binding of apoAI to cells. The increased ABCA1 by ERK1/2 inhibitors was due to increased ABCA1 mRNA and protein stability. The induction of ABCA1 expression and cholesterol efflux by ERK1/2 inhibitors was concentration-dependent. The mechanism study indicated that activation of liver X receptor (LXR) had little effect on ERK1/2 expression and activation. ERK1/2 inhibitors had no effect on macrophage LXR alpha/beta expression, whereas they did not influence the activation or the inhibition of the ABCA1 promoter by LXR or sterol regulatory element-binding protein (SREBP). However, inhibition of ERK1/2 and activation of LXR synergistically induced macrophage cholesterol efflux and ABCA1 expression. Our data suggest that ERK1/2 activity can play an important role in macrophage cholesterol trafficking.	[Zhou, Xiaoye; Hajjar, David P.; Han, Jihong] Cornell Univ, Weill Med Coll, Ctr Vasc Biol, New York, NY 10065 USA; [Zhou, Xiaoye; Hajjar, David P.; Han, Jihong] Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10065 USA; [Zhou, Xiaoye; Yin, Zhinan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Guo, Xianzhi] Nankai Univ, Coll Chem, Tianjin 300071, Peoples R China; [Han, Jihong] Nankai Univ, Minist Educ China, Key Lab Bioact Mat, Tianjin 300071, Peoples R China; [Zhou, Xiaoye] Capital Med Univ, Xuanwu Hosp, Dept Neurobiol, Beijing 100053, Peoples R China	Cornell University; Cornell University; Nankai University; Nankai University; Ministry of Education, China; Nankai University; Capital Medical University	Han, JH (corresponding author), Cornell Univ, Weill Med Coll, Ctr Vasc Biol, 1300 York Ave, New York, NY 10065 USA.	jhan@med.cornell.edu			National Institutes of Health [P01HL046403]; Julia and Gross Foundation; 973 Basic Research Program of China [2010CB945003]; Natural Science Foundation of China (NSFC) [30971271]; Tianjin Municipal Science and Technology Commission of China [08ZCKFSH04400]; Ministry of Science and Technology of China [2006AA02A408]; National Key Scientific Program of China [2007CB914801]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Julia and Gross Foundation; 973 Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Key Scientific Program of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01HL046403 (to D. P. H. and J. H.). This work was also supported by the Julia and Gross Foundation (to D. P. H.), a 973 Basic Research Program of China Grant 2010CB945003 (to J. H.), Natural Science Foundation of China (NSFC) Grant 30971271 (to J. H.), the Tianjin Municipal Science and Technology Commission of China (Grant 08ZCKFSH04400 to J. H.), the Ministry of Science and Technology of China (Grant 2006AA02A408 to X. Z.), and the National Key Scientific Program of China (Grant 2007CB914801 to Z. Y.).	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Arakawa R, 2004, J BIOL CHEM, V279, P6217, DOI 10.1074/jbc.C300553200; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Arora S, 2008, DRUG TODAY, V44, P711, DOI 10.1358/dot.2008.44.9.1263999; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; BRINTON EA, 1989, J CLIN INVEST, V84, P262, DOI 10.1172/JCI114149; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brunham LR, 2009, ARTERIOSCL THROM VAS, V29, P548, DOI 10.1161/ATVBAHA.108.182303; Cavelier LB, 2001, J BIOL CHEM, V276, P18046, DOI 10.1074/jbc.M100565200; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; de Villiers WJS, 1999, J LEUKOCYTE BIOL, V66, P740, DOI 10.1002/jlb.66.5.740; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Haidar B, 2002, J LIPID RES, V43, P2087, DOI 10.1194/jlr.M200235-JLR200; Haidar B, 2004, J BIOL CHEM, V279, P9963, DOI 10.1074/jbc.M313487200; Han JH, 2002, J BIOL CHEM, V277, P23582, DOI 10.1074/jbc.M200685200; Huang ZH, 2006, ARTERIOSCL THROM VAS, V26, P157, DOI 10.1161/01.ATV.0000193627.12516.1d; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joyce CW, 2006, J BIOL CHEM, V281, P33053, DOI 10.1074/jbc.M604526200; Joyce CW, 2002, P NATL ACAD SCI USA, V99, P407, DOI 10.1073/pnas.012587699; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Levin N, 2005, ARTERIOSCL THROM VAS, V25, P135, DOI 10.1161/01.ATV.0000150044.84012.68; Martinez LO, 2003, J BIOL CHEM, V278, P37368, DOI 10.1074/jbc.M307161200; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; See RH, 2002, J BIOL CHEM, V277, P41835, DOI 10.1074/jbc.M204923200; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Swarnakar S, 1999, J BIOL CHEM, V274, P29733, DOI 10.1074/jbc.274.42.29733; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Von Eckardstein A, 2001, FASEB J, V15, P1555, DOI 10.1096/fj.00-0798com; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Wang YT, 2002, J BIOL CHEM, V277, P5692, DOI 10.1074/jbc.M109977200; Yamauchi Y, 2003, J BIOL CHEM, V278, P47890, DOI 10.1074/jbc.M306258200; Zeng LF, 2004, J BIOL CHEM, V279, P48801, DOI 10.1074/jbc.M407817200; ZERIVITZ K, 1989, GENE ANAL TECH, V6, P101, DOI 10.1016/0735-0651(89)90016-2; Zhou XY, 2008, J BIOL CHEM, V283, P2129, DOI 10.1074/jbc.M706636200	54	74	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6316	6326		10.1074/jbc.M109.073601	http://dx.doi.org/10.1074/jbc.M109.073601			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037141	Green Published, hybrid			2022-12-25	WOS:000275367500036
J	Desfrancois, J; Moreau-Aubry, A; Vignard, V; Godet, Y; Khammari, A; Dreno, B; Jotereau, F; Gervois, N				Desfrancois, Juliette; Moreau-Aubry, Agnes; Vignard, Virginie; Godet, Yann; Khammari, Amir; Dreno, Brigitte; Jotereau, Francine; Gervois, Nadine			Double Positive CD4CD8 alpha beta T Cells: A New Tumor-Reactive Population in Human Melanomas	PLOS ONE			English	Article							INVARIANT NKT CELLS; DENDRITIC CELLS; STANDARD PROTEASOME; PERIPHERAL-BLOOD; MEMORY CELLS; IN-VIVO; LYMPHOCYTES; IMMUNOTHERAPY; EXPRESSION; EXPANSION	Background: Double positive (DP) CD4CD8 T alpha beta cells have been reported in normal individuals as well as in different pathological conditions including inflammatory diseases, viral infections and cancer, but their function remains to be elucidated. We recently reported the increased frequency of DP T alpha beta cells in human breast pleural effusions. This manuscript addresses the question of the existence and above all the role of this non-conventional DP sub-population among tumor associated lymphocytes in melanomas. Methodology/Principal Findings: We analyzed the intratumoral cell infiltrate in solid metastasis (n = 6) and tumor invaded lymph nodes (n = 26) samples from melanomas patients by multiparametric cytometry. Here we documented for the first time significant increased frequency of DP T cells in about 60% of melanoma tumors compared to blood samples. Interestingly, a high proportion of these cells produced TNF-alpha in response to autologous melanoma cell lines. Besides, they are characterized by a unique cytokine profile corresponding to higher secretion of IL-13, IL-4 and IL-5 than simple positive T cells. In deep analysis, we derived a representative tumor-reactive DP T cell clone from a melanoma patient's invaded lymph node. This clone was restricted by HLA-A*2402 and recognized both autologous and allogeneic tumor cells of various origins as well as normal cells, suggesting that the target antigen was a ubiquitous self antigen. However, this DP T cell clone failed to kill HLA-A*2402 EBV-transformed B cells, probably due to the constitutive expression of immunoproteasome by these cells. Conclusions/Significance: In conclusion, we can postulate that, according to their broad tumor reactivity and to their original cytokine profile, the tumor associated DP T cells could participate in immune responses to tumors in vivo. Therefore, the presence of these cells and their role will be crucial to address in cancer patients, especially in the context of immunotherapies.	[Desfrancois, Juliette; Moreau-Aubry, Agnes; Vignard, Virginie; Godet, Yann; Khammari, Amir; Dreno, Brigitte; Jotereau, Francine; Gervois, Nadine] INSERM, U892, UMR, Nantes, France; [Moreau-Aubry, Agnes; Jotereau, Francine; Gervois, Nadine] Univ Nantes, Fac Sci, Nantes, France; [Khammari, Amir; Dreno, Brigitte] CHU Nantes, Unit Skin Canc, F-44035 Nantes 01, France; [Dreno, Brigitte] CHU Nantes, GMP Unit Cellular Therapy, F-44035 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Desfrancois, J (corresponding author), INSERM, U892, UMR, Nantes, France.	ngervois@nantes.inserm.fr	Aubry, Agnes/K-8771-2015; Gervois, Nadine/K-6658-2015; Jotereau, Francine/AAU-1735-2020; Jotereau, Francine/L-8668-2015; Vignard, Virginie/K-7540-2015	Gervois, Nadine/0000-0002-0092-3919; Jotereau, Francine/0000-0002-2508-4875; Vignard, Virginie/0000-0002-6702-2824; Godet, Yann/0000-0003-4017-6070; MOREAU-AUBRY, Agnes/0000-0001-5540-3374	Ligue Nationale contre le Cancer; Institut National du Cancer; Association de Recherche contre le Cancer	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by grants awarded by the "Ligue Nationale contre le Cancer" (labellisation 2005). Juliette Desfrancois was recipient of fellowship awarded by the "Institut National du Cancer" and by the "Association de Recherche contre le Cancer''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolopoulos V, 2000, EUR J IMMUNOL, V30, P1733, DOI 10.1002/1521-4141(200006)30:6<1733::AID-IMMU1733>3.0.CO;2-E; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Bagot M, 1998, BLOOD, V91, P4331, DOI 10.1182/blood.V91.11.4331.411k12_4331_4341; Berzofsky JA, 2008, J IMMUNOL, V180, P3627, DOI 10.4049/jimmunol.180.6.3627; Chen JC, 2003, J IMMUNOL METHODS, V279, P123, DOI 10.1016/S0022-1759(03)00236-9; DEMARIA A, 1987, EUR J IMMUNOL, V17, P1815, DOI 10.1002/eji.1830171221; Desfrancois J, 2009, INT J CANCER, V125, P374, DOI 10.1002/ijc.24366; Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Frisan T, 1998, J IMMUNOL, V160, P3281; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Gervois N, 2000, CLIN CANCER RES, V6, P1459; Ghia P, 2007, BRIT J HAEMATOL, V139, P780, DOI 10.1111/j.1365-2141.2007.06867.x; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Hirao J, 1998, CLIN EXP IMMUNOL, V111, P397; JOTEREAU F, 1991, J IMMUNOTHER, V10, P405, DOI 10.1097/00002371-199112000-00003; KHAMMARI A, 2009, J INVEST DERMATOL; Liu TY, 2008, EUR J IMMUNOL, V38, P1012, DOI 10.1002/eji.200737838; Macagno A, 1999, EUR J IMMUNOL, V29, P4037, DOI 10.1002/(SICI)1521-4141(199912)29:12<4037::AID-IMMU4037>3.0.CO;2-T; Martinez-Gallo M, 2008, EUR RESPIR J, V31, P1368, DOI 10.1183/09031936.00061907; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395; Osada T, 2005, INT IMMUNOL, V17, P1143, DOI 10.1093/intimm/dxh292; Pahar B, 2006, EUR J IMMUNOL, V36, P583, DOI 10.1002/eji.200535520; PALIARD X, 1988, NATURE, V335, P642, DOI 10.1038/335642a0; Pandolfino MC, 2001, CANCER IMMUNOL IMMUN, V50, P134, DOI 10.1007/PL00006683; Parel Y, 2004, AUTOIMMUN REV, V3, P215, DOI 10.1016/j.autrev.2003.09.001; Parel Y, 2007, ARTHRITIS RHEUM-US, V56, P3459, DOI 10.1002/art.22927; Pawelec G, 2004, FEBS LETT, V567, P63, DOI 10.1016/j.febslet.2004.02.091; Rahemtullah A, 2006, AM J CLIN PATHOL, V126, P805, DOI 10.1309/Y8KD32QGRYFN1XQX; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sakuishi K, 2007, J IMMUNOL, V179, P3452, DOI 10.4049/jimmunol.179.6.3452; Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886; Sullivan YB, 2001, IMMUNOLOGY, V103, P270, DOI 10.1046/j.1365-2567.2001.01243.x; Suni MA, 2001, EUR J IMMUNOL, V31, P2512, DOI 10.1002/1521-4141(200108)31:8<2512::AID-IMMU2512>3.0.CO;2-M; Terabe M, 2004, CURR OPIN IMMUNOL, V16, P157, DOI 10.1016/j.coi.2004.01.010; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Van den Eynde BJ, 2001, CURR OPIN IMMUNOL, V13, P147, DOI 10.1016/S0952-7915(00)00197-7; Wei LH, 2000, AM J PHYSIOL-CELL PH, V279, pC248, DOI 10.1152/ajpcell.2000.279.1.C248; Weiss L, 1998, J INFECT DIS, V178, P1158, DOI 10.1086/515674; ZANELLI E, 1993, IMMUNOGENETICS, V38, P400, DOI 10.1007/BF00184520; Zloza A, 2003, BLOOD, V102, P2156, DOI 10.1182/blood-2002-07-1972; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	45	51	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8437	10.1371/journal.pone.0008437	http://dx.doi.org/10.1371/journal.pone.0008437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052413	Green Published, Green Submitted, gold			2022-12-25	WOS:000273338500002
J	Villar, AV; Cobo, M; Llano, M; Montalvo, C; Gonzalez-Vilchez, F; Martin-Duran, R; Hurle, MA; Nistal, JF				Villar, Ana V.; Cobo, Manuel; Llano, Miguel; Montalvo, Cecilia; Gonzalez-Vilchez, Francisco; Martin-Duran, Rafael; Hurle, Maria A.; Nistal, J. Francisco			Plasma Levels of Transforming Growth Factor-beta 1 Reflect Left Ventricular Remodeling in Aortic Stenosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CARDIAC FIBROBLASTS; GENDER-DIFFERENCES; VALVE-REPLACEMENT; ANGIOTENSIN-II; TGF-BETA; HYPERTROPHY; EXPRESSION; FIBROSIS; DISEASE	Background:TGF-beta 1 is involved in cardiac remodeling through an auto/paracrine mechanism. The contribution of TGF-beta 1 from plasmatic source to pressure overload myocardial remodeling has not been analyzed. We investigated, in patients with valvular aortic stenosis (AS), and in mice subjected to transverse aortic arch constriction (TAC), whether plasma TGF-beta 1 relates with myocardial remodeling, reflected by LV transcriptional adaptations of genes linked to myocardial hypertrophy and fibrosis, and by heart morphology and function. Methodology/Principal Findings: The subjects of the study were: 39 patients operated of AS; 27 healthy volunteers; 12 mice subjected to TAC; and 6 mice sham-operated. Myocardial samples were subjected to quantitative PCR. Plasma TGF-beta 1 was determined by ELISA. Under pressure overload, TGF-beta 1 plasma levels were significantly increased both in AS patients and TAC mice. In AS patients, plasma TGF-beta 1 correlated directly with aortic transvalvular gradients and LV mass surrogate variables, both preoperatively and 1 year after surgery. Plasma TGF-beta 1 correlated positively with the myocardial expression of genes encoding extracellular matrix (collagens I and III, fibronectin) and sarcomeric (myosin light chain-2, beta-myosin heavy chain) remodelling targets of TGF-beta 1, in TAC mice and in AS patients. Conclusions/Significance: A circulating TGF-beta 1-mediated mechanism is involved, in both mice and humans, in the excessive deposition of ECM elements and hypertrophic growth of cardiomyocytes under pressure overload. The possible value of plasma TGF-beta 1 as a marker reflecting preoperative myocardial remodeling status in AS patients deserves further analysis in larger patient cohorts.	[Villar, Ana V.; Hurle, Maria A.] Univ Cantabria, Inst Formac & Invest Marques de Valdecilla, Fac Med, Div Farmacol, E-39005 Santander, Cantabria, Spain; [Cobo, Manuel; Llano, Miguel; Gonzalez-Vilchez, Francisco; Martin-Duran, Rafael] Hosp Univ Marques de Valdecilla, Inst Formac & Invest Marques de Valdecilla, Serv Cardiol, Santander, Cantabria, Spain; [Montalvo, Cecilia; Nistal, J. Francisco] Hosp Univ Marques de Valdecilla, Inst Formac & Invest Marques de Valdecilla, Serv Cirugia Cardiovasc, Santander, Cantabria, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Villar, AV (corresponding author), Univ Cantabria, Inst Formac & Invest Marques de Valdecilla, Fac Med, Div Farmacol, E-39005 Santander, Cantabria, Spain.	hurlem@unican.es; jfnistal@gmail.com	Villar, Ana/I-5190-2015	Villar, Ana/0000-0003-4588-9598; Hurle, Maria Amor/0000-0002-7710-1358	Instituto de Salud Carlos III [PI060240]; Ministerio de Ciencia e Innovacion [SAF2007-65451]; Comunidad Autonoma de Cantabria	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Cantabria	This study was supported by grants from the Instituto de Salud Carlos III (PI060240) to JFN. and Ministerio de Ciencia e Innovacion (SAF2007-65451) to MAH. Dr. Nistal is in the Scientist Stabilization and Research Activity Intensification Program of the National Health System, funded by the Instituto de Salud Carlos III and Comunidad Autonoma de Cantabria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhar M, 2003, CYTOKINE GROWTH F R, V14, P391, DOI 10.1016/S1359-6101(03)00044-3; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Christakis GT, 1996, ANN THORAC SURG, V62, P1084, DOI 10.1016/0003-4975(96)00533-4; Derhaschnig U, 2002, AM J HYPERTENS, V15, P207, DOI 10.1016/S0895-7061(01)02327-5; DESIMONE G, 1995, HYPERTENSION, V26, P979, DOI 10.1161/01.HYP.26.6.979; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; Diehl P, 2008, THROMB HAEMOSTASIS, V99, P711, DOI 10.1160/TH07-05-0334; Fielitz J, 2001, J AM COLL CARDIOL, V37, P1443, DOI 10.1016/S0735-1097(01)01170-6; Grainger DJ, 2000, CYTOKINE GROWTH F R, V11, P133, DOI 10.1016/S1359-6101(99)00037-4; Gray MO, 1998, CARDIOVASC RES, V40, P352, DOI 10.1016/S0008-6363(98)00121-7; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Kuruvilla L, 2007, CELL BIOCHEM BIOPHYS, V47, P65, DOI 10.1385/CBB:47:1:65; LAVIADAS C, 2000, HYPERTENSION, V36, P547; LINDROOS M, 1993, J AM COLL CARDIOL, V21, P1220, DOI 10.1016/0735-1097(93)90249-Z; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; MONRAD ES, 1988, CIRCULATION, V77, P1345, DOI 10.1161/01.CIR.77.6.1345; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sciarretta S, 2007, AM J HYPERTENS, V20, P784, DOI 10.1016/j.amjhyper.2007.01.023; TAKAHASHI N, 1994, J CLIN INVEST, V94, P1470, DOI 10.1172/JCI117485; Villar AV, 2009, J MOL CELL CARDIOL, V46, P526, DOI 10.1016/j.yjmcc.2008.12.024; VILLARREAL FJ, 1992, AM J PHYSIOL, V262, pH1831; Wasywich CA, 2006, AM J CARDIOL, V97, P1068, DOI 10.1016/j.amjcard.2005.10.048; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	26	51	56	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8476	10.1371/journal.pone.0008476	http://dx.doi.org/10.1371/journal.pone.0008476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041033	Green Published, gold			2022-12-25	WOS:000278068700004
J	de Chiara, C; Menon, RP; Strom, M; Gibson, TJ; Pastore, A				de Chiara, Cesira; Menon, Rajesh P.; Strom, Molly; Gibson, Toby J.; Pastore, Annalisa			Phosphorylation of S776 and 14-3-3 Binding Modulate Ataxin-1 Interaction with Splicing Factors	PLOS ONE			English	Article							POLYGLUTAMINE-INDUCED DISEASE; AXH DOMAIN; MEDIATES NEURODEGENERATION; STRUCTURAL BASIS; PROTEIN; RECOGNITION; SPLICEOSOME; U2AF; IDENTIFICATION; ASSOCIATION	Ataxin-1 (Atx1), a member of the polyglutamine (polyQ) expanded protein family, is responsible for spinocerebellar ataxia type 1. Requirements for developing the disease are polyQ expansion, nuclear localization and phosphorylation of S776. Using a combination of bioinformatics, cell and structural biology approaches, we have identified a UHM ligand motif (ULM), present in proteins associated with splicing, in the C-terminus of Atx1 and shown that Atx1 interacts with and influences the function of the splicing factor U2AF65 via this motif. ULM comprises S776 of Atx1 and overlaps with a nuclear localization signal and a 14-3-3 binding motif. We demonstrate that phosphorylation of S776 provides the molecular switch which discriminates between 14-3-3 and components of the spliceosome. We also show that an S776D Atx1 mutant previously designed to mimic phosphorylation is unsuitable for this aim because of the different chemical properties of the two groups. Our results indicate that Atx1 is part of a complex network of interactions with splicing factors and suggest that development of the pathology is the consequence of a competition of aggregation with native interactions. Studies of the interactions formed by non-expanded Atx1 thus provide valuable hints for understanding both the function of the non-pathologic protein and the causes of the disease.	[de Chiara, Cesira; Menon, Rajesh P.; Strom, Molly; Pastore, Annalisa] Natl Inst Med Res, MRC, London NW7 1AA, England; [Gibson, Toby J.] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany	MRC National Institute for Medical Research; European Molecular Biology Laboratory (EMBL)	de Chiara, C (corresponding author), Natl Inst Med Res, MRC, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk		Gibson, Toby James/0000-0003-0657-5166; de Chiara, Cesira/0000-0002-9766-2515	Medical Research Council; National Institutes of Health (NIH) [U24NS050606]; Dept of Pharmacology, School of Medicine, University of California Davis; MRC [MC_U117584256, MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117584256, MC_U117533887] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept of Pharmacology, School of Medicine, University of California Davis; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Medical Research Council. The monoclonal antibody 11NQ was obtained from the UC/Davis/NINDS/NIMH NeuroMab Facility, supported by National Institutes of Health (NIH) grant U24NS050606 and maintained by the Dept of Pharmacology, School of Medicine, University of California Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Bolger TA, 2007, J BIOL CHEM, V282, P29186, DOI 10.1074/jbc.M704182200; Burright EN, 1997, HUM MOL GENET, V6, P513, DOI 10.1093/hmg/6.4.513; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen YW, 2004, J BIOL CHEM, V279, P3758, DOI 10.1074/jbc.M309817200; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; Corsini L, 2009, J BIOL CHEM, V284, P630, DOI 10.1074/jbc.M805395200; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gibson TJ, 2009, TRENDS BIOCHEM SCI, V34, P471, DOI 10.1016/j.tibs.2009.06.007; Goold R, 2007, HUM MOL GENET, V16, P2122, DOI 10.1093/hmg/ddm162; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Heintz N, 2003, SCIENCE, V301, P59, DOI 10.1126/science.1086311; Irwin S, 2005, J CELL SCI, V118, P233, DOI 10.1242/jcs.01611; JODICE C, 1994, AM J HUM GENET, V54, P959; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kaneko K, 2006, MED HYPOTHESES, V67, P169, DOI 10.1016/j.mehy.2006.01.019; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Liu N, 2006, CELL, V127, P1299, DOI 10.1016/j.cell.2006.12.012; Menon RP, 2006, CELL MOL LIFE SCI, V63, P1677, DOI 10.1007/s00018-006-6097-4; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Omi K, 2008, NEUROSCI LETT, V431, P45, DOI 10.1016/j.neulet.2007.11.018; Orr HT, 2001, HUM MOL GENET, V10, P2307, DOI 10.1093/hmg/10.20.2307; Pacheco TR, 2006, MOL CELL BIOL, V26, P8183, DOI 10.1128/MCB.00350-06; Paulson H, 2003, NAT MED, V9, P825, DOI 10.1038/nm0703-825; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rino J, 2008, MOL CELL BIOL, V28, P3045, DOI 10.1128/MCB.02015-07; Sampath J, 2003, AM J PATHOL, V163, P1781, DOI 10.1016/S0002-9440(10)63538-9; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Smith DJ, 2008, MOL CELL, V30, P657, DOI 10.1016/j.molcel.2008.04.013; Spector DL, 1993, CURR OPIN CELL BIOL, V5, P442, DOI 10.1016/0955-0674(93)90009-F; Tisserant A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001418; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Umahara T, 2007, NEUROSCI LETT, V414, P130, DOI 10.1016/j.neulet.2006.12.026; Valadkhan S, 2007, CURR OPIN STRUC BIOL, V17, P310, DOI 10.1016/j.sbi.2007.05.001; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	51	45	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8372	10.1371/journal.pone.0008372	http://dx.doi.org/10.1371/journal.pone.0008372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037628	Green Published, Green Submitted, gold			2022-12-25	WOS:000272998100006
J	Rajendran, L; Beckmann, J; Magenau, A; Boneberg, EM; Gaus, K; Viola, A; Giebel, B; Illges, H				Rajendran, Lawrence; Beckmann, Julia; Magenau, Astrid; Boneberg, Eva-Maria; Gaus, Katharina; Viola, Antonella; Giebel, Bernd; Illges, Harald			Flotillins Are Involved in the Polarization of Primitive and Mature Hematopoietic Cells	PLOS ONE			English	Article							LEUKEMIC STEM-CELLS; LIPID RAFTS; T-LYMPHOCYTES; EPITHELIAL-CELLS; PROGENITOR CELLS; PLASMA-MEMBRANE; HYALURONIC-ACID; LEADING-EDGE; POLARITY; PROTEINS	Background: Migration of mature and immature leukocytes in response to chemokines is not only essential during inflammation and host defense, but also during development of the hematopoietic system. Many molecules implicated in migratory polarity show uniform cellular distribution under non-activated conditions, but acquire a polarized localization upon exposure to migratory cues. Methodology/Principal Findings: Here, we present evidence that raft-associated endocytic proteins (flotillins) are pre-assembled in lymphoid, myeloid and primitive hematopoietic cells and accumulate in the uropod during migration. Furthermore, flotillins display a polarized distribution during immunological synapse formation. Employing the membrane lipid-order sensitive probe Laurdan, we show that flotillin accumulation in the immunological synapse is concomittant with membrane ordering in these regions. Conclusions: Together with the observation that flotillin polarization does not occur in other polarized cell types such as polarized epithelial cells, our results suggest a specific role for flotillins in hematopoietic cell polarization. Based on our results, we propose that in hematopoietic cells, flotillins provide intrinsic cues that govern segregation of certain microdomain-associated molecules during immune cell polarization.	[Rajendran, Lawrence] Univ Zurich, Dept Psychiat Res, Zurich, Switzerland; [Rajendran, Lawrence; Illges, Harald] Univ Konstanz, Constance, Germany; [Rajendran, Lawrence] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Beckmann, Julia; Giebel, Bernd] Univ Dusseldorf, Inst Transplantat Diagnost & Cellular Therapeut, Dusseldorf, Germany; [Beckmann, Julia; Giebel, Bernd] Univ Klinikum Essen, Inst Transfus Med, Essen, Germany; [Magenau, Astrid; Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Magenau, Astrid; Gaus, Katharina] Prince Wales Hosp, Dept Haematol, Sydney, NSW, Australia; [Boneberg, Eva-Maria; Illges, Harald] Biotechnol Inst Thurgau, Taegerwilen, Switzerland; [Viola, Antonella] Univ Padua, Dept Biomed Sci, Padua, Italy; [Illges, Harald] Univ Appl Sci, Rheinbach, Germany	University of Zurich; University of Konstanz; Max Planck Society; Heinrich Heine University Dusseldorf; University of Duisburg Essen; University of New South Wales Sydney; University of Padua	Rajendran, L (corresponding author), Univ Zurich, Dept Psychiat Res, Zurich, Switzerland.	rajendran@bli.uzh.ch; bernd.giebel@uk-essen.de; harald.illges@fh-brs.de	Agatea, Lisa/L-8267-2016; Giebel, Bernd/AAH-1083-2021; Viola, Antonella/A-4321-2015	Giebel, Bernd/0000-0003-2446-948X; Gaus, Katharina/0000-0002-8009-9658; Rajendran, Lawrence/0000-0002-6390-1821; Viola, Antonella/0000-0002-0125-9271	BBW, Bern, Switzerland [MRTN-CT-2004-005693, QLG1-CT-2001-01536, QLG1-CT-2001-0140]; Deutsche Forschungsgemeinschaft [SPP1109 GI 336/1-4]; Forschungskommission of the HHU-Duesseldorf; Leukamieliga e. V.; Swiss National Science Foundation	BBW, Bern, Switzerland; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungskommission of the HHU-Duesseldorf; Leukamieliga e. V.; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the BBW, Bern, Switzerland through grants MRTN-CT-2004-005693, QLG1-CT-2001-01536 and QLG1-CT-2001-01407 to H. I. as well as by grants from the Deutsche Forschungsgemeinschaft (SPP1109 GI 336/1-4), from the Forschungskommission of the HHU-Duesseldorf and the Leukamieliga e. V. to B. G. Part of this research is supported by the NCCR Neural Plasticity and Repair of the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONCIC B, 2000, J DEV ENTREPRENEURSH, V5, P21; Ariel A, 2000, IMMUNOLOGY, V100, P345, DOI 10.1046/j.1365-2567.2000.00059.x; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; BABUKE T, 2009, CELL SIGNAL; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; BORNENS M, 1991, NEW BIOL, V3, P627; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; del Pozo MA, 1998, CELL ADHES COMMUN, V6, P125, DOI 10.3109/15419069809004468; delPozo MA, 1997, J CELL BIOL, V137, P493; DELPOZO MA, 1995, J CELL BIOL, V131, P495, DOI 10.1083/jcb.131.2.495; Doherty SD, 2006, MELANOMA RES, V16, P461, DOI 10.1097/01.cmr.0000222592.75858.20; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Dustin ML, 2005, SEMIN IMMUNOL, V17, P400, DOI 10.1016/j.smim.2005.09.002; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; GERISCH G, 1993, SYM SOC EXP BIOL, V47, P297; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Giri B, 2007, EUR J IMMUNOL, V37, P2104, DOI 10.1002/eji.200636680; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Gubina E, 2002, BLOOD, V99, P2518, DOI 10.1182/blood.V99.7.2518; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Iida S, 2005, J LEUKOCYTE BIOL, V78, P481, DOI 10.1189/jlb.0904515; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Khaldoyanidi S, 1996, J LEUKOCYTE BIOL, V60, P579, DOI 10.1002/jlb.60.5.579; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lopez-Casas PP, 2003, FEBS LETT, V555, P223, DOI 10.1016/S0014-5793(03)01239-0; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mairhofer M, 2002, BLOOD, V100, P897, DOI 10.1182/blood.V100.3.897; Manes S, 2006, MOL MEMBR BIOL, V23, P59, DOI 10.1080/09687860500430069; Manes S, 2003, TRENDS IMMUNOL, V24, P320, DOI 10.1016/S1471-4906(03)00137-6; Manes S, 2001, SEMIN IMMUNOL, V13, P147, DOI 10.1006/smim.2000.0306; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Millan J, 2002, BLOOD, V99, P978, DOI 10.1182/blood.V99.3.978; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pierini LM, 2001, P NATL ACAD SCI USA, V98, P9471, DOI 10.1073/pnas.181353098; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Rajendran L, 2007, BIOL CHEM, V388, P307, DOI 10.1515/BC.2007.034; Rajendrana L, 2007, NEURODEGENER DIS, V4, P164, DOI 10.1159/000101841; Rossy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005403; Russell S, 2008, J CELL SCI, V121, P131, DOI 10.1242/jcs.021253; Salzer U, 2002, BLOOD, V99, P2569, DOI 10.1182/blood.V99.7.2569; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Samaniego R, 2007, J CELL SCI, V120, P3534, DOI 10.1242/jcs.006296; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Savage NDL, 2002, J IMMUNOL, V168, P3740, DOI 10.4049/jimmunol.168.8.3740; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Serrador JM, 2002, EUR J IMMUNOL, V32, P1560, DOI 10.1002/1521-4141(200206)32:6<1560::AID-IMMU1560>3.0.CO;2-U; Serrador JM, 1999, TRENDS CELL BIOL, V9, P228, DOI 10.1016/S0962-8924(99)01553-6; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Slaughter N, 2003, CLIN IMMUNOL, V108, P138, DOI 10.1016/S1521-6616(03)00097-4; Solomon S, 2002, IMMUNOBIOLOGY, V205, P108, DOI 10.1078/0171-2985-00114; Sotsios Y, 1999, J IMMUNOL, V163, P5954; VAN MEER G, 1988, J CELL BIOCHEM, V36, P51, DOI 10.1002/jcb.240360106; Vermeulen M, 1998, BLOOD, V92, P894, DOI 10.1182/blood.V92.3.894.415k22_894_900; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; WANG JM, 1987, IMMUNOLOGY, V60, P439; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39	68	32	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8290	10.1371/journal.pone.0008290	http://dx.doi.org/10.1371/journal.pone.0008290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027317	Green Published, gold, Green Submitted			2022-12-25	WOS:000272998000001
J	Rhyne, A; Rotjan, R; Bruckner, A; Tlusty, M				Rhyne, Andrew; Rotjan, Randi; Bruckner, Andrew; Tlusty, Michael			Crawling to Collapse: Ecologically Unsound Ornamental Invertebrate Fisheries	PLOS ONE			English	Article							FISH TRADE; SERVICES; ECOSYSTEMS; ECOLOGY; GOODS	Background: Fishery management has historically been an inexact and reactionary discipline, often taking action only after a critical stock suffers overfishing or collapse. The invertebrate ornamental fishery in the State of Florida, with increasing catches over a more diverse array of species, is poised for collapse. Current management is static and the lack of an adaptive strategy will not allow for adequate responses associated with managing this multi-species fishery. The last decade has seen aquarium hobbyists shift their display preference from fish-only tanks to miniature reef ecosystems that include many invertebrate species, creating increased demand without proper oversight. The once small ornamental fishery has become an invertebrate-dominated major industry supplying five continents. Methodology/Principal Findings: Here, we analyzed the Florida Marine Life Fishery (FLML) landing data from 1994 to 2007 for all invertebrate species. The data were organized to reflect both ecosystem purpose (in the wild) and ecosystem services (commodities) for each reported species to address the following question: Are ornamental invertebrates being exploited for their fundamental ecosystem services and economic value at the expense of reef resilience? We found that 9 million individuals were collected in 2007, 6 million of which were grazers. Conclusions/Significance: The number of grazers now exceeds, by two-fold, the number of specimens collected for curio and ornamental purposes altogether, representing a major categorical shift. In general, landings have increased 10-fold since 1994, though the number of licenses has been dramatically reduced. Thus, despite current management strategies, the FLML Fishery appears to be crawling to collapse.	[Rhyne, Andrew; Rotjan, Randi; Tlusty, Michael] Edgerton Res Lab, Boston, MA USA; [Rhyne, Andrew] Roger Williams Univ, Dept Biol & Marine Biol, Bristol, RI 02809 USA; [Rotjan, Randi] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Bruckner, Andrew] Khaled Bin Sultan Living Oceans Fdn, Landover, MD USA	Harvard University	Rhyne, A (corresponding author), Edgerton Res Lab, Boston, MA USA.	arhyne@rwu.edu	Tlusty, Michael/C-5349-2012; Rotjan, Randi D/T-7575-2019; Tlusty, Michael/AAF-9635-2021	Rotjan, Randi D/0000-0002-3401-9784; Tlusty, Michael/0000-0002-7493-2025; Rhyne, Andrew/0000-0001-7252-3431				ANDREWS C, 1990, J FISH BIOL, V37, P53, DOI 10.1111/j.1095-8649.1990.tb05020.x; Brown TC, 2007, NAT RESOUR J, V47, P329; Bruckner AW, 2005, REV BIOL TROP, V53, P127; Burke L., 2004, REEFS RISK CARIBBEAN; Burke L., 2002, REEFS RISK SE ASIA; Calado R, 2003, J CRUSTACEAN BIOL, V23, P963, DOI 10.1651/C-2409; Calado R, 2008, AQUAT CONSERV, V18, P335, DOI 10.1002/aqc.852; Ceballos G., 2010, ISSUES ECOL, V8, P1821; Chiappone M, 2001, REEF ENCOUNTERS, V30, P29; CITES, 2000, C PART GIG 11 M KEN; Daily Gretchen C., 2013, ENCY BIODIVERSITY, P1; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; Gasparini JL, 2005, BIODIVERS CONSERV, V14, P2883, DOI 10.1007/s10531-004-0222-1; HINGCO TG, 1991, ICLARM C P, V22, P249; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; HUGHES TP, 1994, SCIENCE, V256, P1574; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Larkin S.L., 2003, MAR FISH REV, V65, P21; LARKIN SL, 2001, EC PROFILE FLORIDAS; Leslie H. M., 2009, ECOSYSTEM BASED MANA, P55; MORGAN GR, 2001, CORPORATE DOCUMENT R; Morison AK, 2004, FISHERIES MANAG ECOL, V11, P411, DOI 10.1111/j.1365-2400.2004.00414.x; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Rhyne AL, 2004, J SHELLFISH RES, V23, P227; Sall J, 2007, JMP START STAT GUIDE; SAMMARCO PW, 1982, J EXP MAR BIOL ECOL, V61, P31, DOI 10.1016/0022-0981(82)90020-X; SAMMARCO PW, 1982, J EXP MAR BIOL ECOL, V65, P83, DOI 10.1016/0022-0981(82)90177-0; Smith KF, 2008, CONSERV LETT, V1, P103, DOI 10.1111/j.1755-263X.2008.00014.x; Sutinen JG, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P291, DOI 10.1079/9780851996332.0291; Talbot F., 2001, CORAL REEFS MANGROVE; Wabnitz C., 2003, OCEAN AQUARIUM GLOBA	32	71	72	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8413	10.1371/journal.pone.0008413	http://dx.doi.org/10.1371/journal.pone.0008413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027312	Green Submitted, gold, Green Published			2022-12-25	WOS:000272998000017
J	Shriner, D; Adeyemo, A; Gerry, NP; Herbert, A; Chen, GJ; Doumatey, A; Huang, HX; Zhou, J; Christman, MF; Rotimi, CN				Shriner, Daniel; Adeyemo, Adebowale; Gerry, Norman P.; Herbert, Alan; Chen, Guanjie; Doumatey, Ayo; Huang, Hanxia; Zhou, Jie; Christman, Michael F.; Rotimi, Charles N.			Transferability and Fine-Mapping of Genome-Wide Associated Loci for Adult Height across Human Populations	PLOS ONE			English	Article							BODY-MASS INDEX; LINKAGE DISEQUILIBRIUM; AFRICAN-AMERICAN; COMMON VARIANTS; FLIP-FLOP; STATURE; HERITABILITY; SCAN; GENE; REGIONS	Human height is the prototypical polygenic quantitative trait. Recently, several genetic variants influencing adult height were identified, primarily in individuals of East Asian (Chinese Han or Korean) or European ancestry. Here, we examined 152 genetic variants representing 107 independent loci previously associated with adult height for transferability in a well-powered sample of 1,016 unrelated African Americans. When we tested just the reported variants originally identified as associated with adult height in individuals of East Asian or European ancestry, only 8.3% of these loci transferred (p-values <= 0.05 under an additive genetic model with directionally consistent effects) to our African American sample. However, when we comprehensively evaluated all HapMap variants in linkage disequilibrium (r(2) >= 0.3) with the reported variants, the transferability rate increased to 54.1%. The transferability rate was 70.8% for associations originally reported as genome-wide significant and 38.0% for associations originally reported as suggestive. An additional 23 loci were significantly associated but failed to transfer because of directionally inconsistent effects. Six loci were associated with adult height in all three groups. Using differences in linkage disequilibrium patterns between HapMap CEU or CHB reference data and our African American sample, we fine-mapped these six loci, improving both the localization and the annotation of these transferable associations.	[Shriner, Daniel; Adeyemo, Adebowale; Chen, Guanjie; Doumatey, Ayo; Huang, Hanxia; Zhou, Jie; Rotimi, Charles N.] NIH, Ctr Res Gen & Global Hlth, NHGRI, Bethesda, MD 20892 USA; [Gerry, Norman P.; Christman, Michael F.] Coriell Inst Med Res, Camden, NJ USA; [Herbert, Alan] Boston Univ, Sch Med, Dept Genet & Gen, Boston, MA 02118 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Coriell Institute for Medical Research; Boston University	Shriner, D (corresponding author), NIH, Ctr Res Gen & Global Hlth, NHGRI, Bldg 10, Bethesda, MD 20892 USA.	shrinerda@mail.nih.gov; rotimic@mail.nih.gov	Herbert, Alan/AAY-4286-2020	Adeyemo, Adebowale/0000-0002-3105-3231; Herbert, Alan/0000-0002-0093-1572; Shriner, Daniel/0000-0003-1928-5520	National Institutes of Health [S06GM008016-320107, S06GM008016-380111, 2M01RR010284]; Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health [Z01HG200362]; Coriell Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Coriell Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The Howard University Family Study was supported by National Institutes of Health grants S06GM008016-320107 to CNR and S06GM008016-380111 to AA. Enrollment was carried out at the Howard University General Clinical Research Center, supported by National Institutes of Health grant 2M01RR010284. This research was supported in part by the Intramural Research Program of the Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health (Z01HG200362). Genotyping support was provided by the Coriell Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEYEMO A, 2009, PUBLIC HLTH IN PRESS; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Clarke GM, 2007, AM J HUM GENET, V81, P995, DOI 10.1086/521952; Cooper RS, 2008, HUM MOL GENET, V17, pR151, DOI 10.1093/hmg/ddn263; Deng HW, 2002, AM J MED GENET, V113, P29, DOI 10.1002/ajmg.10742; Falush D, 2003, GENETICS, V164, P1567; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-77; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; Johansson A, 2009, HUM MOL GENET, V18, P373, DOI 10.1093/hmg/ddn350; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lei SF, 2009, HUM GENET, V125, P1, DOI 10.1007/s00439-008-0590-9; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li MX, 2004, J HUM GENET, V49, P148, DOI 10.1007/s10038-004-0125-8; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Luke A, 2001, INT J OBESITY, V25, P1034, DOI 10.1038/sj.ijo.0801650; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Moskvina V, 2007, HUM HERED, V64, P63, DOI 10.1159/000101424; MUELLER WH, 1976, AM J PHYS ANTHROPOL, V45, P269, DOI 10.1002/ajpa.1330450212; Mukhopadhyay N, 2003, HUM HERED, V55, P191, DOI 10.1159/000073203; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Price RA, 2000, OBES RES, V8, P360, DOI 10.1038/oby.2000.43; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; ROBERTS DF, 1978, ANN HUM GENET, V42, P15, DOI 10.1111/j.1469-1809.1978.tb00928.x; Sale MM, 2005, ANN HUM GENET, V69, P517, DOI 10.1046/j.1529-8817.2005.00176.x; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Wiltshire S, 2002, AM J HUM GENET, V70, P543, DOI 10.1086/338760; Wu XD, 2003, EUR J HUM GENET, V11, P271, DOI 10.1038/sj.ejhg.5200952; Xu JF, 2002, AM J HUM GENET, V71, P646, DOI 10.1086/342216; Zaykin DV, 2008, AM J HUM GENET, V82, P794, DOI 10.1016/j.ajhg.2008.02.001	39	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8398	10.1371/journal.pone.0008398	http://dx.doi.org/10.1371/journal.pone.0008398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027299	Green Submitted, Green Published, gold			2022-12-25	WOS:000272998000006
J	Pallotta, I; Lovett, M; Rice, W; Kaplan, DL; Balduini, A				Pallotta, Isabella; Lovett, Michael; Rice, William; Kaplan, David L.; Balduini, Alessandra			Bone Marrow Osteoblastic Niche: A New Model to Study Physiological Regulation of Megakaryopoiesis	PLOS ONE			English	Article							PROPLATELET FORMATION; STEM-CELLS; OXYGEN-TENSION; MEGAKARYOCYTES; EXPRESSION; PROTEIN; DIFFERENTIATION; HEMATOPOIESIS; LOCALIZATION; MATURATION	Background: The mechanism by which megakaryocytes (Mks) proliferate, differentiate, and release platelets into circulation are not well understood. Growing evidence indicates that a complex regulatory mechanism, involving cellular interactions, composition of the extracellular matrix and physical parameters such as oxygen tension, may contribute to the quiescent or permissive microenvironment related to Mk differentiation and maturation within the bone marrow. Methodology/Principal Findings: Differentiating human mesenchymal stem cells (hMSCs) into osteoblasts (hOSTs), we established an in vitro model for the osteoblastic niche. We demonstrated for the first time that the combination of HSCs, Mks and hypoxia sustain and promote bone formation by increasing type I collagen release from hOSTs and enhancing its fibrillar organization, as revealed by second harmonic generation microscopy. Through co-culture, we demonstrated that direct cell-cell contact modulates Mk maturation and differentiation. In particular we showed that low oxygen tension and direct interaction of hematopoietic stem cells (HSCs) with hOSTs inhibits Mk maturation and proplatelet formation (PPF). This regulatory mechanism was dependent on the fibrillar structure of type I collagen released by hOSTs and on the resulting engagement of the alpha2beta1 integrin. In contrast, normoxic conditions and the direct interaction of HSCs with undifferentiated hMSCs promoted Mk maturation and PPF, through a mechanism involving the VCAM-1 pathway. Conclusions/Significance: By combining cellular, physical and biochemical parameters, we mimicked an in vitro model of the osteoblastic niche that provides a physiological quiescent microenvironment where Mk differentiation and PPF are prevented. These findings serve as an important step in developing suitable in vitro systems to use for the study and manipulation of Mk differentiation and maturation in both normal and diseased states.	[Pallotta, Isabella; Lovett, Michael; Rice, William; Kaplan, David L.; Balduini, Alessandra] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Pallotta, Isabella; Balduini, Alessandra] Univ Pavia, Dept Biochem, I-27100 Pavia, Italy	Tufts University; University of Pavia	Pallotta, I (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu; alessandra.balduini@tufts.edu	Balduini, Alessandra/K-6802-2016; BALDUINI, ALESSANDRA/AAC-3363-2022; Pallotta, Isabella/J-5759-2019	Balduini, Alessandra/0000-0003-3145-1245; BALDUINI, ALESSANDRA/0000-0003-3145-1245; 	Cariplo Foundation [2006.0596/10.8485]; Banca del Monte di Lombardia Foundation; U.S. National Institutes of Health [NIH P41 EB002520]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	Cariplo Foundation(Fondazione Cariplo); Banca del Monte di Lombardia Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants from Cariplo Foundation (2006.0596/10.8485); Banca del Monte di Lombardia Foundation and the U.S. National Institutes of Health (NIH P41 EB002520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Balduini A, 2004, EXP CELL RES, V300, P84, DOI 10.1016/j.yexcr.2004.07.011; Balduini A, 2009, J THROMB HAEMOST, V7, P478, DOI 10.1111/j.1538-7836.2008.03255.x; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang Y, 2007, BLOOD, V109, P4229, DOI 10.1182/blood-2006-04-020024; Chen Z, 2007, BLOOD, V110, P171, DOI 10.1182/blood-2007-02-071589; Cheng LZ, 2000, J CELL PHYSIOL, V184, P58, DOI 10.1002/(SICI)1097-4652(200007)184:1<58::AID-JCP6>3.0.CO;2-B; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; DORSHKIND K, 1990, ANNU REV IMMUNOL, V8, P111, DOI 10.1146/annurev.iy.08.040190.000551; Georgakoudi I, 2008, TISSUE ENG PART B-RE, V14, P321, DOI 10.1089/ten.teb.2008.0248; Hirao M, 2007, J BONE MINER METAB, V25, P266, DOI 10.1007/s00774-007-0765-9; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kacena MA, 2006, BONE, V39, P978, DOI 10.1016/j.bone.2006.05.019; Larson MK, 2006, PLATELETS, V17, P435, DOI 10.1080/09537100600772637; Larson MK, 2006, BLOOD, V108, P1509, DOI 10.1182/blood-2005-11-011957; LEVEN RM, 1992, EXP HEMATOL, V20, P1316; Liu F, 2008, J BONE MINER METAB, V26, P312, DOI 10.1007/s00774-007-0842-0; LORD BI, 1990, INT J CELL CLONING, V8, P317, DOI 10.1002/stem.5530080501; Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264; MAUPIN P, 1994, J CELL SCI, V107, P3077; Mostafa SS, 2000, BRIT J HAEMATOL, V111, P879, DOI 10.1046/j.1365-2141.2000.02457.x; NEUMAN RE, 1950, J BIOL CHEM, V186, P549; Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311; Nurden P, 2006, BLOOD, V108, P2587, DOI 10.1182/blood-2006-03-009449; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; Pecci A, 2009, THROMB HAEMOSTASIS, V102, P90, DOI 10.1160/TH09-01-0068; Porter RL, 2008, ARCH BIOCHEM BIOPHYS, V473, P193, DOI 10.1016/j.abb.2008.04.001; Rajashekhar G, 2005, J SOC GYNECOL INVEST, V12, P310, DOI 10.1016/j.jsgi.2005.02.010; REDDI AH, 1977, P NATL ACAD SCI USA, V74, P5589, DOI 10.1073/pnas.74.12.5589; Rice WL, 2008, BIOMATERIALS, V29, P2015, DOI 10.1016/j.biomaterials.2007.12.049; Sabri S, 2004, BLOOD, V104, P3117, DOI 10.1182/blood-2003-12-4398; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Schulze H, 2005, J THROMB HAEMOST, V3, P1717, DOI 10.1111/j.1538-7836.2005.01426.x; SEIB FB, 2009, TISSUE EN A IN PRESS; Seri M, 2000, NAT GENET, V26, P103; Takizawa H, 2008, EXP HEMATOL, V36, P897, DOI 10.1016/j.exphem.2008.02.004; Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022; Warren SM, 2001, J SURG RES, V99, P147, DOI 10.1006/jsre.2001.6128; Willam C, 1999, AM J PHYSIOL-HEART C, V276, pH2044, DOI 10.1152/ajpheart.1999.276.6.H2044; WILLIAMS N, 1982, BRIT J HAEMATOL, V52, P173, DOI 10.1111/j.1365-2141.1982.tb03878.x; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; ZOU Z, 2009, BLOOD IN PRESS	46	62	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8359	10.1371/journal.pone.0008359	http://dx.doi.org/10.1371/journal.pone.0008359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027303	Green Submitted, Green Published, gold			2022-12-25	WOS:000272940100007
J	Svensson, K; Granberg, M; Karlsson, L; Neubauerova, V; Forsman, M; Johansson, A				Svensson, Kerstin; Granberg, Malin; Karlsson, Linda; Neubauerova, Vera; Forsman, Mats; Johansson, Anders			A Real-Time PCR Array for Hierarchical Identification of Francisella Isolates	PLOS ONE			English	Article							TULARENSIS SUBSP TULARENSIS; POPULATION-STRUCTURE; MOLECULAR ANALYSIS; TULAREMIA VACCINE; EVOLUTION; ASSAY	A robust, rapid and flexible real-time PCR assay for hierarchical genetic typing of clinical and environmental isolates of Francisella is presented. Typing markers were found by multiple genome and gene comparisons, from which 23 canonical single nucleotide polymorphisms (canSNPs) and 11 canonical insertion-deletion mutations (canINDELs) were selected to provide phylogenetic guidelines for classification from genus to isolate level. The specificity of the developed assay, which uses 68 wells of a 96-well real-time PCR format with a detection limit of 100 pg DNA, was assessed using 62 Francisella isolates of diverse genetic and geographical origins. It was then successfully used for typing 14 F. tularensis subsp. holarctica isolates obtained from tularemia patients in Sweden in 2008 and five more genetically diverse Francisella isolates of global origins. When applied to human ulcer specimens for direct pathogen detection the results were incomplete due to scarcity of DNA, but sufficient markers were identified to detect fine-resolution differences among F. tularensis subsp. holarctica isolates causing infection in the patients. In contrast to other real-time PCR assays for Francisella, which are typically designed for specific detection of a species, subspecies, or strain, this type of assay can be easily tailored to provide appropriate phylogenetic and/or geographical resolution to meet the objectives of the analysis.	[Svensson, Kerstin; Granberg, Malin; Karlsson, Linda; Forsman, Mats; Johansson, Anders] Swedish Def Res Agcy, Div CBRN Def & Secur, Umea, Sweden; [Svensson, Kerstin; Johansson, Anders] Umea Univ, Dept Clin Microbiol Infect Dis & Bacteriol, Umea, Sweden; [Neubauerova, Vera] Cent Mil Hlth Inst, Prague, Czech Republic	Saab Group; Umea University	Svensson, K (corresponding author), Swedish Def Res Agcy, Div CBRN Def & Secur, Umea, Sweden.	kerstin.svensson@foi.se	Forsman, Mats/A-1426-2016; Johansson, Anders/D-2928-2012; Johansson, Anders/H-9362-2017	Forsman, Mats/0000-0002-4466-5325; Johansson, Anders/0000-0003-0548-5943; Johansson, Anders/0000-0003-0548-5943	Swedish Ministry of Foreign Affairs [A4942, A4952]; Medical Faculty, Umea University, Umea; European biodefence laboratory network [EDAB-0060-ESM4-GC]	Swedish Ministry of Foreign Affairs; Medical Faculty, Umea University, Umea; European biodefence laboratory network	This study was supported by the Swedish Ministry of Foreign Affairs (FOI project No. A4942 and A4952) www.ud.se and the Medical Faculty, Umea University, Umea, www.umu.se/medfak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was part of the European biodefence laboratory network (EDAB-0060-ESM4-GC) coordination work on dangerous pathogens.	Barns SM, 2005, APPL ENVIRON MICROB, V71, P5494, DOI 10.1128/AEM.71.9.5494-5500.2005; *CDCP, BIOT; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; Fey PD, 2007, AM J CLIN PATHOL, V128, P926, DOI 10.1309/JN3NTHK4VVWKJT4A; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; Fujita O, 2006, JPN J INFECT DIS, V59, P46; Fulop M, 1996, AM J TROP MED HYG, V54, P364, DOI 10.4269/ajtmh.1996.54.364; Germer Soren, 2003, Methods Mol Biol, V212, P197; Higgins JA, 2000, AM J TROP MED HYG, V62, P310, DOI 10.4269/ajtmh.2000.62.310; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Johansson A, 2000, J CLIN MICROBIOL, V38, P22; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Kugeler KJ, 2006, EMERG INFECT DIS, V12, P1799, DOI 10.3201/eid1211.060629; KUGELER KJ, 2009, CLIN INFECT DIS; Larsson P, 2007, EMERG INFECT DIS, V13, P1725, DOI 10.3201/eid1311.070603; LONG GW, 1993, J CLIN MICROBIOL, V31, P152, DOI 10.1128/JCM.31.1.152-154.1993; Molins CR, 2009, DIAGN MICR INFEC DIS, V64, P6, DOI 10.1016/j.diagmicrobio.2009.01.006; NEWSOM G, 2005, SAN FRANCISCO COMMUN; Nubel U, 2006, J BACTERIOL, V188, P5319, DOI 10.1128/JB.01662-05; Pavkova I, 2006, J PROTEOME RES, V5, P3125, DOI 10.1021/pr0601887; Rohmer L, 2006, INFECT IMMUN, V74, P6895, DOI 10.1128/IAI.01006-06; Rozen S, 2000, Methods Mol Biol, V132, P365; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; Sjostedt A, 1997, J CLIN MICROBIOL, V35, P1045; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Svensson K, 2005, J BACTERIOL, V187, P3903, DOI 10.1128/JB.187.11.3903-3908.2005; Tomaso H, 2007, MOL CELL PROBE, V21, P12, DOI 10.1016/j.mcp.2006.06.001; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003; VOGLER AJ, 2009, J BACTERIOL; Wang J, 2005, BIOTECHNIQUES, V39, P885, DOI 10.2144/000112028; Zhai JH, 1996, J MED MICROBIOL, V45, P477, DOI 10.1099/00222615-45-6-477	35	66	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8360	10.1371/journal.pone.0008360	http://dx.doi.org/10.1371/journal.pone.0008360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027310	Green Published, gold, Green Submitted			2022-12-25	WOS:000272940100008
J	Ishimatsu-Tsuji, Y; Soma, T; Kishimoto, J				Ishimatsu-Tsuji, Yumiko; Soma, Tsutomu; Kishimoto, Jiro			Identification of novel hair-growth inducers by means of connectivity mapping	FASEB JOURNAL			English	Article						Cmap; microarray; hair follicle; cyclosporin; fluphenazine; iloprost	GENOMIC APPROACH; CYCLOSPORINE-A; STEM-CELLS; CYCLE; CANCER; GENES; INHIBITION; RESISTANCE; FOLLICLES; RAPAMYCIN	The aim of this study was to identify novel inducers of hair growth using gene expression profiling at various stages of hair-growth induction. First, we analyzed gene expression at the onset of hair growth in mice induced by cyclosporin A (CsA), a well-known hair-growth inducer, using DNA microarray analysis. The results unveiled genes involved in the step-by-step progression of hair growth, including increases in melanin biosynthesis and decreases in immune response at d 2 and the subsequent stimulation of cell proliferation at d 4, followed by the up-regulation of hair specific keratins at d 7 after CsA treatment. With the use of the connectivity map (Cmap), agents that had a similar "gene signature" to that of the profiles of CsA-treated mice were identified. Several agents, including CsA, were identified by the Cmap and were evaluated for hair induction activity in vivo. One of the proposed agents, fluphenazine (from the d 2 signature) actually induced hair growth in vivo (ED50: 2 mM for single application), and the subsequent application of 5 mM iloprost (from the d 4 signature) significantly enhanced the hair-growth effect of fluphenazine. From these results, Cmap analysis was proven to be a useful method that connects gene expression profiles of complicated biological processes, such as hair-growth induction, to effective agents.-Ishimatsu-Tsuji, Y., Soma, T., Kishimoto, J. Identification of novel hair-growth inducers by means of connectivity mapping. FASEB J. 24, 1489-1496 (2010). www.fasebj.org	[Kishimoto, Jiro] Shiseido Innovat Sci Res & Dev Ctr, Kanazawa Ku, Kanagawa 2368643, Japan	Shiseido Company, Limited	Kishimoto, J (corresponding author), Shiseido Innovat Sci Res & Dev Ctr, Kanazawa Ku, 2-12-1 Fukuura, Kanagawa 2368643, Japan.	jiro.kishimoto@to.shiseido.co.jp	KISHIMOTO, JIRO/AAD-7857-2019; Tsuji, Yumiko/AAV-9817-2020					Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Botchkarev VA, 2003, J INVEST DERM SYMP P, V8, P46, DOI 10.1046/j.1523-1747.2003.12171.x; Christensen A V, 1985, Psychopharmacology Suppl, V2, P182; Gafter-Gvili A, 2003, AM J PHYSIOL-CELL PH, V284, pC1593, DOI 10.1152/ajpcell.00537.2002; Garman KS, 2008, P NATL ACAD SCI USA, V105, P19432, DOI 10.1073/pnas.0806674105; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Ishimatsu-Tsuji Y, 2005, J INVEST DERMATOL, V125, P410, DOI 10.1111/j.0022-202X.2005.23825.x; IWABUCHI T, 1995, J DERMATOL SCI, V9, P64, DOI 10.1016/0923-1811(94)00351-E; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lin KK, 2004, P NATL ACAD SCI USA, V101, P15955, DOI 10.1073/pnas.0407114101; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Michnick SW, 2006, NAT CHEM BIOL, V2, P663, DOI 10.1038/nchembio1206-663; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; PROZIALECK WC, 1982, J PHARMACOL EXP THER, V222, P509; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Riedel RF, 2008, MOL CANCER THER, V7, P3141, DOI 10.1158/1535-7163.MCT-08-0642; Rosenbluth JM, 2008, MOL CELL BIOL, V28, P5951, DOI 10.1128/MCB.00305-08; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Zimmer M, 2008, MOL CELL, V32, P838, DOI 10.1016/j.molcel.2008.12.004	26	20	25	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1489	1496		10.1096/fj.09-145292	http://dx.doi.org/10.1096/fj.09-145292			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20026683				2022-12-25	WOS:000277158900021
J	Tamassia, N; Castellucci, M; Rossato, M; Gasperini, S; Bosisio, D; Giacomelli, M; Badolato, R; Cassatella, MA; Bazzoni, F				Tamassia, Nicola; Castellucci, Monica; Rossato, Marzia; Gasperini, Sara; Bosisio, Daniela; Giacomelli, Mauro; Badolato, Raffaele; Cassatella, Marco A.; Bazzoni, Flavia			Uncovering an IL-10-dependent NF-kappa B recruitment to the IL-1ra promoter that is impaired in STAT3 functionally defective patients	FASEB JOURNAL			English	Article						chromatin modification; inflammation; neutrophils; monocytes; transcription	INTERLEUKIN-1 RECEPTOR ANTAGONIST; HYPER-IGE SYNDROME; DNA-BINDING DOMAIN; GENE-EXPRESSION; HUMAN NEUTROPHILS; AUTOINFLAMMATORY DISEASE; HISTONE MODIFICATIONS; INTERFERON-GAMMA; HUMAN MONOCYTES; MOLECULAR-BASIS	The interleukin 1 receptor antagonist (IL-1ra) is an important negative regulator of the inflammatory response, whose genetic deficiency has been recently shown to cause a severe autoinflammatory syndrome in humans. In this study we characterized the molecular mechanisms whereby interleukin 10 (IL-10) potentiates IL-1ra transcription in LPS-stimulated monocytes and neutrophils. Using chromatin immunoprecipitation, we show that although NF-kappa Bp65 and NF-kappa Bp50 proteins accumulate into the nuclei and bind to the I kappa B alpha promoter during LPS stimulation, they are not recruited to the kappa B sites of the IL-1ra promoter. However, in response to LPS plus IL-10, which were found to induce chromatin acetylation, recruitment of both NF-kappa Bp65 and NF-kappa Bp50 to the IL-1ra promoter efficiently occurs in a STAT-3-dependent manner. Accordingly, in neutrophils from hyper-IgE syndrome patients, who carry a nonfunctional STAT3, IL-10 failed to promote NF-kappa Bp65 recruitment to the IL-1ra promoter and consequently to potentiate LPS-induced IL-1ra transcription. Altogether our findings uncover a novel mechanism whereby IL-10-activated STAT3 modulates IL-1ra transcription in LPS-treated phagocytes by making IL-1ra promoter accessible to readily available nuclear NF-kappa B.-Tamassia, N., Castellucci, M., Rossato, M., Gasperini, S., Bosisio, D., Giacomelli, M., Badolato, R., Cassatella, M. A., Bazzoni, F. Uncovering an IL-10-dependent NF-kappa B recruitment to the IL-1ra promoter that is impaired in STAT3 functionally defective patients. FASEB J. 24, 1365-1375 (2010). www.fasebj.org	[Tamassia, Nicola; Castellucci, Monica; Rossato, Marzia; Gasperini, Sara; Cassatella, Marco A.; Bazzoni, Flavia] Univ Verona, Div Gen Pathol, Dept Pathol, Verona, Italy; [Bosisio, Daniela] Univ Brescia, Dept Biomed Sci & Biotechnol, Unit Gen Pathol & Immunol, Brescia, Italy; [Giacomelli, Mauro; Badolato, Raffaele] Univ Brescia, Inst Mol Med Angelo Nocivelli, Brescia, Italy; [Giacomelli, Mauro; Badolato, Raffaele] Univ Brescia, Dept Pediat, Brescia, Italy	University of Verona; University of Brescia; University of Brescia; University of Brescia	Bazzoni, F (corresponding author), Univ Verona, Div Gen Pathol, Dept Pathol, Str Grazie 8, Verona, Italy.	flavia.bazzoni@univr.it	Giacomelli, Mauro/AGX-9755-2022; Badolato, Raffaele/A-8081-2010; Bazzoni, Flavia/AAB-7674-2019; Tamassia, Nicola/J-8621-2016; Cassatella, M A/B-8037-2013; Rossato, Marzia/AAB-7827-2019	Badolato, Raffaele/0000-0001-7375-5410; Bazzoni, Flavia/0000-0001-6768-8012; Tamassia, Nicola/0000-0003-2990-3003; Cassatella, M A/0000-0001-7824-1806; Rossato, Marzia/0000-0002-6101-1550; BOSISIO, Daniela/0000-0001-6276-5365	Ministero dell'Istruzione, dell'Universita e della Ricerca [20083MNL5X_003, 2007ACZMMZ_005, 2007H9AWXY]; Fondazione Cariverona; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 5839]; Fondazione Cariplo; EU [201461]; European Research Project on Rare Diseases (eRARE)	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariverona(Fondazione Cariverona); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo); EU(European Commission); European Research Project on Rare Diseases (eRARE)	This work was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN Anno 2006 prot. 20083MNL5X_003, 2007 prot. 2007ACZMMZ_005, and prot. 2007H9AWXY), the Fondazione Cariverona, the Associazione Italiana per la Ricerca sul Cancro (AIRC; IG 5839), the Fondazione Cariplo (Nobel project), EU grant FP7 HLH cure (project 201461), and the European Research Project on Rare Diseases (eRARE). We thank Dr. Rene de Waal Malefyt (Schering-Plough Biopharma, Palo Alto, CA, USA) for kindly providing recombinant human IL-10. The authors have no conflicting financial interests.	Aalfs JD, 2000, TRENDS BIOCHEM SCI, V25, P548, DOI 10.1016/S0968-0004(00)01689-3; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Carl VS, 2004, J LEUKOCYTE BIOL, V76, P735, DOI 10.1189/jlb.1003526; Cassatella MA, 2005, EUR J IMMUNOL, V35, P1877, DOI 10.1002/eji.200526088; CASSATELLA MA, 1990, J BIOL CHEM, V265, P20241; CASSATELLA MA, 1994, J EXP MED, V179, P1695, DOI 10.1084/jem.179.5.1695; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Cheung WL, 2000, CURR OPIN CELL BIOL, V12, P326, DOI 10.1016/S0955-0674(00)00096-X; CONSTANTIN G, 1994, FEBS LETT, V350, P66, DOI 10.1016/0014-5793(94)00735-7; Crepaldi L, 2002, INT IMMUNOL, V14, P1145, DOI 10.1093/intimm/dxf079; Crepaldi L, 2001, J IMMUNOL, V167, P2312, DOI 10.4049/jimmunol.167.4.2312; DINARELLO CA, 1991, IMMUNOL TODAY, V12, P404, DOI 10.1016/0167-5699(91)90142-G; DRIPPS DJ, 1991, J BIOL CHEM, V266, P10331; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; HANNUM CH, 1990, NATURE, V343, P336, DOI 10.1038/343336a0; Heimall J, 2010, CLIN REV ALLERG IMMU, V38, P32, DOI 10.1007/s12016-009-8134-1; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; JENKINS JK, 1994, LYMPHOKINE CYTOK RES, V13, P47; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; McDonald PP, 1998, BIOCHEMISTRY-US, V37, P13165, DOI 10.1021/bi972539o; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Natoli G, 2006, FEBS LETT, V580, P2843, DOI 10.1016/j.febslet.2006.02.072; Paulson ML, 2008, CURR OPIN ALLERGY CL, V8, P527, DOI 10.1097/ACI.0b013e3283184210; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Rossato M, 2007, EUR J IMMUNOL, V37, P3176, DOI 10.1002/eji.200737625; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; SMITH MF, 1994, J IMMUNOL, V153, P3584; Smith MF, 1998, J BIOL CHEM, V273, P24272, DOI 10.1074/jbc.273.37.24272; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200; Yu ZY, 2004, J AM SOC NEPHROL, V15, P585, DOI 10.1097/01.ASN.0000114556.19556.F9; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588	39	33	35	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1365	1375		10.1096/fj.09-145573	http://dx.doi.org/10.1096/fj.09-145573			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20032313				2022-12-25	WOS:000277158900010
J	Adam, AP; Sharenko, AL; Pumiglia, K; Vincent, PA				Adam, Alejandro P.; Sharenko, Amy L.; Pumiglia, Kevin; Vincent, Peter A.			Src-induced Tyrosine Phosphorylation of VE-cadherin Is Not Sufficient to Decrease Barrier Function of Endothelial Monolayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR-PERMEABILITY; LEUKOCYTE TRANSMIGRATION; ADHERENS JUNCTIONS; FAMILY KINASES; GROWTH-FACTOR; CELLS; MICE; IDENTIFICATION; P120-CATENIN; ENDOCYTOSIS	Activation of Src family kinases (SFK) and the subsequent phosphorylation of VE-cadherin have been proposed as major regulatory steps leading to increases in vascular permeability in response to inflammatory mediators and growth factors. To investigate Src signaling in the absence of parallel signaling pathways initiated by growth factors or inflammatory mediators, we activated Src and SFKs by expression of dominant negative Csk, expression of constitutively active Src, or knockdown of Csk. Activation of SFK by overexpression of dominant negative Csk induced VE-cadherin phosphorylation at tyrosines 658, 685, and 731. However, dominant negative Csk expression was unable to induce changes in the monolayer permeability. In contrast, expression of constitutively active Src decreased barrier function and promoted VE-cadherin phosphorylation on tyrosines 658 and 731, although the increase in VE-cadherin phosphorylation preceded the increase in permeability by 4-6 h. Csk knockdown induced VE-cadherin phosphorylation at sites 658 and 731 but did not induce a loss in barrier function. Co-immunoprecipitation and immunofluorescence studies suggest that phosphorylation of those sites did not impair VE-cadherin ability to bind p120 and beta-catenin or the ability of these proteins to localize at the plasma membrane. Taken together, our data show that Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to promote an increase in endothelial cell monolayer permeability and suggest that signaling leading to changes in vascular permeability in response to inflammatory mediators or growth factors may require VE-cadherin tyrosine phosphorylation concurrently with other signaling pathways to promote loss of barrier function.	[Adam, Alejandro P.; Sharenko, Amy L.; Vincent, Peter A.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Pumiglia, Kevin] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College; Albany Medical College	Vincent, PA (corresponding author), 47 New Scotland Ave, Albany, NY 12208 USA.	vincenp@mail.amc.edu	Adam, Alejandro/M-6541-2013	Adam, Alejandro/0000-0001-6285-7235; Pumiglia, Kevin/0000-0003-4655-0334	National Institutes of Health [RO1 HL77870]; NATIONAL CANCER INSTITUTE [R01CA081419] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL77870 (to P.A.V.).	Aghajanian A, 2008, J THROMB HAEMOST, V6, P1453, DOI 10.1111/j.1538-7836.2008.03087.x; Alcaide P, 2008, BLOOD, V112, P2770, DOI 10.1182/blood-2008-03-147181; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Broman MT, 2007, TRENDS CARDIOVAS MED, V17, P151, DOI 10.1016/j.tcm.2007.03.004; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Ferreri DM, 2008, CELL COMMUN ADHES, V15, P333, DOI 10.1080/15419060802440377; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Iyer S, 2004, AM J PHYSIOL-LUNG C, V286, pL1143, DOI 10.1152/ajplung.00305.2003; Knezevic II, 2009, J BIOL CHEM, V284, P5381, DOI 10.1074/jbc.M808958200; LAFLAMME SE, 2008, CELL JUNCTIONS ADHES, P169; Lambeng N, 2005, CIRC RES, V96, P384, DOI 10.1161/01.RES.0000156652.99586.9f; Lowell CA, 1998, P NATL ACAD SCI USA, V95, P7580, DOI 10.1073/pnas.95.13.7580; Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Takayama Y, 1999, J BIOL CHEM, V274, P2291, DOI 10.1074/jbc.274.4.2291; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; Turowski P, 2008, J CELL SCI, V121, P29, DOI 10.1242/jcs.022681; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xu M, 2007, AM J PHYSIOL-CELL PH, V293, pC1309, DOI 10.1152/ajpcell.00014.2007; Zhang Y, 2008, GROWTH FACTORS, V26, P125, DOI 10.1080/08977190802105909	36	97	101	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7045	7055		10.1074/jbc.M109.079277	http://dx.doi.org/10.1074/jbc.M109.079277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048167	hybrid, Green Published			2022-12-25	WOS:000275415600018
J	Monsey, J; Shen, W; Schlesinger, P; Bose, R				Monsey, John; Shen, Wei; Schlesinger, Paul; Bose, Ron			Her4 and Her2/neu Tyrosine Kinase Domains Dimerize and Activate in a Reconstituted in Vitro System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; RECEPTOR SIGNALING COMPLEXES; DEPENDENT PROTEIN-KINASE; EGF RECEPTOR; NEUREGULIN RECEPTOR; CARDIAC DEVELOPMENT; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; ERBB RECEPTORS; BREAST-CANCER	Her4 (ErbB-4) and Her2/neu (ErbB-2) are receptor-tyrosine kinases belonging to the epidermal growth factor receptor (EGFR) family. Crystal structures of EGFR and Her4 kinase domains demonstrate kinase dimerization and activation through an allosteric mechanism. The kinase domains form an asymmetric dimer, where the C-lobe surface of one monomer contacts the N-lobe of the other monomer. EGFR kinase dimerization and activation in vitro was previously reported using a nickel-chelating lipid-liposome system, and we now apply this system to all other members of the EGFR family. Polyhistidine-tagged Her4, Her2/neu, and Her3 kinase domains are bound to these nickel-liposomes and are brought to high local concentration, mimicking what happens to full-length receptors in vivo following ligand binding. Addition of nickel-liposomes to Her4 kinase domain results in 40-fold activation in kinase activity and marked enhancement of C-terminal tail autophosphorylation. Activation of Her4 shows a sigmoidal dependence on kinase concentration, consistent with a cooperative process requiring kinase dimerization. Her2/neu kinase activity is also activated by nickel-liposomes, and is increased further by heterodimerization with Her3 or Her4. The ability of Her3 and Her4 to heterodimerize and activate other family members is studied in vitro. Her3 kinase domain readily activates Her2/neu but is a poor activator of Her4, which differs from the prediction made by the asymmetric dimer model. Mutation of Her3 residues (ENI954)-E-952 to the corresponding sequence in Her4 enhanced the ability of Her3 to activate Her4, demonstrating that sequence differences on the C-lobe surface influence the heterodimerization and activation of ErbB kinase domains.	Washington Univ, Div Oncol, Dept Med, Sch Med, St Louis, MO 63110 USA; [Schlesinger, Paul; Bose, Ron] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Bose, R (corresponding author), 660 S Euclid Ave,Campus Box 8069, St Louis, MO 63110 USA.	rbose@dom.wustl.edu	Schlesinger, Paul H/C-6049-2012		National Institutes of Health [K22CA128951]; NATIONAL CANCER INSTITUTE [K22CA128951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant K22CA128951 (NCI Transition Career Development Award, K22) (to R. B.).	ARMSTRONG RN, 1979, BIOCHEMISTRY-US, V18, P1230, DOI 10.1021/bi00574a018; Birchmeier C, 2009, EXP CELL RES, V315, P611, DOI 10.1016/j.yexcr.2008.10.035; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Bose R, 2009, EXP CELL RES, V315, P649, DOI 10.1016/j.yexcr.2008.07.031; Brignola PS, 2002, J BIOL CHEM, V277, P1576, DOI 10.1074/jbc.M105907200; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Esposito EA, 2008, J BIOMOL SCREEN, V13, P810, DOI 10.1177/1087057108322062; Fan YX, 2008, J BIOL CHEM, V283, P1588, DOI 10.1074/jbc.M708116200; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jan AY, 2000, BIOCHEMISTRY-US, V39, P9786, DOI 10.1021/bi9924922; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Kaushansky A, 2008, CHEM BIOL, V15, P808, DOI 10.1016/j.chembiol.2008.07.006; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; Montefusco DJ, 2007, METHOD ENZYMOL, V423, P267, DOI 10.1016/S0076-6879(07)23012-5; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pentassuglia L, 2009, EXP CELL RES, V315, P627, DOI 10.1016/j.yexcr.2008.08.015; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Shrout AL, 2003, BIOCHEMISTRY-US, V42, P13379, DOI 10.1021/bi0352769; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Sun GQ, 1999, BIOCHEMISTRY-US, V38, P5659, DOI 10.1021/bi982793w; SZOKA F, 1980, BIOCHIM BIOPHYS ACTA, V601, P559, DOI 10.1016/0005-2736(80)90558-1; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Wood ER, 2008, P NATL ACAD SCI USA, V105, P2773, DOI 10.1073/pnas.0708281105; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	48	51	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7035	7044		10.1074/jbc.M109.096032	http://dx.doi.org/10.1074/jbc.M109.096032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20022944	Green Published, hybrid			2022-12-25	WOS:000275415600017
J	Shen, Y; Lookene, A; Zhang, L; Olivecrona, G				Shen, Yan; Lookene, Aivar; Zhang, Liyang; Olivecrona, Gunilla			Site-directed Mutagenesis of Apolipoprotein CII to Probe the Role of Its Secondary Structure for Activation of Lipoprotein Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM DODECYL-SULFATE; C-II; AMPHIPATHIC HELIX; LIPID-BINDING; HUMAN SERUM; FRAGMENT; LIPOLYSIS	Apolipoprotein CII (apoCII) is a necessary activator for lipoprotein lipase (LPL). We had identified four residues (Tyr-63, Ile-66, Asp-69, and Gln-70), presumably contained in an alpha-helix, as a potential binding site for LPL. We have now used structure prediction, mutagenesis, and functional assays to explore the functional role of the secondary structure in this part of apoCII. First, mutants were generated by replacements with proline residues to disturb the helical structure. Activation by mutant G65P was reduced by 30%, whereas mutant S54P retained activation ability. Mutants V71P and L72P should be located outside the LPL-binding site, but V71P was totally inactive, whereas activation by L72P was reduced by 65%. Insertion of alanine after Tyr-63, changing the position of the putative LPL-binding site in relation to the hydrophobic face of the alpha-helix, also severely impeded the activation ability, and a double mutant (Y63A/I66A) was completely inactive. Next, to investigate the importance of conserved hydrophobic residues in the C-terminal end of apoCII, Phe-67, Val-71, Leu-72, and Leu-75 were exchanged for polar residues. Only F67S showed dramatic loss of function. Finally, fragment 39-62, previously claimed to activate LPL, was found to be completely inactive. Our data support the view that the helical structure close to the C-terminal end of apoCII is important for activation of LPL, probably by placing residues 63, 66, 69, and 70 in an optimal steric position. The structural requirements for the hydrophobic face on the back side of this helix and further out toward the C terminus were less stringent.	[Shen, Yan; Lookene, Aivar; Zhang, Liyang; Olivecrona, Gunilla] Umea Univ, Dept Med Biosci Physiol Chem, SE-90187 Umea, Sweden; [Lookene, Aivar] Tallinn Univ Technol, Dept Gene Technol, EE-12618 Tallinn, Estonia	Umea University; Tallinn University of Technology	Olivecrona, G (corresponding author), Umea Univ, Dept Med Biosci Physiol Chem, Bldg 6M,3rd Floor, SE-90187 Umea, Sweden.	Gunilla.Olivecrona@medbio.umu.se			Swedish Research Council [12203]; Estonian Science Foundation [6834]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Estonian Science Foundation	This work was supported by Swedish Research Council Grant 12203 and by Estonian Science Foundation Grant 6834.	BALASUBRAMANIAM A, 1986, CHEM PHYS LIPIDS, V39, P341, DOI 10.1016/0009-3084(86)90115-5; BENGTSSON G, 1980, EUR J BIOCHEM, V106, P549, DOI 10.1111/j.1432-1033.1980.tb04602.x; BIER DM, 1970, J LIPID RES, V11, P565; Dahim M, 2001, J LIPID RES, V42, P553; HAVEL RJ, 1973, BIOCHEMISTRY-US, V12, P1828, DOI 10.1021/bi00733a026; KINNUNEN PKJ, 1977, P NATL ACAD SCI USA, V74, P4848, DOI 10.1073/pnas.74.11.4848; KINNUNEN PKJ, 1983, ATHER REV, V11, P65; Lam CW, 2006, CLIN CHIM ACTA, V364, P256, DOI 10.1016/j.cca.2005.07.025; LAROSA JC, 1970, BIOCHEM BIOPH RES CO, V41, P57, DOI 10.1016/0006-291X(70)90468-7; LYCKSELL PO, 1992, EUR J BIOCHEM, V205, P223, DOI 10.1111/j.1432-1033.1992.tb16772.x; MacPhee CE, 2000, BIOCHEMISTRY-US, V39, P3433, DOI 10.1021/bi992523t; MacPhee CE, 1999, ANAL BIOCHEM, V275, P22, DOI 10.1006/abio.1999.4283; MacRaild CA, 2001, BIOCHEMISTRY-US, V40, P5414, DOI 10.1021/bi002821m; MENZEL HJ, 1986, J CLIN INVEST, V77, P595, DOI 10.1172/JCI112342; MYKLEBOST O, 1984, J BIOL CHEM, V259, P4401; Narayanaswami V, 2000, BBA-MOL CELL BIOL L, V1483, P15, DOI 10.1016/S1388-1981(99)00176-6; OHMAN A, 1993, EUR BIOPHYS J BIOPHY, V22, P351, DOI 10.1007/BF00213558; Olivecrona G, 1997, ARTERIOSCL THROM VAS, V17, P1545, DOI 10.1161/01.ATV.17.8.1545; SEGREST JP, 1992, J LIPID RES, V33, P141; Shen Y, 2000, GENE, V254, P189, DOI 10.1016/S0378-1119(00)00268-7; Shen Y, 2002, J BIOL CHEM, V277, P4334, DOI 10.1074/jbc.M105421200; Sparrow J T, 1980, Ann N Y Acad Sci, V348, P187, DOI 10.1111/j.1749-6632.1980.tb21300.x; Storjohann R, 2000, BBA-MOL CELL BIOL L, V1486, P253, DOI 10.1016/S1388-1981(00)00062-7; VAINIO P, 1983, J BIOL CHEM, V258, P5477; VERGER R, 1976, ANNU REV BIOPHYS BIO, V5, P77, DOI 10.1146/annurev.bb.05.060176.000453; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zdunek J, 2003, BIOCHEMISTRY-US, V42, P1872, DOI 10.1021/bi0267184	27	15	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7484	7492		10.1074/jbc.M109.022046	http://dx.doi.org/10.1074/jbc.M109.022046			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042600	Green Published, hybrid			2022-12-25	WOS:000275415600060
J	Alberobello, AT; D'Esposito, V; Marasco, D; Doti, N; Ruvo, M; Bianco, R; Tortora, G; Esposito, I; Fiory, F; Miele, C; Beguinot, F; Formisano, P				Alberobello, A. Teresa; D'Esposito, Vittoria; Marasco, Daniela; Doti, Nunzianna; Ruvo, Menotti; Bianco, Roberto; Tortora, Giampaolo; Esposito, Iolanda; Fiory, Francesca; Miele, Claudia; Beguinot, Francesco; Formisano, Pietro			Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; THERAPEUTIC TARGET; BREAST-CANCER; SOLID TUMORS; ACQUIRED-RESISTANCE; COLORECTAL-CANCER; CARCINOMA CELLS; C-TERMINUS	Insulin-like growth factor-1 (IGF-1) signaling system exerts a broad antiapoptotic function and plays a crucial role in resistance to anticancer therapies. Exposure of MCF-7 breast cancer cells to IGF-1 rapidly and transiently induced tyrosine phosphorylation and activation of phosphoinositide-dependent kinase-1 (PDK1). This was paralleled by Akt/protein kinase B and protein kinase C-zeta phosphorylation, at Thr(308) and Thr(410), respectively. IGF-1 treatment also enhanced PDK1 interaction with IGF-1 receptor (IGF-1R) in intact MCF-7 cells. Pulldown assays revealed that PDK1 bound IGF-1R in vitro and that the region encompassing amino acids 51-359 of PDK1 was necessary for the interaction. Synthetic peptides corresponding to IGF-1R C terminus amino acids 1295-1337 (C43) and to PDK1 amino acids 114-141 reduced in vitro IGF-1R/PDK1 interaction in a concentration-dependent manner. Loading of fluoresceinated-C43 (fluorescein isothiocyanate (FITC)-C43) into MCF-7 cells significantly reduced IGF-1R/PDK1 interaction and phosphorylation of PDK1 substrates. Moreover, FITC-C43 intracellular loading reverted the protective effect of IGF-1 on growth factor deprivation-induced cell death. Finally, the inhibition of IGF-1R/PDK1 interaction and signaling by FITC-C43 was accompanied by 2-fold enhanced killing capacity of cetuximab in human GEO colon adenocarcinoma cells and was sufficient to restore cell death in cetuximab-resistant cell clones. Thus, disruption of PDK1 interaction with IGF-1R reduces IGF-1 survival effects in cancer cells and may enhance cell death by anticancer agents.	[Alberobello, A. Teresa; D'Esposito, Vittoria; Esposito, Iolanda; Fiory, Francesca; Miele, Claudia; Beguinot, Francesco; Formisano, Pietro] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; [Alberobello, A. Teresa; D'Esposito, Vittoria; Esposito, Iolanda; Fiory, Francesca; Miele, Claudia; Beguinot, Francesco; Formisano, Pietro] Univ Naples Federico II, Ist Endocrinol Oncol Sperimentale, CNR, I-80131 Naples, Italy; [Marasco, Daniela] Univ Naples Federico II, Dipartimento Sci Biol, I-80131 Naples, Italy; [Doti, Nunzianna; Ruvo, Menotti] Univ Naples Federico II, Ist Biostutture & Bioimmagini, CNR, I-80131 Naples, Italy; [Bianco, Roberto; Tortora, Giampaolo] Univ Naples Federico II, Dipartimento Endocrinol & Oncol Mol & Clin, I-80131 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; University of Naples Federico II	Formisano, P (corresponding author), Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Via S Pansini 5, I-80131 Naples, Italy.	fpietro@unina.it	Tortora, Giampaolo/AAA-1252-2019; Marasco, Daniela/H-4848-2015; Doti, Nunzianna/ABC-9948-2020; Tortora, Giampaolo/HGB-6261-2022; D'Esposito, Vittoria/K-7633-2016; Formisano, Pietro/J-4237-2018	Marasco, Daniela/0000-0002-6618-2949; D'Esposito, Vittoria/0000-0002-3675-8062; Formisano, Pietro/0000-0001-7020-6870; Tortora, Giampaolo/0000-0002-1378-4962	European Community FP6 EUGENE2 [LSHM-CT-2004-512013]; FP7 PREPROBEDIA [201681]; European Federation for the Study of Diabetes; Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Universita e della Ricerca Scientifica [RBRN07BMCT]; Telethon-Italy	European Community FP6 EUGENE2(European Commission); FP7 PREPROBEDIA; European Federation for the Study of Diabetes; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); Telethon-Italy(Fondazione Telethon)	This work was supported by grants from the European Community FP6 EUGENE2 (Grant LSHM-CT-2004-512013) and the FP7 PREPROBEDIA (Grant 201681), the European Federation for the Study of Diabetes, the Associazione Italiana per la Ricerca sul Cancro, and the Ministero dell'Universita e della Ricerca Scientifica (PRIN and FIRB Grants RBRN07BMCT). The financial support of Telethon-Italy is also gratefully acknowledged.	Ahmed N, 2008, BRIT J CANCER, V98, P1415, DOI 10.1038/sj.bjc.6604306; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Barnes CJ, 2007, CLIN CANCER RES, V13, P4291, DOI 10.1158/1078-0432.CCR-06-2040; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Buck E, 2008, CANCER RES, V68, P8322, DOI 10.1158/0008-5472.CAN-07-6720; Caruso M, 1997, J BIOL CHEM, V272, P7290, DOI 10.1074/jbc.272.11.7290; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Ciardiello F, 2004, CLIN CANCER RES, V10, P784, DOI 10.1158/1078-0432.CCR-1100-03; Dunn SE, 1997, CANCER RES, V57, P2687; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fiory F, 2005, MOL CELL BIOL, V25, P10803, DOI 10.1128/MCB.25.24.10803-10814.2005; FORMISANO P, 1993, J BIOL CHEM, V268, P5241; Formisano P, 1998, J BIOL CHEM, V273, P13197, DOI 10.1074/jbc.273.21.13197; Gallego R, 2009, ENDOCR-RELAT CANCER, V16, P311, DOI 10.1677/ERC-08-0250; Grillo S, 2000, EUR J BIOCHEM, V267, P6642, DOI 10.1046/j.1432-1327.2000.01759.x; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Harris TK, 2003, IUBMB LIFE, V55, P117, DOI 10.1080/1521654031000115951; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Hongo A, 1998, CANCER RES, V58, P2477; Hu YP, 2008, CANCER RES, V68, P8004, DOI 10.1158/0008-5472.CAN-08-0280; Huang F, 2009, CANCER RES, V69, P161, DOI 10.1158/0008-5472.CAN-08-0835; Jimeno A, 2008, CANCER CHEMOTH PHARM, V61, P423, DOI 10.1007/s00280-007-0485-9; Jones HE, 2006, ENDOCR-RELAT CANCER, V13, pS45, DOI 10.1677/erc.1.01275; KATO H, 1993, J BIOL CHEM, V268, P2655; KLIP A, 1982, BIOCHIM BIOPHYS ACTA, V687, P265, DOI 10.1016/0005-2736(82)90555-7; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Kortmansky J, 2005, J CLIN ONCOL, V23, P1875, DOI 10.1200/JCO.2005.03.116; LeRoith D, 2004, CANCER CELL, V5, P201, DOI 10.1016/S1535-6108(04)00054-6; Liu YM, 1998, CANCER RES, V58, P570; Michel JJC, 2005, MOL CELL, V20, P661, DOI 10.1016/j.molcel.2005.10.013; Miller BS, 2005, CANCER RES, V65, P10123, DOI 10.1158/0008-5472.CAN-05-2752; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Ouban A, 2003, HUM PATHOL, V34, P803, DOI 10.1016/S0046-8177(03)00291-0; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Reiss K, 1999, J CELL PHYSIOL, V181, P124, DOI 10.1002/(SICI)1097-4652(199910)181:1<124::AID-JCP13>3.0.CO;2-0; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Ryan PD, 2008, ONCOLOGIST, V13, P16, DOI 10.1634/theoncologist.2007-0199; Sachdev D, 2006, CANCER RES, V66, P2391, DOI 10.1158/0008-5472.CAN-05-3126; Samani A A, 2001, Surg Oncol Clin N Am, V10, P289; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sato S, 2004, J BIOL CHEM, V279, P33759, DOI 10.1074/jbc.M402055200; SEYNAEVE CM, 1993, CANCER RES, V53, P2081; SURMACZ E, 1995, EXP CELL RES, V218, P370, DOI 10.1006/excr.1995.1168; Takahari D, 2009, ONCOLOGY-BASEL, V76, P42, DOI 10.1159/000178164; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Tortora G, 2007, DRUG RESIST UPDATE, V10, P81, DOI 10.1016/j.drup.2007.03.003; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; Wang Q, 2008, J CLIN INVEST, V118, P2389, DOI 10.1172/JCI36260; Wick MJ, 2003, J BIOL CHEM, V278, P42913, DOI 10.1074/jbc.M304172200; Wu YP, 2003, CANCER RES, V63, P4384; Xie ZH, 2003, CANCER RES, V63, P5370; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	58	19	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6563	6572		10.1074/jbc.M109.097410	http://dx.doi.org/10.1074/jbc.M109.097410			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20044479	Green Published, hybrid			2022-12-25	WOS:000275367500061
J	Kalthoff, S; Ehmer, U; Freiberg, N; Manns, MP; Strassburg, CP				Kalthoff, Sandra; Ehmer, Ursula; Freiberg, Nicole; Manns, Michael P.; Strassburg, Christian P.			Interaction between Oxidative Stress Sensor Nrf2 and Xenobiotic-activated Aryl Hydrocarbon Receptor in the Regulation of the Human Phase II Detoxifying UDP-glucuronosyltransferase 1A10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; TRANSCRIPTIONAL ACTIVATION; SUPEROXIDE-DISMUTASE; MEDIATED EXPRESSION; GENE-EXPRESSION; DEFICIENT MICE; AH RECEPTOR; HUMAN COLON; GLUCURONIDATION; PROTEINS	The defense against oxidative stress is a critical feature that prevents cellular and DNA damage. UDP-glucuronosyltransferases (UGTs) catalyze the glucuronidation of xenobiotics, mutagens, and reactive metabolites and thus act as indirect antioxidants. Aim of this study was to elucidate the regulation of UGTs expressed in the mucosa of the gastrointestinal tract by xenobiotics and the main mediator of antioxidant defense, Nrf2 (nuclear factor erythroid 2-related factor 2). Xenobiotic (XRE) and antioxidant (ARE) response elements were detected in the promoters of UGT1A8, UGT1A9, and UGT1A10. Reporter gene experiments demonstrated XRE-mediated induction by dioxin in addition to tert-butylhydroquinone (ARE)-mediated induction of UGT1A8 and UGT1A10, which are expressed in extrahepatic tissue in humans in vivo. The responsible XRE and ARE motifs were identified by mutagenesis. Small interfering RNA knockdown, electrophoretic mobility shifts, and supershifts identified a functional interaction of Nrf2 and the aryl hydrocarbon receptor (AhR). Induction of UGT1A8 and UGT1A10 requires Nrf2 and AhR. It proceeds by utilizing XRE- as well as ARE-binding motifs. In summary, we demonstrate the coordinated AhR- and Nrf2-dependent transcriptional regulation of human UGT1As. Cellular protection by glucuronidation is thus inducible by xenobiotics via AhR and by oxidative metabolites via Nrf2 linking glucuronidation to cellular protection and defense against oxidative stress.	[Kalthoff, Sandra; Ehmer, Ursula; Freiberg, Nicole; Manns, Michael P.; Strassburg, Christian P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany	Hannover Medical School	Strassburg, CP (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	strassburg.christian@mh-hannover.de			Deutsche Forschungsgemeinschaft [SFB621 C3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB621 C3.	Auten RL, 2006, AM J PHYSIOL-LUNG C, V290, pL32, DOI 10.1152/ajplung.00133.2005; BREIMER LH, 1990, MOL CARCINOGEN, V3, P188, DOI 10.1002/mc.2940030405; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Cheng ZQ, 1998, ARCH BIOCHEM BIOPHYS, V356, P301, DOI 10.1006/abbi.1998.0781; Dellinger RW, 2007, CARCINOGENESIS, V28, P2412, DOI 10.1093/carcin/bgm164; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Erichsen TJ, 2008, TOXICOL APPL PHARM, V230, P252, DOI 10.1016/j.taap.2008.02.020; Goetz ME, 2008, CANCER LETT, V266, P73, DOI 10.1016/j.canlet.2008.02.035; Gregory PA, 2004, MOL PHARMACOL, V65, P953, DOI 10.1124/mol.65.4.953; Ho YS, 2004, J BIOL CHEM, V279, P32804, DOI 10.1074/jbc.M404800200; Holtzclaw WD, 2004, ADV ENZYME REGUL, V44, P335, DOI 10.1016/j.advenzreg.2003.11.013; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Iyer LV, 2003, TOXICOL SCI, V73, P36, DOI 10.1093/toxsci/kfg066; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Koo HC, 2005, AM J PHYSIOL-LUNG C, V288, pL718, DOI 10.1152/ajplung.00456.2003; Lankisch TO, 2008, ARCH TOXICOL, V82, P573, DOI 10.1007/s00204-008-0347-1; Marini MG, 1997, J BIOL CHEM, V272, P16490, DOI 10.1074/jbc.272.26.16490; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Mojarrabi B, 1998, BIOCHEM BIOPH RES CO, V247, P704, DOI 10.1006/bbrc.1998.8843; Munzel PA, 2003, BIOCHEM PHARMACOL, V66, P841, DOI 10.1016/S0006-2952(03)00389-7; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nishiyama T, 2008, ARCH BIOCHEM BIOPHYS, V478, P75, DOI 10.1016/j.abb.2008.06.013; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; QUATTROCHI LC, 1993, MOL PHARMACOL, V43, P504; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Reddy VP, 2009, J ALZHEIMERS DIS, V16, P763, DOI 10.3233/JAD-2009-1013; Segal BH, 2007, AM J PHYSIOL-LUNG C, V292, pL760, DOI 10.1152/ajplung.00281.2006; Strassburg C, 2008, CRIT REV CL LAB SCI, V45, P485, DOI 10.1080/10408360802374624 ; Strassburg CP, 1997, CANCER RES, V57, P2979; Strassburg CP, 1998, J BIOL CHEM, V273, P8719, DOI 10.1074/jbc.273.15.8719; Vasiliou V, 1995, BIOCHEM PHARMACOL, V50, P2057, DOI 10.1016/0006-2952(95)02108-6; Venkatraman M, 2008, BIOL PHARM BULL, V31, P1639, DOI 10.1248/bpb.31.1639; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Videan EN, 2009, COMPARATIVE MED, V59, P287; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; WHITLOCK JP, 1990, ANNU REV PHARMACOL, V30, P251; Yeager RL, 2009, TOXICOL SCI, V111, P238, DOI 10.1093/toxsci/kfp115; Yu X, 2005, MUTAT RES-FUND MOL M, V591, P93, DOI 10.1016/j.mrfmmm.2005.04.017	40	87	91	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					5993	6002		10.1074/jbc.M109.075770	http://dx.doi.org/10.1074/jbc.M109.075770			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20053997	Green Published, hybrid			2022-12-25	WOS:000275367500002
J	Sugimoto, S; Yamanaka, K; Nishikori, S; Miyagi, A; Ando, T; Ogura, T				Sugimoto, Shinya; Yamanaka, Kunitoshi; Nishikori, Shingo; Miyagi, Atsushi; Ando, Toshio; Ogura, Teru			AAA(+) Chaperone ClpX Regulates Dynamics of Prokaryotic Cytoskeletal Protein FtsZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI FTSZ; ATP-DEPENDENT PROTEASES; N-TERMINAL DOMAIN; CELL-DIVISION; POLYMER DYNAMICS; GTP HYDROLYSIS; IN-VITRO; HSP104; TUBULIN; VISUALIZATION	AAA(+) chaperone ClpX has been suggested to be a modulator of prokaryotic cytoskeletal protein FtsZ, but the details of recognition and remodeling of FtsZ by ClpX are largely unknown. In this study, we have extensively investigated the nature of FtsZ polymers and mechanisms of ClpX-regulated FtsZ polymer dynamics. We found that FtsZ polymerization is inhibited by ClpX in an ATP-independent manner and that the N-terminal domain of ClpX plays a crucial role for the inhibition of FtsZ polymerization. Single molecule analysis with high speed atomic force microscopy directly revealed that FtsZ polymer is in a dynamic equilibrium between polymerization and depolymerization on a time scale of several seconds. ClpX disassembles FtsZ polymers presumably by blocking reassembly of FtsZ. Furthermore, Escherichia coli cells overproducing ClpX and N-terminal domain of ClpX show filamentous morphology with abnormal localization of FtsZ. These data together suggest that ClpX modulates FtsZ polymer dynamics in an ATP-independent fashion, which is achieved by interaction between the N-terminal domain of ClpX and FtsZ monomers or oligomers.	[Sugimoto, Shinya; Yamanaka, Kunitoshi; Nishikori, Shingo; Ogura, Teru] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto 8600811, Japan; [Miyagi, Atsushi; Ando, Toshio] Kanazawa Univ, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Miyagi, Atsushi] Osaka Univ, Inst Prot Res, Takara Bio Endowed Lab, Osaka 5650874, Japan	Kumamoto University; Kanazawa University; Osaka University	Ogura, T (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, 2-2-1 Honjo, Kumamoto 8600811, Japan.	ogura@gpo.kumamoto-u.ac.jp	ANDO, Toshio/E-7054-2015	ANDO, Toshio/0000-0001-8819-154X; Ogura, Teru/0000-0003-3784-0970; Sugimoto, Shinya/0000-0002-3114-8513	Japan Society for the Promotion of Science; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science, by the Core Research for Evolutional Science and Technology program grant from the Japan Science and Technology Agency, and by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PFLUG ARCH EUR J PHY, V456, P211, DOI 10.1007/s00424-007-0406-0; Beuria TK, 2003, J BIOL CHEM, V278, P3735, DOI 10.1074/jbc.M205760200; BRAMHILL D, 1994, P NATL ACAD SCI USA, V91, P5813, DOI 10.1073/pnas.91.13.5813; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cordell SC, 2003, P NATL ACAD SCI USA, V100, P7889, DOI 10.1073/pnas.1330742100; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Haeusser DP, 2009, J BACTERIOL, V191, P1986, DOI 10.1128/JB.01606-07; Hale CA, 2000, J BACTERIOL, V182, P5153, DOI 10.1128/JB.182.18.5153-5166.2000; Hiraga S, 1998, MOL CELL, V1, P381, DOI 10.1016/S1097-2765(00)80038-6; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Kanemori M, 1997, J BACTERIOL, V179, P7219, DOI 10.1128/jb.179.23.7219-7225.1997; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Matsushita-Ishiodori Y, 2009, GENES CELLS, V14, P925, DOI 10.1111/j.1365-2443.2009.01320.x; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Sugimoto S, 2008, MICROBIOL-SGM, V154, P1876, DOI 10.1099/mic.0.2008/017376-0; Sugimoto S, 2007, FEBS LETT, V581, P2993, DOI 10.1016/j.febslet.2007.05.055; Thibault G, 2006, P NATL ACAD SCI USA, V103, P17724, DOI 10.1073/pnas.0601505103; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; WOO KM, 1992, J BIOL CHEM, V267, P20429; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	42	39	40	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6648	6657		10.1074/jbc.M109.080739	http://dx.doi.org/10.1074/jbc.M109.080739			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20022957	Green Published, hybrid			2022-12-25	WOS:000275367500069
J	Parul, D; Palmer, G; Fabian, M				Parul, Dzmitry; Palmer, Graham; Fabian, Marian			Ligand Trapping by Cytochrome c Oxidase IMPLICATIONS FOR GATING AT THE CATALYTIC CENTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-COPPER OXIDASES; LINKED CONFORMATIONAL-CHANGE; FE(A3)-CU(B) BINUCLEAR SITE; PROTON-PUMPING MECHANISM; BOVINE HEART; CYANIDE BINDING; PARACOCCUS-DENITRIFICANS; INFRARED-SPECTROSCOPY; ESCHERICHIA-COLI; NITRIC-OXIDE	Cytochrome c oxidase is a member of the heme-copper family of oxygen reductases in which electron transfer is linked to the pumping of protons across the membrane. Neither the redox center(s) associated with proton pumping nor the pumping mechanism presumably common to all heme-copper oxidases has been established. A possible conformational coupling between the catalytic center (Fe-a3(3+)-Cu-B(2+)) and a protein site has been identified earlier from ligand binding studies, whereas a structural change initiated by azide binding to the protein has been proposed to facilitate the access of cyanide to the catalytic center of the oxidized bovine enzyme. Here we show that cytochrome oxidase pretreated with a low concentration of azide exhibits a significant increase in the apparent rate of cyanide binding relative to that of free enzyme. However, this increase in rate does not reflect a conformational change enhancing the rapid formation of a Fe-a3(3+)-CN-Cu-B(2+) complex. Instead the cyanide-induced transition of a preformed Fe-a3(3+)-N-3-Cu-B(2+) to the ternary complex of Fe-a3(3+)-N3CuB2+-CN is the most likely reason for the observed acceleration. Significantly, the slow rate of azide release from the ternary complex indicates that cyanide ligated to Cu-B blocks a channel between the catalytic site and the solvent. The results suggest that there is a pathway that originates at Cu-B and that, during catalysis, ligands present at this copper center control access to the iron of heme a(3) from the bulk medium.	[Parul, Dzmitry; Palmer, Graham; Fabian, Marian] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Rice University	Fabian, M (corresponding author), Rice Univ, Dept Biochem & Cell Biol, 6100 Main St,MS 140, Houston, TX 77005 USA.	fabian@rice.edu			National Institutes of Health [GM 084348, GM 35649, GM 080575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, R01GM084348, R01GM080575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 084348 (to M. F.), GM 35649 (to John S. Olson), and GM 080575 (to G. P.).	ALBEN JO, 1981, P NATL ACAD SCI-BIOL, V78, P234, DOI 10.1073/pnas.78.1.234; BRUDVIG GW, 1980, BIOCHEMISTRY-US, V19, P5275, DOI 10.1021/bi00564a020; Brzezinski P, 2008, J BIOENERG BIOMEMBR, V40, P521, DOI 10.1007/s10863-008-9181-7; Butler CS, 1997, BIOCHEMISTRY-US, V36, P16259, DOI 10.1021/bi971481a; DAY EP, 1993, BIOCHEMISTRY-US, V32, P7855, DOI 10.1021/bi00082a003; DYER RB, 1989, J AM CHEM SOC, V111, P7657, DOI 10.1021/ja00201a080; DYER RB, 1991, J AM CHEM SOC, V113, P6276, DOI 10.1021/ja00016a057; DYER RB, 1994, BIOCHEMISTRY-US, V33, P500, DOI 10.1021/bi00168a015; EINARSDOTTIR O, 1993, BIOCHEMISTRY-US, V32, P12013, DOI 10.1021/bi00096a011; Fabian M, 2004, J BIOL CHEM, V279, P16170, DOI 10.1074/jbc.M311834200; FANN YC, 1995, BIOCHEMISTRY-US, V34, P10245, DOI 10.1021/bi00032a019; Fei MJ, 2000, ACTA CRYSTALLOGR D, V56, P529, DOI 10.1107/S0907444900002213; Florens L, 2001, BIOCHEMISTRY-US, V40, P7491, DOI 10.1021/bi0101188; Gennis RB, 1998, BBA-BIOENERGETICS, V1365, P241, DOI 10.1016/S0005-2728(98)00075-9; HILL BC, 1994, FEBS LETT, V354, P284, DOI 10.1016/0014-5793(94)01140-0; HILL BC, 1983, BIOCHEM J, V215, P57, DOI 10.1042/bj2150057; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; Kaila VRI, 2009, BBA-BIOENERGETICS, V1787, P1205, DOI 10.1016/j.bbabio.2009.04.008; Kamiya K, 2007, J AM CHEM SOC, V129, P9663, DOI 10.1021/ja070464y; LI WB, 1993, BIOCHEMISTRY-US, V32, P1833, DOI 10.1021/bi00058a018; Michel H, 1998, P NATL ACAD SCI USA, V95, P12819, DOI 10.1073/pnas.95.22.12819; MITCHELL R, 1994, BBA-BIOENERGETICS, V1186, P19, DOI 10.1016/0005-2728(94)90130-9; Mochizuki M, 2008, BBA-BIOENERGETICS, V1777, pS69, DOI 10.1016/j.bbabio.2008.05.271; Muramoto K, 2007, P NATL ACAD SCI USA, V104, P7881, DOI 10.1073/pnas.0610031104; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Pilet E, 2004, BIOCHEMISTRY-US, V43, P14118, DOI 10.1021/bi0488808; Popovic DM, 2004, FEBS LETT, V566, P126, DOI 10.1016/j.febslet.2004.04.016; Puustinen A, 1999, P NATL ACAD SCI USA, V96, P35, DOI 10.1073/pnas.96.1.35; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; Riistama S, 1996, BBA-BIOENERGETICS, V1275, P1, DOI 10.1016/0005-2728(96)00040-0; Schmidt B, 2003, P NATL ACAD SCI USA, V100, P15539, DOI 10.1073/pnas.2633243100; Sergio PB, 2004, BBA-BIOENERGETICS, V1655, P353, DOI 10.1016/j.bbabio.2003.06.002; Sharpe MA, 2008, J BIOENERG BIOMEMBR, V40, P541, DOI 10.1007/s10863-008-9182-6; Siegbahn PEM, 2008, J PHYS CHEM A, V112, P12772, DOI 10.1021/jp801635c; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; SOULIMANE T, 1995, EUR J BIOCHEM, V227, P588, DOI 10.1111/j.1432-1033.1995.tb20429.x; STEVENS TH, 1979, P NATL ACAD SCI USA, V76, P3320, DOI 10.1073/pnas.76.7.3320; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; THOMSON AJ, 1985, J INORG BIOCHEM, V23, P187, DOI 10.1016/0162-0134(85)85025-X; TSUBAKI M, 1993, BIOCHEMISTRY-US, V32, P174, DOI 10.1021/bi00052a023; Tsubaki M, 1996, J BIOL CHEM, V271, P4017; TSUBAKI M, 1993, BIOCHEMISTRY-US, V32, P164, DOI 10.1021/bi00052a022; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Vamvouka M, 1999, J PHYS CHEM B, V103, P3030, DOI 10.1021/jp984589o; VANBUUREN KJ, 1972, BIOCHIM BIOPHYS ACTA, V256, P258, DOI 10.1016/0005-2728(72)90057-6; VYGODINA TV, 1985, BIOL MEMBRANY, V2, P861; WEVER R, 1973, BIOCHIM BIOPHYS ACTA, V325, P1, DOI 10.1016/0005-2728(73)90144-8; Wikstrom M, 2007, BBA-BIOENERGETICS, V1767, P1200, DOI 10.1016/j.bbabio.2007.06.008; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; YOSHIKAWA S, 1990, J BIOL CHEM, V265, P7945; YOSHIKAWA S, 1992, J BIOL CHEM, V267, P9757; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	54	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4536	4543		10.1074/jbc.M109.078618	http://dx.doi.org/10.1074/jbc.M109.078618			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20037139	Green Published, hybrid			2022-12-25	WOS:000275274800030
J	Cogen, AL; Yamasaki, K; Muto, J; Sanchez, KM; Alexander, LC; Tanios, J; Lai, YP; Kim, JE; Nizet, V; Gallo, RL				Cogen, Anna L.; Yamasaki, Kenshi; Muto, Jun; Sanchez, Katheryn M.; Alexander, Laura Crotty; Tanios, Jackelyn; Lai, Yuping; Kim, Judy E.; Nizet, Victor; Gallo, Richard L.			Staphylococcus epidermidis Antimicrobial delta-Toxin (Phenol-Soluble Modulin-gamma) Cooperates with Host Antimicrobial Peptides to Kill Group A Streptococcus	PLOS ONE			English	Article							INVASIVE BACTERIAL-INFECTION; HUMAN SKIN; NEUTROPHILS; PROTECTS; ANALOGS; AUREUS; LL-37	Antimicrobial peptides play an important role in host defense against pathogens. Recently, phenol-soluble modulins (PSMs) from Staphylococcus epidermidis (S. epidermidis) were shown to interact with lipid membranes, form complexes, and exert antimicrobial activity. Based on the abundance and innocuity of the cutaneous resident S. epidermidis, we hypothesized that their PSMs contribute to host defense. Here we show that S. epidermidis delta-toxin (PSM gamma) is normally present in the epidermis and sparsely in the dermis of human skin using immunohistochemistry. Synthetic delta-toxin interacted with neutrophil extracellular traps (NETs) and colocalized with cathelicidin while also inducing NET formation in human neutrophils. In antimicrobial assays against Group A Streptococcus (GAS), delta-toxin cooperated with CRAMP, hBD2, and hBD3. In whole blood, addition of delta-toxin exerted a bacteriostatic effect on GAS, and in NETs, delta-toxin increased their killing capacity against this pathogen. Coimmunoprecipitation and tryptophan spectroscopy demonstrated direct binding of delta-toxin to host antimicrobial peptides LL-37, CRAMP, hBD2, and hBD3. Finally, in a mouse wound model, GAS survival was reduced (along with Mip-2 cytokine levels) when the wounds were pretreated with delta-toxin. Thus, these data suggest that S. epidermidis-derived delta-toxin cooperates with the host-derived antimicrobial peptides in the innate immune system to reduce survival of an important human bacterial pathogen.	[Cogen, Anna L.; Yamasaki, Kenshi; Muto, Jun; Tanios, Jackelyn; Lai, Yuping; Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA; [Cogen, Anna L.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA; [Sanchez, Katheryn M.; Kim, Judy E.] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA; [Alexander, Laura Crotty; Nizet, Victor; Gallo, Richard L.] Univ Calif San Diego, Dept Pediat, Sch Med, San Diego, CA 92103 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Cogen, AL (corresponding author), Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA.	rgallo@ucsd.edu	Nizet, Victor/AAF-3190-2019; Yamasaki, Kenshi/C-8905-2018; Alexander, Laura Crotty/AIC-1001-2022; Gallo, Richard L/A-8931-2009	Yamasaki, Kenshi/0000-0002-5495-4956; Alexander, Laura Crotty/0000-0002-5091-2660; Gallo, Richard L/0000-0002-1401-7861; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health [P01HL057345, R56AI083358, R01AR45676]; VA Merit award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083358, R56AI083358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045676, R21AR067547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants P01HL057345, R56AI083358, and R01AR45676, and a VA Merit award (RLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman P, 2006, INFECT IMMUN, V74, P6982, DOI 10.1128/IAI.01043-06; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; CORGEN AL, 2009, J INVEST DERMATOL; Dhople VM, 2005, PEPTIDES, V26, P217, DOI 10.1016/j.peptides.2004.09.013; DHOPLE VM, 1993, BIOSCIENCE REP, V13, P245, DOI 10.1007/BF01123506; DHOPLE VM, 1995, PROTEIN ENG, V8, P315, DOI 10.1093/protein/8.3.315; Dorschner RA, 2003, PEDIATR RES, V53, P566, DOI 10.1203/01.PDR.0000057205.64451.B7; Ermert David, 2009, V470, P293, DOI 10.1007/978-1-59745-204-5_21; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Henzler-Wildman KA, 2004, BIOCHEMISTRY-US, V43, P8459, DOI 10.1021/bi036284s; Kai-Larsen Y, 2007, PEDIATR RES, V61, P530, DOI 10.1203/pdr.0b013e318045be83; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; Liles WC, 2001, J LEUKOCYTE BIOL, V70, P96; Luders T, 2003, APPL ENVIRON MICROB, V69, P1797, DOI 10.1128/AEM.69.3.1797-1799.2003; Mehlin C, 1999, J EXP MED, V189, P907, DOI 10.1084/jem.189.6.907; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Yan H, 2001, ANTIMICROB AGENTS CH, V45, P1558, DOI 10.1128/AAC.45.5.1558-1560.2001	26	140	146	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8557	10.1371/journal.pone.0008557	http://dx.doi.org/10.1371/journal.pone.0008557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052280	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000273338500006
J	Ishimaru, N; Nitta, T; Arakaki, R; Yamada, A; Lipp, M; Takahama, Y; Hayashi, Y				Ishimaru, Naozumi; Nitta, Takeshi; Arakaki, Rieko; Yamada, Akiko; Lipp, Martin; Takahama, Yousuke; Hayashi, Yoshio			In Situ Patrolling of Regulatory T Cells Is Essential for Protecting Autoimmune Exocrinopathy	PLOS ONE			English	Article							LYMPHOCYTE EGRESS; TREG; RECEPTORS; DISEASE; FOXP3; CCR7; INHIBITION; EXPRESSION; RETENTION; MIGRATION	Background: Migration of T cells, including regulatory T (Treg) cells, into the secondary lymph organs is critically controlled by chemokines and adhesion molecules. However, the mechanisms by which Treg cells regulate organ-specific autoimmunity via these molecules remain unclear. Although we previously reported autoimmune exocrinopathy resembling Sjogren's syndrome (SS) in the lacrimal and salivary glands from C-C chemokine receptor 7 (CCR7)-deficient mice, it is still unclear whether CCR7 signaling might specifically affect the dynamics and functions of Treg cells in vivo. We therefore investigated the cellular mechanism for suppressive function of Treg cells via CCR7 in autoimmunity using mouse models and human samples. Methods and Findings: Patrolling Treg cells were detected in the exocrine organs such as lacrimal and salivary glands from normal mice that tend to be targets for autoimmunity while the Treg cells were almost undetectable in the exocrine glands of CCR7(-/-) mice. In addition, we found the significantly increased retention of CD4(+)CD25(+)Foxp(3+) Treg cells in the lymph nodes of CCR7(-/-) mice with aging. Although Treg cell egress requires sphingosine 1-phosphate (S1P), chemotactic function to S1P of CCR7-/- Treg cells was impaired compared with that of WT Treg cells. Moreover, the in vivo suppression activity was remarkably diminished in CCR7(-/-)Treg cells in the model where Treg cells were co-transferred with CCR7(-/-) CD25(-)CD4(+) T cells into Rag2(-/-) mice. Finally, confocal analysis showed that CCR7(+)Treg cells were detectable in normal salivary glands while the number of CCR7(+)Treg cells was extremely decreased in the tissues from patients with Sjogren's syndrome. Conclusions: These results indicate that CCR7 essentially governs the patrolling functions of Treg cells by controlling the traffic to the exocrine organs for protecting autoimmunity. Characterization of this cellular mechanism could have clinical implications by supporting development of new diagnosis or treatments for the organ-specific autoimmune diseases such as Sjogren's syndrome and clarifying how the local immune system regulates autoimmunity.	[Ishimaru, Naozumi; Arakaki, Rieko; Yamada, Akiko; Hayashi, Yoshio] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan; [Nitta, Takeshi; Takahama, Yousuke] Univ Tokushima, Grad Sch, Inst Genome Res, Dept Expt Immunol, Tokushima 770, Japan; [Lipp, Martin] Max Delbruck Ctr Mol Med, Dept Mol Tumor Genet & Immunogenet, Berlin, Germany	Tokushima University; Tokushima University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Ishimaru, N (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan.	hayashi@dent.tokushima-u.ac.jp	Takahama, Yousuke/A-5863-2010; Lipp, Martin/G-2235-2010	Takahama, Yousuke/0000-0002-4992-9174; Lipp, Martin/0000-0002-0087-2672	Ministry of Education, Science, Sport, and Culture of Japan [17109016, 17689049]; Uehara Memorial Foundation; Takeda Science Foundation	Ministry of Education, Science, Sport, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by a Grant-in-Aid for Scientific Research (nos. 17109016 and 17689049) from the Ministry of Education, Science, Sport, and Culture of Japan, from the Uehara Memorial Foundation, and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SE, 2008, IMMUNOL REV, V223, P391, DOI 10.1111/j.1600-065X.2008.00634.x; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hill JA, 2007, NAT IMMUNOL, V8, P124, DOI 10.1038/ni0207-124; Huang JH, 2007, J IMMUNOL, V178, P7747, DOI 10.4049/jimmunol.178.12.7747; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Ishimaru N, 2008, J IMMUNOL, V180, P6997, DOI 10.4049/jimmunol.180.10.6997; JIN Y, 2009, INVEST OPHTHALMOL VI; Kaiser A, 2005, J IMMUNOL, V175, P2349, DOI 10.4049/jimmunol.175.4.2349; Kocks JR, 2007, J EXP MED, V204, P723, DOI 10.1084/jem.20061424; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Li XM, 2007, J RHEUMATOL, V34, P2438; Lim HW, 2006, J IMMUNOL, V177, P840, DOI 10.4049/jimmunol.177.2.840; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Makita S, 2004, J IMMUNOL, V173, P3119, DOI 10.4049/jimmunol.173.5.3119; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2003, IMMUNOL REV, V195, P160, DOI 10.1034/j.1600-065X.2003.00068.x; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sojka DK, 2009, EUR J IMMUNOL, V39, P1544, DOI 10.1002/eji.200838603; Stachowiak AN, 2006, J IMMUNOL, V177, P2340, DOI 10.4049/jimmunol.177.4.2340; Takahashi M, 2006, DIGEST DIS SCI, V51, P677, DOI 10.1007/s10620-006-3191-2; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; VANDRIEL IR, 2002, AUTOIMMUN REV, V5, P290; Wei S, 2006, BLOOD, V108, P426, DOI 10.1182/blood-2006-01-0177	49	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8588	10.1371/journal.pone.0008588	http://dx.doi.org/10.1371/journal.pone.0008588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052419	Green Published, Green Submitted, gold			2022-12-25	WOS:000273338500028
J	Palanisamy, V; Sharma, S; Deshpande, A; Zhou, H; Gimzewski, J; Wong, DT				Palanisamy, Viswanathan; Sharma, Shivani; Deshpande, Amit; Zhou, Hui; Gimzewski, James; Wong, David T.			Nanostructural and Transcriptomic Analyses of Human Saliva Derived Exosome	PLOS ONE			English	Article							MESSENGER-RNA; MULTIVESICULAR BODY; HORIZONTAL TRANSFER; CELL; PROTEINS; MICROVESICLES; VESICLES; IDENTIFICATION; ROLES; DIAGNOSTICS	Background: Exosomes, derived from endocytic membrane vesicles are thought to participate in cell-cell communication and protein and RNA delivery. They are ubiquitous in most body fluids (breast milk, saliva, blood, urine, malignant ascites, amniotic, bronchoalveolar lavage, and synovial fluids). In particular, exosomes secreted in human saliva contain proteins and nucleic acids that could be exploited for diagnostic purposes. To investigate this potential use, we isolated exosomes from human saliva and characterized their structural and transcriptome contents. Methodology: Exosomes were purified by differential ultracentrifugation and identified by immunoelectron microscopy (EM), flow cytometry, and Western blot with CD63 and Alix antibodies. We then described the morphology, shape, size distribution, and density using atomic force microscopy (AFM). Microarray analysis revealed that 509 mRNA core transcripts are relatively stable and present in the exosomes. Exosomal mRNA stability was determined by detergent lysis with RNase A treatment. In vitro, fluorescently labeled saliva exosomes could communicate with human keratinocytes, transferring their genetic information to human oral keratinocytes to alter gene expression at a new location. Conclusion: Our findings are consistent with the hypothesis that exosomes shuttle RNA between cells and that the RNAs present in the exosomes may be a possible resource for disease diagnostics.	[Palanisamy, Viswanathan] Med Univ S Carolina, Coll Dent Med, Dept Craniofacial Biol, Charleston, SC 29425 USA; [Sharma, Shivani; Zhou, Hui; Gimzewski, James; Wong, David T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Sharma, Shivani; Zhou, Hui; Gimzewski, James; Wong, David T.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90024 USA; [Deshpande, Amit] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Deshpande, Amit] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90024 USA; [Gimzewski, James] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton Satellite MANA, Tsukuba, Ibaraki, Japan; [Wong, David T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Div Head & Neck Surg Otolaryngol, Sch Med, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Henry Samuel Sch Engn & Appl Sci, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	Medical University of South Carolina; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institute for Materials Science; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Palanisamy, V (corresponding author), Med Univ S Carolina, Coll Dent Med, Dept Craniofacial Biol, Charleston, SC 29425 USA.	visu@musc.edu; dtww@ucla.edu		Palanisamy, Viswanathan/0000-0001-5128-2878; gimzewski, james/0000-0003-4333-6957	National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research (NIDCR) [R01DE017170, U01DE16275, P20RR017696, R00DE018165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017170, U01DE016275, R00DE018165] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	R01DE017170 and U01DE16275 from National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research (NIDCR) for David T. Wong, and P20RR017696 and R00DE018165 from NIH-NIDCR for Viswanathan Palanisamy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Chavez-Munoz C, 2008, J CELL BIOCHEM, V104, P2165, DOI 10.1002/jcb.21774; Defacque H, 2000, EMBO J, V19, P199, DOI 10.1093/emboj/19.2.199; Delcayre A, 2005, BLOOD CELL MOL DIS, V35, P158, DOI 10.1016/j.bcmd.2005.07.003; Delporte C, 2006, BBA-BIOMEMBRANES, V1758, P1061, DOI 10.1016/j.bbamem.2006.01.022; Denzer K, 2000, J CELL SCI, V113, P3365; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fackler OT, 2000, CURR BIOL, V10, P1005, DOI 10.1016/S0960-9822(00)00654-0; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Garcia JM, 2008, RNA, V14, P1424, DOI 10.1261/rna.755908; GONZALEZBEGNE M, 2009, J PROTEOME RES; Gruenberg Jean, 1993, Trends in Cell Biology, V3, P224, DOI 10.1016/0962-8924(93)90116-I; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hu S, 2005, PROTEOMICS, V5, P1714, DOI 10.1002/pmic.200401037; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Kapsogeorgou EK, 2005, ARTHRITIS RHEUM-US, V52, P1517, DOI 10.1002/art.21005; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Kim Y, 2004, CANCER RES, V64, P8980, DOI 10.1158/0008-5472.CAN-04-1926; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Laulagnier K, 2005, BLOOD CELL MOL DIS, V35, P116, DOI 10.1016/j.bcmd.2005.05.010; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Li Y, 2004, J DENT RES, V83, P199, DOI 10.1177/154405910408300303; McManaman JL, 2006, J MAMMARY GLAND BIOL, V11, P249, DOI 10.1007/s10911-006-9031-3; Ogawa Y, 2008, BIOL PHARM BULL, V31, P1059, DOI 10.1248/bpb.31.1059; Palanisamy V, 2008, J DENT RES, V87, P772, DOI 10.1177/154405910808700803; Park NJ, 2006, CLIN CHEM, V52, P988, DOI 10.1373/clinchem.2005.063206; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Prado N, 2008, J IMMUNOL, V181, P1519, DOI 10.4049/jimmunol.181.2.1519; Raab A, 1999, NAT BIOTECHNOL, V17, P902, DOI 10.1038/12898; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Rozmyslowicz T, 2003, AIDS, V17, P33, DOI 10.1097/00002030-200301030-00006; Runz S, 2007, GYNECOL ONCOL, V107, P563, DOI 10.1016/j.ygyno.2007.08.064; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Smalheiser NR, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-35; Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vitorino R, 2004, PROTEOMICS, V4, P1109, DOI 10.1002/pmic.200300638; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	49	224	233	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8577	10.1371/journal.pone.0008577	http://dx.doi.org/10.1371/journal.pone.0008577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052414	Green Submitted, Green Published, gold			2022-12-25	WOS:000273338500020
J	McClendon, AK; Dean, JL; Ertel, A; Knudsen, ES				McClendon, A. Kathleen; Dean, Jeffry L.; Ertel, Adam; Knudsen, Erik S.			Differential Impact of Tumor Suppressor Pathways on DNA Damage Response and Therapy-Induced Transformation in a Mouse Primary Cell Model	PLOS ONE			English	Article							LI-FRAUMENI-SYNDROME; LONG-TERM SURVIVORS; RETINOBLASTOMA SURVIVORS; P53-DEFICIENT MICE; PROSTATE-CANCER; BREAST-CANCER; CYCLE CONTROL; P53; RB; GENE	The RB and p53 tumor suppressors are mediators of DNA damage response, and compound inactivation of RB and p53 is a common occurrence in human cancers. Surprisingly, their cooperation in DNA damage signaling in relation to tumorigenesis and therapeutic response remains enigmatic. In the context of individuals with heritable retinoblastoma, there is a predilection for secondary tumor development, which has been associated with the use of radiation-therapy to treat the primary tumor. Furthermore, while germline mutations of the p53 gene are critical drivers for cancer predisposition syndromes, it is postulated that extrinsic stresses play a major role in promoting varying tumor spectrums and disease severities. In light of these studies, we examined the tumor suppressor functions of these proteins when challenged by exposure to therapeutic stress. To examine the cooperation of RB and p53 in tumorigenesis, and in response to therapy-induced DNA damage, a combination of genetic deletion and dominant negative strategies was employed. Results indicate that loss/inactivation of RB and p53 is not sufficient for cellular transformation. However, these proteins played distinct roles in response to therapy-induced DNA damage and subsequent tumorigenesis. Specifically, RB status was critical for cellular response to damage and senescence, irrespective of p53 function. Loss of RB resulted in a dramatic evolution of gene expression as a result of alterations in epigenetic programming. Critically, the observed changes in gene expression have been specifically associated with tumorigenesis, and RB-deficient, recurred cells displayed oncogenic characteristics, as well as increased resistance to subsequent challenge with discrete therapeutic agents. Taken together, these findings indicate that tumor suppressor functions of RB and p53 are particularly manifest when challenged by cellular stress. In the face of such challenge, RB is a critical suppressor of tumorigenesis beyond p53, and RB-deficiency could promote significant cellular evolution, ultimately contributing to a more aggressive disease.	[McClendon, A. Kathleen; Dean, Jeffry L.; Ertel, Adam; Knudsen, Erik S.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA	Jefferson University	McClendon, AK (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA.	eknudsen@kimmelcancercenter.org			NCI NIH HHS [R01 CA106471, CA106471] Funding Source: Medline; NIEHS NIH HHS [T32 ES07250-16, T32 ES007250] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA106471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007250] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ajioka I, 2008, CELL CYCLE, V7, P735, DOI 10.4161/cc.7.6.5612; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Bettuzzi Saverio, 2003, Acta Biomed, V74, P101; Bosco EE, 2005, NUCLEIC ACIDS RES, V33, P1581, DOI 10.1093/nar/gki283; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Burke L, 2005, CLIN CANCER RES, V11, P232; ENG C, 1993, JNCI-J NATL CANCER I, V85, P1121, DOI 10.1093/jnci/85.14.1121; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fletcher O, 2004, JNCI-J NATL CANCER I, V96, P357, DOI 10.1093/jnci/djh058; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Herceg Z, 2007, MUTAGENESIS, V22, P91, DOI 10.1093/mutage/gel068; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; Janicke RU, 2008, CELL DEATH DIFFER, V15, P959, DOI 10.1038/cdd.2008.33; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kaye FJ, 2004, J NATL CANCER I, V96, P342, DOI 10.1093/jnci/djh080; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Khan SH, 1998, CANCER RES, V58, P396; Kleinerman RA, 2005, J CLIN ONCOL, V23, P2272, DOI 10.1200/JCO.2005.05.054; KNUDSEN ES, 2008, TAILORING RB TUMOUR; Lee JL, 2004, J BIOL CHEM, V279, P14602, DOI 10.1074/jbc.M309008200; Limacher JM, 2001, INT J CANCER, V96, P238, DOI 10.1002/ijc.1021; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mammas IN, 2008, PATHOL ONCOL RES, V14, P345, DOI 10.1007/s12253-008-9056-6; Markey MP, 2007, ONCOGENE, V26, P6307, DOI 10.1038/sj.onc.1210450; Markey MP, 2002, CANCER RES, V62, P6587; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; Mayhew CN, 2007, GASTROENTEROLOGY, V133, P976, DOI 10.1053/j.gastro.2007.06.025; Mayhew Christopher N, 2004, Methods Mol Biol, V281, P3; MAYHEW CN, 2005, CANC RES IN PRESS; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Mimeault M, 2008, CLIN PHARMACOL THER, V83, P673, DOI 10.1038/sj.clpt.6100296; Miyamoto H, 1996, CANCER GENET CYTOGEN, V88, P181, DOI 10.1016/0165-4608(95)00292-8; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Raguz S, 2008, BRIT J CANCER, V99, P387, DOI 10.1038/sj.bjc.6604510; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Seoane M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003632; Sharma A, 2007, CANCER RES, V67, P6192, DOI 10.1158/0008-5472.CAN-06-4424; Sheard MA, 2003, CANCER RES, V63, P7176; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Siddiqui H, 2007, J CELL PHYSIOL, V211, P131, DOI 10.1002/jcp.20913; Srinivasan SV, 2007, J BIOL CHEM, V282, P23867, DOI 10.1074/jbc.M700542200; Stengel KR, 2008, CELL CYCLE, V7, DOI 10.4161/cc.7.8.5737; Tabori U, 2008, CANCER RES, V68, P2053, DOI 10.1158/0008-5472.CAN-07-2091; Tort F, 2006, CANCER RES, V66, P10258, DOI 10.1158/0008-5472.CAN-06-2178; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; Veeck J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-83; Vernell R, 2003, J BIOL CHEM, V278, P46124, DOI 10.1074/jbc.M304930200; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wogan GN, 2004, SEMIN CANCER BIOL, V14, P473, DOI 10.1016/j.semcancer.2004.06.010; Yoshioka N, 2000, J VIROL, V74, P1008, DOI 10.1128/JVI.74.2.1008-1013.2000; Zagorski WA, 2007, CANCER RES, V67, P8264, DOI 10.1158/0008-5472.CAN-06-4753; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486	61	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8558	10.1371/journal.pone.0008558	http://dx.doi.org/10.1371/journal.pone.0008558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049321	gold, Green Published, Green Submitted			2022-12-25	WOS:000273225000019
J	Sinha, S; Schwartz, MD; Qin, AG; Ross, JS				Sinha, Sanjai; Schwartz, Mark D.; Qin, Angie; Ross, Joseph S.			Self-Reported and Actual Beta-Blocker Prescribing for Heart Failure Patients: Physician Predictors	PLOS ONE			English	Article							MEDICATION UNDERUSE; PRIMARY-CARE; MANAGEMENT; DIAGNOSIS; OUTCOMES; ASTHMA; CARVEDILOL; GUIDELINES; MORBIDITY; MORTALITY	Background: Beta-blockers reduce mortality among patients with systolic heart failure (HF), yet primary care provider prescription rates remain low. Objective: To examine the association between primary care physician characteristics and both self-reported and actual prescription of beta-blockers among patients with systolic HF. Design: Cross-sectional survey with supplementary retrospective chart review. Participants: Primary care providers at three New York City Veterans Affairs medical centers. Measurements: Main outcomes were: 1) self-reported prescribing of beta-blockers, and 2) actual prescribing of beta-blockers among HF patients. Physician HF practice patterns and confidence levels, as well as socio-demographic and clinical characteristics, were also assessed. Results: Sixty-nine of 101 physicians (68%) completed the survey examining self-reported prescribing of beta-blockers. Physicians who served as inpatient ward attendings self-reported significantly higher rates of beta-blocker prescribing among their HF patients when compared with physicians who did not attend (78% vs. 58%; p = 0.002), as did physicians who were very confident in managing HF patients when compared with physicians who were not (82% vs. 68%; p = 0.009). Fifty-one of these 69 surveyed physicians (74%) were successfully matched to 287 HF patients for whom beta-blocker prescribing data was available. Physicians with greater self-reported rates of prescribing beta-blockers were significantly more likely to actually prescribe beta-blockers ( p = 0.02); however, no other physician characteristics were significantly associated with actual prescribing of beta-blockers among HF patients. Conclusions: Physician teaching responsibilities and confidence levels were associated with self-reported beta-blocker prescribing among their HF patients. Educational efforts focused on improving confidence levels in HF care and increasing exposure to teaching may improve beta-blocker presciption in HF patients managed in primary care.	[Sinha, Sanjai; Ross, Joseph S.] James J Peters VA Med Ctr, Dept Med, Bronx, NY USA; [Sinha, Sanjai] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Schwartz, Mark D.; Qin, Angie] VA New York Harbor Healthcare Syst, Dept Med, New York, NY USA; [Schwartz, Mark D.; Qin, Angie] NYU, Sch Med, Dept Med, New York, NY USA; [Ross, Joseph S.] Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai	Sinha, S (corresponding author), James J Peters VA Med Ctr, Dept Med, Bronx, NY USA.	Sanjai.Sinha@med.va.gov		Schwartz, Mark/0000-0002-7123-0060; Ross, Joseph/0000-0002-9218-3320	New Researcher Seed Grant, Dept. of Veterans Affairs, Veterans Integrated Service Network 3 Award; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	New Researcher Seed Grant, Dept. of Veterans Affairs, Veterans Integrated Service Network 3 Award(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding source: New Researcher Seed Grant, Dept. of Veterans Affairs, Veterans Integrated Service Network 3 Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari M, 2003, J AM COLL CARDIOL, V41, P62, DOI 10.1016/S0735-1097(02)02493-2; AYANIAN JZ, 1994, NEW ENGL J MED, V331, P1136, DOI 10.1056/NEJM199410273311707; Blanc PD, 2003, AM J MED, V114, P581, DOI 10.1016/S0002-9343(03)00053-6; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; CHARAP MH, 1985, AM J MED, V79, P461, DOI 10.1016/0002-9343(85)90033-6; Fehrenbach SN, 2001, AM J MANAG CARE, V7, P717; Fuat A, 2003, BRIT MED J, V326, P196, DOI 10.1136/bmj.326.7382.196; Gupta R, 2004, AM HEART J, V147, P79, DOI 10.1016/j.ahj.2003.07.022; Haagen EC, 2005, HUM REPROD, V20, P3301, DOI 10.1093/humrep/dei220; Hjalmarson A, 1999, LANCET, V353, P2001; Huiart L, 2005, CHEST, V128, P2640, DOI 10.1378/chest.128.4.2640; Hulsmann M, 2005, EUR J HEART FAIL, V7, P657, DOI 10.1016/j.ejheart.2004.11.011; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Kasje Willeke N, 2005, BMC Fam Pract, V6, P19, DOI 10.1186/1471-2296-6-19; Khunti K, 2002, EUR J HEART FAIL, V4, P771, DOI 10.1016/S1388-9842(02)00119-8; Lechat P, 1999, LANCET, V353, P9; Lenzen MJ, 2005, EUR HEART J, V26, P2706, DOI 10.1093/eurheartj/ehi499; Levy AR, 2002, ANN EPIDEMIOL, V12, P86, DOI 10.1016/S1047-2797(01)00251-4; Levy ML, 2008, EUR RESPIR J, V31, P229, DOI 10.1183/09031936.00157507; Lloyd-Jones D., 2009, HEART DIS STROKE STA; Maggioni AP, 2003, HEART, V89, P299, DOI 10.1136/heart.89.3.299; McKinlay JB, 2007, J GEN INTERN MED, V22, P289, DOI 10.1007/s11606-006-0075-2; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Piette JD, 2004, MED CARE, V42, P102, DOI 10.1097/01.mlr.0000108742.26446.17; Rathore SS, 2006, AM HEART J, V152, P371, DOI 10.1016/j.ahj.2005.12.002; Rutten FH, 2003, EUR J HEART FAIL, V5, P337, DOI 10.1016/S1388-9842(03)00050-3; Sinha S, 2006, J GEN INTERN MED, V21, P1306, DOI 10.1111/j.1525-1497.2006.00601.x; Tseng CW, 2008, DIABETES CARE, V31, P261, DOI 10.2337/dc07-1341; Vollmer WM, 1997, ARCH INTERN MED, V157, P1201, DOI 10.1001/archinte.157.11.1201	30	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8522	10.1371/journal.pone.0008522	http://dx.doi.org/10.1371/journal.pone.0008522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046824	Green Published, gold, Green Submitted			2022-12-25	WOS:000273180200009
J	Zhong, SF; Israel, S; Xue, H; Ebstein, RP; Chew, SH				Zhong, Songfa; Israel, Salomon; Xue, Hong; Ebstein, Richard P.; Chew, Soo Hong			Monoamine Oxidase A Gene (MAOA) Associated with Attitude Towards Longshot Risks	PLOS ONE			English	Article							PROSPECT-THEORY; FINANCIAL RISK; NEUROECONOMICS; DECISION; BEHAVIOR	Decision making often entails longshot risks involving a small chance of receiving a substantial outcome. People tend to be risk preferring ( averse) when facing longshot risks involving significant gains ( losses). This differentiation towards longshot risks underpins the markets for lottery as well as for insurance. Both lottery and insurance have emerged since ancient times and continue to play a useful role in the modern economy. In this study, we observe subjects' incentivized choices in a controlled laboratory setting, and investigate their association with a widely studied, promoter-region repeat functional polymorphism in monoamine oxidase A gene (MAOA). We find that subjects with the high activity (4-repeat) allele are characterized by a preference for the longshot lottery and also less insurance purchasing than subjects with the low activity (3-repeat) allele. This is the first result to link attitude towards longshot risks to a specific gene. It complements recent findings on the neurobiological basis of economic risk taking.	[Zhong, Songfa; Chew, Soo Hong] Hong Kong Univ Sci & Technol, Ctr Expt Business Res, Kowloon, Hong Kong, Peoples R China; [Zhong, Songfa; Chew, Soo Hong] Hong Kong Univ Sci & Technol, Dept Econ, Kowloon, Hong Kong, Peoples R China; [Israel, Salomon; Ebstein, Richard P.] Hebrew Univ Jerusalem, Scheinfeld Ctr Human Genet Social Sci, Jerusalem, Israel; [Xue, Hong] Hong Kong Univ Sci & Technol, Appl Genom Lab, Kowloon, Hong Kong, Peoples R China; [Xue, Hong] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; [Ebstein, Richard P.] Herzog Mem Hosp, Jerusalem, Israel; [Chew, Soo Hong] Natl Univ Singapore, Dept Econ, Singapore 117548, Singapore; [Chew, Soo Hong] Natl Univ Singapore, Dept Finance, Singapore 117548, Singapore	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hebrew University of Jerusalem; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hebrew University of Jerusalem; Herzog Medical Center; National University of Singapore; National University of Singapore	Zhong, SF (corresponding author), Hong Kong Univ Sci & Technol, Ctr Expt Business Res, Kowloon, Hong Kong, Peoples R China.	chew.soohong@gmail.com	Zhong, Songfa Z/I-4718-2016	Xue, Hong/0000-0002-8133-9828; Ebstein, Richard/0000-0002-3626-541X; Chew, Soo Hong/0000-0003-1245-0909; Israel, Salomon/0000-0003-3629-2466	Hong University of Science and Technology [AOE-MG/H-03/06]	Hong University of Science and Technology	Financial support is from the Hong University of Science and Technology ( grant number: AOE-MG/H-03/06; www.ust.hk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allais M, 1953, ECONOMETRICA, V21, P503, DOI 10.2307/1907921; Benjamin D., 2007, BIOSOCIAL SURVEYS, P304; BOOIJ AS, 2009, THEORY DECI IN PRESS; Bossaerts P, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P353, DOI 10.1016/B978-0-12-374176-9.00023-3; Buckholtz JW, 2008, MOL PSYCHIATR, V13, P313, DOI 10.1038/sj.mp.4002020; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Chew SH, 2005, REV ECON STUD, V72, P1009, DOI 10.1111/0034-6527.00359; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Fan J, 2003, P NATL ACAD SCI USA, V100, P7406, DOI 10.1073/pnas.0732088100; Fehr-Duda H, 2006, THEOR DECIS, V60, P283, DOI 10.1007/s11238-005-4590-0; Friedman M, 1948, J POLIT ECON, V56, P279, DOI 10.1086/256692; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Passamonti L, 2006, BIOL PSYCHIAT, V59, P334, DOI 10.1016/j.biopsych.2005.07.027; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Roe BE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006704; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Savage L.J., 1954, FDN STAT; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; SHIH JC, 1993, J PSYCHIATR NEUROSCI, V18, P25; SLOVIC P, 1974, BEHAV SCI, V19, P368, DOI 10.1002/bs.3830190603; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; WILLIAMS LV, 1997, ECON J, P150; Zak PJ, 2004, PHILOS T R SOC B, V359, P1737, DOI 10.1098/rstb.2004.1544; Zhong SF, 2009, P ROY SOC B-BIOL SCI, V276, P4181, DOI 10.1098/rspb.2009.1312; Zhong SF, 2009, TWIN RES HUM GENET, V12, P103, DOI 10.1375/twin.12.1.103	31	37	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8516	10.1371/journal.pone.0008516	http://dx.doi.org/10.1371/journal.pone.0008516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046877	Green Published, gold, Green Submitted			2022-12-25	WOS:000273180200007
J	Paauw, A; Leverstein-van Hall, MA; van Kessel, KPM; Verhoef, J; Fluit, AC				Paauw, Armand; Leverstein-van Hall, Maurine A.; van Kessel, Kok P. M.; Verhoef, Jan; Fluit, Ad C.			Yersiniabactin Reduces the Respiratory Oxidative Stress Response of Innate Immune Cells	PLOS ONE			English	Article							HIGH-PATHOGENICITY ISLAND; HYDROXYL-RADICAL PRODUCTION; SPIN-TRAPPING TECHNIQUES; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; NONRIBOSOMAL PEPTIDE; IRON CHELATORS; LIVER-ABSCESS; IRP2 GENE; ENTEROCOLITICA	Enterobacteriaceae that contain the High Pathogenicity Island (HPI), which encodes the siderophore yersiniabactin, display increased virulence. This increased virulence may be explained by the increased iron scavenging of the bacteria, which would both enhance bacterial growth and limit the availability of iron to cells of the innate immune system, which require iron to catalyze the Haber-Weiss reaction that produces hydroxyl radicals. In this study, we show that yersiniabactin increases bacterial growth when iron-saturated lactoferrin is the main iron source. This suggests that yersiniabactin provides bacteria with additional iron from saturated lactoferrin during infection. Furthermore, the production of ROS by polymorphonuclear leukocytes, monocytes, and a mouse macrophage cell line is blocked by yersiniabactin, as yersiniabactin reduces iron availability to the cells. Importantly, iron functions as a catalyst during the Haber-Weiss reaction, which generates hydroxyl radicals. While the physiologic role of the Haber-Weiss reaction in the production of hydroxyl radicals has been controversial, the siderophores yersiniabactin, aerobactin, and deferoxamine and the iron-chelator deferiprone also reduce ROS production in activated innate immune cells. This suggests that this reaction takes place under physiological conditions. Of the tested iron chelators, yersiniabactin was the most effective in reducing the ROS production in the tested innate immune cells. The likely decreased bacterial killing by innate immune cells resulting from the reduced production of hydroxyl radicals may explain why the HPI-containing Enterobacteriaceae are more virulent. This model centered on the reduced killing capacity of innate immune cells, which is indirectly caused by yersiniabactin, is in agreement with the observation that the highly pathogenic group of Yersinia is more lethal than the weakly pathogenic and the non-pathogenic group.	[Paauw, Armand; Leverstein-van Hall, Maurine A.; van Kessel, Kok P. M.; Verhoef, Jan; Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Paauw, A (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	A.Paauw@umcutrecht.nl			Microbiology Department of the University Medical Centre Utrecht	Microbiology Department of the University Medical Centre Utrecht	The study was funded by the Microbiology Department of the University Medical Centre Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBRUSO DR, 1981, J CLIN INVEST, V67, P352, DOI 10.1172/JCI110042; AUTENRIETH I, 1991, MED MICROBIOL IMMUN, V180, P135; Bach S, 2000, FEMS MICROBIOL LETT, V183, P289, DOI 10.1016/S0378-1097(00)00005-7; Bearden SW, 1997, INFECT IMMUN, V65, P1659, DOI 10.1128/IAI.65.5.1659-1668.1997; Bestebroer J, 2007, BLOOD, V109, P2936, DOI 10.1182/blood-2006-06-015461; Brem D, 2001, MICROBIOL-SGM, V147, P1115, DOI 10.1099/00221287-147-5-1115; BRITIGAN BE, 1988, J EXP MED, V168, P2367, DOI 10.1084/jem.168.6.2367; BRITIGAN BE, 1989, BIOCHEM J, V264, P447, DOI 10.1042/bj2640447; CARNIEL E, 1989, INFECT IMMUN, V57, P540, DOI 10.1128/IAI.57.2.540-545.1989; CARNIEL E, 1992, MOL MICROBIOL, V6, P379, DOI 10.1111/j.1365-2958.1992.tb01481.x; Chambers CE, 1996, BIOMETALS, V9, P157; Chauvaux S, 2007, MICROBIOL-SGM, V153, P3112, DOI 10.1099/mic.0.2007/006213-0; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CLIFFORD DP, 1982, MOL CELL BIOCHEM, V49, P143, DOI 10.1007/BF00231175; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; DEALMEIDA AMP, 1993, MICROB PATHOGENESIS, V14, P9, DOI 10.1006/mpat.1993.1002; EWALD JH, 1994, J INFECT DIS, V170, P140, DOI 10.1093/infdis/170.1.140; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FORMAN HJ, 1986, ANNU REV PHYSIOL, V48, P669; Glickstein H, 2005, BLOOD, V106, P3242, DOI 10.1182/blood-2005-02-0460; GUILVOUT I, 1993, J BACTERIOL, V175, P5488, DOI 10.1128/JB.175.17.5488-5504.1993; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hu J, 2005, WORLD J GASTROENTERO, V11, P5816, DOI 10.3748/wjg.v11.i37.5816; Koczura R, 2003, MICROB PATHOGENESIS, V35, P197, DOI 10.1016/S0882-4010(03)00125-6; KONTOGHIORGHES GJ, 1985, LANCET, V1, P817; Lamb RE, 2008, INT J CLIN PRACT, V62, P1087, DOI 10.1111/j.1742-1241.2008.01789.x; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lawlor MS, 2007, INFECT IMMUN, V75, P1463, DOI 10.1128/IAI.00372-06; Lesic B, 2002, ANTIMICROB AGENTS CH, V46, P1741, DOI 10.1128/AAC.46.6.1741-1745.2002; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; Lin TL, 2008, J BACTERIOL, V190, P515, DOI 10.1128/JB.01219-07; Maczurek A, 2008, ADV DRUG DELIVER REV, V60, P1463, DOI 10.1016/j.addr.2008.04.015; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Mokracka J, 2004, FEMS IMMUNOL MED MIC, V40, P51, DOI 10.1016/S0928-8244(03)00276-1; Neupane GP, 2009, TRANSFUSION, V49, P1762, DOI 10.1111/j.1537-2995.2009.02186.x; PAAUW A, 2009, MICROBIOL, V155, P1558; Paauw A, 2007, J CLIN MICROBIOL, V45, P1420, DOI 10.1128/JCM.02242-06; Paauw A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003018; Pelludat C, 1998, J BACTERIOL, V180, P538, DOI 10.1128/JB.180.3.538-546.1998; Perry RD, 1999, MICROBIOL-UK, V145, P1181, DOI 10.1099/13500872-145-5-1181; Pfeifer BA, 2003, APPL ENVIRON MICROB, V69, P6698, DOI 10.1128/AEM.69.11.6698-6702.2003; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Rahman Irfan, 2002, Current Drug Targets - Inflammation and Allergy, V1, P291, DOI 10.2174/1568010023344607; Rakin A, 1999, INFECT IMMUN, V67, P5265, DOI 10.1128/IAI.67.10.5265-5274.1999; RALPH P, 1977, CANCER RES, V37, P546; Roos D, 2002, SCIENCE, V296, P669, DOI 10.1126/science.1071271; Schubert S, 2002, INFECT IMMUN, V70, P5335, DOI 10.1128/IAI.70.9.5335-5337.2002; Schubert S, 1998, INFECT IMMUN, V66, P480, DOI 10.1128/IAI.66.2.480-485.1998; Schubert S, 2000, J INFECT DIS, V182, P1268, DOI 10.1086/315831; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P11766, DOI 10.1073/pnas.0601182103; Senior K, 2008, LANCET INFECT DIS, V8, P746, DOI 10.1016/S1473-3099(08)70273-1; Smiley ST, 2008, IMMUNOL REV, V225, P256, DOI 10.1111/j.1600-065X.2008.00674.x; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Suo ZC, 2001, P NATL ACAD SCI USA, V98, P99, DOI 10.1073/pnas.021537498; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Wan LL, 2008, MOL CELL, V31, P244, DOI 10.1016/j.molcel.2008.06.004; Wang GP, 2006, J VIROL METHODS, V135, P118, DOI 10.1016/j.jviromet.2006.02.008; WESTLIN WF, 1971, CLIN TOXICOL, V4, P597, DOI 10.3109/15563657108990982	59	46	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8240	10.1371/journal.pone.0008240	http://dx.doi.org/10.1371/journal.pone.0008240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041108	Green Published, gold, Green Submitted			2022-12-25	WOS:000273105200001
J	Jeffs, AR; Glover, AC; Slobbe, LJ; Wang, L; He, SJ; Hazlett, JA; Awasthi, A; Woolley, AG; Marshall, ES; Joseph, WR; Print, CG; Baguley, BC; Eccles, MR				Jeffs, Aaron R.; Glover, Amy C.; Slobbe, Lynn J.; Wang, Li; He, Shujie; Hazlett, Jody A.; Awasthi, Anshul; Woolley, Adele G.; Marshall, Elaine S.; Joseph, Wayne R.; Print, Cristin G.; Baguley, Bruce C.; Eccles, Michael R.			A Gene Expression Signature of Invasive Potential in Metastatic Melanoma Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MITF; BREAST-CANCER; MALIGNANT-MELANOMA; COLON-CANCER; SURVIVAL; MICROENVIRONMENT; PROLIFERATION; PROGRESSION; INHIBITOR; CARCINOMA	Background: We are investigating the molecular basis of melanoma by defining genomic characteristics that correlate with tumour phenotype in a novel panel of metastatic melanoma cell lines. The aim of this study is to identify new prognostic markers and therapeutic targets that might aid clinical cancer diagnosis and management. Principal Findings: Global transcript profiling identified a signature featuring decreased expression of developmental and lineage specification genes including MITF, EDNRB, DCT, and TYR, and increased expression of genes involved in interaction with the extracellular environment, such as PLAUR, VCAN, and HIF1a. Migration assays showed that the gene signature correlated with the invasive potential of the cell lines, and external validation by using publicly available data indicated that tumours with the invasive gene signature were less melanocytic and may be more aggressive. The invasion signature could be detected in both primary and metastatic tumours suggesting that gene expression conferring increased invasive potential in melanoma may occur independently of tumour stage. Conclusions: Our data supports the hypothesis that differential developmental gene expression may drive invasive potential in metastatic melanoma, and that melanoma heterogeneity may be explained by the differing capacity of melanoma cells to both withstand decreased expression of lineage specification genes and to respond to the tumour microenvironment. The invasion signature may provide new possibilities for predicting which primary tumours are more likely to metastasize, and which metastatic tumours might show a more aggressive clinical course.	[Jeffs, Aaron R.; Slobbe, Lynn J.; He, Shujie; Hazlett, Jody A.; Woolley, Adele G.; Eccles, Michael R.] Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin, New Zealand; [Glover, Amy C.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Wang, Li; Print, Cristin G.] Univ Auckland, Sch Med Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Awasthi, Anshul] Univ Otago, Natl Sch Pharm, Dunedin, New Zealand; [Marshall, Elaine S.; Joseph, Wayne R.; Baguley, Bruce C.] Univ Auckland, Res Ctr, Auckland Canc Soc, Auckland 1, New Zealand	University of Otago; University of York - UK; University of Auckland; University of Otago; University of Auckland	Jeffs, AR (corresponding author), Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin, New Zealand.	aaron.jeffs@otago.ac.nz		Print, Cristin/0000-0001-8345-7812	Health Research Council of New Zealand [04/284, 07/284]; New Zealand Lottery [AP 102395]; Otago Medical Research Foundation; Auckland Cancer Society; Hepburn Cancer Research and Mary Manning Memorial Fellowship; Health Research Council of New Zealand International Investment Opportunities Fund; University of Auckland International Doctoral Scholarship	Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Lottery; Otago Medical Research Foundation; Auckland Cancer Society; Hepburn Cancer Research and Mary Manning Memorial Fellowship; Health Research Council of New Zealand International Investment Opportunities Fund; University of Auckland International Doctoral Scholarship	This research was supported by grants from the Health Research Council of New Zealand (04/284 and 07/284; BB, ME); the New Zealand Lottery Grants Board (AP 102395; AJ); the Otago Medical Research Foundation ( AA, AJ); the Auckland Cancer Society ( BB, WJ, EM); the Hepburn Cancer Research and Mary Manning Memorial Fellowship ( WJ, EM); the Health Research Council of New Zealand International Investment Opportunities Fund (CP, LW), and a University of Auckland International Doctoral Scholarship ( LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Baguley BC, 2004, EUR J CANCER, V40, P794, DOI 10.1016/j.ejca.2003.12.019; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Bedogni B, 2005, CANCER CELL, V8, P443, DOI 10.1016/j.ccr.2005.11.005; Bishop JN, 2007, CLIN MED, V7, P283, DOI 10.7861/clinmedicine.7-3-283; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bjornland K, 1999, CANCER RES, V59, P4702; Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; DOMENZAINREYNA C, 2009, J BIOL CHEM; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Folberg R, 2006, AM J PATHOL, V169, P1376, DOI 10.2353/ajpath.2006.060223; Francken AB, 2008, ANN SURG ONCOL, V15, P1476, DOI 10.1245/s10434-007-9717-9; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; He SJ, 2005, MOL CANCER THER, V4, P996, DOI 10.1158/1535-7163.MCT-04-0252; Hocker TL, 2008, J INVEST DERMATOL, V128, P2575, DOI 10.1038/jid.2008.226; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Ivanov SV, 2008, BIOCHEM BIOPH RES CO, V370, P536, DOI 10.1016/j.bbrc.2008.03.066; Jacobs LK, 2008, ANN SURG ONCOL, V15, P1280, DOI 10.1245/s10434-008-9823-3; Lekmine F, 2007, BIOCHEM BIOPH RES CO, V354, P830, DOI 10.1016/j.bbrc.2007.01.075; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; MARSHALL ES, 1994, EUR J CANCER, V30A, P1370, DOI 10.1016/0959-8049(94)90188-0; Mendes O, 2007, CLIN EXP METASTAS, V24, P341, DOI 10.1007/s10585-007-9071-0; Nunez NP, 2006, CANCER LETT, V236, P133, DOI 10.1016/j.canlet.2005.05.009; *NZ HLTH INF SERV, 2007, CANC NEW REG DEATHS; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petermann KB, 2007, J CLIN INVEST, V117, P3922, DOI 10.1172/JCI32163; Rasband W., 2006, IMAGEJ; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ren FH, 2008, J UNIV SCI TECHNOL B, V15, P215, DOI 10.1016/S1005-8850(08)60041-9; Richardson A, 2008, NEW ZEAL MED J, V121, P18; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rofstad EK, 2002, CANCER RES, V62, P1847; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schon M, 2008, JNCI-J NATL CANCER I, V100, P862, DOI 10.1093/jnci/djn174; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Trudel D, 2008, HUM PATHOL, V39, P731, DOI 10.1016/j.humpath.2007.09.021; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wang TL, 2002, P NATL ACAD SCI USA, V99, P16156, DOI 10.1073/pnas.202610899; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Wong FH, 2009, INT J ONCOL, V34, P117, DOI 10.3892/ijo_00000135	50	63	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8461	10.1371/journal.pone.0008461	http://dx.doi.org/10.1371/journal.pone.0008461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041153	Green Published, Green Submitted, gold			2022-12-25	WOS:000273104000021
J	Das, B; Saini, D; Seshadri, M				Das, Birajalaxmi; Saini, Divyalakshmi; Seshadri, M.			Telomere Length in Human Adults and High Level Natural Background Radiation	PLOS ONE			English	Article							SOUTHWEST COAST; CHROMOSOMAL-ABERRATIONS; OXIDATIVE STRESS; HUMAN-POPULATION; SHORTER TELOMERES; PULSE PRESSURE; KERALA; AREAS; ASSOCIATION; DAMAGE	Background: Telomere length is considered as a biomarker of aging, stress, cancer. It has been associated with many chronic diseases such as hypertension and diabetes. Although, telomere shortening due to ionizing radiation has been reported in vitro, no in vivo data is available on natural background radiation and its effect on telomere length. Methodology/Principal Findings: The present investigation is an attempt to determine the telomere length among human adults residing in high level natural radiation areas (HLNRA) and the adjacent normal level radiation areas (NLNRA) of Kerala coast in Southwest India. Genomic DNA was isolated from the peripheral blood mononuclear cells of 310 individuals (HLNRA: N = 233 and NLNRA: N = 77). Telomere length was determined using real time q-PCR. Both telomere (T) and single copy gene (S) specific primers were used to calculate the relative T/S and expressed as the relative telomere length. The telomere length was determined to be 1.22+/-0.15, 1.12+/-0.15, 1.08+/-0.08, 1.12+/-0.11, respectively, among the four dose groups (<= 1.50, 1.51-3.00, 3.01-5.00 and >5.00 mGy per year), which did not show any dose response. The results suggested that the high level natural chronic radiation did not have significant effect on telomere length among young adult population living in HLNRA, which is indicative of better repair of telomeric ends. No significant difference in telomere length was observed between male and female individuals. In the present investigation, although the determination of telomere length was studied among the adults with an age group between 18 to 40 years (mean maternal age: 26.10+/-4.49), a negative correlation was observed with respect to age. However, inter-individual variation was (0.81-1.68) was clearly observed. Conclusions/Significance: In this preliminary investigation, we conclude that elevated level of natural background radiation has no significant effect on telomere length among the adult population residing in HLNRAs of Kerala coast. To our knowledge, this is the first report from HLNRAs of the world where telomere length was determined on human adults. However, more samples from each background dose group and samples from older population need to be studied to derive firm conclusions.	[Das, Birajalaxmi; Saini, Divyalakshmi; Seshadri, M.] Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Mumbai 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Das, B (corresponding author), Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Mumbai 400085, Maharashtra, India.	birajalaxmi@yahoo.co.in						Adaikalakoteswari A, 2005, DIABETIC MED, V22, P1151, DOI 10.1111/j.1464-5491.2005.01574.x; Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; [Anonymous], 2006, SIGMASTAT SOFTWARE V; Aviv A, 1997, HYPERTENSION, V29, P1067, DOI 10.1161/01.HYP.29.5.1067; Aviv A, 2002, HYPERTENSION, V40, P229, DOI 10.1161/01.HYP.0000027280.91984.1B; Aviv A., 2004, SCI AGING KNOWLEDGE, V2004, pp, DOI [10.1126/sageke.2004.51.pe43, DOI 10.1126/SAGEKE.2004.51.PE43]; Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; BHARATWAL D. S., 1958, PROC SECOND INTERNATL CONF PEACEFUL USES ATOMIC ENERGY, V23, P156; Boei JJWA, 2000, INT J RADIAT BIOL, V76, P163, DOI 10.1080/095530000138817; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cheriyan VD, 1999, RADIAT RES, V152, pS154, DOI 10.2307/3580136; COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; Das B, 2009, INT J RADIAT BIOL, V85, P272, DOI 10.1080/09553000902751462; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; GEORGE KP, 1976, SM202703325329 IAEA, V2; Grodstein F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001590; Hande MP, 1998, MUTAT RES-FUND MOL M, V404, P205, DOI 10.1016/S0027-5107(98)00115-8; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Hayata I, 2005, INT CONGR SER, V1276, P17, DOI 10.1016/j.ics.2004.11.022; Hendry JH, 2009, J RADIOL PROT, V29, pA29, DOI 10.1088/0952-4746/29/2A/S03; Hewakapuge Sudinna, 2008, Legal Medicine, V10, P236, DOI 10.1016/j.legalmed.2008.01.007; Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894; Ilmonen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002143; Jaikrishan G, 1999, RADIAT RES, V152, pS149, DOI 10.2307/3580135; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Jennings BJ, 2000, MOL GENET METAB, V71, P32, DOI 10.1006/mgme.2000.3077; Karlsson AO, 2008, FORENS SCI INT-GEN S, V1, P569, DOI 10.1016/j.fsigss.2007.10.153; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LLOYD DC, 1988, INT J RADIAT BIOL, V53, P49, DOI 10.1080/09553008814550411; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Raynaud CM, 2008, ANN ONCOL, V19, P1875, DOI 10.1093/annonc/mdn405; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Salpea KD, 2008, J MOL MED, V86, P815, DOI 10.1007/s00109-008-0347-x; Sgura A, 2007, RADIAT PROT DOSIM, V122, P176; Sharma GG, 2003, ONCOL REP, V10, P1733; Slijepcevic P, 1998, MUTAGENESIS, V13, P45; Starr JM, 2008, MECH AGEING DEV, V129, P745, DOI 10.1016/j.mad.2008.09.020; *STAT INC, 1995, STATISTICA WIND; SUNTA CM, 1993, P INT C HIGH LEV NAT; Thampi MV, 2005, INT CONGR SER, V1276, P8, DOI 10.1016/j.ics.2004.11.152; THAMPI MV, 2002, CYTOGENETIC STUDIES, P207; UNSCEAR, 2000, SOURC EFF ION RAD AN; VANDERHARST P, 2009, J AM COLL CARDIOL, V49, P1460; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2	54	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8440	10.1371/journal.pone.0008440	http://dx.doi.org/10.1371/journal.pone.0008440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037654	Green Published, gold, Green Submitted			2022-12-25	WOS:000272998100020
J	Greub, G; Kebbi-Beghdadi, C; Bertelli, C; Collyn, F; Riederer, BM; Yersin, C; Croxatto, A; Raoult, D				Greub, Gilbert; Kebbi-Beghdadi, Carole; Bertelli, Claire; Collyn, Francois; Riederer, Beat M.; Yersin, Camille; Croxatto, Antony; Raoult, Didier			High Throughput Sequencing and Proteomics to Identify Immunogenic Proteins of a New Pathogen: The Dirty Genome Approach	PLOS ONE			English	Article							HUMAN-ANTIBODY RESPONSES; REAL-TIME PCR; PARACHLAMYDIA-ACANTHAMOEBAE; CHLAMYDIA-TRACHOMATIS; ANTIGEN DISCOVERY; RNA GENES; DNA; PNEUMONIA; AGENTS; ENDOSYMBIONT	Background: With the availability of new generation sequencing technologies, bacterial genome projects have undergone a major boost. Still, chromosome completion needs a costly and time-consuming gap closure, especially when containing highly repetitive elements. However, incomplete genome data may be sufficiently informative to derive the pursued information. For emerging pathogens, i.e. newly identified pathogens, lack of release of genome data during gap closure stage is clearly medically counterproductive. Methods/Principal Findings: We thus investigated the feasibility of a dirty genome approach, i.e. the release of unfinished genome sequences to develop serological diagnostic tools. We showed that almost the whole genome sequence of the emerging pathogen Parachlamydia acanthamoebae was retrieved even with relatively short reads from Genome Sequencer 20 and Solexa. The bacterial proteome was analyzed to select immunogenic proteins, which were then expressed and used to elaborate the first steps of an ELISA. Conclusions/Significance: This work constitutes the proof of principle for a dirty genome approach, i.e. the use of unfinished genome sequences of pathogenic bacteria, coupled with proteomics to rapidly identify new immunogenic proteins useful to develop in the future specific diagnostic tests such as ELISA, immunohistochemistry and direct antigen detection. Although applied here to an emerging pathogen, this combined dirty genome sequencing/proteomic approach may be used for any pathogen for which better diagnostics are needed. These genome sequences may also be very useful to develop DNA based diagnostic tests. All these diagnostic tools will allow further evaluations of the pathogenic potential of this obligate intracellular bacterium.	[Greub, Gilbert; Kebbi-Beghdadi, Carole; Bertelli, Claire; Collyn, Francois; Yersin, Camille; Croxatto, Antony] Univ Lausanne, Univ Hosp Ctr, Inst Microbiol, CRIB, Lausanne, Switzerland; [Riederer, Beat M.] Univ Lausanne, Dept Cellular Biol & Morphol, Lausanne, Switzerland; [Riederer, Beat M.] Cery, Dept Psychiat Neurosci, Prote Unit, Prilly, Switzerland; [Raoult, Didier] Univ Aix Marseille 2, Fac Med, Unite Rickettsies, Marseille, France	University of Lausanne; University of Lausanne; UDICE-French Research Universities; Aix-Marseille Universite	Greub, G (corresponding author), Univ Lausanne, Univ Hosp Ctr, Inst Microbiol, CRIB, Lausanne, Switzerland.	gilbert.greub@chuv.ch	RAOULT, Didier/A-8434-2008; Greub, Gilbert/K-5804-2017; Bertelli, Claire/H-9609-2015	RAOULT, Didier/0000-0002-0633-5974; Greub, Gilbert/0000-0001-9529-3317; Kebbi Beghdadi, Carole/0000-0003-1158-6361; Bertelli, Claire/0000-0003-0550-8981	Swiss National Science Foundation [3200BO-116445]; Infectigen Foundation [In010]; CNRS [UPRESA 6020]; Leenards Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Infectigen Foundation; CNRS(Centre National de la Recherche Scientifique (CNRS)); Leenards Foundation	This project was mainly funded by a grant from the Swiss National Science Foundation no. 3200BO-116445. This project was also partially supported by a grant from the Infectigen Foundation (In010) and by the CNRS (UPRESA 6020). Gilbert Greub is supported by the Leenards Foundation through a career award entitled "Bourse Leenards pour la releve academique en medecine clinique a Lausanne". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Araoz R, 2006, INFECT IMMUN, V74, P175, DOI 10.1128/IAI.74.1.175-182.2006; Baud D, 2007, EMERG INFECT DIS, V13, P1239, DOI 10.3201/eid1308.070315; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Birtles RJ, 1997, LANCET, V349, P925, DOI 10.1016/S0140-6736(05)62701-8; Borel N, 2007, EMERG INFECT DIS, V13, P1904, DOI 10.3201/eid1312.070655; Casson N, 2008, J CLIN MICROBIOL, V46, P1491, DOI 10.1128/JCM.02302-07; Casson N, 2008, MICROB PATHOGENESIS, V45, P92, DOI 10.1016/j.micpath.2008.04.003; CASSON NS, 2008, P ANN M SWISS SOC IN, P17; Centeno C, 2007, CELL DEATH DIFFER, V14, P240, DOI 10.1038/sj.cdd.4401988; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Corsarol D, 2006, CLIN MICROBIOL REV, V19, P283, DOI 10.1128/CMR.19.2.283-297.2006; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Francois P, 2008, J MICROBIOL METH, V72, P296, DOI 10.1016/j.mimet.2007.12.007; Gooskens J, 2006, CLIN MICROBIOL INFEC, V12, P894, DOI 10.1111/j.1469-0691.2006.01509.x; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Greub G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-48; Greub G, 2005, CELL MICROBIOL, V7, P581, DOI 10.1111/j.1462-5822.2004.00488.x; Greub G, 2003, ANN NY ACAD SCI, V990, P311, DOI 10.1111/j.1749-6632.2003.tb07381.x; Greub G, 2003, INFECT IMMUN, V71, P5979, DOI 10.1128/IAI.71.10.5979-5985.2003; Greub G, 2003, EMERG INFECT DIS, V9, P755; Greub G, 2005, AM J MED, V118, P230, DOI 10.1016/j.amjmed.2004.12.014; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Haferkamp I, 2006, MOL MICROBIOL, V60, P1534, DOI 10.1111/j.1365-2958.2006.05193.x; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Jarvie Thomas, 2008, Biotechniques, V44, P829, DOI 10.2144/000112894; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; La Scola B, 2008, GENOME RES, V18, P742, DOI 10.1101/gr.071266.107; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marrie TJ, 2001, EMERG INFECT DIS, V7, P1026, DOI 10.3201/eid0706.010619; McKevitt M, 2003, GENOME RES, V13, P1665, DOI 10.1101/gr.288103; Naidu BR, 1998, IMMUNOL LETT, V62, P111, DOI 10.1016/S0165-2478(98)00029-7; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Pol A, 2007, NATURE, V450, P874, DOI 10.1038/nature06222; Rolain JM, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-1; Sanchez-Campillo M, 1999, ELECTROPHORESIS, V20, P2269, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2269::AID-ELPS2269>3.0.CO;2-D; Senn L, 2008, CLIN INFECT DIS, V46, P1931, DOI 10.1086/588562; Sharma J, 2006, INFECT IMMUN, V74, P1490, DOI 10.1128/IAI.74.3.1490-1499.2006; Sharma J, 2004, INFECT IMMUN, V72, P7164, DOI 10.1128/IAI.72.12.7164-7171.2004; Srivastava N, 2000, HYBRIDOMA, V19, P23, DOI 10.1089/027245700315761; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016	46	55	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8423	10.1371/journal.pone.0008423	http://dx.doi.org/10.1371/journal.pone.0008423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037647	Green Published, Green Submitted, gold			2022-12-25	WOS:000272998100011
J	Steiner, T; Jin, YC; Sendhoff, B				Steiner, Till; Jin, Yaochu; Sendhoff, Bernhard			Vector Field Embryogeny	PLOS ONE			English	Article							HETEROCHRONY; FEEDBACK	We present a novel approach toward evolving artificial embryogenies, which omits the graph representation of gene regulatory networks and directly shapes the dynamics of a system, i.e., its phase space. We show the feasibility of the approach by evolving cellular differentiation, a basic feature of both biological and artificial development. We demonstrate how a spatial hierarchy formulation can be integrated into the framework and investigate the evolution of a hierarchical system. Finally, we show how the framework allows the investigation of allometry, a biological phenomenon, and its role for evolution. We find that direct evolution of allometric change, i.e., the evolutionary adaptation of the speed of system states on transient trajectories in phase space, is advantageous for a cellular differentiation task.	[Steiner, Till; Jin, Yaochu; Sendhoff, Bernhard] Honda Res Inst Europe GmbH, Offenbach, Germany	Honda Motor Company	Steiner, T (corresponding author), Honda Res Inst Europe GmbH, Offenbach, Germany.	till.steiner@honda-ri.de	Jin, Yaochu/GRY-7004-2022; Sendhoff, Bernhard/AAW-6486-2020; Jin, Yaochu/B-3776-2012	Jin, Yaochu/0000-0003-1100-0631; Sendhoff, Bernhard/0000-0002-1233-9584; Jin, Yaochu/0000-0003-1100-0631				Alon U., 2006, INTRO SYSTEMS BIOL D; Arnold DV, 2002, IEEE T EVOLUT COMPUT, V6, P30, DOI [10.1109/4235.985690, 10.1023/A:1015059928466]; Bentley P, 1999, GECCO-99: PROCEEDINGS OF THE GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P35; Bongard JC, 2003, MORPHO-FUNCTIONAL MACHINES: THE NEW SPECIES, P237; Chen G., 2007, IEEE T VISUALIZATION, V13, P1077; Chu D, 2007, IEEE C EVOL COMPUTAT, P875, DOI 10.1109/CEC.2007.4424562; Crombach A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000112; CUSSATBLANC S, 2008, P ALIFE, V11, P134; DOURSAT R, 2008, P ALIFE, V11, P181; DOURSAT R, 2009, GECCO 09, P683; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eggenberger P, 1997, FROM ANIM ANIMAT, P205; Federici D, 2006, ARTIF LIFE, V12, P381, DOI 10.1162/artl.2006.12.3.381; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gayon J, 2000, AM ZOOL, V40, P748, DOI 10.1668/0003-1569(2000)040[0748:HOTCOA]2.0.CO;2; GEARD N, 2006, P ALIFE, V11, P56; Gilbert S.F., 2003, DEV BIOL, V7th Edn; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A, 2001, CHAOS, V11, P247, DOI 10.1063/1.1345727; Gould SJ, 2000, EVOL DEV, V2, P241, DOI 10.1046/j.1525-142x.2000.00067.x; Haddow PC, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P1013; Haken H, 1988, INFORM SELF ORG; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Harding S., 2008, ORGANIC COMPUTING, P201; Huang JF, 2006, LIVER INT, V26, P54; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Jeffery JE, 2002, EVOL DEV, V4, P292, DOI 10.1046/j.1525-142X.2002.02018.x; Jin YC, 2009, IEEE SYMP ART LIFE, P61, DOI 10.1109/ALIFE.2009.4937695; Khalil H.K., 2002, NONLINEAR SYSTEMS 3; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; KOCH AJ, 1994, REV MOD PHYS, V66, P1481, DOI 10.1103/RevModPhys.66.1481; Kowaliw T, 2004, LECT NOTES COMPUT SC, V3102, P93; Leloup JC, 1999, J THEOR BIOL, V198, P445, DOI 10.1006/jtbi.1999.0924; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Miller JF, 2003, LECT NOTES ARTIF INT, V2801, P256; Nicolis G., 1995, INTRO NONLINEAR SCI; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Praun E, 2001, COMP GRAPH, P581, DOI 10.1145/383259.383328; Roggen D, 2007, GENET PROGRAM EVOL M, V8, P61, DOI 10.1007/s10710-006-9019-1; Schwefel H. -P., 1995, EVOLUTION OPTIMUM SE; Stanley K. O., 2004, EFFICIENT EVOLUTION; Stanley KO, 2007, GENET PROGRAM EVOL M, V8, P131, DOI 10.1007/s10710-007-9028-8; Stanley KO, 2003, ARTIF LIFE, V9, P93, DOI 10.1162/106454603322221487; Steiner T, 2007, IEEE C EVOL COMPUTAT, P867, DOI 10.1109/CEC.2007.4424561; STEINER T, 2008, P 10 ANN C GEN EV CO, P851, DOI DOI 10.1145/1389095.1389260; STEINER T, 2006, P ALIFE, V10, P70; Steiner T, 2009, IEEE C EVOL COMPUTAT, P2225, DOI 10.1109/CEC.2009.4983217; Tufte G, 2006, AHS 2006: FIRST NASA/ESA CONFERENCE ON ADAPTIVE HARDWARE AND SYSTEMS, PROCEEDINGS, P137; WOLPERT L, 1983, DEV EVOLUTION, P47; Yogev O, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P1064; Zhang E, 2006, ACM T GRAPHIC, V25, P1294, DOI 10.1145/1183287.1183290	51	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8177	10.1371/journal.pone.0008177	http://dx.doi.org/10.1371/journal.pone.0008177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020063	gold, Green Published			2022-12-25	WOS:000272834200002
J	Briguori, C; Testa, U; Riccioni, R; Colombo, A; Petrucci, E; Condorelli, G; Mariani, G; D'Andrea, D; De Micco, F; Rivera, NV; Puca, AA; Peschle, C; Condorelli, G				Briguori, Carlo; Testa, Ugo; Riccioni, Roberta; Colombo, Antonio; Petrucci, Eleonora; Condorelli, Gerolama; Mariani, Gualtiero; D'Andrea, Davide; De Micco, Francesca; Rivera, Natalia V.; Puca, Annibale Alessandro; Peschle, Cesare; Condorelli, Gianluigi			Correlations between progression of coronary artery disease and circulating endothelial progenitor cells	FASEB JOURNAL			English	Article						endothelium; prognosis	PERIPHERAL-BLOOD; CD34(+) CELLS; EXPRESSION; EVENTS; NUMBER; ATHEROSCLEROSIS; ANGIOGENESIS; MODERATE; THERAPY	The pathophysiology of coronary artery disease (CAD) progression is not well understood. Endothelial progenitor cells (EPCs) may have an important role. In the present observational cohort study we assessed the number of circulating EPCs in 136 patients undergoing elective percutaneous coronary intervention and who had at least one major epicardial vessel with a nonsignificant stenosis [<50% diameter stenosis (DS)], and the relationship between plasma EPC levels and the 24-mo progression of the nonsignificant coronary artery lesion. The following cell populations were analyzed: CD34(+), CD133(+), CD34(+)/KDR+, CD34(+)/VE cadherin(+), and endothelial cell colony-forming units (CFU-ECs). Progression was defined as a >15% DS increase of the objective vessel at follow-up. At 24 mo, 57 patients (42%) experienced significant progression. Independent predictors of disease progression were LDL cholesterol > 100 mg/dl (OR=1.03; 95% CI 1.01-1.04; P=0.001), low plasma levels of CFU-ECs (OR=3.99; 95% CI 1.54-10.37; P=0.005), and male sex (OR=3.42; 95% CI 1.15-10.22; P=0.027). Circulating levels of EPCs are significantly lower in patients with angiographic CAD progression.-Briguori, C., Testa, U., Riccioni, R., Colombo, A., Petrucci, E., Condorelli, G., Mariani, G., D'Andrea, D., De Micco, F., Rivera, N. V., Puca, A. A., Peschle, C., Condorelli, G. Correlations between progression of coronary artery disease and circulating endothelial progenitor cells, FASEB J. 24, 1981-1988 (2010). www.fasebj.org	[Briguori, Carlo; D'Andrea, Davide; De Micco, Francesca] Clin Mediterranea, Lab Intervent Cardiol, I-80121 Naples, Italy; [Briguori, Carlo; D'Andrea, Davide; De Micco, Francesca] Clin Mediterranea, Dept Cardiol, I-80121 Naples, Italy; [Briguori, Carlo; Colombo, Antonio] Vita & Salute Univ, Hosp San Raffaele, Lab Intervent Cardiol, Sch Med, Milan, Italy; [Testa, Ugo; Riccioni, Roberta; Petrucci, Eleonora; Mariani, Gualtiero] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Condorelli, Gerolama] Univ Naples Federico II, Dept Biol Cellular & Mol Pathol, Naples, Italy; [Rivera, Natalia V.; Puca, Annibale Alessandro; Peschle, Cesare; Condorelli, Gianluigi] Ist Ricovero &Cura Carattere Sci Multimed, Milan, Italy; [Rivera, Natalia V.; Puca, Annibale Alessandro; Condorelli, Gianluigi] CNR, Inst Biomed Technol, Milan, Italy	Mediterranean Clinic; Mediterranean Clinic; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Istituto Superiore di Sanita (ISS); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Briguori, C (corresponding author), Clin Mediterranea, Lab Intervent Cardiol, Via Orazio 2, I-80121 Naples, Italy.	carlobriguori@clinicamediterranea.it	Rivera, Natalia/S-4231-2016; Colombo, Antonio/N-2960-2015; Testa, Ugo/J-6472-2016; PETRUCCI, ELEONORA/J-8778-2016; Puca, Annibale Alessandro/K-2099-2018; riccioni, roberta/AAC-5636-2021; Condorelli, Gerolama/AAC-3472-2022; Condorelli, Gianluigi/Q-6736-2017	Rivera, Natalia/0000-0002-1298-1243; Colombo, Antonio/0000-0002-2940-2455; Testa, Ugo/0000-0001-7900-8942; PETRUCCI, ELEONORA/0000-0001-6459-490X; riccioni, roberta/0000-0002-5766-7717; Condorelli, Gerolama/0000-0003-0177-8829; Condorelli, Gianluigi/0000-0003-0481-6843	Italian Ministry of University and Research (FIRB); Ministry of Health	Italian Ministry of University and Research (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ministry of Health	This work is funded by grants from the Italian Ministry of University and Research (FIRB) and the Ministry of Health.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Azen SP, 1996, CIRCULATION, V93, P34, DOI 10.1161/01.CIR.93.1.34; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; CONDORELLI G, 1995, BLOOD, V86, P164, DOI 10.1182/blood.V86.1.164.bloodjournal861164; Eizawa T, 2004, HEART, V90, P685, DOI 10.1136/hrt.2002.008144; Fadini GP, 2007, EXP HEMATOL, V35, P1479, DOI 10.1016/j.exphem.2007.07.013; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE; Gehling UM, 2000, BLOOD, V95, P3106; George J, 2004, EUR HEART J, V25, P1003, DOI 10.1016/j.ehj.2004.03.026; Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6; Gulati R, 2003, CIRC RES, V93, P1023, DOI 10.1161/01.RES.0000105569.77539.21; Guven H, 2006, J AM COLL CARDIOL, V48, P1579, DOI 10.1016/j.jacc.2006.04.101; Hill JM, 2005, J AM COLL CARDIOL, V46, P1643, DOI 10.1016/j.jacc.2005.01.067; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Ito H, 1999, CANCER RES, V59, P5875; Lambiase PD, 2004, CIRCULATION, V109, P2986, DOI 10.1161/01.CIR.0000130639.97284.EC; LICHTLEN PR, 1992, CIRCULATION, V86, P828, DOI 10.1161/01.CIR.86.3.828; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Nowak G, 2004, CIRCULATION, V110, P3699, DOI 10.1161/01.CIR.0000143626.16576.51; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; REIBER JHC, 1989, EUR HEART J, V10, P54, DOI 10.1093/eurheartj/10.suppl_F.54; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sandri M, 2005, CIRCULATION, V111, P3391, DOI 10.1161/CIRCULATIONAHA.104.527135; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; SCHOENFELD DA, 1982, BIOMETRICS, V38, P163, DOI 10.2307/2530299; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; WATERS D, 1993, CIRCULATION, V87, P1067, DOI 10.1161/01.CIR.87.4.1067; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yokoya K, 1999, CIRCULATION, V100, P903, DOI 10.1161/01.CIR.100.9.903	42	73	80	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1981	1988		10.1096/fj.09-138198	http://dx.doi.org/10.1096/fj.09-138198			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20056714				2022-12-25	WOS:000278200000032
J	Kiesler, P; Haynes, PA; Shi, LF; Kao, PN; Wysocki, VH; Vercelli, D				Kiesler, Patricia; Haynes, Paul A.; Shi, Lingfang; Kao, Peter N.; Wysocki, Vicki H.; Vercelli, Donata			NF45 and NF90 Regulate HS4-dependent Interleukin-13 Transcription in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; RANGE INTRACHROMOSOMAL INTERACTIONS; LOCUS-CONTROL REGION; GENE-EXPRESSION; CYTOKINE GENES; MESSENGER-RNA; SUBSEQUENT DEVELOPMENT; HYPERSENSITIVE SITE; STATISTICAL-MODEL; PROMOTER ANALYSIS	Expression of the cytokine interleukin-13 (IL13) is critical for Th2 immune responses and Th2-mediated allergic diseases. Activation of human IL13 expression involves chromatin remodeling and formation of multiple DNase I-hypersensitive sites throughout the locus. Among these, HS4 is detected in the distal IL13 promoter in both naive and polarized CD4(+) T cells. We show herein that HS4 acts as a position-independent, orientation-dependent positive regulator of IL13 proximal promoter activity in transiently transfected, activated human CD4(+) Jurkat T cells and primary murine Th2 cells. The 3'-half of HS4 (HS4-3') was responsible for IL13 up-regulation and bound nuclear factor (NF) 90 and NF45, as demonstrated by DNA affinity chromatography coupled with tandem mass spectrometry, chromatin immunoprecipitation, and gel shift analysis. Notably, the CTGTT NF45/NF90-binding motif within HS4-3' was critical for HS4-dependent upregulation of IL13 expression. Moreover, transfection of HS4-IL13 reporter vectors into primary, in vitro differentiated Th2 cells from wild-type, NF45(+/-), or NF90(+/-) mice showed that HS4 activity was exquisitely dependent on the levels of endogenous NF45 (and to a lesser degree NF90), because HS4-dependent IL13 expression was virtually abrogated in NF45(+/-) cells and reduced in NF90(+/-) cells. Collectively, our results identify NF45 and NF90 as novel regulators of HS4-dependent human IL13 transcription in response to T cell activation.	Univ Arizona, Funct Genom Lab, Arizona Resp Ctr, Tucson, AZ 85719 USA; [Haynes, Paul A.] Univ Arizona, Dept Biochem, Tucson, AZ 85719 USA; [Wysocki, Vicki H.] Univ Arizona, Dept Chem, Tucson, AZ 85719 USA; [Vercelli, Donata] Univ Arizona, Dept Cell Biol, Tucson, AZ 85719 USA; Univ Arizona, Arizona Ctr Biol Complex Dis, Tucson, AZ 85719 USA; [Vercelli, Donata] Univ Arizona, Inst Bio5, Tucson, AZ 85719 USA; [Shi, Lingfang; Kao, Peter N.] Stanford Univ, Med Ctr, Dept Pulm & Crit Care Med, Stanford, CA 94305 USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; Stanford University	Vercelli, D (corresponding author), 1657 E Helen St,Rm 339,Thomas W Keating Biores Bl, Tucson, AZ 85719 USA.	donata@arc.arizona.edu		Haynes, Paul/0000-0003-1472-8249; Wysocki, Vicki/0000-0003-0495-2538	NHLBI [HL66391]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL66391 (to D. V.) from NHLBI.	Andon NL, 2002, PROTEOMICS, V2, P1156, DOI 10.1002/1615-9861(200209)2:9<1156::AID-PROT1156>3.0.CO;2-4; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Boyes J, 1996, EMBO J, V15, P2496, DOI 10.1002/j.1460-2075.1996.tb00607.x; Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Casolaro V, 2008, J ALLERGY CLIN IMMUN, V121, P853, DOI 10.1016/j.jaci.2007.12.1166; Cooper B, 2003, J AM SOC MASS SPECTR, V14, P736, DOI 10.1016/S1044-0305(03)00125-9; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dolganov G, 1996, BLOOD, V87, P3316, DOI 10.1182/blood.V87.8.3316.bloodjournal8783316; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Ghaffar O, 1997, AM J RESP CELL MOL, V17, P17, DOI 10.1165/ajrcmb.17.1.2696; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; KAO PN, 1994, J BIOL CHEM, V269, P20691; Keen JC, 2006, IMMUNOLOGY, V117, P29, DOI 10.1111/j.1365-2567.2005.02260.x; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khaled WT, 2007, DEVELOPMENT, V134, P2739, DOI 10.1242/dev.003194; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lange J, 2003, CLIN EXP ALLERGY, V33, P1537, DOI 10.1046/j.1365-2222.2003.01789.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavenu-Bombled C, 2002, J BIOL CHEM, V277, P18313, DOI 10.1074/jbc.M110013200; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Neaville WA, 2003, J ALLERGY CLIN IMMUN, V112, P740, DOI 10.1016/S0091-6749(03)01868-2; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Novac O, 2001, MOL BIOL CELL, V12, P3386, DOI 10.1091/mbc.12.11.3386; Ohshima Y, 2002, PEDIATR RES, V51, P195, DOI 10.1203/00006450-200202000-00012; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Ribeiro-do-Couto LM, 2001, EUR J IMMUNOL, V31, P3394, DOI 10.1002/1521-4141(200111)31:11<3394::AID-IMMU3394>3.0.CO;2-B; Santangelo S, 2002, J IMMUNOL, V169, P1893, DOI 10.4049/jimmunol.169.4.1893; Shi LF, 2007, J EXP MED, V204, P971, DOI 10.1084/jem.20052078; Shi LF, 2007, NUCLEIC ACIDS RES, V35, P2302, DOI 10.1093/nar/gkm117; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Strempel JM, 2007, J BIOL CHEM, V282, P3738, DOI 10.1074/jbc.M606615200; Tao WA, 2005, NAT METHODS, V2, P591, DOI 10.1038/NMETH776; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Webster RB, 2007, J BIOL CHEM, V282, P700, DOI 10.1074/jbc.M609501200; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhao GH, 2005, EXP CELL RES, V305, P312, DOI 10.1016/j.yexcr.2004.12.030	53	48	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8256	8267		10.1074/jbc.M109.041004	http://dx.doi.org/10.1074/jbc.M109.041004			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20051514	Green Published, hybrid			2022-12-25	WOS:000275413800044
J	Loeb, V; Yakunin, E; Saada, A; Sharon, R				Loeb, Virginie; Yakunin, Eugenia; Saada, Ann; Sharon, Ronit			The Transgenic Overexpression of alpha-Synuclein and Not Its Related Pathology Associates with Complex I Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; FATTY-ACIDS; CELL-DEATH; NEURODEGENERATIVE DISEASES; MITOCHONDRIAL LOCALIZATION; DOPAMINERGIC-NEURONS; RESPIRATORY-CHAIN; OXIDATIVE STRESS; PROTEIN DJ-1; MICE	alpha-Synuclein (alpha S) is a protein involved in the cytopathology and genetics of Parkinson disease and is thought to affect mitochondrial complex I activity. Previous studies have shown that mitochondrial toxins and specifically inhibitors of complex I activity enhance alpha S pathogenesis. Here we show that alpha S overexpression specifically inhibits complex I activity in dopaminergic cells and in A53T alpha S transgenic mouse brains. Importantly, our results indicate that the inhibitory effect on complex I activity is not associated with alpha S-related pathology. Specifically, complex I activity measured in purified mitochondria from A53T alpha S transgenic mouse brains was not affected by mouse age; Parkinson disease-like symptoms; levels of alpha S soluble oligomers; levels of insoluble, lipid-associated alpha S; or alpha S intraneuronal depositions in vivo. Likewise, no correlation was found between complex I activity and polyunsaturated fatty acid-induced alpha S depositions in Lewy body-like inclusions in cultured dopaminergic cells. We further show that the effect of alpha S on complex I activity is not due to altered mitochondrial protein levels or affected complex I assembly. Based on the results herein, we suggest that alpha S expression negatively regulates complex I activity as part of its normal, physiological role.	Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Inst Med Res, IL-91120 Jerusalem, Israel; [Saada, Ann] Hadassah Hebrew Univ, Hadassah Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center		ronitsh@ekmd.huji.ac.il	Saada, Ann/J-6864-2017	Saada, Ann/0000-0003-2951-0656	National Institutes of Health [R01 NS051318]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS051318.	Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Beach TG, 2008, ACTA NEUROPATHOL, V116, P277, DOI 10.1007/s00401-008-0409-8; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hirsch EC, 1999, MOVEMENT DISORD, V14, P383, DOI 10.1002/1531-8257(199903)14:2<383::AID-MDS1037>3.0.CO;2-F; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; LANGSTON JW, 1983, NEW ENGL J MED, V309, P310; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Manning-Bog AB, 2003, J NEUROSCI, V23, P3095; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Meuer K, 2007, CELL DEATH DIFFER, V14, P651, DOI 10.1038/sj.cdd.4402087; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nair VD, 2006, J BIOL CHEM, V281, P39550, DOI 10.1074/jbc.M603950200; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Norris EH, 2007, AM J PATHOL, V170, P658, DOI 10.2353/ajpath.2007.060359; Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; RAGAN CI, 1987, SUBFRACTIONATION MIT, P80; Saada A, 2004, ANAL BIOCHEM, V335, P66, DOI 10.1016/j.ab.2004.08.015; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; SCHAPIRA AH, 1989, LANCET, V333, P1269, DOI DOI 10.1016/S0140-6736(89)92366-0; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tatton WG, 2003, ANN NEUROL, V53, pS61, DOI 10.1002/ana.10489; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhang L, 2008, BRAIN RES, V1244, P40, DOI 10.1016/j.brainres.2008.08.067	68	89	89	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7334	7343		10.1074/jbc.M109.061051	http://dx.doi.org/10.1074/jbc.M109.061051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20053987	Green Published, hybrid			2022-12-25	WOS:000275415600045
J	Samovski, D; Kalderon, B; Yehuda-Shnaidman, E; Bar-Tana, J				Samovski, Dmitri; Kalderon, Bella; Yehuda-Shnaidman, Einav; Bar-Tana, Jacob			Gating of the Mitochondrial Permeability Transition Pore by Long Chain Fatty Acyl Analogs in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BETA,BETA-METHYL-SUBSTITUTED HEXADECANEDIOIC ACID; PANCREATIC BETA-CELLS; PERFUSED-RAT-LIVER; PROTEIN-KINASE-C; ADENYLYL-CYCLASE; THYROID-HORMONE; SERINE PHOSPHORYLATION; PROTONOPHORIC ACTIVITY; PHOSPHATE POTENTIALS	The role played by long chain fatty acids (LCFA) in promoting energy expenditure is confounded by their dual function as substrates for oxidation and as putative classic uncouplers of mitochondrial oxidative phosphorylation. LCFA analogs of the MEDICA (MEthyl-substituted DICarboxylic Acids) series are neither esterified into lipids nor beta-oxidized and may thus simulate the uncoupling activity of natural LCFA in vivo, independently of their substrate role. Treatment of rats or cell lines with MEDICA analogs results in low conductance gating of the mitochondrial permeability transition pore (PTP), with 10-40% decrease in the inner mitochondrial membrane potential. PTP gating by MEDICA analogs is accounted for by inhibition of Raf1 expression and kinase activity, resulting in suppression of the MAPK/RSK1 and the adenylate cyclase/PKA transduction pathways. Suppression of RSK1 and PKA results in a decrease in phosphorylation of their respective downstream targets, Bad(Ser-112) and Bad(Ser-155). Decrease in Bad(Ser-112, Ser-155) phosphorylation results in increased binding of Bad to mitochondrial Bcl2 with concomitant displacement of Bax, followed by PTP gating induced by free mitochondrial Bax. Low conductance PTP gating by LCFA/MEDICA may account for their thyromimetic calorigenic activity in vivo.	[Samovski, Dmitri; Kalderon, Bella; Yehuda-Shnaidman, Einav; Bar-Tana, Jacob] Hebrew Univ Jerusalem, Sch Med, Dept Human Nutr & Metab, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Bar-Tana, J (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Human Nutr & Metab, IL-91120 Jerusalem, Israel.	bartanaj@cc.huji.ac.il	Samovski, Dmitri/AAQ-2014-2020; Samovski, Dmitri/K-3705-2019	Samovski, Dmitri/0000-0002-6860-6688; 	Israeli Science Foundation	Israeli Science Foundation(Israel Science Foundation)	This work was supported by the Israeli Science Foundation.	Alejandro EU, 2008, J BIOL CHEM, V283, P2407, DOI 10.1074/jbc.M703612200; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; BARTANA J, 1989, J MED CHEM, V32, P2072, DOI 10.1021/jm00129a010; Beazely MA, 2005, MOL PHARMACOL, V67, P250, DOI 10.1124/mol.104.001370; Beazely MA, 2006, EUR J PHARMACOL, V535, P1, DOI 10.1016/j.ejphar.2006.01.054; Bernardi P, 2002, VITAM HORM, V65, P97, DOI 10.1016/S0083-6729(02)65061-7; Bobyleva V, 1998, FEBS LETT, V430, P409, DOI 10.1016/S0014-5793(98)00700-5; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brustovetsky N, 2000, J NEUROSCI, V20, P103, DOI 10.1523/JNEUROSCI.20-01-00103.2000; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Choi SE, 2008, ARCH BIOCHEM BIOPHYS, V475, P109, DOI 10.1016/j.abb.2008.04.015; Cnop M, 2008, BIOCHEM SOC T, V36, P909, DOI 10.1042/BST0360909; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Ding QM, 2004, MOL PHARMACOL, V66, P921, DOI 10.1124/mol.66.4.921; Feldman RD, 2007, LIFE SCI, V81, P267, DOI 10.1016/j.lfs.2007.05.015; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; GARFIN DE, 1990, METHOD ENZYMOL, V182, P425; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; HARPER ME, 1993, J BIOL CHEM, V268, P14850; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; Hermesh O, 2000, BBA-BIOENERGETICS, V1457, P166, DOI 10.1016/S0005-2728(00)00097-9; Hermesh O, 1998, J BIOL CHEM, V273, P3937, DOI 10.1074/jbc.273.7.3937; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; KALDERON B, 1992, ENDOCRINOLOGY, V131, P400, DOI 10.1210/en.131.1.400; KALDERON B, 1992, ENDOCRINOLOGY, V131, P1629, DOI 10.1210/en.131.4.1629; Kalderon B, 2002, J LIPID RES, V43, P1125, DOI 10.1194/jlr.M200060-JLR200; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; KINGSLEYHICKMAN PB, 1990, J BIOL CHEM, V265, P1545; Koshkin V, 2008, J BIOL CHEM, V283, P7936, DOI 10.1074/jbc.M705652200; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Mayorek N, 1997, DIABETES, V46, P1958, DOI 10.2337/diabetes.46.12.1958; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Novgorodov SA, 1996, J BIOENERG BIOMEMBR, V28, P139, DOI 10.1007/BF02110644; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Osawa Y, 2007, AM J PHYSIOL-LUNG C, V292, pL1414, DOI 10.1152/ajplung.00123.2006; Russell JC, 1998, DIABETES, V47, P770, DOI 10.2337/diabetes.47.5.770; SCHOLZ R, 1984, EUR J BIOCHEM, V141, P223, DOI 10.1111/j.1432-1033.1984.tb08179.x; SCHONFELD P, 1988, BIOCHIM BIOPHYS ACTA, V936, P280, DOI 10.1016/0005-2728(88)90003-5; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Shabalina IG, 2008, BBA-BIOENERGETICS, V1777, P642, DOI 10.1016/j.bbabio.2008.04.038; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; SOBOLL S, 1984, EUR J BIOCHEM, V141, P231, DOI 10.1111/j.1432-1033.1984.tb08180.x; SOBOLL S, 1993, BIOCHIM BIOPHYS ACTA, V1144, P1, DOI 10.1016/0005-2728(93)90024-A; Tan CM, 2001, BIOCHEMISTRY-US, V40, P1702, DOI 10.1021/bi0015818; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wojtczak L, 1998, ARCH BIOCHEM BIOPHYS, V357, P76, DOI 10.1006/abbi.1998.0777; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yehuda-Shnaidman E, 2005, ENDOCRINOLOGY, V146, P2462, DOI 10.1210/en.2004-1161; Yehuda-Shnaidman E, 2010, FASEB J, V24, P93, DOI 10.1096/fj.09-133538; Yue X, 2006, EUR J PHARMACOL, V540, P57, DOI 10.1016/j.ejphar.2006.04.033; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhou XM, 2000, J BIOL CHEM, V275, P25046, DOI 10.1074/jbc.M002526200; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	66	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6879	6890		10.1074/jbc.M109.080416	http://dx.doi.org/10.1074/jbc.M109.080416			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20037159	Green Published, hybrid			2022-12-25	WOS:000275415600002
J	Maillet, M; Davis, J; Auger-Messier, M; York, A; Osinska, H; Piquereau, J; Lorenz, JN; Robbins, J; Ventura-Clapier, R; Molkentin, JD				Maillet, Marjorie; Davis, Jennifer; Auger-Messier, Mannix; York, Allen; Osinska, Hanna; Piquereau, Jerome; Lorenz, John N.; Robbins, Jeffrey; Ventura-Clapier, Renee; Molkentin, Jeffery D.			Heart-specific Deletion of CnB1 Reveals Multiple Mechanisms Whereby Calcineurin Regulates Cardiac Growth and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; TRANSCRIPTION FACTOR; TRANSGENIC MICE; NF-ATC; CALCIUM; HYPERTROPHY; DEPHOSPHORYLATION; EXPRESSION; PHENOTYPES; EXCHANGER	Calcineurin is a protein phosphatase that is uniquely regulated by sustained increases in intracellular Ca2+ following signal transduction events. Calcineurin controls cellular proliferation, differentiation, apoptosis, and inducible gene expression following stress and neuroendocrine stimulation. In the adult heart, calcineurin regulates hypertrophic growth of cardiomyocytes in response to pathologic insults that are associated with altered Ca2+ handling. Here we determined that calcineurin signaling is directly linked to the proper control of cardiac contractility, rhythm, and the expression of Ca2+- handling genes in the heart. Our approach involved a cardiomyocyte-specific deletion using a CnB1-LoxP-targeted allele in mice and three different cardiac-expressing Cre alleles/transgenes. Deletion of calcineurin with the Nkx2.5-Cre knock-in allele resulted in lethality at 1 day after birth due to altered right ventricular morphogenesis, reduced ventricular trabeculation, septal defects, and valvular overgrowth. Slightly later deletion of calcineurin with the alpha-myosin heavy chain Cre transgene resulted in lethality in early mid adulthood that was characterized by substantial reductions in cardiac contractility, severe arrhythmia, and reduced myocyte content in the heart. Young calcineurin heart-deleted mice died suddenly after pressure overload stimulation or neuroendocrine agonist infusion, and telemetric monitoring of older mice showed arrhythmia leading to sudden death. Mechanistically, loss of calcineurin reduced expression of key Ca2+-handling genes that likely lead to arrhythmia and reduced contractility. Loss of calcineurin also directly impacted cellular proliferation in the postnatal developing heart. These results reveal multiple mechanisms whereby calcineurin regulates cardiac development and myocyte contractility.	[Maillet, Marjorie; Davis, Jennifer; Auger-Messier, Mannix; York, Allen; Osinska, Hanna; Robbins, Jeffrey; Molkentin, Jeffery D.] Univ Cincinnati, Med Ctr, Div Mol Cardiovasc Biol,Dept Pediat, Howard Hughes Med Inst,Cincinnati Childrens Hosp, Cincinnati, OH 45229 USA; [Piquereau, Jerome; Ventura-Clapier, Renee] Univ Paris 11, 1FR141, F-92296 Chatenay Malabry, France; [Lorenz, John N.] Univ Cincinnati, Sch Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; UDICE-French Research Universities; Universite Paris Saclay; University System of Ohio; University of Cincinnati	Molkentin, JD (corresponding author), Univ Cincinnati, Med Ctr, Div Mol Cardiovasc Biol,Dept Pediat, Howard Hughes Med Inst,Cincinnati Childrens Hosp, 240 Albert Sabin Way,MLC7020, Cincinnati, OH 45229 USA.	Jeff.Molkentin@cchmc.org		Ventura-Clapier, Renee/0000-0002-7488-4123; DAVIS, JENNIFER/0000-0003-2380-1321; Molkentin, Jeffery/0000-0002-3558-6529; Piquereau, Jerome/0000-0002-6019-8683	National Institutes of Health; Howard Hughes Medical Institute; Fondation Leducq; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL095353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Fondation Leducq(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant (to J. D. M.). This work was also supported by grants from the Howard Hughes Medical Institute and an international collaborative research grant in cardiovascular disease from the Fondation Leducq (to J. D. M.).	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Anwar A, 2005, J MOL CELL CARDIOL, V39, P911, DOI 10.1016/j.yjmcc.2005.08.001; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Coutu P, 2005, AM J PHYSIOL-HEART C, V288, pH601, DOI 10.1152/ajpheart.00424.2004; Dave V, 2006, J CLIN INVEST, V116, P2597, DOI 10.1172/JCI27331; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; Fewell JG, 1997, AM J PHYSIOL-HEART C, V273, pH1595, DOI 10.1152/ajpheart.1997.273.3.H1595; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Jordan MC, 2002, ANN NY ACAD SCI, V976, P259; Joubert F, 2008, J PHYSIOL-LONDON, V586, P5181, DOI 10.1113/jphysiol.2008.157677; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Lai MM, 2000, J BIOL CHEM, V275, P34017, DOI 10.1074/jbc.C000429200; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Medyouf H, 2008, CELL CYCLE, V7, P297, DOI 10.4161/cc.7.3.5357; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Orie NN, 2009, BRIT J PHARMACOL, V157, P554, DOI 10.1111/j.1476-5381.2009.00221.x; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Schaeffer PJ, 2009, AM J PHYSIOL-HEART C, V297, pH1263, DOI 10.1152/ajpheart.00152.2009; Shigekawa M, 2007, ANN NY ACAD SCI, V1099, P53, DOI 10.1196/annals.1387.059; Tandan S, 2009, CIRC RES, V105, P51, DOI 10.1161/CIRCRESAHA.109.199828; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang ZY, 2001, J BIOL CHEM, V276, P17706, DOI 10.1074/jbc.M100544200; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413	49	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6716	6724		10.1074/jbc.M109.056143	http://dx.doi.org/10.1074/jbc.M109.056143			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037164	Green Published, hybrid			2022-12-25	WOS:000275367500075
J	Scotto-Lavino, E; Garcia-Diaz, M; Du, GW; Frohman, MA				Scotto-Lavino, Elizabeth; Garcia-Diaz, Miguel; Du, Guangwei; Frohman, Michael A.			Basis for the Isoform-specific Interaction of Myosin Phosphatase Subunits Protein Phosphatase 1c beta and Myosin Phosphatase Targeting Subunit 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; MERLIN	Myosin II association with actin, which triggers contraction, is regulated by orchestrated waves of phosphorylation/dephosphorylation of the myosin regulatory light chain. Blocking myosin regulatory light chain phosphorylation with small molecule inhibitors alters the shape, adhesion, and migration of many types of smooth muscle and cancer cells. Dephosphorylation is mediated by myosin phosphatase (MP), a complex that consists of a catalytic subunit (protein phosphatase 1c, PP1c), a large subunit (myosin phosphatase targeting subunit, MYPT), and a small subunit of unknown function. MYPT functions by targeting PP1c onto its substrate, phosphorylated myosin II. Using RNA interference, we show here that stability of PP1c beta and MYPT1 is interdependent; knocking down one of the subunits decreases the expression level of the other. Associated changes in cell shape also occur, characterized by flattening and spreading accompanied by increased cortical actin, and cell numbers decrease secondary to apoptosis. Of the three highly conserved isoforms of PP1c, we show that MYPT1 binding is restricted to PP1c beta, and, using chimeric analysis and site-directed mutations, that the central region of PP1c beta confers the isoformspecific binding. This finding was unexpected because the MP crystal structure has been solved and was reported to identify the variable, C-terminal domain of PP1c beta as being the region key for isoform-specific interaction with MYPT1. These findings suggest a potential screening strategy for cardiovascular and cancer therapeutic agents based on destabilizing MP complex formation and function.	[Scotto-Lavino, Elizabeth; Garcia-Diaz, Miguel; Du, Guangwei; Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Scotto-Lavino, Elizabeth; Du, Guangwei; Frohman, Michael A.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Du, Guangwei] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Health Science Center Houston	Du, GW (corresponding author), SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA.	guangwei.du@uth.tmc.edu; michael@pharm.stonybrook.edu		Du, Guangwei/0000-0003-4193-6975	National Institutes of Health [GM071520, GM084251, GM071475]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084251, R01GM071520, R01GM071475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM071520 and GM084251 (to M. A. F.) and GM071475 (to G. D.).	Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Du GW, 2009, MOL BIOL CELL, V20, P200, DOI 10.1091/mbc.E08-06-0555; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Jung JR, 2005, MOL CELLS, V20, P196; Parra M, 2007, GENE DEV, V21, P638, DOI 10.1101/gad.1513107; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Xia DL, 2005, EXP CELL RES, V304, P506, DOI 10.1016/j.yexcr.2004.11.025	15	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6419	6424		10.1074/jbc.M109.074773	http://dx.doi.org/10.1074/jbc.M109.074773			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20042605	Green Published, hybrid			2022-12-25	WOS:000275367500046
J	Bechah, Y; Paddock, CD; Capo, C; Mege, JL; Raoult, D				Bechah, Yassina; Paddock, Christopher D.; Capo, Christian; Mege, Jean-Louis; Raoult, Didier			Adipose Tissue Serves as a Reservoir for Recrudescent Rickettsia prowazekii Infection in a Mouse Model	PLOS ONE			English	Article							BRILL-ZINSSER-DISEASE; EPIDEMIC TYPHUS; TRENCH FEVER; BODY LOUSE; DEXAMETHASONE; ADIPOCYTE; OUTBREAK; VECTOR; GLUCOCORTICOIDS; TUBERCULOSIS	Brill-Zinsser disease, the relapsing form of epidemic typhus, typically occurs in a susceptible host years or decades after the primary infection; however, the mechanisms of reactivation and the cellular reservoir during latency are poorly understood. Herein we describe a murine model for Brill-Zinsser disease, and use PCR and cell culture to show transient rickettsemia in mice treated with dexamethasone >3 months after clinical recovery from the primary infection. Treatment of similarly infected mice with cyclosporine failed to produce recrudescent bacteremia. Therapy with doxycycline for the primary infection prevented recrudescent bacteremia in most of these mice following treatment with dexamethasone. Rickettsia prowazekii (the etiologic agent of epidemic typhus) was detected by PCR, cell culture, and immunostaining methods in murine adipose tissue, but not in liver, spleen, lung, or central nervous system tissues of mice 4 months after recovery from the primary infection. The lungs of dexamethasone-treated mice showed impaired expression of beta-defensin transcripts that may be involved in the pathogenesis of pulmonary lesions. In vitro, R. prowazekii rickettsiae infected and replicated in the murine adipocyte cell line 3T3-L1. Collectively these data suggest a role for adipose tissue as a potential reservoir for dormant infections with R. prowazekii.	[Bechah, Yassina; Capo, Christian; Mege, Jean-Louis; Raoult, Didier] Univ Mediterranean, Unit Res Emergent & Trop Infect Dis URMITE, CNRS IRD UMR 6236, Fac Med, Marseille, France; [Paddock, Christopher D.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Div Viral & Rickettsial Dis, Atlanta, GA USA	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centers for Disease Control & Prevention - USA	Bechah, Y (corresponding author), Univ Mediterranean, Unit Res Emergent & Trop Infect Dis URMITE, CNRS IRD UMR 6236, Fac Med, Marseille, France.	didier.raoult@medecine.univ-mrs.fr	MEGE, JEAN-LOUIS/O-6063-2016; RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974	French Centre National de la Recherche Scientifique (CNRS)	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This study was founded by the French Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Andersson JO, 2000, RES MICROBIOL, V151, P143, DOI 10.1016/S0923-2508(00)00116-9; Avitsur R, 2005, BRAIN BEHAV IMMUN, V19, P311, DOI 10.1016/j.bbi.2004.09.005; Bechah Y, 2007, MICROBES INFECT, V9, P898, DOI 10.1016/j.micinf.2007.03.008; Birg ML, 1999, J CLIN MICROBIOL, V37, P3722, DOI 10.1128/JCM.37.11.3722-3724.1999; Bise G, 1997, T ROY SOC TROP MED H, V91, P133, DOI 10.1016/S0035-9203(97)90198-X; Brili NE, 1911, AM J MED SCI, V142, P196, DOI 10.1097/00000441-191108000-00004; Brill NE, 1910, AM J MED SCI, V139, P484; Brouqui P, 2005, MEDICINE, V84, P61, DOI 10.1097/01.md.0000152373.07500.6e; Combs TP, 2005, J BIOL CHEM, V280, P24085, DOI 10.1074/jbc.M412802200; Desruisseaux MS, 2007, INFECT IMMUN, V75, P1066, DOI 10.1128/IAI.01455-06; Freylikhman O, 2003, ANN NY ACAD SCI, V990, P496, DOI 10.1111/j.1749-6632.2003.tb07417.x; GREEN CR, 1990, JAMA-J AM MED ASSOC, V264, P1811, DOI 10.1001/jama.1990.03450140031026; Hans Z, 1934, AM J HYG, V20, P513, DOI 10.1093/oxfordjournals.aje.a118091; Hart PD, 1996, INFECT IMMUN, V64, P1491, DOI 10.1128/IAI.64.4.1491-1493.1996; Hashimoto A, 2007, BIOMED PHARMACOTHER, V61, P81, DOI 10.1016/j.biopha.2006.06.023; Houhamdi L, 2006, J INFECT DIS, V194, P1589, DOI 10.1086/508995; KROTKIEWSKI M, 1975, ACTA ENDOCRINOL-COP, V80, P667, DOI 10.1530/acta.0.0800667; Lutwick LI, 2001, LANCET, V357, P1198, DOI 10.1016/S0140-6736(00)04339-7; Massung RF, 2001, CLIN INFECT DIS, V32, P979, DOI 10.1086/319351; Mitchell GB, 2007, INFECT IMMUN, V75, P1325, DOI 10.1128/IAI.00686-06; Mokrani K, 2004, J CLIN MICROBIOL, V42, P3898, DOI 10.1128/JCM.42.8.3898-3900.2004; MURRAY ES, 1950, JAMA-J AM MED ASSOC, V142, P1059, DOI 10.1001/jama.1950.02910320021006; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Niang M, 1999, EMERG INFECT DIS, V5, P716, DOI 10.3201/eid0505.990515; ONG JM, 1992, ENDOCRINOLOGY, V130, P2310, DOI 10.1210/en.130.4.2310; PARKER RT, 1954, J IMMUNOL, V73, P383; PORTNOY J, 1974, CAN MED ASSOC J, V111, P166; PRICE WINSTON H., 1955, JOUR BACT, V69, P106; Raoult D, 1997, EMERG INFECT DIS, V3, P357, DOI 10.3201/eid0303.970313; Raoult D, 1999, CLIN INFECT DIS, V29, P434, DOI 10.1086/520229; Raoult D, 1998, LANCET, V352, P353, DOI 10.1016/S0140-6736(97)12433-3; RAOULT D, 1987, J INFECT DIS, V155, P1059, DOI 10.1093/infdis/155.5.1059; Raoult D, 2004, INFECT DIS CLIN N AM, V18, P127, DOI 10.1016/S0891-5520(03)00093-X; Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454; REILLY PJ, 1980, WESTERN J MED, V133, P338; Renes J, 2005, CELL MOL LIFE SCI, V62, P492, DOI 10.1007/s00018-004-4498-9; ROTH JA, 1982, J AM VET MED ASSOC, V180, P894; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; SLATER GG, 1962, ENDOCRINOLOGY, V70, P18, DOI 10.1210/endo-70-1-18; SMADEL JE, 1952, AM J HYG, V56, P294, DOI 10.1093/oxfordjournals.aje.a119553; Stein A, 1999, LANCET, V353, P1936, DOI 10.1016/S0140-6736(99)01995-9; Tarasevich I, 1998, LANCET, V352, P1151, DOI 10.1016/S0140-6736(05)79799-3	43	38	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8547	10.1371/journal.pone.0008547	http://dx.doi.org/10.1371/journal.pone.0008547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049326	Green Submitted, Green Published, gold			2022-12-25	WOS:000273225000012
J	Codina, M; Li, JL; Gutierrez, J; Kao, JPY; Du, SJ				Codina, Marta; Li, Junling; Gutierrez, Joaquim; Kao, Joseph P. Y.; Du, Shao Jun			Loss of Smyhc1 or Hsp90 alpha 1 Function Results in Different Effects on Myofibril Organization in Skeletal Muscles of Zebrafish Embryos	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; CAENORHABDITIS-ELEGANS; SELECTIVE REMOVAL; ELASTIC FILAMENTS; ACTIN INTERACTION; STRIATED-MUSCLE; THICK FILAMENTS; IN-VIVO; CELLS; SLOW	Background: Myofibrillogenesis requires the correct folding and assembly of sarcomeric proteins into highly organized sarcomeres. Heat shock protein 90 alpha 1 (Hsp90 alpha 1) has been implicated as a myosin chaperone that plays a key role in myofibrillogenesis. Knockdown or mutation of hsp90 alpha 1 resulted in complete disorganization of thick and thin filaments and M-and Z-line structures. It is not clear whether the disorganization of these sarcomeric structures is due to a direct effect from loss of Hsp90 alpha 1 function or indirectly through the disorganization of myosin thick filaments. Methodology/Principal Findings: In this study, we carried out a loss-of-function analysis of myosin thick filaments via gene-specific knockdown or using a myosin ATPase inhibitor BTS (N-benzyl-p-toluene sulphonamide) in zebrafish embryos. We demonstrated that knockdown of myosin heavy chain 1 (myhc1) resulted in sarcomeric defects in the thick and thin filaments and defective alignment of Z-lines. Similarly, treating zebrafish embryos with BTS disrupted thick and thin filament organization, with little effect on the M-and Z-lines. In contrast, loss of Hsp90 alpha 1 function completely disrupted all sarcomeric structures including both thick and thin filaments as well as the M-and Z-lines. Conclusion/Significance: Together, these studies indicate that the hsp90 alpha 1 mutant phenotype is not simply due to disruption of myosin folding and assembly, suggesting that Hsp90 alpha 1 may play a role in the assembly and organization of other sarcomeric structures.	[Codina, Marta; Li, Junling; Du, Shao Jun] Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, Baltimore, MD 21202 USA; [Codina, Marta; Gutierrez, Joaquim] Univ Barcelona, Dept Physiol, Barcelona, Spain; [Kao, Joseph P. Y.] Univ Maryland, Ctr Med Biotechnol, Inst Biotechnol, Baltimore, MD 21201 USA; [Kao, Joseph P. Y.] Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Kao, Joseph P. Y.] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Du, Shao Jun] Univ Maryland, Sch Med, Interdisciplinary Training Program Muscle Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University of Barcelona; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Codina, M (corresponding author), Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, 600 E Lombard St, Baltimore, MD 21202 USA.	dus@umbi.umd.edu	Gutierrez, Joaquim/H-2836-2015	Gutierrez, Joaquim/0000-0002-3126-2236; du, Jim/0000-0001-9227-4153; Kao, Joseph/0000-0002-8875-2180	BARD, the United States-Israel Binational Agricultural Research and Development Fund [IS-3703-05]; University of Maryland Biotechnology Institute	BARD, the United States-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); University of Maryland Biotechnology Institute	This research was supported by research grant No IS-3703-05 from BARD, the United States-Israel Binational Agricultural Research and Development Fund, and an intercenter collaboration grant (Kao-Du) from University of Maryland Biotechnology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkova I, 2005, TRENDS CELL BIOL, V15, P477, DOI 10.1016/j.tcb.2005.07.001; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; BEJSOVEC A, 1988, GENE DEV, V2, P1307, DOI 10.1101/gad.2.10.1307; Boateng SY, 2008, CARDIOVASC RES, V77, P667, DOI 10.1093/cvr/cvm048; Bryson-Richardson R, 2005, DEV DYNAM, V233, P1018, DOI 10.1002/dvdy.20380; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; CHUN MY, 1988, J CELL BIOL, V107, P2613, DOI 10.1083/jcb.107.6.2613; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Cripps RM, 1999, EMBO J, V18, P1793, DOI 10.1093/emboj/18.7.1793; Devoto SH, 1996, DEVELOPMENT, V122, P3371; DIBB NJ, 1985, J MOL BIOL, V183, P543, DOI 10.1016/0022-2836(85)90170-6; Dou Y, 2008, J GEN PHYSIOL, V131, P445, DOI 10.1085/jgp.200809982; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; EPSTEIN HF, 1991, SCIENCE, V251, P1039, DOI 10.1126/science.1998120; EPSTEIN HF, 1992, DEV BIOL, V154, P231, DOI 10.1016/0012-1606(92)90064-N; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; FUNATSU T, 1993, J CELL BIOL, V120, P711, DOI 10.1083/jcb.120.3.711; FUNATSU T, 1990, J CELL BIOL, V110, P53, DOI 10.1083/jcb.110.1.53; Granato M, 1996, DEVELOPMENT, V123, P399; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; HAYASHI T, 1977, J MOL BIOL, V111, P159; Kagawa M, 2006, ZOOL SCI, V23, P969, DOI 10.2108/zsj.23.969; Kontrogianni-Konstantopoulos A, 2006, FASEB J, V20, P2102, DOI 10.1096/fj.06-5761com; Landsverk ML, 2005, CELL MOL LIFE SCI, V62, P2270, DOI 10.1007/s00018-005-5176-2; Li HQ, 2009, FASEB J, V23, P1988, DOI 10.1096/fj.08-125542; LOWEY S, 1969, J MOL BIOL, V42, P1, DOI 10.1016/0022-2836(69)90483-5; McGuigan K, 2004, MOL BIOL EVOL, V21, P1042, DOI 10.1093/molbev/msh103; Moerman DG, 2006, SARCOMERE ASSEMBLY C, P1; Ramachandran I, 2003, CELL MOTIL CYTOSKEL, V55, P61, DOI 10.1002/cm.10113; Sanger JW, 2002, CLIN ORTHOP RELAT R, pS153, DOI 10.1097/01.blo.0000031973.69509.21; Sass JB, 1999, INT J DEV BIOL, V43, P835; Shaw MA, 2003, BIOCHEMISTRY-US, V42, P6128, DOI 10.1021/bi026964f; Soeno Y, 1999, CELL TISSUE RES, V295, P307, DOI 10.1007/s004410051237; Sparrow JC, 2009, NAT REV MOL CELL BIO, V10, P293, DOI 10.1038/nrm2634; Squire JM, 1997, CURR OPIN STRUC BIOL, V7, P247, DOI 10.1016/S0959-440X(97)80033-4; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; van der Ven PFM, 2000, J CELL SCI, V113, P1405; Witt CC, 2006, EMBO J, V25, P3843, DOI 10.1038/sj.emboj.7601242; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	46	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8416	10.1371/journal.pone.0008416	http://dx.doi.org/10.1371/journal.pone.0008416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049323	Green Published, gold, Green Submitted			2022-12-25	WOS:000273225000002
J	Subramanya, S; Mensa-Wilmot, K				Subramanya, Sandesh; Mensa-Wilmot, Kojo			Diacylglycerol-Stimulated Endocytosis of Transferrin in Trypanosomatids Is Dependent on Tyrosine Kinase Activity	PLOS ONE			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL-PHOSPHOLIPASE-C; HEMOGLOBIN ENDOCYTOSIS; AFRICAN TRYPANOSOME; LEISHMANIA-DONOVANI; FLAGELLAR POCKET; PHORBOL ESTERS; BRUCEI-BRUCEI; RECEPTOR; MEMBRANE; DOMAINS	Small molecule regulation of cell function is an understudied area of trypanosomatid biology. In Trypanosoma brucei diacylglycerol (DAG) stimulates endocytosis of transferrin (Tf). However, it is not known whether other trypanosomatidae respond similarly to the lipid. Further, the biochemical pathways involved in DAG signaling to the endocytic system in T. brucei are unknown, as the parasite genome does not encode canonical DAG receptors (e. g. C1-domains). We established that DAG stimulates endocytosis of Tf in Leishmania major, and we evaluated possible effector enzymes in the pathway with multiple approaches. First, a heterologously expressed glycosylphosphatidylinositol phospholipase C (GPI-PLC) activated endocytosis of Tf 300% in L. major. Second, exogenous phorbol ester and DAGs promoted Tf endocytosis in L. major. In search of possible effectors of DAG signaling, we discovered a novel C1-like domain (i.e. C1_5) in trypanosomatids, and we identified protein Tyr kinases (PTKs) linked with C1_5 domains in T. brucei, T. cruzi, and L. major. Consequently, we hypothesized that trypanosome PTKs might be effector enzymes for DAG signaling. General uptake of Tf was reduced by inhibitors of either Ser/Thr or Tyr kinases. However, DAG-stimulated endocytosis of Tf was blocked only by an inhibitor of PTKs, in both T. brucei and L. major. We conclude that (i) DAG activates Tf endocytosis in L. major, and that (ii) PTKs are effectors of DAG-stimulated endocytosis of Tf in trypanosomatids. DAG-stimulated endocytosis of Tf may be a T. brucei adaptation to compete effectively with host cells for vertebrate Tf in blood, since DAG does not enhance endocytosis of Tf in human cells.	[Subramanya, Sandesh; Mensa-Wilmot, Kojo] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Subramanya, S (corresponding author), Texas Tech Univ Hlth Sci Ctr, Dept Biomed Sci, Paul L Foster Sch Med, El Paso, TX USA.	mensawil@uga.edu			National Institutes of Health [AI070141]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health grant number AI070141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvi F, 2007, CELL MOL LIFE SCI, V64, P263, DOI 10.1007/s00018-006-6363-5; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BIRCHALL AM, 1994, J PHARMACOL EXP THER, V268, P922; Britigan BE, 1998, ADV EXP MED BIOL, V443, P135; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Chopra LC, 1997, AM J RESP CELL MOL, V16, P372, DOI 10.1165/ajrcmb.16.4.9115747; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; EICHHOLTZ T, 1992, J BIOL CHEM, V267, P22490; Eltayeb R, 2000, J INFECT DIS, V181, P400, DOI 10.1086/315189; FOX JA, 1986, J BIOL CHEM, V261, P5767; Gruszynski AE, 2006, MOL BIOCHEM PARASIT, V147, P211, DOI 10.1016/j.molbiopara.2006.02.013; HERELD D, 1986, J BIOL CHEM, V261, P3813; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Hurley JH, 1997, PROTEIN SCI, V6, P477; Jonassen I, 1997, COMPUT APPL BIOSCI, V13, P509; Kazanietz MG, 2000, MOL CARCINOGEN, V28, P5, DOI 10.1002/(SICI)1098-2744(200005)28:1<5::AID-MC2>3.0.CO;2-G; KOHNO H, 1986, CELL STRUCT FUNCT, V11, P181, DOI 10.1247/csf.11.181; Kotsonis P, 1996, BRIT J PHARMACOL, V119, P115, DOI 10.1111/j.1476-5381.1996.tb15684.x; Krishnamurthy G, 2005, J BIOL CHEM, V280, P5884, DOI 10.1074/jbc.M411845200; Le TL, 2002, AM J PHYSIOL-CELL PH, V283, pC489, DOI 10.1152/ajpcell.00566.2001; LIBERALI P, 2008, ANN REV CELL DEV BIO; Maier A, 1996, FEBS LETT, V396, P87, DOI 10.1016/0014-5793(96)01073-3; MENSAWILMOT K, 1994, J CELL BIOL, V124, P935, DOI 10.1083/jcb.124.6.935; Merschjohann Karin, 2006, Kinetoplastid Biol Dis, V5, P3, DOI 10.1186/1475-9292-5-3; MORARU II, 1990, FEBS LETT, V274, P93, DOI 10.1016/0014-5793(90)81337-N; MORRIS JC, 1995, J BIOL CHEM, V270, P2517, DOI 10.1074/jbc.270.6.2853; Mustafa E, 1997, J INFECT DIS, V175, P669, DOI 10.1093/infdis/175.3.669; Parsons M, 2000, PARASITOL TODAY, V16, P56, DOI 10.1016/S0169-4758(99)01590-2; Pearson WR, 1996, METHOD ENZYMOL, V266, P227; Rambaratsingh RA, 2003, J BIOL CHEM, V278, P52792, DOI 10.1074/jbc.M308240200; Rashid MB, 1999, EUR J BIOCHEM, V264, P914, DOI 10.1046/j.1432-1327.1999.00690.x; Reinhardt J, 2002, AM J PHYSIOL-RENAL, V283, pF335, DOI 10.1152/ajprenal.00226.2001; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; SCHELL D, 1991, PARASITOL RES, V77, P558, DOI 10.1007/BF00931012; Seebeck T, 2004, CURR MOL MED, V4, P585, DOI 10.2174/1566524043360113; Sengupta S, 1999, J BIOL CHEM, V274, P2758, DOI 10.1074/jbc.274.5.2758; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Singh SB, 2003, EMBO J, V22, P5712, DOI 10.1093/emboj/cdg557; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Steverding D, 1998, PARASITOL RES, V84, P59, DOI 10.1007/s004360050357; STEVERDING D, 1995, J CELL BIOL, V131, P1173, DOI 10.1083/jcb.131.5.1173; Subramanya S, 2006, FEBS J, V273, P2110, DOI 10.1111/j.1742-4658.2006.05225.x; Subramanya S, 2009, BIOCHEM J, V417, P685, DOI 10.1042/BJ20080167; VOYIATZAKI CS, 1992, J BIOL CHEM, V267, P9112; WALLIS AE, 1987, J EXP MED, V166, P1814, DOI 10.1084/jem.166.6.1814; Webb H, 1997, J CELL BIOL, V139, P103, DOI 10.1083/jcb.139.1.103; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Wilson ME, 2002, EXP PARASITOL, V100, P196, DOI 10.1016/S0014-4894(02)00018-8; WILSON ME, 1994, INFECT IMMUN, V62, P3262, DOI 10.1128/IAI.62.8.3262-3269.1994; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; ZHENG Z, 2004, J BIOL CHEM; Zheng ZF, 2004, J BIOL CHEM, V279, P42106, DOI 10.1074/jbc.M403780200	55	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8538	10.1371/journal.pone.0008538	http://dx.doi.org/10.1371/journal.pone.0008538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049089	Green Published, Green Submitted, gold			2022-12-25	WOS:000273225000007
J	Clark-Knowles, KV; Senterman, MK; Collins, O; Vanderhyden, BC				Clark-Knowles, Katherine V.; Senterman, Mary K.; Collins, Olga; Vanderhyden, Barbara C.			Conditional Inactivation of Brca1, p53 and Rb in Mouse Ovaries Results in the Development of Leiomyosarcomas	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; SURFACE EPITHELIUM; TUMOR-FORMATION; BREAST-CANCER; MICE LACKING; DNA-DAMAGE; CYCLE; MUTATIONS; PROTEIN; EXPRESSION	Epithelial ovarian cancer (EOC) is thought to arise in part from the ovarian surface epithelium (OSE); however, the molecular events underlying this transformation are poorly understood. Germline mutations in the BRCA1 tumor suppressor gene result in a significantly increased risk of developing EOC and a large proportion of sporadic EOCs display some sort of BRCA1 dysfunction. To generate a model in which Brca1-mediated transformation can be studied, we previously inactivated Brca1 alone in murine OSE, which resulted in an increased accumulation of premalignant changes, but no tumor formation. In this study, we examined tumor formation in mice with conditionally expressed alleles of Brca1, p53 and Rb, alone or in combination. Intrabursal injection of adenovirus expressing Cre recombinase to inactivate p53 resulted in tumors in 100% of mice. Tumor progression was accelerated in mice with concomitant inactivation of Brca1 and p53, but not Rb and p53. Immunohistologic analyses classified the tumors as leiomyosarcomas that may be arising from the ovarian bursa. Brca1 inactivation in primary cultures of murine OSE cells led to a suppression of proliferation that could be rescued by concomitant inactivation of p53 and/or Rb. Brca1-deficient OSE cells displayed an increased sensitivity to the DNA damaging agent cisplatin, and this effect could be modulated by inactivation of p53 and/or Rb. These results indicate that Brca1 deficiency can accelerate tumor development and alter the sensitivity of OSE cells to chemotherapeutic agents. Intrabursal delivery of adenovirus intended to alter gene expression in the ovarian surface epithelium may, in some strains of mice, result in more rapid transformation of adjacent cells, resulting in leiomyosarcomas.	[Clark-Knowles, Katherine V.; Vanderhyden, Barbara C.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Senterman, Mary K.] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Vanderhyden, Barbara C.] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada; [Clark-Knowles, Katherine V.; Collins, Olga; Vanderhyden, Barbara C.] Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Clark-Knowles, KV (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.	bvanderhyden@ohri.ca			National Cancer Institute of Canada; Canadian Institutes of Health Research; Ontario Graduate Scholarships; Ontario Graduate Scholarship in Science and Technology	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarships(Ontario Graduate Scholarship); Ontario Graduate Scholarship in Science and Technology	This research was supported by funds from the National Cancer Institute of Canada and the Canadian Institutes of Health Research (BCV) and by Ontario Graduate Scholarships and an Ontario Graduate Scholarship in Science and Technology (KVC-K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprelikova ON, 1999, P NATL ACAD SCI USA, V96, P11866, DOI 10.1073/pnas.96.21.11866; Auersperg N, 1998, SEMIN ONCOL, V25, P281; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Aunoble B, 2000, INT J ONCOL, V16, P567; Berchuck A, 1998, CLIN CANCER RES, V4, P2433; Brugarolas J, 1997, NAT MED, V3, P721, DOI 10.1038/nm0797-721; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Chan KYK, 2002, CANCER RES, V62, P4151; Chen JJ, 1999, CANCER RES, V59, p1752S; Clark-Knowles KV, 2007, EXP CELL RES, V313, P133, DOI 10.1016/j.yexcr.2006.09.026; Cressman VL, 1999, CELL GROWTH DIFFER, V10, P1; Deng CX, 2001, MUTAT RES-FUND MOL M, V477, P183, DOI 10.1016/S0027-5107(01)00119-1; DEVOS S, 1994, GYNECOL ONCOL, V54, P205, DOI 10.1006/gyno.1994.1194; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fan SJ, 2001, ONCOGENE, V20, P4827, DOI 10.1038/sj.onc.1204666; FINCH A, 2005, GYNECOL ONCOL; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Geisler JP, 2002, JNCI-J NATL CANCER I, V94, P61; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Heller DS, 2003, INT J GYNECOL CANCER, V13, P303, DOI 10.1046/j.1525-1438.2003.13201.x; Hirst JE, 2009, INT J GYNECOL CANCER, V19, P826, DOI 10.1111/IGC.0b013e3181a1b5dc; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Lanzi C, 1998, BIOCHEM PHARMACOL, V55, P1247, DOI 10.1016/S0006-2952(97)00599-6; Larson JS, 1997, CANCER RES, V57, P3351; LAVIOLETTE L, 2009, ENDOCRINOLO IN PRESS; LeCouter JE, 1998, MOL CELL BIOL, V18, P7455, DOI 10.1128/MCB.18.12.7455; Leiser AL, 2006, GYNECOL ONCOL, V101, P86, DOI 10.1016/j.ygyno.2005.09.055; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; Pal T., 2005, CANCER; Perego P, 1998, ANN ONCOL, V9, P423, DOI 10.1023/A:1008265012435; Ramus SJ, 1999, GENE CHROMOSOME CANC, V25, P91, DOI 10.1002/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5; Roh MH, 2009, AM J SURG PATHOL, V33, P376, DOI 10.1097/PAS.0b013e3181868904; Russell PA, 2000, INT J CANCER, V87, P317, DOI 10.1002/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B; Salazar H, 1996, JNCI-J NATL CANCER I, V88, P1810, DOI 10.1093/jnci/88.24.1810; Schlosshauer PW, 2003, CANCER, V98, P2599, DOI 10.1002/cncr.11848; Sgagias MK, 2004, CELL CYCLE, V3, P1451, DOI 10.4161/cc.3.11.1211; Shao NS, 1996, ONCOGENE, V13, P1; Shaw PA, 2009, MODERN PATHOL, V22, P1133, DOI 10.1038/modpathol.2009.89; Simpson KJ, 2004, INT J DEV BIOL, V48, P675, DOI 10.1387/ijdb.041849ks; Sood AK, 1998, CANCER, V82, P1731, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1738::AID-CNCR21>3.3.CO;2-0; Sundfeldt K, 1997, INT J CANCER, V74, P275, DOI 10.1002/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.3.CO;2-V; Tos APD, 1996, AM J PATHOL, V148, P1037; Vooijs M, 1998, ONCOGENE, V17, P1, DOI 10.1038/sj.onc.1202169; Wang A, 2000, J BIOL CHEM, V275, P4532, DOI 10.1074/jbc.275.6.4532; Werness BA, 1999, HUM PATHOL, V30, P151, DOI 10.1016/S0046-8177(99)90269-1; Woodworth CD, 2004, CARCINOGENESIS, V25, P1771, DOI 10.1093/carcin/bgh170; Xing D, 2009, CANCER RES, V69, P8231, DOI 10.1158/0008-5472.CAN-09-2543; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Yan Y, 2005, ONCOGENE, V24, P3285, DOI 10.1038/sj.onc.1208492; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; Yu V, 2000, BREAST CANCER RES, V2, P82, DOI 10.1186/bcr37; Zweemer RP, 1999, J CLIN PATHOL, V52, P372, DOI 10.1136/jcp.52.5.372	58	46	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8534	10.1371/journal.pone.0008534	http://dx.doi.org/10.1371/journal.pone.0008534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046869	Green Published, Green Submitted, gold			2022-12-25	WOS:000273180200015
J	Lavelin, I; Beer, A; Kam, Z; Boner, V; Oren, M; Navon, A; Geiger, B				Lavelin, Irena; Beer, Avital; Kam, Zvi; Boner, Varda; Oren, Moshe; Navon, Ami; Geiger, Benjamin			Discovery of Novel Proteasome Inhibitors Using a High-Content Cell-Based Screening System	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; MULTIPLE-MYELOMA; BETA-CATENIN; ANTITUMOR ACTIVITIES; 20S PROTEASOME; CANCER-CELLS; P53; APOPTOSIS; PROTEIN; RESOLUTION	The regulated degradation of damaged or misfolded proteins, as well as down-regulation of key signaling proteins, within eukaryotic and bacterial cells is catalyzed primarily by large, ATP-dependent multimeric proteolytic complexes, termed proteasomes. Inhibition of proteasomal activity affects a wide variety of physiological and pathological processes, and was found to be particularly effective for cancer therapy. We report here on the development of a novel high throughput assay for proteasome inhibition using a unique, highly sensitive live-cell screening, based on the cytoplasm-to-nucleus translocation of a fluorescent proteasome inhibition reporter (PIR) protein, consisting of nuclear localization signal-deficient p53 derivative. We further show here that mdm2, a key negative regulator of p53 plays a key role in the accumulation of PIR in the nucleus upon proteasome inhibition. Using this assay, we have screened the NCI Diversity Set library, containing 1,992 low molecular weight synthetic compounds, and identified four proteasome inhibitors. The special features of the current screen, compared to those of other approaches are discussed.	[Lavelin, Irena; Kam, Zvi; Boner, Varda; Oren, Moshe; Geiger, Benjamin] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Beer, Avital; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Lavelin, I (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	benny.geiger@weizmann.ac.il		Oren, Moshe/0000-0003-4311-7172	Israel Science Foundation; Minerva Foundation; German-Israeli Foundation for Scientific Research and Development; Jeanne and Joseph Nissim Foundation for Life Sciences Research; Rolando Uziel	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Jeanne and Joseph Nissim Foundation for Life Sciences Research; Rolando Uziel	This study was supported by grants from the Israel Science Foundation (BG and AN), the Minerva Foundation (AN), the German-Israeli Foundation for Scientific Research and Development (AN), the Jeanne and Joseph Nissim Foundation for Life Sciences Research (BG), and a special gift from Rolando Uziel (AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Almond JB, 2002, LEUKEMIA, V16, P433, DOI 10.1038/sj.leu.2402417; Andreatta C, 2001, BIOTECHNIQUES, V30, P656, DOI 10.2144/01303dd03; Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bonvini P, 2000, BBA-MOL CELL RES, V1495, P308, DOI 10.1016/S0167-4889(99)00162-7; Cavo M, 2006, LEUKEMIA, V20, P1341, DOI 10.1038/sj.leu.2404278; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Chen D, 2007, CANCER RES, V67, P1636, DOI 10.1158/0008-5472.CAN-06-3546; Corey EJ, 1999, CHEM PHARM BULL, V47, P1; Daniel KG, 2004, BIOCHEM PHARMACOL, V67, P1139, DOI 10.1016/j.bcp.2003.10.031; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Dobbelstein M, 1999, ONCOGENE, V18, P2101, DOI 10.1038/sj.onc.1202512; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; ImajohOhmi S, 1995, BIOCHEM BIOPH RES CO, V217, P1070, DOI 10.1006/bbrc.1995.2878; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Klibanov SA, 2001, J CELL SCI, V114, P1867; Latonen L, 2003, CELL SIGNAL, V15, P95, DOI 10.1016/S0898-6568(02)00044-X; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; Liron Y, 2006, J MICROSC-OXFORD, V221, P145, DOI 10.1111/j.1365-2818.2006.01550.x; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Miller CP, 2007, BLOOD, V110, P267, DOI 10.1182/blood-2006-03-013128; Moravec RA, 2009, ANAL BIOCHEM, V387, P294, DOI 10.1016/j.ab.2009.01.016; Nickeleit I, 2008, CANCER CELL, V14, P23, DOI 10.1016/j.ccr.2008.05.016; O'Keefe K, 2003, MOL CELL BIOL, V23, P6396, DOI 10.1128/MCB.23.18.6396-6405.2003; Ocio EM, 2008, LANCET ONCOL, V9, P1157, DOI 10.1016/S1470-2045(08)70304-8; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; Orlowski RZ, 1998, CANCER RES, V58, P4342; Paran Y, 2006, METHOD ENZYMOL, V414, P228, DOI 10.1016/S0076-6879(06)14013-6; Richardson Paul G, 2003, Clin Adv Hematol Oncol, V1, P596; Salomon D, 1997, J CELL BIOL, V139, P1325, DOI 10.1083/jcb.139.5.1325; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Tsukamoto S, 2009, EXPERT OPIN THER TAR, V13, P605, DOI [10.1517/14728220902866851 , 10.1517/14728220902866851]; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980; ZAMBETTI GP, 1993, FASEB J, V7, P855, DOI 10.1096/fasebj.7.10.8344485	44	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8503	10.1371/journal.pone.0008503	http://dx.doi.org/10.1371/journal.pone.0008503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041034	gold, Green Published, Green Submitted			2022-12-25	WOS:000278068700017
J	Corcione, A; Ferretti, E; Bertolotto, M; Fais, F; Raffaghello, L; Gregorio, A; Tenca, C; Ottonello, L; Gambini, C; Furtado, G; Lira, S; Pistoia, V				Corcione, Anna; Ferretti, Elisa; Bertolotto, Maria; Fais, Franco; Raffaghello, Lizzia; Gregorio, Andrea; Tenca, Claudya; Ottonello, Luciano; Gambini, Claudio; Furtado, Glaucia; Lira, Sergio; Pistoia, Vito			CX(3)CR1 Is Expressed by Human B Lymphocytes and Meditates CX(3)CL1 Driven Chemotaxis of Tonsil Centrocytes	PLOS ONE			English	Article							FRACTALKINE RECEPTOR CX(3)CR1; MEMBRANE-BOUND CHEMOKINE; PROTEIN-KINASE CASCADE; GERMINAL-CENTERS; SOMATIC MUTATION; CELL-ADHESION; TNF-ALPHA; ACTIVATION; MIGRATION; GENES	Background: Fractalkine/CX(3)CL1, a surface chemokine, binds to CX(3)CR1 expressed by different lymphocyte subsets. Since CX(3)CL1 has been detected in the germinal centres of secondary lymphoid tissue, in this study we have investigated CX(3)CR1 expression and function in human naive, germinal centre and memory B cells isolated from tonsil or peripheral blood. Methodology/Principal Findings: We demonstrate unambiguously that highly purified human B cells from tonsil and peripheral blood expressed CX(3)CR1 at mRNA and protein levels as assessed by quantitative PCR, flow cytometry and competition binding assays. In particular, naive, germinal centre and memory B cells expressed CX(3)CR1 but only germinal centre B cells were attracted by soluble CX(3)CL1 in a transwell assay. CX(3)CL1 signalling in germinal centre B cells involved PI3K, Erk1/2, p38, and Src phosphorylation, as assessed by Western blot experiments. CX(3)CR1(+) germinal centre B cells were devoid of centroblasts and enriched for centrocytes that migrated to soluble CX(3)CL1. ELISA assay showed that soluble CX(3)CL1 was secreted constitutively by follicular dendritic cells and T follicular helper cells, two cell populations homing in the germinal centre light zone as centrocytes. At variance with that observed in humans, soluble CX(3)CL1 did not attract spleen B cells from wild type mice. OVA immunized CX(3)CR1-/- or CX(3)CL1-/- mice showed significantly decreased specific IgG production compared to wild type mice. Conclusion/Significance: We propose a model whereby human follicular dendritic cells and T follicular helper cells release in the light zone of germinal centre soluble CX(3)CL1 that attracts centrocytes. The functional implications of these results warrant further investigation.	[Corcione, Anna; Ferretti, Elisa; Raffaghello, Lizzia; Pistoia, Vito] IRCCS G Gaslini, Lab Oncol, Genoa, Italy; [Bertolotto, Maria; Ottonello, Luciano] Univ Genoa, Dept Internal Med, Lab Phagocyte Physiopathol & Inflammat, I-16126 Genoa, Italy; [Fais, Franco; Tenca, Claudya] Univ Genoa, Dept Expt Med, Human Anat Sect, Genoa, Italy; [Gregorio, Andrea; Gambini, Claudio] IRCCS G Gaslini, Human Pathol Sect, Genoa, Italy; [Furtado, Glaucia; Lira, Sergio] Mt Sinai Sch Med, Immunobiol Ctr, New York, NY USA	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; Icahn School of Medicine at Mount Sinai	Corcione, A (corresponding author), IRCCS G Gaslini, Lab Oncol, Genoa, Italy.	annacorcione@ospedale-gaslini.ge.it	Gregorio, Anna A/J-1632-2012; FAIS, FRANCO/AAG-3069-2021; Ottonello, Luciano/I-3250-2018; Corcione, Anna/AAA-7370-2020; Fais, Franco/K-1096-2016	FAIS, FRANCO/0000-0002-6643-7083; Ottonello, Luciano/0000-0001-7431-3841; Corcione, Anna/0000-0003-2439-1221; Fais, Franco/0000-0002-6643-7083; Bertolotto, Maria Bianca/0000-0002-4889-8046; Raffaghello, Lizzia/0000-0003-2357-0607	Fondazione Italiana Lotta al Neuroblastoma; Fondazione Italiana Ricerca sul Cancro (F. I. R. C.); Compagnia di S. Paolo [4824 SD/CV-2007.2880]; Fondazione Carige; Associazione Italiana Ricerca sul Cancro (A. I. R. C.); Progetti Strategici Oncologia, Ministero della Salute 2006	Fondazione Italiana Lotta al Neuroblastoma; Fondazione Italiana Ricerca sul Cancro (F. I. R. C.)(Fondazione AIRC per la ricerca sul cancro); Compagnia di S. Paolo(Compagnia di San Paolo); Fondazione Carige(Fondazione Carige); Associazione Italiana Ricerca sul Cancro (A. I. R. C.)(Fondazione AIRC per la ricerca sul cancro); Progetti Strategici Oncologia, Ministero della Salute 2006	LR and AG were supported by Fondazione Italiana Lotta al Neuroblastoma, EF by Fondazione Italiana Ricerca sul Cancro (F. I. R. C.), CT by Compagnia di S. Paolo (4824 SD/CV-2007.2880), MB by Fondazione Carige. Funding: i) Associazione Italiana Ricerca sul Cancro (A. I. R. C.) to VP, and ii) Progetti Strategici Oncologia, Ministero della Salute 2006 to AC and VP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ANDERSSON J, 1994, IMMUNOLOGY, V83, P16; Andreasson U, 2008, CANCER LETT, V259, P138, DOI 10.1016/j.canlet.2007.10.031; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Cambien B, 2001, BLOOD, V97, P2031, DOI 10.1182/blood.V97.7.2031; Casamayor-Palleja M, 2002, BLOOD, V99, P1913, DOI 10.1182/blood.V99.6.1913; CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; Cook DN, 2001, MOL CELL BIOL, V21, P3159, DOI 10.1128/MCB.21.9.3159-3165.2001; CORCIONE A, 1994, J IMMUNOL, V153, P2868; Corcione A, 2000, J NATL CANCER I, V92, P628, DOI 10.1093/jnci/92.8.628; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; Dono M, 1996, EUR J IMMUNOL, V26, P2035, DOI 10.1002/eji.1830260911; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Foussat A, 2001, BLOOD, V98, P1678, DOI 10.1182/blood.V98.6.1678; Hauser AE, 2007, NAT REV IMMUNOL, V7, P499, DOI 10.1038/nri2120; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Imaizumi Tadaatsu, 2004, J Atheroscler Thromb, V11, P15; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kansra V, 2001, J BIOL CHEM, V276, P31831, DOI 10.1074/jbc.M009374200; KIM HS, 1994, J IMMUNOL, V153, P2951; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; KomaiKoma M, 1997, IMMUNOLOGY, V90, P23, DOI 10.1046/j.1365-2567.1997.d01-2131.x; Lebecque S, 1997, J EXP MED, V185, P563, DOI 10.1084/jem.185.3.563; Lefranc MP, 2004, MOL IMMUNOL, V40, P647, DOI 10.1016/j.molimm.2003.09.006; Liao F, 2002, J IMMUNOL, V168, P4871, DOI 10.4049/jimmunol.168.10.4871; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; Ludwig A, 2002, J IMMUNOL, V168, P604, DOI 10.4049/jimmunol.168.2.604; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Montecucco F, 2008, CELL SIGNAL, V20, P557, DOI 10.1016/j.cellsig.2007.11.008; Munoz-Fernandez R, 2006, J IMMUNOL, V177, P280, DOI 10.4049/jimmunol.177.1.280; Nishimura M, 2002, J IMMUNOL, V168, P6173, DOI 10.4049/jimmunol.168.12.6173; Papadopoulos EJ, 2000, EUR J IMMUNOL, V30, P2355, DOI 10.1002/1521-4141(2000)30:8<2355::AID-IMMU2355>3.0.CO;2-#; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Raffaghello L, 2005, ONCOGENE, V24, P4634, DOI 10.1038/sj.onc.1208594; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shang XZ, 2004, CELL IMMUNOL, V229, P106, DOI 10.1016/j.cellimm.2004.06.007; Umehara H, 2001, TRENDS IMMUNOL, V22, P602, DOI 10.1016/S1471-4906(01)02051-8; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; WANG JM, 1993, J IMMUNOL, V150, P3022	48	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8485	10.1371/journal.pone.0008485	http://dx.doi.org/10.1371/journal.pone.0008485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041188	Green Published, Green Submitted, gold			2022-12-25	WOS:000273105200017
J	Rebetz, J; Na, ML; Su, CQ; Holmqvist, B; Edqvist, A; Nyberg, C; Widegren, B; Salford, LG; Sjogren, HO; Arnberg, N; Qian, QJ; Fan, XL				Rebetz, Johan; Na, Manli; Su, Changqing; Holmqvist, Bo; Edqvist, Anna; Nyberg, Cecilia; Widegren, Bengt; Salford, Leif G.; Sjogren, Hans Olov; Arnberg, Niklas; Qian, Qijun; Fan, Xiaolong			Fiber Mediated Receptor Masking in Non-Infected Bystander Cells Restricts Adenovirus Cell Killing Effect but Promotes Adenovirus Host Co-Existence	PLOS ONE			English	Article							MEMBRANE COFACTOR PROTEIN; WILD-TYPE ADENOVIRUS; GENE-TRANSFER; B ADENOVIRUSES; SIALIC-ACID; VECTORS; CD46; INFECTIONS; COXSACKIE; REPLICATION	The basic concept of conditionally replicating adenoviruses (CRAD) as oncolytic agents is that progenies generated from each round of infection will disperse, infect and kill new cancer cells. However, CRAD has only inhibited, but not eradicated tumor growth in xenograft tumor therapy, and CRAD therapy has had only marginal clinical benefit to cancer patients. Here, we found that CRAD propagation and cancer cell survival co-existed for long periods of time when infection was initiated at low multiplicity of infection (MOI), and cancer cell killing was inefficient and slow compared to the assumed cell killing effect upon infection at high MOI. Excessive production of fiber molecules from initial CRAD infection of only 1 to 2% cancer cells and their release prior to the viral particle itself caused a tropism-specific receptor masking in both infected and noninfected bystander cells. Consequently, the non-infected bystander cells were inefficiently bound and infected by CRAD progenies. Further, fiber overproduction with concomitant restriction of adenovirus spread was observed in xenograft cancer therapy models. Besides the CAR-binding Ad4, Ad5, and Ad37, infection with CD46-binding Ad35 and Ad11 also caused receptor masking. Fiber overproduction and its resulting receptor masking thus play a key role in limiting CRAD functionality, but potentially promote adenovirus and host cell co-existence. These findings also give important clues for understanding mechanisms underlying the natural infection course of various adenoviruses.	[Rebetz, Johan; Na, Manli; Edqvist, Anna; Widegren, Bengt; Salford, Leif G.; Sjogren, Hans Olov; Fan, Xiaolong] Lund Univ, Rausing Lab, Lund, Sweden; [Rebetz, Johan; Edqvist, Anna; Widegren, Bengt] Lund Univ, Dept Cell & Organism Biol, Lund, Sweden; [Holmqvist, Bo] Lund Univ, Dept Oncol, Lund, Sweden; [Holmqvist, Bo] Lund Univ, LBIC Opt Imaging Unit, Lund, Sweden; [Nyberg, Cecilia; Arnberg, Niklas] Umea Univ, Div Virol, Dept Clin Microbiol, Umea, Sweden; [Na, Manli; Su, Changqing; Qian, Qijun] Second Mil Med Univ, Lab Gene & Viral Therapy, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Fan, Xiaolong] Beijing Normal Univ, Dept Physiol, Life Sci Coll, Beijing 100875, Peoples R China	Lund University; Lund University; Lund University; Lund University; Umea University; Naval Medical University; Beijing Normal University	Rebetz, J (corresponding author), Lund Univ, Rausing Lab, Lund, Sweden.	Xiaolong.Fan@med.lu.se	Na, Manli/AAM-9864-2020; Arnberg, Niklas/G-2663-2012; Rebetz, Johan/AAK-9569-2021; Arnberg, Niklas/K-5878-2019	Rebetz, Johan/0000-0003-1673-0684; Arnberg, Niklas/0000-0002-7069-6678; Su, Changqing/0000-0002-3396-7248; Na, Manli/0000-0002-7306-8941	Swedish Cancer Society; Swedish Pediatric Cancer Foundation; Swedish Research Council; Lund University Medical Faculty; Hans and Marit Rausing Charitable Foundation; Gunnar Nilsson Cancer Foundation; Erik Philip-Sorensens Foundation; Crafoord Foundation; Lund University Hospital Donation Fund; Royal Physiographic Society in Lund	Swedish Cancer Society(Swedish Cancer Society); Swedish Pediatric Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University Medical Faculty; Hans and Marit Rausing Charitable Foundation; Gunnar Nilsson Cancer Foundation; Erik Philip-Sorensens Foundation; Crafoord Foundation; Lund University Hospital Donation Fund; Royal Physiographic Society in Lund	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by Swedish Cancer Society, Swedish Pediatric Cancer Foundation, Swedish Research Council, Lund University Medical Faculty, Hans and Marit Rausing Charitable Foundation, Gunnar Nilsson Cancer Foundation, Erik Philip-Sorensens Foundation, Crafoord Foundation, Lund University Hospital Donation Fund, and the Royal Physiographic Society in Lund. Xiaolong Fan is a Li Ka Shing Scholar.	Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; BOULANGE.PA, 1973, EUR J BIOCHEM, V39, P37, DOI 10.1111/j.1432-1033.1973.tb03100.x; Cattaneo R, 2004, J VIROL, V78, P4385, DOI 10.1128/JVI.78.9.4385-4388.2004; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; Edqvist A, 2006, MOL THER, V14, P139, DOI 10.1016/j.ymthe.2005.12.018; Fender P, 1997, NAT BIOTECHNOL, V15, P52, DOI 10.1038/nbt0197-52; FOX JP, 1977, AM J EPIDEMIOL, V105, P362, DOI 10.1093/oxfordjournals.aje.a112394; Franqueville L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002894; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Greber UF, 2007, CELL HOST MICROBE, V2, P143, DOI 10.1016/j.chom.2007.08.004; Harrison D, 2001, HUM GENE THER, V12, P1323, DOI 10.1089/104303401750270977; Heise C, 2000, J CLIN INVEST, V105, P847, DOI 10.1172/JCI9762; HONG JS, 1991, VIROLOGY, V185, P758; Hong SS, 2003, J VIROL, V77, P10366, DOI 10.1128/JVI.77.19.10366-10375.2003; Kaye SB, 2005, J MED VIROL, V77, P227, DOI 10.1002/jmv.20440; Krasnykh V, 2000, CANCER RES, V60, P6784; Lichtenstein DL, 2004, CANCER GENE THER, V11, P819, DOI 10.1038/sj.cgt.7700765; Marttila M, 2005, J VIROL, V79, P14429, DOI 10.1128/JVI.79.22.14429-14436.2005; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Nilsson M, 2004, J GENE MED, V6, P631, DOI 10.1002/jgm.543; NORRBY E, 1969, J GEN VIROL, V5, P221, DOI 10.1099/0022-1317-5-2-221; NUMAZAKI Y, 1968, NEW ENGL J MED, V278, P700, DOI 10.1056/NEJM196803282781303; Pring-Akerblom P, 1998, J VIROL, V72, P2297; Russell WC, 2000, J GEN VIROL, V81, P2573, DOI 10.1099/0022-1317-81-11-2573; Sauthoff H, 2003, HUM GENE THER, V14, P425, DOI 10.1089/104303403321467199; Schaack J, 2005, VIRAL IMMUNOL, V18, P79, DOI 10.1089/vim.2005.18.79; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200; Shayakhmetov DM, 2003, J VIROL, V77, P3712, DOI 10.1128/JVI.77.6.3712-3723.2003; SHIELDS AF, 1985, NEW ENGL J MED, V312, P529, DOI 10.1056/NEJM198502283120901; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Tuve S, 2006, J VIROL, V80, P12109, DOI 10.1128/JVI.01370-06; TYLER KL, 1986, SCIENCE, V233, P770, DOI 10.1126/science.3016895; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang Y, 2006, J MOL HISTOL, V37, P153, DOI 10.1007/s10735-006-9055-4; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Wirth T, 2003, CANCER RES, V63, P3181; Wu E, 2004, J VIROL, V78, P3897, DOI 10.1128/JVI.78.8.3897-3905.2004; Zhang Q, 2006, CLIN CANCER RES, V12, P6523, DOI 10.1158/1078-0432.CCR-06-1491; Zhang YM, 2005, J VIROL, V79, P12125, DOI 10.1128/JVI.79.19.12125-12131.2005	43	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8484	10.1371/journal.pone.0008484	http://dx.doi.org/10.1371/journal.pone.0008484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041185	Green Published, Green Submitted, gold			2022-12-25	WOS:000273105200016
J	Kim, W; Silby, MW; Purvine, SO; Nicoll, JS; Hixson, KK; Monroe, M; Nicora, CD; Lipton, MS; Levy, SB				Kim, Wook; Silby, Mark W.; Purvine, Sam O.; Nicoll, Julie S.; Hixson, Kim K.; Monroe, Matt; Nicora, Carrie D.; Lipton, Mary S.; Levy, Stuart B.			Proteomic Detection of Non-Annotated Protein-Coding Genes in Pseudomonas fluorescens Pf0-1	PLOS ONE			English	Article							OVERLAPPING GENES; ESCHERICHIA-COLI; SHIGELLA-FLEXNERI; IN-VIVO; EXPRESSION; INITIATION; DISCOVERY; SEQUENCES; SURVIVAL; BACTERIA	Genome sequences are annotated by computational prediction of coding sequences, followed by similarity searches such as BLAST, which provide a layer of possible functional information. While the existence of processes such as alternative splicing complicates matters for eukaryote genomes, the view of bacterial genomes as a linear series of closely spaced genes leads to the assumption that computational annotations that predict such arrangements completely describe the coding capacity of bacterial genomes. We undertook a proteomic study to identify proteins expressed by Pseudomonas fluorescens Pf0-1 from genes that were not predicted during the genome annotation. Mapping peptides to the Pf0-1 genome sequence identified sixteen non-annotated protein-coding regions, of which nine were antisense to predicted genes, six were intergenic, and one read in the same direction as an annotated gene but in a different frame. The expression of all but one of the newly discovered genes was verified by RT-PCR. Few clues as to the function of the new genes were gleaned from informatic analyses, but potential orthologs in other Pseudomonas genomes were identified for eight of the new genes. The 16 newly identified genes improve the quality of the Pf0-1 genome annotation, and the detection of antisense protein-coding genes indicates the under-appreciated complexity of bacterial genome organization.	[Kim, Wook; Silby, Mark W.; Nicoll, Julie S.; Levy, Stuart B.] Tufts Univ, Sch Med, Ctr Adaptat Genet & Drug Resistance, Boston, MA 02111 USA; [Kim, Wook; Silby, Mark W.; Nicoll, Julie S.; Levy, Stuart B.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Purvine, Sam O.; Hixson, Kim K.; Monroe, Matt; Nicora, Carrie D.; Lipton, Mary S.] Pacific NW Natl Lab, Richland, WA 99352 USA	Tufts University; Tufts University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Kim, W (corresponding author), Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA.	Stuart.Levy@tufts.edu	Lipton, Mary S/H-3913-2012; Purvine, Samuel O/O-3358-2017; Hixson, Kim/AAW-2332-2020; Hixson, Kim/AAJ-7714-2020	Purvine, Samuel O/0000-0002-2257-2400; Hixson, Kim/0000-0003-3915-7040; Hixson, Kim/0000-0003-3716-0326; Silby, Mark/0000-0002-3092-8008	US Department of Energy, Office of Biological and Environmental Research [43488, DE-AC05-76RL01830]; United States Department of Agriculture [2006-35604-16673]; Natural Sciences and Engineering Research Council of Canada	US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); United States Department of Agriculture(United States Department of Agriculture (USDA)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Portions of this research were conducted at the Environmental Molecular Sciences Laboratory (EMSL), U. S. Department of Energy ( DOE) national scientific user facility located at the Pacific Northwest National Laboratory in Richland, Washington. This work was supported by the US Department of Energy, Office of Biological and Environmental Research ( project 43488), and the United States Department of Agriculture ( grant 2006-35604-16673 to SBL). PNNL is a multi-program national laboratory operated by Battelle Memorial Institute for the DOE under Contract DE-AC05-76RL01830. W.K. was supported in part by a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; BARRELL BG, 1976, NATURE, V264, P34, DOI 10.1038/264034a0; BARRICK D, 1994, NUCLEIC ACIDS RES, V22, P1287, DOI 10.1093/nar/22.7.1287; Behrens M, 2002, INFECT IMMUN, V70, P2915, DOI 10.1128/IAI.70.6.2915-2925.2002; BEREMAND MN, 1979, CELL, V18, P257, DOI 10.1016/0092-8674(79)90045-X; Callister SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001542; Castellana NE, 2008, P NATL ACAD SCI USA, V105, P21034, DOI 10.1073/pnas.0811066106; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; COMPEAU G, 1988, APPL ENVIRON MICROB, V54, P2432, DOI 10.1128/AEM.54.10.2432-2438.1988; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Delaye L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-31; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; DREYFUS M, 1988, J MOL BIOL, V204, P79, DOI 10.1016/0022-2836(88)90601-8; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FASANO A, 1995, J CLIN INVEST, V95, P2853, DOI 10.1172/JCI117991; Fukuda Y, 2003, GENE, V323, P181, DOI 10.1016/j.gene.2003.09.021; GODSON GN, 1978, NATURE, V276, P236, DOI 10.1038/276236a0; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Johnson ZI, 2004, GENOME RES, V14, P2268, DOI 10.1101/gr.2433104; KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/pnas.89.20.9489; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim W, 2008, APPL ENVIRON MICROB, V74, P3644, DOI 10.1128/AEM.00429-08; KING EO, 1954, J LAB CLIN MED, V44, P301; Kirner S, 1996, MICROBIOL-UK, V142, P2129, DOI 10.1099/13500872-142-8-2129; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Nagy A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-353; NORMARK S, 1983, ANNU REV GENET, V17, P499, DOI 10.1146/annurev.ge.17.120183.002435; Ochman H, 2002, TRENDS GENET, V18, P335, DOI 10.1016/S0168-9525(02)02668-9; RAK B, 1982, NATURE, V297, P124, DOI 10.1038/297124a0; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Robleto EA, 2003, J BACTERIOL, V185, P453, DOI 10.1128/JB.185.2.453-460.2003; Rowland SL, 2004, MOL CELL, V13, P689, DOI 10.1016/S1097-2765(04)00084-X; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sakharkar KR, 2005, INT J SYST EVOL MICR, V55, P1205, DOI 10.1099/ijs.0.63446-0; Silby MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000094; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Silby MW, 2004, J BACTERIOL, V186, P7411, DOI 10.1128/JB.186.21.7411-7419.2004; Silby MW, 2004, MICROBIOL-SGM, V150, P518, DOI 10.1099/mic.0.26871-0; Veloso F, 2005, OMICS, V9, P91, DOI 10.1089/omi.2005.9.91; Wang LF, 1999, J BACTERIOL, V181, P353, DOI 10.1128/JB.181.1.353-356.1999; Wong RSY, 2000, MOL MICROBIOL, V37, P364, DOI 10.1046/j.1365-2958.2000.01998.x	42	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8455	10.1371/journal.pone.0008455	http://dx.doi.org/10.1371/journal.pone.0008455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041161	Green Published, Green Submitted, gold			2022-12-25	WOS:000273104000017
J	Dharajiya, N; Vaidya, S; Sinha, M; Luxon, B; Boldogh, I; Sur, S				Dharajiya, Nilesh; Vaidya, Swapnil; Sinha, Mala; Luxon, Bruce; Boldogh, Istvan; Sur, Sanjiv			Allergen Challenge Induces Ifng Dependent GTPases in the Lungs as Part of a Th1 Transcriptome Response in a Murine Model of Allergic Asthma	PLOS ONE			English	Article							INTERFERON-INDUCED GTPASES; T-CELLS; AIRWAY INFLAMMATION; CYTOKINE PRODUCTION; GENE-EXPRESSION; DEFICIENT MICE; P47 GTPASES; MOUSE MODEL; GAMMA; IMMUNITY	According to the current paradigm, allergic airway inflammation is mediated by Th2 cytokines and pro-inflammatory chemokines. Since allergic inflammation is self-limited, we hypothesized that allergen challenge simultaneously induces anti-inflammatory genes to counter-balance the effects of Th2 cytokines and chemokines. To identify these putative anti-inflammatory genes, we compared the gene expression profile in the lungs of ragweed-sensitized mice four hours after challenge with either PBS or ragweed extract (RWE) using a micro-array platform. Consistent with our hypothesis, RWE challenge concurrently upregulated Th1-associated early target genes of the Il12/Stat4 pathway, such as p47 and p65 GTPases (Iigp, Tgtp and Gbp1), Socs1, Cxcl9, Cxcl10 and Gadd45g with the Th2 genes Il4, Il5, Ccl2 and Ccl7. These Th1-associated genes remain upregulated longer than the Th2 genes. Augmentation of the local Th1 milieu by administration of Il12 or CpG prior to RWE challenge further upregulated these Th1 genes. Abolition of the Th1 response by disrupting the Ifng gene increased allergic airway inflammation and abrogated RWE challenge-induced upregulation of GTPases, Cxcl9, Cxcl10 and Socs1, but not Gadd45g. Our data demonstrate that allergen challenge induces two sets of Th1-associated genes in the lungs: 1) Ifng-dependent genes such as p47 and p65 GTPases, Socs1, Cxcl9 and Cxcl10 and 2) Ifng-independent Th1-inducing genes like Gadd45g. We propose that allergen-induced airway inflammation is regulated by simultaneous upregulation of Th1 and Th2 genes, and that persistent unopposed upregulation of Th1 genes resolves allergic inflammation.	[Dharajiya, Nilesh; Vaidya, Swapnil; Sur, Sanjiv] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Sinha, Mala; Luxon, Bruce] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Dharajiya, N (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	sasur@utmb.edu	Luxon, Bruce A/C-9140-2012		National Institutes of Health [1R01 HL071163]; NIAID Program Project [1P01 AI062885]; National Heart, Lung and Blood Institute Proteomics Initiative [N01-HV28184]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028184] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Program Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung and Blood Institute Proteomics Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grants from National Institutes of Health (#1R01 HL071163 S. Sur), NIAID Program Project Grant (# 1P01 AI062885 S. Sur, PI on Project 4), National Heart, Lung and Blood Institute Proteomics Initiative (# N01-HV28184) to S. Sur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloebaum RM, 2004, CURR OPIN ALLERGY CL, V4, P63, DOI 10.1097/01.all.0000113681.18759.5e; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Boniface S, 2003, CLIN EXP ALLERGY, V33, P1238, DOI 10.1046/j.1365-2222.2003.01762.x; Carlow DA, 1998, J IMMUNOL, V161, P2348; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; CEMBRZYNSKANOWAK M, 1993, AM REV RESPIR DIS, V147, P291, DOI 10.1164/ajrccm/147.2.291; Choudhury BK, 2002, J IMMUNOL, V169, P5955, DOI 10.4049/jimmunol.169.10.5955; Chtanova T, 2001, J IMMUNOL, V167, P3057, DOI 10.4049/jimmunol.167.6.3057; Conti P, 2001, ALLERGY ASTHMA PROC, V22, P133, DOI 10.2500/108854101778148737; Coyle AJ, 1996, J IMMUNOL, V156, P2680; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Foster PS, 2001, IMMUNOL REV, V179, P173, DOI 10.1034/j.1600-065X.2001.790117.x; Hiroi M, 2003, BIOCHEM J, V376, P393, DOI 10.1042/BJ20030842; HUNT LW, 1994, AM J RESP CRIT CARE, V149, P1471, DOI 10.1164/ajrccm.149.6.8004300; Kopf M, 1995, IMMUNOL REV, V148, P45, DOI 10.1111/j.1600-065X.1995.tb00093.x; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Leonard P, 2003, BIODRUGS, V17, P1, DOI 10.2165/00063030-200317010-00001; Lu BF, 2001, IMMUNITY, V14, P583, DOI 10.1016/S1074-7613(01)00141-8; Lund RJ, 2007, J IMMUNOL, V178, P3648, DOI 10.4049/jimmunol.178.6.3648; Lund RJ, 2004, J IMMUNOL, V172, P6775, DOI 10.4049/jimmunol.172.11.6775; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Michalec L, 2002, J IMMUNOL, V168, P846, DOI 10.4049/jimmunol.168.2.846; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; SHAPIRA SK, 1991, P NATL ACAD SCI USA, V88, P7528, DOI 10.1073/pnas.88.17.7528; Sur S, 2000, EXP LUNG RES, V26, P457; Sur S, 1996, J IMMUNOL, V157, P4173; Sur S, 1999, J IMMUNOL, V162, P6284; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Vestal DJ, 1998, J INTERF CYTOK RES, V18, P977, DOI 10.1089/jir.1998.18.977; Vestal DJ, 2000, J INTERF CYTOK RES, V20, P991, DOI 10.1089/10799900050198435; Walker PS, 1999, P NATL ACAD SCI USA, V96, P6970, DOI 10.1073/pnas.96.12.6970; Wild JS, 2000, J IMMUNOL, V164, P2701, DOI 10.4049/jimmunol.164.5.2701; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Zerrahn J, 2002, J IMMUNOL, V168, P3428, DOI 10.4049/jimmunol.168.7.3428	39	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8172	10.1371/journal.pone.0008172	http://dx.doi.org/10.1371/journal.pone.0008172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027288	Green Published, gold, Green Submitted			2022-12-25	WOS:000272940100001
J	Hwang-Verslues, WW; Kuo, WH; Chang, PH; Pan, CC; Wang, HH; Tsai, ST; Jeng, YM; Shew, JY; Kung, JT; Chen, CH; Lee, EYHP; Chang, KJ; Lee, WH				Hwang-Verslues, Wendy W.; Kuo, Wen-Hung; Chang, Po-Hao; Pan, Chi-Chun; Wang, Hsing-Hui; Tsai, Sheng-Ta; Jeng, Yung-Ming; Shew, Jin-Yu; Kung, John T.; Chen, Chung-Hsuan; Lee, Eva Y. -H. P.; Chang, King-Jen; Lee, Wen-Hwa			Multiple Lineages of Human Breast Cancer Stem/Progenitor Cells Identified by Profiling with Stem Cell Markers	PLOS ONE			English	Article							EXPRESSION; TUMORS; PROGENITORS; CD44(+)/CD24(-); TRANSPORTER; METASTASIS; PHENOTYPE; DISORDER; DIVISION; SUBTYPES	Heterogeneity of cancer stem/progenitor cells that give rise to different forms of cancer has been well demonstrated for leukemia. However, this fundamental concept has yet to be established for solid tumors including breast cancer. In this communication, we analyzed solid tumor cancer stem cell markers in human breast cancer cell lines and primary specimens using flow cytometry. The stem/progenitor cell properties of different marker expressing-cell populations were further assessed by in vitro soft agar colony formation assay and the ability to form tumors in NOD/SCID mice. We found that the expression of stem cell markers varied greatly among breast cancer cell lines. In MDA-MB-231 cells, PROCR and ESA, instead of the widely used breast cancer stem cell markers CD44(+)/CD24(-/low) and ALDH, could be used to highly enrich cancer stem/progenitor cell populations which exhibited the ability to self renew and divide asymmetrically. Furthermore, the PROCR(+)/ESA(+) cells expressed epithelial-mesenchymal transition markers. PROCR could also be used to enrich cells with colony forming ability from MB-361 cells. Moreover, consistent with the marker profiling using cell lines, the expression of stem cell markers differed greatly among primary tumors. There was an association between metastasis status and a high prevalence of certain markers including CD44(+)/CD24(-/low), ESA(+), CD133(+), CXCR4(+) and PROCR(+) in primary tumor cells. Taken together, these results suggest that similar to leukemia, several stem/progenitor cell-like subpopulations can exist in breast cancer.	[Hwang-Verslues, Wendy W.; Chang, Po-Hao; Pan, Chi-Chun; Wang, Hsing-Hui; Tsai, Sheng-Ta; Shew, Jin-Yu; Chen, Chung-Hsuan; Lee, Eva Y. -H. P.; Lee, Wen-Hwa] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Kuo, Wen-Hung; Chang, King-Jen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Jeng, Yung-Ming] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Kung, John T.] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Lee, Eva Y. -H. P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Lee, Eva Y. -H. P.; Lee, Wen-Hwa] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; University of California System; University of California Irvine; University of California System; University of California Irvine	Hwang-Verslues, WW (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	elee@uci.edu; kingjen@ntu.edu.tw; whlee@uci.edu	Kung, John T/AAZ-8354-2021; Chen, Chung-Hsuan/F-7940-2012; Lee, Wen-Hwa/C-2519-2014	Kung, John T/0000-0001-9052-1392; Wang, Hsing-Hui/0000-0003-3283-9583; JENG, YUNG-MING/0000-0002-3878-4491; Chang, King jen/0000-0001-9811-3422; KUO, WEN-HUNG/0000-0002-9881-4605; Hwang-Verslues, Wendy/0000-0002-0383-1710	Academia Sinica Peak Project [2371, 4012]; Academia Sinica Distinguished Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA094170] Funding Source: NIH RePORTER	Academia Sinica Peak Project(Academia Sinica - Taiwan); Academia Sinica Distinguished Postdoctoral Fellowship(Academia Sinica - Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Academia Sinica Peak Project (grant number 2371, 4012, http://www.sinica.edu.tw) and an Academia Sinica Distinguished Postdoctoral Fellowship (http://aao.sinica.edu.tw/pfjob-e.html) to WWHV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cai JL, 2004, J NEUROCHEM, V88, P212, DOI 10.1046/j.1471-4159.2003.02184.x; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dittmer A, 2008, CANCER LETT, V260, P56, DOI 10.1016/j.canlet.2007.10.020; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hwang-Verslues WW, 2008, J FORMOS MED ASSOC, V107, P751, DOI 10.1016/S0929-6646(08)60188-6; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Korkaya H, 2008, ONCOGENE; Krause DS, 2007, TRENDS MOL MED, V13, P470, DOI 10.1016/j.molmed.2007.09.003; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lechner A, 2002, BIOCHEM BIOPH RES CO, V293, P670, DOI 10.1016/S0006-291X(02)00275-9; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Vercauteren SM, 2001, CYTOTHERAPY, V3, P449, DOI 10.1080/146532401317248054; Wang S, 2006, CURR BIOL, V16, P2239, DOI 10.1016/j.cub.2006.09.034; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	44	171	191	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8377	10.1371/journal.pone.0008377	http://dx.doi.org/10.1371/journal.pone.0008377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027313	Green Published, Green Submitted, gold			2022-12-25	WOS:000272940100013
J	Yang, S; Bourne, PE				Yang, Song; Bourne, Philip E.			The Evolutionary History of Protein Domains Viewed by Species Phylogeny	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; MULTIDOMAIN PROTEINS; GENOME EVOLUTION; QUANTIFICATION; DUPLICATION; LIFE; REARRANGEMENTS; ARCHITECTURES; COMBINATIONS; DIVERGENCE	Background: Protein structural domains are evolutionary units whose relationships can be detected over long evolutionary distances. The evolutionary history of protein domains, including the origin of protein domains, the identification of domain loss, transfer, duplication and combination with other domains to form new proteins, and the formation of the entire protein domain repertoire, are of great interest. Methodology/Principal Findings: A methodology is presented for providing a parsimonious domain history based on gain, loss, vertical and horizontal transfer derived from the complete genomic domain assignments of 1015 organisms across the tree of life. When mapped to species trees the evolutionary history of domains and domain combinations is revealed, and the general evolutionary trend of domain and combination is analyzed. Conclusions/Significance: We show that this approach provides a powerful tool to study how new proteins and functions emerged and to study such processes as horizontal gene transfer among more distant species.	[Yang, Song; Bourne, Philip E.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA	University of California System; University of California San Diego	Yang, S (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA.	pbourne@ucsd.edu	Bourne, Philip E/C-2073-2008		National Institutes of Health (NIH) [GM 078596]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078596] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (NIH) grant GM 078596. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bjorklund AK, 2005, J MOL BIOL, V353, P911, DOI 10.1016/j.jmb.2005.08.067; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Doolittle WF, 2007, P NATL ACAD SCI USA, V104, P2043, DOI 10.1073/pnas.0610699104; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Ekman D, 2007, J MOL BIOL, V372, P1337, DOI 10.1016/j.jmb.2007.06.022; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fong JH, 2007, J MOL BIOL, V366, P307, DOI 10.1016/j.jmb.2006.11.017; Gough J, 2005, BIOINFORMATICS, V21, P1464, DOI 10.1093/bioinformatics/bti204; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Itoh M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r121; Koonin EV, 2000, ANNU REV GENOM HUM G, V1, P99, DOI 10.1146/annurev.genom.1.1.99; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kummerfeld SK, 2005, TRENDS GENET, V21, P25, DOI 10.1016/j.tig.2004.11.007; Lee D, 2003, CURR OPIN STRUC BIOL, V13, P359, DOI 10.1016/S0959-440X(03)00079-4; Lee Y, 2006, P NATL ACAD SCI USA, V103, P17885, DOI 10.1073/pnas.0608344103; Lin J, 2000, GENOME RES, V10, P808, DOI 10.1101/gr.10.6.808; Molina F, 1996, EUR J BIOCHEM, V240, P125, DOI 10.1111/j.1432-1033.1996.0125h.x; Moore AD, 2008, TRENDS BIOCHEM SCI, V33, P444, DOI 10.1016/j.tibs.2008.05.008; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [10.1005667/978-3-642-86659-3.567, 10.1007/978-3-642-86659-3, DOI 10.1007/978-3-642-86659-3, 10. 1007/978-3-642-86659-3]; Padyana AK, 2001, BIOCHEM BIOPH RES CO, V282, P893, DOI 10.1006/bbrc.2001.4663; Pasek S, 2006, BIOINFORMATICS, V22, P1418, DOI 10.1093/bioinformatics/btl135; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; Ranea JAG, 2004, J MOL BIOL, V336, P871, DOI 10.1016/j.jmb.2003.12.044; Ranea JAG, 2006, J MOL EVOL, V63, P513, DOI 10.1007/s00239-005-0289-7; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Simpson AGB, 2002, MOL BIOL EVOL, V19, P2071, DOI 10.1093/oxfordjournals.molbev.a004032; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Stern LJ, 2006, CURR OPIN IMMUNOL, V18, P64, DOI 10.1016/j.coi.2005.11.005; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Vogel C, 2005, J MOL BIOL, V346, P355, DOI 10.1016/j.jmb.2004.11.050; Vogel C, 2006, BIOESSAYS, V28, P973, DOI 10.1002/bies.20474; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Wolf YI, 1999, GENOME RES, V9, P17; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306	43	58	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8378	10.1371/journal.pone.0008378	http://dx.doi.org/10.1371/journal.pone.0008378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20041107	Green Published, gold			2022-12-25	WOS:000272940100014
J	Busillo, JM; Armando, S; Sengupta, R; Meucci, O; Bouvier, M; Benovic, JL				Busillo, John M.; Armando, Sylvain; Sengupta, Rajarshi; Meucci, Olimpia; Bouvier, Michel; Benovic, Jeffrey L.			Site-specific Phosphorylation of CXCR4 Is Dynamically Regulated by Multiple Kinases and Results in Differential Modulation of CXCR4 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; MEDIATED ERK ACTIVATION; ANGIOTENSIN-II RECEPTOR; BETA-ARRESTIN; WHIM-SYNDROME; CHEMOKINE RECEPTORS; POSTTRANSLATIONAL MODIFICATIONS; DISTINCT MECHANISMS; PIVOTAL ROLE; LIGASE AIP4	The chemokine receptor CXCR4 is a widely expressed G protein-coupled receptor that has been implicated in a number of diseases including human immunodeficiency virus, cancer, and WHIM syndrome, with the latter two involving dysregulation of CXCR4 signaling. To better understand the role of phosphorylation in regulating CXCR4 signaling, tandem mass spectrometry and phospho-specific antibodies were used to identify sites of agonist-promoted phosphorylation. These studies demonstrated that Ser-321, Ser-324, Ser-325, Ser-330, Ser-339, and two sites between Ser-346 and Ser-352 were phosphorylated in HEK293 cells. We show that Ser-324/5 was rapidly phosphorylated by protein kinase C and G protein-coupled receptor kinase 6 (GRK6) upon CXCL12 treatment, whereas Ser-339 was specifically and rapidly phosphorylated by GRK6. Ser-330 was also phosphorylated by GRK6, albeit with slower kinetics. Similar results were observed in human astroglia cells, where endogenous CXCR4 was rapidly phosphorylated on Ser-324/5 by protein kinase C after CXCL12 treatment, whereas Ser-330 was slowly phosphorylated. Analysis of CXCR4 signaling in HEK293 cells revealed that calcium mobilization was primarily negatively regulated by GRK2, GRK6, and arrestin3, whereas GRK3, GRK6, and arrestin2 played a primary role in positively regulating ERK1/2 activation. In contrast, GRK2 appeared to play a negative role in ERK1/2 activation. Finally, we show that arrestin association with CXCR4 is primarily driven by the phosphorylation of far C-terminal residues on the receptor. These studies reveal that site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases resulting in both positive and negative modulation of CXCR4 signaling.	[Busillo, John M.; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Armando, Sylvain; Bouvier, Michel] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada; [Sengupta, Rajarshi; Meucci, Olimpia] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA	Jefferson University; Universite de Montreal; Drexel University	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	benovic@mail.jci.tju.edu	Bouvier, Michel/H-2758-2014	Bouvier, Michel/0000-0003-1128-0100	National Institutes of Health [GM44944, GM47417, CA129626, DA15014, DA19808]; Pennsylvania Department of Health [AB-0301]; NATIONAL CANCER INSTITUTE [R01CA129626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944, R01GM047417, R37GM047417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015014, R01DA019808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM44944, GM47417, and CA129626 (to J. L. B.) and DA15014 and DA19808 (to O. M.). This work was also supported by Pennsylvania Department of Health Grant AB-0301.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Carr SA, 2005, METHOD ENZYMOL, V405, P82, DOI 10.1016/S0076-6879(05)05005-6; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; COHEN P, 1992, TRENDS BIOCHEM SCI, V17, P408, DOI 10.1016/0968-0004(92)90010-7; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Diaz GA, 2005, CURR ALLERGY ASTHM R, V5, P350, DOI 10.1007/s11882-005-0005-0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Jafri F, 2006, J BIOL CHEM, V281, P19346, DOI 10.1074/jbc.M512643200; Jimenez-Sainz MC, 2006, MOL BIOL CELL, V17, P25, DOI 10.1091/mbc.e05-05-0399; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; Khan MZ, 2004, AIDS RES HUM RETROV, V20, P1063, DOI 10.1089/aid.2004.20.1063; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Kuo FT, 2006, CELL SIGNAL, V18, P1914, DOI 10.1016/j.cellsig.2006.02.009; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McCormick PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008102; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Oliva JL, 2008, J BIOL CHEM, V283, P5466, DOI 10.1074/jbc.M707576200; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Pfleger KDG, 2007, BIOCHEM SOC T, V35, P764, DOI 10.1042/BST0350764; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Pollok-Kopp B, 2003, J BIOL CHEM, V278, P2190, DOI 10.1074/jbc.M209844200; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Schulz S, 2004, EMBO J, V23, P3282, DOI 10.1038/sj.emboj.7600334; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Signoret N, 1998, J CELL SCI, V111, P2819; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Trester-Zedlitz M, 2005, BIOCHEMISTRY-US, V44, P6133, DOI 10.1021/bi0475469; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Vroon A, 2004, J LEUKOCYTE BIOL, V75, P698, DOI 10.1189/jlb.0703320; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; Woerner BM, 2005, CANCER RES, V65, P11392, DOI 10.1158/0008-5472.CAN-05-0847; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Zlotnik A, 2006, CONTRIB MICROBIOL, V13, P191, DOI 10.1159/000092973	65	199	211	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7805	7817		10.1074/jbc.M109.091173	http://dx.doi.org/10.1074/jbc.M109.091173			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048153	Green Published, hybrid			2022-12-25	WOS:000275415600088
J	Kim, MS; Yang, YM; Son, A; Tian, YS; Lee, SI; Kang, SW; Muallem, S; Shin, DM				Kim, Min Seuk; Yang, Yu-Mi; Son, Aran; Tian, Yu Shun; Lee, Syng-Ill; Kang, Sang Won; Muallem, Shmuel; Shin, Dong Min			RANKL-mediated Reactive Oxygen Species Pathway That Induces Long Lasting Ca2+ Oscillations Essential for Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPH-NODE ORGANOGENESIS; RECEPTOR ACTIVATOR; HYDROGEN-PEROXIDE; BONE HOMEOSTASIS; FREE-RADICALS; CELL-FUNCTION; DIFFERENTIATION; CALCIUM; EXPRESSION; CHANNELS	RANKL (receptor activator of NF-kappa B ligand) induces osteoclastogenesis by activating multiple signaling pathways in osteoclast precursor cells, chief among which is induction of long lasting oscillations in the intracellular concentration of Ca2+ ([Ca2+](i)). The [Ca2+](i) oscillations activate calcineurin, which activates the transcription factor NFATc1. The pathway by which RANKL induces [Ca2+](i) oscillations and osteoclastogenesis is poorly understood. Here we report the discovery of a novel pathway induced by RANKL to cause a long lasting increase in reactive oxygen species (ROS) and [Ca2+](i) oscillations that is essential for differentiation of bone marrow-derived monocytes into osteoclasts. The pathway includes RANKL-mediated stimulation of Rac1 to generate ROS, which stimulate phospholipase C gamma 1 to evoke [Ca2+](i) oscillations by stimulating Ca2+ release from the inositol 1,4,5-trisphosphate pool and STIM1-regulated Ca2+ influx. Induction and activation of the pathway is observed only after 24-h stimulation with RANKL and lasts for at least 3 days. The physiological role of the pathway is demonstrated in mice with deletion of the Peroxiredoxin II gene and results in a mark increase is ROS and, consequently, a decrease in bone density. Moreover, bone marrow-derived monocytes in PrxII(-/-) primary culture show increased ROS and spontaneous [Ca2+](i) oscillations. These findings identify the primary RANKL-stimulated pathway to trigger the late stages of osteoclastogenesis and regulate bone resorption.	[Kim, Min Seuk; Yang, Yu-Mi; Son, Aran; Tian, Yu Shun; Lee, Syng-Ill; Shin, Dong Min] Yonsei Univ, Coll Dent, Dept Oral Biol,Brain Korea Project 21, Oral Sci Res Ctr,Ctr Nat Def Syst, Seoul 120752, South Korea; [Kang, Sang Won] Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; [Kang, Sang Won] Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea; [Muallem, Shmuel] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Yonsei University; Yonsei University Health System; Ewha Womans University; Ewha Womans University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Shin, DM (corresponding author), Yonsei Univ, Coll Dent, Dept Oral Biol,Brain Korea Project 21, Oral Sci Res Ctr,Ctr Nat Def Syst, 134 Shinchon Dong, Seoul 120752, South Korea.	dmshin@yuhs.ac		Shin, Dong Min/0000-0001-6042-0435	Korea Healthcare Technology R & D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A084007]	Korea Healthcare Technology R & D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea	This work was supported by Grant A084007 from the Korea Healthcare Technology R & D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; HARRIS ML, 1992, PHARMACOL THERAPEUT, V53, P375, DOI 10.1016/0163-7258(92)90057-7; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kiselyov K, 2006, CELL CALCIUM, V40, P451, DOI 10.1016/j.ceca.2006.08.009; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Marks SC, 2000, INT J DEV BIOL, V44, P309; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; MAYINGI J, 2007, C P IEEE ENG MED BIO, P5119; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Pignatelli P, 1998, BLOOD, V91, P484, DOI 10.1182/blood.V91.2.484.484_484_490; Ramanadham S, 2008, AM J PATHOL, V172, P868, DOI 10.2353/ajpath.2008.070756; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Thyagarajan B, 2001, J BIOL CHEM, V276, P48149, DOI 10.1074/jbc.M103977200; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Varela D, 2004, J BIOL CHEM, V279, P13301, DOI 10.1074/jbc.C400020200; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	46	149	155	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6913	6921		10.1074/jbc.M109.051557	http://dx.doi.org/10.1074/jbc.M109.051557			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048168	hybrid, Green Published			2022-12-25	WOS:000275415600005
J	Vora, SR; Palamakumbura, AH; Mitsi, M; Guo, Y; Pischon, N; Nugent, MA; Trackman, PC				Vora, Siddharth R.; Palamakumbura, Amitha H.; Mitsi, Maria; Guo, Ying; Pischon, Nicole; Nugent, Matthew A.; Trackman, Philip C.			Lysyl Oxidase Propeptide Inhibits FGF-2-induced Signaling and Proliferation of Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; TUMOR-SUPPRESSOR ACTIVITY; COLLAGEN GENE-EXPRESSION; CELL-GROWTH; TRANSCRIPTION FACTOR; BONE-FORMATION; CROSS-LINKS; RECEPTOR; FACTOR-2; BINDING	Pro-lysyl oxidase is secreted as a 50-kDa proenzyme and is then cleaved to a 30-kDa mature enzyme (lysyl oxidase (LOX)) and an 18-kDa propeptide ( lysyl oxidase propeptide (LOX-PP)). The presence of LOX-PP in the cell layers of phenotypically normal osteoblast cultures led us to investigate the effects of LOX-PP on osteoblast differentiation. Data indicate that LOX-PP inhibits terminal mineralization in primary calvaria osteoblast cultures when added at early stages of differentiation, with no effects seen when present at later stages. LOX-PP was found to inhibit serum-and FGF-2-stimulated DNA synthesis and FGF-2-stimulated cell growth. Enzyme-linked immunosorbent assay and Western blot analyses show that LOX-PP inhibits FGF-2-induced ERK1/2 phosphorylation, signaling events that mediate the FGF-2-induced proliferative response. LOX-PP inhibits FGF-2-stimulated phosphorylation of FRS2 alpha and FGF-2-stimulated DNA synthesis, even after inhibition of sulfation of heparan sulfate proteoglycans. These data point to a LOX-PP target at or near the level of fibroblast growth factor receptor binding or activation. Ligand binding assays on osteoblast cell layers with I-125-FGF-2 demonstrate a concentration-dependent inhibition of FGF-2 binding to osteoblasts by LOX-PP. In vitro binding assays with recombinant fibroblast growth factor receptor protein revealed that LOX-PP inhibits FGF-2 binding in an uncompetitive manner. We propose a working model for the respective roles of LOX enzyme and LOX-PP in osteoblast phenotype development in which LOX-PP may act to inhibit the proliferative response possibly to allow cells to exit from the cell cycle and progress to the next stages of differentiation.	[Trackman, Philip C.] Boston Univ, Dept Periodontol & Oral Biol, Goldman Sch Dent Med, Boston, MA 02118 USA; [Mitsi, Maria; Nugent, Matthew A.; Trackman, Philip C.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University	Trackman, PC (corresponding author), Boston Univ, Dept Periodontol & Oral Biol, Goldman Sch Dent Med, 700 Albany St, Boston, MA 02118 USA.	trackman@bu.edu	Trackman, Philip C/AAX-9280-2021; Mitsi, Maria/S-2519-2017	Trackman, Philip C/0000-0001-5064-614X; Nugent, Matthew/0000-0002-8630-4712; Mitsi, Maria/0000-0001-8983-1983	NIDCR, National Institutes of Health [R01 DE14066]; NHLBI, National Institutes of Health [R01 HL56200]; Department of Defense [W81XWH-08-1-0349]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014066] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DE14066 from NIDCR and R01 HL56200 from NHLBI. This work was also supported by Department of Defense Award W81XWH-08-1-0349.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; BAYLINK DJ, 1993, J BONE MINER RES, V8, pS565; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; BERRADA S, 1995, IN VITRO CELL DEV-AN, V31, P698; Boudreaux JM, 1996, J BIOL CHEM, V271, P7508, DOI 10.1074/jbc.271.13.7508; CANALIS E, 1991, ANNU REV MED, V42, P17, DOI 10.1146/annurev.med.42.1.17; CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490; CHEN HSV, 1992, J NEUROSCI, V12, P4427; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; CRONSHAW AD, 1995, BIOCHEM J, V306, P279, DOI 10.1042/bj3060279; De Luca F, 1999, TRENDS ENDOCRIN MET, V10, P61, DOI 10.1016/S1043-2760(98)00120-9; Debiais F, 1998, J BONE MINER RES, V13, P645, DOI 10.1359/jbmr.1998.13.4.645; Fakhry A, 2005, BONE, V36, P254, DOI 10.1016/j.bone.2004.10.003; Fang MA, 2001, J CELL BIOCHEM, V80, P550, DOI 10.1002/1097-4644(20010315)80:4<550::AID-JCB1009>3.3.CO;2-T; Fannon M, 1996, J BIOL CHEM, V271, P17949, DOI 10.1074/jbc.271.30.17949; Feres EJ, 1996, J BIOL CHEM, V271, P6411, DOI 10.1074/jbc.271.11.6411; FRIESEL R, 1986, J BIOL CHEM, V261, P7581; GERSTENFELD LC, 1993, J BONE MINER RES, V8, P1031; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Guo Y, 2007, AM J PHYSIOL-CELL PH, V292, pC2095, DOI 10.1152/ajpcell.00613.2006; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; HOLTHUIS J, 1990, SCIENCE, V247, P1454, DOI 10.1126/science.2321007; Hong HH, 2004, J CELL PHYSIOL, V200, P53, DOI 10.1002/jcp.10476; Hong HH, 1999, LAB INVEST, V79, P1655; Hsieh SC, 1998, J CELL BIOCHEM, V69, P169, DOI 10.1002/(SICI)1097-4644(19980501)69:2<169::AID-JCB7>3.0.CO;2-Q; HURLEY MM, 1993, J BIOL CHEM, V268, P5588; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; Jackson RA, 2007, J CELL PHYSIOL, V210, P38, DOI 10.1002/jcp.20813; Jackson RA, 2006, GENE, V379, P79, DOI 10.1016/j.gene.2006.04.028; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; Kalajzic I, 2003, J CELL BIOCHEM, V88, P1168, DOI 10.1002/jcb.10459; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Kim HJ, 2003, DEV DYNAM, V227, P335, DOI 10.1002/dvdy.10319; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Li CF, 2006, J BONE MINER RES, V21, P946, DOI 10.1359/JBMR.060309; Lian J B, 1995, Iowa Orthop J, V15, P118; Ling L, 2006, J CELL PHYSIOL, V209, P811, DOI 10.1002/jcp.20760; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; Okazaki H, 1999, CALCIFIED TISSUE INT, V64, P542, DOI 10.1007/s002239900646; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; OXLUND H, 1995, BONE, V17, pS365, DOI 10.1016/8756-3282(95)00328-B; Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; PALAMAKUMBURA AH, 2008, J DENT RES, V87, P854; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; Pischon N, 2009, CALCIFIED TISSUE INT, V85, P119, DOI 10.1007/s00223-009-9252-8; RODAN SB, 1989, J BIOL CHEM, V264, P19934; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Tanaka H, 1999, MOL CELL ENDOCRINOL, V150, P1, DOI 10.1016/S0303-7207(99)00046-5; Tang CH, 2007, J CELL PHYSIOL, V211, P45, DOI 10.1002/jcp.20896; Trackman PC, 2005, J CELL BIOCHEM, V96, P927, DOI 10.1002/jcb.20605; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhao YS, 2009, J BIOL CHEM, V284, P1385, DOI 10.1074/jbc.M802612200	80	38	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7384	7393		10.1074/jbc.M109.033597	http://dx.doi.org/10.1074/jbc.M109.033597			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048148	Green Published, hybrid			2022-12-25	WOS:000275415600051
J	Masuda, K; Ishikawa, Y; Onoyama, I; Unno, M; de Alboran, IM; Nakayama, KI; Nakayama, K				Masuda, K.; Ishikawa, Y.; Onoyama, I.; Unno, M.; de Alboran, I. M.; Nakayama, K. I.; Nakayama, K.			Complex regulation of cell-cycle inhibitors by Fbxw7 in mouse embryonic fibroblasts	ONCOGENE			English	Article						cell cycle; CDK inhibitor; ubiquitin ligase; SCF complex; Notch; conditional knockout mouse	F-BOX PROTEIN; FBW7 UBIQUITIN LIGASE; C-MYC; TUMOR-SUPPRESSOR; MICE LACKING; P27(KIP1); NUCLEOPHOSMIN; DEGRADATION; P57(KIP2); EXIT	The F-box protein Fbxw7 (also known as Fbw7, SEL-10, hCdc4 or hAgo) mediates the ubiquitylation and thereby contributes to the degradation of proteins that positively regulate cell cycle. Conditional ablation of Fbxw7 in mouse embryonic fibroblasts (MEFs) induces cell-cycle arrest accompanied by abnormal accumulation of the intracellular domain of Notch1 (NICD1) and c-Myc. However, the molecular mechanisms by which the accumulation of NICD1 and c-Myc induces cell-cycle arrest have remained unclear. We have now examined the expression of cell-cycle inhibitors in Fbxw7-deficient MEFs and found that the abundance of p27(Kip1) and p57(Kip2) is paradoxically decreased. This phenomenon appears to be attributable to the accumulation of NICD1, given that it was recapitulated by overexpression of NICD1 and blocked by ablation of RBP-J. Conversely, the expression of p16(Ink4a) and p19(ARF) was increased in an NICD1-independent manner in Fbxw7-null MEFs. The increased expression of p19(ARF) was recapitulated by overexpression of c-Myc and abolished by ablation of c-Myc, suggesting that the accumulation of c-Myc is primarily responsible for that of p19(ARF). In contrast, the upregulation of p16(Ink4a) appeared to be independent of c-Myc. These results indicate that cell-cycle inhibitors undergo complex regulation by the Fbxw7-mediated proteolytic system. Oncogene (2010) 29, 1798-1809; doi:10.1038/onc.2009.469; published online 21 December 2009	[Masuda, K.; Ishikawa, Y.; Nakayama, K.] Tohoku Univ, Grad Sch Med, Dept Dev Genet, Ctr Translat & Adv Anim Res,Aoba Ku, Sendai, Miyagi 9808575, Japan; [Masuda, K.; Unno, M.] Tohoku Univ, Grad Sch Med, Dept Surg, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Masuda, K.; Ishikawa, Y.; Onoyama, I.; Nakayama, K. I.; Nakayama, K.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Onoyama, I.; Nakayama, K. I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 812, Japan; [de Alboran, I. M.] CSIC, Dept Immunol & Oncol, Natl Biotechnol Ctr, Madrid, Spain	Tohoku University; Tohoku University; Japan Science & Technology Agency (JST); Kyushu University; Consejo Superior de Investigaciones Cientificas (CSIC)	Nakayama, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Dev Genet, Ctr Translat & Adv Anim Res,Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	nakayak2@mail.tains.tohoku.ac.jp	Moreno de Alboran, Ignacio/K-1044-2017; Unno, Michiaki/AAX-5246-2020; Unno, Michiaki/A-8633-2010	Unno, Michiaki/0000-0002-2145-6416; Unno, Michiaki/0000-0002-2145-6416	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T Honjo for providing Rbpj<SUP>F/F</SUP> mice; R Tsunematsu for an NICD1 plasmid; T Kitamura for pMX-puro and Plat-E cells; T Senga, Y Ono and N Kobayashi for technical assistance; and N Yanagihara, N Ishida and other laboratory members for helpful discussion and Y Akaida for help in preparation of the paper. This study was supported in part by a Grant-in-Aid and the Network Medicine Global COE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Bonetti P, 2008, J CELL BIOL, V182, P19, DOI 10.1083/jcb.200711040; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Datta A, 2004, J BIOL CHEM, V279, P36698, DOI 10.1074/jbc.M312305200; de Alboran IM, 2004, CELL DEATH DIFFER, V11, P61, DOI 10.1038/sj.cdd.4401319; Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Ishikawa Y, 2008, ONCOGENE, V27, P6164, DOI 10.1038/onc.2008.216; Jia JL, 2007, MOL CELL BIOL, V27, P7236, DOI 10.1128/MCB.00780-07; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Li ZL, 2008, P NATL ACAD SCI USA, V105, P18794, DOI 10.1073/pnas.0806879105; Lomas J, 2008, FRONT BIOSCI-LANDMRK, V13, P5071, DOI 10.2741/3065; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Onoyama I, 2008, CELL CYCLE, V7, P3307, DOI 10.4161/cc.7.21.6931; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Solomon DA, 2008, CANCER RES, V68, P8657, DOI 10.1158/0008-5472.CAN-08-2084; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; SUNDARAM M, 1993, GENETICS, V135, P765; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Urano T, 1999, J BIOL CHEM, V274, P12197, DOI 10.1074/jbc.274.18.12197; Vernon AE, 2006, EMBO REP, V7, P643, DOI 10.1038/sj.embor.7400691; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zeller KI, 2001, J BIOL CHEM, V276, P48285, DOI 10.1074/jbc.M108506200; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	50	14	15	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	12					1798	1809		10.1038/onc.2009.469	http://dx.doi.org/10.1038/onc.2009.469			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	574VR	20023701				2022-12-25	WOS:000276022800009
J	Solis, CF; Santi-Rocca, J; Perdomo, D; Weber, C; Guillen, N				Solis, Carlos F.; Santi-Rocca, Julien; Perdomo, Doranda; Weber, Christian; Guillen, Nancy			Use of Bacterially Expressed dsRNA to Downregulate Entamoeba histolytica Gene Expression	PLOS ONE			English	Article							AMEBIC LIVER-ABSCESS; ACID-RICH PROTEIN; RNA INTERFERENCE; MOUSE MODEL; ANTISENSE INHIBITION; CYSTEINE PROTEINASES; ESCHERICHIA-COLI; LYSINE-RICH; PARASITE; SUSCEPTIBILITY	Background: Modern RNA interference (RNAi) methodologies using small interfering RNA (siRNA) oligonucleotide duplexes or episomally synthesized hairpin RNA are valuable tools for the analysis of gene function in the protozoan parasite Entamoeba histolytica. However, these approaches still require time-consuming procedures including transfection and drug selection, or costly synthetic molecules. Principal Findings: Here we report an efficient and handy alternative for E. histolytica gene down-regulation mediated by bacterial double-stranded RNA (dsRNA) targeting parasite genes. The Escherichia coli strain HT115 which is unable to degrade dsRNA, was genetically engineered to produce high quantities of long dsRNA segments targeting the genes that encode E. histolytica beta-tubulin and virulence factor KERP1. Trophozoites cultured in vitro were directly fed with dsRNA-expressing bacteria or soaked with purified dsRNA. Both dsRNA delivery methods resulted in significant reduction of protein expression. In vitro host cell-parasite assays showed that efficient downregulation of kerp1 gene expression mediated by bacterial dsRNA resulted in significant reduction of parasite adhesion and lytic capabilities, thus supporting a major role for KERP1 in the pathogenic process. Furthermore, treatment of trophozoites cultured in microtiter plates, with a repertoire of eighty-five distinct bacterial dsRNA segments targeting E. histolytica genes with unknown function, led to the identification of three genes potentially involved in the growth of the parasite. Conclusions: Our results showed that the use of bacterial dsRNA is a powerful method for the study of gene function in E. histolytica. This dsRNA delivery method is also technically suitable for the study of a large number of genes, thus opening interesting perspectives for the identification of novel drug and vaccine targets.	[Solis, Carlos F.; Santi-Rocca, Julien; Perdomo, Doranda; Weber, Christian; Guillen, Nancy] Inst Pasteur, Unite Biol Cellulaire Parasitisme, Paris, France; [Solis, Carlos F.; Santi-Rocca, Julien; Perdomo, Doranda; Weber, Christian; Guillen, Nancy] INSERM, U786, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Solis, CF (corresponding author), Inst Pasteur, Unite Biol Cellulaire Parasitisme, Paris, France.	nguillen@pasteur.fr	Santi-Rocca, Julien/AAD-2448-2020; Weber, Christian/AAW-2153-2020	Santi-Rocca, Julien/0000-0002-9791-3521; Weber, Christian/0000-0003-4610-8714; Perdomo, Doranda/0000-0001-9949-751X	Fondation pour la Recherche Medicale in France; Pasteur-Weizmann Council; European Union; Pasteur-Weizmann Research Council and Genopole Pasteur Ile de France	Fondation pour la Recherche Medicale in France(Institut National du Cancer (INCA) France); Pasteur-Weizmann Council; European Union(European Commission); Pasteur-Weizmann Research Council and Genopole Pasteur Ile de France	This work has been supported by postdoctoral fellowships from the Fondation pour la Recherche Medicale in France to CFS and to JSR as well as a postdoctoral fellowship from the Pasteur-Weizmann Council and a PhD fellowship from the "Regime Social des Independants" in France to JSR and grants to NG from INCO-DEV in the Fifth Framework Program of the European Union, Pasteur-Weizmann Research Council and Genopole Pasteur Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed M, 2005, EXP PARASITOL, V110, P265, DOI 10.1016/j.exppara.2005.02.023; Ankri S, 1999, INFECT IMMUN, V67, P421, DOI 10.1128/IAI.67.1.421-422.1999; Ankri S, 1998, MOL MICROBIOL, V28, P777, DOI 10.1046/j.1365-2958.1998.00837.x; Bansal D, 2006, INDIAN J MED RES, V123, P115; Blazquez S, 2007, INT J PARASITOL, V37, P425, DOI 10.1016/j.ijpara.2006.10.008; CEDENO JR, 1983, J INFECT DIS, V148, P1090, DOI 10.1093/infdis/148.6.1090; CIESLAK PR, 1992, J EXP MED, V176, P1605, DOI 10.1084/jem.176.6.1605; Cottrell TR, 2003, TRENDS MICROBIOL, V11, P37, DOI 10.1016/S0966-842X(02)00004-5; Daneker GW, 1998, IN VITRO CELL DEV-AN, V34, P370, DOI 10.1007/s11626-998-0018-9; De S, 2006, EXP PARASITOL, V113, P239, DOI 10.1016/j.exppara.2006.01.009; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Houpt ER, 2002, J IMMUNOL, V169, P4496, DOI 10.4049/jimmunol.169.8.4496; Issa Z, 2005, INT J PARASITOL, V35, P935, DOI 10.1016/j.ijpara.2005.06.001; Joshua-Tor L, 2006, COLD SPRING HARB SYM, V71, P67, DOI 10.1101/sqb.2006.71.048; Kaur G, 2004, BIOCHEM BIOPH RES CO, V320, P1118, DOI 10.1016/j.bbrc.2004.06.064; KOLBER MA, 1988, J IMMUNOL METHODS, V108, P255, DOI 10.1016/0022-1759(88)90427-9; Leitsch D, 2007, PLOS BIOL, V5, P1820, DOI 10.1371/journal.pbio.0050211; Linford AS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-38; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lotter H, 2006, INFECT IMMUN, V74, P118, DOI 10.1128/IAI.74.1.118-124.2006; Lotter H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000434; Mahmood-Ur-Rahman, 2008, BIOTECHNOL ADV, V26, P202, DOI 10.1016/j.biotechadv.2007.12.002; Marinets A, 1997, J EXP MED, V186, P1557, DOI 10.1084/jem.186.9.1557; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Padilla-Vaca F, 1999, INFECT IMMUN, V67, P2096, DOI 10.1128/IAI.67.5.2096-2102.1999; Pritt BS, 2008, MAYO CLIN PROC, V83, P1154, DOI 10.4065/83.10.1154; Rigothier MC, 2002, INFECT IMMUN, V70, P3208, DOI 10.1128/IAI.70.6.3208-3215.2002; Santi-Rocca J, 2008, CELL MICROBIOL, V10, P202, DOI 10.1111/j.1462-5822.2007.01030.x; Seigneur M, 2005, CELL MICROBIOL, V7, P569, DOI 10.1111/j.1462-5822.2005.00487.x; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; TAKIFF HE, 1989, J BACTERIOL, V171, P2581, DOI 10.1128/jb.171.5.2581-2590.1989; Tavares P, 2005, INFECT IMMUN, V73, P1771, DOI 10.1128/IAI.73.3.1771-1778.2005; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vayssie L, 2004, MOL BIOCHEM PARASIT, V138, P21, DOI 10.1016/j.molbiopara.2004.07.005; Weber C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000165; Zhang Z, 2003, INFECT IMMUN, V71, P5355, DOI 10.1128/IAI.71.9.5355-5359.2003	38	51	54	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8424	10.1371/journal.pone.0008424	http://dx.doi.org/10.1371/journal.pone.0008424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037645	gold, Green Submitted, Green Published			2022-12-25	WOS:000272998100012
J	Voynov, V; Chennamsetty, N; Kayser, V; Helk, B; Forrer, K; Zhang, H; Fritsch, C; Heine, H; Trout, BL				Voynov, Vladimir; Chennamsetty, Naresh; Kayser, Veysel; Helk, Bernhard; Forrer, Kurt; Zhang, Heidi; Fritsch, Cornelius; Heine, Holger; Trout, Bernhardt L.			Dynamic Fluctuations of Protein-Carbohydrate Interactions Promote Protein Aggregation	PLOS ONE			English	Article							FUCOSE-CONTAINING OLIGOSACCHARIDES; FC-GAMMA RECEPTOR; HUMAN BLOOD-GROUP; THERAPEUTIC PROTEINS; FORCE-FIELD; GLYCOSYLATION; BINDING; IGG; RECOGNITION; STABILITY	Protein-carbohydrate interactions are important for glycoprotein structure and function. Antibodies of the IgG class, with increasing significance as therapeutics, are glycosylated at a conserved site in the constant Fc region. We hypothesized that disruption of protein-carbohydrate interactions in the glycosylated domain of antibodies leads to the exposure of aggregation-prone motifs. Aggregation is one of the main problems in protein-based therapeutics because of immunogenicity concerns and decreased efficacy. To explore the significance of intramolecular interactions between aromatic amino acids and carbohydrates in the IgG glycosylated domain, we utilized computer simulations, fluorescence analysis, and site-directed mutagenesis. We find that the surface exposure of one aromatic amino acid increases due to dynamic fluctuations. Moreover, protein-carbohydrate interactions decrease upon stress, while protein-protein and carbohydrate-carbohydrate interactions increase. Substitution of the carbohydrate-interacting aromatic amino acids with non-aromatic residues leads to a significantly lower stability than wild type, and to compromised binding to Fc receptors. Our results support a mechanism for antibody aggregation via decreased protein-carbohydrate interactions, leading to the exposure of aggregation-prone regions, and to aggregation.	[Voynov, Vladimir; Chennamsetty, Naresh; Kayser, Veysel; Trout, Bernhardt L.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Helk, Bernhard; Forrer, Kurt; Zhang, Heidi; Fritsch, Cornelius; Heine, Holger] Novartis Pharma AG, Basel, Switzerland	Massachusetts Institute of Technology (MIT); Novartis	Voynov, V (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	trout@mit.edu	Kayser, Veysel/L-4432-2019	Kayser, Veysel/0000-0003-1310-9534; Chennamsetty, Naresh/0000-0003-4641-7840	Novartis Pharma AG	Novartis Pharma AG	This work was supported by Novartis Pharma AG. Employees of Novartis participated in study design, data collection and analysis, and preparation of the manuscript.	Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bucior I, 2004, J CELL BIOL, V165, P529, DOI 10.1083/jcb.200309005; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chennamsetty N, 2009, J MOL BIOL, V391, P404, DOI 10.1016/j.jmb.2009.06.028; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Cordoba-Rodriguez RV, 2008, BIOPHARM INT, V21, P44; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Egrie JC, 2001, BRIT J CANCER, V84, P3, DOI 10.1054/bjoc.2001.1746; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; Ionescu RM, 2008, J PHARM SCI-US, V97, P1414, DOI 10.1002/jps.21104; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KAYSER V, 2009, MECH THERAPEUT UNPUB; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Kuttel M, 2002, J COMPUT CHEM, V23, P1236, DOI 10.1002/jcc.10119; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; LLOYD KO, 1966, BIOCHEMISTRY-US, V5, P1489, DOI 10.1021/bi00869a007; Lund J, 1996, J IMMUNOL, V157, P4963; MACKERELL J, 1998, J PHYS CHEM B, V102; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; PAINTER TJ, 1965, NATURE, V206, P594, DOI 10.1038/206594a0; Peracaula R, 2008, DIS MARKERS, V25, P207, DOI 10.1155/2008/797629; QUIOCHO FA, 1989, PURE APPL CHEM, V61, P1293, DOI 10.1351/pac198961071293; Radaev S, 2001, J BIOL CHEM, V276, P16478, DOI 10.1074/jbc.M100351200; REGE VP, 1964, NATURE, V203, P360, DOI 10.1038/203360a0; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Spiwok V, 2005, J COMPUT AID MOL DES, V19, P887, DOI 10.1007/s10822-005-9033-z; Taroni C, 2000, PROTEIN ENG, V13, P89, DOI 10.1093/protein/13.2.89; TAVES CJ, 1984, BIOCHEM BIOPH RES CO, V124, P605; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; VOYNOV V, 2009, DESIGN APPL AN UNPUB; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Wei W, 1999, INT J PHARMACEUT, V185, P129, DOI 10.1016/S0378-5173(99)00152-0; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472	39	36	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8425	10.1371/journal.pone.0008425	http://dx.doi.org/10.1371/journal.pone.0008425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037630	Green Published, gold, Green Submitted			2022-12-25	WOS:000272998100013
J	Ribas, L; Li, MS; Doddington, BJ; Robert, J; Seidel, JA; Kroll, JS; Zimmerman, LB; Grassly, NC; Garner, TWJ; Fisher, MC				Ribas, Laia; Li, Ming-Shi; Doddington, Benjamin J.; Robert, Jacques; Seidel, Judith A.; Kroll, J. Simon; Zimmerman, Lyle B.; Grassly, Nicholas C.; Garner, Trenton W. J.; Fisher, Matthew C.			Expression Profiling the Temperature-Dependent Amphibian Response to Infection by Batrachochytrium dendrobatidis	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE DEFENSES; XENOPUS-TROPICALIS; ACTIVE PEPTIDES; RANA-ESCULENTA; SKIN; CHYTRIDIOMYCOSIS; PATHOGEN; DECLINES; DISEASE; FROG	Amphibians are experiencing a panzootic of unprecedented proportions caused by the emergence of Batrachochytrium dendrobatidis (Bd). However, all species are not equally at risk of infection, and risk is further modified by environmental variables, specifically temperature. In order to understand how, and when, hosts mount a response to Bd we analysed infection dynamics and patterns of gene expression in the model amphibian species Silurana (Xenopus) tropicalis. Mathematical modelling of infection dynamics demonstrate the existence of a temperature-dependent protective response that is largely independent of the intrinsic growth-rate of Bd. Using temporal expression-profiling by microarrays and qRT-PCR, we characterise this response in the main amphibian lymphoid tissue, the spleen. We demonstrate that clearance of Bd at the host-optimal temperature is not clearly associated with an adaptive immune response, but rather is correlated with the induction of components of host innate immunity including the expression of genes that are associated with the production of the antimicrobial skin peptide preprocareulein (PPCP) as well as inflammatory responses. We find that adaptive immunity appears to be lacking at host-optimal temperatures. This suggests that either Bd does not stimulate, or suppresses, adaptive immunity, or that trade-offs exist between innate and adaptive limbs of the amphibian immune system. At cold temperatures, S. tropicalis loses the ability to mount a PPCP-based innate response, and instead manifests a more pronounced inflammatory reaction that is characterised by the production of proteases and higher pathogen burdens. This study demonstrates the temperature-dependency of the amphibian response to infection by Bd and indicates the influence that changing climates may exert on the ectothermic host response to pathogens.	[Ribas, Laia; Doddington, Benjamin J.; Seidel, Judith A.; Grassly, Nicholas C.; Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London SW7 2AZ, England; [Li, Ming-Shi; Kroll, J. Simon] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London SW7 2AZ, England; [Robert, Jacques] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Zimmerman, Lyle B.] Natl Inst Med Res, London NW7 1AA, England; [Garner, Trenton W. J.] Zool Soc London, Inst Zool, London NW1 4RY, England	Imperial College London; Imperial College London; University of Rochester; MRC National Institute for Medical Research; Zoological Society of London	Ribas, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London SW7 2AZ, England.	matthew.fisher@imperial.ac.uk	Grassly, Nicholas C/C-6381-2008; Garner, Trenton WJ/D-6873-2011; Fisher, Matthew/B-9094-2011; Ribas, Laia/E-1466-2013; Robert, Jacques/B-2179-2008	Grassly, Nicholas C/0000-0001-6067-4507; Garner, Trenton WJ/0000-0002-0336-9706; Fisher, Matthew/0000-0002-1862-6402; Ribas, Laia/0000-0001-5538-6236; Robert, Jacques/0000-0003-4380-1476; Seidel, Judith/0000-0001-6116-9246	United Kingdom Biotechnology and Biological Research Council (BBSRC) [BB/E0232071]; United Kingdom Natural Environmental Research Council (NERC) [NE/E006701/1]; Royal Society; George John and Sheilah Livanos Charitable Trust; National Institutes of Health (NIH) [R24-AI-059830]; Biotechnology and Biological Sciences Research Council [BB/E023207/1] Funding Source: researchfish; Medical Research Council [MC_U117560482] Funding Source: researchfish; Natural Environment Research Council [NE/E006701/1, NER/A/S/2002/00832] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI059830] Funding Source: NIH RePORTER; BBSRC [BB/E023207/1] Funding Source: UKRI; MRC [MC_U117560482] Funding Source: UKRI; NERC [NE/E006701/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); George John and Sheilah Livanos Charitable Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by United Kingdom Biotechnology and Biological Research Council (BBSRC) grant BB/E0232071 and United Kingdom Natural Environmental Research Council (NERC) grant NE/E006701/1 to MCF and TWJG, a Royal Society grant to MCF, a George John and Sheilah Livanos Charitable Trust grant to MSL, and National Institutes of Health (NIH) grant R24-AI-059830 to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MF, 2001, BBA-PROTEIN STRUCT M, V1550, P81, DOI 10.1016/S0167-4838(01)00272-2; Arron JR., 2002, CURR PROTOC IMMUNOL, P11119, DOI [10.1002/0471142735.im1109ds87, DOI 10.1002/0471142735.IM1109DS51, 10.1002/0471142735.im1109ds51]; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; BREVINS CL, 1990, ANNU REV BIOCHEM, V59, P395; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; CAMPBELL EJ, 1991, J IMMUNOL, V146, P1286; COOPER EL, 1992, CRYOBIOLOGY, V29, P616, DOI 10.1016/0011-2240(92)90066-B; ERSPAMER V, 1984, COMP BIOCHEM PHYS C, V77, P99, DOI 10.1016/0742-8413(84)90137-3; ERSPAMER V, 1984, COMP BIOCHEM PHYS C, V79, P1, DOI 10.1016/0742-8413(84)90153-1; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Fisher P, 2007, IEEE COMPUT INTELL M, V2, P9, DOI 10.1109/MCI.2007.357188; Fujita T, 2004, MOL IMMUNOL, V41, P103, DOI 10.1016/j.molimm.2004.03.026; Gewin V, 2008, PLOS BIOL, V6, P18, DOI 10.1371/journal.pbio.0060024; Graindorge A, 2006, NUCLEIC ACIDS RES, V34, P986, DOI 10.1093/nar/gkj492; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Mangoni ML, 2001, FASEB J, V15, P1431, DOI 10.1096/fj.00-0695fje; Maniero GD, 1997, J COMP PHYSIOL B, V167, P256, DOI 10.1007/s003600050072; Moretti PAB, 2001, GENOMICS, V76, P21, DOI 10.1006/geno.2001.6574; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; Novoradovskaya N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-20; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Park PJ, 2004, J BIOTECHNOL, V112, P225, DOI 10.1016/j.jbiotec.2004.05.006; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Rauter I, 2008, J ALLERGY CLIN IMMUN, V121, P197, DOI 10.1016/j.jaci.2007.08.015; Reading CJ, 2007, OECOLOGIA, V151, P125, DOI 10.1007/s00442-006-0558-1; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 2006, DEV COMP IMMUNOL, V30, P831, DOI 10.1016/j.dci.2005.10.005; Rollins-Smith Louise A, 2009, Front Biosci (Schol Ed), V1, P68; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Rovito SM, 2009, P NATL ACAD SCI USA, V106, P3231, DOI 10.1073/pnas.0813051106; SEKI T, 1989, CELL TISSUE RES, V258, P483; Simmaco M, 1998, SCAND J IMMUNOL, V48, P357; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; TYLER MJ, 1992, J PHARMACOL TOXICOL, V28, P199, DOI 10.1016/1056-8719(92)90004-K; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1	51	108	110	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8408	10.1371/journal.pone.0008408	http://dx.doi.org/10.1371/journal.pone.0008408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027316	Green Published, Green Submitted, gold			2022-12-25	WOS:000272998000013
J	Yang, J; Zhang, WQ; Jiang, W; Sun, XN; Han, YH; Ding, MX; Shi, Y; Deng, HK				Yang, Jie; Zhang, Weiqi; Jiang, Wei; Sun, Xiaoning; Han, Yuhua; Ding, Mingxiao; Shi, Yan; Deng, Hongkui			P21(cip)-Overexpression in the Mouse beta Cells Leads to the Improved Recovery from Streptozotocin-Induced Diabetes	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; PARTIAL-PANCREATECTOMY; ISLET TRANSPLANTATION; TRANSGENIC MICE; INSULIN GENE; CYCLE ARREST; IN-VIVO; REGENERATION; PANCREAS; MODEL	Under normal conditions, the regeneration of mouse beta cells is mainly dependent on their own duplication. Although there is evidence that pancreatic progenitor cells exist around duct, whether non-beta cells in the islet could also potentially contribute to beta cell regeneration in vivo is still controversial. Here, we developed a novel transgenic mouse model to study the pancreatic beta cell regeneration, which could specifically inhibit beta cell proliferation by overexpressing p21(cip) in beta cells via regulation of the Tet-on system. We discovered that p21 overexpression could inhibit beta-cell duplication in the transgenic mice and these mice would gradually suffer from hyperglycemia. Importantly, the recovery efficiency of the p21-overexpressing mice from streptozotocin-induced diabetes was significantly higher than control mice, which is embodied by better physiological quality and earlier emergence of insulin expressing cells. Furthermore, in the islets of these streptozotocin-treated transgenic mice, we found a large population of proliferating cells which expressed pancreatic duodenal homeobox 1 (PDX1) but not markers of terminally differentiated cells. Transcription factors characteristic of early pancreatic development, such as Nkx2.2 and NeuroD1, and pancreatic progenitor markers, such as Ngn3 and c-Met, could also be detected in these islets. Thus, our work showed for the first time that when b cell self-duplication is repressed by p21 overexpression, the markers for embryonic pancreatic progenitor cells could be detected in islets, which might contribute to the recovery of these transgenic mice from streptozotocin-induced diabetes. These discoveries could be important for exploring new diabetes therapies that directly promote the regeneration of pancreatic progenitors to differentiate into islet beta cells in vivo.	[Yang, Jie; Zhang, Weiqi; Jiang, Wei; Ding, Mingxiao; Deng, Hongkui] Peking Univ, MOE Key Lab Cell Proliferat & Differentiat, Coll Life Sci, Beijing 100871, Peoples R China; [Sun, Xiaoning; Shi, Yan; Deng, Hongkui] Peking Univ, Lab Chem Genom, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Han, Yuhua] Beijing Vitalstar Biotech Co Ltd, Beijing, Peoples R China; [Deng, Hongkui] Anim Res Ctr, Beijing Lab, Beijing, Peoples R China	Peking University; Peking University; University Town of Shenzhen	Yang, J (corresponding author), Peking Univ, MOE Key Lab Cell Proliferat & Differentiat, Coll Life Sci, Beijing 100871, Peoples R China.	hongkui_deng@pku.edu	Jiang, Wei/J-7993-2012	Jiang, Wei/0000-0002-6463-7356; Zhang, Weiqi/0000-0002-8885-5104	Ministry of Science and Technology [2006AA02A113]; Science and Technology Plan of Beijing Municipal Government [D07050701350705]; Gongjian project of Beijing Municipal Education Commission; National Basic Research Program for China (973 Program) [2007CB947900, 2009CB941200]; National Natural Science Foundation of China [30830061, 30421004]; 111 Project	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Science and Technology Plan of Beijing Municipal Government; Gongjian project of Beijing Municipal Education Commission; National Basic Research Program for China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project)	This research was supported by Ministry of Science and Technology grant (2006AA02A113), Science and Technology Plan of Beijing Municipal Government (D07050701350705), Gongjian project of Beijing Municipal Education Commission, National Basic Research Program for China (973 Program 2007CB947900, 2009CB941200), National Natural Science Foundation of China (30830061, 30421004) and a 111 Project to HD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; Beattie GM, 1999, DIABETES, V48, P1013, DOI 10.2337/diabetes.48.5.1013; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; BONNERWEIR S, 1981, DIABETES, V30, P64, DOI 10.2337/diabetes.30.1.64; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Cano DA, 2008, DIABETES, V57, P958, DOI 10.2337/db07-0913; Cozar-Castellano I, 2006, DIABETES, V55, P70, DOI 10.2337/diabetes.55.01.06.db05-0632; Cozar-Castellano I, 2006, DIABETES, V55, P3271, DOI 10.2337/db06-0627; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fernandes A, 1997, ENDOCRINOLOGY, V138, P1750, DOI 10.1210/en.138.4.1750; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Garcia-Ocana A, 2001, DIABETES, V50, P2752, DOI 10.2337/diabetes.50.12.2752; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; HUME WJ, 1979, J ORAL PATHOL MED, V8, P3, DOI 10.1111/j.1600-0714.1979.tb01618.x; Kodama S, 2005, BIOCHEM BIOPH RES CO, V327, P1170, DOI 10.1016/j.bbrc.2004.12.120; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; Lee CS, 2006, DIABETES, V55, P269; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Peshavaria M, 2006, DIABETES, V55, P3289, DOI 10.2337/db06-0017; Polak M, 2000, DIABETES, V49, P225, DOI 10.2337/diabetes.49.2.225; RILEY WJ, 1981, DIABETES, V30, P718, DOI 10.2337/diabetes.30.9.718; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Rosenberg L, 1998, MICROSC RES TECHNIQ, V43, P337, DOI 10.1002/(SICI)1097-0029(19981115)43:4<337::AID-JEMT8>3.0.CO;2-U; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; Suzuki S, 2004, DIABETES, V53, pA214, DOI 10.2337/diabetes.53.8.2143; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Trucco M, 2005, J CLIN INVEST, V115, P5, DOI 10.1172/JCI200523935; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Whitson JM, 2009, INT J CANCER, V125, P446, DOI 10.1002/ijc.24370; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	36	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2009	4	12							e8344	10.1371/journal.pone.0008344	http://dx.doi.org/10.1371/journal.pone.0008344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OR	20020058	Green Published, gold, Green Submitted			2022-12-25	WOS:000272834200011
J	Kojic, N; Chung, E; Kho, AT; Park, JA; Huang, A; So, PTC; Tschumperlin, DJ				Kojic, Nikola; Chung, Euiheon; Kho, Alvin T.; Park, Jin-Ah; Huang, Austin; So, Peter T. C.; Tschumperlin, Daniel J.			An EGFR autocrine loop encodes a slow-reacting but dominant mode of mechanotransduction in a polarized epithelium	FASEB JOURNAL			English	Article						airway epithelium; mechanical stress; lateral intercellular space	EPIDERMAL-GROWTH-FACTOR; LATERAL INTERCELLULAR SPACES; C-ERBB RECEPTORS; DIFFERENTIAL REGULATION; SIGNAL-TRANSDUCTION; MECHANICAL-STRESS; GENE-EXPRESSION; SHEAR-STRESS; KINASE; ACTIVATION	The mechanical landscape in biological systems can be complex and dynamic, with contrasting sustained and fluctuating loads regularly superposed within the same tissue. How resident cells discriminate between these scenarios to respond accordingly remains largely unknown. Here, we show that a step increase in compressive stress of physiological magnitude shrinks the lateral intercellular space between bronchial epithelial cells, but does so with strikingly slow exponential kinetics (time constant similar to 110 s). We confirm that epidermal growth factor (EGF)-family ligands are constitutively shed into the intercellular space and demonstrate that a step increase in compressive stress enhances EGF receptor (EGFR) phosphorylation with magnitude and onset kinetics closely matching those predicted by constant-rate ligand shedding in a slowly shrinking intercellular geometry. Despite the modest degree and slow nature of EGFR activation evoked by compressive stress, we find that the majority of transcriptomic responses to sustained mechanical loading require ongoing activity of this autocrine loop, indicating a dominant role for mechanotransduction through autocrine EGFR signaling in this context. A slow deformation response to a step increase in loading, accompanied by synchronous increases in ligand concentration and EGFR activation, provides one means for cells to mount a selective and context-appropriate response to a sustained change in mechanical environment.-Kojic, N., Chung, E., Kho, A. T., Park, J.-A., Huang, A., So, P. T. C., Tschumperlin, D. J. An EGFR autocrine loop encodes a slow-reacting but dominant mode of mechanotransduction in a polarized epithelium. FASEB J. 24, 1604-1615 (2010). www.fasebj.org	[Park, Jin-Ah; Tschumperlin, Daniel J.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Kojic, Nikola; Chung, Euiheon; Kho, Alvin T.; Huang, Austin] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA USA; [Chung, Euiheon] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Kho, Alvin T.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [So, Peter T. C.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT)	Tschumperlin, DJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	dtschump@hsph.harvard.edu	Chung, Euiheon/A-1801-2009	Chung, Euiheon/0000-0002-3326-6927	National Institutes of Health (NIH) [HL082856, HL88028, NS040828]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL091124, R01HL088028, R01HL082856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828, P01NS040828] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank J. Drazen, J. Fredberg, and D. Lauffen-burger for helpful discussions. This work was funded by National Institutes of Health (NIH) grants HL082856 and HL88028, and A.T.K. is funded by NIH NS040828.	AIDA S, 1994, RESPIRATION, V61, P161; Amishima M, 1998, AM J RESP CRIT CARE, V157, P1907, DOI 10.1164/ajrccm.157.6.9609040; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Ateshian GA, 2004, J BIOMECH, V37, P391, DOI 10.1016/S0021-9290(03)00252-5; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Button B, 2007, J PHYSIOL-LONDON, V580, P577, DOI 10.1113/jphysiol.2006.126086; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Christensen JG, 2005, MOL CANCER THER, V4, P938, DOI 10.1158/1535-7163.MCT-04-0208; Chu EK, 2005, AM J RESP CELL MOL, V32, P373, DOI 10.1165/rcmb.2004-0266OC; Chu EK, 2006, AM J RESP CELL MOL, V35, P628, DOI 10.1165/rcmb.2006-0040OC; Coughlin MF, 1996, J APPL PHYSIOL, V80, P1880, DOI 10.1152/jappl.1996.80.6.1880; DEMPSEY PJ, 1994, J BIOL CHEM, V269, P16878; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; FERRIOLA PC, 1992, J CELL PHYSIOL, V152, P302, DOI 10.1002/jcp.1041520211; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; GUNST SJ, 1988, J APPL PHYSIOL, V64, P2522, DOI 10.1152/jappl.1988.64.6.2522; Hamilton LM, 2003, CLIN EXP ALLERGY, V33, P233, DOI 10.1046/j.1365-2222.2003.01593.x; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Haslett JN, 2003, NEUROGENETICS, V4, P163, DOI 10.1007/s10048-003-0148-x; Hollander M, 1973, NONPARAMETRIC STAT M; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kikuchi T, 2004, AM J PHYSIOL-LUNG C, V287, pL119, DOI 10.1152/ajplung.00365.2003; Kojic N, 2008, OPT EXPRESS, V16, P12403, DOI 10.1364/OE.16.012403; Kojic N, 2006, BIOPHYS J, V90, P4261, DOI 10.1529/biophysj.105.078345; Kovbasnjuk ON, 2000, J MEMBRANE BIOL, V175, P9, DOI 10.1007/s002320001050; LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880; Lauffenburger DA, 1998, P NATL ACAD SCI USA, V95, P15368, DOI 10.1073/pnas.95.26.15368; Lehoux S, 2003, J BIOMECH, V36, P631, DOI 10.1016/S0021-9290(02)00441-4; Lehoux S, 2005, CIRCULATION, V111, P643, DOI 10.1161/01.CIR.0000154548.16191.2F; Lenormand G, 2004, J R SOC INTERFACE, V1, P91, DOI 10.1098/rsif.2004.0010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maly IV, 2004, ANN BIOMED ENG, V32, P1319, DOI 10.1114/B:ABME.0000042221.61633.23; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Miettinen PJ, 1997, DEV BIOL, V186, P224, DOI 10.1006/dbio.1997.8593; MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202; Nielsen UB, 2003, P NATL ACAD SCI USA, V100, P9330, DOI 10.1073/pnas.1633513100; Ofek G, 2009, BIOPHYS J, V97, P1873, DOI 10.1016/j.bpj.2009.07.050; Okamoto M, 2002, BBA-GENE STRUCT EXPR, V1574, P24, DOI 10.1016/S0167-4781(01)00345-1; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Park JA, 2009, AM J RESP CELL MOL, V41, P459, DOI 10.1165/rcmb.2008-0195OC; Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005; Polosa R, 2002, J ALLERGY CLIN IMMUN, V109, P75, DOI 10.1067/mai.2002.120274; Polosa R, 1999, AM J RESP CELL MOL, V20, P914, DOI 10.1165/ajrcmb.20.5.3308; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; RAAB G, 1997, BIOCHIM BIOPHYS ACTA, V1333, P179; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; Ressler B, 2000, AM J PHYSIOL-LUNG C, V278, pL1264, DOI 10.1152/ajplung.2000.278.6.L1264; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X; Sorby M, 1996, J BIOL CHEM, V271, P10963; SPORN MB, 1985, NATURE, V313, P745, DOI 10.1038/313745a0; SPRING KR, 1978, SCIENCE, V200, P54, DOI 10.1126/science.635571; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Takeyama K, 2001, AM J RESP CRIT CARE, V163, P511, DOI 10.1164/ajrccm.163.2.2001038; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; Tschumperlin DJ, 2004, NATURE, V429, P83, DOI 10.1038/nature02543; Tschumperlin DJ, 2003, AM J RESP CELL MOL, V28, P142, DOI 10.1165/rcmb.2002-0121OC; Tschumperlin DJ, 2002, AM J PHYSIOL-LUNG C, V282, pL904, DOI 10.1152/ajplung.00270.2001; Tyner JW, 2006, J CLIN INVEST, V116, P309, DOI 10.1172/JCI25167; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Vinante F, 1999, BLOOD, V94, P3169, DOI 10.1182/blood.V94.9.3169.421k30_3169_3177; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Wiggs BR, 1997, J APPL PHYSIOL, V83, P1814, DOI 10.1152/jappl.1997.83.6.1814; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Xia P, 1998, BIOPHYS J, V74, P3302, DOI 10.1016/S0006-3495(98)78037-3; Yoshida T, 2006, ONCOGENE, V25, P6056, DOI 10.1038/sj.onc.1209635; Yoshioka J, 2005, P NATL ACAD SCI USA, V102, P10622, DOI 10.1073/pnas.0501198102; Zhao Q, 2002, P NATL ACAD SCI USA, V99, P5704, DOI 10.1073/pnas.082092399; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	83	17	19	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1604	1615		10.1096/fj.09-145367	http://dx.doi.org/10.1096/fj.09-145367			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20056713	Bronze, Green Published			2022-12-25	WOS:000277158900032
J	Noti, M; Corazza, N; Tuffin, G; Schoonjans, K; Brunner, T				Noti, Mario; Corazza, Nadia; Tuffin, Gerald; Schoonjans, Kristina; Brunner, Thomas			Lipopolysaccharide induces intestinal glucocorticoid synthesis in a TNF alpha-dependent manner	FASEB JOURNAL			English	Article						inflammatory bowel disease; tumor necrosis factor alpha; intestinal epithelial cells; macrophages; TNF receptors	TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-4; FACTOR-KAPPA-B; MOLECULAR-MECHANISMS; EPITHELIAL BARRIER; MICE; ENTEROCYTES; REPRESSION; PROTECTION; APOPTOSIS	Stringent control of immune responses in the intestinal mucosa is critical for the maintenance of immune homeostasis and prevention of tissue damage, such as observed during inflammatory bowel disease. Intestinal epithelial cells, primarily thought to form a simple physical barrier, critically regulate intestinal immune cell functions by producing immunoregulatory glucocorticoids on T-cell activation. In this study we investigated whether stimulation of cells of the innate immune system results in the induction of intestinal glucocorticoids synthesis and what role TNF-alpha plays in this process. Stimulation of the innate immune system with lipopolysaccharide (LPS) led to an up-regulation of colonic steroidogenic enzymes and the induction of intestinal glucocorticoid synthesis. The observed induction was dependent on macrophage effector functions, as depletion of macrophages using clodronate-containing liposomes, but not absence of T and B cells, inhibited intestinal glucocorticoid synthesis. LPS-induced glucocorticoid synthesis was critically dependent on TNF-alpha as it was significantly decreased in TNF-alpha -deficient animals. Both TNF receptor-1 and -2 were found to be equally involved in LPS- and T-cell-induced intestinal GC synthesis. These results describe a novel and critical role of TNF-alpha in immune cell-induced intestinal glucocorticoid synthesis.-Noti, M., Corazza, N., Tuffin, G., Schoonjans, K., Brunner, T. Lipopolysaccharide induces intestinal glucocorticoid synthesis in a TNF alpha-dependent manner. FASEB J. 24, 1340-1346 (2010). www.fasebj.org	[Noti, Mario; Corazza, Nadia; Brunner, Thomas] Univ Bern, Inst Pathol, Div Expt Pathol, CH-3010 Bern, Switzerland; [Tuffin, Gerald] Univ Appl Sci NW Switzerland, Sch Life Sci, Muttenz, Switzerland; [Schoonjans, Kristina] Ecole Polytech Fed Lausanne, Lab Integrat Syst & Physiol, Lausanne, Switzerland	University of Bern; FHNW University of Applied Sciences & Arts Northwestern Switzerland; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Brunner, T (corresponding author), Univ Bern, Inst Pathol, Div Expt Pathol, Murtenstr 31, CH-3010 Bern, Switzerland.	tbrunner@pathology.unibe.ch	Noti, Mario/I-6581-2019	Noti, Mario/0000-0001-9386-1245; Schoonjans, Kristina/0000-0003-1247-4265	Crohn's and Colitis Foundation of America; Swiss National Science Foundation; Oncosuisse	Crohn's and Colitis Foundation of America; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse	The authors thank the T. B. and K. S. lab for technical help. The authors further thank Christoph Mueller (University of Bern, Bern, Switzerland) for providing RAG2<SUP>-/-</SUP>, TNF-alpha<SUP>-/-</SUP>, TNFR1<SUP>-/-</SUP>, and TNFR2<SUP>-/-</SUP> animals and Manfred Kopf (Eidgenossische Technische Hochschule Zurich, Zurich, Switzerland) for the IL-6<SUP>-/-</SUP> mice. This work was supported by grants from the Crohn's and Colitis Foundation of America, the Swiss National Science Foundation, and Oncosuisse to T. B. The authors declare no conflicts of interest.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Bohan A, 2003, J BIOL CHEM, V278, P36688, DOI 10.1074/jbc.M304011200; Boirivant M, 2008, MUCOSAL IMMUNOL, V1, pS47, DOI 10.1038/mi.2008.52; Boivin MA, 2007, AM J PHYSIOL-GASTR L, V292, pG590, DOI 10.1152/ajpgi.00252.2006; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Cario E, 2008, CURR OPIN GASTROEN, V24, P725, DOI 10.1097/MOG.0b013e32830c4341; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cima I, 2004, J EXP MED, V200, P1635, DOI 10.1084/jem.20031958; CLAASSEN I, 1990, J IMMUNOL METHODS, V134, P153, DOI 10.1016/0022-1759(90)90376-7; Corazza N, 1999, J EXP MED, V190, P1479, DOI 10.1084/jem.190.10.1479; Coste A, 2007, P NATL ACAD SCI USA, V104, P13098, DOI 10.1073/pnas.0702440104; Davies E, 2003, CLIN EXP PHARMACOL P, V30, P437, DOI 10.1046/j.1440-1681.2003.03867.x; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; Fries Walter, 2008, Int J Med Sci, V5, P169; GALANOS C, 1993, IMMUNOBIOLOGY, V187, P346, DOI 10.1016/S0171-2985(11)80349-9; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; JACOB CO, 1988, NATURE, V331, P356, DOI 10.1038/331356a0; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Kontoyiannis D, 2000, EUR J IMMUNOL, V30, P2038, DOI 10.1002/1521-4141(200007)30:7<2038::AID-IMMU2038>3.0.CO;2-K; Lee J, 2008, SEMIN IMMUNOPATHOL, V30, P3, DOI 10.1007/s00281-007-0099-7; Marini M, 2003, P NATL ACAD SCI USA, V100, P8366, DOI 10.1073/pnas.1432897100; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Mueller M, 2006, J EXP MED, V203, P2057, DOI 10.1084/jem.20060357; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; Muller CA, 2005, CELL MOL LIFE SCI, V62, P1297, DOI 10.1007/s00018-005-5034-2; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Riccardi C, 2002, PHARMACOL RES, V45, P361, DOI 10.1006/phrs.2002.0969; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Sapolsky RM, 2000, NEUROBIOL DIS, V7, P540, DOI 10.1006/nbdi.2000.0350; Schaaf MJM, 2002, J STEROID BIOCHEM, V83, P37, DOI 10.1016/S0960-0760(02)00263-7; Schenk M, 2007, SEMIN IMMUNOL, V19, P84, DOI 10.1016/j.smim.2006.09.002; Song HL, 2005, WORLD J GASTROENTERO, V11, P3701, DOI 10.3748/wjg.v11.i24.3701; VANROOIJEN N, 1992, RES IMMUNOL, V143, P215; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Xu B, 2009, MOL CELL BIOL, V29, P1719, DOI 10.1128/MCB.01010-08; Yamada Y, 1998, HEPATOLOGY, V28, P959, DOI 10.1002/hep.510280410	42	33	33	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1340	1346		10.1096/fj.09-140913	http://dx.doi.org/10.1096/fj.09-140913			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20056718	Green Submitted			2022-12-25	WOS:000277158900007
J	Skjoedt, MO; Hummelshoj, T; Palarasah, Y; Honore, C; Koch, C; Skjodt, K; Garred, P				Skjoedt, Mikkel-Ole; Hummelshoj, Tina; Palarasah, Yaseelan; Honore, Christian; Koch, Claus; Skjodt, Karsten; Garred, Peter			A Novel Mannose-binding Lectin/Ficolin-associated Protein Is Highly Expressed in Heart and Skeletal Muscle Tissues and Inhibits Complement Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECTIN; MBL; IDENTIFICATION; LOCALIZATION; DEFICIENCY; PROTEASE-2; PATHWAY; FICOLIN; SITES	The human lectin complement pathway involves circulating complexes consisting of mannose-binding lectin (MBL) or three ficolins (ficolin-1, -2, and -3) in association with three MBL/ficolin-associated serine proteases (MASP) (MASP-1, -2, and -3) and a nonenzymatic sMAP. MASP-1 and MASP-3 (MASP1 iso-forms 1 and 2, respectively) are splice variants of the MASP1 gene, whereas MASP-2 and sMAP are splice variants of the MASP2 gene. We have identified a novel serum protein of 45 kDa that is associated with MBL and the ficolins. This protein is named MBL/ficolin-associated protein 1 (MAP-1 corresponding to MASP1 isoform 3). The transcript generating MAP-1 (MASP1_v3) contains exons 1-8 and a novel exon encoding an in-frame stop codon. The corresponding protein lacks the serine protease domains but contains most of the common heavy chain of MASP-1 and MASP-3. Additionally MAP-1 contains 17 unique C-terminal amino acids. By use of quantitative PCR and MAP-1-specific immunohistochemistry, we found that MAP-1 is highly expressed in myocardial and skeletal muscle tissues as well as in liver hepatocytes with a different expression profile than that observed for MASP-1 and MASP-3. MAP-1 co-precipitated from human serum with MBL, ficolin-2, and ficolin-3, and recombinant MAP-1 was able to inhibit complement C4 deposition via both the ficolin-3 and MBL pathway. In conclusion we have identified a novel 45-kDa serum protein derived from the MASP1 gene, which is highly expressed in striated muscle tissues. It is found in complex with MBL and ficolins and may function as a potent inhibitor of the complement system in vivo.	[Garred, Peter] Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, Lab Mol Med,Fac Hlth Sci,Sect 7631, DK-2100 Copenhagen, Denmark; [Skjoedt, Mikkel-Ole; Palarasah, Yaseelan; Koch, Claus; Skjodt, Karsten; Garred, Peter] Univ So Denmark, Fac Hlth Sci, Inst Med Biol, Res Unit Immunol & Microbiol, DK-5000 Odense, Denmark	Rigshospitalet; University of Copenhagen; University of Southern Denmark	Garred, P (corresponding author), Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, Lab Mol Med,Fac Hlth Sci,Sect 7631, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	garred@post5.tele.dk		Palarasah, Yaseelan/0000-0002-9337-0232; Garred, Peter/0000-0002-2876-8586; Skjodt, Karsten/0000-0002-9161-8185; Skjodt, Mikkel-Ole/0000-0003-1306-6482; Honore, Christian/0000-0003-4846-1319	Rigshospitalet; The Capital Region of Denmark; The Novo Nordisk Research Foundation; The Lundbeck Foundation; The John and Birthe Meyer Foundation; The Carlsberg Foundation	Rigshospitalet; The Capital Region of Denmark; The Novo Nordisk Research Foundation; The Lundbeck Foundation(Lundbeckfonden); The John and Birthe Meyer Foundation; The Carlsberg Foundation(Carlsberg Foundation)	This work was supported by Rigshospitalet, The Capital Region of Denmark, The Novo Nordisk Research Foundation, The Lundbeck Foundation, The John and Birthe Meyer Foundation, and The Carlsberg Foundation.	Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Girija UV, 2007, J IMMUNOL, V179, P455, DOI 10.4049/jimmunol.179.1.455; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; Naito H, 1999, J BIOCHEM-TOKYO, V126, P1004, DOI 10.1093/oxfordjournals.jbchem.a022543; Seyfarth J, 2006, MOL IMMUNOL, V43, P962, DOI 10.1016/j.molimm.2005.06.033; Skjoedt MO, 2010, DEV COMP IMMUNOL, V34, P59, DOI 10.1016/j.dci.2009.08.004; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Takahashi M, 2007, ADV EXP MED BIOL, V598, P93; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406	28	112	120	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8234	8243		10.1074/jbc.M109.065805	http://dx.doi.org/10.1074/jbc.M109.065805			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20053996	hybrid, Green Published			2022-12-25	WOS:000275413800042
J	Cloutier, N; Flamand, L				Cloutier, Nathalie; Flamand, Louis			Kaposi Sarcoma-associated Herpesvirus Latency-associated Nuclear Antigen Inhibits Interferon (IFN) beta Expression by Competing with IFN Regulatory Factor-3 for Binding to IFNB Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY EFFUSION LYMPHOMA; INNATE IMMUNE-RESPONSE; GENE-EXPRESSION; ANTIVIRAL RESPONSE; I INTERFERON; TRANSCRIPTIONAL ACTIVATION; NEGATIVE REGULATION; VIRUS-INFECTION; VIRAL PROTEIN; LANA PROTEIN	Host cells respond to viral infections by synthesizing and producing antiviral molecules such as type I interferons (IFN). The Kaposi sarcoma-associated herpesvirus (KSHV) encodes multiple proteins expressed during the lytic replication cycle that alter the antiviral response of the host. Considering that in Kaposi sarcoma lesions and primary effusion lymphoma cells KSHV is latent in the vast majority of cells, we were interested in determining whether latently expressed viral proteins have the ability to modulate IFN synthesis. The latency-associated nuclear antigen (LANA-1) is a large nuclear protein that plays a role in the establishment and maintenance of latent KSHV episome in the nucleus of infected cells. LANA-1 is also described to modulate the cellular transcription. Here, we report that LANA-1 inhibits IFN-beta transcription and synthesis by competing with the binding of interferon regulatory factor-3 (IRF3) to the IFNB promoter. Using mutants of LANA-1, we have identified the central acidic repeated region as the domain essential for interfering with the binding of IRF3 to the positive regulatory domains I-III of the IFNB promoter. In addition, the nuclear localization of LANA-1 proved essential for IFN-beta inhibition. Thus, LANA-1 interferes with the formation of IFN-beta enhanceosome by competing with the fixation of IRF3 and by inhibiting the expression of the CREB-binding protein. The ability of LANA-1 to inhibit IFNB gene expression highlights a new role for this protein in cellular gene modulation and immune evasion strategies.	[Flamand, Louis] Univ Laval, Quebec Res Ctr, Rheumat & Immunol Res Ctr, Virol Lab,CHU, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Fac Med, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University	Flamand, L (corresponding author), Univ Laval, Quebec Res Ctr, Rheumat & Immunol Res Ctr, Virol Lab,CHU, 2705 Laurier Blvd,Rm T1-49, Quebec City, PQ G1V 4G2, Canada.	Louis.Flamand@crchul.ulaval.ca		Flamand, Louis/0000-0001-5010-4586	National Cancer Institute of Canada	National Cancer Institute of Canada(Canadian Cancer Society (CCS))	This work was supported in part by a grant from the National Cancer Institute of Canada (to L. F.).	Areste C, 2009, TRENDS MICROBIOL, V17, P119, DOI 10.1016/j.tim.2008.12.001; AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Bisson SA, 2009, J VIROL, V83, P5056, DOI 10.1128/JVI.02516-08; Bubman D, 2007, ONCOGENE, V26, P4979, DOI 10.1038/sj.onc.1210299; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Cloutier N, 2004, J VIROL METHODS, V122, P1, DOI 10.1016/j.jviromet.2004.07.004; Cloutier N, 2007, EUR J IMMUNOL, V37, P2772, DOI 10.1002/eji.200737181; Coscoy L, 2007, NAT REV IMMUNOL, V7, P391, DOI 10.1038/nri2076; Dittmer D, 1998, J VIROL, V72, P8309, DOI 10.1128/JVI.72.10.8309-8315.1998; DUCKETT CS, 1993, MOL CELL BIOL, V13, P1315, DOI 10.1128/MCB.13.3.1315; Fakhari FD, 2002, J VIROL, V76, P6213, DOI 10.1128/JVI.76.12.6213-6223.2002; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Fuld S, 2006, J VIROL, V80, P3092, DOI 10.1128/JVI.80.6.3092-3097.2006; FUSE A, 1984, GANN, V75, P379; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Godfrey A, 2005, BLOOD, V105, P2510, DOI 10.1182/blood-2004-08-3052; Hiscott J, 1999, J INTERF CYTOK RES, V19, P1, DOI 10.1089/107999099314360; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Jeong JH, 2004, J BIOL CHEM, V279, P16822, DOI 10.1074/jbc.M312801200; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Krithivas A, 2000, J VIROL, V74, P9637, DOI 10.1128/JVI.74.20.9637-9645.2000; LAMARRE D, 1988, BIOCHIM BIOPHYS ACTA, V950, P147, DOI 10.1016/0167-4781(88)90007-3; Lan K, 2004, J VIROL, V78, P6585, DOI 10.1128/JVI.78.12.6585-6594.2004; Lefort S, 2007, J VIROL, V81, P10950, DOI 10.1128/JVI.00183-07; Lefort S, 2009, J VIROL, V83, P5869, DOI 10.1128/JVI.01821-08; Lim C, 2000, J GEN VIROL, V81, P2645, DOI 10.1099/0022-1317-81-11-2645; Lim C, 2001, J BIOL CHEM, V276, P31016, DOI 10.1074/jbc.M102431200; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lin RT, 2001, ONCOGENE, V20, P800, DOI 10.1038/sj.onc.1204163; Liu JY, 2007, J VIROL, V81, P4722, DOI 10.1128/JVI.02548-06; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Naranatt PP, 2004, CANCER RES, V64, P72, DOI 10.1158/0008-5472.CAN-03-2767; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Parravicini C, 2000, AM J PATHOL, V156, P743, DOI 10.1016/S0002-9440(10)64940-1; Perry ST, 2006, J VIROL, V80, P11105, DOI 10.1128/JVI.00846-06; Platt GM, 1999, J VIROL, V73, P9789, DOI 10.1128/JVI.73.12.9789-9795.1999; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; Ramirez S, 1997, J BIOL CHEM, V272, P31016, DOI 10.1074/jbc.272.49.31016; Rasmussen SB, 2009, J GEN VIROL, V90, P74, DOI 10.1099/vir.0.005389-0; Rezaee SAR, 2006, J GEN VIROL, V87, P1781, DOI 10.1099/vir.0.81919-0; Rivas C, 2001, J VIROL, V75, P429, DOI 10.1128/JVI.75.1.429-438.2001; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Schwam DR, 2000, J VIROL, V74, P8532, DOI 10.1128/JVI.74.18.8532-8540.2000; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Talbot SJ, 1999, VIROLOGY, V257, P84, DOI 10.1006/viro.1999.9672; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; WATHELET MG, 1988, EUR J BIOCHEM, V174, P323, DOI 10.1111/j.1432-1033.1988.tb14101.x; Yoneyama M, 2002, J INTERF CYTOK RES, V22, P73, DOI 10.1089/107999002753452674; Zaldumbide A, 2007, MOL IMMUNOL, V44, P1352, DOI 10.1016/j.molimm.2006.05.012; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	61	46	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7208	7221		10.1074/jbc.M109.018838	http://dx.doi.org/10.1074/jbc.M109.018838			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048166	Green Published, hybrid			2022-12-25	WOS:000275415600034
J	Inoue, K; Branigan, D; Xiong, ZG				Inoue, Koichi; Branigan, Deborah; Xiong, Zhi-Gang			Zinc-induced Neurotoxicity Mediated by Transient Receptor Potential Melastatin 7 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR FREE ZINC; SENSING ION CHANNELS; VASCULAR ENDOTHELIAL-CELLS; MILD COGNITIVE IMPAIRMENT; NEURONAL DEATH; METAL-IONS; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; MG2+ HOMEOSTASIS	Transient receptor potential melastatin 7 (TRPM7) channels are novel Ca2+-permeable non-selective cation channels ubiquitously expressed. Activation of TRPM7 channels has been shown to be involved in cellular Mg2+ homeostasis, diseases caused by abnormal magnesium absorption, and in Ca2+-mediated neuronal injury under ischemic conditions. Here we show strong evidence suggesting that TRPM7 channels also play an important role in cellular Zn2+ homeostasis and in Zn2+-mediated neuronal injury. Using a combination of fluorescent Zn2+ imaging, small interfering RNA, pharmacological analysis, and cell injury assays, we show that activation of TRPM7 channels augmented Zn2+-induced injury of cultured mouse cortical neurons. The Zn2+-mediated neurotoxicity was inhibited by nonspecific TRPM7 blockers Gd3+ or 2-aminoethoxydiphenyl borate, and by knockdown of TRPM7 channels with small interfering RNA. In addition, Zn2+-mediated neuronal injury under oxygen-glucose deprivation conditions was also diminished by silencing TRPM7. Furthermore, we show that overexpression of TRPM7 channels in HEK293 cells increased intracellular Zn2+ accumulation and Zn2+-induced cell injury, while silencing TRPM7 by small interfering RNA attenuated the Zn2+-mediated cell toxicity. Thus, TRPM7 channels may represent a novel target for neurological disorders where Zn2+ toxicity plays an important role.	[Inoue, Koichi; Branigan, Deborah; Xiong, Zhi-Gang] Legacy Res, Robert S Dow Neurobiol Labs, Portland, OR 97232 USA		Xiong, ZG (corresponding author), 1225 NE 2nd Ave, Portland, OR 97232 USA.	zxiong@Downeurobiology.org			National Institutes of Health [R01NS47506, R01NS49470]; American Heart Association [0840132N]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049470, R01NS047506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS47506 and R01NS49470 and American Heart Association Grant 0840132N.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Birmingham K, 2002, NAT MED, V8, P5, DOI 10.1038/nm0102-5a; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Calderone A, 2004, J NEUROSCI, V24, P9903, DOI 10.1523/JNEUROSCI.1713-04.2004; Canzoniero LMT, 1999, J NEUROSCI, V19; Capasso M, 2005, J ALZHEIMERS DIS, V8, P93; Cheng CL, 1998, J NEUROCHEM, V71, P2401; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cole TB, 2000, EPILEPSY RES, V39, P153, DOI 10.1016/S0920-1211(99)00121-7; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gee KR, 2002, J AM CHEM SOC, V124, P776, DOI 10.1021/ja011774y; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Hey JG, 2007, STROKE, V38, P670, DOI 10.1161/01.STR.0000251443.68897.99; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Inoue K, 2004, FEBS LETT, V564, P131, DOI 10.1016/S0014-5793(04)00328-X; Inoue K, 2004, GENES CELLS, V9, P59, DOI 10.1111/j.1356-9597.2004.00707.x; Inoue K, 2009, CARDIOVASC RES, V83, P547, DOI 10.1093/cvr/cvp153; Jiang J, 2007, CANCER RES, V67, P10929, DOI 10.1158/0008-5472.CAN-07-1121; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kitamura Y, 2006, BRAIN RES BULL, V69, P622, DOI 10.1016/j.brainresbull.2006.03.004; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; LaRochelle O, 2001, J BIOL CHEM, V276, P41879, DOI 10.1074/jbc.M108313200; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Lovell MA, 2005, NEUROTOX RES, V7, P265, DOI 10.1007/BF03033884; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PALM R, 1983, CLIN CHEM, V29, P486; Rayatzadeh H, 2009, SEIZURE-EUR J EPILEP, V18, P51, DOI 10.1016/j.seizure.2008.06.004; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Sensi SL, 1997, J NEUROSCI, V17, P9554; SIMONS TJ, 1993, J BIOCHEM BIOPH METH, V270, P25; Smith JL, 2006, NEUROSCIENCE, V140, P879, DOI 10.1016/j.neuroscience.2006.02.049; Stork CJ, 2006, J NEUROSCI, V26, P10430, DOI 10.1523/JNEUROSCI.1588-06.2006; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Tombaugh GC, 1996, J PHYSIOL-LONDON, V493, P719, DOI 10.1113/jphysiol.1996.sp021417; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Ueno S, 2002, J CELL BIOL, V158, P215, DOI 10.1083/jcb.200204066; Wei G, 2004, NEUROSCIENCE, V125, P867, DOI 10.1016/j.neuroscience.2004.03.011; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026	55	108	111	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7430	7439		10.1074/jbc.M109.040485	http://dx.doi.org/10.1074/jbc.M109.040485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048154	hybrid, Green Published			2022-12-25	WOS:000275415600055
J	Sakudoh, T; Iizuka, T; Narukawa, J; Sezutsu, H; Kobayashi, I; Kuwazaki, S; Banno, Y; Kitamura, A; Sugiyama, H; Takada, N; Fujimoto, H; Kadono-Okuda, K; Mita, K; Tamura, T; Yamamoto, K; Tsuchida, K				Sakudoh, Takashi; Iizuka, Tetsuya; Narukawa, Junko; Sezutsu, Hideki; Kobayashi, Isao; Kuwazaki, Seigo; Banno, Yutaka; Kitamura, Akitoshi; Sugiyama, Hiromu; Takada, Naoko; Fujimoto, Hirofumi; Kadono-Okuda, Keiko; Mita, Kazuei; Tamura, Toshiki; Yamamoto, Kimiko; Tsuchida, Kozo			A CD36-related Transmembrane Protein Is Coordinated with an Intracellular Lipid-binding Protein in Selective Carotenoid Transport for Cocoon Coloration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SILKWORM BOMBYX-MORI; B TYPE-I; HIGH-DENSITY-LIPOPROTEIN; LINKAGE MAP; SR-BI; MAPPING ANALYSIS; CELLULAR UPTAKE; GENE FAMILY; RECEPTOR; DROSOPHILA	The transport pathway of specific dietary carotenoids from the midgut lumen to the silk gland in the silkworm, Bombyx mori, is a model system for selective carotenoid transport because several genetic mutants with defects in parts of this pathway have been identified that manifest altered cocoon pigmentation. In the wild-type silkworm, which has both genes, Yellow blood (Y) and Yellow cocoon (C), lutein is transferred selectively from the hemolymph lipoprotein to the silk gland cells where it is accumulated into the cocoon. The Y gene encodes an intracellular carotenoid-binding protein (CBP) containing a lipid-binding domain known as the steroidogenic acute regulatory protein-related lipid transfer domain. Positional cloning and transgenic rescue experiments revealed that the C gene encodes Cameo2, a transmembrane protein gene belonging to the CD36 family genes, some of which, such as the mammalian SR-BI and the fruit fly ninaD, are reported as lipoprotein receptors or implicated in carotenoid transport for visual system. In C mutant larvae, Cameo2 expression was strongly repressed in the silk gland in a specific manner, resulting in colorless silk glands and white cocoons. The developmental profile of Cameo2 expression, CBP expression, and lutein pigmentation in the silk gland of the yellow cocoon strain were correlated. We hypothesize that selective delivery of lutein to specific tissue requires the combination of two components: 1) CBP as a carotenoid transporter in cytosol and 2) Cameo2 as a transmembrane receptor on the surface of the cells.	[Sakudoh, Takashi; Takada, Naoko; Fujimoto, Hirofumi; Tsuchida, Kozo] Natl Inst Infect Dis, Div Radiol Protect & Biol, Shinjuku Ku, Tokyo 1628640, Japan; [Iizuka, Tetsuya; Sezutsu, Hideki; Kobayashi, Isao; Tamura, Toshiki] Natl Inst Agrobiol Sci, Transgen Silkworm Res Ctr, Tsukuba, Ibaraki 3058634, Japan; [Narukawa, Junko; Kuwazaki, Seigo; Kadono-Okuda, Keiko; Mita, Kazuei; Yamamoto, Kimiko] Natl Inst Agrobiol Sci, Insect Genome Res Unit, Tsukuba, Ibaraki 3058634, Japan; [Banno, Yutaka] Kyushu Univ, Fukuoka 8128581, Japan; [Kitamura, Akitoshi] Fuji Chem Ind Co Ltd, Div Life Sci, Toyama 9300397, Japan; [Sugiyama, Hiromu] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan	National Institute of Infectious Diseases (NIID); National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; Kyushu University; National Institute of Infectious Diseases (NIID)	Tsuchida, K (corresponding author), 1-23-1 Toyama,Shinjuku, Tokyo 1628640, Japan.	kozo@nih.go.jp	Kobayashi, Isao/E-3338-2010	Sezutsu, Hideki/0000-0001-8886-1611	Kieikai Research Foundation (Japan); Futaba Electronics Memorial Foundation (Japan); Japan Society for the Promotion of Science; Ministry of Agriculture, Forestry and Fisheries (Japan); Ministry of Education, Culture, Sports, Science, and Technology (Japan)	Kieikai Research Foundation (Japan); Futaba Electronics Memorial Foundation (Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry and Fisheries (Japan)(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Kieikai Research Foundation (Japan), the Futaba Electronics Memorial Foundation (Japan), a grant-in-aid for scientific research from the Japan Society for the Promotion of Science, the Insect Technology Project of the Ministry of Agriculture, Forestry and Fisheries (Japan), and the National Bioresource Project (Silkworm) of the Ministry of Education, Culture, Sports, Science, and Technology (Japan).	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Azhar S, 2002, MOL CELL ENDOCRINOL, V195, P1, DOI 10.1016/S0303-7207(02)00222-8; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Connelly MA, 2009, MOL CELL ENDOCRINOL, V300, P83, DOI 10.1016/j.mce.2008.09.011; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; During A, 2008, J LIPID RES, V49, P1715, DOI 10.1194/jlr.M700580-JLR200; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; FUJIMOTO N, 1943, J SERIC SCI JAP, V14, P276; Fujimoto N., 1949, J SERIC SCI JAPAN, V18, P82; Goldberg IJ, 1996, J LIPID RES, V37, P693; GOODWIN TW, 1986, ANNU REV NUTR, V6, P273, DOI 10.1146/annurev.nu.06.070186.001421; Gopalapillai R, 2006, J LIPID RES, V47, P1005, DOI 10.1194/jlr.M500462-JLR200; Gruarin P, 2000, BIOCHEM BIOPH RES CO, V275, P446, DOI 10.1006/bbrc.2000.3333; Hara Wajiro, 2007, Journal of Insect Biotechnology and Sericology, V76, P149; Harizuka M., 1948, J SERIC SCI JAPAN, V17, P1; HARIZUKA MASAKI, 1953, BULL SERICUL EXPT STA [JAPAN], V14, P141; Hoosdally SJ, 2009, J BIOL CHEM, V284, P16277, DOI 10.1074/jbc.M109.007849; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Imamura M, 2003, GENETICS, V165, P1329; Ishii K., 1917, SAKURAKAI ZASSHI, V1, P113; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Kiefer C, 2002, P NATL ACAD SCI USA, V99, P10581, DOI 10.1073/pnas.162182899; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loane E, 2008, SURV OPHTHALMOL, V53, P68, DOI 10.1016/j.survophthal.2007.10.008; Manunta C., 1937, Archivio Zoologico Italiano Torino, V24, P385; MARTINEZ LO, 2007, HIGH DENSITY LIPOPRO, P307; Miao XX, 2005, P NATL ACAD SCI USA, V102, P16303, DOI 10.1073/pnas.0507794102; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Moussa M, 2008, J NUTR, V138, P1432, DOI 10.1093/jn/138.8.1432; Nakajima M., 1963, B FAC AGR TOKYO, V8, P1; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; Niwa R, 2005, INSECT MOL BIOL, V14, P563, DOI 10.1111/j.1365-2583.2005.00587.x; OKU M, 1934, B AGR CHEM SOC JAPAN, V10, P1258; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Sakudoh T, 2005, BIOCHEM BIOPH RES CO, V336, P1125, DOI 10.1016/j.bbrc.2005.08.241; Sakudoh T, 2007, P NATL ACAD SCI USA, V104, P8941, DOI 10.1073/pnas.0702860104; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; SPITSBERG VL, 1995, EUR J BIOCHEM, V230, P872, DOI 10.1111/j.1432-1033.1995.tb20630.x; Sturtevant AH, 1915, AM NAT, V49, P42, DOI 10.1086/279453; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Tabunoki H, 2002, J BIOL CHEM, V277, P32133, DOI 10.1074/jbc.M204507200; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tatematsu K, 2010, TRANSGENIC RES, V19, P473, DOI 10.1007/s11248-009-9328-2; Tazima Y, 1964, GENETICS SILKWORM; Tsuchida K, 2004, J INSECT PHYSIOL, V50, P975, DOI 10.1016/j.jinsphys.2004.08.001; Tsuchida K, 2004, J INSECT PHYSIOL, V50, P363, DOI 10.1016/j.jinsphys.2004.02.006; Tsuchida K, 1998, INSECT BIOCHEM MOLEC, V28, P927, DOI 10.1016/S0965-1748(98)00036-8; Uda H, 1919, GENETICS, V4, P395; van Bennekum A, 2005, BIOCHEMISTRY-US, V44, P4517, DOI 10.1021/bi0484320; VANDERHORST DJ, 2004, COMPREHENSIVE INSECT, P225; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Voolstra O, 2006, BIOCHEMISTRY-US, V45, P13429, DOI 10.1021/bi060701u; Wang T, 2007, J CELL BIOL, V177, P305, DOI 10.1083/jcb.200610081; Yamamoto K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r21; Yamamoto K, 2006, GENETICS, V173, P151, DOI 10.1534/genetics.105.053801; Zhao YP, 2008, INSECT SCI, V15, P399, DOI 10.1111/j.1744-7917.2008.00226.x	64	64	74	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7739	7751		10.1074/jbc.M109.074435	http://dx.doi.org/10.1074/jbc.M109.074435			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20053988	hybrid, Green Published			2022-12-25	WOS:000275415600082
J	Son, BK; Akishita, M; Iijima, K; Ogawa, S; Maemura, K; Yu, J; Takeyama, K; Kato, S; Eto, M; Ouchi, Y				Son, Bo-Kyung; Akishita, Masahiro; Iijima, Katsuya; Ogawa, Sumito; Maemura, Koji; Yu, Jing; Takeyama, Kenichi; Kato, Shigeaki; Eto, Masato; Ouchi, Yasuyoshi			Androgen Receptor-dependent Transactivation of Growth Arrest-specific Gene 6 Mediates Inhibitory Effects of Testosterone on Vascular Calcification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-ARTERY-DISEASE; SMOOTH-MUSCLE-CELLS; PHOSPHATE-INDUCED CALCIFICATION; LOW SERUM TESTOSTERONE; MIDDLE-AGED MEN; CAROTID ATHEROSCLEROSIS; ENDOGENOUS TESTOSTERONE; REPLACEMENT THERAPY; SURVIVAL PATHWAY; ELDERLY MEN	Recent epidemiological studies have found that androgen deficiency is associated with a higher incidence of cardiovascular disease in men. However, little is known about the mechanism underlying the cardioprotective effects of androgens. Here we show the inhibitory effects of testosterone on vascular calcification and a critical role of androgen receptor (AR)-dependent transactivation of growth arrest-specific gene 6 (Gas6), a key regulator of inorganic phosphate (P-i)-induced calcification of vascular smooth muscle cells (VSMC). Testosterone and nonaromatizable androgen dihydrotestosterone inhibited P-i-induced calcification of human aortic VSMC in a concentration-dependent manner. Androgen inhibited P-i-induced VSMC apoptosis, an essential process for VSMC calcification. The effects on VSMC calcification were mediated by restoration of P-i-induced down-regulation of Gas6 expression and a subsequent reduction of Akt phosphorylation. These effects of androgen were blocked by an AR antagonist, flutamide, but not by an estrogen receptor antagonist, ICI 182,780. We then explored the mechanistic role of the AR in Gas6 expression and found an abundant expression of AR predominantly in the nucleus of VSMC and two consensus ARE sequences in the Gas6 promoter region. Dihydrotestosterone stimulated Gas6 promoter activity, and this effect was abrogated by flutamide and by AR siRNA. Site-specific mutation revealed that the proximal ARE was essential for androgen-dependent transactivation of Gas6. Furthermore, chromatin immunoprecipitation assays demonstrated ligand-dependent binding of the AR to the proximal ARE of Gas6. These results indicate that AR signaling directly regulates Gas6 transcription, which leads to inhibition of vascular calcification, and provides a mechanistic insight into the cardioprotective action of androgens.	[Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan; [Yu, Jing] Univ Tokyo, Grad Sch Med, Dept Integrated Tradit Med, Bunkyo Ku, Tokyo 1138655, Japan; [Takeyama, Kenichi; Kato, Shigeaki] Univ Tokyo, Grad Sch Agr & Life Sci, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1138655, Japan; [Maemura, Koji] Nagasaki Univ, Dept Cardiovasc Med, Grad Sch Biomed Sci, Nagasaki 8528501, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Nagasaki University	Akishita, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	akishita-tky@umin.ac.jp		Eto, Masato/0000-0002-6036-3431	Ministry of Health, Labor, and Welfare of Japan [H17-Choju-046]; Ministry of Education, Science, Culture, and Sports of Japan [21390220, 20249041]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Health and Labor Sciences Research Grant H17-Choju-046 from the Ministry of Health, Labor, and Welfare of Japan and Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Culture, and Sports of Japan 21390220 and 20249041.	Akishita M, 2007, HYPERTENS RES, V30, P1029, DOI 10.1291/hypres.30.1029; Alexandersen P, 2006, CLIMACTERIC, V9, P108, DOI 10.1080/13697130600647743; Alexandersen P, 1999, CIRC RES, V84, P813; Balica M, 1997, CIRCULATION, V95, P1954; Bruck B, 1997, ARTERIOSCL THROM VAS, V17, P2192, DOI 10.1161/01.ATV.17.10.2192; Emi Y, 2008, J OBSTET GYNAECOL RE, V34, P890, DOI 10.1111/j.1447-0756.2008.00857.x; Fogari R, 2005, HYPERTENS RES, V28, P625, DOI 10.1291/hypres.28.625; Hak AE, 2002, J CLIN ENDOCR METAB, V87, P3632, DOI 10.1210/jc.87.8.3632; Hanke H, 2001, CIRCULATION, V103, P1382, DOI 10.1161/01.CIR.103.10.1382; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hemers H, 2004, J BIOL CHEM, V279, P30880, DOI 10.1074/jbc.M401615200; Ikeda Y, 2009, ENDOCRINOLOGY, V150, P2857, DOI 10.1210/en.2008-1254; Jeppesen LL, 1996, ARTERIOSCL THROM VAS, V16, P749, DOI 10.1161/01.ATV.16.6.749; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792; Liu PY, 2005, J CLIN ENDOCR METAB, V90, P1041, DOI 10.1210/jc.2004-1211; Makinen J, 2005, J AM COLL CARDIOL, V45, P1603, DOI 10.1016/j.jacc.2005.01.052; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; Mark MR, 1996, J BIOL CHEM, V271, P9785, DOI 10.1074/jbc.271.16.9785; McRobb L, 2009, ENDOCRINOLOGY, V150, P841, DOI 10.1210/en.2008-0760; Mo R, 2007, BIOCHEM BIOPH RES CO, V353, P189, DOI 10.1016/j.bbrc.2006.12.018; MOORADIAN AD, 1987, ENDOCR REV, V8, P1, DOI 10.1210/edrv-8-1-1; Nakamura T., 2002, GERIATR GERONTOL INT, V3, P145, DOI 10.1046/j.1444-1586.2003.00077.x; NAKAO J, 1979, ATHEROSCLEROSIS, V34, P469, DOI 10.1016/0021-9150(79)90071-6; Nathan L, 2001, P NATL ACAD SCI USA, V98, P3589, DOI 10.1073/pnas.051003698; Ong PJL, 2000, AM J CARDIOL, V85, P269, DOI 10.1016/S0002-9149(99)00630-X; Read JT, 2007, J BIOL CHEM, V282, P31954, DOI 10.1074/jbc.M702099200; Rosano GMC, 1999, CIRCULATION, V99, P1666, DOI 10.1161/01.CIR.99.13.1666; Rzewuska-Lech E, 2005, AM J PHYSIOL-ENDOC M, V289, pE105, DOI 10.1152/ajpendo.00366.2004; Shores MM, 2006, ARCH INTERN MED, V166, P1660, DOI 10.1001/archinte.166.15.1660; Simon D, 1997, J CLIN ENDOCR METAB, V82, P682, DOI 10.1210/jc.82.2.682; Son BK, 2006, CIRC RES, V98, P1024, DOI 10.1161/01.RES.0000218859.90970.8d; Son BK, 2008, ENDOCRINOLOGY, V149, P1646, DOI 10.1210/en.2007-1021; Son BK, 2007, EUR J PHARMACOL, V556, P1, DOI 10.1016/j.ejphar.2006.09.070; Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490; Tharp DL, 2009, CARDIOVASC RES, V82, P152, DOI 10.1093/cvr/cvp038; van den Beld AW, 2003, AM J EPIDEMIOL, V157, P25, DOI 10.1093/aje/kwf160; Yaron M, 2009, EUR J ENDOCRINOL, V160, P839, DOI 10.1530/EJE-09-0052; Zhao Y, 2009, MOL CELL BIOL, V29, P1017, DOI 10.1128/MCB.02123-07; Zitzmann M, 2001, J CLIN ENDOCR METAB, V86, P4867, DOI 10.1210/jc.86.10.4867	42	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7537	7544		10.1074/jbc.M109.055087	http://dx.doi.org/10.1074/jbc.M109.055087			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048160	Green Published, hybrid			2022-12-25	WOS:000275415600065
J	Behren, A; Muhlen, S; Sanhueza, GAA; Schwager, C; Plinkert, PK; Huber, PE; Abdollahi, A; Simon, C				Behren, A.; Muehlen, S.; Sanhueza, G. A. Acuna; Schwager, C.; Plinkert, P. K.; Huber, P. E.; Abdollahi, A.; Simon, C.			Phenotype-assisted transcriptome analysis identifies FOXM1 downstream from Ras-MKK3-p38 to regulate in vitro cellular invasion	ONCOGENE			English	Article						MAPK; p38; ras; invasion; FOXM1; MKK3	ACTIVATED PROTEIN-KINASES; BREAST EPITHELIAL-CELLS; SIGNALING PATHWAYS; GENE-EXPRESSION; TRANSGENIC MICE; RAS; P38; CARCINOMA; FIBROBLASTS; SENESCENCE	The Ras oncogene is known to activate three major MAPK pathways, ERK, JNK, p38 and exert distinct cellular phenotypes, that is, apoptosis and invasion through the Ras-MKK3-p38-signaling cascade. We attempted to identify the molecular targets of this pathway that selectively govern the invasive phenotype. Stable transfection of NIH3T3 fibroblasts with MKK3(act) cDNA construct revealed similar p38-dependent in vitro characteristics observed in Ha-Ras(EJ)-transformed NIH3T3 cells, including enhanced invasiveness and anchorage-independent growth correlating with p38 phosphorylation status. To identify the consensus downstream targets of the Ras-MKK3-p38 cascade involved in invasion, in vitro invasion assays were used to isolate highly invasive cells from both, MKK3 and Ha-Ras(EJ) transgenic cell lines. Subsequently a genome-wide transcriptome analysis was employed to investigate differentially regulated genes in invasive Ha-Ras(EJ)- and MKK3(act)-transfected NIH3T3 fibroblasts. Using this phenotype-assisted approach combined with system level protein-interaction network analysis, we identified FOXM1, PLK1 and CDK1 to be differentially regulated in invasive Ha-Ras(EJ)- NIH3T3 and MKK3(act)-NIH3T3 cells. Finally, a FOXM1 RNA-knockdown approach revealed its requirement for both invasion and anchorage-independent growth of Ha-Ras(EJ)- and MKK3(act)-NIH3T3 cells. Together, we identified FOXM1 as a key downstream target of Ras and MKK3-induced cellular in vitro invasion and anchorage-independent growth signaling. Oncogene (2010) 29, 1519-1530; doi:10.1038/onc.2009.436; published online 21 December 2009	[Behren, A.] Ludwig Inst Canc Res Ltd, Melbourne Ctr Clin Sci, Canc Vaccine, Heidelberg, Vic, Australia; [Muehlen, S.] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; [Behren, A.; Muehlen, S.; Plinkert, P. K.; Simon, C.] Univ Heidelberg Hosp, Dept Otolaryngol Head & Neck Surg, Heidelberg, Germany; [Sanhueza, G. A. Acuna] DKFZ, German Canc Res Ctr, Div Signal Transduct & Growth Control, Heidelberg, Germany; [Schwager, C.; Huber, P. E.; Abdollahi, A.] DKFZ, German Canc Res Ctr, Dept Radiat Oncol, Heidelberg, Germany; [Abdollahi, A.] Tufts Univ, Sch Med, Ctr Canc Syst Biol, Caritas St Elizabeths Med Ctr, Boston, MA 02111 USA; [Abdollahi, A.] Harvard Univ, Sch Med, Dept Surg, Karp Family Res Labs,Vasc Biol Program, Boston, MA 02115 USA	Ludwig Institute for Cancer Research; Newcastle University - UK; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); St. Elizabeth's Medical Center; Tufts University; Harvard University; Harvard Medical School	Simon, C (corresponding author), Univ Heidelberg, Dept Otolaryngol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	csimon1407@aol.com	Behren, Andreas/ABZ-2615-2022	Muehlen, Sabrina/0000-0001-7474-705X; Behren, Andreas/0000-0001-5329-280X	German Krebshilfe (Deutsche Krebshilfe) [107691]; NSCOR [NNJ04HJ12G]; DFG [SPP1190, Si634-5/1]	German Krebshilfe (Deutsche Krebshilfe)(Deutsche Krebshilfe); NSCOR; DFG(German Research Foundation (DFG))	We thank Thomas Regiert (DKFZ) for excellent technical assistance with microarray analysis. We also thank J Han (Scripps Research Institute) for providing us with the MKK3(b) expression construct and RH Medema (Laboratory of Experimental Oncology, University Medical Center Utrecht) for the FoxM1 promoter construct. This work was supported by the German Krebshilfe (Deutsche Krebshilfe, 107691, to CS, PH, PP and AA), NSCOR NNJ04HJ12G and DFG-SPP1190 (to AA and PH) and DFG-Si634-5/1 (to CS and PP).	Adam AP, 2009, CANCER RES, V69, P5664, DOI 10.1158/0008-5472.CAN-08-3820; Behren A, 2005, EXP CELL RES, V303, P321, DOI 10.1016/j.yexcr.2004.10.004; BRADLEY MO, 1986, P NATL ACAD SCI USA, V83, P5277, DOI 10.1073/pnas.83.14.5277; Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; Deng QD, 2004, J BIOL CHEM, V279, P1050, DOI 10.1074/jbc.M308644200; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Haq R, 2002, CANCER RES, V62, P5076; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Janulis M, 1999, J BIOL CHEM, V274, P801, DOI 10.1074/jbc.274.2.801; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jin K, 2005, J BIOL CHEM, V280, P42097, DOI 10.1074/jbc.M507301200; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinina OA, 2003, ONCOGENE, V22, P6266, DOI 10.1038/sj.onc.1206640; Korver W, 1997, GENOMICS, V46, P435, DOI 10.1006/geno.1997.5065; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Moon A, 2006, ARCH PHARM RES, V29, P113, DOI 10.1007/BF02974271; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reunanen N, 2002, J BIOL CHEM, V277, P32360, DOI 10.1074/jbc.M204296200; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schwacke JH, 2007, J THEOR BIOL, V246, P604, DOI 10.1016/j.jtbi.2006.12.035; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; STACEY DW, 1984, NATURE, V310, P508, DOI 10.1038/310508a0; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; ZHANG JY, 1992, CANCER RES, V52, P6682	39	34	36	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	10					1519	1530		10.1038/onc.2009.436	http://dx.doi.org/10.1038/onc.2009.436			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	566SD	20023695				2022-12-25	WOS:000275392400010
J	Liu, WH; Yuen, EY; Yan, Z				Liu, Wenhua; Yuen, Eunice Y.; Yan, Zhen			The Stress Hormone Corticosterone Increases Synaptic alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors via Serum- and Glucocorticoid-inducible Kinase (SGK) Regulation of the GDI-Rab4 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-DISSOCIATION INHIBITOR; GTP-BINDING PROTEIN; RAB PROTEINS; PREFRONTAL CORTEX; EARLY ENDOSOMES; GLUTAMATERGIC TRANSMISSION; ENDOCYTIC PATHWAY; CURRENT AMPLITUDE; TRAFFICKING; PLASTICITY	Corticosterone, the major stress hormone, plays an important role in regulating neuronal functions of the limbic system, although the cellular targets and molecular mechanisms of corticosteroid signaling are largely unknown. Here we show that a short treatment of corticosterone significantly increases alpha-amino- 3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)-mediated synaptic transmission and AMPAR membrane trafficking in pyramidal neurons of prefrontal cortex, a key region involved in cognition and emotion. This enhancing effect of corticosterone is through a mechanism dependent on Rab4, the small GTPase-controlling receptor recycling between early endosome and plasma membrane. Guanosine nucleotide dissociation inhibitor (GDI), which regulates the cycle of Rab proteins between membrane and cytosol, forms an increased complex with Rab4 after corticosterone treatment. Corticosterone also triggers an increased GDI phosphorylation at Ser-213 by the serum- and glucocorticoid-inducible kinase (SGK). Moreover, AMPAR synaptic currents and surface expression and their regulation by corticosterone are altered by mutating Ser-213 on GDI. These results suggest that corticosterone, via SGK phosphorylation of GDI at Ser-213, increases the formation of GDI-Rab4 complex, facilitating the functional cycle of Rab4 and Rab4-mediated recycling of AMPARs to the synaptic membrane. It provides a potential mechanism underlying the role of corticosteroid stress hormone in up-regulating excitatory synaptic efficacy in cortical neurons.	[Liu, Wenhua; Yuen, Eunice Y.; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yan, Z (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu		Liu, Wenhua/0000-0003-0903-8497	National Institutes of Health [084233]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant MH 084233 (to Z.Y.).	ARAKI S, 1990, J BIOL CHEM, V265, P13007; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chameau P, 2007, J NEUROPHYSIOL, V97, P5, DOI 10.1152/jn.00821.2006; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Funder JW, 1997, ANNU REV MED, V48, P231, DOI 10.1146/annurev.med.48.1.231; Gerges NZ, 2004, J BIOL CHEM, V279, P43870, DOI 10.1074/jbc.M404982200; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Joels M, 2009, BRAIN RES, V1293, P91, DOI 10.1016/j.brainres.2009.03.036; Karst H, 2005, J NEUROPHYSIOL, V94, P3479, DOI 10.1152/jn.00143.2005; Kaufer D, 2004, NAT NEUROSCI, V7, P947, DOI 10.1038/nn1296; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Lang F, 2001, Sci STKE, V2001, pre17, DOI 10.1126/stke.2001.108.re17; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Martin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004714; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mohrmann K, 2002, J BIOL CHEM, V277, P32029, DOI 10.1074/jbc.M203064200; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Odley A, 2004, P NATL ACAD SCI USA, V101, P7082, DOI 10.1073/pnas.0308335101; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Shisheva A, 1999, BIOCHEMISTRY-US, V38, P11711, DOI 10.1021/bi990200r; Shisheva A, 1997, BIOCHEMISTRY-US, V36, P6564, DOI 10.1021/bi970202g; SHISHEVA A, 1994, MOL CELL BIOL, V14, P3459, DOI 10.1128/MCB.14.5.3459; STEELEMORTIMER O, 1993, FEBS LETT, V329, P313, DOI 10.1016/0014-5793(93)80244-O; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; VANDERSLUIJS P, 1991, P NATL ACAD SCI USA, V88, P6313, DOI 10.1073/pnas.88.14.6313; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; YANG CZ, 1994, J BIOL CHEM, V269, P31891; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; Yuen EY, 2009, J NEUROSCI, V29, P550, DOI 10.1523/JNEUROSCI.5050-08.2009; Yuen EY, 2005, J NEUROSCI, V25, P5488, DOI 10.1523/JNEUROSCI.1187-05.2005; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhong P, 2008, J PHYSIOL-LONDON, V586, P4465, DOI 10.1113/jphysiol.2008.155143	46	55	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6101	6108		10.1074/jbc.M109.050229	http://dx.doi.org/10.1074/jbc.M109.050229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20051515	Green Published, hybrid			2022-12-25	WOS:000275367500013
J	Lucero, HA; Kintsurashvili, E; Marketou, ME; Gavras, H				Lucero, Hector A.; Kintsurashvili, Ekaterina; Marketou, Maria E.; Gavras, Haralambos			Cell Signaling, Internalization, and Nuclear Localization of the Angiotensin Converting Enzyme in Smooth Muscle and Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; EXPRESSION; RECEPTORS; CANCER; GENE; INHIBITORS; PROTEINS; PATHWAYS; DOMAIN; ACE	The angiotensin converting enzyme (ACE) catalyzes the extracellular formation of angiotensin II, and degradation of bradykinin, thus regulating blood pressure and renal handling of electrolytes. We have previously shown that exogenously added ACE elicited transcriptional regulation independent of its enzymatic activity. Because transcriptional regulation generates from protein-DNA interactions within the cell nucleus we have investigated the initial cellular response to exogenous ACE and the putative internalization of the enzyme in smooth muscle cells (SMC) and endothelial cells (EC). The following phenomena were observed when ACE was added to cells in culture: 1) it bound to SMC and EC with high affinity (K-d = 361.5 +/- 60.5 pM) and with a low binding occupancy (B-max = 335.0 +/- 14.0 molecules/cell); 2) it triggered cellular signaling resulting in late activation of focal adhesion kinase and SHP2; 3) it modulated platelet-derived growth factor receptor-beta signaling; 4) it was endocytosed by SMC and EC; and 5) it transited through the early endosome, partially occupied the late endosome and the lysosome, and was localized to the nuclei. The incorporation of ACE or a fragment of it into the nuclei reached saturation at 120 min, and was preceded by a lag time of 40 min. Internalized ACE was partially cleaved into small fragments. These results revealed that extracellular ACE modulated cell signaling properties, and that SMC and EC have a pathway for delivery of extracellular ACE to the nucleus, most likely involving cell surface receptor(s) and requiring transit through late endosome/lysosome compartments.	[Lucero, Hector A.; Kintsurashvili, Ekaterina; Gavras, Haralambos] Boston Univ, Sch Med, Alapis Res Labs, Dept Med, Boston, MA 02118 USA; [Lucero, Hector A.; Kintsurashvili, Ekaterina; Marketou, Maria E.; Gavras, Haralambos] Boston Univ, Sch Med, Hypertens & Atherosclerosis Sect, Dept Med, Boston, MA 02118 USA	Boston University; Boston University	Lucero, HA (corresponding author), 715 Albany St,W508, Boston, MA 02118 USA.	hlucero@bu.edu	vardas, panos/ABF-7144-2020; Vardas, Panos/AAP-5694-2021; Vardas, Panos/AAD-5219-2022		Alapis Research Laboratories	Alapis Research Laboratories	This work was supported in part by Alapis Research Laboratories.	Arnoys EJ, 2007, ACTA HISTOCHEM, V109, P89, DOI 10.1016/j.acthis.2006.10.002; BELDENT V, 1995, J BIOL CHEM, V270, P28962, DOI 10.1074/jbc.270.48.28962; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; Chen ZL, 2006, FASEB J, V20, P2261, DOI 10.1096/fj.06-6113com; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; de Andrade MCC, 2006, AM J PHYSIOL-RENAL, V290, pF364, DOI 10.1152/ajprenal.00110.2005; DOWER SK, 1985, J EXP MED, V162, P501, DOI 10.1084/jem.162.2.501; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Fusek Martin, 2005, Biomedical Papers (Olomouc), V149, P43; GAVRAS H, 1994, HYPERTENSION, V23, P813, DOI 10.1161/01.HYP.23.6.813; HOLYCROSS BJ, 1992, HYPERTENSION, V19, P697, DOI 10.1161/01.HYP.19.6.697; HOOPER NM, 1987, BIOCHEM J, V241, P625, DOI 10.1042/bj2410625; HOWARD TE, 1990, MOL CELL BIOL, V10, P4294, DOI 10.1128/MCB.10.8.4294; Ignjacev-Lazich I, 2005, AM J PHYSIOL-HEART C, V289, pH1814, DOI 10.1152/ajpheart.00581.2005; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Kohlstedt K, 2006, MOL PHARMACOL, V69, P1725, DOI 10.1124/mol.105.020636; Kohlstedt K, 2005, HYPERTENSION, V45, P126, DOI 10.1161/01.HYP.0000150159.48992.11; Kohlstedt K, 2004, CIRC RES, V94, P60, DOI 10.1161/01.RES.0000107195.13573.E4; Kohlstedt K, 2009, MOL PHARMACOL, V75, P685, DOI 10.1124/mol.108.051631; Kondoh G, 2005, NAT MED, V11, P160, DOI 10.1038/nm1179; Leisle L, 2005, NAT MED, V11, P1139, DOI 10.1038/nm1105-1139; Lever AF, 1998, LANCET, V352, P179, DOI 10.1016/S0140-6736(98)03228-0; Lindberg H, 2004, ACTA ONCOL, V43, P142, DOI 10.1080/02841860310022346; LOWENTHAL JW, 1988, J IMMUNOL, V140, P456; Lucero HA, 2008, J BIOL CHEM, V283, P24103, DOI 10.1074/jbc.M709897200; Martin ME, 2007, AAPS J, V9, pE18, DOI 10.1208/aapsj0901003; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Melikov K, 2005, CELL MOL LIFE SCI, V62, P2739, DOI 10.1007/s00018-005-5293-y; Miyazawa N, 2001, J VIROL, V75, P1387, DOI 10.1128/JVI.75.3.1387-1400.2001; MORISHITA R, 1994, J CLIN INVEST, V94, P978, DOI 10.1172/JCI117464; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; RAKUGI H, 1994, J CLIN INVEST, V93, P339, DOI 10.1172/JCI116965; Rosenthal T, 2009, J HUM HYPERTENS, V23, P623, DOI 10.1038/jhh.2009.21; RUBARTELLI A, 1995, TRENDS CELL BIOL, V5, P409, DOI 10.1016/S0962-8924(00)89093-5; Sandholzer J, 2007, BIOCHEM BIOPH RES CO, V360, P370, DOI 10.1016/j.bbrc.2007.06.095; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; SPRAGUE EA, 1985, AM J PATHOL, V121, P433; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; Suikkanen S, 2002, J VIROL, V76, P4401, DOI 10.1128/JVI.76.9.4401-4411.2002; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; WEI L, 1991, J BIOL CHEM, V266, P9002; WEI L, 1991, J BIOL CHEM, V266, P5540; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Yoshiji H, 2004, CURR CANCER DRUG TAR, V4, P555, DOI 10.2174/1568009043332790	45	24	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5555	5568		10.1074/jbc.M109.074740	http://dx.doi.org/10.1074/jbc.M109.074740			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022959	hybrid, Green Published			2022-12-25	WOS:000275327200048
J	Minamide, LS; Maiti, S; Boyle, JA; Davis, RC; Coppinger, JA; Bao, Y; Huang, TY; Yates, J; Bokoch, GM; Bamburg, JR				Minamide, Laurie S.; Maiti, Sankar; Boyle, Judith A.; Davis, Richard C.; Coppinger, Judith A.; Bao, Yunhe; Huang, Timothy Y.; Yates, John; Bokoch, Gary M.; Bamburg, James R.			Isolation and Characterization of Cytoplasmic Cofilin-Actin Rods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPOLYMERIZING FACTOR; F-ACTIN; ADF/COFILIN; PROTEIN; INTRANUCLEAR; EXPRESSION; MECHANISM; ATP; IDENTIFICATION; VISUALIZATION	Cofilin-actin bundles (rods), which form in axons and dendrites of stressed neurons, lead to synaptic dysfunction and may mediate cognitive deficits in dementias. Rods form abundantly in the cytoplasm of non-neuronal cells in response to many treatments that induce rods in neurons. Rods in cell lysates are not stable in detergents or with added calcium. Rods induced by ATP-depletion and released from cells by mechanical lysis were first isolated from two cell lines expressing chimeric actin-depolymerizing factor (ADF)/cofilin fluorescent proteins by differential and equilibrium sedimentation on OptiPrep gradients and then from neuronal and non-neuronal cells expressing only endogenous proteins. Rods contain ADF/cofilin and actin in a 1:1 ratio. Isolated rods are stable in dithiothreitol, EGTA, Ca2+, and ATP. Cofilin-GFP-containing rods are stable in 500 mM NaCl, whereas rods formed from endogenous proteins are significantly less stable in high salt. Proteomic analysis of rods formed from endogenous proteins identified other potential components whose presence in rods was examined by immunofluorescence staining of cells. Only actin and ADF/cofilin are in rods during all phases of their formation; furthermore, the rapid assembly of rods in vitro from these purified proteins at physiological concentration shows that they are the only proteins necessary for rod formation. Cytoplasmic rod formation is inhibited by cytochalasin D and jasplakinolide. Time lapse imaging of rod formation shows abundant small needle-shaped rods that coalesce over time. Rod filament lengths measured by ultrastructural tomography ranged from 22 to 1480 nm. These results suggest rods form by assembly of cofilin-actin subunits, followed by self-association of ADF/cofilin-saturated F-actin.	[Minamide, Laurie S.; Maiti, Sankar; Boyle, Judith A.; Davis, Richard C.; Bao, Yunhe; Bamburg, James R.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Bamburg, James R.] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA; [Coppinger, Judith A.; Huang, Timothy Y.; Yates, John; Bokoch, Gary M.] Scripps Res Inst, La Jolla, CA 92037 USA	Colorado State University; Colorado State University; Scripps Research Institute	Bamburg, JR (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, 1870 Campus Delivery, Ft Collins, CO 80523 USA.	jbamburg@lamar.colostate.edu		coppinger, judith/0000-0001-6813-9840	National Institutes of Health [NS40371, NS43115, HL079442, RR11823-10]; Alzheimer's Association [IIRG-01-2730]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040371, T32NS043115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS40371 and NS43115 (to J.R.B.) and HL079442 and RR11823-10 (to J.Y.). This work was also supported by Alzheimer's Association Grant IIRG-01-2730.	ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; ADAMS ME, 1990, BIOCHEMISTRY-US, V29, P7414, DOI 10.1021/bi00484a009; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Ashworth SL, 2003, AM J PHYSIOL-RENAL, V284, pF852, DOI 10.1152/ajprenal.00210.2002; Bae SM, 2005, GYNECOL ONCOL, V99, P26, DOI 10.1016/j.ygyno.2005.05.041; Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; BERSHADSKY AD, 1980, EXP CELL RES, V127, P421, DOI 10.1016/0014-4827(80)90446-2; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; Chen H, 2004, BIOCHEMISTRY-US, V43, P7127, DOI 10.1021/bi049797n; Davis RC, 2008, ACTA NEUROPATHOL, V115, P205, DOI 10.1007/s00401-007-0275-9; Davis RC, 2009, J ALZHEIMERS DIS, V18, DOI 10.3233/JAD-2009-1122; Devineni N, 1999, BRAIN RES, V823, P129, DOI 10.1016/S0006-8993(99)01147-6; Domazetovska A, 2007, BRAIN, V130, P3275, DOI 10.1093/brain/awm247; FUKUI Y, 1979, EXP CELL RES, V120, P451, DOI 10.1016/0014-4827(79)90412-9; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Goebel HH, 1997, NEUROMUSCULAR DISORD, V7, P13, DOI 10.1016/S0960-8966(96)00404-X; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Jang DH, 2005, P NATL ACAD SCI USA, V102, P16072, DOI 10.1073/pnas.0507675102; KOFFER A, 1988, J MUSCLE RES CELL M, V9, P320, DOI 10.1007/BF01773875; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kuhn TB, 2008, ADV EXP MED BIOL, V644, P232; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; Maloney MT, 2005, J NEUROSCI, V25, P11313, DOI 10.1523/JNEUROSCI.3711-05.2005; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Minamide LS, 2003, METHOD CELL BIOL, V71, P387, DOI 10.1016/S0091-679X(03)01019-7; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pfannstiel J, 2001, J BIOL CHEM, V276, P49476, DOI 10.1074/jbc.M104760200; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Shaw AE, 2004, ELECTROPHORESIS, V25, P2611, DOI 10.1002/elps.200406017; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	46	50	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5450	5460		10.1074/jbc.M109.063768	http://dx.doi.org/10.1074/jbc.M109.063768			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022956	Green Published, hybrid			2022-12-25	WOS:000275327200038
J	Soshi, T; Kuriyama, K; Aritake, S; Enomoto, M; Hida, A; Tamura, M; Kim, Y; Mishima, K				Soshi, Takahiro; Kuriyama, Kenichi; Aritake, Sayaka; Enomoto, Minori; Hida, Akiko; Tamura, Miyuki; Kim, Yoshiharu; Mishima, Kazuo			Sleep Deprivation Influences Diurnal Variation of Human Time Perception with Prefrontal Activity Change: A Functional Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							BRAIN ACTIVATION; WORKING-MEMORY; DIVIDED ATTENTION; DURATION; CORTEX; LONG; DISCRIMINATION; REPRESENTATION; FLUCTUATION; NETWORKS	Human short-time perception shows diurnal variation. In general, short-time perception fluctuates in parallel with circadian clock parameters, while diurnal variation seems to be modulated by sleep deprivation per se. Functional imaging studies have reported that short-time perception recruits a neural network that includes subcortical structures, as well as cortical areas involving the prefrontal cortex (PFC). It has also been reported that the PFC is vulnerable to sleep deprivation, which has an influence on various cognitive functions. The present study is aimed at elucidating the influence of PFC vulnerability to sleep deprivation on short-time perception, using the optical imaging technique of functional near-infrared spectroscopy. Eighteen participants performed 10-s time production tasks before (at 21: 00) and after (at 09: 00) experimental nights both in sleep-controlled and sleep-deprived conditions in a 4-day laboratory-based crossover study. Compared to the sleep-controlled condition, one-night sleep deprivation induced a significant reduction in the produced time simultaneous with an increased hemodynamic response in the left PFC at 09:00. These results suggest that activation of the left PFC, which possibly reflects functional compensation under a sleep-deprived condition, is associated with alteration of short-time perception.	[Soshi, Takahiro; Kuriyama, Kenichi; Aritake, Sayaka; Enomoto, Minori; Hida, Akiko; Tamura, Miyuki; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Dept Psychophysiol, Natl Inst Mental Hlth, Tokyo, Japan; [Soshi, Takahiro; Kuriyama, Kenichi; Kim, Yoshiharu] Natl Ctr Neurol & Psychiat, Dept Adult Mental Hlth, Natl Inst Mental Hlth, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Soshi, T (corresponding author), Natl Ctr Neurol & Psychiat, Dept Psychophysiol, Natl Inst Mental Hlth, Tokyo, Japan.	kenichik@ncnp.go.jp		MISHIMA, KAZUO/0000-0003-1182-1181; Soshi, Takahiro/0000-0003-1924-936X	Ministry of Education, Culture, Sports, and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan; Grants-in-Aid for Scientific Research [22791161, 21390335] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Special Coordination Funds of the Ministry of Education, Culture, Sports, and Technology of Japan and by a Grant-in-Aid for Cooperative Research from the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrilli A, 1997, PERCEPT PSYCHOPHYS, V59, P972, DOI 10.3758/BF03205512; Aschoff J, 1997, CHRONOBIOL INT, V14, P585, DOI 10.3109/07420529709001449; ASCHOFF J, 1985, HUM NEUROBIOL, V4, P41; Aschoff J, 1998, J BIOL RHYTHM, V13, P437, DOI 10.1177/074873098129000264; ASCHOFF J, 1988, ANN NY ACAD SCI, V423, P442; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOYAR RM, 1979, J CLIN ENDOCR METAB, V48, P760, DOI 10.1210/jcem-48-5-760; Bschor T, 2004, ACTA PSYCHIAT SCAND, V109, P222, DOI 10.1046/j.0001-690X.2003.00244.x; Casini L, 1999, NEUROPSYCHOLOGY, V13, P10, DOI 10.1037/0894-4105.13.1.10; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Davidson AJ, 2004, LIVER INT, V24, P179, DOI 10.1111/j.1478-3231.2004.00917.x; Drummond SPA, 2005, PSYCHIAT RES-NEUROIM, V140, P211, DOI 10.1016/j.pscychresns.2005.06.007; Drummond SPA, 1999, NEUROREPORT, V10, P3745, DOI 10.1097/00001756-199912160-00004; Drummond SPA, 2000, NATURE, V403, P655, DOI 10.1038/35001068; Drummond SPA, 2001, NEUROPSYCHOPHARMACOL, V25, pS68, DOI 10.1016/S0893-133X(01)00325-6; Drummond SPA, 2001, J SLEEP RES, V10, P85, DOI 10.1046/j.1365-2869.2001.00245.x; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; FEVRE M, 1978, J CLIN ENDOCR METAB, V47, P1383, DOI 10.1210/jcem-47-6-1383; GIBBON J, 1981, J EXP PSYCHOL ANIM B, V7, P87, DOI 10.1037/0097-7403.7.2.87; Harrington DL, 1998, J NEUROSCI, V18, P1085; HOAGLAND HUDSON, 1933, JOUR GEN PSYCHOL, V9, P267; HORNE JA, 1993, BRIT J PSYCHIAT, V162, P413, DOI 10.1192/bjp.162.3.413; HOSHI Y, 1993, J APPL PHYSIOL, V75, P1842, DOI 10.1152/jappl.1993.75.4.1842; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; JASPER HH, 1958, ELECTROENCEPHALOGR C, V86, P7; Jindal SL, 2002, J ASTHMA, V39, P363, DOI 10.1081/JAS-120004029; KLEBER RJ, 1963, J COMP PHYSIOL PSYCH, V56, P362, DOI 10.1037/h0049227; KRAFT M, 1995, DIS MON, V41, P501; Kuriyama K, 2005, NEUROSCI RES, V53, P123, DOI 10.1016/j.neures.2005.06.006; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Kuriyama K, 2003, NEUROSCI RES, V46, P23, DOI 10.1016/S0168-0102(03)00025-7; Kuriyama K, 2008, J NEUROSCI, V28, P10145, DOI 10.1523/JNEUROSCI.2039-08.2008; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lewis PA, 2002, NEUROREPORT, V13, P1731, DOI 10.1097/00001756-200210070-00008; Livesey AC, 2007, NEUROPSYCHOLOGIA, V45, P321, DOI 10.1016/j.neuropsychologia.2006.06.033; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Maquet P, 1996, NEUROIMAGE, V3, P119, DOI 10.1006/nimg.1996.0014; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; MATTEL MS, 2004, COGNITIVE BRAIN RES, V58, P119; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miro E, 2003, HUM FACTORS, V45, P148, DOI 10.1518/hfes.45.1.148.27227; Moore RY, 1998, CHRONOBIOL INT, V15, P475, DOI 10.3109/07420529808998703; MOOREEDE MC, 1983, NEW ENGL J MED, V309, P469, DOI 10.1056/NEJM198308253090806; Morell V, 1996, SCIENCE, V271, P905, DOI 10.1126/science.271.5251.905; Mu QW, 2005, SLEEP, V28, P55, DOI 10.1093/sleep/28.1.55; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; POPPEL E, 1970, PSYCHOL FORSCH, V34, P182, DOI 10.1007/BF00424544; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; Rammsayer T, 2005, ACTA PSYCHOL, V120, P141, DOI 10.1016/j.actpsy.2005.03.005; Rammsayer TH, 2006, BRAIN RES, V1073, P407, DOI 10.1016/j.brainres.2005.12.019; RAMMSAYER TH, 1992, NEUROPSYCHOBIOLOGY, V26, P71, DOI 10.1159/000118899; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Rubia K, 2004, ACTA NEUROBIOL EXP, V64, P329; Smith A, 2003, NEUROIMAGE, V20, P344, DOI 10.1016/S1053-8119(03)00337-9; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; TYSK L, 1984, PERCEPT MOTOR SKILL, V58, P455, DOI 10.2466/pms.1984.58.2.455; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Volkow ND, 2008, J NEUROSCI, V28, P8454, DOI 10.1523/JNEUROSCI.1443-08.2008; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Zakay D, 2004, ACTA NEUROBIOL EXP, V64, P319	67	23	23	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8395	10.1371/journal.pone.0008395	http://dx.doi.org/10.1371/journal.pone.0008395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049334	Green Published, Green Submitted, gold			2022-12-25	WOS:000273225000001
J	MacKellar, J; Cushman, SW; Periwal, V				MacKellar, Jennifer; Cushman, Samuel W.; Periwal, Vipul			Differential Effects of Thiazolidinediones on Adipocyte Growth and Recruitment in Zucker Fatty Rats	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; PPAR-GAMMA; PIOGLITAZONE	Background: Adipose tissue grows by two mechanisms: hyperplasia ( cell number increase) and hypertrophy ( cell size increase). Thiazolidinediones are insulin-sensitizing peroxisome proliferator-activated receptor gamma agonists that are known to affect the morphology of adipose tissue. Methodology: In this study, adipose cell-size probability distributions were measured in six Zucker fa/fa rats over a period of 24 days, from four weeks of age, using micro-biopsies to obtain subcutaneous ( inguinal) fat tissue from the animals. Three of the rats were gavaged daily with rosiglitazone, a thiazolidinedione, and three served as controls. These longitudinal probability distributions were analyzed to obtain the rate of increase in cell-size diameter in rosiglitazone-treated animals, and the hyperplasia induced by treatment quantitatively. Conclusions: We found that treatment leads to hypertrophy that leads to an approximately linear rate of cell diameter increase ( 2 mu m/day), and that the hyperplasia evident in treated animals occurs largely within the first eight days of treatment. The availability of additional lipid storage due to treatment may alleviate lipotoxicity and thereby promote insulin sensitivity. The hypothesis that a TZD regimen involving repeated treatments of limited duration may suffice for improvements in insulin sensitivity merits further investigation.	[MacKellar, Jennifer; Cushman, Samuel W.] NIDDKD, Diabet Branch, NIH, Bethesda, MD 20892 USA; [Periwal, Vipul] NIDDKD, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	MacKellar, J (corresponding author), NIDDKD, Diabet Branch, NIH, Bethesda, MD 20892 USA.	vipulp@mail.nih.gov	Periwal, Vipul/I-1728-2012	MacKellar, Jennifer/0000-0003-0162-7430	Intramural Research Program of the National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075014, ZIADK013035] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson CX, 2008, DIABETES-METAB RES, V24, P595, DOI 10.1002/dmrr.889; Boden G, 2003, METABOLISM, V52, P753, DOI 10.1016/S0026-0495(03)00055-6; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Gregory P., 2005, BAYESIAN LOGICAL DAT; Hallakou S, 1997, DIABETES, V46, P1393, DOI 10.2337/diabetes.46.9.1393; HIRSCH J, 1968, J LIPID RES, V9, P110; Jiang GQ, 2002, DIABETES, V51, P2412, DOI 10.2337/diabetes.51.8.2412; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; MCLAUGHLIN T, 2009, OBESITY IN PRESS; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Smith SR, 2006, ADIPOCYTES, V2, P11; Tierney L., 1990, LISP STAT OBJECT ORI; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829	14	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8196	10.1371/journal.pone.0008196	http://dx.doi.org/10.1371/journal.pone.0008196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041138	Green Published, Green Submitted, gold			2022-12-25	WOS:000273104000001
J	Ouedraogo, AL; Bousema, T; Schneider, P; de Vlas, SJ; Ilboudo-Sanogo, E; Cuzin-Ouattara, N; Nebie, I; Roeffen, W; Verhave, JP; Luty, AJF; Sauerwein, R				Ouedraogo, Andre Lin; Bousema, Teun; Schneider, Petra; de Vlas, Sake J.; Ilboudo-Sanogo, Edith; Cuzin-Ouattara, Nadine; Nebie, Issa; Roeffen, Will; Verhave, Jan Peter; Luty, Adrian J. F.; Sauerwein, Robert			Substantial Contribution of Submicroscopical Plasmodium falciparum Gametocyte Carriage to the Infectious Reservoir in an Area of Seasonal Transmission	PLOS ONE			English	Article							MALARIA TRANSMISSION; BURKINA-FASO; BLOCKING VACCINES; ANOPHELES-GAMBIAE; WESTERN KENYA; MOSQUITOS; COMBINATION; POPULATIONS; CHILDREN; THAILAND	Background: Man to mosquito transmission of malaria depends on the presence of the sexual stage parasites, gametocytes, that often circulate at low densities. Gametocyte densities below the microscopical threshold of detection may be sufficient to infect mosquitoes but the importance of submicroscopical gametocyte carriage in different transmission settings is unknown. Methodology/Principal Findings: Membrane feeding experiments were carried out on 80 children below 14 years of age at the end of the wet season in an area of seasonal malaria transmission in Burkina Faso. Gametocytes were quantified by microscopy and by Pfs25-based quantitative nucleic acid sequence-based amplification assay (QT-NASBA). The children's infectiousness was determined by membrane feeding experiments in which a venous blood sample was offered to locally reared Anopheles mosquitoes. Gametocytes were detected in 30.0% (24/80) of the children by microscopy compared to 91.6% (65/71) by QT-NASBA (p < 0.001). We observed a strong association between QT-NASBA gametocyte density and infection rates (p = 0.007). Children with microscopically detectable gametocytes were more likely to be infectious (68.2% compared to 31.7% of carriers of submicroscopical gametocytes, p = 0.001), and on average infected more mosquitoes (13.2% compared to 2.3%, p < 0.001). However, because of the high prevalence of submicroscopical gametocyte carriage in the study population, carriers of sub-microscopical gametocytes were responsible for 24.2% of the malaria transmission in this population. Conclusions/Significance: Submicroscopical gametocyte carriage is common in an area of seasonal transmission in Burkina Faso and contributes substantially to the human infectious reservoir. Submicroscopical gametocyte carriage should therefore be considered when implementing interventions that aim to reduce malaria transmission.	[Ouedraogo, Andre Lin; Ilboudo-Sanogo, Edith; Cuzin-Ouattara, Nadine; Nebie, Issa] Ctr Natl Rech & Format le Paludisme, Dept Biomed Sci, Ouagadougou, Burkina Faso; [Ouedraogo, Andre Lin; Roeffen, Will; Verhave, Jan Peter; Luty, Adrian J. F.; Sauerwein, Robert] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Bousema, Teun] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Schneider, Petra] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [de Vlas, Sake J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Radboud University Nijmegen; University of London; London School of Hygiene & Tropical Medicine; University of Edinburgh; Erasmus University Rotterdam; Erasmus MC	Ouedraogo, AL (corresponding author), Ctr Natl Rech & Format le Paludisme, Dept Biomed Sci, Ouagadougou, Burkina Faso.	andrelin.cnrfp@fasonet.bf	Roeffen, W.F.G./L-4607-2015; Luty, Adrian/CAH-2547-2022; Sauerwein, Robert/C-8519-2013; Bousema, Teun/N-3574-2014	Bousema, Teun/0000-0003-2666-094X; Verhave, Jan Peter/0000-0002-5149-8772; Schneider, Petra/0000-0002-2616-237X; Nebie, Issa/0000-0003-3051-3600; de Vlas, Sake J./0000-0002-1830-5668; Luty, Adrian John Frederick/0000-0001-8830-3425	Netherlands Foundation for the Advancement of Tropical Research (WOTRO) [WM 93-350]; Netherlands Organization for Scientific Research (NWO) [825.08.025]; Wellcome Trust	Netherlands Foundation for the Advancement of Tropical Research (WOTRO); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by the Netherlands Foundation for the Advancement of Tropical Research (WOTRO WM 93-350). Teun Bousema is supported by a Rubicon fellowship of the Netherlands Organization for Scientific Research (NWO; Rubicon 825.08.025). Petra Schneider is funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker HA, 2008, TRENDS PARASITOL, V24, P525, DOI 10.1016/j.pt.2008.08.001; Bonnet S, 2000, T ROY SOC TROP MED H, V94, P103, DOI 10.1016/S0035-9203(00)90456-5; Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; BOUDIN C, 1993, AM J TROP MED HYG, V48, P700, DOI 10.4269/ajtmh.1993.48.700; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; Bousema JT, 2006, CURR MOL MED, V6, P223, DOI 10.2174/156652406776055140; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; Coleman RE, 2004, J MED ENTOMOL, V41, P201, DOI 10.1603/0022-2585-41.2.201; Cuzin-Ouattara N, 1999, T ROY SOC TROP MED H, V93, P473, DOI 10.1016/S0035-9203(99)90343-7; Drakeley C, 2006, TRENDS PARASITOL, V22, P424, DOI 10.1016/j.pt.2006.07.001; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P479, DOI 10.4269/ajtmh.1991.45.479; GITHEKO AK, 1992, T ROY SOC TROP MED H, V86, P355, DOI 10.1016/0035-9203(92)90216-Y; GRAVES PM, 1980, T ROY SOC TROP MED H, V74, P738, DOI 10.1016/0035-9203(80)90189-3; JEFFERY GM, 1955, AM J TROP MED HYG, V4, P781, DOI 10.4269/ajtmh.1955.4.781; MUIRHEADTHOMSON RC, 1954, T ROY SOC TROP MED H, V48, P208, DOI 10.1016/0035-9203(54)90067-X; Okell LC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-125; Ouedraogo AL, 2008, ACTA TROP, V105, P28, DOI 10.1016/j.actatropica.2007.09.003; Ouedraogo AL, 2007, AM J TROP MED HYG, V76, P626, DOI 10.4269/ajtmh.2007.76.626; Pethleart A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-34; Pichon G, 2000, PARASITOLOGY, V121, P115, DOI 10.1017/S0031182099006277; PONNUDURAI T, 1986, PARASITOLOGY, V93, P263, DOI 10.1017/S003118200005143X; Sauerwein RW, 2007, MICROBES INFECT, V9, P792, DOI 10.1016/j.micinf.2007.02.011; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Schneider P, 2006, INT J PARASITOL, V36, P403, DOI 10.1016/j.ijpara.2006.01.002; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S8; YOUNG MD, 1948, AM J TROP MED, V28, P303	29	137	138	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8410	10.1371/journal.pone.0008410	http://dx.doi.org/10.1371/journal.pone.0008410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027314	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000272998000015
J	Shigematsu, H; Sokabe, T; Danev, R; Tominaga, M; Nagayama, K				Shigematsu, Hideki; Sokabe, Takaaki; Danev, Radostin; Tominaga, Makoto; Nagayama, Kuniaki			A 3.5-nm Structure of Rat TRPV4 Cation Channel Revealed by Zernike Phase-contrast Cryoelectron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-EVOKED ACTIVATION; ANKYRIN REPEAT DOMAIN; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; POTASSIUM CHANNEL; SYSTEM; LOCALIZATION; EXPRESSION; PROTEIN; OTRPC4	The transient receptor potential vanilloid 4 (TRPV4) is a nonselective cation channel responsive to various stimuli including cell swelling, warm temperatures (27-35 degrees C), and chemical compounds such as phorbol ester derivatives. Here we report the three-dimensional structure of full-length rat TRPV4 purified from baculovirus-infected Sf9 cells. Hexahistidine-tagged rat TRPV4 (His-rTRPV4) was solubilized with detergent and purified through affinity chromatography and size-exclusion chromatography. Chemical cross-linking analysis revealed that detergent-solubilized His-rTRPV4 was a tetramer. The 3.5-nm structure of rat TRPV4 was determined by cryoelectron microscopy using single-particle reconstruction from Zernike phasecontrast images. The overall structure comprises two distinct regions; a larger dense component, likely corresponding to the cytoplasmic N- and C-terminal regions, and a smaller component corresponding to the transmembrane region.	[Shigematsu, Hideki; Danev, Radostin; Nagayama, Kuniaki] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Nanostruct Physiol, Higashiyama Ku, Okazaki, Aichi 4448787, Japan; [Shigematsu, Hideki; Sokabe, Takaaki; Danev, Radostin; Tominaga, Makoto; Nagayama, Kuniaki] Natl Inst Nat Sci, Natl Inst Physiol Sci, Higashiyama Ku, Okazaki, Aichi 4448787, Japan; [Sokabe, Takaaki; Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Higashiyama Ku, Okazaki, Aichi 4448787, Japan; [Danev, Radostin; Tominaga, Makoto; Nagayama, Kuniaki] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan	Nagayama, K (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Nanostruct Physiol, Higashiyama Ku, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	nagayama@nips.ac.jp	Shigematsu, Hideki/E-1052-2017; Nagayama, Kuniaki/O-2522-2018	Shigematsu, Hideki/0000-0003-3951-8651; Sokabe, Takaaki/0000-0003-1280-9424	Ministry of Education, Culture, Sports, Science, and Technology of Japan [2001-2005]; Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation [2006-2009]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by a grant-in-aid for creative scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (2001-2005) and by Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (2006-2009).	Arniges M, 2004, J BIOL CHEM, V279, P54062, DOI 10.1074/jbc.M409708200; Cahalan MD, 2001, NATURE, V411, P542, DOI 10.1038/35079231; Chiu PL, 2007, STRUCTURE, V15, P1053, DOI 10.1016/j.str.2007.06.020; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; Danev R, 2008, J STRUCT BIOL, V161, P211, DOI 10.1016/j.jsb.2007.10.015; Danev R, 2009, ULTRAMICROSCOPY, V109, P312, DOI 10.1016/j.ultramic.2008.12.006; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Fernandez-Ballester G, 2008, J MEMBRANE BIOL, V223, P161, DOI 10.1007/s00232-008-9123-7; Fernandez-Fernandez JM, 2008, PFLUG ARCH EUR J PHY, V457, P149, DOI 10.1007/s00424-008-0516-3; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Garcia-Elias A, 2008, J BIOL CHEM, V283, P31284, DOI 10.1074/jbc.C800184200; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gaudet R, 2008, J PHYSIOL-LONDON, V586, P3565, DOI 10.1113/jphysiol.2008.155812; Guler AD, 2002, J NEUROSCI, V22, P6408; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hosokawa F, 2005, J ELECTRON MICROSC, V54, P317, DOI 10.1093/jmicro/dfi049; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kim LA, 2004, NEURON, V41, P513, DOI 10.1016/S0896-6273(04)00050-9; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; McCleverty CJ, 2006, PROTEIN SCI, V15, P2201, DOI 10.1110/ps.062357206; Mio K, 2005, BIOCHEM BIOPH RES CO, V333, P768, DOI 10.1016/j.bbrc.2005.05.181; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nilius B, 2003, PFLUG ARCH EUR J PHY, V446, P298, DOI 10.1007/s00424-003-1028-9; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Saliez J, 2008, CIRCULATION, V117, P1065, DOI 10.1161/CIRCULATIONAHA.107.731679; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P51448, DOI 10.1074/jbc.M308212200; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Wang Y, 2007, J BIOL CHEM, V282, P36561, DOI 10.1074/jbc.M703903200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8	53	67	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11210	11218		10.1074/jbc.M109.090712	http://dx.doi.org/10.1074/jbc.M109.090712			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20044482	hybrid, Green Published			2022-12-25	WOS:000276286200026
J	Liao, S; Tung, ETK; Zheng, W; Chong, K; Xu, YY; Dai, P; Guo, YY; Bartlam, M; Yuen, KY; Rao, ZH				Liao, Shuang; Tung, Edward T. K.; Zheng, Wei; Chong, Ken; Xu, Yuanyuan; Dai, Peng; Guo, Yingying; Bartlam, Mark; Yuen, Kwok-Yung; Rao, Zihe			Crystal Structure of the Mp1p Ligand Binding Domain 2 Reveals Its Function as a Fatty Acid-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGUS PENICILLIUM-MARNEFFEI; CELL-WALL MANNOPROTEIN; GLYOXYLATE CYCLE; MACROPHAGE; ABUNDANT	Penicillium marneffei is a dimorphic, pathogenic fungus in Southeast Asia that mostly afflicts immunocompromised individuals. As the only dimorphic member of the genus, it goes through a phase transition from a mold to yeast form, which is believed to be a requisite for its pathogenicity. Mp1p, a cell wall antigenic mannoprotein existing widely in yeast, hyphae, and conidia of the fungus, plays a vital role in host immune response during infection. To understand the function of Mp1p, we have determined the x-ray crystal structure of its ligand binding domain 2 (LBD2) to 1.3 angstrom. The structure reveals a dimer between the two molecules. The dimer interface forms a ligand binding cavity, in which electron density was observed for a palmitic acid molecule interacting with LBD2 indirectly through hydrogen bonding networks via two structural water molecules. Isothermal titration calorimetry experiments measured the ligand binding affinity (K-d) of Mp1p at the micromolar level. Mutations of ligand-binding residues, namely S313A and S332A, resulted in a 9-fold suppression of ligand binding affinity. Analytical ultracentrifugation assays demonstrated that both LBD2 and Mp1p are mostly monomeric in vitro, no matter with or without ligand, and our dimeric crystal structure of LBD2 might be the result of crystal packing. Based on the conformation of the ligand-binding pocket in the dimer structure, a model for the closed, monomeric form of LBD2 is proposed. Further structural analysis indicated the biological importance of fatty acid binding of Mp1p for the survival and pathogenicity of the conditional pathogen.	[Tung, Edward T. K.; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Liao, Shuang; Zheng, Wei; Xu, Yuanyuan; Dai, Peng; Guo, Yingying; Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Liao, Shuang; Chong, Ken; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100101, Peoples R China; [Bartlam, Mark; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China	University of Hong Kong; Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Nankai University	Yuen, KY (corresponding author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	kyyuen@hkucc.hku.hk; raozh@xtal.tsinghua.edu.cn	Rao, Zihe/HCH-6944-2022	Bartlam, Mark/0000-0001-5173-5080; Liao, Shuang/0000-0002-1016-6149; Yuen, Kwok-yung/0000-0002-2083-1552	Ministry of Science and Technology 973 [006CB10901, 2007CB914301]; 863 Project [2006AA02A322]; International Cooperation Project [2006DFB32420]	Ministry of Science and Technology 973(National Basic Research Program of China); 863 Project; International Cooperation Project	This work was supported by Ministry of Science and Technology 973 Project Grants 2006CB10901 and 2007CB914301) and 863 Project Grant 2006AA02A322, and International Cooperation Project Grant 2006DFB32420.	Appelberg R, 2006, J LEUKOCYTE BIOL, V79, P1117, DOI 10.1189/jlb.0206079; Balendiran GK, 2000, J BIOL CHEM, V275, P27045; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Canovas D, 2006, MOL MICROBIOL, V62, P1725, DOI 10.1111/j.1365-2958.2006.05477.x; Cao L, 1998, INFECT IMMUN, V66, P966, DOI 10.1128/IAI.66.3.966-973.1998; Cao L, 1998, J CLIN MICROBIOL, V36, P3028, DOI 10.1128/JCM.36.10.3028-3031.1998; Cao L, 1999, J CLIN MICROBIOL, V37, P981, DOI 10.1128/JCM.37.4.981-986.1999; Darios F, 2007, J PHYSIOL-LONDON, V585, P699, DOI 10.1113/jphysiol.2007.136812; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Jordanova R, 2005, J BIOL CHEM, V280, P41429, DOI 10.1074/jbc.M504474200; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; Mazumdar J, 2007, EUKARYOT CELL, V6, P1727, DOI 10.1128/EC.00255-07; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OTWINOWSKI Z, 1997, PROCESSING XRAY DIFF, P307; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Roncal T, 2003, RES MICROBIOL, V154, P539, DOI 10.1016/S0923-2508(03)00168-2; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schymkowitz JWH, 2001, NAT STRUCT BIOL, V8, P888, DOI 10.1038/nsb1001-888; Wenk MR, 2006, FEBS LETT, V580, P5541, DOI 10.1016/j.febslet.2006.07.007; Wong SSY, 2001, J CLIN MICROBIOL, V39, P4535, DOI 10.1128/JCM.39.12.4535-4540.2001; Woo PCY, 2007, J CLIN MICROBIOL, V45, P3647, DOI 10.1128/JCM.00619-07; Yuen K, 2003, ARCH MICROBIOL, V179, P339, DOI 10.1007/s00203-003-0533-8	24	8	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9211	9220		10.1074/jbc.M109.057760	http://dx.doi.org/10.1074/jbc.M109.057760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20053994	Green Published, hybrid			2022-12-25	WOS:000275553700070
J	Li, FW; Patra, KP; Yowell, CA; Dame, JB; Chin, K; Vinetz, JM				Li, Fengwu; Patra, Kailash P.; Yowell, Charles A.; Dame, John B.; Chin, Karen; Vinetz, Joseph M.			Apical Surface Expression of Aspartic Protease Plasmepsin 4, a Potential Transmission-blocking Target of the Plasmodium Ookinete	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VECTOR ANOPHELES-GAMBIAE; FOOD VACUOLE PLASMEPSINS; MALARIA PARASITE; MOSQUITO MIDGUT; INFECTING MAN; FALCIPARUM; PROTEINS; CTRP; IDENTIFICATION; GALLINACEUM	To invade its definitive host, the mosquito, the malaria parasite must cross the midgut peritrophic matrix that is composed of chitin cross-linked by chitin-binding proteins and then develop into an oocyst on the midgut basal lamina. Previous evidence indicates that Plasmodium ookinete-secreted chitinase is important in midgut invasion. The mechanistic role of other ookinete-secreted enzymes in midgut invasion has not been previously examined. De novo mass spectrometry sequencing of a protein obtained by benzamidine affinity column of Plasmodium gallinaceum ookinete axenic culture supernatant demonstrated the presence of an ookinete-secreted plasmepsin, an aspartic protease previously only known to be present in the digestive vacuole of asexual stage malaria parasites. This plasmepsin, the ortholog of Plasmodium falciparum plasmepsin 4, was designated PgPM4. PgPM4 and PgCHT2 (the P. gallinaceum ortholog of P. falciparum chitinase PfCHT1) are both localized on the ookinete apical surface, and both are present in micronemes. Aspartic protease inhibitors (peptidomimetic and natural product), calpain inhibitors, and anti-PgPM4 monoclonal antibodies significantly reduced parasite infectivity for mosquitoes. These results suggest that plasmepsin 4, previously known only to function in the digestive vacuole of asexual blood stage Plasmodium, plays a role in how the ookinete interacts with the mosquito midgut interactions as it becomes an oocyst. These data are the first to delineate a role for an aspartic protease in mediating Plasmodium invasion of the mosquito and demonstrate the potential for plasmepsin 4 as a malaria transmission-blocking vaccine target.	[Vinetz, Joseph M.] Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis,George Palade Labs, La Jolla, CA 92093 USA; [Yowell, Charles A.; Dame, John B.] Univ Florida, Coll Vet Med, Dept Pathobiol, Gainesville, FL 32608 USA	University of California System; University of California San Diego; State University System of Florida; University of Florida	Vinetz, JM (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis,George Palade Labs, 9500 Gilman Dr 0741,Rm 125, La Jolla, CA 92093 USA.	jvinetz@ucsd.edu		Vinetz, Joseph/0000-0001-8344-2004; Dame, John B./0000-0002-5772-5454	USPHS [AI45999]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045999] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI45999 from the USPHS.	Abraham EG, 2004, J BIOL CHEM, V279, P5573, DOI 10.1074/jbc.M307582200; Banerjee R, 2003, MOL BIOCHEM PARASIT, V129, P157, DOI 10.1016/S0166-6851(03)00119-1; Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Bonilla JA, 2007, MOL MICROBIOL, V65, P64, DOI 10.1111/j.1365-2958.2007.05768.x; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; Coombs GH, 2001, TRENDS PARASITOL, V17, P532, DOI 10.1016/S1471-4922(01)02037-2; Dame JB, 2003, MOL BIOCHEM PARASIT, V130, P1, DOI 10.1016/S0166-6851(03)00137-3; De Vries L, 1998, MOL BIOL CELL, V9, P1123, DOI 10.1091/mbc.9.5.1123; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Drew ME, 2008, J BIOL CHEM, V283, P12870, DOI 10.1074/jbc.M708949200; FRANCIS SE, 1994, EMBO J, V13, P306, DOI 10.1002/j.1460-2075.1994.tb06263.x; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Haque TS, 1999, J MED CHEM, V42, P1428, DOI 10.1021/jm980641t; Kaneko O, 2006, PARASITOL INT, V55, P227, DOI 10.1016/j.parint.2006.04.003; Kaslow DC, 2002, CHEM IMMUNOL, V80, P287; KAUSHAL DC, 1984, MOL BIOCHEM PARASIT, V11, P145, DOI 10.1016/0166-6851(84)90061-6; Langer RC, 2002, INFECT IMMUN, V70, P102, DOI 10.1128/IAI.70.1.102-106.2002; Le Bonniec S, 1999, J BIOL CHEM, V274, P14218, DOI 10.1074/jbc.274.20.14218; Li FW, 2005, J INFECT DIS, V192, P878, DOI 10.1086/432552; Li FW, 2004, J BIOL CHEM, V279, P26635, DOI 10.1074/jbc.M401385200; Li T, 2004, MOL BIOCHEM PARASIT, V135, P101, DOI 10.1016/j.molbiopara.2004.01.010; Limviroj W, 2002, J PARASITOL, V88, P664, DOI 10.1645/0022-3395(2002)088[0664:IEMOOP]2.0.CO;2; Malkin EM, 2005, VACCINE, V23, P3131, DOI 10.1016/j.vaccine.2004.12.019; Moskalyk LA, 1996, INSECT MOL BIOL, V5, P261, DOI 10.1111/j.1365-2583.1996.tb00100.x; Nezami A, 2002, BIOCHEMISTRY-US, V41, P2273, DOI 10.1021/bi0117549; Patra KP, 2008, PROTEOMICS, V8, P2492, DOI 10.1002/pmic.200700727; ROSENTHAL PJ, 1995, EXP PARASITOL, V80, P272, DOI 10.1006/expr.1995.1033; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Saul A, 2007, CURR OPIN INFECT DIS, V20, P476, DOI 10.1097/QCO.0b013e3282a95e12; SHAHABUDDIN M, 1995, EXP PARASITOL, V80, P212, DOI 10.1006/expr.1995.1026; Shen ZC, 1997, J BIOL CHEM, V272, P28895, DOI 10.1074/jbc.272.46.28895; Shen ZC, 1998, J BIOL CHEM, V273, P17665, DOI 10.1074/jbc.273.28.17665; Templeton TJ, 2000, MOL MICROBIOL, V36, P1, DOI 10.1046/j.1365-2958.2000.01821.x; Tomas AM, 2001, EMBO J, V20, P3975, DOI 10.1093/emboj/20.15.3975; Tsai YL, 2001, INFECT IMMUN, V69, P4048, DOI 10.1128/IAI.69.6.4048-4054.2001; Vinetz JM, 1999, P NATL ACAD SCI USA, V96, P14061, DOI 10.1073/pnas.96.24.14061; Vinetz JM, 2005, CURR TOP MICROBIOL, V295, P357; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x; Wyatt DM, 2002, FEBS LETT, V513, P159, DOI 10.1016/S0014-5793(02)02241-X; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Yuda M, 2001, MOL BIOCHEM PARASIT, V116, P65, DOI 10.1016/S0166-6851(01)00304-8	41	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8076	8083		10.1074/jbc.M109.063388	http://dx.doi.org/10.1074/jbc.M109.063388			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20056606	Green Published, hybrid			2022-12-25	WOS:000275413800025
J	Grygoruk, A; Fei, H; Daniels, RW; Miller, BR; DiAntonio, A; Krantz, DE				Grygoruk, Anna; Fei, Hao; Daniels, Richard W.; Miller, Bradley R.; DiAntonio, Aaron; Krantz, David E.			A Tyrosine-based Motif Localizes a Drosophila Vesicular Transporter to Synaptic Vesicles in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSE CORE VESICLES; CENTRAL-NERVOUS-SYSTEM; CLONAL CELL-LINES; ACETYLCHOLINE TRANSPORTER; MONOAMINE TRANSPORTER-2; GLUTAMATE TRANSPORTER; PC12 CELLS; NEUROTRANSMITTER CANDIDATES; DOPAMINERGIC-NEURONS; AMINE TRANSPORTER	Vesicular neurotransmitter transporters must localize to synaptic vesicles (SVs) to allow regulated neurotransmitter release at the synapse. However, the signals required to localize vesicular proteins to SVs in vivo remain unclear. To address this question we have tested the effects of mutating proposed trafficking domains in Drosophila orthologs of the vesicular monoamine and glutamate transporters, DVMAT-A and DVGLUT. We show that a tyrosine-based motif (YXXY) is important both for DVMAT-A internalization from the cell surface in vitro, and localization to SVs in vivo. In contrast, DVGLUT deletion mutants that lack a putative C-terminal trafficking domain show more modest defects in both internalization in vitro and trafficking to SVs in vivo. Our data show for the first time that mutation of a specific trafficking motif can disrupt localization to SVs in vivo and suggest possible differences in the sorting of VMATs versus VGLUTs to SVs at the synapse.	Univ Calif Los Angeles, David Geffen Sch Med,Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Hatos Ctr Neuropharmacol, Los Angeles, CA 90095 USA; [Daniels, Richard W.; Miller, Bradley R.; DiAntonio, Aaron] Washington Univ, Dept Dev Biol, Sch Med, St Louis, MO 63110 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Washington University (WUSTL)	Krantz, DE (corresponding author), Gonda Goldschmied Neurosci & Genet Res Ctr, 695 S Charles E Young Dr, Los Angeles, CA 90095 USA.	dkrantz@ucla.edu	Miller, Bradley/G-7426-2014	DiAntonio, Aaron/0000-0002-7262-0968	National Institute of Mental Health [MH076900]; National Institutes of Health [ES015747]; NIEHS [ES016732]; National Institute on Drug Abuse [DA020812]; NIDDK [NS051453]; UCLA Molecular and Cellular and Neurobiology Training [T32MH019384]; Achievement Reward for College Scientists Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015747, P01ES016732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019384, R01MH076900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020812] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UCLA Molecular and Cellular and Neurobiology Training; Achievement Reward for College Scientists Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institute of Mental Health Grant MH076900, National Institutes of Health Grants ES015747 (to D. E. K.) and ES016732 (to M. F. Chesselet) from NIEHS, National Institute on Drug Abuse Grant DA020812, and National Institutes of Health Grant NS051453 from NIDDK (to A. D.). This work was also supported by UCLA Molecular and Cellular and Neurobiology Training Grant T32MH019384 and the Achievement Reward for College Scientists Foundation (to A. G.).	Barbosa J, 2002, J NEUROCHEM, V82, P1221, DOI 10.1046/j.1471-4159.2002.01068.x; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BUTTERWORTH FM, 1995, MUTAT RES-GENET TOX, V342, P61, DOI 10.1016/0165-1218(95)90090-X; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Chen CXQ, 2005, NEUROBIOL DIS, V19, P419, DOI 10.1016/j.nbd.2005.01.014; Colgan L, 2007, TRAFFIC, V8, P512, DOI 10.1111/j.1600-0854.2007.00555.x; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; De Gois S, 2006, CELL MOL NEUROBIOL, V26, P679, DOI 10.1007/s10571-006-9054-8; Edwards R H, 1992, Curr Opin Neurobiol, V2, P586, DOI 10.1016/0959-4388(92)90023-E; Eiden LE, 2004, PFLUG ARCH EUR J PHY, V447, P636, DOI 10.1007/s00424-003-1100-5; Estes PS, 1996, J NEUROSCI, V16, P5443; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Fei H, 2008, TRAFFIC, V9, P1425, DOI 10.1111/j.1600-0854.2008.00771.x; Fei H, 2007, J NEUROCHEM, V101, P1662, DOI 10.1111/j.1471-4159.2007.04518.x; Ferreira LT, 2005, J NEUROCHEM, V94, P957, DOI 10.1111/j.1471-4159.2005.03244.x; Fleckenstein AE, 2003, EUR J PHARMACOL, V479, P283, DOI 10.1016/j.ejphar.2003.08.077; Fleckenstein AE, 2009, NEUROPHARMACOLOGY, V56, P133, DOI 10.1016/j.neuropharm.2008.07.002; Fumagalli F, 1999, J NEUROSCI, V19, P2424; Gainetdinov RR, 1998, J NEUROCHEM, V70, P1973; GREENSPAN RJ, 1997, FLY PUSHING THEORY P, P3; Greer CL, 2005, J NEUROBIOL, V64, P239, DOI 10.1002/neu.20146; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Hannah MJ, 1999, ANNU REV CELL DEV BI, V15, P733, DOI 10.1146/annurev.cellbio.15.1.733; Jahn R, 2007, TRAFFIC, V8, P1121, DOI 10.1111/j.1600-0854.2007.00615.x; Kim MH, 2004, J BIOL CHEM, V279, P12580, DOI 10.1074/jbc.M310681200; Kim MH, 2000, J BIOL CHEM, V275, P6175, DOI 10.1074/jbc.275.9.6175; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; Larsen KE, 2002, J NEUROSCI, V22, P8951; Li HY, 2005, NEURON, V48, P619, DOI 10.1016/j.neuron.2005.09.033; Little KY, 2003, AM J PSYCHIAT, V160, P47, DOI 10.1176/appi.ajp.160.1.47; LIU Y, 1992, P NATL ACAD SCI USA, V89, P9074, DOI 10.1073/pnas.89.19.9074; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; LIU YJ, 1994, J CELL BIOL, V127, P1419, DOI 10.1083/jcb.127.5.1419; Liu YJ, 1997, J CELL BIOL, V139, P907, DOI 10.1083/jcb.139.4.907; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; MANCINI GMS, 1989, J BIOL CHEM, V264, P15247; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; REGNIERVIGOUROUX A, 1991, EMBO J, V10, P3589, DOI 10.1002/j.1460-2075.1991.tb04925.x; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Romero-Calderon R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000245; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sagne C, 1997, FEBS LETT, V417, P177, DOI 10.1016/S0014-5793(97)01279-9; Salazar G, 2005, J CELL SCI, V118, P1911, DOI 10.1242/jcs.02319; Sandoval V, 2002, J NEUROSCI, V22, P8705; Sang TK, 2007, J NEUROSCI, V27, P981, DOI 10.1523/JNEUROSCI.4810-06.2007; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; UITEI K, 1995, NEUROSCI LETT, V195, P187, DOI 10.1016/0304-3940(95)11815-E; UITEI K, 1994, NEUROSCI LETT, V174, P85, DOI 10.1016/0304-3940(94)90125-2; VANDEGOOR J, 1995, P NATL ACAD SCI USA, V92, P5739, DOI 10.1073/pnas.92.12.5739; Varoqui H, 1998, J BIOL CHEM, V273, P9094, DOI 10.1074/jbc.273.15.9094; Vinatier J, 2006, J NEUROCHEM, V97, P1111, DOI 10.1111/j.1471-4159.2006.03821.x; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Waites CL, 2001, J CELL BIOL, V152, P1159, DOI 10.1083/jcb.152.6.1159; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yao J, 2007, J NEUROCHEM, V100, P1387, DOI 10.1111/j.1471-4159.2006.04326.x; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150; Zubieta JK, 2000, AM J PSYCHIAT, V157, P1619, DOI 10.1176/appi.ajp.157.10.1619; Zubieta JK, 2001, BIOL PSYCHIAT, V49, P110, DOI 10.1016/S0006-3223(00)00981-1	64	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6867	6878		10.1074/jbc.M109.073064	http://dx.doi.org/10.1074/jbc.M109.073064			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20053989	Green Published, hybrid			2022-12-25	WOS:000275415600001
J	Preston, P; Wartosch, L; Gunzel, D; Fromm, M; Kongsuphol, P; Ousingsawat, J; Kunzelmann, K; Barhanin, J; Warth, R; Jentsch, TJ				Preston, Patricia; Wartosch, Lena; Guenzel, Dorothee; Fromm, Michael; Kongsuphol, Patthara; Ousingsawat, Jiraporn; Kunzelmann, Karl; Barhanin, Jacques; Warth, Richard; Jentsch, Thomas J.			Disruption of the K+ Channel beta-Subunit KCNE3 Reveals an Important Role in Intestinal and Tracheal Cl- Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; I-KS; CHLORIDE SECRETION; MOUSE MODEL; MEMBRANE-PROTEIN; CHROMANOL 293B; USSING CHAMBER; CAUSE JERVELL; RABBIT COLON; CONDUCTANCE	The KCNE3 beta-subunit constitutively opens outwardly rectifying KCNQ1 (Kv7.1) K+ channels by abolishing their voltage-dependent gating. The resulting KCNQ1/KCNE3 heteromers display enhanced sensitivity to K+ channel inhibitors like chromanol 293B. KCNE3 was also suggested to modify biophysical properties of several other K+ channels, and a mutation in KCNE3 was proposed to underlie forms of human periodic paralysis. To investigate physiological roles of KCNE3, we now disrupted its gene in mice. kcne3(-/-) mice were viable and fertile and displayed neither periodic paralysis nor other obvious skeletal muscle abnormalities. KCNQ1/KCNE3 heteromers are present in basolateral membranes of intestinal and tracheal epithelial cells where they might facilitate transepithelial Cl- secretion through basolateral recycling of K+ ions and by increasing the electrochemical driving force for apical Cl- exit. Indeed, cAMP-stimulated electrogenic Cl- secretion across tracheal and intestinal epithelia was drastically reduced in kcne3(-/-) mice. Because the abundance and subcellular localization of KCNQ1 was unchanged in kcne3(-/-) mice, the modification of biophysical properties of KCNQ1 by KCNE3 is essential for its role in intestinal and tracheal transport. Further, these results suggest KCNE3 as a potential modifier gene in cystic fibrosis.	[Jentsch, Thomas J.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Guenzel, Dorothee; Fromm, Michael; Kunzelmann, Karl] Charite, Inst Klin Physiol, D-12203 Berlin, Germany; [Kongsuphol, Patthara; Ousingsawat, Jiraporn; Warth, Richard] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Barhanin, Jacques] CNRS, F-06108 Nice 2, France; [Barhanin, Jacques] Univ Nice Sophia Antipolis, F-06108 Nice 2, France; [Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Regensburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Jentsch, TJ (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Warth, Richard/N-7119-2014; Fromm, Michael/K-6203-2013	Warth, Richard/0000-0001-6084-0659; Fromm, Michael/0000-0003-4497-7983; Gunzel, Dorothee/0000-0002-7998-7164; Jentsch, Thomas/0000-0002-3509-2553; Preston Ferrer, patricia/0000-0002-7456-2693; Kunzelmann, Karl/0000-0002-4583-7037	Prix Louis Jeantet de Medecine; Deutsche Forschungsgemeinschaft [SFB699-A6]	Prix Louis Jeantet de Medecine; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Prix Louis Jeantet de Medecine (to T. J. J.) and Deutsche Forschungsgemeinschaft Grant SFB699-A6 (to K. K.).	Abbott GW, 2006, FASEB J, V20, P293, DOI 10.1096/fj.05-5070com; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Amasheh S, 2009, BIOCHEM BIOPH RES CO, V378, P45, DOI 10.1016/j.bbrc.2008.10.164; Arrighi I, 2001, P NATL ACAD SCI USA, V98, P8792, DOI 10.1073/pnas.141233398; Bachmann A, 2001, N-S ARCH PHARMACOL, V363, P590, DOI 10.1007/s002100100410; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; Da Silva MRD, 2002, J CLIN ENDOCR METAB, V87, P4881, DOI 10.1210/jc.2002-020698; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Diener M, 1996, BRIT J PHARMACOL, V118, P1477, DOI 10.1111/j.1476-5381.1996.tb15563.x; Drici MD, 1998, CIRC RES, V83, P95, DOI 10.1161/01.RES.83.1.95; Farthing Michael J G, 2004, Curr Gastroenterol Rep, V6, P177, DOI 10.1007/s11894-004-0001-x; Flores CA, 2007, J PHYSIOL-LONDON, V583, P705, DOI 10.1113/jphysiol.2007.134387; Fontaine B, 2008, ADV GENET, V63, P3, DOI 10.1016/S0065-2660(08)01001-8; Gitter AH, 1997, J BIOCHEM BIOPH METH, V35, P81, DOI 10.1016/S0165-022X(97)00028-6; Grahammer F, 2001, J BIOL CHEM, V276, P42268, DOI 10.1074/jbc.M105014200; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; Greger R, 1997, COMP BIOCHEM PHYS A, V118, P271, DOI 10.1016/S0300-9629(96)00304-0; Gunzel D, 2006, AM J PHYSIOL-REG I, V290, pR1496, DOI 10.1152/ajpregu.00470.2005; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Jurkat-Rott K, 2004, NEUROLOGY, V62, P1012, DOI 10.1212/01.WNL.0000119392.29624.88; Jurkat-Rott K, 2007, NEUROTHERAPEUTICS, V4, P216, DOI 10.1016/j.nurt.2007.02.001; Kottgen M, 2003, J CLIN INVEST, V111, P371, DOI 10.1172/JCI200316711; KUNZELMANN K, 1995, PFLUG ARCH EUR J PHY, V431, P1, DOI 10.1007/BF00374371; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Lerche C, 2007, MOL PHARMACOL, V71, P1503, DOI 10.1124/mol.106.031682; Lewis A, 2004, J BIOL CHEM, V279, P7884, DOI 10.1074/jbc.M310501200; Liao TJ, 2005, AM J PHYSIOL-CELL PH, V289, pC564, DOI 10.1152/ajpcell.00561.2004; LOHRMANN E, 1995, PFLUG ARCH EUR J PHY, V429, P517, DOI 10.1007/BF00704157; Lundquist AL, 2006, GENOMICS, V87, P119, DOI 10.1016/j.ygeno.2005.09.004; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MacVinish LJ, 2001, MOL PHARMACOL, V60, P753; MacVinish LJ, 1998, J PHYSIOL-LONDON, V510, P237, DOI 10.1111/j.1469-7793.1998.237bz.x; Matthews JB, 1998, J CLIN INVEST, V101, P2072, DOI 10.1172/JCI1042; McCrossan ZA, 2003, J NEUROSCI, V23, P8077; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Nakajo K, 2007, J GEN PHYSIOL, V130, P269, DOI 10.1085/jgp.200709805; Ohno S, 2009, HUM MUTAT, V30, P557, DOI 10.1002/humu.20834; Reynolds A, 2007, J PHYSIOL-LONDON, V582, P507, DOI 10.1113/jphysiol.2007.129718; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; Sanguinetti MC, 2000, TRENDS PHARMACOL SCI, V21, P199, DOI 10.1016/S0165-6147(00)01475-9; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Sternberg D, 2003, NEUROLOGY, V61, P857, DOI 10.1212/01.WNL.0000082392.66713.E3; Stockmann M, 1999, PFLUG ARCH EUR J PHY, V438, P107, DOI 10.1007/s004240050886; STRABEL D, 1995, EUR J PHARMACOL, V274, P181, DOI 10.1016/0014-2999(94)00728-P; STRONG TV, 1994, J CLIN INVEST, V93, P347, DOI 10.1172/JCI116966; Suessbrich H, 1996, FEBS LETT, V396, P271, DOI 10.1016/0014-5793(96)01113-1; SUGIMOTO T, 1990, J MEMBRANE BIOL, V113, P39, DOI 10.1007/BF01869604; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tinel N, 2000, FEBS LETT, V480, P137, DOI 10.1016/S0014-5793(00)01918-9; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Vallon V, 2005, P NATL ACAD SCI USA, V102, P17864, DOI 10.1073/pnas.0505860102; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Warth R, 2002, PFLUG ARCH EUR J PHY, V443, P822, DOI 10.1007/s00424-001-0751-3; Warth R, 1996, PFLUG ARCH EUR J PHY, V432, P81, DOI 10.1007/s004240050108; Warth R, 1999, PFLUG ARCH EUR J PHY, V438, P437, DOI 10.1007/s004240051059; WELSH MJ, 1982, SCIENCE, V218, P1219, DOI 10.1126/science.6293054; Zdebik AA, 2004, J BIOL CHEM, V279, P22276, DOI 10.1074/jbc.M309899200; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839	72	74	75	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7165	7175		10.1074/jbc.M109.047829	http://dx.doi.org/10.1074/jbc.M109.047829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20051516	Green Published, hybrid			2022-12-25	WOS:000275415600030
J	Wang, T; Shah, YM; Matsubara, T; Zhen, YY; Tanabe, T; Nagano, T; Fotso, S; Krausz, KW; Zabriskie, TM; Idle, JR; Gonzalez, FJ				Wang, Ting; Shah, Yatrik M.; Matsubara, Tsutomu; Zhen, Yueying; Tanabe, Tomotaka; Nagano, Tomokazu; Fotso, Serge; Krausz, Kristopher W.; Zabriskie, T. Mark; Idle, Jeffrey R.; Gonzalez, Frank J.			Control of Steroid 21-oic Acid Synthesis by Peroxisome Proliferator-activated Receptor alpha and Role of the Hypothalamic-Pituitary-Adrenal Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; ALDO-KETO REDUCTASE; NEUROPEPTIDE-Y NPY; NAKED PLASMID DNA; PPAR-ALPHA; ALDEHYDE DEHYDROGENASE; 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE; SUCCESSIVE REACTIONS; TISSUE DISTRIBUTION; OXIDATIVE STRESS	A previous study identified the peroxisome proliferator-activated receptor alpha (PPAR alpha) activation biomarkers 21-steroid carboxylic acids 11 beta-hydroxy-3,20-dioxopregn-4-en-21-oic acid (HDOPA) and 11 beta,20-dihydroxy-3-oxo-pregn-4-en-21-oic acid (DHOPA). In the present study, the molecular mechanism and the metabolic pathway of their production were determined. The PPAR alpha-specific time-dependent increases in HDOPA and 20 alpha-DHOPA paralleled the development of adrenal cortex hyperplasia, hypercortisolism, and spleen atrophy, which was attenuated in adrenalectomized mice. Wy-14,643 activation of PPAR alpha induced hepatic FGF21, which caused increased neuropeptide Y and agouti-related protein mRNAs in the hypothalamus, stimulation of the agouti-related protein/neuropeptide Y neurons, and activation of the hypothalamic-pituitary-adrenal (HPA) axis, resulting in increased adrenal cortex hyperplasia and corticosterone production, revealing a link between PPAR alpha and the HPA axis in controlling energy homeostasis and immune regulation. Corticosterone was demonstrated as the precursor of 21-carboxylic acids both in vivo and in vitro. Under PPAR alpha activation, the classic reductive metabolic pathway of corticosterone was suppressed, whereas an alternative oxidative path-way was uncovered that leads to the sequential oxidation on carbon 21 resulting in HDOPA. The latter was then reduced to the end product 20 alpha-DHOPA. Hepatic cytochromes P450, aldehyde dehydrogenase (ALDH3A2), and 21-hydroxysteroid dehydrogenase (AKR1C18) were found to be involved in this pathway. Activation of PPAR alpha resulted in the induction of Aldh3a2 and Akr1c18, both of which were confirmed as target genes through introduction of promoter luciferase reporter constructs into mouse livers in vivo. This study underscores the power of mass spectrometry-based metabolomics combined with genomic and physiologic analyses in identifying downstream metabolic biomarkers and the corresponding upstream molecular mechanisms.	[Wang, Ting; Shah, Yatrik M.; Matsubara, Tsutomu; Zhen, Yueying; Tanabe, Tomotaka; Nagano, Tomokazu; Krausz, Kristopher W.; Idle, Jeffrey R.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Fotso, Serge; Zabriskie, T. Mark] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Idle, Jeffrey R.] Charles Univ Prague, Inst Pharmacol, Fac Med 1, Prague 12800, Czech Republic	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oregon State University; Charles University Prague	Gonzalez, FJ (corresponding author), NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	fjgonz@helix.nih.gov	Fotso, serge/A-4396-2009; Idle, Jeff/B-1152-2012	Fotso, serge/0000-0001-7117-8568; Idle, Jeff/0000-0002-6143-1520	National Institutes of Health NCI Intramural Research; Center for Gastrointestinal Biology and Disease [P30 DK34987]; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	National Institutes of Health NCI Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Gastrointestinal Biology and Disease; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NCI Intramural Research Program. This work was also supported by Center for Gastrointestinal Biology and Disease Grant P30 DK34987.	ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; Alnouti Y, 2008, TOXICOL SCI, V101, P51, DOI 10.1093/toxsci/kfm280; Ashibe B, 2007, J BIOL CHEM, V282, P20763, DOI 10.1074/jbc.M611853200; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; BRADLOW HL, 1973, J CLIN ENDOCR METAB, V37, P811, DOI 10.1210/jcem-37-5-811; Brereton P, 2001, MOL CELL ENDOCRINOL, V171, P111, DOI 10.1016/S0303-7207(00)00417-2; Burczynski ME, 1999, CANCER RES, V59, P607; CALI JJ, 1991, J BIOL CHEM, V266, P7774; Chen L, 2005, P NATL ACAD SCI USA, V102, P15581, DOI 10.1073/pnas.0503877102; Chikahisa S, 2008, ENDOCRINOLOGY, V149, P5262, DOI 10.1210/en.2008-0285; Cunard R, 2002, J IMMUNOL, V169, P6806, DOI 10.4049/jimmunol.169.12.6806; Dai CS, 2003, J BIOL CHEM, V278, P27080, DOI 10.1074/jbc.M211947200; DELAUNOIT Y, 1992, ENDOCRINOLOGY, V130, P553, DOI 10.1210/en.130.1.553; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dhagat U, 2008, J MED CHEM, V51, P4844, DOI 10.1021/jm8003575; Fan LQ, 1998, J ENDOCRINOL, V158, P237, DOI 10.1677/joe.0.1580237; GOLDSTEIN DS, 1993, J NEUROENDOCRINOL, V5, P475, DOI 10.1111/j.1365-2826.1993.tb00511.x; Griffin JL, 2006, PHILOS T R SOC B, V361, P147, DOI 10.1098/rstb.2005.1734; HAN A, 1983, J BIOL CHEM, V258, P3703; HANSON ES, 1995, J NEUROENDOCRINOL, V7, P273, DOI 10.1111/j.1365-2826.1995.tb00757.x; Imai T, 1998, BIOCHEMISTRY-US, V37, P8097, DOI 10.1021/bi9802768; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ishida N, 2009, PPAR RES, V2009, DOI 10.1155/2009/412949; Liberman AC, 2007, CYTOKINE GROWTH F R, V18, P45, DOI 10.1016/j.cytogfr.2007.01.005; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; LOOMIS CW, 1983, CAN J PHYSIOL PHARM, V61, P431, DOI 10.1139/y83-065; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; MONDER C, 1982, J STEROID BIOCHEM, V16, P613, DOI 10.1016/0022-4731(82)90095-4; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; PETERSON RE, 1960, J CLIN INVEST, V39, P741, DOI 10.1172/JCI104091; REISMAN D, 1995, MOL ENDOCRINOL, V9, P1500, DOI 10.1210/me.9.11.1500; Shafqat N, 2003, BIOCHEM J, V376, P49, DOI 10.1042/BJ20030877; STRICKLER RC, 1981, J BIOL CHEM, V256, P316; WAHLESTEDT C, 1987, BRAIN RES, V417, P33, DOI 10.1016/0006-8993(87)90176-4; Yamazaki T, 1998, BIOCHEMISTRY-US, V37, P2800, DOI 10.1021/bi9715066; Yang JW, 2001, HEPATOLOGY, V33, P848, DOI 10.1053/jhep.2001.23438; Yang Q, 2002, BIOCHEM PHARMACOL, V63, P1893, DOI 10.1016/S0006-2952(02)00923-1; Yokoi Y, 2007, FEBS J, V274, P4837, DOI 10.1111/j.1742-4658.2007.06005.x; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhen Y, 2007, MOL ENDOCRINOL, V21, P2136, DOI 10.1210/me.2007-0150	43	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7670	7685		10.1074/jbc.M109.090175	http://dx.doi.org/10.1074/jbc.M109.090175			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20032461	hybrid, Green Published			2022-12-25	WOS:000275415600077
J	Zhang, R; Chen, HZ; Liu, JJ; Jia, YY; Zhang, ZQ; Yang, RF; Zhang, Y; Xu, J; Wei, YS; Liu, DP; Liang, CC				Zhang, Ran; Chen, Hou-Zao; Liu, Jin-Jing; Jia, Yu-Yan; Zhang, Zhu-Qin; Yang, Rui-Feng; Zhang, Yuan; Xu, Jing; Wei, Yu-Sheng; Liu, De-Pei; Liang, Chih-Chuan			SIRT1 Suppresses Activator Protein-1 Transcriptional Activity and Cyclooxygenase-2 Expression in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALORIE RESTRICTION; C-JUN; IN-VITRO; CHRONIC INFLAMMATION; EPITHELIAL-CELLS; DNA-BINDING; KAPPA-B; DEACETYLASE; MOLECULE; MICE	SIRT1 (Sirtuin type 1), a mammalian orthologue of yeast SIR2 (silent information regulator 2), has been shown to mediate a variety of calorie restriction (CR)-induced physiological events, such as cell fate regulation via deacetylation of the substrate proteins. However, whether SIRT1 deacetylates activator protein-1 (AP-1) to influence its transcriptional activity and target gene expression is still unknown. Here we demonstrate that SIRT1 directly interacts with the basic leucine zipper domains of c-Fos and c-Jun, the major components of AP-1, by which SIRT1 suppressed the transcriptional activity of AP-1. This process requires the deacetylase activity of SIRT1. Notably, SIRT1 reduced the expression of COX-2, a typical AP-1 target gene, and decreased prostaglandin E-2 (PGE(2)) production of peritoneal macrophages (pM Phi s). pM Phi s with SIRT1 overexpression displayed improved phagocytosis and tumoricidal functions, which are associated with depressed PGE(2). Furthermore, SIRT1 protein level was up-regulated in CR mouse pM Phi s, whereas elevated SIRT1 decreased COX-2 expression and improved PGE(2)-related macrophage functions that were reversed following inhibition of SIRT1 deacetylase activity. Thus, our results indicate that SIRT1 may be a mediator of CR-induced macrophage regulation, and its deacetylase activity contributes to the inhibition of AP-1 transcriptional activity and COX-2 expression leading to amelioration of macrophage function.	Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China; Peking Union Med Coll, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, DP (corresponding author), 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	liudp@pumc.edu.cn	Zhang, Ran/GZG-8709-2022	Liu, De-Pei/0000-0002-2636-4297; Chen, Hou-Zao/0000-0001-6805-3182	National Basic Research Program of China [2005CB522402, 2006CB503801]; National 863 Project [2006AA02A406]; National Natural Science Foundation of China [30721063]	National Basic Research Program of China(National Basic Research Program of China); National 863 Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2005CB522402 and 2006CB503801, National 863 Project Grant 2006AA02A406, and National Natural Science Foundation of China Grant 30721063.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; BIRT DF, 1991, CANCER RES, V51, P1851; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Castello L, 2005, FASEB J, V19, P1863, DOI 10.1096/fj.04-2864fje; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dey S, 2008, CARCINOGENESIS, V29, P1920, DOI 10.1093/carcin/bgn175; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Gao ZG, 2008, BIOCHEM BIOPH RES CO, V376, P793, DOI 10.1016/j.bbrc.2008.09.079; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Guo YS, 2001, J BIOL CHEM, V276, P22941, DOI 10.1074/jbc.M101801200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kalain R, 2006, J GERONTOL A-BIOL, V61, P211, DOI 10.1093/gerona/61.3.211; Kim HJ, 2002, J AM AGING ASSOC, V25, P123, DOI 10.1007/s11357-002-0011-2; Kim YJ, 2006, LIFE SCI, V78, P2523, DOI 10.1016/j.lfs.2005.10.034; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lively TN, 2004, J BIOL CHEM, V279, P26257, DOI 10.1074/jbc.M400892200; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Mai V, 2003, CANCER RES, V63, P1752; Martin ML, 1996, MOL CELL BIOL, V16, P2110; Miotto B, 2006, MOL CELL BIOL, V26, P5969, DOI 10.1128/MCB.00696-06; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Przybyszewski J, 2001, CARCINOGENESIS, V22, P1421, DOI 10.1093/carcin/22.9.1421; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; SCHULTZ RM, 1978, SCIENCE, V202, P320, DOI 10.1126/science.694537; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Stapleton PP, 2001, NUTRITION, V17, P41, DOI 10.1016/S0899-9007(00)00502-5; Sun DX, 2001, CLIN DIAGN LAB IMMUN, V8, P1003, DOI 10.1128/CDLI.8.5.1003-1011.2001; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vries RGJ, 2001, EMBO J, V20, P6095, DOI 10.1093/emboj/20.21.6095; Yakar I, 2003, ANN SURG ONCOL, V10, P469, DOI 10.1245/ASO.2003.08.017; Yamada H, 2002, CLIN EXP IMMUNOL, V128, P52, DOI 10.1046/j.1365-2249.2002.01686.x; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006	46	160	176	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7097	7110		10.1074/jbc.M109.038604	http://dx.doi.org/10.1074/jbc.M109.038604			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042607	hybrid, Green Published			2022-12-25	WOS:000275415600023
J	He, SQ; McPhaul, C; Li, JZ; Garuti, R; Kinch, L; Grishin, NV; Cohen, JC; Hobbs, HH				He, Shaoqing; McPhaul, Christopher; Li, John Zhong; Garuti, Rita; Kinch, Lisa; Grishin, Nick V.; Cohen, Jonathan C.; Hobbs, Helen H.			A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC STEATOSIS; ACYL-HYDROLASE; PURIFICATION; ADIPONUTRIN; FAMILY; LIPASE; EXPRESSION; PATATIN	Obesity and insulin resistance are associated with deposition of triglycerides in tissues other than adipose tissue. Previously, we showed that a missense mutation (I148M) in PNPLA3 (patatin-like phospholipase domain-containing 3 protein) is associated with increased hepatic triglyceride content in humans. Here we examined the effect of the I148M substitution on the enzymatic activity and cellular location of PNPLA3. Structural modeling predicted that the substitution of methionine for isoleucine at residue 148 would restrict access of substrate to the catalytic serine at residue 47. In vitro assays using recombinant PNPLA3 partially purified from Sf9 cells confirmed that the wild type enzyme hydrolyzes emulsified triglyceride and that the I148M substitution abolishes this activity. Expression of PNPLA3-I148M, but not wild type PNPLA3, in cultured hepatocytes or in the livers of mice increased cellular triglyceride content. Cell fractionation studies revealed that similar to 90% of wild type PNPLA3 partitioned between membranes and lipid droplets; substitution of isoleucine for methionine at position 148 did not alter the subcellular distribution of the protein. These data are consistent with PNPLA3-I148M promoting triglyceride accumulation by limiting triglyceride hydrolysis.	[He, Shaoqing; McPhaul, Christopher; Li, John Zhong; Garuti, Rita; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Kinch, Lisa; Grishin, Nick V.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cohen, JC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu; helen.hobbs@utsouthwestern.edu	Li, John Zhong/S-2118-2019; Li, Zhong/U-2157-2017	Li, John Zhong/0000-0003-4991-9563; Kinch, Lisa/0000-0003-3041-2615	National Institutes of Health [HL092550, UL1DE019684, PL1DK081182, HL20948]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, RL1HL092550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE019684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [PL1DK081182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL092550, UL1DE019684, PL1DK081182, and HL20948.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brasaemle DL, 2006, CURRENT PROTOCOLS CE; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujimoto T, 2006, ANN NY ACAD SCI, V1086, P104, DOI 10.1196/annals.1377.010; GALLIARD T, 1971, BIOCHEM J, V121, P379, DOI 10.1042/bj1210379; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kantartzis K, 2009, DIABETES, V58, P2616, DOI 10.2337/db09-0279; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; OMURA S, 1986, J ANTIBIOT, V39, P1211, DOI 10.7164/antibiotics.39.1211; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Romeo S, 2010, INT J OBESITY, V34, P190, DOI 10.1038/ijo.2009.216; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; SHEEHAN DC, 1980, THEORY PRACTICE HIST, P205; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; WADA I, 1991, J BIOL CHEM, V266, P19599; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Yuan B, 2000, AM J HUM GENET, V66, P1699, DOI 10.1086/302904	32	449	462	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6706	6715		10.1074/jbc.M109.064501	http://dx.doi.org/10.1074/jbc.M109.064501			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20034933	hybrid, Green Published			2022-12-25	WOS:000275367500074
J	Okazaki, H; Goldstein, JL; Brown, MS; Liang, GS				Okazaki, Hiroaki; Goldstein, Joseph L.; Brown, Michael S.; Liang, Guosheng			LXR-SREBP-1c-Phospholipid Transfer Protein Axis Controls Very Low Density Lipoprotein (VLDL) Particle Size	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-TRANSFER PROTEIN; ELEMENT-BINDING PROTEIN-1C; LIVER-X-RECEPTORS; KNOCKOUT MICE; INSULIN-RESISTANCE; GENE; TRANSCRIPTION; LIPOGENESIS; ACTIVATION; SREBP-1C	Liver X receptors (LXRs) activate triglyceride synthesis in liver directly and indirectly by inducing sterol regulatory element-binding protein-1c (SREBP-1c). When administered to wild-type mice, the LXR activator T0901317 produces a mild and transient hypertriglyceridemia. Here, we show that T0901317 produces massive hypertriglyceridemia when given to mice lacking low density lipoprotein (LDL) receptors (Ldlr(-/-) mice). Triglycerides ranged from 4000 to 6000 mg/dl, and the plasma turned milky. The median diameter of VLDL particles, measured by electron microscopy, increased from 43 to 112 nm, 87% exceeding 80 nm, the size of chylomicrons. Hypertriglyceridemia was prevented in Ldlr(-/-) recipient mice that lacked SREBP-1c (Ldlr(-/-); Srebp-1c(-/-) double knock-out mice). In Ldlr(-/-) mice, T0901317 increased mRNAs not only for enzymes of fatty acid and triglyceride synthesis, but also for phospholipid transfer protein (PLTP), which transfers phospholipids into nascent VLDL, allowing particle expansion. The PLTP increase was blunted in Ldlr(-/-); Srebp-1c(-/-) animals. When Ldlr(-/-); Srebp-1c(-/-) mice received an adenovirus encoding Pltp, the hypertriglyceridemic response to T0901317 was partially restored and the VLDL size increased. We conclude that LXR agonists activate triglyceride synthesis and Pltp transcription by activating Srebp-1c. In concert with the increase in TG synthesis, the increased PLTP permits triglyceride incorporation into abnormally large VLDL, which are removed from plasma by LDL receptors. In the absence of LDL receptors, the large VLDLs accumulate and produce massive hypertriglyceridemia.	[Okazaki, Hiroaki; Goldstein, Joseph L.; Brown, Michael S.; Liang, Guosheng] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu			National Institutes of Health [HL-20948]; Perot Family Foundation; Moss Heart Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; Moss Heart Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-20948, the Perot Family Foundation, and the Moss Heart Foundation.	Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Cao GQ, 2002, J BIOL CHEM, V277, P39561, DOI 10.1074/jbc.M207187200; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Desrumaux C, 1999, ARTERIOSCL THROM VAS, V19, P266, DOI 10.1161/01.ATV.19.2.266; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Goldstein JL, 1983, METABOLIC BASIS INHE, P672; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; HAVEL RJ, 2001, METABOLIC MOL BASES, P2705; Horton JD, 1999, J CLIN INVEST, V103, P1067, DOI 10.1172/JCI6246; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; JIANG XC, 1995, J BIOL CHEM, V270, P17133, DOI 10.1074/jbc.270.29.17133; Jiang XC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1634, DOI 10.2741/jiang1; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; LaFave LT, 2006, ENDOCRINOLOGY, V147, P4044, DOI 10.1210/en.2006-0473; Laffitte BA, 2003, MOL CELL BIOL, V23, P2182, DOI 10.1128/MCB.23.6.2182-2191.2003; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Lie J, 2002, J LIPID RES, V43, P1875, DOI 10.1194/jlr.M200166-JLR200; Mak PA, 2002, J LIPID RES, V43, P2037, DOI 10.1194/jlr.C200014-JLR200; Masson D, 2009, J LIPID RES, V50, pS201, DOI 10.1194/jlr.R800061-JLR200; Okazaki H, 2002, J BIOL CHEM, V277, P31893, DOI 10.1074/jbc.M204016200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Talukdar S, 2006, J LIPID RES, V47, P2451, DOI 10.1194/jlr.M600276-JLR200; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598	30	70	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6801	6810		10.1074/jbc.M109.079459	http://dx.doi.org/10.1074/jbc.M109.079459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037162	Green Published, hybrid			2022-12-25	WOS:000275367500083
J	Subramanyam, M; Takahashi, N; Hasegawa, Y; Mohri, T; Okada, Y				Subramanyam, Muthangi; Takahashi, Nobuyuki; Hasegawa, Yuichi; Mohri, Tatsuma; Okada, Yasunobu			Inhibition of Protein Kinase Akt1 by Apoptosis Signal-regulating Kinase-1 (ASK1) Is Involved in Apoptotic Inhibition of Regulatory Volume Increase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMOTONIC CELL SHRINKAGE; CATION CHANNELS; B-GAMMA; ACTIVATION; STRESS; DEATH; PHOSPHORYLATION; TRANSDUCTION; PATHWAY; PREREQUISITE	Most animal cell types regulate their cell volume after an osmotic volume change. The regulatory volume increase (RVI) occurs through uptake of NaCl and osmotically obliged water after osmotic shrinkage. However, apoptotic cells undergo persistent cell shrinkage without showing signs of RVI. Persistence of the apoptotic volume decrease is a prerequisite to apoptosis induction. We previously demonstrated that volume regulation is inhibited in human epithelial HeLa cells stimulated with the apoptosis inducer. Here, we studied signaling mechanisms underlying the apoptotic inhibition of RVI in HeLa cells. Hypertonic stimulation was found to induce phosphorylation of a Ser/Thr protein kinase Akt (protein kinase B). Shrinkage-induced Akt activation was essential for RVI induction because RVI was suppressed by an Akt inhibitor, expression of a dominant negative form of Akt, or small interfering RNA-mediated knockdown of Akt1 (but not Akt2). Staurosporine, tumor necrosis factor-alpha, or a Fas ligand inhibited both RVI and hypertonicity-induced Akt activation in a manner sensitive to a scavenger for reactive oxygen species (ROS). Any of apoptosis inducers also induced phosphorylation of apoptosis signal-regulating kinase 1 (ASK1) in a ROS-dependent manner. Suppression of (ASK1) expression blocked the effects of apoptosis, in hypertonic conditions, on both RVI induction and Akt activation. Thus, it is concluded that in human epithelial cells, shrinkage-induced activation of Akt1 is involved in the RVI process and that apoptotic inhibition of RVI is caused by inhibition of Akt activation, which results from ROS-mediated activation of ASK1.	[Subramanyam, Muthangi; Takahashi, Nobuyuki; Hasegawa, Yuichi; Mohri, Tatsuma; Okada, Yasunobu] Natl Inst Nat Sci, Dept Cell Physiol, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan	Okada, Y (corresponding author), Natl Inst Nat Sci, Dept Cell Physiol, Okazaki, Aichi 4448585, Japan.	okada@nips.ac.jp	Takahashi, Nobuyuki/AAX-8671-2021	Takahashi, Nobuyuki/0000-0002-9705-662X; Takahashi, Nobuyuki/0000-0003-0126-6292; Mohri, Tatsuma/0000-0002-5744-7925	Ministry of Education, Culture, Sports, Science, and Technology of Japa; Salt Science Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japa(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to Y.O. and N.T.) and from The Salt Science Research Foundation (to N.T.).	Allen RT, 2005, APOPTOSIS, V10, P525, DOI 10.1007/s10495-005-1882-3; Araki T, 2002, BIOCHEM BIOPH RES CO, V290, P1275, DOI 10.1006/bbrc.2002.6329; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Berra E, 1998, J BIOL CHEM, V273, P10792, DOI 10.1074/jbc.273.17.10792; Bortner CD, 1998, BIOCHEM PHARMACOL, V56, P1549, DOI 10.1016/S0006-2952(98)00225-1; Bortner CD, 1996, AM J PHYSIOL-CELL PH, V271, pC950, DOI 10.1152/ajpcell.1996.271.3.C950; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Choi K, 2007, CANCER LETT, V257, P79, DOI 10.1016/j.canlet.2007.07.006; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fujisawa T, 2007, MOL BIOTECHNOL, V37, P13, DOI 10.1007/s12033-007-0053-x; Gomez-Angelats M, 2002, TOXICOL PATHOL, V30, P541, DOI 10.1080/01926230290105820; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Hill MM, 2001, J BIOL CHEM, V276, P25643, DOI 10.1074/jbc.C100174200; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Imoto K, 2006, DIABETES, V55, P1197, DOI 10.2337/db05-1187; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kadowaki H, 2005, CELL DEATH DIFFER, V12, P19, DOI 10.1038/sj.cdd.4401528; Kadowaki H, 2004, J CHEM NEUROANAT, V28, P93, DOI 10.1016/j.jchemneu.2004.05.004; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Koseoglu S, 2007, CANCER BIOL THER, V6, P755, DOI 10.4161/cbt.6.5.3995; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Maeno E, 2006, ACTA PHYSIOL, V187, P217, DOI 10.1111/j.1748-1716.2006.01554.x; Maeno E, 2006, FEBS LETT, V580, P6513, DOI 10.1016/j.febslet.2006.10.074; McConkey David J., 1994, Trends in Cell Biology, V4, P370, DOI 10.1016/0962-8924(94)90087-6; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Nakatani K, 1999, BIOCHEM BIOPH RES CO, V257, P906, DOI 10.1006/bbrc.1999.0559; Nielsen MB, 2008, AM J PHYSIOL-CELL PH, V294, pC1046, DOI 10.1152/ajpcell.00134.2007; Nukui M, 2006, J PHYSIOL SCI, V56, P335, DOI 10.2170/physiolsci.RP009606; Numata T, 2008, APOPTOSIS, V13, P895, DOI 10.1007/s10495-008-0220-y; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Okada Y, 2004, CELL BIOCHEM BIOPHYS, V41, P233, DOI 10.1385/CBB:41:2:233; Okada Y, 2001, COMP BIOCHEM PHYS A, V130, P377, DOI 10.1016/S1095-6433(01)00424-X; OKADA Y, 2001, J PHYSL, V523, P3; Renehan AG, 2001, BMJ-BRIT MED J, V322, P1536, DOI 10.1136/bmj.322.7301.1536; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Shimizu T, 2008, ANTICANCER RES, V28, P75; Shimizu T, 2006, CELL PHYSIOL BIOCHEM, V18, P295, DOI 10.1159/000097607; Shimizu Takahiro, 2007, Shengli Xuebao, V59, P512; Snabaitis AK, 2008, CIRC RES, V103, P881, DOI 10.1161/CIRCRESAHA.108.175877; Sugden PH, 2001, CIRC RES, V88, P975, DOI 10.1161/hh1001.091864; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Terada Y, 2001, KIDNEY INT, V60, P553, DOI 10.1046/j.1523-1755.2001.060002553.x; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Uramoto H, 2003, JPN J PHYSIOL, V53, P357, DOI 10.2170/jjphysiol.53.357; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; Wehner F, 2007, CELL PHYSIOL BIOCHEM, V20, P75, DOI 10.1159/000104155; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714	58	26	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6109	6117		10.1074/jbc.M109.072785	http://dx.doi.org/10.1074/jbc.M109.072785			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20048146	hybrid, Green Published			2022-12-25	WOS:000275367500014
J	Wernick, NLB; De Luca, H; Kam, WR; Lencer, WI				Wernick, Naomi L. B.; De Luca, Heidi; Kam, Wendy R.; Lencer, Wayne I.			N-terminal Extension of the Cholera Toxin A1-chain Causes Rapid Degradation after Retrotranslocation from Endoplasmic Reticulum to Cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETRO-TRANSLOCATION; AAA-ATPASE; PATHWAY; DESTRUCTION; SUBSTRATE; TRANSPORT; PROTEINS; DISORDER; SUBUNIT; CELLS	Cholera toxin travels from the plasma membrane to the endoplasmic reticulum of host cells, where a portion of the toxin, the A1-chain, is unfolded and targeted to a protein-conducting channel for retrotranslocation to the cytosol. Unlike most retrotranslocation substrates, the A1-chain escapes degradation by the proteasome and refolds in the cytosol to induce disease. How this occurs remains poorly understood. Here, we show that an unstructured peptide appended to the N terminus of the A1-chain renders the toxin functionally inactive. Cleavage of the peptide extension prior to cell entry rescues toxin half-life and function. The loss of toxicity is explained by rapid degradation by the proteasome after retrotranslocation to the cytosol. Degradation of the mutant toxin does not follow the N-end rule but depends on the two Lys residues at positions 4 and 17 of the native A1-chain, consistent with polyubiquitination at these sites. Thus, retrotranslocation and refolding of the wild-type A1-chain must proceed in a way that protects these Lys residues from attack by E3 ligases.	[Wernick, Naomi L. B.; De Luca, Heidi; Kam, Wendy R.; Lencer, Wayne I.] Childrens Hosp Boston, Gastrointestinal Cell Biol Lab, Boston, MA 02115 USA; [Lencer, Wayne I.] Harvard Digest Dis Ctr, Boston, MA 02115 USA; [Wernick, Naomi L. B.; De Luca, Heidi; Kam, Wendy R.; Lencer, Wayne I.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lencer, WI (corresponding author), Childrens Hosp Boston, Gastrointestinal Cell Biol Lab, 300 Longwood Ave,Enders 720, Boston, MA 02115 USA.	wayne.lencer@childrens.harvard.edu		Lencer, Wayne/0000-0001-7346-2730	National Institutes of Health [RO1 DK48106, F32 DK078426]; Harvard Digestive Diseases Center [P30 DK034854]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084424, F32DK078426, P30DK034854, R01DK048106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK48106 (to W.I.L.) and F32 DK078426 (N.L.B.W.). This work was also supported by Harvard Digestive Diseases Center Grant P30 DK034854.	Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Dixit G, 2008, EXP BIOL MED, V233, P163, DOI 10.3181/0705-RM-132; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; JOBLING MG, 1991, MOL MICROBIOL, V5, P1755, DOI 10.1111/j.1365-2958.1991.tb01925.x; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; LENCER WI, 1992, J CELL BIOL, V117, P1197, DOI 10.1083/jcb.117.6.1197; LENCER WI, 1995, P NATL ACAD SCI USA, V92, P10094, DOI 10.1073/pnas.92.22.10094; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Lencer WI, 1997, J BIOL CHEM, V272, P15562, DOI 10.1074/jbc.272.24.15562; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a	29	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6145	6152		10.1074/jbc.M109.062067	http://dx.doi.org/10.1074/jbc.M109.062067			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20056601	Green Published, hybrid			2022-12-25	WOS:000275367500018
J	Corazza, A; Rennella, E; Schanda, P; Mimmi, MC; Cutuil, T; Raimondi, S; Giorgetti, S; Fogolari, F; Viglino, P; Frydman, L; Gal, M; Bellotti, V; Brutscher, B; Esposito, G				Corazza, Alessandra; Rennella, Enrico; Schanda, Paul; Mimmi, Maria Chiara; Cutuil, Thomas; Raimondi, Sara; Giorgetti, Sofia; Fogolari, Federico; Viglino, Paolo; Frydman, Lucio; Gal, Maayan; Bellotti, Vittorio; Brutscher, Bernhard; Esposito, Gennaro			Native-unlike Long-lived Intermediates along the Folding Pathway of the Amyloidogenic Protein beta(2)-Microglobulin Revealed by Real-time Two-dimensional NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA-2-MICROGLOBULIN; PHYSIOLOGICAL CONDITIONS; AGGREGATION; SPECTROSCOPY; SPECTRA	beta 2-microglobulin (beta 2m), the light chain of class I major histocompatibility complex, is responsible for the dialysis-related amyloidosis and, in patients undergoing long term dialysis, the full-length and chemically unmodified beta 2m converts into amyloid fibrils. The protein, belonging to the immunoglobulin superfamily, in common to other members of this family, experiences during its folding a long-lived intermediate associated to the trans-to-cis isomerization of Pro-32 that has been addressed as the precursor of the amyloid fibril formation. In this respect, previous studies on the W60G beta 2m mutant, showing that the lack of Trp-60 prevents fibril formation in mild aggregating condition, prompted us to reinvestigate the refolding kinetics of wild type and W60G beta 2m at atomic resolution by real-time NMR. The analysis, conducted at ambient temperature by the band selective flip angle short transient real-time two-dimensional NMR techniques and probing the beta 2m states every 15 s, revealed a more complex folding energy landscape than previously reported for wild type beta 2m, involving more than a single intermediate species, and shedding new light into the fibrillogenic pathway. Moreover, a significant difference in the kinetic scheme previously characterized by optical spectroscopic methods was discovered for the W60G beta 2m mutant.	[Corazza, Alessandra; Rennella, Enrico; Mimmi, Maria Chiara; Fogolari, Federico; Viglino, Paolo; Esposito, Gennaro] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Schanda, Paul; Cutuil, Thomas; Brutscher, Bernhard] Univ Grenoble 1, Ctr Etud Atom, UMR5075,CNRS, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble 9, France; [Raimondi, Sara; Giorgetti, Sofia; Bellotti, Vittorio] Univ Pavia, Dept Biochem, I-27100 Pavia, Italy; [Raimondi, Sara; Giorgetti, Sofia; Bellotti, Vittorio] Fdn IRCCS, Biotechnol Lab, I-27100 Pavia, Italy; [Frydman, Lucio; Gal, Maayan] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel	University of Udine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; University of Pavia; IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione San Matteo; Weizmann Institute of Science	Corazza, A (corresponding author), Univ Udine, Dept Biomed Sci & Technol, Piazzale Kolbe 4, I-33100 Udine, Italy.	alessandra.corazza@uniud.it; gennaro.esposito@uniud.it	Mimmi, Maria Chiara/K-3689-2014; Gal, Maayan/AAO-1171-2021; Mimmi, Maria Chiara/GYD-9155-2022; Schanda, Paul/A-5975-2010; Giorgetti, Sofia/AAD-4341-2019; Bellotti, Vittorio/A-6201-2014; Mimmi, Maria Chiara/AAA-4925-2020; Corazza, Alessandra/AGB-1457-2022	Gal, Maayan/0000-0003-3668-8647; Mimmi, Maria Chiara/0000-0002-5165-9230; Schanda, Paul/0000-0002-9350-7606; Giorgetti, Sofia/0000-0001-9438-6511; Bellotti, Vittorio/0000-0001-8678-662X; Mimmi, Maria Chiara/0000-0002-5165-9230; Corazza, Alessandra/0000-0003-2272-1928; Fogolari, Federico/0000-0001-9862-250X	Ministero dell'Istruzione, dell'Universita e della Ricerca [RBNE03PX83, RBRN07BMCT, PRIN 2007_XY59ZJ_002]; European Union (EU) [LSHM-CT-2005-037525]; EU-NMR [026145]; French Agence Nationale pour la Recherche [ANR-08-BLAN-0210]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); European Union (EU)(CGIAREuropean Commission); EU-NMR; French Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca (FIRB Grant RBNE03PX83 and RBRN07BMCT and PRIN 2007_XY59ZJ_002), the European Union (EU) (EURAMY Project LSHM-CT-2005-037525; EU-NMR Contract 026145), and the French Agence Nationale pour la Recherche (Grant ANR-08-BLAN-0210).	CHENG HN, 1977, BIOPOLYMERS, V16, P1465, DOI 10.1002/bip.1977.360160707; Chiti F, 2001, J BIOL CHEM, V276, P46714, DOI 10.1074/jbc.M107040200; Chiti F, 2001, J MOL BIOL, V307, P379, DOI 10.1006/jmbi.2000.4478; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Corazza A, 2004, J BIOL CHEM, V279, P9176, DOI 10.1074/jbc.M310779200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Esposito G, 2008, J MOL BIOL, V378, P887, DOI 10.1016/j.jmb.2008.03.002; Feige MJ, 2008, P NATL ACAD SCI USA, V105, P13373, DOI 10.1073/pnas.0802809105; Fogolari F, 2007, BIOPHYS J, V92, P1673, DOI 10.1529/biophysj.106.098483; Freeman R, 2003, J BIOMOL NMR, V27, P101, DOI 10.1023/A:1024960302926; Gal M, 2007, J AM CHEM SOC, V129, P1372, DOI 10.1021/ja066915g; Gal M, 2009, J BIOMOL NMR, V43, P1, DOI 10.1007/s10858-008-9284-9; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kameda A, 2005, J MOL BIOL, V348, P383, DOI 10.1016/j.jmb.2005.02.050; Kihara M, 2006, J BIOL CHEM, V281, P31061, DOI 10.1074/jbc.M605358200; KUPCE E, 1995, J MAGN RESON SER A, V115, P273, DOI 10.1006/jmra.1995.1179; Malmodin D, 2005, PROG NUCL MAG RES SP, V46, P109, DOI 10.1016/j.pnmrs.2005.01.002; OKON M, 1992, BIOCHEMISTRY-US, V31, P8906, DOI 10.1021/bi00152a030; Sakata M, 2008, J MOL BIOL, V382, P1242, DOI 10.1016/j.jmb.2008.08.003; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schanda P, 2007, P NATL ACAD SCI USA, V104, P11257, DOI 10.1073/pnas.0702069104; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7	27	51	51	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5827	5835		10.1074/jbc.M109.061168	http://dx.doi.org/10.1074/jbc.M109.061168			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028983	Green Published, hybrid			2022-12-25	WOS:000275327200073
J	Guo, JS; Hong, F; Loke, J; Yea, S; Lim, CL; Lee, U; Mann, DA; Walsh, MJ; Sninsky, JJ; Friedman, SL				Guo, Jinsheng; Hong, Feng; Loke, Johnny; Yea, Steven; Lim, Chooi Ling; Lee, Ursula; Mann, Derek A.; Walsh, Martin J.; Sninsky, John J.; Friedman, Scott L.			A DDX5 S480A Polymorphism Is Associated with Increased Transcription of Fibrogenic Genes in Hepatic Stellate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P68 RNA HELICASE; ALPHA-2(I) COLLAGEN GENE; GROWTH-FACTOR BETA-1; TISSUE INHIBITOR; BINDING-PROTEIN; KUPFFER CELLS; PROMOTER; FIBROSIS; EXPRESSION; LIVER	We recently identified a missense single nucleotide polymorphism (SNP) in DDX5 (rs1140409, p.S480A) that enhances the risk of developing cirrhosis. DDX5 is an ATP-dependent RNA helicase and transcriptional modulator. We hypothesized that the activity of DDX5 in regulating fibrogenic gene transcription in hepatic stellate cells (HSCs) is altered by the S480A SNP. To test this, we employed two approaches: 1) transient overexpression of DDX5 cDNA or siRNA knockdown of endogenous DDX5, with replacement by either DDX5 wild type (WT) or SNP cDNA, or 2) stable expression of exogenous DDX5 WT and SNP in HSC lines. WT DDX5 mRNA in HSCs was inversely correlated with gene expression for alpha 2(I) collagen, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta 1. Stable DDX5 SNP-expressing cells had higher basal and transforming growth factor-beta 1-stimulated expression and enhanced promoter activities of fibrogenic genes. DDX5 variant-expressing cells also had higher Smad3 and AP-1-responsive reporter activities. In a one-hybrid GAL4 system, co-expression of the DDX5 SNP variant with chimeras of GAL4 DNA binding domain linked to JunD or Sp1 displayed higher transactivation of a GAL4-responsive reporter than that of DDX5 WT. Increased fibrogenic gene expression in DDX5 SNP-expressing cells was associated with reduced recruitment of DDX5 homodimers to responsive promoters, but there was no difference in the recruitment of the co-repressor HDAC1 (histone deacetylase 1). These data suggest that DDX5 is a repressor of fibrogenic genes in HSCs through interaction with transcriptional complexes. The enhanced fibrogenic activity of the DDX5 risk variant is linked to a reduced repressive function toward these target genes.	[Guo, Jinsheng; Hong, Feng; Loke, Johnny; Yea, Steven; Lim, Chooi Ling; Lee, Ursula; Friedman, Scott L.] Mt Sinai Sch Med, Div Liver Dis, New York, NY 10029 USA; [Walsh, Martin J.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Guo, Jinsheng] Fu Dan Univ, Shanghai Med Coll, Dept Internal Med, Div Digest Dis,Zhongshan Hosp, Shanghai 200032, Peoples R China; [Mann, Derek A.] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Liver Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Sninsky, John J.] Celera, Alameda, CA 94502 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Fudan University; Newcastle University - UK	Friedman, SL (corresponding author), Mt Sinai Sch Med, Div Liver Dis, Box 1123,1425 Madison Ave,Rm 1170C, New York, NY 10029 USA.	scott.friedman@mssm.edu		guo, Jinsheng/0000-0002-9980-8725; Mann, Derek/0000-0003-0950-243X	National Institutes of Health [DK65521]; Celera; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK065521, R01DK056621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Celera; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK65521. This work was also supported by a research contract from Celera.	Bahr MJ, 1999, HEPATOLOGY, V29, P839, DOI 10.1002/hep.510290333; Bambha K, 2008, HEPATOLOGY, V48, p815A; Bataller R, 2003, HEPATOLOGY, V37, P493, DOI 10.1053/jhep.2003.50127; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bertrand-Philippe M, 2004, J BIOL CHEM, V279, P24530, DOI 10.1074/jbc.M311804200; Camats M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002926; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; de Alwis NMW, 2007, SEMIN LIVER DIS, V27, P44, DOI 10.1055/s-2006-960170; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1992, HEPATOLOGY, V15, P234, DOI 10.1002/hep.1840150211; FRIEDMAN SL, 1987, ANAL BIOCHEM, V161, P207, DOI 10.1016/0003-2697(87)90673-7; Fuller-Pace FV, 2008, BIOCHEM SOC T, V36, P609, DOI 10.1042/BST0360609; Goh PY, 2004, J VIROL, V78, P5288, DOI 10.1128/JVI.78.10.5288-5298.2004; Guo JS, 2007, SEMIN LIVER DIS, V27, P413, DOI 10.1055/s-2007-991517; Hellier S, 2003, HEPATOLOGY, V38, P1468, DOI [10.1016/j.hep.2003.09.027, 10.1053/jhep.2003.09027]; HUANG H, 2008, TXB HEPATOLOGY BASIC, P356; Huang HJ, 2006, GASTROENTEROLOGY, V130, P1679, DOI 10.1053/j.gastro.2006.02.032; Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695; INAGAKI Y, 1995, HEPATOLOGY, V22, P573, DOI 10.1016/0270-9139(95)90582-0; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; KIM SJ, 1989, J BIOL CHEM, V264, P7041; KIM SJ, 1989, J BIOL CHEM, V264, P402; Kim Y, 1998, J BIOL CHEM, V273, P33750, DOI 10.1074/jbc.273.50.33750; Lin SB, 2006, MOL ENDOCRINOL, V20, P3376, DOI 10.1210/me.2006-0177; Martinelli A, 2008, J GASTROEN HEPATOL, V23, P1403, DOI 10.1111/j.1440-1746.2007.05220.x; Nelson JE, 2007, HEPATOLOGY, V46, P723, DOI 10.1002/hep.21742; Ogilvie VC, 2003, NUCLEIC ACIDS RES, V31, P1470, DOI 10.1093/nar/gkg236; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Rombouts K, 2002, EXP CELL RES, V278, P184, DOI 10.1006/excr.2002.5577; Rossler OG, 2000, NUCLEIC ACIDS RES, V28, P932, DOI 10.1093/nar/28.4.932; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Schott E, 2007, J HEPATOL, V47, P203, DOI 10.1016/j.jhep.2007.03.021; Smart DE, 2001, J BIOL CHEM, V276, P24414, DOI 10.1074/jbc.M101840200; TAMAKI T, 1995, J BIOL CHEM, V270, P4299, DOI 10.1074/jbc.270.9.4299; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; Wang HZ, 2009, CELL RES, V19, P1388, DOI 10.1038/cr.2009.113; Wang JC, 2008, LEUKEMIA LYMPHOMA, V49, P2321, DOI 10.1080/10428190802527699; Warner DR, 2004, BIOCHEM BIOPH RES CO, V324, P70, DOI 10.1016/j.bbrc.2004.09.017; Wasmuth HE, 2004, J MOL MED-JMM, V82, P64, DOI 10.1007/s00109-003-0505-0; Wilson BJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-11; Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200	46	29	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5428	5437		10.1074/jbc.M109.035295	http://dx.doi.org/10.1074/jbc.M109.035295			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022962	Green Published, hybrid			2022-12-25	WOS:000275327200036
J	Zamudio, S; Torricos, T; Fik, E; Oyala, M; Echalar, L; Pullockaran, J; Tutino, E; Martin, B; Belliappa, S; Balanza, E; Illsley, NP				Zamudio, Stacy; Torricos, Tatiana; Fik, Ewa; Oyala, Maria; Echalar, Lourdes; Pullockaran, Janet; Tutino, Emily; Martin, Brittney; Belliappa, Sonia; Balanza, Elfride; Illsley, Nicholas P.			Hypoglycemia and the Origin of Hypoxia-Induced Reduction in Human Fetal Growth	PLOS ONE			English	Article							VEIN BLOOD-FLOW; HIGH-ALTITUDE; GESTATIONAL-AGE; HUMAN-FETUS; INSULIN-SECRETION; GLUCOSE-TRANSPORT; PLACENTAL HYPOXIA; OXYGEN DELIVERY; PLASMA-GLUCOSE; VENOUS-BLOOD	Background: The most well known reproductive consequence of residence at high altitude (HA 2700 m) is reduction in fetal growth. Reduced fetoplacental oxygenation is an underlying cause of pregnancy pathologies, including intrauterine growth restriction and preeclampsia, which are more common at HA. Therefore, altitude is a natural experimental model to study the etiology of pregnancy pathophysiologies. We have shown that the proximate cause of decreased fetal growth is not reduced oxygen availability, delivery, or consumption. We therefore asked whether glucose, the primary substrate for fetal growth, might be decreased and/or whether altered fetoplacental glucose metabolism might account for reduced fetal growth at HA. Methods: Doppler and ultrasound were used to measure maternal uterine and fetal umbilical blood flows in 69 and 58 residents of 400 vs 3600 m. Arterial and venous blood samples from mother and fetus were collected at elective cesarean delivery and analyzed for glucose, lactate and insulin. Maternal delivery and fetal uptakes for oxygen and glucose were calculated. Principal Findings: The maternal arterial-venous glucose concentration difference was greater at HA. However, umbilical venous and arterial glucose concentrations were markedly decreased, resulting in lower glucose delivery at 3600 m. Fetal glucose consumption was reduced by >28%, but strongly correlated with glucose delivery, highlighting the relevance of glucose concentration to fetal uptake. At altitude, fetal lactate levels were increased, insulin concentrations decreased, and the expression of GLUT1 glucose transporter protein in the placental basal membrane was reduced. Conclusion/Significance: Our results support that preferential anaerobic consumption of glucose by the placenta at high altitude spares oxygen for fetal use, but limits glucose availability for fetal growth. Thus reduced fetal growth at high altitude is associated with fetal hypoglycemia, hypoinsulinemia and a trend towards lactacidemia. Our data support that placentally-mediated reduction in glucose transport is an initiating factor for reduced fetal growth under conditions of chronic hypoxemia.	[Zamudio, Stacy] Univ Med & Dent New Jersey, Dept Prevent Med & Community Hlth, Newark, NJ 07103 USA; [Fik, Ewa; Oyala, Maria; Pullockaran, Janet; Tutino, Emily; Martin, Brittney; Belliappa, Sonia; Illsley, Nicholas P.] Univ Med & Dent New Jersey, Dept Obstet Gynecol & Womens Hlth, Newark, NJ 07103 USA; [Torricos, Tatiana] Hosp Hernandez Vera, Villa Primer De Mayo, Santa Cruz, Bolivia; [Torricos, Tatiana; Echalar, Lourdes; Balanza, Elfride] Univ San Andreas Mayor, Inst Boliviano Biol Altura, La Paz, Bolivia	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Universidad Mayor de San Andres	Zamudio, S (corresponding author), Univ Med & Dent New Jersey, Dept Prevent Med & Community Hlth, Newark, NJ 07103 USA.	Stacy.Zamudio@gmail.com		Illsley, Nicholas/0000-0002-4336-2832	National Institutes of Health [HD042737, TW007444, HD046982]; National Science Foundation [BCS-0309142]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046982, R01HD042737] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW007444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors would like to acknowledge the support of the National Institutes of Health (HD042737, TW007444, SZ; HD046982, NI) and the National Science Foundation (BCS-0309142, SZ) for the conduct of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2005, PRENATAL DIAG, V25, P99, DOI 10.1002/pd.1091; Acharya G, 2009, ACTA OBSTET GYN SCAN, V88, P104, DOI 10.1080/00016340802460339; Alkalay AL, 2006, AM J PERINAT, V23, P115, DOI 10.1055/s-2006-931912; [Anonymous], 1987, TROPHOBLAST RES; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Barbera A, 1999, AM J OBSTET GYNECOL, V181, P174, DOI 10.1016/S0002-9378(99)70456-4; Baumann MU, 2007, AM J PHYSIOL-CELL PH, V293, pC477, DOI 10.1152/ajpcell.00075.2007; Bernstein IM, 2002, OBSTET GYNECOL, V99, P620, DOI 10.1016/S0029-7844(01)01787-2; BOZZETTI P, 1988, METABOLISM, V37, P358, DOI 10.1016/0026-0495(88)90136-9; Brahimi-Horn Christiane, 2006, Bull Cancer, V93, pE73; CARTER AM, 1989, J DEV PHYSIOL, V12, P305; Carver TD, 1997, AM J PHYSIOL-ENDOC M, V272, pE107, DOI 10.1152/ajpendo.1997.272.1.E107; Cnattingius S, 1998, BRIT MED J, V316, P1483, DOI 10.1136/bmj.316.7143.1483; DESANTO JT, 1993, EARLY HUM DEV, V33, P1, DOI 10.1016/0378-3782(93)90168-T; ECONOMIDES DL, 1989, AM J OBSTET GYNECOL, V160, P385, DOI 10.1016/0002-9378(89)90453-5; ENGEL PC, 1978, ANAL BIOCHEM, V88, P475, DOI 10.1016/0003-2697(78)90447-5; Esterman A, 1997, PLACENTA, V18, P129, DOI 10.1016/S0143-4004(97)90084-9; Gaither K, 1999, J CLIN ENDOCR METAB, V84, P695, DOI 10.1210/jc.84.2.695; Galan HL, 1999, AM J OBSTET GYNECOL, V181, P1149, DOI 10.1016/S0002-9378(99)70098-0; GILFILLAN CA, 1985, BIOL NEONATE, V47, P141, DOI 10.1159/000242105; Giussani DA, 2007, J PHYSIOL-LONDON, V585, P911, DOI 10.1113/jphysiol.2007.141572; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; GRUPPUSO PA, 1981, BIOL NEONATE, V40, P113, DOI 10.1159/000241479; HACK M, 1993, J PEDIATR-US, V122, P887, DOI 10.1016/S0022-3476(09)90012-9; Hay WW, 2006, J PHYSIOL-LONDON, V572, P17, DOI 10.1113/jphysiol.2006.105072; HUBINONT C, 1991, OBSTET GYNECOL, V77, P541; Jensen GM, 1997, AM J PUBLIC HEALTH, V87, P1003, DOI 10.2105/AJPH.87.6.1003; Kamei Y, 1999, ENDOCRINOLOGY, V140, P4236, DOI 10.1210/en.140.9.4236; KHOUZAMI VA, 1981, AM J OBSTET GYNECOL, V139, P423, DOI 10.1016/0002-9378(81)90319-7; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; KITANAKA T, 1989, AM J PHYSIOL, V256, pR1348, DOI 10.1152/ajpregu.1989.256.6.R1348; KITANAKA T, 1989, AM J PHYSIOL, V256, pR1340, DOI 10.1152/ajpregu.1989.256.6.R1340; Konje JC, 2003, BJOG-INT J OBSTET GY, V110, P301, DOI 10.1016/S1470-0328(02)02963-4; Krampl E, 2001, BRIT J OBSTET GYNAEC, V108, P254, DOI 10.1016/S0306-5456(00)00072-3; Krampl E, 2001, DIABETES CARE, V24, P817, DOI 10.2337/diacare.24.5.817; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Lackman F, 2001, AM J OBSTET GYNECOL, V185, P674, DOI 10.1067/mob.2001.116686; Lackman F, 2001, AM J OBSTET GYNECOL, V184, P946, DOI 10.1067/mob.2001.111719; Limesand SW, 2005, AM J PHYSIOL-REG I, V288, pR1297, DOI 10.1152/ajpregu.00494.2004; LUEDER FL, 1992, PEDIATR RES, V32, P436, DOI 10.1203/00006450-199210000-00013; Marconi AM, 2006, PEDIATR RES, V59, P570, DOI 10.1203/01.pdr.0000205477.70391.3e; Marconi AM, 1996, OBSTET GYNECOL, V87, P937, DOI 10.1016/0029-7844(96)00048-8; MARCONI AM, 1993, METABOLISM, V42, P860, DOI 10.1016/0026-0495(93)90060-2; Mason SD, 2007, AM J PHYSIOL-REG I, V293, pR2059, DOI 10.1152/ajpregu.00335.2007; MCLOUGHLIN P, 1992, J APPL PHYSIOL, V73, P937, DOI 10.1152/jappl.1992.73.3.937; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Mongelli M, 2000, CURR OPIN OBSTET GYN, V12, P111, DOI 10.1097/00001703-200004000-00009; Moore LG, 1998, YEARB PHYS ANTHROPOL, V41, P25; Moore LG, 2004, PLACENTA, V25, pS60, DOI 10.1016/j.placenta.2004.01.008; NICOLINI U, 1989, AM J OBSTET GYNECOL, V161, P924, DOI 10.1016/0002-9378(89)90753-9; PALMER SK, 1992, OBSTET GYNECOL, V80, P1000; Postigo L, 2009, J PHYSIOL-LONDON, V587, P693, DOI 10.1113/jphysiol.2008.163634; Romo Agustin, 2009, Pediatr Endocrinol Rev, V6 Suppl 3, P332; Ronzoni S, 2002, AM J OBSTET GYNECOL, V187, P741, DOI 10.1067/mob.2002.124291; Rosenn B M, 2000, J Matern Fetal Med, V9, P29, DOI 10.1002/(SICI)1520-6661(200001/02)9:1<29::AID-MFM7>3.0.CO;2-Z; Rozance PJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1256, DOI 10.1152/ajpendo.00265.2006; Rozance PJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE404, DOI 10.1152/ajpendo.00643.2005; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Setia S, 2006, PATHOLOGY, V38, P236, DOI 10.1080/00313020600696256; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; SONNENBERG GE, 1982, METABOLISM, V31, P1; SUTTON MS, 1990, PEDIATR RES, V28, P383, DOI 10.1203/00006450-199010000-00016; Takaya J, 2007, PEDIATR RES, V62, P700, DOI 10.1203/PDR.0b013e318157d219; VANASSCHE EA, 1983, AM J OBSTET GYNECOL, V146, P349, DOI 10.1016/0002-9378(83)90775-5; Vardhana PA, 2002, PLACENTA, V23, P653, DOI 10.1053/plac.2002.0857; Wilson MJ, 2007, AM J PHYSIOL-REG I, V293, pR1313, DOI 10.1152/ajpregu.00806.2006; Zamudio S, 2006, PLACENTA, V27, P49, DOI 10.1016/j.placenta.2004.12.010; Zamudio S, 2007, J PHYSIOL-LONDON, V582, P883, DOI 10.1113/jphysiol.2007.130708; Zamudio S, 2007, AM J PATHOL, V170, P2171, DOI 10.2353/ajpath.2007.061185; Zamudio S, 2007, FRONT BIOSCI-LANDMRK, V12, P2967, DOI 10.2741/2286	70	92	96	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8551	10.1371/journal.pone.0008551	http://dx.doi.org/10.1371/journal.pone.0008551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049329	gold, Green Published, Green Submitted			2022-12-25	WOS:000273225000014
J	Lamikanra, AA; Theron, M; Kooij, TWA; Roberts, DJ				Lamikanra, Abigail A.; Theron, Michel; Kooij, Taco W. A.; Roberts, David J.			Hemozoin (Malarial Pigment) Directly Promotes Apoptosis of Erythroid Precursors	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TUMOR-NECROSIS-FACTOR; INFECTED ERYTHROCYTES; BONE-MARROW; TNF-ALPHA; IN-VITRO; CASPASE ACTIVATION; OXIDATIVE STRESS; PROGENITOR CELLS; INEFFECTIVE ERYTHROPOIESIS	Severe malarial anemia is the most common syndrome of severe malaria in endemic areas. The pathophysiology of chronic malaria is characterised by a striking degree of abnormal development of erythroid precursors (dyserythropoiesis) and an inadequate erythropoietic response in spite of elevated levels of erythropoietin. The cause of dyserythropoiesis is unclear although it has been suggested that bone-marrow macrophages release cytokines, chemokines or lipo-peroxides after exposure to hemozoin, a crystalloid form of undigested heme moieties from malarial infected erythrocytes, and so inhibit erythropoiesis. However, we have previously shown that hemozoin may directly inhibit erythroid development in vitro and the levels of hemozoin in plasma from patients with malarial anemia and hemozoin within the bone marrow was associated with reduced reticulocyte response. We hypothesized that macrophages may reduce, not enhance, the inhibitory effect of hemozoin on erythropoiesis. In an in vitro model of erythropoiesis, we now show that inhibition of erythroid cell development by hemozoin isolated from P. falciparum is characterised by delayed expression of the erythroid markers and increased apoptosis of progenitor cells. Crucially, macrophages appear to protect erythroid cells from hemozoin, consistent with a direct contribution of hemozoin to the depression of reticulocyte output from the bone marrow in children with malarial anemia. Moreover, hemozoin isolated from P. falciparum in vitro inhibits erythroid development independently of inflammatory mediators by inducing apoptotic pathways that not only involve activation of caspase 8 and cleavage of caspase 3 but also loss of mitochondrial potential. Taken together these data are consistent with a direct effect of hemozoin in inducing apoptosis in developing erythroid cells in malarial anemia. Accumulation of hemozoin in the bone marrow could therefore result in inadequate reticulocytosis in children that have adequate levels of circulating erythropoietin.	[Lamikanra, Abigail A.; Roberts, David J.] John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Lamikanra, Abigail A.; Roberts, David J.] John Radcliffe Hosp, Natl Blood Serv, Oxford Ctr, Oxford OX3 9DU, England; [Theron, Michel] Wellcome Trust Genome Ctr, Wellcome Trust Sanger Inst, Cambridge, England; [Kooij, Taco W. A.] Max Planck Inst Infect Biol, Dept Parasitol, Berlin, Germany	University of Oxford; University of Oxford; Wellcome Trust Sanger Institute; Max Planck Society	Lamikanra, AA (corresponding author), John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England.	david.roberts@ndcls.ox.ac.uk	Theron, Michel/E-2067-2012; Kooij, Taco W.A./L-5623-2015; Lamikanra, Abigail/AAD-9603-2019	Kooij, Taco W.A./0000-0002-8547-7523; Theron, Michel/0000-0002-5781-1985	NHS Blood and Transplant (NHSBT); Howard Hughes Medical Institute; EU BioMalPar NoE; NHS Research and Development; National Institute for Health Research (NIHR)	NHS Blood and Transplant (NHSBT); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EU BioMalPar NoE; NHS Research and Development; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This work was supported by the NHS Blood and Transplant (NHSBT), the Howard Hughes Medical Institute and the EU BioMalPar NoE. The research benefits from NHS Research and Development funding and the National Institute for Health Research (NIHR) Biomedical Research Centre Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLA S, 1980, BRIT J HAEMATOL, V46, P171, DOI 10.1111/j.1365-2141.1980.tb05956.x; ABDALLA SH, 1984, T ROY SOC TROP MED H, V78, P60, DOI 10.1016/0035-9203(84)90173-1; ABDALLA SH, 1988, CLIN LAB HAEMATOL, V10, P33; Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Akanmori BD, 2000, EUR CYTOKINE NETW, V11, P113; Angus BJ, 1997, BLOOD, V90, P2037, DOI 10.1182/blood.V90.5.2037; Arese P, 1997, ANN TROP MED PARASIT, V91, P501, DOI 10.1080/00034989760879; Awandare GA, 2007, INFECT IMMUN, V75, P201, DOI 10.1128/IAI.01327-06; Baliga B, 2003, CELL DEATH DIFFER, V10, P16, DOI 10.1038/sj.cdd.4401166; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Biemba G, 2000, TROP MED INT HEALTH, V5, P256, DOI 10.1046/j.1365-3156.2000.00545.x; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Casals-Pascual C, 2006, BLOOD; Cashman JD, 1999, BLOOD, V94, P3722, DOI 10.1182/blood.V94.11.3722.423k20_3722_3729; Chang KH, 2004, BLOOD, V103, P3727, DOI 10.1182/blood-2003-08-2887; Claessens YE, 2006, AM J RESP CRIT CARE, V174, P51, DOI 10.1164/rccm.200504-561OC; Claessens YE, 2002, BLOOD, V99, P1594, DOI 10.1182/blood.V99.5.1594; DORMER P, 1983, BLUT, V46, P279, DOI 10.1007/BF00319868; Douki JBL, 2003, BLOOD, V101, P5025, DOI 10.1182/blood-2002-12-3710; Dufour C, 2003, BLOOD, V102, P2053, DOI 10.1182/blood-2003-01-0114; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; Fariss MW, 2001, FREE RADICAL BIO MED, V31, P530, DOI 10.1016/S0891-5849(01)00615-3; FIBACH E, 1989, BLOOD, V73, P100; Giribaldi G, 2004, HAEMATOLOGICA, V89, P492; GOGU SR, 1991, EXP HEMATOL, V19, P649; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Griffiths MJ, 2001, BRIT J HAEMATOL, V113, P486, DOI 10.1046/j.1365-2141.2001.02758.x; Hanscheid T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-109; Hemmer CJ, 2008, CRIT CARE MED, V36, P2562, DOI 10.1097/CCM.0b013e31818441ee; Hristoskova S, 2007, EXP CELL RES, V313, P1024, DOI 10.1016/j.yexcr.2006.12.018; Inger L, 2004, METHODS MALARIA RES; Jaramillo M, 2004, J IMMUNOL, V172, P3101, DOI 10.4049/jimmunol.172.5.3101; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Layez C, 2005, BLOOD, V106, P3632, DOI 10.1182/blood-2005-04-1574; Leimberg JM, 2005, HEMATOLOGY, V10, P73, DOI 10.1080/10245330412331269876; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; MAGGIOPRICE L, 1985, BLOOD, V66, P1080; MAYANI H, 1995, EXP HEMATOL, V23, P422; MAZUR EM, 1986, J INTERFERON RES, V6, P199, DOI 10.1089/jir.1986.6.199; McDevitt Michael A, 2004, Curr Hematol Rep, V3, P97; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Papadaki HA, 2002, BLOOD, V100, P474, DOI 10.1182/blood-2002-01-0136; PHILLIPS RE, 1992, BAILLIERE CLIN HAEM, V5, P315, DOI 10.1016/S0950-3536(11)80022-3; Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992; Pootrakul P, 2000, BLOOD, V96, P2606, DOI 10.1182/blood.V96.7.2606.h8002606_2606_2612; Pope SH, 2000, EUR J HAEMATOL, V64, P292, DOI 10.1034/j.1600-0609.2000.90032.x; Pouvelle B, 2000, NAT MED, V6, P1264, DOI 10.1038/81374; Prato M, 2005, J IMMUNOL, V175, P6436, DOI 10.4049/jimmunol.175.10.6436; Rhodes MM, 2008, BLOOD, V111, P1700, DOI 10.1182/blood-2007-06-098178; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rudin W, 1997, PARASITOLOGY, V115, P467, DOI 10.1017/S0031182097001583; Sathyanarayana P, 2008, BLOOD, V111, P5390, DOI 10.1182/blood-2007-10-119743; SCHOFIELD L, 1993, ANN TROP MED PARASIT, V87, P617, DOI 10.1080/00034983.1993.11812820; Schrier SL, 2002, CURR OPIN HEMATOL, V9, P123, DOI 10.1097/00062752-200203000-00007; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Schwarzer E, 2003, BLOOD, V101, P722, DOI 10.1182/blood-2002-03-0979; SHAFFER N, 1991, J INFECT DIS, V163, P96, DOI 10.1093/infdis/163.1.96; SHERRY BA, 1995, J INFLAMM, V45, P85; Silvestris F, 2002, BLOOD, V99, P1305, DOI 10.1182/blood.V99.4.1305; Skorokhod OA, 2004, J IMMUNOL, V173, P4066, DOI 10.4049/jimmunol.173.6.4066; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Taramelli D, 2000, LAB INVEST, V80, P1781, DOI 10.1038/labinvest.3780189; TARUMI T, 1995, EXP HEMATOL, V23, P1310; Testa U, 2004, LEUKEMIA, V18, P1176, DOI 10.1038/sj.leu.2403383; Toure FS, 2008, PARASITE IMMUNOL, V30, P47; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Urban BC, 2005, INFECT IMMUN, V73, P1986, DOI 10.1128/IAI.73.4.1986-1994.2005; Weatherall David J, 2002, Hematology Am Soc Hematol Educ Program, P35; WEISS L, 1990, IMMUNOL LETT, V25, P165, DOI 10.1016/0165-2478(90)90109-4; Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072; Wilson NO, 2008, MOL BIOCHEM PARASIT, V162, P172, DOI 10.1016/j.molbiopara.2008.09.003; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247	76	59	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8446	10.1371/journal.pone.0008446	http://dx.doi.org/10.1371/journal.pone.0008446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041181	Green Published, Green Submitted, gold			2022-12-25	WOS:000273104000011
J	Napthine, S; Lever, RA; Powell, ML; Jackson, RJ; Brown, TDK; Brierley, I				Napthine, Sawsan; Lever, Robert A.; Powell, Michael L.; Jackson, Richard J.; Brown, T. David K.; Brierley, Ian			Expression of the VP2 Protein of Murine Norovirus by a Translation Termination-Reinitiation Strategy	PLOS ONE			English	Article							MESSENGER-RNA; COUPLED TRANSLATION; MUTATIONAL ANALYSIS; RIBOSOMAL-SUBUNITS; CALICIVIRUS; INITIATION; MIGRATION; COMPONENT; SIGNAL; GENE	Background: Expression of the minor virion structural protein VP2 of the calicivirus murine norovirus (MNV) is believed to occur by the unusual mechanism of termination codon-dependent reinitiation of translation. In this process, following translation of an upstream open reading frame (ORF) and termination at the stop codon, a proportion of 40S subunits remain associated with the mRNA and reinitiate at the AUG of a downstream ORF, which is typically in close proximity. Consistent with this, the VP2 start codon (AUG) of MNV overlaps the stop codon of the upstream VP1 ORF (UAA) in the pentanucleotide UAAUG. Principal Findings: Here, we confirm that MNV VP2 expression is regulated by termination-reinitiation and define the mRNA sequence requirements. Efficient reintiation is dependent upon 43 nt of RNA immediately upstream of the UAAUG site. Chemical and enzymatic probing revealed that the RNA in this region is not highly structured and includes an essential stretch of bases complementary to 18S rRNA helix 26 (Motif 1). The relative position of Motif 1 with respect to the UAAUG site impacts upon the efficiency of the process. Termination-reinitiation in MNV was also found to be relatively insensitive to the initiation inhibitor edeine. Conclusions: The termination-reinitiation signal of MNV most closely resembles that of influenza BM2. Similar to other viruses that use this strategy, base-pairing between mRNA and rRNA is likely to play a role in tethering the 40S subunit to the mRNA following termination at the VP1 stop codon. Our data also indicate that accurate recognition of the VP2 ORF AUG is not a pre-requisite for efficient reinitiation of translation in this system.	[Napthine, Sawsan; Lever, Robert A.; Powell, Michael L.; Brown, T. David K.; Brierley, Ian] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; [Jackson, Richard J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge; University of Cambridge	Napthine, S (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	ib103@mole.bio.cam.ac.uk			Biotechnology and Biological Sciences Research Council UK [RG41021]; BBSRC [BB/D008190/1, BB/C007034/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C007034/1, BB/D008190/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council UK (www.bbsrc.ac.uk), grant number RG41021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian G, 2000, EMBO J, V19, P2681, DOI 10.1093/emboj/19.11.2681; Bertram G, 2001, MICROBIOL-SGM, V147, P255, DOI 10.1099/00221287-147-2-255; BRIERLEY I, 1991, J MOL BIOL, V220, P889, DOI 10.1016/0022-2836(91)90361-9; BRIERLEY I, 1992, J MOL BIOL, V227, P463, DOI 10.1016/0022-2836(92)90901-U; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Giedroc DP, 2009, VIRUS RES, V139, P193, DOI 10.1016/j.virusres.2008.06.008; Girnary R, 2007, J GEN VIROL, V88, P226, DOI 10.1099/vir.0.82064-0; Gould PS, 2007, J VIROL, V81, P8488, DOI 10.1128/JVI.00457-07; Gould PS, 2005, J BIOL CHEM, V280, P21972, DOI 10.1074/jbc.M502276200; Grentzmann G, 1998, RNA, V4, P479; HORVATH CM, 1990, EMBO J, V9, P2639, DOI 10.1002/j.1460-2075.1990.tb07446.x; KOZAK M, 1978, J BIOL CHEM, V253, P6568; KOZAK M, 1979, J BIOL CHEM, V254, P4731; KOZAK M, 1983, CELL, V34, P971, DOI 10.1016/0092-8674(83)90554-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luttermann C, 2007, J BIOL CHEM, V282, P7056, DOI 10.1074/jbc.M608948200; Luttermann C, 2009, GENE DEV, V23, P331, DOI 10.1101/gad.507609; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Manktelow E, 2005, NUCLEIC ACIDS RES, V33, P1553, DOI 10.1093/nar/gki299; Meyers G, 2003, J BIOL CHEM, V278, P34051, DOI 10.1074/jbc.M304874200; Meyers G, 2007, J VIROL, V81, P9623, DOI 10.1128/JVI.00771-07; PASSMORE LA, 2007, MOL CELL, P2641; PAVLAKIS G N, 1990, New Biologist, V2, P20; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Powell ML, 2008, RNA, V14, P2394, DOI 10.1261/rna.1231008; Powell ML, 2008, BIOCHEM SOC T, V36, P717, DOI 10.1042/BST0360717; Poyry TAA, 2007, GENE DEV, V21, P3149, DOI 10.1101/gad.439507; SZABO G, 1994, MOL CELL BIOL, V14, P7535, DOI 10.1128/MCB.14.11.7535; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x	33	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8390	10.1371/journal.pone.0008390	http://dx.doi.org/10.1371/journal.pone.0008390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027307	Green Submitted, Green Published, gold			2022-12-25	WOS:000272998000003
J	Bhattacharya, S; Dai, ZP; Li, JQ; Baxter, S; Callaway, DJE; Cowburn, D; Bu, ZM				Bhattacharya, Shibani; Dai, Zhongping; Li, Jianquan; Baxter, Sabine; Callaway, David J. E.; Cowburn, David; Bu, Zimei			A Conformational Switch in the Scaffolding Protein NHERF1 Controls Autoinhibition and Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGER REGULATORY FACTOR; TORSION ANGLE DYNAMICS; X-RAY-SCATTERING; PDZ-DOMAIN; PHOSPHATE-TRANSPORT; PARATHYROID-HORMONE; ADAPTER PROTEINS; TERMINAL DOMAIN; EZRIN; NMR	The mammalian Na+/H+ exchange regulatory factor 1 (NHERF1) is a multidomain scaffolding protein essential for regulating the intracellular trafficking and macromolecular assembly of transmembrane ion channels and receptors. NHERF1 consists of tandem PDZ-1, PDZ-2 domains that interact with the cytoplasmic domains of membrane proteins and a C-terminal (CT) domain that binds the membrane-cytoskeleton linker protein ezrin. NHERF1 is held in an autoinhibited state through intramolecular interactions between PDZ2 and the CT domain that also includes a C-terminal PDZ-binding motif (-SNL). We have determined the structures of the isolated and tandem PDZ2CT domains by high resolution NMR using small angle x-ray scattering as constraints. The PDZ2CT structure shows weak intramolecular interactions between the largely disordered CT domain and the PDZ ligand binding site. The structure reveals a novel helix-turn-helix subdomain that is allosterically coupled to the putative PDZ2 domain by a network of hydrophobic interactions. This helical subdomain increases both the stability and the binding affinity of the extended PDZ structure. Using NMR and small angle neutron scattering for joint structure refinement, we demonstrate the release of intramolecular domain-domain interactions in PDZ2CT upon binding to ezrin. Based on the structural information, we show that human disease-causing mutations in PDZ2, R153Q and E225K, have significantly reduced protein stability. Loss of NHERF1 expressed in cells could result in failure to assemble membrane complexes that are important for normal physiological functions.	[Bhattacharya, Shibani; Cowburn, David] New York Struct Biol Ctr, New York, NY 10031 USA; [Callaway, David J. E.] NYU, Sch Med, New York, NY 10016 USA; [Dai, Zhongping; Li, Jianquan; Baxter, Sabine; Bu, Zimei] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Bu, Zimei] CUNY City Coll, Dept Chem, New York, NY 10031 USA	New York University; Fox Chase Cancer Center; City University of New York (CUNY) System; City College of New York (CUNY)	Callaway, DJE (corresponding author), NYU, Sch Med, New York, NY 10016 USA.	david.callaway@nyu.edu; cowburn@nysbc.org; zimei.bu@fccc.edu	Cowburn, David/A-8448-2008	Cowburn, David/0000-0001-6770-7172	National Institutes of Health [R01 HL086496, R01 GM047021, GM-66354]; W. W. Smith Charitable Trust; Keck Foundation; New York Structural Biology Center; National Science Foundation [DMR-0454672]; National Institute of Standards and Technology, United States Department of Commerce; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047021, P41GM066354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. W. Smith Charitable Trust; Keck Foundation(W.M. Keck Foundation); New York Structural Biology Center; National Science Foundation(National Science Foundation (NSF)); National Institute of Standards and Technology, United States Department of Commerce(National Institute of Standards & Technology (NIST) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL086496 (to Z.B.), R01 GM047021 (to D. C.). This work was also supported by a grant from the W. W. Smith Charitable Trust (to Z.B.). The 900-MHz NMR system was purchased with funds from National Institutes of Health Grant GM-66354, the Keck Foundation, and the member institutions of the New York Structural Biology Center.; This work utilized facilities supported in part by the National Science Foundation under Agreement DMR-0454672. We acknowledge the support of the National Institute of Standards and Technology, United States Department of Commerce, in providing the neutron research facilities used in this work.	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Brenman JE, 1996, J NEUROSCI, V16, P7407; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bu ZM, 2005, P NATL ACAD SCI USA, V102, P17646, DOI 10.1073/pnas.0503388102; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; CAVANAGH J, 1996, PROTEIN NMR SPECTROS, P411; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Cheng H, 2009, STRUCTURE, V17, P660, DOI 10.1016/j.str.2009.03.009; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Finnerty CM, 2004, J CELL SCI, V117, P1547, DOI 10.1242/jcs.01038; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Grishaev A, 2005, J AM CHEM SOC, V127, P16621, DOI 10.1021/ja054342m; Grishaev A, 2008, J BIOMOL NMR, V40, P95, DOI 10.1007/s10858-007-9211-5; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J MOL BIOL, V308, P963, DOI 10.1006/jmbi.2001.4634; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller R., 2004, THESIS SWISS FEDERAL; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kwon SH, 2007, CELL PHYSIOL BIOCHEM, V20, P763, DOI 10.1159/000110436; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee D, 2007, J MOL BIOL, V367, P1007, DOI 10.1016/j.jmb.2007.01.013; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li JQ, 2009, J MOL BIOL, V392, P166, DOI 10.1016/j.jmb.2009.07.005; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lynn GW, 2005, BIOCHEMISTRY-US, V44, P565, DOI 10.1021/bi048347s; Mahon MJ, 2008, AM J PHYSIOL-RENAL, V294, pF667, DOI 10.1152/ajprenal.00276.2007; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mattinen ML, 2002, BIOPHYS J, V83, P1177, DOI 10.1016/S0006-3495(02)75241-7; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Stiffler MA, 2006, J AM CHEM SOC, V128, P5913, DOI 10.1021/ja060943h; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Thelin WR, 2005, J PHYSIOL-LONDON, V567, P13, DOI 10.1113/jphysiol.2005.091041; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050	69	44	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9981	9994		10.1074/jbc.M109.074005	http://dx.doi.org/10.1074/jbc.M109.074005			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20042604	hybrid, Green Published			2022-12-25	WOS:000276165900067
J	Ibanez de Caceres, I; Cortes-Sempere, M; Moratilla, C; Machado-Pinilla, R; Rodriguez-Fanjul, V; Manguan-Garcia, C; Cejas, P; Lopez-Rios, F; Paz-Ares, L; de CastroCarpeno, J; Nistal, M; Belda-Iniesta, C; Perona, R				Ibanez de Caceres, I.; Cortes-Sempere, M.; Moratilla, C.; Machado-Pinilla, R.; Rodriguez-Fanjul, V.; Manguan-Garcia, C.; Cejas, P.; Lopez-Rios, F.; Paz-Ares, L.; de CastroCarpeno, J.; Nistal, M.; Belda-Iniesta, C.; Perona, R.			IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer	ONCOGENE			English	Article						CDDP-resistance; IGFBP-3; NSCLC; hypermethylation	INDUCED DNA HYPERMETHYLATION; EPITHELIAL OVARIAN-CANCER; DRUG-RESISTANCE; BINDING PROTEIN-3; PROMOTER HYPERMETHYLATION; ACQUIRED-RESISTANCE; CPG ISLAND; METHYLATION; GROWTH; GENE	Cisplatin-based chemotherapy is the paradigm of non-small-cell lung cancer (NSCLC) treatment; however, it also induces de novo DNA-hypermethylation, a process that may be involved in the development of drug-resistant phenotypes by inactivating genes required for drug-cytotoxicity. By using an expression microarray analysis, we aimed to identify those genes reactivated in a set of two cisplatin (CDDP) resistant and sensitive NSCLC cell lines after epigenetic treatment. Gene expression, promoter methylation and CDDP-chemoresponse were further analyzed in three matched sets of sensitive/resistant cell lines, 23 human cancer cell lines and 36 NSCLC specimens. Results revealed specific silencing by promoter hypermethylation of IGFBP-3 in CDDP resistant cells, whereas IGFBP-3 siRNA interference, induced resistance to CDDP in sensitive cells (P<0.001). In addition, we found a strong correlation between methylation status and CDDP response in tumor specimens (P<0.001). Thus, stage I patients, whose tumors harbor an unmethylated promoter, had a trend towards increased disease-free survival (DFS). We report that a loss of IGFBP-3 expression, mediated by promoter-hypermethylation, results in a reduction of tumor cell sensitivity to cisplatin in NSCLC. Basal methylation status of IGFBP-3 before treatment may be a clinical biomarker and a predictor of the chemotherapy outcome, helping to identify patients who are most likely to benefit from CDDP therapy alone or in combination with epigenetic treatment. Oncogene (2010) 29, 1681-1690; doi:10.1038/onc.2009.454; published online 21 December 2009	[Ibanez de Caceres, I.] FIB La Paz Univ Hosp, Oncol Res Lab, Inst Invest Biomed Madrid, Res Unit, Madrid 28029, Spain; [Cortes-Sempere, M.; Moratilla, C.; Machado-Pinilla, R.; Rodriguez-Fanjul, V.; Manguan-Garcia, C.; Perona, R.] UAM, Translat Oncol Unit, CSIC H La Paz, Inst Invest Biomed CSIC, Madrid, Spain; [Cejas, P.; de CastroCarpeno, J.; Belda-Iniesta, C.] La Paz Univ Hosp, Translat Oncol Unit, CSIC H La Paz, Dept Med Oncol, Madrid, Spain; [Lopez-Rios, F.] Hosp 12 Octubre, Dept Pathol, E-28041 Madrid, Spain; [Paz-Ares, L.] Hosp 12 Octubre, Dept Med Oncol, E-28041 Madrid, Spain; [Nistal, M.] La Paz Univ Hosp, Dept Pathol, Madrid, Spain	Autonomous University of Madrid; Hospital Universitario La Paz; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Hospital Universitario La Paz	Ibanez de Caceres, I (corresponding author), FIB La Paz Univ Hosp, Oncol Res Lab, Inst Invest Biomed Madrid, Res Unit, C Arturo Duperier 4, Madrid 28029, Spain.	inma.ibanezca@salud.madrid.org	Fanjul, Vanessa VRF Rodriguez/K-8417-2017; Rodríguez, Ferran A. A/H-4892-2011; Paz-Ares, Luis/AAH-2750-2019	Fanjul, Vanessa VRF Rodriguez/0000-0002-3386-5874; Rodríguez, Ferran A. A/0000-0002-2280-8962; Belda Iniesta, Cristobal/0000-0003-3254-7492	Fondo de Investigacion Sanitaria (ISCIII) [CP08/000689; PI-717, PI06-1234, PI08-1485, PS09/00472]; Fundacion Medica Mutua Madrilena	Fondo de Investigacion Sanitaria (ISCIII)(Instituto de Salud Carlos III); Fundacion Medica Mutua Madrilena(Instituto de Salud Carlos III)	We gratefully acknowledge Javier Perez for the artwork and to J Siegfried, for the English correction of the manuscript. Ibanez de Caceres was partially supported by the Fondo de Investigacion Sanitaria (ISCIII) through the 'Miguel Servet' program (CP08/000689; PI-717). Note: Supported by FIS PI06-1234, PI08-1485, PS09/00472 and Fundacion Medica Mutua Madrilena.	Baker EK, 2005, ONCOGENE, V24, P8061, DOI 10.1038/sj.onc.1208955; Baylin SB, 1998, ADV CANCER RES, V72, P141; Belinsky SA, 2003, CANCER RES, V63, P7089; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Carvalho AL, 2008, CLIN CANCER RES, V14, P97, DOI 10.1158/1078-0432.CCR-07-0722; Chang YS, 2002, CLIN CANCER RES, V8, P3669; Chang YS, 2002, CLIN CANCER RES, V8, P3796; Chattopadhyay S, 2006, ONCOGENE, V25, P3335, DOI 10.1038/sj.onc.1209364; Esteller M, 1999, CANCER RES, V59, P793; Gosepath EM, 2008, INT J CANCER, V123, P2013, DOI 10.1002/ijc.23721; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Katsaros D, 2004, GYNECOL ONCOL, V94, P685, DOI 10.1016/j.ygyno.2004.06.018; Koul S, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-16; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Leyland-Jones B, 1999, AM J PATHOL, V155, P77, DOI 10.1016/S0002-9440(10)65102-4; Makarla PB, 2005, CLIN CANCER RES, V11, P5365, DOI 10.1158/1078-0432.CCR-04-2455; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; MCKEAGE MJ, 1995, DRUG SAFETY, V13, P228, DOI 10.2165/00002018-199513040-00003; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Morris MR, 2008, BRIT J CANCER, V98, P496, DOI 10.1038/sj.bjc.6604180; NYCE J, 1989, CANCER RES, V49, P5829; Nyce JW, 1997, MUTAT RES-REV MUTAT, V386, P153, DOI 10.1016/S1383-5742(96)00051-8; Perry AS, 2007, BRIT J CANCER, V96, P1587, DOI 10.1038/sj.bjc.6603767; Plasencia C, 2006, INT J ONCOL, V29, P225; Plumb JA, 2000, CANCER RES, V60, P6039; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; Riedel RF, 2008, MOL CANCER THER, V7, P3141, DOI 10.1158/1535-7163.MCT-08-0642; Roninson IB, 2003, CANCER RES, V63, P2705; Shen DW, 2004, BRIT J CANCER, V91, P270, DOI 10.1038/sj.bjc.6601956; Steele N, 2009, BRIT J CANCER, V100, P758, DOI 10.1038/sj.bjc.6604932; Strathdee G, 1999, ONCOGENE, V18, P2335, DOI 10.1038/sj.onc.1202540; Wiley A, 2006, INT J GYNECOL CANCER, V16, P210, DOI 10.1111/j.1525-1438.2006.00299.x; Yoon JH, 2001, INT J CANCER, V94, P212, DOI 10.1002/ijc.1466; Zhang PL, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-14; Zochbauer-Muller S, 2001, CANCER RES, V61, P249; 2003, CENT EUR J PUBLIC HL, V11, P177	43	89	92	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2010	29	11					1681	1690		10.1038/onc.2009.454	http://dx.doi.org/10.1038/onc.2009.454			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	570RC	20023704				2022-12-25	WOS:000275694700013
J	Gantt, SL; Joseph, CG; Fierke, CA				Gantt, Stephanie L.; Joseph, Caleb G.; Fierke, Carol A.			Activation and Inhibition of Histone Deacetylase 8 by Monovalent Cations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; HUMAN HDAC8; BINDING; NA+; SUBSTRATE; ENZYME; CELLS; SITE; POTASSIUM; INSIGHTS	The metal-dependent histone deacetylases (HDACs) catalyze hydrolysis of acetyl groups from acetyllysine side chains and are targets of cancer therapeutics. Two bound monovalent cations (MVCs) of unknown function have been previously observed in crystal structures of HDAC8; site 1 is near the active site, whereas site 2 is located > 20 angstrom from the catalytic metal ion. Here we demonstrate that one bound MVC activates catalytic activity (K-1/2 = 3.4 mM for K+), whereas the second, weakerbinding MVC (K-1/2 = 26 mM for K+) decreases catalytic activity by 11-fold. The weaker binding MVC also enhances the affinity of the HDAC inhibitor suberoylanilide hydroxamic acid by 5-fold. The site 1 MVC is coordinated by the side chain of Asp-176 that also forms a hydrogen bond with His-142, one of two histidines important for catalytic activity. The D176A and H142A mutants each increase the K-1/2 for potassium inhibition by >= 40-fold, demonstrating that the inhibitory cation binds to site 1. Furthermore, the MVC inhibition is mediated by His-142, suggesting that this residue is protonated for maximal HDAC8 activity. Therefore, His-142 functions either as an electrostatic catalyst or a general acid. The activating MVC binds in the distal site and causes a time-dependent increase in activity, suggesting that the site 2 MVC stabilizes an active conformation of the enzyme. Sodium binds more weakly to both sites and activates HDAC8 to a lesser extent than potassium. Therefore, it is likely that potassium is the predominant MVC bound to HDAC8 in vivo.	Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Joseph, Caleb G.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Fierke, Carol A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fierke, CA (corresponding author), 930 N Univ Ave, Ann Arbor, MI 48109 USA.	fierke@umich.edu			National Institutes of Health [GM40602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM040602, R01GM040602, T32GM008597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM40602 (to C.A.F.).	Andi B, 2005, J BIOL CHEM, V280, P31624, DOI 10.1074/jbc.M502846200; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; BORIN ML, 1993, AM J PHYSIOL, V264, pC1513, DOI 10.1152/ajpcell.1993.264.6.C1513; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Di Cera E, 2006, J BIOL CHEM, V281, P1305, DOI 10.1074/jbc.R500023200; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Hayashi H, 2002, J BIOL CHEM, V277, P11090, DOI 10.1074/jbc.M111868200; Hernick M, 2005, ARCH BIOCHEM BIOPHYS, V433, P71, DOI 10.1016/j.abb.2004.08.006; Holyoak T, 2004, BIOCHEMISTRY-US, V43, P2412, DOI 10.1021/bi035849h; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Hughes FM, 1999, ADV ENZYME REGUL, V39, P157, DOI 10.1016/S0065-2571(98)00010-7; KASNER SE, 1992, AM J PHYSIOL, V262, pF462, DOI 10.1152/ajprenal.1992.262.3.F462; Kern S, 2007, FEBS J, V274, P3578, DOI 10.1111/j.1742-4658.2007.05887.x; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Nielsen TK, 2005, J MOL BIOL, V354, P107, DOI 10.1016/j.jmb.2005.09.065; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Paris M, 2008, J MED CHEM, V51, P1505, DOI 10.1021/jm7011408; Sanghamitra NJM, 2008, BIOCHEMISTRY-US, V47, P1309, DOI 10.1021/bi701783x; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Waltregny D, 2004, AM J PATHOL, V165, P553, DOI 10.1016/S0002-9440(10)63320-2; Wedel T, 2006, NEUROGASTROENT MOTIL, V18, P526, DOI 10.1111/j.1365-2982.2006.00781.x; WOEHL EU, 1995, COORDIN CHEM REV, V144, P147, DOI 10.1016/0010-8545(94)08001-8	32	60	61	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6036	6043		10.1074/jbc.M109.033399	http://dx.doi.org/10.1074/jbc.M109.033399			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20029090	hybrid, Green Published			2022-12-25	WOS:000275367500006
J	LeShane, ES; Shinde, U; Walker, JM; Barry, AN; Blackburn, NJ; Ralle, M; Lutsenko, S				LeShane, Erik S.; Shinde, Ujwal; Walker, Joel M.; Barry, Amanda N.; Blackburn, Ninian J.; Ralle, Martina; Lutsenko, Svetlana			Interactions between Copper-binding Sites Determine the Redox Status and Conformation of the Regulatory N-terminal Domain of ATP7B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSON-DISEASE PROTEIN; MENKES-DISEASE; DEPENDENT INTERACTION; SUPEROXIDE-DISMUTASE; TRANSPORTING ATPASE; CATALYTIC-ACTIVITY; CU(I) BINDING; CHAPERONE; DYNAMICS; ATOX1	Copper-transporting ATPase ATP7B is essential for human copper homeostasis and normal liver function. ATP7B has six N-terminal metal-binding domains (MBDs) that sense cytosolic copper levels and regulate ATP7B. The mechanism of copper sensing and signal integration from multiple MBDs is poorly understood. We show that MBDs communicate and that this communication determines the oxidation state and conformation of the entire N-terminal domain of ATP7B (N-ATP7B). Mutations of copper-coordinating Cys to Ala in any MBD (2, 3, 4, or 6) change the N-ATP7B conformation and have distinct functional consequences. Mutating MBD2 or MBD3 causes Cys oxidation in other MBDs and loss of copper binding. In contrast, mutation of MBD4 and MBD6 does not alter the redox status and function of other sites. Our results suggest that MBD2 and MBD3 work together to regulate access to other metal-binding sites, whereas MBD4 and MBD6 receive copper independently, downstream of MBD2 and MBD3. Unlike Ala substitutions, the Cys-to-Ser mutation in MBD2 preserves the conformation and reduced state of N-ATP7B, suggesting that hydrogen bonds contribute to interdomain communications. Tight coupling between MBDs suggests a mechanism by which small changes in individual sites (induced by copper binding or mutation) result in stabilization of distinct conformations of the entire N-ATP7B and altered exposure of sites for interactions with regulatory proteins.	[Barry, Amanda N.; Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA; [LeShane, Erik S.; Shinde, Ujwal; Walker, Joel M.; Ralle, Martina; Lutsenko, Svetlana] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Blackburn, Ninian J.] Oregon Hlth & Sci Univ, Dept Sci & Engn, Portland, OR 97239 USA	Johns Hopkins University; Oregon Health & Science University; Oregon Health & Science University	Lutsenko, S (corresponding author), Johns Hopkins Univ, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	lutsenko@jhmi.edu	Ralle, Martina/H-2936-2019	Barry, Amanda/0000-0002-7992-0322	National Institutes of Health [R01 DK071865, 5-T32-HL007781]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 DK071865 (to S. L.) and Training Grant 5-T32-HL007781 (to E. S. L.).	Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Banci L, 2005, J MOL BIOL, V352, P409, DOI 10.1016/j.jmb.2005.07.034; Banci L, 2005, FEBS J, V272, P865, DOI 10.1111/j.1742-4658.2004.04526.x; Banci L, 2004, BIOCHEMISTRY-US, V43, P3396, DOI 10.1021/bi036042s; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Banci L, 2006, J BIOL CHEM, V281, P29141, DOI 10.1074/jbc.M603176200; Barry AN, 2008, BIOCHEMISTRY-US, V47, P4916, DOI 10.1021/bi8001049; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Bertini I, 2008, CELL MOL LIFE SCI, V65, P89, DOI 10.1007/s00018-007-7439-6; DeSilva TM, 2005, PROTEINS, V61, P1038, DOI 10.1002/prot.20639; DiDonato M, 2000, BIOCHEMISTRY-US, V39, P1890, DOI 10.1021/bi992222j; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Lim CM, 2006, BIOCHEM BIOPH RES CO, V348, P428, DOI 10.1016/j.bbrc.2006.07.067; Lim CM, 2006, J BIOL CHEM, V281, P14006, DOI 10.1074/jbc.M512745200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; Pilankatta R, 2009, J BIOL CHEM, V284, P21307, DOI 10.1074/jbc.M109.023341; Ralle M, 2004, J INORG BIOCHEM, V98, P765, DOI 10.1016/j.jinorgbio.2004.02.009; Rodriguez-Granillo A, 2008, J PHYS CHEM B, V112, P4583, DOI 10.1021/jp711787x; Rodriguez-Granillo A, 2009, BIOCHEMISTRY-US, V48, P5849, DOI 10.1021/bi900235g; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Subbian E, 2004, BIOCHEMISTRY-US, V43, P14348, DOI 10.1021/bi048397x; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Walker JM, 2004, J BIOL CHEM, V279, P15376, DOI 10.1074/jbc.M400053200; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200	30	33	34	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6327	6336		10.1074/jbc.M109.074633	http://dx.doi.org/10.1074/jbc.M109.074633			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032459	hybrid, Green Published			2022-12-25	WOS:000275367500037
J	Catalano, S; Malivindi, R; Giordano, C; Gu, GW; Panza, S; Bonofiglio, D; Lanzino, M; Sisci, D; Panno, ML; Ando, S				Catalano, Stefania; Malivindi, Rocco; Giordano, Cinzia; Gu, Guowei; Panza, Salvatore; Bonofiglio, Daniela; Lanzino, Marilena; Sisci, Diego; Panno, Maria Luisa; Ando, Sebastiano			Farnesoid X Receptor, through the Binding with Steroidogenic Factor 1-responsive Element, Inhibits Aromatase Expression in Tumor Leydig Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID RECEPTOR; NUCLEAR RECEPTOR; BREAST-CANCER; TESTICULAR AROMATASE; HETERODIMER PARTNER; RESPONSE ELEMENT; GENE-EXPRESSION; RAT TESTIS; FACTOR-I; FXR	The farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily that regulates bile acid homeostasis. It is expressed in the liver and the gastrointestinal tract, but also in several non-enterohepatic tissues including testis. Recently, FXR was identified as a negative modulator of the androgen-estrogen-converting aromatase enzyme in human breast cancer cells. In the present study we detected the expression of FXR in Leydig normal and tumor cell lines and in rat testes tissue. We found, in rat Leydig tumor cells, R2C, that FXR activation by the primary bile acid chenodeoxycholic acid (CDCA) or a synthetic agonist GW4064, through a SHP-independent mechanism, down-regulates aromatase expression in terms of mRNA, protein levels, and its enzymatic activity. Transient transfection experiments, using vector containing rat aromatase promoter PII, evidenced that CDCA reduces basal aromatase promoter activity. Mutagenesis studies, electrophoretic mobility shift, and chromatin immunoprecipitation analysis reveal that FXR is able to compete with steroidogenic factor 1 in binding to a common sequence present in the aromatase promoter region interfering negatively with its activity. Finally, the FXR-mediated anti-proliferative effects exerted by CDCA on tumor Leydig cells are at least in part due to an inhibition of estrogen-dependent cell growth. In conclusion our findings identify for the first time the activators of FXR as negative modulators of the aromatase enzyme in Leydig tumor cell lines.	[Giordano, Cinzia; Ando, Sebastiano] Univ Calabria, Ctr Sanitario, I-87030 Arcavacata Di Rende, CS, Italy; [Catalano, Stefania; Malivindi, Rocco; Giordano, Cinzia; Gu, Guowei; Panza, Salvatore; Bonofiglio, Daniela; Lanzino, Marilena; Sisci, Diego] Univ Calabria, Dept Pharmacobiol, I-87030 Arcavacata Di Rende, CS, Italy; [Panno, Maria Luisa; Ando, Sebastiano] Univ Calabria, Dept Cell Biol, I-87030 Arcavacata Di Rende, CS, Italy	University of Calabria; University of Calabria; University of Calabria	Ando, S (corresponding author), Univ Calabria, Ctr Sanitario, I-87030 Arcavacata Di Rende, CS, Italy.	sebastiano.ando@unical.it	Bonofiglio, Daniela/AAV-8371-2020; Malivindi, Rocco/ABB-8562-2021; /AAD-9701-2019	/0000-0001-6577-1541; CATALANO, Stefania/0000-0002-6352-9628; MALIVINDI, Rocco/0000-0002-8313-2492; BONOFIGLIO, Daniela/0000-0002-4142-0496; GIORDANO, Cinzia/0000-0003-4969-0607; Lanzino, Marilena/0000-0002-6362-5396	PRIN-MIUR (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale-Ministero dell'Istruzione dell'Universita della Ricerca); Associazione Italiana per la Ricerca sul Cancro (AIRC)	PRIN-MIUR (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale-Ministero dell'Istruzione dell'Universita della Ricerca)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by PRIN-MIUR (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale-Ministero dell'Istruzione dell'Universita della Ricerca) and Associazione Italiana per la Ricerca sul Cancro (AIRC).	Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Aquila S, 2003, HUM REPROD, V18, P1650, DOI 10.1093/humrep/deg340; Bosland M C, 1996, Prog Clin Biol Res, V394, P309; Carlone DL, 1997, MOL ENDOCRINOL, V11, P292, DOI 10.1210/me.11.3.292; Carpino A, 2007, EUR J ENDOCRINOL, V157, P239, DOI 10.1530/EJE-07-0029; CARROLL PR, 1987, J UROLOGY, V137, P420, DOI 10.1016/S0022-5347(17)44054-7; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Claudel T, 2002, J CLIN INVEST, V109, P961; Clyne CD, 2002, J BIOL CHEM, V277, P20591, DOI 10.1074/jbc.M201117200; COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258; FITZPATRICK SL, 1994, MOL ENDOCRINOL, V8, P1309, DOI 10.1210/me.8.10.1309; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Fowler KA, 2000, AM J PATHOL, V156, P347, DOI 10.1016/S0002-9440(10)64736-0; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hanley NA, 2001, MOL ENDOCRINOL, V15, P57, DOI 10.1210/me.15.1.57; Hawkins C, 1996, Oncol Nurs Forum, V23, P1203; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; INKSTER S, 1995, J CLIN ENDOCR METAB, V80, P1941, DOI 10.1210/jc.80.6.1941; JACOBS BB, 1967, J NATL CANCER I, V39, P303; Journe F, 2008, BREAST CANCER RES TR, V107, P49, DOI 10.1007/s10549-007-9535-6; Jung D, 2007, J LIPID RES, V48, P2693, DOI 10.1194/jlr.M700351-JLR200; Kaeding J, 2008, BIOCHEM J, V410, P245, DOI 10.1042/BJ20071136; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kocarek TA, 2002, J PHARMACOL TOXICOL, V47, P177, DOI 10.1016/S1056-8719(03)00002-9; Kovacic A, 2004, MOL ENDOCRINOL, V18, P252, DOI 10.1210/me.2003-0211; Laffitte BA, 2000, J BIOL CHEM, V275, P10638, DOI 10.1074/jbc.275.14.10638; Lanzino M, 2001, BIOL REPROD, V64, P1439, DOI 10.1095/biolreprod64.5.1439; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; LEPHART ED, 1991, METHOD ENZYMOL, V206, P477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Miyata M, 2006, DRUG METAB PHARMACOK, V21, P315, DOI 10.2133/dmpk.21.315; Modica S, 2006, FEBS LETT, V580, P5492, DOI 10.1016/j.febslet.2006.07.082; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Nguyen A, 2008, CELL SIGNAL, V20, P2180, DOI 10.1016/j.cellsig.2008.06.014; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pezzi V, 2004, ENDOCRINOLOGY, V145, P2186, DOI 10.1210/en.2003-1366; Pircher PC, 2003, J BIOL CHEM, V278, P27703, DOI 10.1074/jbc.M302128200; Seel WG, 1998, MOL ENDOCRINOL, V12, P1551, DOI 10.1210/mend.12.10.0184; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Sirianni R, 2007, CANCER RES, V67, P8368, DOI 10.1158/0008-5472.CAN-06-4064; Sugawara T, 1996, BIOCHEMISTRY-US, V35, P9052, DOI 10.1021/bi960057r; Swales KE, 2006, CANCER RES, V66, P10120, DOI 10.1158/0008-5472.CAN-06-2399; Volle DH, 2007, GENE DEV, V21, P303, DOI 10.1101/gad.409307; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Young M, 1998, ENDOCRINOLOGY, V139, P5082, DOI 10.1210/en.139.12.5082; Young M, 1997, J STEROID BIOCHEM, V63, P37, DOI 10.1016/S0960-0760(97)00069-1; Zhou J, 2005, CANCER RES, V65, P657	49	51	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5581	5593		10.1074/jbc.M109.052670	http://dx.doi.org/10.1074/jbc.M109.052670			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20026603	Green Published, hybrid			2022-12-25	WOS:000275327200050
J	Santilli, G; Lamorte, G; Carlessi, L; Ferrari, D; Nodari, LR; Binda, E; Delia, D; Vescovi, AL; De Filippis, L				Santilli, Guido; Lamorte, Giuseppe; Carlessi, Luigi; Ferrari, Daniela; Nodari, Laura Rota; Binda, Elena; Delia, Domenico; Vescovi, Angelo L.; De Filippis, Lidia			Mild Hypoxia Enhances Proliferation and Multipotency of Human Neural Stem Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; HUMAN CNS; IN-VITRO; DOPAMINERGIC DIFFERENTIATION; PRECURSOR CELLS; OXYGEN-TENSION; HIF-1; PATHOPHYSIOLOGY	Background: Neural stem cells (NSCs) represent an optimal tool for studies and therapy of neurodegenerative diseases. We recently established a v-myc immortalized human NSC (IhNSC) line, which retains stem properties comparable to parental cells. Oxygen concentration is one of the most crucial environmental conditions for cell proliferation and differentiation both in vitro and in vivo. In the central nervous system, physiological concentrations of oxygen range from 0.55 to 8% oxygen. In particular, in the in the subventricular zone niche area, it's estimated to be 2.5 to 3%. Methodology/Principal Findings: We investigated in vitro the effects of 1, 2.5, 5, and 20% oxygen concentrations on IhNSCs both during proliferation and differentiation. The highest proliferation rate, evaluated through neurosphere formation assay, was obtained at 2.5 and 5% oxygen, while 1% oxygen was most noxious for cell survival. The differentiation assays showed that the percentages of beta-tubIII+ or MAP2+ neuronal cells and of GalC+ oligodendrocytes were significantly higher at 2.5% compared with 1, 5, or 20% oxygen at 17 days in vitro. Mild hypoxia (2.5 to 5% oxygen) promoted differentiation into neuro-oligodendroglial progenitors as revealed by the higher percentage of MAP2+/Ki67+ and GalC+/Ki67+ residual proliferating progenitors, and enhanced the yield of GABAergic and slightly of glutamatergic neurons compared to 1% and 20% oxygen where a significant percentage of GFAP+/nestin+ cells were still present at 17 days of differentiation. Conclusions/Significance: These findings raise the possibility that reduced oxygen levels occurring in neuronal disorders like cerebral ischemia transiently lead to NSC remaining in a state of quiescence. Conversely, mild hypoxia favors NSC proliferation and neuronal and oligodendroglial differentiation, thus providing an important advance and a useful tool for NSC-mediated therapy of ischemic stroke and neurodegenerative diseases like Parkinson's disease, multiple sclerosis, and Alzheimer's disease.	[Santilli, Guido; Lamorte, Giuseppe; Ferrari, Daniela; Nodari, Laura Rota; Binda, Elena; Vescovi, Angelo L.; De Filippis, Lidia] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Carlessi, Luigi; Delia, Domenico] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol, Milan, Italy	University of Milano-Bicocca; Fondazione IRCCS Istituto Nazionale Tumori Milan	Santilli, G (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	vescovi@tin.it; lidia.defilippis@unimib.it	Ferrari, Daniela/AHE-7647-2022; Carlessi, Luigi/D-5802-2017; Vescovi, Angelo Luigi/A-4919-2015; Binda, Elena/B-2650-2017; De Filippis, Lidia/H-3098-2017	Ferrari, Daniela/0000-0001-7251-9854; Carlessi, Luigi/0000-0002-7395-8872; Vescovi, Angelo Luigi/0000-0002-1742-4112; Binda, Elena/0000-0002-8750-2905; Lamorte, Giuseppe/0000-0001-9377-7537; De Filippis, Lidia/0000-0002-2196-9430	Cariplo (Cassa di Risparmio delle Provincie Lombarde) Foundation; Neurothon ONLUS (Organizzazione non lucrativa di utilita sociale) Foundation; Italian Association for Cancer Research; Stemgen Spa	Cariplo (Cassa di Risparmio delle Provincie Lombarde) Foundation(Fondazione Cariplo); Neurothon ONLUS (Organizzazione non lucrativa di utilita sociale) Foundation; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Stemgen Spa	This work was financially supported by grants from Cariplo (Cassa di Risparmio delle Provincie Lombarde) Foundation, Neurothon ONLUS (Organizzazione non lucrativa di utilita sociale) Foundation (a nonprofit organization), the Italian Association for Cancer Research, and Stemgen Spa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgers HF, 2008, EXP BRAIN RES, V188, P33, DOI 10.1007/s00221-008-1336-6; Carlessi L, 2009, CELL DEATH DIFFER, V16, P795, DOI 10.1038/cdd.2009.10; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; De Filippis L, 2007, STEM CELLS, V25, P2312, DOI 10.1634/stemcells.2007-0040; Erba E, 2001, EUR J CANCER, V37, P97, DOI 10.1016/S0959-8049(00)00357-9; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Freyer JP, 1998, J CELL PHYSIOL, V176, P138, DOI 10.1002/(SICI)1097-4652(199807)176:1<138::AID-JCP16>3.3.CO;2-7; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; GRITTI A, 1995, NEUROSCI LETT, V185, P151, DOI 10.1016/0304-3940(95)11247-T; Gritti A, 1999, J NEUROSCI, V19, P3287; Gritti A, 1996, J NEUROSCI, V16, P1091; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Horie N, 2008, CELL MOL NEUROBIOL, V28, P833, DOI 10.1007/s10571-007-9237-y; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Ohta K, 2003, ACT NEUR S, V86, P187; Panchision D, 1998, CURR OPIN CELL BIOL, V10, P727, DOI 10.1016/S0955-0674(98)80114-2; Park KI, 2006, EXP NEUROL, V199, P156, DOI 10.1016/j.expneurol.2006.04.002; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Radley JM, 1999, EXP HEMATOL, V27, P365, DOI 10.1016/S0301-472X(98)00017-4; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2000, ADV EXP MED BIOL, V475, P123; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Studer L, 2000, J NEUROSCI, V20, P7377; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	44	148	174	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8575	10.1371/journal.pone.0008575	http://dx.doi.org/10.1371/journal.pone.0008575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052410	gold, Green Published, Green Submitted			2022-12-25	WOS:000273338500018
J	Simon, GG; Hu, YL; Khan, AM; Zhou, JS; Salmon, J; Chikhlikar, PR; Jung, KO; Marques, ETA; August, JT				Simon, Gregory G.; Hu, Yongli; Khan, Asif M.; Zhou, Jingshi; Salmon, Jerome; Chikhlikar, Priya R.; Jung, Keun-Ok; Marques, Ernesto T. A.; August, J. Thomas			Dendritic Cell Mediated Delivery of Plasmid DNA Encoding LAMP/HIV-1 Gag Fusion Immunogen Enhances T Cell Epitope Responses in HLA DR4 Transgenic Mice	PLOS ONE			English	Article							MEMBRANE-PROTEIN; RHESUS MACAQUES; VACCINE CHIMERA; II COMPARTMENT; GENE-TRANSFER; IN-VITRO; RNA; ANTIGEN; EXPRESSION; TRANSFECTION	This report describes the identification and bioinformatics analysis of HLA-DR4-restricted HIV-1 Gag epitope peptides, and the application of dendritic cell mediated immunization of DNA plasmid constructs. BALB/c (H-2d) and HLA-DR4 (DRA1*0101, DRB1*0401) transgenic mice were immunized with immature dendritic cells transfected by a recombinant DNA plasmid encoding the lysosome-associated membrane protein-1/HIV-1 Gag (pLAMP/gag) chimera antigen. Three immunization protocols were compared: 1) primary subcutaneous immunization with 1x10(5) immature dendritic cells transfected by electroporation with the pLAMP/gag DNA plasmid, and a second subcutaneous immunization with the naked pLAMP/gag DNA plasmid; 2) primary immunization as above, and a second subcutaneous immunization with a pool of overlapping peptides spanning the HIV-1 Gag sequence; and 3) immunization twice by subcutaneous injection of the pLAMP/gag DNA plasmid. Primary immunization with pLAMP/gag-transfected dendritic cells elicited the greatest number of peptide specific T-cell responses, as measured by ex vivo IFN-gamma ELISpot assay, both in BALB/c and HLA-DR4 transgenic mice. The pLAMP/gag-transfected dendritic cells prime and naked DNA boost immunization protocol also resulted in an increased apparent avidity of peptide in the ELISpot assay. Strikingly, 20 of 25 peptide-specific T-cell responses in the HLA-DR4 transgenic mice contained sequences that corresponded, entirely or partially to 18 of the 19 human HLA-DR4 epitopes listed in the HIV molecular immunology database. Selection of the most conserved epitope peptides as vaccine targets was facilitated by analysis of their representation and variability in all reported sequences. These data provide a model system that demonstrates a) the superiority of immunization with dendritic cells transfected with LAMP/gag plasmid DNA, as compared to naked DNA, b) the value of HLA transgenic mice as a model system for the identification and evaluation of epitope-based vaccine strategies, and c) the application of variability analysis across reported sequences in public databases for selection of historically conserved HIV epitopes as vaccine targets.	[Simon, Gregory G.; Zhou, Jingshi; Salmon, Jerome; Chikhlikar, Priya R.; Jung, Keun-Ok; Marques, Ernesto T. A.; August, J. Thomas] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Hu, Yongli; Khan, Asif M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Marques, Ernesto T. A.; August, J. Thomas] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA	Johns Hopkins University; National University of Singapore; Johns Hopkins University	Simon, GG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	gsimon2@jhmi.edu	Khan, Mohammad Asif/F-4663-2010; Marques, Ernesto T. A/L-4967-2013; Marques, Ernesto/L-4514-2013; Khan, M. Asif/ABE-7839-2021; Publica, Inct Saude/J-9544-2013	Khan, Mohammad Asif/0000-0001-9202-279X; Marques, Ernesto T. A/0000-0003-3826-9358; Marques, Ernesto/0000-0003-3826-9358; Khan, M. Asif/0000-0001-9202-279X; Jung, Keunok/0000-0003-2967-8432	National Institute of Allergy and Infectious Diseases [R37-AI41908]; National Cancer Institute [T32 CA9009243]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI041908] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by Grants R37-AI41908 from the National Institute of Allergy and Infectious Diseases, and the National Cancer Institute training grant T32 CA9009243. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arruda LB, 2006, J IMMUNOL, V177, P2265, DOI 10.4049/jimmunol.177.4.2265; Artusio E, 2006, CANCER BIOL THER, V5, P1624, DOI 10.4161/cbt.5.12.3353; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Bedoui S, 2009, IMMUNOL CELL BIOL, V87, P255, DOI 10.1038/icb.2008.105; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bonehill A, 2004, J IMMUNOL, V172, P6649, DOI 10.4049/jimmunol.172.11.6649; Bontkes HJ, 2007, GENE THER, V14, P366, DOI 10.1038/sj.gt.3302874; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Casares S, 1997, J EXP MED, V186, P1481, DOI 10.1084/jem.186.9.1481; Chikhlikar P, 2004, VIROLOGY, V323, P220, DOI 10.1016/j.virol.2004.02.025; Chikhlikar P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000135; Cope AP, 1999, ARTHRITIS RHEUM, V42, P1497, DOI 10.1002/1529-0131(199907)42:7<1497::AID-ANR25>3.0.CO;2-#; De Arruda LB, 2004, IMMUNOLOGY, V112, P126, DOI 10.1111/j.1365-2567.2004.01823.x; Dell K, 2008, ANTIVIR THER, V13, P495; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; FUGGER L, 1994, P NATL ACAD SCI USA, V91, P6151, DOI 10.1073/pnas.91.13.6151; GIESE NA, 1994, J VIROL, V68, P5819, DOI 10.1128/JVI.68.9.5819-5824.1994; Gross DA, 2004, J CLIN INVEST, V113, P425, DOI 10.1172/JCI200419418; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kalergis AM, 2000, J IMMUNOL, V165, P280, DOI 10.4049/jimmunol.165.1.280; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; Kurts C, 2001, J IMMUNOL, V166, P1439, DOI 10.4049/jimmunol.166.3.1439; Landi A, 2007, J LEUKOCYTE BIOL, V82, P849, DOI 10.1189/jlb.0906561; Lenz P, 2003, FEBS LETT, V538, P149, DOI 10.1016/S0014-5793(03)00169-8; Liao XS, 2004, MOL THER, V9, P757, DOI 10.1016/j.ymthe.2004.02.011; Madrenas J, 1996, Semin Immunol, V8, P83, DOI 10.1006/smim.1996.0011; Marques ETA, 2003, J BIOL CHEM, V278, P37926, DOI 10.1074/jbc.M303336200; Melhem NM, 2007, EUR J IMMUNOL, V37, P2164, DOI 10.1002/eji.200636782; Mitchell DA, 2000, J CLIN INVEST, V106, P1065, DOI 10.1172/JCI11405; Nair SK, 2000, NAT MED, V6, P1011, DOI 10.1038/79519; Nair SK, 1998, NAT BIOTECHNOL, V16, P364, DOI 10.1038/nbt0498-364; Nishimura Y, 2004, MOL IMMUNOL, V40, P1089, DOI 10.1016/j.molimm.2003.11.009; Patel SD, 1997, P NATL ACAD SCI USA, V94, P8082, DOI 10.1073/pnas.94.15.8082; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Raviprakash K, 2001, VIROLOGY, V290, P74, DOI 10.1006/viro.2001.1136; Rosati M, 2008, VACCINE, V26, P5223, DOI 10.1016/j.vaccine.2008.03.090; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; ROWELL JF, 1995, J IMMUNOL, V155, P1818; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; WU TC, 1995, P NATL ACAD SCI USA, V92, P11671, DOI 10.1073/pnas.92.25.11671; Xu R, 2008, VACCINE, V26, P4819, DOI 10.1016/j.vaccine.2008.06.103	43	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8574	10.1371/journal.pone.0008574	http://dx.doi.org/10.1371/journal.pone.0008574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052293	Green Published, gold, Green Submitted			2022-12-25	WOS:000273338500017
J	Tang, YZ; Wu, HJ; Ugai, H; Matthews, QL; Curiel, DT				Tang, Yizhe; Wu, Hongju; Ugai, Hideyo; Matthews, Qiana L.; Curiel, David T.			Derivation of a Triple Mosaic Adenovirus for Cancer Gene Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CLINICAL-TRIALS WORLDWIDE; PROTEIN-IX; THYMIDINE KINASE; FUNCTIONAL DISPLAY; IN-VIVO; TRANSCYTOSIS; VECTORS; POLYPEPTIDES; APHTHOVIRUS	A safe and efficacious cancer medicine is necessary due to the increasing population of cancer patients whose particular diseases cannot be cured by the currently available treatment. Adenoviral ( Ad) vectors represent a promising therapeutic medicine for human cancer therapy. However, several improvements are needed in order for Ad vectors to be effective cancer therapeutics, which include, but are not limited to, improvement of cellular uptake, enhanced cancer cell killing activity, and the capability of vector visualization and tracking once injected into the patients. To this end, we attempted to develop an Ad as a multifunctional platform incorporating targeting, imaging, and therapeutic motifs. In this study, we explored the utility of this proposed platform by generating an Ad vector containing the poly-lysine (pK), the herpes simplex virus type 1 (HSV-1) thymidine kinase (TK), and the monomeric red fluorescent protein (mRFP1) as targeting, tumor cell killing, and imaging motifs, respectively. Our study herein demonstrates the generation of the triple mosaic Ad vector with pK, HSV-1 TK, and mRFP1 at the carboxyl termini of Ad minor capsid protein IX (pIX). In addition, the functionalities of pK, HSV-1 TK, and mRFP1 proteins on the Ad vector were retained as confirmed by corresponding functional assays, indicating the potential multifunctional application of this new Ad vector for cancer gene therapy. The validation of the triple mosaic Ad vectors also argues for the ability of pIX modification as a base for the development of multifunctional Ad vectors.	[Tang, Yizhe; Wu, Hongju; Ugai, Hideyo; Matthews, Qiana L.; Curiel, David T.] Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Tang, Yizhe; Wu, Hongju; Ugai, Hideyo; Matthews, Qiana L.; Curiel, David T.] Univ Alabama Birmingham, Dept Pathol, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Tang, Yizhe; Wu, Hongju; Ugai, Hideyo; Matthews, Qiana L.; Curiel, David T.] Univ Alabama Birmingham, Dept Surg, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Tang, Yizhe; Wu, Hongju; Ugai, Hideyo; Matthews, Qiana L.; Curiel, David T.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Tang, Yizhe; Wu, Hongju; Ugai, Hideyo; Matthews, Qiana L.; Curiel, David T.] Univ Alabama Birmingham, Gene Therapy Ctr, Birmingham, AL 35294 USA; [Tang, Yizhe] Univ Alabama Birmingham, Vis Sci Grad Program, Birmingham, AL 35294 USA; [Matthews, Qiana L.] Univ Alabama Birmingham, Ctr AIDS Res, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Tang, YZ (corresponding author), Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA.	curiel@uab.edu	Matthews, Qiana/P-9624-2019; Tang, Yizhe/A-8682-2014; Ugai, Hideyo/K-4920-2017	Tang, Yizhe/0000-0001-5354-478X; Ugai, Hideyo/0000-0002-9121-8480	NIH [5R01CA111569]; Juvenile Diabetes Research Foundation [1-2005-71]; NATIONAL CANCER INSTITUTE [R01CA111569] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant 5R01CA111569 (Dr. D. T. Curiel) and Juvenile Diabetes Research Foundation grant 1-2005-71 ( Dr. H. Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalu A, 1999, J VIROL, V73, P6182, DOI 10.1128/JVI.73.7.6182-6187.1999; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; Campos SK, 2004, HUM GENE THER, V15, P1125, DOI 10.1089/1043034042431182; Di Pasquale G, 2006, MOL THER, V13, P506, DOI 10.1016/j.ymthe.2005.11.007; Dmitriev IP, 2002, J VIROL, V76, P6893, DOI 10.1128/JVI.76.14.6893-6899.2002; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Donnelly MLL, 1997, J GEN VIROL, V78, P13, DOI 10.1099/0022-1317-78-1-13; Edelstein ML, 2007, J GENE MED, V9, P833, DOI 10.1002/jgm.1100; Edelstein ML, 2004, J GENE MED, V6, P597, DOI 10.1002/jgm.619; Glasgow JN, 2006, CANCER GENE THER, V13, P830, DOI 10.1038/sj.cgt.7700928; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Le LP, 2004, MOL IMAGING, V3, P105, DOI 10.1162/1535350041464874; Le LP, 2005, J GEN VIROL, V86, P3201, DOI 10.1099/vir.0.80968-0; Le LP, 2006, JNCI-J NATL CANCER I, V98, P203, DOI 10.1093/jnci/djj022; Li J, 2005, VIROLOGY, V338, P247, DOI 10.1016/j.virol.2005.04.005; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Mathis JM, 2006, J GENE MED, V8, P1105, DOI 10.1002/jgm.935; Matthews QL, 2006, MOL IMAGING, V5, P510, DOI 10.2310/7290.2006.00029; Meulenbroek RA, 2004, MOL THER, V9, P617, DOI 10.1016/j.ymthe.2004.01.012; Mocanu JD, 2007, MOL THER, V15, P921, DOI 10.1038/mt.sj.6300119; Pereboeva L, 2004, VIRUS RES, V105, P35, DOI 10.1016/j.virusres.2004.04.012; Saban SD, 2005, J MOL BIOL, V349, P526, DOI 10.1016/j.jmb.2005.04.034; SHENK T, 1996, ADENOVIRIDAE VIRUSES, P2111; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takayama K, 2003, VIROLOGY, V309, P282, DOI 10.1016/S0042-6822(03)00067-9; Tang Y, 2007, GENE THER, V14, P523, DOI 10.1038/sj.gt.3302888; Tang YZ, 2008, VIROLOGY, V377, P391, DOI 10.1016/j.virol.2008.04.023; Tsuruta Y, 2007, CLIN CANCER RES, V13, P2777, DOI 10.1158/1078-0432.CCR-06-2706; UGAI H, 2009, J MOL BIOL; Vellinga J, 2004, J VIROL, V78, P3470, DOI 10.1128/JVI.78.7.3470-3479.2004; Wadhwa PD, 2002, ANNU REV MED, V53, P437, DOI 10.1146/annurev.med.53.082901.104039; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Wu HJ, 2005, J VIROL, V79, P3382, DOI 10.1128/JVI.79.6.3382-3390.2005; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206; Zhu ZB, 2004, VIROLOGY, V325, P116, DOI 10.1016/j.virol.2004.04.021	36	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8526	10.1371/journal.pone.0008526	http://dx.doi.org/10.1371/journal.pone.0008526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046872	Green Published, gold, Green Submitted			2022-12-25	WOS:000273180200010
J	Hemming, ML; Elias, JE; Gygi, SP; Selkoe, DJ				Hemming, Matthew L.; Elias, Joshua E.; Gygi, Steven P.; Selkoe, Dennis J.			Identification of beta-Secretase (BACE1) Substrates Using Quantitative Proteomics	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ANGIOTENSIN-CONVERTING ENZYME; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; NERVOUS-SYSTEM; ECTODOMAIN PHOSPHORYLATION; TRANSMEMBRANE SEMAPHORIN; REGULATED CLEAVAGE; ASPARTYL PROTEASE; GROWTH	beta-site APP cleaving enzyme 1 (BACE1) is a transmembrane aspartyl protease with a lumenal active site that sheds the ectodomains of membrane proteins through juxtamembrane proteolysis. BACE1 has been studied principally for its role in Alzheimer's disease as the beta-secretase responsible for generating the amyloid-beta protein. Emerging evidence from mouse models has identified the importance of BACE1 in myelination and cognitive performance. However, the substrates that BACE1 processes to regulate these functions are unknown, and to date only a few beta-secretase substrates have been identified through candidate-based studies. Using an unbiased approach to substrate identification, we performed quantitative proteomic analysis of two human epithelial cell lines stably expressing BACE1 and identified 68 putative beta-secretase substrates, a number of which we validated in a cell culture system. The vast majority were of type I transmembrane topology, although one was type II and three were GPI-linked proteins. Intriguingly, a preponderance of these proteins are involved in contact-dependent intercellular communication or serve as receptors and have recognized roles in the nervous system and other organs. No consistent sequence motif predicting BACE1 cleavage was identified in substrates versus non-substrates. These findings expand our understanding of the proteins and cellular processes that BACE1 may regulate, and suggest possible mechanisms of toxicity arising from chronic BACE1 inhibition.	[Hemming, Matthew L.; Selkoe, Dennis J.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Elias, Joshua E.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hemming, ML (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu		Hemming, Mathew/0000-0003-4674-7778	National Institutes of Health [AG06173, AG12749, HG3456, GM67945]; Harvard-MIT Division of Health Sciences and Technology London Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006173, R01AG012749, R37AG006173, RF1AG006173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard-MIT Division of Health Sciences and Technology London Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AG06173, AG12749 (DJS), HG3456, GM67945 (SPG, JEE), and the Harvard-MIT Division of Health Sciences and Technology London Fellowship (MLH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Chang MH, 2008, J MOL ENDOCRINOL, V41, P65, DOI 10.1677/JME-08-0051; Citron M, 2002, J NEUROSCI RES, V70, P373, DOI 10.1002/jnr.10393; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; El-Shewy HM, 2007, J BIOL CHEM, V282, P26150, DOI 10.1074/jbc.M703276200; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Everley PA, 2006, J PROTEOME RES, V5, P1224, DOI 10.1021/pr0504891; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Gruninger-Leitch F, 2002, J BIOL CHEM, V277, P4687, DOI 10.1074/jbc.M109266200; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Hawkes C, 2004, BRAIN RES REV, V44, P117, DOI 10.1016/j.brainresrev.2003.11.002; Heber S, 2000, J NEUROSCI, V20, P7951; Hebert E, 2006, BIOSCIENCE REP, V26, P7, DOI 10.1007/s10540-006-9002-3; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hemming ML, 2008, PLOS BIOL, V6, P2314, DOI 10.1371/journal.pbio.0060257; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; HUNG AY, 1994, EMBO J, V13, P534, DOI 10.1002/j.1460-2075.1994.tb06291.x; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Hussain I, 2003, J BIOL CHEM, V278, P36264, DOI 10.1074/jbc.M304186200; Hussain I, 2007, J NEUROCHEM, V100, P802, DOI 10.1111/j.1471-4159.2006.04260.x; Inagaki S, 2001, J BIOL CHEM, V276, P9174, DOI 10.1074/jbc.M009051200; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Ko JA, 2005, FEBS LETT, V579, P2236, DOI 10.1016/j.febslet.2005.03.022; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mebane-Sims I, 2009, ALZHEIMERS DEMENT, V5, P234, DOI 10.1016/j.jalz.2009.03.001; Natarajan R, 2004, MOL BIOL CELL, V15, P4798, DOI 10.1091/mbc.E04-05-0366; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Sauder JM, 2000, J MOL BIOL, V300, P241, DOI 10.1006/jmbi.2000.3860; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Starr T, 2007, TRAFFIC, V8, P1265, DOI 10.1111/j.1600-0854.2007.00607.x; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Walter J, 1997, J BIOL CHEM, V272, P1896, DOI 10.1074/jbc.272.3.1896; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wolfe MS, 2008, NEUROTHERAPEUTICS, V5, P391, DOI 10.1016/j.nurt.2008.05.010; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zaina S, 1998, J BIOL CHEM, V273, P28610, DOI 10.1074/jbc.273.44.28610	58	138	150	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8477	10.1371/journal.pone.0008477	http://dx.doi.org/10.1371/journal.pone.0008477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041192	gold, Green Published, Green Submitted			2022-12-25	WOS:000273105200012
J	Enzi, B; de Greck, M; Prosch, U; Tempelmann, C; Northoff, G				Enzi, Bjoern; de Greck, Moritz; Proesch, Ulrike; Tempelmann, Claus; Northoff, Georg			Is Our Self Nothing but Reward? Neuronal Overlap and Distinction between Reward and Personal Relevance and Its Relation to Human Personality	PLOS ONE			English	Article							NEURAL ACTIVITY; PHYSIOLOGICAL CONDITION; PREFRONTAL CORTEX; SOCIAL COGNITION; ANTERIOR INSULA; DEFAULT MODE; BRAIN; ACTIVATION; FMRI; EMOTION	Background: The attribution of personal relevance, i.e. relating internal and external stimuli to establish a sense of belonging, is a common phenomenon in daily life. Although previous research demonstrated a relationship between reward and personal relevance, their exact neuronal relationship including the impact of personality traits remains unclear. Methodology/Principal Findings: Using functional magnetic resonance imaging, we applied an experimental paradigm that allowed us to explore the neural response evoked by reward and the attribution of personal relevance separately. We observed different brain regions previously reported to be active during reward and personal relevance, including the bilateral caudate nucleus and the pregenual anterior cingulate cortex (PACC). Additional analysis revealed activations in the right and left insula specific for the attribution of personal relevance. Furthermore, our results demonstrate a negative correlation between signal changes in both the PACC and the left anterior insula during the attribution of low personal relevance and the personality dimension novelty seeking. Conclusion/Significance: While a set of subcortical and cortical regions including the PACC is commonly involved in reward and personal relevance, other regions like the bilateral anterior insula were recruited specifically during personal relevance. Based on our correlation between novelty seeking and signal changes in both regions during personal relevance, we assume that the neuronal response to personally relevant stimuli is dependent on the personality trait novelty seeking.	[Enzi, Bjoern; Northoff, Georg] Otto VonGuericke Univ Magdegurg, Dept Psychiat, D-39016 Magdeburg, Germany; [de Greck, Moritz] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Tempelmann, Claus] Otto VonGuericke Univ Magdegurg, Dept Neurol, D-39016 Magdeburg, Germany; [Proesch, Ulrike] Clin Psychosomat Med & Addict Disorders, Lubstorf, Germany; [Northoff, Georg] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada	Otto von Guericke University; Peking University; Otto von Guericke University; University of Ottawa	Enzi, B (corresponding author), Otto VonGuericke Univ Magdegurg, Dept Psychiat, D-39016 Magdeburg, Germany.	georg.northoff@rohcg.on.ca		Tempelmann, Claus/0000-0001-8570-4960; de Greck, Moritz/0000-0002-4937-1262	Salus Stiftung; Deutsche Forschungsgesellschaft (DFG) [304/4-1]; Sonderforschungsbereich 779 of the Deutsche Forschungsgesellschaft (SFB) [779-A6]; Hope of Depression Research Foundation (HDRF); Schweizer Nationalfonds zur Foerderung der wissenschaftlichen Forschung (FNSNF) [3100A0-100830]; Wissenschaftsrat der Allgemeinen Hospital Gesellschaft (AHG); European Union [STF-25]	Salus Stiftung; Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); Sonderforschungsbereich 779 of the Deutsche Forschungsgesellschaft (SFB)(German Research Foundation (DFG)); Hope of Depression Research Foundation (HDRF); Schweizer Nationalfonds zur Foerderung der wissenschaftlichen Forschung (FNSNF)(Austrian Science Fund (FWF)); Wissenschaftsrat der Allgemeinen Hospital Gesellschaft (AHG); European Union(European Commission)	The study was supported by a Heisenberg grant from the Salus Stiftung, the Deutsche Forschungsgesellschaft (DFG, 304/4-1 to G.N.), the Sonderforschungsbereich 779 of the Deutsche Forschungsgesellschaft (SFB 779-A6 to G.N. and B.E.), the Hope of Depression Research Foundation (HDRF, to G.N), the Schweizer Nationalfonds zur Foerderung der wissenschaftlichen Forschung (FNSNF 3100A0-100830, to G.N.), the Wissenschaftsrat der Allgemeinen Hospital Gesellschaft (AHG Wissenschaftsrat, to U. P) and a fellowship grant of the European Union (STF-25, to M. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bermpohl F, 2008, PSYCHIAT RES-NEUROIM, V164, P81, DOI 10.1016/j.pscychresns.2007.12.019; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Cloninger C. R., 1999, TEMPERAMENT UND CHAR; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; de Greck M, 2008, NEUROIMAGE, V39, P2066, DOI 10.1016/j.neuroimage.2007.11.006; de Greck M, 2009, HUM BRAIN MAPP, V30, P1691, DOI 10.1002/hbm.20634; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gallinat J, 2007, NEUROIMAGE, V34, P671, DOI 10.1016/j.neuroimage.2006.10.004; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gillihan SJ, 2005, PSYCHOL BULL, V131, P76, DOI 10.1037/0033-2909.131.1.76; Goodwin GM, 1997, BRIT J PSYCHIAT, V170, P426, DOI 10.1192/bjp.170.5.426; Grimm S, 2006, NEUROIMAGE, V30, P325, DOI 10.1016/j.neuroimage.2005.09.006; Hautzinger M., 1995, BECK DEPRESSIONS INV; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Legrand D, 2009, PSYCHOL REV, V116, P252, DOI 10.1037/a0014172; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Modinos G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004618; MONTAGUE P, 2006, ANN REV NEUROSCI, V29; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2008, TRENDS COGN SCI, V12, P259, DOI 10.1016/j.tics.2008.04.007; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Northoff G, 2009, HUM BRAIN MAPP, V30, P369, DOI 10.1002/hbm.20510; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Oatley K., 1996, UNDERSTANDING EMOTIO; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Pollard D, 2007, AM BOOK REV, V28, P18, DOI 10.1353/abr.2007.0103; Pollatos O, 2007, BRAIN RES, V1141, P178, DOI 10.1016/j.brainres.2007.01.026; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; STRAKOWSKI SM, 1993, PSYCHIAT RES, V48, P1, DOI 10.1016/0165-1781(93)90107-R; Sugiura M, 2000, NEUROIMAGE, V11, P541, DOI 10.1006/nimg.2000.0564; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Wicker B, 2003, BRAIN RES REV, V43, P224, DOI 10.1016/j.brainresrev.2003.08.003; WITTMANN B, 2008, NEURON, V58	77	95	97	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8429	10.1371/journal.pone.0008429	http://dx.doi.org/10.1371/journal.pone.0008429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	537HN	20041155	Green Published, Green Submitted, gold			2022-12-25	WOS:000273104000004
J	Nakamura, K; Radhakrishnan, K; Wong, YM; Rockson, SG				Nakamura, Kenta; Radhakrishnan, Kavita; Wong, Yat Man; Rockson, Stanley G.			Anti-Inflammatory Pharmacotherapy with Ketoprofen Ameliorates Experimental Lymphatic Vascular Insufficiency in Mice	PLOS ONE			English	Article							GROWTH-FACTOR-C; NECROSIS-FACTOR-ALPHA; STNF-RI; LYMPHANGIOGENESIS; EXPRESSION; TNF; THERAPY; CELLS; ANGIOGENESIS; MACROPHAGES	Background: Disruption of the lymphatic vasculature causes edema, inflammation, and end-tissue destruction. To assess the therapeutic efficacy of systemic anti-inflammatory therapy in this disease, we examined the impact of a nonsteroidal anti-inflammatory drug (NSAID), ketoprofen, and of a soluble TNF-alpha receptor (sTNF-R1) upon tumor necrosis factor (TNF)-alpha activity in a mouse model of acquired lymphedema. Methods and Findings: Lymphedema was induced by microsurgical ablation of major lymphatic conduits in the murine tail. Untreated control mice with lymphedema developed significant edema and extensive histopathological inflammation compared to sham surgical controls. Short-term ketoprofen treatment reduced tail edema and normalized the histopathology while paradoxically increasing TNF-alpha gene expression and cytokine levels. Conversely, sTNF-R1 treatment increased tail volume, exacerbated the histopathology, and decreased TNF-alpha gene expression. Expression of vascular endothelial growth factor-C (VEGF-C), which stimulates lymphangiogenesis, closely correlated with TNF-alpha expression. Conclusions: Ketoprofen therapy reduces experimental post-surgical lymphedema, yet direct TNF-alpha inhibition does not. Reducing inflammation while preserving TNF-alpha activity appears to optimize the repair response. It is possible that the observed favorable responses, at least in part, are mediated through enhanced VEGF-C signaling.	[Nakamura, Kenta; Radhakrishnan, Kavita; Wong, Yat Man; Rockson, Stanley G.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA	Stanford University	Nakamura, K (corresponding author), Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.	srockson@cvmed.stanford.edu		rockson, stanley/0000-0003-1253-474X	Susan G. Komen Breast Cancer Foundation; Western States Affiliate of the American Heart Association; Society of Vascular Medicine	Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Western States Affiliate of the American Heart Association(American Heart Association); Society of Vascular Medicine	This study was supported by the Susan G. Komen Breast Cancer Foundation (to SGR) and the Western States Affiliate of the American Heart Association (to KN). Portions of this work were awarded the Jay D. Coffman Young Investigator Award by the Society of Vascular Medicine in May 2008 (to KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton EL, 1996, DATAMATION, V42, P48; Baluk P, 2009, J CLIN INVEST, V119, P2954, DOI 10.1172/JCI37626; Bush KA, 2002, SCAND J RHEUMATOL, V31, P198, DOI 10.1080/030097402320318378; Cha HS, 2007, J RHEUMATOL, V34, P16; Chen MM, 2003, CIRCULATION, V108, P1432, DOI 10.1161/01.CIR.0000091235.94914.75; Cheung L, 2006, BIODRUGS, V20, P363, DOI 10.2165/00063030-200620060-00007; Edwards CK, 1999, ANN RHEUM DIS, V58, P73; Ghezzi P, 1998, J PHARMACOL EXP THER, V287, P969; Goldman J, 2005, CIRC RES, V96, P1193, DOI 10.1161/01.RES.0000168918.27576.78; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hub E, 1998, AM J PATHOL, V152, P749; Jin Da Pan, 2009, Lymphatic Research and Biology, V7, P47, DOI 10.1089/lrb.2009.0002; Jorres A, 1997, CYTOKINE, V9, P119, DOI 10.1006/cyto.1996.0145; Kunkel S L, 1988, Methods Achiev Exp Pathol, V13, P240; Maini RN, 2000, ANNU REV MED, V51, P207, DOI 10.1146/annurev.med.51.1.207; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Meyer AM, 2006, DIGEST DIS SCI, V51, P168, DOI 10.1007/s10620-006-3103-5; Mouta Carla, 2003, Lymphat Res Biol, V1, P201, DOI 10.1089/153968503768330247; Nakamura K, 2008, INT J CARDIOL; NAKAMURA K, 2008, LYMPHAT RES IN PRESS; Nakaniura K, 2007, MOL DIAGN THER, V11, P227, DOI 10.1007/BF03256244; OLSZEWSKI WL, 1990, LYMPHOLOGY, V23, P23; Paavonen K, 2002, J RHEUMATOL, V29, P39; Pan Da, 2006, Lymphatic Research and Biology, V4, P211, DOI 10.1089/lrb.2006.4405; Pan Da, 2006, Lymphatic Research and Biology, V4, P153, DOI 10.1089/lrb.2006.4.153; RENZ H, 1988, J IMMUNOL, V141, P2388; Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074/jbc.273.14.8413; Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0; Rockson SG, 2008, J AM COLL CARDIOL, V52, P799, DOI 10.1016/j.jacc.2008.06.005; Saito Y, 2006, CIRCULATION, V114, P1177, DOI 10.1161/CIRCULATIONAHA.105.602953; Sanders JE, 1999, COMPUT METH PROG BIO, V59, P167, DOI 10.1016/S0169-2607(99)00003-6; SANTUCCI L, 1994, GUT, V35, P909, DOI 10.1136/gut.35.7.909; Scavelli C, 2004, J ANAT, V204, P433, DOI 10.1111/j.0021-8782.2004.00293.x; Schneider M, 2006, PLOS MED, V3, P970, DOI 10.1371/journal.pmed.0030264; SIRONI M, 1992, INT J IMMUNOPHARMACO, V14, P1045, DOI 10.1016/0192-0561(92)90149-F; Sitzia J, 1995, Eur J Cancer Care (Engl), V4, P11; Skobe M, 2001, AM J PATHOL, V159, P893, DOI 10.1016/S0002-9440(10)61765-8; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Szuba A, 2002, FASEB J, V16, P1985, DOI 10.1096/fj.02-0401fje; Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254; TANNENBAUM CS, 1989, J IMMUNOL, V142, P1274; TSUBOI I, 1995, CYTOKINE, V7, P372, DOI 10.1006/cyto.1995.0047; Ulfgren AK, 2000, ARTHRITIS RHEUM, V43, P2391, DOI 10.1002/1529-0131(200011)43:11<2391::AID-ANR3>3.0.CO;2-F; Wauke K, 2002, J RHEUMATOL, V29, P34; Yoon Y, 2003, J CLIN INVEST, V111, P717, DOI 10.1172/JCI200315830	45	65	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8380	10.1371/journal.pone.0008380	http://dx.doi.org/10.1371/journal.pone.0008380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027220	Green Published, Green Submitted, gold			2022-12-25	WOS:000272940100016
J	Verner-Jeffreys, DW; Welch, TJ; Schwarz, T; Pond, MJ; Woodward, MJ; Haig, SJ; Rimmer, GSE; Roberts, E; Morrison, V; Baker-Austin, C				Verner-Jeffreys, David W.; Welch, Timothy J.; Schwarz, Tamar; Pond, Michelle J.; Woodward, Martin J.; Haig, Sarah J.; Rimmer, Georgina S. E.; Roberts, Edward; Morrison, Victoria; Baker-Austin, Craig			High Prevalence of Multidrug-Tolerant Bacteria and Associated Antimicrobial Resistance Genes Isolated from Ornamental Fish and Their Carriage Water	PLOS ONE			English	Article							QUINOLONE RESISTANCE; AEROMONAS-SALMONICIDA; ANTIBIOTIC-RESISTANCE; DRUG-RESISTANCE; INTEGRONS; ENVIRONMENT; AQUACULTURE; PLASMIDS; IDENTIFICATION; DETERMINANTS	Background: Antimicrobials are used to directly control bacterial infections in pet (ornamental) fish and are routinely added to the water these fish are shipped in to suppress the growth of potential pathogens during transport. Methodology/Principal Findings: To assess the potential effects of this sustained selection pressure, 127 Aeromonas spp. isolated from warm and cold water ornamental fish species were screened for tolerance to 34 antimicrobials. Representative isolates were also examined for the presence of 54 resistance genes by a combination of miniaturized microarray and conventional PCR. Forty-seven of 94 Aeromonas spp. isolates recovered from tropical ornamental fish and their carriage water were tolerant to >= 15 antibiotics, representing seven or more different classes of antimicrobial. The quinolone and fluoroquinolone resistance gene, qnrS2, was detected at high frequency (37% tested recent isolates were positive by PCR). Class 1 integrons, IncA/C broad host range plasmids and a range of other antibiotic resistance genes, including floR, blaTEM21, tet(A), tet(D), tet(E), qacE2, sul1, and a number of different dihydrofolate reductase and aminoglycoside transferase coding genes were also detected in carriage water samples and bacterial isolates. Conclusions: These data suggest that ornamental fish and their carriage water act as a reservoir for both multi-resistant bacteria and resistance genes.	[Verner-Jeffreys, David W.; Schwarz, Tamar; Pond, Michelle J.; Haig, Sarah J.; Rimmer, Georgina S. E.; Roberts, Edward; Baker-Austin, Craig] Weymouth Lab, Ctr Environm Fisheries & Aquaculture Sci, Weymouth, Dorset, England; [Welch, Timothy J.] ARS, USDA, Natl Ctr Cool & Cold Water Aquaculture, Kearneysville, WV USA; [Schwarz, Tamar; Haig, Sarah J.] Univ Glasgow, Div Infect & Immun, Glasgow, Lanark, Scotland; [Woodward, Martin J.; Morrison, Victoria] Vet Labs Agcy, Addlestone, Surrey, England	Centre for Environment Fisheries & Aquaculture Science; United States Department of Agriculture (USDA); University of Glasgow; Veterinary Laboratories Agency	Verner-Jeffreys, DW (corresponding author), Weymouth Lab, Ctr Environm Fisheries & Aquaculture Sci, Weymouth, Dorset, England.	david.verner-jeffreys@cefas.co.uk	Woodward, Martin J/E-8955-2010; Haig, Sarah/H-5986-2019	Haig, Sarah/0000-0002-0004-8894; Welch, Tim/0000-0003-1096-3006	UK government's Department for Environment Food and Rural Affairs [FC1178, FB001, FC1172]	UK government's Department for Environment Food and Rural Affairs	This study was funded by The UK government's Department for Environment Food and Rural Affairs through projects FC1178, FB001 and a sandwich placement studentship for T.S. (Project FC1172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AOKI T, 1971, J GEN MICROBIOL, V65, P343, DOI 10.1099/00221287-65-3-343; Batchelor M, 2008, INT J ANTIMICROB AG, V31, P440, DOI 10.1016/j.ijantimicag.2007.11.017; Cattoir V, 2008, EMERG INFECT DIS, V14, P231, DOI 10.3201/eid1402.070677; Chang YC, 2007, DIAGN MICR INFEC DIS, V59, P191, DOI 10.1016/j.diagmicrobio.2007.04.007; *CLIN LAB STAND I, 2004, M49P CLSI; COLE B, 1999, PUBLICATION CTR TROP, V131; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; DIXON B A, 1990, Journal of Aquatic Animal Health, V2, P295, DOI 10.1577/1548-8667(1990)002&lt;0295:AROASI&gt;2.3.CO;2; Dixon Beverly A., 1993, Journal of the World Aquaculture Society, V24, P102, DOI 10.1111/j.1749-7345.1993.tb00155.x; Egorova S, 2008, EMERG INFECT DIS, V14, P954, DOI 10.3201/eid1406.071168; Enne VI, 2001, LANCET, V357, P1325, DOI 10.1016/S0140-6736(00)04519-0; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; Furushita M, 2003, APPL ENVIRON MICROB, V69, P5336, DOI 10.1128/AEM.69.9.5336-5342.2003; Gaze WH, 2005, ANTIMICROB AGENTS CH, V49, P1802, DOI 10.1128/AAC.49.5.1802-1807.2005; Gillings MR, 2008, FEMS MICROBIOL LETT, V287, P56, DOI 10.1111/j.1574-6968.2008.01291.x; Giraud E, 2004, J MED MICROBIOL, V53, P895, DOI 10.1099/jmm.0.45579-0; Goni-Urriza M, 2002, ANTIMICROB AGENTS CH, V46, P350, DOI 10.1128/AAC.46.2.350-359.2002; Hall RM, 1999, ANN NY ACAD SCI, V870, P68, DOI 10.1111/j.1749-6632.1999.tb08866.x; Izumi S, 2004, APPL ENVIRON MICROB, V70, P3968, DOI 10.1128/AEM.70.7.3968-3972.2004; Jacobs L, 2007, INT J FOOD MICROBIOL, V114, P295, DOI 10.1016/j.ijfoodmicro.2006.09.030; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; Moura A, 2007, J ANTIMICROB CHEMOTH, V60, P1243, DOI 10.1093/jac/dkm340; Musto J, 2006, COMMUN DIS INTELL, V30, P222; O'Brien TF, 2002, CLIN INFECT DIS, V34, pS78, DOI 10.1086/340244; Pan JC, 2008, ANTIMICROB AGENTS CH, V52, P3829, DOI 10.1128/AAC.00375-08; Pond MJ, 2006, AQUACULTURE, V261, P194, DOI 10.1016/j.aquaculture.2006.06.037; Rhodes G, 2000, APPL ENVIRON MICROB, V66, P3883, DOI 10.1128/AEM.66.9.3883-3890.2000; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rosser SJ, 1999, J ANTIMICROB CHEMOTH, V44, P11, DOI 10.1093/jac/44.1.11; Rossolini GM, 1996, MICROB DRUG RESIST, V2, P245, DOI 10.1089/mdr.1996.2.245; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Schmidt AS, 2001, APPL ENVIRON MICROB, V67, P5675, DOI 10.1128/AEM.67.12.5675-5682.2001; Singer RS, 2006, NAT REV MICROBIOL, V4, P943, DOI 10.1038/nrmicro1553; Smith P, 2008, EMERG INFECT DIS, V14, P1327, DOI 10.3201/eid1408.080329; Sorum H, 2003, ANTIMICROB AGENTS CH, V47, P1285, DOI 10.1128/AAC.47.4.1285-1290.2003; TRUST TJ, 1976, ANTIMICROB AGENTS CH, V10, P598, DOI 10.1128/AAC.10.4.598; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Welch TJ, 2009, ANTIMICROB AGENTS CH, V53, P845, DOI 10.1128/AAC.01312-08; Whittington RJ, 2007, PREV VET MED, V81, P92, DOI 10.1016/j.prevetmed.2007.04.007; 1999, REPORT MICROBIAL RES	42	90	98	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8388	10.1371/journal.pone.0008388	http://dx.doi.org/10.1371/journal.pone.0008388			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027306	Green Published, Green Submitted, gold			2022-12-25	WOS:000272940100021
J	Volkmann, G; Liu, XQ				Volkmann, Gerrit; Liu, Xiang-Qin			Protein C-Terminal Labeling and Biotinylation Using Synthetic Peptide and Split-Intein	PLOS ONE			English	Article							CELL-SURFACE PROTEINS; LIVE CELLS; TRANSFERRIN RECEPTOR; MEMBRANE-PROTEINS; SMALL MOLECULES; DNAB INTEIN; IN-VIVO; LIGATION; PCC6803; TAG	Background: Site-specific protein labeling or modification can facilitate the characterization of proteins with respect to their structure, folding, and interaction with other proteins. However, current methods of site-specific protein labeling are few and with limitations, therefore new methods are needed to satisfy the increasing need and sophistications of protein labeling. Methodology: A method of protein C-terminal labeling was developed using a non-canonical split-intein, through an intein-catalyzed trans-splicing reaction between a protein and a small synthetic peptide carrying the desired labeling groups. As demonstrations of this method, three different proteins were efficiently labeled at their C-termini with two different labels (fluorescein and biotin) either in solution or on a solid surface, and a transferrin receptor protein was labeled on the membrane surface of live mammalian cells. Protein biotinylation and immobilization on a streptavidin-coated surface were also achieved in a cell lysate without prior purification of the target protein. Conclusions: We have produced a method of site-specific labeling or modification at the C-termini of recombinant proteins. This method compares favorably with previous protein labeling methods and has several unique advantages. It is expected to have many potential applications in protein engineering and research, which include fluorescent labeling for monitoring protein folding, location, and trafficking in cells, and biotinylation for protein immobilization on streptavidin-coated surfaces including protein microchips. The types of chemical labeling may be limited only by the ability of chemical synthesis to produce the small C-intein peptide containing the desired chemical groups.	[Volkmann, Gerrit; Liu, Xiang-Qin] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada	Dalhousie University	Volkmann, G (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	paul.liu@dal.ca			National Science and Engineering Research Council (NSERC) of Canada	National Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the National Science and Engineering Research Council (NSERC) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2007, CHEM COMMUN, P4995, DOI 10.1039/b712843f; Appleby JH, 2009, J BIOL CHEM, V284, P6194, DOI 10.1074/jbc.M805474200; Brenzel S, 2006, BIOCHEMISTRY-US, V45, P1571, DOI 10.1021/bi051697+; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; EVANS TC, 1998, SEMISYNTHESIS CYTOTO, V7, P2256; George N, 2004, J AM CHEM SOC, V126, P8896, DOI 10.1021/ja048396s; Gilmore JM, 2006, ANGEW CHEM INT EDIT, V45, P5307, DOI 10.1002/anie.200600368; Gong HS, 2008, BBA-PROTEINS PROTEOM, V1784, P1835, DOI 10.1016/j.bbapap.2008.07.017; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Guignet EG, 2004, NAT BIOTECHNOL, V22, P440, DOI 10.1038/nbt954; Guy J, 2007, J AM CHEM SOC, V129, P11969, DOI 10.1021/ja0738125; Kalia J, 2006, CHEMBIOCHEM, V7, P1375, DOI 10.1002/cbic.200600150; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kurpiers T, 2008, CHEMBIOCHEM, V9, P2317, DOI 10.1002/cbic.200800319; Kurpiers T, 2007, ANGEW CHEM INT EDIT, V46, P5234, DOI 10.1002/anie.200700719; Kwon Y, 2006, ANGEW CHEM INT EDIT, V45, P1726, DOI 10.1002/anie.200503475; Lesaicherre ML, 2002, J AM CHEM SOC, V124, P8768, DOI 10.1021/ja0265963; Lin CW, 2006, J AM CHEM SOC, V128, P4542, DOI 10.1021/ja0604111; Ludwig C, 2008, J BIOL CHEM, V283, P25264, DOI 10.1074/jbc.M802972200; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Lue RYP, 2004, J AM CHEM SOC, V126, P1055, DOI 10.1021/ja037914g; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; McCann CM, 2005, BIOTECHNIQUES, V38, P945, DOI 10.2144/05386IT02; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; Southworth MW, 1998, EMBO J, V17, P918, DOI 10.1093/emboj/17.4.918; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; Tsien RY, 2009, ANGEW CHEM INT EDIT, V48, P5612, DOI 10.1002/anie.200901916; Tsukiji S, 2009, CHEMBIOCHEM, V10, P787, DOI 10.1002/cbic.200800724; Wood RJ, 2004, BIOCONJUGATE CHEM, V15, P366, DOI 10.1021/bc0341728; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Yin J, 2004, J AM CHEM SOC, V126, P7754, DOI 10.1021/ja047749k	40	30	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8381	10.1371/journal.pone.0008381	http://dx.doi.org/10.1371/journal.pone.0008381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027230	Green Submitted, Green Published, gold			2022-12-25	WOS:000272940100017
J	Lhee, S; Kolling, DRJ; Nair, SK; Dikanov, SA; Crofts, AR				Lhee, Sangmoon; Kolling, Derrick R. J.; Nair, Satish K.; Dikanov, Sergei A.; Crofts, Antony R.			Modifications of Protein Environment of the [2Fe-2S] Cluster of the bc(1) Complex EFFECTS ON THE BIOPHYSICAL PROPERTIES OF THE RIESKE IRON-SULFUR PROTEIN AND ON THE KINETICS OF THE COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL CYTOCHROME BC(1); COUPLED ELECTRON-TRANSFER; WATER-SOLUBLE FRAGMENT; FORMING HYDROGEN-BONDS; BOVINE HEART; RHODOBACTER-SPHAEROIDES; Q-CYCLE; Q(O) SITE; RHODOPSEUDOMONAS-SPHAEROIDES; UBIHYDROQUINONE OXIDATION	The rate-determining step in the overall turnover of the bc(1) complex is electron transfer from ubiquinol to the Rieske iron-sulfur protein (ISP) at the Q(o)-site. Structures of the ISP from Rhodobacter sphaeroides show that serine 154 and tyrosine 156 form H-bonds to S-1 of the [2Fe-2S] cluster and to the sulfur atom of the cysteine liganding Fe-1 of the cluster, respectively. These are responsible in part for the high potential (E-m,E-7 similar to 300 mV) and low pK(a) (7.6) of the ISP, which determine the overall reaction rate of the bc(1) complex. We have made site-directed mutations at these residues, measured thermodynamic properties using protein film voltammetry to evaluate the E-m and pK(a) values of ISPs, explored the local proton environment through two-dimensional electron spin echo envelope modulation, and characterized function in strains S154T, S154C, S154A, Y156F, and Y156W. Alterations in reaction rate were investigated under conditions in which concentration of one substrate (ubiquinol or ISPox) was saturating and the other was varied, allowing calculation of kinetic terms and relative affinities. These studies confirm that H-bonds to the cluster or its ligands are important determinants of the electrochemical characteristics of the ISP, likely through electron affinity of the interacting atom and the geometry of the H-bonding neighborhood. The calculated parameters were used in a detailed Marcus-Bronsted analysis of the dependence of rate on driving force and pH. The proton-first-then-electron model proposed accounts naturally for the effects of mutation on the overall reaction.	[Nair, Satish K.; Crofts, Antony R.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Lhee, Sangmoon; Kolling, Derrick R. J.; Nair, Satish K.; Crofts, Antony R.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Dikanov, Sergei A.] Univ Illinois, Dept Clin Vet Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Crofts, AR (corresponding author), Univ Illinois, Dept Biochem, 419 Roger Adams Lab,600 S Mathews Ave, Urbana, IL 61801 USA.	a-crofts@life.uiuc.edu	Nair, Satish/AAY-2510-2021	LHEE, SANGMOON/0000-0002-5395-5623	National Institutes of Health; NCRR [GM35438, GM62954, RR15878]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035438, R01GM062954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM35438 (to A. R. C.), GM62954 (to S. A. D.), and S10-RR15878 from NCRR (for instrumentation).	ANDREWS KM, 1984, THESIS U ILLINOIS UR; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Berry EA, 2003, FEBS LETT, V555, P13, DOI 10.1016/S0014-5793(03)01099-8; Brandt U, 1997, BIOCHEMISTRY-US, V36, P11234, DOI 10.1021/bi970968g; Brandt U, 1996, FEBS LETT, V387, P1, DOI 10.1016/0014-5793(96)00436-X; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Cape JL, 2009, BIOCHEMISTRY-US, V48, P10716, DOI 10.1021/bi901205w; Covian R, 2002, J BIOL CHEM, V277, P48449, DOI 10.1074/jbc.M208060200; Covian R, 2001, EUR J BIOCHEM, V268, P5783, DOI 10.1046/j.0014-2956.2001.02521.x; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Crofts AR, 2006, BBA-BIOENERGETICS, V1757, P1019, DOI 10.1016/j.bbabio.2006.02.009; Crofts AR, 2005, RSC BIOMOLEC SCI, P123; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15807, DOI 10.1021/bi990962m; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15791, DOI 10.1021/bi990961u; Crofts AR, 2004, PHOTOSYNTH RES, V80, P223, DOI 10.1023/B:PRES.0000030444.52579.10; Crofts AR, 2004, BBA-BIOENERGETICS, V1655, P77, DOI 10.1016/j.bbabio.2003.10.012; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Crofts AR, 2003, J BIOL CHEM, V278, P36191, DOI 10.1074/jbc.M305461200; CROFTS AR, 1989, PHOTOSYNTH RES, V22, P69, DOI 10.1007/BF00114768; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; Crofts AR, 1999, P NATL ACAD SCI USA, V96, P10021, DOI 10.1073/pnas.96.18.10021; Crofts AR, 2000, BBA-BIOENERGETICS, V1459, P456, DOI 10.1016/S0005-2728(00)00184-5; CROFTS AR, 2002, P 12 C PHOT RES BRIS; Degli Esposti M, 1987, Biochem J, V241, P285; Denke E, 1998, J BIOL CHEM, V273, P9085, DOI 10.1074/jbc.273.15.9085; DIKANOV SA, 1982, CHEM PHYS LETT, V90, P149, DOI 10.1016/0009-2614(82)83630-0; Dikanov SA, 2006, J BIOL CHEM, V281, P27416, DOI 10.1074/jbc.M604103200; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; DING HG, 1992, BIOCHEMISTRY-US, V31, P3144, DOI 10.1021/bi00127a015; DUTTON PL, 1972, EUR J BIOCHEM, V30, P495, DOI 10.1111/j.1432-1033.1972.tb02121.x; Engstrom G, 2002, J BIOL CHEM, V277, P31072, DOI 10.1074/jbc.M202594200; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; GATTI DL, 1989, J MOL BIOL, V205, P421, DOI 10.1016/0022-2836(89)90352-5; Guergova-Kuras M, 1999, PROTEIN EXPRES PURIF, V15, P370, DOI 10.1006/prep.1998.1018; Guergova-Kuras M, 2000, BIOCHEMISTRY-US, V39, P7436, DOI 10.1021/bi992491+; GURBIEL RJ, 1991, BIOCHEMISTRY-US, V30, P11579, DOI 10.1021/bi00113a013; Hammes-Schiffer S, 2008, J PHYS CHEM B, V112, P14108, DOI 10.1021/jp805876e; Hanes CS, 1932, BIOCHEM J, V26, P1406, DOI 10.1042/bj0261406; Hong SJ, 1999, J BIOL CHEM, V274, P33931, DOI 10.1074/jbc.274.48.33931; Hunsicker-Wang LM, 2003, BIOCHEMISTRY-US, V42, P7303, DOI 10.1021/bi0342719; Iwaki M, 2005, BIOCHEMISTRY-US, V44, P4230, DOI 10.1021/bi047533v; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; Kessl JJ, 2003, J BIOL CHEM, V278, P31312, DOI 10.1074/jbc.M304042200; Klingen AR, 2004, BIOCHEMISTRY-US, V43, P12383, DOI 10.1021/bi0488606; Kolling DJ, 2007, STRUCTURE, V15, P29, DOI 10.1016/j.str.2006.11.012; Kolling DRJ, 2009, J PHYS CHEM A, V113, P653, DOI 10.1021/jp806789x; Konkle ME, 2009, BIOCHEMISTRY-US, V48, P9848, DOI 10.1021/bi901126u; KRAMER DM, 1993, BIOCHIM BIOPHYS ACTA, V1184, P251; Leggate EJ, 2005, BIOCHEMISTRY-US, V44, P7048, DOI 10.1021/bi050189x; Lin IJ, 2006, J AM CHEM SOC, V128, P10672, DOI 10.1021/ja0627388; LINK TA, 1994, BBA-BIOENERGETICS, V1185, P81, DOI 10.1016/0005-2728(94)90196-1; Link TA, 1996, EUR J BIOCHEM, V237, P71, DOI 10.1111/j.1432-1033.1996.0071n.x; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; LINK TA, 1992, EUR J BIOCHEM, V208, P685, DOI 10.1111/j.1432-1033.1992.tb17235.x; Manner VW, 2009, J AM CHEM SOC, V131, P9874, DOI 10.1021/ja902942g; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Miller T.M, 2007, CRC HDB CHEM PHYS, V88th; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; NOODLEMAN L, 1984, J AM CHEM SOC, V106, P2316, DOI 10.1021/ja00320a017; PRINCE RC, 1976, FEBS LETT, V65, P117, DOI 10.1016/0014-5793(76)80634-5; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; RIESKE JS, 1964, BIOCHEM BIOPH RES CO, V15, P338, DOI 10.1016/0006-291X(64)90171-8; Samoilova RI, 2002, J BIOL CHEM, V277, P4605, DOI 10.1074/jbc.C100664200; Schroter T, 1998, EUR J BIOCHEM, V255, P100, DOI 10.1046/j.1432-1327.1998.2550100.x; Schutz M, 2000, J MOL BIOL, V300, P663, DOI 10.1006/jmbi.2000.3915; Shan SO, 1996, P NATL ACAD SCI USA, V93, P14474, DOI 10.1073/pnas.93.25.14474; SNOZZI M, 1984, BIOCHIM BIOPHYS ACTA, V766, P451, DOI 10.1016/0005-2728(84)90261-5; Suresh SJ, 2000, J CHEM PHYS, V113, P9727, DOI 10.1063/1.1320822; TAKAMIYA KI, 1979, BIOCHIM BIOPHYS ACTA, V546, P1, DOI 10.1016/0005-2728(79)90166-X; Ugulava NB, 1998, FEBS LETT, V440, P409, DOI 10.1016/S0014-5793(98)01493-8; VANDOREN SR, 1993, BIOCHEMISTRY-US, V32, P8083, DOI 10.1021/bi00083a005; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; YUN CH, 1990, EUR J BIOCHEM, V194, P399, DOI 10.1111/j.1432-1033.1990.tb15633.x; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104; Zu YB, 2003, BIOCHEMISTRY-US, V42, P12400, DOI 10.1021/bi0350957; Zu YB, 2001, J AM CHEM SOC, V123, P9906, DOI 10.1021/ja016532c	80	32	32	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9233	9248		10.1074/jbc.M109.043505	http://dx.doi.org/10.1074/jbc.M109.043505			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20023300	hybrid, Green Published			2022-12-25	WOS:000275553700072
J	Ma, DZ; Bai, XC; Zou, HF; Lai, YM; Jiang, Y				Ma, Dongzhu; Bai, Xiaochun; Zou, Huafei; Lai, Yumei; Jiang, Yu			Rheb GTPase Controls Apoptosis by Regulating Interaction of FKBP38 with Bcl-2 and Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MTOR; PROTEIN; TOR; COMPLEX; GROWTH; RAPTOR; ACTIVATION; INHIBITOR; TARGET; ROLES	FKBP38 is a member of the family of FK506-binding proteins that acts as an inhibitor of the mammalian target of rapamycin (mTOR). The inhibitory action of FKBP38 is antagonized by Rheb, an oncogenic small GTPase, which interacts with FKBP38 and prevents its association with mTOR. In addition to the role in mTOR regulation, FKBP38 is also involved in binding and recruiting Bcl-2 and Bcl-XL, two anti-apoptotic proteins, to mitochondria. In this study, we investigated the possibility that Rheb controls apoptosis by regulating the interaction of FKBP38 with Bcl-2 and Bcl-XL. We demonstrate in vitro that the interaction of FKBP38 with Bcl-2 is regulated by Rheb in a GTP-dependent manner. In cultured cells, the interaction is controlled by Rheb in response to changes in amino acid and growth factor conditions. Importantly, we found that the Rheb-dependent release of Bcl-XL from FKBP38 facilitates the association of this anti-apoptotic protein with the pro-apoptotic protein Bak. Consequently, when Rheb activity increases, cells become more resistant to apoptotic inducers. Our findings reveal a novel mechanism through which growth factors and amino acids control apoptosis.	[Ma, Dongzhu; Zou, Huafei; Lai, Yumei; Jiang, Yu] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Bai, Xiaochun] So Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou 510510, Guangdong, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Southern Medical University - China	Jiang, Y (corresponding author), W1058 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	yuj5@pitt.edu		Bai, Xiaochun/0000-0001-9631-4781	National Institutes of Health [CA129821, GM068832]; NATIONAL CANCER INSTITUTE [R01CA129821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA129821 and GM068832 (to Y.J.).	Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Freilinger A, 2006, ONCOGENE, V25, P6467, DOI 10.1038/sj.onc.1209660; GERMAIN M, 2003, SCI STKE, pPE10; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma DZ, 2008, J BIOL CHEM, V283, P25963, DOI 10.1074/jbc.M802356200; Mak BC, 2004, CANCER INVEST, V22, P588, DOI 10.1081/CNV-200027144; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Nardella C, 2008, GENE DEV, V22, P2172, DOI 10.1101/gad.1699608; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Uhlenbrock K, 2009, FEBS LETT, V583, P965, DOI 10.1016/j.febslet.2009.02.015; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	31	39	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8621	8627		10.1074/jbc.M109.092353	http://dx.doi.org/10.1074/jbc.M109.092353			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20048149	Green Published, hybrid			2022-12-25	WOS:000275553700014
J	Soliman, GA; Acosta-Jaquez, HA; Dunlop, EA; Ekim, B; Maj, NE; Tee, AR; Fingar, DC				Soliman, Ghada A.; Acosta-Jaquez, Hugo A.; Dunlop, Elaine A.; Ekim, Bilgen; Maj, Nicole E.; Tee, Andrew R.; Fingar, Diane C.			mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; TUBEROUS SCLEROSIS COMPLEX-1; MAMMALIAN-CELL SIZE; GENE-PRODUCTS; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; INDUCED INHIBITION; TSC1-TSC2 COMPLEX; BINDING PARTNER; RAG GTPASES; TARGET	The mammalian target of rapamycin (mTOR) Ser/Thr kinase signals in at least two multiprotein complexes distinguished by their different partners and sensitivities to rapamycin. Acute rapamycin inhibits signaling by mTOR complex 1 (mTORC1) but not mTOR complex 2 (mTORC2), which both promote cell growth, proliferation, and survival. Although mTORC2 regulation remains poorly defined, diverse cellular mitogens activate mTORC1 signaling in a manner that requires sufficient levels of amino acids and cellular energy. Before the identification of distinct mTOR complexes, mTOR was reported to autophosphorylate on Ser-2481 in vivo in a rapamycin-and amino acid-insensitive manner. These results suggested that modulation of mTOR intrinsic catalytic activity does not universally underlie mTOR regulation. Here we re-examine the regulation of mTOR Ser-2481 autophosphorylation (Ser(P)-2481) in vivo by studying mTORC-specific Ser(P)-2481 inmTORC1 and mTORC2, with a primary focus on mTORC1. In contrast to previous work, we find that acute rapamycin and amino acid withdrawal markedly attenuate mTORC1-associated mTOR Ser(P)-2481 in cycling cells. Although insulin stimulates both mTORC1- and mTORC2-associated mTOR Ser(P)-2481 in a phosphatidylinositol 3-kinase-dependent manner, rapamycin acutely inhibits insulin-stimulated mTOR Ser(P)-2481 in mTORC1 but not mTORC2. By interrogating diverse mTORC1 regulatory input, we find that without exception mTORC1-activating signals promote, whereas mTORC1-inhibitory signals decrease mTORC1-associated mTOR Ser(P)-2481. These data suggest that mTORC1- and likely mTORC2-associated mTOR Ser-2481 autophosphorylation directly monitors intrinsic mTORC-specific catalytic activity and reveal that rapamycin inhibits mTORC1 signaling in vivo by reducing mTORC1 catalytic activity.	[Soliman, Ghada A.; Acosta-Jaquez, Hugo A.; Ekim, Bilgen; Maj, Nicole E.; Fingar, Diane C.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Soliman, Ghada A.; Fingar, Diane C.] Univ Michigan, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA; [Dunlop, Elaine A.; Tee, Andrew R.] Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cardiff University	Fingar, DC (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	dfingar@umich.edu	/J-6218-2019; Soliman, Ghada A/U-6472-2017	/0000-0002-9209-7561; Soliman, Ghada A/0000-0002-8629-6062; Tee, Andrew/0000-0002-5577-4631	National Institutes of Health [R01 DK-078135, K01 DK-60654]; American Diabetes Association; Michigan Diabetes Research and Training Center; American Heart Association; Worldwide Cancer Research [06-0914] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, K01DK060654, R01DK078135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Michigan Diabetes Research and Training Center; American Heart Association(American Heart Association); Worldwide Cancer Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK-078135 (to D. C. F.) and K01 DK-60654 ( to G. A. S.). This work was also supported by the American Diabetes Association, the Michigan Diabetes Research and Training Center (to D. C. F.), and the American Heart Association (to G. A. S. and B. E.).	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Avruch J, 2009, BIOCHEM SOC T, V37, P223, DOI 10.1042/BST0370223; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, IUBMB LIFE, V60, P483, DOI 10.1002/iub.56; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MACDOUGALD OA, 1995, J BIOL CHEM, V270, P647, DOI 10.1074/jbc.270.2.647; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Rosner M, 2009, HUM MOL GENET, V18, P3298, DOI 10.1093/hmg/ddp271; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; STAN R, 1994, J BIOL CHEM, V269, P32027; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103	69	172	178	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7866	7879		10.1074/jbc.M109.096222	http://dx.doi.org/10.1074/jbc.M109.096222			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20022946	Green Published, hybrid			2022-12-25	WOS:000275413800004
J	Fletcher, PL; Fletcher, MD; Weninger, K; Anderson, TE; Martin, BM				Fletcher, Paul L., Jr.; Fletcher, Maryann D.; Weninger, Keith; Anderson, Trevor E.; Martin, Brian M.			Vesicle-associated Membrane Protein (VAMP) Cleavage by a New Metalloprotease from the Brazilian Scorpion Tityus serrulatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ACINAR-CELLS; SNARE COMPLEX; SINGLE-MOLECULE; BOTULINUM NEUROTOXINS; REGULATED EXOCYTOSIS; SECRETORY GRANULES; GUINEA-PIG; BINDING; FUSION; VENOM	We present evidence that venom from the Brazilian scorpion Tityus serrulatus and a purified fraction selectively cleave essential SNARE proteins within exocrine pancreatic tissue. Western blotting for vesicle-associated membrane protein type v-SNARE proteins (or synaptobrevins) reveals characteristic alterations to venom-treated excised pancreatic lobules in vitro. Immunocytochemistry by electron microscopy confirms both the SNARE identity as VAMP2 and the proteolysis of VAMP2 as a marked decrease in secondary antibody-conjugated colloidal gold particles that are predominantly associated with mature zymogen granules. Studies with recombinant SNARE proteins were used to determine the specific cleavage site in VAMP2 and the susceptibility of VAMP8 (endobrevin). The VAMP2 cleavage site is between the transmembrane anchor and the SNARE motif that assembles into the ternary SNARE complex. Inclusion of divalent chelating agents ( EDTA) with fraction nu, an otherwise active purified component from venom, eliminates SNARE proteolysis, suggesting the active protein is a metalloprotease. The unique cleavages of VAMP2 and VAMP8 may be linked to pancreatitis that develops following scorpion envenomation as both of these v-SNARE proteins are associated with zymogen granule membranes in pancreatic acinar cells. We have isolated antarease, a metalloprotease from fraction nu that cleaves VAMP2, and report its amino acid sequence.	[Fletcher, Paul L., Jr.; Fletcher, Maryann D.] E Carolina Univ, Dept Microbiol & Immunol, Brody Sch Med, Greenville, NC 27834 USA; [Weninger, Keith; Anderson, Trevor E.] N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; [Martin, Brian M.] NIMH, Lab Neurotoxicol, Natl Inst Hlth, Bethesda, MD 20892 USA	University of North Carolina; East Carolina University; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Fletcher, PL (corresponding author), E Carolina Univ, Dept Microbiol & Immunol, Brody Sch Med, Greenville, NC 27834 USA.	fletcherpa@ecu.edu		Fletcher, Paul/0000-0002-3200-4693	East Carolina University Center for Coastal Informatics and Modeling Funds; Burroughs Wellcome Fund; National Institutes of Health; NIMH; Intramural Research Program; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002344] Funding Source: NIH RePORTER	East Carolina University Center for Coastal Informatics and Modeling Funds; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural Research Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the East Carolina University Center for Coastal Informatics and Modeling Funds ( to P. L. F.), a Career Award at the Scientific Interface from the Burroughs Wellcome Fund ( to K. W.), and by the National Institutes of Health, NIMH, Intramural Research Program (to B. M. M.).	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; ANGUS LDG, 1995, ANN TROP PAEDIATR, V15, P285, DOI 10.1080/02724936.1995.11747785; Antonin W, 2002, MOL CELL BIOL, V22, P1545, DOI 10.1128/MCB.22.5.1545-1554.2002; Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; BARTHOLOMEW C, 1970, BMJ-BRIT MED J, V1, P666, DOI 10.1136/bmj.1.5697.666; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; Breidenbach MA, 2005, TRENDS MOL MED, V11, P377, DOI 10.1016/j.molmed.2005.06.012; Brunger AT, 2008, CELL MOL LIFE SCI, V65, P2296, DOI 10.1007/s00018-008-8088-0; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; FLETCHER MD, 1994, CELL TISSUE RES, V278, P255, DOI 10.1007/s004410050215; FLETCHER PL, 1992, EUR J CELL BIOL, V58, P259; Fletcher PL, 1996, TOXICON, V34, P1399, DOI 10.1016/S0041-0101(96)00093-1; FLETCHER PL, 2007, MOL BIOL CELL S, V18, pA272; FLETCHER PL, 2008, MOL BIOL CELL S, V19, pA1727; Fox JW, 2008, FEBS J, V275, P3016, DOI 10.1111/j.1742-4658.2008.06466.x; Gaisano HY, 2000, PANCREAS, V20, P217, DOI 10.1097/00006676-200004000-00001; Gwee MC, 2002, CLIN EXP PHARMACOL P, V29, P795, DOI 10.1046/j.1440-1681.2002.03726.x; Hansen NJ, 1999, J BIOL CHEM, V274, P22871, DOI 10.1074/jbc.274.32.22871; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; ISMAIL M, 1995, TOXICON, V33, P825, DOI 10.1016/0041-0101(95)00005-7; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; JENA BP, 1994, J CELL BIOL, V124, P43, DOI 10.1083/jcb.124.1.43; KLOPPEL G, 1986, VIRCHOWS ARCH A, V409, P791, DOI 10.1007/BF00710764; Li YL, 2007, BIOPHYS J, V93, P2178, DOI 10.1529/biophysj.106.101220; Mayer A, 2002, ANNU REV CELL DEV BI, V18, P289, DOI 10.1146/annurev.cellbio.18.032202.114809; MELDOLESI J, 1971, J CELL BIOL, V49, P109, DOI 10.1083/jcb.49.1.109; Merchant M, 2000, ELECTROPHORESIS, V21, P1164, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1164::AID-ELPS1164>3.0.CO;2-0; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Pellizzari R, 1999, PHILOS T R SOC B, V354, P259, DOI 10.1098/rstb.1999.0377; Pessini AC, 2001, TOXICON, V39, P1495, DOI 10.1016/S0041-0101(01)00122-2; Pickett JA, 2007, BIOCHEM BIOPH RES CO, V359, P599, DOI 10.1016/j.bbrc.2007.05.128; POSSANI LD, 1991, J BIOL CHEM, V266, P3178; POSSANI LD, 1977, ARCH BIOCHEM BIOPHYS, V180, P394, DOI 10.1016/0003-9861(77)90053-4; Rosado JA, 2005, AM J PHYSIOL-CELL PH, V288, pC214, DOI 10.1152/ajpcell.00241.2004; Rossetto O, 2001, TOXICON, V39, P27, DOI 10.1016/S0041-0101(00)00163-X; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SCHEELE GA, 1975, J BIOL CHEM, V250, P2660; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Valentijn JA, 1996, EUR J CELL BIOL, V70, P33; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Wasle B, 2002, CELL SIGNAL, V14, P191, DOI 10.1016/S0898-6568(01)00257-1; Waterman J. A., 1938, Transactions of the Royal Society of Tropical Medicine and Hygiene, V31, P607, DOI 10.1016/S0035-9203(38)90154-3; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; Weninger K, 2003, P NATL ACAD SCI USA, V100, P14800, DOI 10.1073/pnas.2036428100; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4	55	49	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7405	7416		10.1074/jbc.M109.028365	http://dx.doi.org/10.1074/jbc.M109.028365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20026600	Green Published, hybrid			2022-12-25	WOS:000275415600053
J	Liu, BY; Yildirir, G; Wang, JY; Tolun, G; Griffith, JD; Englund, PT				Liu, Beiyu; Yildirir, Gokben; Wang, Jianyang; Tolun, Goekhan; Griffith, Jack D.; Englund, Paul T.			TbPIF1, a Trypanosoma brucei Mitochondrial DNA Helicase, Is Essential for Kinetoplast Minicircle Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERTWINED CATENATED DIMERS; CRITHIDIA-FASCICULATA; SACCHAROMYCES-CEREVISIAE; RNA INTERFERENCE; FISSION YEAST; TOPOISOMERASE; SEGREGATION; LOCALIZATION; EXPRESSION; COMPLEXES	Kinetoplast DNA, the trypanosome mitochondrial genome, is a network of interlocked DNA rings including several thousand minicircles and a few dozen maxicircles. Minicircles replicate after release from the network, and their progeny reattach. Remarkably, trypanosomes have six mitochondrial DNA helicases related to yeast PIF1 helicase. Here we report that one of the six, TbPIF1, functions in minicircle replication. RNA interference (RNAi) of TbPIF1 causes a growth defect and kinetoplast DNA loss. Minicircle replication intermediates decrease during RNAi, and there is an accumulation of multiply interlocked, covalently closed minicircle dimers (fraction U). In studying the significance of fraction U, we found that this species also accumulates during RNAi of mitochondrial topoisomerase II. These data indicate that one function of TbPIF1 is an involvement, together with topoisomerase II, in the segregation of minicircle progeny.	[Englund, Paul T.] Johns Hopkins Med Sch, Dept Biol Chem, Baltimore, MD 21205 USA; [Tolun, Goekhan; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Johns Hopkins University; Johns Hopkins Medicine; University of North Carolina; University of North Carolina Chapel Hill	Englund, PT (corresponding author), Johns Hopkins Med Sch, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	penglund@jhmi.edu	TOLUN, Gökhan/D-1971-2012; Tolun, Gokhan/AAG-9606-2021	TOLUN, Gökhan/0000-0001-6166-9451; Tolun, Gokhan/0000-0001-6166-9451	National Institutes of Health [AI058613, GM31819]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058613 (to P.T.E.) and GM31819 (to J.D.G.).	Abu-Elneel K, 2001, J CELL BIOL, V153, P725, DOI 10.1083/jcb.153.4.725; Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; CHEN JH, 1995, CELL, V80, P61, DOI 10.1016/0092-8674(95)90451-4; Downey N, 2005, EUKARYOT CELL, V4, P765, DOI 10.1128/EC.4.4.765-774.2005; Engel ML, 1998, NUCLEIC ACIDS RES, V26, P4733, DOI 10.1093/nar/26.20.4733; FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Klingbeil MM, 2002, MOL CELL, V10, P175, DOI 10.1016/S1097-2765(02)00571-3; Kulikowicz T, 2006, J BIOL CHEM, V281, P3048, DOI 10.1074/jbc.M505977200; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; Li CJ, 1997, J BIOL CHEM, V272, P20787, DOI 10.1074/jbc.272.33.20787; Liu BY, 2006, MOL CELL BIOL, V26, P5382, DOI 10.1128/mcb.00369-06; Liu BY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000589; Liu BY, 2009, MOL CELL, V35, P490, DOI 10.1016/j.molcel.2009.07.004; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Liu YN, 2007, MOL MICROBIOL, V64, P676, DOI 10.1111/j.1365-2958.2007.05686.x; MELENDY T, 1988, CELL, V55, P1083, DOI 10.1016/0092-8674(88)90252-8; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; PEREZMORGA DL, 1993, NUCLEIC ACIDS RES, V21, P1327, DOI 10.1093/nar/21.5.1327; RAUCH CA, 1993, EMBO J, V12, P403, DOI 10.1002/j.1460-2075.1993.tb05672.x; ROBINSON DR, 1994, J CELL BIOL, V126, P641, DOI 10.1083/jcb.126.3.641; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; RYAN KA, 1989, MOL CELL BIOL, V9, P3212, DOI 10.1128/MCB.9.8.3212; Ryu GH, 2004, NUCLEIC ACIDS RES, V32, P4205, DOI 10.1093/nar/gkh720; Saxowsky TT, 2003, J BIOL CHEM, V278, P49095, DOI 10.1074/jbc.M308565200; Scocca JR, 2008, MOL MICROBIOL, V67, P820, DOI 10.1111/j.1365-2958.2007.06087.x; SHAPIRO TA, 1994, MOL CELL BIOL, V14, P3660, DOI 10.1128/MCB.14.6.3660; Shlomai J, 2004, CURR MOL MED, V4, P623, DOI 10.2174/1566524043360096; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; Tanaka H, 2002, NUCLEIC ACIDS RES, V30, P4728, DOI 10.1093/nar/gkf590; THRESHER R, 1992, METHOD ENZYMOL, V211, P481; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang ZF, 2001, EMBO J, V20, P4674, DOI 10.1093/emboj/20.17.4674; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	42	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7056	7066		10.1074/jbc.M109.084038	http://dx.doi.org/10.1074/jbc.M109.084038			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042610	Green Published, hybrid			2022-12-25	WOS:000275415600019
J	Naik, AK; Lieber, MR; Raghavan, SC				Naik, Abani Kanta; Lieber, Michael R.; Raghavan, Sathees C.			Cytosines, but Not Purines, Determine Recombination Activating Gene (RAG)-induced Breaks on Heteroduplex DNA Structures IMPLICATIONS FOR GENOMIC INSTABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR BREAKPOINT REGION; V(D)J RECOMBINATION; CHROMOSOMAL TRANSLOCATIONS; RAG2 PROTEINS; STRUCTURE REQUIREMENTS; STAGE SPECIFICITY; SIGNAL SEQUENCES; HUMAN-DISEASE; CODING ENDS; IN-VITRO	The sequence specificity of the recombination activating gene (RAG) complex during V(D)J recombination has been well studied. RAGs can also act as structure-specific nuclease; however, little is known about the mechanism of its action. Here, we show that in addition to DNA structure, sequence dictates the pattern and efficiency of RAG cleavage on altered DNA structures. Cytosine nucleotides are preferentially nicked by RAGs when present at single-stranded regions of heteroduplex DNA. Although unpaired thymine nucleotides are also nicked, the efficiency is many fold weaker. Induction of single- or double-strand breaks by RAGs depends on the position of cytosines and whether it is present on one or both of the strands. Interestingly, RAGs are unable to induce breaks when adenine or guanine nucleotides are present at single- strand regions. The nucleotide present immediately next to the bubble sequence could also affect RAG cleavage. Hence, we propose "C(d)C(S)C(S)" (d, double-stranded; s, single-stranded) as a consensus sequence for RAG-induced breaks at single-/double-strand DNA transitions. Such a consensus sequence motif is useful for explaining RAG cleavage on other types of DNA structures described in the literature. Therefore, the mechanism of RAG cleavage described here could explain facets of chromosomal rearrangements specific to lymphoid tissues leading to genomic instability.	Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Lieber, Michael R.] Univ So Calif, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90089 USA	Indian Institute of Science (IISC) - Bangalore; University of Southern California		sathees@biochem.iisc.ernet.in	Naik, Abani K/D-1254-2013	Naik, Abani K/0000-0001-9032-1147; Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345	Department of Science and Technology, India [SR/SO/BB-051/2007]; Indian Institute of Science	Department of Science and Technology, India(Department of Science & Technology (India)); Indian Institute of Science(Indian Institute of Science (IISC) - Bangalore)	This work was supported in part by grants from the Department of Science and Technology, India (SR/SO/BB-051/2007), and an Indian Institute of Science startup grant ( to S. C. R.).	Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Besmer E, 1998, MOL CELL, V2, P817, DOI 10.1016/S1097-2765(00)80296-8; Cuomo CA, 1996, MOL CELL BIOL, V16, P5683; Franco S, 2006, DNA REPAIR, V5, P1030, DOI 10.1016/j.dnarep.2006.05.024; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Grawunder U, 1997, NUCLEIC ACIDS RES, V25, P1375, DOI 10.1093/nar/25.7.1375; Greenbaum JA, 2007, GENOME RES, V17, P940, DOI 10.1101/gr.5602807; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Jones JM, 2001, P NATL ACAD SCI USA, V98, P12926, DOI 10.1073/pnas.221471198; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Lewis SM, 1997, MOL CELL BIOL, V17, P3125, DOI 10.1128/MCB.17.6.3125; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; LIEBER MR, 1987, GENE DEV, V1, P751, DOI 10.1101/gad.1.8.751; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Marculescu R, 2002, J EXP MED, V195, P85, DOI 10.1084/jem.20011578; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Naik AK, 2008, DNA REPAIR, V7, P1384, DOI 10.1016/j.dnarep.2008.04.010; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Nishihara T, 2004, MOL CELL BIOL, V24, P3692, DOI 10.1128/MCB.24.9.3692-3702.2004; Oettinger MA, 2004, IMMUNOL REV, V200, P165, DOI 10.1111/j.0105-2896.2004.00172.x; Raghavan SC, 2007, FRONT BIOSCI, V12, P4402, DOI 10.2741/2397; Raghavan SC, 2007, DNA REPAIR, V6, P751, DOI 10.1016/j.dnarep.2006.12.016; Raghavan SC, 2006, BIOESSAYS, V28, P480, DOI 10.1002/bies.20353; Raghavan SC, 2005, MOL CELL BIOL, V25, P6475, DOI 10.1128/MCB.25.15.6475-6484.2005; Raghavan SC, 2005, J BIOL CHEM, V280, P22749, DOI 10.1074/jbc.M502952200; Raghavan SC, 2005, MOL CELL BIOL, V25, P5904, DOI 10.1128/MCB.25.14.5904-5919.2005; Raghavan SC, 2004, CELL CYCLE, V3, P762; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Raghavan SC, 2001, J BIOL CHEM, V276, P29126, DOI 10.1074/jbc.M103797200; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Roth DB, 2003, NAT REV IMMUNOL, V3, P656, DOI 10.1038/nri1152; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; Rval P, 2008, NUCLEIC ACIDS RES, V36, P2060, DOI 10.1093/nar/gkn049; Sadofsky MJ, 2004, IMMUNOL REV, V200, P83, DOI 10.1111/j.0105-2896.2004.00164.x; Santagata S, 1999, MOL CELL, V4, P935, DOI 10.1016/S1097-2765(00)80223-3; Schatz David G., 2004, Cell, VS116, pS103, DOI 10.1016/S0092-8674(04)00042-X; Schatz DG, 2005, CURR TOP MICROBIOL, V290, P49; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; Shockett PE, 1999, MOL CELL BIOL, V19, P4159; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Yu KF, 1999, MOL CELL BIOL, V19, P8094; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	56	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7587	7597		10.1074/jbc.M109.089631	http://dx.doi.org/10.1074/jbc.M109.089631			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20051517	Green Published, hybrid			2022-12-25	WOS:000275415600070
J	Lee, JH; Kang, Y; Khare, V; Jin, ZY; Kang, MY; Yoon, Y; Hyun, JW; Chung, MH; Cho, SI; Jun, JY; Chang, IY; You, HJ				Lee, J-H; Kang, Y.; Khare, V.; Jin, Z-Y; Kang, M-Y; Yoon, Y.; Hyun, J-W; Chung, M-H; Cho, S-I; Jun, J. Y.; Chang, I-Y; You, H. J.			The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage	ONCOGENE			English	Article						PIG3; DNA damage response; DNA damage checkpoint; gamma-H2AX; DNA repair	DOUBLE-STRAND BREAKS; S-PHASE CHECKPOINT; HISTONE H2AX; ATAXIA-TELANGIECTASIA; ATM ACTIVATION; MRE11-RAD50-NBS1 COMPLEX; ULTRAVIOLET-RADIATION; IONIZING-RADIATION; STRESS RESPONSES; GENOTOXIC STRESS	The p53-inducible gene 3 (PIG3) is originally isolated as a p53 downstream target gene, but its function remains unknown. Here, we report a role of PIG3 in the activation of DNA damage checkpoints, after UV irradiation or radiomimetic drug neocarzinostatin (NCS). We show that depletion of endogenous PIG3 sensitizes cells to DNA damage agents, and impaired DNA repair. PIG3 depletion also allows for UV- and NCS-resistant DNA synthesis and permits cells to progress into mitosis, indicating that PIG3 knockdown can suppress intra-S phase and G2/M checkpoints. PIG3-depleted cells show reduced Chk1 and Chk2 phosphorylation after DNA damage, which may directly contribute to checkpoint bypass. PIG3 exhibited diffuse nuclear staining in the majority of untreated cells and forms discrete nuclear foci in response to DNA damage. PIG3 colocalizes with gamma-H2AX and 53BP1 to sites of DNA damage after DNA damage, and binds to a gamma-H2AX. Notably, PIG3 depletion decreases the efficient induction and maintenance of H2AX phosphorylation after DNA damage. Moreover, PIG3 contributes to the recruitment of 53BP1, Mre11, Rad50 and Nbs1 to the sites of DNA break lesions in response to DNA damage. Our combined results suggest that PIG3 is a critical component of the DNA damage response pathway and has a direct role in the transmission of the DNA damage signal from damaged DNA to the intra-S and G2/M checkpoint machinery in human cells. Oncogene (2010) 29, 1431-1450; doi:10.1038/onc.2009.438; published online 21 December 2009	[Lee, J-H; Kang, Y.; Khare, V.; Jin, Z-Y; Kang, M-Y; Yoon, Y.; You, H. J.] Chosun Univ, Dept Biomat, DNA Repair Res Ctr, Kwangju 501759, South Korea; [Lee, J-H; Kang, Y.; Kang, M-Y; Yoon, Y.; You, H. J.] Chosun Univ, Sch Med, Dept Pharmacol, Kwangju 501759, South Korea; [Hyun, J-W] Cheju Natl Univ, Sch Med, Dept Biochem, Jeju Si, South Korea; [Chung, M-H] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Cho, S-I] Chosun Univ, Sch Med, Dept Otorhinolaryngol, Kwangju 501759, South Korea; [Jun, J. Y.] Chosun Univ, Sch Med, Dept Physiol, Kwangju 501759, South Korea; [Chang, I-Y] Chosun Univ, Sch Med, Dept Anat, Kwangju 501759, South Korea	Chosun University; Chosun University; Jeju National University; Seoul National University (SNU); Chosun University; Chosun University; Chosun University	You, HJ (corresponding author), 2F Chosun Univ, Sch Med, Dept Pharmacol, DNA Repair Res Ctr & Bioengn BD, 375 Seosuk Dong, Kwangju 501759, Chonnam, South Korea.	hjyou@chosun.ac.kr		You, Ho Jin/0000-0002-0530-4017; Lee, Jung-Hee/0000-0002-6889-9126	Ministry of Education, Science and Technology [M 2009-0065519, M 20706000032]; Korean government; Chosun University	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean government(Korean Government); Chosun University	This research was supported by grants (M 2009-0065519 and M 20706000032) from the Ministry of Education, Science and Technology, the Korean government and from the Chosun University, 2002.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ahn JY, 2000, CANCER RES, V60, P5934; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Contente A, 2002, NAT GENET, V30, P315, DOI 10.1038/ng836; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Flatt PM, 2000, CANCER LETT, V156, P63, DOI 10.1016/S0304-3835(00)00441-9; Foray N, 2003, EMBO J, V22, P2860, DOI 10.1093/emboj/cdg274; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Garg R, 2004, MOL CANCER RES, V2, P362; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Horejsi Z, 2004, ONCOGENE, V23, P3122, DOI 10.1038/sj.onc.1207447; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kirkland RA, 2002, J NEUROSCI, V22, P6480; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu QH, 2000, GENE DEV, V14, P1448; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Morgan SE, 1997, MOL CELL BIOL, V17, P2020, DOI 10.1128/MCB.17.4.2020; Nicholls CD, 2004, J BIOL CHEM, V279, P24171, DOI 10.1074/jbc.M401049200; Nicholls CD, 2008, BBA-GENE REGUL MECH, V1779, P838, DOI 10.1016/j.bbagrm.2008.08.009; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Porte S, 2009, J BIOL CHEM, V284, P17194, DOI 10.1074/jbc.M109.001800; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stuck M, 2004, DNA REPAIR, V3, P953, DOI 10.1016/j.dnarep.2004.03.007; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang JL, 2002, CELL CYCLE, V1, P267, DOI 10.4161/cc.1.4.137; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	63	58	64	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	10					1431	1450		10.1038/onc.2009.438	http://dx.doi.org/10.1038/onc.2009.438			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	566SD	20023697				2022-12-25	WOS:000275392400003
J	Albert, A; Yunta, C; Arranz, R; Pena, A; Salido, E; Valpuesta, JM; Martin-Benito, J				Albert, Armando; Yunta, Cristina; Arranz, Rocio; Pena, Alvaro; Salido, Eduardo; Valpuesta, Jose Maria; Martin-Benito, Jaime			Structure of GroEL in Complex with an Early Folding Intermediate of Alanine Glyoxylate Aminotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY HYPEROXALURIA TYPE-1; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; CHAPERONIN GROEL; VISUALIZATION; CONFORMATION; MUTATION; IMAGES; ACTIN	Primary hyperoxaluria type 1 is a rare autosomal recessive disease caused by mutations in the alanine glyoxylate aminotransferase gene (AGXT). We have previously shown that P11L and I340M polymorphisms together with I244T mutation (AGXT-LTM) represent a conformational disease that could be amenable to pharmacological intervention. Thus, the study of the folding mechanism of AGXT is crucial to understand the molecular basis of the disease. Here, we provide biochemical and structural data showing that AGXT-LTM is able to form non-native folding intermediates. The three-dimensional structure of a complex between the bacterial chaperonin GroEL and a folding intermediate of AGXT-LTM mutant has been solved by cryoelectron microscopy. The electron density map shows the protein substrate in a non-native extended conformation that crosses the GroEL central cavity. Addition of ATP to the complex induces conformational changes on the chaperonin and the internalization of the protein substrate into the folding cavity. The structure provides a three-dimensional picture of an in vivo early ATP-dependent step of the folding reaction cycle of the chaperonin and supports a GroEL functional model in which the chaperonin promotes folding of the AGXT-LTM mutant protein through forced unfolding mechanism.	[Albert, Armando] CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estructural, E-28006 Madrid, Spain; [Yunta, Cristina; Salido, Eduardo] Univ La Laguna, Hosp Univ Canarias, Inst Tecnol Biomed, Ctr Invest Biomed Red Enfermedades Raras, E-38320 Tenerife, Spain; [Arranz, Rocio; Pena, Alvaro; Valpuesta, Jose Maria; Martin-Benito, Jaime] Campus Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Albert, A (corresponding author), CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estructural, Serrano 119, E-28006 Madrid, Spain.	xalbert@iqfr.csic.es	Valpuesta, José M/T-1977-2017; Albert, Armando/J-2373-2012; Salido, Eduardo C/I-2232-2015; Valpuesta, Jose M/AAA-6002-2019	Valpuesta, José M/0000-0001-7468-8053; Albert, Armando/0000-0002-0026-6816; Salido, Eduardo C/0000-0001-9599-9854; Martin-Benito Romero, Jaime/0000-0002-8541-4709; Arranz, Rocio/0000-0001-5321-0915	Spanish "Plan Nacional" (Ministerio de Ciencia e Innovacion) [BFU2008-00368/BMC, BFU2007-62382/BMC, SAF2007-62343]; "Factoria de Cristalizacion" Consolider Ingenio 2010	Spanish "Plan Nacional" (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "Factoria de Cristalizacion" Consolider Ingenio 2010(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Grants BFU2008-00368/BMC (to A. A.), BFU2007-62382/BMC (to J.M.V.), and SAF2007-62343 (to E. S.) from the Spanish "Plan Nacional" (Ministerio de Ciencia e Innovacion) and "Factoria de Cristalizacion" Consolider Ingenio 2010 (to A. A.).	BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1995, NAT STRUCT BIOL, V2, P1083, DOI 10.1038/nsb1295-1083; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen DH, 2006, STRUCTURE, V14, P1711, DOI 10.1016/j.str.2006.09.010; Clare DK, 2009, NATURE, V457, P107, DOI 10.1038/nature07479; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Elad N, 2008, J STRUCT BIOL, V162, P108, DOI 10.1016/j.jsb.2007.11.007; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hoppe B, 2009, KIDNEY INT, V75, P1264, DOI 10.1038/ki.2009.32; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Madan D, 2008, J BIOL CHEM, V283, P32003, DOI 10.1074/jbc.M802898200; MARABINI R, 1994, BIOPHYS J, V66, P1804, DOI 10.1016/S0006-3495(94)80974-9; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Sambrook J, 2001, MOL CLONING LAB MANU; Santana A, 2003, P NATL ACAD SCI USA, V100, P7277, DOI 10.1073/pnas.1131968100; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Williams EL, 2009, HUM MUTAT, V30, P910, DOI 10.1002/humu.21021; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	33	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6371	6376		10.1074/jbc.M109.062471	http://dx.doi.org/10.1074/jbc.M109.062471			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20056599	Green Published, hybrid			2022-12-25	WOS:000275367500041
J	Arbel, N; Shoshan-Barmatz, V				Arbel, Nir; Shoshan-Barmatz, Varda			Voltage-dependent Anion Channel 1-based Peptides Interact with Bcl-2 to Prevent Antiapoptotic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELL-DEATH; MITOCHONDRIAL PERMEABILITY TRANSITION; CYTOCHROME-C RELEASE; FAMILY-MEMBERS; MEMBRANE PERMEABILIZATION; ENDOPLASMIC-RETICULUM; CANCER-THERAPY; BH3 DOMAIN; VDAC; PROTEINS	The antiapoptotic proteins of the Bcl-2 family are expressed at high levels in many types of cancer. However, the mechanism by which Bcl-2 family proteins regulate apoptosis is not fully understood. Here, we demonstrate the interaction of Bcl-2 with the outer mitochondrial membrane protein, voltage-dependent anion channel 1 (VDAC1). A direct interaction of Bcl-2 with bilayer-reconstituted purified VDAC was demonstrated, with Bcl-2 decreasing channel conductance. Expression of Bcl-2-GFP prevented apoptosis in cells expressing native but not certain VDAC1 mutants. VDAC1 sequences and amino acid residues important for interaction with Bcl-2 were defined through site-directed mutagenesis. Synthetic peptides corresponding to the VDAC1 N-terminal region and selected sequences bound specifically, in a concentration-and time-dependent manner, to immobilized Bcl-2, as revealed by the real-time surface plasmon resonance. Moreover, expression of the VDAC1-based peptides in cells over-expressing Bcl-2 prevented Bcl-2-mediated protection against staurosporine-induced apoptotic cell death. Similarly, a cell-permeable VDAC1-based synthetic peptide was also found to prevent Bcl-2-GFP-mediated protection against apoptosis. These results point to Bcl-2 as promoting tumor cell survival through binding to VDAC1, thereby inhibiting cytochrome c release and apoptotic cell death. Moreover, these findings suggest that interfering with the binding of Bcl-2 to mitochondria by VDAC1-based peptides may serve to potentiate the efficacy of conventional chemotherapeutic agents.	[Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il			Israel Science Foundation; Ministry of Health, Israel	Israel Science Foundation(Israel Science Foundation); Ministry of Health, Israel	This work was supported in part by grants from the Israel Science Foundation terminal region of VDAC1 constitutes a mobile component and the Chief Scientist Office of the Ministry of Health, Israel.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; De Marchi U, 2004, J BIOL CHEM, V279, P37415, DOI 10.1074/jbc.M314093200; De Pinto V, 2008, J BIOENERG BIOMEMBR, V40, P139, DOI 10.1007/s10863-008-9140-3; De Pinto Vito, 2003, Ital J Biochem, V52, P17; Dias N, 2002, MOL CANCER THER, V1, P347; Dinnen RD, 2007, J BIOL CHEM, V282, P26675, DOI 10.1074/jbc.M701864200; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Halestrap AP, 2000, BIOCHEM SOC T, V28, P170, DOI 10.1042/bst0280170; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Holinger EP, 1999, J BIOL CHEM, V274, P13298, DOI 10.1074/jbc.274.19.13298; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Israelson A, 2008, CELL CALCIUM, V43, P196, DOI 10.1016/j.ceca.2007.05.006; Jarver P, 2004, DRUG DISCOV TODAY, V9, P395, DOI 10.1016/S1359-6446(04)03042-9; Junankar PR, 1995, J MUSCLE RES CELL M, V16, P595, DOI 10.1007/BF00130241; Kim R, 2007, CANCER GENE THER, V14, P1, DOI 10.1038/sj.cgt.7700986; Koppel DA, 1998, J BIOL CHEM, V273, P13794, DOI 10.1074/jbc.273.22.13794; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LAEMMLI UK, 1970, NATURE, V227, P685; Lemasters JJ, 1999, CARDIOVASC RES, V44, P470, DOI 10.1016/S0008-6363(99)00368-5; Leone M, 2003, CANCER RES, V63, P8118; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Mannella CA, 1997, J BIOENERG BIOMEMBR, V29, P525, DOI 10.1023/A:1022489832594; MIYASHITA T, 1993, BLOOD, V81, P151; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Popp B, 1996, J BIOL CHEM, V271, P13593, DOI 10.1074/jbc.271.23.13593; REYMANN S, 1995, BIOCHEM MOL MED, V54, P75, DOI 10.1006/bmme.1995.1011; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Schimmer AD, 2001, CELL DEATH DIFFER, V8, P725, DOI 10.1038/sj.cdd.4400870; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P577, DOI 10.1073/pnas.97.2.577; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Shoshan-Barmatz V, 2004, BBA-BIOENERGETICS, V1657, P105, DOI 10.1016/j.bbabio.2004.02.009; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Sugiyama T, 2002, ONCOGENE, V21, P4944, DOI 10.1038/sj.onc.1205621; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; Tsujimoto Y, 2002, BIOCHIMIE, V84, P187, DOI 10.1016/S0300-9084(02)01370-6; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; Vidal L, 2005, EUR J CANCER, V41, P2812, DOI 10.1016/j.ejca.2005.06.029; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205	67	126	132	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6053	6062		10.1074/jbc.M109.082990	http://dx.doi.org/10.1074/jbc.M109.082990			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037155	hybrid, Green Published			2022-12-25	WOS:000275367500008
J	Bilkovski, R; Schulte, DM; Oberhauser, F; Gomolka, M; Udelhoven, M; Hettich, MM; Roth, B; Heidenreich, A; Gutschow, C; Krone, W; Laudes, M				Bilkovski, Roman; Schulte, Dominik M.; Oberhauser, Frank; Gomolka, Matthias; Udelhoven, Michael; Hettich, Moritz M.; Roth, Bernhard; Heidenreich, Axel; Gutschow, Christian; Krone, Wilhelm; Laudes, Matthias			Role of Wnt-5a in the Determination of Human Mesenchymal Stem Cells into Preadipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UMBILICAL-CORD BLOOD; N-TERMINAL KINASE; TRANSCRIPTION FACTOR FBI-1; HUMAN BONE-MARROW; BINDING-PROTEIN; ADIPOSE-TISSUE; SIGNALING PATHWAY; PROGENITOR CELLS; DIFFERENTIATION; ADIPOGENESIS	Increasing adipocyte size as well as numbers is important in the development of obesity and type 2 diabetes, with adipocytes being generated from mesenchymal precursor cells. This process includes the determination of mesenchymal stem cells (MSC) into preadipocytes (PA) and the differentiation of PA into mature fat cells. Although the process of differentiation has been highly investigated, the determination in humans is poorly understood. In this study, we compared human MSC and human committed PA on a cellular and molecular level to gain further insights into the regulatory mechanisms in the determination process. Both cell types showed similar morphology and expression patterns of common mesenchymal and hematopoietic surface markers. However, although MSC were able to differentiate into adipocytes and osteocytes, PA were only able to undergo adipogenesis, indicating that PA lost their multipotency during determination. WNT-5a expression showed significantly higher levels in MSC compared with PA suggesting that WNT-5a down-regulation might be important in the determination process. Indeed, incubation of human MSC in medium containing neutralizing WNT-5a antibodies abolished their ability to undergo osteogenesis, although adipogenesis was still possible. An opposite effect was achieved using recombinant WNT-5a protein. On a molecular level, WNT-5a was found to promote c-Jun N-terminal kinase-dependent intracellular signaling in MSC. Activation of this noncanonical pathway resulted in the induction of osteopontin expression further indicating pro-osteogenic effects of WNT-5a. Our data suggest that WNT-5a is necessary to maintain osteogenic potential of MSC and that inhibition of WNT-5a signaling therefore plays a role in their determination into PA in humans.	[Hettich, Moritz M.; Krone, Wilhelm] Univ Cologne, Childrens Hosp, Dept Internal Med 2, D-50937 Cologne, Germany; [Hettich, Moritz M.; Krone, Wilhelm] Univ Cologne, Childrens Hosp, Ctr Mol Med, D-50937 Cologne, Germany; [Roth, Bernhard] Univ Cologne, Childrens Hosp, Dept Neonatol, D-50937 Cologne, Germany; [Heidenreich, Axel] Univ Aachen, Dept Urol, D-52074 Aachen, Germany; [Gutschow, Christian] Univ Cologne, Dept Gen & Abdominal Surg, D-50937 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; RWTH Aachen University; University of Cologne	Laudes, M (corresponding author), Univ Cologne, Zentrum Mol Med, Klin & Poliklin Innere Med 2, Kerpener Str 62, D-50937 Cologne, Germany.	matthias.laudes@uk-koeln.de	Laudes, Matthias/C-8885-2011; Schulte, Dominik M/G-8653-2013	Schulte, Dominik M/0000-0002-4622-6051	KollnFortune Program [KF167/2005]	KollnFortune Program	This work was supported by KollnFortune Program Grant KF167/2005 (to M.L.).	Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bowers RR, 2008, CELL CYCLE, V7, P1191, DOI 10.4161/cc.7.9.5815; Bowers RR, 2007, CELL CYCLE, V6, P385, DOI 10.4161/cc.6.4.3804; Chan J, 2006, STEM CELLS, V24, P1879, DOI 10.1634/stemcells.2005-0564; Christodoulides C, 2006, J CELL SCI, V119, P2613, DOI 10.1242/jcs.02975; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Guo J, 2008, BONE, V43, P961, DOI 10.1016/j.bone.2008.06.011; GUO XJ, 1995, MOL CELL BIOL, V15, P476, DOI 10.1128/MCB.15.1.476; Hu D, 2008, CARCINOGENESIS, V29, P2317, DOI 10.1093/carcin/bgn239; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kakinuma S, 2003, STEM CELLS, V21, P217, DOI 10.1634/stemcells.21-2-217; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kim YM, 2008, INT J BIOCHEM CELL B, V40, P2482, DOI 10.1016/j.biocel.2008.04.016; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Laudes M, 2004, J BIOL CHEM, V279, P11711, DOI 10.1074/jbc.M310240200; Laudes M, 2009, EXP CLIN ENDOCR DIAB, V117, P146, DOI 10.1055/s-0028-1100379; Laudes M, 2008, J MOL MED, V86, P597, DOI 10.1007/s00109-008-0326-2; Lee MW, 2005, INT J HEMATOL, V81, P126, DOI 10.1532/IJH97.A10404; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Quasnichka H, 2006, CIRC RES, V99, P1329, DOI 10.1161/01.RES.0000253533.65446.33; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Tchoukalova Y, 2007, DIABETOLOGIA, V50, P151, DOI 10.1007/s00125-006-0496-9; Tchoukalova YD, 2004, AM J PHYSIOL-REG I, V287, pR1132, DOI 10.1152/ajpregu.00337.2004; Tominaga S, 2005, BIOCHEM BIOPH RES CO, V326, P499, DOI 10.1016/j.bbrc.2004.11.056; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wang JF, 2004, HAEMATOLOGICA, V89, P837; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008	39	81	83	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6170	6178		10.1074/jbc.M109.054338	http://dx.doi.org/10.1074/jbc.M109.054338			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032469	Green Published, hybrid			2022-12-25	WOS:000275367500021
J	Guntur, KVP; Guilherme, A; Xue, LT; Chawla, A; Czech, MP				Guntur, Kalyani V. P.; Guilherme, Adilson; Xue, Liting; Chawla, Anil; Czech, Michael P.			Map4k4 Negatively Regulates Peroxisome Proliferator-activated Receptor (PPAR) gamma Protein Translation by Suppressing the Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Cultured Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; AMINO-ACIDS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; TNF-ALPHA; PHAS-I; C-JUN; INITIATION	The receptor peroxisome proliferator-activated receptor gamma (PPAR gamma) is considered a master regulator of adipocyte differentiation and promotes glucose and lipid metabolism in mature adipocytes. We recently identified the yeast Sterile 20 (Ste20) protein kinase ortholog, Map4k4, in an RNA interference-based screen as an inhibitor of PPAR gamma expression in cultured adipocytes. Here, we show that RNA interference-mediated silencing of Map4k4 elevates the levels of both PPAR gamma 1 and PPAR gamma 2 proteins in 3T3-L1 adipocytes without affecting PPAR gamma mRNA levels, suggesting that Map4k4 regulates PPAR gamma at a post-transcriptional step. PPAR gamma degradation rates are remarkably rapid as measured in the presence of cycloheximide (t(1/2) = 2 h), but silencing Map4k4 had no effect on PPAR gamma degradation. However, depletion of Map4k4 significantly enhances [S-35] methionine/cysteine incorporation into proteins, suggesting that Map4k4 signaling decreases protein translation. We show a function of Map4k4 is to inhibit rapamycin-sensitive mammalian target of rapamycin ( mTOR) activity, decreasing 4E-BP1 phosphorylation. In addition, our results show mTOR and 4E-BP1 are required for the increased PPAR gamma protein expression upon Map4k4 knockdown. Consistent with this concept, adenovirus-mediated expression of Map4k4 decreased PPAR gamma protein levels and mTOR phosphorylation. These data show that Map4k4 negatively regulates PPAR gamma post-transcriptionally, by attenuating mTOR signaling and a 4E-BP1-dependent mechanism.	[Guntur, Kalyani V. P.; Guilherme, Adilson; Xue, Liting; Chawla, Anil; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Ste 100, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu			National Institutes of Health [DK30898-25, DK030638-25]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030898, R37DK030898, P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK30898-25 and DK030638-25 (to M. P. C.).	Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; Dumont F J, 1996, Life Sci, V58, P373; Floyd ZE, 2002, J BIOL CHEM, V277, P4062, DOI 10.1074/jbc.M108473200; Gao G, 2003, GENE THER, V10, P1926, DOI 10.1038/sj.gt.3302088; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Lin TA, 1996, J BIOL CHEM, V271, P30199, DOI 10.1074/jbc.271.47.30199; LIN TA, 1995, J BIOL CHEM, V270, P18531, DOI 10.1074/jbc.270.31.18531; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mothe-Satney I, 2004, J BIOL CHEM, V279, P42628, DOI 10.1074/jbc.M405173200; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Zhang B, 1996, MOL ENDOCRINOL, V10, P1457, DOI 10.1210/me.10.11.1457	37	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6595	6603		10.1074/jbc.M109.068502	http://dx.doi.org/10.1074/jbc.M109.068502			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20038583	Green Published, hybrid			2022-12-25	WOS:000275367500064
J	Ogunjimi, AA; Wiesner, S; Briant, DJ; Varelas, X; Sicheri, F; Forman-Kay, J; Wrana, JL				Ogunjimi, Abiodun A.; Wiesner, Silke; Briant, Douglas J.; Varelas, Xaralabos; Sicheri, Frank; Forman-Kay, Julie; Wrana, Jeffrey L.			The Ubiquitin Binding Region of the Smurf HECT Domain Facilitates Polyubiquitylation and Binding of Ubiquitylated Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DETERMINANTS; NMR-SPECTROSCOPY; CELL POLARITY; LIGASE; DEGRADATION; PROTEINS; SYSTEM; RHOA	Mono- and polyubiquitylation of proteins are key steps in a wide range of biological processes. However, the molecular mechanisms that mediate these different events are poorly understood. Here, we employed NMR spectroscopy to map a non-covalent ubiquitin binding surface (UBS) on the Smurf ubiquitin ligase HECT domain. Analysis of mutants of the HECT UBS reveal that interfering with the UBS surface blocked Smurf-dependent degradation of its substrate RhoA in cells. In vitro analysis revealed that the UBS was not required for UbcH7-dependent charging of the HECT catalytic cysteine. Surprisingly, although the UBS was required for polyubiquitylation of both Smurf itself and the Smurf substrate RhoA, it was not required for monoubiquitylation. Furthermore, we show that mutating the UBS interfered with efficient binding of a monou-biquitylated form of RhoA to the Smurf HECT domain. Our findings suggest the UBS promotes polyubiquitylation by stabilizing ubiquitylated substrate binding to the HECT domain.	[Ogunjimi, Abiodun A.; Briant, Douglas J.; Varelas, Xaralabos; Sicheri, Frank; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Wiesner, Silke; Forman-Kay, Julie] Hosp Sick Children, Dept Biochem, Toronto, ON M5G 1X8, Canada; [Sicheri, Frank; Wrana, Jeffrey L.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A1, Canada; [Forman-Kay, Julie] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	wrana@lunenfeld.ca	Sicheri, Frank/F-8856-2013; Wrana, Jeffrey/F-8857-2013; Varelas, Xaralabos/ABB-9141-2020	Varelas, Xaralabos/0000-0002-2882-4541; Wiesner, Silke/0000-0003-0015-0167; Forman-Kay, Julie/0000-0001-8265-972X	Canadian Cancer Society Research Institute; Canadian Institutes of Health Research [57795, 14339]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Cancer Society Research Institute grants (to J.F.-K.) and Canadian Institutes of Health Research Grants 57795 (to F.S.) and 14339 (to J.L.W.).	BARTELS H, 1995, BIOPOLYMERS, V37, P411, DOI 10.1002/bip.360370608; Bottomley MJ, 1999, J BIOMOL NMR, V13, P381, DOI 10.1023/A:1008393903034; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kay LE, 1997, CURR OPIN STRUC BIOL, V7, P722, DOI 10.1016/S0959-440X(97)80084-X; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484	23	55	58	22	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6308	6315		10.1074/jbc.M109.044537	http://dx.doi.org/10.1074/jbc.M109.044537			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20026602	hybrid, Green Published			2022-12-25	WOS:000275367500035
J	Wang, N; Dong, QM; Li, JJ; Jangra, RK; Fan, MY; Brasier, AR; Lemon, SM; Pfeffer, LM; Li, K				Wang, Nan; Dong, Qingming; Li, Jingjing; Jangra, Rohit K.; Fan, Meiyun; Brasier, Allan R.; Lemon, Stanley M.; Pfeffer, Lawrence M.; Li, Kui			Viral Induction of the Zinc Finger Antiviral Protein Is IRF3-dependent but NF-kappa B-independent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR-3; HEPATITIS-C VIRUS; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; SWINE-FEVER VIRUS; RIG-I; ADAPTER PROTEIN; PROTEASOMAL DEGRADATION; TRANSCRIPTION FACTORS; DIARRHEA VIRUS	The zinc finger antiviral protein (ZAP) is an interferon-stimulated gene that restricts the replication of retroviruses, alphaviruses, and filoviruses. Relatively little is known, however, regarding the detailed mechanism of ZAP induction during viral infections. We show that, although being inducible by either interferon or virus, expression of ZAP is more efficiently activated by virus than are several other classical interferon-stimulated genes and that viral induction of ZAP occurs under the direct control of interferon regulatory factor 3 (IRF3) independent of interferon paracrine/autocrine signaling. ZAP was up-regulated in cells unresponsive to type I and III interferons upon engagement of TLR3, retinoic inducible gene I/melanoma differentiation-associated gene 5 pathways, or ectopic expression of a constitutively active IRF3 mutant. Conversely, induction of ZAPby virus or dsRNA was severely impaired in cells expressing a dominant-negative mutant IRF3 and completely abrogated in cells lacking IRF3. In contrast to IRF3, ZAP induction was independent of NF-kappa B activity. Mutational analysis of the human ZAP promoter revealed that multiple interferon-stimulated response elements far distal to the transcription start site serve redundantly to control IRF3-dependent induction of ZAP transcription. Chromatin immunoprecipitation assays demonstrated that IRF3 selectively binds the distal interferon-stimulated response elements in human ZAP promoter following viral infection. Collectively, these data suggest that ZAP is a direct target gene of IRF3 action in cellular antiviral responses.	[Li, Kui] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38163 USA; [Fan, Meiyun; Pfeffer, Lawrence M.] Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Memphis, TN 38163 USA; [Jangra, Rohit K.; Lemon, Stanley M.] Univ Texas Med Branch, Ctr Hepatitis Res, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Jangra, Rohit K.; Lemon, Stanley M.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Brasier, Allan R.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Li, K (corresponding author), 858 Madison Ave,401B Mol Sci Bldg, Memphis, TN 38163 USA.	kli1@uthsc.edu	Jangra, Rohit/AAT-2869-2020; Jangra, Rohit K/B-2492-2012	Jangra, Rohit/0000-0002-3119-0869; Pfeffer, Lawrence/0000-0003-2809-1234; Brasier, Allan/0000-0002-5012-4090	National Institutes of Health [R21-DA018054, R01-AI069285, U19-AI066316, U19-AI40035, R21-AI081058]; NATIONAL CANCER INSTITUTE [R01CA133322, R01CA140346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081058, U19AI040035, R01AI069285, U19AI066316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA018054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health Grants R21-DA018054 and R01-AI069285 (to K. L.), U19-AI066316 (to L. M. P.), and U19-AI40035 and R21-AI081058 (to S. M. L.).	Bauhofer O, 2007, J VIROL, V81, P3087, DOI 10.1128/JVI.02032-06; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Clements JL, 2003, IMMUNOL REV, V191, P211, DOI 10.1034/j.1600-065X.2003.00002.x; Du ZY, 2007, J CELL BIOCHEM, V102, P1087, DOI 10.1002/jcb.21535; Elco CP, 2005, J VIROL, V79, P3920, DOI 10.1128/JVI.79.7.3920-3929.2005; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Floyd-Smith G, 1999, EXP CELL RES, V246, P138, DOI 10.1006/excr.1998.4296; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fredericksen B, 2002, VIRAL IMMUNOL, V15, P29, DOI 10.1089/088282402317340215; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Ikeda M, 1998, VIRUS RES, V56, P157, DOI 10.1016/S0168-1702(98)00063-X; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krasnoselskaya-Riz I, 2002, AIDS RES HUM RETROV, V18, P591, DOI 10.1089/088922202753747941; Langford M P, 1981, Methods Enzymol, V78, P339; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li Kui, 2009, V510, P211, DOI 10.1007/978-1-59745-394-3_16; LIN RT, 1994, J BIOL CHEM, V269, P17542; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lu Y, 2001, ONCOGENE, V20, P4777, DOI 10.1038/sj.onc.1204607; MacDonald MR, 2007, J VIROL, V81, P13509, DOI 10.1128/JVI.00402-07; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Marques J, 2008, J GEN VIROL, V89, P2767, DOI 10.1099/vir.0.2008/003558-0; Melchjorsen J, 2009, J INTERF CYTOK RES, V29, P199, DOI 10.1089/jir.2008.0050; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Muller S, 2007, J VIROL, V81, P2391, DOI 10.1128/JVI.01601-06; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nakaya T, 2001, BIOCHEM BIOPH RES CO, V283, P1150, DOI 10.1006/bbrc.2001.4913; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Pitha PM, 1998, BIOCHIMIE, V80, P651, DOI 10.1016/S0300-9084(99)80018-2; Rebouillat D, 1998, EUR J BIOCHEM, V257, P319, DOI 10.1046/j.1432-1327.1998.2570319.x; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Ronni T, 1998, J INTERF CYTOK RES, V18, P773, DOI 10.1089/jir.1998.18.773; Ryman KD, 2005, J VIROL, V79, P1487, DOI 10.1128/JVI.79.3.1487-1499.2005; Seago J, 2007, J GEN VIROL, V88, P3002, DOI 10.1099/vir.0.82934-0; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; VERHAEGEN M, 1980, P NATL ACAD SCI-BIOL, V77, P4479, DOI 10.1073/pnas.77.8.4479; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Wang Q, 1998, GENE, V222, P83, DOI 10.1016/S0378-1119(98)00476-4; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yen A, 2006, EUR J CELL BIOL, V85, P117, DOI 10.1016/j.ejcb.2005.09.020; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Zhu HZ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-80	68	53	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6080	6090		10.1074/jbc.M109.054486	http://dx.doi.org/10.1074/jbc.M109.054486			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20048147	hybrid, Green Published			2022-12-25	WOS:000275367500011
J	Funakoshi-Tago, M; Tago, K; Abe, M; Sonoda, Y; Kasahara, T				Funakoshi-Tago, Megumi; Tago, Kenji; Abe, Miyuki; Sonoda, Yoshiko; Kasahara, Tadashi			STAT5 Activation Is Critical for the Transformation Mediated by Myeloproliferative Disorder-associated JAK2 V617F Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL T-CELLS; ERYTHROPOIETIN RECEPTOR; POLYCYTHEMIA-VERA; FERM DOMAIN; CYTOKINE-RECEPTOR; KINASE-ACTIVITY; NUDE-MICE; EXPRESSION; MUTATION; PROLIFERATION	It has been well established that disruption of JAK2 signaling regulation is involved in various hematopoietic disorders; however, the detailed mechanism by which abnormal activation of JAK2 exhibits transforming activity remains to be elucidated. Here, to clarify the functional role of the erythropoietin receptor (EpoR) and its downstream transcription factor STAT5 in the abnormal activation of JAK2-induced hematopoietic diseases, we generated a stable transfectant of Ba/F3 cells expressing EpoR and analyzed the molecular mechanism of how JAK2 mutation induces cell growth disorder. JAK2 V617F mutant exhibited transforming activity when EpoR was coexpressed. According to a study utilizing several truncated mutants of EpoR, the ability of EpoR to facilitate the transforming activity of JAK2 V617F mutant required the intracellular domain to interact with STAT5. Strikingly, once the truncated EpoR (EpoR-H) was mutated on Tyr-343, the phosphorylation of which is known to be important for interaction with STAT5, JAK2 V617F mutant failed to exhibit transforming activity, suggesting that STAT5 is critical for JAK2 mutant-induced hematopoietic disorder. Furthermore, the expression of the constitutively active STAT5 mutant exhibited transforming activity in Ba/F3 cells, and short hairpin RNA-mediated knockdown of STAT5 significantly inhibited the transforming activity of JAK2 V617F mutant. Taking these observations together, STAT5 plays an essential role in EpoR-JAK2 V617F mutant-induced hematopoietic disorder. Although it remains unclear why the presence of EpoR is required to activate oncogenic signaling via the JAK2 mutant and STAT5, its interacting ability is a target for the treatment of these hematopoietic diseases.	[Funakoshi-Tago, Megumi; Abe, Miyuki; Sonoda, Yoshiko; Kasahara, Tadashi] Keio Univ, Fac Pharm, Dept Biochem, Minato Ku, Tokyo 1058512, Japan; [Tago, Kenji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Cell Biol, Nara 6300101, Japan	Keio University; Nara Institute of Science & Technology	Funakoshi-Tago, M (corresponding author), Keio Univ, Fac Pharm, Dept Biochem, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	tago-mg@pha.keio.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [19790071]; Research Foundation for Pharmaceutical Sciences; Hi-Tech Research Center Project for Private Universities in Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Foundation for Pharmaceutical Sciences; Hi-Tech Research Center Project for Private Universities in Japan	This work was supported in part by Grant 19790071 from Ministry of Education, Culture, Sports, Science and Technology, the Research Foundation for Pharmaceutical Sciences, and the Hi-Tech Research Center Project for Private Universities in Japan.	Abe M, 2009, INT IMMUNOPHARMACOL, V9, P870, DOI 10.1016/j.intimp.2009.03.011; Chin H, 1997, BIOCHEM BIOPH RES CO, V239, P412, DOI 10.1006/bbrc.1997.7480; Chin H, 1996, BLOOD, V88, P4415, DOI 10.1182/blood.V88.12.4415.bloodjournal88124415; DAMEN JE, 1995, EMBO J, V14, P5557, DOI 10.1002/j.1460-2075.1995.tb00243.x; Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Funakoshi-Tago M, 2006, EMBO J, V25, P4763, DOI 10.1038/sj.emboj.7601365; Funakoshi-Tago M, 2009, J BIOL CHEM, V284, P12680, DOI 10.1074/jbc.M808879200; Gobert S, 1996, EMBO J, V15, P2434, DOI 10.1002/j.1460-2075.1996.tb00601.x; Gregory RC, 1998, BLOOD, V92, P1104, DOI 10.1182/blood.V92.4.1104.416k38_1104_1118; Grimwade LF, 2009, BRIT J HAEMATOL, V147, P495, DOI 10.1111/j.1365-2141.2009.07870.x; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Iwatsuki K, 1997, J BIOL CHEM, V272, P8149, DOI 10.1074/jbc.272.13.8149; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kanie T, 2004, LEUKEMIA, V18, P548, DOI 10.1038/sj.leu.2403266; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Minoo P, 2004, BLOOD, V103, P1398, DOI 10.1182/blood-2003-07-2617; MIURA Y, 1994, J BIOL CHEM, V269, P29962; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; Sawka-Verhelle D, 2000, ENDOCRINOLOGY, V141, P1977, DOI 10.1210/en.141.6.1977; Shide K, 2008, LEUKEMIA, V22, P87, DOI 10.1038/sj.leu.2405043; Storz P, 1999, FEBS LETT, V464, P159, DOI 10.1016/S0014-5793(99)01689-0; Teofili L, 2007, BLOOD, V110, P354, DOI 10.1182/blood-2007-01-069237; Um M, 2006, J BIOL CHEM, V281, P5648, DOI 10.1074/jbc.M510943200; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Zang HS, 2001, EMBO J, V20, P3156, DOI 10.1093/emboj/20.12.3156	36	50	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5296	5307		10.1074/jbc.M109.040733	http://dx.doi.org/10.1074/jbc.M109.040733			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028972	Green Published, hybrid			2022-12-25	WOS:000275327200023
J	Vogel, R; Jansen, C; Roffeis, J; Reddanna, P; Forsell, P; Claesson, HE; Kuhn, H; Walther, M				Vogel, Robert; Jansen, Christian; Roffeis, Jana; Reddanna, Pallu; Forsell, Pontus; Claesson, Hans-Eric; Kuhn, Hartmut; Walther, Matthias			Applicability of the Triad Concept for the Positional Specificity of Mammalian Lipoxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULOCYTE-TYPE 15-LIPOXYGENASE; SITE-DIRECTED MUTAGENESIS; SEQUENCE DETERMINANTS; ARACHIDONIC-ACID; ACTIVE-SITE; OXYGENATION; 12-LIPOXYGENASE; EXPRESSION; CATALYSIS; CLONING	The nomenclature of lipoxygenases (LOXs) is partly based on the positional specificity of arachidonic acid oxygenation, but there is no unifying concept explaining the mechanistic basis of this enzyme property. According to the triad model, Phe-353, Ile-418, and Ile-593 of the rabbit 12/15-LOX form the bottom of the substrate-binding pocket, and introduction of less space-filling residues at either of these positions favors arachidonic acid 12-lipoxygenation. The present study was aimed at exploring the validity of the triad concept for two novel primate 12/15-LOX (Macaca mulatta and Pongo pygmaeus) and for five known members of the mammalian LOX family (human 12/15-LOX, mouse 12/15-LOX, human 15-LOX2, human platelet type 12-LOX, and mouse (12R)-LOX). The enzymes were expressed as N-terminal His tag fusion proteins in E. coli, the potential sequence determinants were mutated, and the specificity of arachidonic acid oxygenation was quantified. Taken together, our data indicate that the triad concept explains the positional specificity of all 12/15-LOXs tested (rabbit, human, M. mulatta, P. pygmaeus, and mouse). For the new enzymes of M. mulatta and P. pygmaeus, the concept had predictive value because the positional specificity predicted on the basis of the amino acid sequence was confirmed experimentally. The specificity of the platelet 12-LOX was partly explained by the triad hypothesis, but the concept was not applicable for 15-LOX2 and (12R)-LOX.	[Vogel, Robert; Jansen, Christian; Roffeis, Jana; Kuhn, Hartmut; Walther, Matthias] Charite, Inst Biochem, D-10117 Berlin, Germany; [Reddanna, Pallu] Univ Hyderabad, Sch Life Sci, Hyderabad 500046, Andhra Pradesh, India; [Forsell, Pontus; Claesson, Hans-Eric] Orexo AB, S-10234 Stockholm, Sweden; [Forsell, Pontus; Claesson, Hans-Eric] Karolinska Inst, Dept Med Biophys & Biochem, S-17177 Stockholm, Sweden	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hyderabad; Karolinska Institutet	Kuhn, H (corresponding author), Charite, Inst Biochem, Monbijoustr 2, D-10117 Berlin, Germany.	hartmut.kuehn@charite.de		Claesson, Hans-Erik/0000-0002-1960-6542; Forsell, Pontus/0000-0002-8384-1547	European Commission [FP6, LSHMCT-2004-0050333]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by European Commission Grant FP6, LSHMCT-2004-0050333 (to H. K.).	Berger M, 1998, J MOL BIOL, V278, P935, DOI 10.1006/jmbi.1998.1737; Borngraber S, 1996, J MOL BIOL, V264, P1145, DOI 10.1006/jmbi.1996.0702; Borngraber S, 1999, J BIOL CHEM, V274, P37345, DOI 10.1074/jbc.274.52.37345; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brash AR, 1996, J BIOL CHEM, V271, P20949, DOI 10.1074/jbc.271.34.20949; BRYANT RW, 1982, J BIOL CHEM, V257, P6050; Burger F, 2000, BIOCHEM J, V348, P329, DOI 10.1042/bj3480329; CHEN XS, 1994, J BIOL CHEM, V269, P13979; CHEN XS, 1993, FASEB J, V7, P694, DOI 10.1096/fasebj.7.8.8500694; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; HAMBERG M, 1980, BIOCHEM BIOPH RES CO, V95, P1090, DOI 10.1016/0006-291X(80)91584-3; HAWKINS DJ, 1987, J BIOL CHEM, V262, P7629; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Koeduka T, 2007, CURR MICROBIOL, V54, P315, DOI 10.1007/s00284-006-0512-9; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N; KUHN H, 1983, FEBS LETT, V153, P353, DOI 10.1016/0014-5793(83)80641-3; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; Meruvu S, 2005, J BIOL CHEM, V280, P36633, DOI 10.1074/jbc.M508260200; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Noverr MC, 2003, CLIN MICROBIOL REV, V16, P517, DOI 10.1128/CMR.16.3.517-533.2003; O'Donnell Valerie B., 2009, V462, P5, DOI 10.1007/978-1-60327-115-8_1; Porta H, 2001, MICROBIOL-SGM, V147, P3199, DOI 10.1099/00221287-147-12-3199; REDDANNA P, 1990, METHOD ENZYMOL, V187, P268; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schwarz K, 2001, J BIOL CHEM, V276, P773, DOI 10.1074/jbc.M005114200; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101; Walther M, 2009, BBA-MOL CELL BIOL L, V1791, P827, DOI 10.1016/j.bbalip.2009.05.007; Walther M, 2002, J BIOL CHEM, V277, P27360, DOI 10.1074/jbc.M203234200; WATANABE T, 1993, BIOCHEM BIOPH RES CO, V192, P1023, DOI 10.1006/bbrc.1993.1519; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yu ZY, 2003, P NATL ACAD SCI USA, V100, P9162, DOI 10.1073/pnas.1633612100	37	68	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5369	5376		10.1074/jbc.M109.057802	http://dx.doi.org/10.1074/jbc.M109.057802			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20026599	Green Published, hybrid			2022-12-25	WOS:000275327200030
J	Edelstein, SJ; Stefan, MI; Le Novere, N				Edelstein, Stuart J.; Stefan, Melanie I.; Le Novere, Nicolas			Ligand Depletion in vivo Modulates the Dynamic Range and Cooperativity of Signal Transduction	PLOS ONE			English	Article							ASPARTATE-TRANSCARBAMYLASE; ESCHERICHIA-COLI; BACTERIAL CHEMOTAXIS; SYSTEMS BIOLOGY; ALLOSTERIC INTERACTIONS; CONFORMATIONAL SPREAD; HUMAN GLUCOKINASE; STRUCTURAL BASIS; PLAUSIBLE MODEL; BINDING	Biological signal transduction commonly involves cooperative interactions in the binding of ligands to their receptors. In many cases, ligand concentrations in vivo are close to the value of the dissociation constant of their receptors, resulting in the phenomenon of ligand depletion. Using examples based on rotational bias of bacterial flagellar motors and calcium binding to mammalian calmodulin, we show that ligand depletion diminishes cooperativity and broadens the dynamic range of sensitivity to the signaling ligand. As a result, the same signal transducer responds to different ranges of signal with various degrees of cooperativity according to its effective cellular concentration. Hence, results from in vitro dose-response analyses cannot be applied directly to understand signaling in vivo. Moreover, the receptor concentration is revealed to be a key element in controlling signal transduction and we propose that its modulation constitutes a new way of controlling sensitivity to signals. In addition, through an analysis of the allosteric enzyme aspartate transcarbamylase, we demonstrate that the classical Hill coefficient is not appropriate for characterizing the change in conformational state upon ligand binding to an oligomeric protein (equivalent to a dose-response curve), because it ignores the cooperativity of the conformational change for the corresponding equivalent monomers, which are generally characterized by a Hill coefficient << 1. Therefore, we propose a new index of cooperativity based on the comparison of the properties of oligomers and their equivalent monomers.	[Edelstein, Stuart J.; Stefan, Melanie I.; Le Novere, Nicolas] European Bioinformat Inst, Hinxton, England	European Molecular Biology Laboratory (EMBL)	Edelstein, SJ (corresponding author), European Bioinformat Inst, Hinxton, England.	lenov@ebi.ac.uk	Le Novère, Nicolas/F-9973-2010	Le Novère, Nicolas/0000-0002-6309-7327; Stefan, Melanie/0000-0002-6086-7357	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	S.E. acknowledges support from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; Belas R, 2008, J BACTERIOL, V190, P1849, DOI 10.1128/JB.01943-07; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Bray D, 2004, ANNU REV BIOPH BIOM, V33, P53, DOI 10.1146/annurev.biophys.33.110502.132703; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; CHANGEUX JP, 1968, BIOCHEMISTRY-US, V7, P553, DOI 10.1021/bi00842a601; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; EDELSTEIN SJ, 1975, ANNU REV BIOCHEM, V44, P209, DOI 10.1146/annurev.bi.44.070175.001233; Endres RG, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.49; FERDINAND W, 1966, BIOCHEM J, V98, P278, DOI 10.1042/bj0980278; Fetler L, 2007, P NATL ACAD SCI USA, V104, P495, DOI 10.1073/pnas.0607641104; GAMBLE E, 1987, SCIENCE, V236, P1311, DOI 10.1126/science.3495885; GERHART JC, 1968, BIOCHEMISTRY-US, V7, P538, DOI 10.1021/bi00842a600; GERHART JC, 1967, J BIOL CHEM, V242, P2886; GERHART JC, 1962, J BIOL CHEM, V237, P891; Giegling I, 2008, PHARMACOPSYCHIATRY, V41, pS32, DOI 10.1055/s-2008-1081200; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; GOLDSTEIN A, 1987, MOL PHARMACOL, V31, P603; GOTO S, 1986, BRAIN RES, V397, P161, DOI 10.1016/0006-8993(86)91381-8; Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017; Hansen CH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040001; Henkin RI, 1997, J DENT RES, V76, P1430, DOI 10.1177/00220345970760080201; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; KAKIUCHI S, 1982, J BIOCHEM-TOKYO, V92, P1041, DOI 10.1093/oxfordjournals.jbchem.a134019; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; KANTROWITZ ER, 1990, TRENDS BIOCHEM SCI, V15, P53, DOI 10.1016/0968-0004(90)90176-C; KARLIN A, 1967, J THEOR BIOL, V16, P306, DOI 10.1016/0022-5193(67)90011-2; Kentner D, 2006, CURR OPIN MICROBIOL, V9, P619, DOI 10.1016/j.mib.2006.10.012; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Kim YB, 2007, BIOCHEMISTRY-US, V46, P1423, DOI 10.1021/bi0617308; KISTER J, 1987, J BIOL CHEM, V262, P12085; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; Le Novere N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-28; Legewie S, 2005, FEBS J, V272, P4071, DOI 10.1111/j.1742-4658.2005.04818.x; LIPSCOMB WN, 1994, ADV ENZYMOL RAMB, V68, P67; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Martinez KL, 2000, BIOCHEMISTRY-US, V39, P6979, DOI 10.1021/bi992811p; McEvoy MM, 1999, J MOL BIOL, V289, P1423, DOI 10.1006/jmbi.1999.2830; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; PORUMB T, 1994, ANAL BIOCHEM, V220, P227, DOI 10.1006/abio.1994.1332; Qian H, 2008, BIOPHYS J, V95, P10, DOI 10.1529/biophysj.108.131771; Rao CV, 2008, TRENDS MICROBIOL, V16, P480, DOI 10.1016/j.tim.2008.07.003; RUBIN MM, 1966, J MOL BIOL, V21, P265, DOI 10.1016/0022-2836(66)90097-0; Salvetti S, 2007, MICROBIOL-SGM, V153, P2541, DOI 10.1099/mic.0.2006/005553-0; SCHACHMAN HK, 1988, J BIOL CHEM, V263, P18583; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Stefan MI, 2008, P NATL ACAD SCI USA, V105, P10768, DOI 10.1073/pnas.0804672105; Stefan MI, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-68; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Thomas DR, 1999, P NATL ACAD SCI USA, V96, P10134, DOI 10.1073/pnas.96.18.10134; Villoslada P, 2009, ANN NEUROL, V65, P124, DOI 10.1002/ana.21634; WEBER K, 1968, NATURE, V218, P1116, DOI 10.1038/2181116a0; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; WHITEHEAD EP, 1978, BIOCHEM J, V171, P501, DOI 10.1042/bj1710501; WILEY DC, 1968, NATURE, V218, P1119, DOI 10.1038/2181119a0; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647	62	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8449	10.1371/journal.pone.0008449	http://dx.doi.org/10.1371/journal.pone.0008449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052284	Green Published, gold			2022-12-25	WOS:000273338500003
J	Creanza, N; Schwarz, JS; Cohen, JE				Creanza, Nicole; Schwarz, Jason S.; Cohen, Joel E.			Intraseasonal Dynamics and Dominant Sequences in H3N2 Influenza	PLOS ONE			English	Article							EVOLUTION; VIRUS; REVEALS	Long-term influenza evolution has been well studied, but the patterns of sequence diversity within seasons are less clear. H3N2 influenza genomes sampled from New York State over ten years indicated intraseasonal changes in evolutionary dynamics. Using the mean Hamming distance of a set of amino acid or nucleotide sequences as an indicator of its diversity, we found that influenza sequence diversity was significantly higher during the early epidemic period than later in the influenza season. Diversity was lowest during the peak of the epidemic, most likely due to the high prevalence of a single dominant amino acid sequence or very few dominant sequences during the peak epidemic period, corresponding with rapid expansion of the viral population. The frequency and duration of dominant sequences varied by influenza protein, but all proteins had an abundance of one distinct sequence during the peak epidemic period. In New York State from 1995 to 2005, high sequence diversity during the early epidemic suggested that seasonal antigenic drift could have occurred primarily in this period, followed by a clonal expansion of typically one clade during the peak of the epidemic, possibly indicating a shift to neutral drift or purifying selection.	[Creanza, Nicole; Schwarz, Jason S.; Cohen, Joel E.] Rockefeller Univ, Lab Populat, New York, NY 10021 USA; [Cohen, Joel E.] Columbia Univ, Earth Inst, New York, NY USA	Rockefeller University; Columbia University	Creanza, N (corresponding author), Rockefeller Univ, Lab Populat, 1230 York Ave, New York, NY 10021 USA.	jschwarz@rockefeller.edu		Creanza, Nicole/0000-0001-8821-7383	U.S. National Science Foundation Graduate Fellowship [DMS-0443803]; U.S. National Institutes of Health [GM66699]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066699] Funding Source: NIH RePORTER	U.S. National Science Foundation Graduate Fellowship(National Science Foundation (NSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NC was supported in part by a U.S. National Science Foundation Graduate Fellowship (nsf. gov). JSS was supported in part by a U.S. National Institutes of Health institutional training grant GM66699 (nih. gov). JEC was supported by US National Science Foundation grant DMS-0443803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boni MF, 2006, P ROY SOC B-BIOL SCI, V273, P1307, DOI 10.1098/rspb.2006.3466; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gog JR, 2008, VACCINE, V26, pC15, DOI 10.1016/j.vaccine.2008.04.008; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lavenu A, 2006, EPIDEMIOL INFECT, V134, P514, DOI 10.1017/S0950268805005686; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; *WHO, 211 WHO	15	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8544	10.1371/journal.pone.0008544	http://dx.doi.org/10.1371/journal.pone.0008544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049091	Green Submitted, gold, Green Published			2022-12-25	WOS:000273225000009
J	Whelan, AO; Coad, M; Cockle, PJ; Hewinson, G; Vordermeier, M; Gordon, SV				Whelan, Adam O.; Coad, Michael; Cockle, Paul J.; Hewinson, Glyn; Vordermeier, Martin; Gordon, Stephen V.			Revisiting Host Preference in the Mycobacterium tuberculosis Complex: Experimental Infection Shows M. tuberculosis H37Rv to Be Avirulent in Cattle	PLOS ONE			English	Article							BOVIS BCG VACCINATION; DIAGNOSTIC REAGENTS; EXPRESSION; IDENTIFICATION; ANTIGENS; MPB83	Experiments in the late 19th century sought to define the host specificity of the causative agents of tuberculosis in mammals. Mycobacterium tuberculosis, the human tubercle bacillus, was independently shown by Smith, Koch, and von Behring to be avirulent in cattle. This finding was erroneously used by Koch to argue the converse, namely that Mycobacterium bovis, the agent of bovine tuberculosis, was avirulent for man, a view that was subsequently discredited. However, reports in the literature of M. tuberculosis isolation from cattle with tuberculoid lesions suggests that the virulence of M. tuberculosis for cattle needs to be readdressed. We used an experimental bovine infection model to test the virulence of well-characterized strains of M. tuberculosis and M. bovis in cattle, choosing the genome-sequenced strains M. tuberculosis H37Rv and M. bovis 2122/97. Cattle were infected with approximately 10(6) CFU of M. tuberculosis H37Rv or M. bovis 2122/97, and sacrificed 17 weeks post-infection. IFN-gamma and tuberculin skin tests indicated that both M. bovis 2122 and M. tuberculosis H37Rv were equally infective and triggered strong cell-mediated immune responses, albeit with some indication of differential antigen-specific responses. Postmortem examination revealed that while M. bovis 2122/97-infected animals all showed clear pathology indicative of bovine tuberculosis, the M. tuberculosis-infected animals showed no pathology. Culturing of infected tissues revealed that M. tuberculosis was able to persist in the majority of animals, albeit at relatively low bacillary loads. In revisiting the early work on host preference across the M. tuberculosis complex, we have shown M. tuberculosis H37Rv is avirulent for cattle, and propose that the immune status of the animal, or genotype of the infecting bacillus, may have significant bearing on the virulence of a strain for cattle. This work will serve as a baseline for future studies into the genetic basis of host preference, and in particular the molecular basis of virulence in M. bovis.	[Whelan, Adam O.; Coad, Michael; Cockle, Paul J.; Hewinson, Glyn; Vordermeier, Martin; Gordon, Stephen V.] Vet Labs Agcy Weybridge, TB Res Grp, New Haw, England; [Gordon, Stephen V.] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Coll Life Sci, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	Veterinary Laboratories Agency; University College Dublin; University College Dublin; University College Dublin; University College Dublin	Whelan, AO (corresponding author), Vet Labs Agcy Weybridge, TB Res Grp, New Haw, England.	stephen.gordon@ucd.ie	Hewinson, Glyn/AAA-2364-2019; Coad, Mick/D-8093-2011; Vordermeier, H Martin/C-6936-2011; Hewinson, Glyn/J-1902-2014; Hewinson, Glyn/F-7077-2010; Whelan, Adam O/C-9497-2011	Gordon, Stephen/0000-0002-4833-5542; Hewinson, Glyn/0000-0002-5517-4281	Department for Environment, Food, and Rural Affairs (Defra), United Kingdom	Department for Environment, Food, and Rural Affairs (Defra), United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA))	This study was funded by the Department for Environment, Food, and Rural Affairs (Defra), United Kingdom. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The manuscript was cleared for publication by Defra.	Bean AGD, 1999, J IMMUNOL, V162, P3504; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; BUDDLE BM, 1995, RES VET SCI, V59, P10, DOI 10.1016/0034-5288(95)90023-3; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; CHATTERJEE D, 1989, INFECT IMMUN, V57, P322, DOI 10.1128/IAI.57.2.322-330.1989; Chen YY, 2009, TUBERCULOSIS, V89, P95, DOI 10.1016/j.tube.2008.07.003; Cockle PJ, 2002, INFECT IMMUN, V70, P6996, DOI 10.1128/IAI.70.12.6996-7003.2002; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; GALLAGHER J, 1977, J HYG-CAMBRIDGE, V79, P155, DOI 10.1017/S0022172400052943; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Golby P, 2007, MICROBIOL-SGM, V153, P3323, DOI 10.1099/mic.0.2007/009894-0; Inwald J, 2003, TUBERCULOSIS, V83, P387, DOI 10.1016/j.tube.2003.08.018; JARNAGIN JL, 1983, AM J VET RES, V44, P1920; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Koch R, 1901, Br Med J, V2, P189; Littel-van den Hurk SV, 1998, J GEN VIROL, V79, P831; Ocepek M, 2005, J CLIN MICROBIOL, V43, P3555, DOI 10.1128/JCM.43.7.3555-3557.2005; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Said-Salim B, 2006, MOL MICROBIOL, V62, P1251, DOI 10.1111/j.1365-2958.2006.05455.x; Smith NH, 2006, J THEOR BIOL, V239, P220, DOI 10.1016/j.jtbi.2005.08.036; SMITH T, 1896, T ASSOC AM PHYSICIAN, V11, P75; Srivastava K, 2008, INDIAN J MED RES, V128, P26; VONBEHRING E, 1901, NOBEL LECT PHYSL MED; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier HM, 1999, CLIN DIAGN LAB IMMUN, V6, P675, DOI 10.1128/CDLI.6.5.675-682.1999; Vordermeier HM, 2001, CLIN DIAGN LAB IMMUN, V8, P571, DOI 10.1128/CDLI.8.3.571-578.2001; Wiker HG, 1996, SCAND J IMMUNOL, V43, P374, DOI 10.1046/j.1365-3083.1996.d01-61.x	27	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8527	10.1371/journal.pone.0008527	http://dx.doi.org/10.1371/journal.pone.0008527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049086	gold, Green Published, Green Submitted			2022-12-25	WOS:000273225000006
J	Karrlander, M; Lindberg, N; Olofsson, T; Kastemar, M; Olsson, AK; Uhrbom, L				Karrlander, Maria; Lindberg, Nanna; Olofsson, Tommie; Kastemar, Marianne; Olsson, Anna-Karin; Uhrbom, Lene			Histidine-Rich Glycoprotein Can Prevent Development of Mouse Experimental Glioblastoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BEVACIZUMAB PLUS IRINOTECAN; IN-VIVO; ANTIANGIOGENIC THERAPY; TUMOR ANGIOGENESIS; POTENT INHIBITOR; CELL; CANCER; GLIOMA; PROGRESSION	Extensive angiogenesis, formation of new capillaries from pre-existing blood vessels, is an important feature of malignant glioma. Several antiangiogenic drugs targeting vascular endothelial growth factor (VEGF) or its receptors are currently in clinical trials as therapy for high-grade glioma and bevacizumab was recently approved by the FDA for treatment of recurrent glioblastoma. However, the modest efficacy of these drugs and emerging problems with anti-VEGF treatment resistance welcome the development of alternative antiangiogenic therapies. One potential candidate is histidine-rich glycoprotein (HRG), a plasma protein with antiangiogenic properties that can inhibit endothelial cell adhesion and migration. We have used the RCAS/TV-A mouse model for gliomas to investigate the effect of HRG on brain tumor development. Tumors were induced with platelet-derived growth factor-B (PDGF-B), in the presence or absence of HRG. We found that HRG had little effect on tumor incidence but could significantly inhibit the development of malignant glioma and completely prevent the occurrence of grade IV tumors (glioblastoma).	[Karrlander, Maria; Lindberg, Nanna; Kastemar, Marianne; Uhrbom, Lene] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; [Olofsson, Tommie] Natl Board Forens Med, Dept Forens Med, Uppsala, Sweden; [Olsson, Anna-Karin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University; Swedish National Board of Forensic Medicine; Uppsala University	Karrlander, M (corresponding author), Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden.	lene.uhrbom@genpat.uu.se			Swedish Cancer Society; Swedish Research Council; Association for International Cancer Research; Swedish Childhood Cancer Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Association for International Cancer Research; Swedish Childhood Cancer Foundation(European Commission)	This work was supported by grants to LU from the Swedish Cancer Society, the Swedish Research Council, the Association for International Cancer Research, and the Swedish Childhood Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Joshua C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000768; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Borza DB, 1996, BIOCHEMISTRY-US, V35, P1925, DOI 10.1021/bi952061t; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dixelius J, 2006, CANCER RES, V66, P2089, DOI 10.1158/0008-5472.CAN-05-2217; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; GOLDMAN CK, 1993, MOL BIOL CELL, V4, P121, DOI 10.1091/mbc.4.1.121; Gorgani NN, 1997, BIOCHEMISTRY-US, V36, P6653, DOI 10.1021/bi962573n; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; Juarez JC, 2002, CANCER RES, V62, P5344; KOIDE T, 1987, FEBS LETT, V216, P17, DOI 10.1016/0014-5793(87)80748-2; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; LAMBWHARTON RJ, 1993, CELL IMMUNOL, V152, P544, DOI 10.1006/cimm.1993.1311; Lee C, 2006, EXP CELL RES, V312, P2547, DOI 10.1016/j.yexcr.2006.04.022; LIJNEN HR, 1983, J BIOL CHEM, V258, P3803; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Olsson AK, 2004, CANCER RES, V64, P599, DOI 10.1158/0008-5472.CAN-03-1941; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; PETROPOULOS CJ, 1992, J VIROL, V66, P3391, DOI 10.1128/JVI.66.6.3391-3397.1992; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; PLATE KH, 1994, INT J CANCER, V59, P520, DOI 10.1002/ijc.2910590415; Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102; SAIGO K, 1989, J BIOL CHEM, V264, P8249; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Simantov R, 2001, J CLIN INVEST, V107, P45, DOI 10.1172/JCI9061; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tchougounova E, 2007, ONCOGENE, V26, P6289, DOI 10.1038/sj.onc.1210455; Uhrbom L, 2005, CANCER RES, V65, P2065, DOI 10.1158/0008-5472.CAN-04-3588; Vanwildemeersch M, 2006, J BIOL CHEM, V281, P10298, DOI 10.1074/jbc.M508483200; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987	41	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8536	10.1371/journal.pone.0008536	http://dx.doi.org/10.1371/journal.pone.0008536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046875	Green Published, gold, Green Submitted			2022-12-25	WOS:000273180200017
J	Li, Q; Kluz, T; Sun, H; Costa, M				Li, Qin; Kluz, Thomas; Sun, Hong; Costa, Max			Mechanisms of c-Myc Degradation by Nickel Compounds and Hypoxia	PLOS ONE			English	Article							PROTEIN STABILITY; MITOCHONDRIAL BIOGENESIS; DNA-DAMAGE; HISTONE H3; FACTOR-I; CELL; TRANSFORMATION; TRANSCRIPTION; GENES; USP28	Nickel (Ni) compounds have been found to cause cancer in humans and animal models and to transform cells in culture. At least part of this effect is mediated by stabilization of hypoxia inducible factor (HIF1a) and activating its downstream signaling. Recent studies reported that hypoxia signaling might either antagonize or enhance c-myc activity depending on cell context. We investigated the effect of nickel on c-myc levels, and demonstrated that nickel, hypoxia, and other hypoxia mimetics degraded c-myc protein in a number of cancer cells (A549, MCF-7, MDA-453, and BT-474). The degradation of the c-Myc protein was mediated by the 26S proteosome. Interestingly, knockdown of both HIF-1 alpha and HIF-2 alpha attenuated c-Myc degradation induced by Nickel and hypoxia, suggesting the functional HIF-1 alpha and HIF-2 alpha was required for c-myc degradation. Further studies revealed two potential pathways mediated nickel and hypoxia induced c-myc degradation. Phosphorylation of c-myc at T58 was significantly increased in cells exposed to nickel or hypoxia, leading to increased ubiquitination through Fbw7 ubiquitin ligase. In addition, nickel and hypoxia exposure decreased USP28, a c-myc de-ubiquitinating enzyme, contributing to a higher steady state level of c-myc ubiquitination and promoting c-myc degradation. Furthermore, the reduction of USP28 protein by hypoxia signaling is due to both protein degradation and transcriptional repression. Nickel and hypoxia exposure significantly increased the levels of dimethylated H3 lysine 9 at the USP28 promoter and repressed its expression. Our study demonstrated that Nickel and hypoxia exposure increased c-myc T58 phosphorylation and decreased USP28 protein levels in cancer cells, which both lead to enhanced c-myc ubiquitination and proteasomal degradation.	[Li, Qin; Kluz, Thomas; Sun, Hong; Costa, Max] New York Univ, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10016 USA	New York University	Li, Q (corresponding author), New York Univ, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10016 USA.	max.costa@nyumc.org	costa, max/H-1754-2012		National Institutes of Environmental Health Sciences [ES000260, ES014454, ES005512, T32-ES07324]; National Cancer Institute [CA16087]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014454, T32ES007324, P30ES000260, R01ES005512] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants ES000260, ES014454, ES005512, and T32-ES07324 from the National Institutes of Environmental Health Sciences, and grant CA16087 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bartholomeusz G, 2007, CANCER RES, V67, P3912, DOI 10.1158/0008-5472.CAN-06-4464; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Chen H, 2009, BIOMETALS, V22, P191, DOI 10.1007/s10534-008-9190-3; CHEN WC, 2006, PLATAX, V3, P9; DOLL R, 1970, BRIT J CANCER, V24, P623, DOI 10.1038/bjc.1970.76; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Ke QD, 2008, TOXICOL APPL PHARM, V228, P190, DOI 10.1016/j.taap.2007.12.015; Ke QD, 2006, CARCINOGENESIS, V27, P1481, DOI 10.1093/carcin/bgl004; Kerckaert GA, 1996, FUND APPL TOXICOL, V34, P67, DOI 10.1006/faat.1996.0176; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kuper CF, 1997, MUTAT RES-FUND MOL M, V380, P19, DOI 10.1016/S0027-5107(97)00123-1; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li Q, 2006, TOXICOL APPL PHARM, V213, P245, DOI 10.1016/j.taap.2005.11.006; Lusher B, 2007, EMBO REP, V8, P1110, DOI 10.1038/sj.embor.7401121; Miller AC, 2001, CARCINOGENESIS, V22, P115, DOI 10.1093/carcin/22.1.115; Popov N, 2007, CELL CYCLE, V6, P2327, DOI 10.4161/cc.6.19.4804; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; PULVERER BJ, 1994, ONCOGENE, V9, P59; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rudolph C, 1999, ANAL BIOCHEM, V269, P66, DOI 10.1006/abio.1999.3095; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	36	42	45	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8531	10.1371/journal.pone.0008531	http://dx.doi.org/10.1371/journal.pone.0008531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046830	Green Published, gold, Green Submitted			2022-12-25	WOS:000273180200012
J	Cremer, TJ; Ravneberg, DH; Clay, CD; Piper-Hunter, MG; Marsh, CB; Elton, TS; Gunns, JS; Amer, A; Kanneganti, TD; Schlesinger, LS; Butchar, JP; Tridandapani, S				Cremer, Thomas J.; Ravneberg, David H.; Clay, Corey D.; Piper-Hunter, Melissa G.; Marsh, Clay B.; Elton, Terry S.; Gunns, John S.; Amer, Amal; Kanneganti, Thirumala-Devi; Schlesinger, Larry S.; Butchar, Jonathan P.; Tridandapani, Susheela			M1R-155 Induction by F. novicida but Not the Virulent F. tularensis Results in SHIP Down-Regulation and Enhanced Pro-Inflammatory Cytokine Response	PLOS ONE			English	Article							VIRUS-INDUCED LYMPHOMAS; FRANCISELLA-TULARENSIS; MONONUCLEAR PHAGOCYTES; SURVIVAL ADVANTAGE; MURINE MACROPHAGES; ACTIVATION; MICRORNA-155; INFECTION; RECEPTOR; MIR-155	The intracellular Gram-negative bacterium Francisella tularensis causes the disease tularemia and is known for its ability to subvert host immune responses. Previous work from our laboratory identified the PI3K/Akt pathway and SHIP as critical modulators of host resistance to Francisella. Here, we show that SHIP expression is strongly down-regulated in monocytes and macrophages following infection with F. tularensis novicida (F.n.). To account for this negative regulation we explored the possibility that microRNAs (miRs) that target SHIP may be induced during infection. There is one miR that is predicted to target SHIP, miR-155. We tested for induction and found that F.n. induced miR-155 both in primary monocytes/ macrophages and in vivo. Using luciferase reporter assays we confirmed that miR-155 led to down-regulation of SHIP, showing that it specifically targets the SHIP 3'UTR. Further experiments showed that miR-155 and BIC, the gene that encodes miR-155, were induced as early as four hours post-infection in primary human monocytes. This expression was dependent on TLR2/MyD88 and did not require inflammasome activation. Importantly, miR-155 positively regulated proinflammatory cytokine release in human monocytes infected with Francisella. In sharp contrast, we found that the highly virulent type A SCHU 54 strain of Francisella tularensis (Ft.) led to a significantly lower miR-155 response than the less virulent F.n. Hence, F.n. induces miR-155 expression and leads to down-regulation of SHIP, resulting in enhanced proinflammatory responses. However, impaired miR-155 induction by SCHU S4 may help explain the lack of both SHIP downregulation and pro-inflammatory response and may account for the virulence of Type A Francisella.	[Cremer, Thomas J.; Tridandapani, Susheela] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Ravneberg, David H.; Clay, Corey D.; Amer, Amal; Schlesinger, Larry S.; Tridandapani, Susheela] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Piper-Hunter, Melissa G.; Marsh, Clay B.; Amer, Amal; Schlesinger, Larry S.; Butchar, Jonathan P.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Elton, Terry S.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Gunns, John S.; Amer, Amal; Schlesinger, Larry S.; Tridandapani, Susheela] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; St Jude Children's Research Hospital	Cremer, TJ (corresponding author), Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA.	tridandapani.2@osu.edu	Kanneganti, Thirumala-Devi/M-9435-2018; Tridandapani, Susheela/E-4209-2011; Amer, Amal/E-2643-2011; Kanneganti, Thirumala-Devi/Y-2503-2019; Butchar, Jonathan/E-2825-2011	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Ravneberg, David/0000-0002-0107-5683	NIH [1-U54-AI-057153]; American Cancer Society Ohio [ROI A1059406, P01 CA095426]; NIH/NIAID [1-T32-AI-065411]; Center for Microbial Interface Biology (CMIB); Ohio State University; NATIONAL CANCER INSTITUTE [P01CA095426] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, T32AI065411, R01AI059406, R21AI083871] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Ohio(American Cancer Society); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Microbial Interface Biology (CMIB); Ohio State University(Ohio State University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program. The authors wish to acknowledge membership within and support from the Region V 'Great Lakes' RCE (NIH award 1-U54-AI-057153). This work was also supported by ROI A1059406 and P01 CA095426. J.P.B. is supported by the American Cancer Society Ohio Division Postdoctoral Fellowship. T.J.C. is sponsored by NIH/NIAID award # 1-T32-AI-065411, a National Research Service Award (NRSA) training grant administered by the Center for Microbial Interface Biology (CMIB), at The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman MJ, 1998, J BIOL CHEM, V273, P33922, DOI 10.1074/jbc.273.51.33922; Ben Nasr A, 2006, J LEUKOCYTE BIOL, V80, P774, DOI 10.1189/jlb.1205755; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; CHASE JC, 2009, INFECT IMMU IN PRESS; Clay CD, 2008, J IMMUNOL, V181, P5568, DOI 10.4049/jimmunol.181.8.5568; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gunn JS, 2007, ANN NY ACAD SCI, V1105, P202, DOI 10.1196/annals.1409.006; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Helgason CD, 1998, EXP HEMATOL, V26, P815; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Lembo A, 2008, J IMMUNOL, V180, P7574, DOI 10.4049/jimmunol.180.11.7574; LOFGREN S, 1983, INFECT IMMUN, V39, P715; Lu F, 2008, J VIROL, V82, P10436, DOI 10.1128/JVI.00752-08; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; MEHTA P, 2009, CURR ENZYME IN PRESS; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Parsa KVL, 2008, MOL IMMUNOL, V45, P3428, DOI 10.1016/j.molimm.2008.04.006; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; Petersen JM, 2005, VET RES, V36, P455, DOI 10.1051/vetres:2005006; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Rajaram MVS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007919; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; SANTIC M, 2009, CELL MICROB IN PRESS; Schulert GS, 2006, J LEUKOCYTE BIOL, V80, P563, DOI 10.1189/jlb.0306219; Strassheim D, 2005, J IMMUNOL, V174, P8064, DOI 10.4049/jimmunol.174.12.8064; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Teng G, 2009, PHILOS T R SOC B, V364, P631, DOI 10.1098/rstb.2008.0209; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zhao YG, 2009, J VIROL, V83, P489, DOI 10.1128/JVI.01166-08	53	126	131	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8508	10.1371/journal.pone.0008508	http://dx.doi.org/10.1371/journal.pone.0008508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041145	Green Published, gold, Green Submitted			2022-12-25	WOS:000278068700021
J	Wisdom, A; Kutkowska, AE; Leitch, ECM; Gaunt, E; Templeton, K; Harvala, H; Simmonds, P				Wisdom, Anne; Kutkowska, Aldona E.; Leitch, E. Carol McWilliam; Gaunt, Eleanor; Templeton, Kate; Harvala, Heli; Simmonds, Peter			Genetics, Recombination and Clinical Features of Human Rhinovirus Species C (HRV-C) Infections; Interactions of HRV-C with Other Respiratory Viruses	PLOS ONE			English	Article							CHILDREN; ILLNESS; INFANTS	To estimate the frequency, molecular epidemiological and clinical associations of infection with the newly described species C variants of human rhinoviruses (HRV), 3243 diagnostic respiratory samples referred for diagnostic testing in Edinburgh were screened using a VP4-encoding region-based selective polymerase chain reaction (PCR) for HRV-C along with parallel PCR testing for 13 other respiratory viruses. HRV-C was the third most frequently detected behind respiratory syncytial virus (RSV) and adenovirus, with 141 infection episodes detected among 1885 subjects over 13 months (7.5%). Infections predominantly targeted the very young (median age 6-12 months; 80% of infections in those <2 years), occurred throughout the year but with peak incidence in early winter months. HRV-C was detected significantly more frequently among subjects with lower (LRT) and upper respiratory tract (URT) disease than controls without respiratory symptoms; HRV-C mono-infections were the second most frequently detected virus (behind RSV) in both disease presentations (6.9% and 7.8% of all cases respectively). HRV variants were classified by VP4/VP2 sequencing into 39 genotypically defined types, increasing the current total worldwide to 60. Through sequence comparisons of the 5'untranslated region (5'UTR), the majority grouped with species A (n = 96; 68%, described as HRV-Ca), the remainder forming a phylogenetically distinct 5'UTR group (HRV-Cc). Multiple and bidirectional recombination events between HRV-Ca and HRV-Cc variants and with HRV species A represents the most parsimonious explanation for their interspersed phylogeny relationships in the VP4/VP2-encoding region. No difference in age distribution, seasonality or disease associations was identified between HRV-Ca and HRV-Cc variants. HRV-C-infected subjects showed markedly reduced detection frequencies of RSV and other respiratory viruses, providing evidence for a major interfering effect of HRV-C on susceptibility to other respiratory virus infections. HRV-C's disease associations, its prevalence and evidence for interfering effects on other respiratory viruses mandates incorporation of rhinoviruses into future diagnostic virology screening.	[Wisdom, Anne; Kutkowska, Aldona E.; Leitch, E. Carol McWilliam; Gaunt, Eleanor; Simmonds, Peter] Univ Edinburgh, Ctr Infect Dis, Edinburgh, Midlothian, Scotland; [Templeton, Kate; Harvala, Heli] Royal Infirm Edinburgh NHS Trust, Specialist Virol Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Simmonds, P (corresponding author), Univ Edinburgh, Ctr Infect Dis, Summerhall, Edinburgh, Midlothian, Scotland.	Peter.Simmonds@ed.ac.uk		Chmielewska, Aldona/0000-0003-3411-6776; Simmonds, Peter/0000-0002-7964-4700; Leitch, Carol/0000-0002-0910-9593; Templeton, Kate/0000-0001-7414-1277; Harvala, Heli/0000-0001-9154-4190				ANDEN KE, 2006, J MED VIROL, V78, P1232; Arruda E, 1997, J CLIN MICROBIOL, V35, P2864, DOI 10.1128/JCM.35.11.2864-2868.1997; Calvo C, 2009, EMERG INFECT DIS, V15, P1506, DOI 10.3201/eid1509.090453; FUCAPHER CR, 1991, VIROLOGY, V180, P814; GALVA C, 2007, PEDIATR INFECT DIS J, V26, P904; GANNT L, 2009, J CLIN VIROL    1009; Gerna G, 2009, J MED VIROL, V81, P1498, DOI 10.1002/jmv.21548; Greer RM, 2009, J CLIN VIROL, V45, P10, DOI 10.1016/j.jcv.2009.03.008; HAN TH, 2009, ARCH VIROL; HARMAN ZG, 2007, J VIROL, V81, P1796; HARVADA H, 2008, J CLIN MICROBIOL, V16, P3116; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355; JARTI T, 2009, PEDIATR INFECT DIS J, V27, P1193; Khetsuriani N, 2008, EMERG INFECT DIS, V14, P1793, DOI 10.3201/eid1411.080386; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; LATT SK, 2009, J INFECT DIS, V200, P1096; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; LIUSUWANON P, 2009, J INFECTION, V59, P115; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847; Miller EK, 2009, J ALLERGY CLIN IMMUN, V123, P98, DOI 10.1016/j.jaci.2008.10.007; Monto AS, 2002, CLIN THER, V24, P1987, DOI 10.1016/S0149-2918(02)80093-5; Peltola V, 2008, J CLIN VIROL, V43, P411, DOI 10.1016/j.jcv.2008.08.014; Peltola V, 2008, J INFECT DIS, V197, P382, DOI 10.1086/525542; Peltola V, 2009, J MED VIROL, V81, P1831, DOI 10.1002/jmv.21590; PIRADLA A, 2009, J CLIN VIROL, V15, P311; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; Savolainen-Kopra C, 2009, PEDIATR INFECT DIS J, V28, P59, DOI 10.1097/INF.0b013e318182c90a; Savolainen-Kopra C, 2009, J CLIN MICROBIOL, V47, P1278, DOI 10.1128/JCM.02130-08; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Stanway G, 2005, VIRUS TAXONOMY, P757; TAMMA K, 2007, MOL BIOL EXD, V21, P1396; TEMPLETON KE, 2001, J CLIN MICROBIOL, V12, P1564; Vesa S, 2001, PEDIATR INFECT DIS J, V20, P574, DOI 10.1097/00006454-200106000-00006; Wang JP, 2007, CELL MICROBIOL, V9, P1641, DOI 10.1111/j.1462-5822.2007.00961.x; Winther B, 2006, J MED VIROL, V78, P644, DOI 10.1002/jmv.20588; WISDOM A, 2009, J CLIN MICROBIO 1014	47	53	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8518	10.1371/journal.pone.0008518	http://dx.doi.org/10.1371/journal.pone.0008518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041158	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000278068700027
J	Jang, YC; Lustgarten, MS; Liu, YH; Muller, FL; Bhattacharya, A; Liang, HY; Salmon, AB; Brooks, SV; Larkin, L; Hayworth, CR; Richardson, A; Van Remmen, H				Jang, Youngmok C.; Lustgarten, Michael S.; Liu, Yuhong; Muller, Florian L.; Bhattacharya, Arunabh; Liang, Hanyu; Salmon, Adam B.; Brooks, Susan V.; Larkin, Lisa; Hayworth, Christopher R.; Richardson, Arlan; Van Remmen, Holly			Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration	FASEB JOURNAL			English	Article						apoptosis; oxidative stress; sarcopenia	SKELETAL-MUSCLE; OXIDATIVE STRESS; MOTOR-NEURONS; MYONUCLEAR NUMBER; MOUSE HINDLIMB; FIBER TYPES; CELL-DEATH; DENERVATION; APOPTOSIS; MICE	Oxidative stress has been implicated in the etiology of age-related muscle loss (sarcopenia). However, the underlying mechanisms by which oxidative stress contributes to sarcopenia have not been thoroughly investigated. To directly examine the role of chronic oxidative stress in vivo, we used a mouse model that lacks the antioxidant enzyme CuZnSOD (Sod1). Sod1(-/-) mice are characterized by high levels of oxidative damage and an acceleration of sarcopenia. In the present study, we demonstrate that muscle atrophy in Sod1(-/-) mice is accompanied by a progressive decline in mitochondrial bioenergetic function and an elevation of mitochondrial generation of reactive oxygen species. In addition, Sod1(-/-) muscle exhibits a more rapid induction of mitochondrial-mediated apoptosis and loss of myonuclei. Furthermore, aged Sod1(-/-) mice show a striking increase in muscle mitochondrial content near the neuromuscular junctions (NMJs). Despite the increase in content, the function of mitochondria is significantly impaired, with increased denervated NMJs and fragmentation of acetylcholine receptors. As a consequence, contractile force in aged Sod1(-/-) muscles is greatly diminished. Collectively, we show that Sod1(-/-) mice display characteristics of normal aging muscle in an accelerated manner and propose that the superoxide-induced NMJ degeneration and mitochondrial dysfunction are potential mechanisms of sarcopenia.-Jang, Y. C., Lustgarten, M. S., Liu, Y., Muller, F. L., Bhattacharya, A., Liang, H., Salmon, A. B., Brooks, S. V., Larkin, L., Hayworth, C. R., Richardson, A., and Van Remmen, H. Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration. FASEB J. 24, 1376-1390 (2010). www.fasebj.org	[Jang, Youngmok C.; Liu, Yuhong; Muller, Florian L.; Bhattacharya, Arunabh; Liang, Hanyu; Salmon, Adam B.; Richardson, Arlan; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78245 USA; [Lustgarten, Michael S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78245 USA; [Jang, Youngmok C.; Lustgarten, Michael S.; Liu, Yuhong; Muller, Florian L.; Bhattacharya, Arunabh; Liang, Hanyu; Salmon, Adam B.; Richardson, Arlan; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78245 USA; [Brooks, Susan V.; Larkin, Lisa] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Hayworth, Christopher R.] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; [Hayworth, Christopher R.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Richardson, Arlan; Van Remmen, Holly] S Texas Vet Hlth Care Syst, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Michigan System; University of Michigan; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Van Remmen, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, 15355 Lambda Dr, San Antonio, TX 78245 USA.	vanremmen@uthscsa.edu		Muller, Florian/0000-0001-7568-2948; Brooks, Susan/0000-0003-1954-967X	American Federation for Aging Research [P01AG020591]; NATIONAL INSTITUTE ON AGING [P01AG020591] Funding Source: NIH RePORTER	American Federation for Aging Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Drs. Charles Epstein (University of California, San Francisco, CA, USA) and Ting Ting Huang (Stanford University, Palo Alto, CA, USA) for providing Sod1-null breeders, Corinne Price for proofreading our manuscript, and Drs. Asish Chaudhuri, Anson Pierce, James Lechleiter, Walter Ward, and Victoria Frohlich for their input and technical assistance. This work was supported by P01AG020591 (to H. V. R., A. R., S. V. B., L. L.), and a Julie Martin Mid-Career grant from the American Federation for Aging Research (to H. V. R.).	Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; Anderson R, 2009, BBA-GEN SUBJECTS, V1790, P1059, DOI 10.1016/j.bbagen.2009.04.005; BaliceGordon RJ, 1997, MUSCLE NERVE, pS83; Bhattacharya A, 2009, J BIOL CHEM, V284, P46, DOI 10.1074/jbc.M806311200; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; BROOKS SV, 1994, MED SCI SPORT EXER, V26, P432; Bruusgaard JC, 2006, J APPL PHYSIOL, V100, P2024, DOI 10.1152/japplphysiol.00913.2005; Bruusgaard JC, 2008, J CLIN INVEST, V118, P1450, DOI 10.1172/JCI34022; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Cederna PS, 2001, J GERONTOL A-BIOL, V56, pB254, DOI 10.1093/gerona/56.6.B254; Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031; Choksi KB, 2008, FREE RADICAL BIO MED, V45, P826, DOI 10.1016/j.freeradbiomed.2008.06.006; Cohen TJ, 2009, FASEB J, V23, P99, DOI 10.1096/fj.08-115931; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Csukly K, 2006, J PHYSIOL-LONDON, V574, P319, DOI 10.1113/jphysiol.2006.109702; Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dupont-Versteegden EE, 2005, EXP GERONTOL, V40, P473, DOI 10.1016/j.exger.2005.04.003; Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048; Flood DG, 1999, AM J PATHOL, V155, P663, DOI 10.1016/S0002-9440(10)65162-0; Giniatullin AR, 2006, J NEUROCHEM, V98, P1789, DOI 10.1111/j.1471-4159.2006.03997.x; Giorgi C, 2008, CURR MOL MED, V8, P119; Grady RM, 2005, P NATL ACAD SCI USA, V102, P4359, DOI 10.1073/pnas.0500711102; Jejurikar SS, 2002, PLAST RECONSTR SURG, V110, P160, DOI 10.1097/00006534-200207000-00027; Kagan VE, 2004, FREE RADICAL BIO MED, V37, P1963, DOI 10.1016/j.freeradbiomed.2004.08.016; Kostrominova TY, 2007, CELL TISSUE RES, V327, P595, DOI 10.1007/s00441-006-0297-y; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Lyons CN, 2006, J GERONTOL A-BIOL, V61, P3, DOI 10.1093/gerona/61.1.3; Lysakowski A, 1999, J COMP NEUROL, V403, P378, DOI 10.1002/(SICI)1096-9861(19990118)403:3<378::AID-CNE7>3.0.CO;2-X; Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004; Moylan JS, 2007, MUSCLE NERVE, V35, P411, DOI 10.1002/mus.20743; Muller F, 2005, FREE RADICAL BIO MED, V39, pS127; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Potthoff MJ, 2007, CURR OPIN RHEUMATOL, V19, P542, DOI 10.1097/BOR.0b013e3282efb761; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Saelim N, 2007, APOPTOSIS, V12, P1781, DOI 10.1007/s10495-007-0109-1; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Shefner JM, 1999, NEUROLOGY, V53, P1239, DOI 10.1212/WNL.53.6.1239; Siu PM, 2005, AM J PHYSIOL-REG I, V289, pR1015, DOI 10.1152/ajpregu.00198.2005; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197; Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013; Wada KI, 2003, JPN J PHYSIOL, V53, P145; Wada KI, 2002, AM J PHYSIOL-CELL PH, V283, pC484, DOI 10.1152/ajpcell.00025.2002; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106	58	197	202	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1376	1390		10.1096/fj.09-146308	http://dx.doi.org/10.1096/fj.09-146308			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20040516	Green Published, Green Submitted			2022-12-25	WOS:000277158900011
J	Colombo, G; Margosio, B; Ragona, L; Neves, M; Bonifacio, S; Annis, DS; Stravalaci, M; Tomaselli, S; Giavazzi, R; Rusnati, M; Presta, M; Zetta, L; Mosher, DF; Ribatti, D; Gobbi, M; Taraboletti, G				Colombo, Giorgio; Margosio, Barbara; Ragona, Laura; Neves, Marco; Bonifacio, Silvia; Annis, Douglas S.; Stravalaci, Matteo; Tomaselli, Simona; Giavazzi, Raffaella; Rusnati, Marco; Presta, Marco; Zetta, Lucia; Mosher, Deane F.; Ribatti, Domenico; Gobbi, Marco; Taraboletti, Giulia			Non-peptidic Thrombospondin-1 Mimics as Fibroblast Growth Factor-2 Inhibitors AN INTEGRATED STRATEGY FOR THE DEVELOPMENT OF NEW ANTIANGIOGENIC COMPOUNDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; MOLECULAR-DYNAMICS; HOT-SPOT; ANGIOGENESIS; PEPTIDE; BINDING; RECEPTOR; FRAGMENT; DESIGN; SHEPHERDIN	Endogenous inhibitors of angiogenesis, such as thrombospondin-1 (TSP-1), are promising sources of therapeutic agents to treat angiogenesis-driven diseases, including cancer. TSP-1 regulates angiogenesis through different mechanisms, including binding and sequestration of the angiogenic factor fibroblast growth factor-2 (FGF-2), through a site located in the calcium binding type III repeats. We hypothesized that the FGF-2 binding sequence of TSP-1 might serve as a template for the development of inhibitors of angiogenesis. Using a peptide array approach followed by binding assays with synthetic peptides and recombinant proteins, we identified a FGF-2 binding sequence of TSP-1 in the 15-mer sequence DDDDDNDKIPD-DRDN. Molecular dynamics simulations, taking the full flexibility of the ligand and receptor into account, and nuclear magnetic resonance identified the relevant residues and conformational determinants for the peptide-FGF interaction. This information was translated into a pharmacophore model used to screen the NCI2003 small molecule databases, leading to the identification of three small molecules that bound FGF-2 with affinity in the submicromolar range. The lead compounds inhibited FGF-2-induced endothelial cell proliferation in vitro and affected angiogenesis induced by FGF-2 in the chicken chorioallantoic membrane assay. These small molecules, therefore, represent promising leads for the development of antiangiogenic agents. Altogether, this study demonstrates that new biological insights obtained by integrated multidisciplinary approaches can be used to develop small molecule mimics of endogenous proteins as therapeutic agents.	[Margosio, Barbara; Bonifacio, Silvia; Giavazzi, Raffaella; Taraboletti, Giulia] Mario Negri Inst Pharmacol Res, Dept Oncol, I-24125 Bergamo, Italy; [Colombo, Giorgio; Neves, Marco; Taraboletti, Giulia] CNR, Ist Chim Riconoscimento Mol, I-20131 Milan, Italy; [Ragona, Laura; Tomaselli, Simona; Zetta, Lucia] CNR, Ist Studio Macromol, I-20133 Milan, Italy; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Stravalaci, Matteo; Gobbi, Marco] Mario Negri Inst Pharmacol Res, Dept Mol Pharmacol & Biochem, I-20156 Milan, Italy; [Rusnati, Marco; Presta, Marco] Univ Brescia, Sch Med, Dept Biomed Sci & Biotechnol, I-25123 Brescia, Italy; [Ribatti, Domenico] Univ Bari, Dept Human Anat & Histol, I-70124 Bari, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio delle Macromolecole (ISMAC-CNR); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Brescia; Universita degli Studi di Bari Aldo Moro	Taraboletti, G (corresponding author), Mario Negri Inst Pharmacol Res, Dept Oncol, Via Gavazzeni,11, I-24125 Bergamo, Italy.	giulia.taraboletti@marionegri.it	Stravalaci, Matteo/AAB-8963-2019; tomaselli, simona/A-6075-2012; Rusnati, Marco/F-1168-2010; Neves, Marco/K-6630-2012; Giavazzi, Raffaella/J-7424-2018; Gobbi, Marco/J-2638-2016; Giavazzi, Raffaella/ABB-9768-2020; Colombo, Giorgio/A-2730-2012; Presta, Marco/B-4345-2010; Taraboletti, Giulia/J-4089-2018; Ragona, Laura/AAB-9691-2020	Stravalaci, Matteo/0000-0002-5636-4204; tomaselli, simona/0000-0002-8627-6838; Rusnati, Marco/0000-0001-9968-5908; Gobbi, Marco/0000-0003-1014-6225; Giavazzi, Raffaella/0000-0001-5249-8208; Colombo, Giorgio/0000-0002-1318-668X; Taraboletti, Giulia/0000-0001-8780-5001; Ragona, Laura/0000-0003-3893-7117; Neves, Marco/0000-0003-0525-7318; PRESTA, Marco/0000-0002-4398-8376	National Institutes of Health [HL054462]; Associazione Italiana per la Ricerca sul Cancro; Fondazione Cariplo; Italian Ministry of Health [GR2007, onc_ord 25/07]; European Union [IP-FP7-HEALTH-2007-ADAMANT, 201342]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo); Italian Ministry of Health(Ministry of Health, Italy); European Union(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL054462, the Associazione Italiana per la Ricerca sul Cancro, Fondazione Cariplo, and the Italian Ministry of Health (GR2007 and onc_ord 25/07), and European Union IP-FP7-HEALTH-2007-ADAMANT, 201342.	Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Berg T, 2003, ANGEW CHEM INT EDIT, V42, P2462, DOI 10.1002/anie.200200558; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Calero S, 2004, CHEM BIODIVERS, V1, P505, DOI 10.1002/cbdv.200490044; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Carlson HA, 2008, J MED CHEM, V51, P6432, DOI 10.1021/jm8006504; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Esteras-Chopo A, 2008, J MOL BIOL, V383, P266, DOI 10.1016/j.jmb.2008.07.076; Fernandez-Tornero C, 2003, J BIOL CHEM, V278, P21774, DOI 10.1074/jbc.M212833200; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Frembgen-Kesner T, 2006, J MOL BIOL, V359, P202, DOI 10.1016/j.jmb.2006.03.021; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Gyurkocza B, 2006, J NATL CANCER I, V98, P1068, DOI 10.1093/jnci/djj300; Hannah BLA, 2004, J BIOL CHEM, V279, P51915, DOI 10.1074/jbc.M409632200; Haviv F, 2005, J MED CHEM, V48, P2838, DOI 10.1021/jm0401560; HOGG PJ, 1994, THROMB HAEMOSTASIS, V72, P787; Iruela-Arispe ML, 2004, INT J BIOCHEM CELL B, V36, P1070, DOI 10.1016/j.biocel.2004.01.025; Kazerounian S, 2008, CELL MOL LIFE SCI, V65, P700, DOI 10.1007/s00018-007-7486-z; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Leali D, 2009, CURR PHARM DESIGN, V15, P3577, DOI 10.2174/138161209789206962; LEALI D, 2009, J CELL MOL IN PRESS; Lerner MG, 2007, J CHEM INF MODEL, V47, P2358, DOI 10.1021/ci700167n; Majluf-Cruz A, 2000, J LAB CLIN MED, V136, P292, DOI 10.1067/mlc.2000.109407; Manetti F, 1998, BIOORGAN MED CHEM, V6, P947, DOI 10.1016/S0968-0896(98)00052-2; Margosio B, 2003, BLOOD, V102, P4399, DOI 10.1182/blood-2003-03-0893; Margosio B, 2008, INT J BIOCHEM CELL B, V40, P700, DOI 10.1016/j.biocel.2007.10.002; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Meli M, 2006, J MED CHEM, V49, P7721, DOI 10.1021/jm060836y; MILNE GWA, 1994, J CHEM INF COMP SCI, V34, P1219, DOI 10.1021/ci00021a032; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murray JK, 2007, BIOPOLYMERS, V88, P657, DOI 10.1002/bip.20741; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Ragona L, 2009, BIOCHEM BIOPH RES CO, V382, P26, DOI 10.1016/j.bbrc.2009.02.092; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Robinson JA, 2008, DRUG DISCOV TODAY, V13, P944, DOI 10.1016/j.drudis.2008.07.008; Slootstra JW, 1996, MOL DIVERS, V1, P87, DOI 10.1007/BF01721323; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Sulochana KN, 2007, CURR PHARM DESIGN, V13, P2074; Taraboletti G, 1997, CELL GROWTH DIFFER, V8, P471; TARABOLETTI G, 1990, J CELL BIOL, V111, P765, DOI 10.1083/jcb.111.2.765; Taraboletti G., 2009, RECENT ADV ANGIOGENE, P112; Thanos CD, 2006, P NATL ACAD SCI USA, V103, P15422, DOI 10.1073/pnas.0607058103; Watkins NA, 2003, BLOOD, V102, P718, DOI 10.1182/blood-2002-11-3497; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Whitty A, 2006, NAT CHEM BIOL, V2, P112, DOI 10.1038/nchembio0306-112; Zhang XF, 2007, MICROVASC RES, V74, P90, DOI 10.1016/j.mvr.2007.04.007	54	61	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8733	8742		10.1074/jbc.M109.085605	http://dx.doi.org/10.1074/jbc.M109.085605			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20056600	Green Published, hybrid			2022-12-25	WOS:000275553700026
J	Fourquet, S; Guerois, R; Biard, D; Toledano, MB				Fourquet, Simon; Guerois, Raphael; Biard, Denis; Toledano, Michel B.			Activation of NRF2 by Nitrosative Agents and H2O2 Involves KEAP1 Disulfide Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; TRANSCRIPTION FACTOR NRF2; UBIQUITIN LIGASE COMPLEX; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; CYSTEINE RESIDUES; ADAPTIVE RESPONSE; PHASE-2 RESPONSE; GENE-EXPRESSION	The NRF2 transcription factor regulates a major environmental and oxidative stress response. NRF2 is itself negatively regulated by KEAP1, the adaptor of a Cul3-ubiquitin ligase complex that marks NRF2 for proteasomal degradation by ubiquitination. Electrophilic compounds activate NRF2 primarily by inhibiting KEAP1-dependent NRF2 degradation, through alkylation of specific cysteines. We have examined the impact on KEAP1 of reactive oxygen and nitrogen species, which are also NRF2 inducers. We found that in untreated cells, a fraction of KEAP1 carried a long range disulfide linking Cys(226) and Cys(613). Exposing cells to hydrogen peroxide, to the nitric oxide donor spermine NONOate, to hypochlorous acid, or to S-nitrosocysteine further increased this disulfide and promoted formation of a disulfide linking two KEAP1 molecules via Cys(151). None of these oxidants, except S-nitrocysteine, caused KEAP1 S-nitrosylation. A cysteine mutant preventing KEAP1 intermolecular disulfide formation also prevented NRF2 stabilization in response to oxidants, whereas those preventing intramolecular disulfide formation were functionally silent. Further, simultaneously inactivating the thioredoxin and glutathione pathways led both to major constitutive KEAP1 oxidation and NRF2 stabilization. We propose that KEAP1 intermolecular disulfide formation via Cys(151) underlies the activation of NRF2 by reactive oxygen and nitrogen species.	[Toledano, Michel B.] CEA Saclay, LSOC, IBITECS, F-91191 Gif Sur Yvette, France; [Guerois, Raphael] CEA Saclay, CNRS, IBITECS, URA 2096, F-91191 Gif Sur Yvette, France; [Guerois, Raphael] CEA Saclay, SB2MS, IBITECS, F-91191 Gif Sur Yvette, France; [Biard, Denis] CNRS, CEA, DSV, iRCM,INSERM,Inst A Lwoff,U935, F-94801 Villejuif, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Toledano, MB (corresponding author), CEA Saclay, LSOC, IBITECS, Bat 142, F-91191 Gif Sur Yvette, France.	michel.toledano@cea.fr	, raph/AAF-4380-2019	BIARD, Denis Serge Francois/0000-0001-9697-4392	ARC; ANR; Region Ile-de-France; Programme Toxicologie Nucleaire fellowship	ARC(Australian Research Council); ANR(French National Research Agency (ANR)); Region Ile-de-France(Region Ile-de-France); Programme Toxicologie Nucleaire fellowship	This work was supported by funds from ARC, ANR, and Region Ile-de-France DIM SEnT (to M. B. T.) and by a Programme Toxicologie Nucleaire fellowship (to S. F.).	Ashino T, 2008, MOL IMMUNOL, V45, P2106, DOI 10.1016/j.molimm.2007.10.011; Biard DSF, 2005, MOL CANCER RES, V3, P519, DOI 10.1158/1541-7786.MCR-05-0044; Buckley BJ, 2008, FREE RADICAL BIO MED, V44, P692, DOI 10.1016/j.freeradbiomed.2007.10.055; Buckley BJ, 2003, BIOCHEM BIOPH RES CO, V307, P973, DOI 10.1016/S0006-291X(03)01308-1; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dhakshinamoorthy S, 2004, J BIOL CHEM, V279, P20096, DOI 10.1074/jbc.M312492200; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Eggler AL, 2009, BIOCHEM J, V422, P171, DOI 10.1042/BJ20090471; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Holland R, 2008, CHEM RES TOXICOL, V21, P2051, DOI 10.1021/tx800226m; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ito N, 2009, GENES CELLS, V14, P167, DOI 10.1111/j.1365-2443.2008.01259.x; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; Sakurai T, 2006, CHEM RES TOXICOL, V19, P1196, DOI 10.1021/tx0601105; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Satoh T, 2008, J NEUROCHEM, V104, P1116, DOI 10.1111/j.1471-4159.2007.05039.x; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Schubot FD, 2006, BIOCHEM BIOPH RES CO, V351, P1, DOI 10.1016/j.bbrc.2006.09.167; Sekhar KR, 2010, TOXICOL APPL PHARM, V244, P21, DOI 10.1016/j.taap.2009.06.016; Stamler JS, 2002, CURR OPIN CHEM BIOL, V6, P779, DOI 10.1016/S1367-5931(02)00383-6; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wilson LA, 2005, FASEB J, V19, P2085, DOI 10.1096/fj.05-4401fje; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhu LX, 2008, AM J PHYSIOL-LUNG C, V294, pL469, DOI 10.1152/ajplung.00310.2007; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	51	268	279	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8463	8471		10.1074/jbc.M109.051714	http://dx.doi.org/10.1074/jbc.M109.051714			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061377	hybrid, Green Published			2022-12-25	WOS:000275413800061
J	Antipova, O; Orgel, JPRO				Antipova, Olga; Orgel, Joseph P. R. O.			In Situ D-periodic Molecular Structure of Type II Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING; CONFORMATIONAL-ANALYSIS; EXTRACELLULAR-MATRIX; DIFFRACTION PATTERN; FIBRIL STRUCTURE; C-TELOPEPTIDES; SEQUENCE DATA; CARTILAGE; SPECTROSCOPY; LAMPREY	Collagens are essential components of extracellular matrices in multicellular animals. Fibrillar type II collagen is the most prominent component of articular cartilage and other cartilage-like tissues such as notochord. Its in situ macromolecular and packing structures have not been fully characterized, but an understanding of these attributes may help reveal mechanisms of tissue assembly and degradation (as in osteo- and rheumatoid arthritis). In some tissues such as lamprey notochord, the collagen fibrillar organization is naturally crystalline and may be studied by x-ray diffraction. We used diffraction data from native and derivative notochord tissue samples to solve the axial, D-periodic structure of type II collagen via multiple isomorphous replacement. The electron density maps and heavy atom data revealed the conformation of the nonhelical telopeptides and the overall D-periodic structure of collagen type II in native tissues, data that were further supported by structure prediction and transmission electron microscopy. These results help to explain the observed differences in collagen type I and type II fibrillar architecture and indicate the collagen type II cross-link organization, which is crucial for fibrillogenesis. Transmission electron microscopy data show the close relationship between lamprey and mammalian collagen fibrils, even though the respective larger scale tissue architecture differs.	[Antipova, Olga] IIT, BioCAT, Chicago, IL 60616 USA; IIT, Ctr Mol Study Condensed Soft Matter CoSM Ctr, Pritzker Inst Biomed Sci & Engn, Chicago, IL 60616 USA; IIT, CSRRI, Chicago, IL 60616 USA; IIT, Dept Biol Chem & Phys Sci, Chicago, IL 60616 USA	Illinois Institute of Technology; Illinois Institute of Technology; Illinois Institute of Technology; Illinois Institute of Technology	Antipova, O (corresponding author), IIT, BioCAT, Chicago, IL 60616 USA.	antiolg@iit.edu; orgel@iit.edu			National Science Foundation [MCB-0644015]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630, P41RR007707] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was also supported by the National Science Foundation (Grant MCB-0644015 CAREER).	Bank RA, 1999, P NATL ACAD SCI USA, V96, P1054, DOI 10.1073/pnas.96.3.1054; Barrea RA, 2009, J SYNCHROTRON RADIAT, V16, P76, DOI 10.1107/S0909049508039782; Bos KJ, 2001, J MOL BIOL, V306, P1011, DOI 10.1006/jmbi.2000.4429; BRADSHAW JP, 1989, J MOL BIOL, V205, P685, DOI 10.1016/0022-2836(89)90314-8; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; BRODSKY B, 1994, J MOL BIOL, V243, P38, DOI 10.1006/jmbi.1994.1628; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Christopher NA, 1996, COMPUT CHEM, V20, P339, DOI 10.1016/0097-8485(95)00075-5; EIKENBERRY EF, 1984, J MOL BIOL, V176, P261, DOI 10.1016/0022-2836(84)90424-8; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fischetti R, 2004, J SYNCHROTRON RADIAT, V11, P399, DOI 10.1107/S0909049504016760; Garnero P, 2009, BONE, V44, P461, DOI 10.1016/j.bone.2008.11.006; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gineyts E, 2000, BIOCHEM J, V345, P481, DOI 10.1042/0264-6021:3450481; HELSETH DL, 1981, J BIOL CHEM, V256, P7118; Holmes DF, 2006, P NATL ACAD SCI USA, V103, P17249, DOI 10.1073/pnas.0608417103; HULMES DJS, 1995, BIOPHYS J, V68, P1661, DOI 10.1016/S0006-3495(95)80391-7; HULMES DJS, 1977, J MOL BIOL, V110, P643, DOI 10.1016/S0022-2836(77)80082-X; KADLER K, 1995, PROTEIN PROFILE, V2, P491; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; KADLER KE, 1987, J BIOL CHEM, V262, P15696; LIU XH, 1993, J BIOMOL STRUCT DYN, V11, P541, DOI 10.1080/07391102.1993.10508014; MARTIN GR, 1961, BIOCHIM BIOPHYS ACTA, V53, P599, DOI 10.1016/0006-3002(61)90227-X; MEEK KM, 1979, J BIOL CHEM, V254, P710; MOW VC, 1997, STRUCTURE FUNCTION A, P113; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Orgel JP, 2000, STRUCT FOLD DES, V8, P137, DOI 10.1016/S0969-2126(00)00089-7; Orgel JPRO, 2001, STRUCTURE, V9, P1061, DOI 10.1016/S0969-2126(01)00669-4; Ortolani F, 2000, BIOPOLYMERS, V54, P448; Ortolani F., 1993, Bollettino Societa Italiana Biologia Sperimentale, V69, P107; OTTER A, 1993, BIOPOLYMERS, V33, P1443, DOI 10.1002/bip.360330914; OTTER A, 1988, BIOCHEMISTRY-US, V27, P3560, DOI 10.1021/bi00410a006; Park H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-599; PASTEELS J, 1958, TRAITE ZOOL, V13, P106; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; PETRUSKA JA, 1964, P NATL ACAD SCI USA, V51, P871, DOI 10.1073/pnas.51.5.871; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Phillips WC, 2002, J SYNCHROTRON RADIAT, V9, P36; Pieper JS, 2002, BIOMATERIALS, V23, P3183, DOI 10.1016/S0142-9612(02)00067-4; PIEZ KA, 1961, BIOCHIM BIOPHYS ACTA, V53, P596, DOI 10.1016/0006-3002(61)90226-8; Prockop D.J., 1976, BIOCH COLLAGENS, P163; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Rajkumar G, 2007, J APPL CRYSTALLOGR, V40, P178, DOI 10.1107/S0021889806048643; ROBINS SP, 1983, BIOCHEM J, V215, P175, DOI 10.1042/bj2150175; Schmitt FO, 1942, J CELL COMPAR PHYSL, V20, P11, DOI 10.1002/jcp.1030200103; SCOTT JE, 1988, BIOCHEM J, V253, P607, DOI 10.1042/bj2530607; SCOTT JE, 1993, DERMATAN SULPHATE PR, P165; Scott John E., 1993, Biochemical Society Transactions, V21, p123S; SCOTT PG, 1986, BIOCHEM BIOPH RES CO, V138, P1348, DOI 10.1016/S0006-291X(86)80431-4; Shintani S, 2000, J MOL EVOL, V51, P363, DOI 10.1007/s002390010098; Weast R.C., HDB CHEM PHYS; WESS TJ, 1995, J MOL BIOL, V248, P487, DOI 10.1006/jmbi.1995.0236; Yu EW, 2001, P NATL ACAD SCI USA, V98, P9517, DOI 10.1073/pnas.161239298; Zhang GJ, 2006, P NATL ACAD SCI USA, V103, P3180, DOI 10.1073/pnas.0508313103	55	46	47	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7087	7096		10.1074/jbc.M109.060400	http://dx.doi.org/10.1074/jbc.M109.060400			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056598	Green Published, hybrid			2022-12-25	WOS:000275415600022
J	Cordoba-Canero, D; Dubois, E; Ariza, RR; Doutriaux, MP; Roldan-Arjona, T				Cordoba-Canero, Dolores; Dubois, Emeline; Ariza, Rafael R.; Doutriaux, Marie-Pascale; Roldan-Arjona, Teresa			Arabidopsis Uracil DNA Glycosylase (UNG) Is Required for Base Excision Repair of Uracil and Increases Plant Sensitivity to 5-Fluorouracil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTIAL-PURIFICATION; ESCHERICHIA-COLI; DEAMINATED CYTOSINE; ABASIC SITES; DAMAGE; CONSEQUENCES; NUCLEAR; CELLS; SMUG1; PATCH	Uracil in DNA arises by misincorporation of dUMP during replication and by hydrolytic deamination of cytosine. This common lesion is actively removed through a base excision repair (BER) pathway initiated by a uracil DNA glycosylase (UDG) activity that excises the damage as a free base. UDGs are classified into different families differentially distributed across eubacteria, archaea, yeast, and animals, but remain to be unambiguously identified in plants. We report here the molecular characterization of AtUNG (Arabidopsis thaliana uracil DNA glycosylase), a plant member of the Family-1 of UDGs typified by Escherichia coli Ung. AtUNG exhibits the narrow substrate specificity and single-stranded DNA preference that are characteristic of Ung homologues. Cell extracts from atung(-/-) mutants are devoid of UDG activity, and lack the capacity to initiate BER on uracil residues. AtUNG-deficient plants do not display any apparent phenotype, but show increased resistance to 5-fluorouracil (5-FU), a cytostatic drug that favors dUMP misincorporation into DNA. The resistance of atung(-/-) mutants to 5-FU is accompanied by the accumulation of uracil residues in DNA. These results suggest that AtUNG excises uracil in vivo but generates toxic AP sites when processing abundant U: A pairs in dTTP-depleted cells. Altogether, our findings point to AtUNG as the major UDG activity in Arabidopsis.	[Cordoba-Canero, Dolores; Ariza, Rafael R.; Roldan-Arjona, Teresa] Univ Cordoba, Dept Genet, E-14071 Cordoba, Spain; [Cordoba-Canero, Dolores; Ariza, Rafael R.; Roldan-Arjona, Teresa] Maimonides Inst Biomed Res IMIBIC, Cordoba 14071, Spain; [Dubois, Emeline; Doutriaux, Marie-Pascale] Univ Paris 11, Inst Biotechnol Plantes, CNRS, UMR8618, F-91405 Orsay, France	Universidad de Cordoba; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Roldan-Arjona, T (corresponding author), Univ Cordoba, Dept Genet, Edif Gregor Mendel,Campus Rabanales S-N, E-14071 Cordoba, Spain.	ge2roarm@uco.es	Roldan-Arjona, Teresa/H-5976-2015; Cordoba Canero, Dolores/H-8450-2018	Roldan-Arjona, Teresa/0000-0003-2842-3956; Cordoba Canero, Dolores/0000-0002-9659-4928; Dubois, Emeline/0000-0002-2515-9128	Ministerio de Educacion y Ciencia, Spain [BFU2007-60956/BMC]; Junta de Andalucia, Spain [P07-CVI-02770]	Ministerio de Educacion y Ciencia, Spain(Spanish Government); Junta de Andalucia, Spain(Junta de Andalucia)	This work was supported by funds from the Ministerio de Educacion y Ciencia, Spain ( Grant Number BFU2007-60956/BMC) and from the Junta de Andalucia, Spain ( Grant Number P07-CVI-02770).	Andersen S, 2005, CARCINOGENESIS, V26, P547, DOI 10.1093/carcin/bgh347; Aravind L, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-4-RESEARCH0007; Bennett SE, 2004, P NATL ACAD SCI USA, V101, P6391, DOI 10.1073/pnas.0401031101; BENSEN RJ, 1987, PLANT PHYSIOL, V83, P149, DOI 10.1104/pp.83.1.149; BLAISDELL P, 1983, J BIOL CHEM, V258, P1603; BONES AM, 1993, PHYSIOL PLANTARUM, V88, P682, DOI 10.1111/j.1399-3054.1993.tb01389.x; Chung JH, 2003, NUCLEIC ACIDS RES, V31, P2045, DOI 10.1093/nar/gkg319; Cordoba-Canero D, 2009, PLANT J, V60, P716, DOI 10.1111/j.1365-313X.2009.03994.x; Dianov GL, 2003, MUTAT RES-FUND MOL M, V531, P157, DOI 10.1016/j.mrfmmm.2003.09.003; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; Fan JS, 2005, FREE RADICAL BIO MED, V38, P1121, DOI 10.1016/j.freeradbiomed.2005.01.012; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Guillet M, 2003, MOL CELL BIOL, V23, P8386, DOI 10.1128/MCB.23.22.8386-8394.2003; Guillet M, 2006, NUCLEIC ACIDS RES, V34, P2056, DOI 10.1093/nar/gkl139; GUTIERREZ C, 1987, MUTAT RES, V181, P111, DOI 10.1016/0027-5107(87)90293-4; Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; Nakamura N, 2008, MUTAGENESIS, V23, P407, DOI 10.1093/mutage/gen030; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Nilsen H, 2001, EMBO J, V20, P4278, DOI 10.1093/emboj/20.15.4278; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Pettersen HS, 2007, NUCLEIC ACIDS RES, V35, P3879, DOI 10.1093/nar/gkm372; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Seiple L, 2006, NUCLEIC ACIDS RES, V34, P140, DOI 10.1093/nar/gkj430; Stivers JT, 2004, SCIENCE, V306, p2042A, DOI 10.1126/science.1104396; Sutherland Betsy M, 2006, Methods Mol Biol, V314, P251; TALPAERTBORLE M, 1982, EUR J BIOCHEM, V124, P435; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Visnes T, 2008, DNA REPAIR, V7, P1869, DOI 10.1016/j.dnarep.2008.07.012; Wyatt MD, 2009, CELL MOL LIFE SCI, V66, P788, DOI 10.1007/s00018-008-8557-5	37	28	30	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7475	7483		10.1074/jbc.M109.067173	http://dx.doi.org/10.1074/jbc.M109.067173			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056608	Green Published, hybrid			2022-12-25	WOS:000275415600059
J	Graham, LV; Sweetwyne, MT; Pallero, MA; Murphy-Ullrich, JE				Graham, Lauren Van Duyn; Sweetwyne, Mariya T.; Pallero, Manuel A.; Murphy-Ullrich, Joanne E.			Intracellular Calreticulin Regulates Multiple Steps in Fibrillar Collagen Expression, Trafficking, and Processing into the Extracellular Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE CALRETICULIN; GROWTH-FACTOR-BETA; RECEPTOR-RELATED PROTEIN; AMINO-ACID DEPRIVATION; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; SUBSTRATUM ADHESION; DERMAL FIBROBLASTS; OXIDATIVE STRESS; APOPTOTIC CELLS	Calreticulin (CRT), a chaperone and Ca2+ regulator, enhances wound healing, and its expression correlates with fibrosis in animal models, suggesting that CRT regulates production of the extracellular matrix. However, direct regulation of collagen matrix by CRT has not been previously demonstrated. We investigated the role of CRT in the regulation of fibrillar collagen expression, secretion, processing, and deposition in the extracellular matrix by fibroblasts. Mouse embryonic fibroblasts deficient in CRT (CRT-/- MEFs) have reduced transcript levels of fibrillar collagen I and III and less soluble collagen as compared with wild type MEFs. Correspondingly, fibroblasts engineered to overexpress CRT have increased collagen type I transcript and protein. Collagen expression appears to be regulated by endoplasmic reticulum (ER) calcium levels and intracellular CRT, because thapsigargin treatment reduced collagen expression, whereas addition of exogenous recombinant CRT had no effect. CRT-/- MEFs exhibited increased ER retention of collagen, and collagen and CRT were co-immunoprecipitated from isolated cell lysates, suggesting that CRT is important for trafficking of collagen through the ER. CRT-/- MEFs also have reduced type I procollagen processing and deposition into the extracellular matrix. The reduced collagen matrix deposition is partly a consequence of reduced fibronectin matrix formation in the CRT-deficient cells. Together, these data show that CRT complexes with collagen in cells and that CRT plays critical roles at multiple stages of collagen expression and processing. These data identify CRT as an important regulator of collagen and suggest that intracellular CRT signaling plays an important role in tissue remodeling and fibrosis.	[Graham, Lauren Van Duyn; Pallero, Manuel A.; Murphy-Ullrich, Joanne E.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Sweetwyne, Mariya T.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Murphy-Ullrich, JE (corresponding author), Volker Hall 668,1670 Univ Blvd, Birmingham, AL 35294 USA.	murphy@uab.edu	Sweetwyne, Mariya/GWR-2481-2022		National Institutes of Health [HL079644, T32 GM008361, T32 HL007918]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015490] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007918, R01HL079644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079644 (to J.E.M.- U.), T32 GM008361 (to L. V. G.), and T32 HL007918 (to M. T. S.) (Medical Scientist Training Program Grants, University of Alabama at Birmingham).	BASTIANUTTO C, 1995, J CELL BIOL, V130, P847, DOI 10.1083/jcb.130.4.847; BLANCK TJJ, 1975, ARCH BIOCHEM BIOPHYS, V171, P259, DOI 10.1016/0003-9861(75)90031-4; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; CHAN D, 1990, BIOCHEM J, V269, P175, DOI 10.1042/bj2690175; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; COPPOLINO M, 1995, J BIOL CHEM, V270, P23132, DOI 10.1074/jbc.270.39.23132; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Corbett EF, 2000, J BIOL CHEM, V275, P27177; Corbett EF, 1999, J BIOL CHEM, V274, P6203, DOI 10.1074/jbc.274.10.6203; Davidson JM, 1997, J BIOL CHEM, V272, P345, DOI 10.1074/jbc.272.1.345; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; EGGLETON P, 1994, CLIN IMMUNOL IMMUNOP, V72, P405, DOI 10.1006/clin.1994.1160; Elton CM, 2002, THROMB HAEMOSTASIS, V88, P648, DOI 10.1055/s-0037-1613270; Fadel MP, 1999, J BIOL CHEM, V274, P15085, DOI 10.1074/jbc.274.21.15085; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; GOLD L, 2010, FASEB J IN PRESS; GRAY AJ, 1995, J BIOL CHEM, V270, P26602, DOI 10.1074/jbc.270.44.26602; Harada K, 2006, J BIOL CHEM, V281, P12841, DOI 10.1074/jbc.M512975200; Heal R, 1998, BIOCHEM J, V329, P389, DOI 10.1042/bj3290389; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; Horino Y, 2002, LIFE SCI, V71, P3031, DOI 10.1016/S0024-3205(02)02142-2; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Kinnula VL, 2005, AM J RESP CRIT CARE, V172, P417, DOI 10.1164/rccm.200501-017PP; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Knee R, 2003, BIOCHEM BIOPH RES CO, V304, P661, DOI 10.1016/S0006-291X(03)00643-0; Koide T, 2005, TOP CURR CHEM, V247, P85, DOI 10.1007/b103820; Kwon MS, 2000, MOL BIOL CELL, V11, P1433, DOI 10.1091/mbc.11.4.1433; Kypreou KP, 2008, PROTEOMICS, V8, P2407, DOI 10.1002/pmic.200700831; Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399; Mehta K, 2002, NUTR REV, V60, P289, DOI 10.1301/002966402320387224; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Midwood KS, 2002, METHOD CELL BIOL, V69, P145, DOI 10.1016/S0091-679X(02)69011-9; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; MURPHYULLRICH JE, 1989, J CELL BIOL, V109, P1309, DOI 10.1083/jcb.109.3.1309; MURPHYULLRICH JE, 1993, J BIOL CHEM, V268, P26784; Nagata K, 1996, TRENDS BIOCHEM SCI, V21, P23, DOI 10.1016/0968-0004(96)80881-4; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Nanney LB, 2008, AM J PATHOL, V173, P610, DOI 10.2353/ajpath.2008.071027; Nunez MT, 2001, J CELL BIOCHEM, V82, P660, DOI 10.1002/jcb.1194; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; OPAS M, 1991, J CELL PHYSIOL, V149, P160, DOI 10.1002/jcp.1041490120; Opas M, 1996, J CELL BIOL, V135, P1913, DOI 10.1083/jcb.135.6.1913; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; Orr AW, 2002, J BIOL CHEM, V277, P20453, DOI 10.1074/jbc.M112091200; Pallero MA, 2008, FASEB J, V22, P3968, DOI 10.1096/fj.07-104802; Papp S, 2008, EXP CELL RES, V314, P1313, DOI 10.1016/j.yexcr.2008.01.008; Papp S, 2007, J BIOL CHEM, V282, P16585, DOI 10.1074/jbc.M701011200; PEERSCHKE EIB, 1990, J IMMUNOL, V145, P2984; PLAKIDOUDYMOCK S, 1994, CELL CALCIUM, V16, P1, DOI 10.1016/S0143-4160(05)80002-8; Poobalarahi F, 2006, AM J PHYSIOL-HEART C, V291, pH2924, DOI 10.1152/ajpheart.00153.2006; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; Razzaque MS, 1998, MODERN PATHOL, V11, P1183; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Shah SV, 2007, J AM SOC NEPHROL, V18, P16, DOI 10.1681/ASN.2006050500; Shalitin N, 2003, J CELL BIOCHEM, V90, P397, DOI 10.1002/jcb.10646; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Stefanovic B, 2004, MOL CELL BIOL, V24, P1758, DOI 10.1128/MCB.24.4.1758-1768.2004; Sugiura T, 2000, NEPHRON, V85, P71, DOI 10.1159/000045633; Taguchi T, 2007, TRENDS MOL MED, V13, P45, DOI 10.1016/j.molmed.2006.12.001; TREVES S, 1990, BIOCHEM J, V271, P473, DOI 10.1042/bj2710473; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tufi R, 2008, CELL DEATH DIFFER, V15, P274, DOI 10.1038/sj.cdd.4402275; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Waser M, 1997, J CELL BIOL, V138, P547, DOI 10.1083/jcb.138.3.547; Wu M, 2007, MATRIX BIOL, V26, P463, DOI 10.1016/j.matbio.2007.02.005; Wu XD, 2007, SHOCK, V27, P572, DOI 10.1097/01.shk.0000246901.58068.a8; Xiao GQ, 1999, J NEUROSCI RES, V58, P652, DOI 10.1002/(SICI)1097-4547(19991201)58:5<652::AID-JNR6>3.0.CO;2-H	74	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7067	7078		10.1074/jbc.M109.006841	http://dx.doi.org/10.1074/jbc.M109.006841			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20044481	Green Published, hybrid			2022-12-25	WOS:000275415600020
J	Hwang, CY; Holl, J; Rajan, D; Lee, Y; Kim, S; Um, M; Kwon, KS; Song, B				Hwang, Chae Young; Holl, Jens; Rajan, Devi; Lee, Younglang; Kim, Susan; Um, Moonkyoung; Kwon, Ki-Sun; Song, Byeongwoon			Hsp70 Interacts with the Retroviral Restriction Factor TRIM5 alpha and Assists the Folding of TRIM5 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MURINE LEUKEMIA-VIRUS; CYTOPLASMIC BODIES; CHAPERONE SUPPRESSION; ANDROGEN RECEPTOR; MOLECULAR-CLONING; EMBRYONIC-CELLS; MONKEY CELLS; OLD-WORLD; PROTEIN	Tripartite motif (TRIM) protein TRIM5 alpha has been shown to restrict human immunodeficiency virus, type 1 infection in Old World monkey cells at the early post-entry step by poorly understood mechanisms. Currently, the physiological function of TRIM5 alpha is not known. In this study, we showed that transiently overexpressed TRIM5 alpha causes a morphological change in HEK293T cells. A proteomics analysis of the protein complexes that were pulled down with hemagglutinin-tagged TRIM5 alpha suggested that the heat shock protein 70 (Hsp70) may serve as a TRIM5 alpha-binding partner. The interaction between Hsp70 and TRIM5 alpha was confirmed by co-localization and co-immunoprecipitation assays. Co-expression of Hsp70 reversed the TRIM5 alpha-induced morphological change in HEK293T cells. Another heat shock protein Hsc70 also bound to TRIM5 alpha, but unlike Hsp70, Hsc70 was not able to reverse the TRIM5 alpha-induced morphological change, suggesting that Hsp70 specifically reverses the morphological change caused by TRIM5 alpha. Studies using a series of TRIM5 alpha deletion mutants demonstrate that, although the PRYSPRY domain is critical for binding to Hsp70, the entire TRIM5 alpha structure is necessary to induce the morphological change of cells. When the ATPase domain of Hsp70 was mutated, the mutated Hsp70 could not counteract the morphological change induced by TRIM5 alpha, indicating that the catalytic activity of Hsp70 protein is important for this function. Co-expression of Hsp70 elevated the levels of TRIM5 alpha in the detergent-soluble fraction with a concomitant decrease in the detergent-insoluble fraction. Together these results suggest that Hsp70 plays critical roles in the cellular management against the TRIM5 alpha-induced cellular insults.	[Song, Byeongwoon] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Hwang, Chae Young; Lee, Younglang; Kwon, Ki-Sun] Korea Res Inst Biosci & Biotechnol, Lab Cell Signaling, Aging Res Ctr, Taejon 305333, South Korea; [Lee, Younglang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Um, Moonkyoung] Boston Biomed Res Inst, Watertown, MA 02472 USA	Emory University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Boston Biomedical Research Institute	Song, B (corresponding author), Emory Univ, Sch Med, Dept Pediat, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	bsong4@emory.edu			Campbell Foundation; Emory University Research Committee; Emory Egleston Children's Research Center; Emory Center for AIDS Research [P30AI050409]; Korea Research Council of Fundamental Science and Technology [M10642040003]; National Research Foundation of Korea [M10503010002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	Campbell Foundation; Emory University Research Committee; Emory Egleston Children's Research Center; Emory Center for AIDS Research; Korea Research Council of Fundamental Science and Technology; National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Campbell Foundation Award, Emory University Research Committee Award, Emory Egleston Children's Research Center Award, and Emory Center for AIDS Research Award P30AI050409 (to B. S.), and partially supported by the Korea Research Council of Fundamental Science and Technology Award M10642040003 and National Research Foundation of Korea Award fM10503010002 (to K.-S.K.).	Agostini I, 2000, EXP CELL RES, V259, P398, DOI 10.1006/excr.2000.4992; Asaoka K, 2005, BIOCHEM BIOPH RES CO, V338, P1950, DOI 10.1016/j.bbrc.2005.10.173; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Campbell EM, 2007, MOL BIOL CELL, V18, P2102, DOI 10.1091/mbc.E06-12-1075; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Diaz-Griffero F, 2006, VIROLOGY, V349, P300, DOI 10.1016/j.virol.2005.12.040; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gongora C, 2000, J INTERF CYTOK RES, V20, P955, DOI 10.1089/10799900050198390; Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002; Hatziioannou T, 2004, J VIROL, V78, P6005, DOI 10.1128/JVI.78.11.6005-6012.2004; Himathongkham S, 1996, VIROLOGY, V219, P485, DOI 10.1006/viro.1996.0276; Hofmann W, 1999, J VIROL, V73, P10020, DOI 10.1128/JVI.73.12.10020-10028.1999; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Mische CC, 2005, J VIROL, V79, P14446, DOI 10.1128/JVI.79.22.14446-14450.2005; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Orimo A, 2000, GENOMICS, V69, P143, DOI 10.1006/geno.2000.6318; Owens CA, 2003, J VIROL, V77, P726, DOI 10.1128/JVI.77.1.726-731.2003; Owens CM, 2004, J VIROL, V78, P5423, DOI 10.1128/JVI.78.10.5423-5437.2004; Perez-Caballero D, 2005, J VIROL, V79, P15567, DOI 10.1128/JVI.79.24.15567-15572.2005; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; SHIBATA R, 1995, J GEN VIROL, V76, P2723, DOI 10.1099/0022-1317-76-11-2723; Song B, 2005, VIROLOGY, V343, P201, DOI 10.1016/j.virol.2005.08.019; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; Towers G, 2000, P NATL ACAD SCI USA, V97, P12295, DOI 10.1073/pnas.200286297; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Xu LX, 2003, EXP CELL RES, V288, P84, DOI 10.1016/S0014-4827(03)00187-3; Yamauchi K, 2008, FEBS J, V275, P1540, DOI 10.1111/j.1742-4658.2008.06313.x; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	54	10	16	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7827	7837		10.1074/jbc.M109.040618	http://dx.doi.org/10.1074/jbc.M109.040618			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20053985	Green Published, hybrid			2022-12-25	WOS:000275415600090
J	Ouchi, N; Asaumi, Y; Ohashi, K; Higuchi, A; Sono-Romanelli, S; Oshima, Y; Walsh, K				Ouchi, Noriyuki; Asaumi, Yasuhide; Ohashi, Koji; Higuchi, Akiko; Sono-Romanelli, Saki; Oshima, Yuichi; Walsh, Kenneth			DIP2A Functions as a FSTL1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; ACTIVATED PROTEIN-KINASE; FOLLISTATIN-LIKE 1; EXPRESSION; AKT; ANGIOGENESIS; GROWTH; GENE; REVASCULARIZATION; CLONING	FSTL1 is an extracellular glycoprotein whose functional significance in physiological and pathological processes is incompletely understood. Recently, we have shown that FSTL1 acts as a muscle-derived secreted factor that is up-regulated by Akt activation and ischemic stress and that FSTL1 exerts favorable actions on the heart and vasculature. Here, we sought to identify the receptor that mediates the cellular actions of FSTL1. We identified DIP2A as a novel FSTL1-binding partner from the membrane fraction of endothelial cells. Co-immunoprecipitation assays revealed a direct physical interaction between FSTL1 and DIP2A. DIP2A was present on the cell surface of endothelial cells, and knockdown of DIP2A by small interfering RNA reduced the binding of FSTL1 to cells. In cultured endothelial cells, knockdown of DIP2A by small interfering RNA diminished FSTL1-stimulated survival, migration, and differentiation into network structures and inhibited FSTL1-induced Akt phosphorylation. In cultured cardiac myocytes, ablation of DIP2A reduced the protective actions of FSTL1 on hypoxia/reoxygenation-induced apoptosis and suppressed FSTL1-induced Akt phosphorylation. These data indicate that DIP2A functions as a novel receptor that mediates the cardiovascular protective effects of FSTL1.	[Ouchi, Noriyuki; Asaumi, Yasuhide; Ohashi, Koji; Higuchi, Akiko; Sono-Romanelli, Saki; Oshima, Yuichi; Walsh, Kenneth] Boston Univ, Sch Med, Mol Cardiol Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Boston University	Walsh, K (corresponding author), Boston Univ, Sch Med, Mol Cardiol Whitaker Cardiovasc Inst, 715 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	OUCHI, Noriyuki/I-7306-2014; OHASHI, Koji/I-7307-2014	Walsh, Kenneth/0000-0001-7580-2276; Asaumi, Yasuhide/0000-0002-9009-7234	National Institutes of Health [HL77774, HL86785, AG15052, HL81587]; Banyu Life Science Foundation International	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Banyu Life Science Foundation International(Banyu Life Science Foundation International)	This work was supported, in whole or in part, by National Institutes of Health Grants HL77774, HL86785, AG15052, and HL81587 (to K. W.). This work was also supported by grants from Banyu Life Science Foundation International (to Y. A.).	Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Chan QKY, 2009, CARCINOGENESIS, V30, P114, DOI 10.1093/carcin/bgn215; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; Kawabata D, 2004, ARTHRITIS RHEUM-US, V50, P660, DOI 10.1002/art.20023; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Le Luduec JB, 2008, AM J TRANSPLANT, V8, P2297, DOI 10.1111/j.1600-6143.2008.02398.x; Mashimo J, 1997, CANCER LETT, V113, P213, DOI 10.1016/S0304-3835(97)04700-9; Miyamae T, 2006, J IMMUNOL, V177, P4758, DOI 10.4049/jimmunol.177.7.4758; Mukhopadhyay M, 2002, GENE, V293, P59, DOI 10.1016/S0378-1119(02)00694-7; Nagase T, 1996, DNA Res, V3, P17, DOI 10.1093/dnares/3.1.17; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2; Sumitomo K, 2000, CANCER LETT, V155, P37, DOI 10.1016/S0304-3835(00)00407-9; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709	25	91	97	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7127	7134		10.1074/jbc.M109.069468	http://dx.doi.org/10.1074/jbc.M109.069468			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20054002	hybrid, Green Published			2022-12-25	WOS:000275415600026
J	Zhao, WQ; Santini, F; Breese, R; Ross, D; Zhang, XD; Stone, DJ; Ferrer, M; Townsend, M; Wolfe, AL; Seager, MA; Kinney, GG; Shughrue, PJ; Ray, WJ				Zhao, Wei-Qin; Santini, Francesca; Breese, Robert; Ross, Dave; Zhang, Xiaohua Douglas; Stone, David J.; Ferrer, Marc; Townsend, Matthew; Wolfe, Abigail L.; Seager, Matthew A.; Kinney, Gene G.; Shughrue, Paul J.; Ray, William J.			Inhibition of Calcineurin-mediated Endocytosis and alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid beta Oligomer-induced Synaptic Disruption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; ALZHEIMERS-DISEASE PATHOLOGY; SCALE RNAI SCREENS; A-BETA; GLUTAMATE-RECEPTOR; TRANSGENIC MICE; ENTORHINAL CORTEX; EXCITATORY SYNAPSES; PRECURSOR PROTEIN; DENDRITIC SPINES	Synaptic degeneration, including impairment of synaptic plasticity and loss of synapses, is an important feature of Alzheimer disease pathogenesis. Increasing evidence suggests that these degenerative synaptic changes are associated with an accumulation of soluble oligomeric assemblies of amyloid beta (A beta) known as ADDLs. In primary hippocampal cultures ADDLs bind to a sub-population of neurons. However the molecular basis of this cell type-selective interaction is not understood. Here, using siRNA screening technology, we identified alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunits and calcineurin as candidate genes potentially involved in ADDL-neuron interactions. Immunocolocalization experiments confirmed that ADDL binding occurs in dendritic spines that express surface AMPA receptors, particularly the calcium-impermeable type II AMPA receptor subunit (GluR2). Pharmacological removal of the surface AMPA receptors or inhibition of AMPA receptors with antagonists reduces ADDL binding. Furthermore, using co-immunoprecipitation and photoreactive amino acid cross-linking, we found that ADDLs interact preferentially with GluR2-containing complexes. We demonstrate that calcineurin mediates an endocytotic process that is responsible for the rapid internalization of bound ADDLs along with surface AMPA receptor subunits, which then both colocalize with cpg2, a molecule localized specifically at the postsynaptic endocytic zone of excitatory synapses that plays an important role in activity-dependent glutamate receptor endocytosis. Both AMPA receptor and calcineurin inhibitors prevent oligomer-induced surface AMPAR and spine loss. These results support a model of disease pathogenesis in which A beta oligomers interact selectively with neurotransmission pathways at excitatory synapses, resulting in synaptic loss via facilitated endocytosis. Validation of this model in human disease would identify therapeutic targets for Alzheimer disease.	[Zhao, Wei-Qin; Breese, Robert; Wolfe, Abigail L.; Seager, Matthew A.; Kinney, Gene G.; Shughrue, Paul J.; Ray, William J.] Merck Res Labs, Dept Neurol, West Point, PA 19486 USA; [Santini, Francesca; Ross, Dave; Ferrer, Marc] Merck Res Labs, N Wales, PA 19454 USA; [Townsend, Matthew] Merck Res Labs, Boston, MA 02115 USA	Merck & Company; Merck & Company; Merck & Company	Zhao, WQ (corresponding author), Merck Res Labs, Dept Neurol, Mail Stop 26A-2000,770 Sunneytown Pike, West Point, PA 19486 USA.	wei-qin_zhao@merck.com	Ray, William J/E-9834-2016	Zhang, Xiaohua Douglas/0000-0002-2486-7931; Ray, William/0000-0002-4491-167X				Abraham G, 2000, BIOORGAN MED CHEM, V8, P2127, DOI 10.1016/S0968-0896(00)00133-4; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; ARMSTRONG DM, 1994, BRAIN RES, V639, P207, DOI 10.1016/0006-8993(94)91732-9; Balannik V, 2005, NEURON, V48, P279, DOI 10.1016/j.neuron.2005.09.024; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Belayev L, 2001, J NEUROTRAUM, V18, P1031, DOI 10.1089/08977150152693728; Biou V, 2008, P NATL ACAD SCI USA, V105, P1038, DOI 10.1073/pnas.0711412105; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carter TL, 2004, EXP NEUROL, V187, P299, DOI 10.1016/j.expneurol.2003.12.010; Catarzi D, 2007, MED RES REV, V27, P239, DOI 10.1002/med.20084; Cha JHJ, 2001, NEUROBIOL DIS, V8, P90, DOI 10.1006/nbdi.2000.0330; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Dineley KT, 2007, NEUROBIOL LEARN MEM, V88, P217, DOI 10.1016/j.nlm.2007.03.010; DONEVAN SD, 1994, J PHARMACOL EXP THER, V271, P25; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; GEDDES JW, 1992, EXP NEUROL, V115, P271, DOI 10.1016/0014-4886(92)90062-U; Gladding CM, 2009, MOL CELL NEUROSCI, V40, P267, DOI 10.1016/j.mcn.2008.10.014; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hering H, 2003, J NEUROSCI, V23, P3262; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Ikonomovic MD, 1997, J NEUROPATH EXP NEUR, V56, P1018, DOI 10.1097/00005072-199709000-00007; Ikonomovic MD, 1995, HIPPOCAMPUS, V5, P469, DOI 10.1002/hipo.450050509; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LASSMANN H, 1993, ANN NY ACAD SCI, V695, P59, DOI 10.1111/j.1749-6632.1993.tb23028.x; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lissin DV, 1999, J NEUROSCI, V19, P1263; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shughrue PJ, 2010, NEUROBIOL AGING, V31, P189, DOI 10.1016/j.neurobiolaging.2008.04.003; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Xiao MY, 2001, NEUROPHARMACOLOGY, V41, P664, DOI 10.1016/S0028-3908(01)00134-4; YASUDA RP, 1995, BRAIN RES, V678, P161, DOI 10.1016/0006-8993(95)00178-S; Zhang XD, 2008, NUCLEIC ACIDS RES, V36, P4667, DOI 10.1093/nar/gkn435; Zhang XHD, 2008, J BIOMOL SCREEN, V13, P363, DOI 10.1177/1087057108317062; Zhang XD, 2007, J BIOMOL SCREEN, V12, P645, DOI 10.1177/1087057107300645; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhao WQ, 2004, J NEUROCHEM, V90, P609, DOI 10.1111/j.1471-4159.2004.02509.x; ZORUMSKI CF, 1993, NEURON, V10, P61, DOI 10.1016/0896-6273(93)90242-J	85	139	143	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7619	7632		10.1074/jbc.M109.057182	http://dx.doi.org/10.1074/jbc.M109.057182			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20032460	Green Published, hybrid			2022-12-25	WOS:000275415600073
J	Dubots, E; Audry, M; Yamaryo, Y; Bastien, O; Ohta, H; Breton, C; Marechal, E; Block, MA				Dubots, Emmanuelle; Audry, Magali; Yamaryo, Yoshiki; Bastien, Olivier; Ohta, Hiroyuki; Breton, Christelle; Marechal, Eric; Block, Maryse A.			Activation of the Chloroplast Monogalactosyldiacylglycerol Synthase MGD1 by Phosphatidic Acid and Phosphatidylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE MEMBRANES; ARABIDOPSIS-THALIANA; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; KINASE-ACTIVITIES; PHOSPHOLIPASE-D; PLANT-CELLS; BIOSYNTHESIS; DIACYLGLYCEROL; GALACTOSYLTRANSFERASE; PHOSPHATIDYLCHOLINE	One of the major characteristics of chloroplast membranes is their enrichment in galactoglycerolipids, monogalactosyldiacylglycerol (MGDG), and digalactosyldiacylglycerol (DGDG), whereas phospholipids are poorly represented, mainly as phosphatidylglycerol (PG). All these lipids are synthesized in the chloroplast envelope, but galactolipid synthesis is also partially dependent on phospholipid synthesis localized in non-plastidial membranes. MGDG synthesis was previously shown essential for chloroplast development. In this report, we analyze the regulation of MGDG synthesis by phosphatidic acid (PA), which is a general precursor in the synthesis of all glycerolipids and is also a signaling molecule in plants. We demonstrate that under physiological conditions, MGDG synthesis is not active when the MGDG synthase enzyme is supplied with its substrates only, i.e. diacylglycerol and UDP-gal. In contrast, PA activates the enzyme when supplied. This is shown in leaf homogenates, in the chloroplast envelope, as well as on the recombinant MGDG synthase, MGD1. PG can also activate the enzyme, but comparison of PA and PG effects on MGD1 activity indicates that PA and PG proceed through different mechanisms, which are further differentiated by enzymatic analysis of point-mutated recombinant MGD1s. Activation of MGD1 by PA and PG is proposed as an important mechanism coupling phospholipid and galactolipid syntheses in plants.	[Block, Maryse A.] Univ Grenoble 1, CEA Grenoble, Physiol Cellulaire Vegetale Lab, IRTSV,CEA,INRA,CNRS, F-38054 Grenoble, France; [Audry, Magali; Breton, Christelle] CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble, France; [Ohta, Hiroyuki] Tokyo Inst Technol, Res Ctr Evolving Earth & Planets, Yokohama, Kanagawa 2268501, Japan; [Ohta, Hiroyuki] Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa 2268501, Japan	INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Tokyo Institute of Technology; Tokyo Institute of Technology	Block, MA (corresponding author), Univ Grenoble 1, CEA Grenoble, Physiol Cellulaire Vegetale Lab, IRTSV,CEA,INRA,CNRS, 17 Rue Martyrs, F-38054 Grenoble, France.	mblock@cea.fr	Ohta, Hiroyuki/B-1840-2014; Bastien, Olivier/B-9723-2008	Ohta, Hiroyuki/0000-0002-1068-3242; Yamaryo-Botte, Yoshiki/0000-0002-9349-4411				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Andersson MX, 2004, BBA-MOL CELL BIOL L, V1684, P46, DOI 10.1016/j.bbalip.2004.06.003; Andrews B, 2000, BIOCHEM BIOPH RES CO, V273, P302, DOI 10.1006/bbrc.2000.2938; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Babiychuk E, 2003, PLANT J, V33, P899, DOI 10.1046/j.1365-313X.2003.01680.x; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Bin Y, 2004, PLANT CELL PHYSIOL, V45, P503, DOI 10.1093/pcp/pch064; Block MA, 2007, PHOTOSYNTH RES, V92, P225, DOI 10.1007/s11120-007-9195-8; Botte C, 2005, J BIOL CHEM, V280, P34691, DOI 10.1074/jbc.M505622200; COVES J, 1988, P NATL ACAD SCI USA, V85, P4966, DOI 10.1073/pnas.85.14.4966; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; DORNE AJ, 1982, FEBS LETT, V145, P30, DOI 10.1016/0014-5793(82)81200-3; DOUCE R, 1990, ANNU REV CELL BIOL, V6, P173, DOI 10.1146/annurev.cb.06.110190.001133; Fritz M, 2007, J BIOL CHEM, V282, P4613, DOI 10.1074/jbc.M606295200; Grange M, 2000, J BIOL CHEM, V275, P33379, DOI 10.1074/jbc.M006329200; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; Jones JA, 2005, BIOCHEMISTRY-US, V44, P13235, DOI 10.1021/bi0505159; Jouhet J, 2003, FEBS LETT, V544, P63, DOI 10.1016/S0014-5793(03)00477-0; JOYARD J, 2010, PROGR LIPID IN PRESS; KELLY AA, 2007, CURRENT ADV BIOCH CE; Kobayashi K, 2007, P NATL ACAD SCI USA, V104, P17216, DOI 10.1073/pnas.0704680104; KUNST L, 1988, P NATL ACAD SCI USA, V85, P4143, DOI 10.1073/pnas.85.12.4143; Li G, 2007, PLANT CELL, V19, P281, DOI 10.1105/tpc.106.041426; Li MY, 2006, PLANT PHYSIOL, V140, P761, DOI 10.1104/pp.105.070995; MALHERBE A, 1992, J BIOL CHEM, V267, P23546; MARECHAL E, 1994, J BIOL CHEM, V269, P5788; Miege C, 1999, EUR J BIOCHEM, V265, P990, DOI 10.1046/j.1432-1327.1999.00801.x; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Muller MO, 2000, J BIOL CHEM, V275, P19475, DOI 10.1074/jbc.M002575200; Nakamura Y, 2007, J BIOL CHEM, V282, P29013, DOI 10.1074/jbc.M704385200; OHTA H, 1995, PLANT LIPID METABOLI; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; Seo YS, 2009, FEBS LETT, V583, P2301, DOI 10.1016/j.febslet.2009.06.021; Siegenthaler PA, 1997, FEBS LETT, V416, P57, DOI 10.1016/S0014-5793(97)01168-X; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Xu CC, 2006, PLANT J, V47, P296, DOI 10.1111/j.1365-313X.2006.02790.x; Yamaryo Y, 2008, FEBS LETT, V582, P685, DOI 10.1016/j.febslet.2008.01.039; Yamaryo Y, 2006, FEBS LETT, V580, P4086, DOI 10.1016/j.febslet.2006.06.050	41	91	95	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6003	6011		10.1074/jbc.M109.071928	http://dx.doi.org/10.1074/jbc.M109.071928			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20023301	Green Published, hybrid			2022-12-25	WOS:000275367500003
J	Johnson, SE; Ilagan, MXG; Kopan, R; Barrick, D				Johnson, Scott E.; Ilagan, M. Xenia G.; Kopan, Raphael; Barrick, Doug			Thermodynamic Analysis of the CSL.Notch Interaction DISTRIBUTION OF BINDING ENERGY OF THE NOTCH RAM REGION TO THE CSL beta-TREFOIL DOMAIN AND THE MODE OF COMPETITION WITH THE VIRAL TRANSACTIVATOR EBNA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; ISOTHERMAL TITRATION CALORIMETRY; ACCESSIBLE SURFACE-AREAS; TRANSCRIPTIONAL ACTIVATION; INTRACELLULAR DOMAIN; NUCLEAR ANTIGEN-2; CRYSTAL-STRUCTURE; LIGAND-BINDING; HEAT-CAPACITY; PROTEIN	The Notch signaling pathway is a cell-cell communication network giving rise to cell differentiation during metazoan development. Activation of the pathway releases the intracellular portion of the Notch receptor to translocate to the nucleus, where it is able to interact with the effector transcription factor CSL, converting CSL from a transcriptional repressor to an activator. This conversion is dependent upon the high affinity binding of the RAM region of the Notch receptor to the beta-trefoil domain (BTD) of CSL. Here we probe the energetics of binding to BTD of each conserved residue of RAM through the use of isothermal titration calorimetry and single residue substitution. We find that although the highly conserved Phi W Phi P motif is the largest determinant of binding, energetically significant interactions are contributed by N-terminal residues, including a conserved Arg/Lys-rich region. Additionally, we present a thermodynamic analysis of the interaction between the Epstein-Barr virus protein EBNA2 with BTD and explore the extent to which the EBNA2- and RAM-binding sites on BTD are nonoverlapping, as proposed by Fuchs et al. ( Fuchs, K. P., Bommer, G., Dumont, E., Christoph, B., Vidal, M., Kremmer, E., and Kempkes, B. (2001) Eur. J. Biochem. 268, 4639-4646). Combining these results with displacement isothermal titration calorimetry, we propose a mechanism by which the Phi W Phi P motif of RAM and EBNA2 compete with one another for binding at the hydrophobic pocket of BTD using overlapping but specific interactions that are unique to each BTD ligand.	[Johnson, Scott E.; Barrick, Doug] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Ilagan, M. Xenia G.; Kopan, Raphael] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Johns Hopkins University; Washington University (WUSTL)	Barrick, D (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, 3400 N Charles St, Baltimore, MD 21218 USA.	barrick@jhu.edu	Kopan, Raphael/AAF-1357-2022; Kopan, Raphael/AFG-3275-2022	Ilagan, Ma Xenia/0000-0003-2888-4859; Kopan, Raphael/0000-0002-0350-2730	National Institutes of Health [GM060001, P50 CA094056]; National Science Foundation Division of Biological Infrastructure for Peptide Synthesis Instrumentation [0500580]; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Division of Biological Infrastructure for Peptide Synthesis Instrumentation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM060001 (to D. B.) and P50 CA094056. This work was also supported by Instrumentation Development Grant 0500580 from the National Science Foundation Division of Biological Infrastructure for Peptide Synthesis Instrumentation.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bertagna A, 2008, BIOCHEM SOC T, V36, P157, DOI 10.1042/BST0360157; Bonde J, 2004, CURR OPIN HEMATOL, V11, P392, DOI 10.1097/01.moh.0000145672.42503.70; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Farrell CJ, 2004, P NATL ACAD SCI USA, V101, P4625, DOI 10.1073/pnas.0306482101; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fuchs KP, 2001, EUR J BIOCHEM, V268, P4639, DOI 10.1046/j.1432-1327.2001.02387.x; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Hayward SD, 2004, SEMIN CANCER BIOL, V14, P387, DOI 10.1016/j.semcancer.2004.04.018; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Hsieh JJD, 1997, J VIROL, V71, P1938, DOI 10.1128/JVI.71.3.1938-1945.1997; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Le Gall M, 2004, J BIOL CHEM, V279, P29418, DOI 10.1074/jbc.M404589200; Le Gall M, 2008, DEV BIOL, V313, P556, DOI 10.1016/j.ydbio.2007.10.030; LING PD, 1995, J VIROL, V69, P1944, DOI 10.1128/JVI.69.3.1944-1950.1995; LING PD, 1993, P NATL ACAD SCI USA, V90, P9237, DOI 10.1073/pnas.90.20.9237; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Macsween KF, 2003, LANCET INFECT DIS, V3, P131, DOI 10.1016/S1473-3099(03)00543-7; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Pace C N, 1986, Methods Enzymol, V131, P266; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Sakai T, 1998, J VIROL, V72, P6034, DOI 10.1128/JVI.72.7.6034-6039.1998; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Street TO, 2008, METHOD CELL BIOL, V84, P295, DOI 10.1016/S0091-679X(07)84011-8; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Velazquez-Campoy A, 2006, BIOPHYS J, V91, P1887, DOI 10.1529/biophysj.106.086561; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-385; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002	47	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6681	6692		10.1074/jbc.M109.019968	http://dx.doi.org/10.1074/jbc.M109.019968			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20028974	hybrid, Green Published			2022-12-25	WOS:000275367500072
J	Jung, S; Marelli, M; Rachubinski, RA; Goodlett, DR; Aitchison, JD				Jung, Sunhee; Marelli, Marcello; Rachubinski, Richard A.; Goodlett, David R.; Aitchison, John D.			Dynamic Changes in the Subcellular Distribution of Gpd1p in Response to Cell Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; TARGETING SIGNAL; LIFE-SPAN; NUCLEAR-LOCALIZATION; CALORIE RESTRICTION; MASS-SPECTROMETRY; GLOBAL ANALYSIS; OSMOTIC-STRESS; YEAST	Gpd1p is a cytosolic NAD(+)-dependent glycerol 3-phosphate dehydrogenase that also localizes to peroxisomes and plays an essential role in the cellular response to osmotic stress and a role in redox balance. Here, we show that Gpd1p is directed to peroxisomes by virtue of an N-terminal type 2 peroxisomal targeting signal (PTS2) in a Pex7p-dependent manner. Significantly, localization of Gpd1p to peroxisomes is dependent on the metabolic status of cells and the phosphorylation of aminoacyl residues adjacent to the targeting signal. Exposure of cells to osmotic stress induces changes in the subcellular distribution of Gpd1p to the cytosol and nucleus. This behavior is similar to Pnc1p, which is coordinately expressed with Gpd1p, and under conditions of cell stress changes its subcellular distribution from peroxisomes to the nucleus where it mediates chromatin silencing. Although peroxisomes are necessary for the beta-oxidation of fatty acids in yeast, the localization of Gpd1p to peroxisomes is not. Rather, shifts in the distribution of Gpd1p to different cellular compartments in response to changing cellular status suggests a role for Gpd1p in the spatial regulation of redox potential, a process critical to cell survival, especially under the complex stress conditions expected to occur in the wild.	[Aitchison, John D.] Inst Syst Biol, Seattle, WA 98103 USA; [Jung, Sunhee; Goodlett, David R.; Aitchison, John D.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Rachubinski, Richard A.; Aitchison, John D.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Goodlett, David R.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; University of Alberta; University of Washington; University of Washington Seattle	Aitchison, JD (corresponding author), Inst Syst Biol, 1441 N 34th St, Seattle, WA 98103 USA.	jaitchison@systemsbiology.org		Marelli, Marcello/0000-0001-7095-8263	National Institutes of Health [GM075152, GM076547, RR022220]; Canadian Institutes for Health Research [53326]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547, R01GM075152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM075152, GM076547, and RR022220. This work was also supported by Canadian Institutes for Health Research Grant 53326.	AbdelRaheim SR, 2001, ARCH BIOCHEM BIOPHYS, V388, P18, DOI 10.1006/abbi.2000.2268; Aguilera J, 2005, MOL MICROBIOL, V56, P228, DOI 10.1111/j.1365-2958.2005.04533.x; Aguilera J, 2001, CURR GENET, V39, P273, DOI 10.1007/s002940100213; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Beopoulos A, 2008, APPL ENVIRON MICROB, V74, P7779, DOI 10.1128/AEM.01412-08; BLOMBERG A, 1992, ADV MICROB PHYSIOL, V33, P145, DOI 10.1016/S0065-2911(08)60217-9; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Boy-Marcotte E, 1999, MOL MICROBIOL, V33, P274, DOI 10.1046/j.1365-2958.1999.01467.x; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Brown A D, 1978, Adv Microb Physiol, V17, P181, DOI 10.1016/S0065-2911(08)60058-2; Cartwright JL, 2000, J BIOL CHEM, V275, P32925, DOI 10.1074/jbc.M005015200; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; EINERHAND AWC, 1991, EUR J BIOCHEM, V200, P113, DOI 10.1111/j.1432-1033.1991.tb21056.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Gardocki ME, 2005, BBA-MOL CELL BIOL L, V1735, P89, DOI 10.1016/j.bbalip.2005.05.006; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Gotta M, 1997, EMBO J, V16, P3243, DOI 10.1093/emboj/16.11.3243; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iida T, 2004, MOL CELL BIOL, V24, P217, DOI 10.1128/MCB.24.1.217-227.2004; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Koerkamp MG, 2002, MOL BIOL CELL, V13, P2783, DOI 10.1091/mbc.E02-02-0075; Larsson C, 1998, YEAST, V14, P347, DOI 10.1002/(SICI)1097-0061(19980315)14:4<347::AID-YEA226>3.0.CO;2-9; LARSSON K, 1993, MOL MICROBIOL, V10, P1101, DOI 10.1111/j.1365-2958.1993.tb00980.x; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Leslie DM, 2002, MOL CELL BIOL, V22, P2544, DOI 10.1128/MCB.22.8.2544-2555.2002; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; LO TWC, 1994, J BIOL CHEM, V269, P32299; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marelli M, 2004, J CELL BIOL, V167, P1099, DOI 10.1083/jcb.200404119; Martins AMTBS, 2001, FEBS LETT, V499, P41, DOI 10.1016/S0014-5793(01)02519-4; Michnick S, 1997, YEAST, V13, P783, DOI 10.1002/(SICI)1097-0061(199707)13:9<783::AID-YEA128>3.0.CO;2-W; Nevoigt E, 1996, YEAST, V12, P1331, DOI 10.1002/(SICI)1097-0061(199610)12:13<1331::AID-YEA28>3.3.CO;2-S; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Ou XJ, 2006, J MOL BIOL, V357, P858, DOI 10.1016/j.jmb.2005.12.074; Panadero J, 2006, J BIOL CHEM, V281, P4638, DOI 10.1074/jbc.M512736200; Petriv OI, 2004, J MOL BIOL, V341, P119, DOI 10.1016/j.jmb.2004.05.064; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Platta HW, 2007, FEBS LETT, V581, P2811, DOI 10.1016/j.febslet.2007.04.001; Rep M, 1999, MICROBIOL-UK, V145, P715, DOI 10.1099/13500872-145-3-715; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Smith JJ, 2009, CURR OPIN CELL BIOL, V21, P119, DOI 10.1016/j.ceb.2009.01.009; Smith JJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100051; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; SZILARD RK, 1995, J CELL BIOL, V131, P1453, DOI 10.1083/jcb.131.6.1453; Thoms S, 2006, BBA-MOL CELL RES, V1763, P1620, DOI 10.1016/j.bbamcr.2006.08.046; Valadi A, 2004, J BIOL CHEM, V279, P39677, DOI 10.1074/jbc.M403310200; VANDERJAGT DL, 1992, J BIOL CHEM, V267, P4364; VANDERLEIJ I, 1992, J CELL BIOL, V119, P153, DOI 10.1083/jcb.119.1.153; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204	71	58	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6739	6749		10.1074/jbc.M109.058552	http://dx.doi.org/10.1074/jbc.M109.058552			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20026609	hybrid, Green Published			2022-12-25	WOS:000275367500077
J	Schietke, R; Warnecke, C; Wacker, I; Schodel, J; Mole, DR; Campean, V; Amann, K; Goppelt-Struebe, M; Behrens, J; Eckardt, KU; Wiesener, MS				Schietke, Ruth; Warnecke, Christina; Wacker, Ingrid; Schoedel, Johannes; Mole, David R.; Campean, Valentina; Amann, Kerstin; Goppelt-Struebe, Margarete; Behrens, Juergen; Eckardt, Kai-Uwe; Wiesener, Michael S.			The Lysyl Oxidases LOX and LOXL2 Are Necessary and Sufficient to Repress E-cadherin in Hypoxia INSIGHTS INTO CELLULAR TRANSFORMATION PROCESSES MEDIATED BY HIF-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINDAU TUMOR-SUPPRESSOR; RENAL-CELL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITIONS; INDUCIBLE FACTORS HIF-1-ALPHA; TRANSCRIPTION FACTOR SNAIL; BREAST-CANCER CELLS; GENE-EXPRESSION; UP-REGULATION; SOLID TUMORS; HIF-1	Hypoxia has been shown to promote tumor metastasis and lead to therapy resistance. Recent work has demonstrated that hypoxia represses E-cadherin expression, a hallmark of epithelial to mesenchymal transition, which is believed to amplify tumor aggressiveness. The molecular mechanism of E-cadherin repression is unknown, yet lysyl oxidases have been implicated to be involved. Gene expression of lysyl oxidase (LOX) and the related LOX-like 2 (LOXL2) is strongly induced by hypoxia. In addition to the previously demonstrated LOX, we characterize LOXL2 as a direct transcriptional target of HIF-1. We demonstrate that activation of lysyl oxidases is required and sufficient for hypoxic repression of E-cadherin, which mediates cellular transformation and takes effect in cellular invasion assays. Our data support a molecular pathway from hypoxia to cellular transformation. It includes up-regulation of HIF and subsequent transcriptional induction of LOX and LOXL2, which repress E-cadherin and induce epithelial to mesenchymal transition. Lysyl oxidases could be an attractive molecular target for cancers of epithelial origin, in particular because they are partly extracellular.	[Wiesener, Michael S.] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Dept Hypertens & Nephrol, Interdisciplinary Ctr Clin Res, D-91054 Erlangen, Germany; [Warnecke, Christina; Goppelt-Struebe, Margarete; Eckardt, Kai-Uwe; Wiesener, Michael S.] Univ Erlangen Nurnberg, Dept Nephrol & Hypertens, D-91054 Erlangen, Germany; [Campean, Valentina; Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany; [Schoedel, Johannes; Mole, David R.] Univ Oxford, Henry Wellcome Bldg Mol Physiol, Oxford OX3 7BN, England	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Oxford	Wiesener, MS (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Dept Hypertens & Nephrol, Interdisciplinary Ctr Clin Res, Glueckstr 6, D-91054 Erlangen, Germany.	mwiesene@molmed.uni-erlangen.de		Schodel, Johannes/0000-0002-3587-8839; Mole, David/0000-0002-0984-300X	Interdisciplinary Centre for Clinical Research; European Commission Sixth Framework Programme (Euroxy); Wellcome Trust; German Research Foundation [SFB 423]	Interdisciplinary Centre for Clinical Research; European Commission Sixth Framework Programme (Euroxy)(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); German Research Foundation(German Research Foundation (DFG))	This work was supported by grants from the Interdisciplinary Centre for Clinical Research (to M. W. and J. B.), the European Commission Sixth Framework Programme (Euroxy) (to K. U. E.), the Wellcome Trust (to J. S.), and the German Research Foundation (SFB 423) (to M. W.).	Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beavon IRG, 1999, J CLIN PATHOL-MOL PA, V52, P179, DOI 10.1136/mp.52.4.179; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Brown JM, 1998, CANCER RES, V58, P1408; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; COHEN R, 2005, CANC KIDNEY, P201; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Giampuzzi M, 2000, J BIOL CHEM, V275, P36341, DOI 10.1074/jbc.M003362200; Gort EH, 2008, ONCOGENE, V27, P1501, DOI 10.1038/sj.onc.1210795; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Jansen MK, 2007, MATRIX BIOL, V26, P136, DOI 10.1016/j.matbio.2006.09.004; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Krishnamachary B, 2003, CANCER RES, V63, P1138; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Li WD, 1997, P NATL ACAD SCI USA, V94, P12817, DOI 10.1073/pnas.94.24.12817; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Maxwell PH, 2002, SEMIN CELL DEV BIOL, V13, P29, DOI 10.1006/scdb.2001.0287; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MELLO MLS, 1995, EXP CELL RES, V220, P374, DOI 10.1006/excr.1995.1328; Nellaiappan K, 2000, J CELL BIOCHEM, V79, P576, DOI 10.1002/1097-4644(20001215)79:4<576::AID-JCB60>3.0.CO;2-A; NOUWEN EJ, 1993, KIDNEY INT, V44, P147, DOI 10.1038/ki.1993.225; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Postovit LM, 2008, J CELL BIOCHEM, V103, P1369, DOI 10.1002/jcb.21517; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rofstad EK, 2000, INT J RADIAT BIOL, V76, P589, DOI 10.1080/095530000138259; RONCHETTI IP, 1986, AM J PATHOL, V124, P436; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Turner KJ, 2002, CANCER RES, V62, P2957; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wiesener MS, 2007, INT J CANCER, V121, P2434, DOI 10.1002/ijc.22961; Wiesener MS, 2001, CANCER RES, V61, P5215; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhong H, 1999, CANCER RES, V59, P5830; Zimmer M, 2004, MOL CANCER RES, V2, P89	71	176	195	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6658	6669		10.1074/jbc.M109.042424	http://dx.doi.org/10.1074/jbc.M109.042424			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20026874	Green Published, hybrid			2022-12-25	WOS:000275367500070
J	Tsujita, K; Itoh, T; Kondo, A; Oyama, M; Kozuka-Hata, H; Irino, Y; Hasegawa, J; Takenawa, T				Tsujita, Kazuya; Itoh, Toshiki; Kondo, Akihiro; Oyama, Masaaki; Kozuka-Hata, Hiroko; Irino, Yasuhiro; Hasegawa, Junya; Takenawa, Tadaomi			Proteome of Acidic Phospholipid-binding Proteins SPATIAL AND TEMPORAL REGULATION OF CORONIN 1A BY PHOSPHOINOSITIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONIN 1B; ACTIN CYTOSKELETON; ARP2/3 COMPLEX; PLASMA-MEMBRANE; MESSENGER-RNAS; F-ACTIN; COFILIN; PHOSPHOINOSITIDES; TRANSLATION; CELLS	Reversible interactions between acidic phospholipids in the cellular membrane and proteins in the cytosol play fundamental roles in a wide variety of physiological events. Here, we present a novel approach to the identification of acidic phospholipid-binding proteins using nano-liquid chromatography-tandem mass spectrometry. Wefound more than 400 proteins, including proteins with previously known acidic phospholipid- binding properties, and confirmed that several candidates, such as Coronin 1A, mDia1 (Diaphanous-related formin-1), PIR121/CYFIP2, EB2 (end plus binding protein-2), KIF21A (kinesin family member 21A), eEF1A1 (translation elongation factor 1 alpha 1), and TRIM2, directly bind to acidic phospholipids. Among such novel proteins, we provide evidence that Coronin 1A activity, which disassembles Arp2/3-containing actin filament branches, is spatially and temporally regulated by phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2). Whereas Coronin 1A co-localizes with PI(4,5)P-2 at the plasma membrane in resting cells, it is dissociated from the plasma membrane during lamellipodia formation where the PI(4,5)P-2 signal is significantly reduced. Our in vitro experiments show that Coronin 1A preferentially binds to PI(4,5)P-2-containing liposomes and that PI(4,5)P-2 antagonizes the ability of Coronin 1A to disassemble actin filament branches, indicating a spatiotemporal regulation of Coronin 1A via a direct interaction with the plasma membrane lipid. Collectively, our proteomics data provide a list of potential acidic phospholipid- binding protein candidates ranging from the actin regulatory proteins to translational regulators.	[Takenawa, Tadaomi] Kobe Univ, Div Lipid Biochem, Dept Biochem & Mol Biol, Grad Sch Med,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Itoh, Toshiki; Kondo, Akihiro; Hasegawa, Junya] Kobe Univ, Div Membrane Biol, Dept Biochem & Mol Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Med Prote Lab, Inst Med Sci, Tokyo 1088639, Japan	Kobe University; Kobe University; University of Tokyo	Takenawa, T (corresponding author), Kobe Univ, Div Lipid Biochem, Dept Biochem & Mol Biol, Grad Sch Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	takenawa@med.kobe-u.ac.jp	Hasegawa, Junya/AAR-1009-2021; Hasegawa, Junya/F-7007-2015; Hasegawa, Junya/I-5282-2019	Hasegawa, Junya/0000-0002-7041-890X; Hasegawa, Junya/0000-0002-7041-890X; Kozuka-Hata, Hiroko/0000-0002-9286-6594; Hasegawa, Junya/0000-0003-1216-7468; Oyama, Masaaki/0000-0001-6478-3735	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for creative scientific research from the Japan Society for the Promotion of Science (to T.T.), grants-in-aid for young scientists from the Japan Society for the Promotion of Science (to K.T. and T.I.), grants-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T.I. and T.T.), and the Global Centers of Excellence Program from the Japan Society for the Promotion of Science (to T.I., J.H., and T.T.).	Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Balastik M, 2008, P NATL ACAD SCI USA, V105, P12016, DOI 10.1073/pnas.0802261105; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Gorbatyuk VY, 2006, MOL CELL, V24, P511, DOI 10.1016/j.molcel.2006.10.007; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Liu G, 2002, MOL BIOL CELL, V13, P579, DOI 10.1091/mbc.01-03-0140; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Oyama M, 2004, GENOME RES, V14, P2048, DOI 10.1101/gr.2384604; Oyama M, 2007, MOL CELL PROTEOMICS, V6, P1000, DOI 10.1074/mcp.M600297-MCP200; Park SJ, 2007, GENES CELLS, V12, P611, DOI 10.1111/j.1365-2443.2007.01081.x; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382	35	25	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6781	6789		10.1074/jbc.M109.057018	http://dx.doi.org/10.1074/jbc.M109.057018			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032464	hybrid, Green Published			2022-12-25	WOS:000275367500081
J	Khair, L; Subramanian, L; Moser, BA; Nakamura, TM				Khair, Lyne; Subramanian, Lakxmi; Moser, Bettina A.; Nakamura, Toru M.			Roles of Heterochromatin and Telomere Proteins in Regulation of Fission Yeast Telomere Recombination and Telomerase Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN PROTEIN; TAZ1 PROTEIN; RNA SUBUNIT; MAINTENANCE; LENGTH; KU; REPLICATION; BINDING; PROTECTION; REQUIRES	When the telomerase catalytic subunit (Trt1/TERT) is deleted, a majority of fission yeast cells survives by circularizing chromosomes. Alternatively, a small minority survives by maintaining telomeric repeats through recombination among telomeres. The recombination-based telomere maintenance in trt1 Delta cells is inhibited by the telomere protein Taz1. In addition, catalytically inactive full-length Trt1 (Trt1-CI) and truncated Trt1 lacking the T-motif and reverse transcriptase (RT) domain (Trt1-Delta T/RT) can strongly inhibit recombination-based survival. Here, we investigated the effects of deleting the heterochromatin proteins Swi6 (HP1 ortholog) and Clr4 (Suv39 family of histone methyltransferases) and the telomere capping complex subunits Poz1 and Ccq1 on Taz1- and Trt1-dependent telomere recombination inhibition. The ability of Taz1 to inhibit telomere recombination did not require Swi6, Clr4, Poz1, or Ccq1. Although Swi6, Clr4, and Poz1 were dispensable for the inhibition of telomere recombination by Trt1-CI, Ccq1 was required for efficient telomere recruitment of Trt1 and Trt1-CI-dependent inhibition of telomere recombination. We also found that Swi6, Clr4, Ccq1, the checkpoint kinase Rad3 (ATR ortholog), and the telomerase regulatory subunit Est1 are all required for Trt1-Delta T/RT to inhibit telomere recombination. However, because loss of Swi6, Clr4, Rad3, Ccq1, or Est1 did not significantly alter the recruitment efficiency of Trt1-Delta T/RT to telomeres, these factors are likely to enhance the ability of Trt1-Delta T/RT to inhibit recombination-based survival by contributing to the negative regulation of telomere recombination.	[Khair, Lyne; Subramanian, Lakxmi; Moser, Bettina A.; Nakamura, Toru M.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Nakamura, TM (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,MC669, Chicago, IL 60607 USA.	nakamut@uic.edu	Nakamura, Toru M/B-2055-2008	Nakamura, Toru M/0000-0001-5752-0814	National Institutes of Health [GM078253]; University of Illinois at Chicago (UIC); UIC Campus Research Board; Sidney Kimmel Scholar program; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Chicago (UIC); UIC Campus Research Board; Sidney Kimmel Scholar program; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078253 (to T.M.N.). This work was also supported by a University of Illinois at Chicago (UIC) start-up fund, UIC Campus Research Board, a Sidney Kimmel Scholar program (to T.M.N.), and a predoctoral fellowship from the American Heart Association (to L. S.).	Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Alfa C., 1993, EXPT FISSION YEAST; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Beernink HTH, 2003, CURR BIOL, V13, P575, DOI 10.1016/S0960-9822(03)00169-6; Bisht KK, 2008, YEAST, V25, P537, DOI 10.1002/yea.1603; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Ekwall K, 1996, J CELL SCI, V109, P2637; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Grewal SIS, 1997, GENETICS, V146, P1221; Haering CH, 2000, P NATL ACAD SCI USA, V97, P6367, DOI 10.1073/pnas.130187397; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Kibe T, 2003, NUCLEIC ACIDS RES, V31, P5054, DOI 10.1093/nar/gkg718; Kibe T, 2007, MOL BIOL CELL, V18, P2378, DOI 10.1091/mbc.E06-12-1084; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Lansdorp PM, 2009, EMBO J, V28, P2532, DOI 10.1038/emboj.2009.172; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Lingner J, 1996, P NATL ACAD SCI USA, V93, P10712, DOI 10.1073/pnas.93.20.10712; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Moser BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000622; Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31; Naito T, 1998, NAT GENET, V20, P203, DOI 10.1038/2517; Nakamura TM, 2002, GENETICS, V161, P1437; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Royle NJ, 2008, CYTOGENET GENOME RES, V122, P281, DOI 10.1159/000167814; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Subramanian L, 2008, MOL CELL BIOL, V28, P1443, DOI 10.1128/MCB.01614-07; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Tomita K, 2008, GENE DEV, V22, P3461, DOI 10.1101/gad.498608; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Webb CJ, 2008, NAT STRUCT MOL BIOL, V15, P34, DOI 10.1038/nsmb1354	46	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5327	5337		10.1074/jbc.M109.078840	http://dx.doi.org/10.1074/jbc.M109.078840			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20040595	Green Published, hybrid			2022-12-25	WOS:000275327200026
J	Lee, Y; Park, J; Kweon, S; Choe, M				Lee, YongChan; Park, JongChan; Kweon, SoonWook; Choe, MuHyeon			Enhanced Formation of Disulfide-bridged Dimer (Fab-PE38)(2) Utilizing Repeats of the Fab Binding Domain of Protein G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY B3; PSEUDOMONAS EXOTOXIN; RECOMBINANT IMMUNOTOXIN; ESCHERICHIA-COLI; FRAGMENT; RENATURATION; PURIFICATION; GLUTATHIONE; BOND	Fab-PE38 used in this study is B3(Fab)-ext-PE38, and it is an antibody toxin that is made by fusing the Pseudomonas exotoxin to the Fab domain of B3 antibody. This antibody toxin selectively binds to cancer cells and kills the target cancer cells. B3(Fab)-ext-PE38 has a cysteine residue on the ext sequence, and (B3(Fab)-ext-PE38)(2) is the disulfide-bridged dimer of the B3(Fab)-ext-PE38 monomer. (B3(Fab)-ext-PE38)(2) has been found to have 11-fold higher cytotoxicity on the CRL-1739 cell line than monomeric B3(scFv)-PE38. We made a recombinant tandem repeat of the domain III of Streptococcal protein G that has Fab binding property up to seven repeats. Multiple monomers were found to form non-covalent complexes with this tandem repeat. Complexes were purified by size-exclusion chromatography, and we could enhance the production of the disulfide-bridged dimer by reduction and oxidation of the complexes. The tandem repeat makes close intermolecular interactions between monomers possible, and the use of it greatly enhances the yield of the disulfide-bridged dimer.	Korea Univ, Coll Life Sci, Seoul 136701, South Korea; Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea	Korea University; Korea University	Choe, M (corresponding author), SeongbugGu AnamDong 5Ga, Seoul 136701, South Korea.	choemh@korea.ac.kr			Korean government (Ministry of Education, Science and Technology) [R01-2006-000-10125-0]	Korean government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a Korea University Grant and Korea Science and Engineering Foundation Grant R01-2006-000-10125-0 funded by the Korean government (Ministry of Education, Science and Technology).	Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; BJORCK L, 1984, J IMMUNOL, V133, P969; BUCHNER J, 1992, BIO-TECHNOL, V10, P682, DOI 10.1038/nbt0692-682; BUCHNER J, 1991, BIO-TECHNOL, V9, P157, DOI 10.1038/nbt0291-157; CHAUDHARY VK, 1990, J BIOL CHEM, V265, P16306; CHOE M, 1994, CANCER RES, V54, P3460; Choi SH, 2001, B KOREAN CHEM SOC, V22, P1361; DERRICK JP, 1992, NATURE, V359, P752, DOI 10.1038/359752a0; HWANG J, 1987, CELL, V48, P129, DOI 10.1016/0092-8674(87)90363-1; KONISHI K, 1991, ARCH BIOCHEM BIOPHYS, V289, P90, DOI 10.1016/0003-9861(91)90446-P; PAI LH, 1991, P NATL ACAD SCI USA, V88, P3358, DOI 10.1073/pnas.88.8.3358; Park JH, 2001, MOL CELLS, V12, P398; PASTAN I, 1991, CANCER RES, V51, P3781; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; Rabenstein DL, 1996, J ORG CHEM, V61, P7391, DOI 10.1021/jo960917+; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; SJOBRING U, 1991, J BIOL CHEM, V266, P399; Swaisgood HE, 2005, BIOTECHNOL ADV, V23, P71, DOI 10.1016/j.biotechadv.2004.09.004; Yoo M, 2006, J MICROBIOL BIOTECHN, V16, P1097	19	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5127	5131		10.1074/jbc.C109.006395	http://dx.doi.org/10.1074/jbc.C109.006395			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022943	Green Published, hybrid			2022-12-25	WOS:000275327200003
J	McRae, S; Pagliai, FA; Mohapatra, NP; Gener, A; Mahmou, ASA; Gunn, JS; Lorca, GL; Gonzalez, CF				McRae, Steven; Pagliai, Fernando A.; Mohapatra, Nrusingh P.; Gener, Alejandro; Mahmou, Asma Sayed Abdelgeliel; Gunn, John S.; Lorca, Graciela L.; Gonzalez, Claudio F.			Inhibition of AcpA Phosphatase Activity with Ascorbate Attenuates Francisella tularensis Intramacrophage Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-PHOSPHATASE; VIRULENCE DETERMINANTS; EXPRESSION; TULAREMIA; PROTEINS; NOVICIDA	Acid phosphatase activity in the highly infectious intracellular pathogen Francisella tularensis is directly related with the ability of these bacteria to survive inside host cells. Pharmacological inactivation of acid phosphatases could potentially help in the treatment of tularemia or even be utilized to neutralize the infection. In the present work, we report inhibitory compounds for three of the four major acid phosphatases produced by F. tularensis SCHU4: AcpA, AcpB, and AcpC. The inhibitors were identified using a catalytic screen from a library of chemicals approved for use in humans. The best results were obtained against AcpA. The two compounds identified, ascorbate (K-i = 380 +/- 160 mu M) and 2-phosphoascorbate (K-i = 3.2 +/- 0.85 mu M) inhibit AcpA in a noncompetitive, nonreversible fashion. A potential ascorbylation site in the proximity of the catalytic pocket of AcpA was identified using site-directed mutagenesis. The effects of the inhibitors identified in vitro were evaluated using bioassays determining the ability of F. tularensis to survive inside infected cells. The presence of ascorbate or 2-phosphoascorbate impaired the intramacrophage survival of F. tularensis in an AcpA-dependent manner as it was probed using knockout strains. The evidence presented herein indicated that ascorbate could be a good alternative to be used clinically to improve treatments against tularemia.	[McRae, Steven; Pagliai, Fernando A.; Gener, Alejandro; Mahmou, Asma Sayed Abdelgeliel; Lorca, Graciela L.; Gonzalez, Claudio F.] Univ Florida, Dept Microbiol & Cell Sci, Inst Food & Agr Sci, Gainesville, FL 32610 USA; [Mohapatra, Nrusingh P.; Gunn, John S.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Mohapatra, Nrusingh P.; Gunn, John S.] Ohio State Univ, Div Infect Dis, Dept Internal Med, Columbus, OH 43210 USA	State University System of Florida; University of Florida; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gonzalez, CF (corresponding author), Univ Florida, Genet Inst, Rm 306, Gainesville, FL 32610 USA.	cfgonzalez@ufl.edu	Gener, Alejandro Rafael/AAC-1139-2020; Pagliai, Fernando A./J-9921-2019; Gunn, John/E-3167-2011	Gener, Alejandro Rafael/0000-0001-7875-2358; Pagliai, Fernando A./0000-0002-0434-4594				Aragon V, 2001, INFECT IMMUN, V69, P177, DOI 10.1128/IAI.69.1.177-185.2001; BACA OG, 1993, INFECT IMMUN, V61, P4232, DOI 10.1128/IAI.61.10.4232-4239.1993; Baron GS, 1999, FEMS MICROBIOL LETT, V176, P85, DOI 10.1111/j.1574-6968.1999.tb13646.x; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Chhatwal GS, 1997, MICROB PATHOGENESIS, V22, P257, DOI 10.1006/mpat.1996.0118; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Felts RL, 2006, J BIOL CHEM, V281, P30289, DOI 10.1074/jbc.M606391200; Gonzalez CF, 2005, J BIOL CHEM, V280, P22590, DOI 10.1074/jbc.M501654200; Gonzalez CF, 2006, J BIOL CHEM, V281, P14514, DOI 10.1074/jbc.M600996200; Hasenkopf K, 2002, J AGR FOOD CHEM, V50, P5697, DOI 10.1021/jf020411u; Hernychova L, 2001, PROTEOMICS, V1, P508, DOI 10.1002/1615-9861(200104)1:4<508::AID-PROT508>3.3.CO;2-B; Khan AS, 2000, LANCET, V356, P1179, DOI 10.1016/S0140-6736(00)02769-0; KLENNER F R, 1951, South Med Surg, V113, P101; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Mandl J, 2009, BRIT J PHARMACOL, V157, P1097, DOI 10.1111/j.1476-5381.2009.00282.x; Mohapatra NP, 2008, INFECT IMMUN, V76, P3690, DOI 10.1128/IAI.00262-08; Mohapatra NP, 2007, INFECT IMMUN, V75, P390, DOI 10.1128/IAI.01226-06; Nobeli I, 2003, J MOL BIOL, V334, P697, DOI 10.1016/j.jmb.2003.10.008; ORTWERTH B, 1980, BIOCHIM BIOPHYS ACTA, V956, P10; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; PAULING L, 1971, AM J CLIN NUTR, V24, P1294; PAULING L, 1989, SCIENCE, V24, P1535; Reilly TJ, 2006, PROTEIN EXPRES PURIF, V45, P132, DOI 10.1016/j.pep.2005.05.001; Reilly TJ, 1996, J BIOL CHEM, V271, P10973, DOI 10.1074/jbc.271.18.10973; SAHA AK, 1985, ARCH BIOCHEM BIOPHYS, V243, P150, DOI 10.1016/0003-9861(85)90783-0; Shoju H, 2006, ANAL BIOCHEM, V353, P290, DOI 10.1016/j.ab.2006.02.024; Simpson GLW, 2000, BBA-MOL BASIS DIS, V1501, P12, DOI 10.1016/S0925-4439(00)00009-0; Sjostedt A, 2003, CURR OPIN MICROBIOL, V6, P66, DOI 10.1016/S1369-5274(03)00002-X; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x	30	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5171	5177		10.1074/jbc.M109.039511	http://dx.doi.org/10.1074/jbc.M109.039511			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028980	hybrid, Green Published			2022-12-25	WOS:000275327200009
J	Rasmussen, T; Edwards, MD; Black, SS; Rasmussen, A; Miller, S; Booth, IR				Rasmussen, Tim; Edwards, Michelle D.; Black, Susan S.; Rasmussen, Akiko; Miller, Samantha; Booth, Ian R.			Tryptophan in the Pore of the Mechanosensitive Channel MscS ASSESSMENT OF PORE CONFORMATIONS BY FLUORESCENCE SPECTROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRONIC-ENERGY TRANSFER; POLARIZATION SPECTRUM; MEMBRANE-PROTEIN; ION CHANNELS; TRANSITIONS; MECHANISM; RESIDUES; DYNAMICS; HELIX	Structural changes in channel proteins give critical insights required for understanding the gating transitions that underpin function. Tryptophan (Trp) is uniquely sensitive to its environment and can be used as a reporter of conformational changes. Here, we have used site-directed Trp insertion within the pore helices of the small mechanosensitive channel protein, MscS, to monitor conformational transitions. We show that Trp can be inserted in place of Leu at the two pore seal positions, Leu(105) and Leu(109), resulting in functional channels. Using Trp(105) as a probe, we demonstrate that the A106V mutation causes a modified conformation in the purified channel protein consistent with a more open state in solution. Moreover, we show that solubilized MscS changes to a more open conformation in the presence of phospholipids or their lysoforms.	[Rasmussen, Tim] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Rasmussen, T (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland.	t.rasmussen@abdn.ac.uk	Rasmussen, Tim/E-8268-2011; Miller, Samantha/A-4799-2010; Rasmussen, Tim/P-7566-2019	Rasmussen, Tim/0000-0003-1126-846X; Rasmussen, Tim/0000-0003-1126-846X; Miller, Samantha/0000-0002-8223-9693	Wellcome Trust [040174, 086903]; MRC [G0400277] Funding Source: UKRI; Medical Research Council [G0400277] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The Wellcome Trust (Grant 040174 and 086903).	Adams PD, 2002, J AM CHEM SOC, V124, P9278, DOI 10.1021/ja0167710; Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Alston RW, 2008, BIOPHYS J, V94, P2280, DOI 10.1529/biophysj.107.116921; Anishkin A, 2004, BIOPHYS J, V86, P2883, DOI 10.1016/S0006-3495(04)74340-4; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; BERRIER C, 1992, EUR J BIOCHEM, V206, P559, DOI 10.1111/j.1432-1033.1992.tb16960.x; Blount P, 1996, BIOL CELL, V87, P1, DOI 10.1016/S0248-4900(97)89832-2; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1997, J BIOL CHEM, V272, P32150, DOI 10.1074/jbc.272.51.32150; Booth IR, 2007, METHOD ENZYMOL, V428, P47, DOI 10.1016/S0076-6879(07)28003-6; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Clark EH, 2003, BIOCHEMISTRY-US, V42, P11065, DOI 10.1021/bi034607e; Coker G., 1994, RESONANCE ENERGY TRA, p[148, 44]; Deitrich CL, 2007, ANAL CHEM, V79, P8381, DOI 10.1021/ac071397t; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; KIRBY EP, 1970, J BIOL CHEM, V245, P6300; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P530; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Marsh D, 1998, BBA-REV BIOMEMBRANES, V1376, P267, DOI 10.1016/S0304-4157(98)00009-4; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Miller S, 2003, J BIOL CHEM, V278, P32246, DOI 10.1074/jbc.M303188200; Okada K, 2002, J BIOL CHEM, V277, P27682, DOI 10.1074/jbc.M202497200; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Pan CP, 2004, BIOPHYS J, V86, P3828, DOI 10.1529/biophysj.103.038901; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Rasmussen A, 2007, BIOCHEMISTRY-US, V46, P10899, DOI 10.1021/bi701056k; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Shapovalov G, 2004, J GEN PHYSIOL, V124, P151, DOI 10.1085/jgp.200409087; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Vasquez V, 2008, SCIENCE, V321, P1210, DOI 10.1126/science.1159674; Vasquez V, 2008, J MOL BIOL, V378, P55, DOI 10.1016/j.jmb.2007.10.086; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; WEBER G, 1960, BIOCHEM J, V75, P345, DOI 10.1042/bj0750345; WEBER G, 1960, BIOCHEM J, V75, P335, DOI 10.1042/bj0750335; WILSON ML, 1985, BIOCHEMISTRY-US, V24, P1920, DOI 10.1021/bi00329a018	40	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5377	5384		10.1074/jbc.M109.071472	http://dx.doi.org/10.1074/jbc.M109.071472			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20037156	Green Published, hybrid			2022-12-25	WOS:000275327200031
J	Bruchas, MR; Land, BB; Lemos, JC; Chavkin, C				Bruchas, Michael R.; Land, Benjamin B.; Lemos, Julia C.; Chavkin, Charles			CRF1-R Activation of the Dynorphin/Kappa Opioid System in the Mouse Basolateral Amygdala Mediates Anxiety-Like Behavior	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; STRESS-INDUCED RELAPSE; ELEVATED PLUS-MAZE; COCAINE SEEKING; HIGH-AFFINITY; ANTAGONIST; INCREASES; DOPAMINE; CORTICOSTERONE; STIMULATION	Stress is a complex human experience and having both rewarding and aversive motivational properties. The adverse effects of stress are well documented, yet many of underlying mechanisms remain unclear and controversial. Here we report that the anxiogenic properties of stress are encoded by the endogenous opioid peptide dynorphin acting in the basolateral amygdala. Using pharmacological and genetic approaches, we found that the anxiogenic-like effects of Corticotropin Releasing Factor (CRF) were triggered by CRF1-R activation of the dynorphin/kappa opioid receptor (KOR) system. Central CRF administration significantly reduced the percent open-arm time in the elevated plus maze (EPM). The reduction in open-arm time was blocked by pretreatment with the KOR antagonist norbinaltorphimine (norBNI), and was not evident in mice lacking the endogenous KOR ligand dynorphin. The CRF1-R agonist stressin 1 also significantly reduced open-arm time in the EPM, and this decrease was blocked by norBNI. In contrast, the selective CRF2-R agonist urocortin III did not affect open arm time, and mice lacking CRF2-R still showed an increase in anxiety-like behavior in response to CRF injection. However, CRF2-R knockout animals did not develop CRF conditioned place aversion, suggesting that CRF1-R activation may mediate anxiety and CRF2-R may encode aversion. Using a phosphoselective antibody (KORp) to identify sites of dynorphin action, we found that CRF increased KORp-immunoreactivity in the basolateral amygdala (BLA) of wildtype, but not in mice pretreated with the selective CRF1-R antagonist, antalarmin. Consistent with the concept that acute stress or CRF injection-induced anxiety was mediated by dynorphin release in the BLA, local injection of norBNI blocked the stress or CRF-induced increase in anxiety-like behavior; whereas norBNI injection in a nearby thalamic nucleus did not. The intersection of stress-induced CRF and the dynorphin/KOR system in the BLA was surprising, and these results suggest that CRF and dynorphin/KOR systems may coordinate stress-induced anxiety behaviors and aversive behaviors via different mechanisms.	[Bruchas, Michael R.; Land, Benjamin B.; Lemos, Julia C.; Chavkin, Charles] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Land, Benjamin B.; Lemos, Julia C.; Chavkin, Charles] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bruchas, MR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	cchavkin@u.washington.edu	Chavkin, Charles/G-2797-2010; Bruchas, Michael/G-7616-2012	Lemos, Julia/0000-0002-5442-8876	US National Institutes of Health, National Institute on Drug Abuse [DA20570, DA16898, DA25182]; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA020570, R00DA025182, R21DA025970, K99DA025182, R01DA016898] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by US National Institutes of Health, National Institute on Drug Abuse (DA20570, DA16898, DA25182) (www.nih.gov) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale TL, 2005, HORM BEHAV, V48, P1, DOI 10.1016/j.yhbeh.2005.01.009; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; BALE TL, 2001, ANN REV PHARM TOXICO, V11, P523; Bilkei-Gorzo A, 2008, PSYCHONEUROENDOCRINO, V33, P425, DOI 10.1016/j.psyneuen.2007.12.010; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; BRUCHAS MR, 2009, BRAIN RES; BRUELAS MR, 2007, J BIOL CHEM, V282, P29803; CADOR M, 1992, BRAIN RES, V597, P304, DOI 10.1016/0006-8993(92)91487-Y; Carey AN, 2007, EUR J PHARMACOL, V569, P84, DOI 10.1016/j.ejphar.2007.05.007; Carlezon WA, 2006, J PHARMACOL EXP THER, V316, P440, DOI 10.1124/jpet.105.092304; Contarino A, 2005, P NATL ACAD SCI USA, V102, P18649, DOI 10.1073/pnas.0506999102; COSTE SC, 2000, NAT GENET, V21, P103; DESOUZA EB, 1987, J NEUROSCI, V7, P88; Erb S, 1998, J NEUROSCI, V18, P5529, DOI 10.1523/JNEUROSCI.18-14-05529.1998; Funk CK, 2007, BIOL PSYCHIAT, V61, P78, DOI 10.1016/j.biopsych.2006.03.063; George O, 2007, P NATL ACAD SCI USA, V104, P17198, DOI 10.1073/pnas.0707585104; GREIBEL G, 2002, J PHARMACOL EXP THER, V301, P333; Hammack SE, 2003, J NEUROSCI, V23, P1019; Heinrichs SC, 1995, ANN NY ACAD SCI, V771, P92, DOI 10.1111/j.1749-6632.1995.tb44673.x; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; HORAN P, 1992, J PHARMACOL EXP THER, V260, P1237; Hubbard DT, 2007, NEUROSCIENCE, V150, P818, DOI 10.1016/j.neuroscience.2007.10.001; Knoll AT, 2007, J PHARMACOL EXP THER, V323, P838, DOI 10.1124/jpet.107.127415; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Kudryavtseva NN, 2004, PEPTIDES, V25, P1355, DOI 10.1016/j.peptides.2004.05.005; LAND BB, 2009, P NATL ACAD SCI US; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Lu L, 2003, J NEUROCHEM, V84, P1378, DOI 10.1046/j.1471-4159.2003.01635.x; McLaughlin JP, 2004, J BIOL CHEM, V279, P1810, DOI 10.1074/jbc.M305796200; MULLER MB, 2008, NAT NEUROSCI, V10, P1100; NIKOLARAKIS KE, 1986, BRAIN RES, V399, P152, DOI 10.1016/0006-8993(86)90610-4; PFEIFFER A, 1986, SCIENCE, V233, P774, DOI 10.1126/science.3016896; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Redila VA, 2008, PSYCHOPHARMACOLOGY, V200, P59, DOI 10.1007/s00213-008-1122-y; Rivier J, 2007, J MED CHEM, V50, P1668, DOI 10.1021/jm0613875; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Sandi C, 2008, EUR J NEUROSCI, V28, P1836, DOI 10.1111/j.1460-9568.2008.06451.x; Shaham Y, 1998, PSYCHOPHARMACOLOGY, V137, P184, DOI 10.1007/s002130050608; Shaham Y, 1997, J NEUROSCI, V17, P2605; SHARIFI N, 2004, J NEUROSCI, V86, P707; Shirayama Y, 2004, J NEUROCHEM, V90, P1258, DOI 10.1111/j.1471-4159.2004.02589.x; Simonin F, 1998, EMBO J, V17, P886, DOI 10.1093/emboj/17.4.886; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; SONG ZH, 1992, EUR J PHARMACOL, V222, P27, DOI 10.1016/0014-2999(92)90458-G; Spina MG, 2000, NEUROPSYCHOPHARMACOL, V22, P230, DOI 10.1016/S0893-133X(99)00108-6; Ugolini A, 2008, FRONT BEHAV NEUROSCI, V2, DOI 10.3389/neuro.08.002.2008; Wall PM, 2001, NEUROSCI BIOBEHAV R, V25, P275, DOI 10.1016/S0149-7634(01)00013-6; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Wang B, 2005, J NEUROSCI, V25, P5389, DOI 10.1523/JNEUROSCI.0955-05.2005; WINMANN W, 2008, NEUROPSYCHOPHARMACOL, V34, P775; Zobel AW, 2000, J PSYCHIATR RES, V34, P171, DOI 10.1016/S0022-3956(00)00016-9	53	137	139	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8528	10.1371/journal.pone.0008528	http://dx.doi.org/10.1371/journal.pone.0008528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YP	20052275	Green Published, Green Submitted, gold			2022-12-25	WOS:000207567200002
J	Nguyen, LN; Trofa, D; Nosanchuk, JD				Nguyen, Long Nam; Trofa, David; Nosanchuk, Joshua D.			Fatty Acid Synthase Impacts the Pathobiology of Candida parapsilosis In Vitro and during Mammalian Infection	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CRYPTOCOCCUS-NEOFORMANS; BIOFILM FORMATION; ALBICANS; INHIBITION; GENE; BIOSYNTHESIS; ARCHITECTURE; RESOLUTION; VIRULENCE	Cytosolic fungal fatty acid synthase is composed of two subunits alpha and beta, which are encoded by Fas1 and Fas2 genes. In this study, the Fas2 genes of the human pathogen Candida parapsilosis were deleted using a modified SAT1 flipper technique. CpFas2 was essential in media lacking exogenous fatty acids and the growth of Fas2 disruptants (Fas2 KO) was regulated by the supplementation of different long chain fatty acids, such as myristic acid (14: 0), palmitic acid (16: 0), and Tween 80, in a dose-specific manner. Lipidomic analysis revealed that Fas2 KO cells were severely restricted in production of unsaturated fatty acids. The Fas2 KO strains were unable to form normal biofilms and were more efficiently killed by murine-like macrophages, J774.16, than the wild type, heterozygous and reconstituted strains. Furthermore, Fas2 KO yeast were significantly less virulent in a systemic murine infection model. The Fas2 KO cells were also hypersensitive to human serum, and inhibition of CpFas2 in WT C. parapsilosis by cerulenin significantly decreased fungal growth in human serum. This study demonstrates that CpFas2 is essential for C. parapsilosis growth in the absence of exogenous fatty acids, is involved in unsaturated fatty acid production, influences fungal virulence, and represents a promising antifungal drug target.	[Nguyen, Long Nam; Trofa, David; Nosanchuk, Joshua D.] Albert Einstein Coll Med, Dept Med, Div Infect Dis, New York, NY USA; [Nosanchuk, Joshua D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA	Yeshiva University; Yeshiva University	Nguyen, LN (corresponding author), Albert Einstein Coll Med, Dept Med, Div Infect Dis, New York, NY USA.	nosanchu@aecom.yu.edu	Nguyen, Long/AAY-6172-2021; Nosanchuk, Joshua/AAS-7801-2021	Nguyen, Long N/0000-0002-9857-2239; Trofa, David/0000-0002-1550-9534	Irma T. Hirschl/Monique Weill-Caulier Trust; IDSA Medical Scholarship	Irma T. Hirschl/Monique Weill-Caulier Trust; IDSA Medical Scholarship	JDN is supported in part by an Irma T. Hirschl/Monique Weill-Caulier Trust Research Award and DT was supported by an IDSA Medical Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chayakulkeeree M, 2007, ANTIMICROB AGENTS CH, V51, P3537, DOI 10.1128/AAC.00442-07; Gacser A, 2007, J CLIN INVEST, V117, P3049, DOI 10.1172/JCI32294; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Johansson P, 2008, P NATL ACAD SCI USA, V105, P12803, DOI 10.1073/pnas.0805827105; Krishnamurthy S, 2004, MICROBIOL-SGM, V150, P1991, DOI 10.1099/mic.0.27029-0; Kuhn DM, 2002, INFECT IMMUN, V70, P878, DOI 10.1128/IAI.70.2.878-888.2002; Kuhn DM, 2004, EMERG INFECT DIS, V10, P1074, DOI 10.3201/eid1006.030873; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martinez LR, 2006, ANTIMICROB AGENTS CH, V50, P1021, DOI 10.1128/AAC.50.3.1021-1033.2006; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Morbidoni HR, 2006, CHEM BIOL, V13, P297, DOI 10.1016/j.chembiol.2006.01.005; Nakamura T, 2003, BRIT J NUTR, V89, P267, DOI 10.1079/BJN2002747; Neugnot V, 2002, EUR J BIOCHEM, V269, P1734, DOI 10.1046/j.1432-1327.2002.02828.x; Ngo SC, 2007, ANTIMICROB AGENTS CH, V51, P2430, DOI 10.1128/AAC.01458-06; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; PFALLER MA, 1995, MYCOPATHOLOGIA, V130, P3, DOI 10.1007/BF01104343; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Rossignol T, 2009, EUKARYOT CELL, V8, P550, DOI 10.1128/EC.00350-08; Schneiter Roger, 2006, Methods Mol Biol, V313, P41; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; Xu DM, 2009, J BIOL CHEM, V284, P19754, DOI 10.1074/jbc.M109.019877; Zhao XJ, 1996, MICROBIOL-UK, V142, P2509, DOI 10.1099/00221287-142-9-2509; Zhao XJ, 1997, INFECT IMMUN, V65, P829, DOI 10.1128/IAI.65.2.829-832.1997	31	32	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8421	10.1371/journal.pone.0008421	http://dx.doi.org/10.1371/journal.pone.0008421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027295	Green Submitted, Green Published, gold			2022-12-25	WOS:000272998000020
J	Hinoue, T; Weisenberger, DJ; Pan, F; Campan, M; Kim, M; Young, J; Whitehall, VL; Leggett, BA; Laird, PW				Hinoue, Toshinori; Weisenberger, Daniel J.; Pan, Fei; Campan, Mihaela; Kim, Myungjin; Young, Joanne; Whitehall, Vicki L.; Leggett, Barbara A.; Laird, Peter W.			Analysis of the Association between CIMP and BRAF(V600E) in Colorectal Cancer by DNA Methylation Profiling	PLOS ONE			English	Article							CPG ISLAND METHYLATION; ABERRANT CRYPT FOCI; SERRATED POLYPS; COLON-CANCER; BRAF MUTATION; MICROSATELLITE INSTABILITY; HYPERPLASTIC POLYPOSIS; GENE-EXPRESSION; KRAS MUTATIONS; CELL-LINES	A CpG island methylator phenotype (CIMP) is displayed by a distinct subset of colorectal cancers with a high frequency of DNA hypermethylation in a specific group of CpG islands. Recent studies have shown that an activating mutation of BRAF (BRAF(V600E)) is tightly associated with CIMP, raising the question of whether BRAF(V600E) plays a causal role in the development of CIMP or whether CIMP provides a favorable environment for the acquisition of BRAF(V600E). We employed Illumina GoldenGate DNA methylation technology, which interrogates 1,505 CpG sites in 807 different genes, to further study this association. We first examined whether expression of BRAF(V600E) causes DNA hypermethylation by stably expressing BRAF(V600E) in the CIMP-negative, BRAF wild-type COLO 320DM colorectal cancer cell line. We determined 100 CIMP-ssociated CpG sites and examined changes in DNA methylation in eight stably transfected clones over multiple passages. We found that BRAF(V600E) is not sufficient to induce CIMP in our system. Secondly, considering the alternative possibility, we identified genes whose DNA hypermethylation was closely linked to BRAF(V600E) and CIMP in 235 primary colorectal tumors. Interestingly, genes that showed the most significant link include those that mediate various signaling pathways implicated in colorectal tumorigenesis, such as BMP3 and BMP6 (BMP signaling), EPHA3, KIT, and FLT1 (receptor tyrosine kinases) and SMO (Hedgehog signaling). Furthermore, we identified CIMP-dependent DNA hypermethylation of IGFBP7, which has been shown to mediate BRAF(V600E)-induced cellular senescence and apoptosis. Promoter DNA hypermethylation of IGFBP7 was associated with silencing of the gene. CIMP-specific inactivation of BRAF(V600E)-induced senescence and apoptosis pathways by IGFBP7 DNA hypermethylation might create a favorable context for the acquisition of BRAF(V600E) in CIMP+ colorectal cancer. Our data will be useful for future investigations toward understanding CIMP in colorectal cancer and gaining insights into the role of aberrant DNA hypermethylation in colorectal tumorigenesis.	[Hinoue, Toshinori; Weisenberger, Daniel J.; Pan, Fei; Laird, Peter W.] Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Hinoue, Toshinori; Campan, Mihaela; Kim, Myungjin; Laird, Peter W.] Univ So Calif, Dept Surg, Los Angeles, CA 90033 USA; [Hinoue, Toshinori; Campan, Mihaela; Kim, Myungjin; Laird, Peter W.] Univ So Calif, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90033 USA; [Young, Joanne] Queensland Inst Med Res, Familial Canc Lab, Herston, Qld 4006, Australia; [Young, Joanne] Univ Queensland, Sch Med, Herston, Qld, Australia; [Whitehall, Vicki L.; Leggett, Barbara A.] Royal Brisbane & Womens Hosp Res Fdn, Conjoint Gastroenterol Lab, Clin Res Ctr, Herston, Qld, Australia	University of Southern California; University of Southern California; University of Southern California; QIMR Berghofer Medical Research Institute; University of Queensland; Royal Brisbane & Women's Hospital	Hinoue, T (corresponding author), Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Los Angeles, CA 90033 USA.	plaird@usc.edu	Whitehall, Vicki L/B-6262-2013; Weisenberger, Daniel/AAA-8314-2020; Young, Joanne P/B-9981-2011; Young, Joanne P/H-7774-2014; Leggett, Barbara A/D-3579-2011; Laird, Peter W/G-8683-2012; Whitehall, Vicki/E-5414-2019	Whitehall, Vicki L/0000-0002-8285-2391; Weisenberger, Daniel/0000-0001-8303-2603; Laird, Peter W/0000-0001-9117-3641; Young, Joanne/0000-0002-1514-1522; Leggett, Barbara/0000-0003-2062-7380	National Institutes of Health (NIH) [R01 CA118699-02, R01 CA075090-09]; NATIONAL CANCER INSTITUTE [R01CA075090, R01CA118699] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health (NIH) grants R01 CA118699-02 (P. W. Laird), R01 CA075090-09 (P. W. Laird). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura S, 2009, GASTROENTEROLOGY, V137, P629, DOI 10.1053/j.gastro.2009.04.059; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bates RC, 2003, CURR BIOL, V13, P1721, DOI 10.1016/j.cub.2003.09.002; Beach R, 2005, AM J PATHOL, V166, P1069, DOI 10.1016/S0002-9440(10)62327-9; Bellone G, 2006, INT J ONCOL, V29, P851; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Bibikova Marina, 2009, V507, P149, DOI 10.1007/978-1-59745-522-0_12; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Cichowski K, 2008, CELL, V133, P958, DOI 10.1016/j.cell.2008.05.027; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Graells J, 2004, J INVEST DERMATOL, V123, P1151, DOI 10.1111/j.0022-202X.2004.23460.x; Haigis KM, 2007, GENE DEV, V21, P361, DOI 10.1101/gad.1532107; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Katari S, 2009, HUM MOL GENET, V18, P3769, DOI 10.1093/hmg/ddp319; Kohonen-Corish MRJ, 2007, ONCOGENE, V26, P4435, DOI 10.1038/sj.onc.1210210; Kraunz KS, 2005, BRIT J CANCER, V93, P949, DOI 10.1038/sj.bjc.6602790; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lin J, 2007, J PATHOL, V212, P83, DOI 10.1002/path.2144; Loh K, 2008, GENE CHROMOSOME CANC, V47, P449, DOI 10.1002/gcc.20552; Martinez R, 2009, EPIGENETICS-US, V4, P255, DOI 10.4161/epi.9130; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Minoo P, 2006, GUT, V55, DOI 10.1136/gut.2005.082859; Minoo P, 2007, J PATHOL, V212, P124, DOI 10.1002/path.2160; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Muthuswami R, 2000, BIOCHEMISTRY-US, V39, P4358, DOI 10.1021/bi992503r; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; O'Brien MJ, 2007, GASTROENTEROL CLIN N, V36, P947, DOI 10.1016/j.gtc.2007.08.007; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Oliveira C, 2004, HUM MOL GENET, V13, P2303, DOI 10.1093/hmg/ddh238; Rosenberg DW, 2007, CANCER RES, V67, P3551, DOI 10.1158/0008-5472.CAN-07-0343; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Schuebel K, 2006, NAT GENET, V38, P738, DOI 10.1038/ng0706-738; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Suter CM, 2003, BRIT J CANCER, V88, P413, DOI 10.1038/sj.bjc.6600699; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Velho S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-255; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Yamashita K, 2003, CANCER CELL, V4, P121, DOI 10.1016/S1535-6108(03)00190-9; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	53	117	119	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8357	10.1371/journal.pone.0008357	http://dx.doi.org/10.1371/journal.pone.0008357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027224	Green Published, gold, Green Submitted			2022-12-25	WOS:000272940100005
J	Kueng, HJ; Manta, C; Haiderer, D; Leb, VM; Schmetterer, KG; Neunkirchner, A; Byrne, RA; Scheinecker, C; Steinberger, P; Seed, B; Pickl, WF				Kueng, Hans J.; Manta, Calin; Haiderer, Daniela; Leb, Victoria M.; Schmetterer, Klaus G.; Neunkirchner, Alina; Byrne, Ruth A.; Scheinecker, Clemens; Steinberger, Peter; Seed, Brian; Pickl, Winfried F.			Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor-ligand interactions	FASEB JOURNAL			English	Article						lipid rafts; viral pseudotyping; glycosyl phosphalidyl inositol anchored proteins; flow cytometry; fluorescent proteins	T-CELL-ACTIVATION; CHRONIC LYMPHOCYTIC-LEUKEMIA; LIPID RAFTS; COSTIMULATORY MOLECULES; INTERLEUKIN-2 RECEPTORS; DENDRITIC CELLS; VIRUS; PROTEIN; EXPRESSION; ANTIGEN	We describe for the first time fluorescent virus-like particles decorated with biologically active mono-and multisubunit immune receptors of choice and the basic application of such fluorosomes (FSs) to visualize and target immune receptor-ligand interactions. For that purpose, human embryonic kidney (HEK)-293 cells were stably transfected with Moloney murine leukemia virus (MoMLV) matrix protein (MA) GFP fusion constructs. To produce FSs, interleukins (ILs), IL-receptors (IL-Rs), and costimulatory molecules were fused to the glycosyl phosphatidyl inositol anchor acceptor sequence of CD16b and coexpressed along with MoMLV group-specific antigen-polymerase (gag-pol) in MA::GFP(+) HEK-293 cells. We show that IL-2 decorated but not control-decorated FSs specifically identify normal and malignant IL-2 receptor-positive (IL-2R(+)) lymphocytes by flow cytometry. In addition to cytokines and costimulatory molecules, FSs were also successfully decorated with the heterotrimeric IL-2Rs, allowing identification of IL-2(+) target cells. Specificity of binding was proven by complete inhibition with nonlabeled, soluble ligands. Moreover, IL-2R FSs efficiently neutralized soluble IL-2 and thus induced unresponsiveness of T cells receiving full activation stimuli via T-cell antigen receptor and CD28. FSs are technically simple, multivalent tools for assessing and blocking mono-and multisubunit immune receptor-ligand interactions with natural constituents in a plasma membrane context.-Kueng, H. J., Manta, C., Haiderer, D., Leb, V. M., Schmetterer, K. G., Neunkirchner, A., Byrne, R. A., Scheinecker, C., Steinberger, P., Seed, B., Pickl, W. F. Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor-ligand interactions. FASEB J. 24, 1572-1582 (2010). www.fasebj.org	[Kueng, Hans J.; Manta, Calin; Haiderer, Daniela; Leb, Victoria M.; Schmetterer, Klaus G.; Neunkirchner, Alina; Steinberger, Peter; Pickl, Winfried F.] Med Univ Vienna, Inst Immunol, Ctr Physiol Pathophysiol & Immunol, A-1090 Vienna, Austria; [Byrne, Ruth A.; Scheinecker, Clemens] Med Univ Vienna, Gen Hosp Vienna, Div Rheumatol, A-1090 Vienna, Austria; [Leb, Victoria M.; Neunkirchner, Alina; Pickl, Winfried F.] Christian Doppler Lab Immunomodulat, Vienna, Austria; [Seed, Brian] Harvard Univ, Sch Med, Ctr Computat & Integrat Biol, Boston, MA USA	Medical University of Vienna; Medical University of Vienna; Harvard University; Harvard Medical School	Pickl, WF (corresponding author), Med Univ Vienna, Inst Immunol, Ctr Physiol Pathophysiol & Immunol, Borschkegasse 8A, A-1090 Vienna, Austria.	winfried.pickl@meduniwien.ac.at	Pickl, Winfried F/E-5682-2011	Reichl, Victoria/0000-0001-7546-3438; Pickl, Winfried F./0000-0003-0430-4952; Schmetterer, Klaus/0000-0001-9328-4871; Steinberger, Peter/0000-0001-6848-4097	Austrian Science Foundation [SFB F1816-B13]; Osterreichische Forschungsforderungsgesellschaft [812079]; Biomay (Vienna, Austria); Christian Doppler Society; U.S. National Institutes of Health	Austrian Science Foundation(Austrian Science Fund (FWF)); Osterreichische Forschungsforderungsgesellschaft; Biomay (Vienna, Austria); Christian Doppler Society; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. Otto Majdic (Institute of Immunology, Medical University of Vienna, Vienna, Austria) for providing mAbs. This work was supported by the Austrian Science Foundation (grant SFB F1816-B13); the Osterreichische Forschungsforderungsgesellschaft (grant 812079); Biomay (Vienna, Austria); and the Christian Doppler Society. B.S. was supported by grants from the U.S. National Institutes of Health.	ARMITAGE RJ, 1986, CLIN EXP IMMUNOL, V63, P298; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; Coffin J, 1997, RETROVIRUSES; Derdak SV, 2006, P NATL ACAD SCI USA, V103, P13144, DOI 10.1073/pnas.0602283103; Driesen J, 2008, IMMUNOBIOLOGY, V213, P849, DOI 10.1016/j.imbio.2008.07.026; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; HARELBELLAN A, 1989, J IMMUNOL METHODS, V119, P127, DOI 10.1016/0022-1759(89)90389-X; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; HOSHINO S, 1990, BLOOD, V76, P767; JADUS MR, 1992, IMMUNOL LETT, V34, P127, DOI 10.1016/0165-2478(92)90238-J; Jaffe ES, 2001, WHO CLASSIFICATION T; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Klingen Y, 2008, J VIROL, V82, P237, DOI 10.1128/JVI.01342-07; Kueng HJ, 2007, J VIROL, V81, P8666, DOI 10.1128/JVI.00682-07; Lanza F, 1997, LEUKEMIA, V11, P1700, DOI 10.1038/sj.leu.2400794; Larson DR, 2005, P NATL ACAD SCI USA, V102, P15453, DOI 10.1073/pnas.0504812102; Leb VM, 2008, J ALLERGY CLIN IMMUN, V121, P64, DOI 10.1016/j.jaci.2007.10.006; Leb VM, 2009, J ALLERGY CLIN IMMUN, V124, P121, DOI 10.1016/j.jaci.2009.04.008; Mire-Sluis A.R., 1998, CYTOKINES; Montillo M, 2005, HAEMATOLOGICA, V90, P391; MOSMANN TR, 1986, P NATL ACAD SCI USA, V83, P5654, DOI 10.1073/pnas.83.15.5654; Noisakran S, 2008, J GEN VIROL, V89, P2492, DOI 10.1099/vir.0.83620-0; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pfistershammer K, 2006, EUR J IMMUNOL, V36, P1104, DOI 10.1002/eji.200535344; Pickl WF, 2001, J VIROL, V75, P7175, DOI 10.1128/JVI.75.15.7175-7183.2001; PURE E, 1981, J IMMUNOL, V127, P1953; ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; SIMMONS D, 1988, NATURE, V333, P568, DOI 10.1038/333568a0; Stauber RH, 1999, BIOCHEM BIOPH RES CO, V258, P695, DOI 10.1006/bbrc.1999.0511; SWAIN SL, 1982, IMMUNOL REV, V63, P111, DOI 10.1111/j.1600-065X.1982.tb00413.x; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; von Bergwelt-Baildon MS, 2006, BLOOD, V108, P228, DOI 10.1182/blood-2005-08-3507; WALDMANN TA, 1986, SCIENCE, V232, P727, DOI 10.1126/science.3008337; Warrington KH, 2004, J VIROL, V78, P6595, DOI 10.1128/JVI.78.12.6595-6609.2004; WATSON J, 1979, J EXP MED, V150, P1510, DOI 10.1084/jem.150.6.1510; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yashiro-Ohtani Y, 2000, J IMMUNOL, V164, P1251, DOI 10.4049/jimmunol.164.3.1251; Yu F, 2001, J VIROL, V75, P2753, DOI 10.1128/JVI.75.6.2753-2764.2001; ZOLA H, 2007, LEUCOCYTE STROMAL CE	48	16	16	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1572	1582		10.1096/fj.09-137281	http://dx.doi.org/10.1096/fj.09-137281			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20056716	Green Published			2022-12-25	WOS:000277158900029
J	Liddiard, K; Hills, R; Burnett, AK; Darley, RL; Tonks, A				Liddiard, K.; Hills, R.; Burnett, A. K.; Darley, R. L.; Tonks, A.			OGG1 is a novel prognostic indicator in acute myeloid leukaemia	ONCOGENE			English	Article						OGG1; acute myeloid leukaemia; prognosis; DNA repair	ACUTE MYELOGENOUS LEUKEMIA; DNA GLYCOSYLASE; EMBRYONIC LETHALITY; PROGENITOR CELLS; EXPRESSION; GENE; DAMAGE; REPAIR; FUSION; AML1-ETO	OGG1 (8-oxoguanine DNA glycosylase) constitutes a key component of the DNA base excision repair pathway, catalysing the removal of 8-oxoguanine nucleotides from DNA, thereby suppressing mutagenesis and cell death. We found that OGG1 expression was significantly downregulated by the RUNX1-ETO fusion protein product of the t(8;21) chromosome translocation in normal haematopoietic progenitor cells and in patients with acute myeloid leukaemia (AML). Further examination of OGG1 expression in 174 AML trial patients using Affymetrix microarrays showed that the prevalence rate of OGG1 expression was 33% and correlated strongly with adverse cytogenetics. OGG1-expressing patients had a worse relapse-free survival and overall survival and an increased risk of relapse at 5-years of follow-up. There remained a trend towards increased relapse rate among OGG1-expressing patients, even after adjusting for other known risk factors in comprehensive stratified analyses. We also determined a trend for OGG1 expression to have a more adverse impact on disease outcome in the context of the FLT3-ITD mutation. This study highlights OGG1 as a valuable prognostic marker that could be used to sub-stratify AML patients to predict those likely to fail conventional chemotherapies but those likely to benefit from novel therapeutic approaches that modulate DNA repair activity. Oncogene (2010) 29, 2005-2012; doi:10.1038/onc.2009.462; published online 21 December 2009	[Liddiard, K.; Hills, R.; Burnett, A. K.; Darley, R. L.; Tonks, A.] Cardiff Univ, Sch Med, Dept Haematol, Cardiff CF14 4XN, S Glam, Wales	Cardiff University	Tonks, A (corresponding author), Cardiff Univ, Sch Med, Dept Haematol, Cardiff CF14 4XN, S Glam, Wales.	tonksa@cf.ac.uk	Tonks, Alex/Y-8301-2019; Tonks, Alex/C-1174-2012; DARLEY, RICHARD/J-8563-2013	Tonks, Alex/0000-0002-6073-4976; Tonks, Alex/0000-0002-6073-4976; Hills, Robert/0000-0003-0166-0062	Wales Office of Research and Development (Welsh Assembly Government); Medical Research Council UK; Leukaemia Research UK	Wales Office of Research and Development (Welsh Assembly Government); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia Research UK	This study was supported by the Wales Office of Research and Development (Welsh Assembly Government) and the Medical Research Council UK. Dr A Tonks is also supported by Leukaemia Research UK. We thank Amanda Gilkes and Megan Musson (Cardiff University) for their technical assistance in processing microarray samples. We also thank Professor Ken Mills (Queen's University, Belfast) for help in microarray analyses. We acknowledge the MRC for access to patient sample material enrolled in the NCRI clinical trials.	Alcalay M, 2003, J CLIN INVEST, V112, P1751, DOI 10.1172/JCI17595; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Bullinger L, 2007, BLOOD, V110, P1291, DOI 10.1182/blood-2006-10-049783; Chatterjee A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-235; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; ERICKSON P, 1992, BLOOD, V80, P1825; Fishel ML, 2003, CANCER RES, V63, P608; FLOYD RA, 1990, CARCINOGENESIS, V11, P1447, DOI 10.1093/carcin/11.9.1447; Frosina G, 2000, EUR J BIOCHEM, V267, P2135, DOI 10.1046/j.1432-1327.2000.01266.x; Grignani F, 1998, CANCER RES, V58, P14; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Gustafson SA, 2009, AM J CLIN PATHOL, V131, P647, DOI 10.1309/AJCP5ETHDXO6NCGZ; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Hill JW, 2007, CANCER DETECT PREV, V31, P237, DOI 10.1016/j.cdp.2007.05.001; Husain A, 1998, CANCER RES, V58, P1120; Hyun JW, 2000, ONCOGENE, V19, P4476, DOI 10.1038/sj.onc.1203787; Hyun JW, 2006, INT J CANCER, V118, P302, DOI 10.1002/ijc.21329; Ishchenko A, 2003, MED SCI MONITOR, V9, pBR16; Jankowska AM, 2008, LEUKEMIA, V22, P551, DOI 10.1038/sj.leu.2405055; KEATING MJ, 1988, LEUKEMIA, V2, P403; Kinsella TJ, 2009, CLIN CANCER RES, V15, P1853, DOI 10.1158/1078-0432.CCR-08-1307; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Krejci O, 2008, BLOOD, V111, P2190, DOI 10.1182/blood-2007-06-093682; LIU P, 1993, SCIENCE, V261, P1041, DOI 10.1126/science.8351518; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; OSHIMURA M, 1982, GANN, V73, P212; Osterod M, 2001, CARCINOGENESIS, V22, P1459, DOI 10.1093/carcin/22.9.1459; Peterson LF, 2004, ONCOGENE, V23, P4255, DOI 10.1038/sj.onc.1207727; Peterson LF, 2007, BLOOD, V109, P4392, DOI 10.1182/blood-2006-03-012575; QUESNEL B, 1993, J CLIN ONCOL, V11, P2370, DOI 10.1200/JCO.1993.11.12.2370; Radyuk SN, 2006, FREE RADICAL BIO MED, V41, P757, DOI 10.1016/j.freeradbiomed.2006.05.021; Rombouts WJC, 2000, LEUKEMIA, V14, P675, DOI 10.1038/sj.leu.2401731; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; Saebo M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-208; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Shirota Y, 2001, J CLIN ONCOL, V19, P4298, DOI 10.1200/JCO.2001.19.23.4298; Sunaga N, 2001, CARCINOGENESIS, V22, P1355, DOI 10.1093/carcin/22.9.1355; Tonks A, 2007, LEUKEMIA, V21, P2495, DOI 10.1038/sj.leu.2404961; Tonks A, 2004, LEUKEMIA, V18, P1238, DOI 10.1038/sj.leu.2403396; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Weiss JM, 2005, MOL CARCINOGEN, V42, P127, DOI 10.1002/mc.20067; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yergeau DA, 1997, NAT GENET, V15, P303, DOI 10.1038/ng0397-303	48	25	25	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	13					2005	2012		10.1038/onc.2009.462	http://dx.doi.org/10.1038/onc.2009.462			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	577CV	20023702				2022-12-25	WOS:000276199600013
J	Borras, L; Gunde, T; Tietz, J; Bauer, U; Hulmann-Cottier, V; Grimshaw, JPA; Urech, DM				Borras, Leo; Gunde, Tea; Tietz, Julia; Bauer, Ulrich; Hulmann-Cottier, Valerie; Grimshaw, John P. A.; Urech, David M.			Generic Approach for the Generation of Stable Humanized Single-chain Fv Fragments from Rabbit Monoclonal Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-P185HER2 ANTIBODY; POSTERIOR SEGMENT; PROTEIN STABILITY; V-H; PHAGE; IMPROVEMENT; REPERTOIRE; FRAMEWORKS; LIBRARIES; AFFINITY	Despite their favorable pharmacokinetic properties, single-chain Fv antibody fragments (scFvs) are not commonly used as therapeutics, mainly due to generally low stabilities and poor production yields. In this work, we describe the identification and optimization of a human scFv scaffold, termed FW1.4, which is suitable for humanization and stabilization of a broad variety of rabbit antibody variable domains. A motif consisting of five structurally relevant framework residues that are highly conserved in rabbit variable domains was introduced into FW1.4 to generate a generically applicable scFv scaffold, termed FW1.4gen. Grafting of complementarity determining regions (CDRs) from 15 different rabbit monoclonal antibodies onto FW1.4 and their derivatives resulted in humanized scFvs with binding affinities in the range from 4.7 x 10(-9) to 1.5 x 10(-11) M. Interestingly, minimalistic grafting of CDRs onto FW1.4gen, without any substitutions in the framework regions, resulted in affinities ranging from 5.7 x 10(-10) to < 1.8 x 10(-12) M. When compared with progenitor rabbit scFvs, affinities of most humanized scFvs were similar. Moreover, in contrast to progenitor scFvs, which were difficult to produce, biophysical properties of the humanized scFvs were significantly improved, as exemplified by generally good production yields in a generic refolding process and by apparent melting temperatures between 53 and 86 degrees C. Thus, minimalistic grafting of rabbit CDRs on the FW1.4gen scaffold presents a simple and reproducible approach to humanize and stabilize rabbit variable domains.	[Borras, Leo; Gunde, Tea; Tietz, Julia; Bauer, Ulrich; Hulmann-Cottier, Valerie; Grimshaw, John P. A.; Urech, David M.] ESBATech, ALCON Biomed Res Unit, CH-8952 Schlieren, Switzerland		Urech, DM (corresponding author), Wagistr 21, CH-8952 Schlieren, Switzerland.	david.urech@esbatech.com						Adair John R., 1994, Human Antibodies and Hybridomas, V5, P41; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Demarest SJ, 2006, PROTEIN ENG DES SEL, V19, P325, DOI 10.1093/protein/gzl016; der Maur Adrian Auf, 2004, Methods (Amsterdam), V34, P215; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; Ewert S, 2004, METHODS, V34, P184, DOI 10.1016/j.ymeth.2004.04.007; Ewert S, 2003, BIOCHEMISTRY-US, V42, P1517, DOI 10.1021/bi026448p; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Furrer E, 2009, INVEST OPHTH VIS SCI, V50, P771, DOI 10.1167/iovs.08-2370; Huang YJ, 2007, HYBRIDOMA, V26, P387, DOI 10.1089/hyb.2007.0517; Hurle Mark R., 1994, Current Opinion in Biotechnology, V5, P428, DOI 10.1016/0958-1669(94)90053-1; Jermutus L, 2001, P NATL ACAD SCI USA, V98, P75, DOI 10.1073/pnas.011311398; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jung S, 1999, J MOL BIOL, V294, P163, DOI 10.1006/jmbi.1999.3196; KABAT EA, 1991, J IMMUNOL, V147, P1709; KETTLEBOROUGH CA, 1991, PROTEIN ENG, V4, P773, DOI 10.1093/protein/4.7.773; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Kodituwakku AP, 2003, IMMUNOL CELL BIOL, V81, P163, DOI 10.1046/j.1440-1711.2003.01152.x; Lanning D, 2000, IMMUNOL REV, V175, P214, DOI 10.1034/j.1600-065X.2000.017516.x; Luo GX, 2003, J IMMUNOL METHODS, V275, P31, DOI 10.1016/S0022-1759(02)00542-2; Monsellier E, 2006, J MOL BIOL, V362, P580, DOI 10.1016/j.jmb.2006.07.044; Mountain A, 1992, Biotechnol Genet Eng Rev, V10, P1; Ottiger M, 2009, INVEST OPHTH VIS SCI, V50, P779, DOI 10.1167/iovs.08-2372; Presta LG, 1997, CANCER RES, V57, P4593; Proba K, 1998, J MOL BIOL, V275, P245, DOI 10.1006/jmbi.1997.1457; Rader C, 2000, J BIOL CHEM, V275, P13668, DOI 10.1074/jbc.275.18.13668; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Steinberger P, 2000, J BIOL CHEM, V275, P36073, DOI 10.1074/jbc.M002765200; Steipe B, 2004, METHOD ENZYMOL, V388, P176; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URECH DM, 2009, ANN RHEUM DIS; Willuda J, 1999, CANCER RES, V59, P5758; Worn A, 1998, BIOCHEMISTRY-US, V37, P13120, DOI 10.1021/bi980712q; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265	37	37	81	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9054	9066		10.1074/jbc.M109.072876	http://dx.doi.org/10.1074/jbc.M109.072876			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20056614	Green Published, hybrid			2022-12-25	WOS:000275553700056
J	Rothery, RA; Bertero, MG; Spreter, T; Bouromand, N; Strynadka, NCJ; Weiner, JH				Rothery, Richard A.; Bertero, Michela G.; Spreter, Thomas; Bouromand, Nasim; Strynadka, Natalie C. J.; Weiner, Joel H.			Protein Crystallography Reveals a Role for the FS0 Cluster of Escherichia coli Nitrate Reductase A (NarGHI) in Enzyme Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMETHYL-SULFOXIDE REDUCTASE; BIS(MOLYBDOPTERIN GUANINE DINUCLEOTIDE)MOLYBDENUM; IRON-SULFUR MOLYBDOENZYME; SITE-DIRECTED MUTAGENESIS; MOLYBDENUM COFACTOR; ELECTRON-TRANSFER; DIMETHYLSULFOXIDE REDUCTASE; CATALYTIC SUBUNIT; FORMATE DEHYDROGENASES; RESPIRATORY COMPLEX	We have used site-directed mutagenesis, EPR spectroscopy, redox potentiometry, and protein crystallography to monitor assembly of the FS0 [4Fe-4S] cluster and molybdo-bis(pyranopterin guanine dinucleotide) cofactor (Mo-bisPGD) of the Escherichia coli nitrate reductase A (NarGHI) catalytic subunit (NarG). Cys and Ser mutants of NarG-His(49) both lack catalytic activity, with only the former assembling FS0 and Mo-bisPGD. Importantly, both prosthetic groups are absent in the NarG-H49S mutant. EPR spectroscopy of the Cys mutant reveals that the E-m value of the FS0 cluster is decreased by at least 500 mV, preventing its participation in electron transfer to the MobisPGD cofactor. To demonstrate that decreasing the FS0 cluster E-m results in decreased enzyme activity, we mutated a critical Arg residue (NarG-Arg(94)) in the vicinity of FS0 to a Ser residue. In this case, the E-m of FS0 is decreased by 115 mV, with a concomitant decrease in enzyme turnover to similar to 30% of the wild type. Analysis of the structure of the NarG-H49S mutant reveals two important aspects of NarGHI maturation: (i) apomolybdo-NarGHI is able to bind GDP moieties at their respective P and Q sites in the absence of the Mo-bisPGD cofactor, and (ii) a critical segment of residues in NarG, (49)HGVNCTG(55), must be correctly positioned to ensure holoenzyme maturation.	[Rothery, Richard A.; Bouromand, Nasim; Weiner, Joel H.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Bertero, Michela G.; Spreter, Thomas; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of Alberta; University of British Columbia	Weiner, JH (corresponding author), Univ Alberta, Dept Biochem, 474 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	joel.weiner@UAlberta.ca		Bertero, Michela/0000-0002-2012-6706; Rothery, Richard/0000-0003-3265-1783	National Institutes of Health [GMO68451-01]; Canadian Institutes of Health Research [MOP15292]; Canada Foundation for Innovation; Alberta Heritage Foundation for Medical Research	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported, in whole or in part, by National Institutes of Health Grant GMO68451-01. This work was also supported by Canadian Institutes of Health Research Grant MOP15292, the Canada Foundation for Innovation, and the Alberta Heritage Foundation for Medical Research.	Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bertero MG, 2005, J BIOL CHEM, V280, P14836, DOI 10.1074/jbc.M410457200; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Blasco F, 1998, MOL MICROBIOL, V28, P435, DOI 10.1046/j.1365-2958.1998.00795.x; BLASCO F, 1989, MOL GEN GENET, V218, P249, DOI 10.1007/BF00331275; Blasco F, 2001, CELL MOL LIFE SCI, V58, P179, DOI 10.1007/PL00000846; BLASCO F, 1992, MOL MICROBIOL, V6, P221, DOI 10.1111/j.1365-2958.1992.tb02003.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buc J, 1995, EUR J BIOCHEM, V234, P766, DOI 10.1111/j.1432-1033.1995.766_a.x; Chan CS, 2006, BIOCHEM BIOPH RES CO, V343, P244, DOI 10.1016/j.bbrc.2006.02.133; Cheng VWT, 2006, J BIOL CHEM, V281, P27662, DOI 10.1074/jbc.M604900200; Daizadeh I, 2002, MOL BIOL EVOL, V19, P406, DOI 10.1093/oxfordjournals.molbev.a004095; Duderstadt RE, 1999, FEBS LETT, V454, P21, DOI 10.1016/S0014-5793(99)00766-8; Gladyshev VN, 1996, J BIOL CHEM, V271, P8095, DOI 10.1074/jbc.271.14.8095; Gonzalez PJ, 2006, J BIOL INORG CHEM, V11, P609, DOI 10.1007/s00775-006-0110-0; Guigliarelli B, 1996, BIOCHEMISTRY-US, V35, P4828, DOI 10.1021/bi952459p; HAGEN WR, 1992, ADV INORG CHEM, V38, P165, DOI 10.1016/S0898-8838(08)60064-1; HEINZINGER NK, 1995, J BACTERIOL, V177, P2813, DOI 10.1128/jb.177.10.2813-2820.1995; Hettmann T, 2003, BIOCHEM BIOPH RES CO, V310, P40, DOI 10.1016/j.bbrc.2003.08.114; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2002, MET IONS BIOL SYST, V39, P187; Hilton JC, 1996, ARCH BIOCHEM BIOPHYS, V325, P139, DOI 10.1006/abbi.1996.0017; Hinsley AP, 2002, MICROBIOL-SGM, V148, P3631, DOI 10.1099/00221287-148-11-3631; Ize B, 2009, MICROBIOL-SGM, V155, P3992, DOI 10.1099/mic.0.033647-0; Jepson BJN, 2007, J BIOL CHEM, V282, P6425, DOI 10.1074/jbc.M607353200; JOHNSON JL, 1990, P NATL ACAD SCI USA, V87, P3190, DOI 10.1073/pnas.87.8.3190; JOHNSON JL, 1982, P NATL ACAD SCI-BIOL, V79, P6856, DOI 10.1073/pnas.79.22.6856; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Jormakka M, 2004, STRUCTURE, V12, P95, DOI 10.1016/j.str.2003.11.020; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; KRAFFT T, 1992, EUR J BIOCHEM, V206, P503, DOI 10.1111/j.1432-1033.1992.tb16953.x; Lanciano P, 2007, J PHYS CHEM B, V111, P13632, DOI 10.1021/jp075243t; Lanciano P, 2007, J BIOL CHEM, V282, P17468, DOI 10.1074/jbc.M700994200; Li HM, 2009, CAN J MICROBIOL, V55, P179, DOI [10.1139/W08-111, 10.1139/w08-111]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magalon A, 1998, BIOCHEMISTRY-US, V37, P7363, DOI 10.1021/bi972858f; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MORPETH FF, 1985, BIOCHEMISTRY-US, V24, P40, DOI 10.1021/bi00322a007; Moser CC, 2008, BBA-BIOENERGETICS, V1777, P1032, DOI 10.1016/j.bbabio.2008.04.021; Moura JJG, 2004, J BIOL INORG CHEM, V9, P791, DOI 10.1007/s00775-004-0573-9; Neumann M, 2009, J BIOL CHEM, V284, P21891, DOI 10.1074/jbc.M109.008565; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; PASCAL MC, 1982, MOL GEN GENET, V188, P103, DOI 10.1007/BF00333001; ROTHERY RA, 1991, BIOCHEMISTRY-US, V30, P8296, DOI 10.1021/bi00098a003; Rothery RA, 1998, BIOCHEM J, V332, P35, DOI 10.1042/bj3320035; Rothery RA, 2001, BIOCHEMISTRY-US, V40, P5260, DOI 10.1021/bi002393k; Rothery RA, 1998, J BIOL CHEM, V273, P7462, DOI 10.1074/jbc.273.13.7462; Rothery RA, 1999, BIOCHEMISTRY-US, V38, P12747, DOI 10.1021/bi990533o; Rothery RA, 2004, BIOCHEMISTRY-US, V43, P5324, DOI 10.1021/bi049938l; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Sambasivarao D, 2000, J BIOL CHEM, V275, P22526, DOI 10.1074/jbc.M909289199; Sargent F, 2007, MICROBIOL-SGM, V153, P633, DOI 10.1099/mic.0.2006/004762-0; Temple CA, 2000, J BIOL CHEM, V275, P40202, DOI 10.1074/jbc.M007407200; Trieber CA, 1996, J BIOL CHEM, V271, P4620; TRIEBER CA, 1994, J BIOL CHEM, V269, P7103; Turner RJ, 2004, CAN J MICROBIOL, V50, P225, DOI 10.1139/W03-117; Vergnes A, 2004, J BIOL CHEM, V279, P41398, DOI 10.1074/jbc.M407087200; Watts CA, 2005, BIOCHEM SOC T, V33, P173, DOI 10.1042/BST0330173; WEINER JH, 1992, BIOCHIM BIOPHYS ACTA, V1102, P1, DOI 10.1016/0167-4838(92)90493-W; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wittekindt C, 2009, J AM CHEM SOC, V131, P8134, DOI 10.1021/ja900352t	66	27	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8801	8807		10.1074/jbc.M109.066027	http://dx.doi.org/10.1074/jbc.M109.066027			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20053990	Green Published, hybrid			2022-12-25	WOS:000275553700032
J	Matsuyama, T; Yamashita, T; Imai, H; Shichida, Y				Matsuyama, Take; Yamashita, Takahiro; Imai, Hiroo; Shichida, Yoshinori			Covalent Bond between Ligand and Receptor Required for Efficient Activation in Rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL SCHIFF-BASE; METARHODOPSIN-II; VISUAL PIGMENTS; CHROMOPHORE CONFIGURATION; CONSTITUTIVE ACTIVATION; COMPLEX-FORMATION; BOVINE RHODOPSIN; 1ST STEP; BINDING; PROTEIN	Rhodopsin is an extensively studied member of the G-protein coupled receptors (GPCRs). Although rhodopsin shares many features with the other GPCRs, it exhibits unique features as a photoreceptor molecule. A hallmark in the molecular structure of rhodopsin is the covalently bound chromophore that regulates the activity of the receptor acting as an agonist or inverse agonist. Here we show the pivotal role of the covalent bond between the retinal chromophore and the lysine residue at position 296 in the activation pathway of bovine rhodopsin, by use of a rhodopsin mutant K296G reconstituted with retinylidene Schiff bases. Our results show that photoreceptive functions of rhodopsin, such as regiospecific photoisomerization of the ligand, and its quantum yield were not affected by the absence of the covalent bond, whereas the activation mechanism triggered by photoisomerization of the retinal was severely affected. Furthermore, our results show that an active state similar to the Meta-II intermediate of wild-type rhodopsin did not form in the bleaching process of this mutant, although it exhibited relatively weak G protein activity after light irradiation because of an increased basal activity of the receptor. We propose that the covalent bond is required for transmitting structural changes from the photoisomerized agonist to the receptor and that the covalent bond forcibly keeps the low affinity agonist in the receptor, resulting in a more efficient G protein activation.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; Kyoto Univ, CREST JST, Kyoto 6068502, Japan; [Imai, Hiroo] Kyoto Univ, Primates Res Inst, Dept Mol Cell Biol, Aichi 4848506, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University		shichida@rh.biophys.kyoto-u.ac.jp		Imai, Hiroo/0000-0003-0729-0322; Matsuyama Hoyos, Takesi/0000-0003-2092-7519	Japanese Ministry of Education, Culture, Sports, Science, and Technology [A06]; Honjo International Scholarship Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Honjo International Scholarship Foundation(Honjo International Scholarship Foundation)	This work was supported in part by a grant-in-aid for scientific research and the Global Center of Excellence Program (A06) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology ( to Y.S.).; Supported by the Honjo International Scholarship Foundation.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; BOWNDS D, 1967, NATURE, V216, P1178, DOI 10.1038/2161178a0; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; COOPER A, 1979, NATURE, V282, P531, DOI 10.1038/282531a0; EMEIS D, 1982, FEBS LETT, V143, P29, DOI 10.1016/0014-5793(82)80266-4; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; HONIG B, 1976, BIOCHEMISTRY-US, V15, P4593, DOI 10.1021/bi00666a008; IMAI H, 1994, BIOCHEMISTRY-US, V33, P14351, DOI 10.1021/bi00251a049; Imai H, 2000, METHOD ENZYMOL, V315, P293; Imamoto Y, 1996, BIOCHEMISTRY-US, V35, P14599, DOI 10.1021/bi9614850; JAGER F, 1994, BIOCHEMISTRY-US, V33, P10878; Kandori H, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1197, DOI 10.1023/A:1013123016803; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Kim JM, 2004, P NATL ACAD SCI USA, V101, P12508, DOI 10.1073/pnas.0404519101; KITO Y, 1968, NATURE, V218, P955, DOI 10.1038/218955a0; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; MATUOKA S, 1984, BIOCHIM BIOPHYS ACTA, V765, P38, DOI 10.1016/0005-2728(84)90154-3; Morizumi T, 2005, BIOCHEMISTRY-US, V44, P9936, DOI 10.1021/bi0504512; Nakamichi H, 2006, ANGEW CHEM INT EDIT, V45, P4270, DOI 10.1002/anie.200600595; PITT GAJ, 1955, BIOCHEM J, V59, P122, DOI 10.1042/bj0590122; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; SHICHIDA Y, 1988, BIOCHEMISTRY-US, V27, P6495, DOI 10.1021/bi00417a044; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Surya A, 1998, EXP EYE RES, V66, P599, DOI 10.1006/exer.1997.0453; SUZUKI H, 1973, J PHYS SOC JPN, V34, P156, DOI 10.1143/JPSJ.34.156; Terakita A, 1998, FEBS LETT, V439, P110, DOI 10.1016/S0014-5793(98)01340-4; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; TREHAN A, 1990, BIOORG CHEM, V18, P30, DOI 10.1016/0045-2068(90)90013-U; Tsukamoto H, 2005, P NATL ACAD SCI USA, V102, P6303, DOI 10.1073/pnas.0500378102; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; Tsutsui K, 2007, BIOCHEMISTRY-US, V46, P6437, DOI 10.1021/bi7003763; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; WANG JK, 1980, BIOCHEMISTRY-US, V19, P5111, DOI 10.1021/bi00563a027; YOSHIZAWA T, 1963, NATURE, V197, P1279, DOI 10.1038/1971279a0; ZHUKOVSKY EA, 1991, SCIENCE, V251, P558, DOI 10.1126/science.1990431	41	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8114	8121		10.1074/jbc.M109.063875	http://dx.doi.org/10.1074/jbc.M109.063875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20042594	Green Published, hybrid			2022-12-25	WOS:000275413800029
J	Shankar, H; Michal, A; Kern, RC; Kang, DS; Gurevich, VV; Benovic, JL				Shankar, Haripriya; Michal, Allison; Kern, Ronald C.; Kang, Dong Soo; Gurevich, Vsevolod V.; Benovic, Jeffrey L.			Non-visual Arrestins Are Constitutively Associated with the Centrosome and Regulate Centrosome Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; GAMMA-TUBULIN COMPLEXES; POLO-LIKE KINASE; BETA-ARRESTIN; BRCA1-DEPENDENT UBIQUITINATION; BETA(2)-ADRENERGIC RECEPTOR; CHROMOSOMAL INSTABILITY; PROSTATE-CANCER; PRIMARY CILIUM; RING COMPLEX	In addition to regulating receptor activity, non-visual arrestins function as scaffolds for numerous intracellular signaling cascades and as regulators of gene transcription. Here we report that the two non-visual arrestins, arrestin2 and arrestin3, localize to the centrosome, a key organelle involved in microtubule nucleation and bipolar mitotic spindle assembly. Both arrestins co-localized with the centrosomal marker gamma-tubulin during interphase and mitosis and were found in purified centrosome preparations. In vitro binding assays demonstrated that both arrestins directly interact with gamma-tubulin. Knockdown of either arrestin by RNA interference resulted in multinucleation, centrosome amplification, and mitotic defects, although only the loss of arrestin2 triggered aberrant microtubule nucleation. Importantly, overexpression of wild type arrestin rescued the multinucleation phenotype and restored normal centrosome number in arrestin siRNA-transfected cells. Moreover, overexpression of arrestin2 or -3 rescued the multinucleation defect observed in MDA-MB-231 breast cancer cells. Taken together, our data reveal that non-visual arrestins are novel centrosomal components and regulate normal centrosome function.	[Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Gurevich, Vsevolod V.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Jefferson University; Vanderbilt University	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	benovic@mail.jci.tju.edu	Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	National Institutes of Health [GM047417, GM077561]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077561, R01GM047417, R37GM047417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM047417 (to J. L. B.) and GM077561 (to V. V. G.).	Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bornens M, 1999, METHOD CELL BIOL, V61, P13; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; Cho HS, 2005, J BIOL CHEM, V280, P805, DOI 10.1074/jbc.M408163200; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; D'Assoro AB, 2002, BREAST CANCER RES TR, V75, P25, DOI 10.1023/A:1016550619925; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Doxsey S, 1998, NAT GENET, V20, P104, DOI 10.1038/2392; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; FELIX MA, 1994, J CELL BIOL, V124, P19, DOI 10.1083/jcb.124.1.19; Feng Y, 1999, BIOCHEM J, V339, P435, DOI 10.1042/0264-6021:3390435; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; GALLANT P, 1992, J CELL BIOL, V117, P213, DOI 10.1083/jcb.117.1.213; Gillies L, 2009, CELL SIGNAL, V21, P675, DOI 10.1016/j.cellsig.2009.01.023; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GOULD RR, 1977, J CELL BIOL, V73, P601, DOI 10.1083/jcb.73.3.601; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hsu LC, 2001, CANCER RES, V61, P7713; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; KELLOGG DR, 1994, ANNU REV BIOCHEM, V63, P639, DOI 10.1146/annurev.bi.63.070194.003231; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Lange BMH, 2000, EMBO J, V19, P1252, DOI 10.1093/emboj/19.6.1252; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Mayor T, 1999, FEBS LETT, V452, P92, DOI 10.1016/S0014-5793(99)00534-7; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Molla-Herman A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003728; Mundell SJ, 1999, BIOCHEMISTRY-US, V38, P8723, DOI 10.1021/bi990361v; Mundt KE, 1997, BIOCHEM BIOPH RES CO, V239, P377, DOI 10.1006/bbrc.1997.7378; Neuhaus EM, 2006, J CELL SCI, V119, P3047, DOI 10.1242/jcs.03046; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Orsini MJ, 1998, J BIOL CHEM, V273, P34616, DOI 10.1074/jbc.273.51.34616; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Pihan GA, 2001, CANCER RES, V61, P2212; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Reagan-Shaw S, 2005, FASEB J, V19, P611, DOI 10.1096/fj.04-2910fje; Sankaran S, 2005, MOL CELL BIOL, V25, P8656, DOI 10.1128/MCB.25.19.8656-8668.2005; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; STEARNS T, 1994, CELL, V76, P623, DOI 10.1016/0092-8674(94)90503-7; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yamamoto Y, 2006, ONCOLOGY-BASEL, V70, P231, DOI 10.1159/000094416; Yang AH, 2003, J NEUROSCI, V23, P10454; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zimmerman W, 1999, CURR OPIN CELL BIOL, V11, P122, DOI 10.1016/S0955-0674(99)80015-5; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	65	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8316	8329		10.1074/jbc.M109.062521	http://dx.doi.org/10.1074/jbc.M109.062521			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20056609	hybrid, Green Published			2022-12-25	WOS:000275413800048
J	Xiong, LW; Kleerekoper, QK; Wang, X; Putkey, JA				Xiong, Liang-Wen; Kleerekoper, Quinn K.; Wang, Xu; Putkey, John A.			Intra- and Interdomain Effects Due to Mutation of Calcium-binding Sites in Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CARDIAC TROPONIN-C; CA2+ BINDING; GLOBULAR DOMAINS; TERMINAL DOMAIN; APO-CALMODULIN; CHANNELS; PROTEINS; PEP-19; MECHANISM	The IQ-motif protein PEP-19, binds to the C-domain of calmodulin (CaM) with significantly different k(on) and k(off) rates in the presence and absence of Ca2+, which could play a role in defining the levels of free CaM during Ca2+ transients. The initial goal of the current study was to determine whether Ca2+ binding to sites III or IV in the C-domain of CaM was responsible for affecting the kinetics of binding PEP-19. EF-hand Ca2+ binding sites were selectively inactivated by the common strategy of changing Asp to Ala at the X-coordination position. Although Ca2+ binding to both sites III and IV appeared necessary for native-like interactions with PEP-19, the data also indicated that the mutations caused undesirable structural alterations as evidenced by significant changes in amide chemical shifts for apoCaM. Mutations in the C-domain also affected chemical shifts in the unmodified N-domain, and altered the Ca2+ binding properties of the N-domain. Conversion of Asp(93) to Ala caused the greatest structural perturbations, possibly due to the loss of stabilizing hydrogen bonds between the side chain of Asp(93) and backbone amides in apo loop III. Thus, although these mutations inhibit binding of Ca2+, the mutated CaM may not be able to support potentially important native-like activity of the apoprotein. This should be taken into account when designing CaM mutants for expression in cell culture.	[Putkey, John A.] Univ Texas Houston, Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas Houston, Houston Med Sch, Struct Biol Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Putkey, JA (corresponding author), Univ Texas Houston, Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	john.putkey@uth.tmc.edu		Wang, Xu/0000-0002-8266-098X	National Institutes of Health [GM069611, NS038310]; American Heart Association [09GRATN2280427]; Robert A. Welch Foundation [AU1144]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM069611 and NS038310, American Heart Association Grant 09GRATN2280427, and Robert A. Welch Foundation Grant AU1144.	Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; Chen YG, 2007, J AM CHEM SOC, V129, P2414, DOI 10.1021/ja067791a; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Deschenes I, 2002, CIRC RES, V90, pE49, DOI 10.1161/01.RES.0000012502.92751.E6; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dodd R, 2008, J BIOL CHEM, V283, P26911, DOI 10.1074/jbc.M801434200; DOTSON DG, 1993, J BIOL CHEM, V268, P24067; Erhardt JA, 2000, NEUROREPORT, V11, P3719, DOI 10.1097/00001756-200011270-00026; Evans TIA, 2009, PROTEINS, V76, P47, DOI 10.1002/prot.22317; Evenas J, 1998, BIOCHEMISTRY-US, V37, P13744, DOI 10.1021/bi9806448; Evenas J, 1997, BIOCHEMISTRY-US, V36, P3448, DOI 10.1021/bi9628275; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Fefeu S, 2000, BIOCHEMISTRY-US, V39, P15920, DOI 10.1021/bi001772a; Gagne SM, 1997, BIOCHEMISTRY-US, V36, P4386, DOI 10.1021/bi963076+; HAIECH J, 1991, J BIOL CHEM, V266, P3427; Joseph JD, 2002, EUKARYOT CELL, V1, P119, DOI 10.1128/EC.01.1.119-125.2002; Kanazawa Y, 2008, NEUROSCIENCE, V154, P473, DOI 10.1016/j.neuroscience.2008.03.044; Kasri NN, 2006, J BIOL CHEM, V281, P8332, DOI 10.1074/jbc.M510971200; Kasri NN, 2004, MOL PHARMACOL, V66, P276, DOI 10.1124/mol.66.2.276; Kasri NN, 2003, J BIOL CHEM, V278, P27548, DOI 10.1074/jbc.M302026200; Kleerekoper QK, 2009, J BIOL CHEM, V284, P7455, DOI 10.1074/jbc.M808067200; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; LEACHMAN SA, 1992, J BIOL CHEM, V267, P4930; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; LEUNG LLK, 1984, J CLIN INVEST, V74, P1764, DOI 10.1172/JCI111595; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; LINSE S, 1991, J BIOL CHEM, V266, P8050; Lundstrom P, 2005, P NATL ACAD SCI USA, V102, P16984, DOI 10.1073/pnas.0504361102; Mahajan A, 2008, BIOPHYS J, V94, P411, DOI 10.1529/biophysj.106.98590; MARTIN SR, 1992, EUR J BIOCHEM, V205, P1107, DOI 10.1111/j.1432-1033.1992.tb16879.x; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; NADIF KN, 2005, MOL PHARM, V68, P241; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; Putkey JA, 2008, J BIOL CHEM, V283, P1401, DOI 10.1074/jbc.M703831200; Rabl CR, 2002, BIOPHYS CHEM, V101, P553, DOI 10.1016/S0301-4622(02)00150-3; Ravindran A, 2008, P NATL ACAD SCI USA, V105, P8154, DOI 10.1073/pnas.0711624105; Ravindran A, 2009, CHANNELS, V3, P25, DOI 10.4161/chan.3.1.7498; REINACH FC, 1986, NATURE, V322, P80, DOI 10.1038/322080a0; RENNER M, 1993, P NATL ACAD SCI USA, V90, P6493, DOI 10.1073/pnas.90.14.6493; SHENG ZL, 1990, J BIOL CHEM, V265, P21554; Slemmon JR, 1996, J BIOL CHEM, V271, P15911, DOI 10.1074/jbc.271.27.15911; Spratt DE, 2007, BBA-PROTEINS PROTEOM, V1774, P1351, DOI 10.1016/j.bbapap.2007.07.019; Stroffekova K, 2008, PFLUG ARCH EUR J PHY, V455, P873, DOI 10.1007/s00424-007-0344-x; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TSALKOVA TN, 1985, J MOL BIOL, V181, P533, DOI 10.1016/0022-2836(85)90425-5; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; Vermassen E, 2004, BIOCHEM BIOPH RES CO, V319, P888, DOI 10.1016/j.bbrc.2004.05.071; Wei F, 2003, J NEUROSCI, V23, P8402; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	54	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8094	8103		10.1074/jbc.M109.065243	http://dx.doi.org/10.1074/jbc.M109.065243			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20048169	hybrid, Green Published			2022-12-25	WOS:000275413800027
J	Edwards, MM; Mammadova-Bach, E; Alpy, F; Klein, A; Hicks, WL; Roux, M; Simon-Assmann, P; Smith, RS; Orend, G; Wu, J; Peachey, NS; Naggert, JK; Lefebvre, O; Nishina, PM				Edwards, Malia M.; Mammadova-Bach, Elmina; Alpy, Fabien; Klein, Annick; Hicks, Wanda L.; Roux, Michel; Simon-Assmann, Patricia; Smith, Richard S.; Orend, Gertraud; Wu, Jiang; Peachey, Neal S.; Naggert, Juergen K.; Lefebvre, Olivier; Nishina, Patsy M.			Mutations in Lama1 Disrupt Retinal Vascular Development and Inner Limiting Membrane Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL GLOBULAR DOMAIN; LAMININ ALPHA-1 CHAIN; COLLAGEN-XVIII; BASEMENT-MEMBRANES; EYE ABNORMALITIES; KNOBLOCH-SYNDROME; GLIAL-CELLS; ENDOSTATIN; EXPRESSION; ZEBRAFISH	The Neuromutagenesis Facility at the Jackson Laboratory generated a mouse model of retinal vasculopathy, nmf223, which is characterized clinically by vitreal fibroplasia and vessel tortuosity. nmf223 homozygotes also have reduced electroretinogram responses, which are coupled histologically with a thinning of the inner nuclear layer. The nmf223 locus was mapped to chromosome 17, and a missense mutation was identified in Lama1 that leads to the substitution of cysteine for a tyrosine at amino acid 265 of laminin alpha 1, a basement membrane protein. Despite normal localization of laminin alpha 1 and other components of the inner limiting membrane, a reduced integrity of this structure was suggested by ectopic cells and blood vessels within the vitreous. Immunohistochemical characterization of nmf223 homozygous retinas demonstrated the abnormal migration of retinal astrocytes into the vitreous along with the persistence of hyaloid vasculature. The Y265C mutation significantly reduced laminin N-terminal domain (LN) interactions in a bacterial two-hybrid system. Therefore, this mutation could affect interactions between laminin alpha 1 and other laminin chains. To expand upon these findings, a Lama1 null mutant, Lama1(tm1.1Olf), was generated that exhibits a similar but more severe retinal phenotype than that seen in nmf223 homozygotes. The increased severity of the Lama1 null mutant phenotype is probably due to the complete loss of the inner limiting membrane in these mice. This first report of viable Lama1 mouse mutants emphasizes the importance of this gene in retinal development. The data presented herein suggest that hypomorphic mutations in human LAMA1 could lead to retinal disease.	[Mammadova-Bach, Elmina; Alpy, Fabien; Klein, Annick; Simon-Assmann, Patricia; Orend, Gertraud; Lefebvre, Olivier] INSERM, U682, F-67200 Strasbourg, France; [Smith, Richard S.; Naggert, Juergen K.] Jackson Lab, Bar Harbor, ME 04609 USA; [Mammadova-Bach, Elmina; Alpy, Fabien; Klein, Annick; Simon-Assmann, Patricia; Orend, Gertraud; Lefebvre, Olivier] Univ Strasbourg, F-67081 Strasbourg, France; [Roux, Michel] Inst Clin Souris, F-67404 Illkirch Graffenstaden, France; [Wu, Jiang; Peachey, Neal S.] Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; [Peachey, Neal S.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Peachey, Neal S.] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Cleveland, OH 44195 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Jackson Laboratory; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Lefebvre, O (corresponding author), INSERM, U682, 3 Ave Moliere, F-67200 Strasbourg, France.	olivier.lefebvre@inserm.fr; patsy.nishina@jax.org	Peachey, Neal/G-5533-2010; Lefebvre, Olivier/S-6436-2019; Orend, Gertraud/E-8446-2015; Lefebvre, Olivier/I-2388-2016; Roux, Michel J/A-3213-2009; Alpy, Fabien/H-8941-2016; Alpy, Fabien/ABD-5893-2020	Peachey, Neal/0000-0002-4419-7226; Lefebvre, Olivier/0000-0001-9130-9174; Orend, Gertraud/0000-0003-2522-1195; Lefebvre, Olivier/0000-0001-9130-9174; Roux, Michel J/0000-0002-5812-5215; Alpy, Fabien/0000-0002-0526-0720; Alpy, Fabien/0000-0002-0526-0720	National Institutes of Health [EY011996, EY016501, R24EY16538, CA34196]; Department of Veterans Affairs; Foundation Fighting Blindness; Research to Prevent Blindness; Association pour la Recherche sur le Cancer [3666]; Institut National du Cancer and Canceropole Grand-Est; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016501, R01EY011996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer and Canceropole Grand-Est; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY011996, EY016501, and R24EY16538 and Grant CA34196 (to The Jackson Laboratory). This work was also supported by the Department of Veterans Affairs, Foundation Fighting Blindness, Research to Prevent Blindness, Association pour la Recherche sur le Cancer Grant 3666, Institut National du Cancer and Canceropole Grand-Est.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Alpy F, 2005, GENESIS, V43, P59, DOI 10.1002/gene.20154; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Biehlmaier O, 2007, INVEST OPHTH VIS SCI, V48, P2887, DOI 10.1167/iovs.06-1212; BUFFONE GJ, 1985, CLIN CHEM, V31, P164; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; COLOGNATOPYKE H, 1995, J BIOL CHEM, V270, P9398, DOI 10.1074/jbc.270.16.9398; De Arcangelis A, 1996, J CELL BIOL, V133, P417, DOI 10.1083/jcb.133.2.417; Denes V, 2007, VISUAL NEUROSCI, V24, P549, DOI 10.1017/S0952523807070514; Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721; Dixelius J, 2004, J BIOL CHEM, V279, P23766, DOI 10.1074/jbc.M311675200; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Duh EJ, 2004, OPHTHALMOLOGY, V111, P1885, DOI 10.1016/j.ophtha.2004.03.030; DZIADEK M, 1985, DEV BIOL, V111, P372, DOI 10.1016/0012-1606(85)90491-9; Ekblom M, 1998, ANN NY ACAD SCI, V857, P194, DOI 10.1111/j.1749-6632.1998.tb10117.x; Ettner N, 1998, FEBS LETT, V430, P217, DOI 10.1016/S0014-5793(98)00601-2; Falk M, 1999, MATRIX BIOL, V18, P557, DOI 10.1016/S0945-053X(99)00047-5; Feldkamper M, 2003, DEV OPHTHALMOL, V37, P34; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Halfter W, 2005, INVEST OPHTH VIS SCI, V46, P1000, DOI 10.1167/iovs.04-1185; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Hurskainen M, 2005, FASEB J, V19, P1564, DOI 10.1096/fj.04-3101fje; Javaherian K, 2002, J BIOL CHEM, V277, P45211, DOI 10.1074/jbc.M206358200; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; KOHNO T, 1987, INVEST OPHTH VIS SCI, V28, P506; Kumagai C, 1997, FEBS LETT, V412, P211, DOI 10.1016/S0014-5793(97)00780-1; Kuo CJ, 2001, J CELL BIOL, V152, P1233, DOI 10.1083/jcb.152.6.1233; Lee Y, 2005, MOL CELL NEUROSCI, V30, P160, DOI 10.1016/j.mcn.2005.07.009; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; LUTTY GA, 1992, ARCH OPHTHALMOL-CHIC, V110, P267, DOI 10.1001/archopht.1992.01080140123039; Malinda KM, 1999, FASEB J, V13, P53, DOI 10.1096/fasebj.13.1.53; Mascarenhas JB, 2005, MATRIX BIOL, V23, P507, DOI 10.1016/j.matbio.2004.11.003; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Mehes E, 2002, CELL MOTIL CYTOSKEL, V53, P203, DOI 10.1002/cm.10062; Menzel O, 2004, HUM MUTAT, V23, P77, DOI 10.1002/humu.10284; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112; Odenthal U, 2004, J BIOL CHEM, V279, P44504, DOI 10.1074/jbc.M402455200; Ohlmann AV, 2004, INVEST OPHTH VIS SCI, V45, P2384, DOI 10.1167/iovs.03-1214; Patton BL, 2008, J CELL SCI, V121, P1593, DOI 10.1242/jcs.015354; Paulus JD, 2006, DEV DYNAM, V235, P213, DOI 10.1002/dvdy.20604; Peachey NS, 2003, EXP EYE RES, V77, P477, DOI 10.1016/S0014-4835(03)00149-0; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Scavello GS, 2005, MOL VIS, V11, P97; Schittny JC, 1989, CURR OPIN CELL BIOL, V1, P983, DOI 10.1016/0955-0674(89)90069-0; Schneiders FI, 2007, J BIOL CHEM, V282, P23750, DOI 10.1074/jbc.M703137200; Semina EV, 2006, DEV BIOL, V299, P63, DOI 10.1016/j.ydbio.2006.07.005; Shichiri M, 2001, FASEB J, V15, P1044, DOI 10.1096/fj.99-1083com; Sorokin LM, 1997, DEV DYNAM, V210, P446, DOI 10.1002/(SICI)1097-0177(199712)210:4<446::AID-AJA8>3.0.CO;2-G; SOROKIN LM, 1992, EXP CELL RES, V201, P137, DOI 10.1016/0014-4827(92)90357-E; Young TL, 1998, AM J HUM GENET, V63, P109, DOI 10.1086/301907; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284; Zinkevich NS, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-13	56	60	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7697	7711		10.1074/jbc.M109.069575	http://dx.doi.org/10.1074/jbc.M109.069575			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048158	Green Published, hybrid			2022-12-25	WOS:000275415600079
J	Oliveira, L; Cuervo, A; Tavares, P				Oliveira, Leonor; Cuervo, Ana; Tavares, Paulo			Direct Interaction of the Bacteriophage SPP1 Packaging ATPase with the Portal Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM RESOLUTION; FUNCTIONAL DOMAINS; TERMINASE ENZYME; LARGE SUBUNIT; DNA; MOTOR; NUCLEASE; REGION; FORMS; GENE	DNA packaging in tailed bacteriophages and other viruses requires assembly of a complex molecular machine at a specific vertex of the procapsid. This machine is composed of the portal protein that provides a tunnel for DNA entry, an ATPase that fuels DNA translocation (large terminase subunit), and most frequently, a small terminase subunit. Here we characterized the interaction between the terminase ATPase subunit of bacteriophage SPP1 (gp2) and the procapsid portal vertex. We found, by affinity pulldown assays with purified proteins, that gp2 interacts with the portal protein, gp6, independently of the terminase small subunit gp1, DNA, or ATP. The gp2-procapsid interaction via the portal protein depends on gp2 concentration and requires the presence of divalent cations. Competition experiments showed that isolated gp6 can only inhibit gp2-procapsid interactions and DNA packaging at gp6: procapsid molar ratios above 10-fold. Assays with gp6 carrying mutations in distinct regions of its structure that affect the portal-induced stimulation of ATPase and DNA packaging revealed that none of these mutations impedes gp2-gp6 binding. Our results demonstrate that the SPP1 packaging ATPase binds directly to the portal and that the interaction is stronger with the portal embedded in procapsids. Identification of mutations in gp6 that allow for assembly of the ATPase-portal complex but impair DNA packaging support an intricate cross-talk between the two proteins for activity of the DNA translocation motor.	[Oliveira, Leonor] CNRS 2472, Inst Federatif Rech 1157, Unite Virol Mol & Struct, Unite Mixte Rech, F-91190 Gif Sur Yvette, France; IFR 115, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Oliveira, L (corresponding author), CNRS 2472, Inst Federatif Rech 1157, Unite Virol Mol & Struct, Unite Mixte Rech, Batiment 14B,Ave Terrasse, F-91190 Gif Sur Yvette, France.	oliveira@vms.cnrs-gif.fr		Cuervo, Ana/0000-0001-9414-503X; Tavares, Paulo/0000-0002-2566-4546	CNRS; Agence Nationale de la Recherche [ANR-06-BLAN-0168]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by CNRS institutional funding and by Agence Nationale de la Recherche Grant ANR-06-BLAN-0168.	Agirrezabala X, 2005, J MOL BIOL, V347, P895, DOI 10.1016/j.jmb.2005.02.005; Alam TI, 2008, MOL MICROBIOL, V69, P1180, DOI 10.1111/j.1365-2958.2008.06344.x; BAZINET C, 1985, ANNU REV MICROBIOL, V39, P109; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camacho AG, 2003, J BIOL CHEM, V278, P23251, DOI 10.1074/jbc.M301805200; Casjens S, 1988, BACTERIOPHAGES, P15; Catalano Carlos Enrique, 2005, P1; CHAI S, 1992, J MOL BIOL, V224, P87, DOI 10.1016/0022-2836(92)90578-8; CHAI SH, 1995, J MOL BIOL, V252, P386, DOI 10.1006/jmbi.1995.0505; Cuervo A, 2007, J BIOL CHEM, V282, P18907, DOI 10.1074/jbc.M701808200; DEMEDICIS E, 1986, APPL ENVIRON MICROB, V52, P567; Droge A, 2000, J MOL BIOL, V296, P103, DOI 10.1006/jmbi.1999.3449; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Gual A, 1998, VIROLOGY, V242, P279, DOI 10.1006/viro.1997.9017; Gual A, 2000, J BIOL CHEM, V275, P35311, DOI 10.1074/jbc.M004309200; GUO PX, 1987, J MOL BIOL, V197, P219, DOI 10.1016/0022-2836(87)90120-3; HAIMA P, 1987, MOL GEN GENET, V209, P335, DOI 10.1007/BF00329663; Harlow E., 1988, ANTIBODIES LAB MANUA; Isidro A, 2004, VIROLOGY, V322, P253, DOI 10.1016/j.virol.2004.02.012; Isidro A, 2004, MOL MICROBIOL, V51, P949, DOI 10.1046/j.1365-2958.2003.03880.x; Jekow P, 1999, EUR J BIOCHEM, V264, P724, DOI 10.1046/j.1432-1327.1999.00601.x; Koti JS, 2008, J MOL BIOL, V381, P1114, DOI 10.1016/j.jmb.2008.04.034; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Lin HC, 1999, J MOL BIOL, V289, P249, DOI 10.1006/jmbi.1999.2781; Lurz R, 2001, J MOL BIOL, V310, P1027, DOI 10.1006/jmbi.2001.4800; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; MORITA M, 1995, J MOL BIOL, V245, P635, DOI 10.1006/jmbi.1994.0052; MORITA M, 1993, VIROLOGY, V193, P748, DOI 10.1006/viro.1993.1183; Newcomb WW, 2001, J VIROL, V75, P10923, DOI 10.1128/JVI.75.22.10923-10932.2001; Oliveira L, 2005, J MOL BIOL, V353, P529, DOI 10.1016/j.jmb.2005.08.063; Oliveira L, 2006, J BIOL CHEM, V281, P21914, DOI 10.1074/jbc.M603314200; Orlova EV, 2003, EMBO J, V22, P1255, DOI 10.1093/emboj/cdg123; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Smits C, 2009, EMBO REP, V10, P592, DOI 10.1038/embor.2009.53; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; TAVARES P, 1992, J MOL BIOL, V225, P81, DOI 10.1016/0022-2836(92)91027-M; VALPUESTA JM, 1994, Q REV BIOPHYS, V27, P107, DOI 10.1017/S0033583500004510; YEO A, 1995, J MOL BIOL, V245, P141, DOI 10.1006/jmbi.1994.0013	43	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7366	7373		10.1074/jbc.M109.061010	http://dx.doi.org/10.1074/jbc.M109.061010			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056615	hybrid, Green Published			2022-12-25	WOS:000275415600049
J	Hou, SW; Vigeland, LE; Zhang, GP; Xu, R; Li, M; Heinemann, SH; Hoshi, T				Hou, Shangwei; Vigeland, Leif E.; Zhang, Guangping; Xu, Rong; Li, Min; Heinemann, Stefan H.; Hoshi, Toshinori			Zn2+ Activates Large Conductance Ca2+-activated K+ Channel via an Intracellular Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNEL; SLO1 BK CHANNELS; CRYSTAL-STRUCTURE; RAT HIPPOCAMPUS; ION CHANNELS; ZINC-BINDING; METAL IONS; VOLTAGE; CA2+; SITES	Zinc is an essential trace element and plays crucial roles in normal development, often as an integral structural component of transcription factors and enzymes. Recent evidence suggests that intracellular Zn2+ functions as a signaling molecule, mediating a variety of important physiological phenomena. However, the immediate effectors of intracellular Zn2+ signaling are not well known. We show here that intracellular Zn2+ potently and reversibly activates large-conductance voltage-and Ca2+-activated Slo1 K+ (BK) channels. The full effect of Zn2+ requires His(365) in the RCK1 (regulator of conductance for K+) domain of the channel. Furthermore, mutation of two nearby acidic residues, Asp(367) and Glu(399), also reduced activation of the channel by Zn2+, suggesting a possible structural arrangement for Zn2+ binding by the aforementioned residues. Extracellular Zn2+ activated Slo1 BK channels when coexpressed with Zn2+-permeable TRPM7 (transient receptor potential melastatin 7) channels. The results thus demonstrate that Slo1 BK channels represent a positive and direct effector of Zn2+ signaling and may participate in sculpting cellular response to an increase in intracellular Zn2+ concentration.	[Hou, Shangwei; Hoshi, Toshinori] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Vigeland, Leif E.] Univ Penn, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Zhang, Guangping] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; [Li, Min] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Li, Min] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Heinemann, Stefan H.] Univ Jena, Dept Biophys, Ctr Mol Biomed, D-07745 Jena, Germany	University of Pennsylvania; University of Pennsylvania; University of Chicago; Johns Hopkins University; Johns Hopkins University; Friedrich Schiller University of Jena	Hou, SW (corresponding author), Univ Penn, Dept Physiol, 3700 Hamilton Walk, Philadelphia, PA 19104 USA.	shangwei@mail.med.upenn.edu	Zhang, Guang-Ping/T-2664-2019; Zhang, Guang-Ping/C-8300-2011	Zhang, Guang-Ping/0000-0002-1620-0221; Zhang, Guang-Ping/0000-0002-1620-0221; Hou, Shangwei/0000-0002-5958-7198; Heinemann, Stefan H./0000-0002-4144-0251	National Institutes of Health [GM057654, MH084691, GM078579]; Deutsche Forschungsgemeinschaft [HE2993/8]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078579, T32GM007517, R01GM057654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health Grants GM057654 (to T. H.), MH084691 (to M. L.), and GM078579 (to M. L. and T. H.). This work was also supported by Deutsche Forschungsgemeinschaft (HE2993/8).	ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; Andersson DA, 2009, P NATL ACAD SCI USA, V106, P8374, DOI 10.1073/pnas.0812675106; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Braun AP, 2001, J PHYSIOL-LONDON, V533, P681, DOI 10.1111/j.1469-7793.2001.00681.x; Chanoit G, 2008, AM J PHYSIOL-HEART C, V295, pH1227, DOI 10.1152/ajpheart.00610.2008; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Cote A, 2005, J PHYSIOL-LONDON, V566, P821, DOI 10.1113/jphysiol.2005.089458; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gribkoff VK, 2001, NAT MED, V7, P471, DOI 10.1038/86546; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Hou SW, 2008, NAT STRUCT MOL BIOL, V15, P403, DOI 10.1038/nsmb.1398; Hou SW, 2008, P NATL ACAD SCI USA, V105, P4039, DOI 10.1073/pnas.0800304105; Hou SW, 2009, CHANNELS, V3, P249; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Karagulova G, 2007, J PHARMACOL EXP THER, V321, P517, DOI 10.1124/jpet.107.119644; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Koch M, 2007, BBA-MOL CELL RES, V1773, P457, DOI 10.1016/j.bbamcr.2006.12.006; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Korndorfer IP, 2000, J MOL BIOL, V300, P917, DOI 10.1006/jmbi.2000.3896; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; Lee S, 2009, AM J PHYSIOL-HEART C, V297, pH569, DOI 10.1152/ajpheart.00293.2009; Li Y, 2001, J NEUROSCI, V21, P8015, DOI 10.1523/JNEUROSCI.21-20-08015.2001; LINK TA, 1995, J BIOL CHEM, V270, P25001, DOI 10.1074/jbc.270.42.25001; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Ma ZM, 2008, J GEN PHYSIOL, V131, P483, DOI 10.1085/jgp.200809980; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; McGwire BS, 1996, J BIOL CHEM, V271, P7903, DOI 10.1074/jbc.271.14.7903; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Miles E W, 1977, Methods Enzymol, V47, P431; Mills DA, 2002, J BIOL CHEM, V277, P14894, DOI 10.1074/jbc.M111922200; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; OBERHAUSER A, 1988, J GEN PHYSIOL, V92, P67, DOI 10.1085/jgp.92.1.67; Ostendorp T, 2005, ACTA CRYSTALLOGR F, V61, P673, DOI 10.1107/S1744309105018014; PANTOLIANO MW, 1982, J INORG BIOCHEM, V17, P325, DOI 10.1016/S0162-0134(00)80093-8; PERMYAKOV E, 2009, METALLOPROTEOMICS, P283; POWELL SR, 1994, AM J PHYSIOL, V266, pH2497, DOI 10.1152/ajpheart.1994.266.6.H2497; Prost AL, 2004, J PHYSIOL-LONDON, V559, P157, DOI 10.1113/jphysiol.2004.065094; Qian X, 2006, J GEN PHYSIOL, V128, P389, DOI 10.1085/jgp.200609486; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sandstead HH, 2000, J NUTR, V130, p347S, DOI 10.1093/jn/130.2.347S; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Sharpley MS, 2006, J BIOL CHEM, V281, P34803, DOI 10.1074/jbc.M607389200; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Shi JY, 2001, J GEN PHYSIOL, V118, P589, DOI 10.1085/jgp.118.5.589; Stork CJ, 2006, J NEUROSCI, V26, P10430, DOI 10.1523/JNEUROSCI.1588-06.2006; Strang C, 2003, J BIOL CHEM, V278, P31361, DOI 10.1074/jbc.M304268200; Sweet TB, 2009, J GEN PHYSIOL, V133, P139, DOI 10.1085/jgp.200810129; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; Torres YP, 2007, J BIOL CHEM, V282, P24485, DOI 10.1074/jbc.R700022200; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Volbeda A, 1996, CURR OPIN STRUC BIOL, V6, P804, DOI 10.1016/S0959-440X(96)80011-X; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239	72	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6434	6442		10.1074/jbc.M109.069211	http://dx.doi.org/10.1074/jbc.M109.069211			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037152	Green Published, hybrid			2022-12-25	WOS:000275367500048
J	Zimmermann, L; Paster, W; Weghuber, J; Eckerstorfer, P; Stockinger, H; Schutz, GJ				Zimmermann, Lars; Paster, Wolfgang; Weghuber, Julian; Eckerstorfer, Paul; Stockinger, Hannes; Schuetz, Gerhard J.			Direct Observation and Quantitative Analysis of Lck Exchange between Plasma Membrane and Cytosol in Living T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-MOLECULE MICROSCOPY; ACYL-PROTEIN THIOESTERASE; TYROSINE KINASE; DIFFUSION; PALMITOYLATION; MICRODOMAINS; BINDING; RAS; FLUORESCENCE; DYNAMICS	Palmitoylation represents a common motif for anchorage of cytosolic proteins to the plasma membrane. Being reversible, it allows for controlled exchange between cytosolic and plasma membrane-bound subpopulations. In this study, we present a live cell single molecule approach for quantifying the exchange kinetics of plasma membrane and cytosolic populations of fluorescently labeled Lck, the key Src family kinase involved in early T cell signaling. Total internal reflection (TIR) fluorescence microscopy was employed for confining the analysis to membrane-proximal molecules. Upon photobleaching Lck-YFP in TIR configuration, fluorescence recovery proceeds first via the cytosol outside of the evanescent field, so that in the early phase fluorescence signal arises predominantly from membrane-proximal cytosolic Lck. The diffusion constant of each molecule allowed us to distinguish whether the molecule has already associated with the plasma membrane or was still freely diffusing in the cytosol. From the number of molecules that inserted during the recovery time we quantified the insertion kinetics: on average, membrane-proximal molecules within the evanescent field needed similar to 400 ms to be inserted. The average lifetime of Lck in the plasma membrane was estimated at 50 s; together with the mobility of 0.26 mu m(2)/s this provides sufficient time to explore the surface of the whole T cell before dissociation into the cytosol. Experiments on palmitoylation-deficient Lck mutants yielded similar on-rates, but substantially increased off-rates. We discuss our findings based on a model for the plasma membrane association and dissociation kinetics of Lck, which accounts for reversible palmitoylation on cysteine 3 and 5.	[Schuetz, Gerhard J.] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Paster, Wolfgang; Eckerstorfer, Paul; Stockinger, Hannes] Med Univ Vienna, Mol Immunol Unit, Inst Hyg & Appl Immunol, Ctr Physiol Pathophysiol & Immunol, A-1090 Vienna, Austria	Johannes Kepler University Linz; Medical University of Vienna	Schutz, GJ (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	gerhard.schuetz@jku.at	Stockinger, Hannes/E-5173-2011; Schuetz, Gerhard/B-1243-2008	Stockinger, Hannes/0000-0001-6404-4430; Schuetz, Gerhard/0000-0003-1542-1089; Paster, Wolfgang/0000-0002-5537-2886; Weghuber, Julian/0000-0001-6312-4666	Austrian Science Fund [Y250B10]; Austrian Federal Ministry for Science and Research; European Union [202272]; Austrian Science Fund (FWF) [Y 250] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Federal Ministry for Science and Research; European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF Project Y250B10), the GEN-AU Project of the Austrian Federal Ministry for Science and Research, and the European Union Project LipidomicNet (Grant 202272).	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Anton O, 2008, J EXP MED, V205, P3201, DOI 10.1084/jem.20080552; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Bijlmakers MJJE, 1999, J CELL BIOL, V145, P457, DOI 10.1083/jcb.145.3.457; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Espenel C, 2008, J CELL BIOL, V182, P765, DOI 10.1083/jcb.200803010; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Haughn L, 1998, J EXP MED, V188, P1575, DOI 10.1084/jem.188.9.1575; Henis YI, 2006, METHODS, V40, P183, DOI 10.1016/j.ymeth.2006.02.003; Ike H, 2003, CHEMPHYSCHEM, V4, P620, DOI 10.1002/cphc.200300670; Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Knight JD, 2009, BIOPHYS J, V96, P566, DOI 10.1016/j.bpj.2008.10.020; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lommerse PHM, 2006, BIOPHYS J, V91, P1090, DOI 10.1529/biophysj.105.079053; Mashanov GI, 2004, J BIOL CHEM, V279, P15274, DOI 10.1074/jbc.M312140200; Mattheyses AL, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2161018; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Ohsugi Y, 2006, BIOPHYS J, V91, P3456, DOI 10.1529/biophysj.105.074625; PAIGE LA, 1993, J BIOL CHEM, V268, P8669; Paster W, 2009, J IMMUNOL, V182, P2160, DOI 10.4049/jimmunol.0802639; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Rhode S, 2009, J BIOL CHEM, V284, P2258, DOI 10.1074/jbc.M807591200; Ritchie K, 2005, BIOPHYS J, V88, P2266, DOI 10.1529/biophysj.104.054106; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Schmidt T, 1996, ANAL CHEM, V68, P4397, DOI 10.1021/ac960710g; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Schutz GJ, 2004, MICROSC RES TECHNIQ, V63, P159, DOI 10.1002/jemt.20016; Schwarzenbacher M, 2008, NAT METHODS, V5, P1053, DOI 10.1038/nmeth.1268; Segura JM, 2008, J BIOL CHEM, V283, P24254, DOI 10.1074/jbc.M803549200; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; Vrljic M, 2002, BIOPHYS J, V83, P2681, DOI 10.1016/S0006-3495(02)75277-6; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Wieser S, 2007, BIOPHYS J, V92, P3719, DOI 10.1529/biophysj.106.095398; Wieser S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2822890; Wieser S, 2008, BIOPHYS J, V95, P5988, DOI 10.1529/biophysj.108.141655; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	46	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6063	6070		10.1074/jbc.M109.025981	http://dx.doi.org/10.1074/jbc.M109.025981			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040600	hybrid, Green Published			2022-12-25	WOS:000275367500009
J	Kraushaar, DC; Yamaguchi, Y; Wang, LC				Kraushaar, Daniel C.; Yamaguchi, Yu; Wang, Lianchun			Heparan Sulfate Is Required for Embryonic Stem Cells to Exit from Self-renewal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GLYPICAN DALLY-LIKE; MOUSE EMBRYOS; ES CELLS; DIFFERENTIATION; DROSOPHILA; PLURIPOTENCY; PROTEOGLYCANS; BIOSYNTHESIS; WINGLESS	Pluripotent embryonic stem cells (ESCs) must select between alternative fates of self-renewal and lineage commitment at each division during continuous proliferation. Heparan sulfate (HS) is a highly sulfated polysaccharide and is present abundantly on the ESC surface. In this study, we investigated the role of HS in ESC self-renewal by examining Ext1(-/-) ESCs that are deficient in HS. We found that Ext1(-/-) ESCs retained their self-renewal potential but failed to transit from self-renewal to differentiation upon removal of leukemia inhibitory factor. Furthermore, we found that the aberrant cell fate commitment is caused by defects in fibroblast growth factor signaling, which directly retained high expression of the pluripotency gene Nanog in Ext1(-/-) ESCs. Therefore, our studies identified and defined HS as a novel factor that controls ESC fate commitment and also delineates that HS facilitates fibroblast growth factor signaling, which, in turn, inhibits Nanog expression and commits ESCs to lineage differentiation.	[Wang, Lianchun] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Yamaguchi, Yu] Burnham Inst Med Res, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Sanford Burnham Prebys Medical Discovery Institute	Wang, LC (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	Lwang@ccrc.uga.edu			National Institutes of Health [P01 HD25936]; University of Georgia Research Foundation; Georgia Cancer Coalition; Cousin fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD025936, R01HD025936] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Research Foundation; Georgia Cancer Coalition; Cousin fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HD25936 (to Y. Y.). This work was also supported in part by the University of Georgia Research Foundation and Georgia Cancer Coalition (to L. W.) and a Cousin fellowship (to D. C. K.).	Baeg GH, 2001, DEVELOPMENT, V128, P87; Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Binari RC, 1997, DEVELOPMENT, V124, P2623; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726; Delehedde M, 2002, BIOCHEM J, V366, P235, DOI 10.1042/BJ20011718; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Faherty S, 2007, IN VITRO CELL DEV-AN, V43, P37, DOI 10.1007/s11626-006-9001-5; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; LI QG, 1990, BIOCHEM BIOPH RES CO, V166, P557, DOI 10.1016/0006-291X(90)90844-D; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Milne CD, 2008, J IMMUNOL, V180, P2839, DOI 10.4049/jimmunol.180.5.2839; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagy A., 2003, MANIPULATING MOUSE E; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Nguyen TT, 2007, REPRODUCTION, V134, P41, DOI 10.1530/REP-06-0087; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Yan D, 2007, DEV BIOL, V312, P203, DOI 10.1016/j.ydbio.2007.09.015; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	42	69	71	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5907	5916		10.1074/jbc.M109.066837	http://dx.doi.org/10.1074/jbc.M109.066837			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022960	Green Published, hybrid			2022-12-25	WOS:000275327200081
J	Ly, TK; Wang, JB; Pereira, R; Rojas, KS; Peng, X; Feng, QY; Cerione, RA; Wilson, KF				Ly, Thi K.; Wang, Jianbin; Pereira, Ryan; Rojas, Katherine S.; Peng, Xu; Feng, Qiyu; Cerione, Richard A.; Wilson, Kristin F.			Activation of the Ran GTPase Is Subject to Growth Factor Regulation and Can Give Rise to Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-BINDING-PROTEIN; U-SNRNA EXPORT; MESSENGER-RNA; NUCLEAR-PROTEIN; MALIGNANT TRANSFORMATION; COMPLEX; CANCER; CYCLE; MECHANISM; RECEPTOR	Although the small GTPase Ran is best known for its roles in nucleocytoplasmic transport, mitotic spindle assembly, and nuclear envelope formation, recent studies have demonstrated the overexpression of Ran in multiple tumor types and that its expression is correlated with a poor patient prognosis, providing evidence for the importance of this GTPase in cell growth regulation. Here we show that Ran is subject to growth factor regulation by demonstrating that it is activated in a serum-dependent manner in human breast cancer cells and, in particular, in response to heregulin, a growth factor that activates the Neu/ErbB2 tyrosine kinase. The heregulin-dependent activation of Ran requires mTOR (mammalian target of rapamycin) and stimulates the capped RNA binding capability of the cap-binding complex in the nucleus, thus influencing gene expression at the level of mRNA processing. We further demonstrate that the excessive activation of Ran has important consequences for cell growth by showing that a novel, activated Ran mutant is sufficient to transform NIH-3T3 cells in an mTOR-and epidermal growth factor receptor-dependent manner and that Ran-transformed cells form tumors in mice.	[Ly, Thi K.; Wang, Jianbin; Rojas, Katherine S.; Peng, Xu; Feng, Qiyu; Cerione, Richard A.; Wilson, Kristin F.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Pereira, Ryan; Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Rojas, Katherine/GRJ-2722-2022		National Institutes of Health [GM040654]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM040654.	Azuma K, 2004, CLIN CANCER RES, V10, P6695, DOI 10.1158/1078-0432.CCR-04-0818; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; CLARKE PR, 1995, J CELL SCI, V108, P1217; DASSO M, 1994, EMBO J, V13, P5732, DOI 10.1002/j.1460-2075.1994.tb06911.x; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7; IZAURRALDE E, 1992, J CELL BIOL, V118, P1287, DOI 10.1083/jcb.118.6.1287; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; KATAOKA N, 1994, NUCLEIC ACIDS RES, V22, P3861, DOI 10.1093/nar/22.19.3861; KATAOKA N, 1995, NUCLEIC ACIDS RES, V23, P3638, DOI 10.1093/nar/23.18.3638; Kurisetty VV, 2008, ONCOGENE, V27, P7139, DOI 10.1038/onc.2008.325; LAZARISKARATZAS A, 1992, GENE DEV, V6, P1631, DOI 10.1101/gad.6.9.1631; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lewis JD, 1996, GENE DEV, V10, P1683, DOI 10.1101/gad.10.13.1683; Lewis JD, 1996, NUCLEIC ACIDS RES, V24, P3332, DOI 10.1093/nar/24.17.3332; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; OHNO M, 1987, P NATL ACAD SCI USA, V84, P5187, DOI 10.1073/pnas.84.15.5187; Ouellet V, 2006, INT J CANCER, V119, P599, DOI 10.1002/ijc.21902; REN MD, 1994, MOL CELL BIOL, V14, P4216, DOI 10.1128/MCB.14.6.4216; Rensen WM, 2008, FRONT BIOSCI-LANDMRK, V13, P4097, DOI 10.2741/2996; SMITH M R, 1990, New Biologist, V2, P648; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wilson KF, 2000, J BIOL CHEM, V275, P37307, DOI 10.1074/jbc.C000482200; Wilson KF, 1999, J BIOL CHEM, V274, P4166, DOI 10.1074/jbc.274.7.4166; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yasuda Y, 2006, EXP CELL RES, V312, P512, DOI 10.1016/j.yexcr.2005.11.017; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024; Yuan Y, 2006, NEUROSCI LETT, V407, P26, DOI 10.1016/j.neulet.2006.06.059; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029	40	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5815	5826		10.1074/jbc.M109.071886	http://dx.doi.org/10.1074/jbc.M109.071886			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028979	Green Published, hybrid			2022-12-25	WOS:000275327200072
J	Saxena, M; Singh, S; Zzaman, S; Bastia, D				Saxena, Mukesh; Singh, Samarendra; Zzaman, Shamsu; Bastia, Deepak			Investigations of pi Initiator Protein-mediated Interaction between Replication Origins alpha and gamma of the Plasmid R6K	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATION HOST FACTOR; COPY-NUMBER CONTROL; ESCHERICHIA-COLI; DNA-REPLICATION; BINDING-SITES; IN-VITRO; CONFORMATIONAL-CHANGES; FUNCTIONAL-ANALYSIS; PURIFIED PROTEINS; RK2 REPLICATION	A typical plasmid replicon of Escherichia coli, such as ori gamma of R6K, contains tandem iterons (iterated initiator protein binding sites), an AT-rich region that melts upon initiator-iteron interaction, two binding sites for the bacterial initiator protein DnaA, and a binding site for the DNA-bending protein IHF. R6K also contains two structurally atypical origins called gamma and beta that are located on either side of gamma and contain a single and a half-iteron, respectively. Individually, these sites do not bind to initiator protein pi but access it by DNA looping-mediated interaction with the seven pi-bound gamma iterons. The pi protein exists in 2 interconvertible forms: inert dimers and active monomers. Initiator dimers generally function as negative regulators of replication by promoting iteron pairing ("handcuffing") between pairs of replicons that turn off both origins. Contrary to this existing paradigm, here we show that both the dimeric and the monomeric pi are necessary for ori alpha-driven plasmid maintenance. Furthermore, efficient looping interaction between alpha and gamma or between 2 gamma iterons in vitro also required both forms of pi. Why does alpha-gamma iteron pairing promote alpha activation rather than repression? We show that a weak, transitory alpha-gamma interaction at the iteron pairs was essential for alpha-driven plasmid maintenance. Swapping the alpha iteron with one of gamma without changing the original sequence context that caused enhanced looping in vitro caused a significant inhibition of alpha-mediated plasmid maintenance. Therefore, the affinity of alpha iteron for pi-bound gamma and not the sequence context determined whether the origin was activated or repressed.	[Saxena, Mukesh; Singh, Samarendra; Zzaman, Shamsu; Bastia, Deepak] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Bastia, D (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	bastia@musc.edu			National Institutes of Health [GM049264]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049264] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM049264 from the National Institutes of Health (to D. B.).	Abhyankar MM, 2004, J BIOL CHEM, V279, P6711, DOI 10.1074/jbc.M312052200; Abhyankar MM, 2003, J BIOL CHEM, V278, P45476, DOI 10.1074/jbc.M308516200; ABLES AL, 1991, P NATL ACAD SCI USA, V88, P9011; BASTIA D, 1996, DNA REPLICATION EUKA; Blasina A, 1996, P NATL ACAD SCI USA, V93, P3559, DOI 10.1073/pnas.93.8.3559; BUSHMAN FD, 1986, P NATL ACAD SCI USA, V83, P9353, DOI 10.1073/pnas.83.24.9353; CHATTORAJ DK, 1985, P NATL ACAD SCI USA, V82, P2588, DOI 10.1073/pnas.82.9.2588; Choy HE, 1997, J MOL BIOL, V272, P293, DOI 10.1006/jmbi.1997.1221; CROSA JH, 1978, J MOL BIOL, V124, P443, DOI 10.1016/0022-2836(78)90181-X; CROSA JH, 1976, J BACTERIOL, V126, P454, DOI 10.1128/JB.126.1.454-466.1976; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; FILUTOWICZ M, 1985, NUCLEIC ACIDS RES, V13, P103, DOI 10.1093/nar/13.1.103; FILUTOWICZ M, 1988, NUCLEIC ACIDS RES, V16, P3829, DOI 10.1093/nar/16.9.3829; FILUTOWICZ M, 1987, J CELL SCI, P15; GERMINO J, 1983, CELL, V34, P125, DOI 10.1016/0092-8674(83)90142-3; HELINSKI DR, 1996, ESCHERICHIA COLI SAL; INUZUKA N, 1980, J BIOL CHEM, V255, P1071; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; KELLEY W, 1985, P NATL ACAD SCI USA, V82, P2574, DOI 10.1073/pnas.82.9.2574; KELLEY WL, 1991, J BIOL CHEM, V266, P15924; KELLEY WL, 1992, P NATL ACAD SCI USA, V89, P5078, DOI 10.1073/pnas.89.11.5078; KHAN SA, 1988, BIOCHIM BIOPHYS ACTA, V951, P375, DOI 10.1016/0167-4781(88)90109-1; Koudelka GB, 2000, CURR BIOL, V10, pR704, DOI 10.1016/S0960-9822(00)00710-7; Kruger R, 2001, J MOL BIOL, V306, P945, DOI 10.1006/jmbi.2000.4426; Kunnimalaiyaan S, 2004, J BIOL CHEM, V279, P41058, DOI 10.1074/jbc.M403151200; Kunnimalaiyaan S, 2007, J BACTERIOL, V189, P4953, DOI 10.1128/JB.00109-07; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; LOVETT MA, 1975, P NATL ACAD SCI USA, V72, P2905, DOI 10.1073/pnas.72.8.2905; Lu YB, 1998, EMBO J, V17, P5192, DOI 10.1093/emboj/17.17.5192; MCEACHERN MJ, 1989, P NATL ACAD SCI USA, V86, P7942, DOI 10.1073/pnas.86.20.7942; MIRON A, 1994, P NATL ACAD SCI USA, V91, P6438, DOI 10.1073/pnas.91.14.6438; MIRON A, 1992, EMBO J, V11, P1205, DOI 10.1002/j.1460-2075.1992.tb05161.x; MUKHERJEE S, 1988, P NATL ACAD SCI USA, V85, P6287, DOI 10.1073/pnas.85.17.6287; MUKHERJEE S, 1985, CELL, V43, P189, DOI 10.1016/0092-8674(85)90023-6; MUKHERJEE S, 1988, CELL, V52, P375, DOI 10.1016/S0092-8674(88)80030-8; Ohlsson R, 2007, CURR OPIN CELL BIOL, V19, P321, DOI 10.1016/j.ceb.2007.04.008; PAL SK, 1988, J BACTERIOL, V170, P3554, DOI 10.1128/jb.170.8.3554-3560.1988; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; PTASHNE M, 2004, GENETIC SWITCH; Ratnakar PVAL, 1996, P NATL ACAD SCI USA, V93, P5522, DOI 10.1073/pnas.93.11.5522; STENZEL TT, 1991, GENE DEV, V5, P1453, DOI 10.1101/gad.5.8.1453; Swan MK, 2006, P NATL ACAD SCI USA, V103, P18481, DOI 10.1073/pnas.0609046103; TOMIZAWA J, 1990, J MOL BIOL, V212, P683, DOI 10.1016/0022-2836(90)90230-J; Toukdarian AE, 1998, GENE, V223, P205, DOI 10.1016/S0378-1119(98)00370-9; Zzaman S, 2005, MOL CELL, V20, P833, DOI 10.1016/j.molcel.2005.10.037; Zzaman S, 2004, J BIOL CHEM, V279, P50886, DOI 10.1074/jbc.M407531200; Zzaman S, 2004, J BIOL CHEM, V279, P17404, DOI 10.1074/jbc.M400021200	47	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5695	5704		10.1074/jbc.M109.067439	http://dx.doi.org/10.1074/jbc.M109.067439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20029091	hybrid, Green Published			2022-12-25	WOS:000275327200062
J	Gao, S; Chen, XY; Yi, QQ; Wang, GC; Pan, GH; Lin, AP; Peng, G				Gao, Shan; Chen, Xiaoyuan; Yi, Qianqian; Wang, Guangce; Pan, Guanghua; Lin, Apeng; Peng, Guang			A Strategy for the Proliferation of Ulva prolifera, Main Causative Species of Green Tides, with Formation of Sporangia by Fragmentation	PLOS ONE			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; CHLOROPHYLL FLUORESCENCE; ENTEROMORPHA; EUTROPHICATION; GERMINATION; PROPAGULES; MACROALGAE; SALINITY; GROWTH; LIGHT	Ulva prolifera, a common green seaweed, is one of the causative species of green tides that occurred frequently along the shores of Qingdao in 2008 and had detrimental effects on the preparations for the 2008 Beijing Olympic Games sailing competition, since more than 30 percent of the area of the games was invaded. In view of the rapid accumulation of the vast biomass of floating U. prolifera in green tides, we investigated the formation of sporangia in disks of different diameters excised from U. prolifera, changes of the photosynthetic properties of cells during sporangia formation, and development of spores. The results suggested that disks less than 1.00 mm in diameter were optimal for the formation of sporangia, but there was a small amount of spore release in these. The highest percentage of area of spore release occurred in disks that were 2.50 mm in diameter. In contrast, sporangia were formed only at the cut edges of larger disks (3.00 mm, 3.50 mm, and 4.00 mm in diameter). Additionally, the majority of spores liberated from the disks appeared vigorous and developed successfully into new individuals. These results implied that fragments of the appropriate size from the U. prolifera thalli broken by a variety of factors via producing spores gave rise to the rapid proliferation of the seaweed under field conditions, which may be one of the most important factors to the rapid accumulation of the vast biomass of U. prolifera in the green tide that occurred in Qingdao, 2008.	[Gao, Shan; Chen, Xiaoyuan; Yi, Qianqian; Wang, Guangce; Pan, Guanghua] Tianjin Univ Sci & Technol, Coll Marine Sci & Engn, Tianjin, Peoples R China; [Wang, Guangce; Lin, Apeng; Peng, Guang] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Lin, Apeng] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Tianjin University Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, S (corresponding author), Tianjin Univ Sci & Technol, Coll Marine Sci & Engn, Tianjin, Peoples R China.	gcwang@ms.qdio.ac.cn	Chen, Xiaoyuan/D-1860-2014	Chen, Xiaoyuan/0000-0002-9622-0870	National Natural Science Foundation of China [30830015]; Project for Supporting the National Development [2008BAC49B01, 2006BAD09A04];  [2006AA10A402];  [2007AA09Z406];  [2006AA05Z112];  [2006AA10A413]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project for Supporting the National Development; ; ; ; 	The work was supported by the National Natural Science Foundation of China (30830015), Project for Supporting the National Development (2008BAC49B01 and 2006BAD09A04), and the 863 Project of China (2006AA10A402, 2007AA09Z406, 2006AA05Z112, and 2006AA10A413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomster J, 2002, AM J BOT, V89, P1756, DOI 10.3732/ajb.89.11.1756; Callow ME, 1997, J PHYCOL, V33, P938, DOI 10.1111/j.0022-3646.1997.00938.x; Dan A, 2002, FISHERIES SCI, V68, P1182, DOI 10.1046/j.1444-2906.2002.00553.x; Ding LanPing, 2009, Oceanologia et Limnologia Sinica / Hai Yang Yu Hu Chao, V40, P68; Figueroa FL, 2003, PHOTOSYNTH RES, V75, P259, DOI 10.1023/A:1023936313544; Fletcher RL., 1996, MARINE BENTHIC VEGET, P7, DOI [10.1007/978-3-642-61398-2_2, DOI 10.1007/978-3-642-61398-2_2]; Franklin LA, 2001, J PHYCOL, V37, P756, DOI 10.1046/j.1529-8817.2001.00156.x; Gahan P. B., 2007, P3, DOI 10.1007/978-1-4020-6352-7_1; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; Hiraoka M, 2004, HYDROBIOLOGIA, V512, P239, DOI 10.1023/B:HYDR.0000020332.12641.a2; Hiraoka M, 2008, J APPL PHYCOL, V20, P97, DOI 10.1007/s10811-007-9186-3; LI DQ, 2008, ENV PROTECTION, V402, P45; Lin A, 2008, J INTEGR PLANT BIOL, V50, P622, DOI 10.1111/j.1744-7909.2008.00647.x; Lobban CS, 1981, BIOL SEAWEEDS; Lotze HK, 2000, J PHYCOL, V36, P287, DOI 10.1046/j.1529-8817.2000.99109.x; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MAZE J, 1993, J APPL PHYCOL, V5, P183, DOI 10.1007/BF00004015; Merceron M, 2007, SCI TOTAL ENVIRON, V384, P293, DOI 10.1016/j.scitotenv.2007.05.007; Nelson TA, 2008, ECOLOGY, V89, P1287, DOI 10.1890/07-0494.1; Poole LJ, 1997, PROG PHYCOL RES, V12, P1; Prasady PWC, 2008, INT J ELECTRON, V95, P111, DOI 10.1080/00207210701828770; Raffaelli DG, 1998, OCEANOGR MAR BIOL<D>, V36, P97; SANTELICES B, 1989, J PHYCOL, V25, P693, DOI 10.1111/j.0022-3646.1989.00693.x; SCHORIES D, 1993, HELGOLANDER MEERESUN, V47, P275, DOI 10.1007/BF02367169; Schramm W, 1999, J APPL PHYCOL, V11, P69, DOI 10.1023/A:1008076026792; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Sousa AI, 2007, J EXP MAR BIOL ECOL, V341, P142, DOI 10.1016/j.jembe.2006.09.020; TAYLOR D, 1995, MAR ECOL PROG SER, V127, P235, DOI 10.3354/meps127235; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; Van den Hoek C, 1996, ALGAE INTRO PHYCOLOG; VASIL IK, 1972, IN VITRO CELL DEV B, V8, P117; [王建伟 WANG Jianwei], 2006, [生态科学, Ecologic Science], V25, P400; Wang YZ, 2008, INT J BEHAV DEV, V32, P13, DOI 10.1177/0165025407084047	35	109	134	6	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8571	10.1371/journal.pone.0008571	http://dx.doi.org/10.1371/journal.pone.0008571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052408	Green Submitted, Green Published, gold			2022-12-25	WOS:000273338500014
J	Krycer, JR; Kristiana, I; Brown, AJ				Krycer, James Robert; Kristiana, Ika; Brown, Andrew John			Cholesterol Homeostasis in Two Commonly Used Human Prostate Cancer Cell-Lines, LNCaP and PC-3	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; REGULATORY ELEMENT; RECEPTOR-ACTIVITY; GENE-EXPRESSION; LDL-RECEPTOR; FEEDBACK-REGULATION; FLUOROMETRIC ASSAY; PLASMA-CHOLESTEROL; LEUKEMIC-CELLS; CULTURED-CELLS	Background: Recently, there has been renewed interest in the link between cholesterol and prostate cancer. It has been previously reported that in vitro, prostate cancer cells lack sterol-mediated feedback regulation of the major transcription factor in cholesterol homeostasis, sterol-regulatory element binding protein 2 (SREBP-2). This could explain the accumulation of cholesterol observed in clinical prostate cancers. Consequently, perturbed feedback regulation to increased sterol levels has become a pervasive concept in the prostate cancer setting. Here, we aimed to explore this in greater depth. Methodology/Principal Findings: After altering the cellular cholesterol status in LNCaP and PC-3 prostate cancer cells, we examined SREBP-2 processing, downstream effects on promoter activity and expression of SREBP-2 target genes, and functional activity (low-density lipoprotein uptake, cholesterol synthesis). In doing so, we observed that LNCaP and PC-3 cells were sensitive to increased sterol levels. In contrast, lowering cholesterol levels via statin treatment generated a greater response in LNCaP cells than PC-3 cells. This highlighted an important difference between these cell-lines: basal SREBP-2 activity appeared to be higher in PC-3 cells, reducing sensitivity to decreased cholesterol levels. Conclusion/Significance:Thus, prostate cancer cells are sensitive to changing sterol levels in vitro, but the extent of this regulation differs between prostate cancer cell-lines. These results shed new light on the regulation of cholesterol metabolism in two commonly used prostate cancer cell-lines, and emphasize the importance of establishing whether or not cholesterol homeostasis is perturbed in prostate cancer in vivo.	[Krycer, James Robert; Kristiana, Ika; Brown, Andrew John] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Krycer, JR (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	aj.brown@unsw.edu.au		Krycer, James/0000-0003-1536-7270	Prostate Cancer Foundation of Australia; Petre Foundation	Prostate Cancer Foundation of Australia; Petre Foundation	AJB's research is supported by a grant from the Prostate Cancer Foundation of Australia (PR36, http://www.prostate.org.au). JRK is the recipient of the Petre Foundation scholarship (http://www.petrefoundation.org.aul. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades A, 2001, GYNECOL ONCOL, V82, P84, DOI 10.1006/gyno.2001.6203; Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Brown AJ, 2007, CLIN EXP PHARMACOL P, V34, P135, DOI 10.1111/j.1440-1681.2007.04565.x; BROWN MS, 1981, NEW ENGL J MED, V305, P515, DOI 10.1056/NEJM198108273050909; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; CERDA SR, 1995, LIPIDS, V30, P1083, DOI 10.1007/BF02536608; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen YF, 2001, INT J CANCER, V91, P41, DOI 10.1002/1097-0215(20010101)91:1<41::AID-IJC1009>3.0.CO;2-2; Chung LW, 1996, UROL ONCOL-SEMIN ORI, V2, P99; Dozmorov MG, 2009, PROSTATE, V69, P1077, DOI 10.1002/pros.20960; Du XM, 2006, MOL BIOL CELL, V17, P2735, DOI 10.1091/mbc.E05-11-1094; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Galea AM, 2009, FREE RADICAL BIO MED, V47, P880, DOI 10.1016/j.freeradbiomed.2009.06.027; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Grand-Perret T, 2001, NAT MED, V7, P1332, DOI 10.1038/nm1201-1332; Hager MH, 2006, CURR OPIN CLIN NUTR, V9, P379, DOI 10.1097/01.mco.0000232896.66791.62; Heemers H, 2001, MOL ENDOCRINOL, V15, P1817, DOI 10.1210/me.15.10.1817; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Hentosh P, 2001, MOL CARCINOGEN, V32, P154, DOI 10.1002/mc.1074; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; KAIGHN ME, 1979, INVEST UROL, V17, P16; KRUTH HS, 1979, J CELL BIOL, V83, P588, DOI 10.1083/jcb.83.3.588; Lin JQ, 1999, CANCER RES, V59, P2891; Liu JW, 1997, J LIPID RES, V38, P2035; Liu JW, 2000, J BIOL CHEM, V275, P5214, DOI 10.1074/jbc.275.7.5214; Locke JA, 2008, PROSTATE, V68, P20, DOI 10.1002/pros.20674; Masquelier M, 2006, LEUKEMIA RES, V30, P136, DOI 10.1016/j.leukres.2005.06.012; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Morris DS, 2007, CELL CYCLE, V6, P1177, DOI 10.4161/cc.6.10.4247; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Sharrard RM, 2007, CELL SIGNAL, V19, P129, DOI 10.1016/j.cellsig.2006.05.029; SIPERSTEIN MD, 1964, CANCER RES, V24, P1108; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; SPORER A, 1982, UROLOGY, V20, P244, DOI 10.1016/0090-4295(82)90631-8; STEPHAN ZF, 1993, J LIPID RES, V34, P325; Swyer GIM, 1942, CANCER RES, V2, P372; Tatidis L, 1997, J LIPID RES, V38, P2436; Teupser D, 1996, BBA-LIPID LIPID MET, V1303, P193, DOI 10.1016/0005-2760(96)00094-X; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Warburg O. H., 1930, METABOLISM TUMOURS I; White CP, 1909, J PATHOL BACTERIOL, V13, P3, DOI 10.1002/path.1700130103; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Wong J, 2008, J BIOL CHEM, V283, P700, DOI 10.1074/jbc.M706416200; Wong J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-10	51	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8496	10.1371/journal.pone.0008496	http://dx.doi.org/10.1371/journal.pone.0008496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041144	Green Published, Green Submitted, gold			2022-12-25	WOS:000278068700011
J	Tong, EHY; Guo, JJ; Xu, SX; Mak, K; Chung, SK; Chung, SSM; Huang, AL; Ko, BCB				Tong, Edith H. Y.; Guo, Jin-Jun; Xu, Song-Xiao; Mak, Keri; Chung, Sookja K.; Chung, Stephen S. M.; Huang, Ali-Long; Ko, Ben C. B.			Inducible Nucleosome Depletion at OREBP-Binding-Sites by Hypertonic Stress	PLOS ONE			English	Article							T-CELL-ACTIVATION; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; HISTONE MODIFICATIONS; CHROMATIN-STRUCTURE; OSMOTIC-STRESS; NUCLEOCYTOPLASMIC TRAFFICKING; STIMULATES TRANSCRIPTION; FACTOR TONEBP/OREBP; GENE-TRANSCRIPTION	Background: Osmotic Response Element-Binding Protein (OREBP), also known as TonEBP or NFAT5, is a unique transcription factor. It is hitherto the only known mammalian transcription factor that regulates hypertonic stress-induced gene transcription. In addition, unlike other monomeric members of the NFAT family, OREBP exists as a homodimer and it is the only transcription factor known to bind naked DNA targets by complete encirclement in vitro. Nevertheless, how OREBP interacts with target DNA, also known as ORE/TonE, and how it elicits gene transcription in vivo, remains unknown. Methodology: Using hypertonic induction of the aldose reductase (AR) gene activation as a model, we showed that OREs contained dynamic nucleosomes. Hypertonic stress induced a rapid and reversible loss of nucleosome(s) around the OREs. The loss of nucleosome(s) was found to be initiated by an OREBP-independent mechanism, but was significantly potentiated in the presence of OREBP. Furthermore, hypertonic induction of AR gene was associated with an OREBP-dependent hyperacetylation of histones that spanned the 59 upstream sequences and at least some exons of the gene. Nevertheless, nucleosome loss was not regulated by the acetylation status of histone. Significance: Our findings offer novel insights into the mechanism of OREBP-dependent transcriptional regulation and provide a basis for understanding how histone eviction and transcription factor recruitment are coupled.	[Tong, Edith H. Y.; Xu, Song-Xiao; Ko, Ben C. B.] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Tong, Edith H. Y.; Xu, Song-Xiao; Ko, Ben C. B.] Chinese Univ Hong Kong, State Key Lab Oncol S China, Hong Kong, Hong Kong, Peoples R China; [Guo, Jin-Jun; Huang, Ali-Long] Chongqing Univ Med Sci, Inst Viral Hepatitis, Minist Educ, Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China; [Mak, Keri; Chung, Sookja K.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Tong, Edith H. Y.; Chung, Stephen S. M.] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chongqing Medical University; University of Hong Kong; University of Hong Kong	Tong, EHY (corresponding author), Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China.	benko@cuhk.edu.hk	Ko, Chi-bun/ACH-7514-2022; Xu, Songxiao/L-5737-2019	Ko, Ben Chi Bun/0000-0003-2027-5899	Research Grant Council [CUHK 7327/04M, CUHK 466108]; Chinese University of Hong Kong Direct [2041317]	Research Grant Council(Hong Kong Research Grants Council); Chinese University of Hong Kong Direct(Chinese University of Hong Kong)	This work was supported by the Research Grant Council Grants CUHK 7327/04M, CUHK 466108 and by the Chinese University of Hong Kong Direct Grant for Research 2041317 ( to B. C. B. K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2001, J BIOL CHEM, V276, P41945, DOI 10.1074/jbc.M108217200; ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Brigotti M, 2003, BIOCHEM J, V369, P369, DOI 10.1042/BJ20021056; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Burg MB, 1996, KIDNEY INT, V49, P1684, DOI 10.1038/ki.1996.247; Burkhart BA, 2007, J BIOL CHEM, V282, P4400, DOI 10.1074/jbc.M609041200; Carey M, 2000, TRANSCRIPTIONAL REGU; Chen XX, 2005, MOL CELL BIOL, V25, P3209, DOI 10.1128/MCB.25.8.3209-3219.2005; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; Irarrazabal CE, 2004, P NATL ACAD SCI USA, V101, P8809, DOI 10.1073/pnas.0403062101; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Katsani KR, 2003, CURR TOP MICROBIOL, V274, P113; Ko BCB, 2000, BIOCHEM BIOPH RES CO, V270, P52, DOI 10.1006/bbrc.2000.2376; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Ko BCB, 1997, J BIOL CHEM, V272, P16431, DOI 10.1074/jbc.272.26.16431; Korber P, 2004, MOL CELL BIOL, V24, P10965, DOI 10.1128/MCB.24.24.10965-10974.2004; Kosuge K, 2007, MOL PHARMACOL, V72, P826, DOI 10.1124/mol.107.034504; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; MAK KM, 2006, 2006 NEUR M PLANN AT; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Na KY, 2003, J AM SOC NEPHROL, V14, P283, DOI 10.1097/01.ASN.0000045050.19544.B2; Nakatani F, 2003, J BIOL CHEM, V278, P15105, DOI 10.1074/jbc.M211470200; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; OwenHughes T, 1996, EMBO J, V15, P4702, DOI 10.1002/j.1460-2075.1996.tb00847.x; PANTAZIS P, 1984, MOL CELL BIOL, V4, P1186, DOI 10.1128/MCB.4.6.1186; Phelan ML, 2000, MOL CELL BIOL, V20, P6380, DOI 10.1128/MCB.20.17.6380-6389.2000; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Reinke H, 2004, BBA-GENE STRUCT EXPR, V1677, P24, DOI 10.1016/j.bbaexp.2003.09.014; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Rim JS, 1998, J BIOL CHEM, V273, P20615, DOI 10.1074/jbc.273.32.20615; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Stroud JC, 2002, NAT STRUCT BIOL, V9, P90, DOI 10.1038/nsb749; TAKENAKA M, 1994, J BIOL CHEM, V269, P29379; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tong EHY, 2006, J BIOL CHEM, V281, P23870, DOI 10.1074/jbc.M602556200; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Waldegger S, 1998, NEPHROL DIAL TRANSPL, V13, P867, DOI 10.1093/ndt/13.4.867; Wang Y, 2005, J BIOL CHEM, V280, P19986, DOI 10.1074/jbc.M501689200; Warskulat U, 2004, J INVEST DERMATOL, V123, P516, DOI 10.1111/j.0022-202X.2004.23313.x; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Xu SX, 2008, J BIOL CHEM, V283, P17624, DOI 10.1074/jbc.M800281200; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhou XM, 2006, AM J PHYSIOL-RENAL, V290, pF1169, DOI 10.1152/ajprenal.00378.2005	71	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8435	10.1371/journal.pone.0008435	http://dx.doi.org/10.1371/journal.pone.0008435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041176	Green Published, gold, Green Submitted			2022-12-25	WOS:000273104000005
J	Wang, YH; Ghoshal, S; Ward, M; de Villiers, W; Woodward, J; Eckhardt, E				Wang, Yuehui; Ghoshal, Sarbani; Ward, Martin; de Villiers, Willem; Woodward, Jerold; Eckhardt, Erik			Chylomicrons Promote Intestinal Absorption and Systemic Dissemination of Dietary Antigen (Ovalbumin) in Mice	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNE-SYSTEM; IN-VIVO; RETINOIC ACID; EMULSIFYING PROPERTIES; TOLERANCE INDUCTION; DENSITY-LIPOPROTEIN; SECRETION; MACROPHAGES; INHIBITION	Background: A small fraction of dietary protein survives enzymatic degradation and is absorbed in potentially antigenic form. This can trigger inflammatory responses in patients with celiac disease or food allergies, but typically induces systemic immunological tolerance (oral tolerance). At present it is not clear how dietary antigens are absorbed. Most food staples, including those with common antigens such as peanuts, eggs, and milk, contain long-chain triglycerides (LCT), which stimulate mesenteric lymph flux and postprandial transport of chylomicrons through mesenteric lymph nodes (MLN) and blood. Most dietary antigens, like ovalbumin (OVA), are emulsifiers, predicting affinity for chylomicrons. We hypothesized that chylomicron formation promotes intestinal absorption and systemic dissemination of dietary antigens. Methodology/Principal Findings: Absorption of OVA into MLN and blood was significantly enhanced when OVA was gavaged into fasted mice together with LCT compared with medium-chain triglycerides (MCT), which do not stimulate chylomicron formation. The effect of LCT was blocked by the addition of an inhibitor of chylomicron secretion, Pluronic L-81. Adoptively transferred OVA-specific DO11.10 T-cells proliferated more extensively in peripheral lymph nodes when OVA was gavaged with LCT than with MCT or LCT plus Pluronic L-81, suggesting that dietary OVA is systemically disseminated. Most dietary OVA in plasma was associated with chylomicrons, suggesting that these particles mediate systemic antigen dissemination. Intestinal-epithelial CaCo-2 cells secreted more cell-associated, exogenous OVA when stimulated with oleic-acid than with butyric acid, and the secreted OVA appeared to be associated with chylomicrons. Conclusions/Significance: Postprandial chylomicron formation profoundly affects absorption and systemic dissemination of dietary antigens. The fat content of a meal may affect immune responses to dietary antigens by modulating antigen absorption and transport.	[Wang, Yuehui; Ghoshal, Sarbani; de Villiers, Willem; Eckhardt, Erik] Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA; [Wang, Yuehui; Ghoshal, Sarbani; de Villiers, Willem; Eckhardt, Erik] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY USA; [Ward, Martin; Woodward, Jerold] Univ Kentucky, Dept Microbiol Immunol & Mol Med, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Wang, YH (corresponding author), Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA.	Erik.eckhardt@uky.edu	Eckhardt, Erik/G-1567-2010; WANG, YUE/GWQ-9256-2022	Eckhardt, Erik/0000-0002-3015-5180	NIH [1P20RR021954-01A2, 1R21EY018952-01A1]; Science and Technology Facilities Council [ST/F002963/1] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY018952] Funding Source: NIH RePORTER; STFC [ST/F002963/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by NIH grants 1P20RR021954-01A2 ( E. E.) and 1R21EY018952-01A1 (J.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspenstrom-Fagerlund B, 2007, TOXICOLOGY, V237, P12, DOI 10.1016/j.tox.2007.04.014; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; Egan RM, 2000, J IMMUNOL, V164, P4543, DOI 10.4049/jimmunol.164.9.4543; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Elsegood CL, 2006, ATHEROSCLEROSIS, V188, P251, DOI 10.1016/j.atherosclerosis.2005.10.043; Fatma S, 2006, J LIPID RES, V47, P2422, DOI 10.1194/jlr.M600211-JLR200; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; HARRIS HW, 1993, J CLIN INVEST, V91, P1028, DOI 10.1172/JCI116259; Harrison EH, 2001, J NUTR, V131, P1405, DOI 10.1093/jn/131.5.1405; Hathaway LJ, 2000, CELL MOL LIFE SCI, V57, P323, DOI 10.1007/PL00000693; Heyman M, 2001, P NUTR SOC, V60, P419, DOI 10.1079/PNS2001117; Hortin GL, 2006, BIOCHEM BIOPH RES CO, V340, P909, DOI 10.1016/j.bbrc.2005.12.098; Hundorfean G, 2007, AM J PHYSIOL-GASTR L, V293, pG798, DOI 10.1152/ajpgi.00135.2007; Hussain MM, 2005, CURR OPIN LIPIDOL, V16, P281, DOI 10.1097/01.mol.0000169347.53568.5a; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; KARPE F, 1995, ARTERIOSCL THROM VAS, V15, P199, DOI 10.1161/01.ATV.15.2.199; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KVIETYS PR, 1991, AM J PHYSIOL, V261, pG384, DOI 10.1152/ajpgi.1991.261.3.G384; Luchoomun J, 1999, J BIOL CHEM, V274, P19565, DOI 10.1074/jbc.274.28.19565; LUSAS EW, 1979, J AM OIL CHEM SOC, V56, P425, DOI 10.1007/BF02671530; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MADARA JL, 1990, J MEMBRANE BIOL, V116, P177, DOI 10.1007/BF01868675; Mallegol J, 2007, GASTROENTEROLOGY, V132, P1866, DOI 10.1053/j.gastro.2007.02.043; Mamo JCL, 1996, BIOCHEMISTRY-US, V35, P10210, DOI 10.1021/bi960188s; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; MINE Y, 1991, J AGR FOOD CHEM, V39, P443, DOI 10.1021/jf00003a003; MIURA S, 1993, IMMUNOLOGY, V78, P142; Miura S, 1998, J GASTROEN HEPATOL, V13, P1183, DOI 10.1046/j.1440-1746.1998.01782.x; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nayak N, 2001, J LIPID RES, V42, P272; Pantoja-Uceda D, 2004, BIOCHEMISTRY-US, V43, P6976, DOI 10.1021/bi0496900; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; SHIMIZU M, 1983, J AGR FOOD CHEM, V31, P1214, DOI 10.1021/jf00120a018; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; TSO P, 1981, AM J PHYSIOL, V241, pG487, DOI 10.1152/ajpgi.1981.241.6.G487; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Van Niel G, 2003, GUT, V52, P1690, DOI 10.1136/gut.52.12.1690; Vreugdenhil ACE, 2003, J IMMUNOL, V170, P1399, DOI 10.4049/jimmunol.170.3.1399; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	40	41	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8442	10.1371/journal.pone.0008442	http://dx.doi.org/10.1371/journal.pone.0008442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041190	Green Published, gold, Green Submitted			2022-12-25	WOS:000273104000008
J	Niederstatter, H; Parson, W				Niederstaetter, Harald; Parson, Walther			Fluorescent Duplex Allele-Specific PCR and Amplicon Melting for Rapid Homogeneous mtDNA Haplogroup H Screening and Sensitive Mixture Detection	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HUMAN MITOCHONDRIAL-DNA; REAL-TIME PCR; SYBR-GREEN-I; CONTROL REGION; POINT MUTATION; HIGH-FREQUENCY; GENOMIC DNA; AMPLIFICATION; HETEROPLASMY	Background: For large scale studies aiming at a better understanding of mitochondrial DNA (mtDNA), sequence variation in particular mt haplogroups (hgs) and population structure, reliable low-cost high-throughput genotyping assays are needed. Furthermore, methods facilitating sensitive mixture detection and relative quantification of allele proportions are indispensable for the study of heteroplasmy, mitochondrial sequence evolution, and mitochondrial disorders. Here the properties of a homogeneous competitive duplex allele specific PCR (ARMS) assay were scrutinized in the light of these requirements. Methodology/Principal Findings: A duplex ARMS assay amplifying either the ancestral mtDNA 2706G allele (non-hg H samples) or the derived 7028C allele (hg H samples) in the presence of SYBR Green fluorescent reporter dye was developed and characterized. Product detection, allele calling, and hg inference were based on the amplicon-characteristic melting-point temperatures obtained with on-line post-PCR fluorescent dissociation curve analysis (DCA). The analytical window of the assay covered at least 5 orders of magnitude of template DNA input with a detection limit in the low picogram range of genomic DNA. A set of forensically relevant test specimens was analyzed successfully. The presence of mtDNA mixtures was detected over a broad range of input DNA amounts and mixture ratios, and the estimation of allele proportions in samples with known total mtDNA content was feasible with limitations. A qualified DNA analyst successfully analyzed similar to 2,200 DNA extracts within three regular working days, without using robotic lab-equipment. By performing the amplification on-line, the assay also facilitated absolute mtDNA quantification. Conclusions: Although this assay was developed just for a particular purpose, the approach is general in that it is potentially suitable in a broad variety of assay-layouts for many other applications, including the analysis of mixtures. Homogeneous ARMS-DCA is a valuable tool for large-volume studies targeting small numbers of single nucleotide polymorphisms (SNPs).	[Niederstaetter, Harald; Parson, Walther] Innsbruck Med Univ, Inst Legal Med, Innsbruck, Austria	Medical University of Innsbruck	Niederstatter, H (corresponding author), Innsbruck Med Univ, Inst Legal Med, Innsbruck, Austria.	harald.niederstaetter@i-med.ac.at	Parson, Walther/AAD-6845-2020	Parson, Walther/0000-0002-5692-2392				AKANE A, 1994, J FORENSIC SCI, V39, P362; AKTIPIS S, 1975, BIOCHEMISTRY-US, V14, P326, DOI 10.1021/bi00673a019; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Bendall KE, 1997, AM J HUM GENET, V61, P1303, DOI 10.1086/301636; Bergstrom CT, 1998, GENETICS, V149, P2135; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Brandstatter A, 2006, ELECTROPHORESIS, V27, P2541, DOI 10.1002/elps.200500772; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Coble MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004838; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; DEFRANCHIS R, 1988, NUCLEIC ACIDS RES, V16, P10355, DOI 10.1093/nar/16.21.10355; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Erali M, 2006, CLIN CHEM, V52, P1443, DOI 10.1373/clinchem.2006.068510; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; FERRIE RM, 1992, AM J HUM GENET, V51, P251; Friedlaender J, 2005, MOL BIOL EVOL, V22, P1506, DOI 10.1093/molbev/msi142; Giglio S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng135; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; Gundry CN, 2008, NUCLEIC ACIDS RES, V36, P3401, DOI 10.1093/nar/gkn204; Hedman J, 2009, BIOTECHNIQUES, V47, P951, DOI 10.2144/000113246; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; Irwin JA, 2009, J MOL EVOL, V68, P516, DOI 10.1007/s00239-009-9227-4; Kermekchiev MB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1055; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kline MC, 2005, J FORENSIC SCI, V50, P571; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; Little S, 1995, CURRENT PROTOCOLS HU; Loreille OM, 2007, FORENSIC SCI INT-GEN, V1, P191, DOI 10.1016/j.fsigen.2007.02.006; MICHAELS GS, 1982, DEV BIOL, V94, P246, DOI 10.1016/0012-1606(82)90088-4; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moreau V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp661; Mulero JJ, 2008, J FORENSIC SCI, V53, P838, DOI 10.1111/j.1556-4029.2008.00760.x; Nath K, 2000, J BIOCHEM BIOPH METH, V42, P15, DOI 10.1016/S0165-022X(99)00033-0; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Niederstatter H, 2007, FORENSIC SCI INT-GEN, V1, P29, DOI 10.1016/j.fsigen.2006.10.007; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Parson W, 2004, HUM MUTAT, V24, P474, DOI 10.1002/humu.20101; Parson W, 2007, FORENSIC SCI INT-GEN, V1, P88, DOI 10.1016/j.fsigen.2007.01.018; Pereira L, 2006, FORENSIC SCI INT, V159, P43, DOI 10.1016/j.forsciint.2005.06.008; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Ruiz-Ponte C, 2000, CLIN CHEM, V46, P1574; Salas A, 2001, INT J LEGAL MED, V114, P186, DOI 10.1007/s004140000164; Santos C, 2008, J MOL EVOL, V67, P191, DOI 10.1007/s00239-008-9138-9; Schon EA, 2003, GENETICS MITOCHONDRI, P111; Seipp MT, 2008, CLIN CHEM, V54, P108, DOI 10.1373/clinchem.2007.097121; SOLIGNAC M, 1983, P NATL ACAD SCI-BIOL, V80, P6942, DOI 10.1073/pnas.80.22.6942; SOMMER SS, 1992, BIOTECHNIQUES, V12, P82; Sutlovic D, 2005, CROAT MED J, V46, P556; Tully LA, 2000, AM J HUM GENET, V67, P432, DOI 10.1086/302996; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757; Zhidkov I, 2009, GENOME RES, V19, P576, DOI 10.1101/gr.086462.108	63	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8374	10.1371/journal.pone.0008374	http://dx.doi.org/10.1371/journal.pone.0008374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020064	gold, Green Published, Green Submitted			2022-12-25	WOS:000272870600013
J	Lee, JY; Lee, YG; Lee, J; Yang, KJ; Kim, AR; Kim, JY; Won, MH; Park, J; Yoo, BC; Kim, S; Cho, WJ; Cho, JY				Lee, Ji Yeon; Lee, Yong Gyu; Lee, Jaehwi; Yang, Keum-Jin; Kim, Ae Ra; Kim, Joo Young; Won, Moo-Ho; Park, Jongsun; Yoo, Byong Chul; Kim, Sanghee; Cho, Won-Jea; Cho, Jae Youl			Akt Cys-310-targeted Inhibition by Hydroxylated Benzene Derivatives Is Tightly Linked to Their Immunosuppressive Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; MACROPHAGE INFLAMMATORY RESPONSE; NITRIC-OXIDE PRODUCTION; TYROSINE PHOSPHORYLATION; PHENOLIC ANTIOXIDANTS; REACTIVE METABOLITE; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; HYDROQUINONE	The hydroxylated benzene metabolite hydroquinone (HQ) is mainly generated from benzene, an important industrial chemical, and is also a common dietary component. Although numerous reports have addressed the tumorigenesis-inducing effects of HQ, few papers have explored its molecular regulatory mechanism in immunological responses. In this study we characterized Akt (protein kinase B)-targeted regulation by HQ and its derivatives, in suppressing inflammatory responses using cellular, molecular, biochemical, and immunopharmacological approaches. HQ down-regulated inflammatory responses such as NO production, surface levels of pattern recognition receptors, and cytokine gene expression with IC50 values that ranged from 5 to 10 mu M. HQ inhibition was mediated by blocking NF-kappa B activation via suppression of its translocation pathway, which is composed of Akt, I kappa B alpha kinase beta, and I kappa B alpha. Of the targets in this pathway, HQ directly targeted and bound to the sulfhydryl group of Cys-310 of Akt and sequentially interrupted the phosphorylation of both Thr-308 and Ser-473 by mediation of beta-mercaptoethanol, according to the liquid chromatography/mass spectroscopy analysis of the interaction of HQ with an Akt-derived peptide. Therefore, our data suggest that Akt and its target site Cys-310 can be considered as a prime molecular target of HQ-mediated immunosuppression and for novel anti Akt-targeted immunosuppressive drugs.	[Lee, Ji Yeon; Lee, Yong Gyu; Kim, Ae Ra; Kim, Joo Young; Cho, Jae Youl] Kangwon Natl Univ, Sch Biosci & Biotechnol, Chunchon 200701, South Korea; [Lee, Ji Yeon; Lee, Yong Gyu; Kim, Ae Ra; Kim, Joo Young; Cho, Jae Youl] Kangwon Natl Univ, Inst Biosci & Biotechnol, Chunchon 200701, South Korea; [Lee, Jaehwi] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Yang, Keum-Jin; Park, Jongsun] Chungnam Natl Univ, Dept Pharmacol, Daejeon Reg Canc Ctr, Canc Res Inst,Coll Med, Taejon 310010, South Korea; [Won, Moo-Ho] Hallym Univ, Coll Med, Dept Anat & Neurobiol, Chucheon 200702, South Korea; [Won, Moo-Ho] Hallym Univ, Coll Med, Inst Neurodegenerat & Neuroregenerat, Chucheon 200702, South Korea; [Kim, Sanghee] Seoul Natl Univ, Coll Pharm, Seoul 151741, South Korea; [Yoo, Byong Chul] Natl Canc Ctr, Res Inst & Hosp, Goyang 410769, South Korea; [Cho, Won-Jea] Chonnam Natl Univ, Coll Pharm, Kwangju 500757, South Korea	Kangwon National University; Kangwon National University; Chung Ang University; Chungnam National University; Hallym University; Hallym University; Seoul National University (SNU); National Cancer Center - Korea (NCC); Chonnam National University	Cho, JY (corresponding author), Kangwon Natl Univ, Sch Biosci & Biotechnol, 192-1 Hyoja 2 Dong, Chunchon 200701, South Korea.	jaecho@kangwon.ac.kr	Park, Jongsun/E-7465-2010	Park, Jongsun/0000-0002-4690-1854; Kim, Sanghee/0000-0001-9125-9541	Ministry of Commerce, Industry and Energy (MOCIE); Korea Industrial Technology Foundation (KOTEF) through the Human Resource Training Project for Regional Innovation	Ministry of Commerce, Industry and Energy (MOCIE)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Industrial Technology Foundation (KOTEF) through the Human Resource Training Project for Regional Innovation	This work was supported by the Ministry of Commerce, Industry and Energy (MOCIE) and Korea Industrial Technology Foundation (KOTEF) through the Human Resource Training Project for Regional Innovation (to J.Y.C.).	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Boatman RJ, 2004, ARCH TOXICOL, V78, P443, DOI 10.1007/s00204-004-0563-2; Butchar JP, 2006, CURR PHARM DESIGN, V12, P4143, DOI 10.2174/138161206778743574; Byeon SE, 2008, J MICROBIOL BIOTECHN, V18, P1984, DOI 10.4014/jmb.0800.189; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Cho JY, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/298010; Cho JY, 2004, PHARMACOL RES, V49, P423, DOI 10.1016/j.phrs.2003.11.003; Cho JY, 2000, BIOL PHARM BULL, V23, P1243; Choi JM, 2008, ARCH PHARM RES, V31, P337, DOI 10.1007/s12272-001-1161-1; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Donald A, 2007, J MED CHEM, V50, P2289, DOI 10.1021/jm0700924; Enkvist E, 2006, J MED CHEM, V49, P7150, DOI 10.1021/jm0605942; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hartnett JC, 2008, BIOORG MED CHEM LETT, V18, P2194, DOI 10.1016/j.bmcl.2007.12.040; Heerding DA, 2008, J MED CHEM, V51, P5663, DOI 10.1021/jm8004527; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jeong SJ, 2005, ONCOGENE, V24, P6719, DOI 10.1038/sj.onc.1208825; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Jung KK, 2006, LIFE SCI, V79, P2022, DOI 10.1016/j.lfs.2006.06.048; Kim AR, 2005, J PHARM PHARMACOL, V57, P475, DOI 10.1211/0022357055731; Kim BH, 2008, ACTA PHARMACOL SIN, V29, P113, DOI 10.1111/j.1745-7254.2008.00725.x; Kim E, 2005, IMMUNOL LETT, V99, P24, DOI 10.1016/j.imlet.2004.11.025; Kleiner HE, 1998, CHEM RES TOXICOL, V11, P1283, DOI 10.1021/tx980134e; Kobori M, 2007, BRIT J PHARMACOL, V150, P209, DOI 10.1038/sj.bjp.0706972; KOSHIHARA Y, 1988, BIOCHEM PHARMACOL, V37, P2161, DOI 10.1016/0006-2952(88)90576-X; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; LAU SS, 1995, DRUG METAB DISPOS, V23, P1136; LEE BL, 1993, J CHROMATOGR-BIOMED, V619, P259, DOI 10.1016/0378-4347(93)80115-K; Lee JY, 2008, N-S ARCH PHARMACOL, V377, P111, DOI 10.1007/s00210-008-0266-y; Lee MH, 2002, IMMUNOLOGY, V106, P496, DOI 10.1046/j.1365-2567.2002.01451.x; Lee YG, 2008, BRIT J PHARMACOL, V154, P852, DOI 10.1038/bjp.2008.136; Lee YG, 2009, INT J BIOCHEM CELL B, V41, P811, DOI 10.1016/j.biocel.2008.08.011; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Li Q, 1996, TOXICOL APPL PHARM, V139, P317, DOI 10.1006/taap.1996.0171; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Ma Q, 2003, MOL PHARMACOL, V64, P211, DOI 10.1124/mol.64.2.211; Ma Q, 2002, J BIOL CHEM, V277, P2477, DOI 10.1074/jbc.M106685200; Malyshev I. Yu., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P1, DOI 10.2174/1568008033340342; MANNING BW, 1994, TOXICOL APPL PHARM, V126, P214, DOI 10.1006/taap.1994.1110; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Motobu M, 2006, PHYTOTHER RES, V20, P359, DOI 10.1002/ptr.1860; Ozes ON, 1999, NATURE, V401, P82; Palaniyar N, 2002, IMMUNOBIOLOGY, V205, P575, DOI 10.1078/0171-2985-00156; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; Poet TS, 2004, TOXICOL SCI, V82, P9, DOI 10.1093/toxsci/kfh229; Pyatt DW, 2000, CELL BIOL TOXICOL, V16, P41, DOI 10.1023/A:1007644620655; Qureshi N, 2005, IMMUNOL RES, V31, P243, DOI 10.1385/IR:31:3:243; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Rouse MB, 2009, BIOORG MED CHEM LETT, V19, P1508, DOI 10.1016/j.bmcl.2009.01.002; Sethi G, 2008, BIOCHEM PHARMACOL, V76, P1404, DOI 10.1016/j.bcp.2008.05.023; Shao D, 2008, INFLAMM RES, V57, P601, DOI 10.1007/s00011-008-8053-2; Toral-Barza L, 2007, MOL CANCER THER, V6, P3028, DOI 10.1158/1535-7163.MCT-07-0211; Weichhart T, 2008, ANN RHEUM DIS, V67, P70, DOI 10.1136/ard.2008.098459; Xu WR, 2004, ONCOL REP, V12, P501; Yang HC, 2007, ARCH PHARM RES, V30, P955, DOI 10.1007/BF02993963; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200; Yoo ES, 2004, J PHARM PHARMACOL, V56, P503, DOI 10.1211/0022357023042; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x	62	55	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9932	9948		10.1074/jbc.M109.074872	http://dx.doi.org/10.1074/jbc.M109.074872			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20054000	Green Published, hybrid			2022-12-25	WOS:000276165900063
J	Ochi, A; Makabe, K; Kuwajima, K; Hori, H				Ochi, Anna; Makabe, Koki; Kuwajima, Kunihiro; Hori, Hiroyuki			Flexible Recognition of the tRNA G18 Methylation Target Site by TrmH Methyltransferase through First Binding and Induced Fit Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEEP TREFOIL KNOT; ACID-SEQUENCE MOTIFS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; AQUIFEX-AEOLICUS; GM18 METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; ACTIVE-SITE; PROTEIN; ENZYME	Transfer RNA (Gm18) methyltransferase (TrmH) catalyzes methyl transfer from S-adenosyl-L-methionine to a conserved G18 in tRNA. We investigated the recognition mechanism of Thermus thermophilus TrmH for its guanosine target. Thirteen yeast tRNAPhe mutant transcripts were prepared in which the modification site and/or other nucleotides in the D-loop were substituted by dG, inosine, or other nucleotides. We then conducted methyl transfer kinetic studies, gel shift assays, and inhibition experiments using these tRNA variants. Sites of methylation were confirmed with RNA sequencing or primer extension. Although the G18G19 sequence is not essential for methylation by TrmH, disruption of G18G19 severely reduces the efficiency of methyl transfer. There is strict recognition of guanosine by TrmH, in that methylation occurs at the adjacent G19 when the G18 is replaced by dG or adenosine. The fact that TrmH methylates guanosine in D-loops from 4 to 12 nucleotides in length suggests that selection of the position of guanosine within the D-loop is relatively flexible. Our studies also demonstrate that the oxygen 6 atom of the guanine base is a positive determinant for TrmH recognition. The recognition process of TrmH for substrate is inducible and product-inhibited, in that tRNAs containing Gm18 are excluded by TrmH. In contrast, substitution of G18 with dG18 results in the formation of a more stable TrmH-tRNA complex. To address the mechanism, we performed the stopped-flow pre-steady state kinetic analysis. The result clearly showed that the binding of TrmH to tRNA is composed of at least three steps, the first bi-molecular binding and the subsequent two uni-molecular induced-fit processes.	[Ochi, Anna; Hori, Hiroyuki] Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Matsuyama, Ehime 7908577, Japan; [Hori, Hiroyuki] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; [Makabe, Koki; Kuwajima, Kunihiro] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Makabe, Koki; Kuwajima, Kunihiro] Inst Mol Sci, Okazaki, Aichi 4448787, Japan	Ehime University; Ehime University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Hori, H (corresponding author), Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Bunkyo 3, Matsuyama, Ehime 7908577, Japan.	hori@eng.ehime-u.ac.jp	Hori, Hiroyuki/AAB-3911-2021		Japan Society for the Promotion of Science [21-10011, 20034041, 19350087]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Research Fellowship for Young Scientists 21-10011 (to A.O.), Grant-in-aid for Science Research on Priority Areas 20034041 (to H. H.), and Grant-in-aid for Science Research 19350087 (to H. H.) from the Japan Society for the Promotion of Science.	Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269; Alsallaq R, 2008, PROTEINS, V71, P320, DOI 10.1002/prot.21679; Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; BRISSETTE P, 1989, ANAL BIOCHEM, V181, P234, DOI 10.1016/0003-2697(89)90235-2; BYSTROM AS, 1982, MOL GEN GENET, V188, P440, DOI 10.1007/BF00330046; Cavaille J, 1999, RNA, V5, P66, DOI 10.1017/S1355838299981475; Chitester BJ, 2002, ARCH BIOCHEM BIOPHYS, V406, P73, DOI 10.1016/S0003-9861(02)00409-5; Christian T, 2004, J MOL BIOL, V339, P707, DOI 10.1016/j.jmb.2004.04.025; Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010; DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; Elkins PA, 2003, J MOL BIOL, V333, P931, DOI 10.1016/j.jmb.2003.09.011; Forouhar F, 2003, PROTEINS, V53, P329, DOI 10.1002/prot.10510; GARCIA GR, 1998, MODIFICATION EDITING, P555; Goto-Ito S, 2008, PROTEINS, V72, P1274, DOI 10.1002/prot.22019; Gustafsson C, 1996, NUCLEIC ACIDS RES, V24, P3756, DOI 10.1093/nar/24.19.3756; HOLMES WM, 1992, J BIOL CHEM, V267, P13440; Hori H, 2003, J BIOL CHEM, V278, P25081, DOI 10.1074/jbc.M212577200; HORI H, 1989, J BIOCHEM-TOKYO, V106, P798, DOI 10.1093/oxfordjournals.jbchem.a122933; Hori H, 2002, GENES CELLS, V7, P259, DOI 10.1046/j.1365-2443.2002.00520.x; Hori H, 1998, J BIOL CHEM, V273, P25721, DOI 10.1074/jbc.273.40.25721; KEITH G, 1995, BIOCHIMIE, V77, P142, DOI 10.1016/0300-9084(96)88118-1; KIM SH, 1974, P NATL ACAD SCI USA, V71, P4970, DOI 10.1073/pnas.71.12.4970; KOREN R, 1976, BIOCHEMISTRY-US, V15, P1165, DOI 10.1021/bi00650a032; KUMAGAI I, 1982, J BIOL CHEM, V257, P7388; Kuratani M, 2008, J MOL BIOL, V375, P1064, DOI 10.1016/j.jmb.2007.11.023; Lim K, 2003, PROTEINS, V51, P56, DOI 10.1002/prot.10323; Liu JY, 2003, PROTEINS, V53, P326, DOI 10.1002/prot.10479; Mosbacher TG, 2005, J MOL BIOL, V345, P535, DOI 10.1016/j.jmb.2004.10.051; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; Nureki O, 2002, ACTA CRYSTALLOGR D, V58, P1129, DOI 10.1107/S0907444902006601; Okamoto H, 2004, J BIOL CHEM, V279, P49151, DOI 10.1074/jbc.M408209200; Persson BC, 1997, NUCLEIC ACIDS RES, V25, P4093, DOI 10.1093/nar/25.20.4093; Pleshe E, 2005, ACTA CRYSTALLOGR F, V61, P722, DOI 10.1107/S1744309105022980; Purta E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-23; Redlak M, 1997, BIOCHEMISTRY-US, V36, P8699, DOI 10.1021/bi9701538; Renalier MH, 2005, RNA, V11, P1051, DOI 10.1261/rna.2110805; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Takeda H, 2006, GENES CELLS, V11, P1353, DOI 10.1111/j.1365-2443.2006.01022.x; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Urbonavicius J, 2002, J BACTERIOL, V184, P5348, DOI 10.1128/JB.184.19.5348-5357.2002; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Watanabe K, 2006, J BIOL CHEM, V281, P34630, DOI 10.1074/jbc.M606141200; Zarembinski TI, 2003, PROTEINS, V50, P177, DOI 10.1002/prot.10311	46	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9018	9029		10.1074/jbc.M109.065698	http://dx.doi.org/10.1074/jbc.M109.065698			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20053984	hybrid, Green Published			2022-12-25	WOS:000275553700053
J	Sawada, K; Ariki, S; Kojima, T; Saito, A; Yamazoe, M; Nishitani, C; Shimizu, T; Takahashi, M; Mitsuzawa, H; Yokota, S; Sawada, N; Fujii, N; Takahashi, H; Kuroki, Y				Sawada, Kaku; Ariki, Shigeru; Kojima, Takashi; Saito, Atsushi; Yamazoe, Masami; Nishitani, Chiaki; Shimizu, Takeyuki; Takahashi, Motoko; Mitsuzawa, Hiroaki; Yokota, Shin-ichi; Sawada, Norimasa; Fujii, Nobuhiro; Takahashi, Hiroki; Kuroki, Yoshio			Pulmonary Collectins Protect Macrophages against Pore-forming Activity of Legionella pneumophila and Suppress Its Intracellular Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; LEGIONNAIRES-DISEASE; SURFACTANT PROTEINS; PHAGOSOME TRAFFICKING; ALVEOLAR MACROPHAGES; CELLULAR-RESPONSE; D BINDS; PHAGOCYTOSIS; BACTERIUM; PHOSPHATIDYLINOSITOL	Pulmonary collectins, surfactant proteins A (SP-A) and D (SP-D), play important roles in innate immunity of the lung. Legionella pneumophila is a bacterial respiratory pathogen that can replicate within macrophages and causes opportunistic infections. L. pneumophila possesses cytolytic activity, resulting from insertion of pores in the macrophage membrane upon contact. We examined whether pulmonary collectins play protective roles against L. pneumophila infection. SP-A and SP-D bound to L. pneumophila and its lipopolysaccharide (LPS) and inhibited the bacterial growth in a Ca2+-dependent manner. The addition of LPS in the culture blocked the inhibitory effects on L. pneumophila growth by the collectins, indicating the importance of LPS-collectin interaction. When differentiated THP-1 cells were infected with L. pneumophila in the presence of SP-A and SP-D, the number of permeable cells was significantly decreased, indicating that pulmonary collectins inhibit pore-forming activity of L. pneumophila. The number of live bacteria within the macrophages on days 1-4 after infection was significantly decreased when infection was performed in the presence of pulmonary collectins. The phagocytosis experiments with the pH-sensitive dye-labeled bacteria revealed that pulmonary collectins promoted bacterial localization to an acidic compartment. In addition, SP-A and SP-D significantly increased the number of L. pneumophila co-localized with LAMP-1. These results indicate that pulmonary collectins protect macrophages against contact-dependent cytolytic activity of L. pneumophila and suppress intracellular growth of the phagocytosed bacteria. The promotion of lysosomal fusion with Legionella-containing phagosomes constitutes a likely mechanism of L. pneumophila growth suppression by the collectins.	[Kuroki, Yoshio] Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Kojima, Takashi; Sawada, Norimasa] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido 0608556, Japan; [Yokota, Shin-ichi; Fujii, Nobuhiro] Sapporo Med Univ, Sch Med, Dept Microbiol, Sapporo, Hokkaido 0608556, Japan; [Mitsuzawa, Hiroaki] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido 0608556, Japan; [Sawada, Kaku; Saito, Atsushi; Yamazoe, Masami; Takahashi, Hiroki] Sapporo Med Univ, Sch Med, Dept Internal Med 3, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Kuroki, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	kurokiy@sapmed.ac.jp	Saito, Atsushi/M-7382-2018; Yokota, Shin-ichi/K-8139-2019; Ariki, Shigeru/E-3861-2014; Takahashi, Motoko/I-3154-2013	Saito, Atsushi/0000-0003-3430-884X; Yokota, Shin-ichi/0000-0002-0831-3429; Ariki, Shigeru/0000-0001-5838-499X; Takahashi, Motoko/0000-0002-2112-6142	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20790574, 20390232, 19041062]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 20790574 (to S. A.) and 20390232 and 19041062 (to Y.K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	AUSBEL FM, 1992, CURRENT PROTOCOLS MO; BASTACKY J, 1995, J APPL PHYSIOL, V79, P1615, DOI 10.1152/jappl.1995.79.5.1615; BAUGHMAN RP, 1993, AM REV RESPIR DIS, V147, P653, DOI 10.1164/ajrccm/147.3.653; Beharka AA, 2002, J IMMUNOL, V169, P3565, DOI 10.4049/jimmunol.169.7.3565; Chiba H, 1999, BIOCHEMISTRY-US, V38, P7321, DOI 10.1021/bi990353e; DAY AJ, 1994, BIOCHEM SOC T, V22, P83, DOI 10.1042/bst0220083; Ferguson JS, 1999, J IMMUNOL, V163, P312; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; GEERTSMA MF, 1994, AM J PHYSIOL-LUNG C, V267, pL578, DOI 10.1152/ajplung.1994.267.5.L578; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860, DOI 10.1164/ajrccm.152.6.8520747; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Kabha K, 1997, AM J PHYSIOL-LUNG C, V272, pL344, DOI 10.1152/ajplung.1997.272.2.L344; KAUFMANN AF, 1981, AM J EPIDEMIOL, V114, P337, DOI 10.1093/oxfordjournals.aje.a113200; Kirby JE, 1998, MOL MICROBIOL, V27, P323, DOI 10.1046/j.1365-2958.1998.00680.x; Kudo K, 2004, J IMMUNOL, V172, P7592, DOI 10.4049/jimmunol.172.12.7592; KUROKI Y, 1985, BIOCHIM BIOPHYS ACTA, V836, P201; KUROKI Y, 1994, J BIOL CHEM, V269, P25943; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; Kuronuma K, 2004, J BIOL CHEM, V279, P21421, DOI 10.1074/jbc.M312490200; LeVine AM, 1997, J IMMUNOL, V158, P4336; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; MARRA A, 1992, P NATL ACAD SCI USA, V89, P9607, DOI 10.1073/pnas.89.20.9607; McCormack FX, 2003, J BIOL CHEM, V278, P36250, DOI 10.1074/jbc.M303086200; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; McIntosh JC, 1996, AM J RESP CELL MOL, V15, P509, DOI 10.1165/ajrcmb.15.4.8879185; Murakami S, 2002, J BIOL CHEM, V277, P6830, DOI 10.1074/jbc.M106671200; Nagae H, 1997, CLIN CHIM ACTA, V266, P157, DOI 10.1016/S0009-8981(97)00124-1; Nie XM, 2008, BIOCHEMISTRY-US, V47, P12878, DOI 10.1021/bi8010175; Ohya M, 2006, BIOCHEMISTRY-US, V45, P8657, DOI 10.1021/bi060176z; PHELPS DS, 1991, AM REV RESPIR DIS, V143, P1072, DOI 10.1164/ajrccm/143.5_Pt_1.1072; Piboonpocanun S, 2005, J BIOL CHEM, V280, P9, DOI 10.1074/jbc.M411570200; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; Sano H, 1999, J IMMUNOL, V163, P387; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Shin S, 2008, CELL MICROBIOL, V10, P1209, DOI 10.1111/j.1462-5822.2008.01145.x; Tino MJ, 1999, AM J PHYSIOL-LUNG C, V276, pL164, DOI 10.1152/ajplung.1999.276.1.L164; Tino MJ, 1996, AM J PHYSIOL-LUNG C, V270, pL677, DOI 10.1152/ajplung.1996.270.4.L677; UCHIDA K, 1987, AGR BIOL CHEM TOKYO, V51, P3107; VANDEGRAAF EA, 1992, J LAB CLIN MED, V120, P252; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	49	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8434	8443		10.1074/jbc.M109.074765	http://dx.doi.org/10.1074/jbc.M109.074765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20056602	Green Published, hybrid			2022-12-25	WOS:000275413800058
J	Aloia, L; Parisi, S; Fusco, L; Pastore, L; Russo, T				Aloia, Luigi; Parisi, Silvia; Fusco, Ludovico; Pastore, Lucio; Russo, Tommaso			Differentiation of Embryonic Stem Cells 1 (Dies1) Is a Component of Bone Morphogenetic Protein 4 (BMP4) Signaling Pathway Required for Proper Differentiation of Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; PLURIPOTENCY; STAT3; ACTIVATION; EXPRESSION; SMAD	Embryonic stem cells (ESCs) are pluripotent cells able to grow indefinitely in culture and to differentiate into all cell types of embryos upon specific stimuli. Molecular mechanisms controlling the unique characteristics of ESCs are still largely unknown. We identified Dies1 (Differentiation of ESCs 1), an unpublished gene, that encodes a type I membrane protein. ESCs stably transfected with Dies1 small hairpin RNAs failed to properly differentiate toward neural and cardiac cell fate upon appropriate stimuli and continued to express markers of undifferentiated cells, such as the membrane-associated alkaline phosphatase, and transcription factors, like Oct3/4 and Nanog, when grown under conditions promoting differentiation. Our results demonstrated that Dies1 is required for BMP4/Smad1 signaling cascade; in undifferentiated ESCs Dies1 knockdown did not affect the expression of leukemia inhibitory factor downstream targets, whereas it resulted in a strong decrease of BMP4 signaling, as demonstrated by the decrease of Id1, -2, and -3 mRNAs, the decreased activity of Id1 gene promoter, and the reduced phospho-Smad1 levels. Dies1 knockdown had no effect in murine ESCs when the expression of the BMP4 receptor Alk3 was suppressed. The phenotype induced by Dies1 suppression in ESCs is due to the indirect activation of the Nodal/Activin pathway, which is a consequence of the BMP4 pathway inhibition and is sufficient to support the mESC undifferentiated state in the absence of leukemia inhibitory factor.	[Fusco, Ludovico; Pastore, Lucio; Russo, Tommaso] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy; [Aloia, Luigi; Parisi, Silvia; Fusco, Ludovico; Pastore, Lucio; Russo, Tommaso] CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [Aloia, Luigi; Parisi, Silvia] European Sch Mol Med SEMM, I-80145 Milan, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate	Russo, T (corresponding author), Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy.	tommaso.russo@unina.it	Pastore, Lucio/F-4668-2010; Pastore, Lucio/AAF-3487-2019; Russo, Tommaso/K-1331-2016	Pastore, Lucio/0000-0001-6894-9317; Russo, Tommaso/0000-0003-4426-0106; Aloia, Luigi/0000-0003-4509-2730	EC-Sirocco Consortium; Associazione Italiana Ricerca sul Cancro; Italian Ministry of Health	EC-Sirocco Consortium; Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by grants from EC-Sirocco Consortium, Associazione Italiana Ricerca sul Cancro, and Italian Ministry of Health.	Aricescu AR, 2007, CURR OPIN CELL BIOL, V19, P543, DOI 10.1016/j.ceb.2007.09.010; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Lee MY, 2009, STEM CELLS, V27, P1858, DOI 10.1002/stem.124; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	26	40	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7776	7783		10.1074/jbc.M109.077156	http://dx.doi.org/10.1074/jbc.M109.077156			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042595	Green Published, hybrid			2022-12-25	WOS:000275415600085
J	Bamberg, CE; Mackay, CR; Lee, H; Zahra, D; Jackson, J; Lim, YS; Whitfeld, PL; Craig, S; Corsini, E; Lu, B; Gerard, C; Gerard, NP				Bamberg, Claire E.; Mackay, Charles R.; Lee, Hyun; Zahra, David; Jackson, Jenny; Lim, Yun Si; Whitfeld, Peter L.; Craig, Stewart; Corsini, Erin; Lu, Bao; Gerard, Craig; Gerard, Norma P.			The C5a Receptor (C5aR) C5L2 Is a Modulator of C5aR-mediated Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYLATION-STIMULATING PROTEIN; BETA-ARRESTIN; 7-TRANSMEMBRANE RECEPTORS; CHEMOATTRACTANT RECEPTOR; HUMAN NEUTROPHILS; COUPLED RECEPTOR; COMPLEMENT C5A; ENDOCYTOSIS; ANAPHYLATOXIN; ACTIVATION	The complement anaphylatoxin C5a is a proinflammatory component of host defense that functions through two identified receptors, C5a receptor (C5aR) and C5L2. C5aR is a classical G protein-coupled receptor, whereas C5L2 is structurally homologous but deficient in G protein coupling. In human neutrophils, we show C5L2 is predominantly intracellular, whereas C5aR is expressed on the plasma membrane. Confocal analysis shows internalized C5aR following ligand binding is co-localized with both C5L2 and beta-arrestin. Antibody blockade of C5L2 results in a dramatic increase in C5a-mediated chemotaxis and ERK1/2 phosphorylation but does not alter C5a-mediated calcium mobilization, supporting its role in modulation of the beta-arrestin pathway. Association of C5L2 with beta-arrestin is confirmed by cellular co-immunoprecipitation assays. C5L2 blockade also has no effect on ligand uptake or C5aR endocytosis in human polymorphonuclear leukocytes, distinguishing its role from that of a rapid recycling or scavenging receptor in this cell type. This is thus the first example of a naturally occurring seven-transmembrane segment receptor that is both obligately uncoupled from G proteins and a negative modulator of signal transduction through the beta-arrestin pathway. Physiologically, these properties provide the possibility for additional fine-tuning of host defense.	[Craig, Stewart; Corsini, Erin; Lu, Bao; Gerard, Craig; Gerard, Norma P.] Harvard Univ, Sch Med, Div Pulm, Dept Pediat,Childrens Hosp, Boston, MA 02115 USA; [Gerard, Norma P.] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Mackay, Charles R.; Lee, Hyun; Zahra, David; Jackson, Jenny; Lim, Yun Si] Garvan Inst Med Res, Immunol & Inflammat Dept, Darlinghurst, NSW 2010, Australia; [Mackay, Charles R.; Whitfeld, Peter L.] G2 Inflammat Pty Ltd, Darlinghurst, NSW 2010, Australia	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Garvan Institute of Medical Research	Gerard, C (corresponding author), 320 Longwood Ave, Boston, MA 02115 USA.	craig.gerard@childrens.harvard.edu; norma.gerard@childrens.harvard.edu	Mackay, Charles R/A-9673-2008; Corsini, Erin/AAG-6248-2020	Mackay, Charles R/0000-0002-6338-7340; Bayley, Erin/0000-0003-4715-0244	National Institutes of Health [HL36162, HL51366]; Medical Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051366, R01HL036162, R37HL036162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL36162 ( to N.P.G.) and HL51366 ( to C. G.). This work was also supported by funding from the Medical Research Council ( to C. R. M.).	BUHL AM, 1994, P NATL ACAD SCI USA, V91, P9190, DOI 10.1073/pnas.91.19.9190; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Cui W, 2007, AM J PHYSIOL-ENDOC M, V293, pE1482, DOI 10.1152/ajpendo.00565.2006; Cui W, 2009, MOL IMMUNOL, V46, P3086, DOI 10.1016/j.molimm.2009.06.007; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Graham GJ, 2006, TRENDS IMMUNOL, V27, P381, DOI 10.1016/j.it.2006.06.006; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Hopken UE, 1997, J EXP MED, V186, P749, DOI 10.1084/jem.186.5.749; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Johswich K, 2007, ADV EXP MED BIOL, V598, P159; Johswich K, 2006, J BIOL CHEM, V281, P39088, DOI 10.1074/jbc.M609734200; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; Kalant D, 2003, J BIOL CHEM, V278, P11123, DOI 10.1074/jbc.M206169200; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MALECH HL, 1977, J CELL BIOL, V75, P666, DOI 10.1083/jcb.75.3.666; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; NOBLE LJ, 1994, J NEUROSCI RES, V38, P654, DOI 10.1002/jnr.490380608; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Perianayagam MC, 2002, KIDNEY INT, V61, P456, DOI 10.1046/j.1523-1755.2002.00139.x; Pruenster M, 2006, BIOCHEM SOC T, V34, P1005, DOI 10.1042/BST0341005; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tsuji RF, 2000, J IMMUNOL, V165, P1588, DOI 10.4049/jimmunol.165.3.1588; Tzafriri AR, 2004, J THEOR BIOL, V229, P127, DOI 10.1016/j.jtbi.2004.03.009; van Lith LHC, 2009, J BIOMOL SCREEN, V14, P1067, DOI 10.1177/1087057109341407; Videm V, 2004, SCAND J IMMUNOL, V59, P25, DOI 10.1111/j.0300-9475.2004.01351.x; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Whistler JL, 2002, TRAFFIC, V3, P866, DOI 10.1034/j.1600-0854.2002.31203.x	41	179	183	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7633	7644		10.1074/jbc.M109.092106	http://dx.doi.org/10.1074/jbc.M109.092106			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20044484	Green Published, hybrid			2022-12-25	WOS:000275415600074
J	Kloer, DP; Rojas, R; Ivan, V; Moriyama, K; van Vlijmen, T; Murthy, N; Ghirlando, R; van der Sluijs, P; Hurley, JH; Bonifacino, JS				Kloer, Daniel P.; Rojas, Raul; Ivan, Viorica; Moriyama, Kengo; van Vlijmen, Thijs; Murthy, Namita; Ghirlando, Rodolfo; van der Sluijs, Peter; Hurley, James H.; Bonifacino, Juan S.			Assembly of the Biogenesis of Lysosome-related Organelles Complex-3 (BLOC-3) and Its Interaction with Rab9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERMANSKY-PUDLAK-SYNDROME; MYOSIN-VA; VESICLE TRAFFICKING; GUNMETAL MOUSE; PROTEIN; GENE; FAMILY; HPS1; MELANOSOMES; TRANSPORT	The Hermansky-Pudlak syndrome (HPS) is a genetic hypopigmentation and bleeding disorder caused by defective biogenesis of lysosome-related organelles (LROs) such as melanosomes and platelet dense bodies. HPS arises from mutations in any of 8 genes in humans and 16 genes in mice. Two of these genes, HPS1 and HPS4, encode components of the biogenesis of lysosome-related organelles complex-3 (BLOC-3). Herein we show that recombinant HPS1-HPS4 produced in insect cells can be efficiently isolated as a 1:1 heterodimer. Analytical ultracentrifugation reveals that this complex has a molecular mass of 146 kDa, equivalent to that of the native complex and to the sum of the predicted molecular masses of HPS1 and HPS4. This indicates that HPS1 and HPS4 interact directly in the absence of any other protein as part of BLOC-3. Limited proteolysis and deletion analyses show that both subunits interact with one another throughout most of their lengths with the sole exception of a long, unstructured loop in the central part of HPS4. An interaction screen reveals a specific and strong interaction of BLOC-3 with the GTP-bound form of the endosomal GTPase, Rab9. This interaction is mediated by HPS4 and the switch I and II regions of Rab9. These characteristics indicate that BLOC-3 might function as a Rab9 effector in the biogenesis of LROs.	[Ghirlando, Rodolfo; Hurley, James H.] NIDDK, NIH, Mol Biol Lab, Bethesda, MD 20892 USA; [Rojas, Raul; Moriyama, Kengo; Murthy, Namita; Bonifacino, Juan S.] Eunice Kennedy Shriver NICHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Ivan, Viorica; van Vlijmen, Thijs; van der Sluijs, Peter] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Utrecht University; Utrecht University Medical Center	Hurley, JH (corresponding author), NIDDK, NIH, Mol Biol Lab, Bldg 50 Rm 4517, Bethesda, MD 20892 USA.	hurley@helix.nih.gov; juan@helix.nih.gov	何, 敏仪/E-6352-2015; van Vlijmen, Thijs/B-4069-2009; Ghirlando, Rodolfo/A-8880-2009	van Vlijmen, Thijs/0000-0002-5882-6660; Bonifacino, Juan S./0000-0002-5673-6370	NICHD; NIDDK; Netherlands' Proteomics Center; DFG-NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007, ZIADK036130] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Netherlands' Proteomics Center; DFG-NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Programs of NICHD (to J. S. B.) and NIDDK (to J. H. H.), the Netherlands' Proteomics Center (to P. v. d. S.), and the DFG-NIH program (to D. P. K.).	Bachli EB, 2004, AM J MED GENET A, V127A, P201, DOI 10.1002/ajmg.a.20683; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Chiang PW, 2003, J BIOL CHEM, V278, P20332, DOI 10.1074/jbc.M300090200; Christoforidis S, 2000, METHODS, V20, P403, DOI 10.1006/meth.2000.0953; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 2000, J BIOL CHEM, V275, P1300, DOI 10.1074/jbc.275.2.1300; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Detter JC, 2000, P NATL ACAD SCI USA, V97, P4144, DOI 10.1073/pnas.080517697; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Espinosa EJ, 2009, CELL, V137, P938, DOI 10.1016/j.cell.2009.03.043; Evans PR, 2002, CURR OPIN STRUC BIOL, V12, P814, DOI 10.1016/S0959-440X(02)00395-0; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; Hoffman-Sommer M, 2005, TRAFFIC, V6, P534, DOI 10.1111/j.1600-0854.2005.00301.x; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Hume AN, 2002, TRAFFIC, V3, P193, DOI 10.1034/j.1600-0854.2002.030305.x; Ito S, 2005, J INVEST DERMATOL, V125, P715, DOI 10.1111/j.0022-202X.2005.23884.x; Kinch LN, 2006, PROTEIN SCI, V15, P2669, DOI 10.1110/ps.062419006; Lee MTG, 2009, TRAFFIC, V10, P1377, DOI 10.1111/j.1600-0854.2009.00942.x; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Li Wei, 2007, Journal of Genetics and Genomics, V34, P669, DOI 10.1016/S1673-8527(07)60076-9; Loftus SK, 2002, P NATL ACAD SCI USA, V99, P4471, DOI 10.1073/pnas.072087599; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Martina JA, 2003, J BIOL CHEM, V278, P29376, DOI 10.1074/jbc.M301294200; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Merithew E, 2001, J BIOL CHEM, V276, P13982, DOI 10.1074/jbc.M009771200; Nazarian R, 2003, P NATL ACAD SCI USA, V100, P8770, DOI 10.1073/pnas.1532040100; Nazarian R, 2008, MOL GENET METAB, V93, P134, DOI 10.1016/j.ymgme.2007.09.001; Oh J, 2000, HUM MOL GENET, V9, P375, DOI 10.1093/hmg/9.3.375; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; Oh J, 1998, AM J HUM GENET, V62, P593, DOI 10.1086/301757; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Seki N, 2000, J HUM GENET, V45, P318, DOI 10.1007/s100380070025; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki T, 2002, NAT GENET, V30, P321, DOI 10.1038/ng835; van der Sluijs P, 2008, METHOD ENZYMOL, V438, P185, DOI 10.1016/S0076-6879(07)38013-0; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Wu XF, 2001, J CELL SCI, V114, P1091; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Zhang Q, 2002, BRIT J HAEMATOL, V117, P414, DOI 10.1046/j.1365-2141.2002.03444.x	45	62	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7794	7804		10.1074/jbc.M109.069088	http://dx.doi.org/10.1074/jbc.M109.069088			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048159	hybrid, Green Published			2022-12-25	WOS:000275415600087
J	Radner, FPW; Streith, IE; Schoiswohl, G; Schweiger, M; Kumari, M; Eichmann, TO; Rechberger, G; Koefeler, HC; Eder, S; Schauer, S; Theussl, HC; Preiss-Landl, K; Lass, A; Zimmermann, R; Hoefler, G; Zechner, R; Haemmerle, G				Radner, Franz P. W.; Streith, Ingo E.; Schoiswohl, Gabriele; Schweiger, Martina; Kumari, Manju; Eichmann, Thomas O.; Rechberger, Gerald; Koefeler, Harald C.; Eder, Sandra; Schauer, Silvia; Theussl, H. Christian; Preiss-Landl, Karina; Lass, Achim; Zimmermann, Robert; Hoefler, Gerald; Zechner, Rudolf; Haemmerle, Guenter			Growth Retardation, Impaired Triacylglycerol Catabolism, Hepatic Steatosis, and Lethal Skin Barrier Defect in Mice Lacking Comparative Gene Identification-58 (CGI-58)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; LIPID STORAGE DISEASE; ADIPOSE TRIGLYCERIDE LIPASE; CHANARIN-DORFMAN-SYNDROME; INSULIN-RESISTANCE; PROTEIN; OBESITY; MOBILIZATION; EXPRESSION; LIPOLYSIS	Comparative gene identification-58 (CGI-58), also designated as alpha/beta-hydrolase domain containing-5 (ABHD-5), is a lipid droplet-associated protein that activates adipose triglyceride lipase (ATGL) and acylates lysophosphatidic acid. Activation of ATGL initiates the hydrolytic catabolism of cellular triacylglycerol (TG) stores to glycerol and nonesterified fatty acids. Mutations in both ATGL and CGI-58 cause "neutral lipid storage disease" characterized by massive accumulation of TG in various tissues. The analysis of CGI-58-deficient (Cgi-58(-/-)) mice, presented in this study, reveals a dual function of CGI-58 in lipid metabolism. First, systemic TG accumulation and severe hepatic steatosis in newborn Cgi-58(-/-) mice establish a limiting role for CGI-58 in ATGL-mediated TG hydrolysis and supply of nonesterified fatty acids as energy substrate. Second, a severe skin permeability barrier defect uncovers an essential ATGL-independent role of CGI-58 in skin lipid metabolism. The neonatal lethal skin barrier defect is linked to an impaired hydrolysis of epidermal TG. As a consequence, sequestration of fatty acids in TG prevents the synthesis of acylceramides, which are essential lipid precursors for the formation of a functional skin permeability barrier. This mechanism may also underlie the pathogenesis of ichthyosis in neutral lipid storage disease patients lacking functional CGI-58.	[Radner, Franz P. W.; Streith, Ingo E.; Schoiswohl, Gabriele; Schweiger, Martina; Kumari, Manju; Eichmann, Thomas O.; Rechberger, Gerald; Eder, Sandra; Preiss-Landl, Karina; Lass, Achim; Zimmermann, Robert; Zechner, Rudolf; Haemmerle, Guenter] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Koefeler, Harald C.] Med Univ Graz, Med Res Ctr, A-8010 Graz, Austria; [Schauer, Silvia; Hoefler, Gerald] Med Univ Graz, Inst Pathol, A-8010 Graz, Austria; [Theussl, H. Christian] Inst Mol Pathol, A-1030 Vienna, Austria	University of Graz; Medical University of Graz; Medical University of Graz; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31, A-8010 Graz, Austria.	rudolf.zechner@uni-graz.at; guenter.haemmerle@uni-graz.at	Lass, Achim/C-3332-2008; Hoefler, Gerald/B-7006-2008; Hoefler, Gerald/H-1796-2016	Lass, Achim/0000-0002-8190-7151; Eichmann, Thomas O./0000-0002-8521-2795; Radner, Franz/0000-0003-3466-0181; Schoiswohl, Gabriele/0000-0002-7346-2834; Haemmerle, Guenter/0000-0001-9900-5896; Hoefler, Gerald/0000-0002-9056-3063; Zimmermann, Robert/0000-0002-7354-870X; Schweiger, Martina/0000-0002-3419-1007; Zechner, Rudolf/0000-0001-5483-1182; Rechberger, Gerald N./0000-0002-0071-317X; Kofeler, Harald/0000-0002-2725-9616	Austrian Ministry for Science and Research; SFB LIPOTOX [F30-B05]; Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [P20602-B05]; Austrian Science Fund (FWF) [F 3002, Z 136, P 20602, W 901] Funding Source: researchfish	Austrian Ministry for Science and Research; SFB LIPOTOX(German Research Foundation (DFG)); Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Grant "GOLD-Genomics of Lipid-associated Disorders" (which is part of the Austrian Genome Project "GEN-AU Genome Research in Austria") funded by the Austrian Ministry for Science and Research and by Grant SFB LIPOTOX F30-B05 and FWF Project P20602-B05 funded by the Austrian Fonds zur Forderung der Wissenschaftlichen Forschung.	Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Akiyama M, 2003, J INVEST DERMATOL, V121, P1029, DOI 10.1046/j.1523-1747.2003.12520.x; Andreadis ST, 2001, FASEB J, V15, P898, DOI 10.1096/fj.00-0324com; AUSUBEL FM, 2004, CURRENT PROTOCOLS MO, V2; Brown JM, 2007, J LIPID RES, V48, P2295, DOI 10.1194/jlr.M700279-JLR200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Caviglia JM, 2009, BBA-MOL CELL BIOL L, V1791, P198, DOI 10.1016/j.bbalip.2008.12.018; CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553; DORFMAN ML, 1974, ARCH DERMATOL, V110, P261, DOI 10.1001/archderm.110.2.261; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Garg A, 2009, BBA-MOL CELL BIOL L, V1791, P507, DOI 10.1016/j.bbalip.2008.12.014; Ghosh AK, 2008, J BIOL CHEM, V283, P24525, DOI 10.1074/jbc.M801783200; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; GUERCIOLINI R, 1997, INT J OBES S3, V21, P12; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; HILAIRE N, 1995, J BIOL CHEM, V270, P27027, DOI 10.1074/jbc.270.45.27027; Hirano K, 2008, NEW ENGL J MED, V359, P2396, DOI 10.1056/NEJMc0805305; HOLM C, 1988, SCIENCE, V241, P1503, DOI 10.1126/science.3420405; Igal RA, 1997, J PEDIATR GASTR NUTR, V25, P541, DOI 10.1097/00005176-199711000-00011; Igal RA, 1996, J BIOL CHEM, V271, P16644, DOI 10.1074/jbc.271.28.16644; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JORDANS GHW, 1953, ACTA MED SCAND, V145, P419; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; McMahon A, 2007, MOL VIS, V13, P258; MONTEROMORAN G, 2010, J LIPID RES IN PRESS; NAVARRO JM, 1995, J BIOL CHEM, V270, P21362, DOI 10.1074/jbc.270.36.21362; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Raben DM, 2005, TRENDS ENDOCRIN MET, V16, P35, DOI 10.1016/j.tem.2005.01.009; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; WERTZ PW, 1985, J INVEST DERMATOL, V84, P410, DOI 10.1111/1523-1747.ep12265510; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	47	147	147	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7300	7311		10.1074/jbc.M109.081877	http://dx.doi.org/10.1074/jbc.M109.081877			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20023287	Green Published, hybrid			2022-12-25	WOS:000275415600042
J	Daly, AC; Vizan, P; Hill, CS				Daly, Amanda C.; Vizan, Pedro; Hill, Caroline S.			Smad3 Protein Levels Are Modulated by Ras Activity and during the Cell Cycle to Dictate Transforming Growth Factor-beta Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TGF-BETA; SIGNALING PATHWAYS; PROSTATE-CANCER; TARGETED DISRUPTION; DEPENDENT KINASES; UBIQUITIN LIGASE; DOWN-REGULATION; TUMOR-CELLS; EXPRESSION	Transforming growth factor beta (TGF-beta) regulates many biological processes, and aberrant TGF-beta signaling is implicated in tumor development. Smad3 is a central component of the TGF-beta signaling pathway, and once activated, Smad3 forms complexes with Smad4 or other receptor-regulated Smads, which accumulate in the nucleus to transcriptionally regulate TGF-beta target genes. Because Smad3 plays a significant role in mediating the activities of TGF-beta, we examined its regulation during tumor development using a well characterized tumor model. We demonstrate that Smad3 levels are dramatically reduced in the tumorigenic cell line transformed with activated H-Ras compared with the normal parental epithelial cells. Interestingly, we also observe a cell cycle-dependent regulation of Smad3 in both cell types, with high Smad3 levels in quiescent cells and a significant drop in Smad3 protein levels in proliferating cells. Smad3 is regulated at the mRNA level and at the level of protein stability. In addition, functional analysis indicates that down-regulation of Smad3 levels is required for the tumor cells to proliferate in the presence of TGF-beta, because ectopic expression of Smad3 in the tumorigenic cell line restores the growth inhibitory response to TGF-beta. In contrast, expression of high levels of Smad3 did not interfere with the ability of these cells to undergo epithelial to mesenchymal transition upon TGF-beta stimulation. Altogether, our results suggest that the level of Smad3 protein is an important determinant of the progression of tumorigenesis. High levels of Smad3 are required for the tumor suppressor activities of TGF-beta, whereas lower levels are sufficient for the tumor promoting functions.	[Daly, Amanda C.; Vizan, Pedro; Hill, Caroline S.] Canc Res UK London Res Inst, Lab Dev Signalling, London WC2A 3PX, England	Cancer Research UK	Hill, CS (corresponding author), 44 Lincolns Inn Fields, London WC2A 3PX, England.	caroline.hill@cancer.org.uk	; Vizan, Pedro/K-5555-2015	Hill, Caroline/0000-0002-8632-0480; Vizan, Pedro/0000-0002-6787-9940	Cancer Research UK; European Union [MRTN-CT-2004-005428]; Marie Curie Intra-European Fellowship [PIEF-GA-2009-235995]	Cancer Research UK(Cancer Research UK); European Union(European Commission); Marie Curie Intra-European Fellowship(European Commission)	This work was supported by Cancer Research UK, a European Union Research Training Network Grant (MRTN-CT-2004-005428), and a Marie Curie Intra-European Fellowship PIEF-GA-2009-235995 (to P. V.).	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Andersson A, 2007, LEUKEMIA, V21, P1198, DOI 10.1038/sj.leu.2404688; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; ENOCH T, 1986, MOL CELL BIOL, V6, P801, DOI 10.1128/MCB.6.3.801; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Han SU, 2004, ONCOGENE, V23, P1333, DOI 10.1038/sj.onc.1207259; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Howell M, 1997, EMBO J, V16, P7411, DOI 10.1093/emboj/16.24.7411; Inman GJ, 2002, J BIOL CHEM, V277, P51008, DOI 10.1074/jbc.M208532200; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jeruss JS, 2003, MOL CELL ENDOCRINOL, V203, P185, DOI 10.1016/S0303-7207(02)00291-5; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Ku JL, 2007, CANCER LETT, V247, P283, DOI 10.1016/j.canlet.2006.05.008; Lancaster JM, 2004, J SOC GYNECOL INVEST, V11, P51, DOI 10.1016/j.jsgi.2003.07.004; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Liu F, 2006, CYTOKINE GROWTH F R, V17, P9, DOI 10.1016/j.cytogfr.2005.09.010; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Nicolas FJ, 2004, J CELL SCI, V117, P4113, DOI 10.1242/jcs.01289; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Nicolas FJ, 2003, J BIOL CHEM, V278, P3251, DOI 10.1074/jbc.M209019200; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tian F, 2003, CANCER RES, V63, P8284; Vijayachandra K, 2003, CANCER RES, V63, P3447; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welsh JB, 2001, CANCER RES, V61, P5974; Wolfraim LA, 2004, NEW ENGL J MED, V351, P552, DOI 10.1056/NEJMoa031197; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang YA, 2006, CANCER CELL, V9, P445, DOI 10.1016/j.ccr.2006.04.025; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	56	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6489	6497		10.1074/jbc.M109.043877	http://dx.doi.org/10.1074/jbc.M109.043877			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037158	Green Published, hybrid			2022-12-25	WOS:000275367500053
J	Wang, ZX; Thurmond, DC				Wang, Zhanxiang; Thurmond, Debbie C.			Differential Phosphorylation of RhoGDI Mediates the Distinct Cycling of Cdc42 and Rac1 to Regulate Second- phase Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; GTP-BINDING PROTEINS; NUCLEOTIDE DISSOCIATION INHIBITOR; FACTOR ATTACHMENT PROTEIN; 1ST PHASE; B-CELLS; GLUCOSE; RELEASE; EXOCYTOSIS; ISLETS	Cdc42 cycling through GTP/GDP states is critical for its function in the second/granule mobilization phase of insulin granule exocytosis in pancreatic islet beta cells, although the identities of the Cdc42 cycling proteins involved remain incomplete. Using a tandem affinity purification-based mass spectrometry screen for Cdc42 cycling factors in beta cells, RhoGDI was identified. RNA interference-mediated depletion of RhoGDI from isolated islets selectively amplified the second phase of insulin release, consistent with the role of RhoGDI as a Cdc42 cycling factor. Replenishment of RhoGDI to RNA interference-depleted cells normalized secretion, confirming the action of RhoGDI to be that of a negative regulator of Cdc42 activation. Given that RhoGDI also regulates Rac1 activation in beta cells, and that Rac1 activation occurs in a Cdc42-dependent manner, the question as to how the beta cell utilized RhoGDI for differential Cdc42 and Rac1 cycling was explored. Co-immunoprecipitation was used to determine that RhoGDI-Cdc42 complexes dissociated upon stimulation of beta cells with glucose for 3 min, correlating with the timing of glucose-induced Cdc42 activation and the onset of RhoGDI tyrosine phosphorylation. Glucose-induced disruption of RhoGDI-Rac1 complexes occurred subsequent to this, coincident with Rac1 activation, which followed the onset of RhoGDI serine phosphorylation. RhoGDI-Cdc42 complex dissociation was blocked by mutation of RhoGDI residue Tyr-156, whereas RhoGDI-Rac1 dissociation was blocked by RhoGDI mutations Y156F and S101A/S174A. Finally, expression of a triple Y156F/S101A/S174A-RhoGDI mutant specifically inhibited only the second/granule mobilization phase of glucose-stimulated insulin secretion, overall supporting the integration of RhoGDI into the activation cycling mechanism of glucose-responsive small GTPases.	[Wang, Zhanxiang; Thurmond, Debbie C.] Indiana Univ Sch Med, Dept Pediat, Basic Diabet Res Grp, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Thurmond, DC (corresponding author), Indiana Univ Sch Med, Dept Pediat, Basic Diabet Res Grp, Herman B Wells Ctr Pediat Res, Barnhill Dr,MS2031, Indianapolis, IN 46202 USA.	dthurmon@iupui.edu			National Institutes of Health [DK076614]; American Diabetes Association Career Development Award [1-03-CD-10]; Indiana University Research Support Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Career Development Award(American Diabetes Association); Indiana University Research Support Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076614 (to D. C. T.). This work was also supported by American Diabetes Association Career Development Award 1-03-CD-10 and an Indiana University Research Support Fund Grant.	Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Gasman S, 2003, CELL SIGNAL, V15, P893, DOI 10.1016/S0898-6568(03)00052-4; Gerich JE, 2002, DIABETES, V51, pS117, DOI 10.2337/diabetes.51.2007.S117; Guerrera IC, 2007, J PROTEOME RES, V6, P2623, DOI 10.1021/pr070078f; Hatlapatka K, 2009, AM J PHYSIOL-ENDOC M, V297, pE315, DOI 10.1152/ajpendo.90981.2008; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Horie M, 2001, CARDIOVASC DRUG THER, V15, P31, DOI 10.1023/A:1011106701063; Johnson JL, 2009, J BIOL CHEM, V284, P23860, DOI 10.1074/jbc.M109.031815; KiralyBorri CE, 1996, BIOCHEM J, V314, P199, DOI 10.1042/bj3140199; Kowluru A, 2005, DIABETES, V54, P3523, DOI 10.2337/diabetes.54.12.3523; Kowluru A, 1996, J CLIN INVEST, V98, P540, DOI 10.1172/JCI118822; Kowluru A, 1997, BIOCHEM PHARMACOL, V54, P1097, DOI 10.1016/S0006-2952(97)00314-6; Kowluru A, 2008, J CELL MOL MED, V12, P164, DOI 10.1111/j.1582-4934.2007.00168.x; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LI GD, 1994, MOL BIOL CELL, V5, P1199, DOI 10.1091/mbc.5.11.1199; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Lim Y, 2003, BIOCHEM BIOPH RES CO, V305, P292, DOI 10.1016/S0006-291X(03)00733-2; MEGLASSON M D, 1986, Diabetes Metabolism Reviews, V2, P163; NESHER R, 1987, ENDOCRINOLOGY, V121, P1017, DOI 10.1210/endo-121-3-1017; Nesher R, 2002, DIABETES, V51, pS53, DOI 10.2337/diabetes.51.2007.S53; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Oh E, 2006, J BIOL CHEM, V281, P17624, DOI 10.1074/jbc.M601581200; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Park KH, 2000, J BIOMAT SCI-POLYM E, V11, P903, DOI 10.1163/156856200744093; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; Rhodes CJ., 2000, DIABETES MELLITUS FU, P20; ROGERS S, 1985, ARCH DIS CHILD, V60, P200, DOI 10.1136/adc.60.3.200; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; SATIN LS, 1985, PFLUG ARCH EUR J PHY, V404, P385, DOI 10.1007/BF00585354; Shigeto M, 2006, J PHARMACOL SCI, V101, P293, DOI 10.1254/jphs.FP0060057; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Straub SG, 2004, DIABETES, V53, P3179, DOI 10.2337/diabetes.53.12.3179; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sugawara K, 2009, GENES CELLS, V14, P445, DOI 10.1111/j.1365-2443.2009.01285.x; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Zhang CL, 2009, SCIENCE, V325, P607, DOI 10.1126/science.1172256; Zhao Y, 2008, J BIOL CHEM, V283, P5306, DOI 10.1074/jbc.M707695200	55	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6186	6197		10.1074/jbc.M109.072421	http://dx.doi.org/10.1074/jbc.M109.072421			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20028975	Green Published, hybrid			2022-12-25	WOS:000275367500023
J	Shokeer, A; Mannervik, B				Shokeer, Abeer; Mannervik, Bengt			Minor Modifications of the C-terminal Helix Reschedule the Favored Chemical Reactions Catalyzed by Theta Class Glutathione Transferase T1-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION; PROTEIN-STRUCTURE; ENZYME EVOLUTION; STRUCTURAL BASIS; EFFICIENCY; PRODUCTS; ISOTHIOCYANATES; DETOXICATION; PROMISCUITY; CONJUGATION	Adaptive responses to novel toxic challenges provide selective advantages to organisms in evolution. Glutathione transferases (GSTs) play a pivotal role in the cellular defense because they are main contributors to the inactivation of genotoxic compounds of exogenous as well as of endogenous origins. GSTs are promiscuous enzymes catalyzing a variety of chemical reactions with numerous alternative substrates. Despite broad substrate acceptance, individual GSTs display pronounced selectivities such that only a limited number of substrates are transformed with high catalytic efficiency. The present study shows that minor structural changes in the C-terminal helix of mouse GST T1-1 induce major changes in the substrate-activity profile of the enzyme to favor novel chemical reactions and to suppress other reactions catalyzed by the parental enzyme.	[Shokeer, Abeer; Mannervik, Bengt] Uppsala Univ, Dept Biochem & Organ Chem, Biomed Ctr, SE-75123 Uppsala, Sweden	Uppsala University	Mannervik, B (corresponding author), Uppsala Univ, Dept Biochem & Organ Chem, Biomed Ctr, Box 576, SE-75123 Uppsala, Sweden.	bengt.mannervik@biorg.uu.se	Shokeer, Abeer/ABA-4836-2020	Shokeer, Abeer/0000-0001-8919-9658	Swedish Research Council; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by the Swedish Research Council and the Swedish Cancer Society.	BJORNESTEDT R, 1992, BIOCHEM J, V282, P505; Board PG, 2005, METHOD ENZYMOL, V401, P61, DOI 10.1016/S0076-6879(05)01004-9; Broo K, 2002, J MOL BIOL, V318, P59, DOI 10.1016/S0022-2836(02)00032-3; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Dagnino-Subiabre A, 2000, BIOCHEM BIOPH RES CO, V274, P32, DOI 10.1006/bbrc.2000.3087; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Gerlt JA, 2009, CURR OPIN CHEM BIOL, V13, P10, DOI 10.1016/j.cbpa.2009.01.014; Griswold KE, 2006, J MOL BIOL, V364, P400, DOI 10.1016/j.jmb.2006.09.012; Habig W H, 1981, Methods Enzymol, V77, P398; HOROVITZ A, 1996, FOLDING DESIGN, V1, P121, DOI DOI 10.1016/S1359-0278(96)00056-9; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Ivarsson Y, 2003, J BIOL CHEM, V278, P8733, DOI 10.1074/jbc.M211776200; JAKOBY WB, 1990, J BIOL CHEM, V265, P20715; Jemth P, 1997, ARCH BIOCHEM BIOPHYS, V348, P247, DOI 10.1006/abbi.1997.0357; Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200; Josephy PD, 2006, MOL TOXICOLOGY, P333; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; KOLM RH, 1995, BIOCHEM J, V311, P453, DOI 10.1042/bj3110453; Kurtovic S, 2009, BIOCHEMISTRY-US, V48, P9330, DOI 10.1021/bi901168q; LAEMMLI UK, 1970, NATURE, V227, P685; Larsson AK, 2004, PROTEIN ENG DES SEL, V17, P49, DOI 10.1093/protein/gzh005; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lien S, 2002, BIOCHEM PHARMACOL, V63, P191, DOI 10.1016/S0006-2952(01)00846-2; Mannervik B., 1978, CONJUGATION REACTION, P101; Matzkin LM, 2008, GENETICS, V178, P1073, DOI 10.1534/genetics.107.083287; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Nilsson LO, 2000, P NATL ACAD SCI USA, V97, P9408, DOI 10.1073/pnas.150084897; Norrgard MA, 2006, P NATL ACAD SCI USA, V103, P4876, DOI 10.1073/pnas.0600849103; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Shokeer A, 2005, BIOCHEM J, V388, P387, DOI 10.1042/BJ20042064; Tars K, 2006, J MOL BIOL, V355, P96, DOI 10.1016/j.jmb.2005.10.049; Wiktelius E, 2007, BIOCHEM J, V406, P115, DOI 10.1042/BJ20070328; Zhao YZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000472	35	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5639	5645		10.1074/jbc.M109.074757	http://dx.doi.org/10.1074/jbc.M109.074757			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022951	Green Published, hybrid			2022-12-25	WOS:000275327200056
J	Fittipaldi, N; Takamatsu, D; Dominguez-Punaro, MD; Lecours, MP; Montpetit, D; Osaki, M; Sekizaki, T; Gottschalk, M				Fittipaldi, Nahuel; Takamatsu, Daisuke; Dominguez-Punaro, Maria de la Cruz; Lecours, Marie-Pier; Montpetit, Diane; Osaki, Makoto; Sekizaki, Tsutomu; Gottschalk, Marcelo			Mutations in the Gene Encoding the Ancillary Pilin Subunit of the Streptococcus suis srtF Cluster Result in Pili Formed by the Major Subunit Only	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; MICROVASCULAR ENDOTHELIAL-CELLS; GERM-FREE PIGS; ESCHERICHIA-COLI; CAPSULAR TYPE-2; VIRULENCE; PROTEIN; IDENTIFICATION; SEROTYPE-2; INFECTION	Pili have been shown to contribute to the virulence of different Gram-positive pathogenic species. Among other critical steps of bacterial pathogenesis, these structures participate in adherence to host cells, colonization and systemic virulence. Recently, the presence of at least four discrete gene clusters encoding putative pili has been revealed in the major swine pathogen and emerging zoonotic agent Streptococcus suis. However, pili production by this species has not yet been demonstrated. In this study, we investigated the functionality of one of these pili clusters, known as the srtF pilus cluster, by the construction of mutant strains for each of the four genes of the cluster as well as by the generation of antibodies against the putative pilin subunits. Results revealed that the S. suis serotype 2 strain P1/7, as well as several other highly virulent invasive S. suis serotype 2 isolates express pili from this cluster. However, in most cases tested, and as a result of nonsense mutations at the 59 end of the gene encoding the minor pilin subunit (a putative adhesin), pili were formed by the major pilin subunit only. We then evaluated the role these pili play in S. suis virulence. Abolishment of the expression of srtF cluster-encoded pili did not result in impaired interactions of S. suis with porcine brain microvascular endothelial cells. Furthermore, non-piliated mutants were as virulent as the wild type strain when evaluated in a murine model of S. suis sepsis. Our results show that srtF cluster-encoded, S. suis pili are atypical compared to other Gram-positive pili. In addition, since the highly virulent strains under investigation are unlikely to produce other pili, our results suggest that pili might be dispensable for critical steps of the S. suis pathogenesis of infection.	[Fittipaldi, Nahuel; Dominguez-Punaro, Maria de la Cruz; Lecours, Marie-Pier; Gottschalk, Marcelo] Univ Montreal, Fac Med Vet, Grp Rech Malad Infect Porc, St Hyacinthe, PQ J2S 7C6, Canada; [Fittipaldi, Nahuel; Dominguez-Punaro, Maria de la Cruz; Lecours, Marie-Pier; Gottschalk, Marcelo] Univ Montreal, Fac Med Vet, Ctr Rech Infectiol Porcine, St Hyacinthe, PQ J2S 7C6, Canada; [Takamatsu, Daisuke; Osaki, Makoto] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Res Team Bacterial Parasit Dis, Tsukuba, Ibaraki, Japan; [Montpetit, Diane] Agr & Agroalimentaire Canada, Ctr Rech & Dev Aliments, St Hyacinthe, PQ, Canada; [Sekizaki, Tsutomu] Univ Tokyo, Res Ctr Food Safety, Grad Sch Agr & Life Sci, Tokyo, Japan	Universite de Montreal; Universite de Montreal; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Agriculture & Agri Food Canada; University of Tokyo	Fittipaldi, N (corresponding author), Univ Montreal, Fac Med Vet, Grp Rech Malad Infect Porc, St Hyacinthe, PQ J2S 7C6, Canada.	marcelo.gottschalk@umontreal.ca	Sekizaki, Tsutomu/AAB-1816-2021; Gottschalk, Marcelo/I-8116-2012	Sekizaki, Tsutomu/0000-0002-8899-2504; Fittipaldi, Nahuel/0000-0001-9553-3798	Natural Sciences and Engineering Research Council of Canada (NSERC) [154280, 380299]; Japan Society for the Promotion of Science (JSPS)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) through grants to MG (# 154280 and Discovery Accelerator Supplement # 380299) and by the Japan Society for the Promotion of Science (JSPS) through a grant to TS. NF, MCDP and MPL are the holders of NSERC postgraduate scholarships. NF is the recipient of a JSPS Summer Program fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Baums CG, 2006, INFECT IMMUN, V74, P6154, DOI 10.1128/IAI.00359-06; Berthelot-Herault F, 2005, CAN J VET RES, V69, P236; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dominguez-Punaro MD, 2008, INFECT IMMUN, V76, P3901, DOI 10.1128/IAI.00350-08; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Fittipaldi N, 2007, APPL ENVIRON MICROB, V73, P4359, DOI 10.1128/AEM.00258-07; Francois B, 1998, J CLIN MICROBIOL, V36, P2395; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Higgins R, 1990, J Vet Diagn Invest, V2, P249; Higgins R, 2006, DIS SWINE, P769; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; JACQUES M, 1990, J BACTERIOL, V172, P2833, DOI 10.1128/jb.172.6.2833-2838.1990; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Li YY, 2007, CLIN VACCINE IMMUNOL, V14, P937, DOI 10.1128/CVI.00046-07; Li YY, 2006, INFECT IMMUN, V74, P305, DOI 10.1128/IAI.74.1.305-312.2006; Maisey HC, 2008, FASEB J, V22, P1715, DOI 10.1096/fj.07-093963; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; McNab Roderick, 1998, Methods in Cell Science, V20, P209, DOI 10.1023/A:1009763626485; MOOR CED, 1963, ANTON VAN LEE J M S, V29, P272, DOI 10.1007/BF02046069; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; MUNIER H, 1991, EUR J BIOCHEM, V196, P469, DOI 10.1111/j.1432-1033.1991.tb15838.x; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Osaki M, 2002, J BACTERIOL, V184, P971, DOI 10.1128/jb.184.4.971-982.2002; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; QUESSY S, 1995, INFECT IMMUN, V63, P1975, DOI 10.1128/IAI.63.5.1975-1979.1995; Rodriguez-Ortega MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-588; Roge J, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-18; Rosch JW, 2008, INFECT IMMUN, V76, P3187, DOI 10.1128/IAI.00054-08; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Segura M, 2002, CLIN EXP IMMUNOL, V127, P243, DOI 10.1046/j.1365-2249.2002.01768.x; Slater JD, 2003, VET MICROBIOL, V93, P197, DOI 10.1016/S0378-1135(03)00030-0; SMITH HE, 1993, INFECT IMMUN, V61, P3318, DOI 10.1128/IAI.61.8.3318-3326.1993; Smith HE, 1999, INFECT IMMUN, V67, P1750; Suankratay Chusana, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P868; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; Takamatsu D, 2009, VET MICROBIOL, V138, P132, DOI 10.1016/j.vetmic.2009.02.013; Teifel M, 1996, EXP CELL RES, V228, P50, DOI 10.1006/excr.1996.0298; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tenenbaum T, 2009, CELL MICROBIOL, V11, P323, DOI 10.1111/j.1462-5822.2008.01255.x; Vanier G, 2008, VET MICROBIOL, V127, P417, DOI 10.1016/j.vetmic.2007.08.032; Vanier G, 2004, INFECT IMMUN, V72, P1441, DOI 10.1128/IAI.72.3.1441-1449.2004; Vanier G, 2009, MICROB PATHOGENESIS, V46, P13, DOI 10.1016/j.micpath.2008.10.003; VECHT U, 1989, AM J VET RES, V50, P1037; VECHT U, 1992, INFECT IMMUN, V60, P550, DOI 10.1128/IAI.60.2.550-556.1992; VECHT U, 1991, INFECT IMMUN, V59, P3156, DOI 10.1128/IAI.59.9.3156-3162.1991; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; YE C, 2008, J INFECT DIS; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zahner D, 2008, J BACTERIOL, V190, P527, DOI 10.1128/JB.01520-07	68	24	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8426	10.1371/journal.pone.0008426	http://dx.doi.org/10.1371/journal.pone.0008426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052283	Green Published, Green Submitted, gold			2022-12-25	WOS:000273338500001
J	Hilty, M; Burke, C; Pedro, H; Cardenas, P; Bush, A; Bossley, C; Davies, J; Ervine, A; Poulter, L; Pachter, L; Moffatt, MF; Cookson, WOC				Hilty, Markus; Burke, Conor; Pedro, Helder; Cardenas, Paul; Bush, Andy; Bossley, Cara; Davies, Jane; Ervine, Aaron; Poulter, Len; Pachter, Lior; Moffatt, Miriam F.; Cookson, William O. C.			Disordered Microbial Communities in Asthmatic Airways	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RIBOSOMAL-RNA GENES; BACTERIAL DIVERSITY; PANDEMIC INFLUENZA; ANAEROBIC-BACTERIA; INFECTION; EXACERBATIONS; SEQUENCES; EPIDEMIC; CHILDREN	Background: A rich microbial environment in infancy protects against asthma [1,2] and infections precipitate asthma exacerbations [3]. We compared the airway microbiota at three levels in adult patients with asthma, the related condition of COPD, and controls. We also studied bronchial lavage from asthmatic children and controls. Principal Findings: We identified 5,054 16S rRNA bacterial sequences from 43 subjects, detecting > 70% of species present. The bronchial tree was not sterile, and contained a mean of 2,000 bacterial genomes per cm(2) surface sampled. Pathogenic Proteobacteria, particularly Haemophilus spp., were much more frequent in bronchi of adult asthmatics or patients with COPD than controls. We found similar highly significant increases in Proteobacteria in asthmatic children. Conversely, Bacteroidetes, particularly Prevotella spp., were more frequent in controls than adult or child asthmatics or COPD patients. Significance: The results show the bronchial tree to contain a characteristic microbiota, and suggest that this microbiota is disturbed in asthmatic airways.	[Hilty, Markus; Cardenas, Paul; Bush, Andy; Bossley, Cara; Davies, Jane; Moffatt, Miriam F.; Cookson, William O. C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Burke, Conor; Ervine, Aaron; Poulter, Len] Connolly Hosp, Dept Resp Med, Dublin, Ireland; [Pedro, Helder] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Inst Gulbenkian Ciencia, Oeiras, Portugal; [Pedro, Helder; Pachter, Lior] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA	Imperial College London; Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa; University of California System; University of California Berkeley	Hilty, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	w.cookson@imperial.ac.uk	Hilty, Markus/H-9560-2019; Cookson, William/HHC-1790-2022	Hilty, Markus/0000-0002-2418-6474; Pachter, Lior/0000-0002-9164-6231; Davies, Jane/0000-0003-3506-1199; Cardenas, Paul/0000-0001-9626-4489	European Commission; Wellcome Trust; Medical Research Council [G0801056B] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the GABRIEL FP6 Integrated Project of the European Commission and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Ahmed S, 2007, APPL ENVIRON MICROB, V73, P7435, DOI 10.1128/AEM.01143-07; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Blasi F, 2007, INT J ANTIMICROB AG, V29, P485, DOI 10.1016/j.ijantimicag.2006.11.029; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Cookson WOCM, 1997, SCIENCE, V275, P41, DOI 10.1126/science.275.5296.41; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Didierlaurent A, 2007, IMMUNOLOGY, V122, P457, DOI 10.1111/j.1365-2567.2007.02729.x; Donnelly D, 2007, THORAX, V62, P80, DOI 10.1136/thx.2006.058933; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Green SJ, 2004, FEMS MICROBIOL LETT, V233, P115, DOI 10.1016/j.femsle.2004.01.049; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Henriksson G, 2004, AM J RESP CELL MOL, V31, P657, DOI 10.1165/rcmb.2004-0207OC; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hussell T, 2009, FUTURE MICROBIOL, V4, P269, DOI 10.2217/FMB.09.3; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kittles RA, 1999, P NATL ACAD SCI USA, V96, P4204, DOI 10.1073/pnas.96.7.4204; Kraft M, 2000, CLIN CHEST MED, V21, P301, DOI 10.1016/S0272-5231(05)70268-9; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; MURRAY PR, 1976, J INFECT DIS, V134, P281, DOI 10.1093/infdis/134.3.281; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Payne D, 2001, ARCH DIS CHILD, V84, P423, DOI 10.1136/adc.84.5.423; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Smith NH, 1999, MOL BIOL EVOL, V16, P773, DOI 10.1093/oxfordjournals.molbev.a026162; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Sutherland ER, 2007, CHEST, V132, P1962, DOI 10.1378/chest.06-2415; Sykes A, 2008, J ALLERGY CLIN IMMUN, V122, P685, DOI 10.1016/j.jaci.2008.08.017; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012	40	1077	1150	7	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8578	10.1371/journal.pone.0008578	http://dx.doi.org/10.1371/journal.pone.0008578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052417	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000273338500021
J	Song, LL; Ponomareva, L; Shen, H; Duan, X; Alimirah, F; Choubey, D				Song, Lynda Li; Ponomareva, Larissa; Shen, Hui; Duan, Xin; Alimirah, Fatouma; Choubey, Divaker			Interferon-Inducible IFI16, a Negative Regulator of Cell Growth, Down-Regulates Expression of Human Telomerase Reverse Transcriptase (hTERT) Gene	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; C-MYC; TUMOR-CELLS; RETINOBLASTOMA PROTEIN; GENOMIC INSTABILITY; PROSTATE-CANCER; MESSENGER-RNA; CYCLE; SENESCENCE; ALPHA	Background: Increased levels of interferon (IFN)-inducible IFI16 protein (encoded by the IFI16 gene located at 1q22) in human normal prostate epithelial cells and diploid fibroblasts (HDFs) are associated with the onset of cellular senescence. However, the molecular mechanisms by which the IFI16 protein contributes to cellular senescence-associated cell growth arrest remain to be elucidated. Here, we report that increased levels of IFI16 protein in normal HDFs and in HeLa cells negatively regulate the expression of human telomerase reverse transcriptase (hTERT) gene. Methodology/Principal Findings: We optimized conditions for real-time PCR, immunoblotting, and telomere repeat amplification protocol (TRAP) assays to detect relatively low levels of hTERT mRNA, protein, and telomerase activity that are found in HDFs. Using the optimized conditions, we report that treatment of HDFs with inhibitors of cell cycle progression, such as aphidicolin or CGK1026, which resulted in reduced steady-state levels of IFI16 mRNA and protein, was associated with increases in hTERT mRNA and protein levels and telomerase activity. In contrast, knockdown of IFI16 expression in cells increased the expression of c-Myc, a positive regulator of hTERT expression. Additionally, over-expression of IFI16 protein in cells inhibited the c-Myc-mediated stimulation of the activity of hTERT-luc-reporter and reduced the steady-state levels of c-Myc and hTERT. Conclusions/Significance: These data demonstrated that increased levels of IFI16 protein in HDFs down-regulate the expression of hTERT gene. Our observations will serve basis to understand how increased cellular levels of the IFI16 protein may contribute to certain aging-dependent diseases.	[Song, Lynda Li; Ponomareva, Larissa; Duan, Xin; Choubey, Divaker] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA; [Ponomareva, Larissa; Shen, Hui; Choubey, Divaker] Cincinnati VA Med Ctr, Cincinnati, OH USA; [Alimirah, Fatouma; Choubey, Divaker] Hines VA Hosp, Hines, IL USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Song, LL (corresponding author), Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA.	Divaker.choubey@uc.edu	Choubey, Divaker/A-4771-2008	Ponomareva, Larissa/0000-0003-2182-8774	National Institutes of Health [AG025036]; Merit Award from the Veterans Administration; NATIONAL INSTITUTE ON AGING [R01AG025036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Award from the Veterans Administration; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a grant from the National Institutes of Health (AG025036) and a Merit Award from the Veterans Administration (to D. C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 1999, CANCER LETT, V142, P23, DOI 10.1016/S0304-3835(99)00109-3; Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Bellon M, 2008, BLOOD, V112, P2946, DOI 10.1182/blood-2008-01-134692; Borden EC, 2000, SEMIN CANCER BIOL, V10, P125, DOI 10.1006/scbi.2000.0315; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Casillas MA, 2003, GENE, V316, P57, DOI 10.1016/S0378-1119(03)00739-X; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Choubey D, 1996, EMBO J, V15, P5668, DOI 10.1002/j.1460-2075.1996.tb00951.x; Choubey D, 1997, ONCOGENE, V15, P291, DOI 10.1038/sj.onc.1201184; Choubey D, 2002, FRONT BIOSCI-LANDMRK, V7, pE252, DOI 10.2741/choubey; CHOUBEY D, 1995, J BIOL CHEM, V270, P6134, DOI 10.1074/jbc.270.11.6134; Choubey D, 2000, J BIOL REG HOMEOS AG, V14, P187; Choubey D, 2008, IMMUNOL LETT, V119, P32, DOI 10.1016/j.imlet.2008.06.001; Choubey D, 2008, FRONT BIOSCI-LANDMRK, V13, P598, DOI 10.2741/2705; Cong YS, 2008, CELL RES, V18, P725, DOI 10.1038/cr.2008.74; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; Egistelli L, 2009, J CELL BIOCHEM, V106, P666, DOI 10.1002/jcb.22053; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; Emerald BS, 2007, J BIOL CHEM, V282, P680, DOI 10.1074/jbc.M600224200; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Fridman AL, 2006, J GERONTOL A-BIOL, V61, P879, DOI 10.1093/gerona/61.9.879; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gunes C, 2000, CANCER RES, V60, P2116; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hahn WC, 2005, CURR MOL MED, V5, P227, DOI 10.2174/1566524053586572; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hiyama E, 2001, NEOPLASIA, V3, P17, DOI 10.1038/sj.neo.7900134; Holt SE, 1996, MOL CELL BIOL, V16, P2932; Horikawa I, 2002, MOL BIOL CELL, V13, P2585, DOI 10.1091/mbc.E01-11-0107; Katayama T, 2007, INT J ONCOL, V31, P613; KELLY JM, 1985, EUR J BIOCHEM, V153, P367, DOI 10.1111/j.1432-1033.1985.tb09312.x; Kim EJ, 2005, J BIOL CHEM, V280, P4913, DOI 10.1074/jbc.M410542200; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Krek W, 1995, CELL, V83, P1149, DOI 10.1016/0092-8674(95)90141-8; Kulaeva OI, 2003, ONCOGENE, V22, P4118, DOI 10.1038/sj.onc.1206594; Lee SH, 2003, ONCOGENE, V22, P381, DOI 10.1038/sj.onc.1206133; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Loayza D, 2004, CELL, V117, P279, DOI 10.1016/S0092-8674(04)00409-X; Luo Q, 2004, ONCOGENE, V23, P1088, DOI 10.1038/sj.onc.1207225; Maellaro E, 2003, BRIT J DERMATOL, V148, P1115, DOI 10.1046/j.1365-2133.2003.05301.x; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Murofushi Y, 2006, INT J ONCOL, V29, P681; Niewold TB, 2007, GENES IMMUN, V8, P492, DOI 10.1038/sj.gene.6364408; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Sen GC, 2000, SEMIN CANCER BIOL, V10, P93, DOI 10.1006/scbi.2000.0312; Shiratsuchi M, 1999, LEUKEMIA LYMPHOMA, V34, P349, DOI 10.3109/10428199909050960; Shou JY, 2002, P NATL ACAD SCI USA, V99, P2830, DOI 10.1073/pnas.052705299; Song LL, 2008, MOL CANCER RES, V6, P1732, DOI 10.1158/1541-7786.MCR-08-0208; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; TOBEY RA, 1988, EXP CELL RES, V179, P400, DOI 10.1016/0014-4827(88)90279-0; Untergasser G, 2002, CANCER RES, V62, P6255; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wang H, 2000, J BIOL CHEM, V275, P27377; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Won J, 2004, P NATL ACAD SCI USA, V101, P11328, DOI 10.1073/pnas.0401801101; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; Xin H, 2004, ONCOGENE, V23, P6209, DOI 10.1038/sj.onc.1207836; Xin H, 2003, ONCOGENE, V22, P4831, DOI 10.1038/sj.onc.1206754; Xu DW, 2000, BLOOD, V96, P4313, DOI 10.1182/blood.V96.13.4313.h8004313_4313_4318; Xu HJ, 1997, ONCOGENE, V15, P2589, DOI 10.1038/sj.onc.1201446; Zhang Y, 2007, FRONT BIOSCI, V12, P4855, DOI 10.2741/2433; Zhao YM, 2008, BIOCHEM BIOPH RES CO, V369, P1114, DOI 10.1016/j.bbrc.2008.03.011	65	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8569	10.1371/journal.pone.0008569	http://dx.doi.org/10.1371/journal.pone.0008569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052289	Green Submitted, Green Published, gold			2022-12-25	WOS:000273338500013
J	Pecioska, S; Zillikens, MC; Henneman, P; Snijders, PJ; Oostra, BA; van Duijn, CM; Aulchenko, YS				Pecioska, Slavica; Zillikens, M. Carola; Henneman, Peter; Snijders, Pieter J.; Oostra, Ben A.; van Duijn, Cornelia M.; Aulchenko, Yurii S.			Association between Type 2 Diabetes Loci and Measures of Fatness	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; RISK LOCI; FTO GENE; OBESITY; VARIANT; SUSCEPTIBILITY; POLYMORPHISM	Background: Type 2 diabetes (T2D) is a metabolic disorder characterized by disturbances of carbohydrate, fat and protein metabolism and insulin resistance. The majority of T2D patients are obese and obesity by itself may be a cause of insulin resistance. Our aim was to evaluate whether the recently identified T2D risk alleles are associated with human measures of fatness as characterized with Dual Energy X-ray Absorptiometry (DEXA). Methodology/Principal Findings: Genotypes and phenotypes of approximately 3,000 participants from cross-sectional ERF study were analyzed. Nine single nucleotide polymorphisms (SNPs) in CDKN2AB, CDKAL1, FTO, HHEX, IGF2BP2, KCNJ11, PPARG, SLC30A8 and TCF7L2 were genotyped. We used linear regression to study association between individual SNPs and the combined allelic risk score with body mass index (BMI), fat mass index (FMI), fat percentage (FAT), waist circumference (WC) and waist to hip ratio (WHR). Significant association was observed between rs8050136 (FTO) and BMI (p = 0.003), FMI (p = 0.007) and WC (p = 0.03); fat percentage was borderline significant (p = 0.053). No other SNPs alone or combined in a risk score demonstrated significant association to the measures of fatness. Conclusions/Significance: From the recently identified T2D risk variants only the risk variant of the FTO gene (rs8050136) showed statistically significant association with BMI, FMI, and WC.	[Pecioska, Slavica; Snijders, Pieter J.; Oostra, Ben A.; van Duijn, Cornelia M.; Aulchenko, Yurii S.] Erasmus MC, Dept Epidemiol & Biostat & Clin Genet, Rotterdam, Netherlands; [Zillikens, M. Carola] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Henneman, Peter] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Aulchenko, Yurii S.] SD RAS, Inst Cytol & Genet, Novosibirsk, Russia	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Pecioska, S (corresponding author), Erasmus MC, Dept Epidemiol & Biostat & Clin Genet, Rotterdam, Netherlands.	i.aoultchenko@erasmusmc.nl	Aulchenko, Yurii/M-8270-2013	Aulchenko, Yurii/0000-0002-7899-1575; Van Duijn, Cornelia/0000-0002-2374-9204	Erasmus Medical Center (MC); Netherlands Organization for Scientific Research (NWO); Center of the Medical Systems Biology (CMSB)	Erasmus Medical Center (MC); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Center of the Medical Systems Biology (CMSB)	This research was supported by the Erasmus Medical Center (MC), the Netherlands Organization for Scientific Research (NWO) and the Center of the Medical Systems Biology (CMSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; Aulchenko YS, 2007, DIABETES, V56, P3020, DOI 10.2337/db07-0338; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; CAMPBELL PJ, 1993, DIABETES, V42, P405, DOI 10.2337/diabetes.42.3.405; Cauchi S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-45; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Ghoussaini M, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-11; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; GRANT SF, 2007, NAT GENET, V38, P320; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; ZEGGINI E, 2008, NAT GENET, V40, P683; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	20	13	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8541	10.1371/journal.pone.0008541	http://dx.doi.org/10.1371/journal.pone.0008541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049090	Green Published, gold, Green Submitted			2022-12-25	WOS:000273225000008
J	Spycher, BD; Silverman, M; Barben, J; Eber, E; Guinand, S; Levy, ML; Pao, C; van Aalderen, WM; van Schayck, OCP; Kuehni, CE				Spycher, Ben D.; Silverman, Michael; Barben, Juerg; Eber, Ernst; Guinand, Stephane; Levy, Mark L.; Pao, Caroline; van Aalderen, Willem M.; van Schayck, Onno C. P.; Kuehni, Claudia E.			A Disease Model for Wheezing Disorders in Preschool Children Based on Clinicians' Perceptions	PLOS ONE			English	Article							1ST 6 YEARS; LUNG-FUNCTION; EARLY-LIFE; ASTHMA; CHILDHOOD; PHENOTYPES; BIRTH; SENSITIZATION; PREDICTORS; INFANCY	Background: Wheezing disorders in childhood vary widely in clinical presentation and disease course. During the last years, several ways to classify wheezing children into different disease phenotypes have been proposed and are increasingly used for clinical guidance, but validation of these hypothetical entities is difficult. Methodology/Principal Findings: The aim of this study was to develop a testable disease model which reflects the full spectrum of wheezing illness in preschool children. We performed a qualitative study among a panel of 7 experienced clinicians from 4 European countries working in primary, secondary and tertiary paediatric care. In a series of questionnaire surveys and structured discussions, we found a general consensus that preschool wheezing disorders consist of several phenotypes, with a great heterogeneity of specific disease concepts between clinicians. Initially, 24 disease entities were described among the 7 physicians. In structured discussions, these could be narrowed down to three entities which were linked to proposed mechanisms: a) allergic wheeze, b) non-allergic wheeze due to structural airway narrowing and c) non-allergic wheeze due to increased immune response to viral infections. This disease model will serve to create an artificial dataset that allows the validation of data-driven multidimensional methods, such as cluster analysis, which have been proposed for identification of wheezing phenotypes in children. Conclusions/Significance: While there appears to be wide agreement among clinicians that wheezing disorders consist of several diseases, there is less agreement regarding their number and nature. A great diversity of disease concepts exist but a unified phenotype classification reflecting underlying disease mechanisms is lacking. We propose a disease model which may help guide future research so that proposed mechanisms are measured at the right time and their role in disease heterogeneity can be studied.	[Spycher, Ben D.; Kuehni, Claudia E.] Univ Bern, ISPM, Bern, Switzerland; [Silverman, Michael] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Barben, Juerg] Childrens Hosp St Gallen, Dept Pulmonol & Allergol, St Gallen, Switzerland; [Eber, Ernst] Med Univ Graz, Dept Paediat, Resp & Allerg Dis Div, Graz, Austria; [Guinand, Stephane] Univ Hosp Geneva, Dept Paediat, Pulmonol Unit, Geneva, Switzerland; [Levy, Mark L.] Univ Edinburgh, Allergy & Resp Res Grp, Div Community Hlth Sci, GP Sect, Edinburgh, Midlothian, Scotland; [Pao, Caroline] Barts & London Childrens Hosp, Dept Paediat, London, England; [van Aalderen, Willem M.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Resp Med & Allergy, NL-1105 AZ Amsterdam, Netherlands; [van Schayck, Onno C. P.] Maastricht Univ, Dept Gen Practice, Maastricht, Netherlands	University of Bern; University of Leicester; Medical University of Graz; University of Geneva; University of Edinburgh; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Maastricht University	Spycher, BD (corresponding author), Univ Bern, ISPM, Bern, Switzerland.	bspycher@ispm.unibe.ch	Eber, Ernst/B-6381-2012; Spycher, Ben D/B-3308-2008	Spycher, Ben D/0000-0002-1430-5695; Kuehni, Claudia E./0000-0001-8957-2002	Asthma UK [07/048]; Swiss National Science Foundation [3233-069348, 3200-069349, 823B-046481]	Asthma UK; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work presented in this paper was funded by Asthma UK (Grant number 07/048) and the Swiss National Science Foundation (PROSPER grant 3233-069348, 3200-069349, and 823B-046481). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2007, CLIN EXP ALLERGY, V37, P1296, DOI 10.1111/j.1365-2222.2007.02796.x; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; DeVincenzo John P, 2005, Pediatr Infect Dis J, V24, pS177, DOI 10.1097/01.inf.0000187274.48387.42; DeVincenzo JP, 2005, PEDIATR INFECT DIS J, V24, pS182; Edwards CA, 2003, CHEST, V124, P18, DOI 10.1378/chest.124.1.18; Frey U, 2001, SWISS MED WKLY, V131, P400; Gold DR, 2006, NEW ENGL J MED, V354, P2058, DOI 10.1056/NEJMe068058; Greenacre M.J., 1984, THEORY APPL CORRES A; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; Henschen M, 2006, EUR RESPIR J, V27, P913, DOI 10.1183/09031936.06.00036305; Hoo AF, 2002, J PEDIATR-US, V141, P652, DOI 10.1067/mpd.2002.128114; Horak E, 2003, BRIT MED J, V326, P422, DOI 10.1136/bmj.326.7386.422; Illi S, 2001, J ALLERGY CLIN IMMUN, V108, P709, DOI 10.1067/mai.2001.118786; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Kaditis AG, 2007, PEDIATR PULM, V42, P407, DOI 10.1002/ppul.20591; Kuehni CE, 2005, SWISS MED WKLY, V135, P95; Kuehni CE, 2001, LANCET, V357, P1821, DOI 10.1016/S0140-6736(00)04958-8; Kulig M, 1999, J ALLERGY CLIN IMMUN, V103, P1173, DOI 10.1016/S0091-6749(99)70195-8; Kurukulaaratchy RJ, 2004, THORAX, V59, P563, DOI 10.1136/thx.2003.010462; Kurukulaaratchy RJ, 2003, CLIN EXP ALLERGY, V33, P573, DOI 10.1046/j.1365-2222.2003.01657.x; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Lau Susanne, 2002, Paediatr Respir Rev, V3, P265, DOI 10.1016/S1526-0542(02)00189-6; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Martinez FD, 1998, J ALLERGY CLIN IMMUN, V102, P915, DOI 10.1016/S0091-6749(98)70328-8; Midodzi WK, 2008, RESPIROLOGY, V13, P537, DOI 10.1111/j.1440-1843.2008.01284.x; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; OSWALD H, 1994, BRIT MED J, V309, P95, DOI 10.1136/bmj.309.6947.95; Psarras Stelios, 2004, Paediatr Respir Rev, V5 Suppl A, pS179, DOI 10.1016/S1526-0542(04)90034-6; Rusconi F, 1999, AM J RESP CRIT CARE, V160, P1617, DOI 10.1164/ajrccm.160.5.9811002; Sherriff A, 2001, INT J EPIDEMIOL, V30, P1473, DOI 10.1093/ije/30.6.1473; Silverman M, 2002, RESP INFECT ALLERGY, P427; Spycher BD, 2008, EUR RESPIR J, V31, P974, DOI 10.1183/09031936.00153507; Spycher BD, 2009, STAT MED, V28, P1927, DOI 10.1002/sim.3550; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Stocks J, 2003, RESPIROLOGY, V8, P266, DOI 10.1046/j.1440-1843.2003.00478.x; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Wardlaw AJ, 2005, CLIN EXP ALLERGY, V35, P1254, DOI 10.1111/j.1365-2222.2005.02344.x; Young S, 2000, EUR RESPIR J, V15, P151, DOI 10.1034/j.1399-3003.2000.15a28.x; Yuan Y., 2012, ANAL RISK FACTORS CH	42	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8533	10.1371/journal.pone.0008533	http://dx.doi.org/10.1371/journal.pone.0008533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046874	Green Published, gold			2022-12-25	WOS:000273180200014
J	Barry, AE; Schultz, L; Buckee, CO; Reeder, JC				Barry, Alyssa E.; Schultz, Lee; Buckee, Caroline O.; Reeder, John C.			Contrasting Population Structures of the Genes Encoding Ten Leading Vaccine-Candidate Antigens of the Human Malaria Parasite, Plasmodium falciparum	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; MULTILOCUS GENOTYPE DATA; SURFACE PROTEIN-1 MSP-1; BAY COHORT PROJECT; PAPUA-NEW-GUINEA; STAGE MALARIA; NATURAL-SELECTION; CIRCUMSPOROZOITE PROTEIN; DIVERSIFYING SELECTION; GEOGRAPHICAL STRUCTURE	The extensive diversity of Plasmodium falciporum antigens is a major obstacle to a broadly effective malaria vaccine but population genetics has rarely been used to guide vaccine design. We have completed a meta-population genetic analysis of the genes encoding ten leading P. falciparum vaccine antigens, including the pre-erythrocytic antigens csp, trap, !sal and glurp; the merozoite antigens eba175, amal, msp's 1, 3 and 4, and the gametocyte antigen pfs48/45. A total of 4553 antigen sequences were assembled from published data and we estimated the range and distribution of diversity worldwide using traditional population genetics, Bayesian clustering and network analysis. Although a large number of distinct haplotypes were identified for each antigen, they were organized into a limited number of discrete subgroups. While the nonmerozoite antigens showed geographically variable levels of diversity and geographic restriction of specific subgroups, the merozoite antigens had high levels of diversity globally, and a worldwide distribution of each subgroup. This shows that the diversity of the non-merozoite antigens is organized by physical or other location-specific barriers to gene flow and that of merozoite antigens by features intrinsic to all populations, one important possibility being the immune response of the human host. We also show that current malaria vaccine formulations are based upon low prevalence haplotypes from a single subgroup and thus may represent only a small proportion of the global parasite population. This study demonstrates significant contrasts in the population structure of P. falciparum vaccine candidates that are consistent with the merozoite antigens being under stronger balancing selection than non-merozoite antigens and suggesting that unique approaches to vaccine design will be required. The results of this study also provide a realistic framework for the diversity of these antigens to be incorporated into the design of next-generation malaria vaccines.	[Barry, Alyssa E.; Schultz, Lee; Reeder, John C.] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Buckee, Caroline O.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Buckee, Caroline O.] Santa Fe Inst, Santa Fe, NM 87501 USA	Burnet Institute; University of Oxford; The Santa Fe Institute	Barry, AE (corresponding author), Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia.	alyssa.barry@burnet.edu.au		Barry, Alyssa/0000-0002-1189-2310; Reeder, John/0000-0003-1395-1289	National Health and Medical Research Council of Australia (NHMRC) [488221]; Victorian Endowment for Science Knowledge and Innovation; Sir Henry Wellcome Trust	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Endowment for Science Knowledge and Innovation; Sir Henry Wellcome Trust	This project was supported by Project Grant 488221 from the National Health and Medical Research Council of Australia (NHMRC). AEB was supported by an Innovation Fellowship from the Victorian Endowment for Science Knowledge and Innovation and a NHMRC Howard Florey Centenary Fellowship. JCR is supported by an NHMRC Research Fellowship. C.O.B. is supported by a Sir Henry Wellcome Trust Postdoctoral Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Amodu OK, 2005, ACTA TROP, V95, P226, DOI 10.1016/j.actatropica.2005.06.017; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 2000, MOL BIOCHEM PARASIT, V106, P321, DOI 10.1016/S0166-6851(99)00222-4; Anthony TG, 2007, MOL BIOCHEM PARASIT, V156, P117, DOI 10.1016/j.molbiopara.2007.07.008; Ariey F, 2001, J INFECT DIS, V184, P237, DOI 10.1086/322012; Baum J, 2003, GENETICS, V163, P1327; Benet A, 2004, MOL BIOCHEM PARASIT, V134, P275, DOI 10.1016/j.molbiopara.2003.12.005; BORRE MB, 1991, MOL BIOCHEM PARASIT, V49, P119, DOI 10.1016/0166-6851(91)90135-S; Bottius E, 1996, J IMMUNOL, V156, P2874; BUTTS CT, 2008, NETWORK CLASSES RELA; Conway DJ, 2001, MOL BIOCHEM PARASIT, V115, P145, DOI 10.1016/S0166-6851(01)00278-X; Cortes A, 2003, INFECT IMMUN, V71, P1416, DOI 10.1128/IAI.71.3.1416-1426.2003; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; Escalante AA, 2001, MOL BIOCHEM PARASIT, V113, P279, DOI 10.1016/S0166-6851(01)00229-8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Ferreira MU, 2003, GENE, V304, P65, DOI 10.1016/S0378-1119(02)01180-0; Ferreira MU, 1998, MEM I OSWALDO CRUZ, V93, P631, DOI 10.1590/S0074-02761998000500013; FIDOCK DA, 1994, J IMMUNOL, V153, P190; Fluck C, 2004, INFECT IMMUN, V72, P6300, DOI 10.1128/IAI.72.11.6300-6305.2004; FORSYTH KP, 1989, AM J TROP MED HYG, V40, P344, DOI 10.4269/ajtmh.1989.40.344; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Genton B, 2007, CURR OPIN INFECT DIS, V20, P467, DOI 10.1097/QCO.0b013e3282dd7a29; Gruner AC, 2001, J INFECT DIS, V184, P892, DOI 10.1086/323394; GUERINMARCHAND C, 1987, NATURE, V329, P164, DOI 10.1038/329164a0; Hartl DL, 2002, TRENDS PARASITOL, V18, P266, DOI 10.1016/S1471-4922(02)02268-7; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1992, GENETICS, V132, P583; HUGHES MK, 1995, MOL BIOCHEM PARASIT, V71, P99, DOI 10.1016/0166-6851(95)00037-2; Hume JCC, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-139; Jalloh A, 2006, J CLIN MICROBIOL, V44, P1229, DOI 10.1128/JCM.44.4.1229-1235.2006; Jongwutiwes S, 2002, MOL BIOL EVOL, V19, P1585, DOI 10.1093/oxfordjournals.molbev.a004220; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; KOCKEN CHM, 1993, MOL BIOCHEM PARASIT, V61, P59, DOI 10.1016/0166-6851(93)90158-T; Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935; Kumkhaek Chutima, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P281; Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601; Moran M., 2007, MALARIA PRODUCT PIPE; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Ofosu-Okyere A, 2001, PARASITOLOGY, V123, P113, DOI 10.1017/S0031182001008162; Polley SD, 2003, GENETICS, V165, P555; Polley SD, 2001, GENETICS, V158, P1505; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Polson HEJ, 2005, MOL BIOCHEM PARASIT, V142, P110, DOI 10.1016/j.molbiopara.2005.02.009; Pritchard JK, 2000, GENETICS, V155, P945; Robert F, 1996, T ROY SOC TROP MED H, V90, P704, DOI 10.1016/S0035-9203(96)90446-0; ROGERS WO, 1992, P NATL ACAD SCI USA, V89, P9176, DOI 10.1073/pnas.89.19.9176; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sallenave-Sales S, 2000, PARASITOL RES, V86, P692, DOI 10.1007/PL00008554; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Team RDC, 2019, R LANG ENV STAT COMP; Thera MA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010034; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang L, 2000, MOL BIOCHEM PARASIT, V109, P189, DOI 10.1016/S0166-6851(00)00248-6; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001; Wellems TE, 2009, J CLIN INVEST, V119, P2496, DOI 10.1172/JCI38307; *WHO, 2008, MAL VACC RAINB TABL; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; YOSHIDA N, 1980, SCIENCE, V207, P71, DOI 10.1126/science.6985745	67	78	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8497	10.1371/journal.pone.0008497	http://dx.doi.org/10.1371/journal.pone.0008497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041125	Green Published, gold			2022-12-25	WOS:000278068700012
J	Smith, RG; Kember, RL; Mill, J; Fernandes, C; Schalkwyk, LC; Buxbaum, JD; Reichenberg, A				Smith, Rebecca G.; Kember, Rachel L.; Mill, Jonathan; Fernandes, Cathy; Schalkwyk, Leonard C.; Buxbaum, Joseph D.; Reichenberg, Abraham			Advancing Paternal Age Is Associated with Deficits in Social and Exploratory Behaviors in the Offspring: A Mouse Model	PLOS ONE			English	Article							BIPOLAR DISORDER; AUTISM; SCHIZOPHRENIA; RISK	Background: Accumulating evidence from epidemiological research has demonstrated an association between advanced paternal age and risk for several psychiatric disorders including autism, schizophrenia and early-onset bipolar disorder. In order to establish causality, this study used an animal model to investigate the effects of advanced paternal age on behavioural deficits in the offspring. Methods: C57BL/6J offspring (n = 12 per group) were bred from fathers of two different ages, 2 months (young) and 10 months (old), and mothers aged 2 months (n = 6 breeding pairs per group). Social and exploratory behaviors were examined in the offspring. Principal Findings:The offspring of older fathers were found to engage in significantly less social (p = 0.02) and exploratory (p = 0.02) behaviors than the offspring of younger fathers. There were no significant differences in measures of motor activity. Conclusions: Given the well-controlled nature of this study, this provides the strongest evidence for deleterious effects of advancing paternal age on social and exploratory behavior. De-novo chromosomal changes and/or inherited epigenetic changes are the most plausible explanatory factors.	[Smith, Rebecca G.; Kember, Rachel L.; Mill, Jonathan; Schalkwyk, Leonard C.; Reichenberg, Abraham] Kings Coll London, MRC, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Fernandes, Cathy] Kings Coll London, Dept Psychol Med & Psychiat, London WC2R 2LS, England; [Buxbaum, Joseph D.; Reichenberg, Abraham] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Seaver Autism Ctr Res & Treatment, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Lab Mol Neuropsychiat, New York, NY USA	University of London; King's College London; University of London; King's College London; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Smith, RG (corresponding author), Kings Coll London, MRC, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England.	cathy.fernandes@kcl.ac.uk	Schalkwyk, Leonard C/A-2150-2010; Buxbaum, Joseph D/G-6001-2010; Mill, Jonathan S/B-3276-2010; Smith, Rebecca G/C-1978-2012; Mill, Jonathan/B-5678-2014; Fernandes, Cathy/F-3422-2011; Kember, Rachel/J-3128-2012; Reichenberg, Abraham/GQB-1227-2022	Schalkwyk, Leonard C/0000-0001-7030-5756; Mill, Jonathan S/0000-0003-1115-3224; Smith, Rebecca G/0000-0001-9264-1056; Mill, Jonathan/0000-0003-1115-3224; Kember, Rachel/0000-0001-8820-2659; Buxbaum, Joseph/0000-0001-8898-8313; Fernandes, Cathy/0000-0001-7318-3352	Beatrice and Samuel A. Seaver Foundation; British Medical Association Margaret Temple Award; National Institute of Health Research (NIHR) Biomedical Research Centre (BRC); Mental Health at the South London; Maudsley National Health Service (NHS) Foundation Trust; King's College London (KCL); Medical Research Council [G9817803B] Funding Source: researchfish	Beatrice and Samuel A. Seaver Foundation; British Medical Association Margaret Temple Award; National Institute of Health Research (NIHR) Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR)); Mental Health at the South London; Maudsley National Health Service (NHS) Foundation Trust; King's College London (KCL); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Beatrice and Samuel A. Seaver Foundation, by a British Medical Association Margaret Temple Award, and National Institute of Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at the South London and Maudsley National Health Service (NHS) Foundation Trust and Institute of Psychiatry, King's College London (KCL) Pilot Award to Drs. Jonathan Mill and Abraham (Avi) Reichenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brotman MA, 2008, J AM ACAD CHILD PSY, V47, P1455, DOI 10.1097/CHI.0b013e318188832e; Buwe A, 2005, CYTOGENET GENOME RES, V111, P213, DOI 10.1159/000086892; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P1211, DOI 10.1093/schbul/sbm145; Green MF, 2006, J CLIN PSYCHIAT, V67, P3, DOI 10.4088/JCP.1006e12; Hall C. S., 1951, HDB EXPT PSYCHOL, P304; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; NOLAN NA, 1973, PSYCHOPHARMACOLOGIA, V29, P277, DOI 10.1007/BF00414043; REICHENBERG A, COGNITIVE N IN PRESS; Rothman KJ., 1997, MODERN EPIDEMIOLOGY, V2nd; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Torrey EF, 2009, SCHIZOPHR RES, V114, P1, DOI 10.1016/j.schres.2009.06.017; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weiser M, 2008, SCHIZOPHRENIA BULL, V34, P1042, DOI 10.1093/schbul/sbn109; Winslow James T, 2003, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0816s22	21	64	64	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8456	10.1371/journal.pone.0008456	http://dx.doi.org/10.1371/journal.pone.0008456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601NW	20041141	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000278068700003
J	Tokuraku, K; Marquardt, M; Ikezu, T				Tokuraku, Kiyotaka; Marquardt, Meg; Ikezu, Tsuneya			Real-Time Imaging and Quantification of Amyloid-beta Peptide Aggregates by Novel Quantum-Dot Nanoprobes	PLOS ONE			English	Article							PROTEIN-DNA COMPLEXES; ALZHEIMERS-DISEASE; IN-VIVO; EXPERIMENTAL CONSTRAINTS; FIBRILS; DEGRADATION; EXPRESSION; RECEPTORS; PATHWAYS; DYNAMICS	Background: Protein aggregation plays a major role in the pathogenesis of neurodegenerative disorders, such as Alzheimer's disease. However, direct real-time imaging of protein aggregation, including oligomerization and fibrillization, has never been achieved. Here we demonstrate the preparation of fluorescent semiconductor nanocrystal (quantum dot; QD)-labeled amyloid-beta peptide (QDA beta) and its advanced applications. Methodology/Principal Findings: The QDA beta construct retained A beta oligomer-forming ability, and the sizes of these oligomers could be estimated from the relative fluorescence intensities of the imaged spots. Both QDA beta coaggregation with intact A beta 42 and insertion into fibrils were detected by fluorescence microscopy. The coaggregation process was observed by real-time 3D imaging using slit-scanning confocal microscopy, which showed a typical sigmoid curve with 1.5 h in the lag-time and 12 h until saturation. Inhibition of coaggregation using an anti-A beta antibody can be observed as 3D images on a microscopic scale. Microglia ingested monomeric QDA beta more significantly than oligomeric QDA beta, and the ingested QDA beta was mainly accumulated in the lysosome. Conclusions/Significance: These data demonstrate that QDAP is a novel nanoprobe for studying A beta oligomerization and fibrillization in multiple modalities and may be applicable for high-throughput drug screening systems.	[Tokuraku, Kiyotaka; Marquardt, Meg; Ikezu, Tsuneya] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Tokuraku, Kiyotaka] Miyakonojo Natl Coll Technol, Dept Chem Sci & Engn, Miyakonojo, Japan	University of Nebraska System; University of Nebraska Medical Center	Tokuraku, K (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.	tikezu@unmc.edu	; Tokuraku, Kiyotaka/D-4542-2014	Ikezu, Tsuneya/0000-0002-3979-8596; Tokuraku, Kiyotaka/0000-0002-7747-4808	NIH [AG032600]; Vada Kinman Oldfield Alzheimer Research Award; University of Nebraska Medical Center (UNMC); NATIONAL INSTITUTE ON AGING [R21AG032600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vada Kinman Oldfield Alzheimer Research Award; University of Nebraska Medical Center (UNMC); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is partly supported by NIH AG032600 (T.I.), Vada Kinman Oldfield Alzheimer Research Award (T.I.), University of Nebraska Medical Center (UNMC) Faculty Retention Fund (T.I.), Nanoimaging Core Facility and grants from NIH (SIG program), UNMC Program of Excellence, Nebraska Research Initiative, and Scholarship for Research Worker Abroad from Institute of National Colleges of Technology of Japan (K.T.). The hinders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Flaherty DP, 2007, J MED CHEM, V50, P4986, DOI 10.1021/jm070085f; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Ji XJ, 2006, COLLOID SURFACE B, V50, P104, DOI 10.1016/j.colsurfb.2006.02.010; Kandimalla KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004627; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lyubchenko YL, 2009, METHODS, V47, P206, DOI 10.1016/j.ymeth.2008.09.002; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6; Tew DJ, 2008, BIOPHYS J, V94, P2752, DOI 10.1529/biophysj.107.119909; Tsay JM, 2005, CHEM BIOL, V12, P1159, DOI 10.1016/j.chembiol.2005.11.002; Vestergaard M, 2008, BIOCHEM BIOPH RES CO, V377, P725, DOI 10.1016/j.bbrc.2008.10.072; Xu G, 2008, BIOCONJUGATE CHEM, V19, P1179, DOI 10.1021/bc700477u; Yamamoto M, 2008, J IMMUNOL, V181, P3877, DOI 10.4049/jimmunol.181.6.3877; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zhang TT, 2006, NANO LETT, V6, P800, DOI 10.1021/nl0603350	40	50	52	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8492	10.1371/journal.pone.0008492	http://dx.doi.org/10.1371/journal.pone.0008492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041162	gold, Green Submitted, Green Published			2022-12-25	WOS:000278068700007
J	Cigana, C; Curcuru, L; Leone, MR; Ierano, T; Lore, NI; Bianconi, I; Silipo, A; Cozzolino, F; Lanzetta, R; Molinaro, A; Bernardini, ML; Bragonzi, A				Cigana, Cristina; Curcuru, Laura; Leone, Maria Rosaria; Ierano, Teresa; Lore, Nicola Ivan; Bianconi, Irene; Silipo, Alba; Cozzolino, Flora; Lanzetta, Rosa; Molinaro, Antonio; Bernardini, Maria Lina; Bragonzi, Alessandra			Pseudomonas aeruginosa Exploits Lipid A and Muropeptides Modification as a Strategy to Lower Innate Immunity during Cystic Fibrosis Lung Infection	PLOS ONE			English	Article							ESCHERICHIA-COLI LIPOPOLYSACCHARIDE; NF-KAPPA-B; PEPTIDOGLYCAN; HOST; BACTERIAL; EXPRESSION; NOD1; PATHOGEN; RECOGNITION; RECEPTORS	Pseudomonas aeruginosa can establish life-long airways chronic infection in patients with cystic fibrosis (CF) with pathogenic variants distinguished from initially acquired strain. Here, we analysed chemical and biological activity of P. aeruginosa Pathogen-Associated Molecular Patterns (PAMPs) in clonal strains, including mucoid and non-mucoid phenotypes, isolated during a period of up to 7.5 years from a CF patient. Chemical structure by MS spectrometry defined lipopolysaccharide (LPS) lipid A and peptidoglycan (PGN) muropeptides with specific structural modifications temporally associated with CF lung infection. Gene sequence analysis revealed novel mutation in pagL, which supported lipid A changes. Both LPS and PGN had different potencies when activating host innate immunity via binding TLR4 and Nod1. Significantly higher NF-kappa B activation, IL-8 expression and production were detected in HEK293hTLR4/MD2-CD14 and HEK293hNod1 after stimulation with LPS and PGN respectively, purified from early P. aeruginosa strain as compared to late strains. Similar results were obtained in macrophages-like cells THP-1, epithelial cells of CF origin IB3-1 and their isogenic cells C38, corrected by insertion of cystic fibrosis transmembrane conductance regulator (CFTR). In murine model, altered LPS structure of P. aeruginosa late strains induces lower leukocyte recruitment in bronchoalveolar lavage and MIP-2, KC and IL-1 beta cytokine levels in lung homogenates when compared with early strain. Histopathological analysis of lung tissue sections confirmed differences between LPS from early and late P. aeruginosa. Finally, in this study for the first time we unveil how P. aeruginosa has evolved the capacity to evade immune system detection, thus promoting survival and establishing favourable conditions for chronic persistence. Our findings provide relevant information with respect to chronic infections in CF.	[Cigana, Cristina; Lore, Nicola Ivan; Bianconi, Irene; Bragonzi, Alessandra] Ist Sci San Raffaele, Infect & Cyst Fibrosis Unit, I-20132 Milan, Italy; [Curcuru, Laura; Bernardini, Maria Lina] Univ Roma La Sapienza, Dipartimento Biol Cellulare & Sviluppo, Rome, Italy; [Leone, Maria Rosaria; Ierano, Teresa; Silipo, Alba; Cozzolino, Flora; Lanzetta, Rosa; Molinaro, Antonio] Univ Naples Federico II, Dipartimento Chim Organ & Biochim, Naples, Italy; [Leone, Maria Rosaria; Ierano, Teresa; Silipo, Alba; Cozzolino, Flora; Lanzetta, Rosa; Molinaro, Antonio] CEINGE Biotecnol Avanzate, Naples, Italy; [Bernardini, Maria Lina] Fdn Cenci Bolognetti, Ist Pasteur, Rome, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sapienza University Rome; University of Naples Federico II; CEINGE Biotecnologie Avanzate; Fondazione Cenci Bolognetti	Cigana, C (corresponding author), Ist Sci San Raffaele, Infect & Cyst Fibrosis Unit, I-20132 Milan, Italy.	bragonzi.alessandra@hsr.it	Lorè, Nicola Ivan/K-9285-2016; Silipo, Alba/L-5929-2014; Bragonzi, Alessandra/AAC-6751-2022; Cigana, Cristina/D-2883-2016; cozzolino, flora/AAA-3155-2022	Lorè, Nicola Ivan/0000-0001-9159-1632; Cigana, Cristina/0000-0003-0436-9721; Molinaro, Antonio/0000-0002-3456-7369; Bianconi, Irene/0000-0002-5923-4296; Bragonzi, Alessandra/0000-0002-5808-7669; cozzolino, flora/0000-0002-4648-8107; silipo, alba/0000-0002-5394-6532; BERNARDINI, Maria/0000-0002-4305-7694; LANZETTA, Rosa/0000-0002-1472-5825	Fondazione per la ricerca sulla Fibrosi Cistica [FFC 8/2007];  [HEALTH-F7-2009-223670]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	Fondazione per la ricerca sulla Fibrosi Cistica(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported to AM and MLB by Fondazione per la ricerca sulla Fibrosi Cistica (FFC# 8/2007) with the contribute of Furla Spa, Grazia Valentini Scagliarini Spa, Delegazione FFC di Bologna and to AB by HEALTH-F7-2009-223670. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Backhed F, 2003, MICROBES INFECT, V5, P1057, DOI 10.1016/S1286-4579(03)00207-7; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; CHAPUT C, 2006, PLOS PATHOG, V2; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cigana C, 2007, ANTIMICROB AGENTS CH, V51, P975, DOI 10.1128/AAC.01142-06; Cigana C, 2006, BIOCHEM BIOPH RES CO, V350, P977, DOI 10.1016/j.bbrc.2006.09.132; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Coats SR, 2003, INFECT IMMUN, V71, P6799, DOI 10.1128/IAI.71.12.6799-6807.2003; Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; EGAN M, 1992, NATURE, V358, P581, DOI 10.1038/358581a0; Ernst RK, 2006, J BACTERIOL, V188, P191, DOI 10.1128/JB.188.1.191-201.2006; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Ernst RK, 2007, J INFECT DIS, V196, P1088, DOI 10.1086/521367; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; GARCIABUSTOS JF, 1987, ANTIMICROB AGENTS CH, V31, P178, DOI 10.1128/AAC.31.2.178; Geurtsen J, 2006, INFECT IMMUN, V74, P5574, DOI 10.1128/IAI.00834-06; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; Kawasaki K, 2004, J BIOL CHEM, V279, P20044, DOI 10.1074/jbc.M401275200; Knirel YA, 2006, J ENDOTOXIN RES, V12, P324, DOI 10.1179/096805106X118906; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Montanari S, 2007, MICROBIOL-SGM, V153, P1445, DOI 10.1099/mic.0.2006/003400-0; Nigro G, 2008, CELL MICROBIOL, V10, P682, DOI 10.1111/j.1462-5822.2007.01075.x; POHLMAN TH, 1987, J EXP MED, V165, P1393, DOI 10.1084/jem.165.5.1393; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; SORRENTINO R, 2008, BRIT J PHARMACOL, V154, P684; STGEME JW, 1991, INFECT IMMUN, V59, P1325, DOI 10.1128/IAI.59.4.1325-1333.1991; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tanamoto K, 2000, J IMMUNOL, V164, P3149, DOI 10.4049/jimmunol.164.6.3149; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; Uehara A, 2005, CELL MICROBIOL, V7, P675, DOI 10.1111/j.1462-5822.2004.00500.x; Verma N, 2009, FEBS LETT, V583, P2968, DOI 10.1016/j.febslet.2009.08.007; Wang G, 2009, J BIOL CHEM, V284, P6790, DOI 10.1074/jbc.M808071200; Wolfert MA, 2007, INFECT IMMUN, V75, P706, DOI 10.1128/IAI.01597-06; Wu MF, 2009, INFECT IMMUN, V77, P615, DOI 10.1128/IAI.00931-08; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	54	87	88	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8439	10.1371/journal.pone.0008439	http://dx.doi.org/10.1371/journal.pone.0008439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037649	Green Published, gold, Green Submitted			2022-12-25	WOS:000272998100019
J	Pilbrough, W; Munro, TP; Gray, P				Pilbrough, Warren; Munro, Trent P.; Gray, Peter			Intraclonal Protein Expression Heterogeneity in Recombinant CHO Cells	PLOS ONE			English	Article							HAMSTER OVARY CELLS; STOCHASTIC GENE-EXPRESSION; ANTIBODY-PRODUCTION; ANTIGEN EXPRESSION; MOLECULAR ANALYSIS; CLONAL VARIATION; DNA INTEGRATION; STABILITY; NOISE; AMPLIFICATION	Therapeutic glycoproteins have played a major role in the commercial success of biotechnology in the post-genomic era. But isolating recombinant mammalian cell lines for large-scale production remains costly and time-consuming, due to substantial variation and unpredictable stability of expression amongst transfected cells, requiring extensive clone screening to identify suitable high producers. Streamlining this process is of considerable interest to industry yet the underlying phenomena are still not well understood. Here we examine an antibody-expressing Chinese hamster ovary (CHO) clone at single-cell resolution using flow cytometry and vectors, which couple light and heavy chain transcription to fluorescent markers. Expression variation has traditionally been attributed to genetic heterogeneity arising from random genomic integration of vector DNA. It follows that single cell cloning should yield a homogeneous cell population. We show, in fact, that expression in a clone can be surprisingly heterogeneous (standard deviation 50 to 70% of the mean), approaching the level of variation in mixed transfectant pools, and each antibody chain varies in tandem. Phenotypic variation is fully developed within just 18 days of cloning, yet is not entirely explained by measurement noise, cell size, or the cell cycle. By monitoring the dynamic response of subpopulations and subclones, we show that cells also undergo slow stochastic fluctuations in expression (half-life 2 to 11 generations). Non-genetic diversity may therefore play a greater role in clonal variation than previously thought. This also has unexpected implications for expression stability. Stochastic gene expression noise and selection bias lead to perturbations from steady state at the time of cloning. The resulting transient response as clones reestablish their expression distribution is not ordinarily accounted for but can contribute to declines in median expression over timescales of up to 50 days. Noise minimization may therefore be a novel strategy to reduce apparent expression instability and simplify cell line selection.	[Pilbrough, Warren; Munro, Trent P.; Gray, Peter] Univ Queensland, AIBN, Brisbane, Qld, Australia; [Munro, Trent P.; Gray, Peter] ACYTE Biotech Pty Ltd, Brisbane, Qld, Australia	University of Queensland	Pilbrough, W (corresponding author), Univ Queensland, AIBN, Brisbane, Qld, Australia.	t.munro@uq.edu.au	Munro, Trent/AAC-1129-2020; Munro, Trent/B-4856-2009	Munro, Trent/0000-0003-1987-2020; 	University of Queensland; Merck Co., Inc.	University of Queensland(University of Queensland); Merck Co., Inc.(Merck & Company)	TPM and PPG are supported by the University of Queensland. WP was supported by Merck & Co., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHLER DW, 1984, CANCER RES, V44, P3317; Bailey CG, 1999, BIOTECHNOL TECH, V13, P615, DOI 10.1023/A:1008926708028; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Barnes LM, 2004, BIOTECHNOL BIOENG, V85, P115, DOI 10.1002/bit.10893; Barnes LM, 2003, BIOTECHNOL BIOENG, V81, P631, DOI 10.1002/bit.10517; Barnes LM, 2001, BIOTECHNOL BIOENG, V73, P261, DOI 10.1002/bit.1059; Barnes LM, 2007, BIOTECHNOL BIOENG, V96, P337, DOI 10.1002/bit.21119; Barnes LM, 2006, BIOTECHNOL BIOENG, V94, P530, DOI 10.1002/bit.20856; Batada NN, 2007, TRENDS GENET, V23, P480, DOI 10.1016/j.tig.2007.08.003; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; Borth N, 2000, BIOTECHNOL BIOENG, V71, P266, DOI 10.1002/1097-0290(2000)71:4<266::AID-BIT1016>3.0.CO;2-2; Brenner N, 2006, PHYS BIOL, V3, P172, DOI 10.1088/1478-3975/3/3/002; Brezinsky SCG, 2003, J IMMUNOL METHODS, V277, P141, DOI 10.1016/S0022-1759(03)00108-X; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen C, 1998, SOMAT CELL MOLEC GEN, V24, P249, DOI 10.1023/B:SCAM.0000007127.80657.10; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; COON JS, 1985, CANCER RES, V45, P3014; DeMaria CT, 2007, BIOTECHNOL PROGR, V23, P465, DOI 10.1021/bp060298i; Derouazi M, 2006, BIOCHEM BIOPH RES CO, V340, P1069, DOI 10.1016/j.bbrc.2005.12.111; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fann CH, 2000, BIOTECHNOL BIOENG, V69, P204; Fann CH, 1999, BIOTECHNOL BIOENG, V63, P464, DOI 10.1002/(SICI)1097-0290(19990520)63:4<464::AID-BIT10>3.0.CO;2-H; FENDROCK B, 1986, HISTOCHEMISTRY, V84, P121, DOI 10.1007/BF00499822; Galbete JL, 2009, MOL BIOSYST, V5, P143, DOI 10.1039/b813657b; GAMEL JW, 1991, CELL PROLIFERAT, V24, P281, DOI 10.1111/j.1365-2184.1991.tb01157.x; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; GRIFFIN JE, 1981, J BIOL CHEM, V256, P3662; HUANG MTF, 1990, NUCLEIC ACIDS RES, V18, P937, DOI 10.1093/nar/18.4.937; Jayapal KR, 2007, CHEM ENG PROG, V103, P40; Jun SC, 2006, BIOTECHNOL PROGR, V22, P770, DOI 10.1021/bp060004t; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P537, DOI 10.1016/0076-6879(90)85044-O; Kim NS, 1998, BIOTECHNOL BIOENG, V60, P679, DOI 10.1002/(SICI)1097-0290(19981220)60:6<679::AID-BIT5>3.0.CO;2-Q; Kim NS, 2001, BIOTECHNOL PROGR, V17, P69, DOI 10.1021/bp000144h; Kim SJ, 1998, BIOTECHNOL BIOENG, V58, P73, DOI 10.1002/(SICI)1097-0290(19980405)58:1<73::AID-BIT8>3.0.CO;2-R; Kim SH, 2007, J MICROBIOL BIOTECHN, V17, P712; KROMENAKER SJ, 1994, BIOTECHNOL PROGR, V10, P299, DOI 10.1021/bp00027a010; Kwaks T, 2005, J BIOTECHNOL, V115, P35, DOI 10.1016/j.jbiotec.2004.07.012; Lattenmayer C, 2006, CYTOTECHNOLOGY, V51, P171, DOI 10.1007/s10616-006-9029-0; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Lloyd DR, 2000, CYTOTECHNOLOGY, V34, P59, DOI 10.1023/A:1008103730027; MCNEALL J, 1989, GENE, V76, P81, DOI 10.1016/0378-1119(89)90010-3; MEISLER MH, 1992, TRENDS GENET, V8, P341, DOI 10.1016/0168-9525(92)90278-C; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Muller K, 2001, J BIOL CHEM, V276, P14271; Neildez-Nguyen TMA, 2008, DIFFERENTIATION, V76, P33, DOI 10.1111/j.1432-0436.2007.00219.x; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PENDSE GJ, 1992, BIOTECHNOL BIOENG, V40, P119, DOI 10.1002/bit.260400117; PETERSON JA, 1983, CANCER RES, V43, P4291; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Pritchard C, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r26; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Ramos CA, 2006, PLOS GENET, V2, P1487, DOI 10.1371/journal.pgen.0020159; Ramunas J, 2007, MOL THER, V15, P810, DOI 10.1038/sj.mt.6300073; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; RUBIN H, 1990, CANCER METAST REV, V9, P1, DOI 10.1007/BF00047585; Sato N, 2004, GENES CELLS, V9, P619, DOI 10.1111/j.1356-9597.2004.00751.x; SCHIMKE RT, 1985, BRIT J CANCER, V51, P459, DOI 10.1038/bjc.1985.66; Schirrmann T, 2008, FRONT BIOSCI-LANDMRK, V13, P4576, DOI 10.2741/3024; Schlatter S, 2005, BIOTECHNOL PROGR, V21, P122, DOI 10.1021/bp049780w; Schroder M, 1997, BIOTECHNOL BIOENG, V53, P547, DOI 10.1002/(SICI)1097-0290(19970320)53:6<547::AID-BIT2>3.0.CO;2-M; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sleiman RJ, 2008, BIOTECHNOL BIOENG, V99, P578, DOI 10.1002/bit.21612; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Strutzenberger K, 1999, J BIOTECHNOL, V69, P215, DOI 10.1016/S0168-1656(99)00044-9; Subkhankulova T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-268; TAUPIER MA, 1983, CANCER RES, V43, P4050; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Voliotis M, 2008, BIOPHYS J, V94, P334, DOI 10.1529/biophysj.107.105767; Voon DC, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni030; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Winnard P, 2006, CANCER GENET CYTOGEN, V164, P174, DOI 10.1016/j.cancergencyto.2005.07.021; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Wurtele H, 2003, GENE THER, V10, P1791, DOI 10.1038/sj.gt.3302074; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yoon SK, 2004, BIOTECHNOL PROGR, V20, P1683, DOI 10.1021/bp049847f; Yoshikawa Y, 2000, BIOTECHNOL PROGR, V16, P710, DOI 10.1021/bp000114e; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	94	144	152	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8432	10.1371/journal.pone.0008432	http://dx.doi.org/10.1371/journal.pone.0008432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037651	Green Published, gold, Green Submitted			2022-12-25	WOS:000272998100017
J	Ubuka, T; Morgan, K; Pawson, AJ; Osugi, T; Chowdhury, VS; Minakata, H; Tsutsui, K; Millar, RP; Bentley, GE				Ubuka, Takayoshi; Morgan, Kevin; Pawson, Adam J.; Osugi, Tomohiro; Chowdhury, Vishwajit S.; Minakata, Hiroyuki; Tsutsui, Kazuyoshi; Millar, Robert P.; Bentley, George E.			Identification of Human GnIH Homologs, RFRP-1 and RFRP-3, and the Cognate Receptor, GPR147 in the Human Hypothalamic Pituitary Axis	PLOS ONE			English	Article							GONADOTROPIN-INHIBITORY HORMONE; RFAMIDE-RELATED PEPTIDE-3; QUAIL COTURNIX-JAPONICA; LPXRF-AMIDE PEPTIDES; LUTEINIZING-HORMONE; HYPOPHYSIOTROPIC ROLE; LH-SECRETION; CHICKEN; BRAIN; EXPRESSION	The existence of a hypothalamic gonadotropin-inhibiting system has been elusive. A neuropeptide named gonadotropin-inhibitory hormone (GnIH, SIKPSAYLPLRF-NH(2)) which directly inhibits gonadotropin synthesis and release from the pituitary was recently identified in quail hypothalamus. Here we identify GnIH homologs in the human hypothalamus and characterize their distribution and biological activity. GnIH homologs were isolated from the human hypothalamus by immunoaffinity purification, and then identified as MPHSFANLPLRF-NH(2) (human RFRP-1) and VPNLPQRF-NH(2) (human RFRP-3) by mass spectrometry. Immunocytochemistry revealed GnIH-immunoreactive neuronal cell bodies in the dorsomedial region of the hypothalamus with axonal projections to GnRH neurons in the preoptic area as well as to the median eminence. RT-PCR and subsequent DNA sequencing of the PCR products identified human GnIH receptor (GPR147) mRNA expression in the hypothalamus as well as in the pituitary. In situ hybridization further identified the expression of GPR147 mRNA in luteinizing hormone producing cells (gonadotropes). Human RFRP-3 has recently been shown to be a potent inhibitor of gonadotropin secretion in cultured sheep pituitary cells by inhibiting Ca(2+) mobilization. It also directly modulates GnRH neuron firing. The identification of two forms of GnIH (RFRP-1 and RFRP-3) in the human hypothalamus which targets human GnRH neurons and gonadotropes and potently inhibit gonadotropin in sheep models provides a new paradigm for the regulation of hypothalamic-pituitary-gonadal axis in man and a novel means for manipulating reproductive functions.	[Ubuka, Takayoshi; Bentley, George E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Ubuka, Takayoshi; Bentley, George E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Morgan, Kevin; Pawson, Adam J.; Millar, Robert P.] Queens Med Res Inst, MRC, Human Reprod Sci Unit, Ctr Reprod Biol, Edinburgh, Midlothian, Scotland; [Osugi, Tomohiro; Chowdhury, Vishwajit S.; Tsutsui, Kazuyoshi] Waseda Univ, Dept Biol, Tokyo, Japan; [Minakata, Hiroyuki] Suntory Inst Bioorgan Res, Osaka 618, Japan; [Millar, Robert P.] Univ Cape Town, Dept Med Biochem, ZA-7925 Cape Town, South Africa	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Edinburgh; Waseda University; Suntory Holdings Ltd; University of Cape Town	Ubuka, T (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	ubukat@berkeley.edu	Pawson, Adam J/Q-5678-2016; Oka, Yoshitaka/C-9670-2010; Millar, Robert P/A-4853-2012	Pawson, Adam J/0000-0003-2280-845X; Oka, Yoshitaka/0000-0002-3482-3051; Osugi, Tomohiro/0000-0001-6987-9576; Sur Chowdhury, Vishwajit/0000-0001-6709-2788; Ubuka, Takayoshi/0000-0002-4731-8118; Millar, Robert P/0000-0003-3606-2708	Hellmann Family Foundation Fund; UC Berkeley; National Science Foundation; Ministry of Education, Science and Culture, Japan	Hellmann Family Foundation Fund; UC Berkeley; National Science Foundation(National Science Foundation (NSF)); Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Hellmann Family Foundation Fund (to G. E. B.), UC Berkeley COR Junior Faculty Research Grant (to G. E. B.), National Science Foundation (to G. E. B.), Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan (to K. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GM, 2009, ENDOCRINOLOGY, V150, P1834, DOI 10.1210/en.2008-1359; BALEN AH, 1995, J REPROD FERTIL, V104, P285; Bentley GE, 2006, HORM BEHAV, V49, P550, DOI 10.1016/j.yhbeh.2005.12.005; Bentley GE, 2003, J NEUROENDOCRINOL, V15, P794, DOI 10.1046/j.1365-2826.2003.01062.x; BURGUS R, 1972, P NATL ACAD SCI USA, V69, P278, DOI 10.1073/pnas.69.1.278; Ciccone NA, 2004, J NEUROENDOCRINOL, V16, P999, DOI 10.1111/j.1365-2826.2005.01260.x; Clarke IJ, 2008, ENDOCRINOLOGY, V149, P5811, DOI 10.1210/en.2008-0575; Ducret E, 2009, ENDOCRINOLOGY, V150, P2799, DOI 10.1210/en.2008-1623; EMONS G, 1994, HUM REPROD, V9, P1364, DOI 10.1093/oxfordjournals.humrep.a138714; Fukusumi S, 2006, PEPTIDES, V27, P1073, DOI 10.1016/j.peptides.2005.06.031; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; HWAN JC, 1987, ENDOCRINOLOGY, V120, P483, DOI 10.1210/endo-120-2-483; Johnson MA, 2007, HORM BEHAV, V51, P171, DOI 10.1016/j.yhbeh.2006.09.009; Kadokawa H, 2009, DOMEST ANIM ENDOCRIN, V36, P219, DOI 10.1016/j.domaniend.2009.02.001; KING JA, 1982, J BIOL CHEM, V257, P729; KING JA, 1982, J BIOL CHEM, V257, P722; Kirby ED, 2009, P NATL ACAD SCI USA, V106, P11324, DOI 10.1073/pnas.0901176106; Kriegsfeld LJ, 2006, P NATL ACAD SCI USA, V103, P2410, DOI 10.1073/pnas.0511003103; MATSUO H, 1971, BIOCHEM BIOPH RES CO, V43, P1334, DOI 10.1016/S0006-291X(71)80019-0; MCCANN SM, 1969, PHYSIOL REV, V49, P240, DOI 10.1152/physrev.1969.49.2.240; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Millar RP, 2000, BRIT MED BULL, V56, P761, DOI 10.1258/0007142001903346; MIYAMOTO K, 1982, BIOCHEM BIOPH RES CO, V107, P820, DOI 10.1016/0006-291X(82)90596-4; Murakami M, 2008, J ENDOCRINOL, V199, P105, DOI 10.1677/JOE-08-0197; Osugi T, 2004, J ENDOCRINOL, V182, P33, DOI 10.1677/joe.0.1820033; SARI IP, 2009, ENDOCRINOLO IN PRESS; Satake H, 2001, BIOCHEM J, V354, P379, DOI 10.1042/0264-6021:3540379; Smith JT, 2008, ENDOCRINOLOGY, V149, P5770, DOI 10.1210/en.2008-0581; Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Tsutsui K, 2006, PEPTIDES, V27, P1121, DOI 10.1016/j.peptides.2005.06.036; Ubuka T, 2005, P NATL ACAD SCI USA, V102, P3052, DOI 10.1073/pnas.0403840102; Ubuka T, 2006, ENDOCRINOLOGY, V147, P1187, DOI 10.1210/en.2005-1178; Ubuka T, 2003, J ENDOCRINOL, V178, P311, DOI 10.1677/joe.0.1780311; Ubuka T, 2008, INTEGR COMP BIOL, V48, P560, DOI 10.1093/icb/icn019; Ubuka T, 2008, ENDOCRINOLOGY, V149, P4229; Ubuka T, 2008, ENDOCRINOLOGY, V149, P268, DOI 10.1210/en.2007-0983; Ubuka T, 2009, J COMP NEUROL, V517, P841, DOI 10.1002/cne.22191; Ukena K, 2003, CELL TISSUE RES, V312, P73, DOI 10.1007/s00441-003-0700-x; Ukena K, 2002, FEBS LETT, V512, P255, DOI 10.1016/S0014-5793(02)02275-5; Ukena K, 2005, MASS SPECTROM REV, V24, P469, DOI 10.1002/mas.20031; Ukena K, 2003, ENDOCRINOLOGY, V144, P3879, DOI 10.1210/en.2003-0359; URBANSKI HF, 1990, J REPROD FERTIL, V90, P157, DOI 10.1530/jrf.0.0900157; WU M, 2009, J PHYSL, P1401; Yin H, 2005, J ENDOCRINOL, V184, P257, DOI 10.1677/joe.1.05926	44	194	201	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8400	10.1371/journal.pone.0008400	http://dx.doi.org/10.1371/journal.pone.0008400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027225	Green Published, gold, Green Submitted			2022-12-25	WOS:000272998000007
J	Zerbino, DR; McEwen, GK; Margulies, EH; Birney, E				Zerbino, Daniel R.; McEwen, Gayle K.; Margulies, Elliott H.; Birney, Ewan			Pebble and Rock Band: Heuristic Resolution of Repeats and Scaffolding in the Velvet Short-Read de Novo Assembler	PLOS ONE			English	Article							SHORT DNA-SEQUENCES; GENOME; ALGORITHM; MILLIONS	Background: Despite the short length of their reads, micro-read sequencing technologies have shown their usefulness for de novo sequencing. However, especially in eukaryotic genomes, complex repeat patterns are an obstacle to large assemblies. Principal Findings: We present a novel heuristic algorithm, Pebble, which uses paired-end read information to resolve repeats and scaffold contigs to produce large-scale assemblies. In simulations, we can achieve weighted median scaffold lengths (N50) of above 1 Mbp in Bacteria and above 100 kbp in more complex organisms. Using real datasets we obtained a 96 kbp N50 in Pseudomonas syringae and a unique 147 kbp scaffold of a ferret BAC clone. We also present an efficient algorithm called Rock Band for the resolution of repeats in the case of mixed length assemblies, where different sequencing platforms are combined to obtain a cost-effective assembly. Conclusions: These algorithms extend the utility of short read only assemblies into large complex genomes. They have been implemented and made available within the open-source Velvet short-read de novo assembler.	[Zerbino, Daniel R.; Birney, Ewan] European Bioinformat Inst, Cambridge, England; [McEwen, Gayle K.; Margulies, Elliott H.] NIH, Genome Technol Branch, NHGRI, Bethesda, MD 20892 USA	European Molecular Biology Laboratory (EMBL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Zerbino, DR (corresponding author), European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge, England.	zerbino@ebi.ac.uk		Birney, Ewan/0000-0001-8314-8497; McEwen, Gayle/0000-0001-5134-1380; Zerbino, Daniel/0000-0001-5350-3056	European Molecular Biology Laboratory; National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200341] Funding Source: NIH RePORTER	European Molecular Biology Laboratory; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	D. R. Z. and E. B. are funded by European Molecular Biology Laboratory's central funds, G. K. M. and E. H. M by the Intramural Research Program of the National Human Genome Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan AN, 2001, BIOINFORMATICS, V17, P327, DOI 10.1093/bioinformatics/17.4.327; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; CHEN J, 2007, ADV GENOME SEQUENCIN; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hossain MS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S16; Huson DH, 2002, J ACM, V49, P603, DOI 10.1145/585265.585267; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MEDVEDEV P, 2008, P 12 ANN RES COMP BI; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Pandey V, 2008, NEXT GENERATION GENO, P29, DOI DOI 10.1002/9783527625130.CH3; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pop M, 2004, GENOME RES, V14, P149; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Whiteford N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni170; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	28	142	143	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8407	10.1371/journal.pone.0008407	http://dx.doi.org/10.1371/journal.pone.0008407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027311	Green Published, Green Submitted, gold			2022-12-25	WOS:000272998000012
J	Irles, P; Belles, X; Piulachs, MD				Irles, Paula; Belles, Xavier; Dolors Piulachs, M.			Brownie, a Gene Involved in Building Complex Respiratory Devices in Insect Eggshells	PLOS ONE			English	Article							DROSOPHILA; COCKROACH; CHORIOGENESIS; EXPRESSION	Background: Insect eggshells must combine protection for the yolk and embryo with provisions for respiration and for the entry of sperm, which are ensured by aeropyles and micropyles, respectively. Insects which oviposit the eggs in an egg-case have a double problem of respiration as gas exchange then involves two barriers. An example of this situation is found in the cockroach Blattella germanica, where the aeropyle and the micropyle are combined in a complex structure called the sponge-like body. The sponge-like body has been well described morphologically, but nothing is known about how it is built up. Methodology/Principal Findings: In a library designed to find genes expressed during late chorion formation in B. germanica, we isolated the novel sequence Bg30009 (now called Brownie), which was outstanding due to its high copy number. In the present work, we show that Brownie is expressed in the follicle cells localized in the anterior pole of the oocyte in late choriogenesis. RNA interference (RNAi) of Brownie impaired correct formation of the sponge-like body and, as a result, the egg-case was also ill-formed and the eggs were not viable. Conclusions/Significance: Results indicate that the novel gene Brownie plays a pivotal role in building up the sponge-like body. Brownie is the first reported gene involved in the construction of complex eggshell respiratory structures.	[Irles, Paula; Belles, Xavier; Dolors Piulachs, M.] UPF, CSIC, Inst Biol Evolut, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Irles, P (corresponding author), UPF, CSIC, Inst Biol Evolut, Barcelona, Spain.	mdolors.piulachs@ibe.upf-csic.es	Piulachs, Maria-Dolors/C-3992-2011; Belles, Xavier/G-2354-2015	Piulachs, Maria-Dolors/0000-0002-4500-2718; Belles, Xavier/0000-0002-1566-303X; Irles, Paula/0000-0003-1968-1902	Ministry of Science and Innovation, Spain [BFU2008-00484, CGL2008-03517/BOS]; Laboratorio Internacional de Cambio Global (LINC-Global); Consejo Superior de Investigaciones Cientificas [I3P]	Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Laboratorio Internacional de Cambio Global (LINC-Global); Consejo Superior de Investigaciones Cientificas	Financial support from the Ministry of Science and Innovation, Spain (projects BFU2008-00484 to MDP and CGL2008-03517/BOS to XB) and from Laboratorio Internacional de Cambio Global (LINC-Global) (Pontificia Universidad Catolica-Consejo Superior de Investigaciones Cientificas) is gratefully acknowledged. PI is recipient of a pre-doctoral research grant (I3P) from the Consejo Superior de Investigaciones Cientificas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.T., 1972, pUnpaginated; BELLES X, 1993, TISSUE CELL, V25, P195, DOI 10.1016/0040-8166(93)90019-H; Ciudad L, 2006, FEBS J, V273, P325, DOI 10.1111/j.1742-4658.2005.05066.x; Claycomb JM, 2004, DEV CELL, V6, P145, DOI 10.1016/S1534-5807(03)00398-8; Fakhouri M, 2006, DEV BIOL, V293, P127, DOI 10.1016/j.ydbio.2006.01.028; Hinton HE, 1981, BIOL INSECT EGGS; Irles P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-206; LAWSON F, 1951, OHIO J SCI, V52, P296; Mullins DE, 2002, J EXP BIOL, V205, P2987; PARKS S, 1987, GENE DEV, V1, P497, DOI 10.1101/gad.1.5.497; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; WIGGLESWORTH VB, 1950, Q J MICROSC SCI, V91, P429	12	15	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2009	4	12							e8353	10.1371/journal.pone.0008353	http://dx.doi.org/10.1371/journal.pone.0008353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533OP	20020062	Green Published, gold			2022-12-25	WOS:000272834000024
J	Cardoso, LEM; Little, PJ; Ballinger, ML; Chan, CK; Braun, KR; Potter-Perigo, S; Bornfeldt, KE; Kinsella, MG; Wight, TN				Cardoso, Luiz E. M.; Little, Peter J.; Ballinger, Mandy L.; Chan, Christina K.; Braun, Kathleen R.; Potter-Perigo, Susan; Bornfeldt, Karin E.; Kinsella, Michael G.; Wight, Thomas N.			Platelet-derived Growth Factor Differentially Regulates the Expression and Post-translational Modification of Versican by Arterial Smooth Muscle Cells through Distinct Protein Kinase C and Extracellular Signal-regulated Kinase Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; TRANSFORMING GROWTH-FACTOR-BETA-1; PHENOTYPIC MODULATION; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; II DECORIN; BIGLYCAN; ACTIVATION; MIGRATION; ATHEROSCLEROSIS	The synthesis of proteoglycans involves steps that regulate both protein and glycosaminoglycan (GAG) synthesis, but it is unclear whether these two pathways are regulated by the same or different signaling pathways. We therefore investigated signaling pathways involved in platelet-derived growth factor (PDGF)-mediated increases in versican core protein and GAG chain synthesis in arterial smooth muscle cells (ASMCs). PDGF treatment of ASMCs resulted in increased versican core protein synthesis and elongation of GAG chains attached to the versican core protein. The effects of PDGF on versican mRNA were blocked by inhibiting either protein kinase C (PKC) or the ERK pathways, whereas the GAG elongation effect of PDGF was blocked by PKC inhibition but not by ERK inhibition. Interestingly, blocking protein synthesis in the presence of cycloheximide abolished the PDGF effect, but not in the presence of xyloside, indicating that GAG synthesis that results from PKC activation is independent from de novo protein synthesis. PDGF also stimulated an increase in the chondroitin-6-sulfate to chondroitin-4-sulfate ratio of GAG chains on versican, and this effect was blocked by PKC inhibitors. These data show that PKC activation is sufficient to cause GAG chain elongation, but both PKC and ERK activation are required for versican mRNA core protein expression. These results indicate that different signaling pathways control different aspects of PDGF-stimulated versican biosynthesis by ASMCs. These data will be useful in designing strategies to interfere with the synthesis of this proteoglycan in various disease states.	[Cardoso, Luiz E. M.; Chan, Christina K.; Braun, Kathleen R.; Potter-Perigo, Susan; Kinsella, Michael G.; Wight, Thomas N.] Benaroya Res Inst Virginia Mason, Hope Heart Program, Seattle, WA 98101 USA; [Little, Peter J.; Ballinger, Mandy L.] Baker IDI Heart & Diabet Inst, Cell Biol Diabet Lab, Melbourne, Vic 3004, Australia; [Little, Peter J.] Monash Univ, Sch Med, Dept Med, Alfred Hosp, Prahran, Vic 3004, Australia; [Little, Peter J.] Monash Univ, Sch Med, Dept Immunol, Alfred Hosp, Prahran, Vic 3004, Australia; [Bornfeldt, Karin E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Benaroya Research Institute; Virginia Mason Medical Center; Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; University of Washington; University of Washington Seattle	Wight, TN (corresponding author), Benaroya Res Inst Virginia Mason, Hope Heart Program, 1201 9th Ave, Seattle, WA 98101 USA.	twight@benaroyaresearch.org	Bornfeldt, Karin/AAI-2241-2019; Little, Peter J./F-9865-2015	Bornfeldt, Karin/0000-0001-9208-6523; Little, Peter J./0000-0002-0335-3835; Ballinger, Mandy/0000-0002-9706-0514	National Institutes of Health [HL18645, HL62887, HL88627]; National Health and Medical Research Council of Australia Research Project [268928]; Diabetes Australia Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645, R01HL062887, R01HL088627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia Research Project(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL18645 (to T.N.W.) and HL62887 and HL88627 (to K. E. B.). This work was also supported by National Health and Medical Research Council of Australia Research Project Grant 268928 and by funds from the Diabetes Australia Research Trust (to P.J.L.).	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; ASANO T, 1984, J PHARMACOL EXP THER, V231, P141; Ballinger ML, 2004, CELL MOL LIFE SCI, V61, P1296, DOI 10.1007/s00018-004-3389-4; BALLINGER ML, 2009, J CELL MOL IN PRESS; BERENSON GS, 1988, ARCH PATHOL LAB MED, V112, P1002; BERGSTRAND H, 1992, J PHARMACOL EXP THER, V263, P1334; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; Bornfeldt KE, 1997, J CLIN INVEST, V100, P875, DOI 10.1172/JCI119603; CAMEJO G, 1980, ATHEROSCLEROSIS, V35, P307, DOI 10.1016/0021-9150(80)90129-X; CARLSON DM, 1968, J BIOL CHEM, V243, P616; Cartel NJ, 2001, AM J PHYSIOL-LUNG C, V281, pL786, DOI 10.1152/ajplung.2001.281.4.L786; CHANG Y, 1983, J BIOL CHEM, V258, P5679; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dadlani H, 2008, J BIOL CHEM, V283, P7844, DOI 10.1074/jbc.M703125200; DAY AA, 1987, BIOCHEM J, V248, P801, DOI 10.1042/bj2480801; FISHER LW, 1989, J BIOL CHEM, V264, P4571; Hascall V.C., 1991, CELL BIOL EXTRACELLU, P149; Hedin U, 1997, J CELL PHYSIOL, V172, P109, DOI 10.1002/(SICI)1097-4652(199707)172:1<109::AID-JCP12>3.0.CO;2-7; HIDAKA Y, 1992, ATHEROSCLEROSIS, V95, P87, DOI 10.1016/0021-9150(92)90179-K; Igarashi M, 1999, J CLIN INVEST, V103, P185, DOI 10.1172/JCI3326; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; JARVELAINEN HT, 1991, J BIOL CHEM, V266, P23274; Kaplan-Albuquerque N, 2005, J BIOL CHEM, V280, P19966, DOI 10.1074/jbc.M500917200; Kinsella MG, 1997, J BIOL CHEM, V272, P318; Kinsella MG, 2004, CRIT REV EUKAR GENE, V14, P203, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.40; Kitagawa H, 2000, J BIOL CHEM, V275, P21075, DOI 10.1074/jbc.M002101200; KOBAYASHI S, 1985, BIOCHIM BIOPHYS ACTA, V841, P71, DOI 10.1016/0304-4165(85)90275-2; KRUSIUS T, 1987, J BIOL CHEM, V262, P13120; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAHY JC, 1991, NEUROSCIENCE, V44, P361, DOI 10.1016/0306-4522(91)90061-R; Little PJ, 2007, VASC HEALTH RISK MAN, V3, P117; Liu J, 1998, AM J PHYSIOL-LUNG C, V274, pL702, DOI 10.1152/ajplung.1998.274.5.L702; Maniatis T, 1982, MOL CLONING LABORATO, P433; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; Prydz K, 2000, J CELL SCI, V113, P193; ROSS R, 1990, PHILOS T ROY SOC B, V327, P155, DOI 10.1098/rstb.1990.0051; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Roy J, 2001, DIFFERENTIATION, V67, P50, DOI 10.1046/j.1432-0436.2001.067001050.x; SCHONHERR E, 1993, ARTERIOSCLER THROMB, V13, P1026, DOI 10.1161/01.ATV.13.7.1026; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Schonherr E, 1997, ARCH BIOCHEM BIOPHYS, V339, P353, DOI 10.1006/abbi.1996.9854; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; WASTESON A, 1971, J CHROMATOGR, V59, P87, DOI 10.1016/S0021-9673(01)80009-1; WASTESON A, 1973, BIOCHEM J, V136, P1069, DOI 10.1042/bj1361069; WIGHT TN, 1983, J CELL BIOL, V96, P167, DOI 10.1083/jcb.96.1.167; WIGHT TN, 1991, CELL BIOL EXTRACELLU, P45, DOI DOI 10.1007/978-1-4615-3770-0_3; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Yamaguchi H, 2004, ARTERIOSCL THROM VAS, V24, P2095, DOI 10.1161/01.ATV.0000144009.35400.65; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	52	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6987	6995		10.1074/jbc.M109.088674	http://dx.doi.org/10.1074/jbc.M109.088674			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042606	Green Published, hybrid			2022-12-25	WOS:000275415600012
J	Gregory, KJ; Hall, NE; Tobin, AB; Sexton, PM; Christopoulos, A				Gregory, Karen J.; Hall, Nathan E.; Tobin, Andrew B.; Sexton, Patrick M.; Christopoulos, Arthur			Identification of Orthosteric and Allosteric Site Mutations in M-2 Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling Bias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2ND EXTRACELLULAR LOOP; CONSERVED DISULFIDE BOND; TRANSMEMBRANE DOMAIN; CONFORMATIONAL-CHANGES; AMINO-ACIDS; SCANNING MUTAGENESIS; DIRECTED MUTAGENESIS; SUBTYPE SELECTIVITY; FUNCTIONAL SELECTIVITY; N-DESMETHYLCLOZAPINE	Muscarinic acetylcholine receptors contain at least one allosteric site that is topographically distinct from the acetylcholine, orthosteric binding site. Although studies have investigated the basis of allosteric modulation at these receptors, less is known about putative allosteric ligands that activate the receptor in their own right. We generated M-2 muscarinic acetylcholine receptor mutations in either the orthosteric site in transmembrane helices 3 and 6 (TM3 and -6) or part of an allosteric site involving the top of TM2, the second extracellular (E2) loop, and the top of TM7 and investigated their effects on the binding and function of the novel selective (putative allosteric) agonists (AC-42 (4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl) piperidine HCl), 77-LH-28-1 (1-(3-(4-butyl-1-piperidinyl)propyl)-3,3-dihydro-2(1H)-quinolinone), and N-desmethylclozapine) as well as the bitopic orthosteric/allosteric ligand, McN-A-343 (4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium). Four classes of agonists were identified, depending on their response to the mutations, suggesting multiple, distinct modes of agonist-receptor interaction. Interestingly, with the exception of 77-LH-28-1, allosteric site mutations had no effect on the affinity of any of the agonists tested, but some mutations in the E2 loop influenced the efficacy of both orthosteric and novel selective agonists, highlighting a role for this region of the receptor in modulating activation status. Two point mutations (Y104(3.33)A (Ballesteros and Weinstein numbers in superscript) in the orthosteric and Y177A in the allosteric site) unmasked ligand-selective and signaling pathway-selective effects, providing evidence for the existence of pathway-specific receptor conformations. Molecular modeling of 77-LH-28-1 and N-desmethylclozapine yielded novel binding poses consistent with the possibility that the functional selectivity of such agents may arise from a bitopic mechanism.	[Gregory, Karen J.; Hall, Nathan E.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Gregory, Karen J.; Hall, Nathan E.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Tobin, Andrew B.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	Monash University; Monash University; University of Leicester	Christopoulos, A (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, 399 Royal Pde, Parkville, Vic 3052, Australia.	arthur.christopoulos@med.monash.edu.au	Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Gregory, Karen/0000-0002-3833-2137; Hall, Nathan/0000-0001-8942-0498	National Health and Medical Research Council (NHMRC) of Australia [519461]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) of Australia Program Grant 519461.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Allman K, 2000, MOL PHARMACOL, V58, P175, DOI 10.1124/mol.58.1.175; Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; Avlani V, 2004, J PHARMACOL EXP THER, V308, P1062, DOI 10.1124/jpet.103.059840; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; BAIG A, 2005, P BR PHARM SOC, V3, pP119; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; BLUML K, 1994, J BIOL CHEM, V269, P18870; Buller S, 2002, MOL PHARMACOL, V61, P160, DOI 10.1124/mol.61.1.160; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; CLARK AL, 1976, BRIT J PHARMACOL, V58, P323, DOI 10.1111/j.1476-5381.1976.tb07708.x; CURTIS CAM, 1989, J BIOL CHEM, V264, P489; DAVIDSON FF, 1994, P NATL ACAD SCI USA, V91, P4029, DOI 10.1073/pnas.91.9.4029; Eglen RM, 2001, TRENDS PHARMACOL SCI, V22, P409, DOI 10.1016/S0165-6147(00)01737-5; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; ELLIS J, 1993, MOL PHARMACOL, V44, P583; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Gnagey AL, 1999, MOL PHARMACOL, V56, P1245, DOI 10.1124/mol.56.6.1245; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Han SJ, 2005, J BIOL CHEM, V280, P24870, DOI 10.1074/jbc.M500379200; Heitz F, 1999, EUR J PHARMACOL, V380, P183, DOI 10.1016/S0014-2999(99)00439-2; HILF G, 1992, CELL SIGNAL, V4, P787, DOI 10.1016/0898-6568(92)90059-H; Hoffmann C, 1999, J BIOL CHEM, V274, P14639, DOI 10.1074/jbc.274.21.14639; Holst B, 2009, MOL PHARMACOL, V75, P44, DOI 10.1124/mol.108.049189; Huang XP, 2007, MOL PHARMACOL, V71, P759, DOI 10.1124/mol.106.028944; Huang XP, 2005, MOL PHARMACOL, V68, P769, DOI 10.1124/mol.105.014043; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Hulme EC, 2003, RECEPTOR CHANNEL, V9, P215, DOI 10.1080/10606820308261; Jager D, 2007, J BIOL CHEM, V282, P34968, DOI 10.1074/jbc.M705563200; JAKUBIK J, 1995, J PHARMACOL EXP THER, V274, P1077; Javitch JA, 1997, J BIOL CHEM, V272, P18546, DOI 10.1074/jbc.272.30.18546; Jones CK, 2008, J NEUROSCI, V28, P10422, DOI 10.1523/JNEUROSCI.1850-08.2008; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Langmead CJ, 2008, BRIT J PHARMACOL, V154, P1104, DOI 10.1038/bjp.2008.152; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; Langmead CJ, 2006, MOL PHARMACOL, V69, P236, DOI 10.1124/mol.105.017814; Lanzafame AA, 2003, RECEPTOR CHANNEL, V9, P241, DOI 10.1080/10606820390217078; LAZARENO S, 1995, MOL PHARMACOL, V48, P362; LEACH K, 2010, NEUROPSYCHO IN PRESS; Lebon G, 2009, MOL PHARMACOL, V75, P331, DOI 10.1124/mol.108.050963; LEPPIK RA, 1994, MOL PHARMACOL, V45, P983; Li JH, 2007, J BIOL CHEM, V282, P26284, DOI 10.1074/jbc.M704875200; Lu ZL, 2001, J BIOL CHEM, V276, P34098, DOI 10.1074/jbc.M104217200; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; LULLMANN H, 1969, EUR J PHARMACOL, V6, P241, DOI 10.1016/0014-2999(69)90181-2; MATSUI H, 1995, MOL PHARMACOL, V47, P88; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Nawaratne V, 2008, MOL PHARMACOL, V74, P1119, DOI 10.1124/mol.108.049353; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Proska J, 1996, EUR J PHARMACOL, V305, P201, DOI 10.1016/0014-2999(96)00169-0; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; SCHWARZ RD, 1995, LIFE SCI, V56, P923, DOI 10.1016/0024-3205(95)00029-6; Spalding TA, 2002, MOL PHARMACOL, V61, P1297, DOI 10.1124/mol.61.6.1297; Spalding TA, 1998, J BIOL CHEM, V273, P21563, DOI 10.1074/jbc.273.34.21563; Spalding TA, 2006, MOL PHARMACOL, V70, P1974, DOI 10.1124/mol.106.024901; STRADER CD, 1988, J BIOL CHEM, V263, P10267; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Trankle C, 1999, MOL PHARMACOL, V56, P962, DOI 10.1124/mol.56.5.962; Trankle C, 2003, MOL PHARMACOL, V64, P180, DOI 10.1124/mol.64.1.180; TUCEK S, 1990, MOL PHARMACOL, V38, P674; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Valant C, 2009, MOL INTERV, V9, P125, DOI 10.1124/mi.9.3.6; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Ward SDC, 2002, J BIOL CHEM, V277, P2247, DOI 10.1074/jbc.M107647200; Ward SDC, 1999, MOL PHARMACOL, V56, P1031, DOI 10.1124/mol.56.5.1031; Ward SDC, 2006, BIOCHEMISTRY-US, V45, P676, DOI 10.1021/bi051503q; Werry TD, 2005, J NEUROCHEM, V93, P1603, DOI 10.1111/j.1471-4159.2005.03161.x; Werry TD, 2006, CURR PHARM DESIGN, V12, P1683, DOI 10.2174/138161206776873725; WESS J, 1991, EMBO J, V10, P3729, DOI 10.1002/j.1460-2075.1991.tb04941.x; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Zahn K, 2002, J PHARMACOL EXP THER, V301, P720, DOI 10.1124/jpet.301.2.720	80	125	128	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7459	7474		10.1074/jbc.M109.094011	http://dx.doi.org/10.1074/jbc.M109.094011			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20051519	Green Published, hybrid			2022-12-25	WOS:000275415600058
J	Selvi, BR; Batta, K; Kishore, AH; Mantelingu, K; Varier, RA; Balasubramanyam, K; Pradhan, SK; Dasgupta, D; Sriram, S; Agrawal, S; Kundu, TK				Selvi, B. Ruthrotha; Batta, Kiran; Kishore, A. Hari; Mantelingu, Kempegowda; Varier, Radhika A.; Balasubramanyam, Karanam; Pradhan, Suman Kalyan; Dasgupta, Dipak; Sriram, Sokalingam; Agrawal, Shipra; Kundu, Tapas K.			Identification of a Novel Inhibitor of Coactivator-associated Arginine Methyltransferase 1 (CARM1)-mediated Methylation of Histone H3 Arg-17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN METHYLATION; TRANSCRIPTIONAL COACTIVATOR; ANDROGEN RECEPTOR; GENE-EXPRESSION; CARM1; REGULATOR; DIFFERENTIATION; ACTIVATION; INSIGHTS; PRMT1	Methylation of the arginine residues of histones by methyl-transferases has important consequences for chromatin structure and gene regulation; however, the molecular mechanism(s) of methyltransferase regulation is still unclear, as is the biological significance of methylation at particular arginine residues. Here, we report a novel specific inhibitor of coactivator-associated arginine methyltransferase 1 (CARM1; also known as PRMT4) that selectively inhibits methylation at arginine 17 of histone H3 (H3R17). Remarkably, this plant-derived inhibitor, called TBBD (ellagic acid), binds to the substrate (histone) preferentially at the signature motif, "KAPRK," where the proline residue (Pro-16) plays a critical role for interaction and subsequent enzyme inhibition. In a promoter-specific context, inhibition of H3R17 methylation represses expression of p21, a p53-responsive gene, thus implicating a possible role for H3 Arg-17 methylation in tumor suppressor function. These data establish TBBD as a novel specific inhibitor of arginine methylation and demonstrate substrate sequence-directed inhibition of enzyme activity by a small molecule and its physiological consequence.	[Selvi, B. Ruthrotha; Batta, Kiran; Kishore, A. Hari; Mantelingu, Kempegowda; Varier, Radhika A.; Balasubramanyam, Karanam; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India; [Pradhan, Suman Kalyan; Dasgupta, Dipak] IAF, Div Biophys, Saha Inst Nucl Phys, Kolkata 700064, W Bengal, India; [Sriram, Sokalingam; Agrawal, Shipra] Inst Bioinformat & Appl Biotechnol, Bangalore 560066, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Saha Institute of Nuclear Physics	Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India.	tapas@jncasr.ac.in	Pradhan, Suman/O-4518-2015	Varier, Radhika/0000-0003-1302-3159; Kempegowda, Mantelingu/0000-0003-1114-8003; Bharathavikru, Ruthrotha Selvi/0000-0002-3096-7461; Kundu, Tapas/0000-0001-7790-214X	Jawaharlal Nehru Centre for Advanced Scientific Research; Department of Biotechnology, Government of India	Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Jawaharlal Nehru Centre for Advanced Scientific Research and the Department of Biotechnology, Government of India.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; B RS, 2009, CHEM BIOL, V16, P203, DOI 10.1016/j.chembiol.2008.12.006; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Chen SL, 2002, J BIOL CHEM, V277, P4324, DOI 10.1074/jbc.M109835200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Dorai T, 2004, CANCER LETT, V215, P129, DOI 10.1016/j.canlet.2004.07.013; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; Frietze S, 2008, CANCER RES, V68, P301, DOI 10.1158/0008-5472.CAN-07-1983; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Hassa PO, 2008, J MOL BIOL, V377, P668, DOI 10.1016/j.jmb.2008.01.044; Hong H, 2004, CANCER-AM CANCER SOC, V101, P83, DOI 10.1002/cncr.20327; Jurenka J, 2008, ALTERN MED REV, V13, P128; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kim J, 2004, J BIOL CHEM, V279, P25339, DOI 10.1074/jbc.M402544200; Kim S, 1998, AMINO ACIDS, V15, P291, DOI 10.1007/BF01320895; Kleinschmidt MA, 2008, NUCLEIC ACIDS RES, V36, P3202, DOI 10.1093/nar/gkn166; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Losso JN, 2004, J NUTR BIOCHEM, V15, P672, DOI 10.1016/j.jnutbio.2004.06.004; Majumder S, 2006, PROSTATE, V66, P1292, DOI 10.1002/pros.20438; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Osborne T, 2008, J AM CHEM SOC, V130, P4574, DOI 10.1021/ja077104v; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Spannhoff A, 2007, BIOORG MED CHEM LETT, V17, P4150, DOI 10.1016/j.bmcl.2007.05.088; Stallcup MR, 2003, J STEROID BIOCHEM, V85, P139, DOI 10.1016/S0960-0760(03)00222-X; SWAMINATHAN V, 2007, CHROMATIN DIS, P397; Teyssier C, 2002, J BIOL CHEM, V277, P46066, DOI 10.1074/jbc.M207623200; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Wu Q, 2009, STEM CELLS, V27, P2637, DOI 10.1002/stem.131; Yadav N, 2008, EMBO REP, V9, P193, DOI 10.1038/sj.embor.7401151; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856	40	65	69	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7143	7152		10.1074/jbc.M109.063933	http://dx.doi.org/10.1074/jbc.M109.063933			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20022955	Green Published, hybrid			2022-12-25	WOS:000275415600028
J	Varela, D; Penna, A; Simon, F; Eguiguren, AL; Leiva-Salcedo, E; Cerda, O; Sala, F; Stutzin, A				Varela, Diego; Penna, Antonello; Simon, Felipe; Luisa Eguiguren, Ana; Leiva-Salcedo, Elias; Cerda, Oscar; Sala, Francisco; Stutzin, Andres			P2X4 Activation Modulates Volume-sensitive Outwardly Rectifying Chloride Channels in Rat Hepatoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED ANION CHANNELS; ATP RELEASE; PURINERGIC RECEPTORS; AGONIST BINDING; CA2+; KINASE; EFFLUX; CONTRIBUTES; MECHANISM; APOPTOSIS	Volume-sensitive outwardly rectifying (VSOR) Cl- channels are critical for the regulatory volume decrease (RVD) response triggered upon cell swelling. Recent evidence indicates that H2O2 plays an essential role in the activation of these channels and that H2O2 per se activates the channels under isotonic iso-volumic conditions. However, a significant difference in the time course for current onset between H2O2-induced and hypotonicity-mediated VSOR Cl- activation is observed. In several cell types, cell swelling induced by hypotonic challenges triggers the release of ATP to the extracellular medium, which in turn, activates purinergic receptors and modulates cell volume regulation. In this study, we have addressed the effect of purinergic receptor activation on H2O2-induced and hypotonicity-mediated VSOR Cl- current activation. Here we show that rat hepatoma cells (HTC) exposed to a 33% hypotonic solution responded by rapidly activating VSOR Cl- current and releasing ATP to the extracellular medium. In contrast, cells exposed to 200 mu M H2O2 VSOR Cl- current onset was significantly slower, and ATP release was not detected. In cells exposed to either 11% hypotonicity or 200 mu M H2O2, exogenous addition of ATP in the presence of extracellular Ca2+ resulted in a decrease in the half-time for VSOR Cl- current onset. Conversely, in cells that overexpress a dominant-negative mutant of the ionotropic receptor P2X4 challenged with a 33% hypotonic solution, the half-time for VSOR Cl- current onset was significantly slowed down. Our results indicate that, at high hypotonic imbalances, swelling-induced ATP release activates the purinergic receptor P2X4, which in turn modulates the time course of VSOR Cl- current onset in a extracellular Ca2+-dependent manner.	[Stutzin, Andres] Univ Chile, CEMC, Fac Med, Santiago 8380453, Chile; [Simon, Felipe] Univ Andres Bello, Dept Ciencias Biol, Fac Ciencias Biol, Santiago 8370134, Chile; [Simon, Felipe] Univ Andres Bello, Fac Med, Santiago 8370134, Chile; [Sala, Francisco] Univ Miguel Hernandez, Inst Neurociencias Alicante, CSIC, St Joan Dalcant, Spain; [Stutzin, Andres] Univ Chile, ICBM, Fac Med, Santiago 8380453, Chile	Universidad de Chile; Universidad Andres Bello; Universidad Andres Bello; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad de Chile	Varela, D (corresponding author), Univ Chile, CEMC, Fac Med, Santiago 8380453, Chile.	dvarela@bitmed.med.uchile.cl	Varela, Diego/AAG-7489-2019; Penna, Antonello/O-6694-2019; Stutzin, Andrés/I-7605-2013; Cerda, Oscar/N-3895-2018	Varela, Diego/0000-0002-9352-414X; Penna, Antonello/0000-0002-8626-4415; Stutzin, Andrés/0000-0002-7264-066X; Cerda, Oscar/0000-0003-2873-5722; Simon, Felipe/0000-0002-2653-9798; Sala, Francisco/0000-0002-2080-7683	FONDAP-Fondecyt, Chile [15010006]	FONDAP-Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP)	This work was supported by FONDAP-Fondecyt 15010006, Chile.	ALVAREZLEEFMANS FJ, 1995, METH NEUROSCI, V27, P361; Barriere H, 2003, J MEMBRANE BIOL, V193, P153, DOI 10.1007/s00232-003-2014-z; Cheema TA, 2007, J PHARMACOL EXP THER, V320, P1068, DOI 10.1124/jpet.106.115741; Crepel V, 1998, J NEUROSCI, V18, P1196; Darby M, 2003, J NEUROPHYSIOL, V89, P1870, DOI 10.1152/jn.00510.2002; Emmett DS, 2008, HEPATOLOGY, V47, P698, DOI 10.1002/hep.22035; Feranchak AP, 1998, J BIOL CHEM, V273, P14906, DOI 10.1074/jbc.273.24.14906; Fernandez-Fernandez JM, 2002, AM J PHYSIOL-CELL PH, V283, pC1705, DOI 10.1152/ajpcell.00245.2002; Fitz J Gregory, 2007, Trans Am Clin Climatol Assoc, V118, P199; Friis MB, 2005, J PHYSIOL-LONDON, V567, P427, DOI 10.1113/jphysiol.2005.087130; Gatof D, 2004, AM J PHYSIOL-GASTR L, V286, pG538, DOI 10.1152/ajpgi.00355.2003; Hazama A, 1999, J GEN PHYSIOL, V114, P525, DOI 10.1085/jgp.114.4.525; Hisadome K, 2002, J GEN PHYSIOL, V119, P511, DOI 10.1085/jgp.20028540; Hoffmann EK, 2000, CELL PHYSIOL BIOCHEM, V10, P273, DOI 10.1159/000016356; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; IWATA K, 1995, J CHROMATOGR B, V667, P339, DOI 10.1016/0378-4347(95)00042-H; Junankar PR, 2002, J BIOL CHEM, V277, P40324, DOI 10.1074/jbc.M204712200; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; MCCARTY NA, 1992, PHYSIOL REV, V72, P1037, DOI 10.1152/physrev.1992.72.4.1037; Mongin AA, 2005, AM J PHYSIOL-CELL PH, V288, pC204, DOI 10.1152/ajpcell.00330.2004; Moore AL, 2002, J BIOL CHEM, V277, P34030, DOI 10.1074/jbc.M205945200; Mori S, 2002, BRAIN RES, V957, P1, DOI 10.1016/S0006-8993(02)03574-6; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Nilius B, 1999, J PHYSIOL-LONDON, V516, P67, DOI 10.1111/j.1469-7793.1999.067aa.x; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Pedersen SF, 1998, J MEMBRANE BIOL, V163, P97, DOI 10.1007/s002329900374; Chaves LAP, 2008, PFLUG ARCH EUR J PHY, V457, P493, DOI 10.1007/s00424-008-0525-2; Roe MW, 2001, J BIOL CHEM, V276, P30871, DOI 10.1074/jbc.M102362200; Roman RM, 1999, AM J PHYSIOL-GASTR L, V276, pG1391, DOI 10.1152/ajpgi.1999.276.6.G1391; Shen MR, 2000, J PHYSIOL-LONDON, V529, P385, DOI 10.1111/j.1469-7793.2000.00385.x; Shi CJ, 1999, J PHYSIOL-LONDON, V521, P57, DOI 10.1111/j.1469-7793.1999.00057.x; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Stutzin A, 2006, ACTA PHYSIOL, V187, P27, DOI 10.1111/j.1748-1716.2006.01537.x; Stutzin A, 1999, AM J PHYSIOL-CELL PH, V277, pC392, DOI 10.1152/ajpcell.1999.277.3.C392; Stutzin A, 1997, AM J PHYSIOL-CELL PH, V273, pC999, DOI 10.1152/ajpcell.1997.273.3.C999; Szabo I, 1998, P NATL ACAD SCI USA, V95, P6169, DOI 10.1073/pnas.95.11.6169; Szucs G, 1996, PFLUG ARCH EUR J PHY, V431, P467, DOI 10.1007/s004240050023; THOMPSON EB, 1966, P NATL ACAD SCI USA, V56, P296, DOI 10.1073/pnas.56.1.296; TILLY BC, 1994, AM J PHYSIOL-CELL PH, V267, pC1271, DOI 10.1152/ajpcell.1994.267.5.C1271; Varela D, 2004, ADV EXP MED BIOL, V559, P141; Varela D, 2004, J BIOL CHEM, V279, P13301, DOI 10.1074/jbc.C400020200; Varela D, 2002, J PHYSIOL-LONDON, V544, P363, DOI 10.1113/jphysiol.2002.026096; Varela D, 2007, CELL PHYSIOL BIOCHEM, V20, P773, DOI 10.1159/000110437; Vazquez-Juarez E, 2008, PFLUG ARCH EUR J PHY, V455, P859, DOI 10.1007/s00424-007-0343-y; Voets T, 1999, P NATL ACAD SCI USA, V96, P5298, DOI 10.1073/pnas.96.9.5298; Wang Y, 1996, P NATL ACAD SCI USA, V93, P12020, DOI 10.1073/pnas.93.21.12020; Yan ZH, 2005, MOL PHARMACOL, V67, P1078, DOI 10.1124/mol.104.010108; Yan ZH, 2006, J BIOL CHEM, V281, P32649, DOI 10.1074/jbc.M512791200; Zemkova H, 2007, J NEUROCHEM, V102, P1139, DOI 10.1111/j.1471-4159.2007.04616.x	51	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7566	7574		10.1074/jbc.M109.063693	http://dx.doi.org/10.1074/jbc.M109.063693			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056605	Green Published, hybrid			2022-12-25	WOS:000275415600068
J	Ohashi, K; Parker, JL; Ouchi, N; Higuchi, A; Vita, JA; Gokce, N; Pedersen, AA; Kalthoff, C; Tullin, S; Sams, A; Summer, R; Walsh, K				Ohashi, Koji; Parker, Jennifer L.; Ouchi, Noriyuki; Higuchi, Akiko; Vita, Joseph A.; Gokce, Noyan; Pedersen, Anette Amstrup; Kalthoff, Christoph; Tullin, Soren; Sams, Anette; Summer, Ross; Walsh, Kenneth			Adiponectin Promotes Macrophage Polarization toward an Anti-inflammatory Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; INFLAMMATORY MARKERS; T-CELLS; OBESE; PROTEIN; FAT; ASSOCIATION; RECRUITMENT; MODULATION	It is established that the adipocyte-derived cytokine adiponectin protects against cardiovascular and metabolic diseases, but the effect of this adipokine on macrophage polarization, an important mediator of disease progression, has never been assessed. We hypothesized that adiponectin modulates macrophage polarization from that resembling a classically activated M1 phenotype to that resembling alternatively-activated M2cells. Peritoneal macrophages and the stromal vascular fraction (SVF) cells of adipose tissue isolated from adiponectin knock-out mice displayed increased M1 markers, including tumor necrosis factor-alpha, interleukin-6, and monocyte chemoattractant protein-1 and decreased M2 markers, including arginase-1, macrophage galactose N-acetyl-galactosamine specific lectin-1, and interleukin-10. The systemic delivery of adenovirus expressing adiponectin significantly augmented arginase-1 expression in peritoneal macrophages and SVF cells in both wild-type and adiponectin knock-out mice. In culture, the treatment of macrophages with recombinant adiponectin protein led to an increase in the levels of M2 markers and a reduction of reactive oxygen species and reactive oxygen species-related gene expression. Adiponectin also stimulated the expression of M2 markers and attenuated the expression of M1 markers in human monocyte-derived macrophages and SVF cells isolated from human adipose tissue. These data show that adiponectin functions as a regulator of macrophage polarization, and they indicate that conditions of high adiponectin expression may deter metabolic and cardiovascular disease progression by favoring an anti-inflammatory phenotype in macrophages.	Boston Univ, Sch Med, Mol Cardiol Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Vita, Joseph A.; Gokce, Noyan] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Evans Dept Med, Boston, MA 02118 USA; [Tullin, Soren; Sams, Anette] Novo Nordisk, Diabet Biol & Pharmacol, DK-2760 Malov, Denmark; [Summer, Ross] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Kalthoff, Christoph] Novo Nordisk, Prot Chem, DK-2760 Malov, Denmark; [Pedersen, Anette Amstrup] Novo Nordisk, Mammalian Cell Technol, DK-2760 Malov, Denmark	Boston University; Boston University; Novo Nordisk; Boston University; Novo Nordisk; Novo Nordisk	Walsh, K (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Mol Cardiol Sect, 715 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	王, 强/F-4212-2011; OHASHI, Koji/I-7307-2014; Sams, Anette/R-1764-2016; OUCHI, Noriyuki/I-7306-2014	Sams, Anette/0000-0002-9203-4333; Walsh, Kenneth/0000-0001-7580-2276; Gokce, Noyan/0000-0003-2920-3445; Vita, Joseph/0000-0001-5607-1797	National Institutes of Health [HL81587, AG15052, HL91949]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091949, P01HL081587, K08HL077138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015052, R37AG015052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL81587, AG15052, and HL91949.	Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Endo M, 2003, AM J PHYSIOL-LUNG C, V285, pL313, DOI 10.1152/ajplung.00434.2002; Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Higuchi A, 2009, CIRC RES, V104, P1058, DOI 10.1161/CIRCRESAHA.109.194506; Jeannin P, 2008, CURR OPIN IMMUNOL, V20, P530, DOI 10.1016/j.coi.2008.04.013; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Krakoff J, 2003, DIABETES CARE, V26, P1745, DOI 10.2337/diacare.26.6.1745; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; North ML, 2009, AM J PHYSIOL-LUNG C, V296, pL911, DOI 10.1152/ajplung.00025.2009; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Summer R, 2008, AM J PHYSIOL-LUNG C, V294, pL1035, DOI 10.1152/ajplung.00397.2007; Summer R, 2007, AM J RESP CELL MOL, V37, P152, DOI 10.1165/rcmb.2006-0386OC; Takaoka M, 2009, CIRC RES, V105, P906, DOI 10.1161/CIRCRESAHA.109.199653; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	43	429	447	4	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6153	6160		10.1074/jbc.M109.088708	http://dx.doi.org/10.1074/jbc.M109.088708			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20028977	Green Published, hybrid			2022-12-25	WOS:000275367500019
J	Lausen, J; Pless, O; Leonard, F; Kuvardina, ON; Koch, B; Leutz, A				Lausen, Joern; Pless, Ole; Leonard, Fransisca; Kuvardina, Olga N.; Koch, Benjamin; Leutz, Achim			Targets of the Tal1 Transcription Factor in Erythrocytes E2 UBIQUITIN CONJUGASE REGULATION BY Tal1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; VASCULAR DEVELOPMENT; DNA-BINDING; PROTEOLYTIC PATHWAY; MYELOID PROGENITORS; CRITICAL REGULATOR; ESCHERICHIA-COLI; SCL/TAL-1 GENE	The Tal1 transcription factor is essential for the development of the hematopoietic system and plays a role during definitive erythropoiesis in the adult. Despite the importance of Tal1 in erythropoiesis, only a small number of erythroid differentiation target genes are known. A chromatin precipitation and cloning approach was established to uncover novel Tal1 target genes in erythropoiesis. The BirA tag/BirA ligase biotinylation system in combination with streptavidin chromatin precipitation (Strep-CP) was used to co-precipitate genomic DNA bound to Tal1. Tal1 was found to bind in the vicinity of 31 genes including the E2-ubiquitin conjugase UBE2H gene. Binding of Tal1 to UBE2H was confirmed by chromatin immunoprecipitation. UBE2H expression is increased during erythroid differentiation of hCD34(+) cells. Tal1 expression activated UBE2H expression, whereas Tal1 knock-down reduced UBE2H expression and ubiquitin transfer activity. This study identifies parts of the ubiquitinylation machinery as a cellular target downstream of the transcription factor Tal1 and provides novel insights into Tal1-regulated erythropoiesis.	[Lausen, Joern; Kuvardina, Olga N.; Koch, Benjamin] Inst Biomed Res, D-60596 Frankfurt, Main, Germany; [Pless, Ole; Leonard, Fransisca; Leutz, Achim] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Leutz, Achim] Humboldt Univ, Inst Biol, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin	Lausen, J (corresponding author), Inst Biomed Res, Paul Ehrlich Str 42-44, D-60596 Frankfurt, Main, Germany.	lausen@em.uni-frankfurt.de	Pless, Ole/E-8348-2016; Leutz, Achim/K-9643-2013	Pless, Ole/0000-0002-1468-316X; Leutz, Achim/0000-0001-8259-927X; Koch, Benjamin/0000-0002-3253-8396	Deutsche Forschungsgemeinschaft [LA 1389/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant LA 1389/3-1 from the Deutsche Forschungsgemeinschaft.	Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; Barton LM, 1999, INT J BIOCHEM CELL B, V31, P1193, DOI 10.1016/S1357-2725(99)00082-5; BASH RO, 1995, BLOOD, V86, P666, DOI 10.1182/blood.V86.2.666.bloodjournal862666; BOCHES FS, 1982, SCIENCE, V215, P978, DOI 10.1126/science.7156977; BRADY G, 1995, CURR BIOL, V5, P909, DOI 10.1016/S0960-9822(95)00181-3; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Chen CY, 2002, EXP HEMATOL, V30, P634, DOI 10.1016/S0301-472X(02)00826-3; de la Grange PB, 2008, STEM CELLS, V26, P1658, DOI 10.1634/stemcells.2007-0952; de la Grange PB, 2006, BLOOD, V108, P2998, DOI 10.1182/blood-2006-05-022988; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ema M, 2003, TRENDS CARDIOVAS MED, V13, P254, DOI 10.1016/S1050-1738(03)00105-1; Ferrando AA, 2004, BLOOD, V103, P1909, DOI 10.1182/blood-2003-07-2577; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gottgens B, 2004, VOX SANG, V87, P15, DOI 10.1111/j.1741-6892.2004.00423.x; Grebenova D, 2006, BLOOD CELL MOL DIS, V37, P210, DOI 10.1016/j.bcmd.2006.08.001; HAAS AL, 1991, ADV EXP MED BIOL, V307, P191; HALDEMAN MT, 1995, J BIOL CHEM, V270, P9507, DOI 10.1074/jbc.270.16.9507; Hall MA, 2005, MOL CELL BIOL, V25, P6355, DOI 10.1128/MCB.25.15.6355-6362.2005; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; HENSOLD JO, 1988, BLOOD, V71, P1153; Hoang T, 1996, BLOOD, V87, P102; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; HOWARD PK, 1985, GENE, V35, P321, DOI 10.1016/0378-1119(85)90011-3; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; KAISER P, 1994, J BIOL CHEM, V269, P8797; Kaiser P, 1995, FEBS LETT, V377, P193, DOI 10.1016/0014-5793(95)01323-7; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Kassouf MT, 2008, BLOOD, V112, P1056, DOI 10.1182/blood-2007-12-128900; Keller MA, 2006, PHYSIOL GENOMICS, V28, P114, DOI 10.1152/physiolgenomics.00055.2006; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; Landry JR, 2008, BLOOD, V111, P3005, DOI 10.1182/blood-2007-07-098830; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Li BH, 2007, BLOOD, V110, P2704, DOI 10.1182/blood-2006-12-064154; Li YP, 2003, FASEB J, V17, P1048, DOI 10.1096/fj.02-0759com; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Mahajan MC, 2009, EXP HEMATOL, V37, P1143, DOI 10.1016/j.exphem.2009.07.001; Marteijn JAF, 2006, LEUKEMIA, V20, P1511, DOI 10.1038/sj.leu.2404319; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; Okamoto Y, 2003, CANCER RES, V63, P4167; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Palomero T, 2006, BLOOD, V108, P986, DOI 10.1182/blood-2005-08-3482; Park ST, 1998, J BIOL CHEM, V273, P7030, DOI 10.1074/jbc.273.12.7030; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Porcher C, 1999, DEVELOPMENT, V126, P4603; PULFORD K, 1995, BLOOD, V85, P675, DOI 10.1182/blood.V85.3.675.bloodjournal853675; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Tang T, 2002, J BIOL CHEM, V277, P18365, DOI 10.1074/jbc.M109812200; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WEFES I, 1995, P NATL ACAD SCI USA, V92, P4982, DOI 10.1073/pnas.92.11.4982; Wen J, 2005, J BIOL CHEM, V280, P12956, DOI 10.1074/jbc.M412721200; Willis MS, 2006, J MOL CELL CARDIOL, V41, P567, DOI 10.1016/j.yjmcc.2006.07.015; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Xu ZX, 2006, BIOCHEM J, V399, P297, DOI 10.1042/BJ20060873	71	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5338	5346		10.1074/jbc.M109.030296	http://dx.doi.org/10.1074/jbc.M109.030296			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028976	Green Published, hybrid			2022-12-25	WOS:000275327200027
J	Parkhurst, CN; Zampieri, N; Chao, MV				Parkhurst, Christopher N.; Zampieri, Niccolo; Chao, Moses V.			Nuclear Localization of the p75 Neurotrophin Receptor Intracellular Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; REGULATED INTRAMEMBRANE PROTEOLYSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; INHIBIT NEURITE OUTGROWTH; AFFINITY NGF RECEPTOR; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE; CELL-DEATH; NOGO RECEPTOR; TRANSLOCATION	The p75 neurotrophin receptor, a member of the tumor necrosis factor superfamily of receptors, undergoes an alpha-secretase-mediated release of its extracellular domain, followed by a gamma-secretase-mediated intramembrane cleavage. Like amyloid precursor protein and Notch, gamma-secretase cleavage of the p75 receptor releases an intracellular domain (ICD). However, it has been experimentally challenging to determine the precise subcellular localization and functional consequences of the p75 ICD. Here, we utilized a nuclear translocation assay and biochemical fractionation approaches to follow the fate of the ICD. We found that the p75 ICD can translocate to the nucleus to activate a green fluorescent protein reporter gene. Furthermore, the p75 ICD was localized in nuclear fractions. Chromatin immunoprecipitation experiments indicated that nerve growth factor induced the association of endogenous p75 with the cyclin E-1 promoter. Expression of the p75 ICD resulted in modulation of gene expression from this locus. These results suggest that the p75 ICD generated by gamma-secretase cleavage is capable of modulating transcriptional events in the nucleus.	[Parkhurst, Christopher N.; Zampieri, Niccolo; Chao, Moses V.] NYU, Sch Med, Skirball Inst Biomol Med, Mol Neurobiol Program, New York, NY 10016 USA; [Chao, Moses V.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Chao, Moses V.] NYU, Sch Med, Dept Physiol & Neurobiol, New York, NY 10016 USA; [Chao, Moses V.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Chao, MV (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.	chao@saturn.med.nyu.edu		Zampieri, Niccolo/0000-0002-2228-9453; Chao, Moses/0000-0002-6969-3744	National Institutes of Health [AG025970]; NATIONAL INSTITUTE ON AGING [R01AG025970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG025970 (to M. V. C.).	Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Ben-Zvi A, 2007, J NEUROSCI, V27, P13000, DOI 10.1523/JNEUROSCI.3373-07.2007; Bengoechea TG, 2009, P NATL ACAD SCI USA, V106, P7870, DOI 10.1073/pnas.0901533106; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chittka A, 2004, J CELL BIOL, V164, P985, DOI 10.1083/jcb.200301106; Chittka A, 1999, P NATL ACAD SCI USA, V96, P10705, DOI 10.1073/pnas.96.19.10705; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; FORNEROD M, 1997, CELL, V90, P1052; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Frade JM, 2005, J NEUROSCI, V25, P1407, DOI 10.1523/JNEUROSCI.3798-04.2005; Frade JM, 1996, NATURE, V383, P166; Haase G, 2008, CURR OPIN NEUROBIOL, V18, P284, DOI 10.1016/j.conb.2008.07.013; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Hoshino A, 2004, MOL CELL, V15, P153, DOI 10.1016/j.molcel.2004.06.017; Hoshino A, 2007, CELL STRESS CHAPERON, V12, P186, DOI 10.1379/CSC-264R.1; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; HUBER LJ, 1995, DEV BIOL, V167, P227, DOI 10.1006/dbio.1995.1019; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Majdan M, 1997, J NEUROSCI, V17, P6988; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Podlesniy P, 2006, AM J PATHOL, V169, P119, DOI 10.2353/ajpath.2006.050787; Powell JC, 2009, J NEUROCHEM, V108, P216, DOI 10.1111/j.1471-4159.2008.05763.x; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; Takahashi Y, 2000, GENE DEV, V14, P804; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang LM, 2008, PLOS BIOL, V6, P2496, DOI 10.1371/journal.pbio.0060289; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	49	56	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5361	5368		10.1074/jbc.M109.045054	http://dx.doi.org/10.1074/jbc.M109.045054			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022966	hybrid, Green Published			2022-12-25	WOS:000275327200029
J	Rossi, CA; Pozzobon, M; Ditadi, A; Archacka, K; Gastaldello, A; Sanna, M; Franzin, C; Malerba, A; Milan, G; Cananzi, M; Schiaffino, S; Campanella, M; Vettor, R; De Coppi, P				Rossi, Carlo A.; Pozzobon, Michela; Ditadi, Andrea; Archacka, Karolina; Gastaldello, Annalisa; Sanna, Marta; Franzin, Chiara; Malerba, Alberto; Milan, Gabriella; Cananzi, Mara; Schiaffino, Stefano; Campanella, Michelangelo; Vettor, Roberto; De Coppi, Paolo			Clonal Characterization of Rat Muscle Satellite Cells: Proliferation, Metabolism and Differentiation Define an Intrinsic Heterogeneity	PLOS ONE			English	Article							REGENERATING SKELETAL-MUSCLE; STEM-CELL; SELF-RENEWAL; IN-VITRO; EXPRESSION; POPULATIONS; QUIESCENT; PROTEIN; GROWTH; ACTIVATION	Satellite cells (SCs) represent a distinct lineage of myogenic progenitors responsible for the postnatal growth, repair and maintenance of skeletal muscle. Distinguished on the basis of their unique position in mature skeletal muscle, SCs were considered unipotent stem cells with the ability of generating a unique specialized phenotype. Subsequently, it was demonstrated in mice that opposite differentiation towards osteogenic and adipogenic pathways was also possible. Even though the pool of SCs is accepted as the major, and possibly the only, source of myonuclei in postnatal muscle, it is likely that SCs are not all multipotent stem cells and evidences for diversities within the myogenic compartment have been described both in vitro and in vivo. Here, by isolating single fibers from rat flexor digitorum brevis (FDB) muscle we were able to identify and clonally characterize two main subpopulations of SCs: the low proliferative clones (LPC) present in major proportion (similar to 75%) and the high proliferative clones (HPC), present instead in minor amount (similar to 25%). LPC spontaneously generate myotubes whilst HPC differentiate into adipocytes even though they may skip the adipogenic program if co-cultured with LPC. LPC and HPC differ also for mitochondrial membrane potential (Delta Psi(m)), ATP balance and Reactive Oxygen Species (ROS) generation underlying diversities in metabolism that precede differentiation. Notably, SCs heterogeneity is retained in vivo. SCs may therefore be comprised of two distinct, though not irreversibly committed, populations of cells distinguishable for prominent differences in basal biological features such as proliferation, metabolism and differentiation. By these means, novel insights on SCs heterogeneity are provided and evidences for biological readouts potentially relevant for diagnostic purposes described.	[Rossi, Carlo A.; Pozzobon, Michela; Ditadi, Andrea; Archacka, Karolina; De Coppi, Paolo] Univ Padua, Dept Pediat, Stem Cell Proc Lab, Padua, Italy; [Rossi, Carlo A.; Gastaldello, Annalisa; Malerba, Alberto; Cananzi, Mara; De Coppi, Paolo] Inst Child Hlth, Surg Unit, London, England; [Rossi, Carlo A.; Gastaldello, Annalisa; Malerba, Alberto; Cananzi, Mara; De Coppi, Paolo] Great Ormond St Hosp Sick Children, Univ Coll London, London, England; [Archacka, Karolina] Univ Warsaw, Dept Cytol, Fac Biol, Warsaw, Poland; [Gastaldello, Annalisa; Campanella, Michelangelo] Univ London Royal Vet Coll, London, England; [Sanna, Marta; Franzin, Chiara; Milan, Gabriella; Vettor, Roberto] Univ Padua, Endocrine Metab Lab, Dept Med & Surg Sci, Padua, Italy; [Schiaffino, Stefano] Venetian Inst Mol Med, Padua, Italy; [Campanella, Michelangelo] UCL, Consortium Mitochondrial Res, London, England	University of Padua; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Warsaw; University of London; University of London Royal Veterinary College; University of Padua; Veneto Institute Molecular Medicine; University of London; University College London	Rossi, CA (corresponding author), Univ Padua, Dept Pediat, Stem Cell Proc Lab, Padua, Italy.	mcampanella@rvc.ac.uk; p.decoppi@ich.ucl.ac.uk	Franzin, Chiara/A-3879-2013; Malerba, Alberto/A-5915-2010; VETTOR, ROBERTO/K-7121-2016; Gastaldello, Annalisa/H-9108-2019; Ditadi, Andrea/K-3461-2016; Milan, Gabriella/AAB-6234-2022; Pozzobon, Michela/X-7504-2019; cananzi, mara/AAS-8540-2020; Gastaldello, Annalisa/AAV-1629-2021; Pozzobon, Michela/G-7974-2018; Malerba, Alberto/H-4353-2012	Gastaldello, Annalisa/0000-0002-4365-1191; Ditadi, Andrea/0000-0003-3283-8943; Milan, Gabriella/0000-0001-8987-5310; Pozzobon, Michela/0000-0001-9213-402X; Pozzobon, Michela/0000-0001-9213-402X; Schiaffino, Stefano/0000-0002-5607-6421; Vettor, Roberto/0000-0003-0625-6667; De Coppi, Paolo/0000-0002-1659-0207; FRANZIN, Chiara/0000-0002-9610-567X; Cananzi, Mara/0000-0002-7177-2847; Archacka, Karolina/0000-0002-0274-9117	Telethon [GGP07216]; FEBS Collaborative Experimental Scholarship; Fondazione Citta' della Speranza [04/02]; CRF; Great Ormond Street Hospital Childrens Charity [V1230] Funding Source: researchfish	Telethon(Fondazione Telethon); FEBS Collaborative Experimental Scholarship; Fondazione Citta' della Speranza; CRF; Great Ormond Street Hospital Childrens Charity	C. A. R. was supported by Telethon (Grant GGP07216). K. A. by FEBS Collaborative Experimental Scholarship for Central & Eastern Europe, A. G. by English Italian Cultural Association il Circolo. This work was supported by Telethon grant (GGP07216) and Fondazione Citta' della Speranza grant (04/02), CRF (University of London), RVC internal funds for supporting the research activity in the M. C. laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; APPELL HJ, 1988, INT J SPORTS MED, V9, P297, DOI 10.1055/s-2007-1025026; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BISCHOFF R, 1994, DEV DYNAM, V201, P41, DOI 10.1002/aja.1002010105; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cooper RN, 1999, J CELL SCI, V112, P2895; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; De Coppi P, 2006, DIABETOLOGIA, V49, P1962, DOI 10.1007/s00125-006-0304-6; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; DIAMOND JM, 1982, NATURE, V300, P683, DOI 10.1038/300683a0; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Freda PU, 2008, J CLIN ENDOCR METAB, V93, P2334, DOI 10.1210/jc.2007-2780; Gallagher D, 2009, AM J CLIN NUTR, V89, P807, DOI 10.3945/ajcn.2008.26955; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Grounds M D, 1993, Mol Cell Biol Hum Dis Ser, V3, P210; GROUNDS MD, 1987, CELL TISSUE RES, V250, P563; HALLCRAG.EC, 1974, EXP NEUROL, V43, P349, DOI 10.1016/0014-4886(74)90176-9; Hammond CL, 2007, J EXP BIOL, V210, P2667, DOI 10.1242/jeb.005751; Heslop L, 2000, J CELL SCI, V113, P2299; Hilton TN, 2008, PHYS THER, V88, P1336, DOI 10.2522/ptj.20080079; Jahagirdar BN, 2005, STEM CELL REV, V1, P53, DOI 10.1385/SCR:1:1:053; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kinkel AD, 2004, CYTOTECHNOLOGY, V46, P49, DOI 10.1007/s10616-004-3903-4; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; Maltby V, 2004, BRIT POULTRY SCI, V45, P491, DOI 10.1080/00071660412331286190; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Milan G, 2004, J CLIN ENDOCR METAB, V89, P2724, DOI 10.1210/jc.2003-032047; Molnar G, 1996, TISSUE CELL, V28, P547, DOI 10.1016/S0040-8166(96)80057-7; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; MORLET K, 1989, ANAT EMBRYOL, V180, P471, DOI 10.1007/BF00305122; Mothe AJ, 2005, J HISTOCHEM CYTOCHEM, V53, P1215, DOI 10.1369/jhc.5A6639.2005; Nesti C, 2007, BIOSCIENCE REP, V27, P165, DOI 10.1007/s10540-007-9044-1; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; RANTANEN J, 1995, LAB INVEST, V72, P341; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Rouger K, 2004, CELL TISSUE RES, V317, P319, DOI 10.1007/s00441-004-0911-9; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1; SCHULTZ E, 1985, MECH AGEING DEV, V30, P63, DOI 10.1016/0047-6374(85)90059-4; SCHULTZ E, 1985, ADV EXP MED BIOL, V182, P73; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Singh NK, 2007, J ANIM SCI, V85, P1126, DOI 10.2527/jas.2006-524; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653; Zhivotovsky B, 2009, SEMIN CANCER BIOL, V19, P1, DOI 10.1016/j.semcancer.2008.12.003	60	58	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8523	10.1371/journal.pone.0008523	http://dx.doi.org/10.1371/journal.pone.0008523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049087	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000273225000005
J	Mishra, PJ; Song, B; Mishra, PJ; Wang, Y; Humeniuk, R; Banerjee, D; Merlino, G; Ju, JF; Bertino, JR				Mishra, Prasun J.; Song, Bo; Mishra, Pravin J.; Wang, Yuan; Humeniuk, Rita; Banerjee, Debabrata; Merlino, Glenn; Ju, Jingfang; Bertino, Joseph R.			MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism	PLOS ONE			English	Article							MIRNA EXPRESSION; DIHYDROFOLATE-REDUCTASE; MICRORNA POLYMORPHISMS; THYMIDYLATE SYNTHASE; CELL; GENES; PHARMACOGENOMICS; DIFFERENTIATION; IDENTIFICATION; BINDING	MicroRNAs (miRNAs) are predicted to regulate approximately 30% of all human genes; however, only a few miRNAs have been assigned their targets and specific functions. Here we demonstrate that miR-24, a ubiquitously expressed miRNA, has an anti-proliferative effect independent of p53 function. Cell lines with differential p53 status were used as a model to study the effects of miR-24 on cell proliferation, cell cycle control, gene regulation and cellular transformation. Overexpression of miR-24 in six different cell lines, independent of p53 function, inhibited cell proliferation and resulted in G2/S cell cycle arrest. MiR-24 over expression in cells with wt-p53 upregulated TP53 and p21 protein; however, in p53-null cells miR-24 still induced cell cycle arrest without the involvement of p21. We show that miR-24 regulates p53-independent cellular proliferation by regulating an S-phase enzyme, dihydrofolate reductase (DHFR) a target of the chemotherapeutic drug methotrexate (MTX). Of interest, we found that a miR-24 target site polymorphism in DHFR 3' UTR that results in loss of miR-24-function and high DHFR levels in the cell imparts a growth advantage to immortalized cells and induces neoplastic transformation. Of clinical significance, we found that miR-24 is deregulated in human colorectal cancer tumors and a subset of tumors has reduced levels of miR-24. A novel function for miR-24 as a p53-independent cell cycle inhibitory miRNA is proposed.	[Mishra, Prasun J.; Merlino, Glenn] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Mishra, Prasun J.; Mishra, Pravin J.; Banerjee, Debabrata; Bertino, Joseph R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med & Pharmacol, Canc Inst New Jersey, Piscataway, NJ 08854 USA; [Song, Bo; Wang, Yuan; Ju, Jingfang] SUNY Stony Brook, Dept Pathol, Med Ctr, Translat Res Lab, Stony Brook, NY 11794 USA; [Humeniuk, Rita] NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mishra, PJ (corresponding author), NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA.	bertinoj@umdnj.edu		Ju, Jingfang/0000-0002-4821-7458	Center of Cancer Research, NCI [CA0810]; NIH [C5IL039280, CA114043]; NATIONAL CANCER INSTITUTE [ZIABC008756, R21CA114043] Funding Source: NIH RePORTER	Center of Cancer Research, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the Center of Cancer Research, NCI, NIH; in part by NCI Cancer Research Training Award C5IL039280 ( to PJM); in part by Stony-Brook Translational Research Laboratory Start-up fund and NIH CA114043 ( to JJ); and in part by NCI Grant CA0810 ( to JRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bertino JR, 2007, PHARMACOGENOMICS, V8, P1625, DOI 10.2217/14622416.8.12.1625; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; DANGERFIELD B, 2000, P AN M AM SOC CLIN, V19, P2000; FUKUDA Y, 2005, NUCL ACIDS S SER, V49, P341, DOI DOI 10.1093/NASS/49.1.341; Gammell P, 2007, J BIOTECHNOL, V130, P213, DOI 10.1016/j.jbiotec.2007.04.020; Gibcus JH, 2009, NEOPLASIA, V11, P167, DOI 10.1593/neo.08980; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LI Y, 1994, ONCOGENE, V9, P2261; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUCKEHUHLE C, 1994, CARCINOGENESIS, V15, P695, DOI 10.1093/carcin/15.4.695; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; MISHRA PJ, 2008, P AM ASS CAN RES APR, P2458; Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Mishra PJ, 2009, PERS MED, V6, P119, DOI 10.2217/17410541.6.2.119; Mishra PJ, 2009, J CLIN INVEST, V119, P2119, DOI 10.1172/JCI40107; MOUSSEAU M, 1993, EUR J CANCER, V29A, P753, DOI 10.1016/S0959-8049(05)80361-2; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Rahman L, 2004, CANCER CELL, V5, P341, DOI 10.1016/S1535-6108(04)00080-7; Scanlon K J, 1989, Cancer Commun, V1, P269; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SIMPSON P, 1982, CIRC RES, V50, P101, DOI 10.1161/01.RES.50.1.101; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; TRIMBLE JJ, 1988, SCIENCE, V239, P1145, DOI 10.1126/science.2830673; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Xi Y, 2008, ONCOL REP, V19, P257	39	94	111	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8445	10.1371/journal.pone.0008445	http://dx.doi.org/10.1371/journal.pone.0008445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041160	Green Published, Green Submitted, gold			2022-12-25	WOS:000273104000010
J	Chen, XJ; Koh, E; Yoder, M; Gumbiner, BM				Chen, Xuejun; Koh, Eunjin; Yoder, Michael; Gumbiner, Barry M.			A Protocadherin-Cadherin-FLRT3 Complex Controls Cell Adhesion and Morphogenesis	PLOS ONE			English	Article							E-CADHERIN; PARAXIAL PROTOCADHERIN; TISSUE RECONSTRUCTION; DISSOCIATED CELLS; MECHANISM; ENDOCYTOSIS; PROTEINS; INVOLVEMENT; NEURONS; RND1	Background: Paraxial protocadherin (PAPC) and fibronectin leucine-rich domain transmembrane protein-3 (FLRT3) are induced by TGF beta signaling in Xenopus embryos and both regulate morphogenesis by inhibiting C-cadherin mediated cell adhesion. Principal Findings: We have investigated the functional and physical relationships between PAPC, FLRT3, and C-cadherin. Although neither PAPC nor FLRT3 are required for each other to regulate C-cadherin adhesion, they do interact functionally and physically, and they form a complex with cadherins. By itself PAPC reduces cell adhesion physiologically to induce cell sorting, while FLRT3 disrupts adhesion excessively to cause cell dissociation. However, when expressed together PAPC limits the cell dissociating and tissue disrupting activity of FLRT3 to make it effective in physiological cell sorting. PAPC counteracts FLRT3 function by inhibiting the recruitment of the GTPase RND1 to the FLRT3 cytoplasmic domain. Conclusions/Significance: PAPC and FLRT3 form a functional complex with cadherins and PAPC functions as a molecular "governor'' to maintain FLRT3 activity at the optimal level for physiological regulation of C-cadherin adhesion, cell sorting, and morphogenesis.	[Chen, Xuejun; Koh, Eunjin; Yoder, Michael; Gumbiner, Barry M.] Univ Virginia, Hlth Sci Ctr, Dept Cell Biol, Charlottesville, VA USA	University of Virginia	Chen, XJ (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	gumbiner@virginia.edu		Koh, Eunjin/0000-0001-8967-6266	US National Institutes of Health [R01GM52717]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052717] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grants R01GM52717 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIEHER WM, 1994, J CELL BIOL, V126, P519, DOI 10.1083/jcb.126.2.519; Chen X, 2007, J BIOL CHEM, V282, P32128, DOI 10.1074/jbc.M705337200; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; Fukuhara A, 2002, ONCOGENE, V21, P7642, DOI 10.1038/sj.onc.1205875; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Karaulanov EE, 2006, EMBO REP, V7, P283, DOI 10.1038/sj.embor.7400614; KARTENBECK J, 1991, J CELL BIOL, V113, P881, DOI 10.1083/jcb.113.4.881; Kim SH, 1998, DEVELOPMENT, V125, P4681; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Medina A, 2004, EMBO J, V23, P3249, DOI 10.1038/sj.emboj.7600329; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Robinson M, 2004, MOL CELL NEUROSCI, V27, P202, DOI 10.1016/j.mcn.2004.06.008; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; STEINBERG MS, 1962, P NATL ACAD SCI USA, V48, P1577, DOI 10.1073/pnas.48.9.1577; STEINBERG MS, 1962, SCIENCE, V137, P762, DOI 10.1126/science.137.3532.762; STEINBERG MS, 1962, P NATL ACAD SCI USA, V48, P1769, DOI 10.1073/pnas.48.10.1769; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020	27	43	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8411	10.1371/journal.pone.0008411	http://dx.doi.org/10.1371/journal.pone.0008411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027292	Green Submitted, Green Published, gold			2022-12-25	WOS:000272998000016
J	Namas, R; Ghuma, A; Torres, A; Polanco, P; Gomez, H; Barclay, D; Gordon, L; Zenker, S; Kim, HK; Hermus, L; Zamora, R; Rosengart, MR; Clermont, G; Peitzman, A; Billiar, TR; Ochoa, J; Pinsky, MR; Puyana, JC; Vodovotz, Y				Namas, Rajaie; Ghuma, Ali; Torres, Andres; Polanco, Patricio; Gomez, Hernando; Barclay, Derek; Gordon, Lisa; Zenker, Sven; Kim, Hyung Kook; Hermus, Linda; Zamora, Ruben; Rosengart, Matthew R.; Clermont, Gilles; Peitzman, Andrew; Billiar, Timothy R.; Ochoa, Juan; Pinsky, Michael R.; Puyana, Juan Carlos; Vodovotz, Yoram			An Adequately Robust Early TNF-alpha Response Is a Hallmark of Survival Following Trauma/Hemorrhage	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELL DYSFUNCTION; HEMORRHAGIC-SHOCK; INFLAMMATORY RESPONSE; SEVERE SEPSIS; UP-REGULATION; NITRIC-OXIDE; TRAUMA; INTERLEUKIN-10; INJURY	Background: Trauma/hemorrhagic shock (T/HS) results in cytokine-mediated acute inflammation that is generally considered detrimental. Methodology/Principal Findings: Paradoxically, plasma levels of the early inflammatory cytokine TNF-alpha (but not IL-6, IL-10, or NO2-/NO3-) were significantly elevated within 6 h post-admission in 19 human trauma survivors vs. 4 non-survivors. Moreover, plasma TNF-alpha was inversely correlated with Marshall Score, an index of organ dysfunction, both in the 23 patients taken together and in the survivor cohort. Accordingly, we hypothesized that if an early, robust pro-inflammatory response were to be a marker of an appropriate response to injury, then individuals exhibiting such a response would be predisposed to survive. We tested this hypothesis in swine subjected to various experimental paradigms of T/HS. Twenty-three anesthetized pigs were subjected to T/HS (12 HS-only and 11 HS + Thoracotomy; mean arterial pressure of 30 mmHg for 45-90 min) along with surgery-only controls. Plasma obtained at pre-surgery, baseline post-surgery, beginning of HS, and every 15 min thereafter until 75 min (in the HS only group) or 90 min (in the HS + Thoracotomy group) was assayed for TNF-alpha, IL-6, IL-10, and NO2-/NO3-. Mean post-surgery +/- HS TNF-alpha levels were significantly higher in the survivors vs. nonsurvivors, while non-survivors exhibited no measurable change in TNF-alpha levels over the same interval. Conclusions/Significance: Contrary to the current dogma, survival in the setting of severe, acute T/HS appears to be associated with an immediate increase in serum TNF-alpha. It is currently unclear if this response was the cause of this protection, a marker of survival, or both. This abstract won a Young Investigator Travel Award at the SHOCK 2008 meeting in Cologne, Germany.	[Namas, Rajaie; Ghuma, Ali; Torres, Andres; Polanco, Patricio; Gomez, Hernando; Barclay, Derek; Gordon, Lisa; Hermus, Linda; Zamora, Ruben; Rosengart, Matthew R.; Peitzman, Andrew; Billiar, Timothy R.; Ochoa, Juan; Puyana, Juan Carlos; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; [Zenker, Sven; Kim, Hyung Kook; Clermont, Gilles; Pinsky, Michael R.; Puyana, Juan Carlos] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Zenker, Sven; Clermont, Gilles; Billiar, Timothy R.; Ochoa, Juan; Pinsky, Michael R.; Puyana, Juan Carlos; Vodovotz, Yoram] Univ Pittsburgh, Ctr Inflammat & Regenerat Modeling, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Namas, R (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.	vodovotzy@upmc.edu	Zenker, Sven/B-1222-2008; Namas, Rajaie/U-2206-2019; Gomez, Hernando/ABB-4589-2020	Zenker, Sven/0000-0003-0774-0725; Namas, Rajaie/0000-0003-0353-895X	National Institutes of Health [RO1-HL-076157, R33-HL-089082, RO1-GM-065914, P50-GM-53789]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089082, R01HL076157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065914, P50GM053789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants RO1-HL-076157, R33-HL-089082, R33-HL-089082, RO1-GM-065914, and P50-GM-53789. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM E, 1995, CRIT CARE MED, V23, P1319, DOI 10.1097/00003246-199508000-00004; Angele MK, 1998, SURGERY, V124, P394, DOI 10.1016/S0039-6060(98)70146-1; AYALA A, 1991, AM J PHYSIOL, V260, pR167, DOI 10.1152/ajpregu.1991.260.1.R167; AYALA A, 1994, ARCH SURG-CHICAGO, V129, P1172; Batistaki C, 2008, VASC PHARMACOL, V48, P85, DOI 10.1016/j.vph.2007.12.003; BEMELMANS MHA, 1993, BRIT J SURG, V80, P1055, DOI 10.1002/bjs.1800800845; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BOGDAN C, 1992, J BIOL CHEM, V267, P23301; Bogdan C, 2000, PROG INFLAM RES, P217; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Buchman Timothy G, 2004, Curr Opin Crit Care, V10, P378, DOI 10.1097/01.ccx.0000139369.65817.b6; CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1; CHAUDRY IH, 1990, AM J PHYSIOL, V259, pR663, DOI 10.1152/ajpregu.1990.259.4.R663; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Cocchi MN, 2007, EMERG MED CLIN N AM, V25, P623, DOI 10.1016/j.emc.2007.06.001; Collins J, 2001, SURG RES, P949; DAMAS P, 1989, CRIT CARE MED, V17, P975, DOI 10.1097/00003246-198910000-00001; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; DeLong WG, 2004, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000130840.64528.1e; DEMARIA EJ, 1993, J TRAUMA, V35, P720, DOI 10.1097/00005373-199311000-00012; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dirriopoulou I, 2008, CYTOKINE, V41, P263, DOI 10.1016/j.cyto.2007.11.019; ENDO S, 1994, CRIT CARE MED, V22, P949, DOI 10.1097/00003246-199406000-00012; Engles RE, 1997, J SURG RES, V69, P425, DOI 10.1006/jsre.1997.5109; FOEX BA, 1993, INJURY, V24, P373, DOI 10.1016/0020-1383(93)90098-Q; Foex BA, 1999, BRIT MED BULL, V55, P726, DOI 10.1258/0007142991902745; Fruchterman TM, 1998, SHOCK, V10, P417, DOI 10.1097/00024382-199812000-00007; Gebhard F, 1998, SHOCK, V10, P237, DOI 10.1097/00024382-199810000-00002; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Godin PJ, 1996, CRIT CARE MED, V24, P1117, DOI 10.1097/00003246-199607000-00009; Huber TS, 2000, SHOCK, V13, P425, DOI 10.1097/00024382-200006000-00002; Jarrar D, 1999, INT J MOL MED, V4, P575; Karakozis S, 2000, J SURG RES, V90, P109, DOI 10.1006/jsre.2000.5860; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Marcu AC, 2007, J TRAUMA, V63, P662, DOI 10.1097/TA.0b013e31802e70d9; Marie C, 1996, MEDIAT INFLAMM, V5, P334, DOI 10.1155/S0962935196000488; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MARZI I, 1995, SHOCK, V3, P27, DOI 10.1097/00024382-199503010-00004; McDaniel DO, 2007, J TRAUMA, V63, P147, DOI 10.1097/TA.0b013e31806bf0ab; Mimasaka S, 2001, TOHOKU J EXP MED, V193, P319, DOI 10.1620/tjem.193.319; Molina PE, 2001, NEUROIMMUNOMODULAT, V9, P125, DOI 10.1159/000049016; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; OCHOA JB, 1991, ANN SURG, V214, P621, DOI 10.1097/00000658-199111000-00013; Pape HC, 2007, INJURY, V38, P1358, DOI 10.1016/j.injury.2007.09.026; Pasquale MD, 1996, CRIT CARE MED, V24, P1238, DOI 10.1097/00003246-199607000-00029; PEITZMAN AB, 1995, CURR PROB SURG, V32, P930; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Platzer C, 2000, J NEUROIMMUNOL, V105, P31, DOI 10.1016/S0165-5728(00)00205-8; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Rivers EP, 2004, CRIT CARE MED, V32, P314, DOI 10.1097/01.CCM.0000104937.09370.53; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; ROGY MA, 1995, J EXP MED, V181, P2289, DOI 10.1084/jem.181.6.2289; Rose S, 1998, LANGENBECK ARCH SURG, V383, P199, DOI 10.1007/s004230050119; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Schneider CP, 2004, BBA-MOL BASIS DIS, V1689, P22, DOI 10.1016/j.bbadis.2004.01.003; Schwacha MG, 2001, AM J PHYSIOL-CELL PH, V281, pC1180, DOI 10.1152/ajpcell.2001.281.4.C1180; Sherry RM, 1996, J TRAUMA, V40, P613, DOI 10.1097/00005373-199604000-00016; Smith RM, 1998, J ROY SOC MED, V91, P417, DOI 10.1177/014107689809100805; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; THIEMERMANN C, 1993, P NATL ACAD SCI USA, V90, P267, DOI 10.1073/pnas.90.1.267; Toth B, 2004, J APPL PHYSIOL, V97, P2184, DOI 10.1152/japplphysiol.00499.2004; VANDERPOLL T, 1995, J IMMUNOL, V155, P5397; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; WANG P, 1993, J SURG RES, V54, P499, DOI 10.1006/jsre.1993.1077; Wang WY, 1998, J SURG RES, V79, P39, DOI 10.1006/jsre.1998.5385; Waxman K, 1996, New Horiz, V4, P153; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; WU HP, 2009, SERIAL CYTOKINE LEVE; YOUN YK, 1992, WORLD J SURG, V16, P30, DOI 10.1007/BF02067111; ZINGARELLI B, 1994, AM J PHYSIOL, V266, pH1512, DOI 10.1152/ajpheart.1994.266.4.H1512	80	44	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8406	10.1371/journal.pone.0008406	http://dx.doi.org/10.1371/journal.pone.0008406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027315	Green Published, gold, Green Accepted			2022-12-25	WOS:000272998000011
J	Steketee, RW; Eisele, TP				Steketee, Richard W.; Eisele, Thomas P.			Is the Scale Up of Malaria Intervention Coverage Also Achieving Equity?	PLOS ONE			English	Article							INSECTICIDE-TREATED BEDNETS; MEASLES VACCINATION; DELIVERY-SYSTEMS; CHILD-MORTALITY; AFRICA; NETS; MORBIDITY; BURDEN; PRINCIPLES; TANZANIA	Background and Methods: Malaria in Africa is most severe in young children and pregnant women, particularly in rural and poor households. In many countries, malaria intervention coverage rates have increased as a result of scale up; but this may mask limited coverage in these highest-risk populations. Reports were reviewed from nationally representative surveys in African malaria-endemic countries from 2006 through 2008 to understand how reported intervention coverage rates reflect access by the most at-risk populations. Results: Reports were available from 27 Demographic and Health Surveys (DHSs), Multiple Indicator Cluster Surveys (MICSs), and Malaria Indicator Surveys (MISs) during this interval with data on household intervention coverage by urban or rural setting, wealth quintile, and sex. Household ownership of insecticide-treated mosquito nets (ITNs) varied from 5% to greater than 60%, and was equitable by urban/rural and wealth quintile status among 13 (52%) of 25 countries. Malaria treatment rates for febrile children under five years of age varied from less than 10% to greater than 70%, and while equitable coverage was achieved in 8 (30%) of 27 countries, rates were generally higher in urban and richest quintile households. Use of intermittent preventive treatment in pregnant women varied from 2% to more than 60%, and again tended to be higher in urban and richest quintile households. Across all countries, there were no significant male/female inequalities seen for children sleeping under ITNs or receiving antimalarial treatment for febrile illness. Parasitemia and anemia rates from eight national surveys showed predominance in poor and rural populations. Conclusions/Significance: Recent efforts to scale up malaria intervention coverage have achieved equity in some countries (especially with ITNs), but delivery methods in other countries are not addressing the most at-risk populations. As countries seek universal malaria intervention coverage, their delivery systems must reach the rural and poor populations; this is not a small task, but it has been achieved in some countries.	[Steketee, Richard W.] MACEPA PATH, Ferney Voltaire, France; [Eisele, Thomas P.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Int Hlth & Dev, New Orleans, LA USA	Tulane University	Steketee, RW (corresponding author), MACEPA PATH, Ferney Voltaire, France.	rsteketee@path.org	Eisele, Thom/AAE-8958-2020		Bill and Melinda Gates Foundation; Department of International Health and Development, Tulane School of Public Health and Tropical Medicine	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department of International Health and Development, Tulane School of Public Health and Tropical Medicine	RWS is funded by the Malaria Control and Evaluation Partnership in Africa program at PATH through a grant from the Bill and Melinda Gates Foundation. TPE is funded by the Department of International Health and Development, Tulane School of Public Health and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GLOB MAL ACT PLAN MA; BINKA FN, 1994, T ROY SOC TROP MED H, V88, P381, DOI 10.1016/0035-9203(94)90391-3; Curtis C, 2003, LANCET INFECT DIS, V3, P304, DOI 10.1016/S1473-3099(03)00612-1; ETTLING M, 1994, TROP MED PARASITOL, V45, P74; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Gates B, 2007, MALARIA FORUM KEYNOT; Grabowsky M, 2005, TROP MED INT HEALTH, V10, P1151, DOI 10.1111/j.1365-3156.2005.01502.x; Grabowsky M, 2005, B WORLD HEALTH ORGAN, V83, P195; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Gwatkin DR, 1999, LANCET, V354, P586, DOI 10.1016/S0140-6736(99)02108-X; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Matovu F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-109; Maxwell CA, 2002, TROP MED INT HEALTH, V7, P1003, DOI 10.1046/j.1365-3156.2002.00966.x; Monasch R, 2004, AM J TROP MED HYG, V71, P232, DOI 10.4269/ajtmh.2004.71.232; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; RBM, 2008, GUID COR POP BAS IND; RBM, 2005, ROLL BACK MAL GLOB S; Rutstein S. O., 2004, DHS WEALTH INDEX; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Steketee RW, 2008, AM J TROP MED HYG, V79, P45, DOI 10.4269/ajtmh.2008.79.45; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; *UN, 2008, WORLD MAL DAY NEW GO; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Webster J, 2005, LANCET INFECT DIS, V5, P709, DOI 10.1016/S1473-3099(05)70269-3; Webster J, 2007, HEALTH POLICY PLANN, V22, P277, DOI 10.1093/heapol/czm021; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN	30	36	36	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8409	10.1371/journal.pone.0008409	http://dx.doi.org/10.1371/journal.pone.0008409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027289	Green Published, Green Submitted, gold			2022-12-25	WOS:000272998000014
J	Aronovich, A; Tchorsh, D; Shezen, E; Rosen, C; Klionsky, Y; Cohen, S; Tal, O; Martinowitz, U; Katchman, H; Eventov-Friedman, S; Amariglio, N; Jacob-Hirsch, J; Rechavi, G; Reisner, Y				Aronovich, Anna; Tchorsh, Dalit; Shezen, Elias; Rosen, Chava; Klionsky, Yael; Cohen, Sivan; Tal, Orna; Martinowitz, Uri; Katchman, Helena; Eventov-Friedman, Smadar; Amariglio, Ninette; Jacob-Hirsch, Jasmine; Rechavi, Gideon; Reisner, Yair			Enhancement of Pig Embryonic Implants in Factor VIII KO Mice: A Novel Role for the Coagulation Cascade in Organ Size Control	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTORS; STEM-CELL NICHE; HEMATOPOIETIC STEM; THROMBIN-CLEAVAGE; OSTEOPONTIN; GROWTH; DIFFERENTIATION; ANGIOGENESIS; HEMOSTASIS; COMPONENT	Very little is known about the mechanisms that contribute to organ size differences between species. In the present study, we used a mouse model of embryonic pig tissue implantation to define the role of host Factor VIII in controlling the final size attained by the implant. We show here that pig embryonic spleen, pancreas, and liver all grow to an increased size in mice that are deficient in the Factor VIII clotting cascade. Similar results were obtained using the transplantation model after treatment with the low molecular weight heparin derivative Clexane which markedly enhanced transplant size. Likewise, enhanced size was found upon treatment with the direct thrombin inhibitor Dabigatran, suggesting that organ size regulation might be mediated by thrombin, downstream of Factor VIII. Considering that thrombin was shown to mediate various functions unrelated to blood clotting, either directly by cleavage of protease-activated receptors (PARs) or indirectly by cleaving osteopontin (OPN) on stroma cells, the role of PAR1 and PAR4 antagonists as well as treatment with cleaved form of OPN (tcOPN) were tested. While the former was not found to have an impact on overgrowth of embryonic pig spleen implants, marked reduction of size was noted upon treatment with the (tcOPN). Collectively, our surprising set of observations suggests that factors of the coagulation cascade have a novel role in organ size control.	[Aronovich, Anna; Tchorsh, Dalit; Shezen, Elias; Rosen, Chava; Klionsky, Yael; Cohen, Sivan; Tal, Orna; Katchman, Helena; Eventov-Friedman, Smadar; Reisner, Yair] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Martinowitz, Uri] Sheba Med Ctr, Israel Natl Hemophilia Ctr, Tel Hashomer, Israel; [Amariglio, Ninette; Jacob-Hirsch, Jasmine; Rechavi, Gideon] Sheba Med Ctr, Canc Res Ctr, Tel Hashomer, Israel	Weizmann Institute of Science; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Aronovich, A (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	yair.reisner@weizmann.ac.il	Reisner, Yair/AAA-4772-2019	Reisner, Yair/0000-0002-3354-6945	Mrs. Erica Drake and the Gabriella Rich Center	Mrs. Erica Drake and the Gabriella Rich Center	This work was supported by Mrs. Erica Drake and the Gabriella Rich Center for Transplantation Biology Research. The funding supported mice and other supplies. There was no other funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Agarwal A, 2008, MOL CANCER THER, V7, P2746, DOI 10.1158/1535-7163.MCT-08-0177; Ahn HS, 2003, CURR PHARM DESIGN, V9, P2349, DOI 10.2174/1381612033453884; Aronovich A, 2006, P NATL ACAD SCI USA, V103, P19075, DOI 10.1073/pnas.0607012103; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Croce K, 2007, CURR OPIN HEMATOL, V14, P55, DOI 10.1097/00062752-200701000-00011; Dekel B, 2003, NAT MED, V9, P53, DOI 10.1038/nm812; DITTMER JE, 1974, AM J ANAT, V141, P155, DOI 10.1002/aja.1001410112; Doyle KP, 2008, J CEREBR BLOOD F MET, V28, P1235, DOI 10.1038/jcbfm.2008.17; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Eventov-Friedman S, 2005, P NATL ACAD SCI USA, V102, P2928, DOI 10.1073/pnas.0500177102; Forsberg EC, 2006, STEM CELL REV, V2, P23, DOI 10.1007/s12015-006-0005-z; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Haylock DN, 2006, BRIT J HAEMATOL, V134, P467, DOI 10.1111/j.1365-2141.2006.06218.x; Haylock DN, 2005, CELL CYCLE, V4, P1353, DOI 10.4161/cc.4.10.2056; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Kelleher FC, 2006, ACTA ONCOL, V45, P375, DOI 10.1080/02841860600602946; Landis RC, 2007, HEMATOL ONCOL CLIN N, V21, P103, DOI 10.1016/j.hoc.2006.11.005; Martin K, 2009, CIRC RES, V105, P214, DOI 10.1161/CIRCRESAHA.109.199984; Martorell L, 2008, THROMB HAEMOSTASIS, V99, P305, DOI 10.1160/TH07-08-0481; METCALF D, 1963, AUST J EXP BIOL MED, V41, P437, DOI 10.1038/icb.1963.64; METCALF D, 1964, TRANSPLANTATION, V2, P387, DOI 10.1097/00007890-196405000-00008; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Roobrouck VD, 2008, EXP CELL RES, V314, P1937, DOI 10.1016/j.yexcr.2008.03.006; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Senger DR, 1996, BBA-MOL CELL RES, V1314, P13, DOI 10.1016/S0167-4889(96)00067-5; SENGER DR, 1995, ANN NY ACAD SCI, V760, P83, DOI 10.1111/j.1749-6632.1995.tb44622.x; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; Slofstra SH, 2007, BLOOD, V110, P3176, DOI 10.1182/blood-2007-02-075440; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Wielders SJH, 2007, J THROMB HAEMOST, V5, P571, DOI 10.1111/j.1538-7836.2007.02364.x	37	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8362	10.1371/journal.pone.0008362	http://dx.doi.org/10.1371/journal.pone.0008362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027227	Green Published, gold, Green Submitted			2022-12-25	WOS:000272940100010
J	Orozco-Barrios, CE; Battaglia-Hsu, SF; Arango-Rodriguez, ML; Ayala-Davila, J; Chery, C; Alberto, JM; Schroeder, H; Daval, JL; Martinez-Fong, D; Gueant, JL				Enrique Orozco-Barrios, Carlos; Battaglia-Hsu, Shyue-Fang; Ligia Arango-Rodriguez, Martha; Ayala-Davila, Jose; Chery, Celine; Alberto, Jean-Marc; Schroeder, Henry; Daval, Jean-Luc; Martinez-Fong, Daniel; Gueant, Jean-Louis			Vitamin B12-Impaired Metabolism Produces Apoptosis and Parkinson Phenotype in Rats Expressing the Transcobalamin-Oleosin Chimera in Substantia Nigra	PLOS ONE			English	Article							HOMOCYSTEINE METABOLISM; COGNITIVE IMPAIRMENT; NEUROTENSIN POLYPLEX; PLASMA HOMOCYSTEINE; LIPID-PEROXIDATION; GENE-TRANSFER; IN-VITRO; DEFICIENCY; LEVODOPA; DNA	Background: Vitamin B12 is indispensable for proper brain functioning and cytosolic synthesis of S-adenosylmethionine. Whether its deficiency produces effects on viability and apoptosis of neurons remains unknown. There is a particular interest in investigating these effects in Parkinson disease where Levodopa treatment is known to increase the consumption of S-adenosylmethionine. To cause deprivation of vitamin B12, we have recently developed a cell model that produces decreased synthesis of S-adenosylmethionine by anchoring transcobalamin (TCII) to the reticulum through its fusion with Oleosin (OLEO). Methodology: Gene constructs including transcobalamin-oleosin (TCII-OLEO) and control constructs, green fluorescent protein-transcobalamin-oleosin (GFP-TCII-OLEO), oleosin-transcobalamin (OLEO-TCII), TCII and OLEO were used for expression in N1E-115 cells (mouse neuroblastoma) and in substantia nigra of adult rats, using a targeted transfection with a Neurotensin polyplex system. We studied the viability and the apoptosis in the transfected cells and targeted tissue. The turning behavior was evaluated in the rats transfected with the different plasmids. Principal Findings: The transfection of N1E-115 cells by the TCII-OLEO-expressing plasmid significantly affected cell viability and increased immunoreactivity of cleaved Caspase-3. No change in propidium iodide uptake (used as a necrosis marker) was observed. The transfected rats lost neurons immunoreactive to tyrosine hydroxylase. The expression of TCII-OLEO was observed in cells immunoreactive to tyrosine hydroxylase of the substantia nigra, with a superimposed expression of cleaved Caspase-3. These cellular and tissular effects were not observed with the control plasmids. Rats transfected with TCII-OLEO expressing plasmid presented with a significantly higher number of turns, compared with those transfected with the other plasmids. Conclusions/Significance: In conclusion, the TCII-OLEO transfection was responsible for apoptosis in N1E-115 cells and rat substantia nigra and for Parkinson-like phenotype. This suggests evaluating whether vitamin B12 deficit could aggravate the PD in patients under Levodopa therapy by impairing S-adenosylmethionine synthesis in substantia nigra.	[Enrique Orozco-Barrios, Carlos; Ligia Arango-Rodriguez, Martha; Ayala-Davila, Jose; Martinez-Fong, Daniel] Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Physiol Biophys & Neurosci, Mexico City, DF, Mexico; [Enrique Orozco-Barrios, Carlos; Battaglia-Hsu, Shyue-Fang; Chery, Celine; Alberto, Jean-Marc; Daval, Jean-Luc; Gueant, Jean-Louis] Nancy Univ, Fac Med, INSERM, U954, Nancy, France; [Schroeder, Henry] Nancy Univ, INRA, URAFPA, Nancy, France	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; INRAE; Universite de Lorraine	Orozco-Barrios, CE (corresponding author), Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Physiol Biophys & Neurosci, Mexico City, DF, Mexico.	jean-louis.gueant@medecine.uhp-nancy.fr	Daval, Jean-Luc/G-6502-2014; Martinez, Isabelle/K-7178-2012	Ayala-Davila, Jose/0000-0002-1865-3662; Orozco-Barrios, Carlos E./0000-0002-3989-1205	French national agency for research; CPER (contrat de projets etat-region) of region of Lorraine (France); Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (CINVESTAV, Mexico)	French national agency for research(French National Research Agency (ANR)); CPER (contrat de projets etat-region) of region of Lorraine (France); Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (CINVESTAV, Mexico)	This study was supported by the French national agency for research (ANR, France, programme de recherche en nutrition et alimentation, project "Nutrivigene"), the CPER (contrat de projets etat-region) of region of Lorraine (France) and Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (CINVESTAV, Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya-Martinez V, 2006, NEUROSCIENCE, V143, P477, DOI 10.1016/j.neuroscience.2006.08.033; Arango-Rodriguez ML, 2006, BBA-GEN SUBJECTS, V1760, P1009, DOI 10.1016/j.bbagen.2006.02.021; Blaise S, 2005, PEDIATR RES, V57, P777, DOI 10.1203/01.PDR.0000161406.19231.98; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Brunaud L, 2003, DIGESTION, V68, P133, DOI 10.1159/000075307; Buccellato FR, 1999, FASEB J, V13, P297, DOI 10.1096/fasebj.13.2.297; Capuano F, 2007, BIOTECHNOL ADV, V25, P203, DOI 10.1016/j.biotechadv.2006.11.006; Cheng H, 1997, EXP NEUROL, V145, P580, DOI 10.1006/exnr.1997.6466; Choi SW, 2004, J NUTR, V134, P750, DOI 10.1093/jn/134.4.750; Chumnantana R, 2005, BBA-GEN SUBJECTS, V1722, P84, DOI 10.1016/j.bbagen.2004.11.013; Daval JL, 2009, P NATL ACAD SCI USA, V106, pE1, DOI 10.1073/pnas.0809217106; de Lau LML, 2006, NEUROLOGY, V67, P315, DOI 10.1212/01.wnl.0000225050.57553.6d; Forges T, 2007, HUM REPROD UPDATE, V13, P225, DOI 10.1093/humupd/dml063; Fuso A, 2005, MOL CELL NEUROSCI, V28, P195, DOI 10.1016/j.mcn.2004.09.007; GHARIB A, 1983, J NEUROCHEM, V40, P1110, DOI 10.1111/j.1471-4159.1983.tb08100.x; Gonzalez-Barrios JA, 2006, MOL THER, V14, P857, DOI 10.1016/j.ymthe.2006.09.001; Ho PI, 2001, J NEUROCHEM, V78, P249, DOI 10.1046/j.1471-4159.2001.00384.x; HSUBATTAGLIA SF, 2009, P NATL ACAD IN PRESS; Jain SK, 2001, FREE RADICAL BIO MED, V30, P232, DOI 10.1016/S0891-5849(00)00462-7; Kannan K, 2004, FREE RADICAL BIO MED, V36, P423, DOI 10.1016/j.freeradbiomed.2003.09.012; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Kuhn W, 1998, EUR NEUROL, V40, P225, DOI 10.1159/000007984; Lamberti P, 2005, MOVEMENT DISORD, V20, P69, DOI 10.1002/mds.20261; Mahfouz MM, 2004, INT J BIOCHEM CELL B, V36, P1919, DOI 10.1016/j.biocel.2004.01.028; Martinez-Fong D, 2000, BRAIN RES PROTOC, V6, P13, DOI 10.1016/S1385-299X(00)00032-5; McLean GR, 1997, BLOOD, V89, P235, DOI 10.1182/blood.V89.1.235.235_235_242; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Miller JW, 1997, CLIN NEUROPHARMACOL, V20, P55, DOI 10.1097/00002826-199702000-00007; Muller T, 1999, LANCET, V354, P126, DOI 10.1016/S0140-6736(99)01660-8; Navarro-Quiroga I, 2002, MOL BRAIN RES, V105, P86, DOI 10.1016/S0169-328X(02)00396-0; Pons L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006325; Raffo E, 2009, EXP NEUROL, V219, P414, DOI 10.1016/j.expneurol.2009.06.014; Rogers JD, 2003, ARCH NEUROL-CHICAGO, V60, P59, DOI 10.1001/archneur.60.1.59; ROTHENBERG SP, 1995, BAILLIERE CLIN HAEM, V8, P499, DOI 10.1016/S0950-3536(05)80218-5; Rubio-Zapata HA, 2009, CANCER GENE THER, V16, P573, DOI 10.1038/cgt.2009.1; Russell JSR, 1900, BRAIN, V23, P39, DOI 10.1093/brain/23.1.39; Scalabrino G, 2004, ANN NEUROL, V56, P886, DOI 10.1002/ana.20325; Scalabrino G, 2009, PROG NEUROBIOL, V88, P203, DOI 10.1016/j.pneurobio.2009.04.004; Smith AD, 2009, AM J CLIN NUTR, V89, p707S, DOI 10.3945/ajcn.2008.26947D; Spada RS, 2007, CLIN CHEM LAB MED, V45, P136, DOI 10.1515/CCLM.2007.065; Tai GH, 2005, METHOD ENZYMOL, V404, P442, DOI 10.1016/S0076-6879(05)04039-5; Tan EK, 2005, AM J MED GENET B, V137B, P1, DOI 10.1002/ajmg.b.30198; Todorovic Z, 2006, J NEUROL SCI, V248, P56, DOI 10.1016/j.jns.2006.05.040; Troen AM, 2008, P NATL ACAD SCI USA, V105, P12474, DOI 10.1073/pnas.0805350105; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103; Yasui K, 2003, ACTA NEUROL SCAND, V108, P66, DOI 10.1034/j.1600-0404.2003.00135.x	46	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8268	10.1371/journal.pone.0008268	http://dx.doi.org/10.1371/journal.pone.0008268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027219	Green Published, gold, Green Submitted			2022-12-25	WOS:000272940100002
J	Peleg-Grossman, S; Golani, Y; Kaye, Y; Melamed-Book, N; Levine, A				Peleg-Grossman, Smadar; Golani, Yael; Kaye, Yuval; Melamed-Book, Naomi; Levine, Alex			NPR1 Protein Regulates Pathogenic and Symbiotic Interactions between Rhizobium and Legumes and Non-Legumes	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; PLANT-DISEASE RESISTANCE; OXYGEN SPECIES PRODUCTION; SALICYLIC-ACID; MEDICAGO-TRUNCATULA; REACTIVE OXYGEN; OXIDATIVE BURST; HYPERSENSITIVE RESPONSE; CELL-DEATH; GENE	Background: Legumes are unique in their ability to establish symbiotic interaction with rhizobacteria from Rhizobium genus, which provide them with available nitrogen. Nodulation factors (NFs) produced by Rhizobium initiate legume root hair deformation and curling that entrap the bacteria, and allow it to grow inside the plant. In contrast, legumes and non-legumes activate defense responses when inoculated with pathogenic bacteria. One major defense pathway is mediated by salicylic acid (SA). SA is sensed and transduced to downstream defense components by a redox-regulated protein called NPR1. Methodology/Principal Findings: We used Arabidopsis mutants in SA defense pathway to test the role of NPR1 in symbiotic interactions. Inoculation of Sinorhizobium meliloti or purified NF on Medicago truncatula or nim1/npr1 A. thaliana mutants induced root hair deformation and transcription of early and late nodulins. Application of S. meliloti or NF on M. truncatula or A. thaliana roots also induced a strong oxidative burst that lasted much longer than in plants inoculated with pathogenic or mutualistic bacteria. Transient overexpression of NPR1 in M. truncatula suppressed root hair curling, while inhibition of NPR1 expression by RNAi accelerated curling. Conclusions/Significance: We show that, while NPR1 has a positive effect on pathogen resistance, it has a negative effect on symbiotic interactions, by inhibiting root hair deformation and nodulin expression. Our results also show that basic plant responses to Rhizobium inoculation are conserved in legumes and non-legumes.	[Peleg-Grossman, Smadar; Golani, Yael; Kaye, Yuval; Melamed-Book, Naomi; Levine, Alex] Hebrew Univ Jerusalem, Dept Plant & Environm Sci, Jerusalem, Israel	Hebrew University of Jerusalem	Peleg-Grossman, S (corresponding author), Hebrew Univ Jerusalem, Dept Plant & Environm Sci, Jerusalem, Israel.	alexl@cc.huji.ac.il	Levine, Alex/A-6867-2008		Israel Science Foundation (ISF); Canadian Friends of the Hebrew University	Israel Science Foundation (ISF)(Israel Science Foundation); Canadian Friends of the Hebrew University	This work was supported in part by the Israel Science Foundation (ISF). YK and YG were supported by the Canadian Friends of the Hebrew University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bent AF, 2000, PLANT PHYSIOL, V124, P1540, DOI 10.1104/pp.124.4.1540; Blanco F, 2005, PLANT MOL BIOL, V59, P927, DOI 10.1007/s11103-005-2227-x; Brewin NJ, 2004, CRIT REV PLANT SCI, V23, P293, DOI 10.1080/07352680490480734; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Catoira R, 2001, DEVELOPMENT, V128, P1507; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; DAZZO FB, 1984, APPL ENVIRON MICROB, V48, P1140, DOI 10.1128/AEM.48.6.1140-1150.1984; de Leon IP, 2002, PLANT J, V29, P61, DOI 10.1046/j.1365-313x.2002.01195.x; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; EGELHOFF TT, 1985, J BACTERIOL, V164, P591, DOI 10.1128/JB.164.2.591-599.1985; Esseling JJ, 2004, PLANT CELL, V16, P933, DOI 10.1105/tpc.019653; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Geurts R, 2002, PLANT CELL, V14, pS239, DOI 10.1105/tpc.002451; GODIARD L, 1994, CURR OPIN GENET DEV, V4, P662, DOI 10.1016/0959-437X(94)90132-M; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Hepworth SR, 2005, PLANT CELL, V17, P1434, DOI 10.1105/tpc.104.030536; Hirsch AM, 1997, PLANT SOIL, V194, P171, DOI 10.1023/A:1004292020902; Jamet A, 2007, J BACTERIOL, V189, P8741, DOI 10.1128/JB.01130-07; Kuppusamy KT, 2004, PLANT PHYSIOL, V136, P3682, DOI 10.1104/pp.104.045575; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Leshem Y, 2006, P NATL ACAD SCI USA, V103, P18008, DOI 10.1073/pnas.0604421103; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Levy M, 2008, MOL PLANT PATHOL, V9, P719, DOI [10.1111/j.1364-3703.2008.00483.x, 10.1111/J.1364-3703.2008.00483.X]; Limpens E, 2003, CURR OPIN PLANT BIOL, V6, P343, DOI 10.1016/S1369-5266(03)00068-2; Liu GS, 2005, PLANT J, V41, P304, DOI 10.1111/j.1365-313X.2004.02296.x; Lohar DP, 2007, NEW PHYTOL, V173, P39, DOI 10.1111/j.1469-8137.2006.01901.x; Martinez-Abarca F, 1998, MOL PLANT MICROBE IN, V11, P153, DOI 10.1094/MPMI.1998.11.2.153; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Murata Y, 2001, PLANT CELL, V13, P2513, DOI 10.1105/tpc.13.11.2513; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Pauly N, 2006, J EXP BOT, V57, P1769, DOI 10.1093/jxb/erj184; Peleg-Grossman S, 2007, J EXP BOT, V58, P1637, DOI 10.1093/jxb/erm013; Peretz Y, 2007, PLANT PHYSIOL, V145, P1251, DOI 10.1104/pp.107.108217; PICHON M, 1992, PLANT CELL, V4, P1199, DOI 10.1105/tpc.4.10.1199; Pilotti M, 2008, TREE GENET GENOMES, V4, P49, DOI 10.1007/s11295-007-0087-z; PISTOLE TG, 1981, ANNU REV MICROBIOL, V35, P85, DOI 10.1146/annurev.mi.35.100181.000505; Ramu SK, 2002, MOL PLANT MICROBE IN, V15, P522, DOI 10.1094/MPMI.2002.15.6.522; Santos R, 2001, MOL PLANT MICROBE IN, V14, P86, DOI 10.1094/MPMI.2001.14.1.86; Sanz A, 1998, PLANT CELL, V10, P1523, DOI 10.1105/tpc.10.9.1523; Schultze M, 1998, ANNU REV GENET, V32, P33, DOI 10.1146/annurev.genet.32.1.33; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Shapiro AD, 2001, PLANT PHYSIOL, V127, P1089, DOI 10.1104/pp.010096; Shirasu K, 1997, PLANT CELL, V9, P261, DOI 10.1105/tpc.9.2.261; Silverstein KAT, 2006, CURR OPIN PLANT BIOL, V9, P142, DOI 10.1016/j.pbi.2006.01.002; SMIT G, 1989, J BACTERIOL, V171, P4054, DOI 10.1128/jb.171.7.4054-4062.1989; Stacey G, 2006, PLANT PHYSIOL, V141, P1473, DOI 10.1104/pp.106.080986; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Tirajoh A, 2005, J EXP BOT, V56, P713, DOI 10.1093/jxb/eri038; van Spronsen PC, 2003, MOL PLANT MICROBE IN, V16, P83, DOI 10.1094/MPMI.2003.16.1.83; VASSE J, 1993, PLANT J, V4, P555, DOI 10.1046/j.1365-313X.1993.04030555.x; Vernoud V, 1999, MOL PLANT MICROBE IN, V12, P604, DOI 10.1094/MPMI.1999.12.7.604; Vorwerk S, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-35; Wais RJ, 2002, PLANT PHYSIOL, V129, P211, DOI 10.1104/pp.010690; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523	59	26	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8399	10.1371/journal.pone.0008399	http://dx.doi.org/10.1371/journal.pone.0008399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027302	Green Submitted, Green Published, gold			2022-12-25	WOS:000272940100025
J	Luttichau, HR				Luttichau, Hans R.			The Cytomegalovirus UL146 Gene Product vCXCL1 Targets Both CXCR1 and CXCR2 as an Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULOCYTE CHEMOTACTIC PROTEIN-2; HUMAN ENDOTHELIAL-CELLS; SEQUENCE VARIABILITY; FUNCTIONAL EXPRESSION; CHEMOKINE RECEPTORS; GRO-ALPHA; VMIP-II; INTERLEUKIN-8; IL-8; BROAD	Large DNA viruses, such as herpesvirus and poxvirus, encode proteins that target and exploit the chemokine system of their host. UL146 and UL147 in the cytomegalovirus (CMV) genome encode the two CXC chemokines vCXCL1 and vCXCL2. In this study, vCXCL1 was probed against a panel of the 18 classified human chemokine receptors. In calcium mobilization assays vCXCL1 acted as an agonist on both CXCR1 and CXCR2 but did not activate or block any of the other 16 chemokine receptors. vCXCL1 was characterized and compared with CXCL1/GRO alpha, CXCL2/GRO beta, CXCL3/GRO gamma, CXCL5/ENA-78, CXCL6/GCP2, CXCL7/NAP-2 and CXCL8/IL-8 in competition binding, calcium mobilization, inositol triphosphate turnover, and chemotaxis assays using CXCR1- and CXCR2-expressing Chinese hamster ovary, 300.19, COS7, and L1.2 cells. The affinities of vCXCL1 for the CXCR1 and CXCR2 receptors were 44 and 5.6 nM, respectively, as determined in competition binding against radioactively labeled CXCL8. In calcium mobilization, phosphatidylinositol turnover, and chemotaxis assays, vCXCL1 acted as a highly efficacious activator of both receptors, with a rather low potency for the CXCR1 receptor but comparable with CXCL5 and CXCL7. It is suggested that CMV uses the UL146 gene product expressed in infected endothelial cells to attract neutrophils by activating their CXCR1 and CXCR2 receptors, whereby neutrophils can act as carriers of the virus to uninfected endothelial cells. In that way a lasting pool of CMV-infected endothelial cells could be maintained.	[Luttichau, Hans R.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark; [Luttichau, Hans R.] Univ Copenhagen, Herlev Hosp, Dept Med O107, Infect Dis Unit, DK-2730 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Luttichau, HR (corresponding author), Univ Copenhagen, Panum Inst 18 6, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	LUTTICHAU@sund.ku.dk		Luttichau, Hans Rudolf/0000-0002-5428-4075	Danish Medical Research Council; Foundation of A. P. Moller and Chastine McKinney Moller; Foundation of Arvid Nilsson; Augustinus Foundation; Beckett-Foundation; Foundation of Bent Bogh and Wife; Foundation of Carl and Ellen Hertz; Foundation of Christian Larsen and Ellen Larsen; Foundation of Frode V. Nyegaard and Wife; Foundation of E. Danielsen and Wife; Foundation of Einar Hansen and Wife; Foundation of Michael Hermann Nielsen; Foundation of Else and Mogens Wedell-Wedellsborg; Foundation of Karl G Andersen; Harboe-Foundation; Foundation of Holger Hjortenberg and Wife; Illum Foundation; Foundation of Johan Boserup and Lise Boserup; Foundation of Niels Hansen and Wife; Foundation of Werner Richter and Wife; Foundation of Ove William Buhl Olesen and Wife; Foundation of Meta and HAkon Bagger; Foundation of Jakob Madsen and Wife	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Foundation of A. P. Moller and Chastine McKinney Moller; Foundation of Arvid Nilsson; Augustinus Foundation; Beckett-Foundation; Foundation of Bent Bogh and Wife; Foundation of Carl and Ellen Hertz; Foundation of Christian Larsen and Ellen Larsen; Foundation of Frode V. Nyegaard and Wife; Foundation of E. Danielsen and Wife; Foundation of Einar Hansen and Wife; Foundation of Michael Hermann Nielsen; Foundation of Else and Mogens Wedell-Wedellsborg; Foundation of Karl G Andersen; Harboe-Foundation; Foundation of Holger Hjortenberg and Wife; Illum Foundation; Foundation of Johan Boserup and Lise Boserup; Foundation of Niels Hansen and Wife; Foundation of Werner Richter and Wife; Foundation of Ove William Buhl Olesen and Wife; Foundation of Meta and HAkon Bagger; Foundation of Jakob Madsen and Wife	This work was supported by grants from the Danish Medical Research Council, the Foundation of A. P. Moller and Chastine McKinney Moller, the Foundation of Arvid Nilsson, the Augustinus Foundation, the Beckett-Foundation, the Foundation of Bent Bogh and Wife, the Foundation of Carl and Ellen Hertz, the Foundation of Christian Larsen and Ellen Larsen, the Foundation of Frode V. Nyegaard and Wife, the Foundation of E. Danielsen and Wife, the Foundation of Einar Hansen and Wife, the Foundation of Michael Hermann Nielsen, the Foundation of Else and Mogens Wedell-Wedellsborg, the Foundation of Karl G Andersen, the Harboe-Foundation, the Foundation of Holger Hjortenberg and Wife, the Illum Foundation, the Foundation of Johan Boserup and Lise Boserup, the Foundation of Niels Hansen and Wife, the Foundation of Werner Richter and Wife, the Foundation of Ove William Buhl Olesen and Wife, the Foundation of Meta and HAkon Bagger, and the Foundation of Jakob Madsen and Wife.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Arav-Boger R, 2006, J INFECT DIS, V193, P788, DOI 10.1086/500508; BenBaruch A, 1997, CYTOKINE, V9, P37, DOI 10.1006/cyto.1996.0133; Cha TA, 1996, J VIROL, V70, P78, DOI 10.1128/JVI.70.1.78-83.1996; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; ClarkLewis I, 1997, METHOD ENZYMOL, V287, P233; Coulin F, 1997, EUR J BIOCHEM, V248, P507, DOI 10.1111/j.1432-1033.1997.00507.x; Dairaghi DJ, 1999, J BIOL CHEM, V274, P21569, DOI 10.1074/jbc.274.31.21569; Dewin DR, 2006, J IMMUNOL, V176, P544, DOI 10.4049/jimmunol.176.1.544; Dong C, 2005, J IMMUNOL METHODS, V302, P136, DOI 10.1016/j.jim.2005.05.008; Endres MJ, 1999, J EXP MED, V189, P1993, DOI 10.1084/jem.189.12.1993; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Hallgren J, 2007, P NATL ACAD SCI USA, V104, P20478, DOI 10.1073/pnas.0709651104; Hassan-Walker AF, 2004, J MED VIROL, V74, P573, DOI 10.1002/jmv.20210; He R, 2006, INTERVIROLOGY, V49, P215, DOI 10.1159/000091468; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; JOHANSEN TE, 1990, FEBS LETT, V267, P289, DOI 10.1016/0014-5793(90)80947-H; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Lindow M, 2003, TRENDS PHARMACOL SCI, V24, P126, DOI 10.1016/S0165-6147(03)00033-6; Liu Y, 1997, J IMMUNOL, V158, P604; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; LOETSCHER P, 1994, FEBS LETT, V341, P187, DOI 10.1016/0014-5793(94)80454-0; Lurain NS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-4; Luttichau HR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-50; Luttichau HR, 2007, J BIOL CHEM, V282, P17794, DOI 10.1074/jbc.M702001200; Luttichau HR, 2003, J BIOL CHEM, V278, P10928, DOI 10.1074/jbc.M211329200; Luttichau HR, 2000, J EXP MED, V191, P171, DOI 10.1084/jem.191.1.171; Luttichau HR, 2001, EUR J IMMUNOL, V31, P1217; Maggi CA, 1997, TRENDS PHARMACOL SCI, V18, P351, DOI 10.1016/S0165-6147(97)90663-5; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Murphy PM, 2000, PHARMACOL REV, V52, P145; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Osborne J, 1999, HUM IMMUNOL, V60, P921, DOI 10.1016/S0198-8859(99)00083-X; Penfold MET, 1999, P NATL ACAD SCI USA, V96, P9839, DOI 10.1073/pnas.96.17.9839; PETZELBAUER P, 1995, CYTOKINE, V7, P267, DOI 10.1006/cyto.1995.0031; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Rosenkilde MM, 2001, ONCOGENE, V20, P1582, DOI 10.1038/sj.onc.1204191; SCHONBECK U, 1995, J IMMUNOL, V154, P2375; Schraufstatter IU, 2001, AM J PHYSIOL-LUNG C, V280, pL1094, DOI 10.1152/ajplung.2001.280.6.L1094; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; SMITH MG, 1956, P SOC EXP BIOL MED, V92, P424, DOI 10.3181/00379727-92-22498; Stine J T, 1999, Chem Immunol, V72, P161, DOI 10.1159/000058732; Tzahar E, 1998, EMBO J, V17, P5948, DOI 10.1093/emboj/17.20.5948; Wolf M, 1998, EUR J IMMUNOL, V28, P164, DOI 10.1002/(SICI)1521-4141(199801)28:01<164::AID-IMMU164>3.0.CO;2-S; Wuyts A, 1998, EUR J BIOCHEM, V255, P67, DOI 10.1046/j.1432-1327.1998.2550067.x; Yang W, 1997, BIOCHEMISTRY-US, V36, P15193, DOI 10.1021/bi971594u	52	60	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9137	9146		10.1074/jbc.M109.002774	http://dx.doi.org/10.1074/jbc.M109.002774			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20044480	Green Published, hybrid			2022-12-25	WOS:000275553700063
J	Hagenbuchner, J; Ausserlechner, MJ; Porto, V; David, R; Meister, B; Bodner, M; Villunger, A; Geiger, K; Obexer, P				Hagenbuchner, Judith; Ausserlechner, Michael J.; Porto, Verena; David, Reinhard; Meister, Bernhard; Bodner, Martin; Villunger, Andreas; Geiger, Kathrin; Obexer, Petra			The Anti-apoptotic Protein BCL2L1/Bcl-xL Is Neutralized by Pro-apoptotic PMAIP1/Noxa in Neuroblastoma, Thereby Determining Bortezomib Sensitivity Independent of Prosurvival MCL1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME INHIBITOR BORTEZOMIB; BH3-ONLY PROTEINS; LEUKEMIA-CELLS; CASPASE ACTIVATION; BCL-2 PROTEINS; GROWTH; DEATH; P53; NOXA; PUMA	Neuroblastoma is the most frequent extracranial solid tumor in children. Here, we report that the proteasome inhibitor bortezomib (PS-341, Velcade) activated the pro-apoptotic BH3-only proteins PMAIP1/Noxa and BBC3/Puma and induced accumulation of anti-apoptotic MCL1 as well as repression of anti-apoptotic BCL2L1/Bcl-xL. Retroviral expression of Bcl-xL, but not of MCL1, prevented apoptosis by bortezomib. Gene knockdown of Noxa by shRNA technology significantly reduced apoptosis, whereas Puma knockdown did not affect cell death kinetics. Immunoprecipitation revealed that endogenous Noxa associated with both, Bcl-xL and MCL1, suggesting that in neuronal cells Noxa can neutralize Bcl-xL, explaining the pronounced protective effect of Bcl-xL. Tetracycline-regulated Noxa expression did not trigger cell death per se but sensitized to bortezomib treatment in a dose-dependent manner. This implies that the induction of Noxa is necessary but not sufficient for bortezomib-induced apoptosis. We conclude that MCL1 steady-state expression levels do not affect sensitivity to proteasome-inhibitor treatment in neuronal tumor cells, and that both the repression of Bcl-xL and the activation of Noxa are necessary for bortezomib-induced cell death.	[Obexer, Petra] Med Univ Innsbruck, Pediat Oncol Res Lab, Tyrolean Canc Res Inst, A-6020 Innsbruck, Austria; [Hagenbuchner, Judith; Obexer, Petra] Med Univ Innsbruck, Dept Pediat 4, A-6020 Innsbruck, Austria; [Ausserlechner, Michael J.; Meister, Bernhard; Bodner, Martin] Med Univ Innsbruck, Dept Pediat 2, A-6020 Innsbruck, Austria; [Villunger, Andreas] Med Univ Innsbruck, Dept Dev Immunol, Bioctr, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Obexer, P (corresponding author), Med Univ Innsbruck, Pediat Oncol Res Lab, Tyrolean Canc Res Inst, Innrain 66, A-6020 Innsbruck, Austria.	Petra.Obexer@i-med.ac.at		Hagenbuchner, Judith/0000-0003-1396-3407; Bodner, Martin/0000-0002-3870-9862; Ausserlechner, Michael/0000-0002-1015-2302	Kinderkrebshilfe Tirol und Vorarlberg; Sudtiroler Krebshilfe-Vereinigung; SVP-Frauen-Initiative; Kinderkrebshilfe Sudtirol-Regenbogen; OeNB Anniversary Fund [11436, 12582]; COMET Center ONCOTYROL; Tiroler Landeskrankenanstalten Ges.m.b.H. (TILAK); Tyrolean Cancer Society; Dept. of Health-Care, Autonomy of South Tyrol.	Kinderkrebshilfe Tirol und Vorarlberg; Sudtiroler Krebshilfe-Vereinigung; SVP-Frauen-Initiative; Kinderkrebshilfe Sudtirol-Regenbogen; OeNB Anniversary Fund; COMET Center ONCOTYROL; Tiroler Landeskrankenanstalten Ges.m.b.H. (TILAK); Tyrolean Cancer Society; Dept. of Health-Care, Autonomy of South Tyrol.	This work was supported by grants from the Kinderkrebshilfe Tirol und Vorarlberg, the Sudtiroler Krebshilfe-Vereinigung, the SVP-Frauen-Initiative, the Kinderkrebshilfe Sudtirol-Regenbogen, the OeNB Anniversary Fund (Projects 11436 and 12582), and the COMET Center ONCOTYROL. The Tyrolean Cancer Research Institute and this study were supported by the Tiroler Landeskrankenanstalten Ges.m.b.H. (TILAK), the Tyrolean Cancer Society, and by the Dept. of Health-Care, Autonomy of South Tyrol.	Adams Julian, 2002, Breast Dis, V15, P61; Armstrong Michael B, 2008, J Exp Ther Oncol, V7, P135; Ausserlechner MJ, 2006, MOL CANCER THER, V5, P1927, DOI 10.1158/1535-7163.MCT-05-0500; Ausserlechner MJ, 2005, LEUKEMIA, V19, P1051, DOI 10.1038/sj.leu.2403729; Ausserlechner MJ, 2004, CELL DEATH DIFFER, V11, P165, DOI 10.1038/sj.cdd.4401328; Blaney SM, 2004, J CLIN ONCOL, V22, P4804, DOI 10.1200/JCO.2004.12.185; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Bui NT, 2001, J CELL BIOL, V152, P753, DOI 10.1083/jcb.152.4.753; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Ding WX, 2007, MOL CANCER THER, V6, P1062, DOI 10.1158/1535-7163.MCT-06-0541; DOLE MG, 1995, CANCER RES, V55, P2576; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Fennell DA, 2008, ONCOGENE, V27, P1189, DOI 10.1038/sj.onc.1210744; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; He Q, 2004, ONCOGENE, V23, P2554, DOI 10.1038/sj.onc.1207351; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Jagannath S, 2004, BRIT J HAEMATOL, V127, P165, DOI 10.1111/j.1365-2141.2004.05188.x; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nencioni A, 2005, BLOOD, V105, P3255, DOI 10.1182/blood-2004-10-3984; Nikrad M, 2005, MOL CANCER THER, V4, P443; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Obexer P, 2009, J BIOL CHEM, V284, P30933, DOI 10.1074/jbc.M109.051441; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Park JR, 2008, PEDIATR CLIN N AM, V55, P97, DOI 10.1016/j.pcl.2007.10.014; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Satou Y, 2004, LEUKEMIA, V18, P1357, DOI 10.1038/sj.leu.2403400; Stepczynska A, 2001, ONCOGENE, V20, P1193, DOI 10.1038/sj.onc.1204221; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Zaman F, 2007, CANCER RES, V67, P10078, DOI 10.1158/0008-5472.CAN-06-3982; Zhu HB, 2005, ONCOGENE, V24, P4993, DOI 10.1038/sj.onc.1208683	36	60	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6904	6912		10.1074/jbc.M109.038331	http://dx.doi.org/10.1074/jbc.M109.038331			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20051518	hybrid, Green Published			2022-12-25	WOS:000275415600004
J	Deng, WY; de Hoog, CL; Yu, HB; Li, YL; Croxen, MA; Thomas, NA; Puente, JL; Foster, LJ; Finlay, BB				Deng, Wanyin; de Hoog, Carmen L.; Yu, Hong B.; Li, Yuling; Croxen, Matthew A.; Thomas, Nikhil A.; Puente, Jose L.; Foster, Leonard J.; Finlay, B. Brett			A Comprehensive Proteomic Analysis of the Type III Secretome of Citrobacter rodentium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; EFFECTOR PROTEIN; ENTEROCYTE EFFACEMENT; VIRULENCE FACTOR; IDENTIFICATION; SYSTEM; TRANSLOCATION; COLONIZATION; LOCUS; SPECIFICITY	Enteropathogenic Escherichia coli, enterohemorrhagic E. coli, and Citrobacter rodentium belong to the family of attaching and effacing (A/E) bacterial pathogens. They intimately attach to host intestinal epithelial cells, trigger the effacement of intestinal microvilli, and cause diarrheal disease. Central to their pathogenesis is a type III secretion system (T3SS) encoded by a pathogenicity island called the locus of enterocyte effacement (LEE). The T3SS is used to inject both LEE- and non-LEE-encoded effector proteins into the host cell, where these effectors modulate host signaling pathways and immune responses. Identifying the effectors and elucidating their functions are central to understanding the molecular pathogenesis of these pathogens. Here we analyzed the type III secretome of C. rodentium using the highly sensitive and quantitative SILAC (stable isotope labeling with amino acids in cell culture)-based mass spectrometry. This approach not only confirmed nearly all known secreted proteins and effectors previously identified by conventional biochemical and proteomic techniques, but also identified several new secreted proteins. The T3SS-dependent secretion of these new proteins was validated, and five of them were translocated into cultured cells, representing new or additional effectors. Deletion mutants for genes encoding these effectors were generated in C. rodentium and tested in a murine infection model. This study comprehensively characterizes the type III secretome of C. rodentium, expands the repertoire of type III secreted proteins and effectors for the A/E pathogens, and demonstrates the simplicity and sensitivity of using SILAC-based quantitative proteomics as a tool for identifying substrates for protein secretion systems.	[Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Foster, Leonard J.; Finlay, B. Brett] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada; [Thomas, Nikhil A.] Dalhousie Univ, Dept Microbiol & Immunol Med, Halifax, NS B3X 1H5, Canada; [Puente, Jose L.] Univ Nacl Autonoma Mexico, Dept Mol Microbiol, Inst Biotecnol, Cuernavaca 62210, Morelos, Mexico	University of British Columbia; University of British Columbia; University of British Columbia; Dalhousie University; Universidad Nacional Autonoma de Mexico	Finlay, BB (corresponding author), 301,2815 East Mall, Vancouver, BC V6T 1Z4, Canada.	bfinlay@interchange.ubc.ca		Thomas, Nikhil/0000-0003-3037-425X; Puente, Jose/0000-0002-8411-4974; Croxen, Matthew/0000-0002-9564-7952	Canadian Institutes of Health Research; Genome Canada/Genome BC; Howard Hughes Medical Institute; Canadian Institutes of Health Research/Canadian Association of Gastroenterology/Ferring Pharmaceuticals; Canadian Foundation for Innovation; British Columbia (BC) Knowledge Development Fund; Michael Smith Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada/Genome BC(Genome Canada); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institutes of Health Research/Canadian Association of Gastroenterology/Ferring Pharmaceuticals(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia (BC) Knowledge Development Fund; Michael Smith Foundation(Michael Smith Foundation for Health Research)	This work was supported in part by Canadian Institutes of Health Research grants, a Genome Canada/Genome BC through the PRoteomics for Emerging PAthogen REsponse project (to L.J.F. and B.B.F.), and a Howard Hughes Medical Institute operating grant (to B.B.F.).; <SUP>2</SUP>Supported by a Canadian Institutes of Health Research postdoctoral fellowship.; <SUP>3</SUP>Supported by a Canadian Institutes of Health Research/Canadian Association of Gastroenterology/Ferring Pharmaceuticals postdoctoral fellowship.; We thank Nikolay Stoynov for technical assistance, and Kristie Keeney and Stephanie Shames for critical reading of the manuscript. Infrastructure used in this project was funded by the Canadian Foundation for Innovation, the British Columbia (BC) Knowledge Development Fund, and the Michael Smith Foundation through the BC Proteomics Network.	Alfano JR, 2009, MOL PLANT PATHOL, V10, P805, DOI 10.1111/j.1364-3703.2009.00588.x; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Arbeloa A, 2008, CELL MICROBIOL, V10, P1429, DOI 10.1111/j.1462-5822.2008.01136.x; Blocker AJ, 2008, P NATL ACAD SCI USA, V105, P6507, DOI 10.1073/pnas.0708344105; Bulgin RR, 2009, CELL MICROBIOL, V11, P217, DOI 10.1111/j.1462-5822.2008.01248.x; Buss C, 2009, CELL MICROBIOL, V11, P661, DOI 10.1111/j.1462-5822.2009.01284.x; Campellone KG, 2004, DEV CELL, V7, P217, DOI 10.1016/j.devcel.2004.07.004; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dahan S, 2005, INFECT IMMUN, V73, P679, DOI 10.1128/IAI.73.2.679-686.2005; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; Deng WY, 2005, INFECT IMMUN, V73, P2135, DOI 10.1128/IAI.73.4.2135-2146.2005; Deng WY, 2003, MOL MICROBIOL, V48, P95, DOI 10.1046/j.1365-2958.2003.03429.x; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Deng WY, 2001, INFECT IMMUN, V69, P6323, DOI 10.1128/IAI.69.10.6323-6335.2001; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Garcia-Angulo VA, 2008, J BACTERIOL, V190, P2388, DOI 10.1128/JB.01602-07; Garmendia J, 2005, J CLIN MICROBIOL, V43, P5715, DOI 10.1128/JCM.43.11.5715-5720.2005; Gauthier A, 2003, INFECT IMMUN, V71, P3310, DOI 10.1128/IAI.71.6.3310-3319.2003; Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Kelly M, 2006, INFECT IMMUN, V74, P2328, DOI 10.1128/IAI.74.4.2328-2337.2006; Kenny B, 2000, CELL MICROBIOL, V2, P579, DOI 10.1046/j.1462-5822.2000.00082.x; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; LEVINE MM, 1978, LANCET, V1, P1119; Loukiadis E, 2008, J BACTERIOL, V190, P275, DOI 10.1128/JB.00844-07; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Mills E, 2008, CELL HOST MICROBE, V3, P104, DOI 10.1016/j.chom.2007.11.007; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Mundy R, 2004, INFECT IMMUN, V72, P2288, DOI 10.1128/IAI.72.4.2288-2302.2004; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ogura Y, 2008, J BACTERIOL, V190, P6948, DOI 10.1128/JB.00625-08; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Petty NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; SCHAUER DB, 1995, J CLIN MICROBIOL, V33, P2064, DOI 10.1128/JCM.33.8.2064-2068.1995; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Sukhan A, 2003, J BACTERIOL, V185, P3480, DOI 10.1128/JB.185.11.3480-3483.2003; Thomas NA, 2005, MOL MICROBIOL, V57, P1762, DOI 10.1111/j.1365-2958.2005.04802.x; Thomas NA, 2007, J BIOL CHEM, V282, P29634, DOI 10.1074/jbc.M706019200; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; Vlisidou I, 2006, FEMS MICROBIOL LETT, V263, P32, DOI 10.1111/j.1574-6968.2006.00410.x; Wickham ME, 2006, J INFECT DIS, V194, P819, DOI 10.1086/506620; Wilson RK, 2001, CELL MICROBIOL, V3, P753, DOI 10.1046/j.1462-5822.2001.00159.x; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	56	56	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6790	6800		10.1074/jbc.M109.086603	http://dx.doi.org/10.1074/jbc.M109.086603			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20034934	Green Published, hybrid			2022-12-25	WOS:000275367500082
J	Nishimura, YV; Sekine, K; Chihama, K; Nakajima, K; Hoshino, M; Nabeshima, Y; Kawauchi, T				Nishimura, Yoshiaki V.; Sekine, Katsutoshi; Chihama, Kaori; Nakajima, Kazunori; Hoshino, Mikio; Nabeshima, Yo-ichi; Kawauchi, Takeshi			Dissecting the Factors Involved in the Locomotion Mode of Neuronal Migration in the Developing Cerebral Cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RADIAL MIGRATION; RNA INTERFERENCE; GENE-TRANSFER; SAD KINASES; CDK5; PHOSPHORYLATION; BRAIN; ORGANIZATION; DOUBLECORTIN	Neuronal migration is essential for proper cortical layer formation and brain function, because migration defects result in neurological disorders such as mental retardation and epilepsy. Neuronal migration is divided into several contiguous steps: early phase (multipolar mode), locomotion mode, and terminal translocation mode. The locomotion mode covers most of the migration route and thereby is the main contributor to cortical layer formation. However, analysis of the molecular mechanisms regulating this mode is difficult due to the secondary effects of defects at the early phase of migration. In this study, we established an ex vivo chemical inhibitor screening, allowing us to directly analyze the locomotion mode of migration. Roscovitine and PP2, inhibitors for Cdk5 and Src family kinases, respectively, suppressed the locomotion mode of migration. In line with this, a small percentage of Cdk5- or Src family kinase (Fyn)-knockdown cells exhibited locomoting morphology but retarded migration, although the majority of cells were stalled at the early phase of migration. We also showed that rottlerin, widely used as a specific inhibitor for protein kinase C delta (PKC delta), suppressed the locomotion mode. Unexpectedly, however, the dominant-negative form as well as RNA interference for PKC delta hardly affected the locomotion, whereas they may disturb terminal translocation. In addition, we found JNK to be a potential downstream target of rottlerin. Taken together, our novel chemical inhibitor screening provides evidence that Cdk5 and Src family kinases regulate the locomotion mode of neuronal migration. It also uncovered roles for Fyn and PKC delta in the early and final phases of migration, respectively.	[Nishimura, Yoshiaki V.; Chihama, Kaori; Hoshino, Mikio; Nabeshima, Yo-ichi; Kawauchi, Takeshi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan; [Kawauchi, Takeshi] Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo 1608582, Japan; [Hoshino, Mikio] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Biochem & Cellular Biol, Tokyo 1878502, Japan; [Kawauchi, Takeshi] JST, Precursory Res Embryon Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Nabeshima, Yo-ichi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan	Kyoto University; Keio University; National Center for Neurology & Psychiatry - Japan; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Hoshino, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.	hoshino@ncnp.go.jp; kawauchi@sc.itc.keio.ac.jp	Nakajima, Kazunori/L-3396-2013; Kawauchi, Takeshi/L-4770-2013	Nakajima, Kazunori/0000-0003-1864-9425; Kawauchi, Takeshi/0000-0002-8650-4474				Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Causeret F, 2007, MOL BIOL CELL, V18, P4327, DOI 10.1091/mbc.E07-04-0372; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Chen JL, 2008, J BIOL CHEM, V283, P34432, DOI 10.1074/jbc.M804239200; Chen Y, 2005, J NEUROSCI, V25, P507, DOI 10.1523/JNEUROSCI.4089-04.2005; Choi DS, 2008, J NEUROSCI, V28, P11890, DOI 10.1523/JNEUROSCI.3156-08.2008; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; des Portes V, 1998, CELL, V92, P51; Fan JH, 2006, J INVEST DERMATOL, V126, P1233, DOI 10.1038/sj.jid.5700149; Galaburda AM, 2006, NAT NEUROSCI, V9, P1213, DOI 10.1038/nn1772; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hirai S, 2006, J NEUROSCI, V26, P11992, DOI 10.1523/JNEUROSCI.2272-06.2006; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Jossin Y, 2003, J NEUROSCI, V23, P9953; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kawauchi T, 2005, BIOCHEM BIOPH RES CO, V331, P50, DOI 10.1016/j.bbrc.2005.03.132; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; LoTurco J, 2009, CEREB CORTEX, V19, pI120, DOI 10.1093/cercor/bhp033; Maa MC, 2008, J BIOL CHEM, V283, P31408, DOI 10.1074/jbc.M801158200; Mishra S, 2006, P NATL ACAD SCI USA, V103, P5191, DOI 10.1073/pnas.0600241103; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Miyamoto Y, 2007, J CELL SCI, V120, P4355, DOI 10.1242/jcs.018218; Miyata T, 2002, J NEUROSCI RES, V69, P861, DOI 10.1002/jnr.10335; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nikolic M, 2004, TRENDS CELL BIOL, V14, P1, DOI 10.1016/j.tcb.2003.10.010; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rakic P, 2006, CEREB CORTEX, V16, pI3, DOI 10.1093/cercor/bhk036; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; SACHS CW, 1995, J BIOL CHEM, V270, P26639, DOI 10.1074/jbc.270.44.26639; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Tabata H, 2003, J NEUROSCI, V23, P9996; Tabata H, 2002, J NEUROSCI RES, V69, P723, DOI 10.1002/jnr.10345; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takuma K, 2001, J BIOL CHEM, V276, P48093, DOI 10.1074/jbc.M108622200; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhao CT, 2009, P NATL ACAD SCI USA, V106, P21353, DOI 10.1073/pnas.0812872106	66	42	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5878	5887		10.1074/jbc.M109.033761	http://dx.doi.org/10.1074/jbc.M109.033761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022952	Green Published, hybrid			2022-12-25	WOS:000275327200078
J	Windhorst, S; Fliegert, R; Blechner, C; Mollmann, K; Hosseini, Z; Gunther, T; Eiben, M; Chang, L; Lin, HY; Fanick, W; Schumacher, U; Brandt, B; Mayr, GW				Windhorst, Sabine; Fliegert, Ralf; Blechner, Christine; Moellmann, Katharina; Hosseini, Zara; Guenther, Thomas; Eiben, Maike; Chang, Lydia; Lin, Hong-Ying; Fanick, Werner; Schumacher, Udo; Brandt, Burkhard; Mayr, Georg W.			Inositol 1,4,5-Trisphosphate 3-Kinase-A Is a New Cell Motility-promoting Protein That Increases the Metastatic Potential of Tumor Cells by Two Functional Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; ACTIN; EXPRESSION; MICE; REORGANIZATION; MIGRATION; ONCOGENE; GROWTH	Cellular migration is an essential prerequisite for metastatic dissemination of cancer cells. This study demonstrates that the neuron/testis-specific F-actin-targeted inositol 1,4,5-trisphosphate 3-kinase-A (ITPKA) is ectopically expressed in different human tumor cell lines and during tumor progression in the metastatic tumor model Balb-neuT. High expression of ITPKA increases invasive migration in vitro and metastasis in a xenograft SCID mouse model. Mechanistic studies show that ITPKA promotes migration of tumor cells by two different mechanisms as follows: growth factor independently high levels of ITPKA induce the formation of large cellular protrusions by directly modulating the actin cytoskeleton. The F-actin binding activity of ITPKA stabilizes and bundles actin filaments and thus increases the levels of cellular F-actin. In growth factor-stimulated cells, the catalytically active domain enhances basal ITPKA-induced migration by activating store-operated calcium entry through production of inositol 1,3,4,5-tetrakisphosphate and subsequent inhibition of inositol phosphate 5-phosphatase. These two functional activities of ITPKA stimulating tumor cell migration place the enzyme among the potential targets of anti-metastatic therapy.	[Windhorst, Sabine; Fliegert, Ralf; Blechner, Christine; Hosseini, Zara; Guenther, Thomas; Chang, Lydia; Lin, Hong-Ying; Fanick, Werner; Mayr, Georg W.] Univ Klinikum Hamburg Eppendorf, Inst Biochem & Mol Biol 1, D-20246 Hamburg, Germany; [Moellmann, Katharina; Eiben, Maike; Brandt, Burkhard] Univ Klinikum Hamburg Eppendorf, Inst Tumorbiol, D-20246 Hamburg, Germany; [Schumacher, Udo] Univ Klinikum Hamburg Eppendorf, Inst Anat Expt Morphol 2, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Windhorst, S (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Biochem & Mol Biol 1, Martinistr 52, D-20246 Hamburg, Germany.	s.windhorst@uke.uni-hamburg.de		Brandt, Burkhard/0000-0003-3681-3049; Gunther, Thomas/0000-0001-9650-0218	Roggenbuck-Stiftung Hamburg	Roggenbuck-Stiftung Hamburg	This work was supported by the Roggenbuck-Stiftung Hamburg.	BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Brandt B, 2005, SEMIN CANCER BIOL, V15, P387, DOI 10.1016/j.semcancer.2005.06.006; Comoglio PM, 2002, J CLIN INVEST, V109, P857, DOI 10.1172/JCI200215392; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; Feldner JC, 2002, EXP CELL RES, V272, P93, DOI 10.1006/excr.2001.5385; Gremm D, 2000, EUR J BIOCHEM, V267, P4339, DOI 10.1046/j.1432-1327.2000.01463.x; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hermosura MC, 2000, NATURE, V408, P735, DOI 10.1038/35047115; Johnson HW, 2009, MOL BIOL CELL, V20, P5166, DOI 10.1091/mbc.E09-01-0083; Jojovic M, 2000, CANCER LETT, V152, P151, DOI 10.1016/S0304-3835(99)00443-7; Jun KS, 1998, LEARN MEMORY, V5, P317; KATSANTONIS J, 1994, CELL BIOCHEM FUNCT, V12, P267, DOI 10.1002/cbf.290120407; Kim IH, 2004, MOL BRAIN RES, V124, P12, DOI 10.1016/j.molbrainres.2003.12.016; KROM YD, 2006, BMC BIOTECHNOL, V28, P6; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Mayr GW, 2005, J BIOL CHEM, V280, P13229, DOI 10.1074/jbc.M500545200; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Murray JW, 1996, J CELL BIOL, V135, P1309, DOI 10.1083/jcb.135.5.1309; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Roesch A, 2003, MELANOMA RES, V13, P503, DOI 10.1097/00008390-200310000-00009; SAUER K, 2009, CURRENT PROTOCOLS IM; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; VANWEYENBERG V, 1995, BIOCHEM J, V306, P429, DOI 10.1042/bj3060429; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Windhorst S, 2008, BIOCHEM J, V414, P407, DOI 10.1042/BJ20080630; Woodring PJ, 1996, BIOCHEM J, V319, P73, DOI 10.1042/bj3190073; Yamashiro S, 1998, MOL BIOL CELL, V9, P993, DOI 10.1091/mbc.9.5.993; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019	31	32	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5541	5554		10.1074/jbc.M109.047050	http://dx.doi.org/10.1074/jbc.M109.047050			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022963	Green Published, hybrid			2022-12-25	WOS:000275327200047
J	Robart, AR; Collins, K				Robart, Aaron R.; Collins, Kathleen			Investigation of Human Telomerase Holoenzyme Assembly, Activity, and Processivity Using Disease-linked Subunit Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW FAILURE; DOMINANT DYSKERATOSIS-CONGENITA; FUNCTIONAL-CHARACTERIZATION; REVERSE-TRANSCRIPTASE; APLASTIC-ANEMIA; HEMATOLOGIC DISORDERS; CLINICAL PRESENTATION; MAMMALIAN TELOMERASE; PULMONARY-FIBROSIS; GENE TERC	After the initial discovery of human telomerase deficiency in the X-linked form of the bone marrow failure syndrome dyskeratosis congenita, mutations in genes encoding telomerase subunits have been identified in patients with a wide spectrum of disorders. Structure/function studies of disease-linked variants of human telomerase RNA (hTR) or telomerase reverse transcriptase (TERT) have exploited in vitro reconstitution of the enzyme catalytic core and/or a PCR-amplified activity assay readout that would not reflect alterations of cellular RNP assembly efficiency, telomeric primer recognition, and/or repeat addition processivity. Here we used telomerase reconstitution in vivo and direct telomeric-repeat primer extension activity assays to compare the ribonucleoprotein (RNP) assembly and activity properties of disease-linked subunit variants in holoenzyme context. Analysis of a large panel of hTR variants revealed numerous biochemical mechanisms for telomerase loss of function, including reduced association of hTR with TERT, reduced RNP catalytic activity, or loss in fidelity of telomeric repeat synthesis. An absolute correlation exists between hTR loss of function and hematopoietic deficiency, but there is no readily apparent telomerase deficiency imposed by an hTR variant linked to pulmonary fibrosis. Some disease-linked TERT variants have altered properties of holoenzyme assembly or repeat addition processivity, but other TERT variants linked to either pulmonary fibrosis or hematopoietic deficiency retained normal hTR interaction and RNP catalytic activity. Combined with additional hTR structure/function studies, our results establish a new resolution of insight into hTR structural requirements for hTR-TERT interaction and for the catalytic cycle of human telomerase holoenzyme.	[Robart, Aaron R.; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu		Robart, Aaron/0000-0002-0518-3972	National Institutes of Health [HL079585]; American Federation for Aging Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL079585, R01HL079585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL079585. This work was also supported by a Breakthroughs in Gerontology Award from the American Federation for Aging Research.	Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Chen JL, 2002, NUCLEIC ACIDS RES, V30, P592, DOI 10.1093/nar/30.2.592; Collins K, 2008, MECH AGEING DEV, V129, P91, DOI 10.1016/j.mad.2007.10.008; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Collins Kathleen, 2009, V13, P285, DOI 10.1007/978-3-540-70840-7_14; Cong YS, 2008, CELL RES, V18, P725, DOI 10.1038/cr.2008.74; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Errington TM, 2008, MOL CELL BIOL, V28, P6510, DOI 10.1128/MCB.00777-08; Fogarty PF, 2003, LANCET, V362, P1628, DOI 10.1016/S0140-6736(03)14797-6; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Ly H, 2005, BLOOD, V106, P1246, DOI 10.1182/blood-2005-01-0247; Ly H, 2005, BLOOD, V105, P2332, DOI 10.1182/blood-2004-09-3659; Ly H, 2003, MOL CELL BIOL, V23, P6849, DOI 10.1128/MCB.23.19.6849-6856.2003; Marrone A, 2007, HAEMATOLOGICA, V92, P1013, DOI 10.3324/haematol.11407; Mitchell JR, 2000, MOL CELL, V6, P361, DOI 10.1016/S1097-2765(00)00036-8; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; ROBART AR, 2010, RNA IN PRESS; Savage SA, 2008, MECH AGEING DEV, V129, P35, DOI 10.1016/j.mad.2007.11.002; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Vulliamy TJ, 2008, BIOCHIMIE, V90, P122, DOI 10.1016/j.biochi.2007.07.017; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Vulliamy TJ, 2005, BLOOD CELL MOL DIS, V34, P257, DOI 10.1016/j.bcmd.2004.12.008; Westin ER, 2007, AGING CELL, V6, P383, DOI 10.1111/j.1474-9726.2007.00288.x; Wilson DB, 2003, LANCET, V361, P1993, DOI 10.1016/S0140-6736(03)13575-1; Wong JMY, 2004, HUM GENET, V115, P448, DOI 10.1007/s00439-004-1178-7; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Xie MY, 2008, J BIOL CHEM, V283, P2049, DOI 10.1074/jbc.M708032200; Xin ZT, 2007, BLOOD, V109, P524, DOI 10.1182/blood-2006-07-035089; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335	46	56	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4375	4386		10.1074/jbc.M109.088575	http://dx.doi.org/10.1074/jbc.M109.088575			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	20022961	hybrid, Green Published			2022-12-25	WOS:000275274800014
J	Kalantri, A; Karambelkar, M; Joshi, R; Kalantri, S; Jajoo, U				Kalantri, Ashwini; Karambelkar, Mandar; Joshi, Rajnish; Kalantri, Shriprakash; Jajoo, Ulhas			Accuracy and Reliability of Pallor for Detecting Anaemia: A Hospital-Based Diagnostic Accuracy Study	PLOS ONE			English	Article							CLINICAL SIGNS; WESTERN KENYA; CONJUNCTIVAL PALLOR; LIKELIHOOD RATIOS; PREGNANT-WOMEN; CHILDREN; RECOGNITION; MODERATE; MALARIA; ABSENCE	Background: Anaemia is a common disorder. Most health providers in resource poor settings rely on physical signs to diagnose anaemia. We aimed to determine the diagnostic accuracy of pallor for anaemia by using haemoglobin as the reference standard. Methodology/Principal Findings: In May 2007, we enrolled consecutive patients over 12 years of age, able to consent and willing to participate and who had a haemoglobin measurement taken within a day of assessment of clinical pallor from outpatient and medicine inpatient department of a teaching hospital. We did a blind and independent comparison of physical signs (examination of conjunctivae, tongue, palms and nailbed for pallor) and the reference standard (haemoglobin estimation by an electronic cell counter). Diagnostic accuracy was measured by calculating likelihood ratio values and 95% confidence intervals (CI) at different haemoglobin thresholds and area under the receiver operating characteristic curve. Two observers examined a subset of patients (n = 128) to determine the inter-observer agreement, calculated by kappa statistics. We studied 390 patients (mean age 40.1 [SD 17.08] years); of whom 48% were women. The haemoglobin was <7 g/dL in 8% (95% confidence interval, 5, 10) patients; <9 g/dL in 21% (17, 26) patients and <12 g/dL in 64% (60, 70) patients. Among patients with haemoglobin <7 g/dL, presence of severe tongue pallor yielded a LR of 9.87 (2.81, 34.6) and its absence yielded a LR of 0. The tongue pallor outperformed other pallor sites and was also the best discriminator of anaemia at haemoglobin thresholds of 7 g/dL and 9 g/dL (area under the receiver operating characteristic curves (ROC area = 0.84 [0.77, 0.90] and 0.71[0.64, 0.76]) respectively. The agreement between the two observers for detection of anaemia was poor (kappa values = 0.07 for conjunctival pallor and 0.20 for tongue pallor). Conclusions/Significance: Clinical assessment of pallor can rule out and modestly rule in severe anaemia.	[Kalantri, Ashwini; Karambelkar, Mandar; Joshi, Rajnish; Kalantri, Shriprakash; Jajoo, Ulhas] Mahatma Gandhi Inst Med Sci, Dept Med, Wardha, Maharashtra, India	Mahatma Gandhi Institute of Medical Sciences, Sevagram	Kalantri, A (corresponding author), Mahatma Gandhi Inst Med Sci, Dept Med, Wardha, Maharashtra, India.	ashwinikalantri@gmail.com	Kalantri, Ashwini/E-7319-2010; Kalantri, Shriprakash/ABG-9318-2021	Kalantri, Ashwini/0000-0001-5013-4371; Kalantri, Shriprakash/0000-0002-1633-1029; Joshi, Rajnish/0000-0002-4702-0522	Indian Council of Medical Research, New Delhi, India	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This study was partly funded by the Indian Council of Medical Research, New Delhi, India. Ashwini Kalantri, a medical student, was awarded the short term studentship (2007) to conduct this study (URL:http://www.icmr.nic.in/shortr.htm). The Indian Council of Medical Research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STAT MED R, DOI [DOI 10.1002/SIM.4780101015, 10.1002/sim.4780101015]; Chalco Juan P, 2005, BMC Pediatr, V5, P46, DOI 10.1186/1471-2431-5-46; Desai MR, 2002, TROP MED INT HEALTH, V7, P831, DOI 10.1046/j.1365-3156.2002.00942.x; Fourn L, 2004, Sante Publique, V16, P123; Gies S, 2003, TROP MED INT HEALTH, V8, P301, DOI 10.1046/j.1365-3156.2003.01037.x; GJORUP T, 1986, AM J EPIDEMIOL, V124, P657, DOI 10.1093/oxfordjournals.aje.a114438; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hung OL, 2000, ACAD EMERG MED, V7, P146, DOI 10.1111/j.1553-2712.2000.tb00518.x; *INT WORK GROUP DI, 1999, INT CONS DIAB FOOT, P60; Kalter HD, 1997, B WORLD HEALTH ORGAN, V75, P103; Lindblade KA, 2006, TROP MED INT HEALTH, V11, P1679, DOI 10.1111/j.1365-3156.2006.01721.x; LUBY SP, 1995, B WORLD HEALTH ORGAN, V73, P477; McGee S, 2002, J GEN INTERN MED, V17, P646; Mogensen CB, 2006, ACTA TROP, V99, P113, DOI 10.1016/j.actatropica.2005.12.010; Mogensen CB, 2006, ACTA TROP, V99, P119, DOI 10.1016/j.actatropica.2005.12.011; Moons KGM, 2004, CLIN CHEM, V50, P473, DOI 10.1373/clinchem.2003.024752; Muhe L, 2000, TROP MED INT HEALTH, V5, P805, DOI 10.1046/j.1365-3156.2000.00637.x; NARDONE DA, 1990, ARCH INTERN MED, V150, P201, DOI 10.1001/archinte.150.1.201; Prakash S, 1999, J Assoc Physicians India, V47, P995; Sheth TN, 1997, J GEN INTERN MED, V12, P102, DOI 10.1007/s11606-006-5004-x; Stoltzfus RJ, 1999, J NUTR, V129, P1675, DOI 10.1093/jn/129.9.1675; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P113; WURAPA FK, 1986, J TROP MED HYG, V89, P33; Zucker JR, 1997, B WORLD HEALTH ORGAN, V75, P97	24	36	36	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8545	10.1371/journal.pone.0008545	http://dx.doi.org/10.1371/journal.pone.0008545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049324	gold, Green Published, Green Submitted			2022-12-25	WOS:000273225000010
J	Tan, CC; Walsh, MJ; Gelb, BD				Tan, Cheryl C.; Walsh, Martin J.; Gelb, Bruce D.			Fgfr3 Is a Transcriptional Target of Ap2 delta and Ash2l-Containing Histone Methyltransferase Complexes	PLOS ONE			English	Article							DEVELOPING MIDBRAIN; ACTIVE GENES; H3; METHYLATION; EXPRESSION; MOUSE; MLL; DIFFERENTIATION; RECEPTORS; HINDBRAIN	Polycomb (PcG) and trithorax (trxG) proteins play important roles in establishing lineage-specific genetic programs through induction of chromatin modifications that lead to gene silencing or activation. Previously, we described an association between the MLL/SET1 complexes and a highly restricted, gene-specific DNA-binding protein Ap2 delta that is required for recruitment of the MLL/SET1 complex to target Hoxc8 specifically. Here, we reduced levels of Ap2 delta and Ash2l in the neuroblastoma cell line, Neuro2A, and analyzed their gene expression profiles using whole-genome mouse cDNA microarrays. This analysis yielded 42 genes that are potentially co-regulated by Ap2 delta and Ash2l, and we have identified evolutionarily conserved Ap2-binding sites in 20 of them. To determine whether some of these were direct targets of the Ap2 delta-Ash2l complex, we analyzed several promoters for the presence of Ap2 delta and Ash2l by chromatin immunoprecipitation (ChIP). Among the targets we screened, we identified Fgfr3 as a direct transcriptional target of the Ap2 delta-Ash2l complex. Additionally, we found that Ap2 delta is necessary for the recruitment of Ash2l-containing complexes to this promoter and that this recruitment leads to trimethylation of lysine 4 of histone H3 (H3K4me3). Thus, we have identified several candidate targets of complexes containing Ap2 delta and Ash2l that can be used to further elucidate their roles during development and showed that Fgfr3 is a novel direct target of these complexes.	[Tan, Cheryl C.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90024 USA; [Walsh, Martin J.; Gelb, Bruce D.] Mt Sinai Sch Med, Dept Pediat, New York, NY USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Walsh, Martin J.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Ctr Mol Cardiol, New York, NY USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Tan, CC (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90024 USA.	bruce.gelb@mssm.edu			National Institutes of Health (NIH) [HD38018]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038018] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by National Institutes of Health (NIH) grant HD38018 to BDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthanarayanan M, 2004, J BIOL CHEM, V279, P54348, DOI 10.1074/jbc.M410021200; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Blak AA, 2005, DEV DYNAM, V233, P1023, DOI 10.1002/dvdy.20386; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Diep DB, 2004, DEV BRAIN RES, V153, P261, DOI 10.1016/j.devbrainres.2004.09.008; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; Reimers D, 2001, NEUROL RES, V23, P612, DOI 10.1179/016164101101199090; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Saarimaki-Vire J, 2007, J NEUROSCI, V27, P8581, DOI 10.1523/JNEUROSCI.0192-07.2007; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Tan CC, 2008, P NATL ACAD SCI USA, V105, P7472, DOI 10.1073/pnas.0711896105; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Zhao F, 2003, GENE EXPR PATTERNS, V3, P213, DOI 10.1016/S1567-133X(02)00067-4	24	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8535	10.1371/journal.pone.0008535	http://dx.doi.org/10.1371/journal.pone.0008535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046871	Green Published, gold, Green Submitted			2022-12-25	WOS:000273180200016
J	Thomas, JH; Emerson, RO; Shendure, J				Thomas, James H.; Emerson, Ryan O.; Shendure, Jay			Extraordinary Molecular Evolution in the PRDM9 Fertility Gene	PLOS ONE			English	Article							HISTONE H3 METHYLTRANSFERASE; CENTROMERE COMPLEXITY; CRYSTAL-STRUCTURE; REPRESSION; MEISETZ; DOMAIN; DNA; SPECIATION; SUBFAMILY; PROTEINS	Recent work indicates that allelic incompatibility in the mouse PRDM9 (Meisetz) gene can cause hybrid male sterility, contributing to genetic isolation and potentially speciation. The only phenotype of mouse PRDM9 knockouts is a meiosis I block that causes sterility in both sexes. The PRDM9 gene encodes a protein with histone H3(K4) trimethyltransferase activity, a KRAB domain, and a DNA-binding domain consisting of multiple tandem C2H2 zinc finger (ZF) domains. We have analyzed human coding polymorphism and interspecies evolutionary changes in the PRDM9 gene. The ZF domains of PRDM9 are evolving very rapidly, with compelling evidence of positive selection in primates. Positively selected amino acids are predominantly those known to make nucleotide specific contacts in C2H2 zinc fingers. These results suggest that PRDM9 is subject to recurrent selection to change DNA-binding specificity. The human PRDM9 protein is highly polymorphic in its ZF domains and nearly all polymorphisms affect the same nucleotide contact residues that are subject to positive selection. ZF domain nucleotide sequences are strongly homogenized within species, indicating that interfinger recombination contributes to their evolution. PRDM9 has previously been assumed to be a transcription factor required to induce meiosis specific genes, a role that is inconsistent with its molecular evolution. We suggest instead that PRDM9 is involved in some aspect of centromere segregation conflict and that rapidly evolving centromeric DNA drives changes in PRDM9 DNA-binding domains.	[Thomas, James H.; Emerson, Ryan O.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Thomas, JH (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jht@u.washington.edu	Emerson, Ryan/F-4545-2010; Shendure, Jay/AAU-3684-2021	Emerson, Ryan/0000-0003-0241-3709; Shendure, Jay/0000-0002-1516-1865	NHLBI [5901HL094976-02]; NHGRI [1921HG004749-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094976] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004749] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The sequencing in the paper was supported by the following grants: NHLBI 5901HL094976-02 "SeattleSeq", http://www.genome.gov/, NHGRI 1921HG004749-01, 'Molecular Tools for Genome Partitioning", http://www.genome.gov/. The computational work had no extramural grant support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Birtle Z, 2006, BIOINFORMATICS, V22, P2841, DOI 10.1093/bioinformatics/btl498; Cellamare A, 2009, MOL BIOL EVOL, V26, P1889, DOI 10.1093/molbev/msp101; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hayashi K, 2006, CELL CYCLE, V5, P615, DOI 10.4161/cc.5.6.2572; Irie S, 2009, J ANDROL, V30, P426, DOI 10.2164/jandrol.108.006262; Kim CA, 1996, NAT STRUCT BIOL, V3, P940, DOI 10.1038/nsb1196-940; Malik HS, 2006, BIOCHEM SOC T, V34, P569, DOI 10.1042/BST0340569; Malik HS, 2009, PROG MOL SUBCELL BIO, V48, P33, DOI 10.1007/978-3-642-00182-6_2; Malik HS, 2002, CURR OPIN GENET DEV, V12, P711, DOI 10.1016/S0959-437X(02)00351-9; Malik HS, 2001, GENETICS, V157, P1293; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PENGUE G, 1994, NUCLEIC ACIDS RES, V22, P2908, DOI 10.1093/nar/22.15.2908; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Thomas JH, 2006, GENETICS, V172, P2269, DOI 10.1534/genetics.105.052746; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	28	61	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8505	10.1371/journal.pone.0008505	http://dx.doi.org/10.1371/journal.pone.0008505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041164	Green Published, gold, Green Submitted			2022-12-25	WOS:000278068700019
J	Loogvali, EL; Kivisild, T; Margus, T; Villems, R				Loogvaeli, Eva-Liis; Kivisild, Toomas; Margus, Tonu; Villems, Richard			Explaining the Imperfection of the Molecular Clock of Hominid Mitochondria	PLOS ONE			English	Article							TIME DEPENDENCY; ADAPTIVE SELECTION; NATURAL-SELECTION; MTDNA VARIATION; DNA-SEQUENCES; EVOLUTION; ORIGIN; POLYMORPHISM; MUTATIONS; GENES	The molecular clock of mitochondrial DNA has been extensively used to date various genetic events. However, its substitution rate among humans appears to be higher than rates inferred from human-chimpanzee comparisons, limiting the potential of interspecies clock calibrations for intraspecific dating. It is not well understood how and why the substitution rate accelerates. We have analyzed a phylogenetic tree of 3057 publicly available human mitochondrial DNA coding region sequences for changes in the ratios of mutations belonging to different functional classes. The proportion of non-synonymous and RNA genes substitutions has reduced over hundreds of thousands of years. The highest mutation ratios corresponding to fast acceleration in the apparent substitution rate of the coding sequence have occurred after the end of the Last Ice Age. We recalibrate the molecular clock of human mtDNA as 7990 years per synonymous mutation over the mitochondrial genome. However, the distribution of substitutions at synonymous sites in human data significantly departs from a model assuming a single rate parameter and implies at least 3 different subclasses of sites. Neutral model with 3 synonymous substitution rates can explain most, if not all, of the apparent molecular clock difference between the intra- and interspecies levels. Our findings imply the sluggishness of purifying selection in removing the slightly deleterious mutations from the human as well as the Neandertal and chimpanzee populations. However, for humans, the weakness of purifying selection has been further exacerbated by the population expansions associated with the out-of Africa migration and the end of the Last Ice Age.	[Loogvaeli, Eva-Liis; Kivisild, Toomas; Villems, Richard] Estonian Bioctr, Tartu, Estonia; [Loogvaeli, Eva-Liis; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; [Kivisild, Toomas] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England; [Margus, Tonu] Univ Tartu, Dept Bioinformat, EE-50090 Tartu, Estonia	Estonian Biocentre; University of Tartu; University of Cambridge; University of Tartu	Loogvali, EL (corresponding author), Estonian Bioctr, Tartu, Estonia.	eva-liis.loogvali@ut.ee	Kivisild, Toomas/P-5889-2017	Kivisild, Toomas/0000-0002-6297-7808; Margus, Tonu/0000-0003-4966-1291	Estonian Science Foundation [6040]; European Union; Estonian Biocentre; Tartu University	Estonian Science Foundation; European Union(European Commission); Estonian Biocentre; Tartu University	This research has been supported by Estonian Science Foundation grant 6040 and by the European Union through the European Regional Development Fund through the Centre of Excellence in Genomics, Estonian Biocentre and Tartu University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat G, 2008, GENETICS, V179, P1409, DOI 10.1534/genetics.107.082198; Adachi J, 1996, MOL BIOL EVOL, V13, P200, DOI 10.1093/oxfordjournals.molbev.a025556; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arnason U, 1996, J MOL EVOL, V42, P145, DOI 10.1007/BF02198840; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bandelt HJ, 2008, HEREDITY, V100, P1, DOI 10.1038/sj.hdy.6801054; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; Emerson BC, 2007, SYST BIOL, V56, P337, DOI 10.1080/10635150701258795; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Endicott P, 2009, TRENDS ECOL EVOL, V24, P515, DOI 10.1016/j.tree.2009.04.006; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Flynn SMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-339; Foley R, 1997, CAMB ARCHAEOL J, V7, P3, DOI 10.1017/S0959774300001451; Forster P, 1996, AM J HUM GENET, V59, P935; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Hasegawa M, 1998, MOL BIOL EVOL, V15, P1499, DOI 10.1093/oxfordjournals.molbev.a025877; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Howell N, 2008, HEREDITY, V101, P107, DOI 10.1038/hdy.2008.52; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Hughes AL, 2007, MOL ECOL, V16, P1369, DOI 10.1111/j.1365-294X.2007.03242.x; Ingman M, 2007, HUM MOL GENET, V16, P2281, DOI 10.1093/hmg/ddm180; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; KIVISILD T, 2002, MOL BIOL EVOL, V1720, P1162; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moilanen JS, 2003, MOL BIOL EVOL, V20, P1195, DOI 10.1093/molbev/msg121; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Nachman MW, 1998, GENETICA, V102-3, P61, DOI 10.1023/A:1017030708374; Nachman MW, 1996, GENETICS, V142, P953; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Nielsen R, 1999, GENETICS, V153, P497; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Pauling L, 1962, HORIZONS BIOCH, P189, DOI DOI 10.1038/NCHEMBIO.2477; Penny D, 2005, NATURE, V436, P183, DOI 10.1038/436183a; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Stringer CB, 1999, J HUM EVOL, V37, P873, DOI 10.1006/jhev.1999.0367; Subramanian S, 2009, MOL BIOL EVOL, V26, P715, DOI 10.1093/molbev/msp005; Sun C, 2007, GENOMICS, V89, P338, DOI 10.1016/j.ygeno.2006.11.005; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407	66	24	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8260	10.1371/journal.pone.0008260	http://dx.doi.org/10.1371/journal.pone.0008260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041137	Green Submitted, gold, Green Published			2022-12-25	WOS:000273105200002
J	Kim, S; Carrillo, M; Kulkarni, V; Jagadeeswaran, P				Kim, Seongcheol; Carrillo, Maira; Kulkarni, Vrinda; Jagadeeswaran, Pudur			Evolution of Primary Hemostasis in Early Vertebrates	PLOS ONE			English	Article							MAST-CELLS; ZEBRAFISH; TRYPSIN; IDENTIFICATION; THROMBOCYTES; THROMBOSIS; RECEPTORS; PROTEASES; ENZYMES; MOUSE	Hemostasis is a defense mechanism which protects the organism in the event of injury to stop bleeding. Recently, we established that all the known major mammalian hemostatic factors are conserved in early vertebrates. However, since their highly vascularized gills experience high blood pressure and are exposed to the environment, even very small injuries could be fatal to fish. Since trypsins are forerunners for coagulation proteases and are expressed by many extrapancreatic cells such as endothelial cells and epithelial cells, we hypothesized that trypsin or trypsin-like proteases from gill epithelial cells may protect these animals from gill bleeding following injuries. In this paper we identified the release of three different trypsins from fish gills into water under stress or injury, which have tenfold greater serine protease activity compared to bovine trypsin. We found that these trypsins activate the thrombocytes and protect the fish from gill bleeding. We found 27 protease-activated receptors (PARs) by analyzing zebrafish genome and classified them into five groups, based on tethering peptides, and two families, PAR1 and PAR2, based on homologies. We also found a canonical member of PAR2 family, PAR2-21A which is activated more readily by trypsin, and PAR2-21A tethering peptide stops gill bleeding just as trypsin. This finding provides evidence that trypsin cleaves a PAR2 member on thrombocyte surface. In conclusion, we believe that the gills are evolutionarily selected to produce trypsin to activate PAR2 on thrombocyte surface and protect the gills from bleeding. We also speculate that trypsin may also protect the fish from bleeding from other body injuries due to quick contact with the thrombocytes. Thus, this finding provides evidence for the role of trypsins in primary hemostasis in early vertebrates.	[Kim, Seongcheol; Carrillo, Maira; Kulkarni, Vrinda; Jagadeeswaran, Pudur] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton	Kim, S (corresponding author), Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA.	jag@unt.edu			National Institutes of Health [HL077910]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077910] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a grant from the National Institutes of Health, HL077910 (to PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SA, 1998, BLOOD COAGUL FIBRIN, V9, P307, DOI 10.1097/00001721-199806000-00002; Ainsworth DM, 2000, J AM VET MED ASSOC, V216, P1282, DOI 10.2460/javma.2000.216.1282; ALLEN DH, 1995, J BIOL CHEM, V270, P1408, DOI 10.1074/jbc.270.3.1408; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Hanumanthaiah R, 2002, BLOOD CELL MOL DIS, V29, P57, DOI 10.1006/bcmd.2002.0534; Hortin GL, 2001, CLIN CHEM, V47, P215; Jagadeeswaran P, 2007, J THROMB HAEMOST, V5, P300, DOI 10.1111/j.1538-7836.2007.02518.x; Jagadeeswaran P, 2005, J THROMB HAEMOST, V3, P46, DOI 10.1111/j.1538-7836.2004.00999.x; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Koshikawa N, 1998, AM J PATHOL, V153, P937, DOI 10.1016/S0002-9440(10)65635-0; Lentink D, 2008, J EXP BIOL, V211, P267, DOI 10.1242/jeb.006155; MAHONEY WC, 1980, EUR J BIOCHEM, V105, P545, DOI 10.1111/j.1432-1033.1980.tb04531.x; MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524; Muller UK, 2000, J EXP BIOL, V203, P193; NEURATH H, 1967, SCIENCE, V158, P1638, DOI 10.1126/science.158.3809.1638; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Silphaduang U, 2001, NATURE, V414, P268, DOI 10.1038/35104690; Smith TG, 2008, BRIT J HAEMATOL, V141, P325, DOI 10.1111/j.1365-2141.2008.07029.x; Thattaliyath B, 2005, BLOOD, V106, P118, DOI 10.1182/blood-2004-10-4118; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V	21	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8403	10.1371/journal.pone.0008403	http://dx.doi.org/10.1371/journal.pone.0008403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037653	Green Published, gold, Green Submitted			2022-12-25	WOS:000272998100008
J	Lin, SW; Huang, YL; Lee, T				Lin, Suewei; Huang, Yaling; Lee, Tzumin			Nuclear Receptor Unfulfilled Regulates Axonal Guidance and Cell Identity of Drosophila Mushroom Body Neurons	PLOS ONE			English	Article							B ECDYSONE RECEPTOR; COUP-TFI; TRANSCRIPTION FACTORS; DOPAMINERGIC-NEURONS; THERAPEUTIC TARGET; TEMPORAL IDENTITY; GENE-EXPRESSION; NERVOUS-SYSTEM; DIFFERENTIATION; MEMORY	Nuclear receptors (NRs) comprise a family of ligand-regulated transcription factors that control diverse critical biological processes including various aspects of brain development. Eighteen NR genes exist in the Drosophila genome. To explore their roles in brain development, we knocked down individual NRs through the development of the mushroom bodies (MBs) by targeted RNAi. Besides recapitulating the known MB phenotypes for three NRs, we found that unfulfilled (unf), an ortholog of human photoreceptor specific nuclear receptor (PNR), regulates axonal morphogenesis and neuronal subtype identity. The adult MBs develop through remodeling of gamma neurons plus de-novo elaboration of both alpha'/beta' and alpha/beta neurons. Notably, unf is largely dispensable for the initial elaboration of gamma neurons, but plays an essential role in their re-extension of axons after pruning during early metamorphosis. The subsequently derived MB neuron types also require unf for extension of axons beyond the terminus of the pruned bundle. Tracing single axons revealed misrouting rather than simple truncation. Further, silencing unf in single-cell clones elicited misguidance of axons in otherwise unperturbed MBs. Such axon guidance defects may occur as MB neurons partially lose their subtype identity, as evidenced by suppression of various MB subtype markers in unf knockdown MBs. In sum, unf governs axonal morphogenesis of multiple MB neuron types, possibly through regulating neuronal subtype identity.	[Lin, Suewei; Lee, Tzumin] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Huang, Yaling; Lee, Tzumin] Howard Hughes Med Inst, Ashburn, VA USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Lin, SW (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	leet@janelia.hhmi.org	Lin, Suewei/AAA-3962-2021	Lin, Suewei/0000-0001-7079-7818	National Institutes of Health (NIH)	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health (NIH) grants to T. L.. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Boyle M, 2006, DEVELOPMENT, V133, P1845, DOI 10.1242/dev.02353; Brown HLD, 2009, DEVELOPMENT, V136, P3247, DOI 10.1242/dev.039859; Chaturvedi RK, 2008, J NEUROCHEM, V106, P506, DOI 10.1111/j.1471-4159.2008.05388.x; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Choi YJ, 2006, DEVELOPMENT, V133, P2223, DOI 10.1242/dev.02376; Chu YP, 2006, J COMP NEUROL, V494, P495, DOI 10.1002/cne.20828; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Culman J, 2007, TRENDS PHARMACOL SCI, V28, P244, DOI 10.1016/j.tips.2007.03.004; DEROSNY E, 2008, BIOCHEMISTRY; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Honjo K, 2005, J NEUROSCI, V25, P7905, DOI 10.1523/JNEUROSCI.2135-05.2005; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Kanai MI, 2005, DEV CELL, V8, P203, DOI 10.1016/j.devcel.2004.12.014; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; KRAMER S, 1995, DEVELOPMENT, V121, P1361; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kurusu M, 2009, DEV BIOL, V326, P224, DOI 10.1016/j.ydbio.2008.11.013; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Le WD, 2008, J NEUROL SCI, V273, P29, DOI 10.1016/j.jns.2008.06.007; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; LORENZ RT, 1991, LIPIDS, V26, P598, DOI 10.1007/BF02536423; Luo GR, 2008, MOL CELL NEUROSCI, V39, P202, DOI 10.1016/j.mcn.2008.06.010; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Martini SR, 2000, DEVELOPMENT, V127, P2663; Martini SR, 2005, J NEUROBIOL, V64, P133, DOI 10.1002/neu.20130; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Milam AH, 2002, P NATL ACAD SCI USA, V99, P473, DOI 10.1073/pnas.022533099; Much JW, 2000, DEVELOPMENT, V127, P703; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Palanker L, 2006, DEVELOPMENT, V133, P3549, DOI 10.1242/dev.02512; PARDEE K, 2004, SCI AGING KNOWLEDGE, pRE8, DOI DOI 10.1126/SAGEKE.2004.47.RE8; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Ponnio T, 2004, MOL CELL BIOL, V24, P9070, DOI 10.1128/MCB.24.20.9070-9078.2004; ROBINOW S, 1993, DEVELOPMENT, V119, P1251; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Schubiger M, 2005, DEVELOPMENT, V132, P5239, DOI 10.1242/dev.02093; Schubiger M, 2000, DEVELOPMENT, V127, P1151; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Shi L, 2007, DEV NEUROBIOL, V67, P1614, DOI 10.1002/dneu.20537; Shi L, 2007, J NEUROSCI, V27, P6723, DOI 10.1523/JNEUROSCI.1517-07.2007; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Sung C, 2009, DEV DYNAM, V238, P171, DOI 10.1002/dvdy.21817; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tang LS, 2006, DEVELOPMENT, V133, P3683, DOI 10.1242/dev.02536; Tran PV, 2003, MOL CELL NEUROSCI, V22, P441, DOI 10.1016/S1044-7431(03)00027-7; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Truman JW, 1996, DEV NEUROSCI-BASEL, V18, P87, DOI 10.1159/000111398; Urbach R, 2003, DEVELOPMENT, V130, P3607, DOI 10.1242/dev.00532; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wightman B, 2005, DEV BIOL, V287, P74, DOI 10.1016/j.ydbio.2005.08.032; Wightman B, 1997, DEVELOPMENT, V124, P2571; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; YANG MY, 1995, NEURON, V15, P45; Yu HH, 2007, TRENDS NEUROSCI, V30, P520, DOI 10.1016/j.tins.2007.07.003; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	73	30	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8392	10.1371/journal.pone.0008392	http://dx.doi.org/10.1371/journal.pone.0008392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027309	Green Published, Green Submitted, gold			2022-12-25	WOS:000272998000004
J	Qadri, YJ; Song, YH; Fuller, CM; Benos, DJ				Qadri, Yawar J.; Song, Yuhua; Fuller, Catherine M.; Benos, Dale J.			Amiloride Docking to Acid-sensing Ion Channel-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; ACTIVATES NA+/H+ EXCHANGE; PROTEIN-LIGAND COMPLEXES; ALPHA-SUBUNIT; BINDING DOMAIN; IDENTIFICATION; PORE; ENAC; TRANSPORT; PSALMOTOXIN-1	Amiloride is a small molecule diuretic, which has been used to dissect sodium transport pathways in many different systems. This drug is known to interact with the epithelial sodium channel and acid-sensing ion channel proteins, as well as sodium/hydrogen antiporters and sodium/calcium exchangers. The exact structural basis for these interactions has not been elucidated as crystal structures of these proteins have been challenging to obtain, though some involved residues and domains have been mapped. This work examines the interaction of amiloride with acid-sensing ion channel-1, a protein whose structure is available using computational and experimental techniques. Using molecular docking software, amiloride and related molecules were docked to model structures of homomeric human ASIC-1 to generate potential interaction sites and predict which analogs would be more or less potent than amiloride. The predictions made were experimentally tested using whole-cell patch clamp. Drugs previously classified as NCX or NHE inhibitors are shown to also inhibit hASIC-1. Potential docking sites were re-examined against experimental data to remove spurious interaction sites. The voltage sensitivity of inhibitors was also examined. Using the aggregated data from these computational and experimental experiments, putative interaction sites for amiloride and hASIC-1 have been defined. Future work will experimentally verify these interaction sites, but at present this should allow for virtual screening of drug libraries at these putative interaction sites.	[Qadri, Yawar J.; Fuller, Catherine M.; Benos, Dale J.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Song, Yuhua] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Benos, DJ (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, UAb Stn, Birmingham, AL 35294 USA.	benos@uab.edu	Fuller, Cathy/B-4046-2011	Qadri, Yawar/0000-0003-2138-4018	National Institutes of Health [DK37206]; AMA foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037206, R56DK037206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AMA foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK37206. This work was also supported by the AMA foundation.	Adams CM, 1999, J BIOL CHEM, V274, P15500, DOI 10.1074/jbc.274.22.15500; BENOS DJ, 1982, AM J PHYSIOL, V242, pC131, DOI 10.1152/ajpcell.1982.242.3.C131; BENOS DJ, 1976, J GEN PHYSIOL, V68, P43, DOI 10.1085/jgp.68.1.43; Benos DJ, 1999, J PHYSIOL-LONDON, V520, P631, DOI 10.1111/j.1469-7793.1999.00631.x; BICKING JB, 1965, J MED CHEM, V8, P638, DOI 10.1021/jm00329a017; Bondarava M, 2009, PFLUG ARCH EUR J PHY, V458, P675, DOI 10.1007/s00424-009-0649-z; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Garnovskaya MN, 2003, J BIOL CHEM, V278, P16908, DOI 10.1074/jbc.M209883200; Garnovskaya MN, 1997, J BIOL CHEM, V272, P7770, DOI 10.1074/jbc.272.12.7770; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hassell AM, 2007, ACTA CRYSTALLOGR D, V63, P72, DOI 10.1107/S0907444906047020; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Hirsh AJ, 2008, J PHARMACOL EXP THER, V325, P77, DOI 10.1124/jpet.107.130443; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ismailov II, 1997, J BIOL CHEM, V272, P21075, DOI 10.1074/jbc.272.34.21075; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jernigan NL, 2009, AM J PHYSIOL-LUNG C, V297, pL271, DOI 10.1152/ajplung.00020.2009; Ji HL, 2004, J BIOL CHEM, V279, P8428, DOI 10.1074/jbc.M312012200; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Kashlan OB, 2005, J BIOL CHEM, V280, P26206, DOI 10.1074/jbc.M503500200; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kelly O, 2003, AM J PHYSIOL-RENAL, V285, pF1279, DOI 10.1152/ajprenal.00094.2003; Kieber-Emmons T, 1999, J BIOL CHEM, V274, P9648, DOI 10.1074/jbc.274.14.9648; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Kuduk SD, 2009, BIOORG MED CHEM LETT, V19, P2514, DOI 10.1016/j.bmcl.2009.03.029; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; LI XJ, 1995, MOL PHARMACOL, V47, P1133; PALMER LG, 1985, J MEMBRANE BIOL, V87, P191, DOI 10.1007/BF01871218; PALMER LG, 1989, BIOPHYS J, V55, P779, DOI 10.1016/S0006-3495(89)82876-0; Pietra F, 2009, J CHEM INF MODEL, V49, P972, DOI 10.1021/ci800463h; Qadri YJ, 2009, J BIOL CHEM, V284, P17625, DOI 10.1074/jbc.M109.003913; Reddy CS, 2006, COMPUT BIOL CHEM, V30, P120, DOI 10.1016/j.compbiolchem.2005.12.002; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Segal A, 2002, PFLUG ARCH EUR J PHY, V443, P882, DOI 10.1007/s00424-001-0773-x; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Tannous BA, 2009, MOL THER, V17, P810, DOI 10.1038/mt.2009.33; Team RDC, 2008, LANGUAGE ENV STAT CO; Teiwes J, 2007, AM J HYPERTENS, V20, P109, DOI 10.1016/j.amjhyper.2006.05.022; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Ye JH, 2007, BIOCHEM BIOPH RES CO, V355, P986, DOI 10.1016/j.bbrc.2007.02.061	51	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9627	9635		10.1074/jbc.M109.082735	http://dx.doi.org/10.1074/jbc.M109.082735			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20048170	hybrid, Green Published			2022-12-25	WOS:000276165900035
J	Fang, QM; Kanugula, S; Tubbs, JL; Tainer, JA; Pegg, AE				Fang, Qingming; Kanugula, Sreenivas; Tubbs, Julie L.; Tainer, John A.; Pegg, Anthony E.			Repair of O-4-Alkylthymine by O-6-Alkylguanine-DNA Alkyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-BINDING MECHANISM; ESCHERICHIA-COLI ADA; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; O(6)-ALKYLGUANINE-DNA ALKYLTRANSFERASE; O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; DIFFERENTIAL INACTIVATION; DAMAGE RECOGNITION; CRYSTAL-STRUCTURE; GENE-PRODUCT	O-6-Alkylguanine-DNA alkyltransferase (AGT) plays a major role in repair of the cytotoxic and mutagenic lesion O-6-methylguanine (m(6)G) in DNA. Unlike the Escherichia coli alkyltransferase Ogt that also repairs O-4-methylthymine (m(4)T) efficiently, the human AGT (hAGT) acts poorly on m(4)T. Here we made several hAGT mutants in which residues near the cysteine acceptor site were replaced by corresponding residues from Ogt to investigate the basis for the inefficiency of hAGT in repair of m(4)T. Construct hAGT-03 (where hAGT sequence-V(149)CSSGAVGN(157)- was replaced with the corresponding Ogt - I(143)GRNGTMTG(151)-) exhibited enhanced m(4)T repair activity in vitro compared with hAGT. Three AGT proteins (hAGT, hAGT-03, and Ogt) exhibited similar protection from killing by N-methyl-N'-nitro-N-nitrosoguanidine and caused a reduction in m(6)G-induced G: C to A: T mutations in both nucleotide excision repair (NER)-proficient and -deficient Escherichia coli strains that lack endogenous AGTs. hAGT-03 resembled Ogt in totally reducing the m(4)T-induced T: A to C: G mutations in NER proficient and -deficient strains. Surprisingly, wild type hAGT expression caused a significant but incomplete decrease in NER-deficient strains but a slight increase in T: A to C: G mutation frequency in NER-proficient strains. The T: A to C: G mutations due to O-4-alkylthymine formed by ethylating and propylating agents were also efficiently reduced by either hAGT-03 or Ogt, whereas hAGT had little effect irrespective of NER status. These results show that specific alterations in the hAGT active site facilitate efficient recognition and repair of O-4-alkylthymines and reveal damage-dependent interactions of base and nucleotide excision repair.	[Fang, Qingming] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Tubbs, Julie L.; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Tubbs, Julie L.; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Fang, QM (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	quf2@psu.edu; aep1@psu.edu	Tainer, John/GWQ-4878-2022; Fang, Qingming/B-6839-2008	Tainer, John/0000-0003-1659-2429; Fang, Qingming/0000-0002-4006-0636	National Institutes of Health United States Public Health Service [R01-CA018137, CA-097209, CA-071976]; NATIONAL CANCER INSTITUTE [R01CA097209, R01CA071976, R01CA018137] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Grants R01-CA018137, CA-097209, and CA-071976.	BASU AK, 1990, MUTAT RES, V233, P189, DOI 10.1016/0027-5107(90)90162-W; BRONSTEIN SM, 1992, CANCER RES, V52, P2008; BRONSTEIN SM, 1991, CANCER RES, V51, P5188; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CRUZEIROHANSSON L, 1994, CARCINOGENESIS, V15, P1525, DOI 10.1093/carcin/15.8.1525; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; Daniels DS, 2000, EMBO J, V19, P1719, DOI 10.1093/emboj/19.7.1719; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; DENENGELSE L, 1986, CARCINOGENESIS, V7, P393; DEVEREUX TR, 1991, CARCINOGENESIS, V12, P299, DOI 10.1093/carcin/12.2.299; DOLAN ME, 1990, P NATL ACAD SCI USA, V87, P5368, DOI 10.1073/pnas.87.14.5368; DOSANJH MK, 1991, BIOCHEMISTRY-US, V30, P7027, DOI 10.1021/bi00242a031; DOSANJH MK, 1990, BIOCHEMISTRY-US, V29, P4698, DOI 10.1021/bi00471a026; Duguid EM, 2005, J MOL BIOL, V350, P657, DOI 10.1016/j.jmb.2005.05.028; ELDER RH, 1994, BIOCHEM J, V298, P231, DOI 10.1042/bj2980231; Encell LP, 1999, BIOCHEMISTRY-US, V38, P12097, DOI 10.1021/bi9913606; Encell LP, 2000, CARCINOGENESIS, V21, P1397, DOI 10.1093/carcin/21.7.1397; Engelbergs J, 1998, P NATL ACAD SCI USA, V95, P1635, DOI 10.1073/pnas.95.4.1635; Fang QM, 2008, BIOCHEMISTRY-US, V47, P10892, DOI 10.1021/bi8008664; Fang QM, 2008, BIOCHEM PHARMACOL, V75, P618, DOI 10.1016/j.bcp.2007.09.022; Fang QM, 2005, BIOCHEMISTRY-US, V44, P15396, DOI 10.1021/bi051460d; Fried MG, 1996, BIOCHEMISTRY-US, V35, P15295, DOI 10.1021/bi960971k; Goodtzova K, 1997, J BIOL CHEM, V272, P8332, DOI 10.1074/jbc.272.13.8332; GRAVES RJ, 1989, CARCINOGENESIS, V10, P661, DOI 10.1093/carcin/10.4.661; Guengerich FP, 2003, BIOCHEMISTRY-US, V42, P10965, DOI 10.1021/bi034937z; HARRIS LC, 1993, BRIT J CANCER, V67, P1196, DOI 10.1038/bjc.1993.225; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Kaina B, 2001, PROG NUCLEIC ACID RE, V68, P41; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; KAWATE H, 1995, CARCINOGENESIS, V16, P1595, DOI 10.1093/carcin/16.7.1595; Kooistra R, 1999, NUCLEIC ACIDS RES, V27, P1795, DOI 10.1093/nar/27.8.1795; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lawley P. D., 1976, CHEM CARCINOGENS AM, V173, P83; Liu LP, 2002, CANCER RES, V62, P3037; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; Luu KX, 2002, BIOCHEMISTRY-US, V41, P8689, DOI 10.1021/bi025857i; MACKAY WJ, 1994, J BACTERIOL, V176, P3224, DOI 10.1128/jb.176.11.3224-3230.1994; MacKerell A. D., 1998, ENCY COMPUTATIONAL C, V1, P271; Margison GP, 2002, BIOESSAYS, V24, P255, DOI 10.1002/bies.10063; Mazon G, 2009, DNA REPAIR, V8, P697, DOI 10.1016/j.dnarep.2009.01.022; Melikishvili M, 2008, BIOCHEMISTRY-US, V47, P13754, DOI 10.1021/bi801666c; Milsom MD, 2008, CANCER RES, V68, P6171, DOI 10.1158/0008-5472.CAN-08-0320; Mol CD, 1999, ANNU REV BIOPH BIOM, V28, P101, DOI 10.1146/annurev.biophys.28.1.101; MOORE MH, 1994, EMBO J, V13, P1495, DOI 10.1002/j.1460-2075.1994.tb06410.x; OTOOLE SM, 1993, CANCER RES, V53, P3895; Paalman SR, 1997, NUCLEIC ACIDS RES, V25, P1795, DOI 10.1093/nar/25.9.1795; PAULY GT, 1995, BIOCHEMISTRY-US, V34, P8924, DOI 10.1021/bi00027a045; Pauly GT, 1998, CARCINOGENESIS, V19, P457, DOI 10.1093/carcin/19.3.457; Pauly GT, 2001, CHEM RES TOXICOL, V14, P894, DOI 10.1021/tx010032f; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; PEGG AE, 1993, BIOCHEMISTRY-US, V32, P11998, DOI 10.1021/bi00096a009; PEGG AE, 1995, PROG NUCLEIC ACID RE, V51, P167, DOI 10.1016/S0079-6603(08)60879-X; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; PRESTON BD, 1986, P NATL ACAD SCI USA, V83, P8501, DOI 10.1073/pnas.83.22.8501; Rasimas JJ, 2003, J BIOL CHEM, V278, P7973, DOI 10.1074/jbc.M211854200; Rasimas JJ, 2007, J BIOL CHEM, V282, P3357, DOI 10.1074/jbc.M608876200; Reese JS, 2008, STEM CELLS, V26, P675, DOI 10.1634/stemcells.2007-0803; SAFFHILL R, 1985, BIOCHIM BIOPHYS ACTA, V823, P111, DOI 10.1016/0304-419X(85)90009-5; SAMSON L, 1988, EMBO J, V7, P2261, DOI 10.1002/j.1460-2075.1988.tb03066.x; Samson L, 1997, CARCINOGENESIS, V18, P919, DOI 10.1093/carcin/18.5.919; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SASSANFAR M, 1991, J BIOL CHEM, V266, P2767; SINGER B, 1990, MUTAT RES, V233, P45, DOI 10.1016/0027-5107(90)90150-3; SINGER B, 1991, CARCINOGENESIS, V12, P949; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Tubbs JL, 2007, DNA REPAIR, V6, P1100, DOI 10.1016/j.dnarep.2007.03.011; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; VOIGT JM, 1989, J BIOL CHEM, V264, P5172; Wibley JEA, 2000, NUCLEIC ACIDS RES, V28, P393, DOI 10.1093/nar/28.2.393; WILKINSON MC, 1989, NUCLEIC ACIDS RES, V17, P8475, DOI 10.1093/nar/17.21.8475; Zang Z, 2005, J BIOL CHEM, V280, P30873, DOI 10.1074/jbc.M505283200; Zhao HF, 2009, BLOOD, V113, P5747, DOI 10.1182/blood-2008-10-186684	74	24	24	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8185	8195		10.1074/jbc.M109.045518	http://dx.doi.org/10.1074/jbc.M109.045518			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20026607	Green Published, hybrid			2022-12-25	WOS:000275413800037
J	Robertson, S; Allie-Reid, F; Vanden Berghe, W; Visser, K; Binder, A; Africander, D; Vismer, M; De Bosscher, K; Hapgood, J; Haegeman, G; Louw, A				Robertson, Steven; Allie-Reid, Fatima; Vanden Berghe, Wim; Visser, Koch; Binder, Anke; Africander, Donita; Vismer, Michael; De Bosscher, Karolien; Hapgood, Janet; Haegeman, Guy; Louw, Ann			Abrogation of Glucocorticoid Receptor Dimerization Correlates with Dissociated Glucocorticoid Behavior of Compound A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOSTEROID-BINDING GLOBULIN; GONADOTROPIN-RELEASING-HORMONE; FACTOR-KAPPA-B; AZIRIDINE PRECURSOR; IN-VIVO; MOLECULAR-MECHANISMS; ANDROGEN RECEPTOR; PLANT-ORIGIN; LIVING CELLS; DNA-BINDING	Compound A (CpdA), a dissociated glucocorticoid receptor modulator, decreases corticosteroid-binding globulin (CBG), adrenocorticotropic hormone (ACTH), and luteneinizing hormone levels in rats. Whether this is due to transcriptional regulation by CpdA is not known. Using promoter reporter assays we show that CpdA, like dexamethasone (Dex), directly transrepresses these genes. Results using a rat Cbg proximal-promoter reporter construct in BWTG3 and HepG2 cell lines support a glucocorticoid receptor (GR)-dependent transrepression mechanism for CpdA. However, CpdA, unlike Dex, does not result in transactivation via glucocorticoid-responsive elements within a promoter reporter construct even when GR is co-transfected. The inability of CpdA to result in transactivation via glucocorticoid-responsive elements is confirmed on the endogenous tyrosine aminotransferase gene, whereas transrepression ability is confirmed on the endogenous CBG gene. Consistent with a role for CpdA in modulating GR activity, whole cell binding assays revealed that CpdA binds reversibly to the GR, but with lower affinity than Dex, and influences association of [H-3] Dex, but has no effect on dissociation. In addition, like Dex, CpdA causes nuclear translocation of the GR, albeit to a lesser degree. Several lines of evidence, including fluorescence resonance energy transfer, co-immunoprecipitation, and nuclear immunofluorescence studies of nuclear localization-deficient GR show that CpdA, unlike Dex, does not elicit ligand-induced GR dimerization. Comparison of the behavior of CpdA in the presence of wild type GR to that of Dex with a dimerization-deficient GR mutant (GR(dim)) strongly supports the conclusion that loss of dimerization is responsible for the dissociated behavior of CpdA.	[Robertson, Steven; Allie-Reid, Fatima; Visser, Koch; Binder, Anke; Africander, Donita; Vismer, Michael; Louw, Ann] Univ Stellenbosch, Dept Biochem, ZA-7602 Stellenbosch, South Africa; [Vanden Berghe, Wim; De Bosscher, Karolien; Haegeman, Guy] Univ Ghent, Dept Physiol, LEGEST, B-9000 Ghent, Belgium; [Hapgood, Janet] Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, South Africa	Stellenbosch University; Ghent University; University of Cape Town	Louw, A (corresponding author), Univ Stellenbosch, Dept Biochem, ZA-7602 Stellenbosch, South Africa.		Berghe, Wim Vanden/S-6425-2018; Hapgood, Janet P/P-2549-2018; Vanden Berghe, Wim/HGE-4696-2022; Louw, Ann/A-7620-2012	Berghe, Wim Vanden/0000-0003-0161-7355; Hapgood, Janet P/0000-0002-4414-4861; Louw, Ann/0000-0002-1021-6732; Africander, Donita/0000-0002-3429-7100; De Bosscher, Karolien/0000-0001-5059-9718	Flemish-South African bilateral [BIL99/39]; Medical Research Council; National Research Foundation; Stellenbosch University (South Africa)	Flemish-South African bilateral; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation; Stellenbosch University (South Africa)	This work was supported in part by Flemish-South African bilateral agreement BIL99/39 and grants from the Medical Research Council, National Research Foundation, and Stellenbosch University (South Africa) (to A.L. and J.H.).	Adcock IM, 2000, PULM PHARMACOL THER, V13, P115, DOI 10.1006/pupt.2000.0243; ADELMAN JP, 1986, P NATL ACAD SCI USA, V83, P179, DOI 10.1073/pnas.83.1.179; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Beato M, 1996, ANN NY ACAD SCI, V784, P93, DOI 10.1111/j.1749-6632.1996.tb16231.x; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Bilodeau S, 2006, GENE DEV, V20, P2871, DOI 10.1101/gad.1444606; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; Carrigan A, 2007, J BIOL CHEM, V282, P10963, DOI 10.1074/jbc.M602931200; Chandran UR, 1999, J BIOL CHEM, V274, P2372, DOI 10.1074/jbc.274.4.2372; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Coghlan MJ, 2003, MOL ENDOCRINOL, V17, P860, DOI 10.1210/me.2002-0355; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Deak T, 1997, AM J PHYSIOL-REG I, V273, pR1998; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; DIAMONDSTONE TI, 1966, ANAL BIOCHEM, V16, P395, DOI 10.1016/0003-2697(66)90220-X; DROUIN J, 1989, MOL CELL BIOL, V9, P5305, DOI 10.1128/MCB.9.12.5305; Harnish DC, 2000, ENDOCRINOLOGY, V141, P3403, DOI 10.1210/en.141.9.3403; Hayashi R, 2004, EUR J PHARMACOL, V500, P51, DOI 10.1016/j.ejphar.2004.07.011; Ingenbleek Y, 1999, NUTRITION, V15, P305, DOI 10.1016/S0899-9007(99)00009-X; Jacobsen BM, 2009, MOL ENDOCRINOL, V23, P989, DOI 10.1210/me.2009-0048; KASTNER P, 1990, J BIOL CHEM, V265, P12163; Louw A, 1999, ENDOCRINOLOGY, V140, P2044, DOI 10.1210/en.140.5.2044; Louw A, 2000, BIOCHEM PHARMACOL, V59, P167, DOI 10.1016/S0006-2952(99)00302-0; Louw A, 1997, BIOCHEM PHARMACOL, V53, P189, DOI 10.1016/S0006-2952(96)00661-2; Louw A, 2000, ENDOCR RES, V26, P729, DOI 10.3109/07435800009048593; Martens C, 2005, MOL ENDOCRINOL, V19, P885, DOI 10.1210/me.2004-0333; McEwan IJ, 1997, BIOESSAYS, V19, P153, DOI 10.1002/bies.950190210; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Radoja N, 2000, MOL CELL BIOL, V20, P4328, DOI 10.1128/MCB.20.12.4328-4339.2000; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Reichardt HM, 2000, Z RHEUMATOL, V59, P1; RIGAUD G, 1991, CELL, V67, P977, DOI 10.1016/0092-8674(91)90370-E; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Sadie H, 2003, ENDOCRINOLOGY, V144, P1958, DOI 10.1210/en.2002-220874; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; Schacke H, 2004, P NATL ACAD SCI USA, V101, P227, DOI 10.1073/pnas.0300372101; Schacke H, 2002, E SCHERING RES FDN W, V40, P357; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schacke Heike, 2004, Curr Opin Investig Drugs, V5, P524; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; SMITH CL, 1992, ENDOCRINOLOGY, V130, P2245, DOI 10.1210/en.130.4.2245; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Sui XM, 1999, J BIOL CHEM, V274, P9449, DOI 10.1074/jbc.274.14.9449; Swart P, 2003, BIOESSAYS, V25, P612, DOI 10.1002/bies.10285; Tanner TM, 2003, MOL CELL ENDOCRINOL, V201, P155, DOI 10.1016/S0303-7207(02)00411-2; THERRIEN M, 1993, MOL CELL BIOL, V13, P2342, DOI 10.1128/MCB.13.4.2342; TRON L, 1984, BIOPHYS J, V45, P939, DOI 10.1016/S0006-3495(84)84240-X; UNDERHILL DA, 1995, GENE, V162, P205, DOI 10.1016/0378-1119(95)00337-6; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Verrijdt G, 2002, BIOCHEM J, V361, P97, DOI 10.1042/0264-6021:3610097; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Weatherman RV, 2002, MOL ENDOCRINOL, V16, P487, DOI 10.1210/me.16.3.487; Webster JC, 1999, TRENDS ENDOCRIN MET, V10, P396, DOI 10.1016/S1043-2760(99)00186-1; Yemelyanov A, 2008, CANCER RES, V68, P4763, DOI 10.1158/0008-5472.CAN-07-6104; Zhang ZR, 2009, J IMMUNOL, V183, P3081, DOI 10.4049/jimmunol.0901088; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006	68	58	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8061	8075		10.1074/jbc.M109.087866	http://dx.doi.org/10.1074/jbc.M109.087866			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20037160	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000275413800024
J	Hattori, T; Umetsu, M; Nakanishi, T; Togashi, T; Yokoo, N; Abe, H; Ohara, S; Adschiri, T; Kumagai, I				Hattori, Takamitsu; Umetsu, Mitsuo; Nakanishi, Takeshi; Togashi, Takanari; Yokoo, Nozomi; Abe, Hiroya; Ohara, Satoshi; Adschiri, Tadafumi; Kumagai, Izumi			High Affinity Anti-inorganic Material Antibody Generation by Integrating Graft and Evolution Technologies POTENTIAL OF ANTIBODIES AS BIOINTERFACE MOLECULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE PANCREAS RIBONUCLEASE; GOLD-BINDING POLYPEPTIDE; HUMAN-PLASMA ALBUMIN; MONOCLONAL-ANTIBODY; PROTEIN; DOMAIN; ADSORPTION; NANOPARTICLES; SELECTION; SURFACES	Recent advances in molecular evolution technology enabled us to identify peptides and antibodies with affinity for inorganic materials. In the field of nanotechnology, the use of the functional peptides and antibodies should aid the construction of interface molecules designed to spontaneously link different nanomaterials; however, few material-binding antibodies, which have much higher affinity than short peptides, have been identified. Here, we generated high affinity antibodies from material-binding peptides by integrating peptide-grafting and phage-display techniques. Amaterial-binding peptide sequence was first grafted into an appropriate loop of the complementarity determining region (CDR) of a camel-type single variable antibody fragment to create a low affinity material-binding antibody. Application of a combinatorial library approach to another CDR loop in the low affinity antibody then clearly and steadily promoted affinity for a specific material surface. Thermodynamic analysis demonstrated that the enthalpy synergistic effect from grafted and selected CDR loops drastically increased the affinity for material surface, indicating the potential of antibody scaffold for creating high affinity small interface units. We show the availability of the construction of antibodies by integrating graft and evolution technology for various inorganic materials and the potential of high affinity material-binding antibodies in biointerface applications.	[Hattori, Takamitsu; Umetsu, Mitsuo; Nakanishi, Takeshi; Kumagai, Izumi] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Umetsu, Mitsuo] Tohoku Univ, Interdisciplinary Res Ctr, Sendai, Miyagi 9808578, Japan; [Togashi, Takanari; Yokoo, Nozomi; Adschiri, Tadafumi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Abe, Hiroya; Ohara, Satoshi] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan	Tohoku University; Tohoku University; Tohoku University; Osaka University	Umetsu, M (corresponding author), Aoba 6-6-11-608,Aoba Ku, Sendai, Miyagi 9808579, Japan.	mitsuo@kuma.che.tohoku.ac.jp; kmiz@kuma.che.tohoku.ac.jp	Adschiri, Tadafumi/E-4867-2010; Ohara, Satoshi/ABA-4925-2020	Hattori, Takamitsu/0000-0002-5502-2595; Togashi, Takanari/0000-0001-9559-7791	Ministry of Education, Science, Sports and Culture of Japan; New Energy and Industrial Technology Development Organization of Japan; Japan Science and Technology of Japan; Japan Society for the Promotion of Science research; Hosokawa Foundation	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Japan Science and Technology of Japan; Japan Society for the Promotion of Science research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hosokawa Foundation	This work was supported by a scientific research grant from the Ministry of Education, Science, Sports and Culture of Japan (to M. U. and I. K.), the Industrial Technology Research Grant Program 2005 of the New Energy and Industrial Technology Development Organization of Japan (to M. U.), proposal-oriented research promotion program of Japan Science and Technology of Japan (to M. U.), Japan Society for the Promotion of Science research fellowships for young scientists (to T. H.), and in part by The Hosokawa Foundation (to M. U.).	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; BARBAS CF, 1993, P NATL ACAD SCI USA, V90, P6385, DOI 10.1073/pnas.90.14.6385; BARBAS CF, 1993, P NATL ACAD SCI USA, V90, P10003, DOI 10.1073/pnas.90.21.10003; Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269; Brown S, 2001, NANO LETT, V1, P391, DOI 10.1021/nl0155173; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Conrath K, 2005, J MOL BIOL, V350, P112, DOI 10.1016/j.jmb.2005.04.050; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Decanniere K, 1999, STRUCTURE, V7, P361, DOI 10.1016/S0969-2126(99)80049-5; Frederickson S, 2006, P NATL ACAD SCI USA, V103, P14307, DOI 10.1073/pnas.0602658103; Geva M, 2003, J AM CHEM SOC, V125, P696, DOI 10.1021/ja027942j; Habermuller L, 2000, FRESEN J ANAL CHEM, V366, P560; Hattori T, 2008, BIOCHEM BIOPH RES CO, V365, P751, DOI 10.1016/j.bbrc.2007.11.062; Itoh Y, 2002, BIOSCI BIOTECH BIOCH, V66, P1084, DOI 10.1271/bbb.66.1084; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kessler N, 1996, FASEB J, V10, P1435, DOI 10.1096/fasebj.10.12.8903514; Kramer RM, 2004, J AM CHEM SOC, V126, P13282, DOI 10.1021/ja046735b; Krauland EM, 2007, BIOTECHNOL BIOENG, V97, P1009, DOI 10.1002/bit.21341; Maenaka K, 1996, BIOCHEM BIOPH RES CO, V218, P682, DOI 10.1006/bbrc.1996.0122; Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Muyldermans S, 1999, J MOL RECOGNIT, V12, P131, DOI 10.1002/(SICI)1099-1352(199903/04)12:2<131::AID-JMR454>3.0.CO;2-M; Muyldermans S, 2001, J Biotechnol, V74, P277; Naik RR, 2002, NAT MATER, V1, P169, DOI 10.1038/nmat758; NORDE W, 1979, J COLLOID INTERF SCI, V71, P350, DOI 10.1016/0021-9797(79)90245-5; NORDE W, 1978, J COLLOID INTERF SCI, V66, P257, DOI 10.1016/0021-9797(78)90303-X; Park TJ, 2006, ANAL CHEM, V78, P7197, DOI 10.1021/ac060976f; Peelle BR, 2005, LANGMUIR, V21, P6929, DOI 10.1021/la050261s; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; Sano K, 2005, SMALL, V1, P826, DOI 10.1002/smll.200500010; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; SATO K, 1994, MOL IMMUNOL, V31, P371; Schembri MA, 1999, FEMS MICROBIOL LETT, V170, P363, DOI 10.1111/j.1574-6968.1999.tb13396.x; Schnirman AA, 2006, NANO LETT, V6, P1870, DOI 10.1021/nl0607636; Tamerler C, 2006, SMALL, V2, P1372, DOI 10.1002/smll.200600070; Tamerler C, 2006, LANGMUIR, V22, P7712, DOI 10.1021/la0606897; Thai CK, 2004, BIOTECHNOL BIOENG, V87, P129, DOI 10.1002/bit.20149; Umetsu M, 2005, ADV MATER, V17, P2571, DOI 10.1002/adma.200500863; Umetsu M, 2008, J MATER RES, V23, P3241, DOI 10.1557/JMR.2008.0401; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Watanabe H, 2007, BIOCONJUGATE CHEM, V18, P645, DOI 10.1021/bc060203y; Watanabe H, 2008, J BIOL CHEM, V283, P36031, DOI 10.1074/jbc.M805547200; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Woodbury RG, 1998, BIOSENS BIOELECTRON, V13, P1117, DOI 10.1016/S0956-5663(98)00060-8	46	23	28	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7784	7793		10.1074/jbc.M109.020156	http://dx.doi.org/10.1074/jbc.M109.020156			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20044483	Green Published, hybrid			2022-12-25	WOS:000275415600086
J	Shanahan, MT; Vidrich, A; Shirafuji, Y; Dubois, CL; Henschen-Edman, A; Hagen, SJ; Cohn, SM; Ouellette, AJ				Shanahan, Michael T.; Vidrich, Alda; Shirafuji, Yoshinori; Dubois, Claire L.; Henschen-Edman, Agnes; Hagen, Susan J.; Cohn, Steven M.; Ouellette, Andre J.			Elevated Expression of Paneth Cell CRS4C in Ileitis-prone SAMP1/YitFc Mice REGIONAL DISTRIBUTION, SUBCELLULAR LOCALIZATION, AND MECHANISM OF ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL HOST-DEFENSE; CYSTEINE-RICH PEPTIDES; MOUSE SMALL-INTESTINE; ALPHA-DEFENSINS; ANTIMICROBIAL PEPTIDES; MATRIX METALLOPROTEINASE-7; HUMAN-NEUTROPHILS; DISULFIDE ARRAY; GENE FAMILY; ACTIVATION	Paneth cells at the base of small intestinal crypts of Lieberkuhn secrete host defense peptides and proteins, including alpha-defensins, as mediators of innate immunity. Mouse Paneth cells also express alpha-defensin-related Defcr-rs genes that code for cysteine-rich sequence 4C (CRS4C) peptides that have a unique CPX triplet repeat motif. In ileitis-prone SAMP1/YitFc mice, Paneth cell levels of CRS4C mRNAs and peptides are induced more than a 1000-fold relative to non-prone strains as early as 4 weeks of age, with the mRNA and peptide levels highest in distal ileum and below detection in duodenum. CRS4C-1 peptides are found exclusively in Paneth cells where they occur only in dense core granules and thus are secreted to function in the intestinal lumen. CRS4C bactericidal peptide activity is membrane-disruptive in that it permeabilizes Escherichia coli and induces rapid microbial cell K+ efflux, but in a manner different from mouse alpha-defensin cryptdin-4. In in vitro studies, inactive pro-CRS4C-1 is converted to bactericidal CRS4C-1 peptide by matrix metalloproteinase-7 (MMP-7) proteolysis of the precursor proregion at the same residue positions that MMP-7 activates mouse pro-alpha-defensins. The absence of processed CRS4C in protein extracts of MMP-7-null mouse ileum demonstrates the in vivo requirement for intracellular MMP-7 in pro-CRS4C processing.	[Shanahan, Michael T.; Ouellette, Andre J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [Shirafuji, Yoshinori; Dubois, Claire L.; Ouellette, Andre J.] Univ Calif Irvine, Dept Pathol & Lab Med, Sch Med, Coll Hlth Sci, Irvine, CA 92697 USA; [Henschen-Edman, Agnes] Univ Calif Irvine, Dept Mol Biol & Biochem, Sch Biol Sci, Irvine, CA 92697 USA; [Vidrich, Alda; Cohn, Steven M.] Univ Virginia, Digest Hlth Ctr Excellence, Charlottesville, VA 22908 USA; [Hagen, Susan J.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Virginia; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ouellette, AJ (corresponding author), Univ So Calif, Dept Pathol & Lab Med, Keck Sch Med, USC Norris Canc Ctr, NRT-7514 Mailcode 9601,1450 Biggy St, Los Angeles, CA 90089 USA.	andre.ouellette@med.usc.edu			National Institutes of Health [R01 DK044632, R01 AI059346, R01 DK064751, P01 DK57880]; Human Frontiers Science Program; Molecular Biology and Morphology Cores of the University of Virginia National Institutes Diabetes and Digestive and Kidney Diseases/National Institutes of Health Digestive Diseases Research Core Center [P30 DK067629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057880, R01DK044632, R01DK064751, P30DK067629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Molecular Biology and Morphology Cores of the University of Virginia National Institutes Diabetes and Digestive and Kidney Diseases/National Institutes of Health Digestive Diseases Research Core Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK044632 and R01 AI059346 and by the Human Frontiers Science Program ( to A.J.O.) and by National Institutes of Health Grants R01 DK064751 and P01 DK57880 ( to S. M. C.) and through the Molecular Biology and Morphology Cores of the University of Virginia National Institutes Diabetes and Digestive and Kidney Diseases/National Institutes of Health Digestive Diseases Research Core Center Grant P30 DK067629.	Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Barnes SL, 2007, J IMMUNOL, V179, P7012, DOI 10.4049/jimmunol.179.10.7012; Baroncelli S, 2007, AIDS RES HUM RETROV, V23, P287, DOI 10.1089/aid.2006.0142; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Clarke LL, 2004, AM J PHYSIOL-GASTR L, V286, pG1050, DOI 10.1152/ajpgi.00393.2003; Elphick D, 2008, AM J PATHOL, V172, P702, DOI 10.2353/ajpath.2008.070755; Figueredo SM, 2009, J BIOL CHEM, V284, P6826, DOI 10.1074/jbc.M807024200; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; GANZ T, 1993, BLOOD, V82, P641; Ge YB, 1997, ARCH HISTOL CYTOL, V60, P133; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Hadjicharalambous C, 2008, BIOCHEMISTRY-US, V47, P12626, DOI 10.1021/bi800335e; HAGEN SJ, 1990, J ELECTRON MICR TECH, V16, P37, DOI 10.1002/jemt.1060160106; HARWIG SSL, 1993, ANAL BIOCHEM, V208, P382, DOI 10.1006/abio.1993.1065; Hornef MW, 2004, NAT IMMUNOL, V5, P836, DOI 10.1038/ni1094; Hristova K, 1996, BIOCHEMISTRY-US, V35, P11888, DOI 10.1021/bi961100d; HUTTNER KM, 1994, GENOMICS, V19, P448, DOI 10.1006/geno.1994.1093; HUTTNER KM, 1994, GENOMICS, V24, P99, DOI 10.1006/geno.1994.1586; Kamdar K, 2008, J BIOL CHEM, V283, P32361, DOI 10.1074/jbc.M805296200; Karlsson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-37; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; LAMBERT PA, 1973, BIOCHEM BIOPH RES CO, V54, P796, DOI 10.1016/0006-291X(73)91494-0; LEHRER RI, 1988, J IMMUNOL METHODS, V108, P153, DOI 10.1016/0022-1759(88)90414-0; Lehrer RI, 2007, CURR OPIN HEMATOL, V14, P16, DOI 10.1097/00062752-200701000-00005; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; MICHAELSON D, 1992, J LEUKOCYTE BIOL, V51, P634, DOI 10.1002/jlb.51.6.634; Miszta A, 2008, J PEPT SCI, V14, P503, DOI 10.1002/psc.938; Mukherjee S, 2008, CELL MOL LIFE SCI, V65, P3019, DOI 10.1007/s00018-008-8182-3; Orlov DS, 2002, J MICROBIOL METH, V49, P325, DOI 10.1016/S0167-7012(01)00383-9; Ouellette AJ, 1999, INFECT IMMUN, V67, P6643; Ouellette AJ, 2000, J BIOL CHEM, V275, P33969, DOI 10.1074/jbc.M004062200; OUELLETTE AJ, 1994, INFECT IMMUN, V62, P5040, DOI 10.1128/IAI.62.11.5040-5047.1994; Ouellette AJ, 1996, FASEB J, V10, P1280, DOI 10.1096/fasebj.10.11.8836041; OUELLETTE AJ, 1990, J BIOL CHEM, V265, P9831; Patil A, 2004, PHYSIOL GENOMICS, V20, P1, DOI 10.1152/physiolgenomics.00150.2004; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; RICE WG, 1987, BLOOD, V70, P757; Rivera-Nieves J, 2003, GASTROENTEROLOGY, V124, P972, DOI 10.1053/gast.2003.50148; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; Satchell DP, 2003, J BIOL CHEM, V278, P13838, DOI 10.1074/jbc.M212115200; Schutte BC, 2002, ANNU REV PHYSIOL, V64, P709, DOI 10.1146/annurev.physiol.64.081501.134340; Selsted M E, 1993, Genet Eng (N Y), V15, P131; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; SELSTED ME, 1989, J BIOL CHEM, V264, P4003; Selsted ME, 2007, CURR PHARM DESIGN, V13, P3061, DOI 10.2174/138161207782110363; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Stappenbeck TS, 2009, GASTROENTEROLOGY, V137, P30, DOI 10.1053/j.gastro.2009.05.013; Tanabe H, 2004, INFECT IMMUN, V72, P1470, DOI 10.1128/IAI.72.3.1470-1478.2004; Tincu JA, 2003, J BIOL CHEM, V278, P13546, DOI 10.1074/jbc.M211332200; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; VALORE EV, 1992, BLOOD, V79, P1538; Vidrich A, 2005, AM J PATHOL, V166, P1055, DOI 10.1016/S0002-9440(10)62326-7; Wang MSC, 1997, ANAL BIOCHEM, V253, P225, DOI 10.1006/abio.1997.2347; Weeks CS, 2006, J BIOL CHEM, V281, P28932, DOI 10.1074/jbc.M602041200; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Wu ZB, 2007, J MOL BIOL, V368, P537, DOI 10.1016/j.jmb.2007.02.040	69	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7493	7504		10.1074/jbc.M109.083220	http://dx.doi.org/10.1074/jbc.M109.083220			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056603	Green Published, hybrid			2022-12-25	WOS:000275415600061
J	Umehara, T; Nakamura, Y; Jang, MK; Nakano, K; Tanaka, A; Ozato, K; Padmanabhan, B; Yokoyama, S				Umehara, Takashi; Nakamura, Yoshihiro; Jang, Moon Kyoo; Nakano, Kazumi; Tanaka, Akiko; Ozato, Keiko; Padmanabhan, Balasundaram; Yokoyama, Shigeyuki			Structural Basis for Acetylated Histone H4 Recognition by the Human BRD2 Bromodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CHROMATIN; BINDING; PROTEIN; CHROMOSOMES; NUCLEOSOME; INSIGHTS; PARTICLE	Recognition of acetylated chromatin by the bromodomains and extra-terminal domain (BET) family proteins is a hallmark for transcriptional activation and anchoring viral genomes to mitotic chromosomes of the host. One of the BET family proteins BRD2 interacts with acetylated chromatin during mitosis and leads to transcriptional activation in culture cells. Here, we report the crystal structures of the N-terminal bromodomain of human BRD2 (BRD2-BD1; residues 74-194) in complex with each of three different Lys-12-acetylated H4 peptides. The BRD2-BD1 recognizes the H4 tail acetylated at Lys-12 (H4K12ac), whereas the side chain of hypoacetylated Lys-8 of H4 binds at the cavity of the dimer interface of BRD2-BD1. From binding studies, we identified the BRD2-BD1 residues that are responsible for recognition of the Lys-12-acetylated H4 tail. In addition, mutationto Lys-8 in the Lys-12-acetylated H4 tail decreased the binding to BRD2-BD1, implicating the critical role of Lys-8 in the Lys-12-acetylated H4 tail for the recognition by BRD2-BD1. Our findings provide a structural basis for deciphering the histone code by the BET bromodomain through the binding with a long segment of the histone H4 tail, which presumably prevents erasure of the histone code during the cell cycle.	[Padmanabhan, Balasundaram; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Jang, Moon Kyoo; Ozato, Keiko] NICHHD, Dept Mol Growth Regulat, Natl Inst Hlth, Bethesda, MD 20892 USA; [Yokoyama, Shigeyuki] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Tokyo	Padmanabhan, B (corresponding author), Aptuit Laurus Pvt, ICICI Knowledge Pk, Hyderabad 500078, Andhra Pradesh, India.	paddy.b@aptuitlaurus.com; yokoyama@biochem.s.u-tokyo.ac.jp	Umehara, Takashi/AHB-1730-2022; Umehara, Takashi/N-5683-2015; Yokoyama, Shigeyuki/N-6911-2015	Umehara, Takashi/0000-0003-3464-2960; Umehara, Takashi/0000-0003-3464-2960; Yokoyama, Shigeyuki/0000-0003-3133-7338; Jang, Moon Kyoo/0000-0002-1657-2877	National Institutes of Health; National Institute of Biomedical Innovation; RIKEN Structural Genomics/Proteomics Initiative; Ministry of Education, Culture, Sports, Science and Technology of Japan	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); RIKEN Structural Genomics/Proteomics Initiative; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, by the RIKEN Structural Genomics/Proteomics Initiative, and the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Denis GV, 2001, FRONT BIOSCI, V6, pD1065; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Huang HD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-57; Hudson BP, 2000, J MOL BIOL, V304, P355, DOI 10.1006/jmbi.2000.4207; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Liu Y, 2008, BIOCHEMISTRY-US, V47, P6403, DOI 10.1021/bi8001659; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Nakamura Y, 2007, J BIOL CHEM, V282, P4193, DOI 10.1074/jbc.M605971200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sasaki K, 2009, P NATL ACAD SCI USA, V106, P16257, DOI 10.1073/pnas.0902150106; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Viejo-Borbolla A, 2005, J VIROL, V79, P13618, DOI 10.1128/JVI.79.21.13618-13629.2005; Wang FN, 2010, BIOCHEM J, V425, P71, DOI 10.1042/BJ20090928; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	41	85	91	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7610	7618		10.1074/jbc.M109.062422	http://dx.doi.org/10.1074/jbc.M109.062422			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048151	Green Published, hybrid			2022-12-25	WOS:000275415600072
J	Ahmed, SM; Daulat, AM; Meunier, A; Angers, S				Ahmed, Syed M.; Daulat, Avais M.; Meunier, Alexandre; Angers, Stephane			G Protein beta gamma Subunits Regulate Cell Adhesion through Rap1a and Its Effector Radil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN CONFORMATION; SIGNALING PATHWAYS; PROSTATE-CANCER; SMALL GTPASE; ACTIVATION; RECEPTORS; MIGRATION; ROLES; INFLAMMATION; POLARIZATION	The activation of several G protein-coupled receptors is known to regulate the adhesive properties of cells in different contexts. Here, we reveal that G beta gamma subunits of heterotrimeric G proteins regulate cell-matrix adhesiveness by activating Rap1a-dependent inside-out signals and integrin activation. We show that G beta gamma subunits enter in a protein complex with activated Rap1a and its effector Radil and establish that this complex is required downstream of receptor stimulation for the activation of integrins and the positive modulation of cell-matrix adhesiveness. Moreover, we demonstrate that G beta gamma and activated Rap1a promote the translocation of Radil to the plasma membrane at sites of cell-matrix contacts. These results add to the molecular understanding of how G protein-coupled receptors impinge on cell adhesion and suggest that the G beta gamma.Rap1.Radil complex plays important roles in this process.	[Ahmed, Syed M.; Daulat, Avais M.; Meunier, Alexandre; Angers, Stephane] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada; [Angers, Stephane] Univ Toronto, Dept Biochem, Fac Med, Toronto, ON M5S 3M2, Canada	University of Toronto; University of Toronto	Angers, S (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, 144 Coll St, Toronto, ON M5S 3M2, Canada.	stephane.angers@utoronto.ca	Angers, Stephane/E-1432-2014; Ahmed, Mukhtar/ABE-8477-2020	Angers, Stephane/0000-0001-7241-9044; Ahmed, Syed Mukhtar/0000-0002-9183-9957; Daulat, Avais/0000-0002-3076-2132	Natural Sciences and Engineering Research Council; Ontario Graduate Scholarship in Science and Technology	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship in Science and Technology	Supported by an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council and recipient of an Ontario Graduate Scholarship in Science and Technology.	Alon R, 2008, CURR OPIN CELL BIOL, V20, P525, DOI 10.1016/j.ceb.2008.04.003; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Bos JL, 1997, FEBS LETT, V410, P59, DOI 10.1016/S0014-5793(97)00324-4; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Carey KD, 2000, MOL CELL BIOL, V20, P8409, DOI 10.1128/MCB.20.22.8409-8419.2000; Carmona G, 2008, BLOOD, V111, P2640, DOI 10.1182/blood-2007-04-086231; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Druey KM, 2009, IMMUNOL RES, V43, P62, DOI 10.1007/s12026-008-8050-0; Dupre DJ, 2007, J BIOL CHEM, V282, P13703, DOI 10.1074/jbc.M608846200; Durand CA, 2006, EUR J IMMUNOL, V36, P2235, DOI 10.1002/eji.200535004; Etzioni A, 2004, CURR OPIN ALLERGY CL, V4, P485, DOI 10.1097/00130832-200412000-00003; Faivre S, 2001, MOL PHARMACOL, V60, P363, DOI 10.1124/mol.60.2.363; Feller SM, 1998, J CELL PHYSIOL, V177, P535, DOI 10.1002/(SICI)1097-4652(199812)177:4<535::AID-JCP5>3.3.CO;2-5; Fraser CC, 2008, INT REV IMMUNOL, V27, P320, DOI 10.1080/08830180802262765; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Hao JJ, 2008, J PROTEOME RES, V7, P2911, DOI 10.1021/pr800016a; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Humrich J, 2005, J BIOL CHEM, V280, P20042, DOI 10.1074/jbc.M409233200; Itoh M, 2007, CANCER RES, V67, P4759, DOI 10.1158/0008-5472.CAN-06-4246; Jeon TJ, 2007, J CELL BIOL, V179, P833, DOI 10.1083/jcb.200705068; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Komarova Yulia A, 2007, Sci STKE, V2007, pre8; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lafuente EM, 2007, LEUKEMIA LYMPHOMA, V48, P987, DOI 10.1080/10428190701242341; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li Y, 2006, J BIOL CHEM, V281, P2506, DOI 10.1074/jbc.M508165200; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; N'Diaye EN, 2003, J CELL BIOL, V163, P1157, DOI 10.1083/jcb.200307155; Nellore A, 2009, J CLIN ENDOCR METAB, V94, P1026, DOI 10.1210/jc.2008-1042; Niggli V, 2009, BIOCHEM BIOPH RES CO, V386, P688, DOI 10.1016/j.bbrc.2009.06.098; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Savli H, 2008, EXP MOL MED, V40, P176, DOI 10.3858/emm.2008.40.2.176; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Smolen GA, 2007, GENE DEV, V21, P2131, DOI 10.1101/gad.1561507; SNYDERMAN R, 1981, SCIENCE, V213, P830, DOI 10.1126/science.6266014; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Su L, 2003, J BIOL CHEM, V278, P15232, DOI 10.1074/jbc.M211888200; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Till KJ, 2008, CANCER RES, V68, P8429, DOI 10.1158/0008-5472.CAN-08-1758; Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004; Tsygankova OA, 2007, MOL CELL BIOL, V27, P6647, DOI 10.1128/MCB.00155-07; VanCompernolle SE, 2003, J IMMUNOL, V171, P2050, DOI 10.4049/jimmunol.171.4.2050; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001; Zhang LZ, 2006, CANCER RES, V66, P898, DOI 10.1158/0008-5472.CAN-05-3025; Zhang ZC, 2005, J BIOL CHEM, V280, P33200, DOI 10.1074/jbc.M505057200	79	38	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6538	6551		10.1074/jbc.M109.069948	http://dx.doi.org/10.1074/jbc.M109.069948			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20048162	Green Published, hybrid			2022-12-25	WOS:000275367500059
J	Nilsson, SC; Nita, I; Mansson, L; Groeneveld, TWL; Trouw, LA; Villoutreix, BO; Blom, AM				Nilsson, Sara C.; Nita, Izabela; Mansson, Lisa; Groeneveld, Tom W. L.; Trouw, Leendert A.; Villoutreix, Bruno O.; Blom, Anna M.			Analysis of Binding Sites on Complement Factor I That Are Required for Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; CONFORMATIONAL-CHANGES; C4B-BINDING PROTEIN; C-3 CONVERTASE; X-RAY; CLEAVAGE; COFACTOR; C3B; SUSCEPTIBILITY; PURIFICATION	The central complement inhibitor factor I (FI) degrades activated complement factors C4b and C3b in the presence of cofactors such as C4b-binding protein, factor H, complement receptor 1, and membrane cofactor protein. FI is a serine protease composed of two chains. The light chain comprises the serine protease domain, whereas the heavy chain contains several domains; that is, the FI and membrane attack complex domain (FIMAC), CD5, low density lipoprotein receptor 1 (LDLr1) and LDLr2 domains. To understand better how FI acts as a complement inhibitor, we used homology-based models of FI domains to predict potential binding sites. Specific amino acids were then mutated to yield 16 well expressed mutants, which were then purified from media of eukaryotic cells for functional analyses. The Michaelis constant (K-m) of all FI mutants toward a small substrate was not altered, whereas some mutants showed increased maximum initial velocity (V-max). All the mutations in the FIMAC domain affected the ability of FI to degrade C4b and C3b irrespective of the cofactor used, whereas only some mutations in the CD5 and LDLr1/2 domains had a similar effect. These same mutants also showed impaired binding to C3met. In conclusion, the FIMAC domain appears to harbor the main binding sites important for the ability of FI to degrade C4b and C3b.	[Blom, Anna M.] Lund Univ, Malmo Univ Hosp, Dept Lab Med, S-20502 Malmo, Sweden; [Trouw, Leendert A.] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands; [Villoutreix, Bruno O.] Univ Paris Diderot, INSERM, MTi U973, F-75205 Paris, France	Lund University; Skane University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Blom, AM (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Lab Med, S-20502 Malmo, Sweden.	Anna.Blom@med.lu.se	Villoutreix, Bruno/I-4565-2015; Blom, Anna/AFS-7369-2022; Trouw, Leendert/AGK-5202-2022; Blom, Anna/B-9607-2009	Villoutreix, Bruno/0000-0002-6456-7730; Trouw, Leendert/0000-0001-5186-2290; Blom, Anna/0000-0002-1348-1734; Groeneveld, Tom/0000-0002-9095-3280	United States Immunodeficiency Network; Swedish Research Council; Soderberg Foundation; Swedish Foundation for Strategic Research; Foundations of Osterlund	United States Immunodeficiency Network; Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Foundations of Osterlund	This work was supported by the United States Immunodeficiency Network, the Swedish Research Council, the Soderberg Foundation, the Swedish Foundation for Strategic Research, and the Foundations of Osterlund, Greta and Johan Kock, Knut and Alice Wallenberg, and Inga-Britt and Arne Lundberg.	ADAMS EM, 1991, J IMMUNOL, V147, P3005; Amadei N, 2001, SCAND J IMMUNOL, V53, P615, DOI 10.1046/j.1365-3083.2001.00931.x; Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Chamberlain D, 1998, BIOCHEMISTRY-US, V37, P13918, DOI 10.1021/bi9805184; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DISCIPIO RG, 1992, J IMMUNOL, V149, P2592; EKDAHL KN, 1990, J IMMUNOL, V144, P4269; FEARON DT, 1979, P NATL ACAD SCI USA, V76, P5867, DOI 10.1073/pnas.76.11.5867; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Fremeaux-Bacchi V, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019083; GIGLI I, 1979, P NATL ACAD SCI USA, V76, P6596, DOI 10.1073/pnas.76.12.6596; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; ISENMAN DE, 1983, J BIOL CHEM, V258, P4238; Kavanagh D, 2008, MOL IMMUNOL, V45, P95, DOI 10.1016/j.molimm.2007.05.004; Krych M, 1998, J BIOL CHEM, V273, P8623, DOI 10.1074/jbc.273.15.8623; MEDOF ME, 1984, J EXP MED, V159, P1669, DOI 10.1084/jem.159.6.1669; Miteva MA, 2005, NUCLEIC ACIDS RES, V33, pW372, DOI 10.1093/nar/gki365; Nilsson SC, 2007, MOL IMMUNOL, V44, P1835, DOI 10.1016/j.molimm.2006.10.005; Nilsson SC, 2010, EUR J IMMUNOL, V40, P172, DOI 10.1002/eji.200939280; Nilsson SC, 2009, EUR J IMMUNOL, V39, P310, DOI 10.1002/eji.200838702; Okroj M, 2008, MOL IMMUNOL, V45, P169, DOI 10.1016/j.molimm.2007.04.025; PERKINS SJ, 1993, BIOCHEM J, V295, P101, DOI 10.1042/bj2950101; Sadallah S, 1999, AM J KIDNEY DIS, V33, P1153, DOI 10.1016/S0272-6386(99)70155-1; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Spiller OB, 2003, J BIOL CHEM, V278, P9283, DOI 10.1074/jbc.M211579200; Thai CT, 2005, J IMMUNOL, V174, P6227, DOI 10.4049/jimmunol.174.10.6227; Tsiftsoglou SA, 2005, BIOCHEMISTRY-US, V44, P6239, DOI 10.1021/bi047680t; Tsiftsoglou SA, 2004, J IMMUNOL, V173, P367, DOI 10.4049/jimmunol.173.1.367; Tsiftsoglou SA, 2006, BBA-PROTEINS PROTEOM, V1764, P1757, DOI 10.1016/j.bbapap.2006.09.007; Vyse TJ, 1996, J CLIN INVEST, V97, P925, DOI 10.1172/JCI118515; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	36	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6235	6245		10.1074/jbc.M109.097212	http://dx.doi.org/10.1074/jbc.M109.097212			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20044478	Green Published, hybrid			2022-12-25	WOS:000275367500028
J	Sensken, SC; Graler, MH				Sensken, Sven-Christian; Graeler, Markus H.			Down- regulation of S1P(1) Receptor Surface Expression by Protein Kinase C Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; LYMPHOCYTE EGRESS; COUPLED RECEPTORS; RENAL-TRANSPLANTATION; THYMOCYTE EMIGRATION; DRUG FTY720; T-CELLS; IN-VIVO; SPHINGOSINE-1-PHOSPHATE; AGONISTS	The sphingosine 1-phosphate receptor type 1 (S1P(1)) is important for the maintenance of lymphocyte circulation. S1P(1) receptor surface expression on lymphocytes is critical for their egress from thymus and lymph nodes. Premature activation-induced internalization of the S1P(1) receptor in lymphoid organs, mediated either by pharmacological agonists or by inhibition of the S1P degrading enzyme S1P-lyase, blocks lymphocyte egress and induces lymphopenia in blood and lymph. Regulation of S1P(1) receptor surface expression is therefore a promising way to control adaptive immunity. Hence, we analyzed potential cellular targets for their ability to alter S1P(1) receptor surface expression without stimulation. The initial observation that preincubation of mouse splenocytes with its natural analog sphingosine was sufficient to block Transwell(TM) chemotaxis to S1P directed subsequent investigations to the underlying mechanism. Sphingosine is known to inhibit protein kinase C (PKC), and PKC inhibition with nanomolar concentrations of staurosporine, calphostin C, and GF109203X down-regulated surface expression of S1P(1) but not S1P(4) in transfected rat hepatoma HTC4 cells. The PKC activator phorbol 12-myristate 13-acetate partially rescued FTY720-induced down-regulation of the S1P(1) receptor, linking PKC activation with S1P(1) receptor surface expression. FTY720, but not FTY720 phosphate, efficiently inhibited PKC. Cell-based efficacy was obvious with 10 nM FTY720, and in vivo treatment of mice with 0.3-3 mg/kg/day FTY720 showed increasing concentration-dependent effectiveness. PKC inhibition therefore may contribute to lymphopenia by down-regulating S1P(1) receptor cell surface expression independently from its activation.	[Sensken, Sven-Christian; Graeler, Markus H.] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany	Hannover Medical School	Graler, MH (corresponding author), Hannover Med Sch, Inst Immunol, Bldg K11,OE 9422,Carl Neuberg Str 1, D-30625 Hannover, Germany.	graeler.markus@mh-hannover.de	Gräler, Markus/ABH-1905-2021	Gräler, Markus/0000-0001-6650-7849	Deutsche Forschungsgemeinschaft [1943/1-4]; Priority Program 1267 [GR-1943/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Priority Program 1267	This work was supported by Deutsche Forschungsgemeinschaft Grants GR-1943/1-4 of the Emmy Noether Program and GR-1943/2-1 of Priority Program 1267 "Sphingolipids: Signal and Disease."	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Bandhuvula P, 2005, J BIOL CHEM, V280, P33697, DOI 10.1074/jbc.C500294200; BAZZI MD, 1987, BIOCHEM BIOPH RES CO, V146, P203, DOI 10.1016/0006-291X(87)90711-X; Berdyshev EV, 2009, J BIOL CHEM, V284, P5467, DOI 10.1074/jbc.M805186200; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Budde K, 2006, CLIN TRANSPLANT, V20, P17, DOI 10.1111/j.1399-0012.2006.00596.x; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Foss FW, 2007, BIOORGAN MED CHEM, V15, P663, DOI 10.1016/j.bmc.2006.10.060; Graeler MH, 2003, J BIOL CHEM, V278, P27737, DOI 10.1074/jbc.C300147200; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1989, CLIN CHIM ACTA, V185, P333, DOI 10.1016/0009-8981(89)90224-6; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Lee TK, 2005, CLIN CANCER RES, V11, P8458, DOI 10.1158/1078-0432.CCR-05-0447; Leitges M, 2007, BIOCHEM SOC T, V35, P1018, DOI 10.1042/BST0351018; Liao JJ, 2007, J BIOL CHEM, V282, P1964, DOI 10.1074/jbc.M608597200; Liu Q, 2008, BLOOD, V111, P275, DOI 10.1182/blood-2006-10-053884; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; O'Brien N, 2009, J LIPID RES, V50, P2245, DOI 10.1194/jlr.M900048-JLR200; O'Connor P, 2009, NEUROLOGY, V72, P73, DOI 10.1212/01.wnl.0000338569.32367.3d; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Payne SG, 2007, BLOOD, V109, P1077, DOI 10.1182/blood-2006-03-011437; Peest U, 2008, J CELL BIOCHEM, V104, P756, DOI 10.1002/jcb.21665; Premenko-Lanier M, 2008, NATURE, V454, P894, DOI 10.1038/nature07199; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sensken SC, 2009, J PHARMACOL EXP THER, V328, P963, DOI 10.1124/jpet.108.148163; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sinha RK, 2009, IMMUNITY, V30, P434, DOI 10.1016/j.immuni.2008.12.018; Tedesco-Silva H, 2007, TRANSPLANTATION, V84, P885, DOI 10.1097/01.tp.0000281385.26500.3b; Vessey DA, 2007, J BIOCHEM MOL TOXIC, V21, P273, DOI 10.1002/jbt.20193; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; WALTON GM, 1987, ANAL BIOCHEM, V161, P425, DOI 10.1016/0003-2697(87)90471-4; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200; Weber C, 2009, J IMMUNOL, V183, P4292, DOI 10.4049/jimmunol.0901724; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628; 2009, NAT REV DRUG DISCOV, V8, P98	46	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6298	6307		10.1074/jbc.M109.049692	http://dx.doi.org/10.1074/jbc.M109.049692			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032465	hybrid, Green Published			2022-12-25	WOS:000275367500034
J	Manna, PT; Smith, AJ; Taneja, TK; Howell, GJ; Lippiat, JD; Sivaprasadarao, A				Manna, Paul T.; Smith, Andrew J.; Taneja, Tarvinder K.; Howell, Gareth J.; Lippiat, Jonathan D.; Sivaprasadarao, Asipu			Constitutive Endocytic Recycling and Protein Kinase C-mediated Lysosomal Degradation Control K-ATP Channel Surface Density	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; SENSITIVE POTASSIUM CHANNELS; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; SULFONYLUREA RECEPTOR; INSULIN-SECRETION; ACTIVATING MUTATIONS; TRAFFICKING; GLUCOSE; RAT; MODULATION	Pancreatic ATP-sensitive potassium (K-ATP) channels control insulin secretion by coupling the excitability of the pancreatic beta-cell to glucose metabolism. Little is currently known about how the plasma membrane density of these channels is regulated. We therefore set out to examine in detail the endocytosis and recycling of these channels and how these processes are regulated. To achieve this goal, we expressed K-ATP channels bearing an extracellular hemagglutinin epitope in human embryonic kidney cells and followed their fate along the endocytic pathway. Our results show that K-ATP channels undergo multiple rounds of endocytosis and recycling. Further, activation of protein kinase C (PKC) with phorbol 12-myristate 13-acetate significantly decreases K-ATP channel surface density by reducing channel recycling and diverting the channel to lysosomal degradation. These findings were recapitulated in the model pancreatic beta-cell line INS1e, where activation of PKC leads to a decrease in the surface density of native K-ATP channels. Because sorting of internalized channels between lysosomal and recycling pathways could have opposite effects on the excitability of pancreatic beta-cells, we propose that PKC-regulated K-ATP channel trafficking may play a role in the regulation of insulin secretion.	[Manna, Paul T.; Smith, Andrew J.; Taneja, Tarvinder K.; Howell, Gareth J.; Lippiat, Jonathan D.; Sivaprasadarao, Asipu] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Multidisciplinary Cardiovasc Res Ctr, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Sivaprasadarao, A (corresponding author), Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Multidisciplinary Cardiovasc Res Ctr, Leeds LS2 9JT, W Yorkshire, England.	a.sivaprasadarao@leeds.ac.uk		Lippiat, Jonathan/0000-0003-3748-7345; Sivaprasadarao, Asipu/0000-0002-6755-3502; Manna, Paul Thomas/0000-0002-2260-2075	Medical Research Council, United Kingdom; BBSRC [BB/D524875/1] Funding Source: UKRI; MRC [G0802050] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524875/1] Funding Source: researchfish; Medical Research Council [G0802050] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council, United Kingdom.	ASHCROFT FM, 1988, J PHYSIOL-LONDON, V400, P501, DOI 10.1113/jphysiol.1988.sp017134; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cartier EA, 2003, J BIOL CHEM, V278, P7081, DOI 10.1074/jbc.M211395200; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Crane A, 2004, J BIOL CHEM, V279, P9080, DOI 10.1074/jbc.M311079200; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; Garg V, 2007, AM J PHYSIOL-HEART C, V293, pH322, DOI 10.1152/ajpheart.01035.2006; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gong Q, 2007, J BIOL CHEM, V282, P13087, DOI 10.1074/jbc.M700767200; Harris TE, 1996, BIOCHEM BIOPH RES CO, V227, P672, DOI 10.1006/bbrc.1996.1567; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jiao JD, 2008, HYPERTENSION, V52, P499, DOI 10.1161/HYPERTENSIONAHA.108.110817; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kwon SH, 2004, P NATL ACAD SCI USA, V101, P15237, DOI 10.1073/pnas.0404877101; Lim A, 2009, DIABETES, V58, P2813, DOI 10.2337/db09-0600; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Mankouri J, 2006, EMBO J, V25, P4142, DOI 10.1038/sj.emboj.7601275; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nesher R, 2002, DIABETES, V51, pS68, DOI 10.2337/diabetes.51.2007.S68; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Partridge CJ, 2001, J BIOL CHEM, V276, P35947, DOI 10.1074/jbc.M104762200; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Shyng SL, 1998, DIABETES, V47, P1145, DOI 10.2337/diabetes.47.7.1145; Sivaprasadarao A, 2007, BIOCHEM SOC T, V35, P1055, DOI 10.1042/BST0351055; Taneja TK, 2009, HUM MOL GENET, V18, P2400, DOI 10.1093/hmg/ddp179; Uchida T, 2007, J BIOL CHEM, V282, P2707, DOI 10.1074/jbc.M610482200; Warwar N, 2006, DIABETES, V55, P590, DOI 10.2337/diabetes.55.03.06.db05-0001; Warwar N, 2008, BBA-MOL CELL RES, V1783, P1929, DOI 10.1016/j.bbamcr.2008.04.007; WILEMAN T, 1984, BIOCHEM J, V220, P665, DOI 10.1042/bj2200665; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Yan FF, 2006, J BIOL CHEM, V281, P33403, DOI 10.1074/jbc.M605195200; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang H, 2004, J PHYSIOL-LONDON, V561, P133, DOI 10.1113/jphysiol.2004.071241	45	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5963	5973		10.1074/jbc.M109.066902	http://dx.doi.org/10.1074/jbc.M109.066902			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20026601	Green Published, hybrid			2022-12-25	WOS:000275327200086
J	Quinn, BA; Brake, T; Hua, X; Baxter-Jones, K; Litwin, S; Ellenson, LH; Connolly, DC				Quinn, Bridget A.; Brake, Tiffany; Hua, Xiang; Baxter-Jones, Kimberly; Litwin, Samuel; Ellenson, Lora Hedrick; Connolly, Denise C.			Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and p53	PLOS ONE			English	Article							MULTIPLE GENETIC CHANGES; SEROUS CARCINOMA; MOUSE MODEL; CANDIDATE PRECURSOR; CANCER; TUMORIGENESIS; MUTATIONS; MODULATION; EXPRESSION; FREQUENCY	Background: Approximately one out of every ten cases of epithelial ovarian cancer (EOC) is inherited. The majority of inherited cases of EOC result from mutations in the breast cancer associated gene 1 (BRCA1). In addition to mutation of BRCA1, mutation of the p53 gene is often found in patients with inherited breast and ovarian cancer syndrome. Methodology/Principal Findings: We investigated the role of loss of function of BRCA1 and p53 in ovarian cancer development using mouse models with conditionally expressed alleles of Brca1 and/or p53. Our results show that ovary-specific Cre-recombinase-mediated conditional inactivation of both Brca1(LoxP/LoxP) and p53(LoxP/LoxP) resulted in ovarian or reproductive tract tumor formation in 54% of mice, whereas conditional inactivation of either allele alone infrequently resulted in tumors (<= 55% of mice). In mice with conditionally inactivated Brca1(LoxP/LoxP) and p53(LoxP/LoxP), ovarian tumors arose after long latency with the majority exhibiting histological features consistent with high grade leiomyosarcomas lacking expression of epithelial, follicular or lymphocyte markers. In addition, tumors with conditional inactivation of both Brca1(LoxP/LoxP) and p53(LoxP/LoxP) exhibited greater genomic instability compared to an ovarian tumor with inactivation of only p53(LoxP/LoxP). Conclusions/Significance: Although conditional inactivation of both Brca1 and p53 results in ovarian tumorigenesis, our results suggest that additional genetic alterations or alternative methods for targeting epithelial cells of the ovary or fallopian tube for conditional inactivation of Brca1 and p53 are required for the development of a mouse model of Brca1-associated inherited EOC.	[Quinn, Bridget A.; Brake, Tiffany; Hua, Xiang; Baxter-Jones, Kimberly; Litwin, Samuel; Connolly, Denise C.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Ellenson, Lora Hedrick] Cornell Univ, Weil Med Coll, NewYork Presbyterian Hosp, New York, NY 10021 USA	Fox Chase Cancer Center; Cornell University; NewYork-Presbyterian Hospital	Quinn, BA (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Denise.Connolly@fccc.edu			United States Army Medical Research and Materiel Command (USAMRMC) [W81XWH-07-1-0303, W81XWH-04-1-0063]; National Cancer Institute; Fox Chase Cancer Center Ovarian Cancer SPORE [P50 CA083638]; Fox Chase Cancer Center Core Grant [P30 CA006927]; NATIONAL CANCER INSTITUTE [P50CA083638] Funding Source: NIH RePORTER	United States Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fox Chase Cancer Center Ovarian Cancer SPORE; Fox Chase Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the United States Army Medical Research and Materiel Command (USAMRMC) Congressionally Directed Medical Research Programs (CDMRP [https://cdmrp.org), W81XWH-07-1-0303 and W81XWH-04-1-0063 grants to DCC), National Cancer Institute [www.nci.nih.gov] grants: Fox Chase Cancer Center Ovarian Cancer SPORE (P50 CA083638), Fox Chase Cancer Center Core Grant (P30 CA006927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIAS EB, 1994, BIOL REPROD, V51, P685, DOI 10.1095/biolreprod51.4.685; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; Brodie SG, 2001, ONCOGENE, V20, P7514, DOI 10.1038/sj.onc.1204929; Buller RE, 2001, CLIN CANCER RES, V7, P831; Chan KYK, 2002, CANCER RES, V62, P4151; Chodankar R, 2005, CURR BIOL, V15, P561, DOI 10.1016/j.cub.2005.01.052; Clark-Knowles KV, 2007, EXP CELL RES, V313, P133, DOI 10.1016/j.yexcr.2006.09.026; Connolly DC, 2003, CANCER RES, V63, P1389; Connolly DC, 2000, AM J PATHOL, V156, P339, DOI 10.1016/S0002-9440(10)64735-9; CONNOLLY DC, 2009, NENOGRATI TRANSGENIS; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DINNER D, 1996, NAT GENET, V4, P42; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Folkins AK, 2008, GYNECOL ONCOL, V109, P168, DOI 10.1016/j.ygyno.2008.01.012; Geisler JP, 2002, JNCI-J NATL CANCER I, V94, P61; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; Hilton JL, 2002, JNCI-J NATL CANCER I, V94, P1396; Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141; Hu YF, 2005, ONCOGENE, V24, P8343, DOI 10.1038/sj.onc.1208985; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; Medeiros F, 2006, AM J SURG PATHOL, V30, P230, DOI 10.1097/01.pas.0000180854.28831.77; NAROL SA, 1991, NAT REV CANCER, V4, P665; NING D, 2006, CANCER RES, V66, P8919; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; PATOES A, 2007, NEW ENGL J MED, V157, P2543; Ramus SJ, 1999, GENE CHROMOSOME CANC, V25, P91, DOI 10.1002/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5; Rathi A, 2002, CLIN CANCER RES, V8, P3324; Rhei E, 1998, CANCER RES, V58, P3193; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Schorge JO, 2000, CANCER RES, V60, P1361; SEMMEL DR, 2002, MODERN PATHOL, V22, P985; SHAW PA, 2009, MOD PATHOL; Signori E, 2001, ONCOGENE, V20, P4596, DOI 10.1038/sj.onc.1204620; Sood AK, 1998, CANCER, V82, P1731, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1738::AID-CNCR21>3.3.CO;2-0; Tashiro H, 1997, AM J PATHOL, V150, P177; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Weber F, 2006, AM J HUM GENET, V78, P961, DOI 10.1086/504090; WOO MM, 2001, GYNECOL ONCOL, V93, P315; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Xing D, 2009, CANCER RES, V69, P8231, DOI 10.1158/0008-5472.CAN-09-2543; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	54	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8404	10.1371/journal.pone.0008404	http://dx.doi.org/10.1371/journal.pone.0008404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YP	20046879	Green Published, gold, Green Submitted			2022-12-25	WOS:000207567200001
J	Yamanaka, N; Wong, CJ; Gertsenstein, M; Casper, RF; Nagy, A; Rogers, IM				Yamanaka, Nobuko; Wong, Christine J.; Gertsenstein, Marina; Casper, Robert F.; Nagy, Andras; Rogers, Ian M.			Bone Marrow Transplantation Results in Human Donor Blood Cells Acquiring and Displaying Mouse Recipient Class I MHC and CD45 Antigens on Their Surface	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; CORD-BLOOD; PURKINJE NEURONS; NOD/SCID MICE; FUSION; CARDIOMYOCYTES; PROTEINS; ENGRAFT; CAPTURE; ORIGIN	Background: Mouse models of human disease are invaluable for determining the differentiation ability and functional capacity of stem cells. The best example is bone marrow transplants for studies of hematopoietic stem cells. For organ studies, the interpretation of the data can be difficult as transdifferentiation, cell fusion or surface antigen transfer (trogocytosis) can be misinterpreted as differentiation. These events have not been investigated in hematopoietic stem cell transplant models. Methodology/Principal Findings: In this study we investigated fusion and trogocytosis involving blood cells during bone marrow transplantation using a xenograft model. We report that using a standard SCID repopulating assay almost 100% of the human donor cells appear as hybrid blood cells containing both mouse and human surface antigens. Conclusion/Significance: Hybrid cells are not the result of cell-cell fusion events but appear to be due to efficient surface antigen transfer, a process referred to as trogocytosis. Antigen transfer appears to be non-random and includes all donor cells regardless of sub-type. We also demonstrate that irradiation preconditioning enhances the frequency of hybrid cells and that trogocytosis is evident in non-blood cells in chimera mice.	[Yamanaka, Nobuko; Wong, Christine J.; Gertsenstein, Marina; Casper, Robert F.; Nagy, Andras; Rogers, Ian M.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Casper, Robert F.; Rogers, Ian M.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Nagy, Andras] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Yamanaka, N (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	rogers@lunenfeld.ca	Casper, Robert F./E-3775-2013; Nagy, Andras/G-6465-2013; Rogers, Ian M/D-5092-2015	Casper, Robert F./0000-0002-6249-462X; Nagy, Andras/0000-0003-4311-0413; Rogers, Ian M/0000-0001-8466-1225	Insception Biosciences, Mississauga, Canada	Insception Biosciences, Mississauga, Canada	This project was supported by Insception Biosciences, Mississauga, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Deb A, 2003, CIRCULATION, V107, P1247, DOI 10.1161/01.CIR.0000061910.39145.F0; Gorin NC, 2002, J HEMATOTH STEM CELL, V11, P277, DOI 10.1089/152581602753658466; Grompe Markus, 2005, V265, P20; Hudrisier D, 2005, EUR J IMMUNOL, V35, P2284, DOI 10.1002/eji.200526266; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Kalberer CP, 2003, BLOOD, V102, P127, DOI 10.1182/blood-2002-07-2024; Kidder BL, 2008, CLONING STEM CELLS, V10, P231, DOI 10.1089/clo.2007.0039; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Madlambayan GJ, 2006, BIOL BLOOD MARROW TR, V12, P1020, DOI 10.1016/j.bbmt.2006.07.005; Madlambayan GJ, 2005, EXP HEMATOL, V33, P1229, DOI 10.1016/j.exphem.2005.05.018; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; MCCULLOCH EA, 1960, RADIAT RES, V13, P115, DOI 10.2307/3570877; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nagy A., 2003, MANIPULATING MOUSE E; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Rampon C, 2008, STEM CELLS, V26, P1673, DOI 10.1634/stemcells.2008-0122; Ratajczak MZ, 2007, LEUKEMIA, V21, P860, DOI 10.1038/sj.leu.2404630; Rechavi O, 2009, FEBS LETT, V583, P1792, DOI 10.1016/j.febslet.2009.03.014; Riond J, 2007, SCAND J IMMUNOL, V66, P441, DOI 10.1111/j.1365-3083.2007.01996.x; Rogers I, 2007, EXP CELL RES, V313, P1839, DOI 10.1016/j.yexcr.2007.02.029; Rogers IM, 2008, BIOL BLOOD MARROW TR, V14, P927, DOI 10.1016/j.bbmt.2008.06.002; Sabzevari H, 2001, J IMMUNOL, V166, P2505, DOI 10.4049/jimmunol.166.4.2505; SHARROW SO, 1981, J IMMUNOL, V126, P1327; Shi DQ, 2004, BLOOD, V104, P290, DOI 10.1182/blood-2003-03-0688; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Sussman MA, 2008, J MOL CELL CARDIOL, V44, P950, DOI 10.1016/j.yjmcc.2008.03.007; Tabiasco J, 2002, EUR J IMMUNOL, V32, P1502, DOI 10.1002/1521-4141(200205)32:5<1502::AID-IMMU1502>3.0.CO;2-Y; Tanaka M, 2000, METH MOL B, V158, P135; TILL JE, 1963, RADIAT RES, V18, P96, DOI 10.2307/3571429; Tisato V, 2007, LEUKEMIA, V21, P1992, DOI 10.1038/sj.leu.2404847; VORMOOR J, 1994, BLOOD, V83, P2489; Wege AK, 2008, CURR TOP MICROBIOL, V324, P149; Yamada S, 2008, STEM CELLS, V26, P2644, DOI 10.1634/stemcells.2008-0187; Zhou P, 2009, HEPATOLOGY, V49, P1992, DOI 10.1002/hep.22862; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	43	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8489	10.1371/journal.pone.0008489	http://dx.doi.org/10.1371/journal.pone.0008489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046883	gold, Green Published, Green Submitted			2022-12-25	WOS:000273180200003
J	Cachay, ER; Sitapati, A; Caperna, J; Freeborn, K; Lonergan, JT; Jocson, E; Mathews, WC				Cachay, Edward R.; Sitapati, Amy; Caperna, Joseph; Freeborn, Kellie; Lonergan, Joseph T.; Jocson, Edward; Mathews, William C.		Owen Clinic Study Grp	Denial of Risk Behavior Does Not Exclude Asymptomatic Anorectal Sexually Transmitted Infection in HIV-Infected Men	PLOS ONE			English	Article							ACID AMPLIFICATION TESTS; NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS; SAN-FRANCISCO; SEX; PREVALENCE; CARE; CALIFORNIA; DIAGNOSIS; ACCURACY	Background:The Centers for Disease Control recommend screening for asymptomatic sexually transmitted infection (STI) among HIV-infected men when there is self-report of unprotected anal-receptive exposure. The study goals were: (1) to estimate the validity and usefulness for screening policies of self-reported unprotected anal-receptive exposure as a risk indicator for asymptomatic anorectal infection with Neisseria gonorrhoeae (GC) and/or Chlamydia trachomatis (CT). (2) to estimate the number of infections that would be missed if anal diagnostic assays were not performed among patients who denied unprotected anorectal exposure in the preceding month. Methods and Findings: Retrospective analysis in HIV primary care and high resolution anoscopy (HRA) clinics. HIV-infected adult men were screened for self-reported exposure during the previous month at all primary care and HRA appointments. Four sub-cohorts were defined based on microbiology methodology (GC culture and CT direct fluorescent antibody vs. GC/ CT nucleic acid amplification test) and clinical setting (primary care vs. HRA). Screening question operating characteristics were estimated using contingency table methods and then pooled across subcohorts. Among 803 patients, the prevalence of anorectal GC/CT varied from 3.5-20.1% in the 4 sub-cohorts. The sensitivity of the screening question for self-reported exposure to predict anorectal STI was higher in the primary care than in the HRA clinic, 86-100% vs. 12-35%, respectively. The negative predictive value of the screening question to predict asymptomatic anorectal STI was.90% in all sub-cohorts. In sensitivity analyses, the probability of being an unidentified case among those denying exposure increased from 0.48.1% in the primary care setting, and from 0.9-18.8% in the HRA setting as the prevalence varied from 1-20%. Conclusion: As STI prevalence increases, denial of unprotected anal-receptive exposure leads to an increasingly unacceptable proportion of unidentified asymptomatic anorectal STI if used as a criterion not to obtain microbiologic assays.	[Cachay, Edward R.; Sitapati, Amy; Caperna, Joseph; Freeborn, Kellie; Lonergan, Joseph T.; Jocson, Edward; Mathews, William C.; Owen Clinic Study Grp] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA	University of California System; University of California San Diego	Cachay, ER (corresponding author), Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA.	cmathews@ucsd.edu	Mathews, William C/E-4451-2010	Mathews, William C/0000-0002-2352-0725	University of California at San Diego Academy of Clinician Scholars; Pacific AIDS Education and Training Center [H4A HA 00058]; University of California at San Diego, Center for AIDS Research [AI 36214]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	University of California at San Diego Academy of Clinician Scholars; Pacific AIDS Education and Training Center; University of California at San Diego, Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the grants of the University of California at San Diego Academy of Clinician Scholars, Pacific AIDS Education and Training Center (H4A HA 00058) and University of California at San Diego, Center for AIDS Research (AI 36214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; BONIN P, 1984, J CLIN MICROBIOL, V19, P218, DOI 10.1128/JCM.19.2.218-220.1984; BOOR M, 1973, J CLIN PSYCHOL, V29, P238, DOI 10.1002/1097-4679(197304)29:2<238::AID-JCLP2270290225>3.0.CO;2-D; Bousman CA, 2009, J AFFECT DISORDERS, V119, P84, DOI 10.1016/j.jad.2009.04.006; Cachay E, 2004, AIDS PATIENT CARE ST, V18, P349, DOI 10.1089/1087291041444050; Chen SY, 2002, AM J PUBLIC HEALTH, V92, P1387, DOI 10.2105/AJPH.92.9.1387-a; Cook RL, 2002, SEX TRANSM INFECT, V78, P190, DOI 10.1136/sti.78.3.190; Grobbee DE, 2009, CLIN EPIDEMIOLOGY PR, P58; Gunn RA, 2008, SEX TRANSM DIS, V35, P845, DOI 10.1097/OLQ.0b013e318177ec70; Hadgu A, 2005, EPIDEMIOLOGY, V16, P604, DOI 10.1097/01.ede.0000173042.07579.17; HANDSFIELD HH, 1974, NEW ENGL J MED, V290, P117, DOI 10.1056/NEJM197401172900301; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOOVER K, 2008, 2008 NAT STD PREV C; Jaccard J, 2004, J HEALTH PSYCHOL, V9, P699, DOI 10.1177/1359105304045354; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; Klausner J. D., 2009, Morbidity and Mortality Weekly Report, V58, P716; Lister NA, 2003, SEX TRANSM DIS, V30, P886, DOI 10.1097/01.OLQ.0000099160.26205.22; Mansergh G, 2008, SEX TRANSM INFECT, V84, P509, DOI 10.1136/sti.2008.031807; Mettey A, 2003, SEX TRANSM INFECT, V79, P466, DOI 10.1136/sti.79.6.466; Mimiaga MJ, 2009, SEX TRANSM DIS, V36, P507, DOI 10.1097/OLQ.0b013e3181a2ad98; Reisner SL, 2009, AIDS BEHAV, V13, P822, DOI 10.1007/s10461-008-9430-0; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; RENAULT CA, 2008, MLO MED LAB OBS, V38, P12; RENAULT CA, 2006, MLO MED LAB OBS, V38, P27; RENAULT CA, 2006, MLO MED LAB OBS, V38, P24; Renault CA, 2006, MLO MED LAB OBS, V38, P21; Renault Cybele A, 2006, MLO Med Lab Obs, V38, P12; Rieg G, 2008, AIDS PATIENT CARE ST, V22, P947, DOI 10.1089/apc.2007.0240; Schachter J, 2008, SEX TRANSM DIS, V35, P637, DOI 10.1097/OLQ.0b013e31817bdd7e; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Vivancos R, 2008, INT J STD AIDS, V19, P370, DOI 10.1258/ijsa.2007.007176	33	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8504	10.1371/journal.pone.0008504	http://dx.doi.org/10.1371/journal.pone.0008504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601NW	20041143	Green Published, gold, Green Submitted			2022-12-25	WOS:000278068700018
J	Kodiha, M; Tran, D; Morogan, A; Qian, C; Stochaj, U				Kodiha, Mohamed; Tran, Dan; Morogan, Andreea; Qian, Cynthia; Stochaj, Ursula			Dissecting the Signaling Events That Impact Classical Nuclear Import and Target Nuclear Transport Factors	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; NUCLEOPORINS NUP153; PROTEIN; LOCALIZATION; INHIBITION; ALPHA; PHOSPHORYLATION; EXPRESSION; KINASE	Background: Signaling through MEK -> ERK1/2 and PI3 kinases is implicated in many aspects of cell physiology, including the survival of oxidant exposure. Oxidants play a role in numerous physiological and pathophysiological processes, many of which rely on transport in and out of the nucleus. However, how oxidative stress impacts nuclear trafficking is not well defined. Methodology/Principal Findings: To better understand the effect of stress on nucleocytoplasmic trafficking, we exposed cells to the oxidant diethyl maleate. This treatment activated MEK -> ERK1/2 as well as PI3 kinase -> Akt cascades and triggered the inhibition of classical nuclear import. To define the molecular mechanisms that regulate nuclear transport, we examined whether MEK and PI3 kinase signaling affected the localization of key transport factors. Using recently developed tools for image acquisition and analysis, the subcellular distributions of importin-alpha, CAS, and nucleoporins Nup153 and Nup88 were quantified in different cellular compartments. These studies identified specific profiles for the localization of transport factors in the nucleus and cytoplasm, and at the nuclear envelope. Our results demonstrate that MEK and PI3 kinase signaling as well as oxidative stress control nuclear trafficking and the localization of transport components. Furthermore, stress not only induced changes in transport factor distribution, but also upregulated post-translational modification of transport factors. Our results are consistent with the idea that the phosphorylation of importin-alpha, CAS, Nup153, and Nup88, and the O-GlcNAc modification of Nup153 increase when cells are exposed to oxidant. Conclusions/Significance: Our studies defined the complex regulation of classical nuclear import and identified key transport factors that are targeted by stress, MEK, and PI3 kinase signaling.	[Kodiha, Mohamed; Tran, Dan; Morogan, Andreea; Qian, Cynthia; Stochaj, Ursula] McGill Univ, Dept Physiol, Montreal, PQ, Canada	McGill University	Kodiha, M (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	ursula.stochaj@mcgill.ca	stochaj, ursula/AAC-1865-2021		Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Heart and Stroke Foundation of Quebec (HSFQ); Heart and Stroke Foundation of Canada (HFSC); McGill University	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Quebec (HSFQ); Heart and Stroke Foundation of Canada (HFSC)(Heart & Stroke Foundation of Canada); McGill University	This research was supported by grants from the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Heart and Stroke Foundation of Quebec (HSFQ) to US. MK is a recipient of a fellowship from the Heart and Stroke Foundation of Canada (HFSC). AM and CQ were supported by research bursaries from McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Hernando A, 2008, J BIOL CHEM, V283, P25082, DOI 10.1074/jbc.M802381200; Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141; Behrens P, 2003, APOPTOSIS, V8, P39, DOI 10.1023/A:1021644918117; Castillo EA, 2002, MOL MICROBIOL, V45, P243, DOI 10.1046/j.1365-2958.2002.03020.x; CHU A, 2001, FASEB J, DOI DOI 10.1096/FJ.00-0680JJE; Chu CT, 2007, J NEUROPATH EXP NEUR, V66, P873, DOI 10.1097/nen.0b013e318156a3d7; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Czubryt MP, 2000, J CELL BIOL, V148, P7, DOI 10.1083/jcb.148.1.7; den Hertog J, 2005, ARCH BIOCHEM BIOPHYS, V434, P11, DOI 10.1016/j.abb.2004.05.024; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fagerlund R, 2008, CELL SIGNAL, V20, P1442, DOI 10.1016/j.cellsig.2008.03.012; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Heistad DD, 2009, CIRC J, V73, P201, DOI 10.1253/circj.CJ-08-1082; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kalas W, 2002, LEUKEMIA LYMPHOMA, V43, P1469, DOI 10.1080/1042819022386815; Kim IS, 2000, J BIOL CHEM, V275, P23139, DOI 10.1074/jbc.M909256199; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Kodiha M, 2008, BBA-MOL CELL RES, V1783, P405, DOI 10.1016/j.bbamcr.2007.10.022; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Kodiha M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.137pl2; Kodiha M, 2009, FEBS LETT, V583, P1987, DOI 10.1016/j.febslet.2009.05.011; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Kumar D, 2002, HERZ, V27, P662, DOI 10.1007/s00059-002-2430-3; Lai KO, 2008, P NATL ACAD SCI USA, V105, P17175, DOI 10.1073/pnas.0803906105; Lee B, 2009, J NEUROCHEM, V108, P1251, DOI 10.1111/j.1471-4159.2008.05864.x; Liu HL, 2005, ACTA PHARMACOL SIN, V26, P1265, DOI 10.1111/j.1745-7254.2005.00192.x; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Menges CW, 2008, ONCOGENE, V27, P2934, DOI 10.1038/sj.onc.1210957; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Scherf U, 1998, BIOCHEM BIOPH RES CO, V250, P623, DOI 10.1006/bbrc.1998.9367; SCHULTE D, 1995, J CELL SCI, V108, P1381; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Stochaj U, 2000, FASEB J, V14, P2130, DOI 10.1096/fj.99-0751fje; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Velloso LA, 2006, DIABETES-METAB RES, V22, P98, DOI 10.1002/dmrr.611; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; ZACHARA NE, 2008, NUCLEUS, V2, P227	48	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8420	10.1371/journal.pone.0008420	http://dx.doi.org/10.1371/journal.pone.0008420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041180	Green Published, gold, Green Submitted			2022-12-25	WOS:000273104000003
J	Liu, XQ; Pawlyk, BS; Adamian, M; Olshevskaya, EV; Dizhoor, AM; Makino, CL; Li, TS				Liu, Xiaoqing; Pawlyk, Basil S.; Adamian, Michael; Olshevskaya, Elena V.; Dizhoor, Alexander M.; Makino, Clint L.; Li, Tiansen			Increased Light Exposure Alleviates One Form of Photoreceptor Degeneration Marked by Elevated Calcium in the Dark	PLOS ONE			English	Article							DOMINANT CONE DEGENERATION; GUANYLATE-CYCLASE; RETINITIS-PIGMENTOSA; TRANSGENIC MICE; MOUSE MODEL; RHODOPSIN; MUTATION; DYSTROPHY; APOPTOSIS; DISEASE	Background: In one group of gene mutations that cause photoreceptor degeneration in human patients, guanylyl cyclase is overactive in the dark. The ensuing excess opening of cGMP-gated cation channels causes intracellular calcium to rise to toxic levels. The Y99C mutation in guanylate cyclase-activating protein 1 (GCAP1) has been shown to act this way. We determined whether prolonged light exposure, which lowers cGMP levels through activation of phototransduction, might protect photoreceptors in a line of transgenic mice carrying the GCAP1-Y99C. Methodology/Principal Findings: We reared cohorts of GCAP1-Y99C transgenic mice under standard cyclic, constant dark and constant light conditions. Mouse eyes were analyzed by histology and by immunofluorescence for GFAP upregulation, a non-specific marker for photoreceptor degeneration. Full-field electroretinograms (ERGs) were recorded to assess retinal function. Consistent with our hypothesis, constant darkness accelerated disease, while continuous lighting arrested photoreceptor degeneration. Conclusions/Significance: In contrast to most forms of retinal degeneration, which are exacerbated by increased exposure to ambient light, a subset with mutations that cause overly active guanylyl cyclase and high intracellular calcium benefitted from prolonged light exposure. These findings may have therapeutic implications for patients with these types of genetic defects.	[Liu, Xiaoqing; Pawlyk, Basil S.; Adamian, Michael] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02115 USA; [Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Hafter Res Labs, Elkins Pk, PA USA; [Makino, Clint L.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Howe Lab, Boston, MA USA; [Li, Tiansen] NEI, Neurodegenerat & Repair Lab, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Liu, XQ (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02115 USA.	tiansen.li@nih.gov	Makino, Clint Lawrence/H-8428-2019	Makino, Clint Lawrence/0000-0002-6005-9069; Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health [EY10309, EY10581, EY11522, EY12944, EY14104]; Macular Vision Research Foundation; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [ZIAEY000490, R01EY010309, R01EY010581, P30EY014104, R01EY011522, R01EY012944, R01EY004939, R29EY010581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macular Vision Research Foundation; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Institutes of Health EY10309, EY10581 (TL), EY11522 (AD), EY12944 (CLM), EY14104 (core grant), the Macular Vision Research Foundation, and the Foundation Fighting Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehr W., 2007, V45, P71; Baehr W, 2009, EXP EYE RES, V89, P2, DOI 10.1016/j.exer.2008.12.016; BERSON EL, 1971, ARCH OPHTHALMOL-CHIC, V85, P521, DOI 10.1001/archopht.1971.00990050523001; Bright SR, 2005, MOL VIS, V11, P1141; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; He LH, 2000, J BIOL CHEM, V275, P12175, DOI 10.1074/jbc.275.16.12175; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; LAVAIL MM, 1975, EXP EYE RES, V21, P167, DOI 10.1016/0014-4835(75)90080-9; LaVail MM, 1999, INVEST OPHTH VIS SCI, V40, P1020; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; Liu CM, 2005, AM J PHYSIOL-CELL PH, V289, pC187, DOI 10.1152/ajpcell.00490.2004; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Naash ML, 1996, INVEST OPHTH VIS SCI, V37, P775; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Nishiguchi KM, 2004, INVEST OPHTH VIS SCI, V45, P3863, DOI 10.1167/iovs.04-0590; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; SANYAL S, 1986, VISION RES, V26, P1177, DOI 10.1016/0042-6989(86)90099-4; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007	25	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8438	10.1371/journal.pone.0008438	http://dx.doi.org/10.1371/journal.pone.0008438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041177	Green Published, Green Submitted, gold			2022-12-25	WOS:000273104000007
J	Schafer, G; Guler, R; Murray, G; Brombacher, F; Brown, GD				Schaefer, Georgia; Guler, Reto; Murray, Graeme; Brombacher, Frank; Brown, Gordon D.			The Role of Scavenger Receptor B1 in Infection with Mycobacterium tuberculosis in a Murine Model	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SR-BI; IMMUNE-RESPONSES; MACROPHAGES; MICE; CELLS; PHAGOCYTOSIS; EXPRESSION; CHOLESTEROL; RECOGNITION	Background: The interaction between Mycobacterium tuberculosis (Mtb) and host cells is complex and far from being understood. The role of the different receptor(s) implicated in the recognition of Mtb in particular remains poorly defined, and those that have been found to have activity in vitro were subsequently shown to be redundant in vivo. Methods and Findings: To identify novel receptors involved in the recognition of Mtb, we screened a macrophage cDNA library and identified scavenger receptor B class 1 (SR-B1) as a receptor for mycobacteria. SR-B1 has been well-described as a lipoprotein receptor which mediates both the selective uptake of cholesteryl esters and the efflux of cholesterol, and has also recently been implicated in the recognition of other pathogens. We show here that mycobacteria can bind directly to SR-B1 on transfected cells, and that this interaction could be inhibited in the presence of a specific antibody to SR-B1, serum or LDL. We define a variety of macrophage populations, including alveolar macrophages, that express this receptor, however, no differences in the recognition and response to mycobacteria were observed in macrophages isolated from SR-B1(-/-) or wild type mice in vitro. Moreover, when wild type and SR-B1(-/-) animals were infected with a low dose of Mtb (100 CFU/mouse) there were no alterations in survival, bacterial burdens, granuloma formation or cytokine production in the lung. However, significant reduction in the production of TNF, IFN gamma, and IL10 were observed in SR-B1(-/-) mice following infection with a high dose of Mtb (1000 CFU/mouse), which marginally affected the size of inflammatory foci but did not influence bacterial burdens. Deficiency of SR-B1 also had no effect on resistance to disease under conditions of varying dietary cholesterol. We did observe, however, that the presence of high levels of cholesterol in the diet significantly enhanced the bacterial burdens in the lung, but this was independent of SR-B1. Conclusion: SR-B1 is involved in mycobacterial recognition, but this receptor plays only a minor role in anti-mycobacterial immunity in vivo. Like many other receptors for these pathogens, the loss of SR-B1 can be functionally compensated for under normal conditions.	[Schaefer, Georgia; Guler, Reto; Brombacher, Frank; Brown, Gordon D.] Univ Cape Town, Div Immunol, IIDMM, ZA-7925 Cape Town, South Africa; [Guler, Reto; Brombacher, Frank] ICGEB, Cape Town, South Africa; [Murray, Graeme] Univ Aberdeen, Sect Translat Med, Div Appl Med, Sch Med & Dent, Foresterhill, Scotland; [Brown, Gordon D.] Univ Aberdeen, Sect Immunol & Infect, Div Appl Med, Inst Med Sci, Foresterhill, Scotland	University of Cape Town; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Aberdeen; University of Aberdeen	Schafer, G (corresponding author), Univ Cape Town, Div Immunol, IIDMM, ZA-7925 Cape Town, South Africa.	gordon.brown@abdn.ac.uk	brown, gordon/B-4249-2012; Guler, Reto/A-4013-2011	brown, gordon/0000-0002-0287-5383	Deutsche Forschungsgemeinschaft (DFG), Germany [SCHA 1470/1-1]; Claude Leon Foundation, South Africa; National Research Foundation (NRF), South Africa; South African Research Chair Initiative of the Department of Science and Technology (DST); Wellcome Trust	Deutsche Forschungsgemeinschaft (DFG), Germany(German Research Foundation (DFG)); Claude Leon Foundation, South Africa; National Research Foundation (NRF), South Africa(National Research Foundation - South Africa); South African Research Chair Initiative of the Department of Science and Technology (DST); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by funding from the Deutsche Forschungsgemeinschaft (DFG), Germany, to GS ( grant SCHA 1470/1-1), the Claude Leon Foundation, South Africa, to GS and RG, the National Research Foundation (NRF), South Africa, to FB, the South African Research Chair Initiative of the Department of Science and Technology (DST) to FB, and the Wellcome Trust to GDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Baranova I, 2002, INFECT IMMUN, V70, P2995, DOI 10.1128/IAI.70.6.2995-3003.2002; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Calvo D, 1997, ARTERIOSCL THROM VAS, V17, P2341, DOI 10.1161/01.ATV.17.11.2341; Catanese MT, 2007, J VIROL, V81, P8063, DOI 10.1128/JVI.00193-07; Connelly MA, 2004, CURR OPIN LIPIDOL, V15, P287, DOI 10.1097/00041433-200406000-00008; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Feng CG, 2003, J IMMUNOL, V171, P4758, DOI 10.4049/jimmunol.171.9.4758; Ferguson JS, 2002, J IMMUNOL, V168, P1309, DOI 10.4049/jimmunol.168.3.1309; Ferguson JS, 1999, J IMMUNOL, V163, P312; Fidge NH, 1999, J LIPID RES, V40, P187; FREEMAN AE, 1970, J NATL CANCER I, V44, P65; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Hall-Stoodley L, 2006, INFECT IMMUN, V74, P3587, DOI 10.1128/IAI.01644-05; Holscher C, 2008, EUR J IMMUNOL, V38, P680, DOI 10.1002/eji.200736458; Hu CG, 2000, J IMMUNOL, V165, P2596, DOI 10.4049/jimmunol.165.5.2596; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Kellner-Weibel G, 2000, BIOCHEMISTRY-US, V39, P221, DOI 10.1021/bi991666c; Le Cabec V, 2002, J IMMUNOL, V169, P2003, DOI 10.4049/jimmunol.169.4.2003; Martens GW, 2008, INFECT IMMUN, V76, P3464, DOI 10.1128/IAI.00037-08; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Peiser L, 2001, MICROBES INFECT, V3, P149, DOI 10.1016/S1286-4579(00)01362-9; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Randhawa AK, 2005, J IMMUNOL, V175, P1805, DOI 10.4049/jimmunol.175.3.1805; Reiling N, 2001, IMMUNOBIOLOGY, V204, P558, DOI 10.1078/0171-2985-00093; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Rodrigues CD, 2008, CELL HOST MICROBE, V4, P271, DOI 10.1016/j.chom.2008.07.012; Sanchez MD, 2006, MICROBES INFECT, V8, P2492, DOI 10.1016/j.micinf.2006.06.005; Schafer G, 2009, J INNATE IMMUN, V1, P231, DOI 10.1159/000173703; Schaefer Georgia, 2009, V531, P1, DOI 10.1007/978-1-59745-396-7_1; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; Stokes RW, 1998, J IMMUNOL, V160, P5514; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Vishnyakova TG, 2006, P NATL ACAD SCI USA, V103, P16888, DOI 10.1073/pnas.0602126103; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Wieland CW, 2007, MICROBES INFECT, V9, P134, DOI 10.1016/j.micinf.2006.10.018; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Zimmerli S, 1996, AM J RESP CELL MOL, V15, P760, DOI 10.1165/ajrcmb.15.6.8969271	51	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8448	10.1371/journal.pone.0008448	http://dx.doi.org/10.1371/journal.pone.0008448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041149	Green Published, gold, Green Submitted			2022-12-25	WOS:000273104000013
J	Li, XX; Xu, YX; Ma, L; Sun, LY; Fu, GF; Hou, YY				Li, Xiaoxi; Xu, Yixin; Ma, Ling; Sun, Lingyun; Fu, Gengfeng; Hou, Yayi			17 beta-Estradiol Enhances the Response of Plasmacytoid Dendritic Cell to CpG	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; STRANDED DNA ANTIBODIES; ALPHA-PRODUCING CELLS; TOLL-LIKE RECEPTORS; I INTERFERON; IFN-ALPHA; INFLUENZA-VIRUS; BACTERIAL-DNA; B-CELLS; ACTIVATION	Gender differences in immune capabilities suggest that sex hormones such as estrogens were involved in the regulation of the immunocompetence. Numerous studies also suggest that plasmacytoid dendritic cells (PDCs) play a pathogenic role in SLE. However, it is unclear whether estrogen can modulate the function of PDCs to influence the development of SLE. In the present study, PDCs from murine spleens were treated with 17 beta-estradiol (E2) and CpG respectively or both in vitro, then cell viability, costimulatory molecule expression, cytokine secretion of PDCs, as well as stimulatory capacity of PDCs to B cells were analyzed. Results showed that E2 and CpG increased the cell viability and costimulatory molecule expression on PDCs synergistically. Moreover, the intracellular and extracellular secretion of IFN-alpha was increased by E2 or E2 plus CpG. In addition, E2 and CpG also increased the stimulatory capacity of PDCs to B cells, and the viability of B cells was decreased after neutralizing IFN-alpha significantly. In the experiments in vivo, mice received daily s.c. injections of E2 and CpG respectively or both, then we found that the plasma concentration of IgM were elevated by E2 and CpG synergistically and the expression of IFN-alpha/beta in spleens were noticeably increased by CpG plus E2 compared with the treatment of E2 or CpG only. This study indicates that E2 could exacerbate PDCs' activation with CpG, which further activates B cells to upregulate susceptibility to autoantigens. IFN-alpha plays an important role in the stimulatory effect of PDCs on B cells. E2 stimulation of IFN-alpha production may result in female prevalence in autoimmune diseases such as SLE through activation of PDCs. This study provides novel evidence of relationship between estrogen and SLE and also sheds light on gender biases among SLE patients.	[Li, Xiaoxi; Xu, Yixin; Ma, Ling; Hou, Yayi] Nanjing Univ, Immunol & Reprod Biol Lab, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Li, Xiaoxi; Xu, Yixin; Ma, Ling; Hou, Yayi] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Sun, Lingyun] Nanjing Univ, Sch Med, Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Fu, Gengfeng] Jiangsu Ctr Dis Prevent & Control, Jiangsu, Peoples R China; [Hou, Yayi] Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Li, XX (corresponding author), Nanjing Univ, Immunol & Reprod Biol Lab, Sch Med, Nanjing 210008, Jiangsu, Peoples R China.	yayihou@nju.edu.cn			National Natural Science Foundation [30771959]; Natural Science Research Foundation of Jiangsu Province [BK2006119]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Research Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work supported by grants from the National Natural Science Foundation (project number: 30771959) and Natural Science Research Foundation of Jiangsu Province ( project number: BK2006119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anolik J, 2004, CURR OPIN RHEUMATOL, V16, P505, DOI 10.1097/01.bor.0000133660.52599.f6; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Bave U, 2001, J AUTOIMMUN, V17, P71, DOI 10.1006/jaut.2001.0519; BEAUMONT V, 1989, CLIN PHYSIOL BIOCH, V7, P263; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Dubois B, 1998, J IMMUNOL, V161, P2223; Facchetti F, 2003, VIRCHOWS ARCH, V443, P703, DOI 10.1007/s00428-003-0918-8; Hartmann G, 1999, P NATL ACAD SCI USA, V96, P9305, DOI 10.1073/pnas.96.16.9305; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; HUMAN JU, 1985, J REPROD IMMUNOL, V7, P111; Iparraguirre A, 2008, J LEUKOCYTE BIOL, V83, P610, DOI 10.1189/jlb.0807511; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jacobi AM, 2005, J EXP MED, V202, P341, DOI 10.1084/jem.20050221; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jiang B, 2007, CELL IMMUNOL, V248, P95, DOI 10.1016/j.cellimm.2007.10.004; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; LAHITA RG, 1982, ARTHRITIS RHEUM, V25, P843, DOI 10.1002/art.1780250726; LAHITA RG, 1981, J CLIN ENDOCR METAB, V53, P174, DOI 10.1210/jcem-53-1-174; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Linnik MD, 2005, ARTHRITIS RHEUM, V52, P1129, DOI 10.1002/art.20980; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Marshall JD, 2007, J LEUKOCYTE BIOL, V82, P497, DOI 10.1189/jlb.0906575; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; PETRI M, 1991, ARTHRITIS RHEUM, V34, P1538; Pisetsky DS, 2006, SCAND J IMMUNOL, V64, P200, DOI 10.1111/j.1365-3083.2006.01822.x; Poeck H, 2004, BLOOD, V103, P3058, DOI 10.1182/blood-2003-08-2972; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; Renaudineau Y, 2004, AUTOIMMUN REV, V3, P516, DOI 10.1016/j.autrev.2004.07.035; RONNBLOM LE, 1990, J INTERN MED, V227, P207; Sato Y, 1999, J RHEUMATOL, V26, P294; STRANNEGARD O, 1982, CLIN EXP IMMUNOL, V50, P246; UROWITZ MB, 1993, ARTHRITIS RHEUM, V36, P1392, DOI 10.1002/art.1780361011; Vallin H, 1999, J IMMUNOL, V163, P6306; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wizemann T. M., 2001, EXPLORING BIOL CONTR; WONG KL, 1991, PEDIAT NEPHROLOGY, V5, P573; Woods A, 2007, J VIROL, V81, P12525, DOI 10.1128/JVI.00839-07; Yang LS, 2006, MOL IMMUNOL, V43, P357, DOI 10.1016/j.molimm.2005.02.012; Yao GH, 2004, INT IMMUNOPHARMACOL, V4, P213, DOI 10.1016/j.intimp.2003.12.005	49	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8412	10.1371/journal.pone.0008412	http://dx.doi.org/10.1371/journal.pone.0008412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037646	gold, Green Published, Green Submitted			2022-12-25	WOS:000272998100009
J	van de Wetering, D; de Paus, RA; van Dissel, JT; van de Vosse, E				van de Wetering, Diederik; de Paus, Roelof A.; van Dissel, Jaap T.; van de Vosse, Esther			Salmonella Induced IL-23 and IL-1 beta Allow for IL-12 Production by Monocytes and M phi 1 through Induction of IFN-gamma in CD56(+) NK/NK-Like T Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; COLONY-STIMULATING FACTOR; HUMAN DENDRITIC CELLS; NATURAL-KILLER-CELLS; INTERFERON-GAMMA; TYPE-2 MACROPHAGES; INTERLEUKIN (IL)-4; MONONUCLEAR-CELLS; CYTOKINE; GENE	Background: The type-1 cytokine pathway plays a pivotal role in immunity against intracellular bacterial pathogens such as Salmonellae and Mycobacteria. Bacterial stimulation of pattern recognition receptors on monocytes, macrophages and dendritic cells initiates this pathway, and results in the production of cytokines that activate lymphocytes to produce interferon (IFN)-gamma. Interleukin (IL)-12 and IL-23 are thought to be the key cytokines required for initiating a type-1 cytokine immune response to Mycobacteria and Salmonellae. The relative contribution of IL-23 and IL-12 to this process is uncertain. Methodology/Principal Findings: We show that various TLR agonists induce the production of IL-23 but not IL-12 in freshly isolated human monocytes and cultured human macrophages. In addition, type 1 pro-inflammatory macrophages (M phi 1) differentiated in the presence of GM-CSF and infected with live Salmonella produce IL-23, IL-1 beta and IL-18, but not IL-12. Supernatants of Salmonella-infected M phi 1 contained more IL-18 and IL-1 beta as compared with supernatants of M phi 1 stimulated with isolated TLR agonists, and induced IFN-gamma production in human CD56(+) cells in an IL-23 and IL-1 beta-dependent but IL-12-independent manner. In addition, IL-23 together with IL-18 or IL-1 beta led to the production of GM-CSF in CD56(+) cells. Both IFN-gamma and GM-CSF enhanced IL-23 production by monocytes in response to TLR agonists, as well as induced IL-12 production. Conclusions/Significance: The findings implicate a positive feedback loop in which IL-23 can enhance its release via induction of IFN-gamma and GM-CSF. The IL-23 induced cytokines allow for the subsequent production of IL-12 and amplify the IFN-gamma production in the type-1 cytokine pathway.	[van de Wetering, Diederik; de Paus, Roelof A.; van Dissel, Jaap T.; van de Vosse, Esther] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van de Wetering, D (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	E.van_de_Vosse@lumc.nl	van de Vosse, Esther/HDO-0723-2022; van de Vosse, Esther/B-7285-2009	van de Vosse, Esther/0000-0001-5199-3426				Abdi K, 2006, SCAND J IMMUNOL, V64, P83, DOI 10.1111/j.1365-3083.2006.01767.x; Bouter H, 2002, CRIT CARE MED, V30, P38, DOI 10.1097/00003246-200201000-00006; BURCHETT SK, 1988, J IMMUNOL, V140, P3473; Butchar JP, 2008, FEBS LETT, V582, P1044, DOI 10.1016/j.febslet.2008.02.058; Butchar JP, 2007, J IMMUNOL, V178, P4445, DOI 10.4049/jimmunol.178.7.4445; Carryn S, 2004, J INFECT DIS, V189, P2101, DOI 10.1086/420848; CHAMPSI JH, 1994, BIOTHERAPY, V7, P187, DOI 10.1007/BF01878485; Cooper MA, 2001, EUR J IMMUNOL, V31, P792, DOI 10.1002/1521-4141(200103)31:3<792::AID-IMMU792>3.0.CO;2-U; DANDREA A, 1995, J EXP MED, V181, P537, DOI 10.1084/jem.181.2.537; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Feinberg J, 2004, EUR J IMMUNOL, V34, P3276, DOI 10.1002/eji.200425221; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Guia S, 2008, BLOOD, V111, P5008, DOI 10.1182/blood-2007-11-122259; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Hayes MP, 1998, BLOOD, V91, P4645, DOI 10.1182/blood.V91.12.4645.412k36_4645_4651; HAYES MP, 1995, BLOOD, V86, P646, DOI 10.1182/blood.V86.2.646.bloodjournal862646; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Hunter CA, 1997, EUR J IMMUNOL, V27, P2787, DOI 10.1002/eji.1830271107; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Marshall JD, 1997, J IMMUNOL, V159, P5705; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pirbonen J, 2002, J IMMUNOL, V169, P5673, DOI 10.4049/jimmunol.169.10.5673; SUZUKI K, 1994, CLIN EXP IMMUNOL, V98, P169; Tominaga K, 2000, INT IMMUNOL, V12, P151, DOI 10.1093/intimm/12.2.151; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; van de Vosse E, 2006, MICROBES INFECT, V8, P1167, DOI 10.1016/j.micinf.2005.10.032; van de Wetering D, 2009, INT IMMUNOL, V21, P145, DOI 10.1093/intimm/dxn132; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; WING EJ, 1989, BLOOD, V73, P643	34	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8396	10.1371/journal.pone.0008396	http://dx.doi.org/10.1371/journal.pone.0008396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027291	Green Published, gold			2022-12-25	WOS:000272940100024
J	Sexton, M; Woodruff, G; Cudaback, E; Kreitzer, FR; Xu, C; Lin, YH; Moller, T; Bai, MF; Manning, HC; Bornhop, D; Stella, N				Sexton, Michelle; Woodruff, Grace; Cudaback, Eiron; Kreitzer, Faith R.; Xu, Cong; Lin, Yi Hsing; Moeller, Thomas; Bai, Mingfeng; Manning, H. Charles; Bornhop, Darryl; Stella, Nephi			Binding of NIR-conPK and NIR-6T to Astrocytomas and Microglial Cells: Evidence for a Protein Related to TSPO	PLOS ONE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; IN-VIVO; HIGH-AFFINITY; MULTIPLE-SCLEROSIS; ISCHEMIC-STROKE; BRAIN-TUMORS; 18 KDA; LIGAND; ACTIVATION; PET	PK 11195 and DAA1106 bind with high-affinity to the translocator protein (TSPO, formerly known as the peripheral benzodiazepine receptor). TSPO expression in glial cells increases in response to cytokines and pathological stimuli. Accordingly, [(11)C]-PK 11195 and [(11)C]-DAA1106 are recognized molecular imaging (MI) agents capable of monitoring changes in TSPO expression occurring in vivo and in response to various neuropathologies. Here we tested the pharmacological characteristics and TSPO-monitoring potential of two novel MI agents: NIR-conPK and NIR-6T. NIR-conPK is an analogue of PK 11195 conjugated to the near-infrared (NIR) emitting fluorophore: IRDye 800CW. NIR-6T is a DAA1106 analogue also conjugated to IRDye 800CW. We found that NIR-6T competed for [(3)H]-PK 11195 binding in astrocytoma cell homogenates with nanomolar affinity, but did not exhibit specific binding in intact astrocytoma cells in culture, indicating that NIR-6T is unlikely to constitute a useful MI agent for monitoring TSPO expression in intact cells. Conversely, we found that NIR-conPK did not compete for [(3)H]-PK 11195 binding in astrocytoma cell homogenate, but exhibited specific binding in intact astrocytoma cells in culture with nanomolar affinity, suggesting that NIR-conPK binds to a protein distinct, but related to, TSPO. Accordingly, treating intact astrocytoma cells and microglia in culture with cytokines led to significant changes in the amount of NIR-conPK specific binding without corresponding change in TSPO expression. Remarkably, the cytokine-induced changes in the protein targeted by NIR-conPK in intact microglia were selective, since IFN-gamma (but not TNF alpha and TGF beta) increased the amount of NIR-conPK specific binding in these cells. Together these results suggest that NIR-conPK binds to a protein that is related to TSPO, and expressed by astrocytomas and microglia. Our results also suggest that the expression of this protein is increased by specific cytokines, and thus allows for the monitoring of a particular subtype of microglia activation.	[Sexton, Michelle] Bastyr Univ, Seattle, WA 98020 USA; [Sexton, Michelle; Woodruff, Grace; Cudaback, Eiron; Kreitzer, Faith R.; Xu, Cong; Lin, Yi Hsing; Stella, Nephi] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Woodruff, Grace] Univ Washington, Neurobiol Undergrad Program, Seattle, WA 98195 USA; [Moeller, Thomas] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Bai, Mingfeng] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Nashville, TN USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Dept Biomed Engn, Nashville, TN 37232 USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Program Chem & Phys Biol, Nashville, TN USA; [Bornhop, Darryl] Vanderbilt Univ, Dept Chem, Nashville, TN USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL); Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Sexton, M (corresponding author), Bastyr Univ, Seattle, WA 98020 USA.	nstella@u.washington.edu	Bai, Mingfeng/F-9246-2010; Möller, Thomas/W-8974-2019; Sexton, Michelle/ABD-9017-2020	Sexton, Michelle/0000-0002-0443-8355; Bai, Mingfeng/0000-0003-1139-0780	National Center for Complementary and Alternative Medicine (NCCAM) [T32ATO-0815-03]; National Institute of Neurological Disorders and Stroke (NINDS); National Science Foundation (NSF) [BES-0323067]; National Institute on Drug Abuse (NIDA) [DA14486]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014486] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Center for Complementary and Alternative Medicine (NCCAM) (T32ATO-0815-03) to MS; National Institute of Neurological Disorders and Stroke (NINDS) to TM; National Science Foundation (NSF) (BES-0323067) to DJB; and National Institute on Drug Abuse (NIDA) (DA14486) to NS. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALLIOT F, 1984, BRAIN RES, V306, P283, DOI 10.1016/0006-8993(84)90377-9; Bai M, 2007, BIOCONJUGATE CHEM, V18, P2018, DOI 10.1021/bc700251e; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; BLACK KL, 1989, J NEUROSURG, V71, P113, DOI 10.3171/jns.1989.71.1.0113; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Buvall L, 2007, J MOL CELL CARDIOL, V42, P1001, DOI 10.1016/j.yjmcc.2007.02.007; BYLUND DB, 1993, AM J PHYSIOL, V265, pL421, DOI 10.1152/ajplung.1993.265.5.L421; Cagnin A, 2004, ANN NEUROL, V56, P894, DOI 10.1002/ana.20332; Cagnin A, 2001, BRAIN, V124, P2014, DOI 10.1093/brain/124.10.2014; Chaki S, 1999, EUR J PHARMACOL, V371, P197, DOI 10.1016/S0014-2999(99)00118-1; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Chen MK, 2004, BRAIN, V127, P1379, DOI 10.1093/brain/awh161; Cleary J, 2007, BIOORG MED CHEM LETT, V17, P1667, DOI 10.1016/j.bmcl.2006.12.102; Costa B, 2006, MOL PHARMACOL, V69, P37, DOI 10.1124/mol.105.015289; Deane NG, 2007, MOL CANCER RES, V5, P341, DOI 10.1158/1541-7786.MCR-06-0225; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Fuller GN, 2002, BRAIN PATHOL, V12, P108; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Gee MS, 2008, RADIOLOGY, V248, P925, DOI 10.1148/radiol.2482071496; Gerhard A, 2005, NEUROIMAGE, V24, P591, DOI 10.1016/j.neuroimage.2004.09.034; Gibson RM, 2004, VET J, V168, P230, DOI 10.1016/j.tvjl.2003.10.016; Giusti L, 2004, CLIN BIOCHEM, V37, P61, DOI 10.1016/j.clinbiochem.2003.10.004; GIUSTI L, 1994, BIOCHEM PHARMACOL, V48, P583, DOI 10.1016/0006-2952(94)90289-5; Goerres GW, 2001, AM J ROENTGENOL, V176, P1016, DOI 10.2214/ajr.176.4.1761016; Gonzalez-Polo RA, 2005, ONCOGENE, V24, P7503, DOI 10.1038/sj.onc.1208907; Gulyas B, 2009, NEUROCHEM INT, V54, P28, DOI 10.1016/j.neuint.2008.10.001; Hans G, 2005, BIOCHEM PHARMACOL, V69, P819, DOI 10.1016/j.bcp.2004.11.029; Hara M, 1998, EUR J PHARMACOL, V345, P339, DOI 10.1016/S0014-2999(98)00016-8; Horrobin DF, 2003, NAT REV DRUG DISCOV, V2, P151, DOI 10.1038/nrd1012; KEEN EM, 1999, METHOD MOL BIOL, P89; KOENIG JA, 1999, METHODS MOL BIOL; KUMANISHI T, 1967, JPN J EXP MED, V37, P461; LIMBIRD LE, 2005, IDENTIFICATION RECEP, P56; Liu J, 2003, J STEROID BIOCHEM, V85, P275, DOI 10.1016/S0960-0760(03)00213-9; Maeda J, 2004, SYNAPSE, V52, P283, DOI 10.1002/syn.20027; Manning HC, 2006, BIOCONJUGATE CHEM, V17, P735, DOI 10.1021/bc060020b; Manning HC, 2002, ORG LETT, V4, P1075, DOI 10.1021/ol017155b; Messmer K, 1998, NEUROSCI LETT, V241, P53, DOI 10.1016/S0304-3940(97)00967-1; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Nutt CL, 2003, CANCER RES, V63, P1602; Okubo T, 2004, BIOORGAN MED CHEM, V12, P423, DOI 10.1016/j.bmc.2003.10.050; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pappata S, 2000, NEUROLOGY, V55, P1052, DOI 10.1212/WNL.55.7.1052; Patel HC, 2003, ANN NY ACAD SCI, V992, P39, DOI 10.1111/j.1749-6632.2003.tb03136.x; Probst KC, 2007, NUCL MED BIOL, V34, P439, DOI 10.1016/j.nucmedbio.2007.02.009; QIAN H, 2008, J FLUORESC; Ryu JK, 2005, NEUROBIOL DIS, V20, P550, DOI 10.1016/j.nbd.2005.04.010; TOLL L, 1995, J PHARMACOL EXP THER, V273, P721; Urano Y, 2008, ANAL SCI, V24, P51, DOI 10.2116/analsci.24.51; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385; Venneti S, 2004, J CLIN INVEST, V113, P981, DOI 10.1172/JCI200420227; VENNETI S, 2006, PROGR NEURO IN PRESS; Venneti S, 2007, EXP NEUROL, V207, P118, DOI 10.1016/j.expneurol.2007.06.003; Venneti S, 2007, J NEUROCHEM, V102, P2118, DOI 10.1111/j.1471-4159.2007.04690.x; Vowinckel E, 1997, J NEUROSCI RES, V50, P345, DOI 10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5; Walter L, 2002, J BIOL CHEM, V277, P20869, DOI 10.1074/jbc.M110813200; Williams Michael, 2004, Curr Opin Investig Drugs, V5, P29; Wilms H, 2003, NEUROBIOL DIS, V14, P417, DOI 10.1016/j.nbd.2003.07.002; Witting A, 2004, P NATL ACAD SCI USA, V101, P3214, DOI 10.1073/pnas.0306707101; ZHU SJ, 1994, MOL PHARMACOL, V45, P255	61	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8271	10.1371/journal.pone.0008271	http://dx.doi.org/10.1371/journal.pone.0008271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020060	Green Published, Green Submitted, gold			2022-12-25	WOS:000272870600003
J	Dennemarker, J; Lohmuller, T; Mayerle, J; Tacke, M; Lerch, MM; Coussens, LM; Peters, C; Reinheckel, T				Dennemaerker, J.; Lohmueller, T.; Mayerle, J.; Tacke, M.; Lerch, M. M.; Coussens, L. M.; Peters, C.; Reinheckel, T.			Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis	ONCOGENE			English	Article						skin cancer; mouse model; protease; cathepsin	TRANSGENIC MICE; EMERGING ROLES; CANCER; EXPRESSION; CARCINOGENESIS; ANGIOGENESIS; CELLS; INVASION; MATRIX; GROWTH	To define a functional role for the endosomal/lysosomal cysteine protease cathepsin L (Ctsl) during squamous carcinogenesis, we generated mice harboring a constitutive Ctsl deficiency in addition to epithelial expression of the human papillomavirus type 16 oncogenes (human cytokeratin 14 (K14)-HPV16). We found enhanced tumor progression and metastasis in the absence of Ctsl. As tumor progression in K14 -HPV16 mice is dependent on inflammation and angiogenesis, we examined immune cell infiltration and vascularization without finding any effect of the Ctsl genotype. In contrast, keratinocyte-specific transgenic expression of cathepsin V, the human orthologue of mouse Ctsl, in otherwise Ctsl-deficient K14 HPV16 mice restored the phenotype observed in the control HPV16 skin. To better understand this phenotype at the molecular level, we measured several oncogenic signal transduction pathways in primary keratinocytes on stimulation with keratinocyte-conditioned cell culture medium. We found increased activation of protein kinase B/Akt and mitogen-activated protein kinase pathways in protease-deficient cells, especially if treated with media conditioned by Ctsl-deficient keratinocytes. Similarly, the level of active GTP-Ras was increased in Ctsl-deficient epidermis. We conclude that Ctsl is critical for the termination of growth factor signaling in the endosomal/lysosomal compartment of keratinocytes and, therefore, functions as an anti-tumor protease. Oncogene (2010) 29, 1611-1621; doi:10.1038/onc.2009.466; published online 21 December 2009	[Dennemaerker, J.; Lohmueller, T.; Tacke, M.; Peters, C.; Reinheckel, T.] Univ Freiburg, Inst Mol Med & Zellforsch, D-79104 Freiburg, Germany; [Mayerle, J.; Lerch, M. M.] Ernst Moritz Arndt Univ Greifswald, Dept Gastroenterol Endocrinol & Nutr, Greifswald, Germany; [Coussens, L. M.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA; [Coussens, L. M.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Peters, C.; Reinheckel, T.] Univ Freiburg, Ctr Biol Signalling Studies, Freiburg, Germany; [Peters, C.; Reinheckel, T.] Univ Freiburg, Ludwig Heilmeyer Comprehens Canc Ctr, Freiburg, Germany	University of Freiburg; Ernst Moritz Arndt Universitat Greifswald; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Freiburg; University of Freiburg	Reinheckel, T (corresponding author), Univ Freiburg, Inst Mol Med & Zellforsch, Stefan Meier Str 17, D-79104 Freiburg, Germany.	Thomas.Reinheckel@uniklinik-freiburg.de	Coussens, Lisa/ABH-9834-2020; Lerch, Markus M./E-2206-2016; Mayerle, Julia/W-7907-2019; Reinheckel, Thomas/AAL-9761-2021	Lerch, Markus M./0000-0002-9643-8263; Reinheckel, Thomas/0000-0001-9866-9105; Mayerle, Julia/0000-0002-3666-6459	Deutsche Krebshilfe [Re106977]; Excellence Initiative of the German Federal and State Governments [EXC 294]; European Union [201279]; NATIONAL CANCER INSTITUTE [R01CA130980] Funding Source: NIH RePORTER	Deutsche Krebshilfe(Deutsche Krebshilfe); Excellence Initiative of the German Federal and State Governments; European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ulrike Reif and Susanne Dollwet-Mack for excellent technical assistance and Dr Marie Follo for comments on the paper. The work was supported by a grant from the Deutsche Krebshilfe (Re106977) and in part by the Excellence Initiative of the German Federal and State Governments (EXC 294) and the European Union Framework Program (FP7 'MICRO-ENVIMET' No 201279).	Abboud-Jarrous G, 2008, J BIOL CHEM, V283, P18167, DOI 10.1074/jbc.M801327200; ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Bernard D, 2003, J INVEST DERMATOL, V120, P592, DOI 10.1046/j.1523-1747.2003.12086.x; Bethel PA, 2009, BIOORG MED CHEM LETT, V19, P4622, DOI 10.1016/j.bmcl.2009.06.090; Boudreau F, 2007, FASEB J, V21, P3853, DOI 10.1096/fj.07-8113com; Bromme D., 2004, HDB PROTEOLYTIC ENZY, P1107; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Coussens LM, 1996, AM J PATHOL, V149, P1899; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dano K, 1999, APMIS, V107, P120, DOI 10.1111/j.1699-0463.1999.tb01534.x; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; DeClerck YA, 2004, AM J PATHOL, V164, P1131, DOI 10.1016/S0002-9440(10)63200-2; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Gondi CS, 2004, CANCER RES, V64, P4069, DOI 10.1158/0008-5472.CAN-04-1243; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Hagemann S, 2004, EUR J CELL BIOL, V83, P775, DOI 10.1078/0171-9335-00404; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Mayerle J, 2005, GASTROENTEROLOGY, V129, P1251, DOI 10.1053/j.gastro.2005.08.002; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Navab R, 2008, ONCOGENE, V27, P4973, DOI 10.1038/onc.2008.144; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Reinheckel T, 2005, J CELL SCI, V118, P3387, DOI 10.1242/jcs.02469; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Tobin DJ, 2002, AM J PATHOL, V160, P1807, DOI 10.1016/S0002-9440(10)61127-3; Tolosa E, 2003, J CLIN INVEST, V112, P517, DOI 10.1172/JCI200318028; Urbich C, 2005, NAT MED, V11, P206, DOI 10.1038/nm1182; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Walz M, 2007, EXP DERMATOL, V16, P715, DOI 10.1111/j.1600-0625.2007.00579.x; Zheng X, 2004, CANCER RES, V64, P1773, DOI 10.1158/0008-5472.CAN-03-0820	48	86	88	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 18	2010	29	11					1611	1621		10.1038/onc.2009.466	http://dx.doi.org/10.1038/onc.2009.466			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	570RC	20023699	Green Accepted			2022-12-25	WOS:000275694700006
J	McLaughlin, M; Alloza, I; Quoc, HP; Scott, CJ; Hirabayashi, Y; Vandenbroeck, K				McLaughlin, Martin; Alloza, Iraide; Quoc, Hung Pham; Scott, Christopher J.; Hirabayashi, Yasuhiko; Vandenbroeck, Koen			Inhibition of Secretion of Interleukin (IL)-12/IL-23 Family Cytokines by 4-Trifluoromethyl-celecoxib Is Coupled to Degradation via the Endoplasmic Reticulum Stress Protein HERP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-COXIB ANALOG; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; CELECOXIB; CELLS; CALCIUM; INTERLEUKIN-12-ALPHA-BETA; 2,5-DIMETHYL-CELECOXIB; INFLAMMATION; USTEKINUMAB	Interleukin-12 (IL-12), p80, and IL-23 are structurally related cytokines sharing a p40 subunit. We have recently demonstrated that celecoxib and its COX-2-independent analogue 4-trifluoromethyl-celecoxib (TFM-C) inhibit secretion but not transcription of IL-12 (p35/p40) and p80 (p40/p40). This is associated with a mechanism involving altered cytokine-chaperone interaction in the endoplasmic reticulum (ER). In the present study, we found that celecoxib and TFM-C also block secretion of IL-23 (p40/p19 heterodimers). Given the putative ER-centric mode of these compounds, we performed a comprehensive RTPCR analysis of 23 ER-resident chaperones/foldases and associated co-factors. This revealed that TFM-C induced 1.5-3-fold transcriptional up-regulation of calreticulin, GRP78, GRP94, GRP170, ERp72, ERp57, ERdj4, and ERp29. However, more significantly, a 7-fold up-regulation of homocysteine-inducible ER protein (HERP) was observed. HERP is part of a high molecular mass protein complex involved in ER-associated protein degradation (ERAD). Using co-immunoprecipitation assays, we show that TFM-C induces protein interaction of p80 and IL-23 with HERP. Both HERP siRNA knockdown and HERP overexpression coupled to cycloheximide chase assays revealed that HERP is necessary for degradation of intracellularly retained p80 by TFM-C. Thus, our data suggest that targeting cytokine folding in the ER by small molecule drugs could be therapeutically exploited to alleviate in appropriate inflammation in autoimmune conditions.	[McLaughlin, Martin; Alloza, Iraide; Quoc, Hung Pham; Vandenbroeck, Koen] Univ Pais Vasco UPV EHU, Neurogenom Lab, Zamudio 48170, Spain; [McLaughlin, Martin; Scott, Christopher J.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland; [Hirabayashi, Yasuhiko] Hikarigaoka Spellman Hosp, Dept Rheumatol, Miyagino Ku, Sendai, Miyagi 9830833, Japan; [Vandenbroeck, Koen] KERBASQUE, Basque Fdn Sci, Bilbao 48011, Spain	University of Basque Country; Queens University Belfast; Basque Foundation for Science	Vandenbroeck, K (corresponding author), Univ Pais Vasco UPV EHU, Neurogenom Lab, Parque Tecnol Bizkaia, Zamudio 48170, Spain.	k.vandenbroeck@ikerbasque.org	Vandenbroeck, Koen/D-6845-2012	Vandenbroeck, Koen/0000-0002-6967-6485; McLaughlin, Martin/0000-0002-9739-7133; Alloza, Iraide/0000-0002-8949-7732	Northern Ireland R&D Office for Health and Personal Social Services, Ikerbasque [RRG11.5 RSG/1726]; Basque Foundation for Science, Bilbao, Spain; Ministerio de Ciencia e Innovacion, Madrid, Spain [MEC-2008, SAF2008-00433]	Northern Ireland R&D Office for Health and Personal Social Services, Ikerbasque; Basque Foundation for Science, Bilbao, Spain; Ministerio de Ciencia e Innovacion, Madrid, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Grants RRG11.5 RSG/1726 (to K. V.) from the Northern Ireland R&D Office for Health and Personal Social Services, Ikerbasque, the Basque Foundation for Science, Bilbao, Spain, and the Ministerio de Ciencia e Innovacion, Madrid, Spain (MEC-2008; SAF2008-00433).	Alloza I, 2006, MOL PHARMACOL, V69, P1579, DOI 10.1124/mol.105.020669; Alloza I, 2005, J PHARM PHARMACOL, V57, P213, DOI 10.1211/0022357055443; Alloza I, 2004, ANAL BIOCHEM, V324, P137, DOI 10.1016/j.ab.2003.09.017; Barnabe N, 1998, J BIOTECHNOL, V60, P67, DOI 10.1016/S0168-1656(97)00188-0; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Grosch S, 2006, JNCI-J NATL CANCER I, V98, P736, DOI 10.1093/jnci/djj206; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Johnson AJ, 2002, BIOCHEM J, V366, P831, DOI 10.1042/BJ20020279; Kardosh A, 2008, CANCER RES, V68, P843, DOI 10.1158/0008-5472.CAN-07-5555; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; Lehner I, 2003, ELECTROPHORESIS, V24, P1795, DOI 10.1002/elps.200305387; Leitzgen K, 1997, J BIOL CHEM, V272, P3117, DOI 10.1074/jbc.272.5.3117; Lenz B, 2006, EXP CELL RES, V312, P4049, DOI 10.1016/j.yexcr.2006.09.004; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; LI WWF, 1993, J BIOL CHEM, V268, P12003; Liang GQ, 2006, MOL CELL BIOL, V26, P7999, DOI 10.1128/MCB.01046-06; Lou JR, 2006, CANCER EPIDEM BIOMAR, V15, P1598, DOI 10.1158/1055-9965.EPI-06-0216; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Mikols CL, 2006, AM J RESP CRIT CARE, V174, P461, DOI 10.1164/rccm.200512-1886OC; Namba T, 2007, MOL PHARMACOL, V71, P860, DOI 10.1124/mol.106.027698; Oka Y, 2007, TOHOKU J EXP MED, V212, P431, DOI 10.1620/tjem.212.431; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Paunovic V, 2008, RHEUMATOLOGY, V47, P771, DOI 10.1093/rheumatology/kem352; Pyrko P, 2008, BIOCHEM PHARMACOL, V75, P395, DOI 10.1016/j.bcp.2007.08.029; Pyrko P, 2007, MOL CANCER THER, V6, P1262, DOI 10.1158/1535-7163.MCT-06-0629; Russell TD, 2003, J IMMUNOL, V171, P6866, DOI 10.4049/jimmunol.171.12.6866; Sai XR, 2003, FEBS LETT, V553, P151, DOI 10.1016/S0014-5793(03)01009-3; Schonthal AH, 2007, BRIT J CANCER, V97, P1465, DOI 10.1038/sj.bjc.6604049; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Torti DC, 2007, J AM ACAD DERMATOL, V57, P1059, DOI 10.1016/j.jaad.2007.07.016; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Tuvia S, 2007, J CELL BIOL, V177, P51, DOI 10.1083/jcb.200611036; Vandenbroeck K, 2004, J PHARM PHARMACOL, V56, P145, DOI 10.1211/0022357022962; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	44	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6960	6969		10.1074/jbc.M109.056614	http://dx.doi.org/10.1074/jbc.M109.056614			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20054003	hybrid, Green Published			2022-12-25	WOS:000275415600009
J	Yang, TB; Chaudhuri, S; Yang, LH; Du, LQ; Poovaiah, BW				Yang, Tianbao; Chaudhuri, Shubho; Yang, Lihua; Du, Liqun; Poovaiah, B. W.			A Calcium/Calmodulin-regulated Member of the Receptor-like Kinase Family Confers Cold Tolerance in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL REGION; FREEZING TOLERANCE; PROTEIN-PHOSPHORYLATION; GENE-EXPRESSION; CALCIUM; ARABIDOPSIS; CALMODULIN; CA2+/CALMODULIN; TRANSCRIPTOME; ACCLIMATION	Cold is a limiting environmental factor that adversely affects plant growth and productivity. Calcium/calmodulin-mediated signaling is believed to play a pivotal role in plant response to cold stress, but its exact role is not clearly understood. Here, we report that CRLK1, a novel calcium/calmodulin-regulated receptor-like kinase, is crucial for cold tolerance in plants. CRLK1 has two calmodulin-binding sites with different affinities as follows: one located at residues 369-390 with a K-d of 25 nM, and the other located at residues 28-112 with a K-d of 160 nM. Calcium/calmodulin stimulated the kinase activity, but the addition of chlorpromazine, a calmodulin antagonist, blocked its stimulation. CRLK1 is mainly localized in the plasma membrane, and its expression is stimulated by cold and hydrogen peroxide treatments. Under normal growth conditions, there is no noticeable phenotypic difference between wild-type and crlk1 knock-out mutant plants. However, as compared with wild-type plants, the crlk1 knock-out mutants exhibited an increased sensitivity to chilling and freezing temperatures. Northern analysis showed that the induction of cold-responsive genes, including CBF1, RD29A, COR15a, and KIN1 in crlk1 mutants, is delayed as compared with wild-type plants. These results indicate that CRLK1 is a positive regulator of cold tolerance in plants. Furthermore, our results suggest that CRLK1 plays a role in bridging calcium/calmodulin signaling and cold signaling.	[Poovaiah, B. W.] Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA; Washington State Univ, Dept Hort, Pullman, WA 99164 USA	Washington State University; Washington State University	Poovaiah, BW (corresponding author), Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA.	poovaiah@wsu.edu			United States Department of Agriculture [2008-35100-04566]; National Institute of Food and Agriculture; National Science Foundation [ISO-0642146]; Washington State University Agricultural Research Center	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Science Foundation(National Science Foundation (NSF)); Washington State University Agricultural Research Center	This work was supported by the National Research Initiative Competitive Grant 2008-35100-04566 from the United States Department of Agriculture, the National Institute of Food and Agriculture, Grant ISO-0642146 from the National Science Foundation, and the Washington State University Agricultural Research Center.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Browse J, 2001, CURR OPIN PLANT BIOL, V4, P241, DOI 10.1016/S1369-5266(00)00167-9; Charpenteau M, 2004, BIOCHEM J, V379, P841, DOI 10.1042/BJ20031045; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Du LQ, 2009, NATURE, V457, P1154, DOI 10.1038/nature07612; Du LQ, 2005, NATURE, V437, P741, DOI 10.1038/nature03973; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Jahn T, 1997, PLANT CELL, V9, P1805, DOI 10.1105/tpc.9.10.1805; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; LARSSON C, 1987, METHOD ENZYMOL, V148, P558; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; MONROY AF, 1993, PLANT PHYSIOL, V102, P1227, DOI 10.1104/pp.102.4.1227; MONROY AF, 1995, PLANT CELL, V7, P321, DOI 10.1105/tpc.7.3.321; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Polisensky DH, 1996, PLANT PHYSIOL, V111, P1271, DOI 10.1104/pp.111.4.1271; POOVAIAH BW, 1973, PLANT PHYSIOL, V52, P236, DOI 10.1104/pp.52.3.236; POOVAIAH BW, 1987, CRC CR REV PLANT SCI, V6, P47, DOI 10.1080/07352688709382247; Reddy ASN, 2001, PLANT SCI, V160, P381, DOI 10.1016/S0168-9452(00)00386-1; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Snyders S, 1999, J BIOL CHEM, V274, P9137, DOI 10.1074/jbc.274.14.9137; Tahtiharju S, 1997, PLANTA, V203, P442, DOI 10.1007/s004250050212; Takezawa D, 1996, J BIOL CHEM, V271, P8126, DOI 10.1074/jbc.271.14.8126; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Tebar F, 2002, MOL BIOL CELL, V13, P2057, DOI 10.1091/mbc.01-12-0571; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Townley HE, 2002, PLANT PHYSIOL, V128, P1169, DOI 10.1104/pp.010814; Vanoosthuyse V, 2003, PLANT PHYSIOL, V133, P919, DOI 10.1104/pp.103.023846; VELUTHAMBI K, 1984, SCIENCE, V223, P167, DOI 10.1126/science.223.4632.167; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yang TB, 2004, J BIOL CHEM, V279, P42552, DOI 10.1074/jbc.M402830200; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Yang TB, 2007, FUNCT PLANT BIOL, V34, P343, DOI 10.1071/FP06293; Zhang L, 2003, TRENDS PLANT SCI, V8, P123, DOI 10.1016/S1360-1385(03)00013-X	41	124	150	9	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7119	7126		10.1074/jbc.M109.035659	http://dx.doi.org/10.1074/jbc.M109.035659			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20026608	Green Published, hybrid			2022-12-25	WOS:000275415600025
J	Morawska-Onyszczuk, M; Bienkowska-Szewczyk, K; Dobbelstein, M				Morawska-Onyszczuk, M.; Bienkowska-Szewczyk, K.; Dobbelstein, M.			Self-association of adenovirus type 5 E1B-55kDa as well as p53 is essential for their mutual interaction	ONCOGENE			English	Article						p53; E1B-55kDa; oligomerization; adenovirus	E1B 55-KILODALTON PROTEIN; TRANSCRIPTIONAL ACTIVATION; NUCLEAR-LOCALIZATION; E4ORF3 PROTEIN; TUMOR-ANTIGEN; DNA; DEGRADATION; BINDING; ONCOPROTEINS; IDENTIFICATION	The adenovirus type 5 E1B-55kDa oncoprotein forms a complex with the tumor suppressor p53 and inactivates it. E1B-55kDa and p53 are each capable of forming oligomers. We mapped the oligomerization domain of E1B-55kDa to the central portion of the protein. Disturbing E1B-55kDa self-association by point mutations at residues 285/286 or 307 not only impairs its intracellular localization to the cytoplasmic clusters, but in addition, its association with p53. Strikingly, tetramerization of p53 is also required for efficient association with E1B-55kDa. Moreover, two different E1B-55kDa mutants defective for p53 binding but proficient for oligomerization can trans-complement each other for p53 relocalization. We propose that the homo-oligomerization of each component enables efficient interaction between E1B-55kDa and p53 through increased avidity. Oncogene (2010) 29, 1773-1786; doi:10.1038/onc.2009.461; published online 21 December 2009	[Morawska-Onyszczuk, M.; Dobbelstein, M.] Univ Gottingen, Dept Mol Oncol, Gottingen Ctr Mol Biosci, D-37077 Gottingen, Germany; [Morawska-Onyszczuk, M.; Bienkowska-Szewczyk, K.] Univ Gdansk, Dept Mol Virol, Intercoll Fac Biotechnol, PL-80952 Gdansk, Poland; [Morawska-Onyszczuk, M.; Bienkowska-Szewczyk, K.] Med Univ Gdansk, Gdansk, Poland	University of Gottingen; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Dobbelstein, M (corresponding author), Univ Gottingen, Dept Mol Oncol, Gottingen Ctr Mol Biosci, Ernst Caspari Haus,Justus Liebig Weg 11, D-37077 Gottingen, Germany.	mdobbel@uni-goettingen.de		Morawska, Magdalena/0000-0003-0449-5226; Bienkowska-szewczyk, Krystyna/0000-0003-3650-2902; Dobbelstein, Matthias/0000-0001-5052-3967	German Cancer Aid/Dr Mildred Scheel Stiftung; EU; German Research Foundation (DFG); Wilhelm Sander Stiftung; Statens Sundhedsvidenskabelige Forskningsrad of Denmark; Danish Cancer Society; Fonden til Laegevidenskabens Fremme; Novonordisk fonden; University of Gottingen; Gottingen Graduate School for Neurosciences and Molecular Biosciences (GGNB)	German Cancer Aid/Dr Mildred Scheel Stiftung(Deutsche Krebshilfe); EU(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); Wilhelm Sander Stiftung; Statens Sundhedsvidenskabelige Forskningsrad of Denmark; Danish Cancer Society(Danish Cancer Society); Fonden til Laegevidenskabens Fremme; Novonordisk fonden(Novo Nordisk Foundation); University of Gottingen; Gottingen Graduate School for Neurosciences and Molecular Biosciences (GGNB)	We thank C Hippel and A Dickmanns for excellent technical assistance. We thank M Oren (Rehovot) and K Vousden (Glasgow) for plasmids and cells. Our work was supported by the German Cancer Aid/Dr Mildred Scheel Stiftung, the EU 6th Framework Program (Integrated Project Active p53), the German Research Foundation (DFG), the Wilhelm Sander Stiftung, the Statens Sundhedsvidenskabelige Forskningsrad of Denmark, the Danish Cancer Society, the Fonden til Laegevidenskabens Fremme, the Novonordisk fonden, the MSc/PhD Molecular Biology Program at the University of Gottingen, and The Gottingen Graduate School for Neurosciences and Molecular Biosciences (GGNB).	Araujo FD, 2005, J VIROL, V79, P11382, DOI 10.1128/JVI.79.17.11382-11391.2005; Baker A, 2007, J VIROL, V81, P7034, DOI 10.1128/JVI.00029-07; BALAGURUMOORTHY P, 1995, P NATL ACAD SCI USA, V92, P8591, DOI 10.1073/pnas.92.19.8591; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Dallaire F, 2009, J VIROL, V83, P5329, DOI 10.1128/JVI.00089-09; DAVIS AC, 1989, IMMUNOL TODAY, V10, P118, DOI 10.1016/0167-5699(89)90244-2; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; DISSANAYAKE S, 1977, IMMUNOLOGY, V32, P309; Dobbelstein M, 1997, EMBO J, V16, P4276, DOI 10.1093/emboj/16.14.4276; Dobner T, 1996, SCIENCE, V272, P1470, DOI 10.1126/science.272.5267.1470; Fleisig HB, 2007, ONCOGENE, V26, P4797, DOI 10.1038/sj.onc.1210281; Gonzalez RA, 2002, J VIROL, V76, P4507, DOI 10.1128/JVI.76.9.4507-4519.2002; Goodrum FD, 1996, J VIROL, V70, P6323, DOI 10.1128/JVI.70.9.6323-6335.1996; GRAND RJA, 1995, VIROLOGY, V207, P255, DOI 10.1006/viro.1995.1074; Harada JN, 2002, J VIROL, V76, P9194, DOI 10.1128/JVI.76.18.9194-9206.2002; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Horridge JJ, 1998, J VIROL, V72, P9374, DOI 10.1128/JVI.72.11.9374-9379.1998; Konig C, 1999, J VIROL, V73, P2253; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leppard KN, 1999, J GEN VIROL, V80, P997, DOI 10.1099/0022-1317-80-4-997; Levine AJ, 2009, VIROLOGY, V384, P285, DOI 10.1016/j.virol.2008.09.034; Lilyestrom W, 2006, GENE DEV, V20, P2373, DOI 10.1101/gad.1456306; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Liu Y, 2005, J VIROL, V79, P14004, DOI 10.1128/JVI.79.22.14004-14016.2005; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; Marshall LJ, 2008, J VIROL, V82, P6395, DOI 10.1128/JVI.00043-08; Martin MED, 1998, J VIROL, V72, P3146, DOI 10.1128/JVI.72.4.3146-3154.1998; Olivier M, 2009, CANCER GENE THER, V16, P1, DOI 10.1038/cgt.2008.69; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Querido E, 1997, J VIROL, V71, P3788, DOI 10.1128/JVI.71.5.3788-3798.1997; Querido E, 2001, J VIROL, V75, P699, DOI 10.1128/JVI.75.2.699-709.2001; Roth J, 1998, J VIROL, V72, P8510, DOI 10.1128/JVI.72.11.8510-8516.1998; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; Schwartz RA, 2008, J VIROL, V82, P9043, DOI 10.1128/JVI.00925-08; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Shen YQ, 2001, J VIROL, V75, P4297, DOI 10.1128/JVI.75.9.4297-4307.2001; Singh RK, 2007, J BIOL CHEM, V282, P10901, DOI 10.1074/jbc.M610879200; Steegenga WT, 1998, ONCOGENE, V16, P349, DOI 10.1038/sj.onc.1201540; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Teodoro JG, 1997, J VIROL, V71, P3620, DOI 10.1128/JVI.71.5.3620-3627.1997; Wienzek S, 2000, J VIROL, V74, P193, DOI 10.1128/JVI.74.1.193-202.2000; ZAJDEL MEB, 1988, ONCOGENE, V2, P579; ZANTEMA A, 1985, MOL CELL BIOL, V5, P3084, DOI 10.1128/MCB.5.11.3084; Zhao LY, 2003, J VIROL, V77, P13171, DOI 10.1128/JVI.77.24.13171-13181.2003	48	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	12					1773	1786		10.1038/onc.2009.461	http://dx.doi.org/10.1038/onc.2009.461			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	574VR	20023703				2022-12-25	WOS:000276022800007
J	Punj, V; Matta, H; Schamus, S; Tamewitz, A; Anyang, B; Chaudhary, PM				Punj, V.; Matta, H.; Schamus, S.; Tamewitz, A.; Anyang, B.; Chaudhary, P. M.			Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a	ONCOGENE			English	Article						KSHV; vFLIP; K13; NF-kB; CXCR4; mir-146a	NF-KAPPA-B; MICROVASCULAR ENDOTHELIAL-CELLS; CELLULAR MICRORNA MIR-146A; GENE-EXPRESSION; LYTIC REPLICATION; INDUCED APOPTOSIS; KINASE COMPLEX; ACTIVATION; HUMAN-HERPESVIRUS-8; TRANSFORMATION	Kaposi's sarcoma (KS)-associated herpesvirus (KSHV)encoded viral FLICE inhibitory protein (vFLIP) K13 is a potent activator of the nuclear factor-kappa B (NF-kappa B) pathway. In this study, we show that infection with KHSV and ectopic expression of K13, but not its NF-kappa B-defective mutant, suppressed the expression of CXCR4. Suppression of CXCR4 by KSHV and K13 was associated with upregulated expression of miR-146a, a microRNA that is known to bind to the 3'-untranslated region of CXCR4 mRNA. Reporter studies identified two NF-kappa B sites in the promoter of miR-146a that were essential for its activation by K13. Accordingly, ectopic expression of K13, but not its NF-kappa B-defective mutant or other vFLIPs, strongly stimulated the miR-146a promoter activity, which could be blocked by specific genetic and pharmacological inhibitors of the NF-kappa B pathway. Finally, expression of CXCR4 was downregulated in clinical samples of KS and this was accompanied by an increased expression of miR-146a. Our results show that K13-induced NF-kappa B activity suppresses CXCR4 through upregulation of miR-146a. Downregulation of CXCR4 expression by K13 may contribute to KS development by promoting premature release of KSHV-infected endothelial progenitors into the circulation. Oncogene (2010) 29, 1835-1844; doi:10.1038/onc.2009.460; published online 21 December 2009	[Punj, V.; Matta, H.; Schamus, S.; Tamewitz, A.; Anyang, B.; Chaudhary, P. M.] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Hillman Canc Ctr,Canc Inst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chaudhary, PM (corresponding author), Univ Pittsburgh, Dept Med, Div Hematol Oncol, Hillman Canc Ctr,Canc Inst, 5117 Ctr Ave,Suite 1-19A, Pittsburgh, PA 15213 USA.	chaudharypm@upmc.edu	Chaudhary, Preet/E-1970-2018		National Institutes of Health [CA85177, CA124621]; Leukemia & Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA124621, R01CA085177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr David Baltimore (California Institute of Technology) for the miR-146a promoter reporter constructs, Dr Parkash Gill for SLK cells, the NIH AIDS Research and Reference Reagent Program for CXCR4 antibodies and the Cancer Specimen Resources at the University of California, San Francisco and George Washington University, Washington, for providing patient samples. This work was supported by grants from the National Institutes of Health (CA85177 and CA124621) and the Leukemia & Lymphoma Society.	Ahn GO, 2009, ANGIOGENESIS, V12, P159, DOI 10.1007/s10456-009-9135-7; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Baxter A, 2004, BIOORG MED CHEM LETT, V14, P2817, DOI 10.1016/j.bmcl.2004.03.058; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chaudhary Preet M., 2008, V1, P186, DOI 10.1159/000141519; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; Ciufo DM, 2001, J VIROL, V75, P5614, DOI 10.1128/JVI.75.12.5614-5626.2001; Dorak T, 2006, REAL TIME PCR; Dourmishev LA, 2003, MICROBIOL MOL BIOL R, V67, P175, DOI 10.1128/MMBR.67.2.175-212.2003; Flore O, 1998, NATURE, V394, P588, DOI 10.1038/29093; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Matta H, 2008, ONCOGENE, V27, P5243, DOI 10.1038/onc.2008.150; Matta H, 2007, ONCOGENE, V26, P1656, DOI 10.1038/sj.onc.1209931; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Moore PS, 2001, PHILOS T R SOC B, V356, P499, DOI 10.1098/rstb.2000.0777; Moses AV, 2002, J VIROL, V76, P8383, DOI 10.1128/JVI.76.16.8383-8399.2002; Moses AV, 1999, J VIROL, V73, P6892, DOI 10.1128/JVI.73.8.6892-6902.1999; Motsch N, 2007, RNA BIOL, V4, P131, DOI 10.4161/rna.4.3.5206; Naranatt PP, 2004, CANCER RES, V64, P72, DOI 10.1158/0008-5472.CAN-03-2767; Pellet C, 2006, J INVEST DERMATOL, V126, P621, DOI 10.1038/sj.jid.5700083; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Poole LJ, 2002, J VIROL, V76, P3395, DOI 10.1128/JVI.76.7.3395-3420.2002; Punj V, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-50; Punj V, 2009, BLOOD, V113, P5660, DOI 10.1182/blood-2008-10-186403; Raggo C, 2005, CANCER RES, V65, P5084, DOI 10.1158/0008-5472.CAN-04-2822; Sakakibara S, 2009, J VIROL, V83, P2140, DOI 10.1128/JVI.01871-08; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; Schulz TF, 2000, J ANTIMICROB CHEMOTH, V45, P15, DOI 10.1093/jac/45.suppl_4.15; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Sun Q, 2003, BLOOD, V101, P1956, DOI 10.1182/blood-2002-07-2072; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Thurau M, 2009, J VIROL, V83, P598, DOI 10.1128/JVI.00629-08; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Xu YY, 2007, J GEN VIROL, V88, P46, DOI 10.1099/vir.0.82375-0; Ye FC, 2008, J VIROL, V82, P4235, DOI 10.1128/JVI.02370-07; Zhao JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001067	49	51	52	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	12					1835	1844		10.1038/onc.2009.460	http://dx.doi.org/10.1038/onc.2009.460			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	574VR	20023696	Green Accepted			2022-12-25	WOS:000276022800012
J	Armstrong, JL; Flockhart, R; Veal, GJ; Lovat, PE; Redfern, CPF				Armstrong, Jane L.; Flockhart, Ross; Veal, Gareth J.; Lovat, Penny E.; Redfern, Christopher P. F.			Regulation of Endoplasmic Reticulum Stress-induced Cell Death by ATF4 in Neuroectodermal Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FENRETINIDE-INDUCED APOPTOSIS; MELANOMA-CELLS; PROTEASOME INHIBITORS; GROWTH ARREST; ALPHA-SUBUNIT; ER STRESS; IN-VITRO; PROTEIN; TRANSLATION; NOXA	The neuroectodermal tumors neuroblastoma and melanoma represent biologically aggressive and chemoresistant cancers. The chemotherapeutic agents fenretinide and bortezomib induce apoptosis through endoplasmic reticulum (ER) stress in these tumor types. The aim of this study was to test the hypothesis that the early events of ER stress signaling and response pathways induced by fenretinide and bortezomib are mediated by the eukaryotic initiation factor 2 alpha (eIF2 alpha)-ATF4 signaling pathway. Treatment of neuroblastoma and melanoma cell lines with fenretinide, bortezomib, or thapsigargin resulted in induction of eIF2 alpha signaling, characterized by increased expression of phosphorylated eIF2 alpha, ATF4, ATF3, and GADD34. These events correlated with induction of the pro-apoptotic protein Noxa. The cytotoxic response, characterized by up-regulation of Noxa and cell death, was dependent on ATF4, but not the ER-related pro-death signaling pathways involving GADD153 or IRE1. Although PERK-dependent phosphorylation of eIF2 alpha enhanced ATF4 protein levels during ER stress, cell death in response to fenretinide, bortezomib, or thapsigargin was not abrogated by inhibition of eIF2 alpha phosphorylation through PERK knockdown or overexpression of wild-type eIF2 alpha. Furthermore, ATF4 induction in response to ER stress was dependent primarily on transcriptional activation, which occurred in a PERK-and phosphorylated eIF2 alpha-independent manner. These results demonstrate that ATF4 mediates ER stress-induced cell death of neuroectodermal tumor cells in response to fenretinide or bortezomib. Understanding the complex regulation of cell death pathways in response to ER stress-inducing drugs has the potential to reveal novel therapeutic targets, thus allowing the development of improved treatment strategies to overcome chemoresistance.	[Armstrong, Jane L.; Flockhart, Ross; Lovat, Penny E.] Univ Newcastle, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Armstrong, JL (corresponding author), Univ Newcastle, Sch Med, Inst Cellular Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	J.L.Armstrong@ncl.ac.uk	Longo, Kenneth A/A-5631-2010	Veal, Gareth/0000-0002-1897-8678; Redfern, Christopher/0000-0002-1833-8048; Armstrong, Jane/0000-0002-5822-0597; Lovat, Penny/0000-0002-6657-6825	Cancer Research UK; Newcastle Healthcare Charity; British Skin Foundation; Engineering and Physical Sciences Research Council [EP/C509005/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Newcastle Healthcare Charity; British Skin Foundation; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Cancer Research UK, the Newcastle Healthcare Charity, and the British Skin Foundation.	Adams J, 1999, CANCER RES, V59, P2615; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Armstrong JL, 2007, APOPTOSIS, V12, P613, DOI 10.1007/s10495-006-0020-1; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Carracedo A, 2006, CANCER RES, V66, P6748, DOI 10.1158/0008-5472.CAN-06-0169; Corazzari M, 2007, BRIT J CANCER, V96, P1062, DOI 10.1038/sj.bjc.6603672; Encinar JA, 2001, J BIOL CHEM, V276, P2742, DOI 10.1074/jbc.M008594200; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Fribley AM, 2006, J BIOL CHEM, V281, P31440, DOI 10.1074/jbc.M604356200; Hamanaka RB, 2009, ONCOGENE, V28, P910, DOI 10.1038/onc.2008.428; Heath-Engel HM, 2008, ONCOGENE, V27, P6419, DOI 10.1038/onc.2008.309; Hill DS, 2009, CLIN CANCER RES, V15, P1192, DOI 10.1158/1078-0432.CCR-08-2150; Iovanna JL, 2002, J GASTROINTEST CANC, V31, P89; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Linder S, 2005, DRUG RESIST UPDATE, V8, P199, DOI 10.1016/j.drup.2005.06.004; Lovat PE, 2000, EXP CELL RES, V260, P50, DOI 10.1006/excr.2000.4988; Lovat PE, 2008, CANCER RES, V68, P5363, DOI 10.1158/0008-5472.CAN-08-0035; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Qin JZ, 2006, CANCER RES, V66, P9636, DOI 10.1158/0008-5472.CAN-06-0747; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Raffaghello L, 2003, INT J CANCER, V104, P559, DOI 10.1002/ijc.10991; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schonthal AH, 2009, CANCER LETT, V275, P163, DOI 10.1016/j.canlet.2008.07.005; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zu K, 2006, ONCOGENE, V25, P546, DOI 10.1038/sj.onc.1209071	41	118	121	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6091	6100		10.1074/jbc.M109.014092	http://dx.doi.org/10.1074/jbc.M109.014092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20022965	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000275367500012
J	Ding, BJ; LeJeune, D; Li, SS				Ding, Baojin; LeJeune, Danielle; Li, Shisheng			The C-terminal Repeat Domain of Spt5 Plays an Important Role in Suppression of Rad26-independent Transcription Coupled Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; CYCLOBUTANE PYRIMIDINE DIMERS; GLOBAL GENOMIC REPAIR; DNA-DEPENDENT ATPASE; SACCHAROMYCES-CEREVISIAE; COCKAYNE-SYNDROME; ELONGATION-FACTOR; IN-VIVO; PREFERENTIAL REPAIR	In eukaryotic cells, transcription coupled nucleotide excision repair (TCR) is believed to be initiated by RNA polymerase II (Pol II) stalled at a lesion in the transcribed strand of a gene. Rad26, the yeast homolog of the human Cockayne syndrome group B (CSB) protein, plays an important role in TCR. Spt4, a transcription elongation factor that forms a complex with Spt5, has been shown to suppress TCR in rad26 Delta cells. Here we present evidence that Spt4 indirectly suppresses Rad26-independent TCR by protecting Spt5 from degradation and stabilizing the interaction of Spt5 with Pol II. We further found that the C-terminal repeat (CTR) domain of Spt5, which is dispensable for cell viability and is not involved in interactions with Spt4 and Pol II, plays an important role in the suppression. The Spt5 CTR is phosphorylated by the Bur kinase. Inactivation of the Bur kinase partially alleviates TCR in rad26 Delta cells. We propose that the Spt5 CTR suppresses Rad26-independent TCR by serving as a platform for assembly of a multiple protein suppressor complex that is associated with Pol II. Phosphorylation of the Spt5 CTR by the Bur kinase may facilitate the assembly of the suppressor complex.	[Ding, Baojin; LeJeune, Danielle; Li, Shisheng] Louisiana State Univ, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Li, SS (corresponding author), Louisiana State Univ, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	shli@vetmed.lsu.edu	Ding, Baojin/J-5479-2015; Li, Shisheng/H-9126-2012	Ding, Baojin/0000-0002-2149-2599; Tatum, Danielle/0000-0002-3281-3853	National Science Foundation [MCB-0745229]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0745229.	Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chen XF, 2007, MOL CELL BIOL, V27, P4617, DOI 10.1128/MCB.00404-07; COLLART MA, 2004, CURRENT PROTOCOLS MO; Ding BJ, 2007, DNA REPAIR, V6, P1661, DOI 10.1016/j.dnarep.2007.06.001; ELLENBERGER T, 2006, DNA REPAIR MUTAGENES; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gillette TG, 2006, EMBO J, V25, P2529, DOI 10.1038/sj.emboj.7601120; Guo M, 2008, STRUCTURE, V16, P1649, DOI 10.1016/j.str.2008.08.013; Guzder SN, 1996, J BIOL CHEM, V271, P18314, DOI 10.1074/jbc.271.31.18314; Guzder SN, 1998, J BIOL CHEM, V273, P6292, DOI 10.1074/jbc.273.11.6292; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Jansen LET, 2000, EMBO J, V19, P6498, DOI 10.1093/emboj/19.23.6498; Jansen LET, 2002, NUCLEIC ACIDS RES, V30, P3532, DOI 10.1093/nar/gkf475; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lee SK, 2001, MOL CELL BIOL, V21, P8651, DOI 10.1128/MCB.21.24.8651-8656.2001; LeJeune D, 2009, DNA REPAIR, V8, P40, DOI 10.1016/j.dnarep.2008.08.010; Li SS, 2006, MOL CELL BIOL, V26, P9430, DOI 10.1128/MCB.01656-06; Li SH, 2006, J BIOL CHEM, V281, P36643, DOI 10.1074/jbc.M604885200; Li SS, 1996, CARCINOGENESIS, V17, P1549, DOI 10.1093/carcin/17.8.1549; Li SS, 2000, METHODS, V22, P170, DOI 10.1006/meth.2000.1058; Li SS, 2004, J BIOL CHEM, V279, P14418, DOI 10.1074/jbc.M312004200; Li SS, 1997, J MOL BIOL, V271, P31, DOI 10.1006/jmbi.1997.1154; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; LOMMEL L, 1991, MUTAT RES, V255, P183, DOI 10.1016/0921-8777(91)90052-Q; LUNDBLAD V, 2004, CURRENT PROTOCOLS MO; MALONE EA, 1993, MOL GEN GENET, V237, P449, DOI 10.1007/BF00279450; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Patturajan M, 1999, J BIOL CHEM, V274, P27823, DOI 10.1074/jbc.274.39.27823; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Ramsey KL, 2004, MOL CELL BIOL, V24, P6362, DOI 10.1128/MCB.24.14.6362-6378.2004; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Ribar B, 2006, MOL CELL BIOL, V26, P3999, DOI 10.1128/MCB.00293-06; Rondon AG, 2003, EMBO J, V22, P612, DOI 10.1093/emboj/cdg047; Sambrook J, 2001, MOL CLONING LAB MANU; Schindler D, 1975, Methods Cell Biol, V12, P17; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; SELBY CP, 1994, MICROBIOL REV, V58, P317, DOI 10.1128/MMBR.58.3.317-329.1994; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SIKORSKI RS, 1989, GENETICS, V122, P19; SWANSON MS, 1991, MOL CELL BIOL, V11, P3009, DOI 10.1128/MCB.11.6.3009; SWANSON MS, 1992, GENETICS, V132, P325; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; VANHOFFEN A, 1993, NUCLEIC ACIDS RES, V21, P5890, DOI 10.1093/nar/21.25.5890; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VERHAGE R, 1994, MOL CELL BIOL, V14, P6135, DOI 10.1128/MCB.14.9.6135; Verhage RA, 1996, MOL CELL BIOL, V16, P496; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; WINSTON F, 1984, GENETICS, V107, P179; Winston F, 2001, GENOME BIOL, V2; Wood A, 2006, CELL CYCLE, V5, P1066, DOI 10.4161/cc.5.10.2769; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; Yao S, 2000, MOL CELL BIOL, V20, P7080, DOI 10.1128/MCB.20.19.7080-7087.2000; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106; Zhu WY, 2007, NUCLEIC ACIDS RES, V35, P4064, DOI 10.1093/nar/gkm430	74	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5317	5326		10.1074/jbc.M109.082818	http://dx.doi.org/10.1074/jbc.M109.082818			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20042611	Green Published, hybrid			2022-12-25	WOS:000275327200025
J	Bell, CE; Watson, AJ				Bell, Christine E.; Watson, Andrew J.			SNAI1 and SNAI2 Are Asymmetrically Expressed at the 2-Cell Stage and Become Segregated to the TE in the Mouse Blastocyst	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NA/K-ATPASE; GENE; EMBRYO; CELL; TROPHECTODERM; EMBRYOGENESIS; PROTEINS; SLUG	SNAI1 and SNAI2 are transcription factors that initiate Epithelial-to-Mesenchymal cell transitions throughout development and in cancer metastasis. Here we show novel expression of SNAI1 and SNAI2 throughout mouse preimplantation development revealing asymmetrical localization of both SNAI1 and SNAI2 in individual blastomeres beginning at the 2-cell stage through to the 8-cell stage where SNAI1 and SNAI2 are then only detected in outer cells and not inner cells of the blastocyst. This study implicates SNAI1 and SNAI2 in the lineage segregation of the trophectoderm and inner cell mass, and provides new insight into these oncogenes.	[Bell, Christine E.; Watson, Andrew J.] Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada; [Bell, Christine E.; Watson, Andrew J.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Watson, Andrew J.] Univ Western Ontario, Dept Med, London, ON, Canada; [Bell, Christine E.; Watson, Andrew J.] Univ Western Ontario, Childrens Hlth Res Inst, London, ON, Canada; [Bell, Christine E.; Watson, Andrew J.] Lawson Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Bell, CE (corresponding author), Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada.	CEJBell@gmail.com	Watson, Andrew J/A-5636-2015	Watson, Andrew J/0000-0002-2344-3061	Canadian Institute for Health Research - Operating [MOP-49-449]	Canadian Institute for Health Research - Operating(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institute for Health Research - Operating Grant #MOP-49-449 (URL: http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antczak M, 1997, MOL HUM REPROD, V3, P1067, DOI 10.1093/molehr/3.12.1067; Bell CE, 2008, MOL HUM REPROD, V14, P691, DOI 10.1093/molehr/gan063; Bischoff M, 2008, DEVELOPMENT, V135, P953, DOI 10.1242/dev.014316; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chandrasekharan N, 2001, NANO LETT, V1, P67, DOI 10.1021/nl000184f; Espineda CE, 2004, MOL BIOL CELL, V15, P1364, DOI 10.1091/mbc.E03-09-0646; FLEMING TP, 1989, J CELL BIOL, V108, P1407, DOI 10.1083/jcb.108.4.1407; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; HAMMERSCHMIDT M, 1993, DEVELOPMENT, V119, P1107; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; Johnson MH, 2004, SEMIN CELL DEV BIOL, V15, P583, DOI 10.1016/j.semcdb.2004.04.002; Madan P, 2007, J BIOL CHEM, V282, P12127, DOI 10.1074/jbc.M700696200; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; ROSSANT J, 1976, J EMBRYOL EXP MORPH, V36, P283; Rukstalis JM, 2007, GENE EXPR PATTERNS, V7, P471, DOI 10.1016/j.modgep.2006.11.001; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Veltmaat JM, 2000, INT J DEV BIOL, V44, P297; Violette MI, 2006, DEV BIOL, V289, P406, DOI 10.1016/j.ydbio.2005.11.004; WATSON AJ, 1988, DEV BIOL, V126, P80, DOI 10.1016/0012-1606(88)90241-2; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yoshino J, 2007, BIOCHEM BIOPH RES CO, V362, P63, DOI 10.1016/j.bbrc.2007.07.146	23	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8530	10.1371/journal.pone.0008530	http://dx.doi.org/10.1371/journal.pone.0008530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046880	Green Published, gold, Green Submitted			2022-12-25	WOS:000273180200011
J	Pasternak, AO; Jurriaans, S; Bakker, M; Prins, JM; Berkhout, B; Lukashov, VV				Pasternak, Alexander O.; Jurriaans, Suzanne; Bakker, Margreet; Prins, Jan M.; Berkhout, Ben; Lukashov, Vladimir V.			Cellular Levels of HIV Unspliced RNA from Patients on Combination Antiretroviral Therapy with Undetectable Plasma Viremia Predict the Therapy Outcome	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; LOAD LESS-THAN-50 COPIES/ML; CD4(+) T-LYMPHOCYTES; RESIDUAL VIREMIA; LATENT RESERVOIR; VIRAL LOAD; PERIPHERAL-BLOOD; DRUG-RESISTANCE; IN-VIVO; REPLICATION	Background: Combination antiretroviral therapy (cART), the standard of care for HIV-1 infection, is considered to be successful when plasma viremia remains below the detection limit of commercial assays. Yet, cART fails in a substantial proportion of patients after the apparent success. No laboratory markers are known that are predictive of cART outcome in initial responders during the period of undetectable plasma viremia. Methodology/Principal Findings: Here, we report the results of a retrospective longitudinal study of twenty-six HIV-infected individuals who initially responded to cART by having plasma viremia suppressed to <50 copies/ml. Eleven of these patients remained virologically suppressed, whereas fifteen experienced subsequent cART failure. Using sensitive methods based on seminested real-time PCR, we measured the levels of HIV-1 proviral (pr) DNA, unspliced ( us) RNA, and multiply spliced RNA in the peripheral blood mononuclear cells (PBMC) of these patients at multiple time points during the period of undetectable plasma viremia on cART. Median under-therapy level of usRNA was significantly higher (0.43 log(10) difference, P = 0.0015) in patients who experienced subsequent cART failure than in successfully treated patients. In multivariate analysis, adjusted for baseline CD4(+) counts, prior ART experience, and particular cART regimens, the maximal usRNA level under therapy was the best independent predictor of subsequent therapy failure ( adjusted odds ratio [95% CI], 24.4 [1.5-389.5], P = 0.024). The only other factor significantly associated with cART failure was prior ART experience ( adjusted odds ratio [ 95% CI], 12.3 [1.1-138.4], P = 0.042). Levels of usRNA under cART inversely correlated with baseline CD4(+) counts ( P = 0.0003), but did not correlate with either baseline usRNA levels or levels of prDNA under therapy. Conclusion: Our data demonstrate that the level of HIV-1 usRNA in PBMC, measured in cART-treated patients with undetectable plasma viremia, is a strong predictive marker for the outcome of therapy.	[Pasternak, Alexander O.; Bakker, Margreet; Berkhout, Ben; Lukashov, Vladimir V.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Jurriaans, Suzanne] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol, NL-1105 AZ Amsterdam, Netherlands; [Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Pasternak, AO (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,CINIMA, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	v.lukashov@amc.uva.nl	Prins, Jan M./AAF-4945-2020; Pasternak, Alexander/P-2067-2017	Pasternak, Alexander/0000-0002-4097-4251	Dutch AIDS Fonds [2004045]; The Netherlands National Institute for Public Health and the Environment	Dutch AIDS Fonds; The Netherlands National Institute for Public Health and the Environment	The study was financially supported by the Dutch AIDS Fonds (http://www.aidsfonds.nl/), grant 2004045. The Amsterdam Cohort Studies are financially supported by The Netherlands National Institute for Public Health and the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, ANTIRETROVIRAL THERA, DOI DOI 10.5588/pha.15.0008; Bagnarelli P, 1996, J VIROL, V70, P7603, DOI 10.1128/JVI.70.11.7603-7613.1996; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fischer M, 2002, ANTIVIR THER, V7, P91; Fischer M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-107; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Gallant JE, 2007, CLIN INFECT DIS, V44, P453, DOI 10.1086/510752; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hatzakis AE, 2004, AIDS, V18, P2261, DOI 10.1097/00002030-200411190-00006; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Hermankova M, 2001, JAMA-J AM MED ASSOC, V286, P196, DOI 10.1001/jama.286.2.196; Hockett RD, 1999, J EXP MED, V189, P1545, DOI 10.1084/jem.189.10.1545; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Kupfer B, 2007, J MED VIROL, V79, P1440, DOI 10.1002/jmv.20993; Le Moing V, 2002, AIDS, V16, P21, DOI 10.1097/00002030-200201040-00004; Lewin SR, 1999, J VIROL, V73, P6099, DOI 10.1128/JVI.73.7.6099-6103.1999; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Miller V, 1999, J INFECT DIS, V180, P530, DOI 10.1086/314890; Mocroft A, 2003, AIDS, V17, P1741, DOI 10.1097/00002030-200308150-00003; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Pasternak AO, 2008, J CLIN MICROBIOL, V46, P2206, DOI 10.1128/JCM.00055-08; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Persaud D, 2000, J CLIN INVEST, V105, P995, DOI 10.1172/JCI9006; Phillips AN, 2004, AIDS, V18, P1795, DOI 10.1097/00002030-200409030-00008; Phillips AN, 2002, J INFECT DIS, V186, P1086, DOI 10.1086/343801; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Shen L, 2008, J ALLERGY CLIN IMMUN, V122, P22, DOI 10.1016/j.jaci.2008.05.033; Shiu C, 2009, J VIROL, V83, P9731, DOI 10.1128/JVI.00570-09; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Smith CJ, 2009, HIV MED, V10, P19, DOI 10.1111/j.1468-1293.2008.00650.x; Smith CJ, 2005, J INFECT DIS, V192, P1387, DOI 10.1086/466534; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Weverling GJ, 1998, AIDS, V12, pF117, DOI 10.1097/00002030-199811000-00003; Yerly S, 2000, AIDS, V14, P2805, DOI 10.1097/00002030-200012220-00001; Zanchetta M, 2006, J INFECT DIS, V193, P1718, DOI 10.1086/504264; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	46	66	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8490	10.1371/journal.pone.0008490	http://dx.doi.org/10.1371/journal.pone.0008490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046870	Green Published, Green Submitted, gold			2022-12-25	WOS:000273180200004
J	Binder, B; Goede, A; Berndt, N; Holzhutter, HG				Binder, Bernd; Goede, Andrean; Berndt, Nikolaus; Holzhuetter, Hermann-Georg			A Conceptual Mathematical Model of the Dynamic Self-Organisation of Distinct Cellular Organelles	PLOS ONE			English	Article							MEMBRANE-FUSION; COAT PROTEINS; SPECIFICITY; ACCUMULATION; AGGREGATION; TRAFFICKING; ENERGETICS; LYSOSOMES; VESICLES	Formation, degradation and renewal of cellular organelles is a dynamic process based on permanent budding, fusion and inter-organelle traffic of vesicles. These processes include many regulatory proteins such as SNAREs, Rabs and coats. Given this complex machinery, a controversially debated issue is the definition of a minimal set of generic mechanisms necessary to enable the self-organization of organelles differing in number, size and chemical composition. We present a conceptual mathematical model of dynamic organelle formation based on interacting vesicles which carry different types of fusogenic proteins (FP) playing the role of characteristic marker proteins. Our simulations (ODEs) show that a de novo formation of non-identical organelles, each accumulating a different type of FP, requires a certain degree of disproportionation of FPs during budding. More importantly however, the fusion kinetics must indispensably exhibit positive cooperativity among these FPs, particularly for the formation of larger organelles. We compared different types of cooperativity: sequential alignment of corresponding FPs on opposite vesicle/organelles during fusion and pre-formation of FP-aggregates (equivalent, e.g., to SNARE clusters) prior to fusion described by Hill kinetics. This showed that the average organelle size in the system is much more sensitive to the disproportionation strength of FPs during budding if the vesicular transport system gets along with a fusion mechanism based on sequential alignments of FPs. Therefore, pre-formation of FP aggregates within the membranes prior to fusion introduce robustness with respect to organelle size. Our findings provide a plausible explanation for the evolution of a relatively large number of molecules to confer specificity on the fusion machinery compared to the relatively small number involved in the budding process. Moreover, we could speculate that a specific cooperativity which may be described by Hill kinetics (aggregates or Rab/SNARE complex formation) is suitable if maturation/identity switching of organelles play a role (bistability).	[Binder, Bernd; Goede, Andrean; Berndt, Nikolaus; Holzhuetter, Hermann-Georg] Charite, Inst Biochem, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Binder, B (corresponding author), Charite, Inst Biochem, D-13353 Berlin, Germany.	bernd.binder@charite.de	; Goede, Andrean/A-6652-2013	Berndt, Nikolaus/0000-0001-5594-9940; Holzhutter, Hermann-Georg/0000-0002-5054-6023; Goede, Andrean/0000-0002-9044-9869	HepatoSys; German Ministry of Education and Research [0313078A]	HepatoSys; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This project was funded by HepatoSys, a competence network systems biology of hepatocytes, initiated by the German Ministry of Education and Research (http://www.hepatosys.de/en/), grant number 0313078A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker R, 1935, ANN PHYS-BERLIN, V24, P719; BENTZ J, 1983, COLLOID SURFACE, V6, P333, DOI 10.1016/0166-6622(83)80026-2; Bethani I, 2007, EMBO J, V26, P3981, DOI 10.1038/sj.emboj.7601820; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BURNS JA, 1985, TRENDS BIOCHEM SCI, V10, P16, DOI 10.1016/0968-0004(85)90008-8; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Comm. Defin. Adv. Concept, 2008, ROL THEOR ADV 21 CEN; Coveney PV, 1998, J CHEM SOC FARADAY T, V94, P233, DOI 10.1039/a703483k; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; DUFOUR JF, 1992, HEPATOLOGY, V16, P997, DOI 10.1002/hep.1840160424; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; HART P, 1983, J EXP MED, V158, P177; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Heinrich R, 2005, J CELL BIOL, V168, P271, DOI 10.1083/jcb.200409087; Hubner K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000079; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; LEIKIN S, 1993, ANNU REV PHYS CHEM, V44, P369, DOI 10.1146/annurev.pc.44.100193.002101; Lu XB, 2008, NAT STRUCT MOL BIOL, V15, P700, DOI 10.1038/nsmb.1433; Luzio JP, 2000, J CELL SCI, V113, P1515; Malinin VS, 2004, BIOPHYS J, V86, P2951, DOI 10.1016/S0006-3495(04)74346-5; Matsuoka K, 1998, MOL CELL, V2, P703, DOI 10.1016/S1097-2765(00)80168-9; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; NIR S, 1982, BIOCHIM BIOPHYS ACTA, V688, P275, DOI 10.1016/0005-2736(82)90604-6; NIR S, 1983, PROG SURF SCI, V13, P1, DOI 10.1016/0079-6816(83)90010-2; Ouar Z, 2003, BIOCHEM J, V370, P185, DOI 10.1042/BJ20021411; Paunov VN, 1996, J COLLOID INTERF SCI, V182, P239, DOI 10.1006/jcis.1996.0456; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; RAND RP, 1989, BIOCHIM BIOPHYS ACTA, V988, P351, DOI 10.1016/0304-4157(89)90010-5; Ravoo BJ, 1999, BIOPHYS J, V76, P374, DOI 10.1016/S0006-3495(99)77204-8; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Sanderfoot AA, 1999, PLANT CELL, V11, P629, DOI 10.1105/tpc.11.4.629; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030	38	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8295	10.1371/journal.pone.0008295	http://dx.doi.org/10.1371/journal.pone.0008295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041124	Green Published, Green Submitted, gold			2022-12-25	WOS:000278068700002
J	Pereira, AHM; Clemente, CFMZ; Cardoso, AC; Theizen, TH; Rocco, SA; Judice, CC; Guido, MC; Pascoal, VDB; Lopes-Cendes, I; Souza, JRM; Franchini, KG				Pereira, Ana Helena M.; Clemente, Carolina F. M. Z.; Cardoso, Alisson C.; Theizen, Thais H.; Rocco, Silvana A.; Judice, Carla C.; Guido, Maria Carolina; Pascoal, Vinicius D. B.; Lopes-Cendes, Iscia; Souza, Jose Roberto M.; Franchini, Kleber G.			MEF2C Silencing Attenuates Load-Induced Left Ventricular Hypertrophy by Modulating mTOR/S6K Pathway in Mice	PLOS ONE			English	Article							FOCAL ADHESION KINASE; INDUCED CARDIAC-HYPERTROPHY; MYOCYTE ENHANCER FACTOR-2; MITOCHONDRIAL BIOGENESIS; TRANSCRIPTION FACTOR; HEART-FAILURE; GENETIC PROGRAM; C-JUN; EXPRESSION; CARDIOMYOPATHY	Background: The activation of the members of the myocyte enhancer factor-2 family (MEF2A, B, C and D) of transcription factors promotes cardiac hypertrophy and failure. However, the role of its individual components in the pathogenesis of cardiac hypertrophy remains unclear. Methodology/Principal Findings: In this study, we investigated whether MEF2C plays a role in mediating the left ventricular hypertrophy by pressure overload in mice. The knockdown of myocardial MEF2C induced by specific small interfering RNA (siRNA) has been shown to attenuate hypertrophy, interstitial fibrosis and the rise of ANP levels in aortic banded mice. We detected that the depletion of MEF2C also results in lowered levels of both PGC-1 alpha and mitochondrial DNA in the overloaded left ventricle, associated with enhanced AMP:ATP ratio. Additionally, MEF2C depletion was accompanied by defective activation of S6K in response to pressure overload. Treatment with the amino acid leucine stimulated S6K and suppressed the attenuation of left ventricular hypertrophy and fibrosis in the aforementioned aortic banded mice. Conclusion/Significance: These findings represent new evidences that MEF2C depletion attenuates the hypertrophic responses to mechanical stress and highlight the potential of MEF2C to be a target for new therapies to cardiac hypertrophy and failure.	[Pereira, Ana Helena M.; Clemente, Carolina F. M. Z.; Cardoso, Alisson C.; Theizen, Thais H.; Rocco, Silvana A.; Judice, Carla C.; Guido, Maria Carolina; Souza, Jose Roberto M.; Franchini, Kleber G.] Univ Estadual Campinas, Dept Internal Med, Sch Med, Sao Paulo, Brazil; [Pascoal, Vinicius D. B.; Lopes-Cendes, Iscia] Univ Estadual Campinas, Dept Med Genet, Sch Med, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Pereira, AHM (corresponding author), Univ Estadual Campinas, Dept Internal Med, Sch Med, Sao Paulo, Brazil.	franchin@unicamp.br	Rocco, Silvana Aparecida/Q-3828-2019; Pascoal, Vinicius/V-3076-2019; Guido, Maria C/R-1331-2017; Rocco, Silvana Aparecida/H-6300-2014; Judice, Carla/P-4738-2014; Guido, Maria Carolina/I-6416-2012; Lopes-Cendes, Iscia/B-9416-2013	Rocco, Silvana Aparecida/0000-0003-4551-3443; Guido, Maria C/0000-0001-5033-869X; Rocco, Silvana Aparecida/0000-0003-4551-3443; Judice, Carla/0000-0003-1839-053X; Guido, Maria Carolina/0000-0001-5033-869X; Lopes-Cendes, Iscia/0000-0002-6221-6822; Cardoso, Alisson/0000-0002-3051-9976; Pascoal, Vinicius/0000-0002-9009-1190; Franchini, Kleber/0000-0002-0190-6635	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/54878-3, 2008/53583-5, 2008/53519-5]; Conselho Nacional de Desenvolvimento Cienti-fico e Tecnologico (CNPq) [305604/2006-6, 501160/2008-6]; Laboratorio Cristalia	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cienti-fico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Laboratorio Cristalia	Funding for this work was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grants 2006/54878-3, 2008/53583-5, 2008/53519-5, Conselho Nacional de Desenvolvimento Cienti-fico e Tecnologico (CNPq) grants 305604/2006-6, 501160/2008-6 and Laboratorio Cristalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978; Czubryt MP, 2004, RECENT PROG HORM RES, V59, P105, DOI 10.1210/rp.59.1.105; Diwan A, 2007, PHYSIOLOGY, V22, P56, DOI 10.1152/physiol.00033.2006; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; KATZ AM, 1994, ANN INTERN MED, V121, P363, DOI 10.7326/0003-4819-121-5-199409010-00009; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Marin TM, 2008, CIRC RES, V103, P813, DOI 10.1161/CIRCRESAHA.108.179754; MOLKENTIN JD, 1993, J BIOL CHEM, V268, P19512; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Nadruz W, 2005, CARDIOVASC RES, V68, P87, DOI 10.1016/j.cardiores.2005.05.011; Nadruz W, 2003, CIRC RES, V92, P243, DOI 10.1161/01.RES.0000053184.94618.97; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Torsoni AS, 2003, CIRC RES, V93, P140, DOI 10.1161/01.RES.0000081595.25297.1B; Vakili BA, 2001, AM HEART J, V141, P334, DOI 10.1067/mhj.2001.113218; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	38	33	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8472	10.1371/journal.pone.0008472	http://dx.doi.org/10.1371/journal.pone.0008472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041152	gold, Green Submitted, Green Published			2022-12-25	WOS:000273105200008
J	Yu, FX; Luo, Y				Yu, Fa-Xing; Luo, Yan			Tandem ChoRE and CCAAT Motifs and Associated Factors Regulate Txnip Expression in Response to Glucose or Adenosine-Containing Molecules	PLOS ONE			English	Article							THIOREDOXIN-INTERACTING PROTEIN; ELEMENT-BINDING PROTEIN; NF-Y; OXIDATIVE STRESS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; CELL-GROWTH; VDUP1; CANCER; APOPTOSIS	Background: Thioredoxin interacting protein (Txnip) is a multifunctional protein involved in regulation of cell cycle events and cellular metabolism. The expression of Txnip is known to be induced by glucose, adenosine-containing molecules, and other physiological cues; however, the underlying regulatory mechanisms remain elusive. Methodology/Principal Findings: In this study, using promoter reporter, electrophoresis mobility shift (EMSA), and chromatin immuno-precipitation (ChIP) assays, we have identified an additional carbohydrate response element (ChoRE) on the promoter of Txnip gene, which functions cooperatively with the earlier identified ChoRE to mediate optimal Txnip expression. However, these two ChoREs are not sufficient to mediate the induction of Txnip expression by glucose or adenosine-containing molecules; and two CCAAT boxes, both of which can recruit nuclear factor Y (NF-Y) to the Txnip promoter, are also required for the induction. Accordingly, we have found that the function of ChoREs and associated factors is contingent on tandem CCAAT boxes, in that occupancy of the Txnip promoter by NF-Y is a prerequisite for efficacious recruitment of Mondo/MLX to ChoREs under glucose stimulation. Conclusions/Significance: Our findings suggest a synergy between the tandem CCAAT and ChoRE motifs and associated NF-Y and Mondo/MLX transcription factors in enhancing transcription from the Txnip promoter. This piece of information will be helpful for future dissection of molecular mechanisms governing the transcriptional regulation of Txnip, a glucose responsive gene.	[Yu, Fa-Xing] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Luo, Yan] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore	Yu, FX (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	yluo@imcb.a-star.edu.sg		Yu, Fa-Xing/0000-0003-4834-9335	Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work has been supported by the Agency for Science, Technology and Research (A*STAR), Singapore (http://www.a-star.edu.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso CR, 1996, J BIOL CHEM, V271, P22271, DOI 10.1074/jbc.271.36.22271; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Billiet L, 2008, J CELL PHYSIOL, V214, P183, DOI 10.1002/jcp.21179; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; Currie RA, 1998, J BIOL CHEM, V273, P1430, DOI 10.1074/jbc.273.3.1430; de Candia P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001670; Donnelly KL, 2004, J NUTR, V134, P1475, DOI 10.1093/jn/134.6.1475; Dutta KK, 2005, LAB INVEST, V85, P798, DOI 10.1038/labinvest.3700280; Ericsson J, 1996, J BIOL CHEM, V271, P24359, DOI 10.1074/jbc.271.40.24359; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Huang DY, 2004, NUCLEIC ACIDS RES, V32, P3935, DOI 10.1093/nar/gkh719; Huang LL, 2000, MOL MED, V6, P849, DOI 10.1007/BF03401823; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; Jeon JH, 2005, CANCER RES, V65, P4485, DOI 10.1158/0008-5472.CAN-04-2271; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kam KY, 2005, MOL ENDOCRINOL, V19, P148, DOI 10.1210/me.2004-0025; Kim KY, 2004, BIOCHEM BIOPH RES CO, V315, P369, DOI 10.1016/j.bbrc.2004.01.047; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; Kolbus A, 2003, BLOOD, V102, P3136, DOI 10.1182/blood-2003-03-0923; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee KN, 2005, IMMUNITY, V22, P195, DOI 10.1016/j.immuni.2004.12.012; Lee MG, 2003, J BIOL CHEM, V278, P41047, DOI 10.1074/jbc.M307031200; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Muoio DM, 2007, CELL METAB, V5, P412, DOI 10.1016/j.cmet.2007.05.011; Nishinaka Y, 2004, CANCER RES, V64, P1287, DOI 10.1158/0008-5472.CAN-03-0908; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Oka S, 2006, ENDOCRINOLOGY, V147, P733, DOI 10.1210/en.2005-0679; Pang ST, 2009, J MOL ENDOCRINOL, V42, P205, DOI 10.1677/JME-08-0033; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Sheth SS, 2006, ONCOGENE, V25, P3528, DOI 10.1038/sj.onc.1209394; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; Song H, 2003, IMMUNOL LETT, V86, P235, DOI 10.1016/S0165-2478(03)00024-5; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Turturro F, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-96; Villard J, 2000, MOL CELL BIOL, V20, P3364, DOI 10.1128/MCB.20.10.3364-3376.2000; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Yamada K, 2000, J BIOL CHEM, V275, P18129, DOI 10.1074/jbc.M001543200; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Yu FX, 2009, MOL ENDOCRINOL, V23, P932, DOI 10.1210/me.2008-0383; Zhu J, 2003, BLOOD, V102, P2420, DOI 10.1182/blood-2003-01-0251	54	32	36	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8397	10.1371/journal.pone.0008397	http://dx.doi.org/10.1371/journal.pone.0008397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027290	Green Published, gold, Green Submitted			2022-12-25	WOS:000272998000005
J	Ichikawa, T; Li, JQ; Meyer, CJ; Janicki, JS; Hannink, M; Cui, TX				Ichikawa, Tomonaga; Li, Jinqing; Meyer, Colin J.; Janicki, Joseph S.; Hannink, Mark; Cui, Taixing			Dihydro-CDDO-Trifluoroethyl Amide (dh404), a Novel Nrf2 Activator, Suppresses Oxidative Stress in Cardiomyocytes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SIGNALING PATHWAY; KEAP1; TRITERPENOIDS; CHEMOPREVENTION; UBIQUITINATION; PHARMACOLOGY; DEGRADATION; MECHANISMS; PROTECTION	Targeting Nrf2 signaling appears to be an attractive approach for the treatment of maladaptive cardiac remodeling and dysfunction; however, pharmacological modulation of the Nrf2 pathway in the cardiovascular system remains to be established. Herein, we report that a novel synthetic triterpenoid derivative, dihydro-CDDO-trifluoroethyl amide (dh404), activates Nrf2 and suppresses oxidative stress in cardiomyocytes. Dh404 interrupted the Keap1-Cul3-Rbx1 E3 ligase complex-mediated Nrf2 ubiquitination and subsequent degradation saturating the binding capacity of Keap1 to Nrf2, thereby rendering more Nrf2 to be translocated into the nuclei to activate Nrf2-driven gene transcription. A mutant Keap1 protein containing a single cysteine-to-serine substitution at residue 151 within the BTB domain of Keap1 was resistant to dh404-induced stabilization of Nrf2 protein. In addition, dh404 did not dissociate the interaction of Nrf2 with the Keap1-Cul3-Rbx1 E3 ligase complex. Thus, it is likely that dh404 inhibits the ability of Keap1-Cul3-Rbx1 E3 ligase complex to target Nrf2 for ubiquitination and degradation via modifying Cys-151 of Keap1 to change the conformation of the complex. Moreover, dh404 was able to stabilize Nrf2 protein, to enhance Nrf2 nuclear translocation, to activate Nrf2-driven transcription, and to suppress angiotensin II (Ang II)-induced oxidative stress in cardiomyocytes. Knockdown of Nrf2 almost blocked the anti-oxidative effect of dh404. Dh404 activated Nrf2 signaling in the heart. Taken together, dh404 appears to be a novel Nrf2 activator with a therapeutic potential for cardiac diseases via suppressing oxidative stress.	[Ichikawa, Tomonaga; Li, Jinqing; Janicki, Joseph S.; Cui, Taixing] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA; [Meyer, Colin J.] Reata Pharmaceut Inc, Dept Pharmacol, Irving, TX USA; [Hannink, Mark] Univ Missouri, Dept Biochem, Columbia, MO USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Missouri System; University of Missouri Columbia	Ichikawa, T (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA.	hanninkm@missouri.edu; Taixing.Cui@uscmed.sc.edu		Li, Jinqing/0000-0003-4635-2661; Cui, Taixing/0000-0002-9528-7299	American Heart Association (AHA) [0865101E]	American Heart Association (AHA)(American Heart Association)	This work was supported by American Heart Association (AHA) Beginning Grant-in-Aid (BGIA) (0865101E). AHA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Buckley BJ, 2008, FREE RADICAL BIO MED, V44, P692, DOI 10.1016/j.freeradbiomed.2007.10.055; CALKINS MJ, 2008, ANTIOXID REDOX SIGNA; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Cui TX, 2002, MOL ENDOCRINOL, V16, P2113, DOI 10.1210/me.2001-0284; Dzau V, 2005, J HYPERTENS, V23, pS9, DOI 10.1097/01.hjh.0000165623.72310.dd; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gagnon C, 1998, FEBS LETT, V431, P107, DOI 10.1016/S0014-5793(98)00741-8; Gillis CN, 1997, BIOCHEM PHARMACOL, V54, P1, DOI 10.1016/S0006-2952(97)00193-7; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; He XQ, 2006, J BIOL CHEM, V281, P23620, DOI 10.1074/jbc.M604120200; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kwak MK, 2004, MUTAT RES-FUND MOL M, V555, P133, DOI 10.1016/j.mrfmmm.2004.06.041; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee JS, 2005, CANCER LETT, V224, P171, DOI 10.1016/j.canlet.2004.09.042; Li JQ, 2009, ARTERIOSCL THROM VAS, V29, P1843, DOI 10.1161/ATVBAHA.109.189480; Li N, 2006, ANTIOXID REDOX SIGN, V8, P88, DOI 10.1089/ars.2006.8.88; Li WG, 2005, J BIOL CHEM, V280, P28430, DOI 10.1074/jbc.M410601200; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; NITURE SK, 2009, J BIOL CHEM; OHBA M, 1994, J CELL BIOL, V126, P1079, DOI 10.1083/jcb.126.4.1079; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; Prisant LM, 2008, AM J MED, V121, pS8, DOI 10.1016/j.amjmed.2008.05.017; Qin FZ, 2006, FREE RADICAL BIO MED, V40, P236, DOI 10.1016/j.freeradbiomed.2005.08.010; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Thimmulappa RK, 2007, ANTIOXID REDOX SIGN, V9, P1963, DOI 10.1089/ars.2007.1745; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Walters DM, 2008, ANTIOXID REDOX SIGN, V10, P321, DOI 10.1089/ars.2007.1901; Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhang YS, 2008, MOL CANCER THER, V7, P3470, DOI 10.1158/1535-7163.MCT-08-0625	49	92	94	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8391	10.1371/journal.pone.0008391	http://dx.doi.org/10.1371/journal.pone.0008391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027226	Green Submitted, Green Published, gold			2022-12-25	WOS:000272940100023
J	Khare, G; Gupta, V; Gupta, RK; Gupta, R; Bhat, R; Tyagi, AK				Khare, Garima; Gupta, Vibha; Gupta, Rakesh K.; Gupta, Radhika; Bhat, Rajiv; Tyagi, Anil K.			Dissecting the Role of Critical Residues and Substrate Preference of a Fatty Acyl-CoA Synthetase (FadD13) of Mycobacterium tuberculosis	PLOS ONE			English	Article							COENZYME-A-SYNTHETASE; AMINO-ACID-RESIDUES; CRYSTAL-STRUCTURE; SIGNATURE MOTIF; BINDING-SITE; SWISS-MODEL; MYMA OPERON; PROTEIN; ENZYME; CELL	Newly emerging multi-drug resistant strains of Mycobacterium tuberculosis (M.tb) everely limit the treatment options for tuberculosis (TB); hence, new antitubercular drugs are urgently needed. The mymA operon is essential for the virulence and intracellular survival of M.tb and thus represents an attractive target for the development of new antitubercular drugs. This study is focused on the structure-function relationship of Fatty Acyl-CoA Synthetase (FadD13, Rv3089) belonging to the mymA operon. Eight site-directed mutants of FadD13 were designed, constructed and analyzed for the structural-functional integrity of the enzyme. The study revealed that mutation of Lys(487) resulted in similar to 95% loss of the activity thus demonstrating its crucial requirement for the enzymatic activity. Comparison of the kinetic parameters showed the residues Lys(172) and Ala(302) to be involved in the binding of ATP and Ser(404) in the binding of CoenzymeA. The influence of mutations of the residues Val(209) and Trp(377) emphasized their importance in maintaining the structural integrity of FadD13. Besides, we show a synergistic influence of fatty acid and ATP binding on the conformation and rigidity of FadD13. FadD13 represents the first Fatty Acyl-CoA Synthetase to display biphasic kinetics for fatty acids. FadD13 exhibits a distinct preference for C-26/C-24 fatty acids, which in the light of earlier reported observations further substantiates the role of the mymA operon in remodeling the cell envelope of intracellular M.tb under acidic conditions. A three-dimensional model of FadD13 was generated; the docking of ATP to the active site verified its interaction with Lys(172), Ala(302) and Lys(487) and corresponded well with the results of the mutational studies. Our study provides a significant understanding of the FadD13 protein including the identification of residues important for its activity as well as in the maintenance of structural integrity. We believe that the findings of this study will provide valuable inputs in the development of inhibitors against the mymA operon, an important target for the development of antitubercular drugs.	[Khare, Garima; Gupta, Vibha; Gupta, Rakesh K.; Gupta, Radhika; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India; [Gupta, Rakesh K.] Univ Delhi, Dept Microbiol, Ram Lal Anand Coll, New Delhi, India; [Bhat, Rajiv] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	University of Delhi; University of Delhi; Jawaharlal Nehru University, New Delhi	Khare, G (corresponding author), Univ Delhi, Dept Biochem, S Campus, New Delhi, India.	aniltyagi@south.du.ac.in		Gupta, Radhika/0000-0002-0445-0194	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported by the Department of Biotechnology, Government of India. GK is grateful to the Council of Scientific and Industrial Research, New Delhi for research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Black PN, 2000, J BIOL CHEM, V275, P38547, DOI 10.1074/jbc.M006413200; Black PN, 1997, J BIOL CHEM, V272, P4896, DOI 10.1074/jbc.272.8.4896; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Calloni G, 2005, J BIOL CHEM, V280, P10607, DOI 10.1074/jbc.M412951200; Cheruvu M, 2007, TUBERCULOSIS, V87, P12, DOI 10.1016/j.tube.2006.01.021; Choi JY, 1999, J BIOL CHEM, V274, P4671, DOI 10.1074/jbc.274.8.4671; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Delano W.L., 2002, DELANO SCI; Digel M, 2009, MOL CELL BIOCHEM, V326, P23, DOI 10.1007/s11010-008-0003-3; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Horswill AR, 2002, BIOCHEMISTRY-US, V41, P2379, DOI 10.1021/bi015647q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutzler JM, 2002, DRUG METAB DISPOS, V30, P355, DOI 10.1124/dmd.30.4.355; Jang J, 2008, TRENDS MICROBIOL, V16, P303, DOI 10.1016/j.tim.2008.04.005; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KNAPP HR, 1986, J INFECT DIS, V154, P84, DOI 10.1093/infdis/154.1.84; KNOLL LJ, 1994, J BIOL CHEM, V269, P16348; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Langer MR, 2002, J BIOL CHEM, V277, P27337, DOI 10.1074/jbc.M203251200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARRABEE AR, 1965, P NATL ACAD SCI USA, V54, P267, DOI 10.1073/pnas.54.1.267; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu XQ, 2008, BIOORG MED CHEM LETT, V18, P5963, DOI 10.1016/j.bmcl.2008.07.130; Mashima T, 2005, JNCI-J NATL CANCER I, V97, P765, DOI 10.1093/jnci/dji133; Matsuda D, 2008, J ANTIBIOT, V61, P318, DOI 10.1038/ja.2008.45; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Sambrook J., MOL CLONING LAB MANU; Sanchez LB, 2000, J BIOL CHEM, V275, P5794, DOI 10.1074/jbc.275.8.5794; Schubert HL, 2006, BIOCHEMISTRY-US, V45, P15188, DOI 10.1021/bi061396f; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Singh A, 2003, FEMS MICROBIOL LETT, V227, P53, DOI 10.1016/S0378-1097(03)00648-7; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Tiganis T, 1996, ARCH BIOCHEM BIOPHYS, V325, P289, DOI 10.1006/abbi.1996.0036; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; VesLosada A, 1996, MOL CELL BIOCHEM, V159, P1; WATKINS PA, 1994, BBA-LIPID LIPID MET, V1214, P288, DOI 10.1016/0005-2760(94)90075-2; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Weimar JD, 2002, J BIOL CHEM, V277, P29369, DOI 10.1074/jbc.M107022200; Wu R, 2007, BIOCHEMISTRY-US, V46, P14487, DOI 10.1021/bi701609w	58	20	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8387	10.1371/journal.pone.0008387	http://dx.doi.org/10.1371/journal.pone.0008387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027301	Green Submitted, gold, Green Published			2022-12-25	WOS:000272940100020
J	Cejas, P; Lopez-Gomez, M; Aguayo, C; Madero, R; Carpeno, JD; Belda-Iniesta, C; Barriuso, J; Garcia, VM; Larrauri, J; Lopez, R; Casado, E; Gonzalez-Baron, M; Feliu, J				Cejas, Paloma; Lopez-Gomez, Miriam; Aguayo, Cristina; Madero, Rosario; de Castro Carpeno, Javier; Belda-Iniesta, Cristobal; Barriuso, Jorge; Moreno Garcia, Victor; Larrauri, Javier; Lopez, Rocio; Casado, Enrique; Gonzalez-Baron, Manuel; Feliu, Jaime			KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; K-RAS MUTATIONS; CETUXIMAB; GENES; LIVER; BRAF; ANTIBODIES; THERAPY; SITES	Background: KRAS mutations in colorectal cancer primary tumors predict resistance to anti-Epidermal Growth Factor Receptor (EGFR) monoclonal antibody therapy in patients with metastatic colorectal cancer, and thus represent a true indicator of EGFR pathway activation status. Methodology/Principal Findings: KRAS mutations were retrospectively studied using polymerase chain reactions and subsequent sequencing of codons 12 and 13 (exon 2) in 110 patients with metastatic colorectal tumors. These studies were performed using tissue samples from both the primary tumor and their related metastases (93 liver, 84%; 17 lung, 16%). All patients received adjuvant 5-Fluorouracil-based polychemotherapy after resection of metastases. None received anti-EGFR therapy. Mutations in KRAS were observed in 37 (34%) of primary tumors and in 40 (36%) of related metastases, yielding a 94% level of concordance (kappa index 0.86). Patients with primary tumors possessing KRAS mutations had a shorter disease-free survival period after metastasis resection (12.0 vs 18.0 months; P = 0.035) than those who did not. A higher percentage of KRAS mutations was detected in primary tumors of patiens with lung metastases than in patients with liver metastases (59% vs 32%; p = 0.054). To further evaluate this finding we analyzed 120 additional patients with unresectable metastatic colorectal cancer who previously had their primary tumors evaluated for KRAS mutational status for clinical purposes. Separately, the analysis of these 120 patients showed a tendency towards a higher degree of KRAS mutations in primary tumors of patients with lung metastases, although it did not reach statistical significance. Taken together the group of 230 patients showed that KRAS was mutated significantly more often in the primary tumors of patients with lung metastases (57% vs 35%; P = 0.006). Conclusions/Significance: Our results suggest a role for KRAS mutations in the propensity of primary colorectal tumors to metastasize to the lung.	[Cejas, Paloma; Lopez-Gomez, Miriam; Aguayo, Cristina; de Castro Carpeno, Javier; Belda-Iniesta, Cristobal; Barriuso, Jorge; Moreno Garcia, Victor; Lopez, Rocio; Gonzalez-Baron, Manuel; Feliu, Jaime] La Paz Univ Hosp, Dept Med Oncol, Madrid, Spain; [Madero, Rosario] La Paz Univ Hosp, Biostat Unit, Madrid, Spain; [Larrauri, Javier] La Paz Univ Hosp, Dept Pathol, Madrid, Spain; [Casado, Enrique] Infanta Sofi Hosp, Dept Med Oncol, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz	Cejas, P (corresponding author), La Paz Univ Hosp, Dept Med Oncol, Madrid, Spain.	jfeliu.hulp@salud.madrid.org		De Castro, Javier/0000-0002-3622-6306; Moreno, Victor/0000-0001-6099-4236; Belda Iniesta, Cristobal/0000-0003-3254-7492	Amgen; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD06-0020-1022]; Fundacion Mutua Madrilena; Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz (FIBHULP), Madrid, Spain	Amgen(Amgen); Red Tematica de Investigacion Cooperativa en Cancer (RTICC); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz (FIBHULP), Madrid, Spain	This work received grant support from Amgen, Red Tematica de Investigacion Cooperativa en Cancer (RTICC, RD06-0020-1022), Fundacion Mutua Madrilena and from Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz (FIBHULP), Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andreyev HJN, 2001, BRIT J CANCER, V85, P692, DOI 10.1054/bjoc.2001.1964; Artale S, 2008, J CLIN ONCOL, V26, P4217, DOI 10.1200/JCO.2008.18.7286; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Etienne-Grimaldi MC, 2008, CLIN CANCER RES, V14, P4830, DOI 10.1158/1078-0432.CCR-07-4906; Fong YM, 1997, J CLIN ONCOL, V15, P938, DOI 10.1200/JCO.1997.15.3.938; Fransen K, 2004, CARCINOGENESIS, V25, P527, DOI 10.1093/carcin/bgh049; Grandal MV, 2008, J CELL MOL MED, V12, P1527, DOI 10.1111/j.1582-4934.2008.00298.x; Jean GW, 2008, PHARMACOTHERAPY, V28, P742, DOI 10.1592/phco.28.6.742; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lockhart C, 2005, SEMIN ONCOL, V32, P52, DOI 10.1053/j.seminoncol.2004.09.036; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; OUDEJANS JJ, 1991, INT J CANCER, V49, P875, DOI 10.1002/ijc.2910490613; Penna C, 2002, SURG CLIN N AM, V82, P1075, DOI 10.1016/S0039-6109(02)00051-8; Rama N, 2009, EUR J CARDIO-THORAC, V35, P444, DOI 10.1016/j.ejcts.2008.10.047; Santini D, 2008, ONCOLOGIST, V13, P1270, DOI 10.1634/theoncologist.2008-0181; Tabernero J, 2007, J CLIN ONCOL, V25, P5225, DOI 10.1200/JCO.2007.13.2183; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wong R, 2008, J CLIN ONCOL, V26, P5668, DOI 10.1200/JCO.2008.19.5024	21	124	131	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8199	10.1371/journal.pone.0008199	http://dx.doi.org/10.1371/journal.pone.0008199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020061	Green Published, Green Submitted, gold			2022-12-25	WOS:000272870600002
J	Xu, HW; Wu, ZY; Fang, F; Guo, L; Chen, D; Chen, JX; Stern, D; Taylor, GA; Jiang, H; Yan, SS				Xu, Hongwei; Wu, Zhi-Ying; Fang, Fang; Guo, Lan; Chen, Doris; Chen, John Xi; Stern, David; Taylor, Gregory A.; Jiang, Hong; Yan, Shirley ShiDu			Genetic deficiency of Irgm1 (LRG-47) suppresses induction of experimental autoimmune encephalomyelitis by promoting apoptosis of activated CD4(+) T cells	FASEB JOURNAL			English	Article						IFN-gamma-mediated apoptosis; EAE/MS; animal model	EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; INTERFERON-GAMMA; MYCOBACTERIAL INFECTION; INTRACELLULAR PATHOGENS; MULTIPLE-SCLEROSIS; MICE DEFICIENT; P47 GTPASES; SURVIVAL; IMMUNITY	The immunity-related GTPase Irgm1, also called LRG-47, is known to regulate host resistance to intracellular pathogens through multiple mechanisms that include controlling the survival of T lymphocytes. Here, we address whether Irgm1 also plays a role in the pathogenesis of experimental autoimmune encephalitis (EAE). We find that Irgm1/LRG-47 is a significant factor in the progression of EAE and multiple sclerosis (MS). Expression of Irgm1 was robustly elevated in MS-affected lesions and in the central nervous system (CNS) of myelin basic protein (MBP)-induced EAE mice, especially in cells of lymphoid and mononuclear phagocyte origin. Homozygous Irgm1 null mice were resistant to MBP-induced EAE, and CD4(+) T cells in spleen and CNS of these mice displayed decreased proliferative capacity, increased apoptosis, and up-regulated interferon (IFN)-gamma induction. Therefore, Irgm1-induced survival of autoreactive CD4(+) T cells contributes significantly to the pathogenesis of EAE. Blockade of Irgm1 may be a potential therapeutic strategy for halting multiple sclerosis.-Xu, H., Wu, Z.-Y., Fang, F., Guo, L., Chen, D., Chen, J. X., Stern, D., Taylor, G. A., Jiang, H., Yan, S. S. Genetic deficiency of Irgm1 (LRG-47) suppresses induction of experimental autoimmune encephalomyelitis by promoting apoptosis of activated CD4(+) T cells. FASEB J. 24, 1583-1592 (2010). www.fasebj.org	[Xu, Hongwei; Wu, Zhi-Ying; Fang, Fang; Guo, Lan; Chen, Doris; Yan, Shirley ShiDu] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Xu, Hongwei; Wu, Zhi-Ying; Fang, Fang; Guo, Lan; Chen, Doris; Yan, Shirley ShiDu] Columbia Univ, Dept Surg, New York, NY 10032 USA; [Jiang, Hong] Columbia Univ, Dept Med, Taub Inst Res Alzheimers Dis & Aging, Coll Phys & Surg, New York, NY 10032 USA; [Xu, Hongwei] Harbin Med Coll, Dept Immunol, Harbin, Peoples R China; [Chen, John Xi] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Stern, David] Univ Cincinnati, Dept Hlth Affairs, Cincinnati, OH USA; [Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Immunol, Div Geriatr, Durham, NC 27710 USA; [Taylor, Gregory A.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Taylor, Gregory A.] Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC USA; [Wu, Zhi-Ying] Fudan Univ, State Key Lab Med Neurobiol, Shanghai Med Coll, Inst Neurol,Huashan Hosp, Shanghai 200433, Peoples R China; [Wu, Zhi-Ying] Fudan Univ, Dept Neurol, Shanghai 200433, Peoples R China	Columbia University; Columbia University; Columbia University; Harbin Medical University; Memorial Sloan Kettering Cancer Center; University System of Ohio; University of Cincinnati; Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Fudan University; Fudan University	Yan, SS (corresponding author), Columbia Univ, Dept Pathol, 650 W 168th St, New York, NY 10032 USA.	sdy1@columbia.edu	Xu, Hongwei/S-3865-2018	Xu, Hongwei/0000-0001-5763-3894	National Institute of Neurological Disorders and Stroke grant [NINDS 042855]; U. S. National Institutes of Health [AI-57831]; Veterans Affairs Merit Review; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057831] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by National Institute of Neurological Disorders and Stroke grant NINDS 042855. The authors thank A. P. Hays ( Department of Pathology, Columbia University) for providing human MS samples and suggestions. G. T. is supported by U. S. National Institutes of Health grant AI-57831 and a Veterans Affairs Merit Review grant.	Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Dalton DK, 2000, J EXP MED, V192, P117, DOI 10.1084/jem.192.1.117; DU Y.S., 1997, P NATL ACAD SCI USA, V94, P5296; Feng CG, 2008, NAT IMMUNOL, V9, P1279, DOI 10.1038/ni.1653; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; Ferber IA, 1996, J IMMUNOL, V156, P5; Gold R, 1997, TRENDS NEUROSCI, V20, P399, DOI 10.1016/S0166-2236(97)01079-5; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hohlfeld R, 2001, CURR OPIN NEUROL, V14, P299, DOI 10.1097/00019052-200106000-00006; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Mahoney JA, 2005, CURR OPIN IMMUNOL, V17, P583, DOI 10.1016/j.coi.2005.09.018; Mao PZ, 2010, BBA-MOL BASIS DIS, V1802, P66, DOI 10.1016/j.bbadis.2009.07.002; O'Connor RA, 2005, J AUTOIMMUN, V24, P93, DOI 10.1016/j.jaut.2005.01.005; PENDER MP, 1991, J NEUROL SCI, V104, P81, DOI 10.1016/0022-510X(91)90219-W; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Santiago HC, 2005, J IMMUNOL, V175, P8165, DOI 10.4049/jimmunol.175.12.8165; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stromnes IM, 2007, NAT IMMUNOL, V8, P19, DOI 10.1038/ni0107-19; TABI Z, 1994, EUR J IMMUNOL, V24, P2609, DOI 10.1002/eji.1830241107; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Taylor GA, 1996, J BIOL CHEM, V271, P20399, DOI 10.1074/jbc.271.34.20399; Todaro M, 2004, J CLIN IMMUNOL, V24, P1, DOI 10.1023/B:JOCI.0000018057.89066.c6; Yan SS, 2003, NAT MED, V9, P287, DOI 10.1038/nm831; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; Zhang HFM, 2003, J BIOL CHEM, V278, P33011, DOI 10.1074/jbc.M305352200	33	28	30	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2010	24	5					1583	1592		10.1096/fj.09-137323	http://dx.doi.org/10.1096/fj.09-137323			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20056715	Bronze, Green Published			2022-12-25	WOS:000277158900030
J	Song, KN; Krause, C; Shi, ST; Patterson, M; Suto, R; Grgurevic, L; Vukicevic, S; van Dinther, M; Falb, D; ten Dijke, P; Alaoui-Ismaili, MH				Song, Kening; Krause, Carola; Shi, Songting; Patterson, Marilyn; Suto, Robert; Grgurevic, Lovorka; Vukicevic, Slobodan; van Dinther, Maarten; Falb, Dean; ten Dijke, Peter; Alaoui-Ismaili, Moulay Hicham			Identification of a Key Residue Mediating Bone Morphogenetic Protein (BMP)-6 Resistance to Noggin Inhibition Allows for Engineered BMPs with Superior Agonist Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOGENIC PROTEIN-1; I RECEPTORS; EXPRESSION; COMPONENTS; BINDING; INDUCE	Bone morphogenetic proteins (BMPs) are used clinically to induce new bone formation in spinal fusions and long bone nonunion fractures. However, large amounts of BMPs are needed to achieve these effects. BMPs were found to increase the expression of antagonists, which potentially limit their therapeutic efficacy. However, the relative susceptibility of osteoinductive BMPs to different antagonists is not well characterized. Here we show that BMP-6 is more resistant to noggin inhibition and more potent in promoting osteoblast differentiation in vitro and inducing bone regeneration in vivo when compared with its closely related BMP-7 paralog. Noggin was found to play a critical role as a negative feedback regulator of BMP-7 but not BMP6-induced biological responses. Using BMP-6/7 chimeras, we identified lysine 60 as a key residue conferring noggin resistance within the BMP-6 protein. A remarkable correlation was found between the presence of a lysine at this position and noggin resistance among a panel of osteoinductive BMPs. Introduction of a lysine residue at the corresponding positions of BMP-2 and BMP-7 allowed for molecular engineering of recombinant BMPs with increased resistance to noggin antagonism.	[Krause, Carola; Shi, Songting; van Dinther, Maarten; ten Dijke, Peter] Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Krause, Carola; Shi, Songting; van Dinther, Maarten; ten Dijke, Peter] Leiden Univ, Ctr Biomed Genet, Med Ctr, NL-2300 RC Leiden, Netherlands; [Song, Kening; Patterson, Marilyn; Falb, Dean; Alaoui-Ismaili, Moulay Hicham] Stryker Biotech, Hopkinton, MA 01748 USA; [Suto, Robert] Xtal BioStruct Inc, Natick, MA 01760 USA; [Grgurevic, Lovorka; Vukicevic, Slobodan] Univ Zagreb, Lab Mineralized Tissues, Sch Med, Zagreb 10000, Croatia	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Zagreb	ten Dijke, P (corresponding author), Leiden Univ, Dept Mol Cell Biol, Med Ctr, POB 9600, NL-2300 RC Leiden, Netherlands.	p.ten_dijke@lumc.nl; Hicham.Alaoui@stryker.com	Vukicevic, Slobodan/AEG-2646-2022; Dijke, Peter ten/AAG-4660-2021	Vukicevic, Slobodan/0000-0003-4076-0285; Dijke, Peter ten/0000-0002-7234-342X; van Dinther, Maarten/0000-0002-9451-8884	Netherlands Organization for Scientific Research [918.66.606]; Innovation-oriented Research Program Genomics [IGE07001]; Center for Biomedical Genetics; Croatian Ministry of Science, Education, and Sports	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Innovation-oriented Research Program Genomics; Center for Biomedical Genetics; Croatian Ministry of Science, Education, and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	This work was supported in part by Netherlands Organization for Scientific Research Grant 918.66.606, Innovation-oriented Research Program Genomics Grant IGE07001, and a grant from the Center for Biomedical Genetics (to P. D.). This work was also supported by a grant from the Croatian Ministry of Science, Education, and Sports (to S. V.).	Alaoui-Ismaili MH, 2009, CYTOKINE GROWTH F R, V20, P501, DOI 10.1016/j.cytogfr.2009.10.001; Allendorph GP, 2007, BIOCHEMISTRY-US, V46, P12238, DOI 10.1021/bi700907k; Burkus J. Kenneth, 2008, P71; COOK SD, 1994, CLIN ORTHOP RELAT R, P302; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; Friedlaender GE, 2004, PROG INFLAM RES, P157; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; GERHART TN, 1993, CLIN ORTHOP RELAT R, P317; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Kaplan FS, 2009, CYTOKINE GROWTH F R, V20, P399, DOI 10.1016/j.cytogfr.2009.10.006; Kloen P, 2002, J BONE JOINT SURG AM, V84A, P1909, DOI 10.2106/00004623-200211000-00001; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Korchynskyi O, 2003, J BONE MINER RES, V18, P1177, DOI 10.1359/jbmr.2003.18.7.1177; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Meyer R A, 2001, BMC Musculoskelet Disord, V2, P2, DOI 10.1186/1471-2474-2-2; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Reddi AH, 2009, CYTOKINE GROWTH F R, V20, P341, DOI 10.1016/j.cytogfr.2009.10.015; Ripamonti U, 2005, CYTOKINE GROWTH F R, V16, P357, DOI 10.1016/j.cytogfr.2005.02.006; Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599; Saremba S, 2008, FEBS J, V275, P172, DOI 10.1111/j.1742-4658.2007.06187.x; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Simic P, 2006, J BIOL CHEM, V281, P25509, DOI 10.1074/jbc.M513276200; Takayama K, 2009, J BONE MINER METAB, V27, P402, DOI 10.1007/s00774-009-0054-x; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Tylzanowski P, 2006, DEV DYNAM, V235, P1599, DOI 10.1002/dvdy.20782; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Vukicevic S, 2008, BONE MORPHOGENETIC P; Vukicevic S, 2009, CYTOKINE GROWTH F R, V20, P441, DOI 10.1016/j.cytogfr.2009.10.020; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Yonemori K, 1997, AM J PATHOL, V150, P1335	38	92	101	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12169	12180		10.1074/jbc.M109.087197	http://dx.doi.org/10.1074/jbc.M109.087197			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20048150	Green Published, hybrid			2022-12-25	WOS:000276787100047
J	Sunters, A; Armstrong, VJ; Zaman, G; Kypta, RM; Kawano, Y; Lanyon, LE; Price, JS				Sunters, Andrew; Armstrong, Victoria J.; Zaman, Gul; Kypta, Robert M.; Kawano, Yoshiaki; Lanyon, Lance E.; Price, Joanna S.			Mechano-transduction in Osteoblastic Cells Involves Strain-regulated Estrogen Receptor alpha-mediated Control of Insulin-like Growth Factor (IGF) I Receptor Sensitivity to Ambient IGF, Leading to Phosphatidylinositol 3-Kinase/AKT-dependent Wnt/LRP5 Receptor-independent Activation of beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIOSTEAL BONE-FORMATION; MECHANICAL STRAIN; NITRIC-OXIDE; ER-ALPHA; ANABOLIC RESPONSE; ADAPTIVE RESPONSE; INDUCED APOPTOSIS; MESSENGER-RNA; BREAST-CANCER; T-ANTIGEN	The capacity of bones to adjust their mass and architecture to withstand the loads of everyday activity derives from the ability of their resident cells to respond appropriately to the strains engendered. To elucidate the mechanisms of strain responsiveness in bone cells, we investigated in vitro the responses of primary mouse osteoblasts and UMR-106 osteoblast-like cells to a single period of dynamic strain. This stimulates a cascade of events, including activation of insulin-like growth factor I receptor (IGF-IR), phosphatidylinositol 3-kinase-mediated phosphorylation of AKT, inhibition of GSK-3 beta, increased activation of beta-catenin, and associated lymphoid-enhancing factor/T cell factor-mediated transcription. Initiation of this pathway does not involve the Wnt/LRP5/Frizzled receptor and does not culminate in increased IGF transcription. The effect of strain on IGF-IR is mimicked by exogenous des-(1-3)IGF-I and is blocked by the IGF-IR inhibitor H1356. Inhibition of strain-related prostanoid and nitric oxide production inhibits strain-related (and basal) AKT activity, but their separate ectopic administration does not mimic it. Strain-related IGF-IR activation of AKT requires estrogen receptor alpha (ER alpha) with which IGF-1R physically associates. The ER blocker ICI 182,780 increases the concentration of des-(1-3) IGF-I necessary to activate this cascade, whereas estrogen inhibits both basal AKT activity and its activation by des-(1-3) IGF-I. These data suggest an initial cascade of strain-related events in osteoblasts in which strain activates IGF-IR, in association with ER alpha, so initiating phosphatidylinositol 3-kinase/AKT-dependent activation of beta-catenin and altered lymphoid-enhancing factor/T cell factor transcription. This cascade requires prostanoid/nitric oxide production and is independent of Wnt/LRP5.	[Sunters, Andrew; Armstrong, Victoria J.; Zaman, Gul; Lanyon, Lance E.; Price, Joanna S.] Univ London Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England; [Kypta, Robert M.; Kawano, Yoshiaki] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, London W12 0NN, England; [Kypta, Robert M.] CIC bioGUNE, Ctr Cooperat Res Biosci, Derio 48160, Spain	University of London; University of London Royal Veterinary College; Imperial College London; CIC bioGUNE	Sunters, A (corresponding author), Univ London Royal Vet Coll, Dept Vet Basic Sci, Royal Coll St, London NW1 0TU, England.	asunters@rvc.ac.uk	cancer, biogune/H-7276-2012; Kypta, Robert/F-7699-2011	Kypta, Robert/0000-0002-2389-310X	Wellcome Trust; BBSRC [BB/D524883/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524883/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust.	Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Ai MR, 2005, AM J HUM GENET, V77, P741, DOI 10.1086/497706; Alexaki VI, 2004, FASEB J, V18, P1594, DOI 10.1096/fj.04-1495fje; Anitha M, 2008, GASTROENTEROLOGY, V134, P1424, DOI 10.1053/j.gastro.2008.02.018; Armour KE, 2001, ENDOCRINOLOGY, V142, P760, DOI 10.1210/en.142.2.760; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bikle D, 2001, J BONE MINER RES, V16, P2320, DOI 10.1359/jbmr.2001.16.12.2320; BINDERMAN I, 1988, CALCIFIED TISSUE INT, V42, P261, DOI 10.1007/BF02553753; Cacciotti P, 2005, CANCER RES, V65, P5256, DOI 10.1158/0008-5472.CAN-05-0127; Campana WM, 1999, J NEUROSCI RES, V57, P332; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; CHAMBERS TJ, 1993, P NATL ACAD SCI USA, V90, P5578, DOI 10.1073/pnas.90.12.5578; Chambers TJ, 1999, OSTEOARTHR CARTILAGE, V7, P422, DOI 10.1053/joca.1998.0231; Cheng MZ, 1999, J BONE MINER RES, V14, P1742, DOI 10.1359/jbmr.1999.14.10.1742; Cheng MZ, 2002, J BONE MINER RES, V17, P593, DOI 10.1359/jbmr.2002.17.4.593; Chun KS, 2007, CANCER RES, V67, P2015, DOI 10.1158/0008-5472.CAN-06-3617; COLSTON KW, 1989, J BONE MINER RES, V4, P625; Costessi A, 2005, BONE, V36, P418, DOI 10.1016/j.bone.2004.10.016; DALLAS SL, 1993, J BONE MINER RES, V8, P251; Damien E, 1998, J BONE MINER RES, V13, P1275, DOI 10.1359/jbmr.1998.13.8.1275; Damien E, 2000, J BONE MINER RES, V15, P2169, DOI 10.1359/jbmr.2000.15.11.2169; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; DeAngelis T, 2006, ONCOGENE, V25, P32, DOI 10.1038/sj.onc.1209013; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Dufour C, 2008, AM J PHYSIOL-ENDOC M, V294, pE794, DOI 10.1152/ajpendo.00791.2007; Fan M, 2006, J CELL PHYSIOL, V207, P454, DOI 10.1002/jcp.20581; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fermor B, 1998, BONE, V22, P637, DOI 10.1016/S8756-3282(98)00047-7; Ferrari SL, 2005, CURR OPIN LIPIDOL, V16, P207, DOI 10.1097/01.mol.0000162326.62419.e4; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Honda K, 2000, J NEUROSCI RES, V60, P321, DOI 10.1002/(SICI)1097-4547(20000501)60:3<321::AID-JNR6>3.3.CO;2-K; Hoyland JA, 1997, BONE, V20, P87, DOI 10.1016/S8756-3282(96)00346-8; Jagger CJ, 1996, J CLIN INVEST, V98, P2351, DOI 10.1172/JCI119047; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jessop HL, 2004, J BONE MINER RES, V19, P938, DOI 10.1359/jbmr.2004.19.6.938; Jessop HL, 2002, BONE, V31, P186, DOI 10.1016/S8756-3282(02)00797-4; Jessop HL, 2001, J BONE MINER RES, V16, P1045, DOI 10.1359/jbmr.2001.16.6.1045; Johnson DL, 1996, AM J PHYSIOL-ENDOC M, V271, pE205, DOI 10.1152/ajpendo.1996.271.1.E205; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Kamata A, 1998, BIOCHEM BIOPH RES CO, V246, P404, DOI 10.1006/bbrc.1998.8632; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kispert A, 1998, DEVELOPMENT, V125, P4225; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Klotz DM, 2002, J BIOL CHEM, V277, P8531, DOI 10.1074/jbc.M109592200; Kodama Y, 2000, CALCIFIED TISSUE INT, V66, P298, DOI 10.1007/s002230010060; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Lanyon L, 2004, J ENDOCRINOL, V182, P183, DOI 10.1677/joe.0.1820183; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; LEAN JM, 1995, AM J PHYSIOL-ENDOC M, V268, pE318, DOI 10.1152/ajpendo.1995.268.2.E318; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; Lee KCL, 2004, J ENDOCRINOL, V182, P193, DOI 10.1677/joe.0.1820193; Li J, 2002, CALCIFIED TISSUE INT, V70, P320, DOI 10.1007/s00223-001-1025-y; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu JM, 2008, J BONE MINER METAB, V26, P159, DOI 10.1007/s00774-007-0799-z; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Mannella P, 2006, J NEUROSCI, V26, P9439, DOI 10.1523/JNEUROSCI.1443-06.2006; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mendez P, 2003, MOL BRAIN RES, V112, P170, DOI 10.1016/S0169-328X(03)00088-3; Mendez P, 2006, FRONT NEUROENDOCRIN, V27, P391, DOI 10.1016/j.yfrne.2006.09.001; Monroe JJ, 1996, BIOCHEM BIOPH RES CO, V225, P320, DOI 10.1006/bbrc.1996.1173; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Nakamura E, 2000, AM J PHYSIOL-CELL PH, V279, pC510, DOI 10.1152/ajpcell.2000.279.2.C510; Namkoong S, 2005, EXP MOL MED, V37, P588, DOI 10.1038/emm.2005.72; NOBLE M, 1995, TRANSGENIC RES, V4, P215, DOI 10.1007/BF01969114; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; Pavalko FM, 2003, J CELL PHYSIOL, V194, P194, DOI 10.1002/jcp.10221; PEAD MJ, 1989, CALCIFIED TISSUE INT, V45, P34, DOI 10.1007/BF02556658; Pitsillides AA, 1995, FASEB J, V9, P1614, DOI 10.1096/fasebj.9.15.8529841; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; RAABCULLEN DM, 1994, CALCIFIED TISSUE INT, V55, P473, DOI 10.1007/BF00298562; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; RAWLINSON SCF, 1991, J BONE MINER RES, V6, P1345; Reijnders CMA, 2007, J ENDOCRINOL, V192, P131, DOI 10.1677/joe.1.06880; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Saxon LK, 2006, BONE, V39, P1261, DOI 10.1016/j.bone.2006.06.030; Smith E, 2005, J BIOL CHEM, V280, P2388, DOI 10.1074/jbc.M406294200; Song RXD, 2006, ENDOCR-RELAT CANCER, V13, pS3, DOI 10.1677/erc.1.01322; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Sun M, 2001, CANCER RES, V61, P5985; Sunters A, 2004, J BIOL CHEM, V279, P9882, DOI 10.1074/jbc.M310184200; Tang LY, 1997, J BONE MINER RES, V12, P276, DOI 10.1359/jbmr.1997.12.2.276; Tessner TG, 2004, J CLIN INVEST, V114, P1676, DOI 10.1172/JCI200422218; Topalli I, 2004, BRAIN RES, V1030, P116, DOI 10.1016/j.brainres.2004.09.057; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; Vilgelm A, 2006, CANCER RES, V66, P3375, DOI 10.1158/0008-5472.CAN-05-4019; Visconti LA, 2004, ARCH ORAL BIOL, V49, P485, DOI 10.1016/j.archoralbio.2004.01.006; Wang XY, 2007, MOL CARCINOGEN, V46, P912, DOI 10.1002/mc.20320; Wang YM, 2006, ENDOCRINOLOGY, V147, P4753, DOI 10.1210/en.2006-0196; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yu YJ, 2008, J VIROL, V82, P4521, DOI 10.1128/JVI.02365-07; Zaman G, 1997, J BONE MINER RES, V12, P769, DOI 10.1359/jbmr.1997.12.5.769; Zaman G, 1999, J BONE MINER RES, V14, P1123, DOI 10.1359/jbmr.1999.14.7.1123; Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504; Zhang S, 2005, J MOL ENDOCRINOL, V35, P433, DOI 10.1677/jme.1.01858	104	96	101	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8743	8758		10.1074/jbc.M109.027086	http://dx.doi.org/10.1074/jbc.M109.027086			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20042609	hybrid, Green Published			2022-12-25	WOS:000275553700027
J	Horibata, Y; Sugimoto, H				Horibata, Yasuhiro; Sugimoto, Hiroyuki			StarD7 Mediates the Intracellular Trafficking of Phosphatidylcholine to Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER PROTEIN; MAMMALIAN-CELLS; LIPID TRANSFER; PHOSPHATIDYLSERINE; TRANSPORT; DOMAIN; MICE	Steroidogenic acute regulatory protein-related lipid transfer (START) domains, found in 15 mammalian proteins termed StarD1-StarD15, are lipid-binding domains implicated in the intracellular lipid transport systems. In the present study, we analyzed the lipid ligand and function of StarD7. We found two variable forms of mammalian StarD7, termed StarD7-I and StarD7-II. Unlike StarD7-II, StarD7-I contained a mitochondrial-targeting sequence in its N terminus. Overexpressed StarD7-I tagged with V5/His in HEPA-1 cells was mainly observed in the mitochondria of cells prepared at low cellular density, but it was distributed in the cytoplasm of high density cells. StarD7-II was constantly distributed in the cytoplasm at any cellular density. Endogenous StarD7 in HEPA-1 cells and rat liver was also distributed in both the cytoplasm and the mitochondria. A protease K protection assay indicated that the mitochondrial StarD7 was associated with the outer mitochondrial membrane. The purified recombinant StarD7 specifically catalyzed the transfer of PC between lipid vesicles in vitro. Furthermore, the intracellular transport of fluorescent PC that was exogenously incorporated into the mitochondria was increased in cells that overexpressed StarD7-I. These results suggest that StarD7 facilitates the delivery of PC to mitochondria in non-vesicular system.	[Horibata, Yasuhiro; Sugimoto, Hiroyuki] Dokkyo Med Univ, Sch Med, Dept Biochem, Mibu, Tochigi 3210293, Japan	Dokkyo Medical University	Sugimoto, H (corresponding author), Dokkyo Med Univ, Sch Med, Dept Biochem, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	h-sugi@dokkyomed.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japanese Government [20770091]	Ministry of Education, Culture, Sports, Science and Technology, Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Young Scientists (B) 20770091 from the Ministry of Education, Culture, Sports, Science and Technology, Japanese Government.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; de Brouwer APM, 2002, EXP CELL RES, V274, P100, DOI 10.1006/excr.2001.5460; Durand S, 2004, PLACENTA, V25, P37, DOI 10.1016/S0143-4004(03)00214-5; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Kang HW, 2009, J LIPID RES, V50, P2212, DOI 10.1194/jlr.M900013-JLR200; Kanno K, 2007, BBA-MOL CELL BIOL L, V1771, P654, DOI 10.1016/j.bbalip.2007.04.003; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kuge O, 2003, J BIOCHEM, V133, P397, DOI 10.1093/jb/mvg052; Morita T, 2004, J CELL SCI, V117, P5759, DOI 10.1242/jcs.01499; NICHOLS JW, 1983, J BIOL CHEM, V258, P5368; NICOLAY K, 1990, BIOCHIM BIOPHYS ACTA, V1025, P49, DOI 10.1016/0005-2736(90)90189-U; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; SLEIGHT RG, 1989, J CELL SCI, V93, P363; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Helvoort A, 1999, P NATL ACAD SCI USA, V96, P11501, DOI 10.1073/pnas.96.20.11501; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; Zhou LY, 2008, J CELL SCI, V121, P2186, DOI 10.1242/jcs.024703; Zhyvoloup A, 2003, J BIOL CHEM, V278, P50316, DOI 10.1074/jbc.M307763200	27	71	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7358	7365		10.1074/jbc.M109.056960	http://dx.doi.org/10.1074/jbc.M109.056960			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042613	Green Published, hybrid			2022-12-25	WOS:000275415600048
J	Sephton, CF; Good, SK; Atkin, S; Dewey, CM; Mayer, P; Herz, J; Yu, G				Sephton, Chantelle F.; Good, Shannon K.; Atkin, Stan; Dewey, Colleen M.; Mayer, Paul, III; Herz, Joachim; Yu, Gang			TDP-43 Is a Developmentally Regulated Protein Essential for Early Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; MESSENGER-RNA; EXPRESSION; DEPLETION; GENE; SPECIFICATION; DROSOPHILA; SCLEROSIS; DISEASE; FAMILY	TDP-43 is a DNA/RNA-binding protein implicated in multiple steps of transcriptional and post-transcriptional regulation of gene expression. Alteration of this multifunctional protein is associated with a number of neurodegenerative diseases including amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin positive inclusions. Whereas a pathological link to neurodegenerative disorders has been established, the cellular and physiological functions of TDP-43 remain unknown. In this study, we show that TDP-43 is a nuclear protein with persistent high-level expression during embryonic development and with progressively decreased protein levels during postnatal development. In mice where the TDP-43 gene (Tardbp) was disrupted using a gene trap that carries a beta-galactosidase marker gene, heterozygous (Tardbp(+/-)) mice are fertile and healthy, but intercrosses of Tardbp(+/-) mice yielded no viable homozygotic null (Tardbp(-/-)) mice. Indeed, Tardbp(-/-) embryos die between 3.5 and 8.5 days of development. Tardbp(-/-) blastocysts grown in cell culture display abnormal expansion of their inner cell mass. The pattern of beta-galactosidase staining at E9.5 Tardbp(+/-) embryos is predominantly restricted to the neuroepithelium and remains prominent in neural progenitors at E10.5-12.5. TDP-43 is detected in spinal cord progenitors and in differentiated motor neurons as well as in the dorsal root ganglia at E12.5. beta-Galactosidase staining of tissues from adult Tardbp(+/-) mice shows widespread expression of TDP-43, including prominent levels in various regions of the central nervous system afflicted in neurodegenerative disorders. These results indicate that TDP-43 is developmentally regulated and indispensible for early embryonic development.	[Yu, Gang] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Atkin, Stan] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yu, G (corresponding author), 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	Gang.Yu@UTSouthwestern.edu			National Institutes of Health [R01 AG029547, AG023104]; Welch Foundation [I-1566]; Ted Nash Longlife Foundation; Consortium for Frontotemporal Dementia Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023104, R01AG029547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Ted Nash Longlife Foundation; Consortium for Frontotemporal Dementia Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG029547 and AG023104, Welch Foundation Grant I-1566, the Ted Nash Longlife Foundation, and the Consortium for Frontotemporal Dementia Research.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; Casafont I, 2009, J STRUCT BIOL, V167, P235, DOI 10.1016/j.jsb.2009.06.006; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Forman MS, 2007, CURR OPIN NEUROBIOL, V17, P548, DOI 10.1016/j.conb.2007.08.005; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Sugita S, 2000, BIOCHEMISTRY-US, V39, P2940, DOI 10.1021/bi9920984; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	31	265	269	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6826	6834		10.1074/jbc.M109.061846	http://dx.doi.org/10.1074/jbc.M109.061846			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040602	Green Published, hybrid			2022-12-25	WOS:000275367500085
J	Zhang, NS; Oliver, SG				Zhang, Nianshu; Oliver, Stephen G.			The Transcription Activity of Gis1 Is Negatively Modulated by Proteasome-mediated Limited Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FINGER PROTEIN GIS1; SACCHAROMYCES-CEREVISIAE; STATIONARY-PHASE; GENE-EXPRESSION; BUDDING YEAST; NUCLEAR-LOCALIZATION; GLUCOSE STARVATION; STRESS-RESPONSE; KINASE RIM15; LIFE-SPAN	The transcriptional response to environmental changes has to be prompt but appropriate. Previously, it has been shown that the Gis1 transcription factor is responsible for regulating the expression of postdiauxic shift genes in response to nutrient starvation, and this transcription regulation is dependent upon the Rim15 kinase. Here we demonstrate that the activity of Gis1 is negatively modulated by proteasome-mediated limited proteolysis. Limited degradation of Gis1 by the proteasome leads to the production of smaller variants, which have weaker transcription activities than the full-length protein. The coiled-coil domain, absent from the smaller variants, is part of the second transcription activation domain in Gis1 and is essential for both the limited proteolysis of Gis1 and its full activity. Endogenous Gis1 and its variants, regardless of their transcription capabilities, activate transcription in a Rim15-dependent manner. However, when the full-length Gis1 accumulates in cells due to overexpression or inhibition of the proteasome function, transcription activation by Gis1 is no longer solely controlled by Rim15. Together, these data strongly indicate that the function of the limited degradation is to ensure that Gis1-dependent transcription is strictly regulated by the Rim15 kinase. Furthermore, we have revealed that the kinase activity of Rim15 is essential for this regulation.	[Zhang, Nianshu] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 1GA, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge; University of Cambridge	Zhang, NS (corresponding author), Univ Cambridge, Cambridge Syst Biol Ctr, Sanger Bldg,80 Tennis Court Rd, Cambridge CB2 1GA, England.	nz228@cam.ac.uk	Oliver, Stephen/AAQ-5992-2021	Oliver, Stephen/0000-0003-3410-6439; Zhang, Nianshu/0000-0002-2690-7554	Biotechnology and Biological Sciences Research Council [BB/C505140/2]; Biotechnology and Biological Sciences Research Council [BB/C505140/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/C505140/2 ( to S. G. O.).	AMBERG DC, 2005, METHODS YEAST GENETI, P200; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Brown AJP, 2001, EMBO J, V20, P3177, DOI 10.1093/emboj/20.12.3177; Cameroni E, 2004, CELL CYCLE, V3, P462; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Fujimuro M, 1998, BIOCHEM BIOPH RES CO, V251, P818, DOI 10.1006/bbrc.1998.9560; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Herman PK, 2002, CURR OPIN MICROBIOL, V5, P602, DOI 10.1016/S1369-5274(02)00377-6; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martinez MJ, 2004, MOL BIOL CELL, V15, P5295, DOI 10.1091/mbc.E03-11-0856; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; Ogiso Y, 1999, BIOCHEM BIOPH RES CO, V258, P448, DOI 10.1006/bbrc.1999.0635; Oliver SG, 1996, NATURE, V379, P597, DOI 10.1038/379597a0; Oshiro J, 2003, J BIOL CHEM, V278, P31495, DOI 10.1074/jbc.M305452200; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Pnueli L, 2004, MOL CELL BIOL, V24, P5197, DOI 10.1128/MCB.24.12.5197-5208.2004; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Reinders A, 1998, GENE DEV, V12, P2943, DOI 10.1101/gad.12.18.2943; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Saldanha AJ, 2004, MOL BIOL CELL, V15, P4089, DOI 10.1091/mbc.e04-04-0306; Santhanam A, 2004, EUKARYOT CELL, V3, P1261, DOI 10.1128/EC.3.5.1261-1271.2004; SIKORSKI RS, 1989, GENETICS, V122, P19; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Tronnersjo S, 2007, MOL GENET GENOMICS, V277, P57, DOI 10.1007/s00438-006-0171-3; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; van der Ven PFM, 2000, J CELL BIOL, V151, P235, DOI 10.1083/jcb.151.2.235; WACH A, 1994, YEAST, V10, P1808; Wanke V, 2005, EMBO J, V24, P4271, DOI 10.1038/sj.emboj.7600889; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; Wilson WA, 2002, CELL, V111, P155, DOI 10.1016/S0092-8674(02)01043-7; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wishart JA, 2006, YEAST, V23, P325, DOI 10.1002/yea.1348; Wu J, 2004, P NATL ACAD SCI USA, V101, P3148, DOI 10.1073/pnas.0308321100; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yen KY, 2003, YEAST, V20, P1255, DOI 10.1002/yea.1037; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zhang NS, 2009, MICROBIOL-SGM, V155, P1690, DOI 10.1099/mic.0.026377-0; Zhang NS, 2003, GENE, V303, P121, DOI 10.1016/S0378-1119(02)01142-3	53	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6465	6476		10.1074/jbc.M109.073288	http://dx.doi.org/10.1074/jbc.M109.073288			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20022953	Green Published, hybrid			2022-12-25	WOS:000275367500051
J	Saykally, JN; Dogan, S; Cleary, MP; Sanders, MM				Saykally, Jessica N.; Dogan, Soner; Cleary, Margot P.; Sanders, Michel M.			The ZEB1 Transcription Factor Is a Novel Repressor of Adiposity in Female Mice	PLOS ONE			English	Article							CALORIC RESTRICTION; STEM-CELLS; OBESITY; EXPRESSION; DELTA-EF1; DIFFERENTIATION; GENE; FAT; FINGER; ZFH-1	Background: Four genome-wide association studies mapped an "obesity'' gene to human chromosome 10p11-12. As the zinc finger E-box binding homeobox 1 (ZEB1) transcription factor is encoded by the TCF8 gene located in that region, and as it influences the differentiation of various mesodermal lineages, we hypothesized that ZEB1 might also modulate adiposity. The goal of these studies was to test that hypothesis in mice. Methodology/Principal Findings: To ascertain whether fat accumulation affects ZEB1 expression, female C57BL/6 mice were fed a regular chow diet (RCD) ad libitum or a 25% calorie-restricted diet from 2.5 to 18.3 months of age. ZEB1 mRNA levels in parametrial fat were six to ten times higher in the obese mice. To determine directly whether ZEB1 affects adiposity, wild type (WT) mice and mice heterozygous for TCF8 (TCF8+/-) were fed an RCD or a high-fat diet (HFD) (60% calories from fat). By two months of age on an HFD and three months on an RCD, TCF8+/- mice were heavier than WT controls, which was attributed by Echo MRI to increased fat mass (at three months on an HFD: 0.517 +/- 0.081 total fat/lean mass versus 0.313 +/- 0.036; at three months on an RCD: 0.175 +/- 0.013 versus 0.124 +/- 0.012). No differences were observed in food uptake or physical activity, suggesting that the genotypes differ in some aspect of their metabolic activity. ZEB1 expression also increases during adipogenesis in cell culture. Conclusion/Significance: These results show for the first time that the ZEB1 transcription factor regulates the accumulation of adipose tissue. Furthermore, they corroborate the genome-wide association studies that mapped an "obesity'' gene at chromosome 10p11-12.	[Saykally, Jessica N.; Dogan, Soner; Sanders, Michel M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Cleary, Margot P.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System	Saykally, JN (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	sande001@umn.edu		DOGAN, SONER/0000-0002-7762-8109	National Institute of Diabetes and Digestive Diseases [DK050456]; National Cancer Institute, [CA116849, CA101858]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA101858, U54CA116849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050456] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the University of Minnesota Obesity Prevention Center Core grant DK050456 from the National Institute of Diabetes and Digestive Diseases ( M. M. S.), by grants CA116849 ( M. M. S.) and CA101858 ( M. P. C.) from the National Cancer Institute, and by the Hormel Foundation ( M. P. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Anose BM, 2005, HORMONAL CARCINOGENESIS IV, P455, DOI 10.1007/0-387-23761-5_48; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Bonorden MJL, 2009, PROSTATE, V69, P317, DOI 10.1002/pros.20878; Bui T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004373; Chambron J-C, 1999, PORPHYRIN HDB, V6, P1; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Cleary MP, 2007, EXP BIOL MED, V232, P70; Clement Karine, 2002, Am J Pharmacogenomics, V2, P177, DOI 10.2165/00129785-200202030-00003; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Dolinkova M, 2008, MOL CELL ENDOCRINOL, V291, P63, DOI 10.1016/j.mce.2008.05.001; Dong CH, 2005, AM J HUM GENET, V76, P427, DOI 10.1086/428438; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Fontemaggi G, 2001, MOL CELL BIOL, V21, P8461, DOI 10.1128/MCB.21.24.8461-8470.2001; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Higashi Y, 1997, J EXP MED, V185, P1467, DOI 10.1084/jem.185.8.1467; HINNAI M, 2000, PAK J FOOD SCI, V10, P5; Hurt EM, 2008, MOL CELL BIOCHEM, V318, P89, DOI 10.1007/s11010-008-9860-z; Inuzuka T, 2009, CANCER RES, V69, P1678, DOI 10.1158/0008-5472.CAN-08-3620; Inuzuka T, 2009, BIOCHEM BIOPH RES CO, V379, P510, DOI 10.1016/j.bbrc.2008.12.101; Jasik CB, 2008, ANN NY ACAD SCI, V1135, P265, DOI 10.1196/annals.1429.009; Jethanandani P, 2005, J BIOL CHEM, V280, P36037, DOI 10.1074/jbc.M508698200; Khan Unab I, 2008, Adolesc Med State Art Rev, V19, P406; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Landisch RM, 2008, MUSCLE NERVE, V38, P1290, DOI 10.1002/mus.21141; Layden MJ, 2006, DEV BIOL, V291, P253, DOI 10.1016/j.ydbio.2005.12.009; Lee HK, 2007, MOL CELL NEUROSCI, V36, P47, DOI 10.1016/j.mcn.2007.05.011; Liskova P, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9495; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; MURRAY E, 2000, MOD ASP IMMUNOBIOL, V1, P2; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Ponticos M, 2004, MOL CELL BIOL, V24, P6151, DOI 10.1128/MCB.24.14.6151-6161.2004; Postigo AA, 1999, MOL CELL BIOL, V19, P7255; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; Price RA, 2001, DIABETOLOGIA, V44, P363, DOI 10.1007/s001250051627; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sabin MA, 2008, FRONT HORM RES, V36, P85, DOI 10.1159/000115356; Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220; Shi HF, 2009, FRONT NEUROENDOCRIN, V30, P396, DOI 10.1016/j.yfrne.2009.03.004; SMAS CM, 1995, BIOCHEM J, V309, P697, DOI 10.1042/bj3090697; Sooy K, 2002, ENDOCRINOLOGY, V143, P3370, DOI 10.1210/en.2001-211441; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Takagi T, 1998, DEVELOPMENT, V125, P21; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Wacker I, 2003, DEVELOPMENT, V130, P3795, DOI 10.1242/dev.00570; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105	60	21	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8460	10.1371/journal.pone.0008460	http://dx.doi.org/10.1371/journal.pone.0008460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041147	gold, Green Submitted, Green Published			2022-12-25	WOS:000273104000020
J	Wallner, M; Himly, M; Neubauer, A; Erler, A; Hauser, M; Asam, C; Mutschlechner, S; Ebner, C; Briza, P; Ferreira, F				Wallner, Michael; Himly, Martin; Neubauer, Angela; Erler, Anja; Hauser, Michael; Asam, Claudia; Mutschlechner, Sonja; Ebner, Christof; Briza, Peter; Ferreira, Fatima			The Influence of Recombinant Production on the Immunologic Behavior of Birch Pollen Isoallergens	PLOS ONE			English	Article							ALLERGEN-SPECIFIC IMMUNOTHERAPY; HIGH-LEVEL EXPRESSION; BET V 1; ESCHERICHIA-COLI; IN-VITRO; 2 PARTS; BET-V-1; ISOFORMS; PURIFICATION; REACTIVITY	Background: Allergic reactions towards the birch major pollen allergen Bet v 1 are among the most common causes of spring pollinosis in the temperate climate zone of the Northern hemisphere. Natural Bet v 1 is composed of a complex mixture of different isoforms. Detailed analysis of recombinant Bet v 1 isoforms revealed striking differences in immunologic as well as allergenic properties of the molecules, leading to a classification of Bet v 1 isoforms into high, medium, and low IgE binding proteins. Especially low IgE binding Bet v 1 isoforms have been described as ideal candidates for desensitizing allergic patients with allergen specific immunotherapy (SIT). Since diagnosis and therapy of allergic diseases are highly dependent on recombinant proteins, continuous improvement of protein production is an absolute necessity. Methodology: Therefore, two different methods for recombinant production of a low IgE binding Bet v 1 isoform were applied; one based on published protocols, the other by implementing latest innovations in protein production. Both batches of Bet v 1.0401 were extensively characterized by an array of physicochemical as well as immunological methods to compare protein primary structure, purity, quantity, folding, aggregation state, thermal stability, and antibody binding capacity. Conclusion: The experiments demonstrated that IgE antibody binding properties of recombinant isoallergens can be significantly influenced by the production method directly affecting possible clinical applications of the molecules.	[Wallner, Michael; Himly, Martin; Erler, Anja; Hauser, Michael; Asam, Claudia; Ferreira, Fatima] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [Neubauer, Angela] Biomay AG, Vienna Competence Ctr, Vienna, Austria; [Mutschlechner, Sonja] Med Univ Vienna, Christian Doppler Lab Immunemodulat, Vienna, Austria; [Ebner, Christof] Allergieambulatorium, Vienna, Austria; [Briza, Peter] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Salzburg University; Medical University of Vienna; Salzburg University	Wallner, M (corresponding author), Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria.	michael.wallner@sbg.ac.at	Ferreira, Fatima/E-4889-2011; Ferreira, Fatima/AAB-4321-2019; Hauser, Michael/P-6148-2017; Wallner, Michael/L-5437-2015; Briza, Peter/D-7309-2012; Himly, Martin/D-1568-2015	Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Hauser, Michael/0000-0001-6558-755X; Wallner, Michael/0000-0001-6568-7892; Briza, Peter/0000-0002-4941-6782; Himly, Martin/0000-0001-5416-085X	Christian Doppler Research Association; Oesterreichische Nationalbank [12533]	Christian Doppler Research Association; Oesterreichische Nationalbank	This work was supported by grants from the Christian Doppler Research Association (www.cdg.ac.at), the Oesterreichische Nationalbank ( Project No. 12533) (www.oenb.at) and Biomay AG (www.biomay.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkerdaas JH, 2003, INT ARCH ALLERGY IMM, V132, P132, DOI 10.1159/000073714; Arquint O, 1999, J ALLERGY CLIN IMMUN, V104, P1239, DOI 10.1016/S0091-6749(99)70019-9; Bohle B, 2006, J ALLERGY CLIN IMMUN, V118, P242, DOI 10.1016/j.jaci.2006.03.011; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Claverol S, 2003, MOL CELL PROTEOMICS, V2, P483, DOI 10.1074/mcp.T300003-MCP200; Ferreira F, 1997, INT ARCH ALLERGY IMM, V113, P125, DOI 10.1159/000237524; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; FERREIRA FD, 1993, J BIOL CHEM, V268, P19574; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Himly M, 2009, ALLERGY; HoffmannSommergruber K, 1997, PROTEIN EXPRES PURIF, V9, P33, DOI 10.1006/prep.1996.0671; Jevsevar S, 2005, BIOTECHNOL PROGR, V21, P632, DOI 10.1021/bp0497839; Kahlert H, 2008, INT ARCH ALLERGY IMM, V145, P193, DOI 10.1159/000109288; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kay AB, 2001, NEW ENGL J MED, V344, P109, DOI 10.1056/NEJM200101113440206; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; SHIRANO Y, 1990, FEBS LETT, V271, P128, DOI 10.1016/0014-5793(90)80388-Y; SWOBODA I, 1995, J BIOL CHEM, V270, P2607, DOI 10.1074/jbc.270.6.2607; Van Ree R, 2008, ALLERGY, V63, P310, DOI 10.1111/j.1398-9995.2007.01612.x; Vaz DC, 2006, PROTEIN SCI, V15, P33, DOI 10.1110/ps.051593306; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Wallner M, 2009, ALLERGY, V64, P452, DOI 10.1111/j.1398-9995.2008.01788.x; Wallner M, 2007, CURR OPIN MOL THER, V9, P160; Weiss C, 1996, INT ARCH ALLERGY IMM, V110, P282, DOI 10.1159/000237300	27	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8457	10.1371/journal.pone.0008457	http://dx.doi.org/10.1371/journal.pone.0008457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041109	Green Published, gold, Green Submitted			2022-12-25	WOS:000273104000018
J	Yang, LJ; Zou, J; Xie, HZ; Li, LL; Wei, YQ; Yang, SY				Yang, Li-Jun; Zou, Jun; Xie, Huan-Zhang; Li, Lin-Li; Wei, Yu-Quan; Yang, Sheng-Yong			Steered Molecular Dynamics Simulations Reveal the Likelier Dissociation Pathway of Imatinib from Its Targeting Kinases c-Kit and Abl	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; THYROID-HORMONE RECEPTORS; LIGAND-BINDING; CONFORMATIONAL TRANSITIONS; CANCER-TREATMENT; STRUCTURAL BASIS; PROTEIN-KINASES; INHIBITORS; DESIGN; AUTOINHIBITION	Development of small molecular kinase inhibitors has recently been the central focus in drug discovery. And type II kinase inhibitors that target inactive conformation of kinases have attracted particular attention since their potency and selectivity are thought to be easier to achieve compared with their counterpart type I inhibitors that target active conformation of kinases. Although mechanisms underlying the interactions between type II inhibitors and their targeting kinases have been widely studied, there are still some challenging problems, for example, how type II inhibitors associate with or dissociate from their targeting kinases. In this investigation, steered molecular dynamics simulations have been carried out to explore the possible dissociation pathways of typical type II inhibitor imatinib from its targeting protein kinases c-Kit and Abl. The simulation results indicate that the most favorable pathway for imatinib dissociation corresponds to the ATP-channel rather than the relatively wider allosteric-pocket-channel, which is mainly due to the different van der Waals interaction that the ligand suffers during dissociation. Nevertheless, the direct reason comes from the fact that the residues composing the ATP-channel are more flexible than that forming the allosteric-pocket-channel. The present investigation suggests that a bulky hydrophobic head is unfavorable, but a large polar tail is allowed for a potent type II inhibitor. The information obtained here can be used to direct the discovery of type II kinase inhibitors.	[Yang, Li-Jun; Zou, Jun; Xie, Huan-Zhang; Li, Lin-Li; Wei, Yu-Quan; Yang, Sheng-Yong] Sichuan Univ, State Key Lab Biotherapy & Canc Ctr, W China Med Sch, W China Hosp, Chengdu 610064, Peoples R China	Sichuan University	Yang, LJ (corresponding author), Sichuan Univ, State Key Lab Biotherapy & Canc Ctr, W China Med Sch, W China Hosp, Chengdu 610064, Peoples R China.	yangsy@scu.edu.cn		Zou, Jun/0000-0002-5395-6052	863 Hi-Tech Program [2006AA020400]; National Natural Science Foundation of China [30772651, 20872100]; Youth Foundation of Sichuan Province [08ZQ026-030]	863 Hi-Tech Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of Sichuan Province	This work was supported by the 863 Hi-Tech Program (2006AA020400), the National Natural Science Foundation of China (30772651 and 20872100) and the Youth Foundation of Sichuan Province (08ZQ026-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Carlsson P, 2006, BIOPHYS J, V91, P3151, DOI 10.1529/biophysj.106.082917; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cowan-Jacob SW, 2007, ACTA CRYSTALLOGR D, V63, P80, DOI 10.1107/S0907444906047287; Dancey J, 2003, NAT REV DRUG DISCOV, V2, P296, DOI 10.1038/nrd1066; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dowell J, 2005, NAT REV DRUG DISCOV, V4, P13, DOI 10.1038/nrd1612; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Genest D, 2008, EUR BIOPHYS J BIOPHY, V37, P369, DOI 10.1007/s00249-007-0220-9; Giamas G, 2007, PHARMACOGENOMICS, V8, P1005, DOI 10.2217/14622416.8.8.1005; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Gua Y, 2009, P NATL ACAD SCI USA, V106, P2589, DOI 10.1073/pnas.0812299106; Huang H, 2009, J CHEM THEORY COMPUT, V5, P1304, DOI 10.1021/ct9000153; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Leech J, 1996, IEEE COMPUT SCI ENG, V3, P38, DOI 10.1109/99.556511; Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marchi M, 1999, J CHEM PHYS, V110, P3697, DOI 10.1063/1.478259; Martinez L, 2006, J MED CHEM, V49, P23, DOI 10.1021/jm050805n; Martinez L, 2008, J PHYS CHEM B, V112, P10741, DOI 10.1021/jp803403c; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Morgan H., 2002, CELL, V109, P275; Murphy E, 2005, EXPERT OPIN THER TAR, V9, P447, DOI 10.1517/14728222.9.3.447; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Okram B, 2006, CHEM BIOL, V13, P779, DOI 10.1016/j.chembiol.2006.05.015; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piccaluga PP, 2006, EXPERT OPIN PHARMACO, V7, P721, DOI 10.1517/14656566.7.6.721; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; Sonoda MT, 2008, MOL ENDOCRINOL, V22, P1565, DOI 10.1210/me.2007-0501; Thaimattam R, 2007, CURR PHARM DESIGN, V13, P2751, DOI 10.2174/138161207781757042; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Vlahos CJ, 2003, NAT REV DRUG DISCOV, V2, P99, DOI 10.1038/nrd1009; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Zou J, 2008, PROTEINS, V72, P323, DOI 10.1002/prot.21928; 1977, J COMPUT PHYS, V23, P327	50	34	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8470	10.1371/journal.pone.0008470	http://dx.doi.org/10.1371/journal.pone.0008470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041122	Green Submitted, gold, Green Published			2022-12-25	WOS:000273104000027
J	Ruskin, DN; Kawamura, M; Masino, SA				Ruskin, David N.; Kawamura, Masahito, Jr.; Masino, Susan A.			Reduced Pain and Inflammation in Juvenile and Adult Rats Fed a Ketogenic Diet	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; CALORIE RESTRICTION; PROTEIN RESTRICTION; LOW-CARBOHYDRATE; KETONE-BODIES; ADENOSINE; METABOLISM; CHILDREN; BRAIN; EXPRESSION	The ketogenic diet is a high-fat, low-carbohydrate regimen that forces ketone-based rather than glucose-based cellular metabolism. Clinically, maintenance on a ketogenic diet has been proven effective in treating pediatric epilepsy and type II diabetes, and recent basic research provides evidence that ketogenic strategies offer promise in reducing brain injury. Cellular mechanisms hypothesized to be mobilized by ketone metabolism and underlying the success of ketogenic diet therapy, such as reduced reactive oxygen species and increased central adenosine, suggest that the ketolytic metabolism induced by the diet could reduce pain and inflammation. To test the effects of a ketone-based metabolism on pain and inflammation directly, we fed juvenile and adult rats a control diet (standard rodent chow) or ketogenic diet (79% fat) ad libitum for 3-4 weeks. We then quantified hindpaw thermal nociception as a pain measure and complete Freund's adjuvant-induced local hindpaw swelling and plasma extravasation (fluid movement from the vasculature) as inflammation measures. Independent of age, maintenance on a ketogenic diet reduced the peripheral inflammatory response significantly as measured by paw swelling and plasma extravasation. The ketogenic diet also induced significant thermal hypoalgesia independent of age, shown by increased hindpaw withdrawal latency in the hotplate nociception test. Anti-inflammatory and hypoalgesic diet effects were generally more robust in juveniles. The ketogenic diet elevated plasma ketones similarly in both age groups, but caused slowed body growth only in juveniles. These data suggest that applying a ketogenic diet or exploiting cellular mechanisms associated with ketone-based metabolism offers new therapeutic opportunities for controlling pain and peripheral inflammation, and that such a metabolic strategy may offer significant benefits for children and adults.	[Ruskin, David N.; Kawamura, Masahito, Jr.; Masino, Susan A.] Trinity Coll, Dept Psychol, Hartford, CT 06106 USA; [Ruskin, David N.; Kawamura, Masahito, Jr.; Masino, Susan A.] Trinity Coll, Neurosci Program, Hartford, CT 06106 USA; [Kawamura, Masahito, Jr.] Jikei Univ, Sch Med, Dept Pharmacol, Minato Ku, Tokyo, Japan	Trinity College; Trinity College; Jikei University	Ruskin, DN (corresponding author), Trinity Coll, Dept Psychol, Hartford, CT 06106 USA.	susan.masino@trincoll.edu			National Institutes of Health [061290]; National Science Foundation [IOS-0843585]; CHDI; Trinity College; Division Of Integrative Organismal Systems [0843585] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS061290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); CHDI; Trinity College; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the National Institutes of Health (061290), National Science Foundation (IOS-0843585), CHDI (www.highqfoundation.org) and Trinity College (www.trincoll.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranano Kristin W, 2008, Curr Treat Options Neurol, V10, P410, DOI 10.1007/s11940-008-0043-8; Becker N, 1997, PAIN, V73, P393, DOI 10.1016/S0304-3959(97)00126-7; Bough KJ, 2003, EPILEPSIA, V44, P752, DOI 10.1046/j.1528-1157.2003.55502.x; Bough KJ, 1999, EPILEPSY RES, V35, P21, DOI 10.1016/S0920-1211(98)00125-9; COLLINS JE, 1985, HUM NUTR-APPL NUTR, V39A, P255; Cullingford TE, 2004, PROSTAG LEUKOTR ESS, V70, P253, DOI 10.1016/j.plefa.2003.09.008; Cullingford T, 2008, EPILEPSIA, V49, P70, DOI 10.1111/j.1528-1167.2008.01840.x; Dickenson AH, 2000, CNS DRUGS, V13, P77, DOI 10.2165/00023210-200013020-00001; EDDY AA, 1994, AM J PHYSIOL, V266, pF884, DOI 10.1152/ajprenal.1994.266.6.F884; Fragasso G, 2008, CURR PHARM DESIGN, V14, P2582, DOI 10.2174/138161208786071245; Giordano M, 2008, DIABETOLOGIA, V51, P21, DOI 10.1007/s00125-007-0874-y; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; HAAS RH, 1986, AM J MED GENET, V24, P225; Hallbook T, 2007, EPILEPSY RES, V77, P134, DOI 10.1016/j.eplepsyres.2007.09.008; Hemingway C, 2001, PEDIATRICS, V108, P898, DOI 10.1542/peds.108.4.898; Hori A, 1997, EPILEPSIA, V38, P750, DOI 10.1111/j.1528-1157.1997.tb01461.x; Iughetti L, 2007, J ENDOCRINOL INVEST, V30, P700; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee HT, 2004, AM J PHYSIOL-RENAL, V286, pF298, DOI 10.1152/ajprenal.00185.2003; Liu YMC, 2003, J AM DIET ASSOC, V103, P707, DOI 10.1053/jada.2003.50136; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Malan TP, 2002, ANESTHESIOLOGY, V96, P1161, DOI 10.1097/00000542-200205000-00020; Mantis JG, 2009, EPILEPSY BEHAV, V15, P133, DOI 10.1016/j.yebeh.2009.02.038; Martinez-Dominguez E, 2001, INFLAMM RES, V50, P102, DOI 10.1007/s000110050731; MASINO SA, 2009, CURR NEUROP IN PRESS; Masino SA, 2008, TRENDS NEUROSCI, V31, P273, DOI 10.1016/j.tins.2008.02.009; Navab M, 2008, CURR OPIN CLIN NUTR, V11, P459, DOI 10.1097/MCO.0b013e32830460c2; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Poon A, 1999, EUR J PHARMACOL, V384, P123, DOI 10.1016/S0014-2999(99)00626-3; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Rodriguez-Enriquez S, 2009, MOL NUTR FOOD RES, V53, P29, DOI 10.1002/mnfr.200700470; SAWYNOK J, 1982, NEUROPHARMACOLOGY, V21, P397, DOI 10.1016/0028-3908(82)90022-3; Seyfried Thomas N, 2005, Nutr Metab (Lond), V2, P30, DOI 10.1186/1743-7075-2-30; Shibolet O, 2002, CLIN IMMUNOL, V105, P48, DOI 10.1006/clim.2002.5260; Silva MC, 2005, NUTR NEUROSCI, V8, P259, DOI 10.1080/10284150500475032; Sorkin LS, 2003, EXP NEUROL, V184, P162, DOI 10.1016/S0014-4886(03)00102-X; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Tendler D, 2007, DIGEST DIS SCI, V52, P589, DOI 10.1007/s10620-006-9433-5; Thio LL, 2006, PEDIATR RES, V60, P413, DOI 10.1203/01.pdr.0000238244.54610.27; Tsutsui S, 2004, J NEUROSCI, V24, P1521, DOI 10.1523/JNEUROSCI.4271-03.2004; Westman EC, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-36; WINYARD PG, 1999, FREE RADICALS INFLAM; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Yudkoff M, 2007, ANNU REV NUTR, V27, P415, DOI 10.1146/annurev.nutr.27.061406.093722; Ziegler DR, 2005, PHYSIOL BEHAV, V84, P421, DOI 10.1016/j.physbeh.2005.01.003	48	108	111	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8349	10.1371/journal.pone.0008349	http://dx.doi.org/10.1371/journal.pone.0008349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20041135	gold, Green Published			2022-12-25	WOS:000272998100005
J	Forgber, M; Gellrich, S; Sharav, T; Sterry, W; Walden, P				Forgber, Michael; Gellrich, Sylke; Sharav, Tumenjargal; Sterry, Wolfram; Walden, Peter			Proteome-Based Analysis of Serologically Defined Tumor-Associated Antigens in Cutaneous Lymphoma	PLOS ONE			English	Article							T-CELL LYMPHOMA; LUNG SQUAMOUS CARCINOMA; HEPATOCELLULAR-CARCINOMA; SEREX IDENTIFICATION; BIOMARKER DISCOVERY; MYCOSIS-FUNGOIDES; CANCER IMMUNOMICS; IMMUNE-RESPONSE; HUMAN NEOPLASMS; TESTIS	Information on specificities of serological responses against tumor cells in cutaneous lymphoma patients is relatively restricted. To advance the knowledge of serological immune responses against and to assess the scope of tumor antigenicity of cutaneous lymphoma, 1- and 2-dimensional Western blot analyses with sera from patients were combined with proteomics-based protein identification. Testing sera from 87 cutaneous lymphoma patients by 1-dimensional Western blot analysis, 64 cases of seroreactivity against lymphoma cells were found. The positive responses were relatively weak, restricted to few antigens in each case, and heterogeneous. To identify the antigens, proteins of the mycosis fungoides cell line MyLa and primary tumor cells were separated by 2-dimensional gel electrophoresis, Western-blotted and probed with heterogeneous and autologous patient sera. The antigens were identified from silver-stained replica gels by MALDI-TOF mass spectrometry. 14 different antigens were assigned and identified with this proteome-serological approach. Only one, vimentin, had been reported before, the other 13 are new antigens for cutaneous lymphomas.	[Forgber, Michael; Gellrich, Sylke; Sharav, Tumenjargal; Sterry, Wolfram; Walden, Peter] Humboldt Univ, Charite Univ Med Berlin, Dept Dermatol Venerol & Allergy, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Forgber, M (corresponding author), Humboldt Univ, Charite Univ Med Berlin, Dept Dermatol Venerol & Allergy, Berlin, Germany.	peter.walden@charite.de		Sharav, Tumenjargal/0000-0003-2980-1875	Volkswagen Foundation, Hannover, Germany [I/77 908]; Deutsche Krebshilfe - Mildred Scheel Stiftung; Deutsche Forschungsgemeinschaft (DFG)	Volkswagen Foundation, Hannover, Germany(Volkswagen); Deutsche Krebshilfe - Mildred Scheel Stiftung(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by a grant from the Volkswagen Foundation, Hannover, Germany, grant I/77 908, the Deutsche Krebshilfe - Mildred Scheel Stiftung, and the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacarese-Hamilton T, 2002, BIOTECHNIQUES, P24; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Caron M, 2007, MOL CELL PROTEOMICS, V6, P1115, DOI 10.1074/mcp.R600016-MCP200; Chan C, 1999, ELECTROPHORESIS, V20, P3467, DOI 10.1002/(SICI)1522-2683(19991101)20:17<3467::AID-ELPS3467>3.3.CO;2-0; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; Craven RA, 2006, PROTEOMICS, V6, P2853, DOI 10.1002/pmic.200500549; Cui JW, 2005, MOL CELL PROTEOMICS, V4, P1718, DOI 10.1074/mcp.M400165-MCP200; De Monte L, 2008, J PROTEOME RES, V7, P504, DOI 10.1021/pr070360m; Eichmuller S, 2003, INT J CANCER, V104, P482, DOI 10.1002/ijc.10967; Eichmuller S, 2001, P NATL ACAD SCI USA, V98, P629, DOI 10.1073/pnas.021386498; EICHMULLER S, ONKOLOGIE, V25, P448; FORGBER M, 2009, PLOS ONE IN PRESS; Forgber M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000040; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Gunawardana CG, 2007, CANCER LETT, V249, P110, DOI 10.1016/j.canlet.2007.01.002; Gure AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F; Hardouin J, 2007, ANN NY ACAD SCI, V1107, P223, DOI 10.1196/annals.1381.024; Hartmann TB, 2008, EXP DERMATOL, V17, P324, DOI 10.1111/j.1600-0625.2007.00637.x; Hartmann TB, 2005, INT J CANCER, V114, P88, DOI 10.1002/ijc.20762; Hartmann TB, 2004, BRIT J DERMATOL, V150, P252, DOI 10.1111/j.1365-2133.2004.05651.x; Hassel JC, 2004, DERMATOLOGY, V209, P296, DOI 10.1159/000080852; Hishizawa M, 2005, BRIT J HAEMATOL, V130, P418, DOI 10.1111/j.1365-2141.2005.05604.x; Huang S, 2002, CANCER IMMUNOL IMMUN, V51, P655, DOI 10.1007/s00262-002-0320-4; Huguet S, 2004, PROTEOMICS, V4, P1341, DOI 10.1002/pmic.200300757; Jager D, 2000, CANCER RES, V60, P3584; Jungblut PR, 2002, METHOD ENZYMOL, V358, P307; KALTOFT K, 1992, IN VITRO CELL DEV-AN, V28A, P161; Kellner R, 2002, PROTEOMICS, V2, P1743, DOI 10.1002/1615-9861(200212)2:12<1743::AID-PROT1743>3.0.CO;2-U; Kersten C, 2004, CANCER IMMUNOL IMMUN, V53, P1119, DOI 10.1007/s00262-004-0558-0; Klemke Claus-Detlev, 2006, J Dtsch Dermatol Ges, V4, P395, DOI 10.1111/j.1610-0387.2006.05982.x; Krackhardt AM, 2002, BLOOD, V100, P2123, DOI 10.1182/blood-2002-02-0513; Krah Alexander, 2004, Methods Mol Med, V94, P19; Lee M, 2007, CANCER IMMUNOL IMMUN, V56, P783, DOI 10.1007/s00262-006-0239-2; Li C, 2006, PROTEOMICS, V6, P547, DOI 10.1002/pmic.200500256; Li C, 2005, PROTEOMICS, V5, P1125, DOI 10.1002/pmic.200401141; Lichtenfels R, 2003, BBA-PROTEINS PROTEOM, V1646, P21, DOI 10.1016/S1570-9639(02)00547-2; Liggins AP, 2005, METH MOLEC MED, V115, P109; Liggins AP, 2004, BRIT J CANCER, V91, P141, DOI 10.1038/sj.bjc.6601875; Liggins AP, 2004, INT J CANCER, V110, P563, DOI 10.1002/ijc.20170; Linnemann T, 2001, EUR J IMMUNOL, V31, P156, DOI 10.1002/1521-4141(200101)31:1<156::AID-IMMU156>3.0.CO;2-P; Looi KS, 2008, J PROTEOME RES, V7, P4004, DOI 10.1021/pr800273h; Mobley JA, 2004, J UROLOGY, V172, P331, DOI 10.1097/01.ju.0000132355.97888.50; Modarressi MH, 2001, GENE, V262, P249; Morra E, 1999, INT J BIOL MARKER, V14, P149, DOI 10.1177/172460089901400305; Neumann F, 2004, CANCER IMMUNOL IMMUN, V53, P589, DOI 10.1007/s00262-003-0492-6; Olsen E, 2007, BLOOD, V110, P1713, DOI 10.1182/blood-2007-03-055749; Philip R, 2007, J PROTEOME RES, V6, P2509, DOI 10.1021/pr0606777; Preuss KD, 2002, IMMUNOL REV, V188, P43, DOI 10.1034/j.1600-065X.2002.18805.x; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Shoshan Stacy H., 2007, Cancer Biomarkers, V3, P141; Tanaka R, 2004, MICROBIOL IMMUNOL, V48, P339, DOI 10.1111/j.1348-0421.2004.tb03515.x; Theinert SM, 2005, BRIT J DERMATOL, V153, P639, DOI 10.1111/j.1365-2133.2005.06669.x; Tomaino B, 2007, J PROTEOME RES, V6, P4025, DOI 10.1021/pr070281a; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P384, DOI 10.1074/mcp.R500009-MCP200; Unwin RD, 2003, PROTEOMICS, V3, P45, DOI 10.1002/pmic.200390008; USENER D, J INVEST DERMATOL, V121, P198; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Yang F, 2007, J PROTEOME RES, V6, P751, DOI 10.1021/pr0602287	59	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2009	4	12							e8376	10.1371/journal.pone.0008376	http://dx.doi.org/10.1371/journal.pone.0008376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534BN	20020065	Green Published, gold, Green Submitted			2022-12-25	WOS:000272870600015
J	Shinohara, M; Ybanez, MD; Win, S; Than, TA; Jain, S; Gaarde, WA; Han, D; Kaplowitz, N				Shinohara, Mie; Ybanez, Maria D.; Win, Sanda; Than, Tin Aung; Jain, Shilpa; Gaarde, William A.; Han, Derick; Kaplowitz, Neil			Silencing Glycogen Synthase Kinase-3 beta Inhibits Acetaminophen Hepatotoxicity and Attenuates JNK Activation and Loss of Glutamate Cysteine Ligase and Myeloid Cell Leukemia Sequence 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; INDUCED LIVER-INJURY; MITOCHONDRIAL PERMEABILITY TRANSITION; GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; PRIMARY MOUSE HEPATOCYTES; TNF-INDUCED APOPTOSIS; DIRECT PHOSPHORYLATION; MURINE HEPATOCYTES; GLUTATHIONE; METABOLISM	Previously we demonstrated that c-Jun N-terminal kinase (JNK) plays a central role in acetaminophen (APAP)-induced liver injury. In the current work, we examined other possible signaling pathways that may also contribute to APAP hepatotoxicity. APAP treatment to mice caused glycogen synthase kinase-3 beta (GSK-3 beta) activation and translocation to mitochondria during the initial phase of APAP-induced liver injury (similar to 1 h). The silencing of GSK-3 beta, but not Akt-2 (protein kinase B) or glycogen synthase kinase-3 beta (GSK-3 beta), using antisense significantly protected mice from APAP-induced liver injury. The silencing of GSK-3 beta affected several key pathways important in conferring protection against APAP-induced liver injury. APAP treatment was observed to promote the loss of glutamate cysteine ligase (GCL, rate-limiting enzyme in GSH synthesis) in liver. The silencing of GSK-3 beta decreased the loss of hepatic GCL, and promoted greater GSH recovery in liver following APAP treatment. Silencing JNK1 and -2 also prevented the loss of GCL. APAP treatment also resulted in GSK-3 beta translocation to mitochondria and the degradation of myeloid cell leukemia sequence 1 (Mcl-1) in mitochondrial membranes in liver. The silencing of GSK-3 beta reduced Mcl-1 degradation caused by APAP treatment. The silencing of GSK-3 beta also resulted in an inhibition of the early phase (0-2 h), and blunted the late phase (after 4 h) of JNK activation and translocation to mitochondria in liver following APAP treatment. Taken together our results suggest that activation of GSK-3 beta is a key mediator of the initial phase of APAP-induced liver injury through modulating GCL and Mcl-1 degradation, as well as JNK activation in liver.	[Shinohara, Mie; Ybanez, Maria D.; Win, Sanda; Than, Tin Aung; Jain, Shilpa; Han, Derick; Kaplowitz, Neil] Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, Los Angeles, CA 90089 USA; [Gaarde, William A.] ISIS Pharmaceut, Carlsbad, CA 92008 USA	University of Southern California; Isis Pharmaceuticals Inc	Kaplowitz, N (corresponding author), 2011 Zonal Ave,HMR 101, Los Angeles, CA 90089 USA.	kaplowit@usc.edu			National Institutes of Health [DK067215, AA016911]; Zumberge award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522, R01DK067215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA016911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zumberge award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK067215 (to N.K.) and AA016911 (to D. H.). This work was also supported by a Zumberge award (Office of the Provost at the University of Southern California; to D. H.).	Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Bajt ML, 2008, J PHARMACOL EXP THER, V324, P8, DOI 10.1124/jpet.107.129445; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Copple IM, 2008, HEPATOLOGY, V48, P1292, DOI 10.1002/hep.22472; Czaja MJ, 2007, SEMIN LIVER DIS, V27, P378, DOI 10.1055/s-2007-991514; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Franklin CC, 2003, FASEB J, V17, P1535, DOI 10.1096/fj.02-0867fje; Goldring CEP, 2004, HEPATOLOGY, V39, P1267, DOI 10.1002/hep.20183; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; HAN D, 2009, HDB EXP PHARM, V196, P267; Han D, 2006, FREE RADICAL BIO MED, V41, P627, DOI 10.1016/j.freeradbiomed.2006.05.002; Han D, 2009, ANTIOXID REDOX SIGN, V11, P2245, DOI [10.1089/ars.2009.2611, 10.1089/ARS.2009.2611]; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Hinson JA, 2004, DRUG METAB REV, V36, P805, DOI 10.1081/DMR-200033494; Hu D, 2008, CARCINOGENESIS, V29, P2317, DOI 10.1093/carcin/bgn239; Iles KE, 2005, FREE RADICAL BIO MED, V38, P547, DOI 10.1016/j.freeradbiomed.2004.11.012; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Ju C, 2002, CHEM RES TOXICOL, V15, P1504, DOI 10.1021/tx0255976; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; Kaplowitz N, 2008, GASTROENTEROLOGY, V135, P1047, DOI 10.1053/j.gastro.2008.08.031; Kim JW, 2003, J BIOL CHEM, V278, P13995, DOI 10.1074/jbc.M300253200; Kodama Y, 2009, GASTROENTEROLOGY, V136, P1423, DOI 10.1053/j.gastro.2008.12.064; LASKIN DL, 1995, HEPATOLOGY, V21, P1045, DOI 10.1002/hep.1840210424; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Lu SC, 2000, CURR TOP CELL REGUL, V36, P95; Matsumaru K, 2003, HEPATOLOGY, V37, P1425, DOI 10.1053/jhep.2003.50230; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; Michael SL, 1999, HEPATOLOGY, V30, P186, DOI 10.1002/hep.510300104; Mishra R, 2007, J BIOL CHEM, V282, P30393, DOI 10.1074/jbc.M705895200; Miura T, 2009, J PHARMACOL SCI, V109, P162, DOI 10.1254/jphs.08R27FM; Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; PARK YJ, 1988, TOXICOLOGY, V52, P165, DOI 10.1016/0300-483X(88)90202-8; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Saberi B, 2008, AM J PHYSIOL-CELL PH, V295, pC50, DOI 10.1152/ajpcell.90654.2007; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; SEELIG GF, 1985, METHOD ENZYMOL, V113, P379; Sumi D, 2007, TOXICOL APPL PHARM, V223, P218, DOI 10.1016/j.taap.2007.06.001; Vick B, 2009, HEPATOLOGY, V49, P627, DOI 10.1002/hep.22664; Warr MR, 2008, CURR MOL MED, V8, P138; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x	49	84	88	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8244	8255		10.1074/jbc.M109.054999	http://dx.doi.org/10.1074/jbc.M109.054999			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061376	hybrid, Green Published			2022-12-25	WOS:000275413800043
J	Delaroche, D; Cantrelle, FX; Subra, F; Van Heijenoort, C; Guittet, E; Jiao, CY; Blanchoin, L; Chassaing, G; Lavielle, S; Auclair, C; Sagan, S				Delaroche, Diane; Cantrelle, Francois-Xavier; Subra, Frederic; Van Heijenoort, Carine; Guittet, Eric; Jiao, Chen-Yu; Blanchoin, Laurent; Chassaing, Gerard; Lavielle, Solange; Auclair, Christian; Sagan, Sandrine			Cell-penetrating Peptides with Intracellular Actin-remodeling Activity in Malignant Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTENNAPEDIA HOMEOBOX PEPTIDE; MARCKS-RELATED PROTEIN; MASS-SPECTROMETRY; F-ACTIN; POLYMERIZATION; BINDING; DELIVERY; PYRENE; DOMAIN; ACID	Cell-penetrating peptides can cross cell membranes and are commonly seen as biologically inert molecules. However, we found that some cell-penetrating peptides could remodel actin cytoskeleton in oncogene-transformed NIH3T3/EWS-Fli cells. These cells have profound actin disorganization related to their tumoral transformation. These arginine- and/or tryptophan-rich peptides could cross cell membrane and induce stress fiber formation in these malignant cells, whereas they had no perceptible effect in non-tumoral fibroblasts. In addition, motility (migration speed, random motility coefficient, wound healing) of the tumor cells could be decreased by the cell-permeant peptides. Although the peptides differently influenced actin polymerization in vitro, they could directly bind monomeric actin as determined by NMR and calorimetry studies. Therefore, cell-penetrating peptides might interact with intracellular protein partners, such as actin. In addition, the fact that they could reverse the tumoral phenotype is of interest for therapeutic purposes.	[Jiao, Chen-Yu; Chassaing, Gerard; Lavielle, Solange; Sagan, Sandrine] Univ Paris 06, CNRS, Lab Biomol, F-75005 Paris, France; [Delaroche, Diane; Cantrelle, Francois-Xavier; Van Heijenoort, Carine; Guittet, Eric] CNRS, Inst Chim Subst Nat, Lab Chim & Biol Struct, F-91198 Gif Sur Yvette, France; [Subra, Frederic; Auclair, Christian] Ecole Normale Super, CNRS, Lab Biotechnol & Pharmacol Genet Appl, F-94235 Cachan, France; [Blanchoin, Laurent] Commissariat Energie Atom Grenoble, Inst Rech Technol & Sci Vivant, Physiol Cellulaire Vegetale Lab, F-38054 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Sagan, S (corresponding author), Univ Paris 06, CNRS, Lab Biomol, 4 Pl Jussieu, F-75005 Paris, France.	sandrine.sagan@upmc.fr	VAN HEIJENOORT, Carine/N-1986-2016; SAGAN, Sandrine/AAA-8537-2022; s, s/GYR-2278-2022; s, s/HHD-0404-2022; S, SAGAN/I-8132-2013; s, s/GVS-3323-2022; QI, DANDAN/GVR-9324-2022; s, s/HIK-1178-2022; van Heijenoort, Carine/AAX-1041-2021	VAN HEIJENOORT, Carine/0000-0002-2839-1037; S, SAGAN/0000-0003-0083-4411; van Heijenoort, Carine/0000-0002-2839-1037; cantrelle, francois-xavier/0000-0002-3413-5443; Guittet, Eric/0000-0002-8368-6719	Agence Nationale pour la Recherche [05-BLAN0269]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale pour la Recherche Grant 05-BLAN0269.	Amsellem V, 2005, EXP CELL RES, V304, P443, DOI 10.1016/j.yexcr.2004.10.035; BROWN SS, 1979, J CELL BIOL, V80, P499, DOI 10.1083/jcb.80.2.499; Burlina F, 2005, ANGEW CHEM INT EDIT, V44, P4244, DOI 10.1002/anie.200500477; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delaroche D, 2007, ANAL CHEM, V79, P1932, DOI 10.1021/ac061108l; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Domanski M, 2004, J BIOL CHEM, V279, P23637, DOI 10.1074/jbc.M311413200; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Dominguez R, 2007, ANN NY ACAD SCI, V1112, P86, DOI 10.1196/annals.1415.011; ENCINAS MV, 1986, PHOTOCHEM PHOTOBIOL, V44, P579, DOI 10.1111/j.1751-1097.1986.tb04712.x; Fotin-Mleczek M, 2005, J CELL SCI, V118, P3339, DOI 10.1242/jcs.02460; Goddard T. D, 2007, SPARKY 3; Hansen M, 2008, ADV DRUG DELIVER REV, V60, P572, DOI 10.1016/j.addr.2007.09.003; Hari SP, 2000, BIOCHEMISTRY-US, V39, P3763, DOI 10.1021/bi9926734; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; JOLIOT AH, 1991, NEW BIOL, V3, P1121; Jones AT, 2008, INT J PHARMACEUT, V354, P34, DOI 10.1016/j.ijpharm.2007.10.046; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Lanzetti L, 2001, EXP CELL RES, V271, P45, DOI 10.1006/excr.2001.5369; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; ORIOLAUDIT C, 1978, EUR J BIOCHEM, V87, P371, DOI 10.1111/j.1432-1033.1978.tb12386.x; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; SAAR K, 2007, HDB CELL PENETRATING, P553; Shikinaka K, 2008, BIOMACROMOLECULES, V9, P537, DOI 10.1021/bm701068n; Spaz JA, 2007, ANAL BIOCHEM, V367, P95, DOI 10.1016/j.ab.2007.04.001; Sroka TC, 2006, CARCINOGENESIS, V27, P1748, DOI 10.1093/carcin/bgl005; Sugiyama S, 2009, DEV GROWTH DIFFER, V51, P369, DOI 10.1111/j.1440-169X.2009.01093.x; Tang JX, 1997, EUR J BIOCHEM, V247, P432, DOI 10.1111/j.1432-1033.1997.00432.x; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Turner JJ, 2007, BLOOD CELL MOL DIS, V38, P1, DOI 10.1016/j.bcmd.2006.10.003; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wohnsland F, 2000, J STRUCT BIOL, V131, P217, DOI 10.1006/jsbi.2000.4299; Wohnsland F, 2000, BIOPHYS CHEM, V85, P169, DOI 10.1016/S0301-4622(00)00113-7; Yang H, 1996, J PHYS CHEM-US, V100, P14533, DOI 10.1021/jp9607531	46	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7712	7721		10.1074/jbc.M109.045872	http://dx.doi.org/10.1074/jbc.M109.045872			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20037163	hybrid, Green Published			2022-12-25	WOS:000275415600080
J	Hayashihara, K; Uchiyama, S; Shimamoto, S; Kobayashi, S; Tomschik, M; Wakamatsu, H; No, D; Sugahara, H; Hori, N; Noda, M; Ohkubo, T; Zlatanova, J; Matsunaga, S; Fukui, K				Hayashihara, Kayoko; Uchiyama, Susumu; Shimamoto, Shigeru; Kobayashi, Shouhei; Tomschik, Miroslav; Wakamatsu, Hidekazu; No, Daisuke; Sugahara, Hiroki; Hori, Naoto; Noda, Masanori; Ohkubo, Tadayasu; Zlatanova, Jordanka; Matsunaga, Sachihiro; Fukui, Kiichi			The Middle Region of an HP1-binding Protein, HP1-BP74, Associates with Linker DNA at the Entry/Exit Site of Nucleosomal DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN METAPHASE CHROMOSOMES; HISTONE H1-LIKE PROTEIN; TOPOISOMERASE-II-ALPHA; HETEROCHROMATIN PROTEIN-1; MITOTIC CHROMOSOMES; TERTIARY STRUCTURE; GLOBULAR DOMAIN; IN-VIVO; H1; CHROMATIN	In higher eukaryotic cells, DNA molecules are present as chromatin fibers, complexes of DNA with various types of proteins; chromatin fibers are highly condensed in metaphase chromosomes during mitosis. Although the formation of the metaphase chromosome structure is essential for the equal segregation of replicated chromosomal DNA into the daughter cells, the mechanism involved in the organization of metaphase chromosomes is poorly understood. To identify proteins involved in the formation and/or maintenance of metaphase chromosomes, we examined proteins that dissociated from isolated human metaphase chromosomes by 0.4 M NaCl treatment; this treatment led to significant chromosome decondensation, but the structure retained the core histones. One of the proteins identified, HP1-BP74 (heterochromatin protein 1-binding protein 74), composed of 553 amino acid residues, was further characterized. HP1-BP74 middle region (BP74Md), composed of 178 amino acid residues (Lys(97)-Lys(274)), formed a chromatosome-like structure with reconstituted mononucleosomes and protected the linker DNA from micrococcal nuclease digestion by similar to 25 bp. The solution structure determined by NMR revealed that the globular domain (Met(153)-Thr(237)) located within BP74Md possesses a structure similar to that of the globular domain of linker histones, which underlies its nucleosome binding properties. Moreover, we confirmed that BP74Md and full-length HP1-BP74 directly binds to HP1 (heterochromatin protein 1) and identified the exact sites responsible for this interaction. Thus, we discovered that HP1-BP74 directly binds to HP1, and its middle region associates with linker DNA at the entry/exit site of nucleosomal DNA in vitro.	[Hayashihara, Kayoko; Uchiyama, Susumu; Kobayashi, Shouhei; Wakamatsu, Hidekazu; No, Daisuke; Hori, Naoto; Noda, Masanori; Matsunaga, Sachihiro; Fukui, Kiichi] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan; [Shimamoto, Shigeru; Sugahara, Hiroki; Ohkubo, Tadayasu] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Tomschik, Miroslav; Zlatanova, Jordanka] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	Osaka University; Osaka University; University of Wyoming	Fukui, K (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan.	kfukui@bio.eng.osaka-u.ac.jp	UCHIYAMA, Susumu/F-9590-2017; Matsunaga, Sachihiro/F-8689-2010; Zlatanova, Jordanka/B-3273-2009; , Miroslav/AAD-9416-2020	UCHIYAMA, Susumu/0000-0002-5181-179X; Matsunaga, Sachihiro/0000-0003-3024-3559; , Miroslav/0000-0002-0758-6169	Ministry of Education, Culture, Sports, Science, and Technology; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by special coordination funds (to K. F. and S. U.) and grants-in-aid for scientific research (to S. U., S. M., and K. F.) from the Ministry of Education, Culture, Sports, Science, and Technology and by the Japan Science and Technology Agency (Bioinformatics Research and Development to S. M. and Sentan to K. F.).	BAX A, 1994, J BIOMOL NMR, V4, P787, DOI 10.1007/BF00398409; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURTON DR, 1978, NUCLEIC ACIDS RES, V5, P3643, DOI 10.1093/nar/5.10.3643; Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732; CERF C, 1994, BIOCHEMISTRY-US, V33, P11079, DOI 10.1021/bi00203a004; Chang CJ, 2003, J CELL SCI, V116, P4715, DOI 10.1242/jcs.00797; Cherukuri S, 2008, MOL BIOL CELL, V19, P1816, DOI 10.1091/mbc.E07-10-1018; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fan JY, 2007, METHODS, V41, P286, DOI 10.1016/j.ymeth.2006.11.001; FLEMMING W, 1982, ZELLSUBSTANZ KERN ZE; Fukui K, 2007, CHEM REC, V7, P230, DOI 10.1002/tcr.20120; Gambe AE, 2007, CYTOM PART A, V71A, P286, DOI 10.1002/cyto.a.20378; GASSER SM, 1987, EXP CELL RES, V173, P85, DOI 10.1016/0014-4827(87)90334-X; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; GEORGEL P, 1993, J BIOL CHEM, V268, P1947; GOULD H, 1998, CHROMATIN PRACTICAL, P22; Hamiche A, 1996, J MOL BIOL, V257, P30, DOI 10.1006/jmbi.1996.0144; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; HAYASHIHARA K, 2008, PROTOCOLS NETWORK, DOI DOI 10.1038/NPROT.2008.166; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Hudson DF, 2003, DEV CELL, V5, P323, DOI 10.1016/S1534-5807(03)00199-0; Kay LE, 1995, PROG BIOPHYS MOL BIO, V63, P277, DOI 10.1016/0079-6107(95)00007-0; KHOCHBIN S, 1994, EUR J BIOCHEM, V225, P501, DOI 10.1111/j.1432-1033.1994.00501.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LE DB, 1996, EMBO J, V15, P6701; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Luger K, 1999, METH MOL B, V119, P1; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; Morrison C, 2002, NUCLEIC ACIDS RES, V30, P5318, DOI 10.1093/nar/gkf665; OHSUMI K, 1993, SCIENCE, V262, P2033, DOI 10.1126/science.8266099; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; PARSEGHIAN MH, 1994, PROTEIN SCI, V3, P575; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; RASHEED BKA, 1989, J CELL SCI, V94, P61; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; Sakaguchi A, 2004, J CELL SCI, V117, P1047, DOI 10.1242/jcs.00977; SEYEDIN SM, 1981, EXP CELL RES, V136, P399, DOI 10.1016/0014-4827(81)90019-7; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Sumner AT, 2003, CHROMOSOMES ORG FUNC, P5; Takata H, 2007, FEBS LETT, V581, P3783, DOI 10.1016/j.febslet.2007.06.076; Takata H, 2007, GENES CELLS, V12, P269, DOI 10.1111/j.1365-2443.2007.01051.x; Tanaka H, 2006, INT J ANDROL, V29, P353, DOI 10.1111/j.1365-2605.2005.00600.x; Tanaka M, 2001, DEVELOPMENT, V128, P655; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Uchiyama S, 2005, J BIOL CHEM, V280, P16994, DOI 10.1074/jbc.M412774200; Ura K, 1996, EMBO J, V15, P4959, DOI 10.1002/j.1460-2075.1996.tb00876.x; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; VONHOLT C, 1989, METHOD ENZYMOL, V170, P431; WUTHRCH K, 1986, NMR PROTEINS NUCL AC; Yamamoto T, 1996, GENE, V173, P281, DOI 10.1016/0378-1119(96)00020-0; Yan W, 2003, P NATL ACAD SCI USA, V100, P10546, DOI 10.1073/pnas.1837812100; Yeong FM, 2003, CURR BIOL, V13, P2058, DOI 10.1016/j.cub.2003.10.032; Zlatanova J, 2008, TRENDS BIOCHEM SCI, V33, P247, DOI 10.1016/j.tibs.2008.04.001	62	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6498	6507		10.1074/jbc.M109.092833	http://dx.doi.org/10.1074/jbc.M109.092833			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20042602	Green Published, hybrid			2022-12-25	WOS:000275367500054
J	Lebaudy, A; Pascaud, F; Very, AA; Alcon, C; Dreyer, I; Thibaud, JB; Lacombe, B				Lebaudy, Anne; Pascaud, Francois; Very, Anne-Alienor; Alcon, Carine; Dreyer, Ingo; Thibaud, Jean-Baptiste; Lacombe, Benoit			Preferential KAT1-KAT2 Heteromerization Determines Inward K+ Current Properties in Arabidopsis Guard Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT POTASSIUM CHANNEL; KAT1; SUBUNIT; AKT2; STOICHIOMETRY; CARROT; KDC1; ION; COOPERATIVITY; RECTIFICATION	Guard cells adjust their volume by changing their ion content due to intense fluxes that, for K+, are believed to flow through inward or outward Shaker channels. Because Shaker channels can be homo-or heterotetramers and Arabidopsis guard cells express at least five genes encoding inward Shaker subunits, including the two major ones, KAT1 and KAT2, the molecular identity of inward Shaker channels operating therein is not yet completely elucidated. Here, we first addressed the properties of KAT1-KAT2 heteromers by expressing KAT1-KAT2 tandems in Xenopus oocytes. Then, computer analyses of the data suggested that coexpression of free KAT1 and KAT2 subunits resulted mainly in heteromeric channels made of two subunits of each type due to some preferential association of KAT1-KAT2 heterodimers at the first step of channel assembly. This was further supported by the analysis of KAT2 effect on KAT1 targeting in tobacco cells. Finally, patch-clamp recordings of native inward channels in wild-type and mutant genotypes strongly suggested that this preferential heteromerization occurs in planta and that Arabidopsis guard cell inward Shaker channels are mainly heteromers of KAT1 and KAT2 subunits.	[Lacombe, Benoit] Univ Montpellier 2, Montpellier SupAgro, INRA, CNRS,UMR 5004,U386, F-34060 Montpellier, France; [Dreyer, Ingo] Univ Potsdam, Inst Biochem & Biol, Heisenberg Grp Biophys & Mol Pflanzenbiol, D-14476 Potsdam, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; University of Potsdam	Lacombe, B (corresponding author), BPMP, Batiment 7,Campus INRA SupAgro,Pl Viala, F-34060 Montpellier, France.	benoit.lacombe@supagro.inra.fr	Lacombe, Benoit/B-1202-2013; Dreyer, Ingo/N-4747-2014	Dreyer, Ingo/0000-0002-2781-0359; Lacombe, Benoit/0000-0001-9924-3093; THIBAUD, Jean-Baptiste/0000-0002-0824-6465; VERY, Anne-Alienor/0000-0003-1961-5243	Institut National de la Recherche Agronomique/Region Languedoc-Roussillon; CNRS; Heisenberg fellowship from the Deutsche Forschungsgemeinschaft; Agence National de la Recherche Genoplante [GPLA06041G]; Agropolis Foundation [0803-022]	Institut National de la Recherche Agronomique/Region Languedoc-Roussillon(Region Occitanie); CNRS(Centre National de la Recherche Scientifique (CNRS)); Heisenberg fellowship from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Agence National de la Recherche Genoplante(French National Research Agency (ANR)); Agropolis Foundation	This work was supported in part by doctoral fellowship grants from the Institut National de la Recherche Agronomique/Region Languedoc-Roussillon (to A. L.) and CNRS (to F. P.), a Heisenberg fellowship from the Deutsche Forschungsgemeinschaft (to I. D.), Agence National de la Recherche Genoplante Grant GPLA06041G (to B. L. and J.-B.T.), and Agropolis Foundation Grant 0803-022 (to J.-B.T.).	Ache P, 2001, PLANT J, V27, P571, DOI 10.1046/j.1365-313X.2001.t01-1-01116.x; Baizabal-Aguirre VM, 1999, J MEMBRANE BIOL, V167, P119, DOI 10.1007/s002329900476; Bregante M, 2008, PLANT MOL BIOL, V66, P61, DOI 10.1007/s11103-007-9252-x; Daram P, 1997, EMBO J, V16, P3455, DOI 10.1093/emboj/16.12.3455; Dreyer I, 2004, BIOPHYS J, V87, P858, DOI 10.1529/biophysj.103.037671; Dreyer I, 1997, BIOPHYS J, V72, P2143, DOI 10.1016/S0006-3495(97)78857-X; Dreyer I, 2009, TRENDS PLANT SCI, V14, P383, DOI 10.1016/j.tplants.2009.04.001; Duby G, 2008, PLANT J, V53, P115, DOI 10.1111/j.1365-313X.2007.03324.x; Ehrhardt T, 1997, FEBS LETT, V409, P166, DOI 10.1016/S0014-5793(97)00502-4; Formentin E, 2004, FEBS LETT, V573, P61, DOI 10.1016/j.febslet.2004.07.052; Gaymard F, 1996, J BIOL CHEM, V271, P22863, DOI 10.1074/jbc.271.37.22863; Geiger D, 2009, J BIOL CHEM, V284, P21288, DOI 10.1074/jbc.M109.017574; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HOSHI T, 1995, J GEN PHYSIOL, V105, P309, DOI 10.1085/jgp.105.3.309; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Hosy E, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-14; Hosy E, 2003, P NATL ACAD SCI USA, V100, P5549, DOI 10.1073/pnas.0733970100; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Ivashikina N, 2005, J GEN PHYSIOL, V125, P483, DOI 10.1085/jgp.200409211; Jeanguenin L, 2008, PLANT SIGNAL BEHAV, V3, P622, DOI 10.4161/psb.3.9.6209; Kwak JM, 2001, PLANT PHYSIOL, V127, P473, DOI 10.1104/pp.010428; Lacombe B, 1998, J MEMBRANE BIOL, V166, P91, DOI 10.1007/s002329900451; Lacombe B, 2000, FEBS LETT, V466, P351, DOI 10.1016/S0014-5793(00)01093-0; Lacombe B, 2000, PLANT CELL, V12, P837, DOI 10.1105/tpc.12.6.837; Lebaudy A, 2008, PLANT J, V54, P1076, DOI 10.1111/j.1365-313X.2008.03479.x; Lebaudy A, 2008, P NATL ACAD SCI USA, V105, P5271, DOI 10.1073/pnas.0709732105; Lebaudy A, 2007, FEBS LETT, V581, P2357, DOI 10.1016/j.febslet.2007.03.058; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Li LG, 2006, P NATL ACAD SCI USA, V103, P12625, DOI 10.1073/pnas.0605129103; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; Luan S, 2009, CURR OPIN PLANT BIOL, V12, P339, DOI 10.1016/j.pbi.2009.05.003; Marten I, 1998, BIOPHYS J, V74, P2953, DOI 10.1016/S0006-3495(98)78002-6; Marten I, 1997, P NATL ACAD SCI USA, V94, P3448, DOI 10.1073/pnas.94.7.3448; MCCORMACK K, 1992, BIOPHYS J, V63, P1406, DOI 10.1016/S0006-3495(92)81703-4; Michard E, 2005, J GEN PHYSIOL, V126, P605, DOI 10.1085/jgp.200509413; Michard E, 2005, PLANT J, V44, P783, DOI 10.1111/j.1365-313X.2005.02566.x; Mikosch M, 2006, PLANT PHYSIOL, V142, P923, DOI 10.1104/pp.106.087064; Naso A, 2006, BIOPHYS J, V91, P3673, DOI 10.1529/biophysj.106.091777; Naso A, 2009, BIOPHYS J, V96, P4063, DOI 10.1016/j.bpj.2009.02.055; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; Picco C, 2004, BIOPHYS J, V86, P224, DOI 10.1016/S0006-3495(04)74098-9; Pilot G, 2001, J BIOL CHEM, V276, P3215, DOI 10.1074/jbc.M007303200; Reintanz B, 2002, P NATL ACAD SCI USA, V99, P4079, DOI 10.1073/pnas.052677799; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Sutter JU, 2006, PLANT CELL, V18, P935, DOI 10.1105/tpc.105.038950; Szyroki A, 2001, P NATL ACAD SCI USA, V98, P2917, DOI 10.1073/pnas.051616698; Urbach S, 2000, PLANT J, V23, P527, DOI 10.1046/j.1365-313x.2000.00828.x; Very AA, 2003, ANNU REV PLANT BIOL, V54, P575, DOI 10.1146/annurev.arplant.54.031902.134831; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Xicluna J, 2007, J BIOL CHEM, V282, P486, DOI 10.1074/jbc.M607607200; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	57	44	46	8	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6265	6274		10.1074/jbc.M109.068445	http://dx.doi.org/10.1074/jbc.M109.068445			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040603	Green Published, hybrid			2022-12-25	WOS:000275367500031
J	Mehta, S; Sibley, LD				Mehta, Simren; Sibley, L. David			Toxoplasma gondii Actin Depolymerizing Factor Acts Primarily to Sequester G-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACANTHAMOEBA ACTOPHORIN ADF/COFILIN; REFLECTION FLUORESCENCE MICROSCOPY; CHICKEN SKELETAL-MUSCLE; F-ACTIN; FILAMENT TURNOVER; CAENORHABDITIS-ELEGANS; BINDING SITE; FACTOR/COFILIN PROTEINS; APICOMPLEXAN PARASITES; MICROFILAMENT DYNAMICS	Toxoplasma gondii is a protozoan parasite belonging to the phylum Apicomplexa. Parasites in this phylum utilize a unique process of motility termed gliding, which is dependent on parasite actin filaments. Surprisingly, 98% of parasite actin is maintained as G-actin, suggesting that filaments are rapidly assembled and turned over. Little is known about the regulated disassembly of filaments in the Apicomplexa. In higher eukaryotes, the related actin depolymerizing factor (ADF) and cofilin proteins are essential regulators of actin filament turnover. ADF is one of the few actin-binding proteins conserved in apicomplexan parasites. In this study we examined the mechanism by which T. gondii ADF (TgADF) regulates actin filament turnover. Unlike other members of the ADF/cofilin (AC) family, apicomplexan ADFs lack key F-actin binding sites. Surprisingly, this promotes their enhanced disassembly of actin filaments. Restoration of the C-terminal F-actin binding site to TgADF stabilized its interaction with filaments but reduced its net filament disassembly activity. Analysis of severing activity revealed that TgADF is a weak severing protein, requiring much higher concentrations than typical AC proteins. Investigation of TgADF interaction with T. gondii actin (TgACT) revealed that TgADF disassembled short TgACT oligomers. Kinetic and steady-state polymerization assays demonstrated that TgADF has strong monomer-sequestering activity, inhibiting TgACT polymerization at very low concentrations. Collectively these data indicate that TgADF promoted the efficient turnover of actin filaments via weak severing of filaments and strong sequestering of monomers. This suggests a dual role for TgADF in maintaining high G-actin concentrations and effecting rapid filament turnover.	[Mehta, Simren; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Sibley, LD (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	sibley@wustl.edu	Mehta, Simren/AAE-8738-2019	Mehta, Simren/0000-0003-0163-5510	National Institutes of Health [AI073155]; Washington University Morse/Berg Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034036, R01AI073155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Morse/Berg Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI073155 (to L.D.S.). This work was also supported by a Washington University Morse/Berg Fellowship (to S.M.).	ABE H, 1989, J BIOCHEM-TOKYO, V106, P172, DOI 10.1093/oxfordjournals.jbchem.a122810; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Allen ML, 1997, MOL BIOCHEM PARASIT, V88, P43, DOI 10.1016/S0166-6851(97)00069-8; Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BAMBURG JR, 1980, FEBS LETT, V121, P178, DOI 10.1016/0014-5793(80)81292-0; Barragan A, 2003, TRENDS MICROBIOL, V11, P426, DOI 10.1016/S0966-842X(03)00205-1; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Bernstein BW, 2000, CELL MOTIL CYTOSKEL, V47, P319, DOI 10.1002/1097-0169(200012)47:4<319::AID-CM6>3.0.CO;2-I; Blanchoin L, 2000, J MOL BIOL, V295, P203, DOI 10.1006/jmbi.1999.3336; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Bowman GD, 2000, PROTEINS, V41, P374, DOI 10.1002/1097-0134(20001115)41:3<374::AID-PROT90>3.0.CO;2-F; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Chen H, 2004, BIOCHEMISTRY-US, V43, P7127, DOI 10.1021/bi049797n; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Fedorov AA, 1997, NAT STRUCT BIOL, V4, P366, DOI 10.1038/nsb0597-366; Ganter M, 2009, MOL MICROBIOL, V74, P1356, DOI 10.1111/j.1365-2958.2009.06828.x; Gordon Jennifer L., 2007, P555; Guan JQ, 2002, BIOCHEMISTRY-US, V41, P5765, DOI 10.1021/bi0121104; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; HARRIS HE, 1980, FEBS LETT, V121, P175, DOI 10.1016/0014-5793(80)81291-9; Hatanaka H, 1996, CELL, V85, P1047, DOI 10.1016/S0092-8674(00)81305-7; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; Joynson DH, 2001, TOXOPLASMOSIS COMPRE; KORN ED, 1978, P NATL ACAD SCI USA, V75, P588, DOI 10.1073/pnas.75.2.588; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonard SA, 1997, NAT STRUCT BIOL, V4, P369, DOI 10.1038/nsb0597-369; MABUCHI I, 1983, J CELL BIOL, V97, P1612, DOI 10.1083/jcb.97.5.1612; Maciver SK, 1998, EUR J BIOCHEM, V256, P388, DOI 10.1046/j.1432-1327.1998.2560388.x; Maciver SK, 1998, CURR OPIN CELL BIOL, V10, P140, DOI 10.1016/S0955-0674(98)80097-5; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Moriyama K, 1999, EMBO J, V18, P6752, DOI 10.1093/emboj/18.23.6752; MORIYAMA K, 1992, J BIOL CHEM, V267, P7240; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Nachmias VT, 1993, CURR OPIN CELL BIOL, V5, P56, DOI 10.1016/S0955-0674(05)80008-0; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P6624, DOI 10.1021/bi00344a049; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; Ono K, 2003, J CELL SCI, V116, P2073, DOI 10.1242/jcs.00421; Ono K, 2008, J CELL SCI, V121, P2662, DOI 10.1242/jcs.034215; Ono S, 1999, J CELL BIOL, V145, P491, DOI 10.1083/jcb.145.3.491; Ono S, 1998, J BIOL CHEM, V273, P3778, DOI 10.1074/jbc.273.6.3778; Ono S, 2001, J BIOL CHEM, V276, P5952, DOI 10.1074/jbc.M007563200; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pope BJ, 2000, J MOL BIOL, V298, P649, DOI 10.1006/jmbi.2000.3688; Poupel O, 1999, MICROBES INFECT, V1, P653, DOI 10.1016/S1286-4579(99)80066-5; QUIRK S, 1993, BIOCHEMISTRY-US, V32, P8525, DOI 10.1021/bi00084a019; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schuler H, 2006, TRAFFIC, V7, P1433, DOI 10.1111/j.1600-0854.2006.00484.x; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; Shaw MK, 1999, P NATL ACAD SCI USA, V96, P9095, DOI 10.1073/pnas.96.16.9095; SHIMIZU N, 1986, J BIOCHEM-TOKYO, V99, P751, DOI 10.1093/oxfordjournals.jbchem.a135534; Shiozaki N, 2009, BIOCHEM BIOPH RES CO, V390, P54, DOI 10.1016/j.bbrc.2009.09.063; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Smertenko AP, 1998, PLANT J, V14, P187, DOI 10.1046/j.1365-313X.1998.00107.x; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458; Xu JH, 2008, PARASITOL RES, V103, P263, DOI 10.1007/s00436-008-0961-0; Yamashiro S, 2005, BIOCHEMISTRY-US, V44, P14238, DOI 10.1021/bi050933d; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410; YONEZAWA N, 1991, J BIOL CHEM, V266, P10485	73	50	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6835	6847		10.1074/jbc.M109.068155	http://dx.doi.org/10.1074/jbc.M109.068155			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20042603	Green Published, hybrid			2022-12-25	WOS:000275367500086
J	Okamoto, M; Liu, WM; Luo, YC; Tanaka, A; Cai, XN; Norris, DA; Dinarello, CA; Fujita, M				Okamoto, Miyako; Liu, Weimin; Luo, Yuchun; Tanaka, Aki; Cai, Xiangna; Norris, David A.; Dinarello, Charles A.; Fujita, Mayumi			Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; TUMOR-GROWTH; IN-VIVO; MOLECULAR PLATFORM; PERIODIC SYNDROMES; IMMUNE-RESPONSES; CARCINOMA-CELLS; CANCER CELLS; ACTIVATION; METASTASIS	Interleukin-1 beta (IL-1 beta) is a pleiotropic cytokine promoting inflammation, angiogenesis, and tissue remodeling as well as regulation of immune responses. Although IL-1 beta contributes to growth and metastatic spread in experimental and human cancers, the molecular mechanisms regulating the conversion of the inactive IL-1 beta precursor to a secreted and active cytokine remains unclear. Here we demonstrate that NALP3 inflammasome is constitutively assembled and activated with cleavage of caspase-1 in human melanoma cells. Late stage human melanoma cells spontaneously secrete active IL-1 beta via constitutive activation of the NALP3 inflammasome and IL-1 receptor signaling, exhibiting a feature of autoinflammatory diseases. Unlike human blood monocytes, these melanoma cells require no exogenous stimulation. In contrast, NALP3 functionality in intermediate stage melanoma cells requires activation of the IL-1 receptor to secrete active IL-1 beta; cells from an early stage of melanoma require stimulation of the IL-1 receptor plus the co-stimulant muramyl dipeptide. The spontaneous secretion of IL-1 beta from melanoma cells was reduced by inhibition of caspase-1 or the use of small interfering RNA directed against ASC. Supernatants from melanoma cell cultures enhanced macrophage chemotaxis and promoted in vitro angiogenesis, both prevented by pretreating melanoma cells with inhibitors of caspases-1 and -5 or IL-1 receptor blockade. These findings implicate IL-1-mediated autoinflammation as contributing to the development and progression of human melanoma and suggest that inhibiting the inflammasome pathway or reducing IL-1 activity can be a therapeutic option for melanoma patients.	[Okamoto, Miyako; Liu, Weimin; Luo, Yuchun; Tanaka, Aki; Cai, Xiangna; Norris, David A.; Fujita, Mayumi] Univ Colorado Denver, Dept Dermatol, Aurora, CO 80045 USA; [Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Fujita, M (corresponding author), Univ Colorado Denver, Dept Dermatol, Mail Stop 8127,12801 E 17th Ave,Rm 4124, Aurora, CO 80045 USA.	mayumi.fujita@ucdenver.edu	Dinarello, Charles/C-8524-2013; Luo, Yuchun/B-8683-2014		National Institutes of Health [CA125833, AI-15614, 5T32AR007411]; Dermatology Foundation; Tadamitsu Cancer Research Fund; NATIONAL CANCER INSTITUTE [R03CA125833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015614, R56AI015614, R37AI015614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; Tadamitsu Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA125833 (to M. F.) and AI-15614 (to C. A. D.). This work was also supported by grants from the Dermatology Foundation (to M. F.) and the Tadamitsu Cancer Research Fund (to M. F.).; Supported by National Institutes of Health Training Grant 5T32AR007411.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Amiri KI, 2005, CANCER METAST REV, V24, P301, DOI 10.1007/s10555-005-1579-7; Arlt A, 2002, CANCER RES, V62, P910; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Bar-Eli M, 1999, PATHOBIOLOGY, V67, P12, DOI 10.1159/000028045; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; den Broeder AA, 2006, ANN RHEUM DIS, V65, P760, DOI 10.1136/ard.2004.033662; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Hoffman HM, 2008, ARTHRITIS RHEUM, V58, P2443, DOI 10.1002/art.23687; Jean D, 2000, MOL CELL BIOCHEM, V212, P19, DOI 10.1023/A:1007128101751; Jin L, 1997, CANCER-AM CANCER SOC, V80, P421, DOI 10.1002/(SICI)1097-0142(19970801)80:3<421::AID-CNCR10>3.0.CO;2-Z; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; Leiter U, 2000, ARCH DERMATOL RES, V292, P225, DOI 10.1007/s004030050479; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Lu T, 2007, P NATL ACAD SCI USA, V104, P4365, DOI 10.1073/pnas.0700118104; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; McCarthy MM, 2008, ANN ONCOL, V19, P590, DOI 10.1093/annonc/mdm545; McConnell BB, 2004, APOPTOSIS, V9, P5, DOI 10.1023/B:APPT.0000012117.32430.0c; Muerkoster SS, 2006, ONCOGENE, V25, P3973, DOI 10.1038/sj.onc.1209423; Muerkoster S, 2004, CANCER RES, V64, P1331, DOI 10.1158/0008-5472.CAN-03-1860; Nakamura Y, 2009, J EXP MED, V206, P1037, DOI 10.1084/jem.20082179; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Paugh BS, 2009, J BIOL CHEM, V284, P3408, DOI 10.1074/jbc.M807170200; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Sanz C, 2004, BIOCHEM J, V384, P281, DOI 10.1042/BJ20040867; Sawai H, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-8; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; SUN WH, 1992, CANCER RES, V52, P5412; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; VIDALVANACLOCHA F, 1994, CANCER RES, V54, P2667; VidalVanaclocha F, 1996, JNCI-J NATL CANCER I, V88, P198, DOI 10.1093/jnci/88.3-4.198; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Yang JM, 2001, CANCER RES, V61, P4901; Yano S, 2003, CANCER SCI, V94, P244, DOI 10.1111/j.1349-7006.2003.tb01428.x	56	227	240	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6477	6488		10.1074/jbc.M109.064907	http://dx.doi.org/10.1074/jbc.M109.064907			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20038581	Green Published, hybrid			2022-12-25	WOS:000275367500052
J	Takemura, T; Nakamura, S; Yokota, D; Hirano, I; Ono, T; Shigeno, K; Fujisawa, S; Ohnishi, K				Takemura, Tomonari; Nakamura, Satoki; Yokota, Daisuke; Hirano, Isao; Ono, Takaaki; Shigeno, Kazuyuki; Fujisawa, Shinya; Ohnishi, Kazunori			Reduction of Raf Kinase Inhibitor Protein Expression by Bcr-Abl Contributes to Chronic Myelogenous Leukemia Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; PHILADELPHIA-CHROMOSOME; HEMATOPOIETIC-CELLS; LIVER-REGENERATION; COLORECTAL-CANCER; TRANSFORMATION; FOXM1; BCR/ABL; PATHWAY; SUPPRESSION	Chronic myelogenous leukemia (CML) is characterized by a reciprocal chromosomal translocation ( 9; 22) that generates the Bcr-Abl fusion gene. The Ras/Raf-1/MEK/ERK pathway is constitutively activated in Bcr-Abl-transformed cells, and Ras activity enhances the oncogenic ability of Bcr-Abl. However, the mechanism by which Bcr-Abl activates the Ras pathway is not completely understood. Raf kinase inhibitor protein (RKIP) inhibits activation of MEK by Raf-1 and its downstream signal transduction, resulting in blocking the MAP kinase pathway. In the present study, we found that RKIP was depleted in CML cells. We investigated the interaction between RKIP and Bcr-Abl in CML cell lines and Bcr-Abl(+) progenitor cells from CML patients. The Abl kinase inhibitors and depletion of Bcr-Abl induced the expression of RKIP and reduced the pERK1/2 status, resulting in inhibited proliferation of CML cells. Moreover, RKIP up-regulated cell cycle regulator FoxM1 expression, resulting in G(1) arrest via p27(Kip1) and p21(Cip1) accumulation. In colony-forming unit granulocyte, erythroid, macrophage, megakaryocyte, colony-forming unit-granulocyte macrophage, and burst-forming unit erythroid, treatment with the Abl kinase inhibitors and depletion of Bcr-Abl induced RKIP and reduced FoxM1 expressions, and inhibited colony formation of Bcr-Abl(+) progenitor cells, whereas depletion of RKIP weakened the inhibition of colony formation activity by the Abl kinase inhibitors in Bcr-Abl(+) progenitor cells. Thus, Bcr-Abl represses the expression of RKIP, continuously activates pERK1/2, and suppresses FoxM1 expression, resulting in proliferation of CML cells.	[Takemura, Tomonari; Nakamura, Satoki; Yokota, Daisuke; Hirano, Isao; Ono, Takaaki; Shigeno, Kazuyuki; Fujisawa, Shinya; Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Dept Internal Med 3, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Takemura, Tomonari; Yokota, Daisuke; Hirano, Isao; Ono, Takaaki; Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Ctr Canc, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Fujisawa, Shinya] Hamamatsu Med Ctr, Div Hematol, Naka Ku, Shizuoka 4328580, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Nakamura, S (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med 3, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	satonaka@hama-med.ac.jp		Ono, Takaaki/0000-0003-3922-7432	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17590987]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research 17590987 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Akaishi J, 2006, ANTICANCER RES, V26, P4437; Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Houben R, 2008, J INVEST DERMATOL, V128, P2003, DOI 10.1038/jid.2008.30; Houben Roland, 2007, J Carcinog, V6, P16, DOI 10.1186/1477-3163-6-16; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Nottage M, 2002, CURR PHARM DESIGN, V8, P2231, DOI 10.2174/1381612023393107; O'Neill E, 2004, BRIT J CANCER, V90, P283, DOI 10.1038/sj.bjc.6601488; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Petrovic V, 2008, J BIOL CHEM, V283, P453, DOI 10.1074/jbc.M705792200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Reuther JY, 1998, GENE DEV, V12, P968, DOI 10.1101/gad.12.7.968; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; RUDKIN GT, 1964, SCIENCE, V144, P1229, DOI 10.1126/science.144.3623.1229; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; SAWYERS CL, 1995, J EXP MED, V181, P307, DOI 10.1084/jem.181.1.307; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schuierer MM, 2006, ONCOL REP, V16, P451; Schuierer MM, 2004, CANCER RES, V64, P5186, DOI 10.1158/0008-5472.CAN-03-3861; Serre L, 2001, J MOL BIOL, V310, P617, DOI 10.1006/jmbi.2001.4784; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Smalley KSM, 2003, INT J CANCER, V104, P527, DOI 10.1002/ijc.10978; Teh MT, 2002, CANCER RES, V62, P4773; VARTICOVSKI L, 1991, MOL CELL BIOL, V11, P1107, DOI 10.1128/MCB.11.2.1107; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Zhang LZ, 2004, SURGERY, V136, P708, DOI 10.1016/j.surg.2003.12.013; Zlobec I, 2008, CLIN CANCER RES, V14, P143, DOI 10.1158/1078-0432.CCR-07-1380	50	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6585	6594		10.1074/jbc.M109.075788	http://dx.doi.org/10.1074/jbc.M109.075788			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20028985	Green Published, hybrid			2022-12-25	WOS:000275367500063
J	Abisambra, JF; Fiorelli, T; Padmanabhan, J; Neame, P; Wefes, I; Potter, H				Abisambra, Jose F.; Fiorelli, Tina; Padmanabhan, Jaya; Neame, Peter; Wefes, Inge; Potter, Huntington			LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; APOLIPOPROTEIN-E; TRANSGENIC MICE; FAMILIAL HYPERCHOLESTEROLEMIA; GENETIC ASSOCIATION; TRANSPORT PROTEIN; HUMAN FIBROBLASTS; DOWNS-SYNDROME	Background: Alzheimer's disease (AD) is a chronic neurodegenerative disorder and the most common form of dementia. The major molecular risk factor for late-onset AD is expression of the epsilon-4 allele of apolipoprotein E (apoE), the major cholesterol transporter in the brain. The low-density lipoprotein receptor (LDLR) has the highest affinity for apoE and plays an important role in brain cholesterol metabolism. Methodology/Principal Findings: Using RT-PCR and western blotting techniques we found that over-expression of APP caused increases in both LDLR mRNA and protein levels in APP transfected H4 neuroglioma cells compared to H4 controls. Furthermore, immunohistochemical experiments showed aberrant localization of LDLR in H4-APP neuroglioma cells, A beta-treated primary neurons, and in the PSAPP transgenic mouse model of AD. Finally, immunofluorescent staining of LDLR and of gamma- and alpha-tubulin showed a change in LDLR localization preferentially away from the plasma membrane that was paralleled by and likely the result of a disruption of the microtubule-organizing center and associated microtubule network. Conclusions/Significance: These data suggest that increased APP expression and A beta exposure alters microtubule function, leading to reduced transport of LDLR to the plasma membrane. Consequent deleterious effects on apoE uptake and function will have implications for AD pathogenesis and/or progression.	[Abisambra, Jose F.; Fiorelli, Tina; Padmanabhan, Jaya; Neame, Peter; Wefes, Inge; Potter, Huntington] Byrd Alzheimers Inst, Tampa, FL USA; [Abisambra, Jose F.; Fiorelli, Tina; Padmanabhan, Jaya; Neame, Peter; Wefes, Inge; Potter, Huntington] Univ S Florida, Dept Mol Med, Tampa, FL USA; [Potter, Huntington] Eric Pfeiffer Suncoast Alzheimers & Gerontol Ctr, Tampa, FL USA; [Potter, Huntington] Florida Alzheimers Dis Res Ctr NIA, Tampa, FL USA	State University System of Florida; University of South Florida	Abisambra, JF (corresponding author), Byrd Alzheimers Inst, Tampa, FL USA.	hpotter@health.usf.edu	Abisambra, Joe/AAP-3269-2020; Abisambra, Jose/V-6860-2019; Padmanabhan, Jaya/A-4226-2012	Abisambra, Jose/0000-0001-6341-679X; Padmanabhan, Jaya/0000-0003-2019-5135	Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute	Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute	Funding provided by the Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute and the Eric Pfeiffer Chair for Research on Alzheimer's Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011; Cheng D, 2005, J MED GENET, V42, P129, DOI 10.1136/jmg.2004.024968; Corder EH, 2006, REJUV RES, V9, P89, DOI 10.1089/rej.2006.9.89; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DAVIS CG, 1986, J BIOL CHEM, V261, P2828; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Fryer JD, 2005, J BIOL CHEM, V280, P25754, DOI 10.1074/jbc.M502143200; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDSTEIN JL, 1976, CURR TOP CELL REGUL, V11, P147; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Gopalraj RK, 2005, NEUROBIOL AGING, V26, P1, DOI 10.1016/j.neurobiolaging.2004.09.001; HAVEL RJ, 1973, P NATL ACAD SCI USA, V70, P2015, DOI 10.1073/pnas.70.7.2015; Howland DS, 1998, J BIOL CHEM, V273, P16576, DOI 10.1074/jbc.273.26.16576; INNERARITY TL, 1978, BIOCHEMISTRY-US, V17, P1440, DOI 10.1021/bi00601a013; INNERARITY TL, 1979, J BIOL CHEM, V254, P4186; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lamsa R, 2008, NEUROBIOL AGING, V29, P848, DOI 10.1016/j.neurobiolaging.2006.12.009; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; Lendon CL, 1997, NEUROSCI LETT, V222, P187, DOI 10.1016/S0304-3940(97)13381-X; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Li JH, 1997, CELL, V90, P917, DOI 10.1016/S0092-8674(00)80356-6; Lopez D, 2007, BBA-MOL CELL BIOL L, V1771, P1216, DOI 10.1016/j.bbalip.2007.05.001; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MURDOCH JC, 1977, BRIT MED J, V2, P226, DOI 10.1136/bmj.2.6081.226; NESS GC, 1986, BIOCHEM J, V233, P167, DOI 10.1042/bj2330167; Nilsson LNG, 2001, J NEUROSCI, V21, P1444, DOI 10.1523/JNEUROSCI.21-05-01444.2001; Nizzari M, 2007, ANN NY ACAD SCI, V1096, P249, DOI 10.1196/annals.1397.091; Padmanabhan J, 2006, BRAIN, V129, P3020, DOI 10.1093/brain/awl255; Papassotiropoulos A, 2005, J CLIN PSYCHIAT, V66, P940, DOI 10.4088/JCP.v66n0720; Potter H, 2001, NEUROBIOL AGING, V22, P923, DOI 10.1016/S0197-4580(01)00308-6; Rasband W., 2006, IMAGEJ; Retz W, 2001, PSYCHIATR GENET, V11, P115, DOI 10.1097/00041444-200109000-00002; Rodriguez E, 2006, J NEUROL, V253, P801, DOI 10.1007/s00415-005-0063-1; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scacchi R, 2001, DEMENT GERIATR COGN, V12, P63, DOI 10.1159/000051237; Shie FS, 2002, NEUROREPORT, V13, P455, DOI 10.1097/00001756-200203250-00019; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; SMITH JR, 1990, J BIOL CHEM, V265, P2306; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; SPARKS DL, 1994, EXP NEUROL, V126, P88, DOI 10.1006/exnr.1994.1044; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; SUDHOF TC, 1985, SCIENCE, V228, P893, DOI 10.1126/science.3873704; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; TOLLESHAUG H, 1982, CELL, V30, P715, DOI 10.1016/0092-8674(82)90276-8; Wijsman EM, 2004, AM J HUM GENET, V75, P398, DOI 10.1086/423393; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; YLAHERTTUALA S, 1989, ATHEROSCLEROSIS, V76, P269, DOI 10.1016/0021-9150(89)90110-X; ZANNIS VI, 1981, AM J HUM GENET, V33, P11; Zou FG, 2008, HUM MOL GENET, V17, P929, DOI 10.1093/hmg/ddm365	67	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8556	10.1371/journal.pone.0008556	http://dx.doi.org/10.1371/journal.pone.0008556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20049331	Green Published, Green Submitted, gold			2022-12-25	WOS:000273225000018
J	Aksglaede, L; Juul, A; Olsen, LW; Sorensen, TIA				Aksglaede, Lise; Juul, Anders; Olsen, Lina W.; Sorensen, Thorkild I. A.			Age at Puberty and the Emerging Obesity Epidemic	PLOS ONE			English	Article							BODY-MASS-INDEX; NUTRITION EXAMINATION SURVEY; SECONDARY SEXUAL CHARACTERISTICS; BLOOD-INSTITUTE GROWTH; 3RD NATIONAL-HEALTH; SECULAR TRENDS; SCHOOL-CHILDREN; AMERICAN BOYS; YOUNG GIRLS; MATURATION	Background: Recent studies have shown that puberty starts at younger ages than previously. It has been hypothesized that the increasing prevalence of childhood obesity is contributing to this trend. The purpose of this study was to analyze the association between prepubertal body mass index (BMI) and pubertal timing, as assessed by age at onset of pubertal growth spurt (OGS) and at peak height velocity (PHV), and the secular trend of pubertal timing given the prepubertal BMI. Methodology/Principal Findings: Annual measurements of height and weight were available in all children born from 1930 to 1969 who attended primary school in the Copenhagen municipality; 156,835 children fulfilled the criteria for determining age at OGS and PHV. The effect of prepubertal BMI at age seven on these markers of pubertal development within and between birth cohorts was analyzed. BMI at seven years was significantly inversely associated with age at OGS and PHV. Dividing the children into five levels of prepubertal BMI, we found a similar secular trend toward earlier maturation in all BMI groups. Conclusion/Significance: The heavier both boys and girls were at age seven, the earlier they entered puberty. Irrespective of level of BMI at age seven, there was a downward trend in the age at attaining puberty in both boys and girls, which suggests that the obesity epidemic is not solely responsible for the trend.	[Aksglaede, Lise; Juul, Anders] Univ Copenhagen, Dept Growth & Reprod, Copenhagen, Denmark; [Olsen, Lina W.; Sorensen, Thorkild I. A.] Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark	University of Copenhagen	Aksglaede, L (corresponding author), Univ Copenhagen, Dept Growth & Reprod, Copenhagen, Denmark.	lise.aksglaede@rh.regionh.dk	Aksglaede, Lise/AAI-7163-2020; Juul, Anders/F-5864-2013	Juul, Anders/0000-0002-0534-4350; Aksglaede, Lise/0000-0001-7885-7467	Danish National Science Foundation; Danish Medical Research Council [271-05-0337]; Faculty of Health Sciences of the University of Copenhagen	Danish National Science Foundation(Danmarks Grundforskningsfond); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Faculty of Health Sciences of the University of Copenhagen	The work has been supported by the Danish National Science Foundation, the Danish Medical Research Council (271-05-0337), and the Faculty of Health Sciences of the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491; Aksglaede L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002728; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Baker JL, 2009, INT J EPIDEMIOL, V38, P656, DOI 10.1093/ije/dyn164; Bau AM, 2009, EUR J ENDOCRINOL, V160, P107, DOI 10.1530/EJE-08-0594; Bini V, 2000, EUR J CLIN NUTR, V54, P214, DOI 10.1038/sj.ejcn.1600922; BIRO FM, 1995, J PEDIATR-US, V127, P100, DOI 10.1016/S0022-3476(95)70265-2; Biro FM, 2001, J PEDIATR-US, V138, P636, DOI 10.1067/mpd.2001.114476; Bua J, 2007, OBESITY, V15, P977, DOI 10.1038/oby.2007.603; Buyken AE, 2009, AM J CLIN NUTR, V89, P221, DOI 10.3945/ajcn.2008.26733; CLELAND WH, 1985, J CLIN ENDOCR METAB, V60, P174, DOI 10.1210/jcem-60-1-174; Davison KK, 2003, PEDIATRICS, V111, P815, DOI 10.1542/peds.111.4.815; Den H.E., 2002, ENV HLTH PERSPECT, V110, P771; Due P, 2007, OBES REV, V8, P187, DOI 10.1111/j.1467-789X.2006.00291.x; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; Fernandez-Fernandez R, 2006, MOL CELL ENDOCRINOL, V254, P127, DOI 10.1016/j.mce.2006.04.026; FOSTER TA, 1977, AM J CLIN NUTR, V30, P582, DOI 10.1093/ajcn/30.4.582; FRISCH RE, 1971, ARCH DIS CHILD, V46, P695, DOI 10.1136/adc.46.249.695; FRISCH RE, 1970, SCIENCE, V169, P397, DOI 10.1126/science.169.3943.397; HARLAN WR, 1979, J PEDIATR-US, V95, P293; He Q, 2001, PEDIATR RES, V49, P244, DOI 10.1203/00006450-200102000-00019; Herman-Giddens ME, 2001, ARCH PEDIAT ADOL MED, V155, P1022, DOI 10.1001/archpedi.155.9.1022; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; Juul A, 2006, INT J ANDROL, V29, P247, DOI 10.1111/j.1365-2605.2005.00556.x; Juul A, 2007, INT J ANDROL, V30, P537, DOI 10.1111/j.1365-2605.2007.00751.x; Kaplowitz PB, 2001, PEDIATRICS, V108, P347, DOI 10.1542/peds.108.2.347; Karpati AM, 2002, J ADOLESCENT HEALTH, V30, P205, DOI 10.1016/S1054-139X(01)00320-2; Koo MM, 1997, ANN HUM BIOL, V24, P61, DOI 10.1080/03014469700004782; Koprowski C, 2001, OBES RES, V9, P478, DOI 10.1038/oby.2001.62; Krebs NF, 2003, PEDIATRICS, V112, P424, DOI 10.1542/peds.112.2.424; Lee JM, 2007, PEDIATRICS, V119, pE624, DOI 10.1542/peds.2006-2188; LEE P A, 1980, Journal of Adolescent Health Care, V1, P26, DOI 10.1016/S0197-0070(80)80005-2; Lee PA, 2001, APMIS, V109, P81, DOI 10.1034/j.1600-0463.2001.d01-107.x; Louis GMB, 2008, PEDIATRICS, V121, pS192, DOI 10.1542/peds.1813E; Mamun AA, 2009, INT J OBESITY, V33, P14, DOI 10.1038/ijo.2008.220; MORRISON JA, 1994, J PEDIATR-US, V124, P889, DOI 10.1016/S0022-3476(05)83176-2; Navarro VM, 2007, REV ENDOCR METAB DIS, V8, P11, DOI 10.1007/s11154-007-9028-2; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Pearson Seija, 2005, Ugeskr Laeger, V167, P158; REYNOLDS EL, 1948, AM J DIS CHILD, V75, P329; Ribeiro J, 2006, ANN HUM BIOL, V33, P55, DOI 10.1080/00207390500434135; Rosenfield RL, 2009, PEDIATRICS, V123, P84, DOI 10.1542/peds.2008-0146; Sandhu J, 2006, INT J OBESITY, V30, P14, DOI 10.1038/sj.ijo.0803156; Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023; Silventoinen K, 2008, PEDIATRICS, V121, pE885, DOI 10.1542/peds.2007-1615; Sorensen K, 2007, J CLIN ENDOCR METAB, V92, P3189, DOI 10.1210/jc.2007-0231; Sun SMS, 2002, PEDIATRICS, V110, P911, DOI 10.1542/peds.110.5.911; Thomsen BL, 1999, INT J OBESITY, V23, P693, DOI 10.1038/sj.ijo.0800907; Wang YF, 2002, PEDIATRICS, V110, P903, DOI 10.1542/peds.110.5.903; Wattigney Wendy A., 1999, Ethnicity and Disease, V9, P181; World Health Organization, 1999, OB PREV MAN GLOB EP; Wu TJ, 2002, PEDIATRICS, V110, P752, DOI 10.1542/peds.110.4.752; Ye XY, 2006, ENVIRON HEALTH PERSP, V114, P1843, DOI 10.1289/ehp.9413; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	54	168	174	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8450	10.1371/journal.pone.0008450	http://dx.doi.org/10.1371/journal.pone.0008450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041184	Green Submitted, gold, Green Published			2022-12-25	WOS:000273104000014
J	van Hateren, KJJ; Landman, GWD; Kleefstra, N; Logtenberg, SJJ; Groenier, KH; Kamper, AM; Houweling, ST; Bilo, HJG				van Hateren, Kornelis J. J.; Landman, Gijs W. D.; Kleefstra, Nanne; Logtenberg, Susan J. J.; Groenier, Klaas H.; Kamper, Adriaan M.; Houweling, Sebastiaan T.; Bilo, Henk J. G.			The Lipid Profile and Mortality Risk in Elderly Type 2 Diabetic Patients: A Ten-Year Follow-Up Study (ZODIAC-13)	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; TOTAL CHOLESTEROL; DISEASE; GUIDELINES; INDIVIDUALS; MELLITUS; PROGRAM; PLASMA; CARE	Background: The precise relationship between the lipid profile and mortality in elderly patients with type 2 diabetes mellitus (T2DM) remains unclear. The aim of this study was to investigate the relationship between the lipid profile over time, and mortality in elderly patients with T2DM. Methods and Findings: In 1998, 881 primary care patients with T2DM aged 60 years and older participated in the ZODIAC study, a prospective observational study. The cohort was divided into two age categories: 60-75 years and older than 75 years. Updated means of all lipid profile indices were calculated after a median follow-up time of 9.8 years. These values were used as time dependent covariates in a Cox proportional hazard model. The cholesterol-HDL ratio and LDL-cholesterol were positively related to both all-cause and cardiovascular mortality in the low age group. In contrast, except for the triglyceride level, none of the other lipid profile indices were related to all-cause mortality in patients aged over 75 years. The mortality risk decreased by 17% (95% CI: 5% to 27%) for each 1 mmol/L higher serum level of triglycerides. The relationships between the various lipid profile indices and cardiovascular mortality were not significant. However, the results were different after stratification for diabetes duration. In the subgroup of elderly patients with a diabetes duration of 8 years and longer, higher lipids were predictive of increased cardiovascular mortality. The main limitation of this study is its observational design, which prevents us drawing conclusions about causality. Conclusion: Although the lipid profile was not predictive in the overall group of elderly patients, higher lipids were related to increased cardiovascular mortality in patients with diabetes of long duration. In order to make valid recommendations concerning lipid-lowering treatment, a randomized controlled trial or a meta-analysis concerning this specific population is mandatory.	[van Hateren, Kornelis J. J.; Landman, Gijs W. D.; Kleefstra, Nanne; Logtenberg, Susan J. J.; Bilo, Henk J. G.] Isala Clin, Ctr Diabet, Zwolle, Netherlands; [Kleefstra, Nanne; Houweling, Sebastiaan T.] Langerhans Med Res Grp, Zwolle, Netherlands; [Logtenberg, Susan J. J.; Kamper, Adriaan M.; Bilo, Henk J. G.] Isala Clin, Dept Internal Med, Zwolle, Netherlands; [Groenier, Klaas H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, NL-9713 AV Groningen, Netherlands; [Houweling, Sebastiaan T.] Gen Practice Sleeuwijk, Sleeuwijk, Netherlands; [Bilo, Henk J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 AV Groningen, Netherlands	Isala Clinics; Langerhans Medical Research Group; Isala Clinics; University of Groningen; University of Groningen	van Hateren, KJJ (corresponding author), Isala Clin, Ctr Diabet, Zwolle, Netherlands.	k.j.j.van.hateren@isala.nl	Landman, Gijs/AAJ-5540-2021	Landman, Gijs/0000-0002-6852-6450; Kleefstra, Nanne/0000-0003-1473-8519				Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; ANDERSON KM, 1987, JAMA-J AM MED ASSOC, V257, P2176, DOI 10.1001/jama.257.16.2176; Brescianini S, 2003, J AM GERIATR SOC, V51, P991, DOI 10.1046/j.1365-2389.2003.51313.x; Brown AF, 2003, J AM GERIATR SOC, V51, P665, DOI 10.1034/j.1600-0579.2003.00211.x; Collins R, 2003, LANCET, V361, P2005; Costa J, 2006, BMJ-BRIT MED J, V332, P1115, DOI 10.1136/bmj.38793.468449.AE; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Durso SC, 2006, JAMA-J AM MED ASSOC, V295, P1935, DOI 10.1001/jama.295.16.1935; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Iversen A, 2009, EUR J INTERN MED, V20, P139, DOI 10.1016/j.ejim.2008.06.003; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Rutten G.E.H.M., 2006, HUIS WETEN, V49, P137; Schatz IJ, 2001, LANCET, V358, P351, DOI 10.1016/S0140-6736(01)05553-2; Schupf N, 2005, J AM GERIATR SOC, V53, P219, DOI 10.1111/j.1532-5415.2005.53106.x; Selvin E, 2006, DIABETES CARE, V29, P2415, DOI 10.2337/dc06-1058; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Ubink-Vetmaat LJ, 2005, NETH J MED, V63, P103; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9	22	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8464	10.1371/journal.pone.0008464	http://dx.doi.org/10.1371/journal.pone.0008464			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041116	gold, Green Submitted, Green Published			2022-12-25	WOS:000273104000024
J	Sen, S; Dong, MM; Kumar, S				Sen, Shamik; Dong, Meimei; Kumar, Sanjay			Isoform-Specific Contributions of alpha-Actinin to Glioma Cell Mechanobiology	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; MYOSIN-II; FOCAL ADHESIONS; MOLECULAR-MECHANISMS; RHO-KINASE; MOTILITY; MIGRATION; INVASION; PROTEIN; SHAPE	Glioblastoma Multiforme (GBM) is a malignant astrocytic tumor associated with low survival rates because of aggressive infiltration of tumor cells into the brain parenchyma. Expression of the actin binding protein alpha-actinin has been strongly correlated with the invasive phenotype of GBM in vivo. To probe the cellular basis of this correlation, we have suppressed expression of the nonmuscle isoforms alpha-actinin-1 and alpha-actinin-4 and examined the contribution of each isoform to the structure, mechanics, and motility of human glioma tumor cells in culture. While subcellular localization of each isoform is distinct, suppression of either isoform yields a phenotype that includes dramatically reduced motility, compensatory upregulation and redistribution of vinculin, reduced cortical elasticity, and reduced ability to adapt to changes in the elasticity of the extracellular matrix (ECM). Mechanistic studies reveal a relationship between alpha-actinin and non-muscle myosin II in which depletion of either alpha-actinin isoform reduces myosin expression and maximal cell-ECM tractional forces. Our results demonstrate that both alpha-actinin-1 and alpha-actinin-4 make critical and distinct contributions to cytoskeletal organization, rigidity-sensing, and motility of glioma cells, thereby yielding mechanistic insight into the observed correlation between alpha-actinin expression and GBM invasiveness in vivo.	[Sen, Shamik; Dong, Meimei; Kumar, Sanjay] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Dong, Meimei] Mannheim Univ Appl Sci, Inst Mol & Cell Biol, Mannheim, Germany	University of California System; University of California Berkeley	Sen, S (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	skumar@berkeley.edu		Sen, Shamik/0000-0002-8639-8659	University of California; Arnold and Mabel Beckman Young; National Institutes of Health (NIH) [1DP2OD004213]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004213] Funding Source: NIH RePORTER	University of California(University of California System); Arnold and Mabel Beckman Young; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	S. K. gratefully acknowledges the support of the University of California, the Arnold and Mabel Beckman Young Investigator Award, and the National Institutes of Health (NIH) Director's New Innovator Award (1DP2OD004213), a part of the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbolina MV, 2008, LAB INVEST, V88, P602, DOI 10.1038/labinvest.2008.25; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Belot N, 2001, GLIA, V36, P375, DOI 10.1002/glia.1124; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Beningo KA, 2006, ARCH BIOCHEM BIOPHYS, V456, P224, DOI 10.1016/j.abb.2006.09.025; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Byfield FJ, 2009, BIOPHYS J, V96, P5095, DOI 10.1016/j.bpj.2009.03.046; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Craig DH, 2007, AM J SURG, V194, P618, DOI 10.1016/j.amjsurg.2007.08.001; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fukushima Y, 1998, INT J CANCER, V76, P63, DOI 10.1002/(SICI)1097-0215(19980330)76:1<63::AID-IJC11>3.0.CO;2-H; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gillespie GY, 1999, CANCER RES, V59, P2076; GLUCK U, 1994, J CELL SCI, V107, P1773; GLUCK U, 1993, P NATL ACAD SCI USA, V90, P383, DOI 10.1073/pnas.90.2.383; Goldmann WH, 2002, BIOCHEM BIOPH RES CO, V290, P749, DOI 10.1006/bbrc.2001.6243; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Lu L, 2008, CELL MOTIL CYTOSKEL, V65, P281, DOI 10.1002/cm.20260; Martens JC, 2008, PFLUG ARCH EUR J PHY, V456, P95, DOI 10.1007/s00424-007-0419-8; Niggli V, 2006, BIOCHEM BIOPH RES CO, V343, P602, DOI 10.1016/j.bbrc.2006.03.022; Omelchenko T, 2002, P NATL ACAD SCI USA, V99, P10452, DOI 10.1073/pnas.152339899; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Salhia B, 2008, CELL MOTIL CYTOSKEL, V65, P12, DOI 10.1002/cm.20240; SEN S, 2009, CELLULAR MOL BIOENGI; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018	49	67	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8427	10.1371/journal.pone.0008427	http://dx.doi.org/10.1371/journal.pone.0008427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037648	Green Published, gold, Green Submitted			2022-12-25	WOS:000272998100014
J	Baldock, PA; Lee, NJ; Driessler, F; Lin, S; Allison, S; Stehrer, B; Lin, EJD; Zhang, L; Enriquez, RF; Wong, IPL; McDonald, MM; During, M; Pierroz, DD; Slack, K; Shi, YC; Yulyaningsih, E; Aljanova, A; Little, DG; Ferrari, SL; Sainsbury, A; Eisman, JA; Herzog, H				Baldock, Paul A.; Lee, Nicola J.; Driessler, Frank; Lin, Shu; Allison, Susan; Stehrer, Bernhard; Lin, En-Ju D.; Zhang, Lei; Enriquez, Ronald F.; Wong, Iris P. L.; McDonald, Michelle M.; During, Matthew; Pierroz, Dominique D.; Slack, Katy; Shi, Yan C.; Yulyaningsih, Ernie; Aljanova, Aygul; Little, David G.; Ferrari, Serge L.; Sainsbury, Amanda; Eisman, John A.; Herzog, Herbert			Neuropeptide Y Knockout Mice Reveal a Central Role of NPY in the Coordination of Bone Mass to Body Weight	PLOS ONE			English	Article							OSTEOBLAST-LIKE CELLS; GENE-EXPRESSION; TRABECULAR BONE; RECEPTOR; LEPTIN; HYPERPHAGIA; HOMEOSTASIS; PATHWAYS; OBESITY; RAT	Changes in whole body energy levels are closely linked to alterations in body weight and bone mass. Here, we show that hypothalamic signals contribute to the regulation of bone mass in a manner consistent with the central perception of energy status. Mice lacking neuropeptide Y (NPY), a well-known orexigenic factor whose hypothalamic expression is increased in fasting, have significantly increased bone mass in association with enhanced osteoblast activity and elevated expression of bone osteogenic transcription factors, Runx2 and Osterix. In contrast, wild type and NPY knockout (NPY(-/-)) mice in which NPY is specifically over expressed in the hypothalamus (AAV-NPY+) show a significant reduction in bone mass despite developing an obese phenotype. The AAV-NPY+ induced loss of bone mass is consistent with models known to mimic the central effects of fasting, which also show increased hypothalamic NPY levels. Thus these data indicate that, in addition to well characterized responses to body mass, skeletal tissue also responds to the perception of nutritional status by the hypothalamus independently of body weight. In addition, the reduction in bone mass by AAV NPY+ administration does not completely correct the high bone mass phenotype of NPY(-/-) mice, indicating the possibility that peripheral NPY may also be an important regulator of bone mass. Indeed, we demonstrate the expression of NPY specifically in osteoblasts. In conclusion, these data identifies NPY as a critical integrator of bone homeostatic signals; increasing bone mass during times of obesity when hypothalamic NPY expression levels are low and reducing bone formation to conserve energy under 'starving' conditions, when hypothalamic NPY expression levels are high.	[Baldock, Paul A.; Driessler, Frank; Allison, Susan; Enriquez, Ronald F.; Wong, Iris P. L.; Eisman, John A.] St Vincents Hosp, Osteoporosis & Bone Biol Program, Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Lee, Nicola J.; Lin, Shu; Stehrer, Bernhard; Zhang, Lei; Slack, Katy; Shi, Yan C.; Yulyaningsih, Ernie; Aljanova, Aygul; Sainsbury, Amanda; Herzog, Herbert] St Vincents Hosp, Neurosci Program, Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Lin, En-Ju D.] Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20007 USA; [McDonald, Michelle M.; Little, David G.] Childrens Hosp Westmead, Dept Orthopaed Res & Biotechnol, Sydney, NSW, Australia; [During, Matthew] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Pierroz, Dominique D.; Ferrari, Serge L.] Univ Hosp Geneva, Serv & Lab Bone Dis, Dept Rehabil & Geriatr, Fac Med, Geneva, Switzerland; [Sainsbury, Amanda] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Baldock, Paul A.; Herzog, Herbert] Univ New S Wales, Fac Med, Sydney, NSW, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Georgetown University; University of Sydney; University of Auckland; University of Geneva; University of New South Wales Sydney; University of New South Wales Sydney	Baldock, PA (corresponding author), St Vincents Hosp, Osteoporosis & Bone Biol Program, Garvan Inst Med Res, Sydney, NSW 2010, Australia.	h.herzog@garvan.org.au	/B-2038-2013; During, Matthew/AAC-1388-2020; Eisman, John A/C-2886-2014; Ferrari, Serge/ABD-2730-2020; /A-4361-2010; /A-6021-2011; Herzog, Herbert/B-8294-2008; /B-6258-2012; Baldock, Paul/B-3840-2012; /E-2900-2010; Salis, Amanda/A-3187-2011; McDonald, Michelle/AAD-4760-2019	/0000-0001-7766-6095; Ferrari, Serge/0000-0002-1372-4417; /0000-0003-2110-2017; Salis, Amanda/0000-0001-9176-1574; McDonald, Michelle/0000-0002-3928-2506; , Herbert/0000-0002-1713-1029; lin, shu/0000-0002-4239-2028	National Health and Medical Research Council [481 355, 427638]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by National Health and Medical Research Council Career Development Award - 481 355 to AS and 427638 to PB and a National Health and Medical Research Council Principal Research Fellowship to HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SJ, 2006, J BIOL CHEM, V281, P23436, DOI 10.1074/jbc.M604839200; Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Baldock PA, 2006, J BONE MINER RES, V21, P1600, DOI 10.1359/JBMR.060705; Blomqvist AG, 1997, TRENDS NEUROSCI, V20, P294, DOI 10.1016/S0166-2236(96)01057-0; Bouxsein ML, 2005, J BONE MINER RES, V20, P635, DOI 10.1359/JBMR.041204; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elefteriou F, 2003, ENDOCRINOLOGY, V144, P3842, DOI 10.1210/en.2003-0369; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Ferrari SL, 2005, ENDOCRINOLOGY, V146, P1854, DOI 10.1210/en.2004-1282; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Hamrick MW, 2008, J BONE MINER RES, V23, P870, DOI [10.1359/jbmr.080213, 10.1359/JBMR.080213]; HEILIG M, 1989, ACTA PHYSIOL SCAND, V137, P243, DOI 10.1111/j.1748-1716.1989.tb08745.x; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; IGWE JC, 2009, J CELL BIOCH; Karl T, 2008, EUR J NEUROSCI, V28, P173, DOI 10.1111/j.1460-9568.2008.06306.x; Kellenberger S, 1998, BONE, V22, P471, DOI 10.1016/S8756-3282(98)00026-X; MOORE RE, 1993, BONE MINER, V23, P301, DOI 10.1016/S0169-6009(08)80105-5; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Reid IR, 2006, J BONE MINER RES, V21, P495, DOI 10.1359/JBMR.051105; Sample SJ, 2008, J BONE MINER RES, V23, P1372, DOI [10.1359/jbmr.080407, 10.1359/JBMR.080407]; SIPOLS AJ, 1995, DIABETES, V44, P147, DOI 10.2337/diabetes.44.2.147; STANLEY BG, 1986, PEPTIDES, V7, P1189; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8	26	124	130	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2009	4	12							e8415	10.1371/journal.pone.0008415	http://dx.doi.org/10.1371/journal.pone.0008415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535US	20027231	Green Published, gold, Green Submitted			2022-12-25	WOS:000272998000019
J	Yoneda, K; Fukuda, J; Sakuraba, H; Ohshima, T				Yoneda, Kazunari; Fukuda, Junya; Sakuraba, Haruhiko; Ohshima, Toshihisa			First Crystal Structure of L-Lysine 6-Dehydrogenase as an NAD-dependent Amine Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-GRAPHICS PROJECT; EPSILON-DEHYDROGENASE; AGROBACTERIUM-TUMEFACIENS; PSEUDOMONAS-PUTIDA; DOMAIN MOTIONS; GENE CLONING; PURIFICATION; HYDROGEN; DATABASE; DENSITY	A gene encoding an L-lysine dehydrogenase was identified in the hyperthermophilic archaeon Pyrococcus horikoshii. The gene was overexpressed in Escherichia coli, and its product was purified and characterized. The expressed enzyme is the most thermostable L-lysine dehydrogenase yet described, with a half-life of 180 min at 100 C. The product of the enzyme's catalytic activity is Delta(1)-piperideine-6-carboxylate, which makes this enzyme an L-lysine 6-dehydrogenase (EC 1.4.1.18) that catalyzes the reductive deamination of the epsilon-amino group and a type of NAD-dependent amine dehydrogenase. The three-dimensional structure of the enzyme was determined using the mercury-based multiple-wavelength anomalous dispersion method at a resolution of 2.44 angstrom in the presence of NAD and sulfate ion. The asymmetric unit consisted of two subunits, and a crystallographic 2-fold axis generated the functional dimer. Each monomer consisted of a Rossmann fold domain and a C-terminal catalytic domain, and the fold of the catalytic domain showed similarity to that of saccharopine reductase. Notably, the structures of subunits A and B differed significantly. In subunit A, the active site contained a sulfate ion that was not seen in subunit B. Consequently, subunit A adopted a closed conformation, whereas subunit B adopted an open one. In each subunit, one NAD molecule was bound to the active site in an anti-conformation, indicating that the enzyme makes use of pro-R-specific hydride transfer between the two hydrides at C-4 of NADH ( type A specificity). This is the first description of the three-dimensional structure of L-lysine 6-dehydrogenase as an NAD-dependent amine dehydrogenase.	[Fukuda, Junya; Ohshima, Toshihisa] Kyushu Univ, Fac Agr, Inst Genet Resources, Fukuoka 8128581, Japan; Tokai Univ, Sch Agr, Dept Biosci, Kumamoto 8691404, Japan; [Sakuraba, Haruhiko] Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan	Kyushu University; Tokai University; Kagawa University	Ohshima, T (corresponding author), Kyushu Univ, Fac Agr, Inst Genet Resources, Fukuoka 8128581, Japan.	ohshima@agr.kyushu-u.ac.jp		Yoneda, Kazunari/0000-0001-9152-8772	Ministry of Education, Science, Sports, Culture, and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Science, Sports, Culture, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the "National Project on Protein Structural and Functional Analysis" promoted by the Ministry of Education, Science, Sports, Culture, and Technology of Japan and by a grant-in-aid for scientific research (C) from the Japan Society for the Promotion of Science.	BAKER PJ, 1992, J MOL BIOL, V228, P662, DOI 10.1016/0022-2836(92)90848-E; BENNER SA, 1982, EXPERIENTIA, V38, P633, DOI 10.1007/BF02327092; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGI W, 1966, NATURE, V211, P854, DOI 10.1038/211854a0; DURHAM DR, 1978, J BACTERIOL, V134, P837, DOI 10.1128/JB.134.3.837-843.1978; HASHIMOTO H, 1990, AGR BIOL CHEM TOKYO, V54, P291, DOI 10.1080/00021369.1990.10869934; HASHIMOTO H, 1989, J BIOCHEM, V106, P76, DOI 10.1093/oxfordjournals.jbchem.a122823; HASHIMOTO H, 1989, AGR BIOL CHEM TOKYO, V53, P1175, DOI 10.1080/00021369.1989.10869411; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Heydari M, 2004, APPL ENVIRON MICROB, V70, P937, DOI 10.1128/AEM.70.2.937-942.2004; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; HUMMEL W, 1989, EUR J BIOCHEM, V184, P1, DOI 10.1111/j.1432-1033.1989.tb14983.x; Johansson E, 2000, STRUCTURE, V8, P1037, DOI 10.1016/S0969-2126(00)00512-8; KUSAKABE H, 1980, J BIOL CHEM, V255, P976; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; Limburg J, 2005, ARCH BIOCHEM BIOPHYS, V436, P8, DOI 10.1016/j.abb.2004.11.024; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MISONO H, 1990, J BIOCHEM-TOKYO, V107, P169, DOI 10.1093/oxfordjournals.jbchem.a123003; MISONO H, 1982, J BACTERIOL, V150, P398, DOI 10.1128/JB.150.1.398-401.1982; MISONO H, 1989, J BIOCHEM, V105, P1002, DOI 10.1093/oxfordjournals.jbchem.a122757; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOZAKI M, 1987, METHOD ENZYMOL, V142, P650; OHSHIMA T, 1978, J BIOL CHEM, V253, P5719; OHSHIMA T, 1989, TRENDS BIOTECHNOL, V7, P210, DOI 10.1016/0167-7799(89)90106-6; Ohshima T., 2000, STEREOSELECTIVE BIOC, P877; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Qi GY, 2005, BIOINFORMATICS, V21, P2832, DOI 10.1093/bioinformatics/bti420; Ruldeekulthamrong P, 2008, BMB REP, V41, P790, DOI 10.5483/BMBRep.2008.41.11.790; Satoh A, 2002, J BIOL CHEM, V277, P2830, DOI 10.1074/jbc.M109090200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	38	7	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8444	8453		10.1074/jbc.M109.084384	http://dx.doi.org/10.1074/jbc.M109.084384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20056607	Green Published, hybrid			2022-12-25	WOS:000275413800059
J	Ahn, JE; Guarino, LA; Zhu-Salzman, K				Ahn, Ji-Eun; Guarino, Linda A.; Zhu-Salzman, Keyan			Coordination of Hepatocyte Nuclear Factor 4 and Seven-up Controls Insect Counter-defense Cathepsin B Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTER-TRANSCRIPTION FACTOR; COLORADO POTATO BEETLES; LIGAND-BINDING DOMAIN; GENE-EXPRESSION; PROTEINASE-INHIBITORS; PROTEASE INHIBITOR; VISCERAL ENDODERM; STRUCTURAL BASIS; FACTOR 4-ALPHA; FACTOR HNF-4	CmCatB, a cathepsin B-type cysteine protease, is insensitive to inhibition by the soybean cysteine protease inhibitor (scN). Cowpea bruchids dramatically induce CmCatB expression when major digestive proteases are inactivated by dietary scN, which is presumably an adaptive strategy that insects use to minimize effects of nutrient deficiency. In this study, we cloned the cowpea bruchid hepatocyte nuclear factor 4 (CmHNF-4) and demonstrated its involvement in transcriptional activation of CmCatB in the digestive tract of scN-adapted bruchids. Electrophoretic mobility shift assays demonstrated that CmHNF-4 binds to a CmCatB promoter region containing two tandem chicken ovalbumin upstream promoter (COUP) sites, which is also the cis-element for Seven-up (CmSvp), a previously identified transcriptional repressor of CmCatB. Although CmSvp is predominantly expressed in unadapted insect midgut, CmHNF-4 is more abundant in adapted bruchids. When transiently expressed in Drosophila S2 cells, CmHNF-4 substantially increased CmCatB expression through COUP binding. CmSvp inhibited CmHNF-4-mediated transcriptional activation even in the absence of its DNA-binding domain. Thus antagonism resulted, at least in part, from protein-protein interactions between CmSvp and CmHNF-4. Association of the two transcription factors was subsequently confirmed by glutathione S-transferase pulldown assays. Interestingly, anti-CmHNF-4 serum caused a supershift not only with nuclear extracts of scN-adapted insect midgut but with that of unadapted control insects as well. The presence of CmHNF-4 in unadapted insects further supported the idea that interplay between CmSvp and CmHNF-4 controls CmCatB transcription activation. Together, these results suggest that coordination between CmHNF-4 and CmSvp is important in counter-defense gene regulation in insects.	[Ahn, Ji-Eun; Guarino, Linda A.; Zhu-Salzman, Keyan] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Zhu-Salzman, Keyan] Texas A&M Univ, Vegetable& Fruit Improvement Ctr, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Zhu-Salzman, K (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	ksalzman@tamu.edu			National Research Initiative; U. S. Department of Agriculture Cooperative State Research, Education, and Extension Service [2005-35604-15438, 2007-35607-17887, 2008-34402-19195]	National Research Initiative(United States Department of Agriculture (USDA)); U. S. Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by the National Research Initiative and special grants of the U. S. Department of Agriculture Cooperative State Research, Education, and Extension Service (Grants 2005-35604-15438, 2007-35607-17887, and 2008-34402-19195).	Ahn JE, 2004, INSECT MOL BIOL, V13, P649, DOI 10.1111/j.0962-1075.2004.00523.x; Ahn JE, 2007, FEBS J, V274, P2800, DOI 10.1111/j.1472-4658.2007.05816.x; [Anonymous], 2001, NUCL RECEPTORS GENET; BOLTER CJ, 1995, J INSECT PHYSIOL, V41, P1071, DOI 10.1016/0022-1910(95)00073-4; Bown DP, 1997, INSECT BIOCHEM MOLEC, V27, P625, DOI 10.1016/S0965-1748(97)00043-X; Broadway RM, 1997, J INSECT PHYSIOL, V43, P855, DOI 10.1016/S0022-1910(97)00028-0; Cairns W, 1996, J BIOL CHEM, V271, P25269, DOI 10.1074/jbc.271.41.25269; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Cloutier C, 2000, ARCH INSECT BIOCHEM, V44, P69, DOI 10.1002/1520-6327(200006)44:2&lt;69::AID-ARCH2&gt;3.0.CO;2-6; Drewes T, 1996, MOL CELL BIOL, V16, P925; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; Duncan SA, 1997, DEVELOPMENT, V124, P279; Eeckhoute J, 2003, NUCLEIC ACIDS RES, V31, P6640, DOI 10.1093/nar/gkg850; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; GUARINO LA, 1991, J VIROL, V65, P3676, DOI 10.1128/JVI.65.7.3676-3680.1991; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Iordanidou P, 2005, J BIOL CHEM, V280, P21810, DOI 10.1074/jbc.M501221200; JOHNSON AD, 1995, CELL, V81, P655, DOI 10.1016/0092-8674(95)90524-3; JONGSMA MA, 1995, P NATL ACAD SCI USA, V92, P8041, DOI 10.1073/pnas.92.17.8041; Kapitskaya MZ, 1998, J BIOL CHEM, V273, P29801, DOI 10.1074/jbc.273.45.29801; KIMURA A, 1993, J BIOL CHEM, V268, P11125; Kistanova E, 2001, BIOCHEM J, V356, P635, DOI 10.1042/0264-6021:3560635; Koo YD, 2008, INSECT MOL BIOL, V17, P235, DOI 10.1111/j.1365-2583.2008.00799.x; Ktistaki E, 1997, MOL CELL BIOL, V17, P2790, DOI 10.1128/MCB.17.5.2790; Lee SB, 2007, PESTIC BIOCHEM PHYS, V88, P237, DOI 10.1016/j.pestbp.2006.12.001; Li TG, 2006, DRUG METAB DISPOS, V34, P756, DOI 10.1124/dmd.105.007575; MADER S, 1993, NUCLEIC ACIDS RES, V21, P1125, DOI 10.1093/nar/21.5.1125; McNair A, 2000, BIOCHEM J, V352, P557, DOI 10.1042/0264-6021:3520557; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; Moon J, 2004, INSECT MOL BIOL, V13, P283, DOI 10.1111/j.0962-1075.2004.00485.x; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Palanker L, 2006, DEVELOPMENT, V133, P3549, DOI 10.1242/dev.02512; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Swevers L, 1998, MECH DEVELOP, V72, P3, DOI 10.1016/S0925-4773(97)00180-9; Ungaro P, 2008, J BIOL CHEM, V283, P30970, DOI 10.1074/jbc.M803895200; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Xu Q, 2004, J MOL ENDOCRINOL, V32, P947, DOI 10.1677/jme.0.0320947; Yanai K, 1999, J BIOL CHEM, V274, P34605, DOI 10.1074/jbc.274.49.34605; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; You M, 2002, ARCH BIOCHEM BIOPHYS, V398, P79, DOI 10.1006/abbi.2001.2713; ZHONG WM, 1993, EMBO J, V12, P537, DOI 10.1002/j.1460-2075.1993.tb05685.x; Zhu-Salzman K, 2003, INSECT MOL BIOL, V12, P135, DOI 10.1046/j.1365-2583.2003.00395.x	44	4	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6573	6584		10.1074/jbc.M109.095596	http://dx.doi.org/10.1074/jbc.M109.095596			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20048156	Green Published, hybrid			2022-12-25	WOS:000275367500062
J	Aouida, M; Poulin, R; Ramotar, D				Aouida, Mustapha; Poulin, Richard; Ramotar, Dindial			The Human Carnitine Transporter SLC22A16 Mediates High Affinity Uptake of the Anticancer Polyamine Analogue Bleomycin-A5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC CATION TRANSPORTERS; ANTITUMOR AGENT BLEOMYCIN; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHARACTERIZATION; MAMMALIAN-CELLS; DRUG BLEOMYCIN; IDENTIFICATION; MECHANISM; RESISTANCE; CLEAVAGE	Bleomycin is used in combination with other antineoplastic agents to effectively treat lymphomas, testicular carcinomas, and squamous cell carcinomas of the cervix, head, and neck. However, resistance to bleomycin remains a persistent limitation in exploiting the full therapeutic benefit of the drug with other types of cancers. Previously, we documented that the Saccharomyces cerevisiae L-carnitine transporter Agp2 is responsible for the high affinity uptake of polyamines and of the polyamine analogue bleomycin-A5. Herein, we document that the human L-carnitine transporter hCT2 encoded by the SLC22A16 gene is involved in bleomycin-A5 uptake, as well as polyamines. We show that NT2/D1 human testicular cancer cells, which highly express hCT2, are extremely sensitive to bleomycin-A5, whereas HCT116 human colon carcinoma cells devoid of detectable hCT2 expression or MCF-7 human breast cancer cells that only weakly express the permease showed striking resistance to the drug. NT2/D1 cells accumulated fluorescein-labeled bleomycin-A5 to substantially higher levels than HCT116 cells. Moreover, L-carnitine protected NT2/D1 cells from the lethal effects of bleomycin-A5 by preventing its influx, and siRNA targeted to hCT2 induced resistance to bleomycin-A5-dependent genotoxicity. Furthermore, hCT2 overexpression induced by transient transfection of a functional hCT2-GFP fusion protein sensitized HCT116 cells to bleomycin-A5. Collectively, our data strongly suggest that hCT2 can mediate bleomycin-A5 and polyamine uptake, and that the rate of bleomycin-A5 accumulation may account for the differential response to the drug in patients.	[Aouida, Mustapha; Ramotar, Dindial] Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ H1T 2M4, Canada; [Poulin, Richard] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Montreal, PQ G1V 0A6, Canada	Universite de Montreal; Laval University	Aouida, M (corresponding author), 5415 Assompt, Montreal, PQ H1T 2M4, Canada.	aouidamustapha@yahoo.fr; dramotar.hmr@ssss.gouv.qc.ca	Aouida, Mustapha/AEJ-4513-2022	Aouida, Mustapha/0000-0001-7945-5320	Canadian Institutes of Health Research [MOP-67196]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-67196 (to D. R.) from the Canadian Institutes of Health Research.	Alnouti Y, 2006, DRUG METAB DISPOS, V34, P477, DOI 10.1121/dmd.105.006932; Aouida M, 2005, J BIOL CHEM, V280, P24267, DOI 10.1074/jbc.M503071200; Aouida M, 2004, BIOCHEM J, V384, P47, DOI 10.1042/BJ20040392; Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Aouida M, 2003, ANTIMICROB AGENTS CH, V47, P2012, DOI 10.1128/AAC.47.6.2012-2014.2003; Azam S, 2008, J BIOL CHEM, V283, P30632, DOI 10.1074/jbc.M801401200; Azam S, 2007, APOPTOSIS, V12, P1243, DOI 10.1007/s10495-006-0050-8; BENNETT RAO, 1993, BIOCHEMISTRY-US, V32, P3188, DOI 10.1021/bi00063a034; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burger RM, 1998, CHEM REV, V98, P1153, DOI 10.1021/cr960438a; Canellos GP, 2004, SEMIN HEMATOL, V41, P26, DOI 10.1053/j.seminhematol.2004.09.005; Daigle ND, 2009, J CELL PHYSIOL, V220, P680, DOI 10.1002/jcp.21814; DAR ME, 1995, NUCLEIC ACIDS RES, V23, P3224, DOI 10.1093/nar/23.16.3224; Dorr RT, 1998, CANCER CHEMOTH PHARM, V42, P149, DOI 10.1007/s002800050798; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Enomoto A, 2002, J BIOL CHEM, V277, P36262, DOI 10.1074/jbc.M203883200; Eraly SA, 2002, BIOCHEM BIOPH RES CO, V297, P1159, DOI 10.1016/S0006-291X(02)02343-4; GILONI L, 1981, J BIOL CHEM, V256, P8608; Gong SM, 2002, EXP HEMATOL, V30, P1162, DOI 10.1016/S0301-472X(02)00901-3; GORDONSMITH RH, 1983, BIOCHEM PHARMACOL, V32, P3701, DOI 10.1016/0006-2952(83)90138-7; Hasne MP, 2005, J BIOL CHEM, V280, P15188, DOI 10.1074/jbc.M411331200; JANI JP, 1992, CANCER RES, V52, P2931; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Lamhonwah AM, 2005, BIOCHEM BIOPH RES CO, V338, P1966, DOI 10.1016/j.bbrc.2005.10.170; Lazo J S, 1996, Cancer Chemother Biol Response Modif, V16, P39; LESSARD M, 1995, J BIOL CHEM, V270, P1685, DOI 10.1074/jbc.270.4.1685; MIYAKI M, 1975, CANCER RES, V35, P2015; NICHOLS CR, 1994, SEMIN ONCOL, V21, P102; Okabe M, 2005, BIOCHEM BIOPH RES CO, V333, P754, DOI 10.1016/j.bbrc.2005.05.174; ORLOWSKI S, 1988, BIOCHEM PHARMACOL, V37, P4727, DOI 10.1016/0006-2952(88)90344-9; PODDEVIN B, 1991, BIOCHEM PHARMACOL, V42, pS67, DOI 10.1016/0006-2952(91)90394-K; PRON G, 1993, BIOCHEM BIOPH RES CO, V194, P333, DOI 10.1006/bbrc.1993.1824; Ramotar D, 2003, CURR GENET, V43, P213, DOI 10.1007/s00294-003-0396-1; Robertson KA, 2001, CANCER RES, V61, P2220; Sanz G, 2002, CANCER RES, V62, P4453; Sato N, 2007, INT J GYNECOL PATHOL, V26, P53, DOI 10.1097/01.pgp.0000225845.67245.b3; SEBTI SM, 1991, CANCER RES, V51, P227; Seiler N, 2003, CURR DRUG TARGETS, V4, P565, DOI 10.2174/1389450033490876; SEILER N, 1990, INT J BIOCHEM, V22, P211, DOI 10.1016/0020-711X(90)90332-W; Song IS, 2004, MOL CANCER THER, V3, P1543; Soulet D, 2004, J BIOL CHEM, V279, P49355, DOI 10.1074/jbc.M401287200; STEIGHNER RJ, 1990, MUTAT RES, V240, P93, DOI 10.1016/0165-1218(90)90012-Q; Tamai I, 2000, J BIOL CHEM, V275, P40064, DOI 10.1074/jbc.M005340200; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; TATES AD, 1994, MUTAT RES, V307, P293, DOI 10.1016/0027-5107(94)90303-4; TOUNEKTI O, 1993, CANCER RES, V53, P5462; UMEZAWA H, 1971, Pure and Applied Chemistry, V28, P665, DOI 10.1351/pac197128040665; Umezawa H, 1965, Antimicrob Agents Chemother (Bethesda), V5, P1079; UMEZAWA H, 1966, J ANTIBIOT, V19, P200; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; WORTH L, 1993, BIOCHEMISTRY-US, V32, P2601, DOI 10.1021/bi00061a018	51	78	80	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6275	6284		10.1074/jbc.M109.046151	http://dx.doi.org/10.1074/jbc.M109.046151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037140	Green Published, hybrid			2022-12-25	WOS:000275367500032
J	Arendt, CS; Ullman, B				Arendt, Cassandra S.; Ullman, Buddy			Role of Transmembrane Domain 4 in Ligand Permeation by Crithidia fasciculata Equilibrative Nucleoside Transporter 2 (CfNT2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE-GUANOSINE TRANSPORTER; SITE-SATURATION MUTAGENESIS; CONFER DRUG-RESISTANCE; LEISHMANIA-DONOVANI; SACCHAROMYCES-CEREVISIAE; S-6-(4-NITROBENZYL)-MERCAPTOPURINE RIBOSIDE; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; POINT MUTATIONS; ALPHA-SUBUNIT	Equilibrative nucleoside transporters play essential roles in nutrient uptake, cardiovascular and renal function, and purine analog drug chemotherapies. Limited structural information is available for this family of transporters; however, residues in transmembrane domains 1, 2, 4, and 5 appear to be important for ligand and inhibitor binding. In order to identify regions of the transporter that are important for ligand specificity, a genetic selection for mutants of the inosine-guanosine-specific Crithidia fasciculata nucleoside transporter 2 (CfNT2) that had gained the ability to transport adenosine was carried out in the yeast Saccharomyces cerevisiae. Nearly all positive clones from the genetic selection carried mutations at lysine 155 in transmembrane domain 4, highlighting lysine 155 as a pivotal residue governing the ligand specificity of CfNT2. Mutation of lysine 155 to asparagine conferred affinity for adenosine on the mutant transporter at the expense of inosine and guanosine affinity due to weakened contacts to the purine ring of the ligand. Following systematic cysteine-scanning mutagenesis, thiol-specific modification of several positions within transmembrane domain 4 was found to interfere with inosine transport capability, indicating that this helix lines the water-filled ligand translocation channel. Additionally, the pattern of modification of transmembrane domain 4 suggested that it may deviate from helicity in the vicinity of residue 155. Position 155 was also protected from modification in the presence of ligand, suggesting that lysine 155 is in or near the ligand binding site. Transmembrane domain 4 and particularly lysine 155 appear to play key roles in ligand discrimination and translocation by CfNT2.	[Arendt, Cassandra S.] Pacific Univ Oregon, Sch Pharm, Hillsboro, OR 97123 USA; [Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Arendt, CS (corresponding author), Pacific Univ Oregon, Sch Pharm, 222 SE 8th Ave,Suite 451, Hillsboro, OR 97123 USA.	csarendt@pacificu.edu			National Institutes of Health [AI023682, AI044138]; American Cancer Society [PF-02-097-01-CSM]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023682, R37AI023682, R01AI044138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI023682 and AI044138. This work was also supported by American Cancer Society Grant PF-02-097-01-CSM (to C.S.A.).	AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Arastu-Kapur S, 2005, J BIOL CHEM, V280, P2213, DOI 10.1074/jbc.M408224200; Arastu-Kapur S, 2003, J BIOL CHEM, V278, P33327, DOI 10.1074/jbc.M305141200; Arendt CS, 2007, ANAL BIOCHEM, V365, P185, DOI 10.1016/j.ab.2007.03.030; ARONOW B, 1987, MOL BIOCHEM PARASIT, V22, P29, DOI 10.1016/0166-6851(87)90066-1; AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Breton A, 2008, GENETICS, V178, P815, DOI 10.1534/genetics.107.083295; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Elwi AN, 2006, BIOCHEM CELL BIOL, V84, P844, DOI 10.1139/O06-198; Endres CJ, 2005, MOL PHARMACOL, V67, P837, DOI 10.1124/mol.104.008102; Endres CJ, 2004, BIOCHEM J, V380, P131, DOI 10.1042/BJ20031880; Galazka J, 2006, INT J BIOCHEM CELL B, V38, P1221, DOI 10.1016/j.biocel.2005.12.016; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Guerra CF, 1998, THEOR CHEM ACC, V99, P391, DOI 10.1007/s002140050021; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Horisberger JD, 2004, J BIOL CHEM, V279, P29542, DOI 10.1074/jbc.M400585200; Hyde RJ, 2001, MOL MEMBR BIOL, V18, P53, DOI 10.1080/09687680110033765; KLAMT A, 1995, J PHYS CHEM-US, V99, P2224, DOI 10.1021/j100007a062; LABAN A, 1990, NATURE, V343, P572, DOI 10.1038/343572a0; Labbe S, 1999, METHOD ENZYMOL, V306, P145; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Liu T, 2008, AM J PHYSIOL-CELL PH, V295, pC64, DOI 10.1152/ajpcell.90602.2007; Liu W, 2005, MOL BIOCHEM PARASIT, V140, P1, DOI 10.1016/j.molbiopara.2004.11.018; Liu W, 2006, MOL BIOCHEM PARASIT, V150, P300, DOI 10.1016/j.molbiopara.2006.09.002; Maser P, 1999, SCIENCE, V285, P242, DOI 10.1126/science.285.5425.242; Molina-Arcas M, 2008, NUCLEOS NUCLEOT NUCL, V27, P769, DOI 10.1080/15257770802145819; Papageorgiou I, 2008, INT J PARASITOL, V38, P641, DOI 10.1016/j.ijpara.2007.10.005; Paproski RJ, 2008, BIOCHEM J, V414, P291, DOI 10.1042/BJ20080074; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rodriguez JI, 2009, J COMPUT CHEM, V30, P1082, DOI 10.1002/jcc.21134; Rodriguez JI, 2009, CHEM PHYS LETT, V472, P149, DOI 10.1016/j.cplett.2009.02.081; SenGupta DJ, 2004, BIOCHEM PHARMACOL, V67, P453, DOI 10.1016/j.bcp.2003.09.018; SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SIKORSKI RS, 1989, GENETICS, V122, P19; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; te Velde G, 2001, J COMPUT CHEM, V22, P931, DOI 10.1002/jcc.1056; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; Valdes R, 2006, J BIOL CHEM, V281, P22647, DOI 10.1074/jbc.M602366200; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Vasudevan G, 1998, P NATL ACAD SCI USA, V95, P9873, DOI 10.1073/pnas.95.17.9873; Vasudevan G, 2001, P NATL ACAD SCI USA, V98, P6092, DOI 10.1073/pnas.101537298; Visser F, 2005, J BIOL CHEM, V280, P11025, DOI 10.1074/jbc.M410348200; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; Visser F, 2007, J BIOL CHEM, V282, P14148, DOI 10.1074/jbc.M701735200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	56	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6024	6035		10.1074/jbc.M109.074351	http://dx.doi.org/10.1074/jbc.M109.074351			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037157	hybrid, Green Published			2022-12-25	WOS:000275367500005
J	Bhatnagar, S; Kumar, A; Makonchuk, DY; Li, H; Kumar, A				Bhatnagar, Shephali; Kumar, Akhilesh; Makonchuk, Denys Y.; Li, Hong; Kumar, Ashok			Transforming Growth Factor-beta-activated Kinase 1 Is an Essential Regulator of Myogenic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; SKELETAL-MUSCLE DIFFERENTIATION; P38 MAP KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAY; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; P38-ALPHA/BETA MAPK; MESSENGER-RNA; WEAK INDUCER	Satellite cells/myoblasts account for the majority of muscle regenerative potential in response to injury and muscular adaptation to exercise. Although the ability to influence this process would provide valuable benefits for treating a variety of patients suffering from muscle loss, the regulatory mechanisms of myogenesis are not completely understood. We have tested the hypothesis that transforming growth factor-beta-activated kinase 1 (TAK1) is an important regulator of skeletal muscle formation. TAK1 is expressed in proliferating C2C12 myoblasts, and its levels are reduced upon differentiation of myoblasts into myotubes. In vivo, TAK1 is predominantly expressed in developing skeletal muscle of young mice. However, the expression of TAK1 was significantly up-regulated in regenerating skeletal muscle of adult mice. Overexpression of a dominant negative mutant of TAK1 or knockdown of TAK1 inhibited the proliferation and differentiation of C2C12 myoblasts. TAK1 was required for the expression of myogenic regulatory factors in differentiating myoblasts. Genetic ablation of TAK1 also inhibited the MyoD-driven transformation of mouse embryonic fibroblasts into myotubes. Inhibition of TAK1 suppressed the differentiation-associated activation of p38 mitogen-activated protein kinase (MAPK) and Akt kinase. Overexpression of a constitutively active mutant of MAPK kinase 6 (MKK6, an upstream activator of p38 MAPK) but not constitutive active Akt restored the myogenic differentiation in TAK1-deficient mouse embryonic fibroblasts. Insulin growth factor 1-induced myogenic differentiation was also found to involve TAK1. Collectively, our results suggest that TAK1 is an important upstream regulator of skeletal muscle cell differentiation.	[Bhatnagar, Shephali; Kumar, Akhilesh; Makonchuk, Denys Y.; Li, Hong; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA	University of Louisville	Kumar, A (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, 500 S Preston St, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu	LI, HONG/A-7133-2013	Kumar, Ashok/0000-0001-8571-2848; Kumar, Ashok/0000-0002-2444-9529	National Institutes of Health [RO1 AG129623]; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AG129623 (to A. K.).	Allamand V, 2000, HUM MOL GENET, V9, P2459, DOI 10.1093/hmg/9.16.2459; Bae GU, 2009, MOL CELL BIOL, V29, P4130, DOI 10.1128/MCB.00199-09; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Cabane C, 2004, CELL SIGNAL, V16, P1405, DOI 10.1016/j.cellsig.2004.05.003; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; Conejo R, 2001, J CELL PHYSIOL, V187, P96, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1058>3.0.CO;2-V; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; de Angelis L, 2005, DEV BIOL, V283, P171, DOI 10.1016/j.ydbio.2005.04.009; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HuangFu WC, 2006, J BIOL CHEM, V281, P28802, DOI 10.1074/jbc.M603627200; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Jiang BH, 1998, P NATL ACAD SCI USA, V95, P14179, DOI 10.1073/pnas.95.24.14179; Kaliman P, 1999, J BIOL CHEM, V274, P17437, DOI 10.1074/jbc.274.25.17437; Kaliman P, 1998, MOL ENDOCRINOL, V12, P66, DOI 10.1210/mend.12.1.0047; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Kumar M, 2009, J IMMUNOL, V182, P2439, DOI 10.4049/jimmunol.0803357; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Li YQ, 2000, CELL SIGNAL, V12, P751, DOI 10.1016/S0898-6568(00)00120-0; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Perry RLS, 2000, FRONT BIOSCI, V5, pD750, DOI 10.2741/Perry; Perry RLS, 2001, MOL CELL, V8, P291, DOI 10.1016/S1097-2765(01)00302-1; Puri PL, 2000, GENE DEV, V14, P574; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Srivastava AK, 2007, J BIOL CHEM, V282, P35113, DOI 10.1074/jbc.M705329200; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Wald D, 2001, EUR J IMMUNOL, V31, P3747, DOI 10.1002/1521-4141(200112)31:12<3747::AID-IMMU3747>3.0.CO;2-E; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	69	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6401	6411		10.1074/jbc.M109.064063	http://dx.doi.org/10.1074/jbc.M109.064063			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20037161	Green Published, hybrid			2022-12-25	WOS:000275367500044
J	Zhai, DY; Yu, E; Jin, CF; Welsh, K; Shiau, CW; Chen, LL; Salvesen, GS; Liddington, R; Reed, JC				Zhai, Dayong; Yu, Eric; Jin, Chaofang; Welsh, Kate; Shiau, Chung-wei; Chen, Lili; Salvesen, Guy S.; Liddington, Robert; Reed, John C.			Vaccinia Virus Protein F1L Is a Caspase-9 Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH PROTEASE; CYTOCHROME-C; ACTIVATION; APOPTOSIS; APAF-1; BCL-2; MITOCHONDRIA; DOMAIN; BAK; RECRUITMENT	Apoptosis plays important roles in host defense, including the elimination of virus-infected cells. The executioners of apoptosis are caspase family proteases. We report that vaccinia virus-encoded F1L protein, previously recognized as anti-apoptotic viral Bcl-2 family protein, is a caspase-9 inhibitor. F1L binds to and specifically inhibits caspase-9, the apical protease in the mitochondrial cell death pathway while failing to inhibit other caspases. In cells, F1L inhibits apoptosis and proteolytic processing of caspases induced by overexpression of caspase-9 but not caspase-8. An N-terminal region of F1L preceding the Bcl-2-like fold accounts for caspase-9 inhibition and significantly contributes to the anti-apoptotic activity of F1L. Viral F1L thus provides the first example of caspase inhibition by a Bcl-2 family member; it functions both as a suppressor of proapoptotic Bcl-2 family proteins and as an inhibitor of caspase-9, thereby neutralizing two sequential steps in the mitochondrial cell death pathway.	[Zhai, Dayong; Yu, Eric; Jin, Chaofang; Welsh, Kate; Shiau, Chung-wei; Chen, Lili; Salvesen, Guy S.; Liddington, Robert; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@sanford-burnham.org		Yu, Eric/0000-0001-7026-7008	National Institutes of Health [P01AI055789]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant P01AI055789.	Aoyagi M, 2007, PROTEIN SCI, V16, P118, DOI 10.1110/ps.062454707; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Boya P, 2004, BBA-BIOENERGETICS, V1659, P178, DOI 10.1016/j.bbabio.2004.08.007; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Chandra D, 2003, J BIOL CHEM, V278, P17408, DOI 10.1074/jbc.M300750200; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Costantini P, 2002, CELL DEATH DIFFER, V9, P82, DOI 10.1038/sj.cdd.4400932; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deveraux QL, 2000, METHOD ENZYMOL, V322, P154; Everett H, 2002, CURR OPIN MICROBIOL, V5, P395, DOI 10.1016/S1369-5274(02)00340-5; Fischer SF, 2006, CELL DEATH DIFFER, V13, P109, DOI 10.1038/sj.cdd.4401718; Haraguchi M, 2000, J EXP MED, V191, P1709, DOI 10.1084/jem.191.10.1709; Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Krajewska M, 1997, CANCER RES, V57, P1605; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Lee SH, 2001, J BIOL CHEM, V276, P34495, DOI 10.1074/jbc.M101415200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Postigo A, 2006, CELL DEATH DIFFER, V13, P1651, DOI 10.1038/sj.cdd.4401853; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; Stennicke HR, 2002, TRENDS BIOCHEM SCI, V27, P94, DOI 10.1016/S0968-0004(01)02045-X; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; Taylor JM, 2006, VIROLOGY, V344, P139, DOI 10.1016/j.virol.2005.09.032; Taylor JM, 2006, J BIOL CHEM, V281, P39728, DOI 10.1074/jbc.M607465200; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100; Wasilenko ST, 2005, J VIROL, V79, P14031, DOI 10.1128/JVI.79.22.14031-14043.2005; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zhai DY, 2003, BIOCHEM J, V376, P229, DOI 10.1042/BJ20030374; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	53	34	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5569	5580		10.1074/jbc.M109.078113	http://dx.doi.org/10.1074/jbc.M109.078113			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022954	Green Published, hybrid			2022-12-25	WOS:000275327200049
J	Chen, EL; Kim, RJ				Chen, Enn-Ling; Kim, Raymond J.			Magnetic Resonance Water Proton Relaxation in Protein Solutions and Tissue: T-1p Dispersion Characterization	PLOS ONE			English	Article							SPIN-LATTICE-RELAXATION; PANCREATIC TRYPSIN-INHIBITOR; BOVINE SERUM-ALBUMIN; CROSS-RELAXATION; HETEROGENEOUS SYSTEMS; BIOPOLYMER SYSTEMS; AQUEOUS-SOLUTION; EXCHANGE; DYNAMICS; DEPENDENCE	Background: Image contrast in clinical MRI is often determined by differences in tissue water proton relaxation behavior. However, many aspects of water proton relaxation in complex biological media, such as protein solutions and tissue are not well understood, perhaps due to the limited empirical data. Principal Findings: Water proton T1, T2, and T-1p of protein solutions and tissue were measured systematically under multiple conditions. Crosslinking or aggregation of protein decreased T2 and T-1p, but did not change high-field T1, T-1p dispersion profiles were similar for crosslinked protein solutions, myocardial tissue, and cartilage, and exhibited power law behavior with T-1p(0) values that closely approximated T2. The T-1p dispersion of mobile protein solutions was flat above 5 kHz, but showed a steep curve below 5 kHz that was sensitive to changes in pH. The T-1p dispersion of crosslinked BSA and cartilage in DMSO solvent closely resembled that of water solvent above 5 kHz but showed decreased dispersion below 5 kHz. Conclusions: Proton exchange is a minor pathway for tissue T1 and T-1p relaxation above 5 kHz. Potential models for relaxation are discussed, however the same molecular mechanism appears to be responsible across 5 decades of frequencies from T-1p to T1.	[Chen, Enn-Ling; Kim, Raymond J.] Duke Univ, Med Ctr, Duke Cardiovasc Magnet Resonance Ctr, Durham, NC 27706 USA; [Chen, Enn-Ling; Kim, Raymond J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Kim, Raymond J.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Chen, EL (corresponding author), Duke Univ, Med Ctr, Duke Cardiovasc Magnet Resonance Ctr, Durham, NC 27706 USA.	Ennling@duke.edu	Kim, Raymond J/B-1426-2008					BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BLOEMBERGEN N, 1948, PHYS REV, V73, P679, DOI 10.1103/PhysRev.73.679; BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535; BROWN RD, 1992, MAGNET RESON MED, V28, P145, DOI 10.1002/mrm.1910280115; BRYANT RG, 1991, MAGNET RESON MED, V21, P117, DOI 10.1002/mrm.1910210114; BRYANT RG, 1980, 178 M AM CHEM SOC WA; CARTER DC, 1989, SCIENCE, V244, P1195, DOI 10.1126/science.2727704; DENISOV VP, 1995, BIOCHEMISTRY-US, V34, P9046, DOI 10.1021/bi00028a013; DENISOV VP, 1995, J MOL BIOL, V245, P682, DOI 10.1006/jmbi.1994.0055; EDZES HT, 1977, NATURE, V265, P521, DOI 10.1038/265521a0; ESCANYE JM, 1982, BIOCHIM BIOPHYS ACTA, V721, P305, DOI 10.1016/0167-4889(82)90083-0; FRAENKEICONRAT H, 1945, J BIOL CHEM, V161, P259; FULLERTON GD, 1980, MAGNETIC RESONANCE I, V1, P88; FULLERTON GD, 1980, MAGNETIC RESONANCE I, V2, P88; FUNG BM, 1974, BIOCHIM BIOPHYS ACTA, V362, P209, DOI 10.1016/0304-4165(74)90042-7; FUNG BM, 1974, BIOCHIM BIOPHYS ACTA, V343, P663, DOI 10.1016/0304-4165(74)90287-6; Glantz S., 1990, PRIMER APPL REGRESSI; GORE JC, 1988, NUCL MAGN RESON, V2, P1070; HALLE B, 1995, BIOPHYS J, V69, P242, DOI 10.1016/S0006-3495(95)79895-2; HILLS BP, 1992, MOL PHYS, V76, P489, DOI 10.1080/00268979200101491; HILLS BP, 1992, MOL PHYS, V76, P509, DOI 10.1080/00268979200101501; KALK A, 1976, J MAGN RESON, V24, P343, DOI 10.1016/0022-2364(76)90115-3; KIMMICH R, 1985, PROG COLL POL SCI S, V71, P66; KIMMICH R, 1986, J MAGN RESON, V68, P263, DOI 10.1016/0022-2364(86)90243-X; KNISPEL RR, 1974, J MAGN RESON, V14, P44, DOI 10.1016/0022-2364(74)90255-8; KOENIG SH, 1993, MAGNET RESON MED, V29, P77, DOI 10.1002/mrm.1910290114; KOENIG SH, 1993, MAGN RESON MED, V30, P685, DOI 10.1002/mrm.1910300606; KOENIG SH, 1993, MAGNET RESON MED, V29, P311, DOI 10.1002/mrm.1910290306; LESTER CC, 1991, MAGNET RESON MED, V22, P143, DOI 10.1002/mrm.1910220115; Liepinsh E, 1996, MAGNET RESON MED, V35, P30, DOI 10.1002/mrm.1910350106; LUFT JH, 1992, J MICROSC-OXFORD, V167, P247, DOI 10.1111/j.1365-2818.1992.tb03235.x; Makela HI, 2001, BIOCHEM BIOPH RES CO, V289, P813, DOI 10.1006/bbrc.2001.6058; MENON RS, 1990, BIOPHYS J, V57, P389, DOI 10.1016/S0006-3495(90)82555-8; OTTING G, 1991, SCIENCE, V254, P974, DOI 10.1126/science.1948083; PACKER KJ, 1977, PHILOS T R SOC B, V278, P59, DOI 10.1098/rstb.1977.0031; POLNASZEK CF, 1984, J CHEM PHYS, V81, P4038, DOI 10.1063/1.448147; RORSCHACH HE, 1986, J MAGN RESON, V70, P79, DOI 10.1016/0022-2364(86)90364-1; SHIRLEY WM, 1982, J AM CHEM SOC, V104, P2910, DOI 10.1021/ja00374a034; Venu K, 1997, J AM CHEM SOC, V119, P3122, DOI 10.1021/ja963611t; Virta A, 1997, MAGNET RESON MED, V37, P53, DOI 10.1002/mrm.1910370109; ZHOU D, 1994, MAGNET RESON MED, V32, P725, DOI 10.1002/mrm.1910320607	41	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8565	10.1371/journal.pone.0008565	http://dx.doi.org/10.1371/journal.pone.0008565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052404	Green Published, Green Submitted, gold			2022-12-25	WOS:000273338500009
J	Clarke, M; Maddera, L; Engel, U; Gerisch, G				Clarke, Margaret; Maddera, Lucinda; Engel, Ulrike; Gerisch, Guenther			Retrieval of the Vacuolar H+-ATPase from Phagosomes Revealed by Live Cell Imaging	PLOS ONE			English	Article							ENDOCYTIC PATHWAY; V-ATPASE; DICTYOSTELIUM-DISCOIDEUM; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; VESICULAR TRAFFICKING; FLUORESCENT PROTEIN; DYNAMICS; MEMBRANE; PHAGOCYTOSIS; MATURATION	Background: The vacuolar H+-ATPase, or V-ATPase, is a highly-conserved multi-subunit enzyme that transports protons across membranes at the expense of ATP. The resulting proton gradient serves many essential functions, among them energizing transport of small molecules such as neurotransmitters, and acidifying organelles such as endosomes. The enzyme is not present in the plasma membrane from which a phagosome is formed, but is rapidly delivered by fusion with endosomes that already bear the V-ATPase in their membranes. Similarly, the enzyme is thought to be retrieved from phagosome membranes prior to exocytosis of indigestible material, although that process has not been directly visualized. Methodology: To monitor trafficking of the V-ATPase in the phagocytic pathway of Dictyostelium discoideum, we fed the cells yeast, large particles that maintain their shape during trafficking. To track pH changes, we conjugated the yeast with fluorescein isothiocyanate. Cells were labeled with VatM-GFP, a fluorescently-tagged transmembrane subunit of the V-ATPase, in parallel with stage-specific endosomal markers or in combination with mRFP-tagged cytoskeletal proteins. Principal Findings: We find that the V-ATPase is commonly retrieved from the phagosome membrane by vesiculation shortly before exocytosis. However, if the cells are kept in confined spaces, a bulky phagosome may be exocytosed prematurely. In this event, a large V-ATPase-rich vacuole coated with actin typically separates from the acidic phagosome shortly before exocytosis. This vacuole is propelled by an actin tail and soon acquires the properties of an early endosome, revealing an unexpected mechanism for rapid recycling of the V-ATPase. Any V-ATPase that reaches the plasma membrane is also promptly retrieved. Conclusions/Signficance: Thus, live cell microscopy has revealed both a usual route and alternative means of recycling the V-ATPase in the endocytic pathway.	[Clarke, Margaret; Maddera, Lucinda] Oklahoma Med Res Fdn, Program Genet Models Dis, Oklahoma City, OK 73104 USA; [Engel, Ulrike] Heidelberg Univ, Nikon Imaging Ctr, Heidelberg, Germany; [Gerisch, Guenther] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Oklahoma Medical Research Foundation; Nikon Corporation; Ruprecht Karls University Heidelberg; Max Planck Society	Clarke, M (corresponding author), Oklahoma Med Res Fdn, Program Genet Models Dis, 825 NE 13th St, Oklahoma City, OK 73104 USA.	clarkem@omrf.org	Engel, Ulrike/AAO-7719-2020; Engel, Ulrike/E-5456-2014	Engel, Ulrike/0000-0002-6953-6845; Maddera, Lucinda/0000-0001-7474-7164	National Science Foundation [MCB-0344541]; Max Planck Society; Deutsche Forschungsgemeinschaft [SPP 1128]	National Science Foundation(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grant MCB-0344541 from the National Science Foundation to MC, and by the Max Planck Society and grants in the SPP 1128 program of the Deutsche Forschungsgemeinschaft to GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBRY L, 1993, J CELL SCI, V105, P861; Benado A, 2009, IMMUNOBIOLOGY, V214, P507, DOI 10.1016/j.imbio.2008.11.011; Bozzaro S, 2008, INT REV CEL MOL BIO, V271, P253, DOI 10.1016/S1937-6448(08)01206-9; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Cardelli J, 2001, TRAFFIC, V2, P311, DOI 10.1034/j.1600-0854.2001.002005311.x; Charette SJ, 2006, FEBS LETT, V580, P4923, DOI 10.1016/j.febslet.2006.08.009; Clague MJ, 2009, EXP CELL RES, V315, P1627, DOI 10.1016/j.yexcr.2008.10.005; Clarke M, 2002, J CELL SCI, V115, P2893; Clarke M, 2002, TRAFFIC, V3, P791, DOI 10.1034/j.1600-0854.2002.31104.x; Clarke M, 2006, MOL BIOL CELL, V17, P4866, DOI 10.1091/mbc.E06-04-0365; Clarke M, 2006, EUR J CELL BIOL, V85, P1001, DOI 10.1016/j.ejcb.2006.05.004; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dieckmann Regis, 2008, V445, P327, DOI 10.1007/978-1-59745-157-4_21; Diez S, 2005, P NATL ACAD SCI USA, V102, P7601, DOI 10.1073/pnas.0408546102; Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579; Dove SK, 2009, BIOCHEM J, V419, P1, DOI 10.1042/BJ20081950; Duhon D, 2002, J MUSCLE RES CELL M, V23, P803, DOI 10.1023/A:1024435913949; Ellson CD, 2001, CURR BIOL, V11, P1631, DOI 10.1016/S0960-9822(01)00447-X; Engel Ulrike, 2009, Biotechnology Journal, V4, P797, DOI 10.1002/biot.200900060; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Gabriel D, 1999, J CELL SCI, V112, P3995; Gauthier NC, 2009, MOL BIOL CELL, V20, P3261, DOI 10.1091/mbc.E09-01-0071; Gerisch G, 2004, EUR J CELL BIOL, V83, P297, DOI 10.1078/0171-9335-00393; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Giorgione J, 2008, CELL MOTIL CYTOSKEL, V65, P721, DOI 10.1002/cm.20293; Gotthardt D, 2002, MOL BIOL CELL, V13, P3508, DOI 10.1091/mbc.E02-04-0206; Heuser J, 2006, EUR J CELL BIOL, V85, P859, DOI 10.1016/j.ejcb.2006.05.011; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Insall R, 2001, CELL MOTIL CYTOSKEL, V50, P115, DOI 10.1002/cm.10005; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Jenne N, 1998, J CELL SCI, V111, P61; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Lee E, 2002, TRAFFIC, V3, P186, DOI 10.1034/j.1600-0854.2002.030304.x; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Liu TY, 1996, J CELL SCI, V109, P1041; LUKACS GL, 1991, J BIOL CHEM, V266, P24540; Maniak M, 2003, TRAFFIC, V4, P1, DOI 10.1034/j.1600-0854.2003.40101.x; Maniak M, 2002, INT REV CYTOL, V221, P257; Maniak M, 2001, BBA-GEN SUBJECTS, V1525, P197, DOI 10.1016/S0304-4165(01)00105-2; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; McNeil PL, 2002, J CELL SCI, V115, P873; Neuhaus EM, 2002, MOL BIOL CELL, V13, P1390, DOI 10.1091/mbc.01-08-0392; NOLTA KV, 1994, BBA-MOL CELL RES, V1224, P237, DOI 10.1016/0167-4889(94)90196-1; Rauchenberger R, 1997, CURR BIOL, V7, P215, DOI 10.1016/S0960-9822(97)70093-9; Recchi C, 2006, NAT CELL BIOL, V8, P107, DOI 10.1038/ncb0206-107; Rezabek BL, 1997, J EUKARYOT MICROBIOL, V44, P284, DOI 10.1111/j.1550-7408.1997.tb05668.x; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Steinberg BE, 2007, P NATL ACAD SCI USA, V104, P9523, DOI 10.1073/pnas.0700783104; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Yeung T, 2006, CURR OPIN CELL BIOL, V18, P429, DOI 10.1016/j.ceb.2006.06.006; YUMURA S, 1985, NATURE, V314, P194, DOI 10.1038/314194a0	56	39	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8585	10.1371/journal.pone.0008585	http://dx.doi.org/10.1371/journal.pone.0008585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052281	gold, Green Submitted, Green Published			2022-12-25	WOS:000273338500027
J	Haney, RA; Feder, ME				Haney, Robert A.; Feder, Martin E.			Contrasting Patterns of Transposable Element Insertions in Drosophila Heat-Shock Promoters	PLOS ONE			English	Article							HSP70 PROMOTER; GENE-EXPRESSION; TATA BOX; EVOLUTION; MELANOGASTER; IDENTIFICATION; SEQUENCES; FAMILY; THERMOTOLERANCE; TRANSPOSITION	The proximal promoter regions of heat-shock genes harbor a remarkable number of P transposable element (TE) insertions relative to both positive and negative control proximal promoter regions in natural populations of Drosophila melanogaster. We have screened the sequenced genomes of 12 species of Drosophila to test whether this pattern is unique to these populations. In the 12 species' genomes, transposable element insertions are no more abundant in promoter regions of single-copy heat-shock genes than in promoters with similar or dissimilar architecture. Also, insertions appear randomly distributed across the promoter region, whereas insertions clustered near the transcription start site in promoters of single-copy heat-shock genes in D. melanogaster natural populations. Hsp70 promoters exhibit more TE insertions per promoter than all other genesets in the 12 species, similarly to in natural populations of D. melanogaster. Insertions in the Hsp70 promoter region, however, cluster away from the transcription start site in the 12 species, but near it in natural populations of D. melanogaster. These results suggest that D. melanogaster heat-shock promoters are unique in terms of their interaction with transposable elements, and confirm that Hsp70 promoters are distinctive in TE insertions across Drosophila.	[Haney, Robert A.; Feder, Martin E.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago	Haney, RA (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	rhaney@uchicago.edu		Haney, Robert/0000-0002-3742-3395	NSF [IOB06-41278]	NSF(National Science Foundation (NSF))	Supported by NSF IOB06-41278 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aminetzach YT, 2005, SCIENCE, V309, P764, DOI 10.1126/science.1112699; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bettencourt BR, 2002, J MOL EVOL, V54, P569, DOI 10.1007/s00239-001-0044-7; Bettencourt BR, 2001, MOL BIOL EVOL, V18, P1272, DOI 10.1093/oxfordjournals.molbev.a003912; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; BUREAU TE, 1994, PLANT CELL, V6, P907, DOI 10.1105/tpc.6.6.907; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Caspi A, 2006, GENOME RES, V16, P260, DOI 10.1101/gr.4361206; Catania F, 2004, MOL ECOL, V13, P2491, DOI 10.1111/j.1365-294X.2004.02263.x; Chen B, 2008, CELL STRESS CHAPERON, V13, P11, DOI 10.1007/s12192-007-0002-4; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; CORCES V, 1984, J BIOL CHEM, V259, P4812; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; El Amrani A, 2002, MOL GENET GENOMICS, V267, P459, DOI 10.1007/s00438-002-0675-4; Evgen'ev MB, 2004, CHROMOSOMA, V113, P223, DOI 10.1007/s00412-004-0312-6; Feder ME, 1997, J THERM BIOL, V22, P1, DOI 10.1016/S0306-4565(96)00028-9; Ganko EW, 2006, J MOL EVOL, V62, P111, DOI 10.1007/s00239-004-0312-4; Gonzalez J, 2008, PLOS BIOL, V6, P2109, DOI 10.1371/journal.pbio.0060251; HALL T, 1999, BIOEDIT SEQUENCE ALI; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; KIDWELL MG, 1983, P NATL ACAD SCI-BIOL, V80, P1655, DOI 10.1073/pnas.80.6.1655; Krebs RA, 1997, CELL STRESS CHAPERON, V2, P60, DOI 10.1379/1466-1268(1997)002<0060:DCOHOI>2.3.CO;2; Kuang HH, 2009, GENOME RES, V19, P42, DOI [10.1101/gr.07816.108, 10.1101/gr.078196.108]; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; LANSMAN RA, 1985, NATURE, V318, P561, DOI 10.1038/318561a0; Lardenois A, 2006, NUCLEIC ACIDS RES, V34, pW578, DOI 10.1093/nar/gkl193; Leibovitch BA, 2002, MOL CELL BIOL, V22, P6148, DOI 10.1128/MCB.22.17.6148-6157.2002; Lerman DN, 2005, MOL BIOL EVOL, V22, P776, DOI 10.1093/molbev/msi063; Liao GC, 2000, P NATL ACAD SCI USA, V97, P3347, DOI 10.1073/pnas.050017397; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; Markow TA, 2007, GENETICS, V177, P1269, DOI 10.1534/genetics.107.074112; Maside X, 2002, CURR BIOL, V12, P1686, DOI 10.1016/S0960-9822(02)01181-8; McCollum AM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-5; Michalak P, 2001, P NATL ACAD SCI USA, V98, P13195, DOI 10.1073/pnas.231478298; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Papatsenko DA, 2002, GENOME RES, V12, P470, DOI 10.1101/gr.212502. Article published online before print in February ; Rashkovetsky E, 2006, HEREDITY, V96, P353, DOI 10.1038/sj.hdy.6800784; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Schlenke TA, 2004, P NATL ACAD SCI USA, V101, P1626, DOI 10.1073/pnas.0303793101; Schmid CD, 2004, NUCLEIC ACIDS RES, V32, pD82, DOI 10.1093/nar/gkh122; Shilova VY, 2006, GENETICS, V173, P809, DOI 10.1534/genetics.105.053959; Silva JC, 2004, GENETICS, V168, P1323, DOI 10.1534/genetics.103.025775; Smith CD, 2007, GENE, V389, P1, DOI 10.1016/j.gene.2006.09.011; STACEY SN, 1986, MOL BIOL EVOL, V3, P522; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Walser JC, 2006, PLOS GENET, V2, P1541, DOI 10.1371/journal.pgen.0020165; Wang J, 2007, J MOL EVOL, V65, P627, DOI 10.1007/s00239-007-9028-6; Weber JA, 1997, MOL CELL BIOL, V17, P3799, DOI 10.1128/MCB.17.7.3799; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Xu L, 2007, BIOCHEM BIOPH RES CO, V364, P668, DOI 10.1016/j.bbrc.2007.10.069; Yang GJ, 2005, PLANT CELL, V17, P1559, DOI 10.1105/tpc.104.030528; Yang HP, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r39; Zatsepina OG, 2001, J EXP BIOL, V204, P1869	59	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8486	10.1371/journal.pone.0008486	http://dx.doi.org/10.1371/journal.pone.0008486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041194	gold, Green Published, Green Submitted			2022-12-25	WOS:000273105200018
J	Lu, J; Zhou, YD; Lin, XJ; Jiang, YZ; Tian, RG; Zhang, YH; Wu, J; Zhang, FW; Zhang, Y; Wang, Y; Bi, SL				Lu, Jian; Zhou, Yongdong; Lin, Xiaojing; Jiang, Yongzhen; Tian, Ruiguang; Zhang, Yonghui; Wu, Jia; Zhang, Fengwei; Zhang, Yong; Wang, Yue; Bi, Shengli			General Epidemiological Parameters of Viral Hepatitis A, B, C, and E in Six Regions of China: A Cross-Sectional Study in 2007	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; E VIRUS; POLYMORPHISMS; PROTEIN; CORE; HEV	Background: Viral hepatitis is a serious health burden worldwide. To date, few reports have addressed the prevalence of hepatitis A, B, C, and E in China. Therefore, the general epidemiological parameters of viral hepatitis remain unknown. Principal Findings: In this cross-sectional study, we performed a serological prevalence analysis of viral hepatitis A, B, C, and E in 8,762 randomly selected Chinese subjects, which represented six areas of China. The overall prevalence of anti-Hepatitis C virus antibody (anti-HCV) was 0.58%, which was much lower than was estimated by WHO. The prevalences of Hepatitis B virus surface antigen (HBsAg), anti-Hepatitis B virus surface protein antibody (HBsAb), and anti-Hepatitis B virus core protein antibody (HBcAb) were 5.84%, 41.31%, and 35.92%, respectively, whereas in the group of subjects less than 5 years old, these prevalences were 1.16%, 46.77%, and 8.69% respectively, which suggests that the Hepatitis B virus (HBV)-carrier population is decreasing, and the nationwide HBV vaccine program has contributed to the lowered HBV prevalence in the younger generation in China. Meanwhile, a large deficit remains in coverage provided by the national HBV immune program. In addition, our data suggested the possibility that HBsAb may not last long enough to protect people from HBV infection throughout life. The overall prevalence of anti-Hepatitis A virus antibody (anti-HAV) and anti-Hepatitis E virus antibody (anti-HEV) were as high as 72.87% and 17.66%, respectively. The indices increased with age, which suggests that a large proportion of Chinese adults are protected by latent infection. Furthermore, the pattern of HEV infection was significantly different among ethnic groups in China. Conclusions: Our study provided much important information concerning hepatitis A, B, C, and E prevalence in China and will contribute to worldwide oversight of viral hepatitis.	[Lu, Jian; Zhou, Yongdong; Lin, Xiaojing; Jiang, Yongzhen; Tian, Ruiguang; Zhang, Yonghui; Wu, Jia; Zhang, Fengwei; Zhang, Yong; Wang, Yue; Bi, Shengli] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Lu, J (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	euy-tokyo@umin.ac.jp; shengli_bi@163.com	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Bi, Shengli/0000-0002-0380-5790	National Research Programs of China [2008ZX10002-001, 2009ZX10004-711]; 863 Hi-Tech Research and Development Program of China [2007AA02Z157]	National Research Programs of China; 863 Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This study was supported by the National Research Programs of China (2008ZX10002-001 and 2009ZX10004-711) and the 863 Hi-Tech Research and Development Program of China (2007AA02Z157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Cao JY, 2009, HEPATOL INT, V3, P356, DOI 10.1007/s12072-008-9116-8; Centers for Disease Control and Prevention (CDC), 2008, MMWR-MORBID MORTAL W, V57, pSS2; Dai Z., 1997, VIRAL HEPATITIS CHIN, P39; DAVID MM, 2008, LANCET INFECT DIS, V8, P710; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Degertekin B, 2008, CURR OPIN GASTROEN, V24, P306, DOI 10.1097/MOG.0b013e3282f70285; Deng Y, 2009, VACCINE, V27, P2085, DOI 10.1016/j.vaccine.2009.02.003; Emerson SU, 2007, PEDIATR INFECT DIS J, V26, P1147, DOI 10.1097/INF.0b013e31815dd7c2; Engle RE, 2002, J CLIN MICROBIOL, V40, P4576, DOI 10.1128/JCM.40.12.4576-4580.2002; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Halbur PG, 2001, J CLIN MICROBIOL, V39, P918, DOI 10.1128/JCM.39.3.918-923.2001; Hoofnagle JH, 1998, DIGESTION, V59, P563, DOI 10.1159/000007532; Huang FF, 2004, J GEN VIROL, V85, P1609, DOI 10.1099/vir.0.79841-0; Jiang Yong-zhen, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P468; Kuiken T, 2003, CURR OPIN BIOTECH, V14, P641, DOI 10.1016/j.copbio.2003.10.010; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; Liao G, 2008, HEPATOLOGY, V47, P25, DOI 10.1002/hep.21992; Lin XJ, 2009, BIOCHEM BIOPH RES CO, V385, P257, DOI 10.1016/j.bbrc.2009.05.068; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; Martin A, 2006, HEPATOLOGY, V43, pS164, DOI 10.1002/hep.21052; Mohanty SR, 2006, NAT CLIN PRACT GASTR, V3, P446, DOI 10.1038/ncpgasthep0550; Mushahwar IK, 2008, J MED VIROL, V80, P646, DOI 10.1002/jmv.21116; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; PURCELL RH, 1994, P NATL ACAD SCI USA, V91, P2401, DOI 10.1073/pnas.91.7.2401; Raimondo G, 2008, J HEPATOL, V49, P677, DOI 10.1016/j.jhep.2008.08.003; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Wang Y, 2006, GASTROENTEROLOGY, V130, P883, DOI 10.1053/j.gastro.2005.12.028; Wang Y, 2004, CLIN CANCER RES, V10, P2441, DOI 10.1158/1078-0432.CCR-1187-3; Wang Y, 2003, HEPATOLOGY, V37, P65, DOI 10.1053/jhep.2003.50017; WHO, HEP A; *WHO, WHOCDSCSREDC200112; World Health Organization, HEP E; World Health Organization (WHO), HEP C; World Health Organization (WHO), HEP B; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x; 2002, NIH CONSENSUS STATE, V19	38	79	95	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8467	10.1371/journal.pone.0008467	http://dx.doi.org/10.1371/journal.pone.0008467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041146	gold, Green Submitted, Green Published			2022-12-25	WOS:000273104000025
J	Bejon, P; Ogada, E; Peshu, N; Marsh, K				Bejon, Philip; Ogada, Edna; Peshu, Norbert; Marsh, Kevin			Interactions between Age and ITN Use Determine the Risk of Febrile Malaria in Children	PLOS ONE			English	Article							TREATED BED NETS; PLASMODIUM-FALCIPARUM TRANSMISSION; SPATIAL-DISTRIBUTION; YOUNG-CHILDREN; WESTERN KENYA; PEDIATRIC MALARIA; CLINICAL MALARIA; MOSQUITO NETS; MORTALITY; AREA	Background: Control measures which reduce individual exposure to malaria are expected to reduce disease, but also to eventually reduce immunity. Reassuringly, long term data following community wide ITN distribution show sustained benefits at a population level. However, the more common practice in Sub-Saharan Africa is to target ITN distribution on young children. There are few data on the long term outcomes of this practice. Methodology/Principal Findings: Episodes of febrile malaria were identified by active surveillance in 383 children over 18 months of follow up. In order to compare the short and long term outcomes of ITN use, we examined interactions between ITN use and age (12-42 months of age versus 42-80 months) in determining the risk of febrile malaria. ITN use and older age protected against the first or only episode of malaria (Hazard Ratio [HR] = 0.33, 95% CI 0.17-0.65 and HR = 0.30, 95% CI 0.17-0.51, respectively). The interaction term between ITN use and older age was HR = 2.91, 95% CI 1.02-8.3, p = 0.045, indicating that ITNs did not protect older children. When multiple episodes were included in analysis, ITN use and older age were again protective against malaria episodes (Incident Rate Ratio [IRR] = 0.43 95% CI 0.27-0.7) and IRR = 0.23, 95% CI 0.13-0.42, respectively) and the interaction term indicated that ITNs did not protect older children (IRR = 2.71, 95% CI 1.3-5.7, p = 0.008). Conclusions/Significance: These data on age interactions with ITN use suggest that larger scale studies on the long term individual outcomes should be undertaken if the policy of targeted ITN use for vulnerable groups is to continue.	[Bejon, Philip; Ogada, Edna; Peshu, Norbert; Marsh, Kevin] KEMRI, Ctr Geog Med Res Coast, Kilifi, Kenya; [Bejon, Philip; Marsh, Kevin] Univ Oxford, Nuffield Dept Med, Oxford, England	University of Oxford	Bejon, P (corresponding author), KEMRI, Ctr Geog Med Res Coast, Kilifi, Kenya.	pbejon@well.ox.ac.uk		Ogada, Edna/0000-0003-0181-2505	Biomedical Research Programme in Oxford; Wellcome Trust; Gates Malaria Partnership; London School of Hygiene & Tropical Medicine	Biomedical Research Programme in Oxford; Wellcome Trust(Wellcome TrustEuropean Commission); Gates Malaria Partnership; London School of Hygiene & Tropical Medicine	PB is funded by the Biomedical Research Programme in Oxford. The study was funded by the Wellcome Trust and by the Gates Malaria Partnership, London School of Hygiene & Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Askjaer N, 2001, CLIN DIAGN LAB IMMUN, V8, P1289, DOI 10.1128/CDLI.8.6.1289-1291.2001; BEJON P, 2009, INFECT IMMUN; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Bejon P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000707; Binka FN, 1998, AM J TROP MED HYG, V59, P80, DOI 10.4269/ajtmh.1998.59.80; Binka FN, 2002, T ROY SOC TROP MED H, V96, P597, DOI 10.1016/S0035-9203(02)90321-4; Diallo DA, 2004, B WORLD HEALTH ORGAN, V82, P85; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Gimnig JE, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.115; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-54; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Kariuki SK, 2003, AM J TROP MED HYG, V68, P108, DOI 10.4269/ajtmh.2003.68.108; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Leenstra T, 2003, AM J TROP MED HYG, V68, P86, DOI 10.4269/ajtmh.2003.68.86; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002081; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sochantha T, 2006, TROP MED INT HEALTH, V11, P1166, DOI 10.1111/j.1365-3156.2006.01673.x; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P100, DOI 10.4269/ajtmh.2003.68.100; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50	34	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8321	10.1371/journal.pone.0008321	http://dx.doi.org/10.1371/journal.pone.0008321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037643	Green Published, gold			2022-12-25	WOS:000272998100003
J	Malla, P; Kanitz, EE; Akhtar, M; Falzon, D; Feldmann, K; Gunneberg, C; Jha, SS; Maharjan, B; Prasai, MK; Shrestha, B; Verma, SC; Zignol, M				Malla, Pushpa; Kanitz, Elisabeth Eva; Akhtar, Mohammad; Falzon, Dennis; Feldmann, Knut; Gunneberg, Christian; Jha, Shyam Sundar; Maharjan, Bhagwan; Prasai, Mohan Kumar; Shrestha, Bhabana; Verma, Sharat Chandra; Zignol, Matteo			Ambulatory-Based Standardized Therapy for Multi-Drug Resistant Tuberculosis: Experience from Nepal, 2005-2006	PLOS ONE			English	Article							PERU; COHORT; HEALTH; LIMA	Objective: The aim of this study was to describe treatment outcomes for multi-drug resistant tuberculosis (MDR-TB) outpatients on a standardized regimen in Nepal. Methodology: Data on pulmonary MDR-TB patients enrolled for treatment in the Green Light Committee-approved National Programme between 15 September 2005 and 15 September 2006 were studied. Standardized regimen was used (8Z-Km-Ofx-Eto-Cs/16Z-Ofx-Eto-Cs) for a maximum of 32 months and follow-up was by smear and culture. Drug susceptibility testing (DST) results were not used to modify the treatment regimen. MDR-TB therapy was delivered in outpatient facilities for the whole course of treatment. Multivariable analysis was used to explain bacteriological cure as a function of sex, age, initial body weight, history of previous treatment and the region of report. Principal Findings: In the first 12-months, 175 laboratory-confirmed MDR-TB cases (62% males) had outcomes reported. Most cases had failed a Category 2 first-line regimen (87%) or a Category 1 regimen (6%), 2% were previously untreated contacts of MDR-TB cases and 5% were unspecified. Cure was reported among 70% of patients (range 38%-93% by Region), 8% died, 5% failed treatment, and 17% defaulted. Unfavorable outcomes were not correlated to the number of resistant drugs at baseline DST. Cases who died had a lower mean body weight than those surviving (40.3 kg vs 47.2 kg, p, 0.05). Default was significantly higher in two regions [Eastern OR = 6.2; 95% CL2.0-18.9; Far West OR = 5.0; 95% CL1.0-24.3]. At logistic regression, cure was inversely associated with body weight,36 kg [Adj. OR = 0.1; 95% CL0.0-0.3; ref. 55-75 kg] and treatment in the Eastern region [Adj. OR = 0.1; 95% CL0.0-0.4; ref. Central region]. Conclusions: The implementation of an ambulatory-based treatment programme for MDR-TB based on a fully standardized regimen can yield high cure rates even in resource-limited settings. The determinants of unfavorable outcome should be investigated thoroughly to maximize likelihood of successful treatment.	[Malla, Pushpa; Jha, Shyam Sundar; Verma, Sharat Chandra] NTC, Minist Hlth & Populat, Kathmandu, Nepal; [Kanitz, Elisabeth Eva; Falzon, Dennis; Gunneberg, Christian; Zignol, Matteo] WHO, CH-1211 Geneva, Switzerland; [Akhtar, Mohammad] WHO, Country Off, Kathmandu, Nepal; [Feldmann, Knut] Kuratorium TB Welt, Gauting, Germany; [Maharjan, Bhagwan; Shrestha, Bhabana] German Nepal TB Project GENTUP, Kathmandu, Nepal; [Prasai, Mohan Kumar] Reg TB Ctr, Pokhara, Nepal	World Health Organization; World Health Organization	Malla, P (corresponding author), NTC, Minist Hlth & Populat, Kathmandu, Nepal.	zignolm@who.int			United States Agency for International Development; Eli Lilly MDR-TB Partnership	United States Agency for International Development(United States Agency for International Development (USAID)); Eli Lilly MDR-TB Partnership(Eli Lilly)	This study was supported by the United States Agency for International Development and Eli Lilly MDR-TB Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barn DS, 2004, INT J TUBERC LUNG S1, V8, pS47; BYRNE A, 2009, 40 UN WORLD IN PRESS; Caminero JA, 2006, INT J TUBERC LUNG D, V10, P829; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Park SK, 2004, INT J TUBERC LUNG D, V8, P361; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; SHRESTHA KB, 2005, INT J TUBERC LUNG S1, V9, pS257; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P560; WHO, 2009, WHOHTMTB2009411; WHO, 2009, WHOHTMTB2009422; WHO, 2000, WHOCDSTB2000279; World Health Organization, 2008, WHOHTMTB2008402; World Health Organization, 2003, TREATM TUB GUID NAT; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	24	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8313	10.1371/journal.pone.0008313	http://dx.doi.org/10.1371/journal.pone.0008313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20041140	Green Published, gold, Green Submitted			2022-12-25	WOS:000272998100002
J	Li, Q; Li, G; Lan, XM; Zheng, M; Chen, KH; Cao, CM; Xiao, RP				Li, Qian; Li, Geng; Lan, Xiaomei; Zheng, Ming; Chen, Kuang-Hueih; Cao, Chun-Mei; Xiao, Rui-Ping			Receptor Interacting Protein 3 Suppresses Vascular Smooth Muscle Cell Growth by Inhibition of the Phosphoinositide 3-Kinase-Akt Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ANGIOTENSIN-CONVERTING ENZYME; RIP-LIKE KINASE; NEOINTIMAL HYPERPLASIA; BALLOON ANGIOPLASTY; DEATH DOMAIN; APOPTOSIS; AKT; PROLIFERATION; RESTENOSIS	Proliferation of vascular smooth muscle cells (VSMCs) is a primary mechanism underlying cardiovascular proliferative disorders. Phosphoinositide 3-kinase (PI3K)-Akt (or protein kinase B) axis has been assigned at the center of pathways that regulate cell proliferation. Here we demonstrate that enhanced PI3K-Akt signaling by mitogenic stimulation or arterial injury profoundly elevates expression of receptor interacting protein 3 (RIP3) in primary cultured rat VSMCs and in vivo and that the up-regulation of RIP3 leads toVSMCgrowth arrest and apoptosis via inhibiting the PI3K-Akt signaling pathway, thereby alleviating balloon injury-induced neointimal formation. Specifically, mitogenic stimulation with platelet-derived growth factor-BB or angiotensin II leads to a profound increase in RIP3 expression, which is abolished by inhibition of PI3K or Akt, and increased PI3K-Akt signaling by expression of a constitutively active PI3K mutant also elevates RIP3 expression. Importantly, adenoviral overexpression of RIP3 not only triggers apoptosis but also causes cell cycle arrest at G(1)/G(0) phases that is associated with suppressed Akt activation. In sharp contrast, RIP3 gene silencing enhances serum- and platelet-derived growth factor-induced cell proliferation and Akt activation. In vivo adenoviral gene delivery of rat RIP3 (rRIP3) increased apoptosis and reduced VSMC proliferation, thus, effectively alleviating balloon injury-induced neointimal formation. The growth-suppressive and pro-apoptotic effects are independent of rRIP3 Ser/Thr kinase activity, because overexpression of a kinase-in-active mutant of rRIP3, similar to its wild type, is sufficient to induce growth arrest and apoptosis. These findings reveal a novel growth-suppressive action of RIP3, marking RIP3 as an important factor to prevent excessive mitogenic stimulation- or injury-induced vascular smooth muscle cells hyperplasia.	[Li, Qian; Lan, Xiaomei; Zheng, Ming; Cao, Chun-Mei; Xiao, Rui-Ping] Peking Univ, Inst Mol Med, Beijing 100083, Peoples R China; [Li, Qian; Li, Geng; Lan, Xiaomei; Xiao, Rui-Ping] Peking Univ, Inst Cardiovasc Sci, Beijing 100083, Peoples R China; [Chen, Kuang-Hueih; Xiao, Rui-Ping] NIA, Cardiovasc Sci Lab, Baltimore, MD 21224 USA	Peking University; Peking University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cao, CM (corresponding author), Peking Univ, Inst Mol Med, Beijing 100083, Peoples R China.	Caochunmei@pku.edu.cn; Xiaor@grc.nia.nih.gov	Xiao, Rui-Ping/AAE-2629-2019; Yimei, Wang/AAE-4083-2019		National Institutes of Health Intramural Research Program, NIA; Peking University; Chinese 973 Program [2007CB512100]	National Institutes of Health Intramural Research Program, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Peking University(Peking University); Chinese 973 Program(National Basic Research Program of China)	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIA (to K.-H.C. and R.-P.X.). This work was also supported by Peking University 985 Project and Chinese 973 Program (2007CB512100) (to Q.Li, G.Li, X.L., M.Z., C.-M.C, and R.-P.X).	Banai S, 1998, CIRCULATION, V97, P1960, DOI 10.1161/01.CIR.97.19.1960; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bennett MR, 1999, CARDIOVASC RES, V41, P361, DOI 10.1016/S0008-6363(98)00212-0; Bilder G, 1999, CIRCULATION, V99, P3292, DOI 10.1161/01.CIR.99.25.3292; BOCHATONPIALLAT ML, 1995, AM J PATHOL, V146, P1059; Braun-Dullaeus RC, 1998, CIRCULATION, V98, P82, DOI 10.1161/01.CIR.98.1.82; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Durand E, 2002, J AM COLL CARDIOL, V39, P1680, DOI 10.1016/S0735-1097(02)01831-4; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; FORRESTER JS, 1991, J AM COLL CARDIOL, V17, P758, DOI 10.1016/S0735-1097(10)80196-2; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Guthikonda S, 1999, CURR OPIN CARDIOL, V14, P283, DOI 10.1097/00001573-199907000-00002; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hu YH, 2000, J MED CHEM, V43, P3045, DOI 10.1021/jm000117y; Huang J, 2005, ARTERIOSCL THROM VAS, V25, P354, DOI 10.1161/01.ATV.0000151619.54108.a5; ITOH H, 1993, J CLIN INVEST, V91, P2268, DOI 10.1172/JCI116454; Kasof GM, 2000, FEBS LETT, V473, P285, DOI 10.1016/S0014-5793(00)01473-3; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kenagy RD, 1997, CIRCULATION, V96, P3555; Malik N, 1998, CIRCULATION, V98, P1657, DOI 10.1161/01.CIR.98.16.1657; Meder D, 2005, SCIENCE, V307, P1731, DOI 10.1126/science.1110551; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Muto A, 2007, J VASC SURG, V45, p15A, DOI 10.1016/j.jvs.2007.02.061; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Novak K, 1998, NAT MED, V4, P989, DOI 10.1038/1965; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Park S, 2009, CANCER RES, V69, P4107, DOI 10.1158/0008-5472.CAN-09-0474; Pazdernik NJ, 1999, MOL CELL BIOL, V19, P6500; POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370; RAKUGI H, 1994, J CLIN INVEST, V93, P339, DOI 10.1172/JCI116965; Shigematsu K, 2000, ARTERIOSCL THROM VAS, V20, P2373, DOI 10.1161/01.ATV.20.11.2373; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; VISWANATHAN M, 1992, J CLIN INVEST, V90, P1707, DOI 10.1172/JCI116043; Vivarelli MS, 2004, J EXP MED, V200, P399, DOI 10.1084/jem.20040446; Yang HM, 2004, CIRCULATION, V110, P301, DOI 10.1161/01.CIR.0000135467.43430.16; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhou RH, 2003, ARTERIOSCL THROM VAS, V23, P2015, DOI 10.1161/01.ATV.0000095161.06906.ED	53	23	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9535	9544		10.1074/jbc.M109.071332	http://dx.doi.org/10.1074/jbc.M109.071332			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20042608	Green Published, hybrid			2022-12-25	WOS:000276165900027
J	Broutin, I; Jomain, JB; Tallet, E; van Agthoven, J; Raynal, B; Hoos, S; Kragelund, BB; Kelly, PA; Ducruix, A; England, P; Goffin, V				Broutin, Isabelle; Jomain, Jean-Baptiste; Tallet, Estelle; van Agthoven, Jan; Raynal, Bertrand; Hoos, Sylviane; Kragelund, Birthe B.; Kelly, Paul A.; Ducruix, Arnaud; England, Patrick; Goffin, Vincent			Crystal Structure of an Affinity-matured Prolactin Complexed to Its Dimerized Receptor Reveals the Topology of Hormone Binding Site 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GROWTH-HORMONE; EXTRACELLULAR DOMAIN; PLACENTAL-LACTOGEN; MODEL; ANTAGONISTS; PROTEINS; IDENTIFICATION; SOFTWARE; PROGRAM; ANALOGS	We report the first crystal structure of a 1:2 hormone.receptor complex that involves prolactin (PRL) as the ligand, at 3.8-angstrom resolution. Stable ternary complexes were obtained by generating affinity-matured PRL variants harboring an N-terminal tail from ovine placental lactogen, a closely related PRL receptor (PRLR) ligand. This structure allows one to draw up an exhaustive inventory of the residues involved at the PRL.PRLR site 2 interface, consistent with all previously reported site-directed mutagenesis data. We propose, with this description, an interaction model involving three structural components of PRL site 2 ("three-pin plug"): the conserved glycine 129 of helix alpha 3, the hydrogen bond network involving surrounding residues (glycine cavity), and the N terminus. The model provides a molecular basis for the properties of the different PRL analogs designed to date, including PRLR antagonists. Finally, comparison of our 1:2 PRL.PRLR2 structure with those of free PRL and its 1:1 complex indicates that the structure of PRL undergoes significant changes when binding the first, but not the second receptor. This suggests that the second PRLR moiety adapts to the 1:1 complex rather than the opposite. In conclusion, this structure will be a useful guiding tool for further investigations of the molecular mechanisms involved in PRLR dimerization and activation, as well as for the optimization of PRLR antagonists, an emerging class of compounds with high therapeutic potential against breast and prostate cancer.	[Broutin, Isabelle; van Agthoven, Jan; Ducruix, Arnaud] Univ Paris 05, Lab Cristallog & RMN Biol, CNRS, UMR 8015, F-75006 Paris, France; [Jomain, Jean-Baptiste; Tallet, Estelle; Kelly, Paul A.; Goffin, Vincent] Equipe PRL GH Pathophysiol, Ctr Rech Croissance & Signalisat, INSERM, U845, F-75015 Paris, France; [Jomain, Jean-Baptiste; Tallet, Estelle; Kelly, Paul A.; Goffin, Vincent] Univ Paris 05, Fac Med Site Necker, F-75015 Paris, France; [Raynal, Bertrand; Hoos, Sylviane; England, Patrick] Inst Pasteur, Dept Biol Struct & Chim, F-75015 Paris, France; [Raynal, Bertrand; Hoos, Sylviane; England, Patrick] CNRS, URA 2185, F-75015 Paris, France; [Kragelund, Birthe B.] Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, DK-2200 Copenhagen N, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Copenhagen	Goffin, V (corresponding author), INSERM, Ctr Rech Croissance & Signalisat, Fac Med Necker, U845, 156 Rue Vaugirard, F-75730 Paris 15, France.	vincent.goffin@inserm.fr	GOFFIN, Vincent/G-3322-2013; Kragelund, Birthe/M-3927-2014; Broutin, Isabelle/A-2003-2017	GOFFIN, Vincent/0000-0002-8021-3086; Kragelund, Birthe/0000-0002-7454-1761; Broutin, isabelle/0000-0001-9862-1232; ENGLAND, Patrick/0000-0001-6410-5918; raynal, Bertrand/0000-0001-5634-0408	INSERM; University Paris Descartes; Agence Nationale de la Recherche [ANR-PCV07_183953]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Descartes; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported in part by INSERM, University Paris Descartes, and the Agence Nationale de la Recherche (Grant ANR-PCV07_183953).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernichtein S, 2003, MOL CELL ENDOCRINOL, V208, P11, DOI 10.1016/S0303-7207(03)00264-8; Bernichtein S, 2003, J BIOL CHEM, V278, P35988, DOI 10.1074/jbc.M305687200; Bogorad RL, 2008, P NATL ACAD SCI USA, V105, P14533, DOI 10.1073/pnas.0800685105; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN WY, 1991, MOL ENDOCRINOL, V5, P1845, DOI 10.1210/mend-5-12-1845; CLEVENGER CV, 1995, AM J PATHOL, V146, P695; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Dagvadorj A, 2007, ENDOCRINOLOGY, V148, P3089, DOI 10.1210/en.2006-1761; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DePalatis L, 2009, PROTEIN EXPRES PURIF, V66, P121, DOI 10.1016/j.pep.2009.02.012; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Elkins PA, 2000, NAT STRUCT BIOL, V7, P808, DOI 10.1038/79047; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; Gertler A, 1996, J BIOL CHEM, V271, P24482, DOI 10.1074/jbc.271.40.24482; GINSBURG E, 1995, CANCER RES, V55, P2591; GOFFIN V, 1994, J BIOL CHEM, V269, P32598; GOFFIN V, 1992, MOL ENDOCRINOL, V6, P1381, DOI 10.1210/me.6.9.1381; Goffin V, 2005, ENDOCR REV, V26, P400, DOI 10.1210/er.2004-0016; Goffin V, 1996, ENDOCR REV, V17, P385, DOI 10.1210/er.17.4.385; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; Goffin V, 1995, PROTEIN ENG, V8, P1215, DOI 10.1093/protein/8.12.1215; Goffin V, 2006, NAT CLIN PRACT ENDOC, V2, P571, DOI 10.1038/ncpendmet0270; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Jomain JB, 2007, J BIOL CHEM, V282, P33118, DOI 10.1074/jbc.M704364200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kinet S, 1999, J BIOL CHEM, V274, P26033, DOI 10.1074/jbc.274.37.26033; Kopchick JJ, 2002, ENDOCR REV, V23, P623, DOI 10.1210/er.2001-0022; KOSSIAKOFF AA, 1994, PROTEIN SCI, V3, P1697, DOI 10.1002/pro.5560031008; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NICOLL CS, 1986, ENDOCR REV, V7, P169, DOI 10.1210/edrv-7-2-169; PARIS N, 1990, BIOTECHNOL APPL BIOC, V12, P436; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Read RJ, 2009, ACTA CRYSTALLOGR D, V65, P140, DOI 10.1107/S0907444908041085; ROZAKISADCOCK M, 1991, J BIOL CHEM, V266, P16472; ROZAKISADCOCK M, 1992, J BIOL CHEM, V267, P7428; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Svensson LA, 2008, J BIOL CHEM, V283, P19085, DOI 10.1074/jbc.M801202200; Teilum K, 2005, J MOL BIOL, V351, P810, DOI 10.1016/j.jmb.2005.06.042; Walsh STR, 2003, PROTEIN SCI, V12, P1960, DOI 10.1110/ps.03133903; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1	47	45	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8422	8433		10.1074/jbc.M109.089128	http://dx.doi.org/10.1074/jbc.M109.089128			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20053995	Green Published, hybrid			2022-12-25	WOS:000275413800057
J	Agarwal, S; Mishra, NK; Bhatnagar, S; Bhatnagar, R				Agarwal, Shivangi; Mishra, Neeraj Kumar; Bhatnagar, Sonika; Bhatnagar, Rakesh			PemK Toxin of Bacillus anthracis Is a Ribonuclease AN INSIGHT INTO ITS ACTIVE SITE, STRUCTURE, AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA INTERFERASE; ESCHERICHIA-COLI; STRESSFUL CONDITIONS; ANTITOXIN SYSTEMS; CATALYTIC SITE; CELL-DEATH; PROTEIN; MAZEF; ENDORIBONUCLEASE; GENOME	Bacillus anthracis genome harbors a toxin-antitoxin (TA) module encoding pemI (antitoxin) and pemK (toxin). This study describes the rPemK as a potent ribonuclease with a preference for pyrimidines (C/U), which is consistent with our previous study that demonstrated it as a translational attenuator. The in silico structural modeling of the PemK in conjunction with the site-directed mutagenesis confirmed the role of His-59 and Glu-78 as an acid-base couple in mediating the ribonuclease activity. The rPemK is shown to form a complex with the rPemI, which is in line with its function as a TA module. This rPemI-rPemK complex becomes catalytically inactive when both the proteins interact in a molar stoichiometry of 1. The rPemI displays vulnerability to proteolysis but attains conformational stability only upon rPemK interaction. The pemI-pemK transcript is shown to be up-regulated upon stress induction with a concomitant increase in the amount of PemK and a decline in the PemI levels, establishing the role of these modules in stress. The artificial perturbation of TA interaction could unleash the toxin, executing bacterial cell death. Toward this end, synthetic peptides are designed to disrupt the TA interaction. The peptides are shown to be effective in abrogating TA interaction in micromolar range in vitro. This approach can be harnessed as a potential antibacterial strategy against anthrax in the future.	[Agarwal, Shivangi; Bhatnagar, Rakesh] Jawaharlal Nehru Univ, Lab Mol Biol & Genet Engn, Sch Biotechnol, New Delhi 110067, India; [Mishra, Neeraj Kumar] Jawaharlal Nehru Univ, Biophys Chem Lab, Sch Biotechnol, New Delhi 110067, India; [Bhatnagar, Sonika] Netaji Subhas Inst Technol, Div Biotechnol, New Delhi 110078, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Netaji Subhas University of Technology	Bhatnagar, R (corresponding author), Jawaharlal Nehru Univ, Lab Mol Biol & Genet Engn, Sch Biotechnol, New Delhi 110067, India.	rakbhat01@yahoo.com		Agarwal, Shivangi/0000-0002-2406-7678; Bhatnagar, Sonika/0000-0002-8818-4240; Mishra, Neeraj/0000-0002-6762-1747	Department of Biotechnology, Delhi, India	Department of Biotechnology, Delhi, India	This work was supported by the Department of Biotechnology, Delhi, India.	Agarwal S, 2007, FEBS LETT, V581, P1727, DOI 10.1016/j.febslet.2007.03.051; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Condon C, 2006, MOL MICROBIOL, V61, P573, DOI 10.1111/j.1365-2958.2006.05270.x; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Fu ZB, 2007, J BACTERIOL, V189, P8871, DOI 10.1128/JB.01272-07; Galvani C, 2001, J BACTERIOL, V183, P2700, DOI 10.1128/JB.183.8.2700-2703.2001; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kamphuis MB, 2006, J MOL BIOL, V357, P115, DOI 10.1016/j.jmb.2005.12.033; Kamphuis MB, 2007, PROTEIN PEPTIDE LETT, V14, P113, DOI 10.2174/092986607779816096; Kedzierska B, 2007, NUCLEIC ACIDS RES, V35, P325, DOI 10.1093/nar/gkl1028; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemos JAC, 2005, FEMS MICROBIOL LETT, V253, P251, DOI 10.1016/j.femsle.2005.09.045; Li GY, 2006, J MOL BIOL, V357, P139, DOI 10.1016/j.jmb.2005.12.035; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Melvin I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S2; Mittenhuber Gerhard, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P295; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Munoz-Gomez AJ, 2004, FEBS LETT, V567, P316, DOI 10.1016/j.febslet.2004.05.005; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Park S, 2008, ARCH MICROBIOL, V189, P541, DOI 10.1007/s00203-007-0341-7; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pellegrini O, 2005, MOL MICROBIOL, V56, P1139, DOI 10.1111/j.1365-2958.2005.04606.x; Pimentel B, 2005, EMBO J, V24, P3459, DOI 10.1038/sj.emboj.7600815; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Tachdjian S, 2006, J BACTERIOL, V188, P4553, DOI 10.1128/JB.00080-06; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tippmann HF, 2004, BRIEF BIOINFORM, V5, P82, DOI 10.1093/bib/5.1.82; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; TSUCHIMOTO S, 1992, J BACTERIOL, V174, P4205, DOI 10.1128/JB.174.13.4205-4211.1992; Vetter SM, 2005, ANTIMICROB AGENTS CH, V49, P1302, DOI 10.1128/AAC.49.4.1302-1305.2005; Wang NR, 2007, ANAL BIOCHEM, V371, P173, DOI 10.1016/j.ab.2007.07.017; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	43	45	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7254	7270		10.1074/jbc.M109.073387	http://dx.doi.org/10.1074/jbc.M109.073387			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20022964	Green Published, hybrid			2022-12-25	WOS:000275415600038
J	Schreiber, R; Uliyakina, I; Kongsuphol, P; Warth, R; Mirza, M; Martins, JR; Kunzelmann, K				Schreiber, Rainer; Uliyakina, Inna; Kongsuphol, Patthara; Warth, Richard; Mirza, Myriam; Martins, Joana R.; Kunzelmann, Karl			Expression and Function of Epithelial Anoctamins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CHLORIDE CHANNELS; ION-TRANSPORT; PROTEIN; CELLS; TMEM16A; BESTROPHIN; COMPLEX; CANCER	The calcium-activated chloride channel anoctamin1 (ANO1; TMEM16A) is fundamental for the function of epithelial organs. Mice lacking ANO1 expression exhibit transport defects and a pathology similar to cystic fibrosis. They also show a general defect of epithelial electrolyte transport. Here we analyzed expression of all ten members (ANO1-ANO10) in a broad range of murine tissues and detected predominant expression of ANO1, 6, 7, 8, 9, 10 in epithelial tissues, while ANO2, 3, 4, 5 are common in neuronal and muscle tissues. When expressed in Fisher Rat Thyroid (FTR) cells, all ANO proteins localized to the plasma membrane but only ANO1, 2, 6, and 7 produced Ca2+ activated Cl- conductance, as analyzed by ATP-induced iodide quenching of YFP fluorescence. In contrast ANO9 and ANO10 suppressed baseline Cl- conductance and coexpression of ANO9 with ANO1 inhibited ANO1 activity. Patch clamping of ANO-expressing FRT cells indicated that apart from ANO1 also ANO6 and 10 produced chloride currents, albeit with very different Ca2+ sensitivity and activation time. We conclude that each tissue expresses a set of anoctamins that form cell- and tissue-specific Ca2+-dependent Cl- channels.	[Schreiber, Rainer; Uliyakina, Inna; Kongsuphol, Patthara; Warth, Richard; Mirza, Myriam; Martins, Joana R.; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany	University of Regensburg	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	Karl.Kunzelmann@vkl.uni-regensburg.de	Martins, Joana/L-2965-2016; Warth, Richard/N-7119-2014	Martins, Joana/0000-0002-3784-9775; Warth, Richard/0000-0001-6084-0659; Kunzelmann, Karl/0000-0002-4583-7037; Uliyakina, Inna/0000-0002-7091-2123	Deutsche Forschungsgemeinschaft [DFG KU 756/8-1, DFG SFB699 A6, A7]; TargetScreen [EU-FP6-2005-LH-037365]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TargetScreen	This work was supported by Deutsche Forschungsgemeinschaft DFG KU 756/8-1, DFG SFB699 A6 and A7, and TargetScreen (EU-FP6-2005-LH-037365).	Aldehni F, 2009, J AM SOC NEPHROL, V20, P1556, DOI 10.1681/ASN.2008090987; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Galietta LJV, 2002, J IMMUNOL, V168, P839, DOI 10.4049/jimmunol.168.2.839; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Galindo BE, 2005, INT J MOL MED, V16, P919; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Heitzmann D, 2008, PHYSIOL REV, V88, P1119, DOI 10.1152/physrev.00020.2007; Kidd JF, 2000, ANNU REV PHYSIOL, V62, P493, DOI 10.1146/annurev.physiol.62.1.493; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Leblanc N, 2005, CAN J PHYSIOL PHARM, V83, P541, DOI 10.1139/Y05-040; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Rochelle LG, 2000, AM J PHYSIOL-LUNG C, V279, pL14, DOI 10.1152/ajplung.2000.279.1.L14; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Soria RB, 2009, J BIOL CHEM, V284, P29405, DOI 10.1074/jbc.M605716200; Spitzner M, 2008, J BIOL CHEM, V283, P7421, DOI 10.1074/jbc.M703758200; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	28	172	195	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7838	7845		10.1074/jbc.M109.065367	http://dx.doi.org/10.1074/jbc.M109.065367			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056604	hybrid, Green Published			2022-12-25	WOS:000275415600091
J	Simao, AMS; Yadav, MC; Narisawa, S; Bolean, M; Pizauro, JM; Hoylaerts, MF; Ciancaglini, P; Millan, JL				Simao, Ana Maria S.; Yadav, Manisha C.; Narisawa, Sonoko; Bolean, Mayte; Pizauro, Joao Martins; Hoylaerts, Marc F.; Ciancaglini, Pietro; Millan, Jose Luis			Proteoliposomes Harboring Alkaline Phosphatase and Nucleotide Pyrophosphatase as Matrix Vesicle Biomimetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT OSSEOUS PLATE; CELL MEMBRANE GLYCOPROTEIN-1; GPI-ANCHORED PROTEIN; MOTILITY-STIMULATING PROTEIN; ATP-INITIATED CALCIFICATION; AIR-WATER-INTERFACE; INORGANIC PYROPHOSPHATE; GROWTH-PLATE; CALCIUM PYROPHOSPHATE; EPIPHYSEAL CARTILAGE	We have established a proteoliposome system as an osteoblast-derived matrix vesicle (MV) biomimetic to facilitate the study of the interplay of tissue-nonspecific alkaline phosphatase (TNAP) and NPP1 (nucleotide pyrophosphatase/phosphodiesterase-1) during catalysis of biomineralization substrates. First, we studied the incorporation of TNAP into liposomes of various lipid compositions (i.e. in pure dipalmitoyl phosphatidylcholine (DPPC), DPPC/dipalmitoyl phosphatidylserine (9:1 and 8:2), and DPPC/dioctadecyl-dimethylammonium bromide (9:1 and 8:2) mixtures. TNAP reconstitution proved virtually complete in DPPC liposomes. Next, proteoliposomes containing either recombinant TNAP, recombinant NPP1, or both together were reconstituted in DPPC, and the hydrolysis of ATP, ADP, AMP, pyridoxal-5'-phosphate (PLP), p-nitrophenyl phosphate, p-nitrophenylthymidine 5'-monophosphate, and PPi by these proteoliposomes was studied at physiological pH. p-Nitrophenylthymidine 5'-monophosphate and PLP were exclusively hydrolyzed by NPP1-containing and TNAP-containing proteoliposomes, respectively. In contrast, ATP, ADP, AMP, PLP, p-nitrophenyl phosphate, and PPi were hydrolyzed by TNAP-, NPP1-, and TNAP plus NPP1- containing proteoliposomes. NPP1 plus TNAP additively hydrolyzed ATP, but TNAP appeared more active in AMP formation than NPP1. Hydrolysis of PPi by TNAP-, and TNAP plus NPP1- containing proteoliposomes occurred with catalytic efficiencies and mild cooperativity, effects comparable with those manifested by murine osteoblast-derived MVs. The reconstitution of TNAP and NPP1 into proteoliposome membranes generates a phospholipid microenvironment that allows the kinetic study of phosphosubstrate catabolism in a manner that recapitulates the native MV microenvironment.	[Simao, Ana Maria S.; Yadav, Manisha C.; Narisawa, Sonoko; Hoylaerts, Marc F.; Ciancaglini, Pietro; Millan, Jose Luis] Sanford Childrens Hlth Res Ctr, Burnham Inst Med Res, La Jolla, CA 92037 USA; [Ciancaglini, Pietro] Univ Sao Paulo, Dept Chem, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14040901 Ribeirao Preto, SP, Brazil; [Pizauro, Joao Martins] Univ Estadual Paulista, Dept Technol, Fac Ciencias Agrarias & Vet Jaboticabal, BR-14884900 Jaboticabal, SP, Brazil; [Hoylaerts, Marc F.] Univ Leuven, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium	Sanford Burnham Prebys Medical Discovery Institute; Universidade de Sao Paulo; Universidade Estadual Paulista; KU Leuven	Millan, JL (corresponding author), Sanford Childrens Hlth Res Ctr, Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	millan@burnham.org	Pizauro, João/D-3171-2012; CIANCAGLINI, PIETRO/X-7410-2019; Ciancaglini, Pietro/C-4842-2012; Bolean, Mayte/A-1484-2014	Pizauro, João/0000-0002-0911-5053; CIANCAGLINI, PIETRO/0000-0002-2785-1345; Ciancaglini, Pietro/0000-0002-2785-1345; Bolean, Mayte/0000-0002-8307-1298; Hoylaerts, Marc/0000-0002-6474-3933	National Institutes of Health [DE12889, AR47908, AR53102]; Thrasher Research Fund; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Excellentie Financiering KULeuven [EF/05/013]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047908, R01AR053102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thrasher Research Fund; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Excellentie Financiering KULeuven(KU Leuven); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE12889, AR47908, and AR53102, by a grant from the Thrasher Research Fund, and by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The Center for Molecular and Vascular Biology is supported by the "Excellentie Financiering KULeuven" (EF/05/013).	ALI SY, 1970, P NATL ACAD SCI USA, V67, P1513, DOI 10.1073/pnas.67.3.1513; Anderson HC, 1997, AM J PATHOL, V151, P1555; Anderson HC, 2005, AM J PATHOL, V166, P1711, DOI 10.1016/S0002-9440(10)62481-9; Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0; Andoh K, 1999, BBA-GENE STRUCT EXPR, V1446, P213, DOI 10.1016/S0167-4781(99)00090-1; Arien A, 1997, J MICROENCAPSUL, V14, P753, DOI 10.3109/02652049709006825; Balcerzak M, 2007, ANAL BIOCHEM, V361, P176, DOI 10.1016/j.ab.2006.10.001; Bellet-Amalric E, 2000, BBA-BIOMEMBRANES, V1467, P131, DOI 10.1016/S0005-2736(00)00218-2; BELLI SI, 1993, EUR J BIOCHEM, V217, P421, DOI 10.1111/j.1432-1033.1993.tb18261.x; Benatti CR, 2007, CHEM PHYS LIPIDS, V145, P27, DOI 10.1016/j.chemphyslip.2006.10.002; Benatti CR, 2001, CHEM PHYS LIPIDS, V111, P93, DOI 10.1016/S0009-3084(01)00134-7; BERNARD GW, 1978, CLIN ORTHOP RELAT R, P218; Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; Boskey A. L., 2006, DYNAMICS BONE CARTIL, P201; Camolezi FL, 2002, INT J BIOCHEM CELL B, V1282, P1; CARRUTHERS A, 1986, TRENDS BIOCHEM SCI, V11, P331, DOI 10.1016/0968-0004(86)90292-6; Ciancaglini P, 2006, BRAZ J MED BIOL RES, V39, P603, DOI 10.1590/S0100-879X2006000500006; CIANCAGLINI P, 1990, INT J BIOCHEM, V22, P385, DOI 10.1016/0020-711X(90)90141-O; CIANCAGLINI P, 2010, J BONE MINER RES, DOI DOI 10.1359/JBMR.091023; CURTI C, 1986, CELL MOL BIOL, V32, P55; Damek-Poprawa M, 2006, BIOCHEMISTRY-US, V45, P3325, DOI 10.1021/bi0515927; Demenis MA, 2000, IUBMB LIFE, V49, P113; Di Mauro S, 2002, J BONE MINER RES, V17, P1383, DOI 10.1359/jbmr.2002.17.8.1383; EANES ED, 1989, ANAT REC, V224, P220, DOI 10.1002/ar.1092240211; EANES ED, 1985, CALCIFIED TISSUE INT, V37, P390, DOI 10.1007/BF02553708; FALLON MD, 1980, LAB INVEST, V43, P489; Frittitta L, 1999, J CLIN ENDOCR METAB, V84, P3620, DOI 10.1210/jc.84.10.3620; Gijsbers R, 2003, BIOCHEM J, V371, P321, DOI 10.1042/BJ20021943; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Hashimoto S, 1998, P NATL ACAD SCI USA, V95, P3094, DOI 10.1073/pnas.95.6.3094; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hosoda N, 1999, EUR J BIOCHEM, V265, P763, DOI 10.1046/j.1432-1327.1999.00779.x; Hoylaerts MF, 1997, J BIOL CHEM, V272, P22781, DOI 10.1074/jbc.272.36.22781; Hsu HHT, 1996, J BIOL CHEM, V271, P26383, DOI 10.1074/jbc.271.42.26383; Hsu HHT, 1999, BBA-BIOMEMBRANES, V1416, P320, DOI 10.1016/S0005-2736(98)00235-1; HUANG R, 1994, J CLIN INVEST, V94, P560, DOI 10.1172/JCI117370; Ierardi DF, 2002, BBA-BIOMEMBRANES, V1567, P183, DOI 10.1016/S0005-2736(02)00615-6; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Johnson K, 1999, J BONE MINER RES, V14, P883, DOI 10.1359/jbmr.1999.14.6.883; Johnson KA, 2000, AM J PHYSIOL-REG I, V279, pR1365, DOI 10.1152/ajpregu.2000.279.4.R1365; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; Kirsch T, 2003, J BONE MINER RES, V18, P1872, DOI 10.1359/jbmr.2003.18.10.1872; KUNITAKE T, 1977, CHEM LETT, P387, DOI 10.1246/cl.1977.387; Lehto MT, 2002, BIOCHEMISTRY-US, V41, P1398, DOI 10.1021/bi011579w; Lehto MT, 2002, BIOCHEMISTRY-US, V41, P8368, DOI 10.1021/bi012038+; Leone F.A., 1997, TRENDS COMP BIOCH PH, V3, P57; Leone FA, 2005, BIOCHEM MOL BIOL EDU, V33, P399, DOI 10.1002/bmb.2005.49403306399; Leone FA, 1998, INT J BIOCHEM CELL B, V30, P89, DOI 10.1016/S1357-2725(97)00077-0; Letho MT, 1998, BIOCHEM J, V332, P101, DOI 10.1042/bj3320101; Liu C, 1999, BLOOD, V93, P2297, DOI 10.1182/blood.V93.7.2297.407k19_2297_2301; MAJESKA RJ, 1975, BIOCHIM BIOPHYS ACTA, V391, P51, DOI 10.1016/0005-2744(75)90151-5; Meerson NR, 1998, HEPATOLOGY, V27, P563, DOI 10.1002/hep.510270234; MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4; MICANOVIC R, 1988, P NATL ACAD SCI USA, V85, P1398, DOI 10.1073/pnas.85.5.1398; MILLAN JL, 1986, J BIOL CHEM, V261, P3112; MilluYn JL., 2006, MAMMALIAN ALKALINE P, DOI 10.1002/3527608060; MORRIS DC, 1992, BONE MINER, V19, P287, DOI 10.1016/0169-6009(92)90877-G; MOSS DW, 1967, BIOCHEM J, V102, P53, DOI 10.1042/bj1020053; MURATA J, 1994, J BIOL CHEM, V269, P30479; Murphy WL, 2000, POLYHEDRON, V19, P357, DOI 10.1016/S0277-5387(99)00366-6; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; New R.R., 1990, LIPOSOMES PRACTICAL; PIZAURO JM, 1987, COMP BIOCHEM PHYS B, V87, P921, DOI 10.1016/0305-0491(87)90413-5; Pizauro JM, 1995, MOL CELL BIOCHEM, V152, P121, DOI 10.1007/BF01076074; PRASAD R, 1996, MANUAL MEMBRANE LIPI; REZENDE AA, 1994, BIOCHEM J, V301, P517, DOI 10.1042/bj3010517; Rezende LA, 1998, CELL MOL BIOL, V44, P293; Roberts S, 2007, J BONE MINER RES, V22, P617, DOI 10.1359/JBMR.070108; Robison R, 1923, BIOCHEM J, V17, P286, DOI 10.1042/bj0170286; Ronzon F, 2002, BBA-BIOMEMBRANES, V1560, P1, DOI 10.1016/S0005-2736(01)00405-9; SAY JC, 1991, BIOCHIM BIOPHYS ACTA, V1074, P256, DOI 10.1016/0304-4165(91)90161-9; Sela J, 2000, CRIT REV ORAL BIOL M, V11, P423, DOI 10.1177/10454411000110040301; Sergienko E, 2009, J BIOMOL SCREEN, V14, P824, DOI 10.1177/1087057109338517; Sesana S, 2008, BIOCHEMISTRY-US, V47, P5433, DOI 10.1021/bi800005s; Sharom FJ, 1996, BIOCHEM CELL BIOL, V74, P701, DOI 10.1139/o96-077; Simao AMS, 2007, COMP BIOCHEM PHYS A, V146, P679, DOI 10.1016/j.cbpa.2006.05.008; STORCH J, 1985, TRENDS BIOCHEM SCI, V10, P418, DOI 10.1016/0968-0004(85)90021-0; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; TERKELTAUB R, 1994, ARTHRITIS RHEUM, V37, P934, DOI 10.1002/art.1780370624; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Wu LNY, 2002, J BIOL CHEM, V277, P5126, DOI 10.1074/jbc.M107899200; Wu LNY, 1997, J BIOL CHEM, V272, P4404, DOI 10.1074/jbc.272.7.4404; Xiao Z, 2007, J CELL PHYSIOL, V210, P325, DOI 10.1002/jcp.20826	84	40	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7598	7609		10.1074/jbc.M109.079830	http://dx.doi.org/10.1074/jbc.M109.079830			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048161	Green Published, hybrid			2022-12-25	WOS:000275415600071
J	Holzel, M; Orban, M; Hochstatter, J; Rohrmoser, M; Harasim, T; Malamoussi, A; Kremmer, E; Langst, G; Eick, D				Holzel, Michael; Orban, Mathias; Hochstatter, Julia; Rohrmoser, Michaela; Harasim, Thomas; Malamoussi, Anastassia; Kremmer, Elisabeth; Langst, Gernot; Eick, Dirk			Defects in 18 S or 28 S rRNA Processing Activate the p53 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOLAR DISRUPTION; CELL-CYCLE; PROTEIN; BIOGENESIS; TRANSCRIPTION; STABILIZATION; INHIBITION; HDM2; MDM2	The p53 tumor suppressor pathway is activated by defective ribosome synthesis. Ribosomal proteins are released from the nucleolus and block human double minute-2 (Hdm2) that targets p53 for degradation. However, it remained elusive how abrogation of individual rRNA processing pathways contributes to p53 stabilization. Here, we show that selective inhibition of 18 S rRNA processing provokes accumulation of p53 as efficiently as abrogated 28 S rRNA maturation. We describe hUTP18 as a novel mammalian rRNA processing factor that is specifically involved in 18 S rRNA production. hUTP18 was essential for the cleavage of the 5'-external transcribed spacer leader sequence from the primary polymerase I transcript, but was dispensable for rRNA transcription. Because maturation of the 28 S rRNA was unaffected in hUTP18-depleted cells, our results suggest that the integrity of both the 18 S and 28 S rRNA synthesis pathways can be monitored independently by the p53 pathway. Interestingly, accumulation of p53 after hUTP18 knock down required the ribosomal protein L11. Therefore, cells survey the maturation of the small and large ribosomal subunits by separate molecular routes, which may merge in an L11-dependent signaling pathway for p53 stabilization.	[Malamoussi, Anastassia; Eick, Dirk] Ctr Integrated Prot Sci, Inst Clin Mol Biol & Tumour Genet, D-85758 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, D-85758 Munich, Germany; [Hochstatter, Julia] Univ Munich, Inst Biochem, D-280539 Munich, Germany; [Langst, Gernot] Univ Regensburg, D-93047 Regensburg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Regensburg	Holzel, M (corresponding author), Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.holzel@nki.nl; eick@helmholtz-muenchen.de	Längst, Gernot/G-5287-2015; Orban, Mathias/AAS-8461-2020	Längst, Gernot/0000-0002-8232-1179; Orban, Mathias/0000-0001-7846-8808; Groth, Julia/0000-0002-7676-6964	Deutsche Forschungsgemeinschaft [SFB684, SFB-Transregio5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB684, SFB-Transregio5.	Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Grimm T, 2006, NUCLEIC ACIDS RES, V34, P3030, DOI 10.1093/nar/gkl378; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Staub E, 2004, BIOESSAYS, V26, P567, DOI 10.1002/bies.20032; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	20	51	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6364	6370		10.1074/jbc.M109.054734	http://dx.doi.org/10.1074/jbc.M109.054734			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20056613	Green Published, hybrid			2022-12-25	WOS:000275367500040
J	Lei, XY; Zhang, S; Barbour, SE; Bohrer, A; Ford, EL; Koizumi, A; Papa, FR; Ramanadham, S				Lei, Xiaoyong; Zhang, Sheng; Barbour, Suzanne E.; Bohrer, Alan; Ford, Eric L.; Koizumi, Akio; Papa, Feroz R.; Ramanadham, Sasanka			Spontaneous Development of Endoplasmic Reticulum Stress That Can Lead to Diabetes Mellitus Is Associated with Higher Calcium-independent Phospholipase A(2) Expression A ROLE FOR REGULATION BY SREBP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; NITRIC-OXIDE SYNTHASE; ELEMENT-BINDING PROTEIN-1; CYTOCHROME-C RELEASE; FATTY-ACID SYNTHASE; ER STRESS; INSULINOMA CELLS; CERAMIDE GENERATION; INDUCED APOPTOSIS; MOUSE MODEL	Our recent studies indicate that endoplasmic reticulum (ER) stress causes INS-1 cell apoptosis by a Ca2+-independent phospholipase A(2) (iPLA(2)beta)-mediated mechanism that promotes ceramide generation via sphingomyelin hydrolysis and subsequent activation of the intrinsic pathway. To elucidate the association between iPLA(2)beta and ER stress, we compared beta-cell lines generated from wild type (WT) and Akita mice. The Akita mouse is a spontaneous model of ER stress that develops hyperglycemia/diabetes due to ER stress-induced beta-cell apoptosis. Consistent with a predisposition to developing ER stress, basal phosphorylated PERK and activated caspase-3 are higher in the Akita cells than WT cells. Interestingly, basal iPLA(2)beta, mature SREBP-1 (mSREBP-1), phosphorylated Akt, and neutral sphingomyelinase (NSMase) are higher, relative abundances of sphingomyelins are lower, and mitochondrial membrane potential (Delta Psi) is compromised in Akita cells, in comparison with WT cells. Exposure to thapsigargin accelerates Delta Psi loss and apoptosis of Akita cells and is associated with increases in iPLA(2)beta, mSREBP-1, and NSMase in both WT and Akita cells. Transfection of Akita cells with iPLA(2)beta small interfering RNA, however, suppresses NSMase message, Delta Psi loss, and apoptosis. The iPLA(2)beta gene contains a sterol-regulatory element, and transfection with a dominant negative SREBP-1 reduces basal mSREBP-1 and iPLA(2)beta in the Akita cells and suppresses increases in mSREBP-1 and iPLA(2)beta due to thapsigargin. These findings suggest that ER stress leads to generation of mSREBP-1, which can bind to the sterol-regulatory element in the iPLA(2)beta gene to promote its transcription. Consistent with this, SREBP-1, iPLA(2)beta, and NSMase messages in Akita mouse islets are higher than in WT islets.	[Lei, Xiaoyong; Zhang, Sheng; Bohrer, Alan; Ford, Eric L.; Ramanadham, Sasanka] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Barbour, Suzanne E.] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Koizumi, Akio] Kyoto Grad Sch Med, Dept Hlth & Environm Sci, Kyoto 6068501, Japan; [Papa, Feroz R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	Washington University (WUSTL); Virginia Commonwealth University; Kyoto University; University of California System; University of California San Francisco	Ramanadham, S (corresponding author), Washington Univ, Sch Med, Dept Med, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	sramanad@dom.wustl.edu		Papa, Feroz/0000-0002-3684-9108	National Institutes of Health [R01-DK69455, P41-RR00954, P60-DK20579, P30-DK56341, DK065671]; American Diabetes Association; National Science Foundation [NSFMCB-0544068]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069455, K08DK065671, P30DK056341, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK69455, P41-RR00954, P60-DK20579, P30-DK56341, and DK065671. This work was also supported by a grant from the American Diabetes Association (to S. R.) and National Science Foundation Grant NSFMCB-0544068 (to S. E. B.).	Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Bernard C, 1999, FASEB J, V13, P1195, DOI 10.1096/fasebj.13.10.1195; Boilard E, 2001, J BIOL CHEM, V276, P17568, DOI 10.1074/jbc.M006152200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; CORBETT JA, 1992, DIABETES, V41, P897, DOI 10.2337/diabetes.41.8.897; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Diaz-Horta O, 2002, DIABETES, V51, P1815, DOI 10.2337/diabetes.51.6.1815; Fonseca SG, 2005, J BIOL CHEM, V280, P39609, DOI 10.1074/jbc.M507426200; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P437, DOI 10.1016/S1044-0305(99)00150-6; Isenovic E, 2000, HYPERTENSION, V35, P249, DOI 10.1161/01.HYP.35.1.249; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kayo T, 1998, J CLIN INVEST, V101, P2112, DOI 10.1172/JCI1842; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; KRONCKE KD, 1993, BIOCHIM BIOPHYS ACTA, V1182, P221, DOI 10.1016/0925-4439(93)90144-P; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Ma ZM, 2001, J BIOL CHEM, V276, P13198, DOI 10.1074/jbc.M010423200; Ma ZM, 1997, J BIOL CHEM, V272, P11118; Maggi LB, 2002, J BIOL CHEM, V277, P38449, DOI 10.1074/jbc.M206247200; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; Mathews CE, 2002, TRANSPLANTATION, V73, P1333, DOI 10.1097/00007890-200204270-00024; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200; Nozaki J, 2004, GENES CELLS, V9, P261, DOI 10.1111/j.1356-9597.2004.00721.x; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ramanadham S, 2003, BIOCHEMISTRY-US, V42, P13929, DOI 10.1021/bi034843p; Ramanadham S, 1999, J BIOL CHEM, V274, P13915, DOI 10.1074/jbc.274.20.13915; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; SATO R, 1994, J BIOL CHEM, V269, P17267; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schmidt RE, 2009, EXP NEUROL, V216, P207, DOI 10.1016/j.expneurol.2008.11.019; Seashols SJ, 2004, BBA-MOL CELL BIOL L, V1684, P29, DOI 10.1016/j.bbalip.2004.05.003; Socha L, 2003, ANN NY ACAD SCI, V1005, P178, DOI 10.1196/annals.1288.022; STEFAN Y, 1982, DIABETES, V31, P694, DOI 10.2337/diabetes.31.8.694; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; Tanaka H, 2000, BIOCHEM BIOPH RES CO, V272, P320, DOI 10.1006/bbrc.2000.2776; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Tithof PK, 2000, TOXICOL SCI, V53, P40, DOI 10.1093/toxsci/53.1.40; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wang ZP, 2005, J BIOL CHEM, V280, P6840, DOI 10.1074/jbc.M405287200; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Williams SD, 2001, AM J PHYSIOL-HEART C, V281, pH168, DOI 10.1152/ajpheart.2001.281.1.H168; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887	70	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6693	6705		10.1074/jbc.M109.084293	http://dx.doi.org/10.1074/jbc.M109.084293			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032468	hybrid, Green Published			2022-12-25	WOS:000275367500073
J	Boles, NC; Peddibhotla, S; Chen, AJ; Goodell, MA; Rosen, JM				Boles, Nathan C.; Peddibhotla, Sirisha; Chen, Alice J.; Goodell, Margaret A.; Rosen, Jeffrey M.			Chk1 Haploinsufficiency Results in Anemia and Defective Erythropoiesis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CELL-CYCLE; KINASE; DIFFERENTIATION; ENUCLEATION; ACTIVATION; MATURATION; INSIGHTS; GENES	Background: Erythropoiesis is a highly regulated and well-characterized developmental process responsible for providing the oxygen transport system of the body. However, few of the mechanisms involved in this process have been elucidated. Checkpoint Kinase 1 (Chk1) is best known for its role in the cell cycle and DNA damage pathways, and it has been shown to play a part in several pathways which when disrupted can lead to anemia. Methodology/Principal Findings: Here, we show that haploinsufficiency of Chk1 results in 30% of mice developing anemia within the first year of life. The anemic Chk1+/- mice exhibit distorted spleen and bone marrow architecture, and abnormal erythroid progenitors. Furthermore, Chk1+/- erythroid progenitors exhibit an increase in spontaneous DNA damage foci and improper contractile actin ring formation resulting in aberrant enucleation during erythropoiesis. A decrease in Chk1 RNA has also been observed in patients with refractory anemia with excess blasts, further supporting a role for Chk1 in clinical anemia. Conclusions/Significance: Clinical trials of Chk1 inhibitors are currently underway to treat cancer, and thus it will be important to track the effects of these drugs on red blood cell development over an extended period. Our results support a role for Chk1 in maintaining the balance between erythroid progenitors and enucleated erythroid cells during differentiation. We show disruptions in Chk1 levels can lead to anemia.	[Boles, Nathan C.; Peddibhotla, Sirisha] Baylor Coll Med, Interdepartmental Program Cell & Mol Biol, Houston, TX 77030 USA; [Chen, Alice J.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Goodell, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Rosen, Jeffrey M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Boles, NC (corresponding author), Baylor Coll Med, Interdepartmental Program Cell & Mol Biol, Houston, TX 77030 USA.	goodell@bcm.edu; jrosen@bcm.edu		Goodell, Margaret A./0000-0003-1111-2932	National Institutes of Health [CA16303(JMR), DK58192 (MAG), HL08100 (MAG)]; Department of Defense Biomedical Research Commercialization Program [W81XWH-06-1-0305]; Ellison foundation [AGSS178706]; NATIONAL CANCER INSTITUTE [R01CA016303, R37CA016303, P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Biomedical Research Commercialization Program; Ellison foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health CA16303(JMR), DK58192 (MAG), HL08100 (MAG), Department of Defense Biomedical Research Commercialization Program W81XWH-06-1-0305 (SP), and the Ellison foundation (AGSS178706 to MAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams James David, 2006, Chin Med, V1, P3, DOI 10.1186/1749-8546-1-3; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; CHALLEN G, 2008, CYTOMETRY IN PRESS; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Clark AJ, 2004, BLOOD, V104, P1324, DOI 10.1182/blood-2004-02-0618; Dirlam A, 2007, MOL CELL BIOL, V27, P8713, DOI 10.1128/MCB.01118-07; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Enders GH, 2008, J BIOL CHEM, V283, P17749, DOI 10.1074/jbc.R800021200; Groth A, 2003, EMBO J, V22, P1676, DOI 10.1093/emboj/cdg151; Guervilly JH, 2008, HUM MOL GENET, V17, P679, DOI 10.1093/hmg/ddm340; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kruse A, 2008, CONTRIB NEPHROL, V161, P247, DOI 10.1159/000130698; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Liu QH, 2000, GENE DEV, V14, P1448; Matsuura K, 2008, J BIOL CHEM, V283, P25485, DOI 10.1074/jbc.M803111200; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; PEDDIBHOTLA S, 2009, CELL CYCLE IN PRESS; Peddibhotla S, 2009, P NATL ACAD SCI USA, V106, P5159, DOI 10.1073/pnas.0806671106; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Peller S, 2003, ONCOGENE, V22, P4648, DOI 10.1038/sj.onc.1206541; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Shimada M, 2008, CELL CYCLE, V7, P1555, DOI 10.4161/cc.7.11.6062; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432; Takagaki K, 2005, GENES CELLS, V10, P97, DOI 10.1111/j.1365-2443.2005.00821.x; TakanoOhmuro H, 1996, CELL MOTIL CYTOSKEL, V34, P95, DOI 10.1002/(SICI)1097-0169(1996)34:2<95::AID-CM2>3.0.CO;2-H; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zaugg K, 2007, P NATL ACAD SCI USA, V104, P3805, DOI 10.1073/pnas.0611584104; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247	37	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8581	10.1371/journal.pone.0008581	http://dx.doi.org/10.1371/journal.pone.0008581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052416	Green Published, gold, Green Submitted			2022-12-25	WOS:000273338500023
J	Friswell, MK; Gika, H; Stratford, IJ; Theodoridis, G; Telfer, B; Wilson, ID; McBain, AJ				Friswell, Melissa K.; Gika, Helen; Stratford, Ian J.; Theodoridis, Georgios; Telfer, Brian; Wilson, Ian D.; McBain, Andrew J.			Site and Strain-Specific Variation in Gut Microbiota Profiles and Metabolism in Experimental Mice	PLOS ONE			English	Article							REAL-TIME PCR; ANTIBIOTIC-INDUCED ALTERATIONS; HUMAN INTESTINAL MICROBIOTA; FECAL MICROBIOTA; GASTROINTESTINAL-TRACT; HOST GENETICS; MICROFLORA; COMMENSAL; BACTERIA; DISEASE	Background: The gastrointestinal tract microbiota (GTM) of mammals is a complex microbial consortium, the composition and activities of which influences mucosal development, immunity, nutrition and drug metabolism. It remains unclear whether the composition of the dominant GTM is conserved within animals of the same strain and whether stable GTMs are selected for by host-specific factors or dictated by environmental variables. Methodology/Principal Findings: The GTM composition of six highly inbred, genetically distinct strains of mouse (C3H, C57, GFEC, CD1, CBA nu/nu and SCID) was profiled using eubacterial -specific PCR-DGGE and quantitative PCR of feces. Animals exhibited strain-specific fecal eubacterial profiles that were highly stable (c. >95% concordance over 26 months for C57). Analyses of mice that had been relocated before and after maturity indicated marked, reproducible changes in fecal consortia and that occurred only in young animals. Implantation of a female BDF1 mouse with genetically distinct (C57 and Agoutie) embryos produced highly similar GTM profiles (c. 95% concordance) between mother and offspring, regardless of offspring strain, which was also reflected in urinary metabolite profiles. Marked institution-specific GTM profiles were apparent in C3H mice raised in two different research institutions. Conclusion/Significance: Strain-specific data were suggestive of genetic determination of the composition and activities of intestinal symbiotic consortia. However, relocation studies and uterine implantation demonstrated the dominance of environmental influences on the GTM. This was manifested in large variations between isogenic adult mice reared in different research institutions.	[Friswell, Melissa K.; McBain, Andrew J.] Univ Manchester, Sch Pharm & Pharmaceut Sci, Microbiol Res Grp, Manchester, Lancs, England; [Stratford, Ian J.; Telfer, Brian] Univ Manchester, Sch Pharm & Pharmaceut Sci, Expt Oncol Res Grp, Manchester, Lancs, England; [Gika, Helen; Theodoridis, Georgios; Wilson, Ian D.] AstraZeneca, Dept Clin Pharmacol, Macclesfield, Cheshire, England; [Gika, Helen; Theodoridis, Georgios] Aristotle Univ Thessaloniki, Dept Chem, GR-54006 Thessaloniki, Greece	University of Manchester; University of Manchester; AstraZeneca; Aristotle University of Thessaloniki	Friswell, MK (corresponding author), Univ Manchester, Sch Pharm & Pharmaceut Sci, Microbiol Res Grp, Manchester, Lancs, England.	andrew.mcbain@manchester.ac.uk	Wilson, Ian David/ABG-4451-2021; Wilson, Ian/Z-3019-2019; Theodoridis, Georgios/B-6676-2012; Gika, Helen/I-3638-2012	Theodoridis, Georgios/0000-0002-2015-108X; Gika, Helen/0000-0002-1893-937X; Wilson, Ian/0000-0002-8558-7394; Telfer, Brian/0000-0003-1857-5120; stratford, ian/0000-0002-5222-4765; McBain, Andrew/0000-0002-5255-5425	MRC programme [G0500366]; Medical Research Council [G0500366] Funding Source: researchfish; MRC [G0500366] Funding Source: UKRI	MRC programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was partially funded by an MRC programme grant (G0500366). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AstraZeneca contributed by performing the urinary analyses.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Cash HL, 2005, ASM NEWS, V71, P77; Clayton TA, 2007, ARCH TOXICOL, V81, P201, DOI 10.1007/s00204-006-0136-7; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Dicksved J, 2007, APPL ENVIRON MICROB, V73, P2284, DOI 10.1128/AEM.02223-06; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; Fushuku S, 2008, EXP ANIM TOKYO, V57, P489, DOI 10.1538/expanim.57.489; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hopkins MJ, 2002, DIGEST LIVER DIS, V34, pS12, DOI 10.1016/S1590-8658(02)80157-8; Jernberg C, 2005, APPL ENVIRON MICROB, V71, P501, DOI 10.1128/AEM.71.1.501-506.2005; Kelly D, 2005, MOL IMMUNOL, V42, P895, DOI 10.1016/j.molimm.2004.12.003; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Maukonen J, 2008, J MED MICROBIOL, V57, P1560, DOI 10.1099/jmm.0.47352-0; McCracken VJ, 2001, J NUTR, V131, P1862, DOI 10.1093/jn/131.6.1862; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Nyhlen A, 2002, SCAND J INFECT DIS, V34, P17, DOI 10.1080/00365540110076994; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Phipps AN, 1998, XENOBIOTICA, V28, P527, DOI 10.1080/004982598239443; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; SPEAR PG, 1974, J EXP MED, V139, P249, DOI 10.1084/jem.139.2.249; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; VANDERWAAIJ D, 1984, A VAN LEEUW J MICROB, V50, P745, DOI 10.1007/BF02386238; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; Wilson ID, 2009, CURR PHARM DESIGN, V15, P1519, DOI 10.2174/138161209788168173; Wise MG, 2005, APPL ENVIRON MICROB, V71, P3911, DOI 10.1128/AEM.71.7.3911-3916.2005; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Zoetendal EG, 2006, MOL MICROBIOL, V59, P1639, DOI 10.1111/j.1365-2958.2006.05056.x; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	47	156	163	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8584	10.1371/journal.pone.0008584	http://dx.doi.org/10.1371/journal.pone.0008584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052418	Green Published, Green Submitted, gold			2022-12-25	WOS:000273338500026
J	Johnson, AC; Myers, B; Lazovic, J; Towner, R; Greenwood-Van Meerveld, B				Johnson, Anthony C.; Myers, Brent; Lazovic, Jelena; Towner, Rheal; Greenwood-Van Meerveld, Beverley			Brain Activation in Response to Visceral Stimulation in Rats with Amygdala Implants of Corticosterone: An fMRI Study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; C-FOS EXPRESSION; THERAPEUTIC IMPLICATIONS; COLORECTAL DISTENSION; MOLECULAR-MECHANISMS; SPINAL-CORD; RECTAL PAIN; PATHOBIOLOGY; TRANSMISSION; PROJECTIONS	Background: Although visceral pain of gastrointestinal (GI) origin is the major complaint in patients with irritable bowel syndrome (IBS) it remains poorly understood. Brain imaging studies suggest a defect in brain-gut communication in IBS with a greater activation of central arousal circuits including the amygdala. Previously, we found that stereotaxic implantation of corticosterone (CORT) onto the amygdala in rats induced anxiety and colonic hypersensitivity. In the present study we used functional magnetic resonance imaging (fMRI) to identify specific brain sites activated in a rat model characterized by anxiety and colonic hypersensitivity. Methodology/Principal Findings: Anesthetized male rats received micropellets (30 mu g each) of either CORT or cholesterol (CHOL), to serve as a control, implanted stereotaxically on the dorsal margin of each amygdala. Seven days later, rats were anesthetized and placed in the fMRI magnet (7T). A series of isobaric colorectal balloon distensions (CRD - 90s 'off', 30s 'on', 8 replicates) at two pressures (40 and 60 mmHg) were performed in a standard block-design. Cross correlation statistical analysis was used to determine significant differences between distended and non-distended states in CORT and CHOL-treated animals. Analysis of the imaging data demonstrated greater overall brain activation in response to CRD in rats with CORT implants compared to CHOL controls. Additionally, CORT implants produced significant positive bilateral increases in MRI signal in response to CRD in specific nuclei known as integration sites important in anxiety and pain perception. Conclusions and Significance: These data indicate that chronic exposure of the amygdala to elevated levels of CORT enhances overall brain activation in response to CRD, and identified other specific brain regions activated in response to mechanical distension of the colon. These results demonstrate the feasibility of performing fMRI imaging in a rodent model that supports clinical observations in IBS patients with enhanced amygdala activation and symptomatology of abdominal pain and anxiety.	[Greenwood-Van Meerveld, Beverley] Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA; [Johnson, Anthony C.; Myers, Brent; Greenwood-Van Meerveld, Beverley] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK USA; [Lazovic, Jelena] CALTECH, Div Biol, Biol Imaging Ctr, Pasadena, CA 91125 USA; [Towner, Rheal] Oklahoma Med Res Fdn, Adv Magnet Resonance Ctr, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Oklahoma System; University of Oklahoma Health Sciences Center; California Institute of Technology; Oklahoma Medical Research Foundation	Johnson, AC (corresponding author), Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA.	Beverley-Greenwood@ouhsc.edu	Johnson, Anthony C/J-1775-2012; Lazovic Zinnanti, Jelena/HGD-8286-2022; Johnson, Anthony C./R-7175-2019	Johnson, Anthony C/0000-0002-0939-6027; Lazovic Zinnanti, Jelena/0000-0001-7646-6104; Johnson, Anthony C./0000-0002-0939-6027; Towner, Rheal/0000-0001-7368-8983	Oklahoma Center for Neuroscience at the University of Oklahoma Health Sciences Center; Veterans Affairs [I01BX002188] Funding Source: NIH RePORTER	Oklahoma Center for Neuroscience at the University of Oklahoma Health Sciences Center; Veterans Affairs(US Department of Veterans Affairs)	This research was supported by the Oklahoma Center for Neuroscience at the University of Oklahoma Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addolorato G, 1998, HEPATO-GASTROENTEROL, V45, P1559; AGARWAL MK, 1993, NEUROENDOCRINOLOGY, V58, P575, DOI 10.1159/000126593; Baklavadzhyan O G, 2000, Neurosci Behav Physiol, V30, P231, DOI 10.1007/BF02463163; BEAULIEU S, 1989, NEUROENDOCRINOLOGY, V49, P255, DOI 10.1159/000125125; Bonaz B, 2002, AM J GASTROENTEROL, V97, P654; BOUGHTONSMITH NK, 1988, BRIT J PHARMACOL, V94, P65, DOI 10.1111/j.1476-5381.1988.tb11500.x; DEFIORE CH, 1983, BRAIN RES, V278, P93, DOI 10.1016/0006-8993(83)90227-5; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DIORIO D, 1993, J NEUROSCI, V13, P3839; Febo M, 2005, J NEUROSCI, V25, P11637, DOI 10.1523/JNEUROSCI.3604-05.2005; Febo M, 2008, HORM BEHAV, V54, P330, DOI 10.1016/j.yhbeh.2008.02.024; Feldman S, 1998, BRAIN RES BULL, V45, P389, DOI 10.1016/S0361-9230(97)00384-5; Ferris CF, 2006, J NEUROENDOCRINOL, V18, P307, DOI 10.1111/j.1365-2826.2006.01424.x; Forss N, 2005, NEUROIMAGE, V24, P132, DOI 10.1016/j.neuroimage.2004.09.032; Garakani Amir, 2003, Am J Ther, V10, P61, DOI 10.1097/00045391-200301000-00014; Gebhart GF, 2000, AM J PHYSIOL-GASTR L, V278, pG834, DOI 10.1152/ajpgi.2000.278.6.G834; GREENWOOD B, 1990, BRAIN RES, V520, P192, DOI 10.1016/0006-8993(90)91705-L; Greenwood-Van Meerveld B, 2001, BRAIN RES, V893, P135, DOI 10.1016/S0006-8993(00)03305-9; Grundy D, 2004, GUT, V53, P5, DOI 10.1136/gut.2003.033415; Gwee KA, 1999, GUT, V44, P400, DOI 10.1136/gut.44.3.400; HOLSTEGE G, 1987, J COMP NEUROL, V260, P98, DOI 10.1002/cne.902600109; Ji YP, 2007, J PAIN, V8, P494, DOI 10.1016/j.jpain.2007.01.006; Jones MP, 2006, NEUROGASTROENT MOTIL, V18, P91, DOI 10.1111/j.1365-2982.2005.00730.x; Kern MK, 2001, AM J PHYSIOL-GASTR L, V281, pG1512, DOI 10.1152/ajpgi.2001.281.6.G1512; KOVACS KJ, 1988, BRAIN RES, V474, P205, DOI 10.1016/0006-8993(88)90435-0; Ladabaum U, 2000, AM J PHYSIOL-GASTR L, V279, pG1, DOI 10.1152/ajpgi.2000.279.1.G1; Lazovic J, 2005, NEUROGASTROENT MOTIL, V17, P548, DOI 10.1111/j.1365-2982.2005.00655.x; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; May A, 2007, NEUROL SCI, V28, pS101, DOI 10.1007/s10072-007-0760-x; Mayer EA, 2001, AM J PHYSIOL-GASTR L, V280, pG519, DOI 10.1152/ajpgi.2001.280.4.G519; MAYER EA, 2000, GUT S4, V47, P869; MERTZ H, 1995, GASTROENTEROLOGY, V109, P40, DOI 10.1016/0016-5085(95)90267-8; Monnikes H, 2003, BRAIN RES, V966, P253, DOI 10.1016/S0006-8993(02)04197-5; Moshiree B, 2006, GUT, V55, P905, DOI 10.1136/gut.2005.078287; Myers B, 2007, AM J PHYSIOL-GASTR L, V292, pG1622, DOI 10.1152/ajpgi.00080.2007; Naliboff BD, 2003, GASTROENTEROLOGY, V124, P1738, DOI 10.1016/S0016-5085(03)00400-1; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; RITCHIE J, 1973, GUT, V14, P125, DOI 10.1136/gut.14.2.125; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Schmithorst VJ, 2001, IEEE T MED IMAGING, V20, P535, DOI 10.1109/42.929619; Shepard JD, 2003, BRAIN RES, V963, P203, DOI 10.1016/S0006-8993(02)03978-1; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Traub RJ, 1996, NEUROSCI LETT, V215, P165, DOI 10.1016/S0304-3940(96)12978-5; TRAUB RJ, 1992, PAIN, V49, P393, DOI 10.1016/0304-3959(92)90247-9; Travagli RA, 2001, AM J PHYSIOL-GASTR L, V281, pG595, DOI 10.1152/ajpgi.2001.281.3.G595; Uchida S, 2008, EUR J NEUROSCI, V27, P2250, DOI 10.1111/j.1460-9568.2008.06218.x; Wang J, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-28; Wang Z, 2008, PAIN, V138, P233, DOI 10.1016/j.pain.2008.04.018; WHITEHEAD WE, 1990, GASTROENTEROLOGY, V98, P1187, DOI 10.1016/0016-5085(90)90332-U; WHITEHEAD WE, 1992, GUT, V33, P825, DOI 10.1136/gut.33.6.825; Wilder-Smith CH, 2004, GUT, V53, P1595, DOI 10.1136/gut.2003.028514; Willis WD, 1999, P NATL ACAD SCI USA, V96, P7675, DOI 10.1073/pnas.96.14.7675; Wood JD, 2007, WORLD J GASTROENTERO, V13, P1313, DOI 10.3748/wjg.v13.i9.1313; ZHUO M, 1992, J NEUROPHYSIOL, V67, P1599, DOI 10.1152/jn.1992.67.6.1599	55	33	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8573	10.1371/journal.pone.0008573	http://dx.doi.org/10.1371/journal.pone.0008573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052291	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000273338500016
J	Day, A; Dong, J; Funari, VA; Harry, B; Strom, SP; Cohn, DH; Nelson, SF				Day, Allen; Dong, Jun; Funari, Vincent A.; Harry, Bret; Strom, Samuel P.; Cohn, Dan H.; Nelson, Stanley F.			Disease Gene Characterization through Large-Scale Co-Expression Analysis	PLOS ONE			English	Article							JOUBERT-SYNDROME; CENTROSOMAL PROTEIN; CANDIDATE GENES; RENAL SYNDROME; HUMAN TISSUES; AHI1 GENE; MUTATIONS; EXPRESSION; PRIORITIZATION; IDENTIFICATION	Background: In the post genome era, a major goal of biology is the identification of specific roles for individual genes. We report a new genomic tool for gene characterization, the UCLA Gene Expression Tool (UGET). Results: Celsius, the largest co-normalized microarray dataset of Affymetrix based gene expression, was used to calculate the correlation between all possible gene pairs on all platforms, and generate stored indexes in a web searchable format. The size of Celsius makes UGET a powerful gene characterization tool. Using a small seed list of known cartilage-selective genes, UGET extended the list of known genes by identifying 32 new highly cartilage-selective genes. Of these, 7 of 10 tested were validated by qPCR including the novel cartilage-specific genes SDK2 and FLJ41170. In addition, we retrospectively tested UGET and other gene expression based prioritization tools to identify disease-causing genes within known linkage intervals. We first demonstrated this utility with UGET using genetically heterogeneous disorders such as Joubert syndrome, microcephaly, neuropsychiatric disorders and type 2 limb girdle muscular dystrophy (LGMD2) and then compared UGET to other gene expression based prioritization programs which use small but discrete and well annotated datasets. Finally, we observed a significantly higher gene correlation shared between genes in disease networks associated with similar complex or Mendelian disorders. Discussion: UGET is an invaluable resource for a geneticist that permits the rapid inclusion of expression criteria from one to hundreds of genes in genomic intervals linked to disease. By using thousands of arrays UGET annotates and prioritizes genes better than other tools especially with rare tissue disorders or complex multi-tissue biological processes. This information can be critical in prioritization of candidate genes for sequence analysis.	[Day, Allen; Dong, Jun; Harry, Bret; Strom, Samuel P.; Cohn, Dan H.; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Inst Mol Biol, Los Angeles, CA 90095 USA; [Funari, Vincent A.; Cohn, Dan H.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Funari, Vincent A.; Cohn, Dan H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Day, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Inst Mol Biol, Los Angeles, CA 90095 USA.	snelson@ucla.edu	Strom, Samuel/C-8692-2014; Nelson, Stanley F/D-4771-2009	Strom, Samuel/0000-0003-3254-7564; Nelson, Stanley F/0000-0002-2082-3114	National Institute of Neurological Disorders and Stroke (NINDS) [U24NS052108]; National Institutes of Health Neuroscience Microarray Consortium [HD22657]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS052108] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health Neuroscience Microarray Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded by a grant from the National Institute of Neurological Disorders and Stroke (NINDS) U24NS052108 that supports the National Institutes of Health Neuroscience Microarray Consortium and HD22657 to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brzustowicz Linda M, 2008, Curr Psychiatry Rep, V10, P158, DOI 10.1007/s11920-008-0027-0; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; CARROLL L, 2009, MOL PSYCHIAT; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Day A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r112; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Funari VA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-165; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Greco D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001880; Guglieri M, 2008, CURR OPIN NEUROL, V21, P576, DOI 10.1097/WCO.0b013e32830efdc2; Hans M, 1999, J NEUROSCI, V19, P1610; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; Kobayashi N, 2008, BIOINFORMATICS, V24, P1002, DOI 10.1093/bioinformatics/btn054; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Liang S, 2006, PHYSIOL GENOMICS, V26, P158, DOI 10.1152/physiolgenomics.00313.2005; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; MAESTRINI E, 2009, MOL PSYCHIAT; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Muragaki Y, 1996, NAT GENET, V12, P103, DOI 10.1038/ng0196-103; Nagarajan R, 2002, P NATL ACAD SCI USA, V99, P8998, DOI 10.1073/pnas.132080999; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ritvo E R, 1991, J Child Psychol Psychiatry, V32, P1031, DOI 10.1111/j.1469-7610.1991.tb01928.x; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Rossi S, 2006, NUCLEIC ACIDS RES, V34, pW285, DOI 10.1093/nar/gkl340; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Seelow D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003874; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Spellman PT, 2002, GENOME BIOL, V3; Steinhauser D, 2004, BIOINFORMATICS, V20, P3647, DOI 10.1093/bioinformatics/bth398; Steinhauser D, 2004, BIOINFORMATICS, V20, P1928, DOI 10.1093/bioinformatics/bth182; Stopkova P, 2004, PSYCHIAT RES, V127, P157, DOI 10.1016/j.psychres.2004.03.003; STROM S, 2009, MOL PSYCHIAT; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thornblad TA, 2007, TWIN RES HUM GENET, V10, P861, DOI 10.1375/twin.10.6.861; Tompson SW, 2009, AM J HUM GENET, V84, P72, DOI 10.1016/j.ajhg.2008.12.001; Utsch B, 2006, PEDIATR NEPHROL, V21, P32, DOI 10.1007/s00467-005-2054-y; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2005, ANN NEUROL, V57, P513, DOI 10.1002/ana.20422; Valente EM, 2008, EUR J MED GENET, V51, P1, DOI 10.1016/j.ejmg.2007.11.003; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Verma R, 2008, BIOL PSYCHIAT, V63, P1185, DOI 10.1016/j.biopsych.2008.02.005; Wang Y, 2008, BRIT J CANCER, V98, P1023, DOI 10.1038/sj.bjc.6604207; Whetzel PL, 2006, BIOINFORMATICS, V22, P866, DOI 10.1093/bioinformatics/btl005; Wilson BJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-419; Yu W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-528; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239	70	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2009	4	12							e8491	10.1371/journal.pone.0008491	http://dx.doi.org/10.1371/journal.pone.0008491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	538JK	20046828	Green Published, gold, Green Submitted			2022-12-25	WOS:000273180200005
J	Iijima, K; Zhao, LJ; Shenton, C; Iijima-Ando, K				Iijima, Koichi; Zhao, LiJuan; Shenton, Christopher; Iijima-Ando, Kanae			Regulation of Energy Stores and Feeding by Neuronal and Peripheral CREB Activity in Drosophila	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM-MEMORY; MALE COURTSHIP BEHAVIOR; RESPONSE ELEMENT; GENE-EXPRESSION; FAT-BODY; ADIPOKINETIC HORMONE; CIRCADIAN-RHYTHMS; STRESS RESISTANCE; TAKEOUT GENE	The cAMP-responsive transcription factor CREB functions in adipose tissue and liver to regulate glycogen and lipid metabolism in mammals. While Drosophila has a homolog of mammalian CREB, dCREB2, its role in energy metabolism is not fully understood. Using tissue-specific expression of a dominant-negative form of CREB (DN-CREB), we have examined the effect of blocking CREB activity in neurons and in the fat body, the primary energy storage depot with functions of adipose tissue and the liver in flies, on energy balance, stress resistance and feeding behavior. We found that disruption of CREB function in neurons reduced glycogen and lipid stores and increased sensitivity to starvation. Expression of DN-CREB in the fat body also reduced glycogen levels, while it did not affect starvation sensitivity, presumably due to increased lipid levels in these flies. Interestingly, blocking CREB activity in the fat body increased food intake. These flies did not show a significant change in overall body size, suggesting that disruption of CREB activity in the fat body caused an obese-like phenotype. Using a transgenic CRE-luciferase reporter, we further demonstrated that disruption of the adipokinetic hormone receptor, which is functionally related to mammalian glucagon and p-adrenergic signaling, in the fat body reduced CRE-mediated transcription in flies. This study demonstrates that CREB activity in either neuronal or peripheral tissues regulates energy balance in Drosophila, and that the key signaling pathway regulating CREB activity in peripheral tissue is evolutionarily conserved.	[Iijima, Koichi; Zhao, LiJuan] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Farber Inst Neurosci, Lab Neurodegenerat & Metab Dis, Philadelphia, PA 19107 USA; [Shenton, Christopher; Iijima-Ando, Kanae] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Farber Inst Neurosci, Lab Neurogenet & Pathobiol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Iijima, K (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Farber Inst Neurosci, Lab Neurodegenerat & Metab Dis, Philadelphia, PA 19107 USA.	koichi.iijima@jefferson.edu; kanae.iijima-ando@jefferson.edu			Farber Institute for Neurosciences; Thomas Jefferson University; Gilbert Foundation/the American Federation for Aging Research; Alzheimer's Association [NIRG-08-91985]; National Institutes of Health [R01AG032279]; NATIONAL INSTITUTE ON AGING [R01AG032279] Funding Source: NIH RePORTER	Farber Institute for Neurosciences; Thomas Jefferson University; Gilbert Foundation/the American Federation for Aging Research; Alzheimer's Association(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by start-up funds from the Farber Institute for Neurosciences. K. I. is supported by a pilot research grant from the Thomas Jefferson University, and grants from Gilbert Foundation/the American Federation for Aging Research (http://www.afar.org/), the Alzheimer's Association (NIRG-08-91985)(http://www.alz.org/index.asp). K. I. and K. I.-A. are supported by the National Institutes of Health (R01AG032279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Bharucha KN, 2008, J EXP BIOL, V211, P3103, DOI 10.1242/jeb.016451; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Cheong J, 1998, J BIOL CHEM, V273, P22714, DOI 10.1074/jbc.273.35.22714; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Djawdan M, 1998, PHYSIOL ZOOL, V71, P584, DOI 10.1086/515963; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Iijima-Ando K, 2005, METHOD ENZYMOL, V393, P302, DOI 10.1016/S0076-6879(05)93013-9; Iijima-Ando K, 2008, J BIOL CHEM, V283, P19066, DOI 10.1074/jbc.M710509200; Iijima-Andot K, 2005, P NATL ACAD SCI USA, V102, P10261, DOI 10.1073/pnas.0503937102; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; LEE MJ, 1995, ANAL BIOCHEM, V228, P155, DOI 10.1006/abio.1995.1327; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; LONDOS C, 1985, J BIOL CHEM, V260, P5139; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lorenz MW, 2001, ARCH INSECT BIOCHEM, V47, P198, DOI 10.1002/arch.1052; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Okamura T, 2007, MOL BIOL CELL, V18, P1519, DOI 10.1091/mbc.E06-10-0909; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061; Van der Horst DJ, 2003, COMP BIOCHEM PHYS B, V136, P217, DOI 10.1016/S1096-4959(03)00151-9; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; YIN JCP, 1995, MOL CELL BIOL, V15, P5123; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	53	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8498	10.1371/journal.pone.0008498	http://dx.doi.org/10.1371/journal.pone.0008498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041126	gold, Green Submitted, Green Published			2022-12-25	WOS:000278068700013
J	Richmond, TK; Subramanian, SV				Richmond, Tracy K.; Subramanian, S. V.			School Variation in Asthma: Compositional or Contextual?	PLOS ONE			English	Article							MULTILEVEL ANALYSIS; SOCIOECONOMIC-STATUS; ENVIRONMENTAL ALLERGENS; CHILDHOOD ASTHMA; PREVALENCE; CHILDREN; DISPARITIES; RISK; ASSOCIATIONS; COMMUNITIES	Background:Childhood asthma prevalence and morbidity have been shown to vary by neighborhood. Less is known about between-school variation in asthma prevalence and whether it exists beyond what one might expect due to students at higher risk of asthma clustering within different schools. Our objective was to determine whether between-school variation in asthma prevalence exists and if so, if it is related to the differential distribution of individual risk factors for and correlates of asthma or to contextual influences of schools. Methods: Cross-sectional analysis of 16,640 teens in grades 7-12 in Wave 1 (data collected in 1994-5) of the National Longitudinal Study of Adolescent Health. Outcome was current diagnosis of asthma as reported by respondents' parents. Two-level random effects models were used to assess the contribution of schools to the variance in asthma prevalence before and after controlling for individual attributes. Results:The highest quartile schools had mean asthma prevalence of 21.9% compared to the lowest quartile schools with mean asthma prevalence of 7.1%. In our null model, the school contributed significantly to the variance in asthma (sigma(2)(u0) = 0.27, CI: 0.20, 0.35). Controlling for individual, school and neighborhood attributes reduced the between-school variance modestly (sigma(2)(u0) = 0.19 CI: 0.13-0.29). Conclusion: Significant between-school variation in current asthma prevalence exists even after controlling for the individual, school and neighborhood factors. This provides evidence for school level contextual influences on asthma. Further research is needed to determine potential mechanisms through which schools may influence asthma outcomes.	[Richmond, Tracy K.] Childrens Hosp, Div Adolescent Med, Boston, MA 02115 USA; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth SVS, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Richmond, TK (corresponding author), Childrens Hosp, Div Adolescent Med, 300 Longwood Ave, Boston, MA 02115 USA.	tracy.richmond@childrens.harvard.edu			Charles H. Hood Foundation Child Health Research Award; National Institutes of Health Career Development Award [IK01HD058042-01A1, NHLBI 1 K25 HL081275]; Maternal and Child Health Leadership Education in Adolescent Health Training Program; National Institute of Child Health and Human Development [P0I-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921, K01HD058042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	Charles H. Hood Foundation Child Health Research Award; National Institutes of Health Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maternal and Child Health Leadership Education in Adolescent Health Training Program; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Tracy Richmond was supported by the Charles H. Hood Foundation Child Health Research Award, the National Institutes of Health Career Development Award (IK01HD058042-01A1), and the Maternal and Child Health Leadership Education in Adolescent Health Training Program. S V Subramanian is supported by the National Institutes of Health Career Development Award (NHLBI 1 K25 HL081275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research uses data from the Add Health project, a program designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullen Harris, and funded by a grant P0I-HD31921 from the National Institute of Child Health and Human Development, with cooperative funding from 17 other agencies. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Persons interested in obtaining data files from Add Health should contact Add Health, Carolina Population Center, 123 W. Franklin Street, Chapel Hill, NC 27516-2524 (addhealth@unc.edu).	Abramson SL, 2006, J SCHOOL HEALTH, V76, P246, DOI 10.1111/j.1746-1561.2006.00105.x; Akinbami LJ, 2005, PEDIATRICS, V115, P1254, DOI 10.1542/peds.2004-0897; Aligne CA, 2000, AM J RESP CRIT CARE, V162, P873; Almqvist C, 1999, J ALLERGY CLIN IMMUN, V103, P1012, DOI 10.1016/S0091-6749(99)70172-7; Amr S, 2003, ANN ALLERG ASTHMA IM, V90, P34, DOI 10.1016/S1081-1206(10)63611-3; Aveyard P, 2004, SOC SCI MED, V58, P2253, DOI 10.1016/j.socscimed.2003.08.012; Basagana X, 2004, AM J EPIDEMIOL, V160, P178, DOI 10.1093/aje/kwh186; BATTISTICH V, 1995, AM EDUC RES J, V32, P627, DOI 10.3102/00028312032003627; Blakely T, 2006, METHODS SOCIAL EPIDE; BLOOM B, 2005, VITAL HLTH STAT  DEC, P1; Cagney KA, 2004, J GEN INTERN MED, V19, P229, DOI 10.1111/j.1525-1497.2004.30359.x; Chen E, 2006, J ALLERGY CLIN IMMUN, V117, P1014, DOI 10.1016/j.jaci.2006.01.036; Chew GL, 2005, INDOOR AIR, V15, P228, DOI 10.1111/j.1600-0668.2005.00363.x; Claudio L, 2006, ANN EPIDEMIOL, V16, P332, DOI 10.1016/j.annepidem.2005.06.046; GEORGE R, 2000, HIGH, V0084; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; Goldstein H., 2003, MULTILEVEL STAT MODE; Goodman E, 2003, J PEDIATR-US, V143, P451, DOI 10.1067/S0022-3476(03)00456-6; Juhn YJ, 2005, SOC SCI MED, V60, P2453, DOI 10.1016/j.socscimed.2004.11.034; Kim JL, 2007, INDOOR AIR, V17, P153, DOI 10.1111/j.1600-0668.2006.00466.x; King G., 1998, ANN M AM POL SCI ASS; Kumar Revathy, 2002, Prev Sci, V3, P105, DOI 10.1023/A:1015431300471; LEE VE, 1989, SOCIOL EDUC, V62, P172, DOI 10.2307/2112866; LITONJUA AA, 1999, PEDIAT PULMONOL, V28, P294; Maes L, 2003, SOC SCI MED, V56, P517, DOI 10.1016/S0277-9536(02)00052-7; McDaniel M, 2006, PEDIATRICS, V117, pE868, DOI 10.1542/peds.2005-1721; Moore L, 2001, TOB CONTROL, V10, P117, DOI 10.1136/tc.10.2.117; Perzanowski MS, 1999, J ALLERGY CLIN IMMUN, V103, P1018, DOI 10.1016/S0091-6749(99)70173-9; Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention, 1998, MMWR RECOMMENDATIONS, V47, P1; Quinn K, 2006, AM J PUBLIC HEALTH, V96, P1599, DOI 10.2105/AJPH.2005.071514; RABEHESKETH S, 2005, MULTILIVEL LONGITUDI; Raudenbush S. W., 2002, HIERARCHICAL LINEAR, V1; Rauh VA, 2002, ENVIRON HEALTH PERSP, V110, P323, DOI 10.1289/ehp.02110s2323; Richmond TK, 2006, PEDIATRICS, V117, P2158, DOI 10.1542/peds.2005-1920; Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588; Saha C, 2005, ARCH PEDIAT ADOL MED, V159, P759, DOI 10.1001/archpedi.159.8.759; Salmond C, 1999, J EPIDEMIOL COMMUN H, V53, P476, DOI 10.1136/jech.53.8.476; Santilli J, 2003, ANN ALLERG ASTHMA IM, V90, P203, DOI 10.1016/S1081-1206(10)62142-4; Savilahti R, 2001, ALLERGY, V56, P175, DOI 10.1034/j.1398-9995.2001.056002175.x; Schwartz J, 2004, PEDIATRICS, V113, P1037; SELLSTROM E, 2005, J EPIDEMIOL COMMUNIT, V60, P139; Shanawani H, 2006, CLIN CHEST MED, V27, P17, DOI 10.1016/j.ccm.2005.11.002; Shankardass K, 2007, SOC SCI MED, V65, P1792, DOI 10.1016/j.socscimed.2007.05.048; Smedje G, 2001, INT J TUBERC LUNG D, V5, P1059; *STATACORP, STAT STAT SOFTW; Stingone JA, 2006, ANN ALLERG ASTHMA IM, V97, P244, DOI 10.1016/S1081-1206(10)60021-X; STRUNK RC, 1985, JAMA-J AM MED ASSOC, V254, P1193; Subramanian S. V., 2003, Neighborhoods and health, P65; Subramanian SV, 2004, SOC SCI MED, V58, P1961, DOI 10.1016/S0277-9536(03)00415-5; Swahn MH, 2006, AM J PUBLIC HEALTH, V96, P802, DOI 10.2105/AJPH.2005.066514; Tortolero SR, 2002, J SCHOOL HEALTH, V72, P33, DOI 10.1111/j.1746-1561.2002.tb06509.x; Tranter DC, 2005, CLIN EXP ALLERGY, V35, P126, DOI 10.1111/j.1365-2222.2005.02149.x; TURYK M, 2007, PEDIAT ALLERGY IMMUN, P1; *US BUR CENS, 1995, CURR POP SURV; *US GEN ACC OFF, 1996, SCH FAC AM SCH REP; Vig RS, 2006, ANN NY ACAD SCI, V1088, P65, DOI 10.1196/annals.1366.023; Watson JP, 1996, EUR RESPIR J, V9, P2087, DOI 10.1183/09031936.96.09102087; Weil CM, 1999, PEDIATRICS, V104, P1274, DOI 10.1542/peds.104.6.1274; Wilcox P, 2001, JUSTICE Q, V18, P509, DOI 10.1080/07418820100095001; Wright RJ, 2004, AM J PUBLIC HEALTH, V94, P625, DOI 10.2105/AJPH.94.4.625; Wright RJ, 2001, ENVIRON HEALTH PERSP, V109, P1085, DOI 10.2307/3454965; Wright RJ, 2006, CLIN CHEST MED, V27, P413, DOI 10.1016/j.ccm.2006.04.003; 2003, ADD HLTH RES DESIGN, V1; 2003, ADD HLTH RES DESIGN, V3; 2003, ADD HLTH RES DESIGN, V2	65	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8512	10.1371/journal.pone.0008512	http://dx.doi.org/10.1371/journal.pone.0008512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601NW	20041121	Green Published, Green Submitted, gold			2022-12-25	WOS:000278068700023
J	Su, B; Wurtzer, S; Rameix-Welti, MA; Dwyer, D; van der Werf, S; Naffakh, N; Clavel, F; Labrosse, B				Su, Bin; Wurtzer, Sebastien; Rameix-Welti, Marie-Anne; Dwyer, Dominic; van der Werf, Sylvie; Naffakh, Nadia; Clavel, Francois; Labrosse, Beatrice			Enhancement of the Influenza A Hemagglutinin (HA)Mediated Cell-Cell Fusion and Virus Entry by the Viral Neuraminidase (NA)	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; RECEPTOR-BINDING; SYNCYTIUM FORMATION; HOST-RANGE; SPECIFICITY; SENSITIVITY; INHIBITORS; CARBOHYDRATE; REPLICATION; DETERMINANT	Background:The major role of the neuraminidase (NA) protein of influenza A virus is related to its sialidase activity, which disrupts the interaction between the envelope hemagglutin (HA) protein and the sialic acid receptors expressed at the surface of infected cells. This enzymatic activity is known to promote the release and spread of progeny viral particles following their production by infected cells, but a potential role of NA in earlier steps of the viral life cycle has never been clearly demonstrated. In this study we have examined the impact of NA expression on influenza HA-mediated viral membrane fusion and virion infectivity. Methodology/Principal Findings:The role of NA in the early stages of influenza virus replication was examined using a cellcell fusion assay that mimics HA-mediated membrane fusion, and a virion infectivity assay using HIV-based pseudoparticles expressing influenza HA and/or NA proteins. In the cell-cell fusion assay, which bypasses the endocytocytosis step that is characteristic of influenza virus entry, we found that in proper HA maturation conditions, NA clearly enhanced fusion in a dose-dependent manner. Similarly, expression of NA at the surface of pseudoparticles significantly enhanced virion infectivity. Further experiments using exogeneous soluble NA revealed that the most likely mechanism for enhancement of fusion and infectivity by NA was related to desialylation of virion-expressed HA. Conclusion/Significance: The NA protein of influenza A virus is not only required for virion release and spread but also plays a critical role in virion infectivity and HA-mediated membrane fusion.	[Su, Bin; Wurtzer, Sebastien; Clavel, Francois; Labrosse, Beatrice] Univ Paris Diderot Paris 7, Hop St Louis, Inst Univ Hematol, INSERM,U941, Paris, France; [Rameix-Welti, Marie-Anne; van der Werf, Sylvie; Naffakh, Nadia] Univ Paris Diderot Paris 7, CNRS, URA 3015, Inst Pasteur,Unite Genet Mol Virus ARN, Paris, France; [Dwyer, Dominic] Univ Sydney, Westmead Hosp, ICPMR, Ctr Infect Dis & Microbiol, Sydney, NSW 2006, Australia	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Sydney	Su, B (corresponding author), Univ Paris Diderot Paris 7, Hop St Louis, Inst Univ Hematol, INSERM,U941, Paris, France.	beatrice.labrosse@inserm.fr	LABROSSE, Béatrice/M-9920-2017; Rameix-Welti, Marie-Anne/H-7526-2019; SU, Bin/H-1236-2012	LABROSSE, Béatrice/0000-0002-0658-4903; wurtzer, sebastien/0000-0002-9628-1075; Rameix-Welti, Marie-Anne/0000-0002-5901-3856; Naffakh, Nadia/0000-0002-0424-0277; van der WERF, Sylvie/0000-0002-1148-4456	Institut de Medecine et d'Epidemiologie Applique (IMEA); Fondation Internationale Leon MBA	Institut de Medecine et d'Epidemiologie Applique (IMEA); Fondation Internationale Leon MBA	This work was supported by the Institut de Medecine et d'Epidemiologie Applique (IMEA) Fondation Internationale Leon MBA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright AV, 1998, J NEUROVIROL, V4, P486, DOI 10.3109/13550289809113493; Bar S, 2006, J VIROL, V80, P2815, DOI 10.1128/JVI.80.6.2815-2822.2006; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; DAVISPOYNTER N, 1994, J VIROL, V68, P7586, DOI 10.1128/JVI.68.11.7586-7590.1994; Gambaryan A, 2005, VIROLOGY, V334, P276, DOI 10.1016/j.virol.2005.02.003; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; HORIMOTO T, 1994, J VIROL, V68, P604; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; KAWAOKA Y, 1989, J VIROL, V63, P3296, DOI 10.1128/JVI.63.8.3296-3300.1989; Kobayashi M, 2006, J VIROL, V80, P1817, DOI 10.1128/JVI.80.4.1817-1825.2006; Labrosse B, 1998, J VIROL, V72, P6381, DOI 10.1128/JVI.72.8.6381-6388.1998; Lewis DB, 2006, ANNU REV MED, V57, P139, DOI 10.1146/annurev.med.57.121304.131333; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Neumann T, 2005, VIROLOGY, V333, P251, DOI 10.1016/j.virol.2004.12.035; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; Rameix-Welti MA, 2006, ANTIMICROB AGENTS CH, V50, P3809, DOI 10.1128/AAC.00645-06; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Shtyrya Y, 2009, GLYCOCONJUGATE J, V26, P99, DOI 10.1007/s10719-008-9169-x; Sun JF, 2002, J BIOL CHEM, V277, P9825, DOI 10.1074/jbc.M110764200; Sun JF, 2001, VIROLOGY, V284, P26, DOI 10.1006/viro.2001.0889; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; WILEY DC, 1977, VIROLOGY, V79, P446, DOI 10.1016/0042-6822(77)90371-3; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Yang P, 1997, VIROLOGY, V229, P155, DOI 10.1006/viro.1996.8421	35	87	90	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8495	10.1371/journal.pone.0008495	http://dx.doi.org/10.1371/journal.pone.0008495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041119	Green Published, gold			2022-12-25	WOS:000278068700010
J	Vicente, D; Esnal, O; de Goicoechea, MJL; Cisterna, R; Perez-Trallero, E				Vicente, Diego; Esnal, Olatz; Jose Lopez de Goicoechea, M.; Cisterna, Ramon; Perez-Trallero, Emilio			Influence of Two Vaccination Campaigns on Genetic Diversity of Invasive Neisseria meningitidis Isolates in Northern Spain (1997-2008)	PLOS ONE			English	Article							C CONJUGATE VACCINES; POPULATION-STRUCTURE; IDENTIFICATION; CARRIAGE; DISEASE	Background: Neisseria meningitidis diversifies rapidly, due to its high recombination rates. The aim of this study was to analyze the possible impact of two vaccination campaigns (a once-off A/C polysaccharide vaccination campaign in people aged 18 months to 20 years old in 1997, and a meningococcal C conjugate vaccination campaign in children aged <= 6 years old from 2000 to 2008) on diversification of the population of invasive isolates obtained between 1997 and 2008. All of the 461 available isolates were included (2, 319, 123, 11 and 6 belonging to serogroups A, B, C, Y and W-135, respectively). Methodology/Principal Findings: The isolates were analyzed for diversity using multilocus sequence typing, eBURST and the S.T.A.R.T.2 program. One hundred and seven sequence types (ST) and 20 clonal complexes were obtained. Five different STs (ST11, ST8, ST33, 511163 and ST3496) included 56.4% of the isolates. With the exception of ST11, all other STs were associated with a specific serogroup. Epidemic circulation of serogroup C ST8 isolates was detected in 1997-1998, as well as epidemic circulation of ST11 isolates (serogroups B and C) in 2002-2004. The epidemic behavior of serogroup B ST11 (ST11_B:2a:P1.5) was similar, although with lesser intensity, to that of ST11 of serogroup C. Although clonality increased during epidemic years, the overall diversity of the meningococcal population did not increase throughout the 12 years of the study. Conclusion: The overall diversity of the meningococcal population, measured by the frequency of STs and clonal complexes, numbers of alleles, polymorphic sites, and index of association, remained relatively constant throughout the study period, contradicting previous findings by other researchers.	[Vicente, Diego; Perez-Trallero, Emilio] Hosp Donostia, Microbiol Serv, San Sebastian, Spain; [Vicente, Diego; Perez-Trallero, Emilio] Hosp Donostia, Reference Lab Meningococcal Infect Basque Country, San Sebastian, Spain; [Vicente, Diego; Esnal, Olatz; Perez-Trallero, Emilio] Biomed Res Ctr Network Resp Dis CIBERES, San Sebastian, Spain; [Jose Lopez de Goicoechea, M.] Hosp Galdakao, Microbiol Serv, Galdakao, Bizkaia, Spain; [Cisterna, Ramon] Hosp Basurto, Microbiol Serv, Bilbao, Spain; [Perez-Trallero, Emilio] Univ Basque Country, Fac Med, Dept Prevent Med & Publ Hlth, San Sebastian, Spain	University Hospital Donostia; University Hospital Donostia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBERESP; Galdakao Hospital; Basurto Hospital; University of Basque Country	Vicente, D (corresponding author), Hosp Donostia, Microbiol Serv, San Sebastian, Spain.	mikrobiol@terra.es						Achtman M, 2004, INT J MED MICROBIOL, V294, P67, DOI 10.1016/j.ijmm.2004.06.028; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Diggle MA, 2005, J CLIN MICROBIOL, V43, P4649, DOI 10.1128/JCM.43.9.4649-4653.2005; *EU MENNET, 2005, IMP MEN EP POP BIOL; Holmes EC, 1999, MOL BIOL EVOL, V16, P741, DOI 10.1093/oxfordjournals.molbev.a026159; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Lipsitch M, 2007, J R SOC INTERFACE, V4, P787, DOI 10.1098/rsif.2007.0229; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Maiden MCJ, 1999, LANCET, V354, P615, DOI 10.1016/S0140-6736(99)00252-4; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Perez-Trallero E, 2002, LANCET, V360, P953, DOI 10.1016/S0140-6736(02)11061-0; Ramsay M., 2006, INVASIVE NEISSERIA M; Russell JE, 2008, MICROBIOL-SGM, V154, P1170, DOI 10.1099/mic.0.2007/014761-0; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Takahashi H, 2004, J MED MICROBIOL, V53, P1175, DOI 10.1099/0022-1317-53-11-1175; Takahashi H, 2004, J MED MICROBIOL, V53, P657, DOI 10.1099/jmm.0.45541-0; Vicente D, 2006, CLIN MICROBIOL INFEC, V12, P812, DOI 10.1111/j.1469-0691.2006.01451.x; Vicente D, 2005, J MED MICROBIOL, V54, P381, DOI 10.1099/jmm.0.45855-0; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	21	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8501	10.1371/journal.pone.0008501	http://dx.doi.org/10.1371/journal.pone.0008501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041148	gold, Green Published			2022-12-25	WOS:000278068700016
J	de Castro, F; Gaedke, U; Boenigk, J				de Castro, Francisco; Gaedke, Ursula; Boenigk, Jens			Reverse Evolution: Driving Forces Behind the Loss of Acquired Photosynthetic Traits	PLOS ONE			English	Article							FRESH-WATER HABITATS; OPERON COPY NUMBER; GROWTH-RATE; BACTERIA; GENOME; STRATEGIES; PREDATION; PLANKTON; DNA; SEQUENCES	Background: The loss of photosynthesis has occurred often in eukaryotic evolution, even more than its acquisition, which occurred at least nine times independently and which generated the evolution of the supergroups Archaeplastida, Rhizaria, Chromalveolata and Excavata. This secondary loss of autotrophic capability is essential to explain the evolution of eukaryotes and the high diversity of protists, which has been severely underestimated until recently. However, the ecological and evolutionary scenarios behind this evolutionary "step back'' are still largely unknown. Methodology/Principal Findings: Using a dynamic model of heterotrophic and mixotrophic flagellates and two types of prey, large bacteria and ultramicrobacteria, we examine the influence of DOC concentration, mixotroph's photosynthetic growth rate, and external limitations of photosynthesis on the coexistence of both types of flagellates. Our key premises are: large bacteria grow faster than small ones at high DOC concentrations, and vice versa; and heterotrophic flagellates are more efficient than the mixotrophs grazing small bacteria (both empirically supported). We show that differential efficiency in bacteria grazing, which strongly depends on cell size, is a key factor to explain the loss of photosynthesis in mixotrophs (which combine photosynthesis and bacterivory) leading to purely heterotrophic lineages. Further, we show in what conditions an heterotroph mutant can coexist, or even out-compete, its mixotrophic ancestor, suggesting that bacterivory and cell size reduction may have been major triggers for the diversification of eukaryotes. Conclusions/Significance: Our results suggest that, provided the mixotroph's photosynthetic advantage is not too large, the (small) heterotroph will also dominate in nutrient-poor environments and will readily invade a community of mixotrophs and bacteria, due to its higher efficiency exploiting the ultramicrobacteria. As carbon-limited conditions were presumably widespread throughout Earth history, such a scenario may explain the numerous transitions from phototrophy to mixotrophy and further to heterotrophy within virtually all major algal lineages. We challenge prevailing concepts that affiliated the evolution of phagotrophy with eutrophic or strongly light-limited environments only.	[de Castro, Francisco; Gaedke, Ursula] Univ Potsdam, Dept Ecol & Ecosyst Modelling, Potsdam, Germany; [Boenigk, Jens] Austrian Acad Sci, Inst Limnol, A-5310 Mondsee, Austria	University of Potsdam; Austrian Academy of Sciences	de Castro, F (corresponding author), Univ Potsdam, Dept Ecol & Ecosyst Modelling, Potsdam, Germany.	decastro.f@gmail.com	de Castro, Francisco/G-2213-2011; Boenigk, Jens/A-9377-2013	de Castro, Francisco/0000-0001-8834-3363; 	EU [MTKDCT 2006-042261]; Marie Curie Host Fellowship; FWF [18315]	EU(European Commission); Marie Curie Host Fellowship(European Commission); FWF(Austrian Science Fund (FWF))	F. de Castro was supported by the EU project FEMMES (MTKDCT 2006-042261), a Marie Curie Host Fellowship for Transfer of Knowledge. Jens Boenigk was supported in part by FWF project 18315. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bodyl A, 2009, TRENDS ECOL EVOL, V24, P119, DOI 10.1016/j.tree.2008.11.003; Boenigk J, 2000, AQUAT MICROB ECOL, V22, P243, DOI 10.3354/ame022243; Boenigk J, 2005, ENVIRON MICROBIOL, V7, P685, DOI 10.1111/j.1462-2920.2005.00743.x; Boenigk J, 2004, APPL ENVIRON MICROB, V70, P5787, DOI 10.1128/AEM.70.10.5787-5793.2004; Boenigk J, 2006, AQUAT MICROB ECOL, V44, P71, DOI 10.3354/ame044071; CARON DA, 1990, LIMNOL OCEANOGR, V35, P192, DOI 10.4319/lo.1990.35.1.0192; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Fegatella F, 1998, APPL ENVIRON MICROB, V64, P4433; Fenchel T, 1998, BACTERIAL BIOGEOCHEMISTRY: THE ECOPHYSIOLOGY OF MINERAL CYCLING, 2ND EDITION, P4; FENCHEL T, 1986, ADV MICROB ECOL, V9, P57; Fenchel T., 1987, ECOLOGY OF PROTOZOA, DOI [10.1007/978-3-662-06817-5, DOI 10.1007/978-3-662-06817-5, DOI 10.1007/978-3-662-25981-8]; GAUDY AF, 1971, APPL MICROBIOL, V22, P1041, DOI 10.1128/AEM.22.6.1041-1047.1971; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gonzalez JM, 1996, MAR BIOL, V126, P785, DOI 10.1007/BF00351345; Hachtel W, 1998, ENDOCYTOBIOSIS CELL, V12, P191; Hahn MW, 2003, APPL ENVIRON MICROB, V69, P1442, DOI 10.1128/AEM.69.3.1442-1451.2003; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Havskum H, 1996, MAR ECOL PROG SER, V137, P251, DOI 10.3354/meps137251; Holen DA, 1999, FRESHWATER BIOL, V42, P445, DOI 10.1046/j.1365-2427.1999.00476.x; Katechakis A, 2006, OECOLOGIA, V148, P692, DOI 10.1007/s00442-006-0413-4; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Lanier W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002171; Mallet MA, 2006, J EUKARYOT MICROBIOL, V53, P79, DOI 10.1111/j.1550-7408.2005.00079.x; Massana R, 2002, APPL ENVIRON MICROB, V68, P4554, DOI 10.1128/AEM.68.9.4554-4558.2002; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; NEDWELL DB, 1994, APPL ENVIRON MICROB, V60, P1984, DOI 10.1128/AEM.60.6.1984-1992.1994; NYGAARD K, 1993, LIMNOL OCEANOGR, V38, P273, DOI 10.4319/lo.1993.38.2.0273; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Pernthaler J, 1997, APPL ENVIRON MICROB, V63, P4778, DOI 10.1128/AEM.63.12.4778-4783.1997; Pfandl K, 2004, J EUKARYOT MICROBIOL, V51, P626, DOI 10.1111/j.1550-7408.2004.tb00596.x; Raven JA, 1997, LIMNOL OCEANOGR, V42, P198, DOI 10.4319/lo.1997.42.1.0198; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Sanchez-Puerta MV, 2008, J PHYCOL, V44, P1097, DOI 10.1111/j.1529-8817.2008.00559.x; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Stibor H, 2003, PROTIST, V154, P91, DOI 10.1078/143446103764928512; Thingstad TF, 1996, ECOLOGY, V77, P2108, DOI 10.2307/2265705; Troost TA, 2005, AM NAT, V166, pE45, DOI 10.1086/432038; Unrein F, 2007, LIMNOL OCEANOGR, V52, P456, DOI 10.4319/lo.2007.52.1.0456; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Wu QL, 2004, APPL ENVIRON MICROB, V70, P332, DOI 10.1128/AEM.70.1.332-339.2004	43	23	23	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8465	10.1371/journal.pone.0008465	http://dx.doi.org/10.1371/journal.pone.0008465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041159	gold, Green Published, Green Submitted			2022-12-25	WOS:000273105200006
J	Jorgensen, ND; Peng, Y; Ho, CCY; Rideout, HJ; Petrey, D; Liu, P; Dauer, WT				Jorgensen, Nathan D.; Peng, Yong; Ho, Cherry C. -Y.; Rideout, Hardy J.; Petrey, Donald; Liu, Peng; Dauer, William T.			The WD40 Domain Is Required for LRRK2 Neurotoxicity	PLOS ONE			English	Article							FAMILIAL PARKINSONS-DISEASE; KINASE-ACTIVITY; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; RISK-FACTOR; ROC DOMAIN; PROTEIN; REPEAT; MUTATIONS; GENE; VARIANT	Background: Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson disease (PD). LRRK2 contains an "enzymatic core'' composed of GTPase and kinase domains that is flanked by leucine-rich repeat (LRR) and WD40 protein-protein interaction domains. While kinase activity and GTP-binding have both been implicated in LRRK2 neurotoxicity, the potential role of other LRRK2 domains has not been as extensively explored. Principal Findings: We demonstrate that LRRK2 normally exists in a dimeric complex, and that removing the WD40 domain prevents complex formation and autophosphorylation. Moreover, loss of the WD40 domain completely blocks the neurotoxicity of multiple LRRK2 PD mutations. Conclusion: These findings suggest that LRRK2 dimerization and autophosphorylation may be required for the neurotoxicity of LRRK2 PD mutations and highlight a potential role for the WD40 domain in the mechanism of LRRK2-mediated cell death.	[Jorgensen, Nathan D.; Peng, Yong; Ho, Cherry C. -Y.; Rideout, Hardy J.] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA; [Petrey, Donald; Liu, Peng] Columbia Univ, Dept Biochem & Mol Biophys, Med Ctr, New York, NY USA; [Dauer, William T.] Univ Michigan, Dept Neurol, Sch Med, Ann Arbor, MI USA; [Dauer, William T.] Univ Michigan, Dept Cell & Dev Biol, Sch Med, Ann Arbor, MI USA	Columbia University; Columbia University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jorgensen, ND (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA.	dauer@umich.edu		Dauer, William/0000-0003-1775-7504	National Institutes of Health (NIH); Spitzer Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spitzer Foundation	National Institutes of Health (NIH) and Spitzer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; Dawson TM, 2003, J CLIN INVEST, V111, P145, DOI 10.1172/JCI200317575; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Di Fonzo A, 2006, NEUROGENETICS, V7, P133, DOI 10.1007/s10048-006-0041-5; Farrer MJ, 2007, NEUROLOGY, V69, P1732, DOI 10.1212/01.wnl.0000279588.20391.88; Farrer MJ, 2007, PARKINSONISM RELAT D, V13, P89, DOI 10.1016/j.parkreldis.2006.12.001; Funayama M, 2007, NEUROREPORT, V18, P273, DOI 10.1097/WNR.0b013e32801254b6; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Gotthardt K, 2008, EMBO J, V27, P2352, DOI 10.1038/emboj.2008.167; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; IMAI Y, 2008, EMBO J; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Jorgensen ND, 2007, J NEUROCHEM, V102, P2040, DOI 10.1111/j.1471-4159.2007.04678.x; Khan NL, 2005, BRAIN, V128, P2786, DOI 10.1093/brain/awh667; Klein C, 2007, CURR OPIN NEUROL, V20, P453, DOI 10.1097/WCO.0b013e3281e6692b; Korr D, 2006, CELL SIGNAL, V18, P910, DOI 10.1016/j.cellsig.2005.08.015; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Marin I, 2008, J MOL EVOL, V67, P41, DOI 10.1007/s00239-008-9122-4; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Muir T, 2001, ENVIRON HEALTH PERSP, V109, P885, DOI 10.2307/3454651; Nussbaum RL, 1997, HUM MOL GENET, V6, P1687, DOI 10.1093/hmg/6.10.1687; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Tan EK, 2007, HUM GENET, V120, P857, DOI 10.1007/s00439-006-0268-0; Tang CL, 2003, J MOL BIOL, V334, P1043, DOI 10.1016/j.jmb.2003.10.025; Taylor JP, 2007, NEUROGENETICS, V8, P95, DOI 10.1007/s10048-006-0075-8; VANEGMOND WN, 2008, J BIOL CHEM; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Yu LH, 2000, PROTEIN SCI, V9, P2470, DOI 10.1110/ps.9.12.2470; Zhou HY, 2003, PROTEIN SCI, V12, P2121, DOI 10.1002/pro.122121; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	46	80	80	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8463	10.1371/journal.pone.0008463	http://dx.doi.org/10.1371/journal.pone.0008463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041156	Green Published, Green Submitted, gold			2022-12-25	WOS:000273104000023
J	Yan, JB; Shah, T; Warburton, ML; Buckler, ES; McMullen, MD; Crouch, J				Yan, Jianbing; Shah, Trushar; Warburton, Marilyn L.; Buckler, Edward S.; McMullen, Michael D.; Crouch, Jonathan			Genetic Characterization and Linkage Disequilibrium Estimation of a Global Maize Collection Using SNP Markers	PLOS ONE			English	Article							INBRED LINES; CIMMYT MAIZE; POPULATION-STRUCTURE; GENOME ORGANIZATION; SEQUENCE DIVERSITY; SSR MARKERS; ASSOCIATION; GERMPLASM; LOCI; SELECTION	A newly developed maize Illumina GoldenGate Assay with 1536 SNPs from 582 loci was used to genotype a highly diverse global maize collection of 632 inbred lines from temperate, tropical, and subtropical public breeding programs. A total of 1229 informative SNPs and 1749 haplotypes within 327 loci was used to estimate the genetic diversity, population structure, and familial relatedness. Population structure identified tropical and temperate subgroups, and complex familial relationships were identified within the global collection. Linkage disequilibrium (LD) was measured overall and within chromosomes, allelic frequency groups, subgroups related by geographic origin, and subgroups of different sample sizes. The LD decay distance differed among chromosomes and ranged between 1 to 10 kb. The LD distance increased with the increase of minor allelic frequency (MAF), and with smaller sample sizes, encouraging caution when using too few lines in a study. The LD decay distance was much higher in temperate than in tropical and subtropical lines, because tropical and subtropical lines are more diverse and contain more rare alleles than temperate lines. A core set of inbreds was defined based on haplotypes, and 60 lines capture 90% of the haplotype diversity of the entire panel. The defined core sets and the entire collection can be used widely for different research targets.	[Yan, Jianbing; Crouch, Jonathan] Int Maize & Wheat Improvement Ctr, Genet Resources Program, Mexico City, DF, Mexico; [Yan, Jianbing] Int Crops Res Inst Semi Arid Trop, Dept Bioinformat, Hyderabad, Andhra Pradesh, India; [Shah, Trushar] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China; [Warburton, Marilyn L.] ARS, Corn Host Plant Resistance Res Unit, USDA, Starkville, MS USA; [Buckler, Edward S.] Cornell Univ, Inst Genom Div, Ithaca, NY USA; [Buckler, Edward S.] ARS, Plant Soil & Nutr Res Unit, USDA, Ithaca, NY USA; [Buckler, Edward S.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO USA; [McMullen, Michael D.] ARS, Plant Genet Res Unit, USDA, Columbia, MO USA	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); China Agricultural University; United States Department of Agriculture (USDA); Cornell University; United States Department of Agriculture (USDA); Cornell University; University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Yan, JB (corresponding author), Int Maize & Wheat Improvement Ctr, Genet Resources Program, Mexico City, DF, Mexico.	marilyn.warburton@ars.usda.gov	Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022; Warburton, Marilyn/J-2250-2017	Buckler, Edward/0000-0002-3100-371X; Shah, Trushar/0000-0002-0091-7981; Warburton, Marilyn/0000-0002-9542-9912	National Science Foundation [DBI0321467]; United States Department of Agriculture - Agriculture Research Service	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture - Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the Generation Challenge Program of the Consultative Group on International Agricultural Research, the National Science Foundation Plant Genome Award DBI0321467 and funds provided by the United States Department of Agriculture - Agriculture Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Belo A, 2008, MOL GENET GENOMICS, V279, P1, DOI 10.1007/s00438-007-0289-y; Bernardo R, 2009, CROP SCI, V49, P419, DOI 10.2135/cropsci2008.08.0452; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; Gethi JG, 2002, CROP SCI, V42, P951, DOI 10.2135/cropsci2002.0951; Global Crop Diversity Trust (GCDT), 2007, GLOB STRAT EXS CONS; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hall T.A., 2001, BIOLIGN ALIGNMENT MU; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; HEDRICK PW, 1987, GENETICS, V117, P331; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Jung M, 2004, THEOR APPL GENET, V109, P681, DOI 10.1007/s00122-004-1695-8; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Laborda PR, 2005, THEOR APPL GENET, V111, P1288, DOI 10.1007/s00122-005-0055-7; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu KJ, 2003, GENETICS, V165, P2117; Long AD, 1999, GENOME RES, V9, P720; Lu H, 2001, THEOR APPL GENET, V103, P613, DOI 10.1007/PL00002917; Messing J, 2004, P NATL ACAD SCI USA, V101, P14349, DOI 10.1073/pnas.0406163101; Palaisa KA, 2003, PLANT CELL, V15, P1795, DOI 10.1105/tpc.012526; Pritchard JK, 2000, GENETICS, V155, P945; Reif JC, 2005, THEOR APPL GENET, V111, P838, DOI 10.1007/s00122-005-0004-5; Reif JC, 2004, CROP SCI, V44, P326, DOI 10.2135/cropsci2004.0326; Reif JC, 2003, THEOR APPL GENET, V107, P947, DOI 10.1007/s00122-003-1333-x; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Tarter JA, 2004, THEOR APPL GENET, V109, P609, DOI 10.1007/s00122-004-1660-6; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Xia XC, 2005, CROP SCI, V45, P2573, DOI 10.2135/cropsci2005.0246; Xia XC, 2004, CROP SCI, V44, P2230, DOI 10.2135/cropsci2004.2230; Xie CX, 2008, MOL BREEDING, V21, P407, DOI 10.1007/s11032-007-9140-8; YAN J, 2009, MOL BREED UNPUB; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2009, PLANT GENOME-US, V2, P63, DOI 10.3835/plantgenome2008.09.0009; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	51	272	294	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8451	10.1371/journal.pone.0008451	http://dx.doi.org/10.1371/journal.pone.0008451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041112	Green Published, gold, Green Accepted			2022-12-25	WOS:000273104000015
J	Nunemaker, CS; Dishinger, JF; Dula, SB; Wu, RP; Merrins, MJ; Reid, KR; Sherman, A; Kennedy, RT; Satin, LS				Nunemaker, Craig S.; Dishinger, John F.; Dula, Stacey B.; Wu, Runpei; Merrins, Matthew J.; Reid, Kendra R.; Sherman, Arthur; Kennedy, Robert T.; Satin, Leslie S.			Glucose Metabolism, Islet Architecture, and Genetic Homogeneity in Imprinting of [Ca2+](i) and Insulin Rhythms in Mouse Islets	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; CYTOPLASMIC CA2+; IN-VIVO; ELECTRICAL-ACTIVITY; OXYGEN-CONSUMPTION; MICROFLUIDIC CHIP; SINGLE ISLETS; B-CELLS; OSCILLATIONS; SECRETION	We reported previously that islets isolated from individual, outbred Swiss-Webster mice displayed oscillations in intracellular calcium ([Ca2+](i)) that varied little between islets of a single mouse but considerably between mice, a phenomenon we termed "islet imprinting." We have now confirmed and extended these findings in several respects. First, imprinting occurs in both inbred (C57BL/6J) as well as outbred mouse strains (Swiss-Webster; CD1). Second, imprinting was observed in NAD(P) H oscillations, indicating a metabolic component. Further, short-term exposure to a glucose-free solution, which transiently silenced [Ca2+](i) oscillations, reset the oscillatory patterns to a higher frequency. This suggests a key role for glucose metabolism in maintaining imprinting, as transiently suppressing the oscillations with diazoxide, a KATP-channel opener that blocks [Ca2+](i) influx downstream of glucose metabolism, did not change the imprinted patterns. Third, imprinting was not as readily observed at the level of single beta cells, as the [Ca2+](i) oscillations of single cells isolated from imprinted islets exhibited highly variable, and typically slower [Ca2+](i) oscillations. Lastly, to test whether the imprinted [Ca2+](i) patterns were of functional significance, a novel microchip platform was used to monitor insulin release from multiple islets in real time. Insulin release patterns correlated closely with [Ca2+](i) oscillations and showed significant mouseto- mouse differences, indicating imprinting. These results indicate that islet imprinting is a general feature of islets and is likely to be of physiological significance. While islet imprinting did not depend on the genetic background of the mice, glucose metabolism and intact islet architecture may be important for the imprinting phenomenon.	[Nunemaker, Craig S.; Dula, Stacey B.; Wu, Runpei] Univ Virginia, Dept Med, Div Endocrinol & Metab, Charlottesville, VA 22903 USA; [Dishinger, John F.; Reid, Kendra R.; Kennedy, Robert T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Merrins, Matthew J.; Satin, Leslie S.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Kennedy, Robert T.; Satin, Leslie S.] Univ Michigan, Brehm Diabet Ctr, Ann Arbor, MI 48109 USA; [Sherman, Arthur] NIH, Lab Biol Modeling, Bethesda, MD 20892 USA	University of Virginia; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA	Nunemaker, CS (corresponding author), Univ Virginia, Dept Med, Div Endocrinol & Metab, Charlottesville, VA 22903 USA.	lsatin@umich.edu	Kennedy, Robert/G-9095-2016	Kennedy, Robert/0000-0003-2447-7471; Nunemaker, Craig/0000-0003-2894-3388; Merrins, Matthew J./0000-0003-1599-9227; Sherman, Arthur/0000-0002-8372-5941	NIH [RO1 DK46409, R37 DK0469690, 1K01 DK081621]; NIH-NIDDK (National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013027, K01DK081621, R01DK046409] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIDDK (National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Satin's laboratory is supported by RO1 DK46409 from the NIH. Dr. Kennedy's laboratory is supported by NIH R37 Grant DK0469690. Dr. Nunemaker's laboratory is supported by NIH 1K01 DK081621. Dr. Sherman was supported by the Intramural Research Program of the NIH-NIDDK (National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; BECKER PL, 1987, AM J PHYSIOL, V253, pC613, DOI 10.1152/ajpcell.1987.253.4.C613; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; Bergsten P, 2002, DIABETES, V51, pS171, DOI 10.2337/diabetes.51.2007.S171; Bertram R, 2004, BIOPHYS J, V87, P3074, DOI 10.1529/biophysj.104.049262; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Berts A, 1996, BBA-MOL CELL RES, V1310, P212, DOI 10.1016/0167-4889(95)00173-5; Berts A, 1996, ENDOCRINOLOGY, V137, P693, DOI 10.1210/en.137.2.693; Brissova Marcela, 2008, P3, DOI 10.1007/978-4-431-75452-7_1; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Calabrese A, 2003, DIABETES, V52, P417, DOI 10.2337/diabetes.52.2.417; Capeau J, 2008, DIABETES METAB, V34, P649, DOI 10.1016/S1262-3636(08)74600-7; CARTER JD, 2009, BIOL PROCED IN PRESS; COOK DL, 1983, METABOLISM, V32, P681, DOI 10.1016/0026-0495(83)90124-5; Dishinger JF, 2009, ANAL CHEM, V81, P3119, DOI 10.1021/ac900109t; EDDLESTONE GT, 1984, J MEMBRANE BIOL, V77, P1, DOI 10.1007/BF01871095; GILON P, 1995, ENDOCRINOLOGY, V136, P5725, DOI 10.1210/en.136.12.5725; Gilon P, 2002, DIABETES, V51, pS144, DOI 10.2337/diabetes.51.2007.S144; GILON P, 1993, J BIOL CHEM, V268, P22265; Heart E, 2006, AM J PHYSIOL-ENDOC M, V290, pE143, DOI 10.1152/ajpendo.00216.2005; Henquin JC, 2006, DIABETES, V55, P441, DOI 10.2337/diabetes.55.02.06.db05-1051; HENQUIN JC, 1982, PFLUG ARCH EUR J PHY, V393, P322, DOI 10.1007/BF00581418; Jahanshahi P, 2009, ENDOCRINOLOGY, V150, P607, DOI 10.1210/en.2008-0773; Jung SK, 2000, J BIOL CHEM, V275, P6642, DOI 10.1074/jbc.275.9.6642; Kennedy RT, 2002, DIABETES, V51, pS152, DOI 10.2337/diabetes.51.2007.S152; KOMJATI M, 1986, ENDOCRINOLOGY, V118, P312, DOI 10.1210/endo-118-1-312; Krippeit-Drews P, 2000, BIOCHEM BIOPH RES CO, V267, P179, DOI 10.1006/bbrc.1999.1921; Kulkarni RN, 2004, DIABETES, V53, P1517, DOI 10.2337/diabetes.53.6.1517; Liu YJ, 1998, J PHYSIOL-LONDON, V508, P471, DOI 10.1111/j.1469-7793.1998.471bq.x; LONGO EA, 1991, J BIOL CHEM, V266, P9314; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; MARTIN F, 1995, J PHYSIOL-LONDON, V486, P361, DOI 10.1113/jphysiol.1995.sp020818; MATTHEWS DR, 1983, DIABETOLOGIA, V24, P231; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Najjar SM, 2005, CELL METAB, V2, P43, DOI 10.1016/j.cmet.2005.06.001; Nunemaker CS, 2006, BIOPHYS J, V91, P2082, DOI 10.1529/biophysj.106.087296; Nunemaker CS, 2005, DIABETES, V54, pA407; Nunemaker CS, 2005, DIABETES, V54, P3517, DOI 10.2337/diabetes.54.12.3517; Nunemaker CS, 2004, ENDOCRINE, V25, P61, DOI 10.1385/ENDO:25:1:61; PAOLISSO G, 1988, J CLIN ENDOCR METAB, V66, P1220, DOI 10.1210/jcem-66-6-1220; PEIRIS AN, 1992, J CLIN ENDOCR METAB, V75, P290, DOI 10.1210/jc.75.1.290; Porksen N, 2002, Diabetes Nutr Metab, V15, P9; Porksen N, 2002, DIABETES, V51, pS245, DOI 10.2337/diabetes.51.2007.S245; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rocheleau JV, 2004, J BIOL CHEM, V279, P31780, DOI 10.1074/jbc.M314005200; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; Roper MG, 2003, ANAL CHEM, V75, P4711, DOI 10.1021/ac0346813; Satin LS, 1998, ENDOCRINE, V8, P213, DOI 10.1385/ENDO:8:3:213; SHERMAN A, 1991, BIOPHYS J, V59, P547, DOI 10.1016/S0006-3495(91)82271-8; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4; Zimliki CL, 2004, BIOPHYS J, V87, P193, DOI 10.1529/biophysj.103.038471	53	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8428	10.1371/journal.pone.0008428	http://dx.doi.org/10.1371/journal.pone.0008428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037650	Green Published, Green Submitted, gold			2022-12-25	WOS:000272998100015
J	Salvatore, MF; Pruett, BS; Spann, SL; Dempsey, C				Salvatore, Michael F.; Pruett, Brandon S.; Spann, Sandy L.; Dempsey, Charles			Aging Reveals a Role for Nigral Tyrosine Hydroxylase ser31 Phosphorylation in Locomotor Activity Generation	PLOS ONE			English	Article							NIGROSTRIATAL DOPAMINE SYSTEM; AGE-RELATED DECLINE; STRIATAL DOPAMINE; SUBSTANTIA-NIGRA; NEUROTROPHIC FACTOR; CATECHOLAMINE BIOSYNTHESIS; COMMUNITY POPULATION; PARKINSONIAN SIGNS; NUCLEUS-ACCUMBENS; NERVE-TERMINALS	Background: Tyrosine hydroxylase (TH) regulates dopamine (DA) bioavailability. Its product, L-DOPA, is an established treatment for Parkinson's disease (PD), suggesting that TH regulation influences locomotion. Site-specific phosphorylation of TH at ser31 and ser40 regulates activity. No direct evidence shows that ser40 phosphorylation is the dominating mechanism of regulating TH activity in vivo, and physiologically-relevant stimuli increase L-DOPA biosynthesis independent of ser40 phosphorylation. Significant loss of locomotor activity occurs in aging as in PD, despite less loss of striatal DA or TH in aging compared to the loss associated with symptomatic PD. However, in the substantia nigra (SN), there is equivalent loss of DA or TH in aging and at the onset of PD symptoms. Growth factors increase locomotor activity in both PD and aging models and increase DA bioavailability and ser31 TH phosphorylation in SN, suggesting that ser31 TH phosphorylation status in the SN, not striatum, regulates DA bioavailability necessary for locomotor activity. Methodology and Principal Findings: We longitudinally characterized locomotor activity in young and older Brown-Norway Fischer 344 F-1 hybrid rats (18 months apart in age) at two time periods, eight months apart. The aged group served as an intact and pharmacologically-naive source of deficient locomotor activity. Following locomotor testing, we analyzed DA tissue content, TH protein, and TH phosphorylation in striatum, SN, nucleus accumbens, and VTA. Levels of TH protein combined with ser31 phosphorylation alone reflected inherent differences in DA levels among the four regions. Measures strictly pertaining to locomotor activity initiation significantly correlated to DA content only in the SN. Nigral TH protein and ser31 phosphorylation together significantly correlated to test subject's maximum movement number, horizontal activity, and duration. Conclusions/Significance: Together, these results show ser31 TH phosphorylation regulates DA bioavailability in intact neuropil, its status in the SN may regulate locomotor activity generation, and it may represent an accurate target for treating locomotor deficiency. They also show that neurotransmitter regulation in cell body regions can mediate behavioral outcomes and that ser31 TH phosphorylation plays a role in behaviors dependent upon catecholamines, such as dopamine.	[Salvatore, Michael F.; Pruett, Brandon S.; Spann, Sandy L.; Dempsey, Charles] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Salvatore, MF (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA.	msalva@lsuhsc.edu	Pruett, Brandon/ABE-4419-2020; Salvatore, Michael/ABC-8926-2021	Pruett, Brandon/0000-0001-9760-1635; 	American Federation for Aging Research	American Federation for Aging Research	This work was funded by a grant award to Michael F. Salvatore by the American Federation for Aging Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DR, 2006, EUR J NEUROSCI, V24, P617, DOI 10.1111/j.1460-9568.2006.04953.x; Beeler JA, 2009, NEUROPSYCHOPHARMACOL, V34, P1149, DOI 10.1038/npp.2008.117; Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; BROWN VJ, 1991, BRAIN, V114, P513, DOI 10.1093/brain/114.1.513; Buchman AS, 2009, ARCH INTERN MED, V169, P1139, DOI 10.1001/archinternmed.2009.135; Cardozo-Pelaez F, 1999, MOVEMENT DISORD, V14, P972, DOI 10.1002/1531-8257(199911)14:6<972::AID-MDS1010>3.0.CO;2-0; Cass WA, 2002, BRAIN RES, V938, P29, DOI 10.1016/S0006-8993(02)02481-2; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; Collier TJ, 2007, NEUROBIOL DIS, V26, P56, DOI 10.1016/j.nbd.2006.11.013; Connor JR, 2009, BRAIN, V132, P2403, DOI 10.1093/brain/awp125; Cruz-Muros I, 2007, EXP NEUROL, V204, P147, DOI 10.1016/j.expneurol.2006.10.004; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Emborg ME, 1998, J COMP NEUROL, V401, P253; EMERICH DF, 1993, BRAIN RES BULL, V32, P477, DOI 10.1016/0361-9230(93)90294-L; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fleischman DA, 2007, EXP AGING RES, V33, P59, DOI 10.1080/03610730601006370; Fortin GD, 2006, J NEUROCHEM, V96, P1740, DOI 10.1111/j.1471-4159.2006.03699.x; FREED CR, 1985, SCIENCE, V229, P62, DOI 10.1126/science.4012312; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gerhardt GA, 2002, J NEUROCHEM, V80, P168, DOI 10.1046/j.0022-3042.2001.00684.x; Grondin R, 2003, J NEUROSCI, V23, P1974; Harada K, 1996, J NEUROCHEM, V67, P629; Haycock JW, 1998, J NEUROCHEM, V71, P1670; HAYCOCK JW, 1990, J BIOL CHEM, V265, P11682; Haycock JW, 2003, J NEUROCHEM, V87, P574, DOI 10.1046/j.1471-4159.2003.02017.x; HAYCOCK JW, 1991, J BIOL CHEM, V266, P5650; Hebert MA, 1998, BRAIN RES, V797, P42, DOI 10.1016/S0006-8993(98)00370-9; Hebert MA, 1997, J PHARMACOL EXP THER, V282, P760; HEFTI F, 1980, BRAIN RES, V195, P123, DOI 10.1016/0006-8993(80)90871-9; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; Hoffman AF, 1998, J PHARMACOL EXP THER, V287, P487; Hornykiewicz O, 1986, ADV NEUROL, V45, P19; HUANG RL, 1995, NEUROSCI LETT, V200, P61, DOI 10.1016/0304-3940(95)12084-H; HUDSON JL, 1993, BRAIN RES, V626, P167, DOI 10.1016/0006-8993(93)90576-9; IRWIN I, 1994, NEURODEGENERATION, V3, P251; KISH SJ, 1992, J NEUROCHEM, V58, P642, DOI 10.1111/j.1471-4159.1992.tb09766.x; Kliem MA, 2007, J NEUROPHYSIOL, V98, P1489, DOI 10.1152/jn.00171.2007; Kubis N, 2000, BRAIN, V123, P366, DOI 10.1093/brain/123.2.366; LAVICKY J, 1993, J NEUROCHEM, V60, P602, DOI 10.1111/j.1471-4159.1993.tb03191.x; MARSHALL JF, 1990, NEUROBIOL AGING, V11, P131, DOI 10.1016/0197-4580(90)90046-3; McCormack AL, 2004, J COMP NEUROL, V471, P387, DOI 10.1002/cne.20036; Murray AM, 2004, J GERONTOL A-BIOL, V59, P864; Ossowska K, 2001, BRAIN RES, V907, P71, DOI 10.1016/S0006-8993(01)02601-4; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Parkinson JA, 1999, J NEUROSCI, V19, P2401; PHELAN JP, 1994, J GERONTOL, V49, pB1, DOI 10.1093/geronj/49.1.B1; PONZIO F, 1982, NEUROBIOL AGING, V3, P23, DOI 10.1016/0197-4580(82)90057-4; Prettyman R, 1998, AGE AGEING, V27, P557, DOI 10.1093/ageing/27.5.557; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; ROBERTSON GS, 1989, J NEUROSCI, V9, P3326; Rudow G, 2008, ACTA NEUROPATHOL, V115, P461, DOI 10.1007/s00401-008-0352-8; Salvatore MF, 2005, MOL BRAIN RES, V139, P341, DOI 10.1016/j.molbrainres.2005.06.002; Salvatore MF, 2004, J NEUROCHEM, V90, P245, DOI 10.1111/j.1471-4159.2004.02496.x; Salvatore MF, 2003, NEUROBIOL AGING, V24, P1147, DOI 10.1016/S0197-4580(03)00129-5; Salvatore MF, 2001, J NEUROCHEM, V79, P349, DOI 10.1046/j.1471-4159.2001.00593.x; Salvatore MF, 2000, J NEUROCHEM, V75, P225, DOI 10.1046/j.1471-4159.2000.0750225.x; Salvatore MF, 2009, EXP NEUROL, V219, P197, DOI 10.1016/j.expneurol.2009.05.013; Sanchez HL, 2008, NEUROSCIENCE, V154, P1598, DOI 10.1016/j.neuroscience.2008.04.016; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; SPANGLER EL, 1994, NEUROBIOL AGING, V15, P319, DOI 10.1016/0197-4580(94)90027-2; SPROTT RL, 1997, ILAR J, V38, P1; Thompson LH, 2009, EUR J NEUROSCI, V30, P625, DOI 10.1111/j.1460-9568.2009.06878.x; Trevitt JT, 2001, PSYCHOPHARMACOLOGY, V156, P32; WAYMIRE JC, 1991, J NEUROCHEM, V57, P1313, DOI 10.1111/j.1471-4159.1991.tb08296.x; WOLF ME, 1991, J NEUROCHEM, V56, P1191, DOI 10.1111/j.1471-4159.1991.tb11410.x; Yurek DM, 1998, BRAIN RES, V791, P246, DOI 10.1016/S0006-8993(98)00110-3	69	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8466	10.1371/journal.pone.0008466	http://dx.doi.org/10.1371/journal.pone.0008466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037632	gold, Green Published, Green Submitted			2022-12-25	WOS:000272998100021
J	Chen, HB; Giri, NC; Zhang, RH; Yamane, K; Zhang, Y; Maroney, M; Costa, M				Chen, Haobin; Giri, Nitai Charan; Zhang, Ronghe; Yamane, Kenichi; Zhang, Yi; Maroney, Michael; Costa, Max			Nickel Ions Inhibit Histone Demethylase JMJD1A and DNA Repair Enzyme ABH2 by Replacing the Ferrous Iron in the Catalytic Centers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; LYSINE METHYLATION; ALKYLATION DAMAGE; ESCHERICHIA-COLI; MAMMALIAN-CELLS; TISSUE-CULTURE; A549 CELLS; ACTIVATION; COMPLEXES; JHDM2A	Iron- and 2-oxoglutarate-dependent dioxygenases are a diverse family of non-heme iron enzymes that catalyze various important oxidations in cells. A key structural motif of these dioxygenases is a facial triad of 2-histidines-1-carboxylate that coordinates the Fe(II) at the catalytic site. Using histone demethylase JMJD1A and DNA repair enzyme ABH2 as examples, we show that this family of dioxygenases is highly sensitive to inhibition by carcinogenic nickel ions. We find that, with iron, the 50% inhibitory concentrations of nickel (IC50 [Ni(II)]) are 25 mu M for JMJD1A and 7.5 mu M for ABH2. Without iron, JMJD1A is 10 times more sensitive to nickel inhibition with an IC50 [Ni(II)] of 2.5 mu M, and approximately one molecule of Ni(II) inhibits one molecule of JMJD1A, suggesting that nickel causes inhibition by replacing the iron. Furthermore, nickel-bound JMJD1A is not reactivated by excessive iron even up to a 2 mM concentration. Using x-ray absorption spectroscopy, we demonstrate that nickel binds to the same site in ABH2 as iron, and replacement of the iron by nickel does not prevent the binding of the cofactor 2-oxoglutarate. Finally, we show that nickel ions target and inhibit JMJD1A in intact cells, and disruption of the iron-binding site decreases binding of nickel ions to ABH2 in intact cells. Together, our results reveal that the members of this dioxygenase family are specific targets for nickel ions in cells. Inhibition of these dioxygenases by nickel is likely to have widespread impacts on cells (e.g. impaired epigenetic programs and DNA repair) and may eventually lead to cancer development.	[Chen, Haobin; Zhang, Ronghe; Costa, Max] NYU, Sch Med, Dept Environm Med, New York, NY 10016 USA; [Giri, Nitai Charan; Maroney, Michael] Univ Massachusetts, Dept Chem, Amherst, MA 01002 USA; [Yamane, Kenichi; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	New York University; University of Massachusetts System; University of Massachusetts Amherst; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Chen, HB (corresponding author), NYU, Sch Med, Dept Environm Med, New York, NY 10016 USA.	haobin.chen@nyumc.org; max.costa@nyumc.org	costa, max/H-1754-2012	Zhang, Yi/0000-0002-2789-0811; Maroney, Michael/0000-0002-5598-3038; Giri, Nitai/0000-0002-0476-840X	NIEHS [ES000260, ES014454, ES005512]; NCI [CA16087]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005512, P30ES000260, R01ES014454] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES000260, ES014454, and ES005512 from NIEHS and Grant CA16087 from NCI.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; Bal W, 2000, CHEM RES TOXICOL, V13, P616, DOI 10.1021/tx000044l; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chen HB, 2006, MOL CELL BIOL, V26, P3728, DOI 10.1128/MCB.26.10.3728-3737.2006; Chen HB, 2005, TOXICOL APPL PHARM, V206, P275, DOI 10.1016/j.taap.2004.11.011; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; COLPAS GJ, 1991, INORG CHEM, V30, P920, DOI 10.1021/ic00005a010; COSTA M, 1981, TOXICOL APPL PHARM, V60, P313, DOI 10.1016/0041-008X(91)90234-6; COSTA M, 1981, CANCER RES, V41, P2868; Davidson T, 2005, MOL CELL BIOCHEM, V279, P157, DOI 10.1007/s11010-005-8288-y; Davidson TL, 2006, MOL CARCINOGEN, V45, P479, DOI 10.1002/mc.20176; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Golebiowski F, 2005, MOL CELL BIOCHEM, V279, P133, DOI 10.1007/s11010-005-8285-1; Govindarajan B, 2002, MOL MED, V8, P1; GRANDJEAN P, 1988, AM J IND MED, V13, P193; *INT ASS STUD PAIN, 1990, MONOGRAPH IASP, P1; Ju TT, 2006, J MOL BIOL, V363, P823, DOI 10.1016/j.jmb.2006.08.060; Kang J, 2003, TOXICOL SCI, V74, P279, DOI 10.1093/toxsci/kfg137; Karaczyn A, 2006, J CELL BIOCHEM, V97, P1025, DOI 10.1002/jcb.20705; Karaczyn AA, 2005, CHEM RES TOXICOL, V18, P1934, DOI 10.1021/tx050122a; Karaczyn AA, 2006, EXP CELL RES, V312, P3252, DOI 10.1016/j.yexcr.2006.06.025; Ke QD, 2008, CARCINOGENESIS, V29, P1276, DOI 10.1093/carcin/bgn084; Ke QD, 2008, TOXICOL APPL PHARM, V228, P190, DOI 10.1016/j.taap.2007.12.015; Ke QD, 2007, TOXICOL APPL PHARM, V219, P18, DOI 10.1016/j.taap.2006.08.013; Ke QD, 2006, CARCINOGENESIS, V27, P1481, DOI 10.1093/carcin/bgl004; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Konijn AM, 1999, BLOOD, V94, P2128, DOI 10.1182/blood.V94.6.2128.418k20_2128_2134; Kowara R, 2004, MOL CELL BIOCHEM, V255, P195, DOI 10.1023/B:MCBI.0000007275.22785.91; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; LEE YW, 1995, MOL CELL BIOL, V15, P2547; Leitch S, 2007, J AM CHEM SOC, V129, P5085, DOI 10.1021/ja068505y; Lockman K, 2007, CIRC RES, V101, pE115, DOI 10.1161/CIRCRESAHA.107.164178; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Mishina Y, 2004, J AM CHEM SOC, V126, P16930, DOI 10.1021/ja045066z; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Padden KM, 2001, J AM CHEM SOC, V123, P1072, DOI 10.1021/ja003282b; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; RANDALL CR, 1995, INORG CHEM, V34, P1036, DOI 10.1021/ic00109a007; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Straganz GD, 2006, CHEMBIOCHEM, V7, P1536, DOI 10.1002/cbic.200600152; Sutherland JE, 2001, MUTAT RES-FUND MOL M, V479, P225, DOI 10.1016/S0027-5107(01)00163-4; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Topol IA, 2006, J PHYS CHEM A, V110, P4223, DOI 10.1021/jp055633k; Webb SM, 2005, PHYS SCRIPTA, VT115, P1011; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yan Y, 2003, TOXICOL APPL PHARM, V190, P272, DOI 10.1016/S0041-008X(03)00169-8; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Zhou X, 2009, TOXICOL APPL PHARM, V236, P78, DOI 10.1016/j.taap.2009.01.009	53	104	107	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7374	7383		10.1074/jbc.M109.058503	http://dx.doi.org/10.1074/jbc.M109.058503			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20042601	Green Published, hybrid			2022-12-25	WOS:000275415600050
J	Chen, XQ; Simon, ES; Xiang, Y; Kachman, M; Andrews, PC; Wang, YZ				Chen, Xuequn; Simon, Eric S.; Xiang, Yi; Kachman, Maureen; Andrews, Philip C.; Wang, Yanzhuang			Quantitative Proteomics Analysis of Cell Cycle-regulated Golgi Disassembly and Reassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE SYSTEM; STACKING FACTOR; PROTEINS; FRAGMENTS; CISTERNAE; NETWORK; COMPLEX; BINDING; APPARATUS; GRASP65	During mitosis, the stacked structure of the Golgi undergoes a continuous fragmentation process. The generated mitotic fragments are evenly distributed into the daughter cells and reassembled into new Golgi stacks. This disassembly and reassembly process is critical for Golgi biogenesis during cell division, but the underlying molecular mechanism is poorly understood. In this study, we have recapitulated this process using an in vitro assay and analyzed the proteins associated with interphase and mitotic Golgi membranes using a proteomic approach. Incubation of purified rat liver Golgi membranes with mitotic HeLa cell cytosol led to fragmentation of the membranes; subsequent treatment of these membranes with interphase cytosol allowed the reassembly of the Golgi fragments into new Golgi stacks. These membranes were then used for quantitative proteomics analyses by combining the isobaric tags for relative and absolute quantification approach with OFFGEL isoelectric focusing separation and liquid chromatography-matrix assisted laser desorption ionization-tandem mass spectrometry. In three independent experiments, a total of 1,193 Golgi-associated proteins were identified and quantified. These included broad functional categories, such as Golgi structural proteins, Golgi resident enzymes, SNAREs, Rab GTPases, cargo, and cytoskeletal proteins. More importantly, the combination of the quantitative approach with Western blotting allowed us to unveil 84 proteins with significant changes in abundance under the mitotic condition compared with the interphase condition. Among these proteins, several COPI coatomer subunits (alpha, beta, gamma, and delta) are of particular interest. Altogether, this systematic quantitative proteomic study revealed candidate proteins of the molecular machinery that control the Golgi disassembly and reassembly processes in the cell cycle.	[Simon, Eric S.; Kachman, Maureen; Andrews, Philip C.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Xiang, Yi; Wang, Yanzhuang] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Andrews, PC (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	andrewsp@umich.edu; yzwang@umich.edu	Wang, Yanzhuang/AAE-5299-2019	Wang, Yanzhuang/0000-0002-1864-7094; Andrews, Philip/0000-0001-6843-5420	National Institutes of Health [P41 RR018627, GM087364]; Pardee Cancer Research Foundation; American Cancer Society [RGS-09-278-01-CSM]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pardee Cancer Research Foundation; American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41 RR018627 (to P. A.) and GM087364 (to Y. W.). This work was also partially supported by the Pardee Cancer Research Foundation and the American Cancer Society (RGS-09-278-01-CSM to Y. W.).	Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; Agop-Nersesian C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000270; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Barr FA, 2005, J CELL BIOL, V168, P993, DOI 10.1083/jcb.200501088; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BROWNHILL K, 2009, SEMIN CELL IN PRESS; Giansanti MG, 2007, MOL BIOL CELL, V18, P5034, DOI 10.1091/mbc.E07-05-0415; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Infante C, 1999, J CELL BIOL, V145, P83, DOI 10.1083/jcb.145.1.83; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Linstedt AD, 2004, CELL, V118, P271, DOI 10.1016/j.cell.2004.07.015; Liu ZH, 2007, DEV CELL, V12, P839, DOI 10.1016/j.devcel.2007.05.007; LUCOCQ JM, 1989, J CELL BIOL, V109, P463, DOI 10.1083/jcb.109.2.463; Matheson J, 2005, BIOCHEM SOC T, V33, P1290, DOI 10.1042/BST0331290; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; MISTELI T, 1994, J CELL BIOL, V125, P269, DOI 10.1083/jcb.125.2.269; Mogelsvang S, 2006, CURR OPIN CELL BIOL, V18, P438, DOI 10.1016/j.ceb.2006.06.001; Pfeffer S, 2005, BIOCHEM SOC T, V33, P627, DOI 10.1042/BST0330627; Pfeffer SR, 1995, COLD SPRING HARB SYM, V60, P221, DOI 10.1101/SQB.1995.060.01.025; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; Rios RM, 2004, CELL, V118, P323; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Schonteich E, 2007, EUR J CELL BIOL, V86, P417, DOI 10.1016/j.ejcb.2007.05.004; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Tang DM, 2008, J BIOL CHEM, V283, P6085, DOI 10.1074/jbc.M707715200; Taylor RS, 2000, ELECTROPHORESIS, V21, P3441, DOI 10.1002/1522-2683(20001001)21:16<3441::AID-ELPS3441>3.0.CO;2-G; Valderrama F, 2001, TRAFFIC, V2, P717, DOI 10.1034/j.1600-0854.2001.21006.x; Wang Y, 2005, CELL BIOL LAB HDB, P33; Wang Yanzhuang, 2008, P580, DOI 10.1007/978-3-211-76310-0_34; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Wu CC, 2000, TRAFFIC, V1, P769, DOI 10.1034/j.1600-0854.2000.011004.x; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Xiang Y, 2007, J BIOL CHEM, V282, P21829, DOI 10.1074/jbc.M611716200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	51	31	33	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7197	7207		10.1074/jbc.M109.047084	http://dx.doi.org/10.1074/jbc.M109.047084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056612	Green Published, hybrid			2022-12-25	WOS:000275415600033
J	Papasergi, S; Garibaldi, M; Tuscano, G; Signorino, G; Ricci, S; Peppoloni, S; Pernice, I; Lo Passo, C; Teti, G; Felici, F; Beninati, C				Papasergi, Salvatore; Garibaldi, Manuela; Tuscano, Giovanna; Signorino, Giacomo; Ricci, Susanna; Peppoloni, Samuele; Pernice, Ida; Lo Passo, Carla; Teti, Giuseppe; Felici, Franco; Beninati, Concetta			Plasminogen- and Fibronectin-binding Protein B Is Involved in the Adherence of Streptococcus pneumoniae to Human Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; PYOGENES CHALLENGE; HOST-CELLS; SURFACE; MICE; TRANSMIGRATION; VACCINATION; PNEUMOCOCCI; VIRULENCE; RESPONSES	Streptococcus pneumoniae is a major cause of morbidity and mortality worldwide. The ability of this bacterium to adhere to epithelial cells is considered as an essential early step in colonization and infection. By screening a whole genome phage display library with sera from infected patients, we previously identified three antigenic fragments matching open reading frame spr0075 of the strain R6 genome. This locus encodes for an similar to 120-kDa protein, herein referred to as plasminogen- and fibronectin-binding protein B (PfbB), which displays an LPXTG cell wall anchoring motif and six repetitive domains. In this study, by using isogenic pfbB-deleted mutants of the encapsulated D39 and of the unencapsulated DP1004 type 2 pneumococcal strains, we show that PfbB is involved in S. pneumoniae adherence to various epithelial respiratory tract cell lines. Our data suggest that PfbB directly mediates bacterial adhesion, because fluorescent beads coated with the recombinant PfbB sp17 fragment ( encompassing one of the six repetitive domains and the C-terminal region) efficiently bound to epithelial cells. Mutants lacking PfbB bound to fibronectin and plasminogen considerably less efficiently than wild type bacteria, whereas sp17-coated beads specifically bound to both of these substrates. Taken together, our data suggest that, by directly interacting with fibronectin, PfbB significantly increases the ability of S. pneumoniae to adhere to human epithelial cells.	[Papasergi, Salvatore; Garibaldi, Manuela; Tuscano, Giovanna; Signorino, Giacomo; Teti, Giuseppe; Beninati, Concetta] Univ Messina, Elie Metchnikoff Dept, I-98125 Messina, Italy; [Ricci, Susanna] Univ Siena, Dipartimento Biol Mol, I-53100 Siena, Italy; [Peppoloni, Samuele] Univ Modena & Reggio Emilia, Dipartimento Sci Sanita Pubbl, I-41125 Modena, Italy; [Pernice, Ida; Lo Passo, Carla] Univ Messina, Dipartimento Sci Vita M Malpighi, I-98165 Messina, Italy; [Felici, Franco] Univ Molise, Dipartimento Sci Tecnol Ambiente & Terr, I-86090 Pesche, IS, Italy	University of Messina; University of Siena; Universita di Modena e Reggio Emilia; University of Messina; University of Molise	Beninati, C (corresponding author), Policlin Univ, Elie Metchnikoff Dept, Torre Biol IIp, Via Consolare Valeria SNC, I-98125 Messina, Italy.	cbeninati@unime.it	ricci, susanna/R-4184-2018; Peppoloni, Samuele/L-2177-2016; Felici, Franco/H-5693-2012; papasergi, salvatore/AAE-8818-2021	ricci, susanna/0000-0002-2279-6391; Peppoloni, Samuele/0000-0003-4191-6974; Felici, Franco/0000-0003-2205-5195; Lo Passo, Carla/0000-0001-5531-6748; BENINATI, Concetta/0000-0001-8305-1337; Signorino, Giacomo/0000-0002-5366-6020; Pernice, Ida/0000-0001-8328-2776	MIUR PRIN/COFIN	MIUR PRIN/COFIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported in part by grants from the MIUR PRIN/COFIN 2005 Research Program of Italy.	Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Attali C, 2008, INFECT IMMUN, V76, P466, DOI 10.1128/IAI.01261-07; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Beghetto E, 2006, FEMS MICROBIOL LETT, V262, P14, DOI 10.1111/j.1574-6968.2006.00360.x; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bootsma HJ, 2007, INFECT IMMUN, V75, P5489, DOI 10.1128/IAI.01823-06; Bumbaca D, 2004, OMICS, V8, P341, DOI 10.1089/omi.2004.8.341; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Guzman CA, 1999, J INFECT DIS, V179, P901, DOI 10.1086/314655; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Iannelli F, 1999, J BACTERIOL, V181, P2652, DOI 10.1128/JB.181.8.2652-2654.1999; Kawabata S, 2001, INFECT IMMUN, V69, P924, DOI 10.1128/IAI.69.2.924-930.2001; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Knodler LA, 2001, NAT REV MOL CELL BIO, V2, P578, DOI 10.1038/35085062; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; SHOEMAKER NB, 1974, MOL GEN GENET, V128, P283, DOI 10.1007/BF00268516; Sinha A, 2007, LANCET, V369, P389, DOI 10.1016/S0140-6736(07)60195-0; Terao Y, 2005, J INFECT DIS, V192, P2081, DOI 10.1086/498162; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; VANDERFLIER M, 1995, INFECT IMMUN, V63, P4317, DOI 10.1128/IAI.63.11.4317-4322.1995; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	30	43	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7517	7524		10.1074/jbc.M109.062075	http://dx.doi.org/10.1074/jbc.M109.062075			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048164	hybrid, Green Published			2022-12-25	WOS:000275415600063
J	Senatore, A; Spafford, JD				Senatore, Adriano; Spafford, J. David			Transient and Big Are Key Features of an Invertebrate T-type Channel (LCa(v)3) from the Central Nervous System of Lymnaea stagnalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-II LOOP; CALCIUM-CHANNEL; STRUCTURAL DETERMINANTS; CA2+ CHANNELS; SURFACE EXPRESSION; CA(V)3.2; BLOCK; MIBEFRADIL; INACTIVATION; PHARMACOLOGY	Here we describe features of the first non-mammalian T-type calcium channel (LCa(v)3) expressed in vitro. This molluscan channel possesses combined biophysical properties that are reminiscent of all mammalian T-type channels. It exhibits T-type features such as "transient" kinetics, but the "tiny" label, usually associated with Ba2+ conductance, is hard to reconcile with the "bigness" of this channel in many respects. LCa(v)3 is 25% larger than any voltage-gated ion channel expressed to date. It codes for a massive, 322-kDa protein that conducts large macroscopic currents in vitro. LCa(v)3 is also the most abundant Ca2+ channel transcript in the snail nervous system. A window current at typical resting potentials appears to be at least as large as that reported for mammalian channels. This distant gene provides a unique perspective to analyze the structural, functional, drug binding, and evolutionary aspects of T-type channels.	[Senatore, Adriano; Spafford, J. David] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Spafford, JD (corresponding author), Univ Waterloo, Dept Biol, B1-173, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca			Natural Science and Engineering Research Council (NSERC) of Canada; NSERC Alexander Graham Bell Canada	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Alexander Graham Bell Canada	This work was supported by the Natural Science and Engineering Research Council (NSERC) of Canada and a NSERC Alexander Graham Bell Canada Graduate Scholarships ( doctoral) ( to A. Senatore).	Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Atwood HL, 2006, SCIENCE, V312, P1008, DOI 10.1126/science.1128445; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; Bittner KC, 2008, BIOPHYS J, V95, P931, DOI 10.1529/biophysj.107.128124; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Carbone E, 2006, CELL CALCIUM, V40, P147, DOI 10.1016/j.ceca.2006.04.019; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chemin J, 2000, FEBS LETT, V478, P166, DOI 10.1016/S0014-5793(00)01832-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Di Biase V, 2005, J CELL BIOL, V171, P695, DOI 10.1083/jcb.200503077; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ertel S I, 1997, Expert Opin Investig Drugs, V6, P569, DOI 10.1517/13543784.6.5.569; Ferron L, 2003, CIRC RES, V93, P1241, DOI 10.1161/01.RES.0000106134.69300.B7; Gomora JC, 2002, BIOPHYS J, V83, P229, DOI 10.1016/S0006-3495(02)75164-3; Gray LS, 2006, CELL CALCIUM, V40, P115, DOI 10.1016/j.ceca.2006.04.014; HAGIWARA S, 1975, J GEN PHYSIOL, V65, P617, DOI 10.1085/jgp.65.5.617; Iftinca MC, 2009, TRENDS PHARMACOL SCI, V30, P32, DOI 10.1016/j.tips.2008.10.004; Kang HW, 2010, J BIOL CHEM, V285, P3271, DOI 10.1074/jbc.M109.067660; Kang HW, 2006, J BIOL CHEM, V281, P4823, DOI 10.1074/jbc.M510197200; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Lalevee N, 2005, CARDIOVASC RES, V67, P216, DOI 10.1016/j.cardiores.2005.05.009; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lee TS, 2006, PHARMACOLOGY, V78, P11, DOI 10.1159/000094900; Lin YCJ, 2001, J EXP BIOL, V204, P3717; Lory P, 2006, CELL CALCIUM, V40, P135, DOI 10.1016/j.ceca.2006.04.017; MACKIE GO, 1985, NATURE, V313, P791, DOI 10.1038/313791a0; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; McRory JE, 2001, J BIOL CHEM, V276, P3999, DOI 10.1074/jbc.M008215200; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; Obejero-Paz CA, 2008, J GEN PHYSIOL, V132, P239, DOI 10.1085/jgp.200809988; Perchenet L, 2000, N-S ARCH PHARMACOL, V361, P590, DOI 10.1007/s002100000238; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Serrano JR, 1999, J GEN PHYSIOL, V114, P185, DOI 10.1085/jgp.114.2.185; Shcheglovitov A, 2008, FEBS LETT, V582, P3765, DOI 10.1016/j.febslet.2008.10.013; Shin HS, 2008, CURR OPIN PHARMACOL, V8, P33, DOI 10.1016/j.coph.2007.12.003; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; Spafford JD, 2003, J BIOL CHEM, V278, P21178, DOI 10.1074/jbc.M302212200; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Steger KA, 2005, J EXP BIOL, V208, P2191, DOI 10.1242/jeb.01616; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; Talavera K, 2001, J BIOL CHEM, V276, P45628, DOI 10.1074/jbc.M103047200; Talavera K, 2006, PFLUG ARCH EUR J PHY, V453, P189, DOI 10.1007/s00424-006-0129-7; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Wu SW, 2000, J PHARMACOL EXP THER, V292, P939	50	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7447	7458		10.1074/jbc.M109.090753	http://dx.doi.org/10.1074/jbc.M109.090753			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056611	hybrid, Green Published			2022-12-25	WOS:000275415600057
J	Bullmann, L; Haarmann, R; Mirus, O; Bredemeier, R; Hempel, F; Maier, UG; Schleiff, E				Bullmann, Lars; Haarmann, Raimund; Mirus, Oliver; Bredemeier, Rolf; Hempel, Franziska; Maier, Uwe G.; Schleiff, Enrico			Filling the Gap, Evolutionarily Conserved Omp85 in Plastids of Chromalveolates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE BIOGENESIS; PROTEIN TRANSLOCATION; IMPORT; COMPLEX; COMPONENTS; PREDICTION; APICOPLAST; TOC75; MITOCHONDRIAL; TRANSPORTERS	Chromalveolates are a diverse group of protists that include many ecologically and medically relevant organisms such as diatoms and apicomplexan parasites. They possess plastids generally surrounded by four membranes, which evolved by engulfment of a red alga. Today, most plastid proteins must be imported, but many aspects of protein import into complex plastids are still cryptic. In particular, how proteins cross the third outermost membrane has remained unexplained. We identified a protein in the third outermost membrane of the diatom Phaeodactylum tricornutum with properties comparable to those of the Omp85 family. We demonstrate that the targeting route of P. tricornutum Omp85 parallels that of the translocation channel of the outer envelope membrane of chloroplasts, Toc75. In addition, the electrophysiological properties are similar to those of the Omp85 proteins involved in protein translocation. This supports the hypothesis that P. tricornutum Omp85 is involved in precursor protein translocation, which would close a gap in the fundamental understanding of the evolutionary origin and function of protein import in secondary plastids.	Univ Marburg, D-35032 Marburg, Germany; [Haarmann, Raimund; Mirus, Oliver; Bredemeier, Rolf; Schleiff, Enrico] Goethe Univ Frankfurt, Cluster Excellence Frankfurt, D-60438 Frankfurt, Germany; [Haarmann, Raimund; Mirus, Oliver; Bredemeier, Rolf; Schleiff, Enrico] Goethe Univ Frankfurt, Ctr Membrane Prote, Dept Biosci, D-60438 Frankfurt, Germany	Philipps University Marburg; Goethe University Frankfurt; Goethe University Frankfurt		maier@staff.uni-marburg.de; schleiff@bio.uni-frankfurt.de	Schleiff, Enrico/C-5105-2017	Schleiff, Enrico/0000-0002-0518-3489	Deutsche Forschungsgemeinschaft [SFB TR1/A10, SFB807/P17]; Volkswagenstiftung; Graduate School [1216, SFB 593]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagenstiftung(Volkswagen); Graduate School	This work was supported by the Deutsche Forschungsgemeinschaft (SFB TR1/A10 (to O.M. and E.S.) and SFB807/P17 (to R.H. and E.S.)), the Volkswagenstiftung (to R.B. and E.S.), Graduate School 1216 (to L.B. and U.G.M.), and SFB 593 (to F.H. and U.G.M.).	Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baldwin A, 2005, PLANT PHYSIOL, V138, P715, DOI 10.1104/pp.105.063289; Baldwin AJ, 2006, FEBS J, V273, P1547, DOI 10.1111/j.1742-4658.2006.05175.x; Benning C, 2005, J BIOL CHEM, V280, P2397, DOI 10.1074/jbc.R400032200; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bolte K, 2009, J EUKARYOT MICROBIOL, V56, P9, DOI 10.1111/j.1550-7408.2008.00370.x; Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Ertel F, 2005, J BIOL CHEM, V280, P28281, DOI 10.1074/jbc.M503035200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gould SB, 2006, MOL BIOL EVOL, V23, P2413, DOI 10.1093/molbev/msl113; Gould SB, 2006, J MOL EVOL, V62, P674, DOI 10.1007/s00239-005-0099-y; Gross J, 2009, NAT REV GENET, V10, P495, DOI 10.1038/nrg2610; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Hempel F, 2009, MOL BIOL EVOL, V26, P1781, DOI 10.1093/molbev/msp079; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Hust B, 2006, PLANT BIOLOGY, V8, P18, DOI 10.1055/s-2005-873044; Inoue K, 2005, J CELL BIOL, V171, P425, DOI 10.1083/jcb.200506171; Kalanon M, 2009, EUKARYOT CELL, V8, P1146, DOI 10.1128/EC.00061-09; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kilian O, 2004, J MOL EVOL, V58, P712, DOI 10.1007/s00239-004-2593-z; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Loffelhardt W, 2007, SYMBIOSIS, V44, P33; Miege C, 1999, EUR J BIOCHEM, V265, P990, DOI 10.1046/j.1432-1327.1999.00801.x; Minh BQ, 2005, BIOINFORMATICS, V21, P3794, DOI 10.1093/bioinformatics/bti594; Mirus O, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-254; Nicolaisen K, 2009, MOL MICROBIOL, V74, P58, DOI 10.1111/j.1365-2958.2009.06850.x; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Ruffolo CG, 1996, INFECT IMMUN, V64, P3161, DOI 10.1128/IAI.64.8.3161-3167.1996; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Smart OS, 1997, BIOPHYS J, V72, P1109, DOI 10.1016/S0006-3495(97)78760-5; Sommer MS, 2007, MOL BIOL EVOL, V24, P918, DOI 10.1093/molbev/msm008; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; THOMAS WR, 1986, INFECT IMMUN, V52, P812, DOI 10.1128/IAI.52.3.812-817.1986; TRANEL PJ, 1995, EMBO J, V14, P2436, DOI 10.1002/j.1460-2075.1995.tb07241.x; Tuteja R, 2005, ARCH BIOCHEM BIOPHYS, V441, P107, DOI 10.1016/j.abb.2005.07.013; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Winzeler EA, 2008, NATURE, V455, P751, DOI 10.1038/nature07361; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wunder T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-236	59	63	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6848	6856		10.1074/jbc.M109.074807	http://dx.doi.org/10.1074/jbc.M109.074807			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20042599	hybrid, Green Published			2022-12-25	WOS:000275367500087
J	Collins, JM; Neville, MJ; Hoppa, MB; Frayn, KN				Collins, Jennifer M.; Neville, Matt J.; Hoppa, Michael B.; Frayn, Keith N.			De Novo Lipogenesis and Stearoyl-CoA Desaturase Are Coordinately Regulated in the Human Adipocyte and Protect against Palmitate-induced Cell Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOUNSATURATED FATTY-ACIDS; INSULIN SENSITIVITY; ADIPOSE-TISSUE; GLYCERIDE SYNTHESIS; ECTOPIC FAT; BETA-CELLS; MICE; DIFFERENTIATION; DISRUPTION; INHIBITION	De novo lipogenesis (DNL) is paradoxically up-regulated by its end product, saturated fatty acids (SAFAs). We tested the hypothesis that SAFA-induced up-regulation of DNL reflects coordinate up-regulation of elongation and desaturation pathways for disposal of SAFAs and production of monounsaturated fatty acids to protect cells from SAFA toxicity. Human preadipocytes were differentiated in vitro for 14 days with [U-C-13] palmitate (0-200 mu M) to distinguish exogenous fatty acids from those synthesized by DNL. Exogenous palmitate up-regulated DNL (p < 0.001) concomitantly with SCD and elongation (each p < 0.001). Adipocytes from some donors were intolerant to high palmitate concentrations (400 mu M). Palmitate-intolerant cells showed lower TG accumulation. They had lower expression of SCD mRNA and less monounsaturated fatty acids in TG, emphasizing the importance of desaturation for dealing with exogenous SAFAs. There was greater [U-C-13] palmitate incorporation in phospholipids. SCD knockdown with small interfering RNA caused down-regulation of DNL and of expression of DNL-related genes, with reduced membrane fluidity (p < 0.02) and insulin sensitivity (p < 0.01), compared with scrambled small interfering RNA controls. There was preferential channeling of DNL-derived versus exogenous palmitate into elongation and of DNL-derived versus exogenous stearate into desaturation. DNL may not act primarily to increase fat stores but may serve as a key regulator, in tandem with elongation and desaturation, to maintain cell membrane fluidity and insulin sensitivity within the human adipocyte.	[Collins, Jennifer M.; Neville, Matt J.; Hoppa, Michael B.; Frayn, Keith N.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England	University of Oxford	Frayn, KN (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, S Parks Rd, Oxford OX3 7LJ, England.	keith.frayn@oxlip.ox.ac.uk			Humane Research Trust	Humane Research Trust	This work was supported by the Humane Research Trust.	AMRI EZ, 1994, J LIPID RES, V35, P930; AMRI EZ, 1991, J LIPID RES, V32, P1449; Arsov T, 2006, BIOCHEM BIOPH RES CO, V342, P1152, DOI 10.1016/j.bbrc.2006.02.032; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Busch AK, 2005, DIABETES, V54, P2917, DOI 10.2337/diabetes.54.10.2917; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Chong MFF, 2008, AM J CLIN NUTR, V87, P817, DOI 10.1093/ajcn/87.4.817; Cong WN, 2008, LIFE SCI, V82, P983, DOI 10.1016/j.lfs.2008.01.022; Dey D, 2007, MOL CELL BIOCHEM, V300, P149, DOI 10.1007/s11010-006-9378-1; Diraison F, 2003, J LIPID RES, V44, P846, DOI 10.1194/jlr.M200461-JLR200; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garg Abhimanyu, 2006, Clin Cornerstone, V8 Suppl 4, pS7, DOI 10.1016/S1098-3597(06)80039-6; GATES AH, 1965, SCIENCE, V148, P1471, DOI 10.1126/science.148.3676.1471; Gomez FE, 2002, BIOCHEMISTRY-US, V41, P5473, DOI 10.1021/bi012177r; GRUNFELD C, 1981, BIOCHEM BIOPH RES CO, V103, P219, DOI 10.1016/0006-291X(81)91682-X; Hauner H, 2000, METH MOL B, V155, P239; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; MacDonald MLE, 2009, ARTERIOSCL THROM VAS, V29, P341, DOI 10.1161/ATVBAHA.108.181099; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Major CA, 2008, J LIPID RES, V49, P1456, DOI 10.1194/jlr.M700596-JLR200; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; Miyazaki M, 2001, J LIPID RES, V42, P1018; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Moffitt JH, 2005, DIABETOLOGIA, V48, P1819, DOI 10.1007/s00125-005-1861-9; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; OLEFSKY JM, 1975, J CLIN INVEST, V56, P1499, DOI 10.1172/JCI108231; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinnick KE, 2008, OBESITY, V16, P522, DOI 10.1038/oby.2007.110; Rader DJ, 2007, AM J MED, V120, pS12, DOI 10.1016/j.amjmed.2007.01.003; Rasouli N, 2007, DIABETES OBES METAB, V9, P1, DOI 10.1111/j.1463-1326.2006.00590.x; Riserus U, 2005, DIABETES, V54, P1379, DOI 10.2337/diabetes.54.5.1379; Roberts R, 2009, DIABETOLOGIA, V52, P882, DOI 10.1007/s00125-009-1300-4; SAGGERSON ED, 1972, BIOCHEM J, V128, P1069, DOI 10.1042/bj1281069; SAGGERSON ED, 1971, EUR J BIOCHEM, V23, P109, DOI 10.1111/j.1432-1033.1971.tb01597.x; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3; Tanti JF, 2000, METH MOL B, V155, P157; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Warensjo E, 2008, NUTR METAB CARDIOVAS, V18, P683, DOI 10.1016/j.numecd.2007.11.002; Yee JK, 2008, J LIPID RES, V49, P2124, DOI 10.1194/jlr.M700600-JLR200	45	78	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6044	6052		10.1074/jbc.M109.053280	http://dx.doi.org/10.1074/jbc.M109.053280			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20032470	hybrid, Green Published			2022-12-25	WOS:000275367500007
J	Fouladkou, F; Lu, C; Jiang, C; Zhou, LM; She, YM; Walls, JR; Kawabe, H; Brose, N; Henkelman, RM; Huang, A; Bruneau, BG; Rotin, D				Fouladkou, Fatemeh; Lu, Chen; Jiang, Chong; Zhou, Limei; She, Yimin; Walls, Jonathon R.; Kawabe, Hiroshi; Brose, Nils; Henkelman, R. M.; Huang, Annie; Bruneau, Benoit G.; Rotin, Daniela			The Ubiquitin Ligase Nedd4-1 Is Required for Heart Development and Is a Suppressor of Thrombospondin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; VIRUS-LIKE PARTICLES; FACTOR MULTIMER SIZE; GROWTH-FACTOR; EBOLA-VIRUS; STABILITY; DOMAINS; PROTEIN; MOTIF; GENE	Nedd4 (Nedd4-1) is a Hect domain E3 ubiquitin ligase that also contains a C2 domain and three WW domains. Despite numerous in vitro studies, its biological function in vivo is not well understood. Here we show that disruption of Nedd4-1 in mice (leaving Nedd4-2 intact) caused embryonic lethality at mid gestation, with pronounced heart defects (double-outlet right ventricle and atrioventricular cushion defects) and vasculature abnormalities. Quantitative mass spectrometry and immunoblot analyses of lysates from the wild type and knock-out mouse embryonic fibroblasts to identify Nedd4-1 in vivo targets revealed dramatically increased amounts of thrombospondin-1 (Tsp-1) in the knock-out mouse embryonic fibroblasts and embryos. Tsp-1 is an inhibitor of angiogenesis, and its elevated level was mediated primarily by enhanced transcription. Interestingly, the administration of aspirin (an inhibitor of Tsp-1) to the pregnant heterozygote mothers led to a reduction in Tsp-1 levels and a substantial rescue of the embryonic lethality. These results suggest that Nedd4-1 is a suppressor of Tsp1 and that increased levels of Tsp-1 in the Nedd4-1 knock-out mice may have contributed to the developmental defect observed in the embryos.	[Rotin, Daniela] Hosp Sick Children, Cell Biol Program, MaRS TMDT, Toronto, ON M5G 1L7, Canada; [Henkelman, R. M.; Huang, Annie; Rotin, Daniela] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON M5G 1L7, Canada; [Kawabe, Hiroshi; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Bruneau, Benoit G.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Dept Pediat, San Francisco, CA 94158 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Max Planck Society; University of California System; University of California San Francisco; The J David Gladstone Institutes	Rotin, D (corresponding author), Hosp Sick Children, Cell Biol Program, MaRS TMDT, Rm 11-305,101 Coll St, Toronto, ON M5G 1L7, Canada.	drotin@sickkids.ca	amsalu, ribka/G-8780-2019; Kawabe, Hiroshi/U-7325-2018; HENKELMAN, MARK/W-6847-2019	Bruneau, Benoit/0000-0002-0804-7597; Kawabe, Hiroshi/0000-0001-5650-8696; She, Yi-Min/0000-0002-0571-4630	Canadian Institute of Health Research [MOP 13494]; National Cancer Institute of Canada/Canadian Cancer Society Research Institute; Deutsche Forschungsgemeinschaft [SFB271/B11]; European Union; Canadian Foundation for Innovation; Ontario Research and Development Challenge Fund; Japan Society for the Promotion of Science for Research Abroad; Canada Research Chair award	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada/Canadian Cancer Society Research Institute; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research and Development Challenge Fund(General Electric); Japan Society for the Promotion of Science for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by Canadian Institute of Health Research Grant MOP 13494 (to D.R.), by the National Cancer Institute of Canada/Canadian Cancer Society Research Institute (to D.R.), by Deutsche Forschungsgemeinschaft Grant SFB271/B11 (to N.B.), and by the European Union (EUSynapse) (to N.B.). This work was also supported in part by the Canadian Foundation for Innovation and the Ontario Research and Development Challenge Fund.; <SUP>1</SUP>Supported by a Fellowship from the Japan Society for the Promotion of Science for Research Abroad.; <SUP>2</SUP>Recipient of a Canada Research Chair award.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095; Bonnefoy A, 2006, BLOOD, V107, P955, DOI 10.1182/blood-2004-12-4856; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Coppinger JA, 2007, BLOOD, V109, P4786, DOI 10.1182/blood-2006-07-038539; Cyrus T, 2002, CIRCULATION, V106, P1282, DOI 10.1161/01.CIR.0000027816.54430.96; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dussart S, 2005, J MOL BIOL, V345, P547, DOI 10.1016/j.jmb.2004.10.067; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Embark HM, 2004, KIDNEY INT, V66, P1918, DOI 10.1111/j.1523-1755.2004.00966.x; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; GASCA S, 1995, DEV GENET, V17, P141, DOI 10.1002/dvg.1020170206; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Guo NH, 1997, CANCER RES, V57, P1735; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Isenberg JS, 2008, BLOOD, V111, P613, DOI 10.1182/blood-2007-06-098392; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Liu Y, 2009, DEV BIOL, V330, P153, DOI 10.1016/j.ydbio.2009.03.023; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Medina G, 2008, VIROLOGY, V377, P30, DOI 10.1016/j.virol.2008.04.024; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Obler D, 2008, J MED GENET, V45, P481, DOI 10.1136/jmg.2008.057984; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Pham N, 2001, J BIOL CHEM, V276, P46995, DOI 10.1074/jbc.M108373200; Pimanda JE, 2004, J BIOL CHEM, V279, P21439, DOI 10.1074/jbc.M313560200; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Pradervand S, 1999, J AM SOC NEPHROL, V10, P2527; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Serebruany VL, 2004, THROMB RES, V113, P197, DOI 10.1016/j.thromres.2004.03.002; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 1997, AM J PHYSIOL-CELL PH, V272, pC1871, DOI 10.1152/ajpcell.1997.272.6.C1871; TOLSMA SS, 1993, J CELL BIOL, V122, P497, DOI 10.1083/jcb.122.2.497; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Urata S, 2007, J VIROL, V81, P4895, DOI 10.1128/JVI.02829-06; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Xie LJ, 2001, J EXP MED, V193, P1341, DOI 10.1084/jem.193.12.1341; Yang BL, 2008, NAT IMMUNOL, V9, P1356, DOI 10.1038/ni.1670; Yang QW, 2003, CANCER RES, V63, P6299; Yasuda J, 2003, J VIROL, V77, P9987, DOI 10.1128/JVI.77.18.9987-9992.2003; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	67	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6770	6780		10.1074/jbc.M109.082347	http://dx.doi.org/10.1074/jbc.M109.082347			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20026598	hybrid, Green Published			2022-12-25	WOS:000275367500080
J	Tan, YF; You, HH; Wu, C; Altomare, DA; Testa, JR				Tan, Yinfei; You, Huihong; Wu, Chao; Altomare, Deborah A.; Testa, Joseph R.			Appl1 Is Dispensable for Mouse Development, and Loss of Appl1 Has Growth Factor-selective Effects on Akt Signaling in Murine Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPONECTIN RECEPTORS; PROTEIN APPL1; MICE LACKING; KINASE AKT2; CELL-DEATH; BAR-PH; PATHWAY; TRANSDUCTION; ACTIVATION; APOPTOSIS	The adaptor protein APPL1 (adaptor protein containing pleckstrin homology (PH), phosphotyrosine binding (PTB), and leucine zipper motifs) was first identified as a binding protein of AKT2 by yeast two-hybrid screening. APPL1 was subsequently found to bind to several membrane-bound receptors and was implicated in their signal transduction through AKT and/or MAPK pathways. To determine the unambiguous role of Appl1 in vivo, we generated Appl1 knock-out mice. Here we report that Appl1 knock-out mice are viable and fertile. Appl1-null mice were born at expected Mendelian ratios, without obvious phenotypic abnormalities. Moreover, Akt activity in various fetal tissues was unchanged compared with that observed in wildtype littermates. Studies of isolated Appl1(-/-) murine embryonic fibroblasts (MEFs) showed that Akt activation by epidermal growth factor, insulin, or fetal bovine serum was similar to that observed in wild-type MEFs, although Akt activation by HGF was diminished in Appl1(-/-) MEFs. To rule out a possible redundant role played by the related Appl2, we used small interfering RNA to knock down Appl2 expression in Appl1(-/-) MEFs. Unexpectedly, cell survival was unaffected under normal culture conditions, and activation of Akt was unaltered following epidermal growth factor stimulation, although Akt activity did decrease further after HGF stimulation. Furthermore, we found that Appl proteins are required for HGF-induced cell survival and migration via activation of Akt. Our studies suggest that Appl1 is dispensable for development and only participate in Akt signaling under certain conditions.	[Tan, Yinfei; You, Huihong; Altomare, Deborah A.; Testa, Joseph R.] Fox Chase Canc Ctr, Canc Genet & Signaling Program, Philadelphia, PA 19111 USA; [Wu, Chao] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Testa, JR (corresponding author), 333 Cottman Ave, Philadelphia, PA 19111 USA.	Joseph.Testa@fccc.edu			National Institutes of Health [CA77429, CA06927]; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA077429, P30CA006927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77429 (to J.R.T.) and CA06927 (to Fox Chase Cancer Center) from the NCI and an appropriation from the Commonwealth of Pennsylvania.	Chandrasekar B, 2008, J BIOL CHEM, V283, P24889, DOI 10.1074/jbc.M804236200; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cheng JQ, 1996, P NATL ACAD SCI USA, V93, P3636, DOI 10.1073/pnas.93.8.3636; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Chial HJ, 2008, TRAFFIC, V9, P215, DOI 10.1111/j.1600-0854.2007.00680.x; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cox DM, 2002, BIOTECHNIQUES, V33, P267, DOI 10.2144/02332bm02; Dooher JE, 2004, J VIROL, V78, P1645, DOI 10.1128/JVI.78.4.1645-1656.2004; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Kim D, 2005, FRONT BIOSCI-LANDMRK, V10, P975, DOI 10.2741/1592; Ko ML, 2009, J NEUROCHEM, V108, P1607, DOI 10.1111/j.1471-4159.2009.05931.x; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Liu J, 2002, J BIOL CHEM, V277, P26281, DOI 10.1074/jbc.M204679200; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; McCrea HJ, 2008, BIOCHEM BIOPH RES CO, V369, P493, DOI 10.1016/j.bbrc.2008.02.067; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Nechamen CA, 2004, BIOL REPROD, V71, P629, DOI 10.1095/biolreprod.103.025833; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; RONG S, 1994, P NATL ACAD SCI USA, V91, P4731, DOI 10.1073/pnas.91.11.4731; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Staiger H, 2007, DIABETIC MED, V24, P817, DOI 10.1111/j.1464-5491.2007.02166.x; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Yang L, 2003, J BIOL CHEM, V278, P16820, DOI 10.1074/jbc.M213163200; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	31	41	41	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6377	6389		10.1074/jbc.M109.068452	http://dx.doi.org/10.1074/jbc.M109.068452			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20040596	Green Published, hybrid			2022-12-25	WOS:000275367500042
J	Chang, AN; Chen, GH; Gerard, RD; Kamm, KE; Stull, JT				Chang, Audrey N.; Chen, Guohua; Gerard, Robert D.; Kamm, Kristine E.; Stull, James T.			Cardiac Myosin Is a Substrate for Zipper-interacting Protein Kinase (ZIPK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHORYLATION; PHOSPHATASE-ASSOCIATED KINASE; SKELETAL-MUSCLE CONTRACTION; SMOOTH-MUSCLE; IDENTIFICATION; HEART; HYPERTROPHY; MYOCARDIUM; ACTIVATION; APOPTOSIS	Zipper-interacting protein kinase (ZIPK) is a member of the death-associated protein kinase family associated with apoptosis in nonmuscle cells where it phosphorylates myosin regulatory light chain (RLC) to promote membrane blebbing. ZIPK mRNA and protein are abundant in heart tissue and isolated ventricular neonatal rat cardiac myocytes. An unbiased substrate search performed with purified ZIPK on heart homogenates led to the discovery of a prominent 20-kDa protein substrate identified as RLC of ventricular myosin. Biochemical analyses showed ZIPK phosphorylated cardiac RLC at Ser-15 with a V-max value 2-fold greater than the value for smooth/non-muscle RLC; cardiac RLC is a favorable biochemical substrate. Knockdown of ZIPK in cardiac myocytes by small interfering RNA significantly decreased the extent of RLC Ser-15 phosphorylation. Thus, ZIPK may act as a cardiac RLC kinase and thereby affect contractility.	[Chang, Audrey N.; Chen, Guohua; Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Stull, JT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	james.stull@utsouthwestern.edu			National Institutes of Health [HL080536, HL026043]; Moss Heart Fund; Fouad A. and Val Imm Bashour; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007360, R01HL026043, R37HL026043, R01HL080536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Fund; Fouad A. and Val Imm Bashour; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080536 and HL026043 ( to J.T.S.). This work was also supported by grants from the Moss Heart Fund and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology.	Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Dias FAL, 2006, J MOL CELL CARDIOL, V41, P330, DOI 10.1016/j.yjmcc.2006.05.012; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Endo A, 2004, J BIOL CHEM, V279, P42055, DOI 10.1074/jbc.M403676200; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; Ihara E, 2007, AM J PHYSIOL-CELL PH, V292, pC1951, DOI 10.1152/ajpcell.00434.2006; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kawai T, 2003, MOL CELL BIOL, V23, P6174, DOI 10.1128/MCB.23.17.6174-6186.2003; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Levine RJC, 1996, BIOPHYS J, V71, P898, DOI 10.1016/S0006-3495(96)79293-7; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; Morley SJ, 2008, DEV CELL, V15, P639, DOI 10.1016/j.devcel.2008.10.007; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; MURAKAMI U, 1976, J BIOCHEM, V80, P611, DOI 10.1093/oxfordjournals.jbchem.a131316; Niiro N, 2001, J BIOL CHEM, V276, P29567, DOI 10.1074/jbc.M102753200; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; SILVER PJ, 1986, J MOL CELL CARDIOL, V18, P31, DOI 10.1016/S0022-2828(86)80980-4; SIMPSON P, 1982, CIRC RES, V51, P787, DOI 10.1161/01.RES.51.6.787; SIMPSON P, 1982, CIRC RES, V50, P101, DOI 10.1161/01.RES.50.1.101; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Stelzer JE, 2006, J GEN PHYSIOL, V128, P261, DOI 10.1085/jgp.200609547; STULL JT, 1986, ENZYMES, V17, P113; SWEENEY HL, 1986, AM J PHYSIOL, V250, pC657, DOI 10.1152/ajpcell.1986.250.4.C657; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; TOHTONG R, 1995, NATURE, V374, P650, DOI 10.1038/374650a0; Wu XD, 1999, J BIOL CHEM, V274, P20328, DOI 10.1074/jbc.274.29.20328; Yang YH, 1998, J STRUCT BIOL, V122, P139, DOI 10.1006/jsbi.1998.3979; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102	36	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5122	5126		10.1074/jbc.C109.076489	http://dx.doi.org/10.1074/jbc.C109.076489			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20038585	hybrid, Green Published			2022-12-25	WOS:000275327200002
J	Hurskainen, M; Ruggiero, F; Hagg, P; Pihlajaniemi, T; Huhtala, P				Hurskainen, Merja; Ruggiero, Florence; Hagg, Pasi; Pihlajaniemi, Taina; Huhtala, Pirkko			Recombinant Human Collagen XV Regulates Cell Adhesion and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE ZONES; EXON-INTRON ORGANIZATION; HUMAN TISSUES; XVIII COLLAGEN; ALPHA-1 CHAIN; PROLYL 4-HYDROXYLASE; SULFATE PROTEOGLYCAN; CORRESPONDING GENE; ENDOSTATIN; DOMAIN	The C-terminal end of collagen XV, restin, has been the focus of several studies, but the functions of full-length collagen XV have remained unknown. We describe here studies on the production, purification, and function of collagen XV and the production of a monoclonal N-terminal antibody to it. Full-length human collagen XV was produced in insect cells using baculo-viruses and purified from the cell culture medium. The yield was 15 mg/liter of cell culture medium. The collagen XV was shown to be trimeric, with disulfide bonds in the collagenous region. Rotary shadowing electron microscopy revealed rod-like molecules with a mean length of 241.8 nm and with a globular domain at one end. The globular domain was verified to be the N-terminal end by N-terminal antibody binding. The molecules show flexibility in their conformation, presumably due to the many interruptions in their collagenous domains. The ability of collagen XV to serve as a substrate for cells was tested in cell adhesion assays, and it was shown that cells did not bind to collagen XV coated surfaces. When added to the culture medium of fibroblasts and fibrosarcoma cells, however, collagen XV rapidly bound to their fibronectin network. Solid phase assays showed that collagen XV binds to fibronectin, laminin, and vitronectin and that it binds to the collagen/gelatin-binding domain of fibronectin. No binding was detected to fibrillar collagens, fibril-associated collagens, or decorin. Interestingly, collagen XV was found to inhibit the adhesion and migration of fibrosarcoma cells when present in fibronectin-containing matrices.	[Hurskainen, Merja; Hagg, Pasi; Pihlajaniemi, Taina; Huhtala, Pirkko] Univ Oulu, Inst Biomed, Oulu Ctr Cell Matrix Res, Bioctr Oulu,Dept Med Biochem & Mol Biol, Oulu 90014, Finland; [Ruggiero, Florence] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, F-69361 Lyon 07, France	University of Oulu; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Huhtala, P (corresponding author), Univ Oulu, Inst Biomed, Oulu Ctr Cell Matrix Res, Bioctr Oulu,Dept Med Biochem & Mol Biol, Aapistie 7, Oulu 90014, Finland.	pirkko.huhtala@oulu.fi		RUGGIERO, Florence/0000-0003-2915-5359; Pihlajaniemi, Taina/0000-0002-1664-9045; Hurskainen, Merja/0000-0001-8270-8974	European Commission [504 743]; Research Council for Health of the Academy of Finland [115237, 114784]; Sigrid Juselius Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); Research Council for Health of the Academy of Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by European Commission Grant 504 743, Research Council for Health of the Academy of Finland Grants 115237 and 114784, and a grant from the Sigrid Juselius Foundation.	Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Amenta PS, 2000, HUM PATHOL, V31, P359, DOI 10.1016/S0046-8177(00)80251-8; Amenta PS, 2005, J HISTOCHEM CYTOCHEM, V53, P165, DOI 10.1369/jhc.4A6376.2005; Amenta PS, 2003, J PATHOL, V199, P298, DOI 10.1002/path.1303; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Eklund L, 2001, P NATL ACAD SCI USA, V98, P1194, DOI 10.1073/pnas.031444798; Eriksson K, 2003, FEBS LETT, V536, P19, DOI 10.1016/S0014-5793(03)00003-6; Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083; Fukushige T, 2005, J DERMATOL, V32, P74; Hagg PM, 1997, AM J PATHOL, V150, P2075; Hagg PM, 1998, J BIOL CHEM, V273, P17824, DOI 10.1074/jbc.273.28.17824; Halfter W, 1998, J BIOL CHEM, V273, P25404, DOI 10.1074/jbc.273.39.25404; Harris A, 2007, MOL CANCER RES, V5, P1241, DOI 10.1158/1541-7786.MCR-07-0200; Hurskainen M, 2005, FASEB J, V19, P1564, DOI 10.1096/fj.04-3101fje; *INV CORP, 2008, BAC TO BAC BAC EXPR; Jin XM, 2001, CANCER GENE THER, V8, P982, DOI 10.1038/sj.cgt.7700396; John H, 2005, BBA-PROTEINS PROTEOM, V1747, P161, DOI 10.1016/j.bbapap.2004.10.013; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; KIVIRIKKO S, 1994, J BIOL CHEM, V269, P4773; KIVIRIKKO S, 1995, AM J PATHOL, V147, P1500; Li DQ, 2000, J BIOL CHEM, V275, P22339, DOI 10.1074/jbc.M000519200; Marneros AG, 2004, EMBO J, V23, P89, DOI 10.1038/sj.emboj.7600014; MURAGAKI Y, 1994, J BIOL CHEM, V269, P4042; MURAGAKI Y, 1995, P NATL ACAD SCI USA, V92, P8763, DOI 10.1073/pnas.92.19.8763; Musso O, 1998, HEPATOLOGY, V28, P98, DOI 10.1002/hep.510280115; Myers JC, 1996, CELL TISSUE RES, V286, P493, DOI 10.1007/s004410050719; Myers JC, 2007, BIOCHEM J, V404, P535, DOI 10.1042/BJ20070201; Nyberg P, 2003, J BIOL CHEM, V278, P22404, DOI 10.1074/jbc.M210325200; Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200; Olsson AK, 2004, CANCER RES, V64, P9012, DOI 10.1158/0008-5472.CAN-04-2172; Ramchandran R, 1999, BIOCHEM BIOPH RES CO, V255, P735, DOI 10.1006/bbrc.1999.0248; REHN M, 1994, J BIOL CHEM, V269, P13929; REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234; Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9; SARRET Y, 1992, J INVEST DERMATOL, V99, P656, DOI 10.1111/1523-1747.ep12668151; Sasaki T, 2000, J MOL BIOL, V301, P1179, DOI 10.1006/jmbi.2000.3996; Snellman A, 2000, J BIOL CHEM, V275, P8936, DOI 10.1074/jbc.275.12.8936; Tomono Y, 2002, CELL STRUCT FUNCT, V27, P9, DOI 10.1247/csf.27.9; Vuorela A, 1997, EMBO J, V16, P6702, DOI 10.1093/emboj/16.22.6702; Wickstrom SA, 2004, J BIOL CHEM, V279, P20178, DOI 10.1074/jbc.M312921200; Wilson RF, 2003, ANTICANCER RES, V23, P1289; XU R, 2002, XUE YU SHENG WU WU L, V34, P138; Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414	43	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5258	5265		10.1074/jbc.M109.033787	http://dx.doi.org/10.1074/jbc.M109.033787			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20040604	Green Published, hybrid			2022-12-25	WOS:000275327200019
J	Seifert, EL; Estey, C; Xuan, JY; Harper, ME				Seifert, Erin L.; Estey, Carmen; Xuan, Jian Y.; Harper, Mary-Ellen			Electron Transport Chain-dependent and -independent Mechanisms of Mitochondrial H2O2 Emission during Long-chain Fatty Acid Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SPECIES GENERATION; NICOTINAMIDE-NUCLEOTIDE TRANSHYDROGENASE; ALPHA-KETOGLUTARATE DEHYDROGENASE; INSULIN-RESISTANCE; RAT-HEART; COMPLEX-III; SUPEROXIDE-PRODUCTION; MUSCLE MITOCHONDRIA; LIVER-MITOCHONDRIA; ENERGY-METABOLISM	Oxidative stress in skeletal muscle is a hallmark of various pathophysiologic states that also feature increased reliance on long-chain fatty acid (LCFA) substrate, such as insulin resistance and exercise. However, little is known about the mechanistic basis of the LCFA-induced reactive oxygen species (ROS) burden in intact mitochondria, and elucidation of this mechanistic basis was the goal of this study. Specific aims were to determine the extent to which LCFA catabolism is associated with ROS production and to gain mechanistic insights into the associated ROS production. Because intermediates and by-products of LCFA catabolism may interfere with antioxidant mechanisms, we predicted that ROS formation during LCFA catabolism reflects a complex process involving multiple sites of ROS production as well as modified mitochondrial function. Thus, we utilized several complementary approaches to probe the underlying mechanism(s). Using skeletal muscle mitochondria, our findings indicate that even a low supply of LCFA is associated with ROS formation in excess of that generated by NADH-linked substrates. Moreover, ROS production was evident across the physiologic range of membrane potential and was relatively insensitive to membrane potential changes. Determinations of topology and membrane potential as well as use of inhibitors revealed complex III and the electron transfer flavoprotein (ETF) and ETF-oxidoreductase, as likely sites of ROS production. Finally, ROS production was sensitive to matrix levels of LCFA catabolic intermediates, indicating that mitochondrial export of LCFA catabolic intermediates can play a role in determining ROS levels.	[Seifert, Erin L.; Estey, Carmen; Xuan, Jian Y.; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	Maryellen.Harper@uottawa.ca	Harper, Mary-Ellen/C-3103-2009	Harper, Mary-Ellen/0000-0003-3864-5886	Canadian Institutes of Health Research; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was supported by the Canadian Institutes of Health Research (Institute of Nutrition, Metabolism, and Diabetes) (to M.- E. H.) and by a fellowship from the Canadian Diabetes Association (to E. L. S.). Part of this work was presented at the Obesity Society Meeting, 2007.	Abdul-Ghani MA, 2009, DIABETOLOGIA, V52, P574, DOI 10.1007/s00125-009-1264-4; Abdul-Ghani MA, 2008, AM J PHYSIOL-ENDOC M, V295, pE678, DOI 10.1152/ajpendo.90287.2008; Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Benderdour M, 2003, J BIOL CHEM, V278, P45154, DOI 10.1074/jbc.M306285200; Bhattacharya A, 2009, J BIOL CHEM, V284, P46, DOI 10.1074/jbc.M806311200; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; BRASS EP, 1980, BIOCHEM J, V188, P451, DOI 10.1042/bj1880451; BROWN GC, 2002, BIOENERGETICS PRACTI, P49; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chinopoulos C, 2000, NEUROCHEM INT, V36, P483, DOI 10.1016/S0197-0186(99)00161-8; Ciapaite J, 2005, DIABETES, V54, P944, DOI 10.2337/diabetes.54.4.944; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; FARRELL SO, 1984, J BIOL CHEM, V259, P3089; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034; HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3; Jackson MJ, 2008, FREE RADICAL BIO MED, V44, P132, DOI 10.1016/j.freeradbiomed.2007.06.003; JOCELYN PC, 1985, BIOCHEM PHARMACOL, V34, P1588, DOI 10.1016/0006-2952(85)90706-3; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Lambert AJ, 2008, FEBS LETT, V582, P1711, DOI 10.1016/j.febslet.2008.04.030; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; LYSIAK W, 1988, J BIOL CHEM, V263, P1151; Mingrone G, 2004, ANN NY ACAD SCI, V1033, P99, DOI 10.1196/annals.1320.009; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Noland RC, 2009, J BIOL CHEM, V284, P22840, DOI 10.1074/jbc.M109.032888; Pedersen A, 2008, J BIOENERG BIOMEMBR, V40, P463, DOI 10.1007/s10863-008-9170-x; Penzo D, 2002, BBA-BIOENERGETICS, V1555, P160, DOI 10.1016/S0005-2728(02)00272-4; Power RA, 2007, DIABETOLOGIA, V50, P824, DOI 10.1007/s00125-007-0605-4; Ramsay RR, 1999, AM J MED SCI, V318, P28, DOI 10.1097/00000441-199907000-00005; RAMSAY RR, 1987, BIOCHEM J, V241, P883, DOI 10.1042/bj2410883; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; RYDSTROM J, 1972, EUR J BIOCHEM, V31, P496, DOI 10.1111/j.1432-1033.1972.tb02557.x; Sauer SW, 2008, BBA-BIOENERGETICS, V1777, P1276, DOI 10.1016/j.bbabio.2008.05.447; Savitha S, 2007, MECH AGEING DEV, V128, P206, DOI 10.1016/j.mad.2006.11.029; Savitha S, 2007, EUR J PHARMACOL, V574, P61, DOI 10.1016/j.ejphar.2007.07.016; Schonfeld P, 2007, BBA-BIOENERGETICS, V1767, P1032, DOI 10.1016/j.bbabio.2007.04.005; Schonfeld P, 2009, FREE RADICAL BIO MED, V47, P503, DOI 10.1016/j.freeradbiomed.2009.05.006; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; Shabalina IG, 2006, BIOCHEM J, V399, P405, DOI 10.1042/BJ20060706; Sipos I, 2003, NEUROCHEM RES, V28, P1575, DOI 10.1023/A:1025634728227; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; STANLEY KK, 1975, BIOCHEM J, V150, P77, DOI 10.1042/bj1500077; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Tretter L, 2007, NEUROCHEM RES, V32, P569, DOI 10.1007/s11064-006-9130-y; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wensaas AJ, 2009, DIABETES, V58, P527, DOI 10.2337/db08-1043; Wieckowski MR, 2000, FEBS LETT, V484, P61, DOI 10.1016/S0014-5793(00)02127-X; WOLDEGIORGIS G, 1982, J BIOL CHEM, V257, P4783; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	73	184	188	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5748	5758		10.1074/jbc.M109.026203	http://dx.doi.org/10.1074/jbc.M109.026203			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20032466	Green Published, hybrid			2022-12-25	WOS:000275327200067
J	Elfving, K; Olsen, B; Bergstrom, S; Waldenstrom, J; Lundkvist, A; Sjostedt, A; Mejlon, H; Nilsson, K				Elfving, Karin; Olsen, Bjorn; Bergstrom, Sven; Waldenstrom, Jonas; Lundkvist, Ake; Sjostedt, Anders; Mejlon, Hans; Nilsson, Kenneth			Dissemination of Spotted Fever Rickettsia Agents in Europe by Migrating Birds	PLOS ONE			English	Article							PASSERINE BIRDS; INFECTED TICKS; HELVETICA; AESCHLIMANNII; PREVALENCE	Migratory birds are known to play a role as long-distance vectors for many microorganisms. To investigate whether this is true of rickettsial agents as well, we characterized tick infestation and gathered ticks from 13,260 migratory passerine birds in Sweden. A total of 1127 Ixodes spp. ticks were removed from these birds and the extracted DNA from 957 of them was available for analyses. The DNA was assayed for detection of Rickettsia spp. using real-time PCR, followed by DNA sequencing for species identification. Rickettsia spp. organisms were detected in 108 (11.3%) of the ticks. Rickettsia helvetica, a spotted fever rickettsia associated with human infections, was predominant among the PCR-positive samples. In 9 (0.8%) of the ticks, the partial sequences of 17kDa and ompB genes showed the greatest similarity to Rickettsia monacensis, an etiologic agent of Mediterranean spotted fever-like illness, previously described in southern Europe as well as to the Rickettsia sp. IrITA3 strain. For 15 (1.4%) of the ticks, the 17kDa, ompB, gltA and ompA genes showed the greatest similarity to Rickettsia sp. strain Davousti, Rickettsia japonica and Rickettsia heilongjiangensis, all closely phylogenetically related, the former previously found in Amblyomma tholloni ticks in Africa and previously not detected in Ixodes spp. ticks. The infestation prevalence of ticks infected with rickettsial organisms was four times higher among ground foraging birds than among other bird species, but the two groups were equally competent in transmitting Rickettsia species. The birds did not seem to serve as reservoir hosts for Rickettsia spp., but in one case it seems likely that the bird was rickettsiemic and that the ticks had acquired the bacteria from the blood of the bird. In conclusion, migratory passerine birds host epidemiologically important vector ticks and Rickettsia species and contribute to the geographic distribution of spotted fever rickettsial agents and their diseases.	[Elfving, Karin; Waldenstrom, Jonas; Nilsson, Kenneth] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden; [Olsen, Bjorn; Waldenstrom, Jonas] Kalmar Univ, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Bergstrom, Sven] Umea Univ, Dept Mol Biol, Umea, Sweden; [Lundkvist, Ake] Swedish Inst Infect Dis Control, Solna, Sweden; [Sjostedt, Anders] Umea Univ Hosp, Dept Clin Microbiol, S-90185 Umea, Sweden; [Mejlon, Hans] Uppsala Univ, Museum Evolut, Uppsala, Sweden; [Nilsson, Kenneth] Clin Res Ctr, Dalarna, Falun, Sweden; [Elfving, Karin; Nilsson, Kenneth] Falun Cent Hosp, Dept Clin Microbiol, Falun, Sweden	Uppsala University; Uppsala University Hospital; Linnaeus University; University of Kalmar; Umea University; Swedish Institute for Infectious Disease Control; Umea University; Uppsala University; Falun Hospital	Elfving, K (corresponding author), Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden.	kenneth.nilsson@medsci.uu.se	Sjöstedt, Anders/AAC-6575-2020; Waldenström, Jonas/E-4460-2013	Sjöstedt, Anders/0000-0002-0768-8405; Waldenström, Jonas/0000-0002-1152-4235; Olsen, Bjorn/0000-0002-4646-691X	Swedish Research Council [07922]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning Formas; Swedish Foundation for Strategic Research; JC Kempe Foundation; National Institutes of Health [AI37248]; Center of Clinical Research Dalarna [9028]; Uppsala Orebro-Regional Research Council [25021]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037248] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning Formas(Swedish Research Council Formas); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); JC Kempe Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Clinical Research Dalarna; Uppsala Orebro-Regional Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the grants from the Swedish Research Council (VR-M) 07922, the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning Formas), Swedish Foundation for Strategic Research, the JC Kempe Foundation, National Institutes of Health grant AI37248 and also by grants from the Center of Clinical Research Dalarna (9028) and Uppsala Orebro-Regional Research Council (25021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JF, 1986, INFECT IMMUN, V51, P394, DOI 10.1128/IAI.51.2.394-396.1986; Bjoersdorff A, 2001, EMERG INFECT DIS, V7, P877; Bown KJ, 2003, EMERG INFECT DIS, V9, P63; BURGDORFER W, 1975, ANN NY ACAD SCI, V266, P61, DOI 10.1111/j.1749-6632.1975.tb35088.x; BURGDORFER W, 1967, ANNU REV ENTOMOL, V12, P347, DOI 10.1146/annurev.en.12.010167.002023; BURGDORFER W, 1966, B WORLD HEALTH ORGAN, V35, P149; Choi YJ, 2005, CLIN DIAGN LAB IMMUN, V12, P759, DOI 10.1128/CDLI.12.6.759-763.2005; Comstedt P, 2006, EMERG INFECT DIS, V12, P1087; COWAN G.O., 2003, MANSONS TROPICAL DIS, V21, P891; Fournier PE, 2000, EMERG INFECT DIS, V6, P389, DOI 10.3201/eid0604.000412; Fournier PE, 2002, J CLIN MICROBIOL, V40, P2176, DOI 10.1128/JCM.40.6.2176-2181.2002; Fransson T., 2008, SWEDISH BIRD RINGING, V3; Leitner M, 2002, AM J TROP MED HYG, V67, P166, DOI 10.4269/ajtmh.2002.67.166; Lundstrom JO, 2001, J MED ENTOMOL, V38, P289, DOI 10.1603/0022-2585-38.2.289; Matsumoto K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-74; Nilsson K, 1999, LANCET, V354, P1169, DOI 10.1016/S0140-6736(99)04093-3; Nilsson K, 2009, J INFECTION, V58, P79, DOI 10.1016/j.jinf.2008.06.005; Nilsson K, 1997, J CLIN MICROBIOL, V35, P243, DOI 10.1128/JCM.35.1.243-247.1997; OLSEN B, 1995, APPL ENVIRON MICROB, V61, P3082; Olsen B, 1998, EPIDEMIOL INFECT, V121, P481, DOI 10.1017/S0950268898001320; Palmgren H, 1997, SCAND J INFECT DIS, V29, P565, DOI 10.3109/00365549709035895; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Parola P, 2005, VET RES, V36, P469, DOI 10.1051/vetres:2005004; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; Santos-Silva MM, 2006, EXP APPL ACAROL, V39, P331, DOI 10.1007/s10493-006-9008-3; Sekeyova Z, 2000, J MED ENTOMOL, V37, P707, DOI 10.1603/0022-2585-37.5.707; Shpynov S, 2004, J CLIN MICROBIOL, V42, P2221, DOI 10.1128/JCM.42.5.2221-2223.2004; Simser JA, 2002, APPL ENVIRON MICROB, V68, P4559, DOI 10.1128/AEM.68.9.4559-4566.2002; STANCZAK J, 2009, INT JEN S TICK BORN; Stenos J, 2005, AM J TROP MED HYG, V73, P1083, DOI 10.4269/ajtmh.2005.73.1083; Waldenstrom J, 2007, EMERG INFECT DIS, V13, P1215, DOI 10.3201/eid1308.061416	33	105	109	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8572	10.1371/journal.pone.0008572	http://dx.doi.org/10.1371/journal.pone.0008572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052286	Green Published, Green Submitted, gold			2022-12-25	WOS:000273338500015
J	Dias, JM; Losberger, C; Deruaz, M; Power, CA; Proudfoot, AEI; Shaw, JP				Dias, Joao M.; Losberger, Christophe; Deruaz, Maud; Power, Christine A.; Proudfoot, Amanda E. I.; Shaw, Jeffrey P.			Structural Basis of Chemokine Sequestration by a Tick Chemokine Binding Protein: The Crystal Structure of the Complex between Evasin-1 and CCL3	PLOS ONE			English	Article							ELECTRON-DENSITY MAPS; MIP-1-ALPHA; RANTES; IDENTIFICATION; MANIPULATION; REFINEMENT; MIP-1-BETA; MIMICRY; SYSTEM	Background:Chemokines are a subset of cytokines responsible for controlling the cellular migration of inflammatory cells through interaction with seven transmembrane G protein-coupled receptors. The blocking of a chemokine-receptor interaction results in a reduced inflammatory response, and represents a possible anti-inflammatory strategy, a strategy that is already employed by some virus and parasites. Anti-chemokine activity has been described in the extracts of tick salivary glands, and we have recently described the cloning and characterization of such chemokine binding proteins from the salivary glands, which we have named Evasins. Methodology/Principal Findings: We have solved the structure of Evasin-1, a very small and highly selective chemokinebinding protein, by x-ray crystallography and report that the structure is novel, with no obvious similarity to the previously described structures of viral chemokine binding proteins. Moreover it does not possess a known fold. We have also solved the structure of the complex of Evasin-1 and its high affinity ligand, CCL3. The complex is a 1:1 heterodimer in which the Nterminal region of CCL3 forms numerous contacts with Evasin-1, including prominent it-it interactions between residues Trp89 and Phe14 of the binding protein and Phe29 and Phe13 of the chemokine. Conclusions/Significance:However, these interactions do not appear to be crucial for the selectivity of the binding protein, since these residues are found in CCL5, which is not a ligand for Evasin-1. The selectivity of the interaction would appear to lie in the N-terminal residues of the chemokine, which form the "address" whereas the hydrophobic interactions in the rest of the complex would serve primarily to stabilize the complex. A thorough understanding of the binding mode of this small protein, and its other family members, could be very informative in the design of potent neutralizing molecules of proinflammatory mediators of the immune system, such as chemokines.	[Dias, Joao M.; Losberger, Christophe; Deruaz, Maud; Power, Christine A.; Proudfoot, Amanda E. I.; Shaw, Jeffrey P.] Merck Serono SA, Merck Serono Geneva Res Ctr, Geneva, Switzerland	Merck KGaA; EMD Serono Inc.	Dias, JM (corresponding author), Scripps Res Inst, Ollmann Saphire Lab, La Jolla, CA 92037 USA.	Jeffrey.Shaw@merckserono.net			European Union [LSHB-CT-2005-518167]	European Union(European Commission)	J.M.D. was a Serono SA-funded and employed postdoctoral fellow. This research was financed by internal funding from MerckSerono SA. The funders had no role in study design, data collection and analysis, or preparation of the manuscript and approved the decision to publish. AEIP and MD were also partially supported by the European Union FP6 (INNOCHEM, grant number LSHB-CT-2005-518167).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Alcami A, 2000, TRENDS MICROBIOL, V8, P410, DOI 10.1016/S0966-842X(00)01830-8; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; ALCAMI A, 2003, METH MOL B, V239, P167; Alcami A, 2007, EUR J IMMUNOL, V37, P880, DOI 10.1002/eji.200737215; Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Alexander-Brett JM, 2007, J EXP MED, V204, P3157, DOI 10.1084/jem.20071677; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Blanpain C, 2001, J LEUKOCYTE BIOL, V69, P977; Born TL, 2000, J IMMUNOL, V164, P3246, DOI 10.4049/jimmunol.164.6.3246; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burns JM, 2002, J BIOL CHEM, V277, P2785, DOI 10.1074/jbc.M109884200; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Dabbagh K, 2000, J IMMUNOL, V165, P3418, DOI 10.4049/jimmunol.165.6.3418; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeRider ML, 2006, J BIOMOL NMR, V36, P22, DOI [10.1007/s10858-005-6276-x, 10.1007/s10858-006-9021-1]; DERUAZ M, 2008, J EXP MED; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Esteban DJ, 2004, J GEN VIROL, V85, P1291, DOI 10.1099/vir.0.79902-0; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gillespie RD, 2000, PARASITE IMMUNOL, V22, P319, DOI 10.1046/j.1365-3024.2000.00309.x; Hajnicka V, 2005, PARASITOLOGY, V130, P333, DOI 10.1017/S0031182004006535; Hajnicka V, 2001, PARASITE IMMUNOL, V23, P483, DOI 10.1046/j.1365-3024.2001.00403.x; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Johnson Z, 2003, INFLAMM RES, V52, pS187, DOI 10.1007/BF03354218; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lorenzo ME, 2001, SEMIN IMMUNOL, V13, P1, DOI 10.1006/smim.2000.0290; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nuara AA, 2007, J GEN VIROL, V88, P51, DOI 10.1099/vir.0.82324-0; Nuara AA, 2006, J VIROL, V80, P10675, DOI 10.1128/JVI.01015-06; Nuttall PA, 1998, PARASITOLOGY, V116, pS65, DOI 10.1017/S003118200008495X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Proudfoot AEI, 2000, METH MOL B, V138, P75; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P215; PROUDFOOT AEI, 1995, FEBS LETT, V376, P19, DOI 10.1016/0014-5793(95)01235-X; RIBEIRO JMC, 1985, J EXP MED, V161, P332, DOI 10.1084/jem.161.2.332; Roovers RC, 2007, CURR OPIN MOL THER, V9, P327; Sakala IG, 2007, J VIROL, V81, P3346, DOI 10.1128/JVI.01927-06; Schoeler GB, 2001, ANN TROP MED PARASIT, V95, P755, DOI 10.1080/0003498012011118; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Tasaki Y, 1999, GENOMICS, V55, P353, DOI 10.1006/geno.1998.5670; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Zhang L, 2006, P NATL ACAD SCI USA, V103, P13985, DOI 10.1073/pnas.0602142103; Zoffmann S, 2001, J MED CHEM, V44, P215, DOI 10.1021/jm000982i	56	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2009	4	12							e8514	10.1371/journal.pone.0008514	http://dx.doi.org/10.1371/journal.pone.0008514			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601NW	20041127	gold, Green Submitted, Green Published			2022-12-25	WOS:000278068700025
J	Dillon, J; Andrianakis, I; Bull, K; Glautier, S; O'Connor, V; Holden-Dye, L; James, C				Dillon, James; Andrianakis, Ioannis; Bull, Kate; Glautier, Steve; O'Connor, Vincent; Holden-Dye, Lindy; James, Christopher			AutoEPG: Software for the Analysis of Electrical Activity in the Microcircuit Underpinning Feeding Behaviour of Caenorhabditis elegans	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; C-ELEGANS; GLUTAMATERGIC NEUROTRANSMISSION; 5-HT7-LIKE RECEPTOR; PHARYNGEAL MUSCLE; MOTOR-NEURON; SYSTEM; 5-HT; CONDUCTANCE; MOVEMENT	Background: The pharyngeal microcircuit of the nematode Caenorhabditis elegans serves as a model for analysing neural network activity and is amenable to electrophysiological recording techniques. One such technique is the electropharyngeogram (EPG) which has provided insight into the genetic basis of feeding behaviour, neurotransmission and muscle excitability. However, the detailed manual analysis of the digital recordings necessary to identify subtle differences in activity that reflect modulatory changes within the underlying network is time consuming and low throughput. To address this we have developed an automated system for the high-throughput and discrete analysis of EPG recordings (AutoEPG). Methodology/Principal Findings: AutoEPG employs a tailor made signal processing algorithm that automatically detects different features of the EPG signal including those that report on the relaxation and contraction of the muscle and neuronal activity. Manual verification of the detection algorithm has demonstrated AutoEPG is capable of very high levels of accuracy. We have further validated the software by analysing existing mutant strains with known pharyngeal phenotypes detectable by the EPG. In doing so, we have more precisely defined an evolutionarily conserved role for the calcium-dependent potassium channel, SLO-1, in modulating the rhythmic activity of neural networks. Conclusions/Significance: AutoEPG enables the consistent analysis of EPG recordings, significantly increases analysis throughput and allows the robust identification of subtle changes in the electrical activity of the pharyngeal nervous system. It is anticipated that AutoEPG will further add to the experimental tractability of the C. elegans pharynx as a model neural circuit.	[Dillon, James; Bull, Kate; O'Connor, Vincent; Holden-Dye, Lindy] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Andrianakis, Ioannis; James, Christopher] Univ Southampton, Signal Proc & Control Grp, Inst Sound & Vibrat Res, Southampton, Hants, England; [Glautier, Steve] Univ Southampton, Sch Psychol, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton	Dillon, J (corresponding author), Univ Southampton, Sch Biol Sci, Southampton, Hants, England.	jcd@soton.ac.uk	James, Christopher/AAV-4770-2020; Glautier, Steven/H-5444-2011	Glautier, Steven/0000-0001-8852-3268; Holden-Dye, Lindy/0000-0002-9704-1217; O'Connor, Vincent/0000-0003-3185-5709; Dillon, James/0000-0003-3244-7483	BBSRC [BB/E022251/1]; Biotechnology and Biological Sciences Research Council [BB/E022251/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work has been funded by the BBSRC (www.bbsrc.ac.uk) as part of a 'cross-council MRC/BBSRC initiative in mental health.' Grant Number BB/E022251/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery L, 1995, METHOD CELL BIOL, V48, P251; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BRENNER S, 1974, GENETICS, V77, P71; Buckingham Steven D., 2008, Invertebrate Neuroscience, V8, P121, DOI 10.1007/s10158-008-0077-3; Chiang JTA, 2006, J EXP BIOL, V209, P1859, DOI 10.1242/jeb.02165; Cronin Christopher J., 2006, V351, P241; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Franks Christopher J., 2006, Invertebrate Neuroscience, V6, P105, DOI 10.1007/s10158-006-0023-1; Hobson RJ, 2006, GENETICS, V172, P159, DOI 10.1534/genetics.105.044495; Hobson RJ, 2003, J NEUROCHEM, V87, P22, DOI 10.1046/j.1471-4159.2003.01967.x; Holden-Dye Lindy, 2007, Invertebrate Neuroscience, V7, P199, DOI 10.1007/s10158-007-0057-z; Huang KM, 2008, J NEUROSCI METH, V171, P153, DOI 10.1016/j.jneumeth.2008.01.027; James CJ, 1999, CLIN NEUROPHYSIOL, V110, P2049, DOI 10.1016/S1388-2457(99)00168-6; James CJ, 2003, ARTIF INTELL MED, V28, P89, DOI 10.1016/S0933-3657(03)00037-X; Jin W, 2000, BRAIN RES, V860, P21, DOI 10.1016/S0006-8993(00)01943-0; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Li HY, 1997, P NATL ACAD SCI USA, V94, P5912, DOI 10.1073/pnas.94.11.5912; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Niacaris T, 2003, J EXP BIOL, V206, P223, DOI 10.1242/jeb.00101; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Papaioannou Sylvana, 2008, Invertebrate Neuroscience, V8, P91, DOI 10.1007/s10158-008-0072-8; Pemberton DJ, 2001, MOL PHARMACOL, V59, P1037, DOI 10.1124/mol.59.5.1037; RAIZEN DM, 1995, GENETICS, V141, P1365; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Restif C, 2008, LECT NOTES COMPUT SC, V5241, P35, DOI 10.1007/978-3-540-85988-8_5; Rogers CM, 2001, J NEUROBIOL, V49, P235, DOI 10.1002/neu.1078; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Traub RD, 2003, J NEUROPHYSIOL, V89, P909, DOI 10.1152/jn.00573.2002; Tsechpenakis G, 2008, IEEE T BIO-MED ENG, V55, P1539, DOI 10.1109/TBME.2008.918582; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0	35	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8482	10.1371/journal.pone.0008482	http://dx.doi.org/10.1371/journal.pone.0008482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041123	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000273105200015
J	Fenton, K; Fismen, S; Hedberg, A; Seredkina, N; Fenton, C; Mortensen, ES; Rekvig, OP				Fenton, Kristin; Fismen, Silje; Hedberg, Annica; Seredkina, Natalya; Fenton, Chris; Mortensen, Elin Synnove; Rekvig, Ole Petter			Anti-dsDNA Antibodies Promote Initiation, and Acquired Loss of Renal Dnase1 Promotes Progression of Lupus Nephritis in Autoimmune (NZBxNZW)F1 Mice	PLOS ONE			English	Article							GLOMERULAR MESANGIAL CELLS; MATRIX-METALLOPROTEINASE ACTIVITY; MURINE LUPUS; ALPHA-ACTININ; MATRIX-METALLOPROTEINASE-9 EXPRESSION; NEPHRITOGENIC ANTIBODIES; BASEMENT-MEMBRANE; PLASMA-LEVELS; HUMAN GENOME; HUMAN SLE	Background: Lupus nephritis is characterized by deposition of chromatin fragment-IgG complexes in the mesangial matrix and glomerular basement membranes (GBM). The latter defines end-stage disease. Methodology/Principals: In the present study we determined the impact of antibodies to dsDNA, renal Dnase1 and matrix metalloprotease (MMP) mRNA levels and enzyme activities on early and late events in murine lupus nephritis. The major focus was to analyse if these factors were interrelated, and if changes in their expression explain basic processes accounting for lupus nephritis. Findings: Early phases of nephritis were associated with chromatin-IgG complex deposition in the mesangial matrix. A striking observation was that this event correlated with appearance of anti-dsDNA antibodies and mild or clinically silent nephritis. These events preceded down-regulation of renal Dnase1. Later, renal Dnase1 mRNA level and enzyme activity were reduced, while MMP2 mRNA level and enzyme activity increased. Reduced levels of renal Dnase1 were associated in time with deficient fragmentation of chromatin from dead cells. Large fragments were retained and accumulated in GBM. Also, since chromatin fragments are prone to stimulate Toll-like receptors in e. g. dendritic cells, this may in fact explain increased expression of MMPs. Significance: These scenarios may explain the basis for deposition of chromatin-IgG complexes in glomeruli in early and late stages of nephritis, loss of glomerular integrity and finally renal failure.	[Fenton, Kristin; Hedberg, Annica; Seredkina, Natalya; Rekvig, Ole Petter] Univ Tromso, Inst Med Biol, Dept Biochem, Fac Med, Tromso, Norway; [Mortensen, Elin Synnove] Univ Tromso, Inst Med Biol, Dept Pathol, Fac Med, Tromso, Norway; [Fismen, Silje; Mortensen, Elin Synnove] Univ Hosp No Norway, Dept Pathol, Tromso, Norway; [Rekvig, Ole Petter] Univ Hosp No Norway, Dept Rheumatol, Tromso, Norway; [Fenton, Chris] Univ Tromso, Fac Med, Microarray Platform, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Fenton, K (corresponding author), Univ Tromso, Inst Med Biol, Dept Biochem, Fac Med, Tromso, Norway.	olepr@fagmed.uit.no	Rekvig, Ole Petter/V-7113-2019; Fenton, Kristin/AAY-4459-2021	Fenton, Kristin/0000-0002-8356-2628	Foundation for Health and Rehabilitation through the Norwegian Rheumatology Organization [2004/2/0250]; Northern Norway Regional Health Authority Medical Research Program [SFP-100-04, SFP-101-04]; Thematic Research Support; University of Tromso	Foundation for Health and Rehabilitation through the Norwegian Rheumatology Organization; Northern Norway Regional Health Authority Medical Research Program; Thematic Research Support; University of Tromso	This work was supported by Foundation for Health and Rehabilitation through the Norwegian Rheumatology Organization (project 2004/2/0250), from Northern Norway Regional Health Authority Medical Research Program (Grants # SFP-100-04, SFP-101-04, and Thematic Research Support), and from University of Tromso, as a Milieu support given to OPR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amital H, 2005, J IMMUNOL, V175, P5516, DOI 10.4049/jimmunol.175.8.5516; Amoura Z, 1997, ARTHRITIS RHEUM, V40, P2217, DOI 10.1002/art.1780401217; Amoura Z, 1999, ARTHRITIS RHEUM, V42, P833, DOI 10.1002/1529-0131(199905)42:5<833::AID-ANR1>3.3.CO;2-K; Basnakian AG, 2005, J AM SOC NEPHROL, V16, P697, DOI 10.1681/ASN.2004060494; CHAN TM, 1992, CLIN EXP IMMUNOL, V88, P68; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Chen M, 2005, RENAL FAILURE, V27, P507, DOI 10.1080/08860220500198151; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Dai Y, 2009, RHEUMATOL INT, V29, P749, DOI 10.1007/s00296-008-0758-6; Daikh D, 1997, J LEUKOCYTE BIOL, V62, P156, DOI 10.1002/jlb.62.2.156; Deocharan B, 2002, J IMMUNOL, V168, P3072, DOI 10.4049/jimmunol.168.6.3072; Doerfler W, 2006, CURR TOP MICROBIOL, V301, P125; Gesualdi NM, 2007, STRESS, V10, P342, DOI 10.1080/10253890701314863; Haugbro K, 2004, ANN RHEUM DIS, V63, P386, DOI 10.1136/ard.2003.016303; Kalaaji M, 2007, KIDNEY INT, V71, P664, DOI 10.1038/sj.ki.5002133; Kalaaji M, 2006, ARTHRITIS RHEUM-US, V54, P914, DOI 10.1002/art.21622; Kalaaji M, 2006, AM J PATHOL, V168, P1779, DOI 10.2353/ajpath.2006.051329; Krieg AM, 1998, BIODRUGS, V10, P341, DOI 10.2165/00063030-199810050-00001; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Krieg AM, 2007, IMMUNITY, V27, P695, DOI 10.1016/j.immuni.2007.11.001; Licht R, 2001, ARTHRITIS RHEUM-US, V44, P1320, DOI 10.1002/1529-0131(200106)44:6<1320::AID-ART224>3.0.CO;2-X; Lim EJ, 2006, FEBS LETT, V580, P4533, DOI 10.1016/j.febslet.2006.06.100; Lim EJ, 2007, EXP MOL MED, V39, P239, DOI 10.1038/emm.2007.27; Mason LJ, 2004, ARTHRITIS RHEUM-US, V50, P866, DOI 10.1002/art.20103; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Mjelle JE, 2007, ANN RHEUM DIS, V66, P1661, DOI 10.1136/ard.2007.070482; Nephritis L, 2008, AM J PATHOL, V172, P275, DOI 10.2353/ajpath.2008.070563; Mortensen ES, 2009, J AM SOC NEPHROL, V20, P696, DOI 10.1681/ASN.2008010112; Mostoslavsky G, 2001, EUR J IMMUNOL, V31, P1221, DOI 10.1002/1521-4141(200104)31:4<1221::AID-IMMU1221>3.0.CO;2-P; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Napirei M, 2004, ARTHRITIS RHEUM-US, V50, P1873, DOI 10.1002/art.20267; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Qureshi F, 2000, AM J REPROD IMMUNOL, V44, P136, DOI 10.1111/j.8755-8920.2000.440302.x; RADEKE HH, 1994, J IMMUNOL, V153, P1281; Rekvig OP, 2003, ARTHRITIS RHEUM-US, V48, P300, DOI 10.1002/art.10739; Rekvig OP, 1997, J CLIN INVEST, V99, P2045, DOI 10.1172/JCI119373; ROSENTHAL AL, 1977, ANAL BIOCHEM, V80, P76, DOI 10.1016/0003-2697(77)90627-3; Roth R, 1996, J IMMUNOL, V157, P2924; SABBAGA J, 1989, EUR J IMMUNOL, V19, P137, DOI 10.1002/eji.1830190122; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Seredkina N, 2009, AM J PATHOL IN PRESS; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; Tveita AA, 2008, ARTHR RES T IN PRESS; Tveita AA, 2008, KIDNEY INT, V74, P1150, DOI 10.1038/ki.2008.308; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P485; Zhang Q, 2008, ANN RHEUM DIS, V67, P1633, DOI 10.1136/ard.2007.079574; Zykova SN, 2008, ARTHRITIS RHEUM-US, V58, P813, DOI 10.1002/art.23276	51	85	93	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8474	10.1371/journal.pone.0008474	http://dx.doi.org/10.1371/journal.pone.0008474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041189	Green Submitted, Green Published, gold			2022-12-25	WOS:000273105200010
J	Li, WLS; Rodrigo, AG				Li, Wai Lok Sibon; Rodrigo, Allen G.			Covariation of Branch Lengths in Phylogenies of Functionally Related Genes	PLOS ONE			English	Article							EVOLUTIONARY RATE VARIATION; INTERACTING PROTEINS; MOLECULAR EVOLUTION; ADAPTIVE EVOLUTION; POSITIVE SELECTION; DIVERGENCE TIME; COEVOLUTION; PREDICTION; SEQUENCE; DATABASE	Recent studies have shown evidence for the coevolution of functionally-related genes. This coevolution is a result of constraints to maintain functional relationships between interacting proteins. The studies have focused on the correlation in gene tree branch lengths of proteins that are directly interacting with each other. We here hypothesize that the correlation in branch lengths is not limited only to proteins that directly interact, but also to proteins that operate within the same pathway. Using generalized linear models as a basis of identifying correlation, we attempted to predict the gene ontology (GO) terms of a gene based on its gene tree branch lengths. We applied our method to a dataset consisting of proteins from ten prokaryotic species. We found that the degree of accuracy to which we could predict the function of the proteins from their gene tree varied substantially with different GO terms. In particular, our model could accurately predict genes involved in translation and certain ribosomal activities with the area of the receiver-operator curve of up to 92%. Further analysis showed that the similarity between the trees of genes labeled with similar GO terms was not limited to genes that physically interacted, but also extended to genes functioning within the same pathway. We discuss the relevance of our findings as it relates to the use of phylogenetic methods in comparative genomics.	[Li, Wai Lok Sibon; Rodrigo, Allen G.] Univ Auckland, Bioinformat Inst, Auckland 1, New Zealand; [Li, Wai Lok Sibon] Univ Auckland, Dept Comp Sci, Auckland 1, New Zealand; [Rodrigo, Allen G.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Li, WLS (corresponding author), Univ Auckland, Bioinformat Inst, Auckland 1, New Zealand.	a.rodrigo@auckland.ac.nz	Rodrigo, Allen/E-8905-2015	Rodrigo, Allen/0000-0002-8327-7317	Biomatters	Biomatters	Wai Lok Sibon Li was partially funded by Biomatters during the period of research outlined in this paper. The commercial funder was not involved in any of the following aspects of the research: study design; collection, analysis, and interpretation of data; writing of the paper; or decision to submit for publication. An early revision of the manuscript was first reviewed by the funder, but no changes were made as a result of the review. The algorithm described here may be implemented in the funding company's software packages. This will pose no restrictions toward anyone interested in reproducing or building on the algorithm, as the described algorithm uses generic statistical methods that are not exclusive to the authors' study, and that have previously been published. No patents have been placed on the methodology described. In addition, all data used in this paper is publicly available. The involvement of the funder does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fay JC, 2003, ANNU REV GENOM HUM G, V4, P213, DOI 10.1146/annurev.genom.4.020303.162528; FOLEY DH, 1972, IEEE T INFORM THEORY, V18, P618, DOI 10.1109/TIT.1972.1054863; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fryxell KJ, 1996, TRENDS GENET, V12, P364, DOI 10.1016/S0168-9525(96)80020-5; Gertz J, 2003, BIOINFORMATICS, V19, P2039, DOI 10.1093/bioinformatics/btg278; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; Gillmor SA, 2000, J MOL BIOL, V299, P993, DOI 10.1006/jmbi.2000.3812; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Goh CS, 2002, J MOL BIOL, V324, P177, DOI 10.1016/S0022-2836(02)01038-0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hakes L, 2007, P NATL ACAD SCI USA, V104, P7999, DOI 10.1073/pnas.0609962104; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Jucovic M, 1996, P NATL ACAD SCI USA, V93, P2343, DOI 10.1073/pnas.93.6.2343; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Kim WK, 2004, BIOINFORMATICS, V20, P1138, DOI 10.1093/bioinformatics/bth053; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Leinonen R, 2004, BIOINFORMATICS, V20, P3236, DOI 10.1093/bioinformatics/bth191; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; MARINORAMIREZ L, 2006, EVOLUTIONARY BIOINFO, P295; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Pages S, 1997, PROTEINS, V29, P517, DOI 10.1002/(SICI)1097-0134(199712)29:4<517::AID-PROT11>3.3.CO;2-I; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; Ramani AK, 2003, J MOL BIOL, V327, P273, DOI 10.1016/S0022-2836(03)00114-1; Ranwez V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-241; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross HA, 2002, J VIROL, V76, P11715, DOI 10.1128/JVI.76.22.11715-11720.2002; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sato T., 2003, GENOME INFORM, V14, P496; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Shakhnovich BE, 2005, GENOME RES, V15, P385, DOI 10.1101/gr.3133605; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shapiro BJ, 2008, PLOS GENET, V4, DOI [10.1371/journal.pgen.0040023.eor, 10.1371/journal.pgen.0040023]; SIEPEL A, 2006, NEW METHODS DETECTIN, DOI DOI 10.1007/11732990; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Singh S, 2008, EVOL BIOINFORM, V4, P217; Sumiyama K, 2002, MOL BIOL EVOL, V19, P1093, DOI 10.1093/oxfordjournals.molbev.a004167; Tan SH, 2004, NUCLEIC ACIDS RES, V32, pW69, DOI 10.1093/nar/gkh471; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wolf YI, 2006, P ROY SOC B-BIOL SCI, V273, P1507, DOI 10.1098/rspb.2006.3472; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Wu CH, 2004, COMPUT BIOL CHEM, V28, P87, DOI 10.1016/j.compbiolchem.2003.10.003; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148	64	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8487	10.1371/journal.pone.0008487	http://dx.doi.org/10.1371/journal.pone.0008487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041191	gold, Green Published, Green Submitted			2022-12-25	WOS:000273105200019
J	May, MR; Provance, MC; Sanders, AC; Ellstrand, NC; Ross-Ibarra, J				May, Michael R.; Provance, Mitchell C.; Sanders, Andrew C.; Ellstrand, Norman C.; Ross-Ibarra, Jeffrey			A Pleistocene Clone of Palmer's Oak Persisting in Southern California	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC-VARIATION; WILD RADISH; ANCIENT	Background: The distribution of Palmer's oak (Quercus palmeri Engelm.) includes numerous isolated populations that are presumably relicts of a formerly larger range that has contracted due to spreading aridity following the end of the Pleistocene. Principal Findings: We investigated a recently discovered disjunct population of Palmer's oak in the Jurupa Mountains of Riverside County, California. Patterns of allozyme polymorphism, morphological homogeneity, widespread fruit abortion, and evidence of fire resprouting all strongly support the hypothesis that the population is a single clone. The size of the clone and estimates of annual growth from multiple populations lead us to conclude that the clone is in excess of 13,000 years old. Conclusions: The ancient age of the clone implies it originated during the Pleistocene and is a relict of a vanished vegetation community. Range contraction after climate change best explains the modern disjunct distribution of Q. palmeri and perhaps other plants in California.	[May, Michael R.] Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA; [Provance, Mitchell C.; Sanders, Andrew C.; Ellstrand, Norman C.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Ellstrand, Norman C.] Univ Calif Riverside, Ctr Conservat Biol, Riverside, CA 92521 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Davis	May, MR (corresponding author), Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA.	rossibarra@ucdavis.edu	Ross-Ibarra, Jeffrey/D-7782-2011	Ross-Ibarra, Jeffrey/0000-0003-1656-4954				Alfonso-Corrado C, 2004, EVOL ECOL, V18, P585, DOI 10.1007/s10682-004-5145-5; Ally D, 2008, MOL ECOL, V17, P4897, DOI 10.1111/j.1365-294X.2008.03962.x; ASHTON GC, 1961, AUST J BIOL SCI, V14, P248, DOI 10.1071/BI9610248; DeWoody J, 2008, WEST N AM NATURALIST, V68, P493, DOI 10.3398/1527-0904-68.4.493; ELLSTRAND NC, 1985, AM NAT, V126, P606, DOI 10.1086/284442; ELLSTRAND NC, 1984, AM NAT, V123, P819, DOI 10.1086/284241; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; *FLOR N AM ED COMM, 1993, FLOR N AM MEX; Griffin J, 1978, FREMONTIA, V6, P8; GRIFFIN J R, 1976, Madrono, V23, P295; Griffin JR, 1972, PSW82 USDA FOR SERV; HANDEL SN, 1985, AM NAT, V125, P367, DOI 10.1086/284348; Hijmans R.J., 2001, PLANT GENETIC RESOUR, V127, P15, DOI DOI 10.1016/j.compositesa.2008.10.018; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Leskinen P. H., 1975, Madrono, V23, P234; Lynch AJJ, 1998, AUST J BOT, V46, P25, DOI 10.1071/BT96120; Mayes SG, 1998, AM J BOT, V85, P1609, DOI 10.2307/2446489; Miller M, 2000, US FOR SERV RMRS-P, P9; MITTON JB, 1979, J HERED, V70, P86, DOI 10.1093/oxfordjournals.jhered.a109220; Mock KE, 2008, MOL ECOL, V17, P4827, DOI 10.1111/j.1365-294X.2008.03963.x; Montalvo AM, 1997, AM J BOT, V84, P1553, DOI 10.2307/2446617; Owen LA, 2003, GEOLOGY, V31, P729, DOI 10.1130/G19561.1; PAYSEN TE, 1991, FOREST SCI, V37, P17; Peakall R, 2003, MOL ECOL, V12, P2331, DOI 10.1046/j.1365-294X.2003.01926.x; Provance Mitchell C., 2000, Madrono, V47, P139; ROBERTS FM, 2004, VASCULAR PLANTS W RI; TUCKER J M, 1982, Aliso, V10, P321; VASEK FC, 1980, AM J BOT, V67, P246, DOI 10.2307/2442649; WARTER JK, 1976, SPECIAL PUBL CALIFOR, V2; WHERRY E T, 1972, Castanea, V37, P94	31	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8346	10.1371/journal.pone.0008346	http://dx.doi.org/10.1371/journal.pone.0008346			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20041136	Green Published, gold			2022-12-25	WOS:000272998100004
J	Kwant-Mitchell, A; Pek, EA; Rosenthal, KL; Ashkar, AA				Kwant-Mitchell, Amanda; Pek, Elishka A.; Rosenthal, Kenneth L.; Ashkar, Ali A.			Development of Functional Human NK Cells in an Immunodeficient Mouse Model with the Ability to Provide Protection against Tumor Challenge	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; BONE-MARROW; CORD BLOOD; HEMATOPOIETIC-CELLS; POTENTIAL ROLE; IMMUNE-SYSTEM; IN-VITRO; T-CELLS; ENGRAFTMENT; DEFICIENT	Studies of human NK cells and their role in tumor suppression have largely been restricted to in vitro experiments which lack the complexity of whole organisms, or mouse models which differ significantly from humans. In this study we showed that, in contrast to C57BL/6 Rag2(-/-)/gamma(-/-)(c) and NOD/Scid mice, newborn BALB/c Rag2(-/-)/gamma(-/-)(c) mice can support the development of human NK cells and CD56+ T cells after intrahepatic injection with hematopoietic stem cells. The human CD56(+) cells in BALB/c Rag2(-/-)/gamma(-/-)(c) mice were able to produce IFN-gamma in response to human IL-15 and polyI:C. NK cells from reconstituted Rag2(-/-)/gamma(-/-)(c) mice were also able to kill and inhibit the growth of K562 cells in vitro and were able to produce IFN-gamma in response to stimulation with K562 cells. In vivo, reconstituted Rag2(-/-)/gamma(-/-)(c) mice had higher survival rates after K562 challenge compared to non-reconstituted Rag2(-/-)/gamma(-/-)(c) mice and were able to control tumor burden in various organs. Reconstituted Rag2(-/-)/gamma(-/-)(c) mice represent a model in which functional human NK and CD56+ T cells can develop from stem cells and can thus be used to study human disease in a more clinically relevant environment.	[Kwant-Mitchell, Amanda; Pek, Elishka A.; Rosenthal, Kenneth L.; Ashkar, Ali A.] McMaster Univ, Hlth Sci Ctr, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON, Canada	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba	Kwant-Mitchell, A (corresponding author), McMaster Univ, Hlth Sci Ctr, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON, Canada.	ashkara@mcmaster.ca		Ashkar, Ali/0000-0003-1139-1468	Canadian Institutes of Health Research; Canadian Breast Cancer Foundation (Ontario Chaper); RxD/CIHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation (Ontario Chaper); RxD/CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from Canadian Institutes of Health Research and Canadian Breast Cancer Foundation (Ontario Chaper). AAA is a recipient of a career award in Health Sciences from Rx&D/CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of themanuscript.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Baxevanis CN, 2003, J IMMUNOL, V171, P2953, DOI 10.4049/jimmunol.171.6.2953; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Carayol G, 1998, EUR J IMMUNOL, V28, P1991, DOI 10.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO;2-7; Cashman JD, 1997, BLOOD, V89, P4307, DOI 10.1182/blood.V89.12.4307; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; Dewan MZ, 2006, CANCER SCI, V97, P1381, DOI 10.1111/j.1349-7006.2006.00319.x; FEUER G, 1995, J VIROL, V69, P1328, DOI 10.1128/JVI.69.2.1328-1333.1995; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Gritzapis AD, 2002, CANCER IMMUNOL IMMUN, V51, P440, DOI 10.1007/s00262-002-0298-y; Guimaraes F, 2006, LEUKEMIA, V20, P833, DOI 10.1038/sj.leu.2404147; HESSELTON RM, 1995, J INFECT DIS, V172, P974, DOI 10.1093/infdis/172.4.974; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kalberer CP, 2003, BLOOD, V102, P127, DOI 10.1182/blood-2002-07-2024; KAMELREID S, 1989, SCIENCE, V246, P1597, DOI 10.1126/science.2595371; Kawano T, 1998, P NATL ACAD SCI USA, V95, P5690, DOI 10.1073/pnas.95.10.5690; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Langhans B, 2005, J IMMUNOL METHODS, V306, P161, DOI 10.1016/j.jim.2005.08.010; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Legrand N, 2006, J IMMUNOL, V176, P2053, DOI 10.4049/jimmunol.176.4.2053; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Macchiarini Francesca, 2005, J Exp Med, V202, P1307, DOI 10.1084/jem.20051547; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Mrozek E, 1996, BLOOD, V87, P2632, DOI 10.1182/blood.V87.7.2632.bloodjournal8772632; Nieda M, 2001, BLOOD, V97, P2067, DOI 10.1182/blood.V97.7.2067; ORTALDO JR, 1991, CELL IMMUNOL, V136, P486, DOI 10.1016/0008-8749(91)90369-M; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2004, IMMUNOL REV, V202, P275, DOI 10.1111/j.0105-2896.2004.00199.x; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Sun JC, 2008, J IMMUNOL, V181, P7453, DOI 10.4049/jimmunol.181.11.7453; Taniguchi M, 2003, NAT IMMUNOL, V4, P1164, DOI 10.1038/ni1203-1164; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Ueda T, 2000, J CLIN INVEST, V105, P1013, DOI 10.1172/JCI8583; Wallace ME, 2005, SPRINGER SEMIN IMMUN, V27, P49, DOI 10.1007/s00281-004-0195-x; WHITESIDE TL, 1995, CURR OPIN IMMUNOL, V7, P704, DOI 10.1016/0952-7915(95)80080-8; Williams NS, 1997, J EXP MED, V186, P1609, DOI 10.1084/jem.186.9.1609; Woo SY, 2003, BRIT J HAEMATOL, V121, P148, DOI 10.1046/j.1365-2141.2003.04230.x; Yokoyama WM, 2006, IMMUNOL REV, V214, P143, DOI 10.1111/j.1600-065X.2006.00458.x; Yoshino H, 2000, BONE MARROW TRANSPL, V26, P1211, DOI 10.1038/sj.bmt.1702702; Yu HX, 1998, BLOOD, V92, P3647, DOI 10.1182/blood.V92.10.3647.422k43_3647_3657	48	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8379	10.1371/journal.pone.0008379	http://dx.doi.org/10.1371/journal.pone.0008379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027308	Green Published, gold, Green Submitted			2022-12-25	WOS:000272940100015
J	Tenenbaum, J; Ayoub, MA; Perkovska, S; Adra-Delenne, AL; Mendre, C; Ranchin, B; Bricca, G; Geelen, G; Mouillac, B; Durroux, T; Morin, D				Tenenbaum, Julie; Ayoub, Mohammed A.; Perkovska, Sanja; Adra-Delenne, Anne-Laure; Mendre, Christiane; Ranchin, Bruno; Bricca, Giamperro; Geelen, Ghislaine; Mouillac, Bernard; Durroux, Thierry; Morin, Denis			The Constitutively Active V2 Receptor Mutants Conferring NSIAD Are Weakly Sensitive to Agonist and Antagonist Regulation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; RESONANCE ENERGY-TRANSFER; INAPPROPRIATE ANTIDIURESIS; NEPHROGENIC SYNDROME; BETA-ARRESTIN; LIVING CELLS; HYPONATREMIA; MUTATION; BRET	Patients having the nephrogenic syndrome of inappropriate antidiuresis present either the R137C or R137L V2 mutated receptor. While the clinical features have been characterized, the molecular mechanisms of functioning of these two mutants remain elusive. In the present study, we compare the pharmacological properties of R137C and R137L mutants with the wild-type and the V2 D136A receptor, the latter being reported as a highly constitutively active receptor. We have performed binding studies, second messenger measurements and BRET experiments in order to evaluate the affinities of the ligands, their agonist and antagonist properties and the ability of the receptors to recruit beta-arrestins, respectively. The R137C and R137L receptors exhibit small constitutive activities regarding the G(s) protein activation. In addition, these two mutants induce a constitutive beta-arrestin recruitment. Of interest, they also exhibit weak sensitivities to agonist and to inverse agonist in term of G(s) protein coupling and beta-arrestin recruitment. The small constitutive activities of the mutants and the weak regulation of their functioning by agonist suggest a poor ability of the antidiuretic function to be adapted to the external stimuli, giving to the environmental factors an importance which can explain some of the phenotypic variability in patients having NSIAD.	[Tenenbaum, Julie; Ayoub, Mohammed A.; Perkovska, Sanja; Adra-Delenne, Anne-Laure; Mendre, Christiane; Mouillac, Bernard; Durroux, Thierry; Morin, Denis] CNRS, Inst Genom Fonct, UMR 5203, Montpellier, France; [Tenenbaum, Julie; Ayoub, Mohammed A.; Perkovska, Sanja; Adra-Delenne, Anne-Laure; Mendre, Christiane; Mouillac, Bernard; Durroux, Thierry; Morin, Denis] INSERM, U661, Montpellier, France; [Tenenbaum, Julie; Ayoub, Mohammed A.; Perkovska, Sanja; Adra-Delenne, Anne-Laure; Mendre, Christiane; Mouillac, Bernard; Durroux, Thierry; Morin, Denis] Univ Montpellier 1 2, Montpellier, France; [Ranchin, Bruno] Univ Lyon 1, Ctr Reference Malad Renales Rares, Dept Nephrol Rhumatol Neurol HDJ & Dialyse, Hosp Civils Lyon,HFME,UFR Med Lyon Est, F-69365 Lyon, France; [Ranchin, Bruno] Univ Lyon 1, INSERM, U499, F-69365 Lyon, France; [Bricca, Giamperro] Univ Lyon 1, Pharmacol Lab, UFR Med Lyon Est, F-69365 Lyon, France; [Bricca, Giamperro] Univ Lyon 1, INSERM, ERI 22, F-69365 Lyon, France; [Geelen, Ghislaine] UFR Med Lyon Est, EFEM, CBN, Hop Croix Rousse,Hosp Civils Lyon,Lab Physiol, Lyon, France; [Morin, Denis] Nephrol Pediat CHU Montpellier, Ctr Reference Malad Renales Rares Sud Ouest, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Universite de Montpellier; CHU de Montpellier	Tenenbaum, J (corresponding author), CNRS, Inst Genom Fonct, UMR 5203, Montpellier, France.	tdurroux@igf.cnrs.fr	MOUILLAC, Bernard/M-3896-2014	MOUILLAC, Bernard/0000-0002-3906-8673; AYOUB, Mohammed Akli/0000-0003-0022-578X; Durroux, Thierry/0000-0003-1091-6066	CNRS; INSERM	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by research grants from CNRS and INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Bes DF, 2007, PEDIATR NEPHROL, V22, P463, DOI 10.1007/s00467-006-0344-7; Bichet DG, 2006, ADV CHRONIC KIDNEY D, V13, P96, DOI 10.1053/j.ackd.2006.01.006; Charest PG, 2005, EMBO REP, V6, P334, DOI 10.1038/sj.embor.7400373; Decaux G, 2007, J AM SOC NEPHROL, V18, P606, DOI 10.1681/ASN.2006090987; Feldman BJ, 2005, NEW ENGL J MED, V352, P1884, DOI 10.1056/NEJMoa042743; GUPTA S, 2009, EUR J ENDOCRINOL; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Marcialis MA, 2008, PEDIATR NEPHROL, V23, P2267, DOI 10.1007/s00467-008-0913-z; Morin D, 1998, FEBS LETT, V441, P470, DOI 10.1016/S0014-5793(98)01585-3; Morin D, 1998, ADV EXP MED BIOL, V449, P391; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Orcel H, 2009, MOL PHARMACOL, V75, P637, DOI 10.1124/mol.108.049031; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Soule S, 2008, ANN CLIN BIOCHEM, V45, P520, DOI 10.1258/acb.2007.007211; Thompson Miles D., 2008, V448, P109, DOI 10.1007/978-1-59745-205-2_7	19	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2009	4	12							e8383	10.1371/journal.pone.0008383	http://dx.doi.org/10.1371/journal.pone.0008383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535AY	20027297	Green Published, gold, Green Submitted			2022-12-25	WOS:000272940100018
J	Cooper, EM; Boeke, JD; Cohen, RE				Cooper, Eric M.; Boeke, Jef D.; Cohen, Robert E.			Specificity of the BRISC Deubiquitinating Enzyme Is Not Due to Selective Binding to Lys(63)-linked Polyubiquitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-BINDING; STRUCTURAL BASIS; DNA; COMPLEX; BRCA1; CHAIN; REVEALS; IDENTIFICATION; DETERMINANTS; DEGRADATION	BRISC (Brcc36-containing isopeptidase complex) is a four-subunit deubiquitinating (DUB) enzyme that has a catalytic subunit, called Brcc36, that is a member of the JAMM/MPN+ family of zinc metalloproteases. A notable feature of BRISC is its high specificity for cleaving Lys(63)-linked polyubiquitin. Here, we show that BRISC selectivity is not due to preferential binding to Lys(63)-linked polyubiquitin but is instead dictated by how the substrate isopeptide linkage is oriented within the enzyme active site. BRISC possesses a high affinity binding site for the ubiquitin hydrophobic surface patch that accounts for the bulk of the affinity between enzyme and substrate. Although BRISC can interact with either subunit of a diubiquitin conjugate, substrate cleavage occurs only when BRISC is bound to the hydrophobic patch of the distal (i.e. the "S1") ubiquitin at a ubiquitin-ubiquitin cleavage site. The importance of the Lys(63)-linked proximal (S1') ubiquitin was underscored by our finding that BRISC could not cleave the isopeptide bond joining a ubiquitin to a non-ubiquitin substrate. Finally, we also show that Abro1, another BRISC subunit, binds directly to Brcc36 and that the Brcc36-Abro1 heterodimer includes a minimal complex with Lys(63)-specific DUB activity.	[Cooper, Eric M.; Cohen, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Cooper, Eric M.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Cooper, Eric M.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Cooper, EM (corresponding author), 733 N Broadway,320 BRB, Baltimore, MD 21205 USA.	emcooper@jhsph.edu; bob.cohen@colostate.edu		Boeke, Jef/0000-0001-5322-4946	National Institutes of Health Roadmap [RR020839]; Ruth Kirschstein Postdoctoral Fellowship [5F32GM075712]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075712] Funding Source: NIH RePORTER	National Institutes of Health Roadmap(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth Kirschstein Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Roadmap Grant RR020839 (to R. E. C. and J. D. B.). This work was also supported by Ruth Kirschstein Postdoctoral Fellowship 5F32GM075712 (to E. M. C.).	Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bellare P, 2006, RNA, V12, P292, DOI 10.1261/rna.2152306; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; PICKART CM, 1986, J BIOL CHEM, V261, P210; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	42	47	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10344	10352		10.1074/jbc.M109.059667	http://dx.doi.org/10.1074/jbc.M109.059667			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20032457	Green Published, hybrid			2022-12-25	WOS:000276264600019
J	Petrovic, N; Walden, TB; Shabalina, IG; Timmons, JA; Cannon, B; Nedergaard, J				Petrovic, Natasa; Walden, Tomas B.; Shabalina, Irina G.; Timmons, James A.; Cannon, Barbara; Nedergaard, Jan			Chronic Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Activation of Epididymally Derived White Adipocyte Cultures Reveals a Population of Thermogenically Competent, UCP1-containing Adipocytes Molecularly Distinct from Classic Brown Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; FAT-CELLS; MITOCHONDRIAL BIOGENESIS; ADULT HUMANS; NONSHIVERING THERMOGENESIS; TRANSCRIPTIONAL CONTROL; UNCOUPLING PROTEIN-1; COLD-ACCLIMATION; SKELETAL-MUSCLE; GENE-EXPRESSION	The recent insight that brown adipocytes and muscle cells share a common origin and in this respect are distinct from white adipocytes has spurred questions concerning the origin and molecular characteristics of the UCP1-expressing cells observed in classic white adipose tissue depots under certain physiological or pharmacological conditions. Examining precursors from the purest white adipose tissue depot (epididymal), we report here that chronic treatment with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone promotes not only the expression of PGC-1 alpha and mitochondriogenesis in these cells but also a norepinephrine-augmentable UCP1 gene expression in a significant subset of the cells, providing these cells with a genuine thermogenic capacity. However, although functional thermogenic genes are expressed, the cells are devoid of transcripts for the novel transcription factors now associated with classic brown adipocytes (Zic1, Lhx8, Meox2, and characteristically PRDM16) or for myocyte-associated genes (myogenin and myomirs (muscle-specific microRNAs)) and retain white fat characteristics such as Hoxc9 expression. Co-culture experiments verify that the UCP1-expressing cells are not proliferating classic brown adipocytes (adipomyocytes), and these cells therefore constitute a subset of adipocytes ("brite" adipocytes) with a developmental origin and molecular characteristics distinguishing them as a separate class of cells.	[Petrovic, Natasa; Walden, Tomas B.; Shabalina, Irina G.; Cannon, Barbara; Nedergaard, Jan] Stockholm Univ, Wenner Gren Inst, Arrhenius Labs, SE-10691 Stockholm, Sweden; [Timmons, James A.; Cannon, Barbara] Univ London Royal Vet Coll, Life Style Res Grp, London NW1 0TU, England	Stockholm University; University of London; University of London Royal Veterinary College	Petrovic, N (corresponding author), Stockholm Univ, Wenner Gren Inst, Arrhenius Labs, F3, SE-10691 Stockholm, Sweden.	natasa.petrovic@wgi.su.se	Nedergaard, Jan/Q-8286-2019; Nedergaard, Jan/A-1706-2010; Timmons, James A/M-6350-2019; Shabalina, Irina/AAC-3720-2019; Shabalina, Irina G/A-4225-2011; Timmons, James A/J-4698-2014; Cannon, Barbara/B-3089-2016	Timmons, James A/0000-0002-2255-1220; Shabalina, Irina/0000-0002-2915-6450; Shabalina, Irina G/0000-0002-2915-6450; Timmons, James A/0000-0002-2255-1220; Nedergaard, Jan/0000-0003-2070-1587; Cannon, Barbara/0000-0001-6594-2363	Swedish Research Council; European Union Collaborative Project ADAPT [201100]; Jeansson Foundation; COST Action Mitofood; Biotechnology and Biological Sciences Research Council [BB/G013128/1] Funding Source: researchfish; BBSRC [BB/G013128/1] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union Collaborative Project ADAPT(European Commission); Jeansson Foundation; COST Action Mitofood(European Cooperation in Science and Technology (COST)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Swedish Research Council, the European Union Collaborative Project ADAPT(contract 201100), the Jeansson Foundation, and the COST Action Mitofood.	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2008, NATURE, V454, P947, DOI 10.1038/454947a; Carmona MC, 2007, DIABETES, V56, P2797, DOI 10.2337/db06-1734; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; COUSIN B, 1992, J CELL SCI, V103, P931; Crisan M, 2008, STEM CELLS, V26, P2425, DOI 10.1634/stemcells.2008-0325; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Digby JE, 1998, DIABETES, V47, P138, DOI 10.2337/diabetes.47.1.138; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Esser V, 1996, J BIOL CHEM, V271, P6972, DOI 10.1074/jbc.271.12.6972; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fukui Y, 2000, DIABETES, V49, P759, DOI 10.2337/diabetes.49.5.759; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Golozoubova V, 2006, AM J PHYSIOL-ENDOC M, V291, pE350, DOI 10.1152/ajpendo.00387.2005; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Laplante M, 2003, DIABETES, V52, P291, DOI 10.2337/diabetes.52.2.291; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LONCAR D, 1988, J ULTRA MOL STRUCT R, V101, P109, DOI 10.1016/0889-1605(88)90001-8; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Moulin K, 2001, BIOCHEM J, V356, P659, DOI 10.1042/bj3560659; NECHAD M, 1983, EXP CELL RES, V149, P105, DOI 10.1016/0014-4827(83)90384-1; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Petrovic N, 2008, AM J PHYSIOL-ENDOC M, V295, pE287, DOI 10.1152/ajpendo.00035.2008; PUIGSERVER P, 1992, BIOCHEM J, V284, P393, DOI 10.1042/bj2840393; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sell H, 2004, ENDOCRINOLOGY, V145, P3925, DOI 10.1210/en.2004-0321; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; Shabalina IG, 2008, BBA-BIOENERGETICS, V1777, P642, DOI 10.1016/j.bbabio.2008.04.038; SKALA J, 1970, COMP BIOCHEM PHYSIOL, V33, P509, DOI 10.1016/0010-406X(70)90368-3; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Timmons JA, 2009, NEW ENGL J MED, V361, P415, DOI 10.1056/NEJMc091009; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Tvrdik P, 1997, J BIOL CHEM, V272, P31738, DOI 10.1074/jbc.272.50.31738; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	60	973	1023	4	68	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7153	7164		10.1074/jbc.M109.053942	http://dx.doi.org/10.1074/jbc.M109.053942			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20028987	Green Published, hybrid			2022-12-25	WOS:000275415600029
J	Sugiura, Y; Araki, K; Iemura, S; Natsume, T; Hoseki, J; Nagata, K				Sugiura, Yoshimi; Araki, Kazutaka; Iemura, Shun-ichiro; Natsume, Tohru; Hoseki, Jun; Nagata, Kazuhiro			Novel Thioredoxin-related Transmembrane Protein TMX4 Has Reductase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MISFOLDED PROTEINS; LIVING CELLS; BINDING SITE; REDOX STATE; IN-VIVO; ISOMERASE; ERP57	In the endoplasmic reticulum (ER), a number of thioredoxin (Trx) superfamily proteins are present to enable correct disulfide bond formation of secretory and membrane proteins via Trx-like domains. Here, we identified a novel transmembrane Trx-like protein 4 (TMX4), in the ER of mammalian cells. TMX4, a type I transmembrane protein, was localized to the ER and possessed a Trx-like domain that faced the ER lumen. A maleimide alkylation assay showed that a catalytic CXXC motif in the TMX4 Trx-like domain underwent changes in its redox state depending on cellular redox conditions, and, in the normal state, most of the endogenous TMX4 existed in the oxidized form. Using a purified recombinant protein containing the Trx-like domain of TMX4 (TMX4-Trx), we confirmed that this domain had reductase activity in vitro. The redox potential of this domain (-171.5 mV; 30 degrees C at pH 7.0) indicated that TMX4 could work as a reductase in the environment of the ER. TMX4 had no effect on the acceleration of ER-associated degradation. Because TMX4 interacted with calnexin and ERp57 by co-immunoprecipitation assay, the role of TMX4 may be to enable protein folding in cooperation with these proteins consisting of folding complex in the ER.	Kyoto Univ, Dept Mol & Cellular Biol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan	Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST)	Nagata, K (corresponding author), 53 Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan.	nagata@frontier.kyoto-u.ac.jp	Araki, Kazutaka/L-6296-2018; Hoseki, Jun/AAE-6704-2020; Natsume, Tohru/M-7627-2018	Araki, Kazutaka/0000-0003-2901-2454; Natsume, Tohru/0000-0002-1510-2582	Uehara Memorial Foundation [19G50314, 19058008]; Takeda Foundation; New Energy and Industrial Technology Development Organization; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [19GS0314] Funding Source: KAKEN	Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Foundation(Takeda Science Foundation (TSF)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Creative Scientific Research 19G50314 and Scientific Research 19058008 (to K. N.), by the Uehara Memorial Foundation and the Takeda Foundation (to J. H.), by the New Energy and Industrial Technology Development Organization (to T. N.), and by a fellowship from the Japan Society for the Promotion of Science (to K. A.).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; Haugstetter J, 2007, J BIOL CHEM, V282, P33859, DOI 10.1074/jbc.M706442200; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; KISHIGAMI S, 1995, FEBS LETT, V364, P55, DOI 10.1016/0014-5793(95)00354-C; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; LAMBERT N, 1985, BIOCHEM J, V228, P635, DOI 10.1042/bj2280635; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P619, DOI 10.1021/bi00217a005; Matsuo Y, 2004, ARCH BIOCHEM BIOPHYS, V423, P81, DOI 10.1016/j.abb.2003.11.003; Matsuo Y, 2001, J BIOL CHEM, V276, P10032, DOI 10.1074/jbc.M011037200; Matsuo Y, 2009, MOL BIOL CELL, V20, P4552, DOI 10.1091/mbc.E09-05-0439; Meng XF, 2003, BIOCHEM GENET, V41, P99, DOI 10.1023/A:1022073917044; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Roth D, 2010, BIOCHEM J, V425, P195, DOI 10.1042/BJ20091064; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wu HH, 2000, BIOCHEM J, V351, P87, DOI 10.1042/0264-6021:3510087; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200	39	29	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7135	7142		10.1074/jbc.M109.082545	http://dx.doi.org/10.1074/jbc.M109.082545			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056998	hybrid, Green Published			2022-12-25	WOS:000275415600027
J	Sun, JL; Li, R				Sun, Jianlong; Li, Rong			Human Negative Elongation Factor Activates Transcription and Regulates Alternative Transcription Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; IMMUNODEFICIENCY-VIRUS TRANSCRIPTION; BREAST-CANCER CELLS; GENE-EXPRESSION; NELF; PROMOTER; DROSOPHILA; COFACTOR; COMPLEX; GENOME	The human negative elongation factor (NELF) is a four-subunit protein complex that inhibits the movement of RNA polymerase II (RNAPII) at an early elongation stage in vitro. NELF-mediated stalling of RNAPII also attenuates transcription of a number of inducible genes in human cells. To obtain a genome-wide understanding of human NELF-mediated transcriptional regulation in vivo, we carried out an exon array study in T47D breast cancer cells with transient small interfering RNA knockdown of individual NELF subunits. Upon depletion of NELF-A, -C, or -E, the vast majority of NELF-regulated genes were downregulated. Many of the down-regulated genes encode proteins that play key roles in cell cycle progression. Consequently, NELF knockdown resulted in significant reduction in DNA synthesis and cell proliferation. Chromatin immunoprecipitation showed that NELF knockdown led to dissociation of RNAPII from the promoter-proximal region of the cell cycle-regulating genes. This was accompanied by decreased histone modifications associated with active transcription initiation (H3K9Ac) and elongation (H3K36Me3), as well as reduced recruitment of the general transcription factor TFIIB and increased overall histone occupancy at a subset of the down-regulated promoters. Lastly, our study indicates that NELF regulates alternative transcription initiation of BSG (Basigin) gene by differentially influencing RNAPII density at the two neighboring exons at the 5' end of the gene. Taken together, our data suggest a diverse transcriptional consequence of NELF-mediated RNAPII pausing in the human genome.	[Sun, Jianlong; Li, Rong] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Inst Biotechnol, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio	Li, R (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Inst Biotechnol, 15355 Lambda Dr, San Antonio, TX 78245 USA.	lir3@uthscsa.edu			National Institutes of Health [DK064604]; Max and Minnie Tomerlin Voelcker Scholar; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max and Minnie Tomerlin Voelcker Scholar; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK064604. This work was also supported by a Max and Minnie Tomerlin Voelcker Scholar Award (to R. L.).	Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2007, ONCOGENE, V26, P2543, DOI 10.1038/sj.onc.1210047; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Sun J, 2007, J STEROID BIOCHEM, V107, P131, DOI 10.1016/j.jsbmb.2007.05.031; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200	32	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6443	6452		10.1074/jbc.M109.084285	http://dx.doi.org/10.1074/jbc.M109.084285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20028984	Green Published, hybrid			2022-12-25	WOS:000275367500049
J	Tateno, H; Ohnishi, K; Yabe, R; Hayatsu, N; Sato, T; Takeya, M; Narimatsu, H; Hirabayashi, J				Tateno, Hiroaki; Ohnishi, Koji; Yabe, Rikio; Hayatsu, Norihito; Sato, Takashi; Takeya, Motohiro; Narimatsu, Hisashi; Hirabayashi, Jun			Dual Specificity of Langerin to Sulfated and Mannosylated Glycans via a Single C-type Carbohydrate Recognition Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTAL AFFINITY-CHROMATOGRAPHY; MANNAN-BINDING PROTEIN; CENTRAL-NERVOUS-SYSTEM; KERATAN SULFATE; DENDRITIC CELLS; DC-SIGN; BIRBECK GRANULES; LECTIN; EXPRESSION; LIGANDS	Langerin is categorized as a C-type lectin selectively expressed in Langerhans cells, playing roles in the first line of defense against pathogens and in Birbeck granule formation. Although these functions are thought to be exerted through glycan-binding activity of the C-type carbohydrate recognition domain, sugar-binding properties of Langerin have not been fully elucidated in relation to its biological functions. Here, we investigated the glycan-binding specificity of Langerin using comprehensive glycoconjugate microarray, quantitative frontal affinity chromatography, and conventional cell biological analyses. Langerin showed outstanding affinity to galactose-6-sulfated oligosaccharides, including keratan sulfate, while it preserved binding activity to mannose, as a common feature of the C-type lectins with an EPN motif. By a mutagenesis study, Lys-299 and Lys-313 were found to form extended binding sites for sulfated glycans. Consistent with the former observation, the sulfated Langerin ligands were found to be expressed in brain and spleen, where the transcript of keratan sulfate 6-O-sulfotransferase is expressed. Moreover, such sulfated ligands were up-regulated in glioblastoma relative to normal brain tissues, and Langerin-expressing cells were localized in malignant brain tissues. Langerin also recognized pathogenic fungi, such as Candida and Malassezia, expressing heavily mannosylated glycans. These observations provide strong evidence that Langerin mediates diverse functions on Langerhans cells through dual recognition of sulfated as well as mannosylated glycans by its uniquely evolved C-type carbohydrate-recognition domain.	[Tateno, Hiroaki; Yabe, Rikio; Hayatsu, Norihito; Sato, Takashi; Narimatsu, Hisashi; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan; [Ohnishi, Koji; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto 8608556, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Kumamoto University	Hirabayashi, J (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	jun-hirabayashi@aist.go.jp	Hirabayashi, Jun/M-3998-2018; Tateno, Hiroaki/M-2706-2018; Sato, Takashi/M-2577-2018; Narimatsu, Hisashi/M-4757-2018	Hirabayashi, Jun/0000-0002-8571-359X; Tateno, Hiroaki/0000-0003-3006-1659; Sato, Takashi/0000-0002-9973-8923; Narimatsu, Hisashi/0000-0002-8402-133X; Ohnishi, Koji/0000-0002-6790-6902	New Energy and Industrial Technology Development Organization; Ministry of Education, Science and Culture of Japan; National BioResource Project in Japan	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National BioResource Project in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the New Energy and Industrial Technology Development Organization, grants-in-aid for scientific research from the Ministry of Education, Science and Culture of Japan (to H. T.), and the National BioResource Project in Japan.	Akama TO, 2001, J BIOL CHEM, V276, P16271, DOI 10.1074/jbc.M009995200; Bertolotto A, 1998, J NEUROIMMUNOL, V85, P69, DOI 10.1016/S0165-5728(97)00251-8; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Campanero-Rhodes MA, 2006, BIOCHEM BIOPH RES CO, V344, P1141, DOI 10.1016/j.bbrc.2006.03.223; Chatwell L, 2008, MOL IMMUNOL, V45, P1981, DOI 10.1016/j.molimm.2007.10.030; CHERNIAK R, 1994, INFECT IMMUN, V62, P1507, DOI 10.1128/IAI.62.5.1507-1512.1994; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Delcommenne M, 2002, GLYCOBIOLOGY, V12, P613, DOI 10.1093/glycob/cwf080; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Hayatsu N, 2008, BIOCHEM BIOPH RES CO, V368, P217, DOI 10.1016/j.bbrc.2008.01.058; Idoyaga J, 2009, P NATL ACAD SCI USA, V106, P1524, DOI 10.1073/pnas.0812247106; Jander S, 1996, GLIA, V18, P255, DOI 10.1002/(SICI)1098-1136(199611)18:3<255::AID-GLIA9>3.0.CO;2-Y; Jones LL, 2002, J NEUROSCI, V22, P4611, DOI 10.1523/JNEUROSCI.22-11-04611.2002; Kato Y, 2008, BIOCHEM BIOPH RES CO, V369, P1041, DOI 10.1016/j.bbrc.2008.02.130; Kimura N, 2007, J BIOL CHEM, V282, P32200, DOI 10.1074/jbc.M702341200; Kissenpfennig A, 2005, MOL CELL BIOL, V25, P88, DOI 10.1128/MCB.25.1.88-99.2005; Ma Y, 1999, P NATL ACAD SCI USA, V96, P371, DOI 10.1073/pnas.96.2.371; McDermott R, 2004, J INVEST DERMATOL, V123, P72, DOI 10.1111/j.0022-202X.2004.22728.x; MEYER K, 1953, J BIOL CHEM, V205, P611; Nakamura-Tsuruta S, 2006, J BIOCHEM, V140, P285, DOI 10.1093/jb/mvj148; NELSON RD, 1991, CLIN MICROBIOL REV, V4, P1; Nonaka M, 2008, J IMMUNOL, V180, P3347, DOI 10.4049/jimmunol.180.5.3347; Romani N, 2003, APMIS, V111, P725, DOI 10.1034/j.1600-0463.2003.11107805.x; Saeland E, 2007, CANCER IMMUNOL IMMUN, V56, P1225, DOI 10.1007/s00262-006-0274-z; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; Tateno H, 2005, GLYCOBIOLOGY, V15, P1125, DOI 10.1093/glycob/cwi097; Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068; Tateno H, 2007, NAT PROTOC, V2, P2529, DOI 10.1038/nprot.2007.357; Taylor ME, 2009, GLYCOBIOLOGY, V19, P1155, DOI 10.1093/glycob/cwp076; Terada M, 2005, J BIOL CHEM, V280, P10897, DOI 10.1074/jbc.M413092200; Thepaut M, 2009, BIOCHEMISTRY-US, V48, P2684, DOI 10.1021/bi802151w; Torii T, 2000, GLYCOBIOLOGY, V10, P203, DOI 10.1093/glycob/10.2.203; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Valladeau J, 2003, IMMUNOL RES, V28, P93, DOI 10.1385/IR:28:2:93; van Gisbergen KPJM, 2005, CANCER RES, V65, P5935, DOI 10.1158/0008-5472.CAN-04-4140; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x	44	58	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6390	6400		10.1074/jbc.M109.041863	http://dx.doi.org/10.1074/jbc.M109.041863			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20026605	Green Published, hybrid			2022-12-25	WOS:000275367500043
J	Chang, PC; Izumiya, Y; Wu, CY; Fitzgerald, LD; Campbell, M; Ellison, TJ; Lam, KS; Luciw, PA; Kung, HJ				Chang, Pei-Ching; Izumiya, Yoshihiro; Wu, Chun-Yi; Fitzgerald, Latricia D.; Campbell, Mel; Ellison, Thomas J.; Lam, Kit S.; Luciw, Paul A.; Kung, Hsing-Jien			Kaposi's Sarcoma-associated Herpesvirus (KSHV) Encodes a SUMO E3 ligase That Is SIM-dependent and SUMO-2/3-specific	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-ASSOCIATED PROTEIN; EPSTEIN-BARR-VIRUS; CELL-CYCLE ARREST; K-BZIP; TRANSCRIPTIONAL REPRESSION; HUMAN CYTOMEGALOVIRUS; LYTIC REPLICATION; TUMOR-SUPPRESSOR; GROWTH ARREST; SUMOYLATION	Sumoylation has emerged as a major post-translational modification of cellular proteins, affecting a variety of cellular processes. Viruses have exploited the sumoylation pathway to advance their own replication by evolving several ways to perturb the host sumoylation apparatus. However, there has been no report of virally encoded enzymes directly involved in catalyzing the sumoylation reaction. Here, we report that the K-bZIP protein encoded by Kaposi's sarcoma-associated herpesvirus (KSHV) is a SUMO E3 ligase with specificity toward SUMO2/3. K-bZIP is a nuclear factor that functions to modulate viral gene expression and to prolong the G1 phase, allowing viral transcription and translation to proceed at the early stage of infection. In addition to functioning as a transcriptional factor, we show that K-bZIP carries a SIM (SUMO-interacting motif), which specifically binds to SUMO-2/3 but not SUMO-1. K-bZIP catalyzes its own SUMO modification as well as that of its interacting partners such as the cellular tumor suppressor proteins p53 and Rb, both in vitro and in vivo. This reaction depends on an intact SIM. Sumoylation of p53 leads to its activation and K-bZIP is recruited to several p53 target chromatin sites in a SIM-dependent manner. In addition to the identification of a viral SUMO-2/3 E3 ligase, our results provide additional insights into the mechanisms whereby K-bZIP induces cell cycle arrest.	[Chang, Pei-Ching; Fitzgerald, Latricia D.; Campbell, Mel; Ellison, Thomas J.; Kung, Hsing-Jien] Univ Calif Davis, Dept Biol Chem & Mol Med, Davis, CA 95616 USA; [Chang, Pei-Ching; Izumiya, Yoshihiro; Wu, Chun-Yi; Fitzgerald, Latricia D.; Campbell, Mel; Ellison, Thomas J.; Lam, Kit S.; Kung, Hsing-Jien] Univ Calif Davis, UC Davis Canc Ctr, Davis, CA 95616 USA; [Izumiya, Yoshihiro] Univ Calif Davis, Dept Dermatol, Davis, CA 95616 USA; [Wu, Chun-Yi; Lam, Kit S.] Univ Calif Davis, Div Hematol & Oncol, Dept Internal Med, Davis, CA 95616 USA; [Luciw, Paul A.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Luciw, Paul A.] Univ Calif Davis, Dept Pathol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Kung, HJ (corresponding author), UC Davis Canc Ctr, Res 3 Rm 2400,4645 2nd Ave, Sacramento, CA 95817 USA.	hkung@ucdavis.edu	Kung, Hsing-Jien/C-7651-2013	Ellison, Thomas/0000-0001-9231-918X; Izumiya, Yoshihiro/0000-0002-9184-2603	National Institutes of Health [R01 CA114575, DE019085]; NATIONAL CANCER INSTITUTE [R01CA114575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P01DE019085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported, in whole or in part, by National Institutes of Health Grants R01 CA114575 and DE019085.	Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; AuCoin DP, 2004, VIROLOGY, V318, P542, DOI 10.1016/j.virol.2003.10.016; Bailey D, 2002, J GEN VIROL, V83, P2951, DOI 10.1099/0022-1317-83-12-2951; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Boggio R, 2007, J BIOL CHEM, V282, P15376, DOI 10.1074/jbc.M700889200; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; Chang PC, 2009, CANCER RES, V69, P5681, DOI 10.1158/0008-5472.CAN-08-4570; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Flemington EK, 2001, J VIROL, V75, P4475, DOI 10.1128/JVI.75.10.4475-4481.2001; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hofmann H, 2000, J VIROL, V74, P2510, DOI 10.1128/JVI.74.6.2510-2524.2000; Huh YH, 2008, J VIROL, V82, P10444, DOI 10.1128/JVI.00833-08; Izumiya Y, 2005, J VIROL, V79, P9912, DOI 10.1128/JVI.79.15.9912-9925.2005; Izumiya Y, 2003, J VIROL, V77, P9652, DOI 10.1128/JVI.77.17.9652-9661.2003; Izumiya Y, 2003, J VIROL, V77, P1441, DOI 10.1128/JVI.77.2.1441-1451.2003; Izumiya Y, 2007, J VIROL, V81, P1072, DOI 10.1128/JVI.01473-06; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Katano H, 2001, VIROLOGY, V286, P446, DOI 10.1006/viro.2001.1005; Ledl A, 2005, ONCOGENE, V24, P3810, DOI 10.1038/sj.onc.1208539; Li TW, 2006, J BIOL CHEM, V281, P36221, DOI 10.1074/jbc.M608236200; Lin SF, 1999, J VIROL, V73, P1909, DOI 10.1128/JVI.73.3.1909-1917.1999; Lukac DM, 2001, J VIROL, V75, P6786, DOI 10.1128/JVI.75.15.6786-6799.2001; Marcos-Villar L, 2009, J VIROL, V83, P8849, DOI 10.1128/JVI.00339-09; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Muller S, 1999, J VIROL, V73, P5137; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Park J, 2000, J VIROL, V74, P11977, DOI 10.1128/JVI.74.24.11977-11982.2000; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rosas-Acosta G, 2005, VIROLOGY, V331, P190, DOI 10.1016/j.virol.2004.10.025; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; Wilson VG, 2001, VIRUS RES, V81, P17, DOI 10.1016/S0168-1702(01)00365-3; Wu FY, 2003, J VIROL, V77, P8893, DOI 10.1128/JVI.77.16.8893-8914.2003; Wu FY, 2002, P NATL ACAD SCI USA, V99, P10683, DOI 10.1073/pnas.162352299; Wu PL, 2006, J BIOL CHEM, V281, P7937, DOI 10.1074/jbc.M513035200; Wu YC, 2007, BIOCHEM SOC T, V35, P1433, DOI 10.1042/BST0351433; Wu YC, 2009, VIROLOGY, V387, P176, DOI 10.1016/j.virol.2009.02.002; Xie P, 2008, CELL SIGNAL, V20, P1671, DOI 10.1016/j.cellsig.2008.05.012; Yamanegi K, 2005, J VIROL, V79, P14207, DOI 10.1128/JVI.79.22.14207-14221.2005	50	72	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5266	5273		10.1074/jbc.M109.088088	http://dx.doi.org/10.1074/jbc.M109.088088			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20034935	Green Published, hybrid			2022-12-25	WOS:000275327200020
J	Qiao, XY; Pham, DNT; Luo, HY; Wu, JP				Qiao, Xiaoying; Pham, Diep Ngoc Thi; Luo, Hongyu; Wu, Jiangping			Ran Overexpression Leads to Diminished T Cell Responses and Selectively Modulates Nuclear Levels of c-Jun and c-Fos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; GENE-EXPRESSION; MESSENGER-RNA; RAN/TC4; IMPORT; MOUSE; TRANSCRIPTION; TRANSPORT; MITOSIS; MEMBERS	Ras-related nuclear protein (Ran) is a Ras family GTPase, and its documented functions are the regulation of DNA replication, cell cycle progression, nuclear structure formation, RNA processing and exportation, and nuclear protein importation. In this study, we performed detailed mapping of Ran expression during mouse ontogeny using in situ hybridization. High Ran expression was found in various organs and tissues including the thymus cortex and spleen white pulp. Ran was induced in T cells 24 h after their activation. The function of Ran in the immune system was investigated using Ran transgenic (Tg) mice. In Ran Tg T cells, there was compromised activation marker expression, lymphokine secretion, and proliferation upon T cell receptor activation in vitro when compared with wild type T cells. Tg mice also manifested defective delayed type hypersensitivity in vivo. Upon PMA and ionomycin stimulation, Tg T cells were defective in nuclear accumulation of AP-1 factors (c-Jun and c-Fos) but not NF-kappa B family members. Our experiments showed that Ran had important regulatory function in T cell activation. One of the possible mechanisms is that intracellular Ran protein levels control the nuclear retention for selective transcription factors such as c-Jun and c-Fos of AP-1, which is known to be critical in T cell activation and proliferation and lymphokine secretion.	[Qiao, Xiaoying; Pham, Diep Ngoc Thi; Luo, Hongyu; Wu, Jiangping] Notre Dame Hosp, CRCHUM, Immunol Lab, Montreal, PQ H2L 4M1, Canada; [Wu, Jiangping] Notre Dame Hosp, CRCHUM, Serv Nephrol, Montreal, PQ H2L 4M1, Canada	Universite de Montreal; Universite de Montreal	Wu, JP (corresponding author), Notre Dame Hosp, CRCHUM, Immunol Lab, 1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.	jianping.wu@umontreal.ca			Canadian Institutes of Health Research [MOP57697, MOP69089, PPP86159, IMH- 79565, MOP97829]; Kidney Foundation of Canada; Heart and Stroke Foundation of Quebec; J.- Louis Levesque Foundation; Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Heart and Stroke Foundation of Quebec; J.- Louis Levesque Foundation; Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research	This work was supported by grants from the Canadian Institutes of Health Research (Grants MOP57697, MOP69089, and PPP86159 to J. W. and Grants IMH- 79565 and MOP97829 to H. L.), the Kidney Foundation of Canada, the Heart and Stroke Foundation of Quebec, and the J.- Louis Levesque Foundation (to J. W.). It was also supported by a group grant from Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research.	Arnold M, 2006, J BIOL CHEM, V281, P5492, DOI 10.1074/jbc.M513281200; BELHUMEUR P, 1993, MOL CELL BIOL, V13, P2152, DOI 10.1128/MCB.13.4.2152; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; COUTAVAS EE, 1994, MAMM GENOME, V5, P623, DOI 10.1007/BF00411457; DRIVAS G, 1991, MAMM GENOME, V1, P112, DOI 10.1007/BF02443787; DRIVAS GT, 1990, MOL CELL BIOL, V10, P1793, DOI 10.1128/MCB.10.4.1793; KADOWAKI T, 1993, EMBO J, V12, P2929, DOI 10.1002/j.1460-2075.1993.tb05955.x; LEDERER JA, 1994, J IMMUNOL, V152, P77; Lopez-Casas PP, 2002, MECH DEVELOP, V113, P103, DOI 10.1016/S0925-4773(02)00007-2; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Malnou CE, 2007, J BIOL CHEM, V282, P31046, DOI 10.1074/jbc.M702833200; Marcinkiewicz M, 2002, J NEUROPATH EXP NEUR, V61, P815, DOI 10.1093/jnen/61.9.915; Marusina AI, 2008, J IMMUNOL, V180, P409, DOI 10.4049/jimmunol.180.1.409; MATSUMOTO T, 1993, MOL BIOL CELL, V4, P337, DOI 10.1091/mbc.4.3.337; MATSUMOTO T, 1991, CELL, V66, P347, DOI 10.1016/0092-8674(91)90624-8; Mondino A, 1996, J IMMUNOL, V157, P2048; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Nieland JD, 1998, CANCER GENE THER, V5, P259; REN MD, 1993, J CELL BIOL, V120, P313, DOI 10.1083/jcb.120.2.313; SAZER S, 1994, EMBO J, V13, P606, DOI 10.1002/j.1460-2075.1994.tb06298.x; Sekimoto T, 1996, J BIOL CHEM, V271, P31017, DOI 10.1074/jbc.271.49.31017; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200	23	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5488	5496		10.1074/jbc.M109.058024	http://dx.doi.org/10.1074/jbc.M109.058024			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20028981	hybrid, Green Published			2022-12-25	WOS:000275327200042
J	Yamamoto, T; Shimizu, Y; Ueda, T; Shiro, Y				Yamamoto, Tatsuya; Shimizu, Yoshihiro; Ueda, Takuya; Shiro, Yoshitsugu			Mg2+ Dependence of 70 S Ribosomal Protein Flexibility Revealed by Hydrogen/Deuterium Exchange and Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RIBOSOMES; HYDROGEN-EXCHANGE; ANGSTROM RESOLUTION; ASSEMBLY MAP; TRANSFER-RNA; SUBUNIT; 50S; RIBONUCLEOPROTEIN; DISSOCIATION; ACTIVATION	The ribosome from Escherichia coli requires a specific concentration of Mg2+ to maintain the 70 S complex formation and allow protein synthesis, and then the structure must be stable and flexible. How does the ribosome acquire these conflicting factors at the same time? Here, we investigated the hydrogen/deuterium exchange of 52 proteins in the 70 S ribosome, which controlled stability and flexibility under various Mg2+ concentrations, using mass spectrometry. Many proteins exhibited a sigmoidal curve for Mg2+ concentration dependence, incorporating more deuterium at lower Mg2+ concentration. By comparing deuterium incorporation with assembly, we have discovered a typical mechanism of complexes for acquiring both stability and flexibility at the same time. In addition, we got information of the localization of flexibility in ribosomal function by the analysis of related proteins with stalk protein, tRNA, mRNA, and nascent peptide, and demonstrate the relationship between structure, assembly, flexibility, and function of the ribosome.	[Yamamoto, Tatsuya; Shiro, Yoshitsugu] RIKEN SPring 8 Ctr, Harima Inst, Biometal Sci Lab, Sayo, Hongo 6795148, Japan; [Shimizu, Yoshihiro; Ueda, Takuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan	RIKEN; University of Tokyo	Yamamoto, T (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, Biometal Sci Lab, 1-1-1 Kouto, Sayo, Hongo 6795148, Japan.	tyamamot@spring8.or.jp	Shiro, Yoshitsugu Y/J-3757-2014; Shimizu, Yoshihiro/A-6472-2016; Ueda, Takuya/K-5217-2014	Shiro, Yoshitsugu Y/0000-0003-0695-8327; Shimizu, Yoshihiro/0000-0003-3499-1394; Ueda, Takuya/0000-0002-7760-8271; Yamamoto, Tatsuya/0000-0001-8356-8248	Ministry of Education, Culture, Sports Science, and Technology of Japan [20770129]	Ministry of Education, Culture, Sports Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Young Scientist (B) 20770129 from the Ministry of Education, Culture, Sports Science, and Technology of Japan.	Antoun Ayman, 2004, Biol Proced Online, V6, P35, DOI 10.1251/bpo71; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Blaha G, 2002, BIOPHYS CHEM, V96, P153, DOI 10.1016/S0301-4622(02)00021-2; BONNET D, 1980, NUCLEIC ACIDS RES, V8, P2489, DOI 10.1093/nar/8.11.2489; CHAO FC, 1957, ARCH BIOCHEM BIOPHYS, V70, P426, DOI 10.1016/0003-9861(57)90130-3; COTTER RI, 1971, EUR J BIOCHEM, V23, P468, DOI 10.1111/j.1432-1033.1971.tb01642.x; GESTELAND RF, 1966, J MOL BIOL, V18, P356, DOI 10.1016/S0022-2836(66)80253-X; Grondek JF, 2004, RNA, V10, P1861, DOI 10.1261/rna.7130504; HEROLD M, 1987, J BIOL CHEM, V262, P8826; Liiv A, 2006, J BIOL CHEM, V281, P29850, DOI 10.1074/jbc.M603013200; Lim WK, 2009, P NATL ACAD SCI USA, V106, P2595, DOI 10.1073/pnas.0812588106; LUCASLENARD J, 1967, P NATL ACAD SCI USA, V57, P1050, DOI 10.1073/pnas.57.4.1050; Mandell JG, 1998, ANAL CHEM, V70, P3987, DOI 10.1021/ac980553g; MIZUSHIMA S, 1970, NATURE, V226, P1214, DOI 10.1038/2261214a0; O'Connor M, 2004, NUCLEIC ACIDS RES, V32, P5750, DOI 10.1093/nar/gkh913; Ohashi H, 2007, BIOCHEM BIOPH RES CO, V352, P270, DOI 10.1016/j.bbrc.2006.11.017; Recht MI, 2004, J MOL BIOL, V344, P395, DOI 10.1016/j.jmb.2004.09.009; ROHL R, 1982, P NATL ACAD SCI-BIOL, V79, P729, DOI 10.1073/pnas.79.3.729; Rostom AA, 2000, P NATL ACAD SCI USA, V97, P5185, DOI 10.1073/pnas.97.10.5185; SCHILLINGBARTETZKO S, 1992, J BIOL CHEM, V267, P4703; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; SPIERER P, 1979, NUCLEIC ACIDS RES, V6, P1669, DOI 10.1093/nar/6.4.1669; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yamamoto T, 2004, J BIOCHEM, V135, P17, DOI 10.1093/jb/mvh002; Yamamoto T, 2006, FEBS LETT, V580, P3638, DOI 10.1016/j.febslet.2006.05.049; Yu SN, 2006, BIOCHEMISTRY-US, V45, P15318, DOI 10.1021/bi061701x; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	30	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5646	5652		10.1074/jbc.M109.081836	http://dx.doi.org/10.1074/jbc.M109.081836			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	20022945	hybrid, Green Published			2022-12-25	WOS:000275327200057
J	Whalen, KE; Lane, AL; Kubanek, J; Hahn, ME				Whalen, Kristen E.; Lane, Amy L.; Kubanek, Julia; Hahn, Mark E.			Biochemical Warfare on the Reef: The Role of Glutathione Transferases in Consumer Tolerance of Dietary Prostaglandins	PLOS ONE			English	Article							GORGONIAN PLEXAURA-HOMOMALLA; STOLONIFER CLAVULARIA-VIRIDIS; CYPHOMA-GIBBOSUM GASTROPODA; S-TRANSFERASES; CHEMICAL DEFENSE; FALL ARMYWORM; ANTIPROLIFERATIVE ACTIVITY; BIOTRANSFORMATION ENZYMES; BROMINATED PHENOL; GROWTH-INHIBITION	Background: Despite the profound variation among marine consumers in tolerance for allelochemically-rich foods, few studies have examined the biochemical adaptations underlying diet choice. Here we examine the role of glutathione S-transferases (GSTs) in the detoxification of dietary allelochemicals in the digestive gland of the predatory gastropod Cyphoma gibbosum, a generalist consumer of gorgonian corals. Controlled laboratory feeding experiments were used to investigate the influence of gorgonian diet on Cyphoma GST activity and isoform expression. Gorgonian extracts and semi-purified fractions were also screened to identify inhibitors and possible substrates of Cyphoma GSTs. In addition, we investigated the inhibitory properties of prostaglandins (PGs) structurally similar to antipredatory PGs found in high concentrations in the Caribbean gorgonian Plexaura homomalla. Principal Findings: Cyphoma GST subunit composition was invariant and activity was constitutively high regardless of gorgonian diet. Bioassay-guided fractionation of gorgonian extracts revealed that moderately hydrophobic fractions from all eight gorgonian species examined contained putative GST substrates/inhibitors. LC-MS and NMR spectral analysis of the most inhibitory fraction from P. homomalla subsequently identified prostaglandin A(2) (PGA(2)) as the dominant component. A similar screening of commercially available prostaglandins in series A, E, and F revealed that those prostaglandins most abundant in gorgonian tissues (e. g., PGA(2)) were also the most potent inhibitors. In vivo estimates of PGA(2) concentration in digestive gland tissues calculated from snail grazing rates revealed that Cyphoma GSTs would be saturated with respect to PGA(2) and operating at or near physiological capacity. Significance: The high, constitutive activity of Cyphoma GSTs is likely necessitated by the ubiquitous presence of GST substrates and/or inhibitors in this consumer's gorgonian diet. This generalist's GSTs may operate as 'all-purpose' detoxification enzymes, capable of conjugating or sequestering a broad range of lipophilic gorgonian compounds, thereby allowing this predator to exploit a range of chemically-defended prey, resulting in a competitive dietary advantage for this species.	[Whalen, Kristen E.; Hahn, Mark E.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Lane, Amy L.; Kubanek, Julia] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kubanek, Julia] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	Woods Hole Oceanographic Institution; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Whalen, KE (corresponding author), Univ New S Wales, Ctr Marine BioInnovat, Sydney, NSW, Australia.	whalen@msi.ucsb.edu	Hahn, Mark/AAV-7516-2020	Hahn, Mark/0000-0003-4358-2082; Kubanek, Julia/0000-0003-4482-1831; Lane, Amy/0000-0002-8386-364X	Ocean Life Institute; Robert H. Cole Endowed Ocean Ventures Fund (WHOI); National Undersea Research Center - Program Development Proposal [CMRC-03PRMN0103A]; Hope Noyes Smith; National Science Foundation	Ocean Life Institute; Robert H. Cole Endowed Ocean Ventures Fund (WHOI); National Undersea Research Center - Program Development Proposal; Hope Noyes Smith; National Science Foundation(National Science Foundation (NSF))	Financial support for this work was provided by the Ocean Life Institute Tropical Research Initiative Grant (WHOI) to KEW and MEH; the Robert H. Cole Endowed Ocean Ventures Fund (WHOI) to KEW; the National Undersea Research Center - Program Development Proposal (CMRC-03PRMN0103A) to KEW; Walter A. and Hope Noyes Smith, and a National Science Foundation Graduate Research Fellowship to KEW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalias A, 2000, Z NATURFORSCH C, V55, P425; ATSMON J, 1990, CANCER RES, V50, P1879; BAKER BJ, 1994, J NAT PROD, V57, P1346, DOI 10.1021/np50112a003; Beuckmann CT, 2000, NEUROCHEM RES, V25, P733, DOI 10.1023/A:1007579507804; Bogaards JJP, 1997, CHEM RES TOXICOL, V10, P310, DOI 10.1021/tx9601770; CAGEN LM, 1975, BIOCHIM BIOPHYS ACTA, V398, P205, DOI 10.1016/0005-2760(75)90184-8; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; Chiappone M, 2003, CARIBB J SCI, V39, P116; CIERESZKO LS, 1987, B MAR SCI, V41, P634; CIERESZKO LS, 1985, EXPERIENTIA, V41, P37, DOI 10.1007/BF02005860; COLL JC, 1992, CHEM REV, V92, P613, DOI 10.1021/cr00012a006; DeBusk BC, 2000, COMP BIOCHEM PHYS C, V127, P133, DOI 10.1016/S0742-8413(00)00141-9; Fernandes S, 2009, J EXP ZOOL PART A, V311A, P226, DOI 10.1002/jez.524; Fukushima M, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P415; GERHART DJ, 1984, MAR ECOL PROG SER, V19, P181, DOI 10.3354/meps019181; GERHART DJ, 1991, AM J PHYSIOL, V260, pR839, DOI 10.1152/ajpregu.1991.260.5.R839; Guillet G, 2000, ENVIRON ENTOMOL, V29, P135, DOI 10.1603/0046-225X(2000)029[0135:BABAOG]2.0.CO;2; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HARVELL CD, 1989, LIMNOL OCEANOGR, V34, P382, DOI 10.4319/lo.1989.34.2.0382; HARVELL CD, 1987, MAR ECOL PROG SER, V38, P37, DOI 10.3354/meps038037; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HONDA A, 1987, MOL PHARMACOL, V32, P530; HONN KV, 1985, BIOCHEM BIOPH RES CO, V129, P34, DOI 10.1016/0006-291X(85)91398-1; Hubatsch I, 2002, CHEM RES TOXICOL, V15, P1114, DOI 10.1021/tx020027r; IGUCHI K, 1987, CHEM PHARM BULL, V35, P4375; KATO T, 1986, CANCER RES, V46, P3538; Kawamoto Y, 2000, J BIOL CHEM, V275, P11291, DOI 10.1074/jbc.275.15.11291; KETLEY JN, 1975, J BIOL CHEM, V250, P8670; Kostaropoulos I, 2001, INSECT BIOCHEM MOLEC, V31, P313, DOI 10.1016/S0965-1748(00)00123-5; Kuhajek JM, 2003, COMP BIOCHEM PHYS C, V134, P473, DOI 10.1016/S1532-0456(03)00040-1; LASKER HR, 1988, BIOL BULL, V174, P254, DOI 10.2307/1541952; LEE K, 1992, BIOCHEM SYST ECOL, V20, P197, DOI 10.1016/0305-1978(92)90054-H; LEE KW, 1991, INSECT BIOCHEM, V21, P353, DOI 10.1016/0020-1790(91)90001-U; LEE RF, 1988, MAR ENVIRON RES, V24, P97, DOI 10.1016/0141-1136(88)90262-0; Li XC, 2004, P NATL ACAD SCI USA, V101, P2939, DOI 10.1073/pnas.0308691101; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Murphy RC, 2002, PROSTAG OTH LIPID M, V68-9, P471, DOI 10.1016/S0090-6980(02)00049-7; NARUMIYA S, 1987, J PHARMACOL EXP THER, V242, P306; NARUMIYA S, 1986, J PHARMACOL EXP THER, V239, P506; NOYORI R, 1993, SCIENCE, V259, P44, DOI 10.1126/science.8418493; O'Neal W, 2002, MAR ECOL PROG SER, V240, P117, DOI 10.3354/meps240117; Paumi CM, 2004, BIOCHEMISTRY-US, V43, P2345, DOI 10.1021/bi035936+; PAWLIK JR, 1987, J EXP MAR BIOL ECOL, V108, P55, DOI 10.1016/0022-0981(87)90130-4; PAWLIK JR, 1989, MAR ECOL PROG SER, V52, P95, DOI 10.3354/meps052095; Regoli F, 1997, HYDROBIOLOGIA, V355, P139, DOI 10.1023/A:1003094515903; RODRIGUEZ AD, 1995, TETRAHEDRON, V51, P4571, DOI 10.1016/0040-4020(95)00216-U; Sanchez-Gomez FJ, 2007, ARCH BIOCHEM BIOPHYS, V457, P150, DOI 10.1016/j.abb.2006.10.032; SCHNEIDER WP, 1977, J AM CHEM SOC, V99, P1222, DOI 10.1021/ja00446a039; SCHNEIDER WP, 1972, J AM CHEM SOC, V94, P2122, DOI 10.1021/ja00761a060; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sotka E. E., 2008, P203, DOI 10.1007/978-3-540-74181-7_10; SOTKA EE, 2009, INTEGRATIVE IN PRESS, DOI DOI 10.1093/ICB/ICP1049; SPRAGGINS RL, 1972, TETRAHEDRON LETT, V42, P4343; Stanley DW, 2008, INSECT BIOCHEM MOLEC, V38, P275, DOI 10.1016/j.ibmb.2007.11.004; Strange RC, 2000, TOXICOL LETT, V112, P357, DOI 10.1016/S0378-4274(99)00230-1; Uchida K, 2000, MECH AGEING DEV, V116, P135, DOI 10.1016/S0047-6374(00)00129-9; van Iersel MLPS, 1999, BIOCHEM PHARMACOL, V57, P1383, DOI 10.1016/S0006-2952(99)00048-9; Vasconcelos VM, 2007, TOXICON, V50, P740, DOI 10.1016/j.toxicon.2007.06.010; VROLIJK NH, 1992, MAR ECOL PROG SER, V88, P237, DOI 10.3354/meps088237; WADLEIGH RW, 1988, J CHEM ECOL, V14, P1279, DOI 10.1007/BF01019352; WADLEIGH RW, 1987, INSECT BIOCHEM, V17, P759, DOI 10.1016/0020-1790(87)90046-1; WEINHEIMER AJ, 1969, TETRAHEDRON LETT, P5185; WHALEN KE, 2009, MOL ECOLOGY IN PRESS; WHALEN KE, 2008, FUNCTIONAL CHARACTER; Whalen KE, 2008, ARCH BIOCHEM BIOPHYS, V478, P7, DOI 10.1016/j.abb.2008.07.007; YU SJ, 1989, PESTIC BIOCHEM PHYS, V35, P97, DOI 10.1016/0048-3575(89)90107-7; Yu SJ, 2000, PESTIC BIOCHEM PHYS, V68, P173, DOI 10.1006/pest.2000.2514; Yu SJ, 1999, PESTIC BIOCHEM PHYS, V63, P163, DOI 10.1006/pest.1999.2402	68	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8537	10.1371/journal.pone.0008537	http://dx.doi.org/10.1371/journal.pone.0008537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20052279	Green Published, gold, Green Submitted			2022-12-25	WOS:000273338600005
J	Field, MC; Sergeenko, T; Wang, YN; Bohm, S; Carrington, M				Field, Mark C.; Sergeenko, Tatiana; Wang, Ya-Nan; Boehm, Susanne; Carrington, Mark			Chaperone Requirements for Biosynthesis of the Trypanosome Variant Surface Glycoprotein	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; GPI-ANCHORED PROTEINS; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; INTRACELLULAR-TRANSPORT; AFRICAN TRYPANOSOMES; MEMBRANE-PROTEIN; RNA INTERFERENCE; ER EXIT; BRUCEI	Background: Trypanosoma brucei does not respond transcriptionally to several endoplasmic reticulum ( ER) stress conditions, including tunicamycin or dithiothreitol, indicating the absence of a conventional unfolded protein response. This suggests divergent mechanisms for quality control (QC) of ER protein folding and export may be present in trypanosomes. As the variant surface glycoprotein (VSG) represents similar to 90% of trypanosome plasma membrane protein, it is possible that VSG has evolved to fold efficiently to minimize ER folding burden. Methodology/Principal Findings: We demonstrate the presence of a QC system by pharmacological inhibition of the trypanosome 26S proteasome. This indicates active proteasome-mediated VSG turnover as similar to 2.5 fold more VSG is recovered from cell lysates following MG132 inhibition. An in silico scan of the trypanosome genome identified 28 open reading frames likely to encode polypeptides participating in ER nascent chain maturation. By RNA interference we monitored the importance of these gene products to proliferation, VSG abundance and cell morphology. 68% of the cohort were required for normal proliferation, and depletion of most of these factors resulted in increased VSG abundance, suggesting involvement in ERQC and degradation. Conclusions/Significance: The retention of genes for, and the involvement of many gene products in, VSG folding indicates a substantial complexity within the pathways required to perform this role. Counterintuitively, for a super-abundant antigen VSG is apparently made in excess. The biosynthetic excess VSG appears to be turned over efficiently by the proteasome, implying that considerable VSG is rejected by the trypanosome ERQC mechanism. Accordingly, the VSG polypeptide is not well optimized for folding, as only similar to 30% attains the native state. Finally as much of the core ERQC system is functionally conserved in trypanosomes, the pathway has an ancient evolutionary origin, and was present in the last common eukaryotic ancestor.	[Field, Mark C.; Sergeenko, Tatiana; Wang, Ya-Nan; Boehm, Susanne] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Wang, Ya-Nan] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Carrington, Mark] Univ Cambridge, Dept Biochem, Cambridge CB2 1QP, England	University of Cambridge; China Agricultural University; University of Cambridge	Field, MC (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mcf34@cam.ac.uk	Field, Mark/AAD-6455-2021; Carrington, Mark/N-4892-2018; Carrington, Mark/N-3653-2019	Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Field, Mark/0000-0002-4866-2885	Wellcome Trust; CamPOD	Wellcome Trust(Wellcome TrustEuropean Commission); CamPOD	This work was funded by project and program grant support from the Wellcome Trust (to MCF and MC) and benefited from equipment grant support from CamPOD, which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; BANGS JD, 1986, J CELL BIOL, V103, P255, DOI 10.1083/jcb.103.1.255; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bohme U, 2002, J CELL SCI, V115, P805; Bue CA, 2009, J BIOL CHEM, V284, P24049, DOI 10.1074/jbc.M109.022590; Campillo N, 2003, MOL BIOCHEM PARASIT, V127, P79, DOI 10.1016/S0166-6851(02)00306-7; Carrington M, 1996, MOL BIOCHEM PARASIT, V81, P119, DOI 10.1016/0166-6851(96)02706-5; Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x; Chung WL, 2004, J BIOL CHEM, V279, P54887, DOI 10.1074/jbc.M409311200; Dhir V, 2004, MOL BIOCHEM PARASIT, V137, P253, DOI 10.1016/j.molbiopara.2004.06.007; DUSZENKO M, 1988, J CELL BIOL, V106, P77, DOI 10.1083/jcb.106.1.77; ENGSTLER M, 2007, TRYPANOSOMES GENOME; Field MC, 2009, INT REV CEL MOL BIO, V278, P1, DOI 10.1016/S1937-6448(09)78001-3; FIELD MC, 1994, J BIOL CHEM, V269, P10830; Goldshmidt H, 2008, J BIOL CHEM, V283, P32085, DOI 10.1074/jbc.M801499200; Grunfelder CG, 2002, TRAFFIC, V3, P547, DOI 10.1034/j.1600-0854.2002.30805.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Izquierdo L, 2009, EUKARYOT CELL, V8, P230, DOI 10.1128/EC.00361-08; Jones DC, 2005, J BIOL CHEM, V280, P35929, DOI 10.1074/jbc.M509130200; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Kanehara K, 2007, SEMIN CELL DEV BIOL, V18, P743, DOI 10.1016/j.semcdb.2007.09.007; Kirst ME, 2005, PLANT PHYSIOL, V138, P218, DOI 10.1104/pp.105.060087; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Koumandou VL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-298; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEUNG KF, 2010, J BIOL CHEM UNPUB; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; Mehlert A, 2002, GLYCOBIOLOGY, V12, P607, DOI 10.1093/glycob/cwf079; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Misselwitz E, 1999, J BIOL CHEM, V274, P20110, DOI 10.1074/jbc.274.29.20110; Mitra T, 2008, INT J ECON THEORY, V4, P53, DOI 10.1111/j.1742-7363.2007.00068.x; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; Muller J, 2005, PLANT CELL, V17, P149, DOI 10.1105/tpc.104.026625; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; PARLATI F, 1995, J BIOL CHEM, V270, P244, DOI 10.1074/jbc.270.1.244; Parodi AJ, 1998, BRAZ J MED BIOL RES, V31, P601, DOI 10.1590/S0100-879X1998000500002; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Rubotham J, 2005, J BIOL CHEM, V280, P10410, DOI 10.1074/jbc.M409375200; SEYFANG A, 1990, J PROTOZOOL, V37, P546, DOI 10.1111/j.1550-7408.1990.tb01263.x; Sheader K, 2005, P NATL ACAD SCI USA, V102, P8716, DOI 10.1073/pnas.0501886102; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Subramaniam C, 2006, EUKARYOT CELL, V5, P1539, DOI 10.1128/EC.00141-06; Van Hellemond JJ, 2000, MOL BIOCHEM PARASIT, V111, P275, DOI 10.1016/S0166-6851(00)00318-2; Velloso LM, 2003, J MOL BIOL, V334, P845, DOI 10.1016/j.jmb.2003.10.031; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Wang J, 2003, MOL BIOCHEM PARASIT, V128, P135, DOI 10.1016/S0166-6851(03)00055-0; Watanabe R, 2004, CURR OPIN CELL BIOL, V16, P350, DOI 10.1016/j.ceb.2004.06.010; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yamamoto M, 2008, PLANT CELL PHYSIOL, V49, P1547, DOI 10.1093/pcp/pcn119; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; ZIEGELBAUER K, 1992, J BIOL CHEM, V267, P10797	68	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8468	10.1371/journal.pone.0008468	http://dx.doi.org/10.1371/journal.pone.0008468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052285	gold, Green Published, Green Submitted			2022-12-25	WOS:000273338500004
J	Sorice, M; Matarrese, P; Manganelli, V; Tinari, A; Giammarioli, AM; Mattei, V; Misasi, R; Garofalo, T; Malorni, W				Sorice, Maurizio; Matarrese, Paola; Manganelli, Valeria; Tinari, Antonella; Giammarioli, Anna Maria; Mattei, Vincenzo; Misasi, Roberta; Garofalo, Tina; Malorni, Walter			Role of GD3-CLIPR-59 Association in Lymphoblastoid T Cell Apoptosis Triggered by CD95/Fas	PLOS ONE			English	Article							LIPID RAFTS; GD3 GANGLIOSIDE; PERMEABILITY TRANSITION; SIGNALING COMPLEX; MITOCHONDRIA; MICRODOMAINS; ACTIVATION; DYNAMICS; PROTEIN; DEATH	We previously found that a directional movement of the raft component GD3 towards mitochondria, by its association with microtubules, was mandatory to late apoptogenic events triggered by CD95/Fas. Since CLIPR-59, CLIP-170-related protein, has recently been identified as a microtubule binding protein associated with lipid rafts, we analyzed the role of GD3-CLIPR-59 association in lymphoblastoid T cell apoptosis triggered by CD95/Fas. To test whether CLIPR-59 could play a role at the raft-microtubule junction, we performed a series of experiments by using immunoelectron microscopy, static or flow cytometry and biochemical analyses. We first assessed the presence of CLIPR-59 molecule in lymphoblastoid T cells (CEM). Then, we demonstrated that GD3-microtubule interaction occurs via CLIPR-59 and takes place at early time points after CD95/Fas ligation, preceding the association GD3-tubulin. GD3-CLIPR-59 association was demonstrated by fluorescence resonance energy transfer (FRET) analysis. The key role of CLIPR-59 in this dynamic process was clarified by the observation that silencing CLIPR-59 by siRNA affected the kinetics of GD3-tubulin association, spreading of GD3 towards mitochondria and apoptosis execution. We find that CLIPR-59 may act as a typical chaperone, allowing a prompt interaction between tubulin and the raft component GD3 during cell apoptosis triggered by CD95/Fas. On the basis of the suggested role of lipid rafts in conveying pro-apoptotic signals these results disclose new perspectives in the understanding of the mechanisms by which raft-mediated pro-apoptotic signals can directionally reach their target, i.e. the mitochondria, and trigger apoptosis execution.	[Sorice, Maurizio; Manganelli, Valeria; Mattei, Vincenzo; Misasi, Roberta; Garofalo, Tina] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Sorice, Maurizio; Mattei, Vincenzo; Garofalo, Tina] Univ La Sapienza, Lab Expt Med & Environm Pathol, Rieti, Italy; [Matarrese, Paola; Malorni, Walter] Ist Super Sanita, Dept Drug Res & Evaluat, Sect Cell Aging & Degenerat, I-00161 Rome, Italy; [Tinari, Antonella; Giammarioli, Anna Maria] Ist Super Sanita, Dept Technol & Hlth, Sect Ultrastruct Infect Pathol, I-00161 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Sorice, M (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	maurizio.sorice@uniroma1.it	Sousa, Maria/HCI-9642-2022; Sorice, Maurizio/Q-5079-2019; Mattei, Vincenzo/AAQ-3667-2020; Giammarioli, Anna Maria/AAY-7686-2020; Matarrese, Paola/A-4369-2014; TINARI, ANTONELLA/F-2109-2015	Mattei, Vincenzo/0000-0003-4677-088X; matarrese, paola/0000-0001-5477-3752; Sorice, Maurizio/0000-0003-3534-1502; malorni, walter/0000-0002-1223-7000; Garofalo, Tina/0000-0003-0645-2510	Ministero dell'Istruzione, Universitae Ricerca (MIUR); FIRB-MIUR [RBPR05NWWC-011]; Telethon [GGP06254B]	Ministero dell'Istruzione, Universitae Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); FIRB-MIUR(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Telethon(Fondazione Telethon)	This work was supported by funds from Ministero dell'Istruzione, Universitae Ricerca (MIUR) to MS, from FIRB-MIUR RBPR05NWWC-011 and Telethon (Grant GGP06254B) to WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Garcia-Ruiz C, 2000, FASEB J, V14, P847, DOI 10.1096/fasebj.14.7.847; Garcia-Ruiz C, 2002, J BIOL CHEM, V277, P36443, DOI 10.1074/jbc.M206021200; Garofalo T, 2005, CELL DEATH DIFFER, V12, P1378, DOI 10.1038/sj.cdd.4401672; Garofalo T, 2003, J BIOL CHEM, V278, P8309, DOI 10.1074/jbc.M207618200; Giammarioli AM, 2001, FEBS LETT, V506, P45, DOI 10.1016/S0014-5793(01)02776-4; Hueber AO, 2002, EMBO REP, V3, P190, DOI 10.1093/embo-reports/kvf022; KOTANI M, 1994, GLYCOBIOLOGY, V4, P855, DOI 10.1093/glycob/4.6.855; Lallemand-Breitenbach V, 2004, J BIOL CHEM, V279, P41168, DOI 10.1074/jbc.M406482200; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Malisan F, 2002, J EXP MED, V196, P1535, DOI 10.1084/jem.20020960; Malorni W, 2008, METHOD ENZYMOL, V442, P125, DOI 10.1016/S0076-6879(08)01406-7; Malorni W, 2007, APOPTOSIS, V12, P941, DOI 10.1007/s10495-007-0757-1; Perez F, 2002, J CELL BIOL, V156, P631, DOI 10.1083/jcb.200111003; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Pizzo P, 2003, CURR OPIN IMMUNOL, V15, P255, DOI 10.1016/S0952-7915(03)00038-4; Rickard JE, 1996, TRENDS CELL BIOL, V6, P178, DOI 10.1016/0962-8924(96)10017-9; Rippo MR, 2000, FASEB J, V14, P2047, DOI 10.1096/fj.99-1028com; Scheel-Toellner D, 2002, BIOCHEM BIOPH RES CO, V297, P876, DOI 10.1016/S0006-291X(02)02311-2; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sorice M, 2009, FASEB J, V23, P3298, DOI 10.1096/fj.08-128140; Sorice M, 2009, FEBS LETT, V583, P2447, DOI 10.1016/j.febslet.2009.07.018; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; YUASA H, 1990, TISSUE ANTIGENS, V36, P47, DOI 10.1111/j.1399-0039.1990.tb01799.x; Zamzami N, 2001, METHOD CELL BIOL, V65, P147, DOI 10.1016/S0091-679X(01)65009-X; Zhuang LY, 2002, CANCER RES, V62, P2227	28	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2010	5	1							e8567	10.1371/journal.pone.0008567	http://dx.doi.org/10.1371/journal.pone.0008567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NE	20052288	Green Submitted, gold, Green Published			2022-12-25	WOS:000273338500011
J	Khan, AA; Priya, S; Saha, B				Khan, Aslam Ali; Priya, Shilpee; Saha, Bhaskar			IL-2 Regulates SEB Induced Toxic Shock Syndrome in BALB/c Mice	PLOS ONE			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; IMMUNE ACTIVATION; CYTOKINE RELEASE; GENE-EXPRESSION; DENDRITIC CELLS; T-CELLS; SUPERANTIGENS; INTERLEUKIN-2; LYMPHOCYTES; DEFICIENT	Background: Toxic Shock Syndrome (TSS) is characterized by fever, rash, hypotension, constitutional symptoms, and multi-organ involvement and is caused by Staphylococcus aureus enterotoxins such as Staphylococcal Enterotoxin B (SEB). SEB binds to the MHC-II alpha chain and is recognized by the TCR beta chain of the V beta 8 TCR(+) T cells. The binding of SEB to V beta chain results in rapid activation of T cells and production of inflammatory cytokines, such as Interleukin-2 (IL-2), Interferon-gamma and Tumor Necrosis Factor-alpha which mediate TSS. Although IL2 was originally identified as the T cell growth factor and was proposed to contribute to T cell differentiation, its role in TSS remains unexplored. Methodology/Principal Findings: Mice were injected with D-Gal (25 mg/mouse). One hour after D-Galactosamine (D-Gal) injection each mouse was injected with SEB (20 mu g/mouse. Mice were then observed for 72 hrs and death was recorded at different times. We tested Interleukin-12, IFN gamma, and IL-2 deficient mice (IL-2(-/-)), but only the IL-2 deficient mice were resistant to SEB induced toxic shock syndrome. More importantly reconstitution of IL-2 in IL-2 deficient mice restored the shock. Interestingly, SEB induced IL-2 production from T cells was dependent on p38MAPK activation in macrophages as inhibition of it in macrophages significantly inhibited IL-2 production from T cells. Conclusion: This study shows the importance of IL-2 in TSS which has not been previously explored and it also shows that regulating macrophages function can regulate T cells and TSS.	[Khan, Aslam Ali] Washington Univ, St Louis, MO 63130 USA; [Priya, Shilpee; Saha, Bhaskar] Natl Ctr Cell Sci, Pune, Maharashtra, India	Washington University (WUSTL); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Khan, AA (corresponding author), Washington Univ, St Louis, MO 63130 USA.	khana@vision.wustl.edu			Council of Scientific and Industrial Research (CSIR); Defence Research and Development Organization (DRDO), India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Defence Research and Development Organization (DRDO), India(Defence Research & Development Organisation (DRDO))	Council of Scientific and Industrial Research (CSIR), Defence Research and Development Organization (DRDO), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUDPIRAK E, 1995, IMMUNOL LETT, V46, P9, DOI 10.1016/0165-2478(94)00005-C; ACHARYA KR, 1994, NATURE, V367, P94, DOI 10.1038/367094a0; Aicher A, 1999, J IMMUNOL, V163, P5786; Andreae S, 2003, BLOOD, V102, P2130, DOI 10.1182/blood-2003-01-0273; BACHMANN MF, 1995, J VIROL, V69, P4842, DOI 10.1128/JVI.69.8.4842-4846.1995; Batten M, 2004, J IMMUNOL, V172, P812, DOI 10.4049/jimmunol.172.2.812; Baxter AG, 2002, NAT REV IMMUNOL, V2, P439, DOI 10.1038/nri823; Burns LJ, 2003, BONE MARROW TRANSPL, V32, P177, DOI 10.1038/sj.bmt.1704086; CAR BD, 1994, J EXP MED, V179, P1437, DOI 10.1084/jem.179.5.1437; Davison S, 1999, BRIT J DERMATOL, V140, P845, DOI 10.1046/j.1365-2133.1999.02813.x; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; Khan AA, 2008, J LEUKOCYTE BIOL, V83, P1363, DOI 10.1189/jlb.1007686; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; LAGOO AS, 1994, J IMMUNOL, V152, P1641; LEE VTP, 1992, J INFECT DIS, V166, P911, DOI 10.1093/infdis/166.4.911; Matsuda Y, 2003, EMERG INFECT DIS, V9, P387, DOI 10.3201/eid0903.020360; MIETHKE T, 1993, IMMUNOBIOLOGY, V189, P270, DOI 10.1016/S0171-2985(11)80362-1; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Neumann B, 1997, J IMMUNOL, V158, P1862; Papageorgiou AC, 2000, TRENDS MICROBIOL, V8, P369, DOI 10.1016/S0966-842X(00)01793-5; Saha B, 1996, J EXP MED, V183, P2675, DOI 10.1084/jem.183.6.2675; SCHROCK CG, 1980, JAMA-J AM MED ASSOC, V243, P1231, DOI 10.1001/jama.1980.03300380013006; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; ten Hove T, 2002, GUT, V50, P507, DOI 10.1136/gut.50.4.507; TRIZIO D, 1974, J IMMUNOL, V113, P1093	25	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8473	10.1371/journal.pone.0008473	http://dx.doi.org/10.1371/journal.pone.0008473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041187	gold, Green Published			2022-12-25	WOS:000273105200009
J	Madhavan, R; Gong, ZLL; Ma, JJ; Chan, AWS; Peng, HB				Madhavan, Raghavan; Gong, Zhuolin L.; Ma, Jin Jin; Chan, Ariel W. S.; Peng, H. Benjamin			The Function of Cortactin in the Clustering of Acetylcholine Receptors at the Vertebrate Neuromuscular Junction	PLOS ONE			English	Article							POSTSYNAPTIC DIFFERENTIATION; TYROSINE PHOSPHATASE; SYNAPSE FORMATION; ARP2/3 COMPLEX; MUSCLE-CELLS; P120 CATENIN; BETA-SUBUNIT; AGRIN; PHOSPHORYLATION; MUSK	Background: Postsynaptic enrichment of acetylcholine receptors (AChRs) at the vertebrate neuromuscular junction (NMJ) depends on the activation of the muscle receptor tyrosine MuSK by neural agrin. Agrin-stimulation of MuSK is known to initiate an intracellular signaling cascade that leads to the clustering of AChRs in an actin polymerization-dependent manner, but the molecular steps which link MuSK activation to AChR aggregation remain incompletely defined. Methodology/Principal Findings: In this study we used biochemical, cell biological and molecular assays to investigate a possible role in AChR clustering of cortactin, a protein which is a tyrosine kinase substrate and a regulator of F-actin assembly and which has also been previously localized at AChR clustering sites. We report that cortactin was co-enriched at AChR clusters in situ with its target the Arp2/3 complex, which is a key stimulator of actin polymerization in cells. Cortactin was further preferentially tyrosine phosphorylated at AChR clustering sites and treatment of myotubes with agrin significantly enhanced the tyrosine phosphorylation of cortactin. Importantly, forced expression in myotubes of a tyrosine phosphorylation-defective cortactin mutant (but not wild-type cortactin) suppressed agrin-dependent AChR clustering, as did the reduction of endogenous cortactin levels using RNA interference, and introduction of the mutant cortactin into muscle cells potently inhibited synaptic AChR aggregation in response to innervation. Conclusion: Our results suggest a novel function of phosphorylation-dependent cortactin signaling downstream from agrin/MuSK in facilitating AChR clustering at the developing NMJ.	[Madhavan, Raghavan; Gong, Zhuolin L.; Ma, Jin Jin; Chan, Ariel W. S.; Peng, H. Benjamin] Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Madhavan, R (corresponding author), Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China.	penghb@ust.hk			Research Grants Council (RGC) [HKUST6401/05M, HKUST6417/06M]; Academic Outreach Endowment (AOE) [B-15/01]	Research Grants Council (RGC)(Hong Kong Research Grants Council); Academic Outreach Endowment (AOE)	This work was supported by Research Grants Council (RGC) grants HKUST6401/05M and HKUST6417/06M, and Academic Outreach Endowment (AOE) grant grant/B-15/01 (http://www.ugc.edu.hk/eng/rgc/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Borges LS, 2001, J CELL BIOL, V153, P1, DOI 10.1083/jcb.153.1.1; Borges LS, 2008, J NEUROSCI, V28, P11468, DOI 10.1523/JNEUROSCI.2508-08.2008; Bruneau EG, 2009, FASEB J, V23, P679, DOI 10.1096/fj.08-107946; Camilleri AA, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-46; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Daggett DF, 1996, MOL CELL NEUROSCI, V7, P75, DOI 10.1006/mcne.1996.0006; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; EDWARDS C, 1976, J NEUROBIOL, V7, P377, DOI 10.1002/neu.480070409; FERTUCK HC, 1976, J CELL BIOL, V69, P144, DOI 10.1083/jcb.69.1.144; Friese MB, 2007, DEVELOPMENT, V134, P4167, DOI 10.1242/dev.010702; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Geng L, 2008, CHEM-BIOL INTERACT, V175, P108, DOI 10.1016/j.cbi.2008.04.017; Geng L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-80; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hering H, 2003, J NEUROSCI, V23, P11759; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Linnoila J, 2008, NEURON, V60, P625, DOI 10.1016/j.neuron.2008.09.025; Luo Z, 2003, NEURON, V40, P703, DOI 10.1016/S0896-6273(03)00695-0; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Luo ZG, 2003, J NEUROCYTOL, V32, P697, DOI 10.1023/B:NEUR.0000020618.65271.63; Madhavan R, 2005, IUBMB LIFE, V57, P719, DOI 10.1080/15216540500338739; Madhavan R, 2005, MOL CELL NEUROSCI, V28, P403, DOI 10.1016/j.mcn.2004.10.005; Madhavan R, 2003, J NEUROCYTOL, V32, P685, DOI 10.1023/B:NEUR.0000020617.05656.68; Madhavan R, 2006, J NEUROBIOL, V66, P1511, DOI 10.1002/neu.20320; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Moransard M, 2003, J BIOL CHEM, V278, P7350, DOI 10.1074/jbc.M210865200; Nizhynska V, 2007, DEV NEUROBIOL, V67, P1047, DOI 10.1002/dneu.20371; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Peng HB, 1997, J NEUROCYTOL, V26, P637, DOI 10.1023/A:1018545827369; PENG HB, 1991, METHOD CELL BIOL, V36, P511; Qian YPK, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-70; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Smith CL, 2001, J NEUROSCI, V21, P3151, DOI 10.1523/JNEUROSCI.21-09-03151.2001; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weston C, 2003, J BIOL CHEM, V278, P6450, DOI 10.1074/jbc.M210249200; Wiesner A, 2006, CELL MOL LIFE SCI, V63, P2818, DOI 10.1007/s00018-006-6081-z; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhao XTT, 2007, DEV NEUROBIOL, V67, P1789, DOI 10.1002/dneu.20556	55	25	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2009	4	12							e8478	10.1371/journal.pone.0008478	http://dx.doi.org/10.1371/journal.pone.0008478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HZ	20041195	Green Published, gold, Green Submitted			2022-12-25	WOS:000273105200013
J	Kerbiriou, M; Teng, L; Benz, N; Trouve, P; Ferec, C				Kerbiriou, Mathieu; Teng, Ling; Benz, Nathalie; Trouve, Pascal; Ferec, Claude			The Calpain, Caspase 12, Caspase 3 Cascade Leading to Apoptosis Is Altered in F508del-CFTR Expressing Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNFOLDED PROTEIN RESPONSE; MUTANT CYSTIC-FIBROSIS; EPITHELIAL-CELLS; DELTA-F508 CFTR; DEATH PROGRAM; ACTIVATION; IDENTIFICATION; MECHANISM	In cystic fibrosis (CF), the most frequent mutant variant of the cystic fibrosis transmembrane conductance regulator (CFTR), F508del-CFTR protein, is misfolded and retained in the endoplasmic reticulum (ER). We previously showed that the unfolded protein response (UPR) may be triggered in CF. Since prolonged UPR activation leads to apoptosis via the calcium-calpain-caspase-12-caspase-3 cascade and because apoptosis is altered in CF, our aim was to compare the ER stress-induced apoptosis pathway between wild type (Wt) and F508del-CFTR expressing cells. Here we show that the calcium-calpain-caspase-12-caspase-3 cascade is altered in F508del-CFTR expressing cells. We propose that this alteration is involved in the altered apoptosis triggering observed in CF.	[Kerbiriou, Mathieu; Teng, Ling; Benz, Nathalie; Trouve, Pascal; Ferec, Claude] INSERM, Brest, France; [Kerbiriou, Mathieu; Teng, Ling; Benz, Nathalie; Trouve, Pascal; Ferec, Claude] Univ Brest, Fac Med & Sci Sante, Brest, France; [Ferec, Claude] Etab Francais du Sang Bretagne, Brest, France; [Ferec, Claude] CHU Brest, Hop Morvan, Genet Mol Lab, F-29285 Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale	Kerbiriou, M (corresponding author), INSERM, Brest, France.	pascal.trouve@univ-brest.fr; claude.ferec@univ-brest.fr	Ferec, Claude/ABG-9699-2020	Ferec, Claude/0000-0002-2325-0710	Gaetan Salaun; Etablissement Francais du Sang; French CF foundation "Vaincre la Mucoviscidose''; French foundation "Fondation pour la Recherche Medicale"	Gaetan Salaun; Etablissement Francais du Sang; French CF foundation "Vaincre la Mucoviscidose''; French foundation "Fondation pour la Recherche Medicale"	This work was supported by grants from the association Gaetan Salaun, the "Etablissement Francais du Sang'' and the French CF foundation "Vaincre la Mucoviscidose''. Mathieu Kerbiriou was supported by the French foundation "Fondation pour la Recherche Medicale''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj G, 2006, BIOCHEM BIOPH RES CO, V345, P1558, DOI 10.1016/j.bbrc.2006.05.059; Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Cannon CL, 2003, AM J RESP CELL MOL, V29, P188, DOI 10.1165/rcmb.4898; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Das A, 2006, INT J CANCER, V119, P2575, DOI 10.1002/ijc.22228; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Gilbert A, 1998, EXP CELL RES, V242, P144, DOI 10.1006/excr.1998.4101; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P3587, DOI 10.1073/pnas.93.8.3587; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heijerman Harry, 2005, J Cyst Fibros, V4 Suppl 2, P3, DOI 10.1016/j.jcf.2005.05.005; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Jungas T, 2002, J BIOL CHEM, V277, P27912, DOI 10.1074/jbc.M110288200; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Konstan MW, 1997, PEDIATR PULM, V24, P137, DOI 10.1002/(SICI)1099-0496(199708)24:2<137::AID-PPUL13>3.0.CO;2-3; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Le Drevo MA, 2008, BBA-MOL BASIS DIS, V1782, P605, DOI 10.1016/j.bbadis.2008.08.002; Lien YC, 2008, HISTOL HISTOPATHOL, V23, P1299, DOI 10.14670/HH-23.1299; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Maiuri L, 1997, FEBS LETT, V408, P225, DOI 10.1016/S0014-5793(97)00347-5; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Roy S, 2008, P NATL ACAD SCI USA, V105, P4133, DOI 10.1073/pnas.0706658105; Sergeev IN, 2004, J STEROID BIOCHEM, V89-90, P419, DOI 10.1016/j.jsbmb.2004.03.010; Shellman YG, 2008, J INVEST DERMATOL, V128, P949, DOI 10.1038/sj.jid.5701114; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wu AW, 2004, WORLD J GASTROENTERO, V10, P2323; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	49	35	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8436	10.1371/journal.pone.0008436	http://dx.doi.org/10.1371/journal.pone.0008436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20041182	Green Submitted, gold, Green Published			2022-12-25	WOS:000273104000006
J	Giamarellos-Bourboulis, EJ; Raftogiannis, M; Antonopoulou, A; Baziaka, F; Koutoukas, P; Savva, A; Kanni, T; Georgitsi, M; Pistiki, A; Tsaganos, T; Pelekanos, N; Athanassia, S; Galani, L; Giannitsioti, E; Kavatha, D; Kontopidou, F; Mouktaroudi, M; Poulakou, G; Sakka, V; Panagopoulos, P; Papadopoulos, A; Kanellakopoulou, K; Giamarellou, H				Giamarellos-Bourboulis, Evangelos J.; Raftogiannis, Maria; Antonopoulou, Anastasia; Baziaka, Fotini; Koutoukas, Pantelis; Savva, Athina; Kanni, Theodora; Georgitsi, Marianna; Pistiki, Aikaterini; Tsaganos, Thomas; Pelekanos, Nikolaos; Athanassia, Sofia; Galani, Labrini; Giannitsioti, Efthymia; Kavatha, Dimitra; Kontopidou, Flora; Mouktaroudi, Maria; Poulakou, Garyfallia; Sakka, Vissaria; Panagopoulos, Periklis; Papadopoulos, Antonios; Kanellakopoulou, Kyriaki; Giamarellou, Helen			Effect of the Novel Influenza A (H1N1) Virus in the Human Immune System	PLOS ONE			English	Article							REGULATORY T-CELLS; EXPRESSION	Background: The pandemic by the novel H1N1 virus has created the need to study any probable effects of that infection in the immune system of the host. Methodology/Principal Findings: Blood was sampled within the first two days of the presentation of signs of infection from 10 healthy volunteers; from 18 cases of flu-like syndrome; and from 31 cases of infection by H1N1 confirmed by reverse RTPCR. Absolute counts of subtypes of monocytes and of lymphocytes were determined after staining with monoclonal antibodies and analysis by flow cytometry. Peripheral blood mononuclear cells (PBMCs) were isolated from patients and stimulated with various bacterial stimuli. Concentrations of tumour necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-18, interferon (FN)-alpha and of IFN-gamma were estimated in supernatants by an enzyme immunoassay. Infection by H1N1 was accompanied by an increase of monocytes. PBMCs of patients evoked strong cytokine production after stimulation with most of bacterial stimuli. Defective cytokine responses were shown in response to stimulation with phytohemagglutin and with heat-killed Streptococcus pneumoniae. Adaptive immune responses of H1N1-infected patients were characterized by decreases of CD4-lymphocytes and of B-lymphocytes and by increase of T-regulatory lymphocytes (Tregs). Conclusions/Significance: Infection by the H1N1 virus is accompanied by a characteristic impairment of the innate immune responses characterized by defective cytokine responses to S. pneumoniae. Alterations of the adaptive immune responses are predominated by increase of Tregs. These findings signify a predisposition for pneumococcal infections after infection by H1N1 influenza.	[Giamarellos-Bourboulis, Evangelos J.; Raftogiannis, Maria; Antonopoulou, Anastasia; Baziaka, Fotini; Koutoukas, Pantelis; Savva, Athina; Kanni, Theodora; Georgitsi, Marianna; Pistiki, Aikaterini; Tsaganos, Thomas; Pelekanos, Nikolaos; Athanassia, Sofia; Galani, Labrini; Giannitsioti, Efthymia; Kavatha, Dimitra; Kontopidou, Flora; Mouktaroudi, Maria; Poulakou, Garyfallia; Sakka, Vissaria; Panagopoulos, Periklis; Papadopoulos, Antonios; Kanellakopoulou, Kyriaki; Giamarellou, Helen] Univ Athens, Sch Med, Dept Internal Med 4, GR-11527 Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens	Giamarellos-Bourboulis, EJ (corresponding author), Univ Athens, Sch Med, Dept Internal Med 4, GR-11527 Athens, Greece.	giamarel@ath.forthnet.gr	Giannitsioti, Efthymia/AAQ-5897-2020; Giamarellos-Bourboulis, Evangelos/AAD-7155-2019; Tsaganos, Thomas/AAK-8088-2020; PAPADOPOULOS, ANTONIOS/AAD-7808-2019; Sakka, Vissaria/GLN-7705-2022	Giamarellos-Bourboulis, Evangelos/0000-0003-4713-3911; GIANNITSIOTI, EFTHYMIA/0000-0003-2715-7457; Giamarellou, Helen/0000-0002-7387-5065				Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; *EUR CTR DIS CONTR, 2009, PAND INFL H1N1; Giamarellos-Bourboulis EJ, 2009, DIAGN MICR INFEC DIS, V63, P62, DOI 10.1016/j.diagmicrobio.2008.09.003; *HLTH PROT AG HLTH, 2009, EP NEW INFL H1N1 VIR, P14; Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981; Majlessi L, 2008, MICROBES INFECT, V10, P1030, DOI 10.1016/j.micinf.2008.07.017; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Shen LS, 2009, CLIN IMMUNOL, V131, P109, DOI 10.1016/j.clim.2008.11.010; Tschoeke SK, 2005, CRIT CARE MED, V33, P236, DOI 10.1097/01.CCM.0000150835.66819.CA; Witte W, 2007, J ANTIMICROB CHEMOTH, V60, P1258, DOI 10.1093/jac/dkm384; World Health Organisation, WHO PAND H1N1 2009 U; Zhu X, 2009, J CLIN LAB ANAL, V23, P197, DOI 10.1002/jcla.20331; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	16	52	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8393	10.1371/journal.pone.0008393	http://dx.doi.org/10.1371/journal.pone.0008393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037642	Green Submitted, Green Published, gold			2022-12-25	WOS:000272998100007
J	Pascua, PNQ; Song, MS; Lee, JH; Park, KJ; Kwon, HI; Baek, YH; Hong, SP; Rho, JB; Kim, CJ; Poo, H; Ryoo, TS; Sung, MH; Choi, YK				Pascua, Philippe Noriel Q.; Song, Min-Suk; Lee, Jun Han; Park, Kuk Jin; Kwon, Hyeok-il; Baek, Yun Hee; Hong, Seung-Pyo; Rho, Jong-Bok; Kim, Chul-Joong; Poo, Haryoung; Ryoo, Thomas S.; Sung, Moon-Hee; Choi, Young Ki			Evaluation of the Efficacy and Cross-Protectivity of Recent Human and Swine Vaccines against the Pandemic (H1N1) 2009 Virus Infection	PLOS ONE			English	Article							INFLUENZA-A H1N1; MULTIPLE SEQUENCE ALIGNMENT; UNITED-STATES; CLUSTAL-X; PATHOGENESIS; PIGS; TRANSMISSION; VACCINATION; FERRETS; GENERATION	The current pandemic (H1N1) 2009 virus remains transmissible among humans worldwide with cases of reverse zoonosis, providing opportunities to produce more pathogenic variants which could pose greater human health concerns. To investigate whether recent seasonal human or swine H1N1 vaccines could induce cross-reactive immune responses against infection with the pandemic (H1N1) 2009 virus, mice, ferrets or mini-pigs were administered with various regimens (once or twice) and antigen content (1.77, 3.5 or 7.5 mu g HA) of a-Brsibane/59/07, a-CAN01/04 or RgCA/04/09xPR8 vaccine. Receipt of a-CAN01/04 (2-doses) but not a-Brisbane/59/07 induced detectable but modest (20-40 units) cross-reactive serum antibody against CA/04/09 by hemagglutinin inhibition (HI) assays in mice. Only double administration (7.5 mu g HA) of both vaccine in ferrets could elicit cross-reactivity (30-60 HI titers). Similar antigen content of a-CAN01/04 in mini-pigs also caused a modest similar to 30 HI titers (twice vaccinated). However, vaccine-induced antibody titers could not suppress active virus replication in the lungs (mice) or virus shedding (ferrets and pigs) of immunized hosts intranasally challenged with CA/04/09. Furthermore, neither ferrets nor swine could abrogate aerosol transmission of the virus into naive contact animals. Altogether, these results suggest that neither recent human nor animal H1N1 vaccine could provide complete protectivity in all animal models. Thus, this study warrants the need for strain-specific vaccines that could yield the optimal protection desired for humans and/or animals.	[Pascua, Philippe Noriel Q.; Song, Min-Suk; Lee, Jun Han; Park, Kuk Jin; Kwon, Hyeok-il; Baek, Yun Hee; Choi, Young Ki] Chungbuk Natl Univ, Coll Med, Cheongju, South Korea; [Pascua, Philippe Noriel Q.; Song, Min-Suk; Lee, Jun Han; Park, Kuk Jin; Kwon, Hyeok-il; Baek, Yun Hee; Choi, Young Ki] Chungbuk Natl Univ, Med Res Inst, Cheongju, South Korea; [Hong, Seung-Pyo; Rho, Jong-Bok; Sung, Moon-Hee] Bioleaders Corp, Taejon, South Korea; [Kim, Chul-Joong] Chungnam Natl Univ, Coll Vet Med, Taejon, South Korea; [Poo, Haryoung] Korean Res Inst Biosci & Biotechnol, Taejon, South Korea; [Ryoo, Thomas S.] Genet Korea Ltd, Prestige World Genet, Pyongtaek, South Korea	Chungbuk National University; Chungbuk National University; Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Pascua, PNQ (corresponding author), Chungbuk Natl Univ, Coll Med, Cheongju, South Korea.	choiki55@chungbuk.ac.kr	Pascua, Philippe Noriel/H-3426-2019	Pascua, Philippe Noriel/0000-0001-6777-2994; Kim, Chul-Joong/0000-0001-8827-6332	Korea Research Council of Fundamental Science and Technology; Korea Research Institute of Bioscience and Biotechnology (KRIBB) Initiative Program [NTM1300811]; National Research Foundation of Korea [E00375]; National Veterinary Research and Quarantine Service, Korea (NVRQS) [Z-AD14-2009-13]; Bioleaders Corp.; PWG Genetics Korea	Korea Research Council of Fundamental Science and Technology; Korea Research Institute of Bioscience and Biotechnology (KRIBB) Initiative Program; National Research Foundation of Korea(National Research Foundation of Korea); National Veterinary Research and Quarantine Service, Korea (NVRQS); Bioleaders Corp.; PWG Genetics Korea	This research work was supported in part by a Top Brand Project grant from Korea Research Council of Fundamental Science and Technology, Korea Research Institute of Bioscience and Biotechnology (KRIBB) Initiative Program (NTM1300811), by grant E00375 from the National Research Foundation of Korea, by grant Z-AD14-2009-13 from the National Veterinary Research and Quarantine Service, Korea (NVRQS), Bioleaders Corp., and PWG Genetics Korea. The funders, Bioleaders Corporation and Prestige World Genetics (PWG), Genetics Korea, had input in data collection, but had no roles in the study design, data analysis, or preparation of the manuscript.	Aiyar A, 2000, Methods Mol Biol, V132, P221; Brookes SM, 2009, VET REC, V164, P760, DOI 10.1136/vr.164.24.760; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Cohen J, 2009, SCIENCE, V324, P1496, DOI 10.1126/science.324_1496; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Gargiullo P., 2009, Morbidity and Mortality Weekly Report, V58, P1241; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Kim JK, 2008, J VIROL, V82, P11374, DOI 10.1128/JVI.01176-08; Lange E, 2009, J GEN VIROL, V90, P2119, DOI 10.1099/vir.0.014480-0; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; MURPHY BR, 1989, CURR TOP MICROBIOL, V146, P107; Nicholls H, 2006, PLOS BIOL, V4, P156, DOI 10.1371/journal.pbio.0040050; *OIE, 2009, WORLD AN HLTH INF DA, V22; Palmer DF, 1975, IMMUNOLOGY SERIES, V6, P25; Pascua PNQ, 2008, VIRUS RES, V138, P43, DOI 10.1016/j.virusres.2008.08.005; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; REED LJ, 1938, AM J HYG, V27; Scholtissek C, 1995, VIRUS GENES, V11, P209, DOI 10.1007/BF01728660; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Song MS, 2009, VACCINE, V27, P3145, DOI 10.1016/j.vaccine.2009.03.061; Stohr K, 2003, VACCINE, V21, P1744, DOI 10.1016/S0264-410X(03)00065-3; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trifonov V, 2009, EURO SURVEILL, V14; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	36	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2009	4	12							e8431	10.1371/journal.pone.0008431	http://dx.doi.org/10.1371/journal.pone.0008431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UT	20037716	Green Published, Green Submitted, gold			2022-12-25	WOS:000272998100016
